PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Young, SRL; Hum, JM; Rodenberg, E; Turner, CH; Pavalko, FM				Young, Suzanne R. L.; Hum, Julia M.; Rodenberg, Eric; Turner, Charles H.; Pavalko, Fredrick M.			Non-Overlapping Functions for Pyk2 and FAK in Osteoblasts during Fluid Shear Stress-Induced Mechanotransduction	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BONE-CELLS; MC3T3-E1 OSTEOBLASTS; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; PROSTAGLANDIN RELEASE; SIGNAL-TRANSDUCTION; MECHANICAL STRAIN; NITRIC-OXIDE; FLOW	Mechanotransduction, the process by which cells convert external mechanical stimuli such as fluid shear stress (FSS) into biochemical changes, plays a critical role in maintenance of the skeleton. We have proposed that mechanical stimulation by FSS across the surfaces of bone cells results in formation of unique signaling complexes called mechanosomes that are launched from sites of adhesion with the extracellular matrix and with other bone cells [1]. Deformation of adhesion complexes at the cell membrane ultimately results in alteration of target gene expression. Recently, we reported that focal adhesion kinase (FAK) functions as a part of a mechanosome complex that is required for FSS-induced mechanotransduction in bone cells. This study extends this work to examine the role of a second member of the FAK family of non-receptor protein tyrosine kinases, proline-rich tyrosine kinase 2 (Pyk2), and determine its role during osteoblast mechanotransduction. We use osteoblasts harvested from mice as our model system in this study and compared the contributions of Pyk2 and FAK during FSS induced mechanotransduction in osteoblasts. We exposed Pyk2(+/+) and Pyk2(-/-) primary calvarial osteoblasts to short period of oscillatory fluid flow and analyzed downstream activation of ERK1/2, and expression of c-fos, cyclooxygenase-2 and osteopontin. Unlike FAK, Pyk2 was not required for fluid flow-induced mechanotransduction as there was no significant difference in the response of Pyk2(+/+) and Pyk2(-/-) osteoblasts to short periods of fluid flow (FF). In contrast, and as predicted, FAK(-/-) osteoblasts were unable to respond to FF. These data indicate that FAK and Pyk2 have distinct, non-redundant functions in launching mechanical signals during osteoblast mechanotransduction. Additionally, we compared two methods of generating FF in both cell types, oscillatory pump method and another orbital platform method. We determined that both methods of generating FF induced similar responses in both primary calvarial osteoblasts and immortalized calvarial osteoblasts.	[Young, Suzanne R. L.; Hum, Julia M.; Rodenberg, Eric; Pavalko, Fredrick M.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Turner, Charles H.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Young, SRL (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA.	fpavalko@iupui.edu			NIH [AR049728, AR052682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049728, R01AR052682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was funded by the grants NIH AR049728, AR052682. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Bidwell JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe51; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Charoonpatrapong-Panyayong K, 2007, J CELL BIOCHEM, V102, P1202, DOI 10.1002/jcb.21349; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Damsky C, 2002, CURR OPIN CELL BIOL, V14; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Harder AT, 2003, J CLIN PHARMACOL, V43, P807, DOI 10.1177/0091270003256061; JACKSON ME, 1994, J CELL BIOCHEM, V55, P366, DOI 10.1002/jcb.240550314; Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jiang GL, 2002, AM J PHYSIOL-ENDOC M, V283, pE383, DOI 10.1152/ajpendo.00547.2001; Kalogeropoulos M, 2010, FASEB J, V24, P2893, DOI 10.1096/fj.09-148908; Kapur S, 2004, BONE, V35, P525, DOI 10.1016/j.bone.2004.04.007; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Miller SB, 2006, SEMIN ARTHRITIS RHEU, V36, P37, DOI 10.1016/j.semarthrit.2006.03.005; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Norvell SM, 2004, J APPL PHYSIOL, V96, P957, DOI 10.1152/japplphysiol.00869.2003; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Peake MA, 2003, FEBS LETT, V537, P117, DOI 10.1016/S0014-5793(03)00108-X; Pfaff M, 2001, J CELL SCI, V114, P2775; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Radi ZA, 2005, INFLAMM RES, V54, P358, DOI 10.1007/s00011-005-1367-4; Raisz Lawrence G., 2001, American Journal of Medicine, V110, p43S; Reich KM, 1997, ENDOCRINOLOGY, V138, P1014, DOI 10.1210/en.138.3.1014; REICH KM, 1991, AM J PHYSIOL, V261, pC428, DOI 10.1152/ajpcell.1991.261.3.C428; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; Tanaka SM, 2005, CALCIFIED TISSUE INT, V76, P261, DOI 10.1007/s00223-004-0238-2; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Xiong WC, 1998, J CELL SCI, V111, P1981; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Young SRL, 2010, BONE, V47, P74, DOI 10.1016/j.bone.2010.03.014; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	58	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16026	10.1371/journal.pone.0016026	http://dx.doi.org/10.1371/journal.pone.0016026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283581	Green Submitted, gold, Green Published			2022-12-27	WOS:000286661400022
J	Hessel, A; Schwendinger, M; Holzer, GW; Orlinger, KK; Coulibaly, S; Savidis-Dacho, H; Zips, ML; Crowe, BA; Kreil, TR; Ehrlich, HJ; Barrett, PN; Falkner, FG				Hessel, Annett; Schwendinger, Michael; Holzer, Georg W.; Orlinger, Klaus K.; Coulibaly, Sogue; Savidis-Dacho, Helga; Zips, Marie-Luise; Crowe, Brian A.; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel; Falkner, Falko G.			Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity	PLOS ONE			English	Article							T-CELL EPITOPES; VIRUS; INFECTION; SEQUENCE; STRAIN; MICE	Background: New highly pathogenic H5N1 influenza viruses are continuing to evolve with a potential threat for an influenza pandemic. So far, the H5N1 influenza viruses have not widely circulated in humans and therefore constitute a high risk for the non immune population. The aim of this study was to evaluate the cross-protective potential of the hemagglutinins of five H5N1 strains of divergent clades using a live attenuated modified vaccinia Ankara (MVA) vector vaccine. Methodology/Principal Findings: The replication-deficient MVA virus was used to express influenza hemagglutinin (HA) proteins. Specifically, recombinant MVA viruses expressing the HA genes of the clade 1 virus A/Vietnam/1203/2004 (VN/ 1203), the clade 2.1.3 virus A/Indonesia/5/2005 (IN5/05), the clade 2.2 viruses A/turkey/Turkey/1/2005 (TT01/05) and A/chicken/Egypt/3/2006 (CE/06), and the clade 2.3.4 virus A/Anhui/1/2005 (AH1/05) were constructed. These experimental live vaccines were assessed in a lethal mouse model. Mice vaccinated with the VN/1203 hemagglutinin-expressing MVA induced excellent protection against all the above mentioned clades. Also mice vaccinated with the IN5/05 HA expressing MVA induced substantial protection against homologous and heterologous AH1/05 challenge. After vaccination with the CE/06 HA expressing MVA, mice were fully protected against clade 2.2 challenge and partially protected against challenge of other clades. Mice vaccinated with AH1/05 HA expressing MVA vectors were only partially protected against homologous and heterologous challenge. The live vaccines induced substantial amounts of neutralizing antibodies, mainly directed against the homologous challenge virus, and high levels of HA-specific IFN-gamma secreting CD4 and CD8 T-cells against epitopes conserved among the H5 clades and subclades. Conclusions/Significance: The highest level of cross-protection was induced by the HA derived from the VN/1203 strain, suggesting that pandemic H5 vaccines utilizing MVA vector technology, should be based on the VN/1203 hemagglutinin. Furthermore, the recombinant MVA-HA-VN, as characterized in the present study, would be a promising candidate for such a vaccine.	[Hessel, Annett; Holzer, Georg W.; Orlinger, Klaus K.; Coulibaly, Sogue; Kreil, Thomas R.; Falkner, Falko G.] Baxter Biosci, Dept Virol, Biomed Res Ctr, Orth, Austria; [Schwendinger, Michael; Crowe, Brian A.] Baxter Biosci, Dept Immunol, Biomed Res Ctr, Orth, Austria; [Savidis-Dacho, Helga] Baxter Biosci, Dept Anim Models, Biomed Res Ctr, Orth, Austria; [Zips, Marie-Luise] Baxter Biosci, Dept Bacteriol, Biomed Res Ctr, Orth, Austria; [Ehrlich, Hartmut J.; Barrett, P. Noel] Baxter Biosci, Global R&D Vaccines, Biomed Res Ctr, Orth, Austria		Hessel, A (corresponding author), Baxter Biosci, Dept Virol, Biomed Res Ctr, Orth, Austria.	falknef@baxter.com			Baxter BioScience	Baxter BioScience	This study was funded by Baxter BioScience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Boon ACM, 2009, CURR TOP MICROBIOL, V333, P25, DOI 10.1007/978-3-540-92165-3_2; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carroll MW, 1997, CURR OPIN BIOTECH, V8, P573, DOI 10.1016/S0958-1669(97)80031-6; Crevar CJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-131; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 1998, J IMMUNOL, V160, P322; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hessel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012217; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Holzer GW, 1999, J VIROL, V73, P4536, DOI 10.1128/JVI.73.6.4536-4542.1999; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-80; Mayr A, 1978, Dev Biol Stand, V41, P225; MAYR A, 1975, INFECTION, V3, P9; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; Murakami S, 2008, VACCINE, V26, P6398, DOI 10.1016/j.vaccine.2008.08.053; REED L. J., 1938, AMER JOUR HYG, V27, P493; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; Su Y, 2008, ARCH VIROL, V153, P2253, DOI 10.1007/s00705-008-0255-y; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; WRIGHT PF, 2007, FIELDS VIROLOGY, P1728; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	38	44	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16247	10.1371/journal.pone.0016247	http://dx.doi.org/10.1371/journal.pone.0016247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283631	gold, Green Published, Green Submitted			2022-12-27	WOS:000286523400028
J	Narita, K; Hisamoto, M; Okuda, T; Takeda, S				Narita, Keishi; Hisamoto, Masashi; Okuda, Tohru; Takeda, Sen			Differential Neuroprotective Activity of Two Different Grape Seed Extracts	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; RESVERATROL; GLUTAMATE; POLYPHENOLS; BRAIN; PROLIFERATION; MECHANISMS; VARIETIES; INJURY; EGCG	Glutamate excitotoxicity is one of the major events that takes place during various neurotoxic injuries such as brain ischemia. We prepared grape seed extracts, from two different varieties, containing high amounts of polyphenols but little resveratrol. Their neuroprotective effects were investigated using primary culture of neonatal mouse hippocampal neurons treated with an excitotoxic concentration of glutamate. Koshu, a white, local variety of V. vinifera, alleviated the acute inactivation of Erk1/2 and dendrite retraction in cultured hippocampal neurons exposed to a toxic concentration of glutamate (1.0 ng/ml). By contrast, Muscat Bailey A, a red, hybrid variety (Muscat Humburg x Bailey), failed to show any neuroprotective effect. Unlike brain-derived neurotrophic factor and other neuroprotective cytokines, Koshu extract did not induce Akt phosphorylation. Koshu extract also augmented neuron survival rate 24 hours after glutamate toxicity. The comparison of polyphenols between the two samples by liquid chromatography/time-of-flight mass spectrometry demonstrated that Koshu had higher amounts of low molecular weight polyphenols along with several Koshu-specific procyanidin oligomers. These data suggest the presence of high affinity molecular targets for polyphenols in hippocampal neurons, which induce neuroprotective effects in a manner different from BDNF, and the importance of low molecular weight polyphenols and/or procyanidin oligomers for neuroprotection.	[Narita, Keishi; Takeda, Sen] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Yamanashi, Japan; [Hisamoto, Masashi; Okuda, Tohru] Univ Yamanashi, Inst Enol & Viticulture, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Narita, K (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Yamanashi, Japan.	stakeda@yamanashi.ac.jp	Narita, Keishi/E-3539-2010; Takeda, Sen/I-8462-2012	Narita, Keishi/0000-0002-7602-8523; Takeda, Sen/0000-0001-7090-2139	Ministry of Education, Culture, Sports, Science Technology	Ministry of Education, Culture, Sports, Science Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a University Yamanashi Grape Polyphenols project from the Ministry of Education, Culture, Sports, Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Brown L, 2009, ALCOHOL CLIN EXP RES, V33, P1513, DOI 10.1111/j.1530-0277.2009.00989.x; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Constant J, 1997, CLIN CARDIOL, V20, P420, DOI 10.1002/clc.4960200504; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dore S, 2005, NEUROSIGNALS, V14, P61, DOI 10.1159/000085386; Fujishita K, 2009, CELL MOL NEUROBIOL, V29, P1121, DOI 10.1007/s10571-009-9403-5; Fujji H, 2006, BIOSCI BIOTECH BIOCH, V70, P2104, DOI 10.1271/bbb.60053; Gao ZB, 2006, BRAIN RES, V1111, P41, DOI 10.1016/j.brainres.2006.06.096; Guendez R, 2005, PHYTOCHEM ANALYSIS, V16, P17, DOI 10.1002/pca.804; Han YS, 2006, J PHARMACOL EXP THER, V318, P238, DOI 10.1124/jpet.106.102319; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Hwang IK, 2004, LIFE SCI, V75, P1989, DOI 10.1016/j.lfs.2004.05.013; Kammerer D, 2004, J AGR FOOD CHEM, V52, P4360, DOI 10.1021/jf049613b; Levinthal DJ, 2005, J BIOL CHEM, V280, P5875, DOI 10.1074/jbc.M410771200; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Lotito SB, 2000, BIOCHEM BIOPH RES CO, V276, P945, DOI 10.1006/bbrc.2000.3571; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Okuda Tohru, 2002, Journal of Wine Research, V13, P93, DOI 10.1080/0957126022000017963; Patra SK, 2008, J PHYSIOL PHARMACOL, V59, P217; Reed JD, 2005, PHYTOCHEMISTRY, V66, P2248, DOI 10.1016/j.phytochem.2005.05.015; Campos-Esparza MR, 2009, CELL CALCIUM, V45, P358, DOI 10.1016/j.ceca.2008.12.007; Suenaga F, 2008, FEBS LETT, V582, P586, DOI 10.1016/j.febslet.2008.01.024; Takahashi T, 1999, J INVEST DERMATOL, V112, P310, DOI 10.1046/j.1523-1747.1999.00532.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233; Yanagida F, 2008, LETT APPL MICROBIOL, V47, P134, DOI 10.1111/j.1472-765X.2008.02398.x; Yazawa K, 2006, FEBS LETT, V580, P6623, DOI 10.1016/j.febslet.2006.11.011	32	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14575	10.1371/journal.pone.0014575	http://dx.doi.org/10.1371/journal.pone.0014575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283677	Green Submitted, Green Published, gold			2022-12-27	WOS:000286523400001
J	Gopalan, S; Ausubel, FM				Gopalan, Suresh; Ausubel, Frederick M.			A High Throughput Amenable Arabidopsis-P. aeruginosa System Reveals a Rewired Regulatory Module and the Utility to Identify Potent Anti-Infectives	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; VIRULENCE FACTORS; PSEUDOMONAS; GACA; PATHOGENICITY; INFLAMMATION; EXPRESSION; MUTUALISM; INTESTINE; DISEASE	We previously demonstrated that in a metasystem consisting of Arabidopsis seedlings growing in liquid medium (in 96 well plates) even microbes considered to be innocuous such as laboratory strains of E. coli and B. subtilis can cause potent damage to the host. We further posited that such environment-induced adaptations are brought about by 'system status changes' (rewiring of pre-existing cellular signaling networks and components) of the host and the microbe, and that prolongation of such a situation could lead to the emergence of pathogenic states in real-life. Here, using this infection model, we show that the master regulator GacA of the human opportunistic pathogen P. aeruginosa (strain PA14) is dispensable for pathogenesis, as evidenced by three independent read-outs. The gene expression profile of the host after infection with wild type PA14 or the gacA mutant are also identical. GacA normally acts upstream of the quorum sensing regulatory circuit (that includes the regulator LasR) that controls a subset of virulence factors. Double mutants in gacA and lasR behave similar to the lasR mutant, as seen by abrogation of a characteristic cell type specific host cell damage caused by PA14 or the gacA mutant. This indicates that a previously unrecognized regulatory mechanism is operative under these conditions upstream of LasR. In addition, the detrimental effect of PA14 on Arabidopsis seedlings is resistant to high concentrations of the aminoglycoside antibiotic gentamicin. These data suggest that the Arabidopsis seedling infection system could be used to identify anti-infectives with potentially novel modes of action.	[Gopalan, Suresh; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gopalan, Suresh; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gopalan, S (corresponding author), ReSurfX LLC, Lexington, MA USA.	gopalans@resurfx.com			NIH [R37 GM48707]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by grant R37 GM48707 from NIH to F.M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gauthier JD, 2010, MICROBIOL-SGM, V156, P3722, DOI 10.1099/mic.0.043422-0; Gopalan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003891; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16381	10.1371/journal.pone.0016381	http://dx.doi.org/10.1371/journal.pone.0016381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283656	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300042
J	Beyerlein, A; Toschke, AM; Rosario, AS; von Kries, R				Beyerlein, Andreas; Toschke, Andre M.; Rosario, Angelika Schaffrath; von Kries, Ruediger			Risk Factors for Obesity: Further Evidence for Stronger Effects on Overweight Children and Adolescents Compared to Normal-Weight Subjects	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OVERWEIGHT; PRESCHOOL-CHILDREN; TRENDS; HEALTH; TELEVISION; POPULATION; PREVALENCE; EPIDEMIC; CURVES	Background: We recently showed that in preschoolers risk factors for overweight show stronger associations with BMI in children with high BMI values. However, it is unclear whether these findings might also pertain to adolescents. Methods: We extracted data on 3-10 year-old (n = 7,237) and 11-17 year-old (n = 5,986) children from a representative cross-sectional German health survey (KiGGS) conducted between 2003 and 2006 and calculated quantile regression models for each age group. We used z-scores of children's body mass index (BMI) as outcome variable and maternal BMI, maternal smoking in pregnancy, low parental socioeconomic status, exclusive formula-feeding and high TV viewing time as explanatory variables. Results: In both age groups, the estimated effects of all risk factors except formula-feeding on BMI z-score were greatest for children with the highest BMI z-score. The median BMI z-score of 11-17 year-old children with high TV viewing time, for example, was 0.11 [95% CI: 0.03, 0.19] units higher than the median BMI z-score of teenage children with low TV viewing time. This risk factor was associated with an average difference of 0.18 [0.06, 0.30] units at the 90(th) percentile of BMI z-score and of 0.20 [0.07, 0.33] units at the 97(th) percentile. Conclusions: We confirmed that risk factors for childhood overweight are associated with greater shifts in the upper parts of the children's BMI distribution than in the middle and lower parts. These findings pertain also to teenagers and might possibly help to explain the secular shift in the upper BMI percentiles in children and adolescents.	[Beyerlein, Andreas; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Toschke, Andre M.] Univ Munich, Dept Med Informat Biometry & Epidemiol, Munich, Germany; [Toschke, Andre M.] Univ Munich, Munich Ctr Hlth Sci, Munich, Germany; [Rosario, Angelika Schaffrath] Robert Koch Inst, D-1000 Berlin, Germany	University of Munich; University of Munich; University of Munich; Robert Koch Institute	Beyerlein, A (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany.	andreas.beyerlein@med.uni-muenchen.de	Beyerlein, Andreas/I-7504-2019	Beyerlein, Andreas/0000-0001-6603-5036	Ludwig-Maximilians University Innovative Research Priority Project Munich Center for Health Sciences; DFG (Deutsche Forschungsgemeinschaft) [KR 1926/3-1]; German Ministry of Health; Ministry of Education and Research; Robert Koch Institute	Ludwig-Maximilians University Innovative Research Priority Project Munich Center for Health Sciences; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry of Health; Ministry of Education and Research; Robert Koch Institute	This work was supported by the Ludwig-Maximilians University Innovative Research Priority Project Munich Center for Health Sciences (sub-project 1), and by grants from the DFG (Deutsche Forschungsgemeinschaft, grant KR 1926/3-1). The KiGGS study was funded by the German Ministry of Health, the Ministry of Education and Research, and the Robert Koch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; Apfelbacher CJ, 2008, J EPIDEMIOL COMMUN H, V62, P125, DOI 10.1136/jech.2007.062117; Armstrong MEG, 2006, SAMJ S AFR MED J, V96, P439; Beyerlein A, 2010, INT J OBESITY, V34, P642, DOI 10.1038/ijo.2009.301; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Christakis DA, 2009, ACTA PAEDIATR, V98, P8, DOI 10.1111/j.1651-2227.2008.01027.x; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Gorard S, 2004, COMP EDUC, V40, P15, DOI 10.1080/0305006042000184863; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; JENKINS SP, 2008, OXFORD REV ED, V34; Kalies H, 2002, INT J OBESITY, V26, P1211, DOI 10.1038/sj.ijo.0802013; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kautiainen S, 2002, INT J OBESITY, V26, P544, DOI 10.1038/sj.ijo.0801928; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Koenker R., 1994, ASYMPTOTIC STAT, P349, DOI [10.1007/978-3-642-57984-4_29, DOI 10.1007/978-3-642-57984-4_29]; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Komlos J, 2009, AM J HUM BIOL, V21, P151, DOI 10.1002/ajhb.20806; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; POSKITT EME, 1995, ACTA PAEDIATR, V84, P961, DOI 10.1111/j.1651-2227.1995.tb13806.x; Robinson TN, 1998, JAMA-J AM MED ASSOC, V279, P959, DOI 10.1001/jama.279.12.959; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; Toschke AM, 2005, INT J OBESITY, V29, P875, DOI 10.1038/sj.ijo.0802989; Toschke AM, 2003, AM J MED GENET A, V119A, P95, DOI 10.1002/ajmg.a.20050; Toschke AM, 2007, AM J CLIN NUTR, V85, P1578, DOI 10.1093/ajcn/85.6.1578; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Winkler J., 1999, GESUNDHEITSWESEN, V61, pS178	32	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15739	10.1371/journal.pone.0015739	http://dx.doi.org/10.1371/journal.pone.0015739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283747	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200011
J	Garcia-Garcia, JM; Blanquer, R; Rodrigo, T; Cayla, JA; Caminero, JA; Vidal, R; Casals, M; Ruiz-Manzano, J				Garcia-Garcia, Jose-Maria; Blanquer, Rafael; Rodrigo, Teresa; Cayla, Joan A.; Caminero, Jose A.; Vidal, Rafael; Casals, Marti; Ruiz-Manzano, Juan		Working Grp Completion TB	Social, Clinical and Microbiological Differential Characteristics of Tuberculosis among Immigrants in Spain	PLOS ONE			English	Article							FOREIGN-BORN; RESISTANT TUBERCULOSIS; EPIDEMIOLOGY; TRENDS	Background: To identify the differential tuberculosis (TB) characteristics within the immigrant population with respect to natives in Spain. Methodology/Principal Findings: A prospective cohort study design was implemented to examine the TB cases diagnosed and starting standard antituberculous treatment in Spain, between January 1st 2006 and March 31st 2007. A logistic regression analysis was performed to determine differential characteristics. 1,490 patients were included in the study population, 1,048 natives and 442 (29.7%) immigrants. According to the multivariate analysis, the following variables were significantly associated with immigrant TB cases: younger age (OR = 3.79; CI:2.16-6.62), living in group situation (OR = 7.61; CI:3.38-12.12), lower frequency of disabled (OR:0.08; CI:0.02-0.26) and retired (OR:0.21; CI:0.09-0.48) employment status, lower frequency of pulmonary disease presentation (OR = 0.47; CI:0.24-0.92), primary or emergency care admission (OR = 1.80; CI:1.05-3.06 and OR = 2.16; CI:1.36-3.45), drug resistance (OR = 1.86; CI:1.01-3.46), treatment default (OR:2.12; CI:1.18-3.81), lower frequency of alcohol and cigarette consumption (OR = 2.10; CI:1.42-3.11 and OR = 2.85; CI: 2.10-3.87 respectively), more directly observed treatment (OR = 1.68; CI:1.04-2.69), and poor understanding of TB disease and its treatment (OR = 3.11; CI:1.86-5.20). The low percentage of primary MDR-TB in the native population (0.1% vs. 2.2% of immigrants) should be noted. Conclusions/Significance: The differences show the need to introduce specific strategies in the management of TB within the immigrant population, including the improvement of social and work conditions.	[Garcia-Garcia, Jose-Maria; Blanquer, Rafael; Rodrigo, Teresa; Cayla, Joan A.; Caminero, Jose A.; Vidal, Rafael; Casals, Marti; Ruiz-Manzano, Juan; Working Grp Completion TB] Soc Espanola Neumol & Cirugia Toracica SEPAR, Programa Integrado Invest TB PII TB, Barcelona, Spain; [Garcia-Garcia, Jose-Maria] Hosp San Agustin, Aviles, Spain; [Blanquer, Rafael] Hosp Univ Dr Peset Valencia, Valencia, Spain; [Rodrigo, Teresa] SEPAR, Fdn Respira, Barcelona, Spain; [Cayla, Joan A.] Agencia Salud Publ Barcelona, Serv Epidemiol, Unidad Invest TB Barcelona, Barcelona, Spain; [Caminero, Jose A.] Hosp Gen Univ Gran Canaria Dr Negrin, Canary Islands, Spain; [Caminero, Jose A.] Int Union TB & Lung Dis, Paris, France; [Vidal, Rafael; Ruiz-Manzano, Juan] CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Vidal, Rafael] Hosp Vall Ebron, Barcelona, Spain; [Casals, Marti] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Casals, Marti] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Casals, Marti] Univ Int Catalunya, Dept Ciencias Basiques, Barcelona, Spain; [Ruiz-Manzano, Juan] Hosp Badalona Germans Trias & Pujol, Badalona, Spain	Hospital San Agustin; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Universitat Internacional de Catalunya (UIC); Hospital Germans Trias i Pujol	Garcia-Garcia, JM (corresponding author), Soc Espanola Neumol & Cirugia Toracica SEPAR, Programa Integrado Invest TB PII TB, Barcelona, Spain.	josemaria.garciag@sespa.princast.es	Anibarro, Luis/A-3959-2009; Casals, Martí/M-8388-2019	Anibarro, Luis/0000-0001-8790-6320; Casals, Martí/0000-0002-1775-8331; Gullon, Jose Antonio/0000-0002-3007-0873; MEDINA GALLARDO, JUAN FRANCISCO/0000-0001-5400-1592; RODRIGO, TERESA/0000-0003-3663-5828; Borderias, Luis/0000-0003-3296-9644; de Souza Galvao, Maria Luiza/0000-0001-9703-989X; Cayla, Joan A./0000-0003-3891-111X; Garcia-Garcia, Jose-Maria/0000-0002-2809-6230	SEPAR PII TB (Integrated Investigation Programme in Tuberculosis of the Spanish Respiratory and Thoracic Surgery Society)	SEPAR PII TB (Integrated Investigation Programme in Tuberculosis of the Spanish Respiratory and Thoracic Surgery Society)	The study was funded by the SEPAR PII TB (Integrated Investigation Programme in Tuberculosis of the Spanish Respiratory and Thoracic Surgery Society). (www.separ.es.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2008, CLIN INFECT DIS, V47, P1277, DOI 10.1086/592572; Alberte-Castineiras A, 2006, INT J TUBERC LUNG D, V10, P554; Arnaez AA, 2005, MED CLIN-BARCELONA, V125, P210, DOI 10.1157/13077375; Bernal MLPD, 2005, INT J TUBERC LUNG D, V9, P1230; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Cayla JA, 2003, MED CLIN-BARCELONA, V121, P549, DOI 10.1157/13053401; Cayla JA, 2003, MED CLIN-BARCELONA, V121, P494, DOI 10.1157/13053140; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; French CE, 2007, INT J TUBERC LUNG D, V11, P577; Inigo J, 2006, INT J TUBERC LUNG D, V10, P550; Laifer G, 2007, AM J MED, V120, P350, DOI 10.1016/j.amjmed.2006.10.025; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; ORCAU A, 2009, TUBERCULOSIS BARCELO; Ramos JM, 2006, MED CLIN-BARCELONA, V126, P277, DOI 10.1157/13085283; Ramos JM, 2004, ENFERM INFEC MICR CL, V22, P315, DOI 10.1157/13063041; Ruiz-Manzano J, 2008, ARCH BRONCONEUMOL, V44, P551, DOI 10.1016/S1579-2129(08)60102-0; Sanz-Pelaez O, 2006, MED CLIN-BARCELONA, V126, P259, DOI 10.1157/13085289; Valles X, 2002, MED CLIN-BARCELONA, V118, P376, DOI 10.1016/S0025-7753(02)72391-9; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2009, MIN M HIGH M XDR TB; World Health Organization, 2010, WHOHTMTB20103; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	25	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16272	10.1371/journal.pone.0016272	http://dx.doi.org/10.1371/journal.pone.0016272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283716	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200046
J	Yuan, A; Lin, CY; Chou, CH; Shih, CM; Chen, CY; Cheng, HW; Chen, YF; Chen, JJW; Chen, JH; Yang, PC; Chang, C				Yuan, Ang; Lin, Chien-Yuan; Chou, Cheng-Hung; Shih, Chia-Ming; Chen, Chih-Yuan; Cheng, Hao-Wei; Chen, Yi-Fang; Chen, Jeremy J. W.; Chen, Jyh-Horng; Yang, Pan-Chyr; Chang, Chen			Functional and Structural Characteristics of Tumor Angiogenesis in Lung Cancers Overexpressing Different VEGF Isoforms Assessed by DCE- and SSCE-MRI	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONTRAST-ENHANCED MRI; CELL-ASSOCIATED ISOFORM; MESSENGER-RNA; VASCULAR-PERMEABILITY; EXTRACELLULAR-MATRIX; EXPRESSION PATTERN; HUMAN-MELANOMA; COLON-CANCER; METASTASIS	The expressions of different vascular endothelial growth factor (VEGF) isoforms are associated with the degree of tumor invasiveness and the patient's prognosis in human cancers. We hypothesized that different VEGF isoforms can exert different effects on the functional and structural characteristics of tumor angiogenesis. We used dynamic contrast-enhanced MRI (DCE-MRI) and steady-state contrast-enhanced MRI (SSCE-MRI) to evaluate in vivo vascular functions (e.g., perfusion and permeability) and structural characteristics (e.g., vascular size and vessel density) of the tumor angiogenesis induced by different VEGF isoforms (VEGF121, VEGF165, and VEGF189) in a murine xenograft model of human lung cancer. Tumors overexpressing VEGF189 were larger than those overexpressing the other two VEGF isoforms. The K(trans) map obtained from DCE-MRI revealed that the perfusion and permeability functions of tumor microvessels was highest in both the rim and core regions of VEGF189-overexpressing tumors (p < 0.001 for both tumor rim and core). The relative vessel density and relative vessel size indexes derived from SSCE-MRI revealed that VEGF189-overexpressing tumors had the smallest (p < 0.05) and the most-dense (p < 0.01) microvessels, which penetrated deeply from the tumor rim into the core, followed by the VEGF165-overepxressing tumor, whose microvessels were located mainly in the tumor rim. The lowest-density microvessels were found in the VEGF121-overexpressing tumor; these microvessels had a relatively large lumen and were found mainly in the tumor rim. We conclude that among the three VEGF isoforms evaluated, VEGF189 induces the most densely sprouting and smallest tumor microvessels with the highest in vivo perfusion and permeability functions. These characteristics of tumor microvessels may contribute to the reported adverse effects of VEGF189 overexpression on tumor progression, metastasis, and patient survival in several human cancers, including non-small cell lung cancer, and suggest that applying aggressive therapy may be necessary in human cancers in which VEGF189 is overexpressed.	[Yuan, Ang; Cheng, Hao-Wei; Chen, Yi-Fang; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Chien-Yuan; Chou, Cheng-Hung; Shih, Chia-Ming; Chen, Chih-Yuan; Chang, Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci & Mol Biol, Taichung 40227, Taiwan; [Chen, Jyh-Horng] Natl Taiwan Univ, Inst Biomed Elect & Bioinformat, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan University	Yuan, A (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	pcyang@ntu.edu.tw; bmcchen@ibms.sinica.edu.tw	Tu, Yiling/C-5610-2011; Chang, Chen/B-5079-2009	Chen, Jeremy J.W./0000-0003-1049-3825; YANG, PAN-CHYR/0000-0001-6330-6048; YUAN, ANG/0000-0002-5664-1339	National Science Council [NSC 98-3112-B-001-019]; Center for Genomic Medicine, National Taiwan University College of Medicine; Department of Medical Research, National Taiwan University Hospital, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Center for Genomic Medicine, National Taiwan University College of Medicine; Department of Medical Research, National Taiwan University Hospital, Taiwan, ROC	The study is funded by National Science Council (http://web1.nsc.gov.tw), grant number NSC 98-3112-B-001-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the technical assistance from the Functional and Micro-Magnetic Resonance Imaging Center supported by the National Research Program for Genomic Medicine, National Science Council; Center for Genomic Medicine, National Taiwan University College of Medicine; and Department of Medical Research, National Taiwan University Hospital, Taiwan, ROC. The authors also thank Miss Sui-Shan Lin for cell culture and operation on image scanning.	Ancelin M, 2002, P NATL ACAD SCI USA, V99, P6023, DOI 10.1073/pnas.082110999; Barrett T, 2007, J MAGN RESON IMAGING, V26, P235, DOI 10.1002/jmri.20991; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; Chen JJW, 2001, CANCER RES, V61, P5223; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Cressey R, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-128; Cuenod CA, 2006, ABDOM IMAGING, V31, P188, DOI 10.1007/s00261-005-0386-5; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 2006, TUMOR ANGIOGENESIS; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Goh V, 2006, ABDOM IMAGING, V31, P194, DOI 10.1007/s00261-005-0387-4; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Jacobsen J, 2006, BJU INT, V97, P1102, DOI 10.1111/j.1464-410X.2006.06138.x; Jensen JH, 2000, MAGNET RESON MED, V44, P224, DOI 10.1002/1522-2594(200008)44:2<224::AID-MRM9>3.0.CO;2-M; Kusters B, 2003, CANCER RES, V63, P5408; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Mattei MG, 1996, GENOMICS, V32, P168, DOI 10.1006/geno.1996.0098; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Neeman M, 2003, ANNU REV BIOMED ENG, V5, P29, DOI 10.1146/annurev.bioeng.5.040202.121606; Oshika Y, 1998, INT J ONCOL, V12, P541; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Parker G J, 1999, Top Magn Reson Imaging, V10, P130, DOI 10.1097/00002142-199904000-00006; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Schaefer JF, 2006, LUNG CANCER-J IASLC, V53, P39, DOI 10.1016/j.lungcan.2006.03.010; SHIH C, 2009, P INT SOC MAG RESON, V17, P2286; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tokunaga T, 1998, ONCOL REP, V5, P1115; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; WEIDNER N, 1995, AM J PATHOL, V147, P9; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Wu EX, 2004, NMR BIOMED, V17, P478, DOI 10.1002/nbm.923; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Yuan A, 2001, J CLIN ONCOL, V19, P432, DOI 10.1200/JCO.2001.19.2.432; Yuan A, 2002, J CLIN ONCOL, V20, P900, DOI 10.1200/JCO.20.4.900	49	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16062	10.1371/journal.pone.0016062	http://dx.doi.org/10.1371/journal.pone.0016062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283766	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200026
J	Garcia-Gonzalez, F; Simmons, LW				Garcia-Gonzalez, Francisco; Simmons, Leigh W.			Good Genes and Sexual Selection in Dung Beetles (Onthophagus taurus): Genetic Variance in Egg-to-Adult and Adult Viability	PLOS ONE			English	Article							SPERM COMPETITION; MATE CHOICE; EVOLUTION; COEVOLUTION; PHENOTYPE; CONFLICT; FITNESS; MALES	Whether species exhibit significant heritable variation in fitness is central for sexual selection. According to good genes models there must be genetic variation in males leading to variation in offspring fitness if females are to obtain genetic benefits from exercising mate preferences, or by mating multiply. However, sexual selection based on genetic benefits is controversial, and there is limited unambiguous support for the notion that choosy or polyandrous females can increase the chances of producing offspring with high viability. Here we examine the levels of additive genetic variance in two fitness components in the dung beetle Onthophagus taurus. We found significant sire effects on egg-to-adult viability and on son, but not daughter, survival to sexual maturity, as well as moderate coefficients of additive variance in these traits. Moreover, we do not find evidence for sexual antagonism influencing genetic variation for fitness. Our results are consistent with good genes sexual selection, and suggest that both pre- and postcopulatory mate choice, and male competition could provide indirect benefits to females.	[Garcia-Gonzalez, Francisco; Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia	University of Western Australia	Garcia-Gonzalez, F (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia.	pgarcia@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011; Garcia-Gonzalez, Francisco/A-3780-2008	Simmons, Leigh W/0000-0003-0562-1474; Garcia-Gonzalez, Francisco/0000-0001-9515-9038	Australian Research Council	Australian Research Council(Australian Research Council)	Funding was provided by Australian Research Council grants to FGG and to LWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; BURT A, 1995, EVOLUTION, V49, P1, DOI 10.1111/j.1558-5646.1995.tb05954.x; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Charlesworth B, 1987, SEXUAL SELECTION TES, P21; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Garcia-Gonzalez F, 2004, AM NAT, V164, P457, DOI 10.1086/423987; Garcia-Gonzalez F, 2007, EVOLUTION, V61, P816, DOI 10.1111/j.1558-5646.2007.00084.x; Hanski I., 1991, DUNG BEETLE ECOLOGY; Hood G.M., 2009, POPTOOLS VERSION 3 1; Houle D, 2002, P ROY SOC B-BIOL SCI, V269, P97, DOI 10.1098/rspb.2001.1823; HOULE D, 1992, GENETICS, V130, P195; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2000, EVOLUTION, V54, P936, DOI 10.1111/j.0014-3820.2000.tb00093.x; Hunt J, 2002, P NATL ACAD SCI USA, V99, P6828, DOI 10.1073/pnas.092676199; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kotiaho JS, 2003, AM NAT, V161, P852, DOI 10.1086/375173; Lynch M., 1998, GENETICS ANAL QUANTI; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Rantala MJ, 2007, HEREDITY, V98, P329, DOI 10.1038/sj.hdy.6800945; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Simmons LW, 2007, P NATL ACAD SCI USA, V104, P16604, DOI 10.1073/pnas.0704871104; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons Leigh W., 2011, P66; Simmons LW, 2009, CURR BIOL, V19, P1442, DOI 10.1016/j.cub.2009.06.056; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; StatSoft I., 2007, STAT DAT AN SOFTW SY; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006	41	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16233	10.1371/journal.pone.0016233	http://dx.doi.org/10.1371/journal.pone.0016233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267411	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500047
J	Dempster, T; Sanchez-Jerez, P; Fernandez-Jover, D; Bayle-Sempere, J; Nilsen, R; Bjorn, PA; Uglem, I				Dempster, Tim; Sanchez-Jerez, Pablo; Fernandez-Jover, Damian; Bayle-Sempere, Just; Nilsen, Rune; Bjorn, Pal-Arne; Uglem, Ingebrigt			Proxy Measures of Fitness Suggest Coastal Fish Farms Can Act as Population Sources and Not Ecological Traps for Wild Gadoid Fish	PLOS ONE			English	Article							SALMON FARMS; ATLANTIC COD; SPATIOTEMPORAL DISTRIBUTION; SEA LICE; AGGREGATION; MOVEMENTS; INFECTION; PATTERNS; ENERGY; SALAR	Background: Ecological traps form when artificial structures are added to natural habitats and induce mismatches between habitat preferences and fitness consequences. Their existence in terrestrial systems has been documented, yet little evidence suggests they occur in marine environments. Coastal fish farms are widespread artificial structures in coastal ecosystems and are highly attractive to wild fish. Methodology/Principal Findings: To investigate if coastal salmon farms act as ecological traps for wild Atlantic cod (Gadus morhua) and saithe (Pollachius virens), we compared proxy measures of fitness between farm-associated fish and control fish caught distant from farms in nine locations throughout coastal Norway, the largest coastal fish farming industry in the world. Farms modified wild fish diets in both quality and quantity, thereby providing farm-associated wild fish with a strong trophic subsidy. This translated to greater somatic (saithe: 1.06-1.12 times; cod: 1.06-1.11 times) and liver condition indices (saithe: 1.4-1.8 times; cod: 2.0-2.8 times) than control fish caught distant from farms. Parasite loads of farm-associated wild fish were modified from control fish, with increased external and decreased internal parasites, however the strong effect of the trophic subsidy overrode any effects of altered loads upon condition. Conclusions and Significance: Proxy measures of fitness provided no evidence that salmon farms function as ecological traps for wild fish. We suggest fish farms may act as population sources for wild fish, provided they are protected from fishing while resident at farms to allow their increased condition to manifest as greater reproductive output.	[Dempster, Tim] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Dempster, Tim] SINTEF Fisheries & Aquaculture, Trondheim, Norway; [Sanchez-Jerez, Pablo; Fernandez-Jover, Damian; Bayle-Sempere, Just] Univ Alicante, Dept Marine Sci & Appl Biol, E-03080 Alicante, Spain; [Bjorn, Pal-Arne; Uglem, Ingebrigt] NOFIMA, Tromso, Norway; [Uglem, Ingebrigt] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	University of Melbourne; SINTEF; Universitat d'Alacant; Nofima; Norwegian Institute Nature Research	Dempster, T (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	tim.dempster@sintef.no	Bayle-Sempere, Just Tomàs/J-1574-2012; Sanchez-Jerez, Pablo/L-4750-2014; Dempster, Tim/E-9630-2011	Bayle-Sempere, Just Tomàs/0000-0001-6841-1824; Sanchez-Jerez, Pablo/0000-0003-4047-238X; Dempster, Tim/0000-0001-8041-426X; Fernandez-Jover, Damian/0000-0002-2553-6472	Norwegian Research Council [173384]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding was provided by the Norwegian Research Council Havet og kysten program to the CoastACE project (no: 173384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol O, 2010, J APPL ICHTHYOL, V26, P11, DOI 10.1111/j.1439-0426.2009.01348.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BERG E, 2008, KYST HAVBRUK, P79; Bjorn PA, 2009, AQUACULTURE, V286, P36, DOI 10.1016/j.aquaculture.2008.08.038; Bricknell IR, 2006, ICES J MAR SCI, V63, P253, DOI 10.1016/j.icesjms.2005.10.009; Bustnes JO, 2010, ENVIRON SCI TECHNOL, V44, P8736, DOI 10.1021/es102195d; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Dempster T, 2002, MAR ECOL PROG SER, V242, P237, DOI 10.3354/meps242237; Dempster T, 2010, ESTUAR COAST SHELF S, V86, P271, DOI 10.1016/j.ecss.2009.11.007; Dempster T, 2009, MAR ECOL PROG SER, V385, P1, DOI 10.3354/meps08050; Diamant A., 2007, CIESM WORKSHOP MONOG, V32, P49; *FAO, 2009, FISHST PLUS AQ PROD; Fernandez-Jover D, 2008, ICES J MAR SCI, V65, P1153, DOI 10.1093/icesjms/fsn091; Fernandez-Jover D, 2007, MAR ENVIRON RES, V63, P1, DOI 10.1016/j.marenvres.2006.05.002; FERNANDEZJOVER D, 2011, EST COAST S IN PRESS; Gjosaeter J., 2008, KYST HAVBRUK, P52; Graham DA, 2006, DIS AQUAT ORGAN, V72, P193, DOI 10.3354/dao072193; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Hemmingsen W, 2001, ADV MAR BIOL, V40, P1, DOI 10.1016/S0065-2881(01)40002-2; Heuch PA, 2007, DIS AQUAT ORGAN, V77, P149, DOI 10.3354/dao01833; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Jorstad KE, 2008, REV FISH SCI, V16, P285, DOI 10.1080/10641260701678017; KHAN RA, 1993, J PARASITOL, V79, P954, DOI 10.2307/3283738; Klimpel S, 2004, PARASITOL RES, V94, P1, DOI 10.1007/s00436-004-1154-0; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2010, AQUACULT ENV INTERAC, V1, P21, DOI 10.3354/aei0004; Kutti T, 2007, AQUACULTURE, V262, P355, DOI 10.1016/j.aquaculture.2006.10.008; Lambert Y, 1997, CAN J FISH AQUAT SCI, V54, P104, DOI 10.1139/cjfas-54-S1-104; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Maurstad A, 2007, HUM ECOL, V35, P601, DOI 10.1007/s10745-007-9126-5; *NORW DIR FISH, 2009, STAT AQ 2008; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Salze G, 2005, AQUAC RES, V36, P1488, DOI 10.1111/j.1365-2109.2005.01367.x; Skjaeraasen JE, 2006, CAN J FISH AQUAT SCI, V63, P310, DOI 10.1139/F05-218; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thorstad Eva B., 2008, NINA Temahefte, V36, P1; Uglem I, 2008, AQUAC RES, V39, P158, DOI 10.1111/j.1365-2109.2007.01872.x; Uglem I, 2010, AQUACULT ENV INTERAC, V1, P11, DOI 10.3354/aei00003; Uglem I, 2009, MAR ECOL PROG SER, V384, P251, DOI 10.3354/meps08001; Wallace IS, 2008, J FISH DIS, V31, P177, DOI 10.1111/j.1365-2761.2007.00886.x	41	59	59	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15646	10.1371/journal.pone.0015646	http://dx.doi.org/10.1371/journal.pone.0015646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264217	gold, Green Published, Green Submitted			2022-12-27	WOS:000286517600011
J	Hao, P; Zheng, HJ; Yu, Y; Ding, GH; Gu, WY; Chen, ST; Yu, ZH; Ren, SX; Oda, M; Konno, T; Wang, SY; Li, XA; Ji, ZS; Zhao, GP				Hao, Pei; Zheng, Huajun; Yu, Yao; Ding, Guohui; Gu, Wenyi; Chen, Shuting; Yu, Zhonghao; Ren, Shuangxi; Oda, Munehiro; Konno, Tomonobu; Wang, Shengyue; Li, Xuan; Ji, Zai-Si; Zhao, Guoping			Complete Sequencing and Pan-Genomic Analysis of Lactobacillus delbrueckii subsp bulgaricus Reveal Its Genetic Basis for Industrial Yogurt Production	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GRAM-NEGATIVE BACTERIA; STREPTOCOCCUS-THERMOPHILUS; MAXIMUM-LIKELIHOOD; FLAVOR FORMATION; MISMATCH REPAIR; SIGNAL PEPTIDES; IDENTIFICATION; PREDICTION; DATABASE	Lactobacillus delbrueckii subsp. bulgaricus (Lb. bulgaricus) is an important species of Lactic Acid Bacteria (LAB) used for cheese and yogurt fermentation. The genome of Lb. bulgaricus 2038, an industrial strain mainly used for yogurt production, was completely sequenced and compared against the other two ATCC collection strains of the same subspecies. Specific physiological properties of strain 2038, such as lysine biosynthesis, formate production, aspartate-related carbon-skeleton intermediate metabolism, unique EPS synthesis and efficient DNA restriction/modification systems, are all different from those of the collection strains that might benefit the industrial production of yogurt. Other common features shared by Lb. bulgaricus strains, such as efficient protocooperation with Streptococcus thermophilus and lactate production as well as well-equipped stress tolerance mechanisms may account for it being selected originally for yogurt fermentation industry. Multiple lines of evidence suggested that Lb. bulgaricus 2038 was genetically closer to the common ancestor of the subspecies than the other two sequenced collection strains, probably due to a strict industrial maintenance process for strain 2038 that might have halted its genome decay and sustained a gene network suitable for large scale yogurt production.	[Hao, Pei; Yu, Yao; Ding, Guohui; Li, Xuan; Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Key Lab Syst Biol, Shanghai, Peoples R China; [Zheng, Huajun; Gu, Wenyi; Chen, Shuting; Ren, Shuangxi; Wang, Shengyue; Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Oda, Munehiro; Konno, Tomonobu; Ji, Zai-Si] Meiji Dairies Corp, Div Res & Dev, Odawara, Japan; [Hao, Pei; Yu, Zhonghao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Zheng, Huajun; Zhao, Guoping] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Yu, Yao] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Meiji Holdings Co., Ltd.; Chinese Academy of Sciences; Fudan University; Chinese Academy of Sciences; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Hao, P (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Key Lab Syst Biol, Shanghai, Peoples R China.	lixuan@sippe.ac.cn; ZAI-SI_JI@meiji-milk.com; gpzhao@sibs.ac.cn	Zheng, Huajun/AAN-4973-2020; Yu, Zhonghao/F-5459-2011; Yu, Yao/B-5868-2015	Yu, Zhonghao/0000-0001-7144-9356; Hao, Pei/0000-0002-1498-7059; Zhao, Guo-Ping/0000-0002-7621-6620; Yu, Yao/0000-0002-2727-1746	National High Technology Research and Development Program of China [2007AA02Z330, 2007AA02Z331]; National Natural Science Foundation of China [30830002]; Meiji Dairies Corporation	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Meiji Dairies Corporation	This work was partly supported by grants from the National High Technology Research and Development Program of China (Contract No. 2007AA02Z330 and 2007AA02Z331) the National Natural Science Foundation of China (30830002), and by funding from Meiji Dairies Corporation. ZSJ conceived the study. MO and TK performed the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Ardo Y, 2006, BIOTECHNOL ADV, V24, P238, DOI 10.1016/j.biotechadv.2005.11.005; Azcarate-Peril MA, 2004, APPL ENVIRON MICROB, V70, P5315, DOI 10.1128/AEM.70.9.5315-5322.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Broadbent JR, 2003, J DAIRY SCI, V86, P407, DOI 10.3168/jds.S0022-0302(03)73619-4; Burrus V, 2001, APPL ENVIRON MICROB, V67, P1522, DOI 10.1128/AEM.67.4.1522-1528.2001; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DEVEREUX R, 1994, APPL ENVIRON MICROB, V60, P3437, DOI 10.1128/AEM.60.9.3437-3439.1994; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Ding GH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003357; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Klingberg TD, 2005, INT J FOOD MICROBIOL, V105, P419, DOI 10.1016/j.ijfoodmicro.2005.03.020; Kullen MJ, 1999, MOL MICROBIOL, V33, P1152, DOI 10.1046/j.1365-2958.1999.01557.x; Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x; Lim EM, 2000, ELECTROPHORESIS, V21, P2557, DOI 10.1002/1522-2683(20000701)21:12&lt;2557::AID-ELPS2557&gt;3.0.CO;2-B; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marilley L, 2004, INT J FOOD MICROBIOL, V90, P139, DOI 10.1016/S0168-1605(03)00304-0; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Perriere G, 2000, GENOME RES, V10, P379, DOI 10.1101/gr.10.3.379; Razeto A, 2002, J MOL BIOL, V318, P109, DOI 10.1016/S0022-2836(02)00086-4; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Ritz H, 2001, J BIOL CHEM, V276, P22273, DOI 10.1074/jbc.M100752200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; van Kranenburg R, 2002, INT DAIRY J, V12, P111, DOI 10.1016/S0958-6946(01)00132-7; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vaningelgem F, 2004, APPL ENVIRON MICROB, V70, P900, DOI 10.1128/AEM.70.2.900-912.2004; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Yang W, 2000, MUTAT RES-DNA REPAIR, V460, P245, DOI 10.1016/S0921-8777(00)00030-6; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZHENG HJ, 2008, MOL BIOL, V3, P15	48	69	74	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15964	10.1371/journal.pone.0015964	http://dx.doi.org/10.1371/journal.pone.0015964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264216	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600014
J	Niikura, T; Sidahmed, E; Hirata-Fukae, C; Aisen, PS; Matsuoka, Y				Niikura, Takako; Sidahmed, Elkhansa; Hirata-Fukae, Chiho; Aisen, Paul S.; Matsuoka, Yasuji			A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RESCUE FACTOR HUMANIN; NEURONAL CELL-DEATH; A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; NEUROPROTECTIVE FACTOR; BEHAVIORAL DEFICITS; COGNITIVE DEFICITS; PEPTIDE HUMANIN	Humanin (HN), a 24-residue peptide, was identified as a novel neuroprotective factor and shows anti-cell death activity against a wide spectrum of Alzheimer's disease (AD)-related cytotoxicities, including exposure to amyloid beta (Abeta), in vitro. We previously demonstrated that the injection of S14G-HN, a highly potent HN derivative, into brain ameliorated memory loss in an Abeta-injection mouse model. To fully understand HN's functions under AD-associated pathological conditions, we examined the effect of S14G-HN on triple transgenic mice harboring APP(swe), tau(P310L), and PS-1(M146V) that show the age-dependent development of multiple pathologies relating to AD. After 3 months of intranasal treatment, behavioral analyses showed that S14G-HN ameliorated cognitive impairment in male mice. Moreover, ELISA and immunohistochemical analyses showed that Abeta levels in brains were markedly lower in S14G-HN-treated male and female mice than in vehicle control mice. We also found the expression level of neprilysin, an Abeta degrading enzyme, in the outer molecular layer of hippocampal formation was increased in S14G-HN-treated mouse brains. NEP activity was also elevated by S14G-HN treatment in vitro. These findings suggest that decreased Abeta level in these mice is at least partly attributed to S14G-HN-induced increase of neprilysin level. Although HN was identified as an anti-neuronal death factor, these results indicate that HN may also have a therapeutic effect on amyloid accumulation in AD.	[Niikura, Takako] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Niikura, Takako; Sidahmed, Elkhansa; Hirata-Fukae, Chiho; Matsuoka, Yasuji] Georgetown Univ, Dept Neurol, Washington, DC USA; [Aisen, Paul S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Simon Fraser University; Georgetown University; University of California System; University of California San Diego	Niikura, T (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	tniikura@sfu.ca			National Institutes of Health [AG026478, AG022455]; Natural Sciences and Engineering Research Council of Canada [386973-2010]; NATIONAL INSTITUTE ON AGING [R01AG026478, K01AG022455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partly supported by the National Institutes of Health (grants AG026478 and AG022455 to YM) (www.nih.gov) and Natural Sciences and Engineering Research Council of Canada (386973-2010 to TN) (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Craft S, 2006, ALZ DIS ASSOC DIS, V20, P298, DOI 10.1097/01.wad.0000213866.86934.7e; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; HOANG PT, 2009, METABOLISM; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2005, J MOL NEUROSCI, V25, P165, DOI 10.1385/JMN:25:2:165; Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Kharebava G, 2008, J NEUROSCI, V28, P11409, DOI 10.1523/JNEUROSCI.2135-08.2008; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Niikura T., 2007, INT J MED BIOL FRONT, V12, P199, DOI [10.2174/157015906776359577, DOI 10.2174/157015906776359577]; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Nitta A, 1997, JPN J PHARMACOL, V73, P51, DOI 10.1254/jjp.73.51; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Schmidt Stephen D., 2004, V299, P267; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; William H, 2002, DRUG DELIV TECHNOL, V2, P46; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; YAMADA M, 2007, NEUROPSYCHOPHARMACOL; Yamada M, 2008, NEUROPSYCHOPHARMACOL, V33, P2020, DOI 10.1038/sj.npp.1301591; Yamaguchi Y, 2002, BRAIN RES, V945, P259, DOI 10.1016/S0006-8993(02)02816-0; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200	75	59	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16259	10.1371/journal.pone.0016259	http://dx.doi.org/10.1371/journal.pone.0016259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264226	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600024
J	Huang, QY; Zheng, LL; Zhu, YM; Zhang, JF; Wen, HX; Huang, JW; Niu, JJ; Zhao, XL; Li, QG				Huang, Qiuying; Zheng, Linlin; Zhu, Yumei; Zhang, Jiafeng; Wen, Huixin; Huang, Jianwei; Niu, Jianjun; Zhao, Xilin; Li, Qingge			Multicolor Combinatorial Probe Coding for Real-Time PCR	PLOS ONE			English	Article							MOLECULAR BEACONS; BETA-THALASSEMIA; DIGITAL PCR; DIAGNOSIS	The target volume of multiplex real-time PCR assays is limited by the number of fluorescent dyes available and the number of fluorescence acquisition channels present in the PCR instrument. We hereby explored a probe labeling strategy that significantly increased the target volume of real-time PCR detection in one reaction. The labeling paradigm, termed "Multicolor Combinatorial Probe Coding'' (MCPC), uses a limited number (n) of differently colored fluorophores in various combinations to label each probe, enabling one of 2(n)-1 genetic targets to be detected in one reaction. The proof-of-principle of MCPC was validated by identification of one of each possible 15 human papillomavirus types, which is the maximum target number theoretically detectable by MCPC with a 4-color channel instrument, in one reaction. MCPC was then improved from a one-primer-pair setting to a multiple-primer-pair format through Homo-Tag Assisted Non-Dimer (HAND) system to allow multiple primer pairs to be included in one reaction. This improvement was demonstrated via identification of one of the possible 10 foodborne pathogen candidates with 10 pairs of primers included in one reaction, which had limit of detection equivalent to the uniplex PCR. MCPC was further explored in detecting combined genotypes of five beta-globin gene mutations where multiple targets were co-amplified. MCPC strategy could expand the scope of real-time PCR assays in applications which are unachievable by current labeling strategy.	[Huang, Qiuying; Zheng, Linlin; Zhu, Yumei; Zhang, Jiafeng; Li, Qingge] Xiamen Univ, Engn Res Ctr Mol Diagnost, Minist Educ, Dept Biomed Sci, Xiamen, Peoples R China; [Huang, Qiuying; Zheng, Linlin; Zhu, Yumei; Zhang, Jiafeng; Li, Qingge] Xiamen Univ, Key Lab Cell Biol & Tumor Cell Engn, Minist Educ, Sch Life Sci, Xiamen, Peoples R China; [Wen, Huixin; Huang, Jianwei; Niu, Jianjun] Xiamen Ctr Dis Control & Prevent, Dept Microbiol, Xiamen, Peoples R China; [Zhao, Xilin] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA	Xiamen University; Xiamen University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Huang, QY (corresponding author), Xiamen Univ, Engn Res Ctr Mol Diagnost, Minist Educ, Dept Biomed Sci, Xiamen, Peoples R China.	qgli@xmu.edu.cn	Zhao, Xilin/Y-6795-2019	Zhao, Xilin/0000-0001-8375-8658; Niu, Jianjun/0000-0003-1960-654X	National Nature Science Foundation of China [30371366]; Science Research Foundation of Ministry of Health; United Fujian Provincial Health and Education, People's Republic of China [WKJ2005-2-002, WKJ2008-2-39]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Research Foundation of Ministry of Health; United Fujian Provincial Health and Education, People's Republic of China	This work was supported by the National Nature Science Foundation of China (30371366) www.nsfc.gov.cn and the Science Research Foundation of Ministry of Health and United Fujian Provincial Health and Education Project for Tackling the Key Research, People's Republic of China (WKJ2005-2-002 and WKJ2008-2-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Gibson NJ, 2006, CLIN CHIM ACTA, V363, P32, DOI 10.1016/j.cccn.2005.06.022; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang QY, 2007, CLIN CHEM, V53, P1741, DOI 10.1373/clinchem.2007.087502; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Kaltenboeck B, 2005, ADV CLIN CHEM, V40, P219, DOI 10.1016/S0065-2423(05)40006-2; Kanavakis E, 1997, MOL HUM REPROD, V3, P523, DOI 10.1093/molehr/3.6.523; Lee LG, 1999, BIOTECHNIQUES, V27, P342, DOI 10.2144/99272rr01; Li QG, 2000, ANAL SCI, V16, P245, DOI 10.2116/analsci.16.245; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Saunders Nicholas A, 2004, Methods Mol Biol, V266, P191; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Tyagi S, 2000, NAT BIOTECHNOL, V18, P1191, DOI 10.1038/81192; Vet JAM, 1999, P NATL ACAD SCI USA, V96, P6394, DOI 10.1073/pnas.96.11.6394; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	21	28	34	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16033	10.1371/journal.pone.0016033	http://dx.doi.org/10.1371/journal.pone.0016033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264249	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500023
J	Akundi, RS; Huang, ZY; Eason, J; Pandya, JD; Zhi, LT; Cass, WA; Sullivan, PG; Bueler, H				Akundi, Ravi S.; Huang, Zhenyu; Eason, Joshua; Pandya, Jignesh D.; Zhi, Lianteng; Cass, Wayne A.; Sullivan, Patrick G.; Bueeler, Hansruedi			Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice	PLOS ONE			English	Article							NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3-BETA; NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; C-JUN PHOSPHORYLATION; GROWTH-FACTOR-ALPHA; FOS MESSENGER-RNA; PARKINSONS-DISEASE; OXIDATIVE STRESS; MOUSE MODEL	Background: PTEN-induced kinase 1 (PINK1) is linked to recessive Parkinsonism (EOPD). Pink1 deletion results in impaired dopamine (DA) release and decreased mitochondrial respiration in the striatum of mice. To reveal additional mechanisms of Pink1-related dopaminergic dysfunction, we studied Ca2+ vulnerability of purified brain mitochondria, DA levels and metabolism and whether signaling pathways implicated in Parkinson's disease (PD) display altered activity in the nigrostriatal system of Pink1(-/-) mice. Methods and Findings: Purified brain mitochondria of Pink1(-/-) mice showed impaired Ca2+ storage capacity, resulting in increased Ca2+ induced mitochondrial permeability transition (mPT) that was rescued by cyclosporine A. A subpopulation of neurons in the substantia nigra of Pink1(-/-) mice accumulated phospho-c-Jun, showing that Jun N-terminal kinase (JNK) activity is increased. Pink1(-/-) mice 6 months and older displayed reduced DA levels associated with increased DA turnover. Moreover, Pink1(-/-) mice had increased levels of IL-1 beta, IL-12 and IL-10 in the striatum after peripheral challenge with lipopolysaccharide (LPS), and Pink1(-/-) embryonic fibroblasts showed decreased basal and inflammatory cytokine-induced nuclear factor kappa-beta (NF-kappa B) activity. Quantitative transcriptional profiling in the striatum revealed that Pink1(-/-) mice differentially express genes that (i) are upregulated in animals with experimentally induced dopaminergic lesions, (ii) regulate innate immune responses and/or apoptosis and (iii) promote axonal regeneration and sprouting. Conclusions: Increased mitochondrial Ca2+ sensitivity and JNK activity are early defects in Pink1(-/-) mice that precede reduced DA levels and abnormal DA homeostasis and may contribute to neuronal dysfunction in familial PD. Differential gene expression in the nigrostriatal system of Pink1(-/-) mice supports early dopaminergic dysfunction and shows that Pink1 deletion causes aberrant expression of genes that regulate innate immune responses. While some differentially expressed genes may mitigate neurodegeneration, increased LPS-induced brain cytokine expression and impaired cytokine-induced NF-kappa B activation may predispose neurons of Pink1(-/-) mice to inflammation and injury-induced cell death.	[Akundi, Ravi S.; Huang, Zhenyu; Eason, Joshua; Pandya, Jignesh D.; Zhi, Lianteng; Cass, Wayne A.; Sullivan, Patrick G.; Bueeler, Hansruedi] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Sullivan, Patrick G.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Akundi, RS (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA.	hansruedi.bueler@uky.edu	Büeler, Hansruedi/J-6965-2017; Akundi, Ravi Shankar/J-2673-2019	Büeler, Hansruedi/0000-0002-4892-7177; Akundi, Ravi Shankar/0000-0003-3782-5965	National Center for Research Resources (NCRR) [P20 RR15592]; Parkinson Schweiz; American Parkinson's Disease Association (APDA); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Parkinson Schweiz; American Parkinson's Disease Association (APDA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a COBRE grant (P20 RR15592) from the National Center for Research Resources (NCRR), as well as by grants from Parkinson Schweiz and the American Parkinson's Disease Association (APDA) to H.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Badiani A, 1998, J NEUROSCI, V18, P10579; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Cadet P, 2003, INT J MOL MED, V12, P485; Campbell G, 2005, EXP NEUROL, V192, P340, DOI 10.1016/j.expneurol.2004.11.026; Cao JP, 2008, BRAIN RES BULL, V76, P505, DOI 10.1016/j.brainresbull.2008.03.007; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Desteno DA, 2009, NEUROSCIENCE, V162, P118, DOI 10.1016/j.neuroscience.2009.04.052; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; Doucet JP, 1996, EUR J NEUROSCI, V8, P365, DOI 10.1111/j.1460-9568.1996.tb01220.x; DRAGUNOW M, 1995, MOL BRAIN RES, V30, P393, DOI 10.1016/0169-328X(95)00037-S; DRAGUNOW M, 1991, MOL BRAIN RES, V10, P355, DOI 10.1016/0169-328X(91)90096-G; Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410; Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Francis JS, 2004, MOL BRAIN RES, V124, P199, DOI 10.1016/j.molbrainres.2003.10.027; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Garcia-Gorostiaga I, 2009, ANN NEUROL, V65, P759, DOI 10.1002/ana.21687; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gayle DA, 2002, DEV BRAIN RES, V133, P27, DOI 10.1016/S0165-3806(01)00315-7; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HARDING AJ, 1994, J NEUROSCI METH, V51, P83, DOI 10.1016/0165-0270(94)90028-0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; JOH TH, 1993, ADV NEUROL, V60, P316; Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Liang YD, 2009, BRAIN RES, V1286, P221, DOI 10.1016/j.brainres.2009.06.049; Lin ST, 2008, MOL CELL BIOCHEM, V315, P41, DOI 10.1007/s11010-008-9787-4; Liu M, 2010, J NEUROCHEM, V112, P773, DOI 10.1111/j.1471-4159.2009.06497.x; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McCoy MK, 2008, MOL THER, V16, P1572, DOI 10.1038/mt.2008.146; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Nagao M, 2009, NEUROSCI LETT, V449, P103, DOI 10.1016/j.neulet.2008.10.104; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nilsson A, 2005, NEUROREPORT, V16, P213, DOI 10.1097/00001756-200502280-00002; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Pearson AG, 2003, MOL BRAIN RES, V120, P38, DOI 10.1016/j.molbrainres.2003.09.014; POOLE AC, 2008, P NATL ACAD SCI US; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rentzos M, 2009, ACTA NEUROL SCAND, V119, P332, DOI 10.1111/j.1600-0404.2008.01103.x; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Song DY, 2008, EXP NEUROL, V209, P268, DOI 10.1016/j.expneurol.2007.09.033; Sossi V, 2002, J CEREBR BLOOD F MET, V22, P232, DOI 10.1097/00004647-200202000-00011; SPINA MB, 1989, P NATL ACAD SCI USA, V86, P1398, DOI 10.1073/pnas.86.4.1398; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 2000, NEUROSCIENCE, V99, P457, DOI 10.1016/S0306-4522(00)00213-X; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tang WH, 2009, CELL RES, V19, P758, DOI 10.1038/cr.2009.57; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Teismann P, 2001, NEUROREPORT, V12, P1049, DOI 10.1097/00001756-200104170-00037; Timmons S, 2009, NEUROSCI LETT, V467, P30, DOI 10.1016/j.neulet.2009.09.055; Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; VIVESBAUZA C, 2009, P NATL ACAD SCI US; Vlug AS, 2005, EUR J NEUROSCI, V22, P1881, DOI 10.1111/j.1460-9568.2005.04389.x; Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winter C, 1998, BRAIN RES, V801, P198, DOI 10.1016/S0006-8993(98)00601-5; Winter C, 2002, MOL BRAIN RES, V104, P194, DOI 10.1016/S0169-328X(02)00378-9; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	143	127	134	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16038	10.1371/journal.pone.0016038	http://dx.doi.org/10.1371/journal.pone.0016038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249202	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000011
J	Kang, DD; Lin, YY; Moreno, JR; Randall, TD; Khader, SA				Kang, Dongwan D.; Lin, Yinyao; Moreno, Javier-Rangel; Randall, Troy D.; Khader, Shabaana A.			Profiling Early Lung Immune Responses in the Mouse Model of Tuberculosis	PLOS ONE			English	Article							MHC CLASS-II; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; GRANULOMA-FORMATION; INTERFERON-GAMMA; NEUTROPHIL MIGRATION; PEPTIDE ENA-78; INFECTION; RECEPTOR; MACROPHAGES	Tuberculosis (TB) is caused by the intracellular bacteria Mycobacterium tuberculosis, and kills more than 1.5 million people every year worldwide. Immunity to TB is associated with the accumulation of IFN gamma-producing T helper cell type 1 (Th1) in the lungs, activation of M. tuberculosis-infected macrophages and control of bacterial growth. However, very little is known regarding the early immune responses that mediate accumulation of activated Th1 cells in the M. tuberculosis-infected lungs. To define the induction of early immune mediators in the M. tuberculosis-infected lung, we performed mRNA profiling studies and characterized immune cells in M. tuberculosis-infected lungs at early stages of infection in the mouse model. Our data show that induction of mRNAs involved in the recognition of pathogens, expression of inflammatory cytokines, activation of APCs and generation of Th1 responses occurs between day 15 and day 21 post infection. The induction of these mRNAs coincides with cellular accumulation of Th1 cells and activation of myeloid cells in M. tuberculosis-infected lungs. Strikingly, we show the induction of mRNAs associated with Gr1(+) cells, namely neutrophils and inflammatory monocytes, takes place on day 12 and coincides with cellular accumulation of Gr1(+) cells in M. tuberculosis-infected lungs. Interestingly, in vivo depletion of Gr1(+) neutrophils between days 10-15 results in decreased accumulation of Th1 cells on day 21 in M. tuberculosis-infected lungs without impacting overall protective outcomes. These data suggest that the recruitment of Gr1(+) neutrophils is an early event that leads to production of chemokines that regulate the accumulation of Th1 cells in the M. tuberculosis-infected lungs.	[Kang, Dongwan D.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Kang, Dongwan D.; Lin, Yinyao; Khader, Shabaana A.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Infect Dis, Pittsburgh, PA 15261 USA; [Moreno, Javier-Rangel; Randall, Troy D.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester	Kang, DD (corresponding author), Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA.	Shabaana.Khader@chp.edu		A Khader, Shabaana/0000-0002-9545-4982; Rangel-Moreno, Javier/0000-0002-9738-1182	Children's Hospital of Pittsburgh; Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System [HL69409, AI072689];  [1K99/R00AI075106-01];  [R21AI083541]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075106, R21AI083541, R01AI072689, R00AI075106] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh; Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by 1K99/R00AI075106-01, R21AI083541 and Children's Hospital of Pittsburgh to SAK; HL69409 and AI072689 to TDR and a Research Advisory Committee Grant from Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; APPELBERG R, 1994, IMMUNOLOGY, V82, P361; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bjorkman L, 2008, J LEUKOCYTE BIOL, V83, P245, DOI 10.1189/jlb.0607-408; Boles KS, 1999, TISSUE ANTIGENS, V54, P27, DOI 10.1034/j.1399-0039.1999.540103.x; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Casanova JL, 2001, SWISS MED WKLY, V131, P445; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHANG MS, 1994, J BIOL CHEM, V269, P25277; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DEBEER FC, 1984, THORAX, V39, P196, DOI 10.1136/thx.39.3.196; DENIS M, 1991, J INFECT DIS, V163, P919, DOI 10.1093/infdis/163.4.919; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Gonzalez-Juarrero M, 2009, AM J RESP CELL MOL, V40, P398, DOI 10.1165/rcmb.2008-0248OC; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Koenig R, 2008, SCIENCE, V319, P894, DOI 10.1126/science.319.5865.894; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; MAY ME, 1987, INFECT IMMUN, V55, P2304, DOI 10.1128/IAI.55.9.2304-2307.1987; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Noss EH, 2000, CELL IMMUNOL, V201, P63, DOI 10.1006/cimm.2000.1633; Olakanmi O, 2004, INFECT IMMUN, V72, P2022, DOI 10.1128/IAI.72.4.2022-2028.2004; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Pasquinelli V, 2004, J IMMUNOL, V172, P1177, DOI 10.4049/jimmunol.172.2.1177; Pechkovsky DV, 2000, FEMS IMMUNOL MED MIC, V29, P27, DOI 10.1111/j.1574-695X.2000.tb01501.x; Pflugh DL, 2000, J IMMUNOL, V165, P313, DOI 10.4049/jimmunol.165.1.313; Pompei L, 2007, J IMMUNOL, V178, P5192, DOI 10.4049/jimmunol.178.8.5192; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Riedel DD, 1997, INFECT IMMUN, V65, P4620, DOI 10.1128/IAI.65.11.4620-4623.1997; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Roberts AD, 2002, METHOD MICROBIOL, V32, P433; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Singh PP, 2006, MICROBES INFECT, V8, P541, DOI 10.1016/j.micinf.2005.08.007; Sommer G, 2008, J CELL BIOCHEM, V104, P2241, DOI 10.1002/jcb.21782; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zenaro E, 2009, J LEUKOCYTE BIOL, V86, P1393, DOI 10.1189/jlb.0409242	79	85	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16161	10.1371/journal.pone.0016161	http://dx.doi.org/10.1371/journal.pone.0016161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249199	Green Published, gold, Green Accepted			2022-12-27	WOS:000286515000023
J	Deng, YQ; Dai, JX; Ji, GH; Jiang, T; Wang, HJ; Yang, HO; Tan, WL; Liu, R; Yu, M; Ge, BX; Zhu, QY; Qin, ED; Guo, YJ; Qin, CF				Deng, Yong-Qiang; Dai, Jian-Xin; Ji, Guang-Hui; Jiang, Tao; Wang, Hua-Jing; Yang, Hai-ou; Tan, Weng-Long; Liu, Ran; Yu, Man; Ge, Bao-Xue; Zhu, Qing-Yu; Qin, E-De; Guo, Ya-Jun; Qin, Cheng-Feng			A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein	PLOS ONE			English	Article							VIRUS ENVELOPE PROTEIN; DENGUE VIRUS; WEST-NILE; DOMAIN-III; JAPANESE ENCEPHALITIS; STRUCTURAL BASIS; E-GLYCOPROTEIN; INFECTION; TYPE-2; IDENTIFICATION	Flaviviruses are a group of human pathogenic, enveloped RNA viruses that includes dengue (DENV), yellow fever (YFV), West Nile (WNV), and Japanese encephalitis (JEV) viruses. Cross-reactive antibodies against Flavivirus have been described, but most of them are generally weakly neutralizing. In this study, a novel monoclonal antibody, designated mAb 2A10G6, was determined to have broad cross-reactivity with DENV 1-4, YFV, WNV, JEV, and TBEV. Phage-display biopanning and structure modeling mapped 2A10G6 to a new epitope within the highly conserved flavivirus fusion loop peptide, the (DRXW101)-D-98 motif. Moreover, in vitro and in vivo experiments demonstrated that 2A10G6 potently neutralizes DENV 1-4, YFV, and WNV and confers protection from lethal challenge with DENV 1-4 and WNV in murine model. Furthermore, functional studies revealed that 2A10G6 blocks infection at a step after viral attachment. These results define a novel broadly flavivirus cross-reactive mAb with highly neutralizing activity that can be further developed as a therapeutic agent against severe flavivirus infections in humans.	[Deng, Yong-Qiang; Jiang, Tao; Liu, Ran; Yu, Man; Zhu, Qing-Yu; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Dai, Jian-Xin; Ji, Guang-Hui; Wang, Hua-Jing; Guo, Ya-Jun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Dai, Jian-Xin; Wang, Hua-Jing; Yang, Hai-ou; Tan, Weng-Long; Guo, Ya-Jun] State Key Lab Antibody Med & Targeted Therapy, Shanghai, Peoples R China; [Ge, Bao-Xue] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci, Shanghai 200030, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Deng, YQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	yjguo@smmu.edu.cn; cfqin@hotmail.com	Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926; Ji, Guanghui/0000-0003-3763-2311	National Natural Science Foundation of China [30972613]; Major Special Program of National Science and Technology of China [2008ZX10004-014, 2009ZX10004-015]; International Foundation for Science [F/4622-1]; 973 projects of the National Science and Technology of China; 863 projects of the National Science and Technology of China [2010CB833605, 2006aa02A244]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Special Program of National Science and Technology of China; International Foundation for Science(International Foundation for Science); 973 projects of the National Science and Technology of China(National Basic Research Program of China); 863 projects of the National Science and Technology of China(National High Technology Research and Development Program of China)	This work was supported by, in part, by the National Natural Science Foundation of China (No. 30972613), the Major Special Program of National Science and Technology of China (2008ZX10004-014 and 2009ZX10004-015), International Foundation for Science (F/4622-1), and 973 and 863 projects of the National Science and Technology of China (2010CB833605 and 2006aa02A244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Goncalvez AP, 2004, J VIROL, V78, P12910, DOI 10.1128/JVI.78.23.12910-12918.2004; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MARASCO WA, 2007, NAT BIOTECHNOL, V23, P1421; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, EXPERT OPIN BIOL TH, V7, P885, DOI 10.1517/14712598.7.6.885; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Ray D, 2006, DRUG DISCOV, V1, P45; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Volkova TD, 1999, ARCH VIROL, V144, P1035, DOI 10.1007/s007050050566; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0	40	109	118	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16059	10.1371/journal.pone.0016059	http://dx.doi.org/10.1371/journal.pone.0016059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264311	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000018
J	Inclan, YF; Huseby, MJ; Engel, JN				Inclan, Yuki F.; Huseby, Medora J.; Engel, Joanne N.			FimL Regulates cAMP Synthesis in Pseudomonas aeruginosa	PLOS ONE			English	Article							CHP CHEMOSENSORY SYSTEM; ADENYLATE-CYCLASE; CYCLIC-AMP; TWITCHING MOTILITY; ESCHERICHIA-COLI; GENETIC-ANALYSIS; MOUSE MODEL; IN-VITRO; VIRULENCE; EXPRESSION	Pseudomonas aeruginosa, a ubiquitous bacteria found in diverse ecological niches, is an important cause of acute infections in immunocompromised individuals and chronic infections in patients with Cystic Fibrosis. One signaling molecule required for the coordinate regulation of virulence factors associated with acute infections is 3', 5'-cyclic adenosine monophosphate, (cAMP), which binds to and activates a catabolite repressor homolog, Vfr. Vfr controls the transcription of many virulence factors, including those associated with Type IV pili (TFP), the Type III secretion system (T3SS), the Type II secretion system, flagellar-mediated motility, and quorum sensing systems. We previously identified FimL, a protein with histidine phosphotransfer-like domains, as a regulator of Vfr-dependent processes, including TFP-dependent motility and T3SS function. In this study, we carried out genetic and physiologic studies to further define the mechanism of action of FimL. Through a genetic screen designed to identify suppressors of FimL, we found a putative cAMP-specific phosphodiesterase (CpdA), suggesting that FimL regulates cAMP levels. Inactivation of CpdA increases cAMP levels and restores TFP-dependent motility and T3SS function to fimL mutants, consistent with in vivo phosphodiesterase activity. By constructing combinations of double and triple mutants in the two adenylate cyclase genes (cyaA and cyaB), fimL, and cpdA, we show that Delta fimL mutants resemble Delta cyaB mutants in TM defects, decreased T3SS transcription, and decreased cAMP levels. Similar to some of the virulence factors that they regulate, we demonstrate that CyaB and FimL are polarly localized. These results reveal new complexities in the regulation of diverse virulence pathways associated with acute P. aeruginosa infections.	[Inclan, Yuki F.; Huseby, Medora J.; Engel, Joanne N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Engel, Joanne N.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Inclan, Yuki F.; Huseby, Medora J.; Engel, Joanne N.] Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Inclan, YF (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Jengel@medicine.ucsf.edu			NIH [R01 AI42806]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 AI42806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Buddelmeijer N, 2006, J BACTERIOL, V188, P2928, DOI 10.1128/JB.188.8.2928-2935.2006; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; Ellefson DD, 1997, J BACTERIOL, V179, P825, DOI 10.1128/jb.179.3.825-830.1997; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Gorke B, 2008, NAT REV MICROBIOL, V6, DOI 10.1038/nrmicro1932-c2; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Kanack KJ, 2006, MICROBIOL-SGM, V152, P3485, DOI 10.1099/mic.0.29008-0; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Leech AJ, 2006, J BACTERIOL, V188, P8479, DOI 10.1128/JB.00157-06; LIU PV, 1966, J INFECT DIS, V116, P481, DOI 10.1093/infdis/116.4.481; Macfadyen LP, 1998, J BACTERIOL, V180, P4401, DOI 10.1128/JB.180.17.4401-4405.1998; Mandell GL, 2010, MANDELL DOUGLAS BENN; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Monod J., 1942, ACTUALITES SCI IND; NICAS TI, 1984, INFECT IMMUN, V45, P470, DOI 10.1128/IAI.45.2.470-474.1984; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; SAIER MH, 1975, J BIOL CHEM, V250, P7593; SIEGEL LS, 1977, J BACTERIOL, V129, P87, DOI 10.1128/JB.129.1.87-96.1977; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TSUDA M, 1983, J BACTERIOL, V153, P1018, DOI 10.1128/JB.153.2.1018-1026.1983; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; WEST SEH, 1994, J BACTERIOL, V176, P7532, DOI 10.1128/JB.176.24.7532-7542.1994; Whitchurch CB, 2004, MOL MICROBIOL, V52, P873, DOI 10.1111/j.1365-2958.2004.04026.x; Whitchurch CB, 2005, MOL MICROBIOL, V55, P1357, DOI 10.1111/j.1365-2958.2005.04479.x; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4	46	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15867	10.1371/journal.pone.0015867	http://dx.doi.org/10.1371/journal.pone.0015867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264306	Green Published, gold, Green Submitted			2022-12-27	WOS:000286514000008
J	Ali, MM; Amialchuk, A; Dwyer, DS				Ali, Mir M.; Amialchuk, Aliaksandr; Dwyer, Debra S.			The Social Contagion Effect of Marijuana Use among Adolescents	PLOS ONE			English	Article							DRUG-USE; ALCOHOL-CONSUMPTION; SUBSTANCE USE; PEER	Background: Research on adolescent substance use has consistently identified a strong relationship between adolescent behavior and the behavior of their peers. However, peer effects are difficult to estimate and causal interpretations must be undertaken with caution since individuals in most cases choose with whom to associate. In this paper we seek to empirically quantify the causal role of peer social networks in explaining marijuana usage among adolescents. Methods and Findings: Using data from a nationally representative sample of adolescents we utilize a multivariate structural model with school-level fixed effects to account for the problems of contextual effects, correlated effects and peer selections to purge the potential biases from the estimates of peer influence. Our peer group measures are drawn not only from the nomination of close friends (N = 6,377), but also from classmates (N = 19,335). Marijuana usage among the peer groups were constructed using the peers' own report of their marijuana consumption. Controlling for parent level characteristics, and other demographic parameters, we find that a 10% increase in the proportion of close friends and classmates who use marijuana increases the probability that an individual chooses to use marijuana by 5%. Conclusion: Our findings indicate that peer effects are important determinants of marijuana use even after controlling for potential biases We also found evidence to show that the influence of close friends and the more exogenous classmates are quite similar in magnitude under our preferred specification, supporting theory predicting the importance of peer influence. Effective policy aimed at reducing marijuana usage among adolescents would consider these significant peer effects.	[Ali, Mir M.; Amialchuk, Aliaksandr] Univ Toledo, Dept Econ, Toledo, OH 43606 USA; [Dwyer, Debra S.] SUNY Stony Brook, Sch Hlth Technol & Management, Stony Brook, NY 11794 USA; [Dwyer, Debra S.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Ali, Mir M.] US FDA, Off Regulat Policy & Social Sci, College Pk, MD USA	University System of Ohio; University of Toledo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Food & Drug Administration (FDA)	Ali, MM (corresponding author), Univ Toledo, Dept Econ, 2801 W Bancroft St, Toledo, OH 43606 USA.	mir.ali@fda.hhs.gov			National Institute of Child Health and Human Development [P01- HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The views expressed here are those of the authors and do not necessarily reflect the views of the Food and Drug Administration. This research uses data from Add Health, a program project designed by J. Richard Udry Peter S. Bearman, and Kathleen Mullan Harris, and funded by a grant P01- HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 (addhealth@unc.edu).	Aarons GA, 1999, J ADOLESCENT HEALTH, V24, P412, DOI 10.1016/S1054-139X(99)00006-3; Ali MM, 2010, ADDICT BEHAV, V35, P337, DOI 10.1016/j.addbeh.2009.12.002; Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; ANGIRST J, 1999, HDB LABOR EC, P1277; Bauman KE, 1996, ADDICTION, V91, P185, DOI 10.1111/j.1360-0443.1996.tb03175.x; BOONSTRA H, 2001, GUTTMACHER REPORT PU, V4, P3; Brook JS, 2006, J ADOLESCENT HEALTH, V38, P26, DOI 10.1016/j.jadohealth.2004.08.004; Chen CY, 2009, ADDICT BEHAV, V34, P319, DOI 10.1016/j.addbeh.2008.10.021; Clark AE, 2007, J HEALTH ECON, V26, P763, DOI 10.1016/j.jhealeco.2006.11.005; De Micheli D, 2002, ADDICT BEHAV, V27, P87, DOI 10.1016/S0306-4603(00)00167-2; Duncan GJ, 2005, J ABNORM CHILD PSYCH, V33, P375, DOI 10.1007/s10802-005-3576-2; Engels RCME, 2006, ADDICT BEHAV, V31, P440, DOI 10.1016/j.addbeh.2005.05.026; Etile D, 2005, ADDICT BEHAV, V30, P963; EVANS N, 1995, AM J PUBLIC HEALTH, V85, P1064, DOI 10.2105/AJPH.85.8_Pt_1.1064; Fletcher A, 2008, J ADOLESCENT HEALTH, V42, P209, DOI 10.1016/j.jadohealth.2007.09.020; Hayashi Fumio, 2000, ECONOMETRICS; Kawaguchi D, 2004, J POPUL ECON, V17, P351, DOI 10.1007/s00148-003-0158-x; Lundborg P, 2006, J HEALTH ECON, V25, P214, DOI 10.1016/j.jhealeco.2005.02.001; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mittelhammer R. C., 2000, ECONOMETRIC FDN; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Norton EC, 1998, HEALTH ECON, V7, P439, DOI 10.1002/(SICI)1099-1050(199808)7:5<439::AID-HEC362>3.0.CO;2-9; Simons-Morton B, 2006, ADDICT BEHAV, V31, P1211, DOI 10.1016/j.addbeh.2005.09.006	23	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16183	10.1371/journal.pone.0016183	http://dx.doi.org/10.1371/journal.pone.0016183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LL	21264337	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100030
J	Mendizabal, I; Valente, C; Gusmao, A; Alves, C; Gomes, V; Goios, A; Parson, W; Calafell, F; Alvarez, L; Amorim, A; Gusmao, L; Comas, D; Prata, MJ				Mendizabal, Isabel; Valente, Cristina; Gusmao, Alfredo; Alves, Cintia; Gomes, Veronica; Goios, Ana; Parson, Walther; Calafell, Francesc; Alvarez, Luis; Amorim, Antonio; Gusmao, Leonor; Comas, David; Joao Prata, Maria			Reconstructing the Indian Origin and Dispersal of the European Roma: A Maternal Genetic Perspective	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; MACROHAPLOGROUP-M; Y-CHROMOSOME; MTDNA; LINEAGES; GYPSIES; DIVERSITY; HISTORY; EASTERN; POPULATIONS	Previous genetic, anthropological and linguistic studies have shown that Roma (Gypsies) constitute a founder population dispersed throughout Europe whose origins might be traced to the Indian subcontinent. Linguistic and anthropological evidence point to Indo-Aryan ethnic groups from North-western India as the ancestral parental population of Roma. Recently, a strong genetic hint supporting this theory came from a study of a private mutation causing primary congenital glaucoma. In the present study, complete mitochondrial control sequences of Iberian Roma and previously published maternal lineages of other European Roma were analyzed in order to establish the genetic affinities among Roma groups, determine the degree of admixture with neighbouring populations, infer the migration routes followed since the first arrival to Europe, and survey the origin of Roma within the Indian subcontinent. Our results show that the maternal lineage composition in the Roma groups follows a pattern of different migration routes, with several founder effects, and low effective population sizes along their dispersal. Our data allowed the confirmation of a North/West migration route shared by Polish, Lithuanian and Iberian Roma. Additionally, eleven Roma founder lineages were identified and degrees of admixture with host populations were estimated. Finally, the comparison with an extensive database of Indian sequences allowed us to identify the Punjab state, in North-western India, as the putative ancestral homeland of the European Roma, in agreement with previous linguistic and anthropological studies.	[Mendizabal, Isabel; Calafell, Francesc; Comas, David] CEXS UPF PRBB, CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain; [Valente, Cristina; Gusmao, Alfredo; Alves, Cintia; Gomes, Veronica; Goios, Ana; Alvarez, Luis; Amorim, Antonio; Gusmao, Leonor; Joao Prata, Maria] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Valente, Cristina; Amorim, Antonio; Joao Prata, Maria] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria; [Calafell, Francesc; Comas, David] CIBERESP, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universidade do Porto; Universidade do Porto; Medical University of Innsbruck; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Mendizabal, I (corresponding author), CEXS UPF PRBB, CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain.	david.comas@upf.edu	Comas, David/D-5382-2014; Parson, Walther/AAD-6845-2020; Gusmao, Leonor/B-3122-2013; Alvarez, Luis/J-6022-2013; Gomes, Verónica/J-6041-2013; ALVES, CINTIA/C-7208-2013; Prata, Maria João/A-6945-2010; Gusmão, Leonor/L-8931-2019; Amorim, Antonio/A-7938-2008; Goios, Ana/J-6012-2013; Calafell, Francesc/C-8595-2014; Mendizabal, Isabel/AAD-7249-2021; Mendizabal, Isabel/L-8750-2014	Comas, David/0000-0002-5075-0956; Gusmao, Leonor/0000-0003-0432-6481; Alvarez, Luis/0000-0003-1311-4536; ALVES, CINTIA/0000-0002-9492-5922; Prata, Maria João/0000-0002-0583-1028; Gusmão, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Goios, Ana/0000-0002-3297-8420; Calafell, Francesc/0000-0002-1083-9438; Gomes, Veronica/0000-0003-2815-6376; Parson, Walther/0000-0002-5692-2392; Valente, Cristina/0000-0002-4721-9718; Mendizabal, Isabel/0000-0002-9018-3474	Basque Government (Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza) [BFI107.4]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/63343/2009, SFRH/BD/36045/2007, SFRH/BPD/43646/2008, SFRH/BPD/65000/2009, PTDC/ANT/70413/2006, POCI 2010]; Programa Operacional Ciencia e Inovacao; Direccion General de Investigacion, Ministerio de Educacion y Ciencia, Spain [CGL2009-14944/BOS]; Direccio General de Recerca, Generalitat de Catalunya [2009SGR1101]; Austrian Science Fund (FWF) [TR397]	Basque Government (Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza)(Basque Government); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Ciencia e Inovacao; Direccion General de Investigacion, Ministerio de Educacion y Ciencia, Spain(Spanish Government); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	IM was supported by a fellowship by the Basque Government (Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza, BFI107.4). Fundacao para a Ciencia e Tecnologia (FCT) supported CV, VG, AG and LA through grants SFRH/BD/63343/2009, SFRH/BD/36045/2007, SFRH/BPD/43646/2008 and SFRH/BPD/65000/2009, respectively. This work was partially financed by FCT through project PTDC/ANT/70413/2006 and POCI 2010, Programa Operacional Ciencia e Inovacao; Direccion General de Investigacion, Ministerio de Educacion y Ciencia, Spain (CGL2009-14944/BOS); Direccio General de Recerca, Generalitat de Catalunya (2009SGR1101) and the Austrian Science Fund (FWF): TR397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Alvarez J. Carlos, 2007, Legal Medicine, V9, P293, DOI 10.1016/j.legalmed.2007.05.005; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ARIAS DL, 2001, GAZETA ANTROPOLOGI, V17, P13; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; COLOCCI A, 1889, GLI ZINGARA STORIA P; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Dubut V, 2009, ANN HUM GENET, V73, P314, DOI 10.1111/j.1469-1809.2009.00519.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez O, 2008, TISSUE ANTIGENS, V71, P426, DOI 10.1111/j.1399-0039.2008.01016.x; Fraser A., 1992, GYPSIES; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Gusmao A, 2010, AM J PHYS ANTHROPOL, V141, P507, DOI 10.1002/ajpa.21166; Hancock I, 1987, SCHOLARSHIP GYPSY ST, P1; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Hurles ME, 2002, GENETICS, V160, P289; IOVITA R, 2004, AM ANTHROPOL, V106, P15; Irwin J, 2007, INT J LEGAL MED, V121, P377, DOI 10.1007/s00414-006-0128-4; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Malyarchuk BA, 2006, ANN HUM GENET, V70, P195, DOI 10.1111/j.1529-8817.2005.00222.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Nei M., 1987, MOL EVOLUTIONARY GEN; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; REYNIERS A, 1995, INT MIGRATION LABOUR, V1; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; TAJIMA F, 1983, GENETICS, V105, P437; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Weyrauch W.O., 2001, GYPSY LAW ROMANI LEG	43	55	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15988	10.1371/journal.pone.0015988	http://dx.doi.org/10.1371/journal.pone.0015988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264345	Green Published, gold			2022-12-27	WOS:000286513100023
J	Mizuguchi, Y; Mishima, T; Yokomuro, S; Arima, Y; Kawahigashi, Y; Shigehara, K; Kanda, T; Yoshida, H; Uchida, E; Tajiri, T; Takizawa, T				Mizuguchi, Yoshiaki; Mishima, Takuya; Yokomuro, Shigeki; Arima, Yasuo; Kawahigashi, Yutaka; Shigehara, Kengo; Kanda, Tomohiro; Yoshida, Hiroshi; Uchida, Eiji; Tajiri, Takashi; Takizawa, Toshihiro			Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION; GENES; MOUSE; IDENTIFICATION; MODULATION; CANCER; MIRNAS	MicroRNAs (miRNAs) participate in crucial biological processes, and it is now evident that miRNA alterations are involved in the progression of human cancers. Recent studies on miRNA profiling performed with cloning suggest that sequencing is useful for the detection of novel miRNAs, modifications, and precise compositions and that miRNA expression levels calculated by clone count are reproducible. Here we focus on sequencing of miRNA to obtain a comprehensive profile and characterization of these transcriptomes as they relate to human liver. Sequencing using 454 sequencing and conventional cloning from 22 pair of HCC and adjacent normal liver (ANL) and 3 HCC cell lines identified reliable reads of more than 314000 miRNAs from HCC and more than 268000 from ANL for registered human miRNAs. Computational bioinformatics identified 7 novel miRNAs with high conservation, 15 novel opposite miRNAs, and 3 novel antisense miRNAs. Moreover sequencing can detect miRNA modifications including adenosine-to-inosine editing in miR-376 families. Expression profiling using clone count analysis was used to identify miRNAs that are expressed aberrantly in liver cancer including miR-122, miR-21, and miR-34a. Furthermore, sequencing-based miRNA clustering, but not individual miRNA, detects high risk patients who have high potentials for early tumor recurrence after liver surgery (P = 0.006), and which is the only significant variable among pathological and clinical and variables (P = 0,022). We believe that the combination of sequencing and bioinformatics will accelerate the discovery of novel miRNAs and biomarkers involved in human liver cancer.	[Mizuguchi, Yoshiaki; Yokomuro, Shigeki; Arima, Yasuo; Kawahigashi, Yutaka; Shigehara, Kengo; Kanda, Tomohiro; Yoshida, Hiroshi; Uchida, Eiji; Tajiri, Takashi] Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, Tokyo 113, Japan; [Mizuguchi, Yoshiaki; Mishima, Takuya; Kawahigashi, Yutaka; Shigehara, Kengo; Kanda, Tomohiro; Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Anat & Med, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Mizuguchi, Y (corresponding author), Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, 1-1-5 Sendagi, Tokyo 113, Japan.	yoshi1224@gmail.com; t-takizawa@nms.ac.jp	Mishima, Takuya/G-1671-2011		Ministry of Education, Science, Sports, and Culture of Japan [19-879, S0801034]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Ministry of Education, Science, Sports, and Culture of Japan, through two separate grants: 1) Grants-in-Aid for Scientific Research, Research Fellowships for young scientists (#19-879; http://www.jsps.go.jp/english/e-grants/grants.html) and 2) Core Research Project for Private University: matching fund subsidy (#S0801034; http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LCSGo, 2000, GEN RUL CLIN PATH ST; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Sobin, 2009, UICC TNM CLASSIFICAT; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	30	59	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15304	10.1371/journal.pone.0015304	http://dx.doi.org/10.1371/journal.pone.0015304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283620	gold, Green Published, Green Submitted			2022-12-27	WOS:000286661400007
J	Tuzmen, C; Erman, B				Tuzmen, Ceren; Erman, Burak			Identification of Ligand Binding Sites of Proteins Using the Gaussian Network Model	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASE A1-1; ACETYL-COA CARBOXYLASE; HUMAN HEME OXYGENASE; RECEPTOR TYROSINE KINASES; COENZYME-A CARBOXYLASE; CARBONIC-ANHYDRASE-II; ACTIVE-SITE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; S-TRANSFERASE	The nonlocal nature of the protein-ligand binding problem is investigated via the Gaussian Network Model with which the residues lying along interaction pathways in a protein and the residues at the binding site are predicted. The predictions of the binding site residues are verified by using several benchmark systems where the topology of the unbound protein and the bound protein-ligand complex are known. Predictions are made on the unbound protein. Agreement of results with the bound complexes indicates that the information for binding resides in the unbound protein. Cliques that consist of three or more residues that are far apart along the primary structure but are in contact in the folded structure are shown to be important determinants of the binding problem. Comparison with known structures shows that the predictive capability of the method is significant.	[Tuzmen, Ceren; Erman, Burak] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University	Tuzmen, C (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	berman@ku.edu.tr	erman, burak/F-5900-2015	erman, burak/0000-0002-2496-6059				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Allardyce CS, 1999, BIOCHEM J, V343, P525, DOI 10.1042/0264-6021:3430525; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; ATKINS WM, 1993, J BIOL CHEM, V268, P19188; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; BJORNESTEDT R, 1995, J MOL BIOL, V247, P765; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; CALABRETTA B, 1986, P NATL ACAD SCI USA, V83, P1495, DOI 10.1073/pnas.83.5.1495; CALABRETTA B, 1985, P NATL ACAD SCI USA, V82, P4463, DOI 10.1073/pnas.82.13.4463; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Castle JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004369; Cvetkovic D.C., 1997, EIGENSPACES GRAPHS; DOMSIC JF, 2010, STRUCTURAL KINETIC S; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Haliloglu T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000845; Haliloglu T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088103; Haliloglu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228102; Hansen SK, 2005, BIOCHEMISTRY-US, V44, P7704, DOI 10.1021/bi047417s; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; JEREMY M, 2007, BIOCHEMISTRY-US, P254; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Komatsu K, 2000, CLIN CANCER RES, V6, P172; Kuhnert DC, 2005, J MOL BIOL, V349, P825, DOI 10.1016/j.jmb.2005.04.025; La Mar GN, 2001, J BIOL CHEM, V276, P15676, DOI 10.1074/jbc.M009974200; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Li YM, 2004, J BIOL CHEM, V279, P10195, DOI 10.1074/jbc.M308379200; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MANI RS, 1992, BIOCHEMISTRY-US, V31, P11896, DOI 10.1021/bi00162a031; Maupin CM, 2009, J AM CHEM SOC, V131, P7598, DOI 10.1021/ja8091938; Mizoue LS, 2002, CURR OPIN STRUC BIOL, V12, P459, DOI 10.1016/S0959-440X(02)00348-2; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; MURPHY LC, 1988, J BIOL CHEM, V263, P2397; Nathaniel C, 2003, BIOCHEM J, V372, P241, DOI 10.1042/BJ20021765; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; PERRY RDL, 1949, PSYCHOMETRIKA, V14, P95; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; PORTER GBC, 2010, CATALYTIC SITE ATLAS; Scapin G, 2003, BIOCHEMISTRY-US, V42, P11451, DOI 10.1021/bi035098j; Scapin G, 2001, PROTEIN SCI, V10, P1596, DOI 10.1110/ps.11001; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Sudo T, 1999, FEBS LETT, V444, P11, DOI 10.1016/S0014-5793(99)00014-9; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Thorson JS, 1998, J AM CHEM SOC, V120, P451, DOI 10.1021/ja9731682; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; WAKIL SJ, 1986, ANN NY ACAD SCI, V478, P203, DOI 10.1111/j.1749-6632.1986.tb15532.x; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Yogurtcu ON, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078517; EMBL EBI PDBSUM	72	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16474	10.1371/journal.pone.0016474	http://dx.doi.org/10.1371/journal.pone.0016474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283550	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400054
J	Bonney, KM; Taylor, JM; Daniels, MD; Epting, CL; Engman, DM				Bonney, Kevin M.; Taylor, Joann M.; Daniels, Melvin D.; Epting, Conrad L.; Engman, David M.			Heat-Killed Trypanosoma cruzi Induces Acute Cardiac Damage and Polyantigenic Autoimmunity	PLOS ONE			English	Article							EXPERIMENTAL CHAGAS-DISEASE; T-CELL RESPONSES; TH17 CELLS; TROPONIN-I; MYOSIN AUTOIMMUNITY; INTERFERON-GAMMA; HELPER TYPE-1; ANTIBODIES; MICE; AUTOANTIBODIES	Chagas heart disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially fatal cardiomyopathy often associated with cardiac autoimmunity. T. cruzi infection induces the development of autoimmunity to a number of antigens via molecular mimicry and other mechanisms, but the genesis and pathogenic potential of this autoimmune response has not been fully elucidated. To determine whether exposure to T. cruzi antigens alone in the absence of active infection is sufficient to induce autoimmunity, we immunized A/J mice with heat-killed T. cruzi (HKTC) emulsified in complete Freund's adjuvant, and compared the resulting immune response to that induced by infection with live T. cruzi. We found that HKTC immunization is capable of inducing acute cardiac damage, as evidenced by elevated serum cardiac troponin I, and that this damage is associated with the generation of polyantigenic humoral and cell-mediated autoimmunity with similar antigen specificity to that induced by infection with T. cruzi. However, while significant and preferential production of Th1 and Th17-associated cytokines, accompanied by myocarditis, develops in T. cruzi-infected mice, HKTC-immunized mice produce lower levels of these cytokines, do not develop Th1-skewed immunity, and lack tissue inflammation. These results demonstrate that exposure to parasite antigen alone is sufficient to induce autoimmunity and cardiac damage, yet additional immune factors, including a dominant Th1/Th17 immune response, are likely required to induce cardiac inflammation.	[Bonney, Kevin M.; Daniels, Melvin D.; Epting, Conrad L.; Engman, David M.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bonney, Kevin M.; Taylor, Joann M.; Daniels, Melvin D.; Engman, David M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Epting, Conrad L.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Bonney, KM (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	k-bonney@northwestern.edu	Engman, David/T-6747-2018	Engman, David/0000-0001-5869-9844	National Institutes of Health (NIH) [HL075822, AI007476]; American Heart Association; Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant HL075822 (to D.M.E.), NIH training grant AI007476 (to M.D.D.), and a predoctoral fellowship from the American Heart Association (to K.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Karin G. Klein for production of the pKK25-pLysE plasmid and Manuel Fresno, Universidad Autonoma de Madrid, Spain for providing the Cha expression plasmid. This work was supported by the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility.	Barr SC, 2005, ANTIMICROB AGENTS CH, V49, P5160, DOI 10.1128/AAC.49.12.5160-5161.2005; Bergami PL, 1997, FEMS IMMUNOL MED MIC, V18, P75, DOI 10.1016/S0928-8244(97)00026-6; BONFA E, 1993, J IMMUNOL, V150, P3917; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Cardillo F, 2007, IMMUNOLOGY, V122, P584, DOI 10.1111/j.1365-2567.2007.02677.x; Chan LS, 1998, J INVEST DERMATOL, V110, P103, DOI 10.1046/j.1523-1747.1998.00107.x; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Collinson PO, 2007, MED PRIN PRACT, V16, P247, DOI 10.1159/000102146; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cooke Anne, 2006, Review of Diabetic Studies, V3, P72, DOI 10.1900/RDS.2006.3.72; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Cunha-Neto E, 1995, Sao Paulo Med J, V113, P757; CunhaNeto E, 1996, J CLIN INVEST, V98, P1709, DOI 10.1172/JCI118969; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; DAVILA DF, 1989, PARASITOL TODAY, V5, P327, DOI 10.1016/0169-4758(89)90127-0; DECARVALHO LCP, 2002, J AUTOIMMUN, V18, P131; DOSSANTOS RR, 1992, J EXP MED, V175, P29, DOI 10.1084/jem.175.1.29; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; GAZZINELLI R, 1988, T ROY SOC TROP MED H, V82, P574, DOI 10.1016/0035-9203(88)90513-5; Giordanengo L, 2000, MUSCLE NERVE, V23, P1407, DOI 10.1002/1097-4598(200009)23:9<1407::AID-MUS12>3.3.CO;2-V; Giordanengo L, 2000, EUR J IMMUNOL, V30, P3181, DOI 10.1002/1521-4141(200011)30:11&lt;3181::AID-IMMU3181&gt;3.0.CO;2-A; Girones N, 2001, J CLIN INVEST, V107, P985, DOI 10.1172/JCI10734; Girones N, 2001, CLIN DIAGN LAB IMMUN, V8, P1039, DOI 10.1128/CDLI.8.6.1039-1043.2001; Girones N, 2007, ANN NY ACAD SCI, V1107, P434, DOI 10.1196/annals.1381.046; Godsel LM, 2003, J IMMUNOL, V171, P346, DOI 10.4049/jimmunol.171.1.346; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; GUEDES PMD, PLOS NEGL TROP DIS, V4, pE604; Guo SQ, 2009, J IMMUNOL, V182, P6179, DOI 10.4049/jimmunol.0803821; Hamm CW, 2002, CIRCULATION, V106, P2871, DOI 10.1161/01.CIR.0000044342.50593.63; Hessel MHM, 2008, PFLUG ARCH EUR J PHY, V455, P979, DOI 10.1007/s00424-007-0354-8; Hoft DF, 2002, INFECT IMMUN, V70, P6715, DOI 10.1128/IAI.70.12.6715-6725.2002; Hyland KV, 2007, INFECT IMMUN, V75, P3641, DOI 10.1128/IAI.00423-07; Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301; KAYA Z, 2009, CLIN IMMUNOL; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; KIPNIS TL, 1981, AM J TROP MED HYG, V30, P47, DOI 10.4269/ajtmh.1981.30.47; Konstadoulakis M M, 1993, J Clin Lab Immunol, V40, P61; Krebs P, 2007, J AUTOIMMUN, V28, P224, DOI 10.1016/j.jaut.2007.01.003; LANE JR, 1992, J EXP MED, V175, P1123, DOI 10.1084/jem.175.4.1123; Leon JS, 2004, INFECT IMMUN, V72, P3410, DOI 10.1128/IAI.72.6.3410-3417.2004; Leon JS, 2003, J IMMUNOL, V171, P4271, DOI 10.4049/jimmunol.171.8.4271; Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001; Li Y, 2006, J IMMUNOL, V177, P8234, DOI 10.4049/jimmunol.177.11.8234; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2005, J IMMUNOL, V174, P1594, DOI 10.4049/jimmunol.174.3.1594; MOLINA HA, 1988, IMMUNOLOGY, V64, P725; MOLINA HA, 1989, IMMUNOLOGY, V66, P289; Motran CC, 2000, CLIN IMMUNOL, V97, P89, DOI 10.1006/clim.2000.4919; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; NEU N, 1987, J IMMUNOL, V138, P2488; Nussinovitch U, 2010, HEART, V96, P1518, DOI 10.1136/hrt.2010.195255; O'Brien PJ, 2006, LAB ANIM-UK, V40, P153, DOI 10.1258/002367706776319042; RIZZO LV, 1989, INFECT IMMUN, V57, P2640, DOI 10.1128/IAI.57.9.2640-2644.1989; ROSSI MA, 1990, AM HEART J, V120, P233, DOI 10.1016/0002-8703(90)90191-Y; SANTOSBU.CA, 1974, J EXP MED, V140, P38, DOI 10.1084/jem.140.1.38; Schijman AG, 2004, AM J TROP MED HYG, V70, P210, DOI 10.4269/ajtmh.2004.70.210; SCHMITT E, 1994, EUR J IMMUNOL, V24, P343, DOI 10.1002/eji.1830240211; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; TERNYNCK T, 1990, J IMMUNOL, V144, P1504; TIBBETTS RS, 1994, J IMMUNOL, V152, P1493; Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393; Valaperti A, 2008, J IMMUNOL, V180, P2686, DOI 10.4049/jimmunol.180.4.2686; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Watthanakulpanich D, 2008, ACTA TROP, V106, P90, DOI 10.1016/j.actatropica.2008.01.008; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889	73	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14571	10.1371/journal.pone.0014571	http://dx.doi.org/10.1371/journal.pone.0014571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283741	Green Published, gold			2022-12-27	WOS:000286522300009
J	Tsagaratou, A; Kontoyiannis, DL; Mosialos, G				Tsagaratou, Ageliki; Kontoyiannis, Dimitris L.; Mosialos, George			Truncation of the Deubiquitinating Domain of CYLD in Myelomonocytic Cells Attenuates Inflammatory Responses	PLOS ONE			English	Article							NF-KAPPA-B; ENZYME CYLD; NEGATIVE REGULATOR; MICE; MACROPHAGES; ACTIVATION; MODULATOR; RECEPTOR	The cylindromatosis tumor suppressor (CYLD) is a deubiquitinating enzyme that has been implicated in various aspects of adaptive and innate immune responses. Nevertheless, the role of CYLD in the function of specific types of immune cells remains elusive. In this report we have used conditional gene targeting in mice to address the role of the deubiquitinating activity of CYLD in the myelomonocytic lineage. Truncation of the deubiquitinating domain of CYLD specifically in myelomonocytic cells impaired the development of lethal LPS-induced endotoxic shock and the accumulation of thioglycollate-elicited peritoneal macrophages. Our data establish CYLD as a regulator of monocyte-macrophage activation in response to inflammatory stimuli and identify it as a potential target for therapeutic intervention in relevant inflammatory disorders in humans.	[Tsagaratou, Ageliki; Mosialos, George] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Macedonia, Greece; [Tsagaratou, Ageliki; Kontoyiannis, Dimitris L.] Biomed Sci Res Ctr Al Fleming, Inst Immunol, Vari, Greece	Aristotle University of Thessaloniki; Alexander Fleming Biomedical Sciences Research Center	Tsagaratou, A (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Macedonia, Greece.	gmosialo@bio.auth.gr		Tsagaratou, Ageliki/0000-0002-7121-3789; Tsangaratou, Angeliki/0000-0001-9895-0394; Kontoyiannis, Dimitris/0000-0003-4682-9490	General Secretariat for Research and Technology of the Hellenic Ministry of Education	General Secretariat for Research and Technology of the Hellenic Ministry of Education	This work was supported by the General Secretariat for Research and Technology of the Hellenic Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kolls JK, 2007, IMMUNITY, V27, P187, DOI 10.1016/j.immuni.2007.08.004; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; MELLINGHOFF I, 1991, VIROLOGY, V185, P922, DOI 10.1016/0042-6822(91)90574-U; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Timmer AM, 2008, J EXP MED, V205, P1255, DOI 10.1084/jem.20081056; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Trompouki E, 2009, NEOPLASIA, V11, P469, DOI 10.1593/neo.81424; Tsagaratou A, 2010, J IMMUNOL, V185, P2032, DOI 10.4049/jimmunol.0903919; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	23	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16397	10.1371/journal.pone.0016397	http://dx.doi.org/10.1371/journal.pone.0016397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283724	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200059
J	Bridier, A; Le Coq, D; Dubois-Brissonnet, F; Thomas, V; Aymerich, S; Briandet, R				Bridier, Arnaud; Le Coq, Dominique; Dubois-Brissonnet, Florence; Thomas, Vincent; Aymerich, Stephane; Briandet, Romain			The Spatial Architecture of Bacillus subtilis Biofilms Deciphered Using a Surface-Associated Model and In Situ Imaging	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; LASER-SCANNING MICROSCOPY; MASTER REGULATOR; GENES; MOTILITY; TRANSCRIPTION; IDENTIFICATION; EXPRESSION; FLAGELLA; SPO0A	The formation of multicellular communities known as biofilms is the part of bacterial life cycle in which bacteria display cooperative behaviour and differentiated phenotypes leading to specific functions. Bacillus subtilis is a Gram-positive bacterium that has served for a decade as a model to study the molecular pathways that control biofilm formation. Most of the data on B. subtilis biofilms have come from studies on the formation of pellicles at the air-liquid interface, or on the complex macrocolonies that develop on semi-solid nutritive agar. Here, using confocal laser scanning microcopy, we show that B. subtilis strains of different origins are capable of forming biofilms on immersed surfaces with dramatically protruding "beanstalk-like'' structures with certain strains. Indeed, these structures can reach a height of more than 300 mu m with one undomesticated strain from a medical environment. Using 14 GFP-labeled mutants previously described as affecting pellicle or complex colony formation, we have identified four genes whose inactivation significantly impeded immersed biofilm development, and one mutation triggering hyperbiofilm formation. We also identified mutations causing the three-dimensional architecture of the biofilm to be altered. Taken together, our results reveal that B. subtilis is able to form specific biofilm features on immersed surfaces, and that the development of these multicellular surface-associated communities involves regulation pathways that are common to those governing the formation of pellicle and/or complex colonies, and also some specific mechanisms. Finally, we propose the submerged surface-associated biofilm as another relevant model for the study of B. subtilis multicellular communities.	[Bridier, Arnaud; Le Coq, Dominique; Aymerich, Stephane; Briandet, Romain] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Bridier, Arnaud; Dubois-Brissonnet, Florence] AgroParisTech, UMR MICALIS 1319, Jouy En Josas, France; [Thomas, Vincent] Steris, Fontenay Aux Roses, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Bridier, A (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	romain.briandet@jouy.inra.fr	Thomas, Vincent/A-8941-2012; Thomas, Vincent/AAB-6394-2022; bridier, arnaud/D-7183-2013; Thomas, Vincent/AAB-8982-2019; Briandet, Romain/AAD-2102-2020	Thomas, Vincent/0000-0003-4034-9525; Thomas, Vincent/0000-0003-4034-9525; bridier, arnaud/0000-0003-4812-3301; Briandet, Romain/0000-0002-8123-3492; Le Coq, Dominique/0000-0001-5756-2280; Bridier, Arnaud/0000-0002-7221-8944; Dubois-Brissonnet, Florence/0000-0003-2998-7518	Essonne Departement [A02137]	Essonne Departement	This study received support from a public grant "MEDICEN-Region Paris, Ile-de-France'' in the framework of the "Global deconta'' program (http://www.medicen.org/). This national scientific program was coordinated by V. Thomas, employed by Steris SA. V. Thomas participated in the design of the study, but not in data collection and analysis, decision to publish, or preparation of the manuscript. The "Essonne Departement'' is also acknowledged for its financial support of the confocal microscopy facility (public grant ASTRE n<SUP>o</SUP>A02137). The "Essonnes Departement'' had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati G, 2004, J BACTERIOL, V186, P6003, DOI 10.1128/jb.186.18.6003-6014.2004; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chai YR, 2009, MOL MICROBIOL, V74, P876, DOI 10.1111/j.1365-2958.2009.06900.x; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Costerton J. William, 2007, V1, P1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; CRUTZ AM, 1992, J BACTERIOL, V174, P6087, DOI 10.1128/JB.174.19.6087-6095.1992; DAHL MK, 1992, J BIOL CHEM, V267, P14509; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hamon MA, 2004, MOL MICROBIOL, V52, P847, DOI 10.1111/j.1365-2958.2004.04023.x; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hamze K, 2009, MICROBIOL-SGM, V155, P398, DOI 10.1099/mic.0.021477-0; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; Jules M, 2009, J BACTERIOL, V191, P3168, DOI 10.1128/JB.01783-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KIEL JAKW, 1995, APPL ENVIRON MICROB, V61, P4244, DOI 10.1128/AEM.61.12.4244-4250.1995; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kobayashi K, 2008, MOL MICROBIOL, V69, P1399, DOI 10.1111/j.1365-2958.2008.06369.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kuehn M, 1998, APPL ENVIRON MICROB, V64, P4115; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Martin DJH, 2008, J HOSP INFECT, V69, P377, DOI 10.1016/j.jhin.2008.04.010; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Nagorska K, 2008, J BACTERIOL, V190, P3546, DOI 10.1128/JB.01665-07; Ohsawa T, 2009, BIOSCI BIOTECH BIOCH, V73, P2096, DOI 10.1271/bbb.90341; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Stover AG, 1999, J BACTERIOL, V181, P7065; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Verhamme DT, 2009, J BACTERIOL, V191, P100, DOI 10.1128/JB.01236-08; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Xavier JB, 2003, WATER SCI TECHNOL, V47, P31, DOI 10.2166/wst.2003.0273; YANG M, 1987, J BACTERIOL, V169, P434, DOI 10.1128/jb.169.1.434-437.1987	56	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16177	10.1371/journal.pone.0016177	http://dx.doi.org/10.1371/journal.pone.0016177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267464	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500044
J	Furuya, EY; Dick, A; Perencevich, EN; Pogorzelska, M; Goldmann, D; Stone, PW				Furuya, E. Yoko; Dick, Andrew; Perencevich, Eli N.; Pogorzelska, Monika; Goldmann, Donald; Stone, Patricia W.			Central Line Bundle Implementation in US Intensive Care Units and Impact on Bloodstream Infections	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CHLORHEXIDINE; SURVEILLANCE; SAFETY	Background: Central line-associated bloodstream infections (CLABSI) represent a serious patient safety issue. To prevent these infections, bundled interventions are increasingly recommended. We examine the extent of adoption of Central Line (CL) Bundle elements throughout US intensive care units (ICU) and determine their effectiveness in preventing CLABSIs. Methodology/Principal Findings: In this cross-sectional study, National Healthcare Safety Network (NHSN) hospitals provided the following: ICU-specific NHSN-reported rates of CLABSI/1,000 central line days; policies and compliance rates regarding bundle components; and other setting characteristics. In 250 hospitals the mean CLABSI rate was 2.1 per 1000 central line days and 49% reported having a written CL Bundle policy. However, of those that monitored compliance, only 38% reported very high compliance with the CL Bundle. Only when an ICU had a policy, monitored compliance, and had >= 95% compliance did CLABSI rates decrease. Complying with any one of three CL Bundle elements resulted in decreased CLABSI rates (beta = -1.029, p = 0.015). If an ICU without good bundle compliance achieved high compliance with any one bundle element, we estimated that its CLABSI rate would decrease by 38%. Conclusions/Significance: In NHSN hospitals across the US, the CL Bundle is associated with lower infection rates only when compliance is high. Hospitals must target improving bundle implementation and compliance as opposed to simply instituting policies.	[Furuya, E. Yoko] Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA; [Dick, Andrew] RAND Corp, Boston, MA USA; [Perencevich, Eli N.] Iowa City VA, Dept Internal Med, Iowa City, IA USA; [Perencevich, Eli N.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Pogorzelska, Monika] Columbia Univ, Sch Nursing, New York, NY USA; [Goldmann, Donald] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Donald] Childrens Hosp, Boston, MA 02115 USA; [Stone, Patricia W.] Columbia Univ, Sch Nursing, New York, NY USA	Columbia University; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Columbia University; Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Columbia University	Furuya, EY (corresponding author), Columbia Univ Coll Phys & Surg, Div Infect Dis, 630 W 168th St, New York, NY 10032 USA.	ps2024@columbia.edu		Pogorzelska-Maziarz, Monika/0000-0002-3449-9722; Perencevich, Eli/0000-0002-3721-3355	National Institutes of Health [R01NR010107]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was funded by National Institutes of Health (R01NR010107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; *CDCP, 2008, NHSN MAN PAT SAF COM; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Emori TG, 1998, INFECT CONT HOSP EP, V19, P308; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; *HLTH RES ED TRUST, HRET HOSP ASS ANN PA; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; Horan TC, 1997, AM J INFECT CONTROL, V25, P73, DOI 10.1016/S0196-6553(97)90031-6; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Irizarry L, 1996, CHEMOTHERAPY, V42, P248, DOI 10.1159/000239451; Kaissi A, 2006, HEALTH CARE MANAG, V25, P292, DOI 10.1097/00126450-200610000-00002; Kampf G, 1998, J HOSP INFECT, V38, P297, DOI 10.1016/S0195-6701(98)90078-0; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; *MILL LIV CAMP, 2006, GETT START KIT HOW T; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Perencevich EN, 2007, INFECT CONT HOSP EP, V28, P1121, DOI 10.1086/521852; Pronovost Peter, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Sticca G, 2004, Ann Ig, V16, P187; Stone PW, 2009, AM J INFECT CONTROL, V37, P351, DOI 10.1016/j.ajic.2008.11.001; Stone PW, 2006, CRIT CARE MED, V34, P1907, DOI 10.1097/01.CCM.0000218411.53557.29; Thongpiyapoom Somchit, 2004, Journal of the Medical Association of Thailand, V87, P819; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Wootton M, 2009, INFECT CONT HOSP EP, V30, P226, DOI 10.1086/595691; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060; 2005, MMWR MORBIDITY MORTA, V54, P1013	29	147	153	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15452	10.1371/journal.pone.0015452	http://dx.doi.org/10.1371/journal.pone.0015452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267440	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500023
J	Kosuge, H; Sherlock, SP; Kitagawa, T; Terashima, M; Barral, JK; Nishimura, DG; Dai, HJ; McConnell, MV				Kosuge, Hisanori; Sherlock, Sarah P.; Kitagawa, Toshiro; Terashima, Masahiro; Barral, Joelle K.; Nishimura, Dwight G.; Dai, Hongjie; McConnell, Michael V.			FeCo/Graphite Nanocrystals for Multi-Modality Imaging of Experimental Vascular Inflammation	PLOS ONE			English	Article							MACROPHAGES IN-VIVO; PLAQUE DESTABILIZATION; CONTRAST AGENT; ATHEROSCLEROSIS; MRI; VISUALIZATION; EXPRESSION; CELLS; MICE	Background: FeCo/graphitic-carbon nanocrystals (FeCo/GC) are biocompatible, high-relaxivity, multi-functional nanoparticles. Macrophages represent important cellular imaging targets for assessing vascular inflammation. We evaluated FeCo/GC for vascular macrophage uptake and imaging in vivo using fluorescence and MRI. Methods and Results: Hyperlipidemic and diabetic mice underwent carotid ligation to produce a macrophage-rich vascular lesion. In situ and ex vivo fluorescence imaging were performed at 48 hours after intravenous injection of FeCo/GC conjugated to Cy5.5 (n = 8, 8 nmol of Cy5.5/mouse). Significant fluorescence signal from FeCo/GC-Cy5.5 was present in the ligated left carotid arteries, but not in the control (non-ligated) right carotid arteries or sham-operated carotid arteries (p = 0.03 for ligated vs. non-ligated). Serial in vivo 3T MRI was performed at 48 and 72 hours after intravenous FeCo/GC (n = 6, 270 mu g Fe/mouse). Significant T2* signal loss from FeCo/GC was seen in ligated left carotid arteries, not in non-ligated controls (p = 0.03). Immunofluorescence staining showed colocalization of FeCo/GC and macrophages in ligated carotid arteries. Conclusions: FeCo/GC accumulates in vascular macrophages in vivo, allowing fluorescence and MR imaging. This multifunctional high-relaxivity nanoparticle platform provides a promising approach for cellular imaging of vascular inflammation.	[Kosuge, Hisanori; Kitagawa, Toshiro; Terashima, Masahiro; McConnell, Michael V.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Sherlock, Sarah P.; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University	Kosuge, H (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	mcconnell@stanford.edu	Dai, Hongjie/ABC-4574-2021	McConnell, Michael/0000-0001-8743-0932	National Institutes of Health [R01-HL078678]; American Heart Association [0825272-F]; Stanford Bio-X Interdisciplinary Initiative; GE Healthcare; NATIONAL CANCER INSTITUTE [R01CA135109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stanford Bio-X Interdisciplinary Initiative; GE Healthcare(General ElectricGE Healthcare); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (R01-HL078678, nih.gov), the American Heart Association (0825272-F, heart.org), and Stanford Bio-X Interdisciplinary Initiatives Program (biox.stanford.edu), as well as MRI research support from GE Healthcare (gehealthcare.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Cormode DP, 2008, SMALL, V4, P1437, DOI 10.1002/smll.200701285; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Fortin JP, 2008, EUR BIOPHYS J BIOPHY, V37, P223, DOI 10.1007/s00249-007-0197-4; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harmon KJ, 2000, AM J PATHOL, V156, P1741, DOI 10.1016/S0002-9440(10)65045-6; Howarth SPS, 2009, EUR J RADIOL, V70, P555, DOI 10.1016/j.ejrad.2008.01.047; Hyafil F, 2006, ARTERIOSCL THROM VAS, V26, P176, DOI 10.1161/01.ATV.0000194098.82677.57; Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Kolodgie FD, 2003, CIRCULATION, V108, P3134, DOI 10.1161/01.CIR.0000105761.00573.50; Lee JH, 2009, MAGN RESON MED, V62, P1497, DOI 10.1002/mrm.22132; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Seo WS, 2006, NAT MATER, V5, P971, DOI 10.1038/nmat1775; TERASHIMA M, 2010, MOL IMAGING BIO 1106; Terashima M, 2011, BIOMATERIALS, V32, P1430, DOI 10.1016/j.biomaterials.2010.09.029; Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Yu ZG, 2004, AM J PHYSIOL-RENAL, V286, pF720, DOI 10.1152/ajprenal.00165.2003	29	25	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14523	10.1371/journal.pone.0014523	http://dx.doi.org/10.1371/journal.pone.0014523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264237	gold, Green Published			2022-12-27	WOS:000286516500005
J	Vo, LTK; Walther, DB; Kramer, AF; Erickson, KI; Boot, WR; Voss, MW; Prakash, RS; Lee, H; Fabiani, M; Gratton, G; Simons, DJ; Sutton, BP; Wang, MY				Vo, Loan T. K.; Walther, Dirk B.; Kramer, Arthur F.; Erickson, Kirk I.; Boot, Walter R.; Voss, Michelle W.; Prakash, Ruchika S.; Lee, Hyunkyu; Fabiani, Monica; Gratton, Gabriele; Simons, Daniel J.; Sutton, Bradley P.; Wang, Michelle Y.			Predicting Individuals' Learning Success from Patterns of Pre-Learning MRI Activity	PLOS ONE			English	Article							BASAL GANGLIA; SKILL ACQUISITION; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; VIDEO GAME; PERFORMANCE; DOPAMINE; TASK; DETERMINANTS; DEPLETION	Performance in most complex cognitive and psychomotor tasks improves with training, yet the extent of improvement varies among individuals. Is it possible to forecast the benefit that a person might reap from training? Several behavioral measures have been used to predict individual differences in task improvement, but their predictive power is limited. Here we show that individual differences in patterns of time-averaged T2*-weighted MRI images in the dorsal striatum recorded at the initial stage of training predict subsequent learning success in a complex video game with high accuracy. These predictions explained more than half of the variance in learning success among individuals, suggesting that individual differences in neuroanatomy or persistent physiology predict whether and to what extent people will benefit from training in a complex task. Surprisingly, predictions from white matter were highly accurate, while voxels in the gray matter of the dorsal striatum did not contain any information about future training success. Prediction accuracy was higher in the anterior than the posterior half of the dorsal striatum. The link between trainability and the time-averaged T2*-weighted signal in the dorsal striatum reaffirms the role of this part of the basal ganglia in learning and executive functions, such as task-switching and task coordination processes. The ability to predict who will benefit from training by using neuroimaging data collected in the early training phase may have far-reaching implications for the assessment of candidates for specific training programs as well as the study of populations that show deficiencies in learning new skills.	[Vo, Loan T. K.; Kramer, Arthur F.; Voss, Michelle W.; Lee, Hyunkyu; Fabiani, Monica; Gratton, Gabriele; Simons, Daniel J.; Sutton, Bradley P.; Wang, Michelle Y.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Vo, Loan T. K.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Walther, Dirk B.; Prakash, Ruchika S.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Kramer, Arthur F.; Voss, Michelle W.; Fabiani, Monica; Gratton, Gabriele; Simons, Daniel J.; Wang, Michelle Y.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Sutton, Bradley P.; Wang, Michelle Y.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Wang, Michelle Y.] Univ Illinois, Dept Stat, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Vo, LTK (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	bernhardt-walther.1@osu.edu	Prakash, Ruchika S/K-2030-2013; Simons, Daniel J./P-3625-2019; Sutton, Bradley P./A-4801-2008; Kramer, Arthur/AAB-2937-2019	Sutton, Bradley P./0000-0002-8443-0408; Gratton, Gabriele/0000-0003-3634-7463; Fabiani, Monica/0000-0002-7579-2773; Kramer, Arthur/0000-0001-5870-2724; Lauwereyns, Jan/0000-0003-0551-2550	Office of Naval Research [N00014-07-1-0903]; NATIONAL INSTITUTE ON AGING [K25AG033725] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the Office of Naval Research (grant award number N00014-07-1-0903). The Office of Naval Research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2000, J EXP PSYCHOL-APPL, V6, P259, DOI 10.1037//1076-898X.6.4.259; Ackerman PL, 1995, J EXP PSYCHOL-APPL, V1, P270, DOI 10.1037/1076-898X.1.4.270; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AMALRIC M, 1987, J NEUROSCI, V7, P2129; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Boot WR, 2010, ACTA PSYCHOL, V135, P349, DOI 10.1016/j.actpsy.2010.09.005; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; DONCHIN E, 1989, ACTA PSYCHOL, P71; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; MANE A, 1989, ACTA PSYCHOL, V71, P17, DOI 10.1016/0001-6918(89)90003-6; Meiran N, 2004, BRAIN COGNITION, V54, P260, DOI 10.1016/j.bandc.2004.02.043; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Ragozzino ME, 2002, BRAIN RES, V953, P205, DOI 10.1016/S0006-8993(02)03287-0; ROBBINS TW, 1990, BEHAV BRAIN RES, V38, P243, DOI 10.1016/0166-4328(90)90179-I; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Tuffiash M, 2007, J EXP PSYCHOL-APPL, V13, P124, DOI 10.1037/1076-898X.13.3.124; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	32	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16093	10.1371/journal.pone.0016093	http://dx.doi.org/10.1371/journal.pone.0016093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710MS	21264257	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000286516500027
J	Brackman, G; Celen, S; Hillaert, U; Van Calenbergh, S; Cos, P; Maes, L; Nelis, HJ; Coenye, T				Brackman, Gilles; Celen, Shari; Hillaert, Ulrik; Van Calenbergh, Serge; Cos, Paul; Maes, Louis; Nelis, Hans J.; Coenye, Tom			Structure-Activity Relationship of Cinnamaldehyde Analogs as Inhibitors of AI-2 Based Quorum Sensing and Their Effect on Virulence of Vibrio spp	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; HARVEYI; EXPRESSION; REGULATOR; SEQUENCE; PROTEIN; LUMINESCENCE; AUTOINDUCER; VULNIFICUS; SMCR	Background: Many bacteria, including Vibrio spp., regulate virulence gene expression in a cell-density dependent way through a communication process termed quorum sensing (QS). Hence, interfering with QS could be a valuable novel antipathogenic strategy. Cinnamaldehyde has previously been shown to inhibit QS-regulated virulence by decreasing the DNA-binding ability of the QS response regulator LuxR. However, little is known about the structure-activity relationship of cinnamaldehyde analogs. Methodology/Principal Findings: By evaluating the QS inhibitory activity of a series of cinnamaldehyde analogs, structural elements critical for autoinducer-2 QS inhibition were identified. These include an alpha, beta unsaturated acyl group capable of reacting as Michael acceptor connected to a hydrophobic moiety and a partially negative charge. The most active cinnamaldehyde analogs were found to affect the starvation response, biofilm formation, pigment production and protease production in Vibrio spp in vitro, while exhibiting low cytotoxicity. In addition, these compounds significantly increased the survival of the nematode Caenorhabditis elegans infected with Vibrio anguillarum, Vibrio harveyi and Vibrio vulnificus. Conclusions/Significance: Several new and more active cinnamaldehyde analogs were discovered and they were shown to affect Vibrio spp. virulence factor production in vitro and in vivo. Although ligands for LuxR have not been identified so far, the nature of different cinnamaldehyde analogs and their effect on the DNA binding ability of LuxR suggest that these compounds act as LuxR-ligands.	[Brackman, Gilles; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Celen, Shari; Hillaert, Ulrik; Van Calenbergh, Serge] Univ Ghent, Med Chem Lab, B-9000 Ghent, Belgium; [Cos, Paul; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium	Ghent University; Ghent University; University of Antwerp	Brackman, G (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	tom.coenye@UGent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Van Calenbergh, Serge/A-3167-2008; Maes, Louis JRM/A-2384-2017; cos, paul/AAU-3896-2020; Cos, Paul/L-9717-2015	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Van Calenbergh, Serge/0000-0002-4201-1264; Maes, Louis JRM/0000-0002-2324-9509; cos, paul/0000-0003-4361-8911; Cos, Paul/0000-0003-4361-8911	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Fund for Scientific research - Flanders (FWO-Vlaanderen); Ghent University	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific research - Flanders (FWO-Vlaanderen)(FWO); Ghent University(Ghent University)	This work was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, www.iwt.be), Fund for Scientific research - Flanders (FWO-Vlaanderen, www.fwo.be) and by the Special Research Fund (BOF) of Ghent University (www.ugent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Battistuzzi G, 2003, ORG LETT, V5, P777, DOI 10.1021/ol034071p; Brackman G, 2009, RES MICROBIOL, V160, P144, DOI 10.1016/j.resmic.2008.12.003; Brackman G, 2009, MICROBIOL-SGM, V155, P4114, DOI 10.1099/mic.0.032474-0; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Defoirdt T, 2006, APPL ENVIRON MICROB, V72, P6419, DOI 10.1128/AEM.00753-06; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Lautens M, 2004, J ORG CHEM, V69, P3478, DOI 10.1021/jo049874k; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Niu C, 2006, LETT APPL MICROBIOL, V43, P489, DOI 10.1111/j.1472-765X.2006.02001.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Stiernagle Theresa, 2006, WormBook, P1; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; TOPLISS JG, 1972, J MED CHEM, V15, P1066, DOI 10.1021/jm00280a017; TOPLISS JG, 1977, J MED CHEM, V20, P463, DOI 10.1021/jm00214a001; Wu ZX, 2004, J MED CHEM, V47, P3282, DOI 10.1021/jm0499615; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	31	89	95	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16084	10.1371/journal.pone.0016084	http://dx.doi.org/10.1371/journal.pone.0016084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249192	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000017
J	Mengatto, CM; Mussano, F; Honda, Y; Colwell, CS; Nishimura, I				Mengatto, Cristiane Machado; Mussano, Federico; Honda, Yoshitomo; Colwell, Christopher S.; Nishimura, Ichiro			Circadian Rhythm and Cartilage Extracellular Matrix Genes in Osseointegration: A Genome-Wide Screening of Implant Failure by Vitamin D Deficiency	PLOS ONE			English	Article							BONE; CLOCK; CALCIUM; MOUSE; TRANSCRIPTION; CHONDROCYTE; PHYSIOLOGY; GENETICS; COLLAGEN; SURFACE	Background: Successful dental and orthopedic implants require the establishment of an intimate association with bone tissue; however, the mechanistic explanation of how biological systems accomplish osseointegration is still incomplete. We sought to identify critical gene networks involved in osseointegration by exploring the implant failure model under vitamin D deficiency. Methodology: Adult male Sprague-Dawley rats were exposed to control or vitamin D-deficient diet prior to the osteotomy surgery in the femur bone and the placement of T-shaped Ti4Al6V implant. Two weeks after the osteotomy and implant placement, tissue formed at the osteotomy site or in the hollow chamber of T-shaped implant was harvested and total RNA was evaluated by whole genome microarray analyses. Principal Findings: Two-way ANOVA of microarray data identified 103 genes that were significantly (. 2 fold) modulated by the implant placement and vitamin D deficiency. Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses assigned the highest z-score to the circadian rhythm pathway including neuronal PAS domain 2 (NPAS2), and period homolog 2 (Per2). NPAS2 and Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/Bmal 1) were upregulated around implant and diminished by vitamin D deficiency, whereas the expression pattern of Per2 was complementary. Hierarchical cluster analysis further revealed that NPAS2 was in a group predominantly composed of cartilage extracellular matrix (ECM) genes. Whereas the expression of bone ECM genes around implant was not significantly affected by vitamin D deficiency, cartilage ECM genes were modulated by the presence of the implant and vitamin D status. In a proof-of-concept in vitro study, the expression of cartilage type II and X collagens was found upregulated when mouse mesenchymal stem cells were cultured on implant disk with 1,25D supplementation. Conclusions: This study suggests that the circadian rhythm system and cartilage extracellular matrix may be involved in the establishment of osseointegration under vitamin D regulation.	[Mengatto, Cristiane Machado; Mussano, Federico; Honda, Yoshitomo; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA; [Mengatto, Cristiane Machado] Univ Estadual Campinas, Piracicaba Sch Dent, Dept Prosthodont & Periodontol, Sao Paulo, Brazil; [Mussano, Federico] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Colwell, Christopher S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Universidade Estadual de Campinas; University of Turin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mengatto, CM (corresponding author), Univ Calif Los Angeles, Sch Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA.	inishimura@dentistry.ucla.edu	Honda, Yoshitomo/AAC-3994-2020; Mengatto, Cristiane Machado/E-7285-2016; Colwell, Chris/AAM-6111-2020	Honda, Yoshitomo/0000-0002-4392-2318; Mengatto, Cristiane Machado/0000-0002-1059-8419; Colwell, Christopher/0000-0002-1059-184X; Mussano, Federico/0000-0001-5800-0749	Coordination for the Improvement of Higher Education Personnel (CAPES), Sao Paulo, Brazil; Biomet3I, Palm Beach Garden, FL; National Center for Research Resources, National Institutes of Health (NCRR/NIH) [C06 RR014529]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER	Coordination for the Improvement of Higher Education Personnel (CAPES), Sao Paulo, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Biomet3I, Palm Beach Garden, FL; National Center for Research Resources, National Institutes of Health (NCRR/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported, in part by the Doctoral Program Scholarship from Coordination for the Improvement of Higher Education Personnel (CAPES), Sao Paulo, Brazil (for CMM) and Biomet3I, Palm Beach Garden, FL (for IN). This investigation was conducted in part in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR014529 from the National Center for Research Resources, National Institutes of Health (NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. S., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P344; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; ALBREKTSSON T, 1987, ACTA ORTHOP SCAND, V58, P567, DOI 10.3109/17453678709146401; Alvim-Pereira F, 2008, INT J ORAL MAX IMPL, V23, P409; BARSHAVIT Z, 1983, J CLIN INVEST, V72, P526, DOI 10.1172/JCI111000; Borgs L, 2009, CELL CYCLE, V8, P832, DOI 10.4161/cc.8.6.7869; Carinci F, 2004, CLIN ORAL IMPLAN RES, V15, P180, DOI 10.1111/j.1600-0501.2004.00997.x; Carinci Francesco, 2003, J Oral Implantol, V29, P215, DOI 10.1563/1548-1336(2003)029<0215:AOOMCR>2.3.CO;2; Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163; Davies John E, 2003, J Dent Educ, V67, P932; Devlin B, 2003, HEREDITY, V91, P537, DOI 10.1038/sj.hdy.6800370; ECONS MJ, 1992, J CLIN ENDOCR METAB, V75, P408, DOI 10.1210/jc.75.2.408; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernes de Abreu DA., 2009, PSYCHONEUROENDOCR S1, V34, pS265, DOI DOI 10.1016/J.PSYNEUEN.2009.05.023; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Heaney RP, 2003, AM J CLIN NUTR, V78, P912, DOI 10.1093/ajcn/78.5.912; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; Hirani V, 2010, AGE AGEING, V39, P62, DOI [10.1093/ageing/afp195, 10.1093/ageing/afp102]; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; HOKUGO A, 2010, J BONE MINER RES; Holahan CM, 2008, INT J ORAL MAX IMPL, V23, P905; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; IWASA F, 2009, BIOMATERIALS; Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x; KHAN WS, 2010, J ORTHOP RES; Kim CS, 2006, J ORAL REHABIL, V33, P368, DOI 10.1111/j.1365-2842.2005.01553.x; Kojima N, 2008, CLIN ORAL IMPLAN RES, V19, P173, DOI 10.1111/j.1600-0501.2007.01432.x; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002; Lekholm U, 2003, PERIODONTOL 2000, V33, P194, DOI 10.1046/j.0906-6713.2003.03316.x; Lin A, 2009, INT J ORAL MAX IMPL, V24, P808; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008; MARKWAY BD, 2009, CELL TRANSPLANT; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020; Mendes VC, 2009, J BIOMED MATER RES A, V90A, P577, DOI 10.1002/jbm.a.32126; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Nishimura I, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/24/245101; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reginster JY, 2005, CURR MED RES OPIN, V21, P579, DOI 10.1185/030079905X41435; Saintonge S, 2009, PEDIATRICS, V123, P797, DOI 10.1542/peds.2008-1195; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Schwartz Zvi, 2005, Alpha Omegan, V98, P9; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	58	39	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15848	10.1371/journal.pone.0015848	http://dx.doi.org/10.1371/journal.pone.0015848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264318	gold, Green Submitted, Green Published			2022-12-27	WOS:000286514000007
J	Zinocker, S; Wang, MY; Gaustad, P; Kvalheim, G; Rolstad, B; Vaage, JT				Zinocker, Severin; Wang, Meng-Yu; Gaustad, Peter; Kvalheim, Gunnar; Rolstad, Bent; Vaage, John T.			Mycoplasma Contamination Revisited: Mesenchymal Stromal Cells Harboring Mycoplasma hyorhinis Potently Inhibit Lymphocyte Proliferation In Vitro	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; ADIPOSE-TISSUE; IMMUNOSUPPRESSIVE PROPERTIES; INTERNATIONAL-SOCIETY; FAIL; SUPPRESSION; RESISTANT; CULTURES	Background: Mesenchymal stromal cells (MSC) have important immunomodulatory effects that can be exploited in the clinical setting, e. g. in patients suffering from graft-versus-host disease after allogeneic stem cell transplantation. In an experimental animal model, cultures of rat T lymphocytes were stimulated in vitro either with the mitogen Concanavalin A or with irradiated allogeneic cells in mixed lymphocyte reactions, the latter to simulate allo-immunogenic activation of transplanted T cells in vivo. This study investigated the inhibitory effects of rat bone marrow-derived MSC subsequently found to be infected with a common mycoplasma species (Mycoplasma hyorhinis) on T cell activation in vitro and experimental graft-versus-host disease in vivo. Principal Findings: We found that M. hyorhinis infection increased the anti-proliferative effect of MSC dramatically, as measured by both radiometric and fluorimetric methods. Inhibition could not be explained solely by the well-known ability of mycoplasmas to degrade tritiated thymidine, but likely was the result of rapid dissemination of M. hyorhinis in the lymphocyte culture. Conclusions: This study demonstrates the potent inhibitory effect exerted by M. hyorhinis in standard lymphocyte proliferation assays in vitro. MSC are efficient vectors of mycoplasma infection, emphasizing the importance of monitoring cell cultures for contamination.	[Zinocker, Severin; Vaage, John T.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Zinocker, Severin; Rolstad, Bent] Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0027 Oslo, Norway; [Wang, Meng-Yu] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Tumor Biol, Oslo, Norway; [Gaustad, Peter] Univ Oslo, Rikshosp, Inst Microbiol, N-0027 Oslo, Norway; [Kvalheim, Gunnar] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Cellular Therapy, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Zinocker, S (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway.	j.t.vaage@medisin.uio.no	Zinöcker, Severin/G-9026-2011	Zinöcker, Severin/0000-0003-1730-0125; Vaage, John T./0000-0003-0988-5768	European Commission [MRTN-CT-2004-512253]; Research Council of Norway and the Norwegian Cancer Society	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway and the Norwegian Cancer Society	This work was supported by the Marie Curie Research Training Network grant MRTN-CT-2004-512253 ('TRANS-NET') under the European Commission's Sixth Framework Programme (Ph.D. grant to SZ), and by the Research Council of Norway and the Norwegian Cancer Society (grants to BR and JTV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Badillo AT, 2008, BRIT J HAEMATOL, V141, P224, DOI 10.1111/j.1365-2141.2008.07040.x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jarvinen L, 2008, J IMMUNOL, V181, P4389, DOI 10.4049/jimmunol.181.6.4389; Kagemann G, 2005, BIOL CHEM, V386, P1055, DOI 10.1515/BC.2005.121; KOSTYAL DA, 1995, INFECT IMMUN, V63, P3858, DOI 10.1128/IAI.63.10.3858-3863.1995; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; MERKENSCHLAGER M, 1988, IMMUNOLOGY, V63, P125; Mielcarek M, 2011, BIOL BLOOD MARROW TR, V17, P214, DOI 10.1016/j.bbmt.2010.08.015; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nestvold JM, 2008, TRANSPLANTATION, V85, P102, DOI 10.1097/01.tp.0000296856.53493.1f; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POLLACK JD, 1983, YALE J BIOL MED, V56, P709; Prigozhina TB, 2008, EXP HEMATOL, V36, P1370, DOI 10.1016/j.exphem.2008.04.022; RAJ N, 2002, J COMP PATHOL, V140, P85, DOI DOI 10.1016/J.JCPA.2008.08.004; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rosner C, 2010, IMMUNOGENETICS, V62, P149, DOI 10.1007/s00251-010-0424-5; Shahzad W, 2010, VET IMMUNOL IMMUNOP, V136, P116, DOI 10.1016/j.vetimm.2010.02.001; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; SINIGAGLIA F, 1985, EUR J IMMUNOL, V15, P692, DOI 10.1002/eji.1830150710; SINIGAGLIA F, 1985, J IMMUNOL METHODS, V76, P85, DOI 10.1016/0022-1759(85)90483-1; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; Totte P, 2008, VET RES, V39, DOI 10.1051/vetres:2007046; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Vanden Bush TJ, 2004, BIOCHEM BIOPH RES CO, V315, P336, DOI 10.1016/j.bbrc.2004.01.063; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	14	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16005	10.1371/journal.pone.0016005	http://dx.doi.org/10.1371/journal.pone.0016005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264307	Green Published, gold, Green Submitted			2022-12-27	WOS:000286514000015
J	Lele, UN; Baig, UI; Watve, MG				Lele, Uttara N.; Baig, Ulfat I.; Watve, Milind G.			Phenotypic Plasticity and Effects of Selection on Cell Division Symmetry in Escherichia coli	PLOS ONE			English	Article							STEM-CELLS; LIFE-SPAN; EVOLUTION; PROTEINS; YEAST; RESTRICTION; SENESCENCE; BACTERIA; SIR2	Aging has been demonstrated in unicellular organisms and is presumably due to asymmetric distribution of damaged proteins and other components during cell division. Whether the asymmetry-induced aging is inevitable or an adaptive and adaptable response is debated. Although asymmetric division leads to aging and death of some cells, it increases the effective growth rate of the population as shown by theoretical and empirical studies. Mathematical models predict on the other hand, that if the cells divide symmetrically, cellular aging may be delayed or absent, growth rate will be reduced but growth yield will increase at optimum repair rates. Therefore in nutritionally dilute (oligotrophic) environments, where growth yield may be more critical for survival, symmetric division may get selected. These predictions have not been empirically tested so far. We report here that Escherichia coli grown in oligotrophic environments had greater morphological and functional symmetry in cell division. Both phenotypic plasticity and genetic selection appeared to shape cell division time asymmetry but plasticity was lost on prolonged selection. Lineages selected on high nutrient concentration showed greater frequency of presumably old or dead cells. Further, there was a negative correlation between cell division time asymmetry and growth yield but there was no significant correlation between asymmetry and growth rate. The results suggest that cellular aging driven by asymmetric division may not be hardwired but shows substantial plasticity as well as evolvability in response to the nutritional environment.	[Lele, Uttara N.; Baig, Ulfat I.] Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India; [Watve, Milind G.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Lele, UN (corresponding author), Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India.	milind@iiserpune.ac.in			Council for Scientific and Industrial Research, India	Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	UL was supported by a junior research fellowship by the Council for Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Johnson LR, 2006, MECH AGEING DEV, V127, P786, DOI 10.1016/j.mad.2006.07.004; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P1011, DOI 10.1016/j.mad.2005.03.021; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lin HF, 1997, DEVELOPMENT, V124, P2463; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; NYSTROM T, 1995, J BACTERIOL, V177, P5707, DOI 10.1128/jb.177.19.5707-5710.1995; Pfeiffer T, 2002, Z PHYS CHEM, V216, P51, DOI 10.1524/zpch.2002.216.1.051; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009; Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Turke PW, 2008, Q REV BIOL, V83, P243, DOI 10.1086/590509; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Watve M, 2000, CURR SCI INDIA, V78, P1535; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150	28	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e14516	10.1371/journal.pone.0014516	http://dx.doi.org/10.1371/journal.pone.0014516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249222	gold, Green Published, Green Submitted			2022-12-27	WOS:000286513100002
J	Phang, BH; Chua, HW; Li, HH; Linn, YC; Sabapathy, K				Phang, Beng Hooi; Chua, Hui Wan; Li, Huihua; Linn, Yeh Ching; Sabapathy, Kanaga			Characterization of Novel and Uncharacterized p53 SNPs in the Chinese Population - Intron 2 SNP Co-Segregates with the Common Codon 72 Polymorphism	PLOS ONE			English	Article							LUNG-CANCER SUSCEPTIBILITY; COLORECTAL-CANCER; INCREASED RISK; BREAST-CANCER; ONSET AGE; ASSOCIATION; GENE; VARIANTS; PROMOTES; LEUKEMIA	Multiple single nucleotide polymorphisms (SNPs) have been identified in the tumor suppressor gene p53, though the relevance of many of them is unclear. Some of them are also differentially distributed in various ethnic populations, suggesting selective functionality. We have therefore sequenced all exons and flanking regions of p53 from the Singaporean Chinese population and report here the characterization of some novel and uncharacterized SNPs - four in intron 1 (nucleotide positions 8759/10361/10506/11130), three in intron 3 (11968/11969/11974) and two in the 3'UTR (19168/19514). Allelic frequencies were determined for all these and some known SNPs, and were compared in a limited scale to leukemia and lung cancer patient samples. Intron 2 (11827) and 7 (14181/14201) SNPs were found to have a high minor allele frequency of between 26-47%, in contrast to the lower frequencies found in the US population, but similar in trend to the codon 72 polymorphism (SNP12139) that shows a distribution pattern correlative with latitude. Several of the SNPs were linked, such as those in introns 1, 3 and 7. Most interestingly, we noticed the co-segregation of the intron 2 and the codon 72 SNPs, the latter which has been shown to be expressed in an allele-specific manner, suggesting possible regulatory crosstalk. Association analysis indicated that the T/G alleles in both the co-segregating intron 7 SNPs and a 4tagSNP haplotype was strongly associated increased susceptibility to lung cancer in non-smoker females [ OR: 1.97 (1.32, 3.394)]. These data together demonstrate high SNP diversity in p53 gene between different populations, highlighting ethnicity-based differences, and their association with cancer risk.	[Phang, Beng Hooi; Chua, Hui Wan; Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore; [Li, Huihua] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Linn, Yeh Ching] Singapore Gen Hosp, Dept Hematol, Singapore 0316, Singapore; [Sabapathy, Kanaga] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Sabapathy, Kanaga] Duke Natl Univ Singapore, Canc & Stem Cell Biol Program, Grad Sch Med, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore	Phang, BH (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore.	cmrksb@nccs.com.sg			National Medical Research Council; Singhealth Research Foundation	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singhealth Research Foundation(SingHealth)	The authors acknowledge the grant support from the National Medical Research Council and the Singhealth Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Biros E, 2001, LUNG CANCER, V31, P157, DOI 10.1016/S0169-5002(00)00188-4; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Buyru N, 2003, ONCOL REP, V10, P711; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chua HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-88; Damin APS, 2006, CANCER DETECT PREV, V30, P523, DOI 10.1016/j.cdp.2006.09.007; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Gu Qi-hua, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P319; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Khadang B, 2007, CANCER GENET CYTOGEN, V173, P38, DOI 10.1016/j.cancergencyto.2006.09.010; Kupper M, 2001, BRIT J HAEMATOL, V112, P768, DOI 10.1046/j.1365-2141.2001.02566.x; Lavin LF, 1999, INT J RADIAT BIOL, V75, P1201; Lehman TA, 2000, CANCER RES, V60, P1062; Li Ye-qing, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P386; Lum SS, 2008, CARCINOGENESIS, V29, P754, DOI 10.1093/carcin/bgn024; Mabrouk I, 2003, ANN NY ACAD SCI, V1010, P764, DOI 10.1196/annals.1299.137; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Papadakis E. N., 2000, Molecular Cell Biology Research Communications, V3, P389, DOI 10.1006/mcbr.2000.0241; PETITJEAN A, 2002, REV ONCOGENE, V26, P2157; Phang BH, 2008, EUR J CANCER, V44, P760, DOI 10.1016/j.ejca.2008.02.007; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; PROSSER J, 1991, NUCLEIC ACIDS RES, V19, P4799, DOI 10.1093/nar/19.17.4799-a; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Siddique MM, 2005, CANCER EPIDEM BIOMAR, V14, P2245, DOI 10.1158/1055-9965.EPI-05-0153; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Toyama T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1682; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang YC, 1999, CLIN CANCER RES, V5, P129; Wang-Gohrke S, 1999, BRIT J CANCER, V81, P179, DOI 10.1038/sj.bjc.6690669; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681	40	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15320	10.1371/journal.pone.0015320	http://dx.doi.org/10.1371/journal.pone.0015320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249215	Green Submitted, Green Published, gold			2022-12-27	WOS:000286513100005
J	Palacios-Chaves, L; Conde-Alvarez, R; Gil-Ramirez, Y; Zuniga-Ripa, A; Barquero-Calvo, E; Chacon-Diaz, C; Chaves-Olarte, E; Arce-Gorvel, V; Gorvel, JP; Moreno, E; de Miguel, MJ; Grillo, MJ; Moriyon, I; Iriarte, M				Palacios-Chaves, Leyre; Conde-Alvarez, Raquel; Gil-Ramirez, Yolanda; Zuniga-Ripa, Amaia; Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Arce-Gorvel, Vilma; Gorvel, Jean-Pierre; Moreno, Edgardo; de Miguel, Maria-Jesus; Grillo, Maria-Jesus; Moriyon, Ignacio; Iriarte, Maite			Brucella abortus Ornithine Lipids Are Dispensable Outer Membrane Components Devoid of a Marked Pathogen-Associated Molecular Pattern	PLOS ONE			English	Article							BACTERICIDAL CATIONIC PEPTIDES; PSEUDOMONAS-FLUORESCENS; LIPOPOLYSACCHARIDE; RESISTANCE; MUTANTS; CELLS; MICE; PHOSPHATIDYLCHOLINE; FLAVOBACTERIUM; IDENTIFICATION	The brucellae are alpha-Proteobacteria facultative intracellular parasites that cause an important zoonosis. These bacteria escape early detection by innate immunity, an ability associated to the absence of marked pathogen-associated molecular patterns in the cell envelope lipopolysaccharide, lipoproteins and flagellin. We show here that, in contrast to the outer membrane ornithine lipids (OL) of other Gram negative bacteria, Brucella abortus OL lack a marked pathogen-associated molecular pattern activity. We identified two OL genes (olsB and olsA) and by generating the corresponding mutants found that olsB deficient B. abortus did not synthesize OL or their lyso-OL precursors. Liposomes constructed with B. abortus OL did not trigger IL-6 or TNF-alpha release by macrophages whereas those constructed with Bordetella pertussis OL and the olsB mutant lipids as carriers were highly active. The OL deficiency in the olsB mutant did not promote proinflammatory responses or generated attenuation in mice. In addition, OL deficiency did not increase sensitivity to polymyxins, normal serum or complement consumption, or alter the permeability to antibiotics and dyes. Taken together, these observations indicate that OL have become dispensable in the extant brucellae and are consistent within the trend observed in alpha-Proteobacteria animal pathogens to reduce and eventually eliminate the envelope components susceptible of recognition by innate immunity.	[Palacios-Chaves, Leyre; Conde-Alvarez, Raquel; Gil-Ramirez, Yolanda; Zuniga-Ripa, Amaia; Moriyon, Ignacio; Iriarte, Maite] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Conde-Alvarez, Raquel] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Fac Sci Luminy, INSERM,CNRS,U631,UMR6102, Marseille, France; [Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Pedro, Costa Rica; [de Miguel, Maria-Jesus] CITA, Unidad Sanidad Anim, Zaragoza, Spain; [Grillo, Maria-Jesus] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Pamplona, Spain	University of Navarra; University of Basel; Universidad Costa Rica; Universidad Nacional Costa Rica; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Costa Rica; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra	Palacios-Chaves, L (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.	miriart@unav.es	BARQUERO-CALVO, ELIAS/GLU-1867-2022; Conde-Álvarez, Raquel/K-5854-2014; Moriyon, Ignacio/N-4764-2016; Grilló, María-Jesús/F-9621-2011; Zúñiga-Ripa, Amaia/ABB-4859-2020; ZÃÃiga, Amaia/GXF-9866-2022; De Miguel, María Jesús/K-5860-2014; ZUÑIGA-RIPA, AMAIA/F-5117-2017; IRIARTE, MAITE/L-9460-2014; Gorvel, Jean-Pierre/O-1332-2018	BARQUERO-CALVO, ELIAS/0000-0003-4428-3340; Conde-Álvarez, Raquel/0000-0003-0046-3577; Moriyon, Ignacio/0000-0002-4288-0195; Grilló, María-Jesús/0000-0002-1819-0186; Zúñiga-Ripa, Amaia/0000-0001-7865-8994; De Miguel, María Jesús/0000-0002-5037-3687; ZUÑIGA-RIPA, AMAIA/0000-0001-7865-8994; IRIARTE, MAITE/0000-0002-6726-8920; Gorvel, Jean-Pierre/0000-0002-2829-9804; Arce-Gorvel, Vilma/0000-0003-0090-837X	Ministerio de Ciencia y Tecnologia of Spain [AGL2008-04514-C03]; Universidad Nacional de Costa Rica; S-Conare UNA/UCR, Costa Rica [IFEG29]; NeTropica [P00059, F00013-02]; MICIT/CONICIT [IFDG12]; Fundacion CRUSA-CSIC [CR2008-0006]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale and the Ministry of Education in France; Ministerio de Ciencia y Tecnologia of Spain; University of Navarra	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad Nacional de Costa Rica; S-Conare UNA/UCR, Costa Rica; NeTropica; MICIT/CONICIT; Fundacion CRUSA-CSIC; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale and the Ministry of Education in France; Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Navarra	Research at the laboratories of the authors is supported by the Ministerio de Ciencia y Tecnologia of Spain (AGL2008-04514-C03); FIDA, Universidad Nacional de Costa Rica; FS-Conare UNA/UCR IFEG29 Costa Rica; NeTropica P00059 and F00013-02; MICIT/CONICIT IFDG12; Fundacion CRUSA-CSIC (CR2008-0006); Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale and the Ministry of Education in France. Fellowship support for L.P.-C., Y.G.-R. and A.Z.-R from the Ministerio de Ciencia y Tecnologia of Spain, Gobierno de Navarra and Friends of the University of Navarra is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993; DETEJADA GM, 1995, INFECT IMMUN, V63, P3054; DETEJADA GM, 1993, J BACTERIOL, V175, P5273; DORRER E, 1977, ARCH MICROBIOL, V114, P87, DOI 10.1007/BF00429636; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996; GAMAZO C, 1987, INFECT IMMUN, V55, P609, DOI 10.1128/IAI.55.3.609-615.1987; Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Grillo MJ, 2006, VACCINE, V24, P2910, DOI 10.1016/j.vaccine.2005.12.038; Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; IRIARTE M, 2004, MOL CELL BIOL, P159; Kato H, 1997, MICROBIOL IMMUNOL, V41, P101, DOI 10.1111/j.1348-0421.1997.tb01175.x; KAWAI Y, 1985, EUR J BIOCHEM, V147, P367, DOI 10.1111/j.1432-1033.1985.tb08759.x; Kawai Y, 1985, Dev Biol Stand, V61, P249; Kawai Y, 1999, FEMS IMMUNOL MED MIC, V23, P67, DOI 10.1016/S0928-8244(98)00122-9; KAWAI Y, 1991, INFECT IMMUN, V59, P2560, DOI 10.1128/IAI.59.8.2560-2566.1991; KAWAI Y, 1991, FEMS MICROBIOL LETT, V83, P127; Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P205; KAWAI Y, 1989, INFECT IMMUN, V57, P2086, DOI 10.1128/IAI.57.7.2086-2091.1989; Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P197, DOI 10.1016/S0928-8244(00)00156-5; Kong WM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-12; KUPFER D, 1984, J BACTERIOL, V159, P776, DOI 10.1128/JB.159.2.776-779.1984; Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005; Lin MQ, 2003, CELL MICROBIOL, V5, P809, DOI 10.1046/j.1462-5822.2003.00322.x; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; MORIYON I, 1982, J BACTERIOL, V152, P822; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Rikihisa Y, 2006, CURR OPIN MICROBIOL, V9, P95, DOI 10.1016/j.mib.2005.12.003; Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; THIELE O W, 1973, European Journal of Biochemistry, V34, P333, DOI 10.1111/j.1432-1033.1973.tb02764.x; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200	55	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16030	10.1371/journal.pone.0016030	http://dx.doi.org/10.1371/journal.pone.0016030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249206	Green Published, gold, Green Submitted			2022-12-27	WOS:000286512900019
J	Batista-Nascimento, L; Neef, DW; Liu, PCC; Rodrigues-Pousada, C; Thiele, DJ				Batista-Nascimento, Liliana; Neef, Daniel W.; Liu, Phillip C. C.; Rodrigues-Pousada, Claudina; Thiele, Dennis J.			Deciphering Human Heat Shock Transcription Factor 1 Regulation via Post-Translational Modification in Yeast	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; FACTOR-I; POLYGLUTAMINE TOXICITY; MOLECULAR CHAPERONES; NUCLEAR-LOCALIZATION; FACTOR TRIMERIZATION; HUNTINGTONS-DISEASE; GENE-TRANSCRIPTION	Heat shock transcription factor 1 (HSF1) plays an important role in the cellular response to proteotoxic stresses. Under normal growth conditions HSF1 is repressed as an inactive monomer in part through post-translation modifications that include protein acetylation, sumoylation and phosphorylation. Upon exposure to stress HSF1 homotrimerizes, accumulates in nucleus, binds DNA, becomes hyper-phosphorylated and activates the expression of stress response genes. While HSF1 and the mechanisms that regulate its activity have been studied for over two decades, our understanding of HSF1 regulation remains incomplete. As previous studies have shown that HSF1 and the heat shock response promoter element (HSE) are generally structurally conserved from yeast to metazoans, we have made use of the genetically tractable budding yeast as a facile assay system to further understand the mechanisms that regulate human HSF1 through phosphorylation of serine 303. We show that when human HSF1 is expressed in yeast its phosphorylation at S303 is promoted by the MAP-kinase Slt2 independent of a priming event at S307 previously believed to be a prerequisite. Furthermore, we show that phosphorylation at S303 in yeast and mammalian cells occurs independent of GSK3, the kinase primarily thought to be responsible for S303 phosphorylation. Lastly, while previous studies have suggested that S303 phosphorylation represses HSF1-dependent transactivation, we now show that S303 phosphorylation also represses HSF1 multimerization in both yeast and mammalian cells. Taken together, these studies suggest that yeast cells will be a powerful experimental tool for deciphering aspects of human HSF1 regulation by post-translational modifications.	[Batista-Nascimento, Liliana; Rodrigues-Pousada, Claudina] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Genom & Stress Lab, Oeiras, Portugal; [Neef, Daniel W.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Liu, Phillip C. C.] Incyte Corp, Appl Technol Grp, Wilmington, DE USA	Universidade Nova de Lisboa; Duke University; Incyte	Batista-Nascimento, L (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Genom & Stress Lab, Oeiras, Portugal.	dennis.thiele@duke.edu		Rodrigues-Pousada, Claudina/0000-0002-5075-3639	National Institutes of Health [GM076954, R01-NS065890]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39389/2007, PTDC/BIAMIC/108747/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health National Research Service Award (NRSA) Postdoctoral Fellowship GM076954 (to DWN), grant R01-NS065890 (to DJT), and grants from the Fundacao para a Ciencia e Tecnologia (No. SFRH/BD/39389/2007 to LB-N and No. PTDC/BIAMIC/108747/2008 to CR-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PCCL contributed to this manuscript before employment at Incyte Corporation, which had no involvement in this study.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ahn SG, 2001, GENE DEV, V15, P2134, DOI 10.1101/gad.894801; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; Liu PCC, 1999, J BIOL CHEM, V274, P17219, DOI 10.1074/jbc.274.24.17219; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; MAZZONI C, 1993, J CELL BIOL, V123, P1821, DOI 10.1083/jcb.123.6.1821; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Orosz A, 1996, MOL CELL BIOL, V16, P7018; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rimoldi M, 2001, BRAIN RES BULL, V56, P353, DOI 10.1016/S0361-9230(01)00602-5; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Xia WL, 1998, J BIOL CHEM, V273, P8749, DOI 10.1074/jbc.273.15.8749; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	49	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15976	10.1371/journal.pone.0015976	http://dx.doi.org/10.1371/journal.pone.0015976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253609	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900033
J	Gilmore, SJ				Gilmore, Stephen J.			Control Strategies for Endemic Childhood Scabies	PLOS ONE			English	Article							DISEASE; IVERMECTIN; CHILDREN; MODEL	Human scabies is a major global public health issue, with an estimated 300 million cases per year worldwide. Prevalence rates are particularly high in many third-world regions and within various indigenous communities in developed countries. Infestation with Sarcoptes Scabiei is associated with group-A streptococcal pyoderma which in turn predisposes to rheumatic fever, acute glomerulonephritis and their respective long-term sequelae: rheumatic heart disease and chronic renal insufficiency. The documented difficulties inherent in achieving scabies control within affected communities have motivated us to develop a network-dependent Monte-Carlo model of the scabies contagion, with the dual aims of gaining insight into its dynamics, and in determining the effects of various treatment strategies. Here we show that scabies burden is adversely affected by increases in average network degree, prominent network clustering, and by a person-to-person transmissibility of greater magnitude. We demonstrate that creating a community-specific model allows for the determination of an effective treatment protocol that can satisfy any pre-defined target prevalence. We find frequent low-density treatment protocols are inherently advantageous in comparison with infrequent mass screening and treatment regimes: prevalence rates are lower when compared with protocols that administer the same number of treatments over a given time interval less frequently, and frequent low-density treatment protocols have economic, practical and public acceptance advantages that may facilitate their long-term implementation. This work demonstrates the importance of stochasticity, community structure and the heterogeneity of individuals in influencing the dynamics of the human scabies contagion, and provides a practical method for investigating the outcomes of various intervention strategies.	Univ Queensland, Dermatol Res Ctr, Sch Med, Princess Alexandra Hosp, Brisbane, Qld, Australia	University of Queensland	Gilmore, SJ (corresponding author), Univ Queensland, Dermatol Res Ctr, Sch Med, Princess Alexandra Hosp, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au			University of Queensland, Brisbane, Australia	University of Queensland, Brisbane, Australia(University of Queensland)	This work was supported by The University of Queensland, Brisbane, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; Australian Bureau of Statistics Australian Institute of Health Welfare, 2008, HLTH WELF AUSTR AB T; Carapetis JR, 1996, MED J AUSTRALIA, V164, P146, DOI 10.5694/j.1326-5377.1996.tb122012.x; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P275, DOI 10.2471/BLT.07.043034; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Johnston G, 2005, BMJ-BRIT MED J, V331, P619, DOI 10.1136/bmj.331.7517.619; Karthikeyan K, 2005, POSTGRAD MED J, V81, P7, DOI 10.1136/pgmj.2003.018390; La Vincente S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000444; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; LIN XD, 1993, MATH BIOSCI, V118, P181, DOI 10.1016/0025-5564(93)90051-B; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; REID HFM, 1990, EPIDEMIOL INFECT, V105, P595, DOI 10.1017/S0950268800048238; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Savin JA, 2005, J ROY SOC MED, V98, P124, DOI 10.1258/jrsm.98.3.124; Speare R, 2004, B WORLD HEALTH ORGAN, V82, P562; Steer AC, 2009, B WHO, V87; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Strong M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000320.pub2; TAPLIN D, 1983, J AM ACAD DERMATOL, V9, P546, DOI 10.1016/S0190-9622(83)70167-2; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; White AV, 2001, MED J AUSTRALIA, V174, P492, DOI 10.5694/j.1326-5377.2001.tb143394.x	26	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15990	10.1371/journal.pone.0015990	http://dx.doi.org/10.1371/journal.pone.0015990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283575	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400020
J	Meyer-Hoffert, U; Zimmermann, A; Czapp, M; Bartels, J; Koblyakova, Y; Glaser, R; Schroder, JM; Gerstel, U				Meyer-Hoffert, Ulf; Zimmermann, Alexandra; Czapp, Manfred; Bartels, Joachim; Koblyakova, Yulia; Glaeser, Regine; Schroeder, Jens-Michael; Gerstel, Ulrich			Flagellin Delivery by Pseudomonas aeruginosa Rhamnolipids Induces the Antimicrobial Protein Psoriasin in Human Skin	PLOS ONE			English	Article							BACTERIAL FLAGELLIN; SURFACE-PROPERTIES; PEPTIDE; BIOSURFACTANT; MICROBIOTA; MECHANISM	The opportunistic pathogen Pseudomonas aeruginosa can cause severe infections in patients suffering from disruption or disorder of the skin barrier as in burns, chronic wounds, and after surgery. On healthy skin P. aeruginosa causes rarely infections. To gain insight into the interaction of the ubiquitous bacterium P. aeruginosa and healthy human skin, the induction of the antimicrobial protein psoriasin by P. aeruginosa grown on an ex vivo skin model was analyzed. We show that presence of the P. aeruginosa derived biosurfactant rhamnolipid was indispensable for flagellin-induced psoriasin expression in human skin, contrary to in vitro conditions. The importance of the bacterial virulence factor flagellin as the major inducing factor of psoriasin expression in skin was demonstrated by use of a flagellin-deficient mutant. Rhamnolipid mediated shuttle across the outer skin barrier was not restricted to flagellin since rhamnolipids enable psoriasin expression by the cytokines IL-17 and IL-22 after topical application on human skin. Rhamnolipid production was detected for several clinical strains and the formation of vesicles was observed under skin physiological conditions. In conclusion we demonstrate herein that rhamnolipids enable the induction of the antimicrobial protein psoriasin by flagellin in human skin without direct contact of bacteria and responding cells. Hereby, human skin might control the microflora to prevent colonization of unwanted microbes in the earliest steps before potential pathogens can develop strategies to subvert the immune response.	[Meyer-Hoffert, Ulf; Zimmermann, Alexandra; Czapp, Manfred; Bartels, Joachim; Koblyakova, Yulia; Glaeser, Regine; Schroeder, Jens-Michael; Gerstel, Ulrich] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Meyer-Hoffert, U (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	Ugerstel@dermatology.uni-kiel.de	Meyer-Hoffert, Ulf/F-4623-2012; Gläser, Regine/B-3168-2010	Meyer-Hoffert, Ulf/0000-0003-2305-1428; Bartels, Joachim/0000-0003-4395-4552	medical faculty Kiel	medical faculty Kiel	This study was supported by grants of the medical faculty Kiel (U. Meyer-Hoffert, U. Gerstel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtin A, 2008, FASEB J, V22, P2168, DOI 10.1096/fj.07-104117; Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Benincasa M, 2004, ANTON LEEUW INT J G, V85, P1, DOI 10.1023/B:ANTO.0000020148.45523.41; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bosgelmez-Tinaz G, 2008, MICROB PATHOGENESIS, V44, P13, DOI 10.1016/j.micpath.2007.06.005; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Cao B, 2004, J HOSP INFECT, V57, P112, DOI 10.1016/j.jhin.2004.03.021; Choi MJ, 2005, SKIN PHARMACOL PHYS, V18, P209, DOI 10.1159/000086666; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Dahrazma B, 2008, J COLLOID INTERF SCI, V319, P590, DOI 10.1016/j.jcis.2007.11.045; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Deziel E, 1999, BBA-MOL CELL BIOL L, V1440, P244, DOI 10.1016/S1388-1981(99)00129-8; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Gerstel U, 2009, CELL MICROBIOL, V11, P842, DOI 10.1111/j.1462-5822.2009.01299.x; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Haba E, 2003, BIOTECHNOL BIOENG, V81, P316, DOI 10.1002/bit.10474; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; KOCH AK, 1991, J BACTERIOL, V173, P4212, DOI 10.1128/jb.173.13.4212-4219.1991; Lequette Y, 2005, J BACTERIOL, V187, P37, DOI 10.1128/JB.187.1.37-44.2005; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; NOBLE W. C., 1981, MICROBIOLOGY HUMAN S; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Ramphal R, 1996, AM J RESP CRIT CARE, V154, pS170, DOI 10.1164/ajrccm/154.4_Pt_2.S170; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; Stipcevic T, 2005, J DERMATOL SCI, V40, P141, DOI 10.1016/j.jdermsci.2005.08.005; SYLDATK C, 1985, Z NATURFORSCH C, V40, P61; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; ZHANG YM, 1994, APPL ENVIRON MICROB, V60, P2101, DOI 10.1128/AEM.60.6.2101-2106.1994	42	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16433	10.1371/journal.pone.0016433	http://dx.doi.org/10.1371/journal.pone.0016433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283546	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400052
J	Wu, JA; Ye, SY; Xu, XF; Xie, HY; Zhou, L; Zheng, SS				Wu, Jian; Ye, SunYi; Xu, XiaoFeng; Xie, Haiyang; Zhou, Lin; Zheng, ShuSen			Recipient Outcomes after ABO-Incompatible Liver Transplantation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BLOOD-GROUP BARRIERS; SINGLE-CENTER EXPERIENCE; BILIARY COMPLICATIONS; HEPATITIS-C; AGE; IMMUNOSUPPRESSION; PLASMAPHERESIS; REJECTION; FIBROSIS; CHILDREN	Background: ABO-incompatible live transplantation (ILT) is not occasionally performed due to a relative high risk of graft failure. Knowledge of both graft and patient survival rate after ILT is essential for donor selection and therapeutic strategy. We systematically reviewed studies containing outcomes after ILT compared to that after ABO-compatible liver transplantation (CLT). Methodology/Principal Findings: We carried out a comprehensive search strategy on MEDLINE (1966-July 2010), EMBASE (1980-July 2010), Biosis Preview (1969-July 2010), Science Citation Index (1981-July 2010), Cochrane Database of Systematic Reviews (Cochrane Library, issue 7, 2010) and the National Institute of Health (July 2010). Two reviewers independently assessed the quality of each study and abstracted outcome data. Fourteen eligible studies were included which came from various medical centers all over the world. Meta-analysis results showed that no significantly statistical difference was found in pediatric graft survival rate, pediatric and adult patient survival rate between ILT and CLT group. In adult subgroup, the graft survival rate after ILT was significantly lower than that after CLT. The value of totally pooled OR was 0.64 (0.55, 0.74), 0.92 (0.62, 1.38) for graft survival rate and patient survival rate respectively. The whole complication incidence (including acute rejection and biliary complication) after ILT was higher than that after CLT, as the value of totally pooled OR was 3.02 (1.33, 6.85). Similarly, in acute rejection subgroup, the value of OR was 2.02 (1.01, 4.02). However, it was 4.08 (0.90, 18.51) in biliary complication subgroup. Conclusions/Significance: In our view, pediatric ILT has not been a contraindication anymore due to a similar graft and patient survival rate between ILT and CLT group. Though adult graft survival rate is not so satisfactory, ILT is undoubtedly life-saving under exigent condition. Most studies included in our analysis are observational researches. Larger scale of researches and Randomized-Control Studies are still needed.	[Wu, Jian; Ye, SunYi; Xu, XiaoFeng; Xie, Haiyang; Zhou, Lin; Zheng, ShuSen] Zhejiang Univ, Key Lab Combined Multi Organ Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jian; Ye, SunYi; Xu, XiaoFeng; Xie, Haiyang; Zhou, Lin; Zheng, ShuSen] Zhejiang Univ, Key Lab Organ Transplantat, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jian; Ye, SunYi; Xu, XiaoFeng; Xie, Haiyang; Zhou, Lin; Zheng, ShuSen] Zhejiang Univ, Div Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Sch Med,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Wu, JA (corresponding author), Zhejiang Univ, Key Lab Combined Multi Organ Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			Fundamental Research Funds for the Central Universities, China; National Key Technology RD Program [2008BAI60B02]; Science and Technology Bureau of Zhejiang Province [2006C13020]	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); National Key Technology RD Program(National Key Technology R&D Program); Science and Technology Bureau of Zhejiang Province	This study was supported by the Fundamental Research Funds for the Central Universities, China; National Key Technology R&D Program (No. 2008BAI60B02); Major Program of Science and Technology Bureau of Zhejiang Province (No. 2006C13020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjoro K, 2003, TRANSPLANTATION, V75, P347, DOI 10.1097/01.TP.0000044359.72379.E5; Busquets J, 2007, J GASTROINTEST SURG, V11, P458, DOI 10.1007/s11605-007-0116-0; CACCIARELLI TV, 1995, TRANSPLANTATION, V60, P757, DOI 10.1097/00007890-199510150-00024; Chui AKK, 1997, AUST NZ J SURG, V67, P275, DOI 10.1111/j.1445-2197.1997.tb01962.x; DEMETRIS AJ, 1988, AM J PATHOL, V132, P489; Egawa H, 2008, HEPATOLOGY, V47, P143, DOI 10.1002/hep.21928; Eid A, 1998, TRANSPLANT P, V30, P701, DOI 10.1016/S0041-1345(98)00014-1; FARGES O, 1995, TRANSPLANTATION, V59, P1124, DOI 10.1097/00007890-199504270-00009; Fehr T, 2009, TRANSPLANTATION, V87, P1837, DOI 10.1097/TP.0b013e3181a6bac5; FERRIANI VPL, 1990, ACTA PAEDIATR SCAND, V79, P322, DOI 10.1111/j.1651-2227.1990.tb11464.x; FONG SW, 1974, TRANSFUSION, V14, P551, DOI 10.1111/j.1537-2995.1974.tb04576.x; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Garcia-Gil FA, 2006, TRANSPL P, V38, P2465, DOI 10.1016/j.transproceed.2006.08.072; GUGENHEIM J, 1990, LANCET, V336, P519, DOI 10.1016/0140-6736(90)92082-S; Hanto DW, 2003, LIVER TRANSPLANT, V9, P22, DOI 10.1053/jlts.2003.50011; Heffron T, 2006, LIVER TRANSPLANT, V12, P972, DOI 10.1002/lt.20760; Heffron TG, 2010, PEDIATR TRANSPLANT, V14, P228, DOI 10.1111/j.1399-3046.2009.01202.x; Hernandez Q, 1999, TRANSPLANT P, V31, P2407, DOI 10.1016/S0041-1345(99)00405-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iwamoto H, 2008, TRANSPL P, V40, P2539, DOI 10.1016/j.transproceed.2008.07.042; Kozaki K, 2005, THER APHER DIAL, V9, P285, DOI 10.1111/j.1744-9987.2005.00304.x; LO CM, 1994, TRANSPLANTATION, V58, P543, DOI 10.1097/00007890-199409150-00003; Matsuno N, 2007, CLIN TRANSPLANT, V21, P638, DOI 10.1111/j.1399-0012.2007.00702.x; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nakamura Y, 2004, TRANSPL P, V36, P2269, DOI 10.1016/j.transproceed.2004.08.094; Rayhill SC, 2007, TRANSPLANTATION, V84, P331, DOI 10.1097/01.tp.0000270313.31328.63; REDING R, 1992, SURG GYNECOL OBSTET, V174, P59; RENARD TH, 1992, TRANSPLANTATION, V53, P116, DOI 10.1097/00007890-199201000-00022; SANCHEZURDAZPAL L, 1993, ANN SURG, V218, P152, DOI 10.1097/00000658-199308000-00006; Skogsberg U, 2006, TRANSPLANT P, V38, P2667, DOI 10.1016/j.transproceed.2006.07.025; STARZL TE, 1992, LANCET, V340, P876, DOI 10.1016/0140-6736(92)93286-V; Stewart ZA, 2009, LIVER TRANSPLANT, V15, P883, DOI 10.1002/lt.21723; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TOKUNAGA Y, 1993, TRANSPLANT INT, V6, P313, DOI 10.1111/j.1432-2277.1993.tb00673.x; Toso C, 2007, TRANSPL INT, V20, P675, DOI 10.1111/j.1432-2277.2007.00492.x; Ueda M, 2006, LIVER TRANSPLANT, V12, P1326, DOI 10.1002/lt.20826; Urbani L, 2008, J CLIN APHERESIS, V23, P55, DOI 10.1002/jca.20156; Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248; Yang Yang, 2007, Zhonghua Yi Xue Za Zhi, V87, P2833	39	80	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16521	10.1371/journal.pone.0016521	http://dx.doi.org/10.1371/journal.pone.0016521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283553	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400057
J	Ryan, J; Curran, CE; Hennessy, E; Newell, J; Morris, JC; Kerin, MJ; Dwyer, RM				Ryan, James; Curran, Catherine E.; Hennessy, Emer; Newell, John; Morris, John C.; Kerin, Michael J.; Dwyer, Roisin M.			The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue	PLOS ONE			English	Article							THYROID-HORMONE RECEPTORS; RETINOIC ACID RECEPTORS; SODIUM/IODIDE SYMPORTER; GENE-EXPRESSION; CANCER CELLS; TRANSCRIPTION; THYROGLOBULIN; METASTASES	Introduction: The presence, relevance and regulation of the Sodium Iodide Symporter (NIS) in human mammary tissue remains poorly understood. This study aimed to quantify relative expression of NIS and putative regulators in human breast tissue, with relationships observed further investigated in vitro. Methods: Human breast tissue specimens (malignant n = 75, normal n = 15, fibroadenoma n = 10) were analysed by RQ-PCR targeting NIS, receptors for retinoic acid (RAR alpha, RAR beta), oestrogen (ER alpha), thyroid hormones (THR alpha, THR beta), and also phosphoinositide-3-kinase (PI3K). Breast cancer cells were treated with Retinoic acid (ATRA), Estradiol and Thyroxine individually and in combination followed by analysis of changes in NIS expression. Results: The lowest levels of NIS were detected in normal tissue (Mean(SEM) 0.70(0.12) Log(10) Relative Quantity (RQ)) with significantly higher levels observed in fibroadenoma (1.69(0.21) Log(10)RQ, p < 0.005) and malignant breast tissue (1.18(0.07) Log(10)RQ, p < 0.05). Significant positive correlations were observed between human NIS and ER alpha (r = 0.22, p < 0.05) and RAR alpha (r = 0.29, p < 0.005), with the strongest relationship observed between NIS and RAR beta (r = 0.38, p < 0.0001). An inverse relationship between NIS and PI3K expression was also observed (r = -0.21, p < 0.05). In vitro, ATRA, Estradiol and Thyroxine individually stimulated significant increases in NIS expression (range 6-16 fold), while ATRA and Thyroxine combined caused the greatest increase (range 16-26 fold). Conclusion: Although NIS expression is significantly higher in malignant compared to normal breast tissue, the highest level was detected in fibroadenoma. The data presented supports a role for retinoic acid and estradiol in mammary NIS regulation in vivo, and also highlights potential thyroidal regulation of mammary NIS mediated by thyroid hormones.	[Ryan, James; Curran, Catherine E.; Hennessy, Emer; Kerin, Michael J.; Dwyer, Roisin M.] Natl Univ Ireland Galway, Sch Med, Div Surg, Galway, Ireland; [Newell, John] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland; [Newell, John] Natl Univ Ireland Galway, Clin Res Facil, Galway, Ireland; [Morris, John C.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Mayo Clinic	Ryan, J (corresponding author), Natl Univ Ireland Galway, Sch Med, Div Surg, Galway, Ireland.	roisin.dwyer@nuigalway.ie	Kerin, Michael J/D-6748-2013; Dwyer, Roisin M/C-6654-2013	Dwyer, Roisin M/0000-0002-5854-0339; Newell, John/0000-0001-7685-6655; Kerin, Michael/0000-0003-4164-5561	Cancer Research Ireland; Health Research Board of Ireland; National Breast Cancer Research Institute (NBCRI)	Cancer Research Ireland; Health Research Board of Ireland; National Breast Cancer Research Institute (NBCRI)	This study was supported by funding from Cancer Research Ireland (www.cancer.ie/research) (J. Ryan), Health Research Board of Ireland (www.hrb.ie) (R. M. Dwyer, J. Newell), and the National Breast Cancer Research Institute (NBCRI) (www.nbcri.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi H, 2006, BIOCHEM BIOPH RES CO, V345, P1487, DOI 10.1016/j.bbrc.2006.05.049; Alotaibi H, 2010, NUCLEIC ACIDS RES, V38, P3172, DOI 10.1093/nar/gkq023; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Berger F, 2006, BIOCHEM BIOPH RES CO, V349, P1258, DOI 10.1016/j.bbrc.2006.08.170; Castro MR, 1999, J CLIN ENDOCR METAB, V84, P2957, DOI 10.1210/jc.84.8.2957; Choe JG, 2005, NUCL MED COMMUN, V26, P1155, DOI 10.1097/00006231-200512000-00017; Conde I, 2006, ANN ONCOL, V17, P60, DOI 10.1093/annonc/mdj040; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Kilbane MT, 2000, J CLIN ENDOCR METAB, V85, P1245, DOI 10.1210/jc.85.3.1245; Knostman KAB, 2004, J CLIN ENDOCR METAB, V89, P5196, DOI 10.1210/jc.2004-0907; Knostman KAB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-137; Kogai T, 2005, ENDOCRINOLOGY, V146, P3059, DOI 10.1210/en.2004-1334; Lee S, 2005, MOL ENDOCRINOL, V19, P863, DOI 10.1210/me.2004-0210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Moon DH, 2001, NUCL MED BIOL, V28, P829; NAGAYA T, 1993, J BIOL CHEM, V268, P15766; Ohashi E, 2009, CANCER RES, V69, P3443, DOI 10.1158/0008-5472.CAN-08-3234; Renier C, 2010, J NEURO-ONCOL, V96, P331, DOI 10.1007/s11060-009-9971-8; Renier C, 2009, ANN SURG ONCOL, V16, P962, DOI 10.1245/s10434-008-0280-9; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Rudnicka L, 2003, FOLIA HISTOCHEM CYTO, V41, P37; Silva EG, 2002, INT J SURG PATHOL, V10, P33, DOI 10.1177/106689690201000106; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Suzuki K, 1999, ENDOCRINOLOGY, V140, P5422, DOI 10.1210/en.140.11.5422; Suzuki K, 1998, P NATL ACAD SCI USA, V95, P8251, DOI 10.1073/pnas.95.14.8251; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Upadhyay G, 2003, BREAST CANCER RES TR, V77, P157, DOI 10.1023/A:1021321409159; Wallden B, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-140; Wapnir IL, 2004, CLIN CANCER RES, V10, P4294, DOI 10.1158/1078-0432.CCR-04-0074; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544; Willhauck MJ, 2008, BREAST CANCER RES TR, V109, P263, DOI 10.1007/s10549-007-9646-0; Willhauck MJ, 2011, BREAST CANCER RES TR, V125, P377, DOI 10.1007/s10549-010-0835-x	35	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16023	10.1371/journal.pone.0016023	http://dx.doi.org/10.1371/journal.pone.0016023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283523	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600019
J	Ping, Y; Waro, G; Licursi, A; Smith, S; Vo-Ba, DA; Tsunoda, S				Ping, Yong; Waro, Girma; Licursi, Ashley; Smith, Sarah; Vo-Ba, Dai-An; Tsunoda, Susan			Shal/K(v)4 Channels Are Required for Maintaining Excitability during Repetitive Firing and Normal Locomotion in Drosophila	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; RHYTHMICALLY ACTIVE NEURONS; CA1 PYRAMIDAL NEURONS; OUTWARD K+ CURRENT; POTASSIUM CHANNELS; I-A; SYNAPTIC-TRANSMISSION; FLIGHT MUSCLES; NERVOUS-SYSTEM; SHAKER MUTANTS	Background: Rhythmic behaviors, such as walking and breathing, involve the coordinated activity of central pattern generators in the CNS, sensory feedback from the PNS, to motoneuron output to muscles. Unraveling the intrinsic electrical properties of these cellular components is essential to understanding this coordinated activity. Here, we examine the significance of the transient A-type K+ current (I-A), encoded by the highly conserved Shal/K(v)4 gene, in neuronal firing patterns and repetitive behaviors. While I-A is present in nearly all neurons across species, elimination of I-A has been complicated in mammals because of multiple genes underlying I-A, and/or electrical remodeling that occurs in response to affecting one gene. Methodology/Principal Findings: In Drosophila, the single Shal/K(v)4 gene encodes the predominant I-A current in many neuronal cell bodies. Using a transgenically expressed dominant-negative subunit (DNK(v)4), we show that I-A is completely eliminated from cell bodies, with no effect on other currents. Most notably, DNK(v)4 neurons display multiple defects during prolonged stimuli. DNK(v)4 neurons display shortened latency to firing, a lower threshold for repetitive firing, and a progressive decrement in AP amplitude to an adapted state. We record from identified motoneurons and show that Shal/K(v)4 channels are similarly required for maintaining excitability during repetitive firing. We then examine larval crawling, and adult climbing and grooming, all behaviors that rely on repetitive firing. We show that all are defective in the absence of Shal/K(v)4 function. Further, knock-out of Shal/K(v)4 function specifically in motoneurons significantly affects the locomotion behaviors tested. Conclusions/Significance: Based on our results, Shal/K(v)4 channels regulate the initiation of firing, enable neurons to continuously fire throughout a prolonged stimulus, and also influence firing frequency. This study shows that Shal/K(v)4 channels play a key role in repetitively firing neurons during prolonged input/output, and suggests that their function and regulation are important for rhythmic behaviors.	[Ping, Yong; Waro, Girma; Licursi, Ashley; Smith, Sarah; Vo-Ba, Dai-An; Tsunoda, Susan] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Ping, Y (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	susan.tsunoda@colostate.edu		Ping, Yong/0000-0003-1066-5471	National Institutes of Health [R01 GM083335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the National Institutes of Health (R01 GM083335 to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bergquist S, 2010, NEURON, V66, P220, DOI 10.1016/j.neuron.2010.03.023; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; BROADIE KS, 1993, J NEUROSCI, V13, P167; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Choi JC, 2004, J NEUROPHYSIOL, V91, P2353, DOI 10.1152/jn.01115.2003; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Diao FQ, 2010, MOL CELL NEUROSCI, V45, P75, DOI 10.1016/j.mcn.2010.06.001; Diao FQ, 2009, MOL CELL NEUROSCI, V42, P33, DOI 10.1016/j.mcn.2009.05.003; Fawcett GL, 2006, J BIOL CHEM, V281, P30725, DOI 10.1074/jbc.M605814200; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gasque G, 2005, J NEUROSCI, V25, P2348, DOI 10.1523/JNEUROSCI.4384-04.2005; Hess D, 2001, P NATL ACAD SCI USA, V98, P5276, DOI 10.1073/pnas.091096198; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lee D, 2003, J NEUROSCI, V23, P4625; Lee D, 2000, J NEUROSCI, V20, P2104; Lee D, 1999, J NEUROSCI, V19, P5311; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lim A, 2009, J NEUROSCI, V29, P951, DOI 10.1523/JNEUROSCI.2582-08.2009; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Malin SA, 2001, J NEUROSCI, V21, P8004, DOI 10.1523/JNEUROSCI.21-20-08004.2001; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PHILLIS RW, 1993, GENETICS, V133, P581; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rogero O, 1997, J NEUROSCI, V17, P5108; Ryglewski S, 2009, J NEUROPHYSIOL, V102, P3673, DOI 10.1152/jn.00693.2009; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SALKOFF L, 1985, J PHYSIOL-PARIS, V80, P275; SALKOFF LB, 1983, J PHYSIOL-LONDON, V337, P687, DOI 10.1113/jphysiol.1983.sp014649; Schaefer JE, 2010, J NEUROPHYSIOL, V104, P1257, DOI 10.1152/jn.00298.2010; Shibata R, 2000, J NEUROSCI, V20, P4145; SOLC CK, 1987, SCIENCE, V236, P1094, DOI 10.1126/science.2437657; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Su HL, 2003, J NEUROSCI, V23, P9246; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Ueda A, 2006, J NEUROSCI, V26, P6238, DOI 10.1523/JNEUROSCI.0862-06.2006; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WU CF, 1985, J NEUROSCI, V5, P2626; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; ZAGOTTA WN, 1988, J NEUROSCI, V8, P4765	61	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16043	10.1371/journal.pone.0016043	http://dx.doi.org/10.1371/journal.pone.0016043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264215	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600017
J	Gannavaram, S; Sharma, P; Duncan, RC; Salotra, P; Nakhasi, HL				Gannavaram, Sreenivas; Sharma, Paresh; Duncan, Robert C.; Salotra, Poonam; Nakhasi, Hira L.			Mitochondrial Associated Ubiquitin Fold Modifier-1 Mediated Protein Conjugation in Leishmania donovani	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; PARASITIC PROTOZOA; LIGASE; IDENTIFICATION; SYSTEM; PROTEASOME; EXPRESSION; GENES; TARENTOLAE	In this report, we demonstrate the existence of the ubiquitin fold modifier-1 (Ufm1) and its conjugation pathway in trypanosomatid parasite Leishmania donovani. LdUfm1 is activated by E1-like enzyme LdUba5. LdUfc1 (E2) specifically interacted with LdUfm1 and LdUba5 to conjugate LdUfm1 to proteinaceous targets. Mass spectrometry analysis revealed that LdUfm1 is conjugated to Leishmania protein targets that are associated with mitochondria. Immunofluorescence experiments showed that Leishmania Ufm1, Uba5 and Ufc1 are associated with the mitochondria. The demonstration that all the components of this system as well as the substrates are associated with mitochondrion suggests it may have physiological roles not yet described in any other organism. Overexpression of a non-conjugatable form of LdUfm1 and an active site mutant of LdUba5 resulted in reduced survival of Leishmania in the macrophage. Since mitochondrial activities are developmentally regulated in the life cycle of trypanosomatids, Ufm1 mediated modifications of mitochondrial proteins may be important in such regulation. Thus, Ufm1 conjugation pathway in Leishmania could be explored as a potential drug target in the control of Leishmaniasis.	[Gannavaram, Sreenivas; Duncan, Robert C.; Nakhasi, Hira L.] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Sharma, Paresh; Salotra, Poonam] Inst Pathol ICMR, New Delhi, India	US Food & Drug Administration (FDA)	Gannavaram, S (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	salotra@vsnl.com; hira.nakhasi@fda.hhs.gov	Duncan, Robert/I-8168-2015	Duncan, Robert/0000-0001-8409-2501; Gannavaram, Sreenivas/0000-0002-6557-8220; Salotra, Poonam/0000-0002-4057-4872				Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; FLEISCHMANN J, 1994, GENE, V144, P45, DOI 10.1016/0378-1119(94)90201-1; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Goldenberg SJ, 2010, BIOCHEM SOC T, V38, P132, DOI 10.1042/BST0380132; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hashimoto M, 2010, CELL MICROBIOL, V12, P19, DOI 10.1111/j.1462-5822.2009.01375.x; Henriquez Diana A., 1993, Biological Research, V26, P151; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Horrocks P, 2000, MOL BIOCHEM PARASIT, V105, P115, DOI 10.1016/S0166-6851(99)00174-7; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KIRCHHOFF LV, 1988, J BIOL CHEM, V263, P12698; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; LIAO S, 2010, EXP CELL RES; Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018; LOWRIE DJ, 1993, AM J TROP MED HYG, V49, P545, DOI 10.4269/ajtmh.1993.49.545; MAGNANI M, 1991, J BIOL CHEM, V266, P21018; Manning-Cela R, 2006, ARCH MED RES, V37, P593, DOI 10.1016/j.arcmed.2005.11.013; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Maslov DA, 2006, MOL BIOCHEM PARASIT, V148, P69, DOI 10.1016/j.molbiopara.2006.02.021; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; Srividya G, 2007, PARASITOLOGY, V134, P1527, DOI 10.1017/S003118200700296X; TATSUMI K, 2009, J BIOL CHEM; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	44	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16156	10.1371/journal.pone.0016156	http://dx.doi.org/10.1371/journal.pone.0016156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264253	gold, Green Published, Green Submitted			2022-12-27	WOS:000286516500032
J	Mohn, D; Zehnder, M; Stark, WJ; Imfeld, T				Mohn, Dirk; Zehnder, Matthias; Stark, Wendelin J.; Imfeld, Thomas			Electrochemical Disinfection of Dental Implants - a Proof of Concept	PLOS ONE			English	Article							ESCHERICHIA-COLI; PERI-IMPLANTITIS; ELECTRIC-CURRENT; DRINKING-WATER; INACTIVATION	Background: Peri-implantitis has gained significant clinical attention in recent years. This disease is an inflammatory reaction to microorganisms around dental implants. Due to the limited accessibility, non-invasive antimicrobial strategies are of high interest. An unexpected approach to implant disinfection may evolve from electrolysis. Given the electrical conductivity of titanium implants, alkalinity or active oxidants can be generated in body fluids. We investigated the use of dental titanium implants as electrodes for the local generation of disinfectants. Our hypothesis was that electrolysis can reduce viable counts of adhering bacteria, and that this reduction should be greater if active oxidative species are generated. Methodology/Principal Findings: As model systems, dental implants, covered with a mono-species biofilm of Escherichia coli C43, were placed in photographic gelatin prepared with physiological saline. Implants were treated by a continuous current of 0 - 10 mA for 15 minutes. The reduction of viable counts was investigated on cathodes and anodes. In separate experiments, the local change in pH was visualized using color indicators embedded in the gelatin. Oxidative species were qualitatively detected by potassium iodide-starch paper. The in situ generated alkaline environment around cathodic implants caused a reduction of up to 2 orders of magnitude in viable E. coli counts. On anodic implants, in contrast to cathodic counterparts, oxidative species were detected. Here, a current of merely 7.5 mA caused complete kill of the bacteria. Conclusions/Significance: This laboratory study shows that electrochemical treatment may provide access to a new way to decontaminate dental implants in situ.	[Mohn, Dirk; Stark, Wendelin J.] ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland; [Zehnder, Matthias; Imfeld, Thomas] Univ Zurich, Ctr Dent Med, Dept Prevent Dent Periodontol & Cariol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mohn, D (corresponding author), ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland.	thomas.imfeld@zzmk.uzh.ch	Stark, Wendelin J./A-8680-2008; Mohn, Dirk/N-3035-2019; Mohn, Dirk/K-8574-2012	Mohn, Dirk/0000-0003-0907-7074; Zehnder, Matthias/0000-0001-9545-7828	Department of Preventive Dentistry and Oral Epidemiology, University of Zurich, Center for Dental Medicine	Department of Preventive Dentistry and Oral Epidemiology, University of Zurich, Center for Dental Medicine	This work was financially supported by the Department of Preventive Dentistry and Oral Epidemiology, University of Zurich, Center for Dental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 1993, P 1 EUR WORKSH PER, P365; Bergmann H, 2005, ELECTROCHIM ACTA, V50, P5218, DOI 10.1016/j.electacta.2005.01.061; Brandle N, 2008, J ENDODONT, V34, P579, DOI 10.1016/j.joen.2008.02.027; CLESCERL L, 1999, STANDARD METHODS EXA, pCH4; CZARNETZKI LR, 1992, J APPL ELECTROCHEM, V22, P315, DOI 10.1007/BF01092683; DAVIS CP, 1982, J CLIN MICROBIOL, V15, P891, DOI 10.1128/JCM.15.5.891-894.1982; DAVIS CP, 1994, ANTIMICROB AGENTS CH, V38, P2768, DOI 10.1128/AAC.38.12.2768; Drees KP, 2003, WATER RES, V37, P2291, DOI 10.1016/S0043-1354(03)00009-5; Dychdala G.R., 1991, CHLORINE CHLORINE CO, V4th ed., P131; German Institute for Standardization, 2005, EFF CURR HUM BEING 1; GROSSMAN LI, 1931, DENT COSMOS, V73, P147; Hong SH, 2008, BIOTECHNOL BIOENG, V100, P379, DOI 10.1002/bit.21760; Jeong J, 2009, WATER RES, V43, P895, DOI 10.1016/j.watres.2008.11.033; Kakisis I, 2008, COCHRANE DATABASE SY, V2; Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Martinez-Huitle CA, 2008, ANGEW CHEM INT EDIT, V47, P1998, DOI 10.1002/anie.200703621; Mombelli A, 1994, Periodontol 2000, V4, P74, DOI 10.1111/j.1600-0757.1994.tb00007.x; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x; PAREILLEUX A, 1970, APPL MICROBIOL, V19, P421, DOI 10.1128/AEM.19.3.421-424.1970; PATERMARAKIS G, 1990, WATER RES, V24, P1491, DOI 10.1016/0043-1354(90)90083-I; RAJESHWAR K, 1994, J APPL ELECTROCHEM, V24, P1077; SCHONE E, 1879, LIEBIGS ANN, V195, P228; Siren EK, 1997, INT ENDOD J, V30, P91, DOI 10.1046/j.1365-2591.1997.00057.x; SOMMER RF, 1961, CLIN ENDODONTICS MAN, P199; SUNADA I, 1962, J DENT RES, V41, P375, DOI 10.1177/00220345620410020801; Urano H, 2006, J BIOSCI BIOENG, V102, P457, DOI 10.1263/jbb.102.457	29	32	32	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16157	10.1371/journal.pone.0016157	http://dx.doi.org/10.1371/journal.pone.0016157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264247	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500033
J	Pasquevich, KA; Ibanez, AE; Coria, LM; Samartino, CG; Estein, SM; Zwerdling, A; Barrionuevo, P; Oliveira, FS; Seither, C; Warzecha, H; Oliveira, SC; Giambartolomei, GH; Cassataro, J				Pasquevich, Karina A.; Ibanez, Andres E.; Coria, Lorena M.; Garcia Samartino, Clara; Estein, Silvia M.; Zwerdling, Astrid; Barrionuevo, Paula; Oliveira, Fernanda S.; Seither, Christine; Warzecha, Heribert; Oliveira, Sergio C.; Giambartolomei, Guillermo H.; Cassataro, Juliana			An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; OUTER-MEMBRANE PROTEIN-31; BRUCELLA-ABORTUS; HOST-DEFENSE; T-CELLS; KLEBSIELLA-PNEUMONIAE; BALB/C MICE; TH17 CELLS; INFECTION; IMMUNIZATION	As Brucella infections occur mainly through mucosal surfaces, the development of mucosal administered vaccines could be radical for the control of brucellosis. In this work we evaluated the potential of Brucella abortus 19 kDa outer membrane protein (U-Omp19) as an edible subunit vaccine against brucellosis. We investigated the protective immune response elicited against oral B. abortus infection after vaccination of mice with leaves from transgenic plants expressing U-Omp19; or with plant-made or E. coli-made purified U-Omp19. All tested U-Omp19 formulations induced protection against Brucella when orally administered without the need of adjuvants. U-Omp19 also induced protection against a systemic challenge when parenterally administered. This built-in adjuvant ability of U-Omp19 was independent of TLR4 and could be explained at least in part by its capability to activate dendritic cells in vivo. While unadjuvanted U-Omp19 intraperitoneally administered induced a specific Th1 response, following U-Omp19 oral delivery a mixed specific Th1-Th17 response was induced. Depletion of CD4(+) T cells in mice orally vaccinated with U-Omp19 resulted in a loss of the elicited protection, indicating that this cell type mediates immune protection. The role of IL-17 against Brucella infection has never been explored. In this study, we determined that if IL-17A was neutralized in vivo during the challenge period, the mucosal U-Omp19 vaccine did not confer mucosal protection. On the contrary, IL-17A neutralization during the infection did not influence at all the subsistence and growth of this bacterium in PBS-immunized mice. All together, our results indicate that an oral unadjuvanted vaccine based on U-Omp19 induces protection against a mucosal challenge with Brucella abortus by inducing an adaptive IL-17 immune response. They also indicate different and important new aspects i) IL-17 does not contribute to reduce the bacterial burden in non vaccinated mice and ii) IL-17 plays a central role in vaccine mediated anti-Brucella mucosal immunity.	[Pasquevich, Karina A.; Ibanez, Andres E.; Coria, Lorena M.; Garcia Samartino, Clara; Zwerdling, Astrid; Barrionuevo, Paula; Giambartolomei, Guillermo H.; Cassataro, Juliana] Univ Buenos Aires, Fac Med, Lab Inmunogenet, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina; [Pasquevich, Karina A.; Ibanez, Andres E.; Coria, Lorena M.; Garcia Samartino, Clara; Zwerdling, Astrid; Barrionuevo, Paula; Giambartolomei, Guillermo H.; Cassataro, Juliana] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral IDEHU CONICET, Buenos Aires, DF, Argentina; [Estein, Silvia M.] Univ Nacl, Ctr Prov Buenos Aires, Lab Inmunol, Dept Sanidad Anim & Med Prevent,Fac Ciencias Vet, Tandil, Argentina; [Oliveira, Fernanda S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Seither, Christine; Warzecha, Heribert] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal de Minas Gerais; Technical University of Darmstadt	Pasquevich, KA (corresponding author), Univ Buenos Aires, Fac Med, Lab Inmunogenet, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina.	jucassat@ffyb.uba.ar	Oliveira, Sergio Costa/AAG-5408-2021	Oliveira, Sergio Costa/0000-0003-4062-5577; Pasquevich, Karina Alejandra/0000-0003-4448-0977; ESTEIN, SILVIA/0000-0002-9533-0680; Cassataro, Juliana/0000-0002-7122-869X	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina) [PICT 2006 Nu 1670]; ANPCyT/CNPq PICT [2008 Nu 18, CONICET: PIP 5239]; Universidad de Buenos Aires [M408]; CNPq/Prosul [490485/2007-3]; CNPq/ANPCyT [490528/2008-2]; INCT/Vacinas	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina)(ANPCyT); ANPCyT/CNPq PICT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); CNPq/Prosul(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/ANPCyT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); INCT/Vacinas	This work was supported by grants from the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina): PICT 2006 Nu 1670, ANPCyT/CNPq PICT 2008 Nu 18, CONICET: PIP 5239; and from the Universidad de Buenos Aires: M408 (to JC). This work was also supported by grants from CNPq/Prosul #490485/2007-3, CNPq/ANPCyT # 490528/2008-2, and INCT/Vacinas (to SCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2002, INFECT IMMUN, V70, P1915, DOI 10.1128/IAI.70.4.1915-1923.2002; Ashford DA, 2004, VACCINE, V22, P3435, DOI 10.1016/j.vaccine.2004.02.041; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Bowden RA, 2000, MICROBES INFECT, V2, P481, DOI 10.1016/S1286-4579(00)00317-8; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Cabrera A, 2009, IMMUNOBIOLOGY, V214, P467, DOI 10.1016/j.imbio.2008.11.016; Cassataro J, 2005, INFECT IMMUN, V73, P8079, DOI 10.1128/IAI.73.12.8079-8088.2005; Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005; Cassataro J, 2007, VACCINE, V25, P5958, DOI 10.1016/j.vaccine.2007.05.049; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P632; Delpino MV, 2007, INFECT IMMUN, V75, P299, DOI 10.1128/IAI.00952-06; Florentino MA, 2008, VET MICROBIOL, V132, P302, DOI 10.1016/j.vetmic.2008.05.003; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Golding B, 2001, MICROBES INFECT, V3, P43, DOI 10.1016/S1286-4579(00)01350-2; Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Izadjoo MJ, 2004, INFECT IMMUN, V72, P4031, DOI 10.1128/IAI.72.7.4031-4039.2004; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liljeqvist S, 1999, J BIOTECHNOL, V73, P1, DOI 10.1016/S0168-1656(99)00107-8; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Magnani DM, 2009, INFECT IMMUN, V77, P5181, DOI 10.1128/IAI.00231-09; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Mason HS, 2002, TRENDS MOL MED, V8, P324, DOI 10.1016/S1471-4914(02)02360-2; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nicoletti P, 1990, Adv Biotechnol Processes, V13, P147; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pasquali P, 2003, INFECT IMMUN, V71, P2326, DOI 10.1128/IAI.71.5.2326-2330.2003; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; PERKINS SD, 2010, FEMS MICROBIOL REV; Pontes DS, 2004, J DRUG TARGET, V11, P489, DOI 10.1080/10611860410001670035; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rice J., 2005, Animal Health Research Reviews, V6, P199, DOI 10.1079/AHR2005110; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Sala F, 2003, VACCINE, V21, P803, DOI 10.1016/S0264-410X(02)00603-5; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Shewen PE, 2009, VET IMMUNOL IMMUNOP, V128, P192, DOI 10.1016/j.vetimm.2008.10.297; Sieve AN, 2009, EUR J IMMUNOL, V39, P426, DOI 10.1002/eji.200838726; STABEL TJ, 1990, INFECT IMMUN, V58, P2048, DOI 10.1128/IAI.58.7.2048-2055.1990; STEVENS MG, 1995, INFECT IMMUN, V63, P264, DOI 10.1128/IAI.63.1.264-270.1995; Streatfield SJ, 2006, METHODS, V38, P150, DOI 10.1016/j.ymeth.2005.09.013; Tibor A, 1999, INFECT IMMUN, V67, P4960, DOI 10.1128/IAI.67.9.4960-4962.1999; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Velikovsky CA, 2003, INFECT IMMUN, V71, P5750, DOI 10.1128/IAI.71.10.5750-5755.2003; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	66	78	82	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16203	10.1371/journal.pone.0016203	http://dx.doi.org/10.1371/journal.pone.0016203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264260	gold, Green Submitted, Green Published			2022-12-27	WOS:000286516500038
J	Poole, KES; Treece, GM; Ridgway, GR; Mayhew, PM; Borggrefe, J; Gee, AH				Poole, Kenneth E. S.; Treece, Graham M.; Ridgway, Gerard R.; Mayhew, Paul M.; Borggrefe, Jan; Gee, Andrew H.			Targeted Regeneration of Bone in the Osteoporotic Human Femur	PLOS ONE			English	Article							DENSITY	We have recently developed image processing techniques for measuring the cortical thicknesses of skeletal structures in vivo, with resolution surpassing that of the underlying computed tomography system. The resulting thickness maps can be analysed across cohorts by statistical parametric mapping. Applying these methods to the proximal femurs of osteoporotic women, we discover targeted and apparently synergistic effects of pharmaceutical osteoporosis therapy and habitual mechanical load in enhancing bone thickness.	[Poole, Kenneth E. S.; Mayhew, Paul M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Treece, Graham M.; Gee, Andrew H.] Univ Cambridge, Dept Engn, Cambridge CB2 2QQ, England; [Ridgway, Gerard R.] UCL, Inst Neurol, London, England; [Borggrefe, Jan] Univ Schleswig Holstein, Dept Diagnost Radiol, Kiel, Germany	University of Cambridge; University of Cambridge; University of London; University College London; University of Kiel; Schleswig Holstein University Hospital	Poole, KES (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	kp254@nhs.net	Borggrefe, Jan/N-6549-2018; Ridgway, Gerard/F-5145-2010	Borggrefe, Jan/0000-0003-2908-7560; Ridgway, Gerard/0000-0002-7676-7860	Arthritis Research UK; Cambridge Biomedical Research Centre (National Institute for Health Research)	Arthritis Research UK(Versus Arthritis); Cambridge Biomedical Research Centre (National Institute for Health Research)(National Institute for Health Research (NIHR))	This work was supported by an Arthritis Research UK Clinician Scientist Fellowship award to KESP (The FEMCO study, ARC17822, http://www.arthritisresearchuk.org/) and by the Cambridge Biomedical Research Centre (National Institute for Health Research), an institutional award that supports PMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Borggrefe J, 2010, J BONE MINER RES, V25, P472, DOI 10.1359/jbmr.090820; Burr DB, 2010, LANCET, V375, P1672, DOI 10.1016/S0140-6736(10)60444-8; Eastell R, 2009, J BONE MINER RES, V24, P726, DOI 10.1359/JBMR.081215; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; Misof BM, 2003, J CLIN ENDOCR METAB, V88, P1150, DOI 10.1210/jc.2002-021988; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Roberts MD, 2009, J BIOMECH, V42, P2431, DOI 10.1016/j.jbiomech.2009.08.030; Roux W., 1885, ARCH ANAT PHYSL ANAT, V9, P120; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Treece GM, 2010, MED IMAGE ANAL, V14, P276, DOI 10.1016/j.media.2010.01.003; Worsley K., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/s1053-8119(09)70882-1, DOI 10.1016/S1053-8119(09)70882-1, 10.1016/S1053-8119(09)70882-1]	17	42	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16190	10.1371/journal.pone.0016190	http://dx.doi.org/10.1371/journal.pone.0016190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264263	Green Published, gold			2022-12-27	WOS:000286516500037
J	Thalhammer, A; Bencokova, Z; Poole, R; Loenarz, C; Adam, J; O'Flaherty, L; Schodel, J; Mole, D; Giaslakiotis, K; Schofield, CJ; Hammond, EM; Ratcliffe, PJ; Pollard, PJ				Thalhammer, Armin; Bencokova, Zuzana; Poole, Rachel; Loenarz, Christoph; Adam, Julie; O'Flaherty, Linda; Schoedel, Johannes; Mole, David; Giaslakiotis, Konstantinos; Schofield, Christopher J.; Hammond, Ester M.; Ratcliffe, Peter J.; Pollard, Patrick J.			Human AlkB Homologue 5 Is a Nuclear 2-Oxoglutarate Dependent Oxygenase and a Direct Target of Hypoxia-Inducible Factor 1 alpha ( HIF-1 alpha)	PLOS ONE			English	Article							DNA-DAMAGE; HISTONE DEMETHYLASES; FACTOR HIF; EXPRESSION; HYDROXYLASE; FAMILY; GENE; IDENTIFICATION; ACTIVATION; INDUCTION	Human 2-oxoglutarate oxygenases catalyse a range of biological oxidations including the demethylation of histone and nucleic acid substrates and the hydroxylation of proteins and small molecules. Some of these processes are centrally involved in regulation of cellular responses to hypoxia. The ALKBH proteins are a sub-family of 2OG oxygenases that are defined by homology to the Escherichia coli DNA-methylation repair enzyme AlkB. Here we report evidence that ALKBH5 is probably unique amongst the ALKBH genes in being a direct transcriptional target of hypoxia inducible factor-1 (HIF-1) and is induced by hypoxia in a range of cell types. We show that purified recombinant ALKBH5 is a bona fide 2OG oxygenase that catalyses the decarboxylation of 2OG but appears to have different prime substrate requirements from those so far defined for other ALKBH family members. Our findings define a new class of HIF-transcriptional target gene and suggest that ALKBH5 may have a role in the regulation of cellular responses to hypoxia.	[Thalhammer, Armin; Loenarz, Christoph; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England; [Thalhammer, Armin; Loenarz, Christoph; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford Ctr Integrat Syst Biol, Oxford, England; [Bencokova, Zuzana; Poole, Rachel; Hammond, Ester M.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Giaslakiotis, Konstantinos] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Thalhammer, A (corresponding author), Univ Oxford, Chem Res Lab, Oxford, England.	patrick.pollard@well.ox.ac.uk	Pollard, Patrick/F-7516-2012	Pollard, Patrick/0000-0002-4459-4993; Ratcliffe, Peter/0000-0002-2853-806X; Schodel, Johannes/0000-0002-3587-8839; Loenarz, Christoph/0000-0002-8843-2531; Mole, David/0000-0002-0984-300X; Schofield, Christopher/0000-0002-0290-6565; Adam, Julie/0000-0002-7980-7151; Hammond, Ester/0000-0002-2335-3146	Beit Memorial Fellowship; Rhodes Scholarship; Wellcome Trust [WT91112]; Cancer Research UK [C6079/A9485, C6515/A9321]; Biological and Biotechnological Research Council; BBSRC [BB/D011523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; Cancer Research UK [6947] Funding Source: researchfish	Beit Memorial Fellowship; Rhodes Scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biological and Biotechnological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	PJP is in receipt of a Beit Memorial Fellowship. CL is in receipt of a Rhodes Scholarship. AT is in receipt of a Cancer Research UK Studentship. This work was supported by the Wellcome Trust [WT91112], Cancer Research UK [C6079/A9485] and [C6515/A9321], and the Biological and Biotechnological Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; MULLER TA, 2009, DNA REPAIR AMST; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; PIRES IM, 2010, CANC RES; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; SABOURIN PJ, 1982, J BIOL CHEM, V257, P7460; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Sowter HM, 2003, CANCER RES, V63, P6130; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Wykoff CC, 2000, CANCER RES, V60, P7075; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106	39	95	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16210	10.1371/journal.pone.0016210	http://dx.doi.org/10.1371/journal.pone.0016210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264265	Green Published, Green Submitted, gold			2022-12-27	WOS:000286516500039
J	Orru, M; Bakesova, J; Brugarolas, M; Quiroz, C; Beaumont, V; Goldberg, SR; Lluis, C; Cortes, A; Franco, R; Casado, V; Canela, EI; Ferre, S				Orru, Marco; Bakesova, Jana; Brugarolas, Marc; Quiroz, Cesar; Beaumont, Vahri; Goldberg, Steven R.; Lluis, Carme; Cortes, Antoni; Franco, Rafael; Casado, Vicent; Canela, Enric I.; Ferre, Sergi			Striatal Pre- and Postsynaptic Profile of Adenosine A(2A) Receptor Antagonists	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINE-D-2 RECEPTORS; BASAL GANGLIA; D2 DOPAMINE; HETEROMERS; NEUROTRANSMISSION; PHOSPHORYLATION; DISORDERS	Striatal adenosine A(2A) receptors (A(2A)Rs) are highly expressed in medium spiny neurons (MSNs) of the indirect efferent pathway, where they heteromerize with dopamine D-2 receptors (D(2)Rs). A(2A)Rs are also localized presynaptically in corticostriatal glutamatergic terminals contacting MSNs of the direct efferent pathway, where they heteromerize with adenosine A(1) receptors (A(1)Rs). It has been hypothesized that postsynaptic A(2A)R antagonists should be useful in Parkinson's disease, while presynaptic A(2A)R antagonists could be beneficial in dyskinetic disorders, such as Huntington's disease, obsessive-compulsive disorders and drug addiction. The aim or this work was to determine whether selective A(2A)R antagonists may be subdivided according to a preferential pre-versus postsynaptic mechanism of action. The potency at blocking the motor output and striatal glutamate release induced by cortical electrical stimulation and the potency at inducing locomotor activation were used as in vivo measures of pre- and postsynaptic activities, respectively. SCH-442416 and KW-6002 showed a significant preferential pre-and postsynaptic profile, respectively, while the other tested compounds (MSX-2, SCH-420814, ZM-241385 and SCH-58261) showed no clear preference. Radioligand-binding experiments were performed in cells expressing A(2A)R-D2R and A(1)R-A(2A)R heteromers to determine possible differences in the affinity of these compounds for different A(2A)R heteromers. Heteromerization played a key role in the presynaptic profile of SCH-442416, since it bound with much less affinity to A(2A)R when co-expressed with D2R than with A(1)R. KW-6002 showed the best relative affinity for A(2A)R coexpressed with D2R than co-expressed with A(1)R, which can at least partially explain the postsynaptic profile of this compound. Also, the in vitro pharmacological profile of MSX-2, SCH-420814, ZM-241385 and SCH-58261 was is in accordance with their mixed pre-and postsynaptic profile. On the basis of their preferential pre-versus postsynaptic actions, SCH-442416 and KW-6002 may be used as lead compounds to obtain more effective antidyskinetic and antiparkinsonian compounds, respectively.	[Orru, Marco; Quiroz, Cesar; Goldberg, Steven R.; Ferre, Sergi] NIDA, IRP, NIH, DHHS, Baltimore, MD USA; [Bakesova, Jana; Brugarolas, Marc; Lluis, Carme; Cortes, Antoni; Franco, Rafael; Casado, Vicent; Canela, Enric I.] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Beaumont, Vahri] CHDI Fdn, CHDI Management, Los Angeles, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); CIBERNED; University of Barcelona	Orru, M (corresponding author), NIDA, IRP, NIH, DHHS, Baltimore, MD USA.	sferre@intra.nida.nih.gov	Canela, Enric I./M-8726-2013; Franco, Rafael/C-3694-2015; Casadó, Vicent/K-1660-2014; Orrù, Marco/ABE-4316-2021; Ferre, Sergi/K-6115-2014	Canela, Enric I./0000-0003-4992-7440; Franco, Rafael/0000-0003-2549-4919; Casadó, Vicent/0000-0002-1764-3825; Ferre, Sergi/0000-0002-1747-1779; Beaumont, Vahri/0000-0002-6488-2175; Brugarolas, Marc/0000-0002-2277-1266	National Institute on Drug Abuse; CHDI Foundation; Spanish Ministerio de Ciencia y Tecnologia [SAF2008-00146, SAF2008-03229-E]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); CHDI Foundation; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Work supported by the National Institute on Drug Abuse, Intramural Research Program, CHDI Foundation and by the Spanish Ministerio de Ciencia y Tecnologia (grant numbers SAF2008-00146 and SAF2008-03229-E). The co-author Vahri Baumont, scientific manager from CHDI Foundation, participated in the design of the experiments. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azdad K, 2009, NEUROPSYCHOPHARMACOL, V34, P972, DOI 10.1038/npp.2008.144; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Casad V, 2007, PHARMACOL THERAPEUT, V116, P343, DOI 10.1016/j.pharmthera.2007.05.010; CASADO V, 1990, ANAL BIOCHEM, V184, P117, DOI 10.1016/0003-2697(90)90022-2; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Chen JF, 2001, P NATL ACAD SCI USA, V98, P1970, DOI 10.1073/pnas.98.4.1970; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Ciruela F, 1995, J NEUROSCI RES, V42, P818, DOI 10.1002/jnr.490420610; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; FRANCO R, 2005, TRENDS BIOCHEM SCI, V26, P221; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Jenner P, 2003, NEUROLOGY, V61, pS4, DOI 10.1212/WNL.61.6_suppl_3.S4; Kaasinen V, 2000, J NUCL MED, V41, P65; Navarro G, 2009, J BIOL CHEM, V284, P28058, DOI 10.1074/jbc.M109.034231; Obeso JA, 2002, NEWS PHYSIOL SCI, V17, P51, DOI 10.1152/rips.01363.2001; Pinna A, 2002, EUR J PHARMACOL, V446, P75, DOI 10.1016/S0014-2999(02)01818-6; Quarta D, 2004, J NEUROCHEM, V91, P873, DOI 10.1111/j.1471-4159.2004.02761.x; Quiroz C, 2010, EXP NEUROL, V224, P292, DOI 10.1016/j.expneurol.2010.04.004; Quiroz C, 2009, THESCIENTIFICWORLDJO, V9, P1321, DOI 10.1100/tsw.2009.143; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Varani K, 2010, FASEB J, V24, P587, DOI 10.1096/fj.09-141044	31	89	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16088	10.1371/journal.pone.0016088	http://dx.doi.org/10.1371/journal.pone.0016088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264319	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000020
J	Wilson, D; Badri, M; Maartens, G				Wilson, Douglas; Badri, Motasim; Maartens, Gary			Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence Population	PLOS ONE			English	Article							CRP RAPID TEST; FEBRILE CHILDREN; GENERAL-PRACTICE; DIAGNOSIS; PROCALCITONIN; INFECTIONS; MANAGEMENT; PNEUMONIA; PROGRESS; IMPACT	Background: Delayed diagnosis has contributed to the high mortality of sputum smear-negative tuberculosis (SNTB) in high HIV prevalence countries. New diagnostic strategies for SNTB are urgently needed. C-reactive protein (CRP) is a non-specific inflammatory protein that is usually elevated in patients with tuberculosis, but its role in the diagnosis of tuberculosis is uncertain. Methodology/Principal Findings: To determine the diagnostic utility of CRP we prospectively evaluated the performance of CRP as a screening test for SNTB in symptomatic ambulatory tuberculosis suspects followed up for 8 weeks in KwaZuluNatal, South Africa. Confirmed tuberculosis was defined as positive culture or acid-fast bacilli with granulomata on histology, and possible tuberculosis as documented response to antitubercular therapy. The CRP quotient was defined as a multiple of the upper limit of normal of the serum CRP result. Three hundred and sixty four participants fulfilled entry criteria: 135 (37%) with confirmed tuberculosis, 114 (39%) with possible tuberculosis, and 115 (24%) without tuberculosis. The median CRP quotient was 15.4 (IQR 7.2; 23.3) in the confirmed tuberculosis group, 5.8 (IQR 1.4; 16.0) in the group with possible tuberculosis, and 0.7 (IQR 0.2; 2.2) in the group without tuberculosis (p<0.0001). The CRP quotient above the upper limit of normal had sensitivity 0.98 (95% CI 0.94; 0.99), specificity 0.59 (95% CI 0.50; 0.68), positive predictive value 0.74 (95% CI 0.67; 0.80), negative predictive value 0.96 (95% CI 0.88; 0.99), and diagnostic odds ratio 63.7 (95% CI 19.1; 212.0) in the confirmed tuberculosis group compared with the group without tuberculosis. Higher CRP quotients improved specificity at the expense of sensitivity. Significance: In high HIV prevalence settings a normal CRP could be a useful test in combination with clinical evaluation to rule out tuberculosis in ambulatory patients. Point-of-care CRP should be further evaluated in primary care clinics.	[Wilson, Douglas] Univ KwaZulu Natal, Dept Med, Edendale Hosp, Kwa Zulu, South Africa; [Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Cape Town	Wilson, D (corresponding author), Univ KwaZulu Natal, Dept Med, Edendale Hosp, Kwa Zulu, South Africa.	wilsondpk@gmail.com	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019; Badri, Motasim/E-1141-2013	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Badri, Motasim/0000-0002-5268-6492	BMS Secure the Future; Fogarty International Center [U2RTW007370]; FOGARTY INTERNATIONAL CENTER [U2RTW007370] Funding Source: NIH RePORTER	BMS Secure the Future; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by BMS Secure the Future http://www.securethefuture.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GM was supported in part by the Fogarty International Center Grant Number U2RTW007370. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health.	Bjerrum L, 2004, BRIT J GEN PRACT, V54, P659; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cals JWL, 2010, FAM PRACT, V27, P212, DOI 10.1093/fampra/cmp088; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Choi CM, 2007, INT J TUBERC LUNG D, V11, P233; Cohen R, 2008, ARCH PEDIATRIE, V15, P1126, DOI 10.1016/j.arcped.2008.03.007; Cohen R, 2006, ARCH PEDIATRIE, V13, P1566, DOI 10.1016/j.arcped.2006.09.003; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Grutzmeier S, 1999, SCAND J INFECT DIS, V31, P229, DOI 10.1080/00365549950163491; *IT COOP S AFR, DEM HLTH IND KWAZULU; Kang Young Ae, 2009, Korean Journal of Internal Medicine, V24, P337, DOI 10.3904/kjim.2009.24.4.337; Lawn SD, 2001, T ROY SOC TROP MED H, V95, P41, DOI 10.1016/S0035-9203(01)90328-1; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Monteny M, 2006, CLIN CHEM LAB MED, V44, P1428, DOI 10.1515/CCLM.2006.270; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; *NAT DEP HLTH S AF, 2007, NAT HIV SYPH SURV; Nyamande K, 2006, INT J TUBERC LUNG D, V10, P510; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604; Statistics South Africa, 2009, MORT CAUS DEATH S AF; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WHO, 2007, IMPR DIAGN TREATM SM; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31	25	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15248	10.1371/journal.pone.0015248	http://dx.doi.org/10.1371/journal.pone.0015248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249220	gold, Green Published, Green Submitted			2022-12-27	WOS:000286513100004
J	Graham, M; Liang, BH; Van Domselaar, G; Bastien, N; Beaudoin, C; Tyler, S; Kaplen, B; Landry, E; Li, Y				Graham, Morag; Liang, Binhua; Van Domselaar, Gary; Bastien, Nathalie; Beaudoin, Carole; Tyler, Shaun; Kaplen, Brynn; Landry, Erika; Li, Yan		Natl Influenza A H1N1pdm Genomics	Nationwide Molecular Surveillance of Pandemic H1N1 Influenza A Virus Genomes: Canada, 2009	PLOS ONE			English	Article							HEMAGGLUTININ; REPLICATION; ASSOCIATION; EMERGENCE; INFECTION; PROTEINS; PROGRESS	Background: In April 2009, a novel triple-reassortant swine influenza A H1N1 virus ("A/H1N1pdm"; also known as SOIV) was detected and spread globally as the first influenza pandemic of the 21(st) century. Sequencing has since been conducted at an unprecedented rate globally in order to monitor the diversification of this emergent virus and to track mutations that may affect virus behavior. Methodology/Principal Findings: By Sanger sequencing, we determined consensus whole-genome sequences for A/H1N1pdm viruses sampled nationwide in Canada over 33 weeks during the 2009 first and second pandemic waves. A total of 235 virus genomes sampled from unique subjects were analyzed, providing insight into the temporal and spatial trajectory of A/H1N1pdm lineages within Canada. Three clades (2, 3, and 7) were identifiable within the first two weeks of A/H1N1pdm appearance, with clades 5 and 6 appearing thereafter; further diversification was not apparent. Only two viral sites displayed evidence of adaptive evolution, located in hemagglutinin (HA) corresponding to D222 in the HA receptor-binding site, and to E374 at HA2-subunit position 47. Among the Canadian sampled viruses, we observed notable genetic diversity (1.47x10(-3) amino acid substitutions per site) in the gene encoding PBI, particularly within the viral genomic RNA (vRNA)-binding domain (residues 493-757). This genome data set supports the conclusion that A/H1N1pdm is evolving but not excessively relative to other H1N1 influenza A viruses. Entropy analysis was used to investigate whether any mutated A/H1N1pdm protein residues were associated with infection severity; however no virus genotypes were observed to trend with infection severity. One virus that harboured heterozygote coding mutations, including PB2 D567D/G, was attributed to a severe and potentially mixed infection; yet the functional significance of this PB2 mutation remains unknown. Conclusions/Significance: These findings contribute to enhanced understanding of Influenza A/H1N1pdm viral dynamics.	[Graham, Morag; Liang, Binhua; Van Domselaar, Gary; Bastien, Nathalie; Beaudoin, Carole; Tyler, Shaun; Kaplen, Brynn; Landry, Erika; Li, Yan] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Graham, Morag; Van Domselaar, Gary; Li, Yan] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB, Canada; [Beaudoin, Carole] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba	Graham, M (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	morag.graham@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407	Public Health Agency of Canada (PHAC)	Public Health Agency of Canada (PHAC)	This work was supported by federal funds from the Public Health Agency of Canada (PHAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H., 2006, Virologie (Montrouge), V10, P301, DOI [10.1684/vir.2006.0006, 10.1684/vir.2011.7062]; Barman S, 2000, J VIROL, V74, P6538, DOI 10.1128/JVI.74.14.6538-6545.2000; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Domingo E, 2010, VET RES, V41, DOI 10.1051/vetres/2010010; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Embree J, 2010, BIOCHEM CELL BIOL, V88, P589, DOI 10.1139/O10-025; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Furuse Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-67; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jombart T, 2011, HEREDITY, V106, P383, DOI 10.1038/hdy.2010.78; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Lin DZ, 2007, ACTA BIOCH BIOPH SIN, V39, P155, DOI 10.1111/j.1745-7270.2007.00263.x; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; MAURERSTROH S, 2010, PLOS CURR INFLUENZA, pN1162; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nelson M, 2009, PLOS CURR INFLUENZA, P1; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; *STAT CAN, 2010, CAN COMMUN HLTH SURV, P2; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2010, TRANSCR OP STAT VIRT; *WHO, 2010, PAND HINI 2009 UPD 1; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Yang H, 2010, PLOS CURR INFLUENZA, pRRN1152; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zwickl DJ., 2006, THESIS; 2009, FLUWATCH        0823; 2010, FLUWATCH        0117	64	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16087	10.1371/journal.pone.0016087	http://dx.doi.org/10.1371/journal.pone.0016087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249207	Green Submitted, gold, Green Published			2022-12-27	WOS:000286512900021
J	Huang, T; Wan, SB; Xu, ZP; Zheng, YF; Feng, KY; Li, HP; Kong, XY; Cai, YD				Huang, Tao; Wan, Sibao; Xu, Zhongping; Zheng, Yufang; Feng, Kai-Yan; Li, Hai-Peng; Kong, Xiangyin; Cai, Yu-Dong			Analysis and Prediction of Translation Rate Based on Sequence and Functional Features of the mRNA	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN EXPRESSION; GENE-EXPRESSION; CODON USAGE; FEATURE-SELECTION; ABUNDANCE; MODEL	Protein concentrations depend not only on the mRNA level, but also on the translation rate and the degradation rate. Prediction of mRNA's translation rate would provide valuable information for in-depth understanding of the translation mechanism and dynamic proteome. In this study, we developed a new computational model to predict the translation rate, featured by (1) integrating various sequence-derived and functional features, (2) applying the maximum relevance & minimum redundancy method and incremental feature selection to select features to optimize the prediction model, and (3) being able to predict the translation rate of RNA into high or low translation rate category. The prediction accuracies under rich and starvation condition were 68.8% and 70.0%, respectively, evaluated by jackknife cross-validation. It was found that the following features were correlated with translation rate: codon usage frequency, some gene ontology enrichment scores, number of RNA binding proteins known to bind its mRNA product, coding sequence length, protein abundance and 5'UTR free energy. These findings might provide useful information for understanding the mechanisms of translation and dynamic proteome. Our translation rate prediction model might become a high throughput tool for annotating the translation rate of mRNAs in large-scale.	[Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao; Feng, Kai-Yan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Wan, Sibao] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China; [Xu, Zhongping; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xu, Zhongping; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Yufang] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Li, Hai-Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai University; Fudan University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	lihaipeng@picb.ac.cn; xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624; cai, yudong/0000-0001-5664-7979	Chinese Academy of Sciences [KSCX1-YW-R-74]; Systems Biology Research Foundation of Shanghai University; Shanghai Science and Technology Committee [09DZ227180]; National Basic Research Program of China [2011CB510102, 2011CB510101]	Chinese Academy of Sciences(Chinese Academy of Sciences); Systems Biology Research Foundation of Shanghai University(Shanghai University); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX1-YW-R-74), Systems Biology Research Foundation of Shanghai University, Shanghai Science and Technology Committee (09DZ227180), Shanghai Science and Technology Committee (09DZ227180), the National Basic Research Program of China (2011CB510102, 2011CB510101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN JE, 1979, J BIOL CHEM, V254, P1927; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Charif D, 2005, BIOINFORMATICS, V21, P545, DOI 10.1093/bioinformatics/bti037; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V44, P60, DOI 10.1002/prot.1072.abs; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Glass GV, 1995, STAT METHODS ED PSYC, V3rd; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; LILJENSTROM H, 1987, J THEOR BIOL, V124, P43, DOI 10.1016/S0022-5193(87)80251-5; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Osada Y, 1999, BIOINFORMATICS, V15, P578, DOI 10.1093/bioinformatics/15.7.578; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Ringner M, 2005, PLOS COMPUT BIOL, V1, P585, DOI 10.1371/journal.pcbi.0010072; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tuller T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-391; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	47	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16036	10.1371/journal.pone.0016036	http://dx.doi.org/10.1371/journal.pone.0016036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253596	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900037
J	Stefflova, K; Dulik, MC; Barnholtz-Sloan, JS; Pai, AA; Walker, AH; Rebbeck, TR				Stefflova, Klara; Dulik, Matthew C.; Barnholtz-Sloan, Jill S.; Pai, Athma A.; Walker, Amy H.; Rebbeck, Timothy R.			Dissecting the Within-Africa Ancestry of Populations of African Descent in the Americas	PLOS ONE			English	Article							CASE-CONTROL ASSOCIATION; Y-CHROMOSOME; MITOCHONDRIAL-DNA; ADMIXTURE PROPORTIONS; GENETIC-STRUCTURE; UNITED-STATES; MTDNA; STRATIFICATION; DIVERSITY; HISTORY	Background: The ancestry of African-descended Americans is known to be drawn from three distinct populations: African, European, and Native American. While many studies consider this continental admixture, few account for the genetically distinct sources of ancestry within Africa - the continent with the highest genetic variation. Here, we dissect the within-Africa genetic ancestry of various populations of the Americas self-identified as having primarily African ancestry using uniparentally inherited mitochondrial DNA. Methods and Principal Findings: We first confirmed that our results obtained using uniparentally-derived group admixture estimates are correlated with the average autosomal-derived individual admixture estimates (hence are relevant to genomic ancestry) by assessing continental admixture using both types of markers (mtDNA and Y-chromosome vs. ancestry informative markers). We then focused on the within-Africa maternal ancestry, mining our comprehensive database of published mtDNA variation (similar to 5800 individuals from 143 African populations) that helped us thoroughly dissect the African mtDNA pool. Using this well-defined African mtDNA variation, we quantified the relative contributions of maternal genetic ancestry from multiple W/WC/SW/SE (West to South East) African populations to the different pools of today's African-descended Americans of North and South America and the Caribbean. Conclusions: Our analysis revealed that both continental admixture and within-Africa admixture may be critical to achieving an adequate understanding of the ancestry of African-descended Americans. While continental ancestry reflects gender-specific admixture processes influenced by different socio-historical practices in the Americas, the within-Africa maternal ancestry reflects the diverse colonial histories of the slave trade. We have confirmed that there is a genetic thread connecting Africa and the Americas, where each colonial system supplied their colonies in the Americas with slaves from African colonies they controlled or that were available for them at the time. This historical connection is reflected in different relative contributions from populations of W/WC/SW/SE Africa to geographically distinct Africa-derived populations of the Americas, adding to the complexity of genomic ancestry in groups ostensibly united by the same demographic label.	[Stefflova, Klara; Walker, Amy H.; Rebbeck, Timothy R.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Dulik, Matthew C.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Pai, Athma A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Case Western Reserve University; University of Chicago; University of Pennsylvania; Pennsylvania Medicine	Stefflova, K (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	Klara.Stefflova@cancer.org.uk	Rebbeck, Timothy/GLU-8348-2022; Barnholtz-Sloan, Jill/A-4817-2011	Rebbeck, Timothy/0000-0002-4799-1900; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Pai, Athma/0000-0002-7995-9948; Barsi, Klara/0000-0001-9338-0468	Public Health Service [R29-ES08031, R01-CA85074, P50-CA105641]; NATIONAL CANCER INSTITUTE [P50CA105641, R01CA085074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008031] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants to TRR from the Public Health Service (R29-ES08031, R01-CA85074, and P50-CA105641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Benn-Torres J, 2008, ANN HUM GENET, V72, P90, DOI 10.1111/j.1469-1809.2007.00398.x; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Bonilla C, 2004, AM J HUM BIOL, V16, P289, DOI 10.1002/ajhb.20025; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Ribeiro-dos-Santos AKC, 2007, FORENSIC SCI INT, V167, P77, DOI 10.1016/j.forsciint.2005.12.033; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Goncalves VF, 2007, GENET MOL RES, V6, P256; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Guerreiro V, 2009, GENET MOL BIOL, V32, P1, DOI 10.1590/S1415-47572009005000001; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hammer MF, 2006, FORENSIC SCI INT, V164, P45, DOI 10.1016/j.forsciint.2005.11.013; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; McLean DC, 2005, AM J PHYS ANTHROPOL, V127, P427, DOI 10.1002/ajpa.20047; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Miljkovic-Gacic I, 2005, HUM HERED, V60, P129, DOI 10.1159/000089553; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Rawley J, 2005, TRANSATLANTIC SLAVE; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Silva DA, 2006, AM J HUM BIOL, V18, P829, DOI 10.1002/ajhb.20567; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; SLATKIN M, 1995, GENETICS, V139, P457; Stefflova K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007842; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wang YT, 2004, GENET EPIDEMIOL, V27, P14, DOI 10.1002/gepi.20003; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141	60	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14495	10.1371/journal.pone.0014495	http://dx.doi.org/10.1371/journal.pone.0014495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710KZ	21253579	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900004
J	MacTavish, H; Diallo, JS; Huang, BC; Stanford, M; Le Boeuf, F; De Silva, N; Cox, J; Simmons, JG; Guimond, T; Falls, T; McCart, AJ; Atkins, H; Breitbach, C; Kirn, D; Thorne, S; Bell, JC				MacTavish, Heather; Diallo, Jean-Simon; Huang, Baocheng; Stanford, Marianne; Le Boeuf, Fabrice; De Silva, Naomi; Cox, Julie; Simmons, John Graydon; Guimond, Tanya; Falls, Theresa; McCart, Andrea J.; Atkins, Harry; Breitbach, Caroline; Kirn, David; Thorne, Stephen; Bell, John C.			Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors	PLOS ONE			English	Article							INNATE ANTIVIRAL RESPONSE; TUMOR-SPECIFIC DEFECTS; T-CELL LYMPHOMA; TRICHOSTATIN-A; GENE-EXPRESSION; IN-VITRO; CANCER; PROTEIN; AGENTS; POXVIRUS	Histone deacetylase inhibitors (HDI) dampen cellular innate immune response by decreasing interferon production and have been shown to increase the growth of vesicular stomatitis virus and HSV. As attenuated tumour-selective oncolytic vaccinia viruses (VV) are already undergoing clinical evaluation, the goal of this study is to determine whether HDI can also enhance the potency of these poxviruses in infection-resistant cancer cell lines. Multiple HDIs were tested and Trichostatin A (TSA) was found to potently enhance the spread and replication of a tumour selective vaccinia virus in several infection-resistant cancer cell lines. TSA significantly decreased the number of lung metastases in a syngeneic B16F10LacZ lung metastasis model yet did not increase the replication of vaccinia in normal tissues. The combination of TSA and VV increased survival of mice harbouring human HCT116 colon tumour xenografts as compared to mice treated with either agent alone. We conclude that TSA can selectively and effectively enhance the replication and spread of oncolytic vaccinia virus in cancer cells.	[MacTavish, Heather; Diallo, Jean-Simon; Stanford, Marianne; Le Boeuf, Fabrice; De Silva, Naomi; Cox, Julie; Simmons, John Graydon; Guimond, Tanya; Falls, Theresa; Atkins, Harry; Bell, John C.] Ottawa Hosp, Ctr Canc Therapeut, Res Inst, Ottawa, ON, Canada; [MacTavish, Heather; Diallo, Jean-Simon; Stanford, Marianne; Le Boeuf, Fabrice; De Silva, Naomi; Cox, Julie; Simmons, John Graydon; Atkins, Harry; Bell, John C.] Univ Ottawa, Ottawa, ON, Canada; [Huang, Baocheng; Thorne, Stephen] Univ Pittsburgh, Dept Surg, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Huang, Baocheng; Thorne, Stephen] Univ Pittsburgh, Dept Immunol, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Breitbach, Caroline; Kirn, David; Thorne, Stephen; Bell, John C.] Jennerex Biotherapeut Ltd, San Francisco, CA USA; [McCart, Andrea J.] Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	MacTavish, H (corresponding author), Ottawa Hosp, Ctr Canc Therapeut, Res Inst, Ottawa, ON, Canada.	jbell@ohri.ca	Falls, Theresa/GWZ-9829-2022; Diallo, Jean-Simon/G-4465-2017	Falls, Theresa/0000-0001-5995-9118; Diallo, Jean-Simon/0000-0002-4862-2795; Stanford, Marianne/0000-0003-0432-3707	Terry Fox Foundation; Ottawa Regional Cancer Foundation; FRSQ; CIHR; OGSST; Ontario Institute for Cancer Research; Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ)	Terry Fox Foundation; Ottawa Regional Cancer Foundation; FRSQ(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); OGSST; Ontario Institute for Cancer Research; Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This study was supported by grants to JB and HA from the Terry Fox Foundation and the Ottawa Regional Cancer Foundation; JSD is a recipient of an FRSQ post-doctoral fellowship. FB is a recipient of a CIHR post-doctoral fellowship. HM is supported by an OGSST studentship. JB is supported by the Ontario Institute for Cancer Research. JB, DK, ST, and CB are affiliated with or employed by Jennerex Biotherapeutics. With the exception of JB and ST who are affiliated with Jennerex Biotherapeutics, the funders had no role in study design, data collection and analysis, or decision to publish.; We would like to thank Dr. Anne-Marie Mes-Masson for kindly providing the normal ovarian cell lines. To this end, tumor banking was supported by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ), affiliated to the Canadian Tumor Repository Network (CTRNet). We would also like to thank Dominique Vaillant and Stefanie Reid for their technical assistance.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Arsenio J, 2008, VIROLOGY, V377, P124, DOI 10.1016/j.virol.2008.04.014; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; CHOU TC, 1977, J BIOL CHEM, V252, P6438; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Diallo JS, 2010, MOL THER, V18, P1123, DOI 10.1038/mt.2010.67; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Genin P, 2003, J VIROL, V77, P7113, DOI 10.1128/JVI.77.12.7113-7119.2003; Kirn DH, 2007, PLOS MED, V4, P2001, DOI 10.1371/journal.pmed.0040353; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Kirstein JM, 2009, CLIN EXP METASTAS, V26, P121, DOI 10.1007/s10585-008-9221-z; Liu TC, 2008, MOL THER, V16, P1637, DOI 10.1038/mt.2008.143; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; McCart JA, 2001, CANCER RES, V61, P8751; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moreira JMA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-30; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015; Stanford MM, 2008, MOL THER, V16, P52, DOI 10.1038/sj.mt.6300348; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vlasakova J, 2007, BLOOD, V109, P1373, DOI 10.1182/blood-2006-02-003418; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; XU B, 1994, BLOOD, V84, P1942; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang ZN, 2005, ANN NY ACAD SCI, V1056, P69, DOI 10.1196/annals.1352.005	43	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14462	10.1371/journal.pone.0014462	http://dx.doi.org/10.1371/journal.pone.0014462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21283510	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000285793600005
J	Abhary, M; Siritunga, D; Stevens, G; Taylor, NJ; Fauquet, CM				Abhary, Mohammad; Siritunga, Dimuth; Stevens, Gene; Taylor, Nigel J.; Fauquet, Claude M.			RETRACTED: Transgenic Biofortification of the Starchy Staple Cassava (Manihot esculenta) Generates a Novel Sink for Protein (Retracted article. See vol. 7, 2012)	PLOS ONE			English	Article; Retracted Publication							RECOMBINANT STORAGE PROTEIN; ZEOLIN; PLANTS; FOOD; GENE	Although calorie dense, the starchy, tuberous roots of cassava provide the lowest sources of dietary protein within the major staple food crops (Manihot esculenta Crantz). (Montagnac JA, Davis CR, Tanumihardjo SA. (2009) Compr Rev Food Sci Food Saf 8:181-194). Cassava was genetically modified to express zeolin, a nutritionally balanced storage protein under control of the patatin promoter. Transgenic plants accumulated zeolin within de novo protein bodies localized within the root storage tissues, resulting in total protein levels of 12.5% dry weight within this tissue, a fourfold increase compared to non-transgenic controls. No significant differences were seen for morphological or agronomic characteristics of transgenic and wild type plants in the greenhouse and field trials, but relative to controls, levels of cyanogenic compounds were reduced by up to 55% in both leaf and root tissues of transgenic plants. Data described here represent a proof of concept towards the potential transformation of cassava from a starchy staple, devoid of storage protein, to one capable of supplying inexpensive, plant-based proteins for food, feed and industrial applications.	[Abhary, Mohammad; Taylor, Nigel J.; Fauquet, Claude M.] Donald Danforth Plant Sci Ctr, Int Lab Trop Agr Biotechnol, St Louis, MO USA; [Siritunga, Dimuth] Univ Puerto Rico Mayaguez, Dept Biol, Mayaguez, PR USA; [Stevens, Gene] Univ Missouri, Delta Ctr, Portageville, MO USA	Donald Danforth Plant Science Center; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Missouri System; University of Missouri Columbia	Abhary, M (corresponding author), Donald Danforth Plant Sci Ctr, Int Lab Trop Agr Biotechnol, St Louis, MO USA.	iltab@danforthcenter.org			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellucci M, 2007, J BIOTECHNOL, V131, P97, DOI 10.1016/j.jbiotec.2007.06.004; Bellucci M, 2007, PLANT CELL TISS ORG, V90, P85, DOI 10.1007/s11240-007-9258-8; Chakraborty S, 2000, P NATL ACAD SCI USA, V97, P3724, DOI 10.1073/pnas.050012697; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; EGNIN M, 2001, IN VITRO CELL DEV, V37, P36; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; KAWANO K, 1990, EUPHYTICA, V46, P195, DOI 10.1007/BF00027218; KAWANO K, 1987, CROP SCI, V27, P69, DOI 10.2135/cropsci1987.0011183X002700010018x; Kim J., 1992, Molecular approaches to improving food quality and safety., P1; KOSTERTOPFER M, 1989, MOL GEN GENET, V219, P390, DOI 10.1007/BF00259611; Mainieri D, 2004, PLANT PHYSIOL, V136, P3447, DOI 10.1104/pp.104.046409; Montagnac JA, 2009, COMPR REV FOOD SCI F, V8, P181, DOI 10.1111/j.1541-4337.2009.00077.x; Nassar NMA, 2007, GENET MOL RES, V6, P292; Omole T. A., 1977, Cassava as animal feed., P51; ROSLING H, 1988, CASSAVA TOXICITY FOO; Schreuder MM, 2001, EUPHYTICA, V120, P35, DOI 10.1023/A:1017530932536; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Siritunga D, 2004, PLANT MOL BIOL, V56, P661, DOI 10.1007/s11103-004-3415-9; Sreeja VG, 2002, PLANT FOOD HUM NUTR, V57, P141, DOI 10.1023/A:1015200529646; Stephenson K, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-9; Stupak M, 2006, TRENDS FOOD SCI TECH, V17, P634, DOI 10.1016/j.tifs.2006.06.004; Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2; Yeoh HH, 1996, J SCI FOOD AGR, V70, P51, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;51::AID-JSFA463&gt;3.0.CO;2-W; YOUNG VR, 1994, AM J CLIN NUTR, V59, p1203S, DOI 10.1093/ajcn/59.5.1203S; Zhang P, 2003, TRANSGENIC RES, V12, P243, DOI 10.1023/A:1022918925882; 2007, WHO TECHNICAL REPORT	27	15	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16256	10.1371/journal.pone.0016256	http://dx.doi.org/10.1371/journal.pone.0016256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283593	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400039
J	Ferri, F; Campione, GC; Volta, RD; Gianelli, C; Gentilucci, M				Ferri, Francesca; Campione, Giovanna Cristina; Volta, Riccardo Dalla; Gianelli, Claudia; Gentilucci, Maurizio			Social Requests and Social Affordances: How They Affect the Kinematics of Motor Sequences during Interactions between Conspecifics	PLOS ONE			English	Article							PREHENSION MOVEMENTS; INTENTION; TRANSPORT	The present study aimed at determining whether and what factors affect the control of motor sequences related to interactions between conspecifics. Experiment 1 demonstrated that during interactions between conspecifics guided by the social intention of feeding, a social affordance was activated, which modified the kinematics of sequences constituted by reaching-grasping and placing. This was relative to the same sequence directed to an inanimate target. Experiments 2 and 4 suggested that the related-to-feeding social request emitted by the receiver (i.e. the request gesture of mouth opening) is prerequisite in order to activate a social affordance. Specifically, the two experiments showed that the social request to be fed activated a social affordance even when the sequences directed towards a conspecific were not finalized to feed. Experiment 3 showed that moving inside the peripersonal space of a conspecific, who did not produce any social request, marginally affected the sequence. Finally, experiments 5 and 6 indicated that the gaze of a conspecific is necessary to make a social request effective at activating a social affordance. Summing up, the results of the present study suggest that the control of motor sequences can be changed by the interaction between giver and receiver: the interaction is characterized by a social affordance that the giver activates on the basis of social requests produced by the receiver. The gaze of the receiver is a prerequisite to make a social request effective.	[Ferri, Francesca; Campione, Giovanna Cristina; Volta, Riccardo Dalla; Gianelli, Claudia; Gentilucci, Maurizio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	gentiluc@unipr.it	Gianelli, Claudia/AAC-1518-2019; Ferri, Francesca/AAC-2527-2022	Ferri, Francesca/0000-0003-1821-5870; DALLA VOLTA, Riccardo/0000-0002-2621-4459; Campione, Giovanna Cristina/0000-0003-0410-5400; Gianelli, Claudia/0000-0002-3970-9055	MUR (Ministero dell'Universita e della Ricerca)	MUR (Ministero dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MUR (Ministero dell'Universita e della Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri F, 2007, EXP BRAIN RES, V180, P421, DOI 10.1007/s00221-007-0869-4; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gentilucci M, 1997, EXP BRAIN RES, V115, P116, DOI 10.1007/PL00005671; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson-Frey SH, 2004, VIS COGN, V11, P371, DOI 10.1080/13506280344000329; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; LOVELAND K A, 1991, Ecological Psychology, V3, P99, DOI 10.1207/s15326969eco0302_3; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Mon-Williams M, 2000, EXP BRAIN RES, V134, P268, DOI 10.1007/s002210000479; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ORAM M, 1993, J NEUROPHYSIOL, V76, P109; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.	25	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15855	10.1371/journal.pone.0015855	http://dx.doi.org/10.1371/journal.pone.0015855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710PJ	21283642	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400006
J	Murakami, Y; Toyoda, H; Tanaka, M; Kuroda, M; Harada, Y; Matsuda, F; Tajima, A; Kosaka, N; Ochiya, T; Shimotohno, K				Murakami, Yoshiki; Toyoda, Hidenori; Tanaka, Masami; Kuroda, Masahiko; Harada, Yoshinori; Matsuda, Fumihiko; Tajima, Atsushi; Kosaka, Nobuyoshi; Ochiya, Takahiro; Shimotohno, Kunitada			The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families	PLOS ONE			English	Article							MICRORNA EXPRESSION; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; MIR-200 FAMILY; STELLATE CELLS; EPIDEMIOLOGY; MECHANISMS; INFECTION; CIRRHOSIS; RNA	Background: Chronic hepatitis C (CH) can develop into liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Liver fibrosis and HCC development are strongly correlated, but there is no effective treatment against fibrosis because the critical mechanism of progression of liver fibrosis is not fully understood. microRNAs (miRNAs) are now essential to the molecular mechanisms of several biological processes. In order to clarify how the aberrant expression of miRNAs participates in development of the liver fibrosis, we analyzed the liver fibrosis in mouse liver fibrosis model and human clinical samples. Methodology: In a CCL(4)-induced mouse liver fibrosis model, we compared the miRNA expression profile from CCL(4) and olive oil administrated liver specimens on 4, 6, and 8 weeks. We also measured expression profiles of human miRNAs in the liver biopsy specimens from 105 CH type C patients without a history of anti-viral therapy. Principle Findings: Eleven mouse miRNAs were significantly elevated in progressed liver fibrosis relative to control. By using a large amount of human material in CH analysis, we determined the miRNA expression pattern according to the grade of liver fibrosis. We detected several human miRNAs whose expression levels were correlated with the degree of progression of liver fibrosis. In both the mouse and human studies, the expression levels of miR-199a, 199a*, 200a, and 200b were positively and significantly correlated to the progressed liver fibrosis. The expression level of fibrosis related genes in hepatic stellate cells (HSC), were significantly increased by overexpression of these miRNAs. Conclusion: Four miRNAs are tightly related to the grade of liver fibrosis in both human and mouse was shown. This information may uncover the critical mechanism of progression of liver fibrosis. miRNA expression profiling has potential for diagnostic and therapeutic applications.	[Murakami, Yoshiki; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Tanaka, Masami; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Harada, Yoshinori] Kyoto Prefectural Univ Med, Dept Pathol & Cell Regulat, Kyoto, Japan; [Tajima, Atsushi] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 104, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan	Kyoto University; Ogaki Municipal Hospital; Tokyo Medical University; Kyoto Prefectural University of Medicine; Tokai University; National Cancer Center - Japan; Chiba Institute of Technology	Murakami, Y (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	ymurakami@genome.med.kyoto-u.ac.jp	Tajima, Atsushi/C-1053-2008; Matsuda, Fumihiko/B-9893-2009; Ochiya, Takahiro/AAH-7585-2019	Tajima, Atsushi/0000-0001-6808-5491; Harada, Yoshinori/0000-0001-5942-130X	Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Ministry of Health, Labour and Welfare (Y.M, and K.S). This work was also supported by the 'Strategic Research-Based Support' Project for private universities; with matching funds from the Ministry of Education, Culture, Sports, Science and Technology (M.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; FRIEDMAN SL, 2008, TOXICOLOGY; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; JIN X, 2008, DIG LIVER DIS; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; MARQUEZ RT, 2010, LAB INVEST; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; OGAWA T, 2009, BIOCH BIOPHYS RES CO; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; RODERBURG C, 2010, HEPATOLOGY; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	27	209	228	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16081	10.1371/journal.pone.0016081	http://dx.doi.org/10.1371/journal.pone.0016081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283674	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400016
J	Mosch, K; Franz, H; Soeroes, S; Singh, PB; Fischle, W				Mosch, Kerstin; Franz, Henriette; Soeroes, Szabolcs; Singh, Prim B.; Fischle, Wolfgang			HP1 Recruits Activity-Dependent Neuroprotective Protein to H3K9me3 Marked Pericentromeric Heterochromatin for Silencing of Major Satellite Repeats	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; HISTONE H3; TRANSCRIPTIONAL REPRESSION; MAMMALIAN HETEROCHROMATIN; CHROMOSOME SEGREGATION; BINDING MODULES; SHADOW DOMAIN; FISSION YEAST; LYSINE 9; CHROMATIN	H3 lysine 9 trimethylation (H3K9me3) is a histone posttranslational modification (PTM) that has emerged as hallmark of pericentromeric heterochromatin. This constitutive chromatin domain is composed of repetitive DNA elements, whose transcription is differentially regulated. Mammalian cells contain three HP1 proteins, HP1 alpha, HP1 beta and HP1 gamma These have been shown to bind to H3K9me3 and are thought to mediate the effects of this histone PTM. However, the mechanisms of HP1 chromatin regulation and the exact functional role at pericentromeric heterochromatin are still unclear. Here, we identify activity-dependent neuroprotective protein (ADNP) as an H3K9me3 associated factor. We show that ADNP does not bind H3K9me3 directly, but that interaction is mediated by all three HP1 isoforms in vitro. However, in cells ADNP localization to areas of pericentromeric heterochromatin is only dependent on HP1 alpha and HP1 beta. Besides a PGVLL sequence patch we uncovered an ARKS motif within the ADNP homeodomain involved in HP1 dependent H3K9me3 association and localization to pericentromeric heterochromatin. While knockdown of ADNP had no effect on HP1 distribution and heterochromatic histone and DNA modifications, we found ADNP silencing major satellite repeats. Our results identify a novel factor in the translation of H3K9me3 at pericentromeric heterochromatin that regulates transcription.	[Mosch, Kerstin; Franz, Henriette; Soeroes, Szabolcs; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, Gottingen, Germany; [Singh, Prim B.] Res Ctr Borstel, Div Immunoepigenet, Borstel, Germany	Max Planck Society; Forschungszentrum Borstel	Mosch, K (corresponding author), Max Planck Inst Biophys Chem, Lab Chromatin Biochem, Gottingen, Germany.	wfischl@gwdg.de	Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; Franz, Henriette/0000-0001-9358-7442	Max Planck Society via Network of Excellence "The Epigenome'' of the European Union	Max Planck Society via Network of Excellence "The Epigenome'' of the European Union	This work was funded by the Max Planck Society via intramural funds as well as by the Network of Excellence "The Epigenome'' of the European Union FP6 (NET program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brown JP, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-9; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Delattre M, 2000, J CELL SCI, V113, P4253; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Eymery A, 2009, INT J DEV BIOL, V53, P259, DOI 10.1387/ijdb.082673ae; Falandry C, 2010, J BIOL CHEM, V285, P20234, DOI 10.1074/jbc.M109.052399; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; FRANZ H, 2009, J BIOL CHEM, V5, P5; Furman S, 2004, NEURON GLIA BIOL, V1, P193, DOI 10.1017/S1740925X05000013; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gozes I, 1999, ANN NY ACAD SCI, V897, P125, DOI 10.1111/j.1749-6632.1999.tb07884.x; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Horakova AH, 2010, J STRUCT BIOL, V169, P124, DOI 10.1016/j.jsb.2009.09.007; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon SH, 2008, MOL CELLS, V26, P217; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Linder B, 2001, EMBO REP, V2, P211, DOI 10.1093/embo-reports/kve039; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Qu Jian-hui, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P520; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Steingart RA, 2006, MOL CELL ENDOCRINOL, V252, P148, DOI 10.1016/j.mce.2006.03.029; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Zamir I, 1997, P NATL ACAD SCI USA, V94, P14400, DOI 10.1073/pnas.94.26.14400; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1; Zemlyak I, 2007, PEPTIDES, V28, P2004, DOI 10.1016/j.peptides.2007.08.004	73	43	43	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15894	10.1371/journal.pone.0015894	http://dx.doi.org/10.1371/journal.pone.0015894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267468	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500031
J	Bakanda, C; Birungi, J; Mwesigwa, R; Zhang, W; Hagopian, A; Ford, N; Mills, EJ				Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert; Zhang, Wendy; Hagopian, Amy; Ford, Nathan; Mills, Edward J.			Density of Healthcare Providers and Patient Outcomes: Evidence from a Nationally Representative Multi-Site HIV Treatment Program in Uganda	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-RESOURCES; DRUG-RESISTANCE; SCALING-UP; ADHERENCE; AFRICA; POPULATION; HIV/AIDS	Objective: We examined the association between density of healthcare providers and patient outcomes using a large nationally representative cohort of patients receiving combination antiretroviral therapy (cART) in Uganda. Design: We obtained data from The AIDS Support Organization (TASO) in Uganda. Patients 18 years of age and older who initiated cART at TASO between 2004 and 2008 contributed to this analysis. The number of healthcare providers per 100 patients, the number of patients lost to follow-up per 100 person years and number of deaths per 100 person years were calculated. Spearman correlation was used to identify associations between patient loss to follow-up and mortality with the healthcare provider-patient ratios. Results: We found no significant associations between the number of patients lost to follow-up and physicians (p = 0.45), nurses (p = 0.93), clinical officers (p = 0.80), field officers (p = 0.56), and healthcare providers overall (p = 0.83). Similarly, no significant associations were observed between mortality and physicians (p = 0.65), nurses (p = 0.49), clinical officers (p = 0.73), field officers (p = 0.78), and healthcare providers overall (p = 0.73). Conclusions: Patient outcomes, as measured by loss to follow-up and mortality, were not significantly associated with the number of doctors, nurses, clinical officers, field officers, or healthcare providers overall. This may suggest that that other factors, such as the presence of volunteer patient supporters or broader political or socioeconomic influences, may be more closely associated with outcomes of care among patients on cART in Uganda.	[Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert] AIDS Support Org, Kampala, Uganda; [Zhang, Wendy] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hagopian, Amy] Univ Cape Town, Div Infect Dis, ZA-7925 Cape Town, South Africa; [Ford, Nathan] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	B.C. Centre for Excellence in HIV/AIDS; University of Cape Town; University of Washington; University of Washington Seattle; University of Ottawa	Bakanda, C (corresponding author), AIDS Support Org, Kampala, Uganda.	edward.mills@uottawa.ca						Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; BOYARINOVA G, 2007, J NURSING ALLIED HLT, V1, P1; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Knodel J, 2010, RES AGING, V32, P19, DOI 10.1177/0164027509348130; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; LAMBDIN B, 2010, PATIENT VOLUME HUMAN; Marino P, 2007, SOC WORK HEALTH CARE, V45, P67, DOI 10.1300/J010v45n01_05; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills Edward J, 2009, Curr HIV/AIDS Rep, V6, P201, DOI 10.1007/s11904-009-0027-7; O'Brien Daniel P, 2010, Confl Health, V4, P12, DOI 10.1186/1752-1505-4-12; Parkhurst JO, 2004, SOC SCI MED, V59, P1913, DOI 10.1016/j.socscimed.2004.02.026; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Robinson JJA, 2001, J ADV NURS, V34, P445, DOI 10.1046/j.1365-2648.2001.01773.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *UNAIDS, 2009, AIDS EP UPD; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16279	10.1371/journal.pone.0016279	http://dx.doi.org/10.1371/journal.pone.0016279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710ND	21264224	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600025
J	Baron, T; Vulin, J; Biacabe, AG; Lakhdar, L; Verchere, J; Torres, JM; Bencsik, A				Baron, Thierry; Vulin, Johann; Biacabe, Anne-Gaelle; Lakhdar, Latefa; Verchere, Jeremy; Torres, Juan-Maria; Bencsik, Anna			Emergence of Classical BSE Strain Properties during Serial Passages of H-BSE in Wild-Type Mice	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; MOLECULAR ANALYSIS; PRION DISEASES; TRANSGENIC MICE; SCRAPIE AGENT; VARIANT CJD; IDENTIFICATION; SIMILARITIES	Background: Two distinct forms of atypical spongiform encephalopathies (H-BSE and L-BSE) have recently been identified in cattle. Transmission studies in several wild-type or transgenic mouse models showed that these forms were associated with two distinct major strains of infectious agents, which also differed from the unique strain that had been isolated from cases of classical BSE during the food-borne epizootic disease. Methodology/Principal Findings: H-BSE was monitored during three serial passages in C57BL/6 mice. On second passage, most of the inoculated mice showed molecular features of the abnormal prion protein (PrP(d)) and brain lesions similar to those observed at first passage, but clearly distinct from those of classical BSE in this mouse model. These features were similarly maintained during a third passage. However, on second passage, some of the mice exhibited distinctly different molecular and lesion characteristics, reminiscent of classical BSE in C57Bl/6 mice. These similarities were confirmed on third passage from such mice, for which the same survival time was also observed as with classical BSE adapted to C57Bl/6 mice. Lymphotropism was rarely detected in mice with H-BSE features. In contrast, PrP(d) was detectable, on third passage, in the spleens of most mice exhibiting classical BSE features, the pattern being indistinguishable from that found in C57Bl/6 mice infected with classical BSE. Conclusion/Significance: Our data demonstrate the emergence of a prion strain with features similar to classical BSE during serial passages of H-BSE in wild-type mice. Such findings might help to explain the origin of the classical BSE epizootic disease, which could have originated from a putatively sporadic form of BSE.	[Baron, Thierry; Vulin, Johann; Biacabe, Anne-Gaelle; Lakhdar, Latefa; Verchere, Jeremy; Bencsik, Anna] Agence Francaise Secur Sanit Aliments Lyon, Lyon, France; [Torres, Juan-Maria] Ist Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain		Baron, T (corresponding author), Agence Francaise Secur Sanit Aliments Lyon, Lyon, France.	thierry.baron@anses.fr	BENCSIK, Anna A/HGC-4260-2022; Torres, Juan Maria/L-8768-2013	BENCSIK, Anna A/0000-0002-8671-6290; Torres, Juan Maria/0000-0003-0443-9232				Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Baron T, 2006, LANCET, V367, P297, DOI 10.1016/S0140-6736(06)68060-4; Baron TGM, 2001, J VIROL, V75, P107, DOI 10.1128/JVI.75.1.107-114.2001; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Baron T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010310; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Bencsik A, 2005, J VIROL METHODS, V124, P197, DOI 10.1016/j.jviromet.2004.11.027; Bencsik A, 2007, HISTOCHEM CELL BIOL, V127, P531, DOI 10.1007/s00418-007-0276-8; Bencsik AA, 2006, J HISTOCHEM CYTOCHEM, V54, P849, DOI 10.1369/jhc.5C6895.2006; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Brown DA, 2003, NEUROPATH APPL NEURO, V29, P262, DOI 10.1046/j.1365-2990.2003.00462.x; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRUCE ME, 1996, PRION DIS, P223; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Green R, 2005, J COMP PATHOL, V132, P117, DOI 10.1016/j.jcpa.2004.08.002; Hagiwara K, 2007, JPN J INFECT DIS, V60, P305; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Kuczius T, 1998, J INFECT DIS, V178, P693, DOI 10.1086/515337; Lasmezas CI, 1996, J GEN VIROL, V77, P1601, DOI 10.1099/0022-1317-77-7-1601; Lezmi S, 2006, J HISTOCHEM CYTOCHEM, V54, P1087, DOI 10.1369/jhc.5A6892.2006; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Nicot S, 2010, J GEN VIROL, V91, P570, DOI 10.1099/vir.0.014464-0; Okada H, 2011, VET PATHOL, V48, P942, DOI 10.1177/0300985810382672; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; WILESMITH JW, 1988, VET REC, V123, P638	42	48	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15839	10.1371/journal.pone.0015839	http://dx.doi.org/10.1371/journal.pone.0015839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264286	Green Published, Green Submitted, gold			2022-12-27	WOS:000286516500012
J	Trimble, MJ; van Aarde, RJ				Trimble, Morgan J.; van Aarde, Rudi J.			Decline of Birds in a Human Modified Coastal Dune Forest Landscape in South Africa	PLOS ONE			English	Article							POPULATION DECLINES; CONSERVATION; ABUNDANCE; COMMUNITIES; HABITATS; BIODIVERSITY; RANGE	Previous studies demonstrate that old-growth forest remnants and vegetation regenerating after anthropogenic disturbance provide habitat for birds in a human modified coastal dune forest landscape in northern KwaZulu-Natal, South Africa. However, occurrence does not ensure persistence. Based on a 13-year monitoring database we calculated population trends for 37 bird species and general trends in overall bird density in different vegetation types. We evaluated species' characteristics as covariates of population trend and assessed changes in rainfall and proportional area and survey coverage per vegetation type. 76% of species assessed have declined, 57% significantly so at an average rate of 13.9% per year. Overall, bird density has fallen at 12.2% per year across old-growth forest and woody regenerating vegetation types. Changes in proportional area and coverage per vegetation type may partly explain trends for a few species but are unlikely to account for most. Below average rainfall may have contributed to bird declines. However, other possibilities warrant further investigation. Species with larger range extents tended to decline more sharply than did others, and these species may be responding to environmental changes on a broader geographical scale. Our results cast doubt on the future persistence of birds in this human modified landscape. More research is needed to elucidate the mechanisms driving population decline in the study area and to investigate whether the declines identified here are more widespread across the region and perhaps the continent.	[Trimble, Morgan J.; van Aarde, Rudi J.] Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa	University of Pretoria	Trimble, MJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa.	rjvaarde@zoology.up.ac.za	Trimble, Morgan J/B-1161-2010	Trimble, Morgan J/0000-0002-9914-0788	Richards Bay Minerals; National Research Foundation	Richards Bay Minerals; National Research Foundation	Richards Bay Minerals and the National Research Foundation provided support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKINS RA, 1987, WILSON BULL, V99, P7; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BirdLife International, 2004, STAT WORLDS BIRDS 20; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Camphysen CJ, 2001, ENVIRON POLLUT, V112, P443, DOI 10.1016/S0269-7491(00)00138-X; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Dunn EH, 2002, CONSERV BIOL, V16, P1632, DOI 10.1046/j.1523-1739.2002.01250.x; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; FAABORG J, 1982, Wilson Bulletin, V94, P20; FRY DM, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432528; Grainger MJ, 2011, RESTOR ECOL, V19, P111, DOI 10.1111/j.1526-100X.2009.00630.x; GRAINGER MJ, 2011, RESTOR ECOL IN PRESS; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Haskell DG, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000063; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Komar O, 2006, BIRD CONSERV INT, V16, P1, DOI 10.1017/S0959270906000074; Kritzinger JJ, 1998, S AFR J SCI, V94, P71; Kuper W, 2004, ANN MO BOT GARD, V91, P525; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Low A. B., 1998, VEGETATION S AFRICA; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Mehlman DW, 1997, ECOL APPL, V7, P614; Nel DC, 2002, POLAR BIOL, V25, P81, DOI 10.1007/s003000100315; OLSEN P, 2008, STAT AUSTR BIRDS 200; Peakall DB, 2000, ECOTOXICOLOGY, V9, P239, DOI 10.1023/A:1026541210511; Petit LJ, 1999, ECOGRAPHY, V22, P292, DOI 10.1111/j.1600-0587.1999.tb00505.x; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sekercioglu CH, 2002, BIOL CONSERV, V107, P229, DOI 10.1016/S0006-3207(02)00097-6; Sigel BJ, 2006, CONSERV BIOL, V20, P111, DOI 10.1111/j.1523-1739.2005.00293.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; STEENKAMP Y, 2004, HOTSPOTS REVISITED E; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Thomas L., 2009, DISTANCE 6 0 RELEASE; Underhill LG, 2005, ICES J MAR SCI, V62, P360, DOI 10.1016/j.icesjms.2005.01.005; *US COMM, 2009, STAT BIRDS US AM 200; vanAarde RJ, 1996, LANDSCAPE URBAN PLAN, V34, P277, DOI 10.1016/0169-2046(95)00237-5; VANAARDE RJ, 1980, S AFR J WILDL RES, V10, P123; vanAarde RJ, 1996, RESTOR ECOL, V4, P334, DOI 10.1111/j.1526-100X.1996.tb00186.x; VanWyk AE, 1996, BIODIVERSITY OF AFRICAN PLANTS, P198; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Wassenaar TD, 2005, ECOLOGY, V86, P655, DOI 10.1890/03-0836; Wikelski M, 2004, ECOL SOC, V9; Zuur Alain F., 2009, P1; [No title captured]	60	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16176	10.1371/journal.pone.0016176	http://dx.doi.org/10.1371/journal.pone.0016176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249203	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000026
J	Chang, AL; Blakeslee, AMH; Miller, AW; Ruiz, GM				Chang, Andrew L.; Blakeslee, April M. H.; Miller, A. Whitman; Ruiz, Gregory M.			Establishment Failure in Biological Invasions: A Case History of Littorina littorea in California, USA	PLOS ONE			English	Article							MARINE SPECIES INTRODUCTION; SAN-FRANCISCO BAY; NORTH-AMERICA; GENETIC DIVERSITY; CARCINUS-MAENAS; INTERTIDAL ZONE; GREEN CRAB; SNAIL; ATLANTIC; POPULATION	Background: The early stages of biological invasions are rarely observed, but can provide significant insight into the invasion process as well as the influence vectors have on invasion success or failure. Methodology/Principal Findings: We characterized three newly discovered populations of an introduced gastropod, Littorina littorea (Linne, 1758), in California, USA, comparing them to potential source populations in native Europe and the North American East Coast, where the snail is also introduced. Demographic surveys were used to assess spatial distribution and sizes of the snail in San Francisco and Anaheim Bays, California. Mitochondrial DNA was sequenced and compared among these nascent populations, and various populations from the North American East Coast and Europe, to characterize the California populations and ascertain their likely source. Demographic and genetic data were considered together to deduce likely vectors for the California populations. We found that the three large California L. littorea populations contained only adult snails and had unexpectedly high genetic diversity rather than showing an extreme bottleneck as typically expected in recent introductions. Haplotype diversity in Californian populations was significantly reduced compared to European populations, but not compared to East Coast populations. Genetic analyses clearly suggested the East Coast as the source region for the California introductions. Conclusions and Significance: The California L. littorea populations were at an early, non-established phase of invasion with no evidence of recruitment. The live seafood trade is the most likely invasion vector for these populations, as it preferentially transports large numbers of adult L. littorea, matching the demographic structure of the introduced California L. littorea populations. Our results highlight continued operation of live seafood trade vectors and the influence of vectors on the demographic and genetic structure of the resulting populations, especially early stages of the invasion process.	[Chang, Andrew L.; Blakeslee, April M. H.; Miller, A. Whitman; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Chang, AL (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	changal@si.edu	Chang, Andrew/J-8058-2016; Miller, Whitman/C-7811-2017	Chang, Andrew/0000-0002-7870-285X; Ruiz, Gregory/0000-0003-2499-441X; Blakeslee, April/0000-0001-9667-2175; Miller, Whitman/0000-0003-0484-182X	National Science Foundation; Smithsonian Institution; Smithsonian Marine Science Network	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network)	Financial support was provided by a National Science Foundation Graduate Research Fellowship to ALC, Smithsonian Institution Postdoctoral Fellowships to ALC and AMHB, and a Smithsonian Marine Science Network Postdoctoral Fellowship to AMHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoramoorthy G, 2007, HUM ECOL, V35, P251, DOI 10.1007/s10745-006-9068-3; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Anderson J.L., 2003, INT SEAFOOD TRADE; Behrens Yamada S, 2001, GLOBAL INVADER EUROP; BERTNESS MD, 1984, ECOLOGY, V65, P370, DOI 10.2307/1941400; Blakeslee AMH, 2008, MOL ECOL, V17, P3684, DOI 10.1111/j.1365-294X.2008.03865.x; *BOD OC OBS NOD, 2009, FORT POINT WAT QUAL; Brawley SH, 2009, P NATL ACAD SCI USA, V106, P8239, DOI 10.1073/pnas.0812300106; BRENCHLEY GA, 1983, BIOL BULL, V165, P543, DOI 10.2307/1541464; Byers JE, 2008, ECOLOGY, V89, P439, DOI 10.1890/06-1036.1; CARLTON J, 1969, Veliger, V11, P283; Carlton JT, 1998, VELIGER, V41, P333; CARLTON JT, 1979, HIST BIOGEOGRAPHY EC; Chapman JW, 2008, BIOL INVASIONS, V10, P131, DOI 10.1007/s10530-007-9115-z; Chapman JW, 2007, BIOL INVASIONS, V9, P995, DOI 10.1007/s10530-007-9098-9; Clarke KR, 2006, PRIMER V6 USER MANUA; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; COHEN AN, 1995, MAR BIOL, V122, P225; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Costello CJ, 2003, P NATL ACAD SCI USA, V100, P3321, DOI 10.1073/pnas.0636536100; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Cunningham CW, 2008, BIOL INVASIONS, V10, P1, DOI 10.1007/s10530-007-9099-8; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; GARDNER JPA, 1987, OPHELIA, V27, P181, DOI 10.1080/00785236.1987.10422021; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; GROSHOLZ ED, 1995, MAR BIOL, V122, P239; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LANE ED, 1975, CALIFORNIA DEP FISH, V165, P1; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Miller AW, 2007, MAR ECOL PROG SER, V332, P41, DOI 10.3354/meps332041; Miller A. Whitman, 2009, V204, P153; Miller A. Whitman, 2000, THESIS U CALIFORNIA; Miller AW, 2004, J PHYCOL, V40, P1028, DOI 10.1111/j.1529-8817.2004.04081.x; *NAT BALL INF CLEA, 2010, NBIC ONL DAT; Reid D. G., 1996, SYSTEMATICS EVOLUTIO; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Severinghaus LL, 1999, BIOL CONSERV, V89, P301, DOI 10.1016/S0006-3207(98)00155-4; Smith JFH, 1999, J ASIAN STUD, V58, P51, DOI 10.2307/2658389; Steneck RS, 2001, MARINE COMMUNITY ECOLOGY, P445; *SURV USG, 2010, SAN FRANC BAY WAT QU; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Torchin ME, 2005, BIOL INVASIONS, V7, P885, DOI 10.1007/s10530-004-2967-6; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Wares JP, 2002, ECOL LETT, V5, P577, DOI 10.1046/j.1461-0248.2002.00359.x; WELLS HARRY W., 1965, CHESAPEAKE SCI, V6, P38, DOI 10.1007/BF02688314; WILLIAMS EE, 1964, J ANIM ECOL, V33, P413, DOI 10.2307/2562; YAMADA SB, 1987, J EXP MAR BIOL ECOL, V105, P187, DOI 10.1016/0022-0981(87)90171-7	54	23	25	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16035	10.1371/journal.pone.0016035	http://dx.doi.org/10.1371/journal.pone.0016035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264336	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100025
J	Grangeiro, A; Escuder, MM; Menezes, PR; Alencar, R; de Castilho, EA				Grangeiro, Alexandre; Escuder, Maria Mercedes; Menezes, Paulo Rossi; Alencar, Rosa; de Castilho, Euclides Ayres			Late Entry into HIV Care: Estimated Impact on AIDS Mortality Rates in Brazil, 2003-2006	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; UNITED-STATES; HIV-1-INFECTED PATIENTS; GENDER-DIFFERENCES; INFECTED PATIENTS; MEDICAL-CARE; SAO-PAULO; DIAGNOSIS; SURVIVAL; DELAY	Background: Worldwide, a high proportion of HIV-infected individuals enter into HIV care late. Here, our objective was to estimate the impact that late entry into HIV care has had on AIDS mortality rates in Brazil. Methodology/Principal Findings: We analyzed data from information systems regarding HIV-infected adults who sought treatment at public health care facilities in Brazil from 2003 to 2006. We initially estimated the prevalence of late entry into HIV care, as well as the probability of death in the first 12 months, the percentage of the risk of death attributable to late entry, and the number of avoidable deaths. We subsequently adjusted the annual AIDS mortality rate by excluding such deaths. Of the 115,369 patients evaluated, 50,358 (43.6%) had entered HIV care late, and 18,002 died in the first 12 months, representing a 16.5% probability of death in the first 12 months (95% CI: 16.3-16.7). By comparing patients who entered HIV care late with those who gained timely access, we found that the risk ratio for death was 49.5 (95% CI: 45.1-54.2). The percentage of the risk of death attributable to late entry was 95.5%, translating to 17,189 potentially avoidable deaths. Averting those deaths would have lowered the 2003-2006 AIDS mortality rate by 39.5%. Including asymptomatic patients with CD4(+) T cell counts >200 and <= 350 cells/mm(3) in the group who entered HIV care late increased this proportion by 1.8%. Conclusions/Significance: In Brazil, antiretroviral drugs reduced AIDS mortality by 43%. Timely entry would reduce that rate by a similar proportion, as well as resulting in a 45.2% increase in the effectiveness of the program for HIV care. The World Health Organization recommendation that asymptomatic patients with CD4(+) T cell counts <= 350 cells/mm(3) be treated would not have a significant impact on this scenario.	[Grangeiro, Alexandre; Menezes, Paulo Rossi; de Castilho, Euclides Ayres] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Escuder, Maria Mercedes] Secretaria Estado Saude Sao Paulo, Inst Saude, Sao Paulo, Brazil; [Alencar, Rosa] Secretaria Estado Saude Sao Paulo, Ctr Referencia & Treinamento DST Aids, Sao Paulo, Brazil	Universidade de Sao Paulo	Grangeiro, A (corresponding author), Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil.	ale.grangeiro@gmail.com	Menezes, Paulo R/C-9985-2010; Menezes, Paulo/AAM-3529-2021; DE CASTILHO, EUCLIDES AYRES/K-7906-2016	Menezes, Paulo R/0000-0001-6330-3314; Menezes, Paulo/0000-0001-6330-3314; Castilho, Euclides/0000-0002-7352-8784	Brazilian National Ministry of Health; Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ, German Agency for Technical Cooperation) in Brazil; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Brazilian National Ministry of Health; Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ, German Agency for Technical Cooperation) in Brazil; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by the Brazilian National Ministry of Health Sexually Transmitted Diseases and AIDS Program and by the Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ, German Agency for Technical Cooperation) in Brazil. PRM is the recipient of a scholarship from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development). The funders had no role in study design, data collection, data analysis, decision to publish, or manuscript preparation.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Braga P, 2007, AIDS PATIENT CARE ST, V21, P321, DOI 10.1089/apc.2006.0111; Braga PE, 2007, CAD SAUDE PUBLICA, V23, P2653, DOI 10.1590/S0102-311X2007001100013; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; *BRAZ MIN HLTH HLT, 2008, UN GEN ASS SPEC SESS; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c; CARNICERPONT D, 2006, CURRENT HIV RES, V7, P237; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Delpierre C, 2007, INT J STD AIDS, V18, P312, DOI 10.1258/095646207780749709; DONNELL D, 2010, LANCET, DOI DOI 10.1016/SO140-6736(10)60705-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; FRANCA I, 2008, REV SAUDE PUBL S1, V42, pNI201; FUENTE L, 2009, J EPIDEMIOL COMMUNIT, V63, P552; Gonçalves Valéria Freire, 2008, Rev. bras. epidemiol., V11, P356, DOI 10.1590/S1415-790X2008000300003; Grangeiro A, 2009, CAD SAUDE PUBLICA, V25, P2053, DOI 10.1590/S0102-311X2009000900019; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Jorge Maria Helena Prado de Mello, 2007, Ciênc. saúde coletiva, V12, P643, DOI 10.1590/S1413-81232007000300014; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kelsey JL., 1996, METHODS OBSERVATIONA; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lucena FF, 2006, CADERNOS SAUDE COLET, V14, P305; Fernandes JRM, 2009, CAD SAUDE PUBLICA, V25, P1369, DOI 10.1590/S0102-311X2009000600019; *MIN SAUD BRAS, 2000, REC TER ANT AD AD IN; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Fonseca MGP, 2010, CAD SAUDE PUBLICA, V26, P1431, DOI 10.1590/S0102-311X2010000700022; Reed JB, 2009, AIDS PATIENT CARE ST, V23, P765, DOI 10.1089/apc.2008.0213; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; SIGHEN V, 2005, J ACQ IMMUN DEF SYND, V40, P212; Signorelli C, 2006, EUR J PUBLIC HEALTH, V16, P498, DOI 10.1093/eurpub/ckl024; Souza PRB, 2007, CLINICS, V62, P579, DOI 10.1590/S1807-59322007000500008; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; The Strategies for Management of Antiretroviral Therapy (SMART) Study Group, 2008, JID, V197, P1133; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Valente de Lemos K R, 2001, Cad Saude Publica, V17, P617, DOI 10.1590/S0102-311X2001000300016; *WHO JOINT UN PROG, 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2009, RAP ADV ANT THER HIV; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	47	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14585	10.1371/journal.pone.0014585	http://dx.doi.org/10.1371/journal.pone.0014585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283618	gold, Green Submitted, Green Published			2022-12-27	WOS:000286661400003
J	Kessler, H; Taubner, S; Buchheim, A; Munte, TF; Stasch, M; Kachele, H; Roth, G; Heinecke, A; Erhard, P; Cierpka, M; Wiswede, D				Kessler, Henrik; Taubner, Svenja; Buchheim, Anna; Muente, Thomas F.; Stasch, Michael; Kaechele, Horst; Roth, Gerhard; Heinecke, Armin; Erhard, Peter; Cierpka, Manfred; Wiswede, Daniel			Individualized and Clinically Derived Stimuli Activate Limbic Structures in Depression: An fMRI Study	PLOS ONE			English	Article							BRAIN ACTIVATION; MAJOR DEPRESSION; NEGATIVE AFFECT; MOOD DISORDERS; AMYGDALA; RESPONSES; FEATURES; SYSTEM; MODEL; PANAS	Objectives: In the search for neurobiological correlates of depression, a major finding is hyperactivity in limbic-paralimbic regions. However, results so far have been inconsistent, and the stimuli used are often unspecific to depression. This study explored hemodynamic responses of the brain in patients with depression while processing individualized and clinically derived stimuli. Methods: Eighteen unmedicated patients with recurrent major depressive disorder and 17 never-depressed control subjects took part in standardized clinical interviews from which individualized formulations of core interpersonal dysfunction were derived. In the patient group such formulations reflected core themes relating to the onset and maintenance of depression. In controls, formulations reflected a major source of distress. This material was thereafter presented to subjects during functional magnetic resonance imaging (fMRI) assessment. Results: Increased hemodynamic responses in the anterior cingulate cortex, medial frontal gyrus, fusiform gyrus and occipital lobe were observed in both patients and controls when viewing individualized stimuli. Relative to control subjects, patients with depression showed increased hemodynamic responses in limbic-paralimbic and subcortical regions (e.g. amygdala and basal ganglia) but no signal decrease in prefrontal regions. Conclusions: This study provides the first evidence that individualized stimuli derived from standardized clinical interviewing can lead to hemodynamic responses in regions associated with self-referential and emotional processing in both groups and limbic-paralimbic and subcortical structures in individuals with depression. Although the regions with increased responses in patients have been previously reported, this study enhances the ecological value of fMRI findings by applying stimuli that are of personal relevance to each individual's depression.	[Kessler, Henrik; Taubner, Svenja; Roth, Gerhard; Wiswede, Daniel] Hanse Inst Adv Study, Delmenhorst, Germany; [Kessler, Henrik; Kaechele, Horst; Wiswede, Daniel] Univ Ulm, Dept Psychosomat Med & Psychotherapy, Ulm, Germany; [Taubner, Svenja] Univ Kassel, Inst Social Therapy Supervis & Coaching, Kassel, Germany; [Buchheim, Anna] Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria; [Muente, Thomas F.] Univ Magdeburg, Dept Neuropsychol, D-39106 Magdeburg, Germany; [Stasch, Michael; Cierpka, Manfred] Heidelberg Univ, Inst Psychosomat Cooperat Res & Family Therapy, Heidelberg, Germany; [Roth, Gerhard; Erhard, Peter] Univ Bremen, Brain Res Inst, Bremen, Germany; [Heinecke, Armin] Brain Innovat, Maastricht, Netherlands; [Kessler, Henrik] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Wiswede, Daniel] Univ Jena, Dept Gen Psychol 2, Jena, Germany	Ulm University; Universitat Kassel; University of Innsbruck; Otto von Guericke University; Ruprecht Karls University Heidelberg; University of Bremen; Maastricht University; University of Bonn; Friedrich Schiller University of Jena	Kessler, H (corresponding author), Hanse Inst Adv Study, Delmenhorst, Germany.	henrik.kessler@ukb.uni-bonn.de	Münte, Thomas/C-2077-2014; Taubner, Svenja/AAY-5144-2020	Taubner, Svenja/0000-0001-8058-762X; Wiswede, Daniel/0000-0002-2702-8316; Buchheim, Anna/0000-0002-1339-5246	Hanse Institute for Advanced Study, Delmenhorst; DFG; International Psychoanalytic Association	Hanse Institute for Advanced Study, Delmenhorst; DFG(German Research Foundation (DFG)); International Psychoanalytic Association	Subjects were paid by research funds from the Hanse Institute for Advanced Study, Delmenhorst. Armin Heinecke is employed by BrainInnovation, Maastricht, Netherlands, as a member of the software support team. The funder had a role in the preparation of data for publication. DW, ST and HK were fellows of the Hanse Institute for Advanced Study, Delmenhorst, during data acquisition. AB and HK were fellows of the Hanse Institute for Advanced Study during the preparation phase of the study. TM is supported by grants from the DFG. This study was supported by a research grant of the International Psychoanalytic Association. Those institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedny M, 2006, BRAIN LANG, V98, P127, DOI 10.1016/j.bandl.2006.04.008; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Cierpka M, 2007, PSYCHOPATHOLOGY, V40, P209, DOI 10.1159/000101363; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gross S, 2007, PSYCHOTHER RES, V17, P522, DOI 10.1080/10503300701320629; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Hautzinger M, 1994, BECK DEPRESSIONS INV; Klerman GL, 1984, INTERPERSONAL PSYCHO; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kumari V, 2006, ACTA NEUROPSYCHIATR, V18, P61, DOI 10.1111/j.1601-5215.2006.00127.x; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LEMOGNE C, 2009, SOC COGN AFFECT NEUR; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McCullough JP, 2003, J CLIN PSYCHOL, V59, P833, DOI 10.1002/jclp.10176; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OPD Task Force, 2008, OP PSYCH DIAGN OPD 2; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; Talairach J., 1988, COPLANAR STEREOTAXIC; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whalen Paul J, 2002, Semin Clin Neuropsychiatry, V7, P234, DOI 10.1053/scnp.2002.35219; WITTCHEN HU, M SKID 1 STRUKTURIER	41	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15712	10.1371/journal.pone.0015712	http://dx.doi.org/10.1371/journal.pone.0015712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283580	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400012
J	Reda, AA				Reda, Ayalu Aklilu			Reliability and Validity of the Ethiopian Version of the Hospital Anxiety and Depression Scale (HADS) in HIV Infected Patients	PLOS ONE			English	Article							PARALLEL ANALYSIS	Background: The hospital anxiety and depression scale (HADS) is a widely used instrument for evaluating psychological distress from anxiety and depression. HADS has not yet been validated in Ethiopia. The aim of this study was to evaluate the reliability and validity of the Amharic (Ethiopian language) version of HADs among HIV infected patients. Methods: The translated scale was administered to 302 HIV/AIDS patients on follow up for and taking anti-retroviral treatment. Consistency assessment was conducted using Cronbach's alpha, test-retest reliability using intra-class correlation coefficients (ICC). Construct validity was examined using principal components analysis (PCA). Parallel analysis, Kaiser's criterion and the scree test were used for factor extraction. Results: The internal consistency was 0.78 for the anxiety, 0.76 for depression subscales and 0.87 for the full scale of HADS. The intra-class correlation coefficient (ICC) was 80%, 86%, and 84% for the anxiety and depression subscales, and total score respectively. PCA revealed a one dimensional scale. Conclusion: This preliminary validation study of the Ethiopian version of the HADs indicates that it has promising acceptability, reliability and validity. The adopted scale has a single underlying dimension as indicated by Razavi's model. The HADS can be used to examine psychological distress in HIV infected patients. Findings are discussed and recommendations made.	Haramaya Univ, Dept Publ Hlth, Coll Hlth Sci, Harar, Ethiopia	Haramaya University	Reda, AA (corresponding author), Haramaya Univ, Dept Publ Hlth, Coll Hlth Sci, Harar, Ethiopia.	ayaluaklilu@yahoo.com			Haramaya University	Haramaya University	Haramaya University (http://www.haramaya.edu.et/) provided funds and transportation facility for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIODUN OA, 1994, BRIT J PSYCHIAT, V165, P669, DOI 10.1192/bjp.165.5.669; ANDERSSON E, 1993, SOC BEHAV PERSONAL, V21, P197, DOI 10.2224/sbp.1993.21.3.197; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BURGESS A, 1993, AIDS, V7, P1001, DOI 10.1097/00002030-199307000-00015; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CHATURVEDI SK, 1991, BRIT J PSYCHIAT, V159, P298, DOI 10.1192/bjp.159.2.298a; Costello A.M., 2005, PRACT ASSESS RES EVA, V10, P7, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868]; Dinno A, 2009, MULTIVAR BEHAV RES, V44, P362, DOI 10.1080/00273170902938969; FERNANDEZ F, 2006, PSYCHIAT ASPECTS HIV; Friedman S, 2001, PSYCHIAT RES, V104, P247, DOI 10.1016/S0165-1781(01)00309-2; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Karimova Gk, 2003, Psychol Health Med, V8, P89, DOI 10.1080/1354850021000059296; LAUTENSCHLAGER GJ, 1989, MULTIVAR BEHAV RES, V24, P365, DOI 10.1207/s15327906mbr2403_6; Martin C.R., 1999, PSYCHOL HEALTH MED, V4, P369, DOI 10.1080/135485099106117; Martin CR, 2005, CURR PSYCHIATRY REV, V1, P69, DOI 10.2174/1573400052953510; Montazeri A, 2003, HLTH QUALITY LIFE OU, V1; RAZAVI D, 1990, BRIT J PSYCHIAT, V156, P79, DOI 10.1192/bjp.156.1.79; RAZAVI D, 1989, REV PSYCHOL APPL, V40, P143; Savard J, 1998, J PERS ASSESS, V71, P349, DOI 10.1207/s15327752jpa7103_5; Savard J, 1999, AIDS BEHAV, V3, P167, DOI DOI 10.1023/A:1025444225120; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; SNAITH RP, 2003, HLTH QUALITY LIFE OU, V1; STAVRAKAKI C, 1986, BRIT J PSYCHIAT, V149, P7, DOI 10.1192/bjp.149.1.7; Streiner D. L., 2003, HLTH MEASUREMENT SCA; WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	29	68	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16049	10.1371/journal.pone.0016049	http://dx.doi.org/10.1371/journal.pone.0016049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283565	Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400023
J	Hayward, A; Gillooly, JF				Hayward, April; Gillooly, James F.			The Cost of Sex: Quantifying Energetic Investment in Gamete Production by Males and Females	PLOS ONE			English	Article							SPERM COMPETITION; TESTIS SIZE; MAMMALS; METABOLISM; EVOLUTION; NUMBER; BIRDS	The relative energetic investment in reproduction between the sexes forms the basis of sexual selection and life history theories in evolutionary biology. It is often assumed that males invest considerably less in gametes than females, but quantifying the energetic cost of gamete production in both sexes has remained a difficult challenge. For a broad diversity of species (invertebrates, reptiles, amphibians, fishes, birds, and mammals), we compared the cost of gamete production between the sexes in terms of the investment in gonad tissue and the rate of gamete biomass production. Investment in gonad biomass was nearly proportional to body mass in both sexes, but gamete biomass production rate was approximately two to four orders of magnitude higher in females. In both males and females, gamete biomass production rate increased with organism mass as a power law, much like individual metabolic rate. This suggests that whole-organism energetics may act as a primary constraint on gamete production among species. Residual variation in sperm production rate was positively correlated with relative testes size. Together, these results suggest that understanding the heterogeneity in rates of gamete production among species requires joint consideration of the effects of gonad mass and metabolism.	[Hayward, April; Gillooly, James F.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Hayward, A (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	april.hayward@ufl.edu			University of Florida	University of Florida(University of Florida)	This work was funded by the University of Florida. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2007, OIKOS, V116, P1073, DOI 10.1111/j.2007.0030-1299.16079.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Calder WA., 1984, SIZE FUNCTION LIFE H; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GINSBERG JR, 1989, TRENDS ECOL EVOL, V4, P74, DOI 10.1016/0169-5347(89)90152-3; HAMILTON MJ, 2010, P ROYAL SOC B; Hemmingsen AM., 1960, REPORTS STENO MEM HO, V9, P1; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; King J.R., 1973, P78; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kokko H, 2003, TRENDS ECOL EVOL, V18, P103, DOI 10.1016/S0169-5347(03)00009-0; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Salvante KG, 2010, J EXP BIOL, V213, P1991, DOI 10.1242/jeb.036319; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Trivers R., 1972, SEXUAL SELECTION DES, P139; Vezina F, 2005, J EXP BIOL, V208, P2533, DOI 10.1242/jeb.01675	28	160	160	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16557	10.1371/journal.pone.0016557	http://dx.doi.org/10.1371/journal.pone.0016557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283632	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400042
J	Radpour, R; Barekati, Z; Kohler, C; Lv, Q; Burki, N; Diesch, C; Bitzer, J; Zheng, H; Schmid, S; Zhong, XY				Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Lv, Qing; Buerki, Nicole; Diesch, Claude; Bitzer, Johannes; Zheng, Hong; Schmid, Seraina; Zhong, Xiao Yan			Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer	PLOS ONE			English	Article							DNA METHYLATION; CLINICOPATHOLOGICAL FEATURES; PROMOTER HYPERMETHYLATION; PROGNOSTIC MARKER; MATERNAL PLASMA; MASS ARRAY; FETAL DNA; RAR-BETA; SERUM; PROFILE	Background: Aberrant DNA methylation patterns might be used as a biomarker for diagnosis and management of cancer patients. Methods and Findings: To achieve a gene panel for developing a breast cancer blood-based test we quantitatively assessed the DNA methylation proportion of 248 CpG sites per sample (total of 31,248 sites in all analyzed samples) on 10 candidate genes (APC, BIN1, BMP6, BRCA1, CST6, ESR-b, GSTP1, P16, P21 and TIMP3). The number of 126 samples consisting of two different cohorts was used (first cohort: plasma samples from breast cancer patients and normal controls; second cohort: triple matched samples including cancerous tissue, matched normal tissue and serum samples). In the first cohort, circulating cell free methylated DNA of the 8 tumor suppressor genes (TSGs) was significantly higher in patients with breast cancer compared to normal controls (P<0.01). In the second cohort containing triple matched samples, seven genes showed concordant hypermethylated profile in tumor tissue and serum samples compared to normal tissue (P<0.05). Using eight genes as a panel to develop a blood-based test for breast cancer, a sensitivity and specificity of more than 90% could be achieved in distinguishing between tumor and normal samples. Conclusions: Our study suggests that the selected TSG panel combined with the high-throughput technology might be a useful tool to develop epigenetic based predictive and prognostic biomarker for breast cancer relying on pathologic methylation changes in tumor tissue, as well as in circulation.	[Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Zhong, Xiao Yan] Univ Basel, Womens Hosp, Dept Biomed, Lab Gynecol Oncol, Basel, Switzerland; [Lv, Qing] Sichuan Univ, W China Sch Med, W China Hosp, Dept Breast Surg, Chengdu 610064, Peoples R China; [Bitzer, Johannes; Schmid, Seraina] Univ Basel, Dept Obstet & Gynecol, Womens Hosp, Basel, Switzerland; [Buerki, Nicole; Diesch, Claude] Kantonsspital Liestal, Dept Obstet & Gynecol, CH-4410 Liestal, Switzerland; [Zheng, Hong] Sichuan Univ, W China Sch Med, W China Hosp, Lab Mol Diag Canc,Dept Oncol,State Key Lab Biothe, Chengdu 610064, Peoples R China	University of Basel; Sichuan University; University of Basel; Kantonsspital Baselland; Sichuan University	Radpour, R (corresponding author), Univ Basel, Womens Hosp, Dept Biomed, Lab Gynecol Oncol, Basel, Switzerland.	sschmid@uhbs.ch; zhongx@uhbs.ch	; Radpour, Ramin/J-4949-2014	Buerki, Nicole/0000-0002-2625-7619; Radpour, Ramin/0000-0002-5632-7833	Swiss National Science Foundation [320000-119722/1, 320030_124958/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation (320000-119722/1 and 320030_124958/1) (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SEER CANC STAT REV 1; Barekati Z, 2010, HUM MOL GENET, V19, P2936, DOI 10.1093/hmg/ddq199; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Dulaimi E, 2004, CLIN CANCER RES, V10, P6189, DOI 10.1158/1078-0432.CCR-04-0597; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Giacona MB, 1998, PANCREAS, V17, P89, DOI 10.1097/00006676-199807000-00012; Jahr S, 2001, CANCER RES, V61, P1659; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LEON SA, 1977, CANCER RES, V37, P646; Li SY, 2006, CANCER LETT, V237, P272, DOI 10.1016/j.canlet.2005.06.011; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Muller HM, 2003, CANCER RES, V63, P7641; Parrella P, 2004, CLIN CANCER RES, V10, P5349, DOI 10.1158/1078-0432.CCR-04-0555; Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149; Radpour R, 2008, MOL CANCER RES, V6, P1702, DOI 10.1158/1541-7786.MCR-08-0262; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Radpour R, 2009, J PROTEOME RES, V8, P5264, DOI 10.1021/pr900591w; Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060; Shinozaki M, 2005, CLIN CANCER RES, V11, P2156, DOI 10.1158/1078-0432.CCR-04-1810; Shukla S, 2006, EPIGENETICS-US, V1, P88, DOI 10.4161/epi.1.2.2679; SUNAMI EVA, 2009, ANAL METHYLATED CIRC, P349; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tao MH, 2009, BREAST CANCER RES TR, V114, P559, DOI 10.1007/s10549-008-0028-z; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Wong TS, 2004, CLIN CANCER RES, V10, P2401, DOI 10.1158/1078-0432.CCR-03-0139; Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1	35	101	112	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16080	10.1371/journal.pone.0016080	http://dx.doi.org/10.1371/journal.pone.0016080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283676	Green Submitted, gold, Green Published			2022-12-27	WOS:000286523400015
J	Van Kerkhove, MD; Mumford, E; Mounts, AW; Bresee, J; Ly, S; Bridges, CB; Otte, J				Van Kerkhove, Maria D.; Mumford, Elizabeth; Mounts, Anthony W.; Bresee, Joseph; Ly, Sowath; Bridges, Carolyn B.; Otte, Joachim			Highly Pathogenic Avian Influenza (H5N1): Pathways of Exposure at the Animal-Human Interface, a Systematic Review	PLOS ONE			English	Review							TO-PERSON TRANSMISSION; HEALTH-CARE WORKERS; A H5N1; RISK-FACTORS; POULTRY WORKERS; ANTI-H5 ANTIBODY; VIRUS-INFECTION; LOW-FREQUENCY; HONG-KONG; PANDEMICS	Background: The threat posed by highly pathogenic avian influenza A H5N1 viruses to humans remains significant, given the continued occurrence of sporadic human cases (499 human cases in 15 countries) with a high case fatality rate (approximately 60%), the endemicity in poultry populations in several countries, and the potential for reassortment with the newly emerging 2009 H1N1 pandemic strain. Therefore, we review risk factors for H5N1 infection in humans. Methods and Findings: Several epidemiologic studies have evaluated the risk factors associated with increased risk of H5N1 infection among humans who were exposed to H5N1 viruses. Our review shows that most H5N1 cases are attributed to exposure to sick poultry. Most cases are sporadic, while occasional limited human-to-human transmission occurs. The most commonly identified factors associated with H5N1 virus infection included exposure through contact with infected blood or bodily fluids of infected poultry via food preparation practices; touching and caring for infected poultry; consuming uncooked poultry products; exposure to H5N1 via swimming or bathing in potentially virus laden ponds; and exposure to H5N1 at live bird markets. Conclusions: Research has demonstrated that despite frequent and widespread contact with poultry, transmission of the H5N1 virus from poultry to humans is rare. Available research has identified several risk factors that may be associated with infection including close direct contact with poultry and transmission via the environment. However, several important data gaps remain that limit our understanding of the epidemiology of H5N1 in humans. Although infection in humans with H5N1 remains rare, human cases continue to be reported and H5N1 is now considered endemic among poultry in parts of Asia and in Egypt, providing opportunities for additional human infections and for the acquisition of virus mutations that may lead to more efficient spread among humans and other mammalian species. Collaboration between human and animal health sectors for surveillance, case investigation, virus sharing, and risk assessment is essential to monitor for potential changes in circulating H5N1 viruses and in the epidemiology of H5N1 in order to provide the best possible chance for effective mitigation of the impact of H5N1 in both poultry and humans. Disclaimer: The opinions expressed in this article are those of the authors and do not necessarily reflect those of the institutions or organizations with which they are affiliated.	[Van Kerkhove, Maria D.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, London, England; [Mumford, Elizabeth; Mounts, Anthony W.] WHO, Global Influenza Programme, CH-1211 Geneva, Switzerland; [Bresee, Joseph; Bridges, Carolyn B.] Ctr Dis Control & Prevent, Influenza Div, NCIRD, Atlanta, GA USA; [Ly, Sowath] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Otte, Joachim] Food & Agr Org United Nations, Anim Prod & Hlth Div, Rome, Italy	Imperial College London; World Health Organization; Centers for Disease Control & Prevention - USA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Food & Agriculture Organization of the United Nations (FAO)	Van Kerkhove, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, London, England.	m.vankerkhove@imperial.ac.uk		Mumford, Elizabeth/0000-0002-9548-9675; Van Kerkhove, Maria/0000-0002-6135-0018	United Kingdom Department for International Development (DFID) [GCP/INT/804/UK]; Medical Research Council; Bill and Melinda Gates Foundation; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish	United Kingdom Department for International Development (DFID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the United Kingdom Department for International Development (DFID), funders of the HPAI research project (GCP/INT/804/UK); the Medical Research Council (MVK); and the Bill and Melinda Gates Foundation (MVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Areechokchai Darin, 2006, MMWR Suppl, V55, P3; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bird SM, 2008, LANCET, V372, P696, DOI 10.1016/S0140-6736(08)61126-5; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Cai W, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-170; CAVAILLER P, 2010, J CLIN VIROL MAR, V29; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; *FAO, 2004, FAO RECOMM PREV CONT; Fasina FO, 2010, EUROSURVEILLANCE, V15, P4; Gilsdorf A, 2006, Euro Surveill, V11, P3, DOI 10.2807/esm.11.05.00620-en; Greiner M, 2007, BERL MUNCH TIERARZTL, V120, P98, DOI 10.2376/0005-9366-120-98; Gross PA, 1996, ANN INTERN MED, V124, P682, DOI 10.7326/0003-4819-124-7-199604010-00010; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; HORBY P, 2010, EPIDEMIOLOGY INFECT, P1; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Hsieh YC, 2006, J FORMOS MED ASSOC, V105, P1, DOI 10.1016/S0929-6646(09)60102-9; INDRIANI R, 2010, EMERG INFEC IN PRESS; Kandun IN, 2010, ZOONOSES PUBLIC HLTH, V57, P285, DOI 10.1111/j.1863-2378.2009.01246.x; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Lu CY, 2008, CHINESE MED J-PEKING, V121, P2050, DOI 10.1097/00029330-200810020-00020; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; OTTE M, 2010, IMPLICATION IN PRESS; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; RABINOWITZ P, 2009, ZOONOSES PUBLIC 0326; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Schultsz C, 2005, EMERG INFECT DIS, V11, P1158; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Van Kerkhove MD, 2008, INFLUENZA OTHER RESP, V2, P155, DOI 10.1111/j.1750-2659.2008.00052.x; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WER, 2008, WEEKLY EPIDEMIOLOGIC, V83, P357; *WHO, 2006, WHO REV LAT AV EV PO; *WHO, 2010, WKLY EPIDEMIOL REC, V85, P13; *WHO, 2009, PREP 2 WAV LESS CURR; *WHO, 2006, WHO AV INFL; *WHO, 2006, AV INFL SIT IND; WHO, 2010, CUM NUMB CONF HUM CA; *WHO, 2004, AV INFL SIT VIETN; *WHO, 2009, CUM NUMB CONF HUM CA; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P183; World Health Organization (WHO), 2010, SIT UPD AV INFL; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu-lin Wang, 2009, Zhonghua Yufang Yixue Zazhi, V43, P41, DOI 10.3760/cma.j.issn.0253-9624.2009.01.010; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	67	109	112	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14582	10.1371/journal.pone.0014582	http://dx.doi.org/10.1371/journal.pone.0014582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283678	gold, Green Published, Green Submitted			2022-12-27	WOS:000286523400004
J	Hsu, RJ; Hsiao, KM; Lin, MJ; Li, CY; Wang, LC; Chen, LK; Pan, HC				Hsu, Ren-Jun; Hsiao, Kuang-Ming; Lin, Min-Jon; Li, Chui-Yen; Wang, Li-Chun; Chen, Luen-Kui; Pan, Huichin			Long Tract of Untranslated CAG Repeats Is Deleterious in Transgenic Mice	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FRAGILE-X PREMUTATION; EXPANDED CTG REPEATS; MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; SKELETAL-MUSCLE; CUG REPEATS; MEDIATED NEURODEGENERATION; DROSOPHILA MODEL; BINDING PROTEIN	The most frequent trinucleotide repeat found in human disorders is the CAG sequence. Expansion of CAG repeats is mostly found in coding regions and is thought to cause diseases through a protein mechanism. Recently, expanded CAG repeats were shown to induce toxicity at the RNA level in Drosophila and C. elegans. These findings raise the possibility that CAG repeats may trigger RNA-mediated pathogenesis in mammals. Here, we demonstrate that transgenic mice expressing EGFP transcripts with long CAG repeats in the 39 untranslated region develop pathogenic features. Expression of the transgene was directed to the muscle in order to compare the resulting phenotype to that caused by the CUG expansion, as occurs in myotonic dystrophy. Transgenic mice expressing 200, but not those expressing 0 or 23 CAG repeats, showed alterations in muscle morphology, histochemistry and electrophysiology, as well as abnormal behavioral phenotypes. Expression of the expanded CAG repeats in testes resulted in reduced fertility due to defective sperm motility. The production of EGFP protein was significantly reduced by the 200 CAG repeats, and no polyglutamine-containing product was detected, which argues against a protein mechanism. Moreover, nuclear RNA foci were detected for the long CAG repeats. These data support the notion that expanded CAG repeat RNA can cause deleterious effects in mammals. They also suggest the possible involvement of an RNA mechanism in human diseases with long CAG repeats.	[Hsu, Ren-Jun; Li, Chui-Yen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsiao, Kuang-Ming] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Lin, Min-Jon; Wang, Li-Chun; Chen, Luen-Kui; Pan, Huichin] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Pan, Huichin] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; National Chung Cheng University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hsu, RJ (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	hp29@csmu.edu.tw			National Science Council of Taiwan [NSC91-2320-B040-034, NSC92-2320-B040-046, NSC93-2320-B040-054, NSC94-2320-B040-045, NSC95-2320-B040-040-MY2]; National Science Council; Ministry of Education	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported by grants NSC91-2320-B040-034, NSC92-2320-B040-046, NSC93-2320-B040-054, NSC94-2320-B040-045 and NSC95-2320-B040-040-MY2 from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. S. Noguchi for kindly providing the plasmid 5'gsg-EGFP, and Dr. M. Hsieh for mutant ataxin-3 expressing cells and the anti-polyglutamine monoclonal antibody. We also thank Dr. H. Li and IMB Transgenic Core Facility (Academia Sinica) for assistance in microinjection of the transgenes. Confocal microscopy and flow cytometry were performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council and Ministry of Education.	Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Arenas J, 1998, ANN NEUROL, V43, P397, DOI 10.1002/ana.410430321; AUGER J, 1993, J HISTOCHEM CYTOCHEM, V41, P1247, DOI 10.1177/41.8.8331289; Bando Y, 2005, NEUROCHEM INT, V46, P11, DOI 10.1016/j.neuint.2004.07.005; BULBRING E, 1946, BRIT J PHARM CHEMOTH, V1, P38; CASH K, 1994, LAB HISTOPATHOLOGY C, P7; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen KY, 2007, BIOCHEM BIOPH RES CO, V352, P774, DOI 10.1016/j.bbrc.2006.11.102; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Hsiao KM, 1999, J CLIN LAB ANAL, V13, P188, DOI 10.1002/(SICI)1098-2825(1999)13:4<188::AID-JCLA8>3.0.CO;2-G; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Jasinska A, 2003, NUCLEIC ACIDS RES, V31, P5463, DOI 10.1093/nar/gkg767; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; McLaughlin BA, 1996, AM J HUM GENET, V59, P561; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Noguchi S, 2001, FEBS LETT, V495, P77, DOI 10.1016/S0014-5793(01)02368-7; ONO S, 1986, J NEUROL SCI, V74, P247, DOI 10.1016/0022-510X(86)90110-3; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Siciliano G, 2001, BRAIN RES BULL, V56, P405, DOI 10.1016/S0361-9230(01)00653-0; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Troiano L, 1998, EXP CELL RES, V241, P384, DOI 10.1006/excr.1998.4064; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540; WANG LC, 2010, CELL MOL LI IN PRESS; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	65	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16417	10.1371/journal.pone.0016417	http://dx.doi.org/10.1371/journal.pone.0016417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283659	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300044
J	Garcia, MN; Farias, MSD; Avila, MM; Rabinovich, RD				Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Mercedes Avila, Maria; Daniel Rabinovich, Roberto			Presence of p24-Antigen Associated to Erythrocyte in HIV-Positive Individuals Even in Patients with Undetectable Plasma Viral Load	PLOS ONE			English	Article							RED-BLOOD-CELLS; IMMUNE-COMPLEXES; IN-VIVO; P24 ANTIGEN; T-CELLS; COMPLEMENT; RECEPTOR; INFECTION; EXPRESSION; BINDING	Background: HIV adherence to erythrocytes has been demonstrated in vitro, and it has been suggested that erythrocytes may be carriers of the virus. However, the association between HIV particles or viral proteins and erythrocytes in HIV-infected individuals is still to be elucidated. Methodology/Principal Findings: HIV-positive participants (n = 112) were classified into two groups according to values of three plasma viral loads (pVL) determined during the 12-month period prior to the study. The first group included 71 individuals with detectable pVL, whereas the second group included 41 individuals with undetectable pVL. Plasma viral load, erythrocyte-associated p24-antigen and p24-antigen in plasma were determined at the moment of the study. A total of 51 out of the 71 patients with detectable pVL showed erythrocyte-associated p24-antigen whereas 13 showed p24-antigen in plasma. Twenty-two out of the 51 patients with erythrocyte-associated p24-antigen showed pVL<10,000 copies/ml and undetectable p24-antigen in plasma. The data indicates that the amount of erythrocyte-associated p24-antigen was not related to p24-antigen in plasma or pVL levels in this group. Among the 41 patients with prior undetectable pVL, eight presented detectable pVL and erythrocyte-associated p24-antigen at the moment of the study. The other 33 showed undetectable pVL and five of these presented erythrocyte-associated p24-antigen. A positive relationship was found between the presence of erythrocyte-associated p24-antigen and the detectable pVL at the moment of the study (p<0.00001). Even more, in another series of assays, a detectable viral load associated to erythrocytes was determined and it was always accompanied by erythrocyte-associated p24-antigen detection. Conclusions/Significance: This study demonstrates the presence of erythrocyte-associated p24-antigen in HIV-infected individuals. Since erythrocyte-associated p24-antigen is not always related to pVL or p24-antigen in plasma, erythrocyte-associated p24-antigen showed viral expression not represented in plasma. Therefore, the determination of erythrocyte-associated p24-antigen may contribute to better understand the kinetics and/or evolution of HIV infection.	[Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Mercedes Avila, Maria; Daniel Rabinovich, Roberto] Univ Buenos Aires, Natl Reference Ctr AIDS, Sch Med, Dept Microbiol, Buenos Aires, DF, Argentina	University of Buenos Aires	Garcia, MN (corresponding author), Univ Buenos Aires, Natl Reference Ctr AIDS, Sch Med, Dept Microbiol, Buenos Aires, DF, Argentina.	mgarcia@fmed.uba.ar		Garcia, Maria Noe/0000-0002-2167-1298	Argentina's National Agency for Promotion of Science and Technology [PICT 2067]; National Council for Technology and Scientific Research [PIP 6118]	Argentina's National Agency for Promotion of Science and Technology(ANPCyT); National Council for Technology and Scientific Research	This work was partly supported by grants from Argentina's National Agency for Promotion of Science and Technology (www.agencia.gov.ar) (PICT 2067 to Maria Mercedes Avila) and the National Council for Technology and Scientific Research (www.conicet.gov.ar) (PIP 6118 to Maria Mercedes Avila). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Banki Z, 2006, J IMMUNOL, V177, P3469, DOI 10.4049/jimmunol.177.5.3469; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; COHEN JHM, 1988, PRESSE MED, V17, P727; Farias MSD, 2009, J VIROL METHODS, V158, P6, DOI 10.1016/j.jviromet.2009.01.010; Fierer DS, 2007, J INFECT DIS, V196, P587, DOI 10.1086/519741; Gulzar N, 2008, CURR HIV RES, V6, P585, DOI 10.2174/157016208786501544; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; Prado JG, 2004, J CLIN MICROBIOL, V42, P1620, DOI 10.1128/JCM.42.4.1620-1625.2004; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHIFFERLI JA, 1988, J IMMUNOL, V140, P899; Schupbach J, 2003, INT ARCH ALLERGY IMM, V132, P196, DOI 10.1159/000074552; Schupbach J, 2005, JAIDS-J ACQ IMM DEF, V40, P250, DOI 10.1097/01.qai.0000181281.75670.56; Schupbach Jorg, 2002, AIDS Reviews, V4, P83; TAUSK FA, 1986, J CLIN INVEST, V78, P977, DOI 10.1172/JCI112688; Terpos E, 2008, MED SCI MONITOR, V14, pCR276	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14544	10.1371/journal.pone.0014544	http://dx.doi.org/10.1371/journal.pone.0014544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267446	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500014
J	Stuhrmann, B; Huber, F; Kas, J				Stuhrmann, Bjoern; Huber, Florian; Kaes, Josef			Robust Organizational Principles of Protrusive Biopolymer Networks in Migrating Living Cells	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; FLUORESCENT SPECKLE MICROSCOPY; ARP2/3 COMPLEX; QUANTITATIVE-ANALYSIS; FILAMENT TURNOVER; DEPOLYMERIZING FACTOR; LEADING-EDGE; CELLULAR MOTILITY; RETROGRADE FLOW; NONMUSCLE CELLS	Cell migration is associated with the dynamic protrusion of a thin actin-based cytoskeletal extension at the cell front, which has been shown to consist of two different substructures, the leading lamellipodium and the subsequent lamellum. While the formation of the lamellipodium is increasingly well understood, organizational principles underlying the emergence of the lamellum are just beginning to be unraveled. We report here on a 1D mathematical model which describes the reaction-diffusion processes of a polarized actin network in steady state, and reproduces essential characteristics of the lamellipodium-lamellum system. We observe a steep gradient in filament lengths at the protruding edge, a local depolymerization maximum a few microns behind the edge, as well as a differential dominance of the network destabilizer ADF/cofilin and the stabilizer tropomyosin. We identify simple and robust organizational principles giving rise to the derived network characteristics, uncoupled from the specifics of any molecular implementation, and thus plausibly valid across cell types. An analysis of network length dependence on physico-chemical system parameters implies that to limit array treadmilling to cellular dimensions, network growth has to be truncated by mechanisms other than aging-induced depolymerization, e. g., by myosin-associated network dissociation at the transition to the cell body. Our work contributes to the analytical understanding of the cytoskeletal extension's bisection into lamellipodium and lamellum and sheds light on how cells organize their molecular machinery to achieve motility.	[Stuhrmann, Bjoern; Huber, Florian; Kaes, Josef] Univ Leipzig, Inst Soft Matter Phys, Leipzig, Germany	Leipzig University	Stuhrmann, B (corresponding author), FOM Inst AMOLF, Biol Soft Matter Grp, Amsterdam, Netherlands.	stuhrmann@amolf.nl	Huber, Florian/F-6191-2011	Huber, Florian/0000-0002-3535-9406; Kas, Josef A./0000-0003-3158-2480	Leipzig Graduate College [GK 1097]; Graduate School "Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)"	Leipzig Graduate College; Graduate School "Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)"	This work has been supported by the Leipzig Graduate College "GK 1097 InterNeuro -Interdisciplinary Approaches in Cellular Neuroscience" (http://www.uni-leipzig.de/ineuro/) and the Graduate School "Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)" (http://www.buildmona.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Adachi T, 2009, J BIOMECH, V42, P297, DOI 10.1016/j.jbiomech.2008.11.012; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; ALT W, 2009, CELL MECH, P89; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROSCHAT KO, 1990, J BIOL CHEM, V265, P21323; Brunner CA, 2006, EUR BIOPHYS J BIOPHY, V35, P713, DOI 10.1007/s00249-006-0079-1; Bugyi B, 2008, FEBS LETT, V582, P2086, DOI 10.1016/j.febslet.2008.02.065; CARLIER MF, 1991, J BIOL CHEM, V266, P1; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carlsson AE, 2006, BIOPHYS J, V90, P413, DOI 10.1529/biophysj.105.069765; Carlsson AE, 2003, BIOPHYS J, V84, P2907, DOI 10.1016/S0006-3495(03)70018-6; Carlsson AE, 2008, METHOD CELL BIOL, V84, P911, DOI 10.1016/S0091-679X(07)84029-5; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Edelstein-Keshet L, 2001, J MATH BIOL, V43, P325, DOI 10.1007/s002850100102; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fleischer F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/420; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gopinathan A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058103; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huber F, 2008, BIOPHYS J, V95, P5508, DOI 10.1529/biophysj.108.134817; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kueh HY, 2010, BIOPHYS J, V99, P2153, DOI 10.1016/j.bpj.2010.07.038; Kuusela E, 2009, J MATH BIOL, V58, P135, DOI 10.1007/s00285-008-0179-x; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Novak IL, 2008, BIOPHYS J, V95, P1627, DOI 10.1529/biophysj.108.130096; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Plastino J, 2005, CURR OPIN CELL BIOL, V17, P62, DOI 10.1016/j.ceb.2004.12.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Rubinstein B, 2005, MULTISCALE MODEL SIM, V3, P413, DOI 10.1137/04060370X; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; Schreiber CH, 2010, P NATL ACAD SCI USA, V107, P9141, DOI 10.1073/pnas.1002538107; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Small JV, 2010, TRENDS CELL BIOL, V20, P628, DOI 10.1016/j.tcb.2010.08.006; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Weichsel J, 2010, P NATL ACAD SCI USA, V107, P6304, DOI 10.1073/pnas.0913730107; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	87	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14471	10.1371/journal.pone.0014471	http://dx.doi.org/10.1371/journal.pone.0014471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267070	gold, Green Published			2022-12-27	WOS:000286519500002
J	Gonzalez-Bosquet, J; Calcei, J; Wei, JS; Garcia-Closas, M; Sherman, ME; Hewitt, S; Vockley, J; Lissowska, J; Yang, HP; Khan, J; Chanock, S				Gonzalez-Bosquet, Jesus; Calcei, Jacob; Wei, Jun S.; Garcia-Closas, Montserrat; Sherman, Mark E.; Hewitt, Stephen; Vockley, Joseph; Lissowska, Jolanta; Yang, Hannah P.; Khan, Javed; Chanock, Stephen			Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers	PLOS ONE			English	Article							CELL LUNG-CANCER; PARAFFIN-EMBEDDED TISSUES; BREAST-CANCER; ACTIVATING MUTATIONS; AMPLICON ANALYSIS; GENE-MUTATIONS; SINGLE CELLS; RISK-FACTORS; GENOME; AMPLIFICATION	Identification of somatic mutations in cancer is a major goal for understanding and monitoring the events related to cancer initiation and progression. High resolution melting (HRM) curve analysis represents a fast, post-PCR high-throughput method for scanning somatic sequence alterations in target genes. The aim of this study was to assess the sensitivity and specificity of HRM analysis for tumor mutation screening in a range of tumor samples, which included 216 frozen pediatric small rounded blue-cell tumors as well as 180 paraffin-embedded tumors from breast, endometrial and ovarian cancers (60 of each). HRM analysis was performed in exons of the following candidate genes known to harbor established commonly observed mutations: PIK3CA, ERBB2, KRAS, TP53, EGFR, BRAF, GATA3, and FGFR3. Bi-directional sequencing analysis was used to determine the accuracy of the HRM analysis. For the 39 mutations observed in frozen samples, the sensitivity and specificity of HRM analysis were 97% and 87%, respectively. There were 67 mutation/variants in the paraffin-embedded samples, and the sensitivity and specificity for the HRM analysis were 88% and 80%, respectively. Paraffin-embedded samples require higher quantity of purified DNA for high performance. In summary, HRM analysis is a promising moderate-throughput screening test for mutations among known candidate genomic regions. Although the overall accuracy appears to be better in frozen specimens, somatic alterations were detected in DNA extracted from paraffin-embedded samples.	[Gonzalez-Bosquet, Jesus; Calcei, Jacob; Chanock, Stephen] NCI, Lab Translat Genom, DHHS, NIH, Bethesda, MD 20892 USA; [Wei, Jun S.; Khan, Javed] NCI, Adv Technol Ctr, Pediat Oncol Branch, Ctr Canc Res,DHHS,NIH, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat; Sherman, Mark E.; Yang, Hannah P.] NCI, Hormonal & Reprod Epidemiol Branch, Div Canc Epidemiol & Genet, DHHS,NIH, Bethesda, MD 20892 USA; [Hewitt, Stephen] NCI, Tissue Array Res Program, DHHS, NIH, Bethesda, MD 20892 USA; [Vockley, Joseph] NCI, Off Canc Genom, DHHS, NIH, Bethesda, MD 20892 USA; [Lissowska, Jolanta] M Sklodowska Curie Inst Oncol & Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Maria Sklodowska-Curie National Research Institute of Oncology	Gonzalez-Bosquet, J (corresponding author), NCI, Lab Translat Genom, DHHS, NIH, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Calcei, Jacob/AAY-1260-2020; Khan, Javed/P-9157-2014; Garcia-Closas, Montserrat/F-3871-2015; Garcia-Closas, Montserrat/AAZ-6930-2021; Lissowska, Jolanta/AAH-3252-2020	Calcei, Jacob/0000-0002-4895-1046; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lissowska, Jolanta/0000-0003-2695-5799; Gonzalez Bosquet, Jesus/0000-0002-2079-4528; Hewitt, Stephen/0000-0001-8283-1788	NATIONAL CANCER INSTITUTE [ZIACP010201, ZIASC010366, ZIABC010591, ZICBC011257, ZIABC010998] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brinton LA, 2007, BRIT J CANCER, V96, P1450, DOI 10.1038/sj.bjc.6603731; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Chanock SJ, 2007, NAT GENET, V39, P283, DOI 10.1038/ng0307-283; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dedhia P, 2007, ASIAN PAC J CANCER P, V8, P55; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Dobrowolski SE, 2005, HUM MUTAT, V25, P306, DOI 10.1002/humu.20137; Fadhil W, 2010, J CLIN PATHOL, V63, P134, DOI 10.1136/jcp.2009.070508; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Closas M, 2006, BRIT J CANCER, V95, P123, DOI 10.1038/sj.bjc.6603207; Garcia-Closas M, 2006, HUM GENET, V119, P376, DOI 10.1007/s00439-006-0135-z; Garcia-Closas M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-60; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haque KA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-20; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Krypuy M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-168; Lax SF, 2000, CANCER-AM CANCER SOC, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.3.CO;2-L; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lonie Lorne, 2006, Hum Mutat, V27, P1160, DOI 10.1002/humu.9467; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rivero ERC, 2006, PATHOL RES PRACT, V202, P523, DOI 10.1016/j.prp.2006.02.007; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith GD, 2008, J CLIN PATHOL, V61, P487, DOI 10.1136/jcp.2007.051425; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Staats B, 2005, NAT GENET, V37, P109, DOI 10.1038/ng0205-109; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Takano EA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-59; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wen L, 2001, MOL BIOTECHNOL, V17, P135, DOI 10.1385/MB:17:2:135; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Willmore C, 2004, AM J CLIN PATHOL, V122, P206, DOI 10.1309/4E6UYBY62N2FCA6N; Willmore-Payne C, 2006, MODERN PATHOL, V19, p319A; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	50	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14522	10.1371/journal.pone.0014522	http://dx.doi.org/10.1371/journal.pone.0014522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264207	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600006
J	Ohmine, S; Sakuma, R; Sakuma, T; Thatava, T; Takeuchi, H; Ikeda, Y				Ohmine, Seiga; Sakuma, Ryuta; Sakuma, Toshie; Thatava, Tayaramma; Takeuchi, Hiroaki; Ikeda, Yasuhiro			The Antiviral Spectra of TRIM5 alpha Orthologues and Human TRIM Family Proteins against Lentiviral Production	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; INFECTIOUS MOLECULAR CLONE; RETROVIRUS RESTRICTION; ENVELOPE SEQUENCE; HIV-1 ISOLATE; FULL-LENGTH; OLD-WORLD; GAG; TYPE-2; DOMAIN	Background: Rhesus monkey TRIM5 alpha (TRIM5 alpha rh) recognizes the incoming HIV-1 core through its C-terminal B30.2(PRYSPRY) domain and promotes its premature disassembly or degradation before reverse transcription. Previously, we have shown that TRIM5 alpha rh blocks HIV-1 production through the N-terminal RBCC domain by the recognition of Gag polyproteins. Although all TRIM family proteins have RBCC domains, it remains elusive whether they possess similar late-restriction activities. Methodology/Principal Findings: We examined the antiviral spectra of TRIM5 alpha orthologues and human TRIM family members which have a genetic locus proximal to human TRIM5 alpha (TRIM5 alpha hu), against primate lentiviral production. When HIV-1 virus-like particles (VLPs) were generated in the presence of TRIM5 alpha proteins, rhesus, African green and cynomolgus monkey TRIM5 alpha (TRIM5 alpha ag and TRIM5 alpha cy), but not TRIM5 alpha hu, were efficiently incorporated into VLPs, suggesting an interaction between HIV-1 Gag and TRIM5 alpha proteins. TRIM5 alpha rh potently restricted the viral production of HIV-1 groups M and O and HIV-2, but not simian lentiviruses including SIV(MAC)1A11, SIV(AGM)Tan-1 or SIV(AGM)SAB-1. TRIM5 alpha hu did not show notable late restriction activities against these lentiviruses. TRIM5 alpha ag and TRIM5 alpha cy showed intermediate restriction phenotypes against HIV-1 and HIV-2, but showed no restriction activity against SIV production. A series of chimeric TRIM5 alpha constructs indicated that the N-terminal region of TRIM5 alpha ag and TRIM5 alpha cy are essential for the late restriction activity, while the C-terminal region of TRIM5 alpha cy negatively regulates the late restriction activity against HIV-1. When select human TRIM family proteins were examined, TRIM21 and 22 were efficiently incorporated into HIV-1 VLPs, while only TRIM22 reduced HIV-1 titers up to 5-fold. The antiviral activities and encapsidation efficiencies did not correlate with their relative expression levels in the producer cells. Conclusions/Significance: Our results demonstrated the variations in the late restriction activities among closely related TRIM5 alpha orthologues and a subset of human TRIM family proteins, providing further insights into the late restriction activities of TRIM proteins.	[Ohmine, Seiga; Sakuma, Ryuta; Sakuma, Toshie; Thatava, Tayaramma; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Takeuchi, Hiroaki] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan	Mayo Clinic; University of Tokyo	Ohmine, S (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu	Takeuchi, Hiroaki/F-9728-2012	Takeuchi, Hiroaki/0000-0002-5689-9858	National Institutes of Health; Mayo Foundation; Siebens Ph.D. Training Fellowship;  [1R56AI074363-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Siebens Ph.D. Training Fellowship; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health, 1R56AI074363-01A1 (YI), the Mayo Foundation (YI), and the Siebens Ph.D. Training Fellowship (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; CHARNEAU P, 1994, VIROLOGY, V205, P247, DOI 10.1006/viro.1994.1640; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Dittmar MT, 1999, AIDS RES HUM RETROV, V15, P707, DOI 10.1089/088922299310791; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; Ikeda Y, 2004, J VIROL, V78, P11816, DOI 10.1128/JVI.78.21.11816-11822.2004; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; JIN MJ, 1994, EMBO J, V13, P2935, DOI 10.1002/j.1460-2075.1994.tb06588.x; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; KIM FM, 1995, J VIROL, V69, P1755, DOI 10.1128/JVI.69.3.1755-1761.1995; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li X, 2007, VIROLOGY, V360, P419, DOI 10.1016/j.virol.2006.10.035; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; LUCIW PA, 1992, AIDS RES HUM RETROV, V8, P395, DOI 10.1089/aid.1992.8.395; Maillard PV, 2010, J VIROL, V84, P5790, DOI 10.1128/JVI.02413-09; Morner A, 1999, J VIROL, V73, P2343; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Pacheco B, 2010, VIROLOGY, V408, P204, DOI 10.1016/j.virol.2010.09.019; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sakuma R, 2007, GENE THER, V14, P185, DOI 10.1038/sj.gt.3302852; SAKUMA R, 2009, J BIOL CHEM; Sakuma R, 2008, NAT MED, V14, P236, DOI 10.1038/nm0308-236; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tebit DM, 2004, VIROLOGY, V326, P329, DOI 10.1016/j.virol.2004.05.027; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035	51	15	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16121	10.1371/journal.pone.0016121	http://dx.doi.org/10.1371/journal.pone.0016121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264255	Green Published, Green Submitted, gold			2022-12-27	WOS:000286516500030
J	Ansari, MA; Pope, EC; Carpenter, S; Scholte, EJ; Butt, TM				Ansari, Minshad Ali; Pope, Edward C.; Carpenter, Simon; Scholte, Ernst-Jan; Butt, Tariq M.			Entomopathogenic Fungus as a Biological Control for an Important Vector of Livestock Disease: The Culicoides Biting Midge	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; CULEX-QUINQUEFASCIATUS; MOSQUITOS; EFFICACY; NUBECULOSUS; INFECTION; DIPTERA; CATTLE	Background: The recent outbreak of bluetongue virus in northern Europe has led to an urgent need to identify control measures for the Culicoides (Diptera: Ceratopogonidae) biting midges that transmit it. Following successful use of the entomopathogenic fungus Metarhizium anisopliae against larval stages of biting midge Culicoides nubeculosus Meigen, we investigated the efficacy of this strain and other fungi (Beauveria bassiana, Isaria fumosorosea and Lecanicillium longisporum) as biocontrol agents against adult C. nubeculosus in laboratory and greenhouse studies. Methodology/Findings: Exposure of midges to 'dry' conidia of all fungal isolates caused significant reductions in survival compared to untreated controls. Metarhizium anisopliae strain V275 was the most virulent, causing a significantly decrease in midge survival compared to all other fungal strains tested. The LT(50) value for strain V275 was 1.42 days compared to 2.21-3.22 days for the other isolates. The virulence of this strain was then further evaluated by exposing C. nubeculosus to varying doses (10(8)-10(11) conidia m(-2)) using different substrates (horse manure, damp peat, leaf litter) as a resting site. All exposed adults were found to be infected with the strain V275 four days after exposure. A further study exposed C. nubeculosus adults to 'dry' conidia and 'wet' conidia (conidia suspended in 0.03% aq. Tween 80) of strain V275 applied to damp peat and leaf litter in cages within a greenhouse. 'Dry' conidia were more effective than 'wet' conidia, causing 100% mortality after 5 days. Conclusion/Significance: This is the first study to demonstrate that entomopathogenic fungi are potential biocontrol agents against adult Culicoides, through the application of 'dry' conidia on surfaces (e. g., manure, leaf litter, livestock) where the midges tend to rest. Subsequent conidial transmission between males and females may cause an increased level of fungi-induced mortality in midges thus reducing the incidence of disease.	[Ansari, Minshad Ali; Pope, Edward C.; Butt, Tariq M.] Swansea Univ, Swansea, W Glam, Wales; [Carpenter, Simon] Inst Anim Hlth, Vector Borne Dis Programme, Pirbright, England; [Scholte, Ernst-Jan] Natl Ctr Monitoring Vectors, Minist Agr Nat & Food Qual, Wageningen, Netherlands	Swansea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Ansari, MA (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	m.a.ansari@swansea.ac.uk	Pope, Edward/G-5665-2011; Carpenter, Simon T/C-2718-2013	Pope, Edward/0000-0001-5781-5575; Carpenter, Simon T/0000-0001-5775-045X; Butt, Tariq/0000-0002-8789-9543	European Regional Development Fund (ERDF) through the Ireland-Wales Programme (INTERREG 4A); BBSRC [BBS/E/I/00001445] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001445] Funding Source: researchfish	European Regional Development Fund (ERDF) through the Ireland-Wales Programme (INTERREG 4A)(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the IMPACT project, which is partly funded by the European Regional Development Fund (ERDF) through the Ireland-Wales Programme (INTERREG 4A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2008, ENTOMOL EXP APPL, V127, P80, DOI 10.1111/j.1570-7458.2008.00674.x; Ansari MA, 2010, ACTA TROP, V113, P1, DOI 10.1016/j.actatropica.2009.08.022; Ansari MA, 2009, CROP PROT, V28, P269, DOI 10.1016/j.cropro.2008.11.003; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Bukhari T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-22; Butt TM, 1998, BIOCONTROL SCI TECHN, V8, P533, DOI 10.1080/09583159830045; Carpenter S, 2008, MED VET ENTOMOL, V22, P175, DOI 10.1111/j.1365-2915.2008.00743.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Darbro JM, 2009, AM J TROP MED HYG, V80, P992, DOI 10.4269/ajtmh.2009.80.992; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Howard AFV, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-87; JENKINS NE, 1998, BIOCONTROL NEWS INFO, V19, P21; Kannan SK, 2008, AFR J BIOTECHNOL, V7, P838; LACEY CM, 1988, J INVERTEBR PATHOL, V52, P108, DOI 10.1016/0022-2011(88)90109-7; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mnyone LL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-309; Papadopoulos E, 2009, VET PARASITOL, V163, P110, DOI 10.1016/j.vetpar.2009.03.041; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; Scholte Ernst-Jan, 2004, Malar J, V3, P45, DOI 10.1186/1475-2875-3-45; Skrobek A, 2008, BIOCONTROL, V53, P361, DOI 10.1007/s10526-007-9077-1; SPSS, 2007, SPSS STAT SOFTW VERS; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; SWEENEY W, 1985, INTEGRATED MOSQUITO, V2, P269; Unkles SE, 2004, BIOCONTROL SCI TECHN, V14, P397, DOI 10.1080/09583150310001639178; Webb L, 2010, B ENTOMOL RES, V100, P175, DOI 10.1017/S0007485309006981; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963	33	54	57	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16108	10.1371/journal.pone.0016108	http://dx.doi.org/10.1371/journal.pone.0016108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264343	gold, Green Submitted, Green Published			2022-12-27	WOS:000286513100026
J	Evans, JA; Leise, TL; Castanon-Cervantes, O; Davidson, AJ				Evans, Jennifer A.; Leise, Tanya L.; Castanon-Cervantes, Oscar; Davidson, Alec J.			Intrinsic Regulation of Spatiotemporal Organization within the Suprachiasmatic Nucleus	PLOS ONE			English	Article							CIRCADIAN OSCILLATIONS; PROTEIN EXPRESSION; NEURONS; CLOCK; MOUSE; PHASE; INDUCTION; GENES; MPER1; PER1	The mammalian pacemaker in the suprachiasmatic nucleus (SCN) contains a population of neural oscillators capable of sustaining cell-autonomous rhythms in gene expression and electrical firing. A critical question for understanding pacemaker function is how SCN oscillators are organized into a coherent tissue capable of coordinating circadian rhythms in behavior and physiology. Here we undertake a comprehensive analysis of oscillatory function across the SCN of the adult PER2::LUC mouse by developing a novel approach involving multi-position bioluminescence imaging and unbiased computational analyses. We demonstrate that there is phase heterogeneity across all three dimensions of the SCN that is intrinsically regulated and extrinsically modulated by light in a region-specific manner. By investigating the mechanistic bases of SCN phase heterogeneity, we show for the first time that phase differences are not systematically related to regional differences in period, waveform, amplitude, or brightness. Furthermore, phase differences are not related to regional differences in the expression of arginine vasopressin and vasoactive intestinal polypeptide, two key neuropeptides characterizing functionally distinct subdivisions of the SCN. The consistency of SCN spatiotemporal organization across individuals and across planes of section suggests that the precise phasing of oscillators is a robust feature of the pacemaker important for its function.	[Evans, Jennifer A.; Castanon-Cervantes, Oscar; Davidson, Alec J.] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Leise, Tanya L.] Amherst Coll, Dept Math, Amherst, MA 01002 USA	Morehouse School of Medicine; Amherst College	Evans, JA (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	adavidson@msm.edu		Leise, Tanya/0000-0002-7458-7604	NINDS/NIH [U54NS060659]; NCI/NIH [P20CA132389]; NCMHD/NIH [S21MD000101]; NCRR/NIH [G12-RR03034]; Georgia Research Alliance; NSF Center for Behavioral Neuroscience; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCMHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Georgia Research Alliance; NSF Center for Behavioral Neuroscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NINDS/NIH grant U54NS060659, NCI/NIH grant P20CA132389, NCMHD/NIH grant S21MD000101, NCRR/NIH grant G12-RR03034, the Georgia Research Alliance, and the NSF Center for Behavioral Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Butler MP, 2009, J BIOL RHYTHM, V24, P340, DOI 10.1177/0748730409344800; Dardente H, 2002, BRAIN RES, V958, P261, DOI 10.1016/S0006-8993(02)03563-1; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Drouyer E, 2010, J COMP NEUROL, V518, P1249, DOI 10.1002/cne.22272; Fisher NI, 1995, STAT ANAL CIRCULAR D; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jobst EE, 2004, NEUROSCIENCE, V123, P87, DOI 10.1016/j.neuroscience.2003.08.059; Jobst EE, 2002, EUR J NEUROSCI, V16, P2469, DOI 10.1046/j.1460-9568.2002.02309.x; Kalsbeek A, 2006, CHRONOBIOL INT, V23, P521, DOI 10.1080/07420520600651073; Karatsoreos IN, 2004, J NEUROSCI, V24, P68, DOI 10.1523/JNEUROSCI.1666-03.2004; Klein DC, SUPRACHIASMATIC NUCL; Kriegsfeld LJ, 2004, J COMP NEUROL, V468, P361, DOI 10.1002/cne.10995; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; LEVINE JD, 2002, BMC NEUROSCI, V3; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Nagano M, 2003, J NEUROSCI, V23, P6141; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; YAN L, 2009, REV ENDOCR METAB DIS; Yan L, 2008, EUR J NEUROSCI, V28, P2108, DOI 10.1111/j.1460-9568.2008.06493.x; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yan LL, 2002, EUR J NEUROSCI, V15, P1153, DOI 10.1046/j.1460-9568.2002.01955.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	48	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15869	10.1371/journal.pone.0015869	http://dx.doi.org/10.1371/journal.pone.0015869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249213	gold, Green Published, Green Submitted			2022-12-27	WOS:000286512900010
J	Patel, S; Macaulay, K; Woodgett, JR				Patel, Satish; Macaulay, Katrina; Woodgett, James R.			Tissue-Specific Analysis of Glycogen Synthase Kinase-3 alpha (GSK-3 alpha) in Glucose Metabolism: Effect of Strain Variation	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-2; BETA-CELLS; HOMEOSTASIS; INHIBITION; LIVER; ACTIVATION; EXPRESSION; GSK-3-BETA; PLAYS; MICE	Background: Over-activity and elevated expression of glycogen synthase kinase-3 (GSK-3) has been implicated in the etiology of insulin resistance and Type 2 diabetes. Administration of specific GSK-3 inhibitors to diabetic or obese rodent models improves glycaemic control and insulin sensitivity. However, due to the indiscriminatory nature of these inhibitors, the relative contribution of the two isoforms of GSK-3 (GSK-3 alpha and GSK-3 beta) is not known. Recently, we demonstrated that an out-bred strain of mice (ICR) lacking expression of GSK-3 alpha in all tissues displayed improved insulin sensitivity and enhanced hepatic glucose metabolism. We also found that muscle (but not liver) inactivation of GSK-3 beta conferred insulin and glucose sensitization in an in-bred strain of mice (C57BL/6). Methodology/Principal Findings: Here, we have employed tissue-specific deletion of GSK-3 alpha, to examine the relative contribution of two insulin-sensitive tissues, muscle and liver, towards the insulin sensitization phenotype originally observed in the global GSK-3 alpha KO animals. We found that mice in which GSK-3 alpha has been inactivated in either skeletal-muscle or liver displayed no differences in glucose tolerance or insulin sensitivity compared to wild type littermates. Given the strain differences in our original analyses, we examined the insulin and glucose sensitivity of global GSK-3 alpha KO animals bred onto a C57BL/6 background. These animals also revealed no significant differences in glucose metabolism/insulin sensitivity compared to their wild type littermates. Furthermore, deletion of hepatic GSK-3 alpha on the out-bred, ICR background failed to reproduce the insulin sensitivity manifested by the global deletion of this isoform. Conclusions/Significance: From these data we conclude that the improved insulin sensitivity and hepatic glucose homeostasis phenotype observed upon global inactivation of GSK-3 alpha is strain-specific. We surmise that the insulin-sensitization observed in the out-bred strain of mice lacking GSK-3 alpha is mediated by indirect means that do not require intrinsic function of GSK-3 alpha in skeletal muscle and liver tissues.	[Patel, Satish; Macaulay, Katrina; Woodgett, James R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Patel, S (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	woodgett@lunenfeld.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797	Canadian Institutes of Health Research [MOP 74711]; Canadian Diabetes Association [OG-3-07-2425-JW]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	Canadian Institutes of Health Research - http://www.cihr-irsc.gc.ca MOP 74711. Canadian Diabetes Association OG-3-07-2425-JW - http://www.diabetes.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cline GW, 2002, DIABETES, V51, pA314; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dokken BB, 2006, AM J PHYSIOL-ENDOC M, V291, pE207, DOI 10.1152/ajpendo.00628.2005; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; MacAulay K, 2008, EXPERT OPIN THER TAR, V12, P1265, DOI 10.1517/14728222.12.10.1265 ; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	27	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15845	10.1371/journal.pone.0015845	http://dx.doi.org/10.1371/journal.pone.0015845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253590	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900013
J	Bartels, MD; Hansen, LH; Boye, K; Sorensen, SJ; Westh, H				Bartels, Mette Damkjaer; Hansen, Lars Hestbjerg; Boye, Kit; Sorensen, Soren J.; Westh, Henrik			An Unexpected Location of the Arginine Catabolic Mobile Element (ACME) in a USA300-Related MRSA Strain	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CASSETTE CHROMOSOME MEC; USA300; MULTIPLEX; VIRULENCE; CLONE; GENE; PCR	In methicillin resistant Staphylococcus aureus (MRSA), the arginine catabolic mobile element (ACME) was initially described in USA300 (t008-ST8) where it is located downstream of the staphylococcal cassette chromosome mec (SCCmec). A common health-care associated MRSA in Copenhagen, Denmark (t024-ST8) is clonally related to USA300 and is frequently PCR positive for the ACME specific arcA-gene. This study is the first to describe an ACME element upstream of the SCCmec in MRSA. By traditional SCCmec typing schemes, the SCCmec of t024-ST8 strain M1 carries SCCmec IVa, but full sequencing of the cassette revealed that the entire J3 region had no homology to published SCCmec IVa. Within the J3 region of M1 was a 1705 bp sequence only similar to a sequence in S. haemolyticus strain JCSC1435 and 2941 bps with no homology found in GenBank. In addition to the usual direct repeats (DR) at each extremity of SCCmec, M1 had two new DR between the orfX gene and the J3 region of the SCCmec. The region between the orfX DR (DR1) and DR2 contained the ccrAB4 genes. An ACME II-like element was located between DR2 and DR3. The entire 26,468 bp sequence between DR1 and DR3 was highly similar to parts of the ACME composite island of S. epidermidis strain ATCC12228. Sequencing of an ACME negative t024-ST8 strain (M299) showed that DR1 and the sequence between DR1 and DR3 was missing. The finding of a mobile ACME II-like element inserted downstream of orfX and upstream of SCCmec indicates a novel recombination between staphylococcal species.	[Bartels, Mette Damkjaer; Boye, Kit; Westh, Henrik] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark; [Hansen, Lars Hestbjerg; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Westh, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Bartels, MD (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark.	mette.damkjaer@dadlnet.dk	Sørensen, Søren Johannes/N-2120-2019; Bartels, Mette Damkjær/AAY-5809-2020; Sørensen, Søren J/J-5015-2014	Sørensen, Søren Johannes/0000-0001-6227-9906; Bartels, Mette Damkjær/0000-0002-8187-3684; Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Westh, Henrik/0000-0001-5681-647X				Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Bordoni R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-464; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08	17	33	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16193	10.1371/journal.pone.0016193	http://dx.doi.org/10.1371/journal.pone.0016193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283578	gold, Green Published			2022-12-27	WOS:000286661400033
J	Deo, RC; Wilson, JG; Xing, C; Lawson, K; Kao, WHL; Reich, D; Tandon, A; Akylbekova, E; Patterson, N; Mosley, TH; Boerwinkle, E; Taylor, HA				Deo, Rahul C.; Wilson, James G.; Xing, Chao; Lawson, Kim; Kao, W. H. Linda; Reich, David; Tandon, Arti; Akylbekova, Ermeg; Patterson, Nick; Mosley, Thomas H., Jr.; Boerwinkle, Eric; Taylor, Herman A., Jr.			Single-Nucleotide Polymorphisms in LPA Explain Most of the Ancestry-Specific Variation in Lp(a) Levels in African Americans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TRANSCRIPTION-FACTOR-BINDING; ATHEROSCLEROSIS RISK; PLASMA LIPOPROTEIN(A); JACKSON HEART; APOLIPOPROTEIN(A) SIZE; CARDIOVASCULAR HEALTH; APO(A) GENE; ASSOCIATION; ISOFORMS	Lipoprotein(a) (Lp(a)) is an important causal cardiovascular risk factor, with serum Lp(a) levels predicting atherosclerotic heart disease and genetic determinants of Lp(a) levels showing association with myocardial infarction. Lp(a) levels vary widely between populations, with African-derived populations having nearly 2-fold higher Lp(a) levels than European Americans. We investigated the genetic basis of this difference in 4464 African Americans from the Jackson Heart Study (JHS) using a panel of up to 1447 ancestry informative markers, allowing us to accurately estimate the African ancestry proportion of each individual at each position in the genome. In an unbiased genome-wide admixture scan for frequency-differentiated genetic determinants of Lp(a) level, we found a convincing peak (LOD = 13.6) at 6q25.3, which spans the LPA locus. Dense fine-mapping of the LPA locus identified a number of strongly associated, common biallelic SNPs, a subset of which can account for up to 7% of the variation in Lp(a) level, as well as >70% of the African-European population differences in Lp(a) level. We replicated the association of the most strongly associated SNP, rs9457951 (p = 6x10(-22), 27% change in Lp(a) per allele, similar to 5% of Lp(a) variance explained in JHS), in 1,726 African Americans from the Dallas Heart Study and found an even stronger association after adjustment for the kringle(IV) repeat copy number. Despite the strong association with Lp(a) levels, we find no association of any LPA SNP with incident coronary heart disease in 3,225 African Americans from the Atherosclerosis Risk in Communities Study.	[Deo, Rahul C.; Reich, David; Tandon, Arti; Patterson, Nick] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02163 USA; [Deo, Rahul C.] Harvard Univ, Sch Med, Div Cardiol, Massachusetts Gen Hosp, Boston, MA USA; [Deo, Rahul C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Wilson, James G.; Akylbekova, Ermeg; Mosley, Thomas H., Jr.; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Lawson, Kim; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Lawson, Kim; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Reich, David; Patterson, Nick] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Akylbekova, Ermeg; Taylor, Herman A., Jr.] Jackson State Univ, Jackson, MS USA; [Taylor, Herman A., Jr.] Tougaloo Coll, Tougaloo, MS USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Jackson State University; Tougaloo College	Deo, RC (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02163 USA.	rdeo@partners.org		Xing, Chao/0000-0002-1838-0502	National Heart, Lung, and Blood Institute and the National Center on Minority Health and Health Disparities [R01 HL084107]; NIH [N01-HC-95170, N01-HC-95171, N01-HC-95172]; National Institutes of Health [T32 HL007208, K08 HL098361]; Donald W. Reynolds Foundation; NHLBI [HL082896, HL092550]; National Center for Research Resources [UL1RR024982]; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; WHLK [R21DK073482, K01DK067207]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055016, N01HC055015, N01HC095171, N01HC055019, N01HC055022, N01HC095170, N01HC095172, N01HC055018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL055018, R41HL055018, R01HL084107, R01HL082896, T32HL007208, R41HL095172, R41HL055019, RL1HL092550, K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067207, R21DK073482] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and the National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Institute on Minority Health & Health Disparities (NIMHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WHLK; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the National Heart, Lung, and Blood Institute and the National Center on Minority Health and Health Disparities through R01 HL084107 to JGW and NIH contracts N01-HC-95170, N01-HC-95171, and N01-HC-95172. RCD was supported by National Institutes of Health grant T32 HL007208 and K08 HL098361. The Dallas Heart Study was supported by the Donald W. Reynolds Foundation and grants HL082896 and HL092550 from NHLBI. CX was supported by a Pilot Award from UL1RR024982 from the National Center for Research Resources. The ARIC Study was carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI) contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022 with support for this analysis by R21DK073482 and K01DK067207 (WHLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Chretien JP, 2006, J MED GENET, V43, P917, DOI 10.1136/jmg.2006.042119; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Draper NR, 1998, APPL REGRESSION ANAL, P407; GAVISH D, 1989, J CLIN INVEST, V84, P2021, DOI 10.1172/JCI114395; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Guerra R, 2005, CIRCULATION, V111, P1471, DOI 10.1161/01.CIR.0000159263.50305.BD; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Marcovina SM, 1996, CLIN CHEM, V42, P436; Marcovina SM, 1996, J LIPID RES, V37, P2569; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mooser V, 1997, AM J HUM GENET, V61, P402, DOI 10.1086/514851; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SANDHOLZER C, 1991, HUM GENET, V86, P607; Schreiner PJ, 1996, ARTERIOSCL THROM VAS, V16, P471, DOI 10.1161/01.ATV.16.3.471; SCHREINER PJ, 1993, ARTERIOSCLER THROMB, V13, P826, DOI 10.1161/01.ATV.13.6.826; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WHITE AL, 1994, J BIOL CHEM, V269, P9060; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhou M, 2001, AM STAT, V55, P153, DOI 10.1198/000313001750358491	40	50	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14581	10.1371/journal.pone.0014581	http://dx.doi.org/10.1371/journal.pone.0014581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283670	gold, Green Submitted, Green Published			2022-12-27	WOS:000286523400003
J	Dou, XY; Wang, Q; Qi, ZQ; Song, WW; Wang, W; Guo, M; Zhang, HF; Zhang, ZG; Wang, P; Zheng, XB				Dou, Xianying; Wang, Qi; Qi, Zhongqiang; Song, Wenwen; Wang, Wei; Guo, Min; Zhang, Haifeng; Zhang, Zhengguang; Wang, Ping; Zheng, Xiaobo			MoVam7, a Conserved SNARE Involved in Vacuole Assembly, Is Required for Growth, Endocytosis, ROS Accumulation, and Pathogenesis of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; ASPERGILLUS-NIDULANS; SEQUENCE ALIGNMENT; USTILAGO-MAYDIS; FULL VIRULENCE; PX DOMAIN; T-SNARE; GRISEA	Soluble NSF attachment protein receptor (SNARE) proteins play a central role in membrane fusion and vesicle transport of eukaryotic organisms including fungi. We previously identified MoSce22 as a homolog of Saccharomyces cerevisiae SNARE protein Sec22 to be involved in growth, stress resistance, and pathogenicity of Magnaporthe oryzae. Here, we provide evidences that MoVam7, an ortholog of S. cerevisiae SNARE protein Vam7, exerts conserved functions in vacuolar morphogenesis and functions in pathogenicity of M. oryzae. Staining with neutral red and FM4-64 revealed the presence of abnormal fragmented vacuoles and an absence of the Spitzenkorper body in the Delta Movam7 mutant. The Delta Movam7 mutant also exhibited reduced vegetative growth, poor conidiation, and failure to produce the infection structure appressorium. Additionally, treatments with cell wall perturbing agents indicated weakened cell walls and altered distributions of the cell wall component chitin. Furthermore, the Delta Movam7 mutant showed a reduced accumulation of reactive oxygen species (ROS) in the hyphal apex and failed to cause diseases on the rice plant. In summary, our studies indicate that MoVam7, like MoSec22, is a component of the SNARE complex whose functions in vacuole assembly also underlies the growth, conidiation, appressorium formation, and pathogenicity of M. oryzae. Further studies of MoVam7, MoSec22, and additional members of the SNARE complex are likely to reveal critical mechanisms in vacuole formation and membrane trafficking that is linked to fungal pathogenicity.	[Dou, Xianying; Wang, Qi; Qi, Zhongqiang; Song, Wenwen; Wang, Wei; Guo, Min; Zhang, Haifeng; Zhang, Zhengguang; Zheng, Xiaobo] Nanjing Agr Univ, Key Lab Monitoring & Management Crop Dis & Pest I, Minist Agr, Nanjing, Peoples R China; [Dou, Xianying; Wang, Qi; Qi, Zhongqiang; Song, Wenwen; Wang, Wei; Guo, Min; Zhang, Haifeng; Zhang, Zhengguang; Zheng, Xiaobo] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Ping] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA USA; [Wang, Ping] Louisiana State Univ, Res Inst Children, Hlth Sci Ctr, New Orleans, LA USA	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, ZG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014		Special Fund for Agro-Scientific Research in the Public Interest [200803008]; Natural Science Foundations of China [30771394, 30971890]; Ministry of Education of China [NCET-07-0442]; US grant [NIH/NIAID AI054958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958] Funding Source: NIH RePORTER	Special Fund for Agro-Scientific Research in the Public Interest; Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); US grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Special Fund for Agro-Scientific Research in the Public Interest (200803008 to ZG Zhang), the Natural Science Foundations of China (30771394 and 30971890 to XB Zheng), and the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZG Zhang). Research in Ping Wang's lab was partially supported by a US grant (NIH/NIAID AI054958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Caracuel-Rios Z, 2007, CURR OPIN MICROBIOL, V10, P339, DOI 10.1016/j.mib.2007.05.019; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Ellson CD, 2002, J CELL SCI, V115, P1099; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Fujikawa T, 2009, MOL MICROBIOL, V73, P553, DOI 10.1111/j.1365-2958.2009.06786.x; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Hoffmann J, 1998, FUNGAL GENET BIOL, V24, P77, DOI 10.1006/fgbi.1998.1059; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Pratelli J, 2004, TRENDS PLANT SCI, V9, P187, DOI 10.1016/j.tplants.2004.02.007; Sietsma JH, 1996, MICROBIOL-UK, V142, P1591, DOI 10.1099/13500872-142-7-1591; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsui MMK, 2001, MOL BIOL CELL, V12, P521, DOI 10.1091/mbc.12.3.521; VALENT B, 1991, GENETICS, V127, P87; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; WADA Y, 1992, J BIOL CHEM, V267, P18671; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zheng W, 2007, EUKARYOT CELL, V6, P2240, DOI 10.1128/EC.00104-07; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	44	70	79	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16439	10.1371/journal.pone.0016439	http://dx.doi.org/10.1371/journal.pone.0016439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283626	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400035
J	Gibert, Y; Lattanzi, VJ; Zhen, AW; Vedder, L; Brunet, F; Faasse, SA; Babitt, JL; Lin, HY; Hammerschmidt, M; Fraenkel, PG				Gibert, Yann; Lattanzi, Victoria J.; Zhen, Aileen W.; Vedder, Lea; Brunet, Frederic; Faasse, Sarah A.; Babitt, Jodie L.; Lin, Herbert Y.; Hammerschmidt, Matthias; Fraenkel, Paula G.			BMP Signaling Modulates Hepcidin Expression in Zebrafish Embryos Independent of Hemojuvelin	PLOS ONE			English	Article							IRON OVERLOAD; SOLUBLE HEMOJUVELIN; SEQUENCE ALIGNMENT; MEMBRANE; MODEL; GENE; FERROPORTIN1; CLEAVAGE; MUTANTS; DEFECTS	Hemojuvelin (Hjv), a member of the repulsive-guidance molecule (RGM) family, upregulates transcription of the iron regulatory hormone hepcidin by activating the bone morphogenetic protein (BMP) signaling pathway in mammalian cells. Mammalian models have identified furin, neogenin, and matriptase-2 as modifiers of Hjv's function. Using the zebrafish model, we evaluated the effects of hjv and its interacting proteins on hepcidin expression during embryonic development. We found that hjv is strongly expressed in the notochord and somites of the zebrafish embryo and that morpholino knockdown of hjv impaired the development of these structures. Knockdown of hjv or other hjv-related genes, including zebrafish orthologs of furin or neogenin, however, failed to decrease hepcidin expression relative to liver size. In contrast, overexpression of bmp2b or knockdown of matriptase-2 enhanced the intensity and extent of hepcidin expression in zebrafish embryos, but this occurred in an hjv-independent manner. Furthermore, we demonstrated that zebrafish hjv can activate the human hepcidin promoter and enhance BMP responsive gene expression in vitro, but is expressed at low levels in the zebrafish embryonic liver. Taken together, these data support an alternative mechanism for hepcidin regulation during zebrafish embryonic development, which is independent of hjv.	[Gibert, Yann; Lattanzi, Victoria J.; Zhen, Aileen W.; Vedder, Lea; Fraenkel, Paula G.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Gibert, Yann; Lattanzi, Victoria J.; Zhen, Aileen W.; Vedder, Lea; Fraenkel, Paula G.] Harvard Univ, Sch Med, Boston, MA USA; [Brunet, Frederic] Ecole Normale Super, Inst Genom Fonct Lyon, Lyon, France; [Faasse, Sarah A.; Babitt, Jodie L.; Lin, Herbert Y.] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA; [Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, Cologne, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Harvard University; Massachusetts General Hospital; University of Cologne	Gibert, Y (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA.	pfraenke@bidmc.harvard.edu		Fraenkel, Paula/0000-0001-8894-0117; Brunet, Frederic/0000-0001-5145-8925	NIH [K08 DK061685, 3P30 DK034854-24S1, K08 DK075846, R01 DK087727, R01 DK071837, R01 DK069533]; Cooley's Anemia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, R01DK071837, P30DK034854, K08DK061685, K08DK075846, R01DK069533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooley's Anemia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH K08 DK061685 (P.G.F.), 3P30 DK034854-24S1 (P.G.F.), K08 DK075846 (J.L.B.), R01 DK087727 (J.L.B), R01 DK071837 (H.Y.L.), R01 DK069533 (H.Y.L) and the Cooley's Anemia Foundation (P.G.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; ARNDT S, 2009, GASTROENTEROLOGY; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Camberlein E, 2007, HAEMATOLOGICA, V93, P111, DOI 10.3324/haematol.11656; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; De Domenico I, 2007, BLOOD, V110, P3780, DOI 10.1182/blood-2007-07-100248; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fraenkel PG, 2009, BLOOD, V113, P2843, DOI 10.1182/blood-2008-06-165340; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; KAUTZ L, 2010, HAEMATOLOGICA; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; NUSSLEINVOLHARD C, 2005, ZEBRAFISH PRACTICAL, P68; NUSSLEINVOLHARD C, 2005, ZEBRAFISH PRACTICAL, P45; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Parkin CA, 2009, INT J DEV BIOL, V53, P45, DOI 10.1387/ijdb.082669cp; Ransom DG, 1996, DEVELOPMENT, V123, P311; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse B., 2001, R01RR15402 NIH ZFIN; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wingert RA, 2004, DEVELOPMENT, V131, P6225, DOI 10.1242/dev.01540; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200	60	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14553	10.1371/journal.pone.0014553	http://dx.doi.org/10.1371/journal.pone.0014553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283739	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300003
J	Huege, J; Goetze, J; Schwarz, D; Bauwe, H; Hagemann, M; Kopka, J				Huege, Jan; Goetze, Jan; Schwarz, Doreen; Bauwe, Hermann; Hagemann, Martin; Kopka, Joachim			Modulation of the Major Paths of Carbon in Photorespiratory Mutants of Synechocystis	PLOS ONE			English	Article							METABOLIC FLUX ANALYSIS; SP STRAIN PCC-6803; MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; WILD-TYPE; CYCLE; CYANOBACTERIA; MICROORGANISMS; PURIFICATION; ARABIDOPSIS	Background: Recent studies using transcript and metabolite profiles of wild-type and gene deletion mutants revealed that photorespiratory pathways are essential for the growth of Synechocystis sp. PCC 6803 under atmospheric conditions. Pool size changes of primary metabolites, such as glycine and glycolate, indicated a link to photorespiration. Methodology/Principal Findings: The (13)C labelling kinetics of primary metabolites were analysed in photoautotrophically grown cultures of Synechocystis sp. PCC 6803 by gas chromatography-mass spectrometry (GC-MS) to demonstrate the link with photorespiration. Cells pre-acclimated to high CO(2) (5%, HC) or limited CO(2) (0.035%, LC) conditions were pulse-labelled under very high (2% w/w) (13)C-NaHCO(3) (VHC) conditions followed by treatment with ambient (12)C at HC and LC conditions, respectively. The (13)C enrichment, relative changes in pool size, and (13)C flux of selected metabolites were evaluated. We demonstrate two major paths of CO(2) assimilation via Rubisco in Synechocystis, i.e., from 3PGA via PEP to aspartate, malate and citrate or, to a lesser extent, from 3PGA via glucose-6-phosphate to sucrose. The results reveal evidence of carbon channelling from 3PGA to the PEP pool. Furthermore, (13)C labelling of glycolate was observed under conditions thought to suppress photorespiration. Using the glycolate-accumulating Delta glcD1 mutant, we demonstrate enhanced (13)C partitioning into the glycolate pool under conditions favouring photorespiration and enhanced (13)C partitioning into the glycine pool of the glycine-accumulating Delta gcvT mutant. Under LC conditions, the photorespiratory mutants Delta glcD1 and Delta gcvT showed enhanced activity of the additional carbon-fixing PEP carboxylase pathway. Conclusions/Significance: With our approach of non-steady-state (13)C labelling and analysis of metabolite pool sizes with respective (13)C enrichments, we identify the use and modulation of major pathways of carbon assimilation in Synechocystis in the presence of high and low inorganic carbon supplies.	[Huege, Jan] Leibniz Inst Plant Genet & Crop Plant Res, Dept Physiol & Cell Biol, Gatersleben, Germany; [Goetze, Jan] Univ Potsdam, Dept Chem, Potsdam, Germany; [Schwarz, Doreen; Bauwe, Hermann; Hagemann, Martin] Univ Rostock, Dept Plant Physiol, Rostock, Germany; [Kopka, Joachim] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Potsdam; University of Rostock; Max Planck Society	Huege, J (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Dept Physiol & Cell Biol, Gatersleben, Germany.	Kopka@mpimp-golm.mpg.de	Götze, Jan/N-4922-2016; Götze, Jan Philipp/AAS-2821-2020	Götze, Jan/0000-0003-2211-2057; Götze, Jan Philipp/0000-0003-2211-2057; Schwarz, Doreen/0000-0002-1071-5865; Kopka, Joachim/0000-0001-9675-4883	DFG (Deutsche Forschungsgemeinschaft); Max Planck Society; Bundesministerium fur Bildung und Forschung (BMBF) [FOOD-CT-2006-036220]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant from the DFG (Deutsche Forschungsgemeinschaft) to M.H. and J.K. and by the Max Planck Society. The development of the CORRECTOR software tool was supported in part by the European META-PHOR project, FOOD-CT-2006-036220, and the GoFORSYS project (http://www.goforsys.de/) funded by the Bundesministerium fur Bildung und Forschung (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, MOL PLANT, V2, P32, DOI 10.1093/mp/ssn075; Allwood JW, 2009, METABOLOMICS, V5, P479, DOI 10.1007/s11306-009-0169-z; Bauwe H, 2010, BIOCHEM SOC T, V38, P677, DOI 10.1042/BST0380677; CALVIN M, 1956, J CHEM SOC, P1895, DOI 10.1039/jr9560001895; CALVIN M, 1961, NOBEL LECT CHEM 1942, P618; Cegelski L, 2006, J MAGN RESON, V178, P1, DOI 10.1016/j.jmr.2005.10.010; COLMAN B, 1989, AQUAT BOT, V34, P211, DOI 10.1016/0304-3770(89)90057-0; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; DOHLER G, 1974, PLANTA, V118, P259, DOI 10.1007/BF00384781; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Huege J, 2007, PHYTOCHEMISTRY, V68, P2258, DOI 10.1016/j.phytochem.2007.03.026; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; HUSIC DW, 1987, CRIT REV PLANT SCI, V5, P45, DOI 10.1080/07352688709382234; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; KELLY GJ, 1977, PLANT PHYSIOL, V60, P295, DOI 10.1104/pp.60.2.295; Knoll Andrew H., 2008, P1; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Krall L, 2009, J CHROMATOGR B, V877, P2952, DOI 10.1016/j.jchromb.2009.07.006; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Maheswaran M, 2006, J BACTERIOL, V188, P2730, DOI 10.1128/JB.188.7.2730-2734.2006; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; NORMAN EG, 1991, PLANT PHYSIOL, V95, P693, DOI 10.1104/pp.95.3.693; Ratcliffe RG, 2006, PLANT J, V45, P490, DOI 10.1111/j.1365-313X.2005.02649.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roessner-Tunali U, 2004, PLANT J, V39, P668, DOI 10.1111/j.1365-313X.2004.02157.x; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Shastri AA, 2007, PHYTOCHEMISTRY, V68, P2302, DOI 10.1016/j.phytochem.2007.03.042; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; Tabita FR, 2009, P NATL ACAD SCI USA, V106, P21015, DOI 10.1073/pnas.0912486107; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; Tolbert NE, 1997, ANNU REV PLANT PHYS, V48, P1, DOI 10.1146/annurev.arplant.48.1.1; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wittmann C, 1999, BIOTECHNOL BIOENG, V62, P739, DOI 10.1002/(SICI)1097-0290(19990320)62:6<739::AID-BIT13>3.0.CO;2-E; WOLFE RR, 2004, ISOTOPE TRACERS META, P21; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226	40	65	66	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16278	10.1371/journal.pone.0016278	http://dx.doi.org/10.1371/journal.pone.0016278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283704	Green Published, gold			2022-12-27	WOS:000286522300029
J	BenMessaoud, C; Kharrazi, H; MacDorman, KF				BenMessaoud, Christine; Kharrazi, Hadi; MacDorman, Karl F.			Facilitators and Barriers to Adopting Robotic-Assisted Surgery: Contextualizing the Unified Theory of Acceptance and Use of Technology	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY	Robotic-assisted surgical techniques are not yet well established among surgeon practice groups beyond a few surgical subspecialties. To help identify the facilitators and barriers to their adoption, this belief-elicitation study contextualized and supplemented constructs of the unified theory of acceptance and use of technology (UTAUT) in robotic-assisted surgery. Semi-structured individual interviews were conducted with 21 surgeons comprising two groups: users and nonusers. The main facilitators to adoption were Perceived Usefulness and Facilitating Conditions among both users and nonusers, followed by Attitude Toward Using Technology among users and Extrinsic Motivation among nonusers. The three main barriers to adoption for both users and nonusers were Perceived Ease of Use and Complexity, Perceived Usefulness, and Perceived Behavioral Control. This study's findings can assist surgeons, hospital and medical school administrators, and other policy makers on the proper adoption of robotic-assisted surgery and can guide future research on the development of theories and framing of hypotheses.	[BenMessaoud, Christine; Kharrazi, Hadi; MacDorman, Karl F.] Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA; [MacDorman, Karl F.] Purdue Univ, Sch Engn & Technol, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University	BenMessaoud, C (corresponding author), Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA.	kmacdorm@indiana.edu	MacDorman, Karl/AAH-4483-2020; Kharrazi, Hadi/Q-1725-2015	MacDorman, Karl/0000-0003-1093-4184; Kharrazi, Hadi/0000-0003-1481-4323	Android Science Center	Android Science Center	This study was supported by an IUPUI Signature Center grant for the Android Science Center: http://www.iupui.edu/research/signaturecenters_07_08.html. There is no grant number. The total size of the grant is $420,000; however, the grant is used only to pay the PLoS ONE publication fee. The study itself is based on an unfunded MS in health informatics thesis of the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1980, UNDERSTANDING ATTITU; Berci G, 2004, SURG ENDOSC, V18, P1, DOI 10.1007/s00464-003-8270-2; BERGERON B, 2002, MEDSCAPE GEN MED, V4; Bocca S, 2007, REPROD BIOMED ONLINE, V14, P765, DOI 10.1016/S1472-6483(10)60680-3; Camarillo DB, 2004, AM J SURG, V188, p2S, DOI 10.1016/j.amjsung.2004.08.025; Chau PYK, 2002, J MANAGE INFORM SYST, V18, P191, DOI 10.1080/07421222.2002.11045699; Creswell J.W., 2015, RES DESIGN QUALITATI, V4th ed.; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Donias HW, 2002, AM SURGEON, V68, P177; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Finan MA, 2010, SURG ENDOSC, V24, P1256, DOI 10.1007/s00464-009-0756-0; FURUKAWA T, 2001, MINIM INVASIV THER, V10, P283, DOI DOI 10.1080/136457001753337320; GOMEZ G, 2004, SABISTON TXB SURG; HAGGAG AA, 2006, INTERNET J HLTH, V5, P3; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Holden R, 2009, BEHAV INFORM TECHNOL, V28, P21, DOI 10.1080/01449290601138245; Kvale S, 1996, INTERVIEWS INTRO QUA; Lanfranco AR, 2004, ANN SURG, V239, P14, DOI 10.1097/01.sla.0000103020.19595.7d; LOWENFELS AB, 2004, ROBOTICS; Malhotra Y., 1999, PROC HAWAII INT C SY, P14, DOI DOI 10.1109/HICSS.1999.772658; Marescaux J., 2005, EUR SURG, V37, P279; Matthews CA, 2010, J WOMENS HEALTH, V19, P863, DOI 10.1089/jwh.2009.1773; MCLEOD IK, 2005, ENT-EAR NOSE THROAT, V84, P484; Meadows Michelle, 2002, FDA Consum, V36, P10; Morris Bishoy, 2005, MedGenMed, V7, P72; Murphy DA, 2006, J THORAC CARDIOV SUR, V132, P776, DOI 10.1016/j.jtcvs.2006.04.052; Nazemi T, 2006, INT J UROL, V13, P248, DOI 10.1111/j.1442-2042.2006.01273.x; Neuendorf K. A, 2002, CONTENT ANAL GUIDEBO; Nguyen NT, 2004, AM SURGEON, V70, P914; RAWSTORNE P, 2000, P 21 INT C INF SYST, P35; Schurr MO, 1999, EUR J CARDIO-THORAC, V16, pS97, DOI 10.1016/S1010-7940(99)00281-X; Tabor Wendy, 2007, Nursing, V37, P48; Talamini MA, 2005, JAMA-J AM MED ASSOC, V293, P863, DOI 10.1001/jama.293.7.863; VAN J, 2007, CHICAGO TRIBUNE 0907; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; von Gruenigen VE, 2009, J GYNECOL SURG, V25, P67, DOI 10.1089/gyn.2008.0002; Yarbrough AK, 2007, MED CARE RES REV, V64, P650, DOI 10.1177/1077558707305942	38	71	72	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16395	10.1371/journal.pone.0016395	http://dx.doi.org/10.1371/journal.pone.0016395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OX	21283719	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200058
J	Gu, WD; Muller, G; Schlein, Y; Novak, RJ; Beier, JC				Gu, Weidong; Mueller, Guenter; Schlein, Yosef; Novak, Robert J.; Beier, John C.			Natural Plant Sugar Sources of Anopheles Mosquitoes Strongly Impact Malaria Transmission Potential	PLOS ONE			English	Article							INOCULATION RATES; SAND FLIES; POPULATIONS; PARAMETERS; SERGENTII; VECTORS; ECOLOGY; AFRICA	An improved knowledge of mosquito life history could strengthen malaria vector control efforts that primarily focus on killing mosquitoes indoors using insecticide treated nets and indoor residual spraying. Natural sugar sources, usually floral nectars of plants, are a primary energy resource for adult mosquitoes but their role in regulating the dynamics of mosquito populations is unclear. To determine how the sugar availability impacts Anopheles sergentii populations, mark-release-recapture studies were conducted in two oases in Israel with either absence or presence of the local primary sugar source, flowering Acacia raddiana trees. Compared with population estimates from the sugar-rich oasis, An. sergentii in the sugar-poor oasis showed smaller population size (37,494 vs. 85,595), lower survival rates (0.72 vs. 0.93), and prolonged gonotrophic cycles (3.33 vs. 2.36 days). The estimated number of females older than the extrinsic incubation period of malaria (10 days) in the sugar rich site was 4 times greater than in the sugar poor site. Sugar feeding detected in mosquito guts in the sugar-rich site was significantly higher (73%) than in the sugar-poor site (48%). In contrast, plant tissue feeding (poor quality sugar source) in the sugar-rich habitat was much less (0.3%) than in the sugar-poor site (30%). More important, the estimated vectorial capacity, a standard measure of malaria transmission potential, was more than 250-fold higher in the sugar-rich oasis than that in the sugar-poor site. Our results convincingly show that the availability of sugar sources in the local environment is a major determinant regulating the dynamics of mosquito populations and their vector potential, suggesting that control interventions targeting sugar-feeding mosquitoes pose a promising tactic for combating transmission of malaria parasites and other pathogens.	[Gu, Weidong; Novak, Robert J.] Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL 35294 USA; [Mueller, Guenter; Schlein, Yosef] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Fac Med, IMRIC,Kuvin Ctr Study Infect & Trop Dis, Jerusalem, Israel; [Beier, John C.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Ctr Global Hlth Sci, Miami, FL 33136 USA	University of Alabama System; University of Alabama Birmingham; Hebrew University of Jerusalem; University of Miami	Gu, WD (corresponding author), Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL 35294 USA.	wgu@uab.edu			Bill and Melinda Gates Foundation [47302]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This project was supported by the Bill and Melinda Gates Foundation (grant 47302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INS TREAT MOSQ NETS; AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; BEIER MS, 1987, J AM MOSQUITO CONTR, V3, P266; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Chambers RG, 2008, LANCET, V371, P1399, DOI 10.1016/S0140-6736(08)60609-1; Corbet S. A., 1979, Plant Cell and Environment, V2, P293, DOI 10.1111/j.1365-3040.1979.tb00084.x; DYE C, 1986, Parasitology Today, V2, P203; FARID M. A., 1956, BULL WORLD HEALTH ORGAN, V15, P821; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; KASTEN FH, 1980, METHODS FLUORESCENCE; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P147, DOI 10.2987/8756-971X(2008)24[147:DOASAA]2.0.CO;2; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; SCHLEIN Y, 1995, J MED ENTOMOL, V32, P882, DOI 10.1093/jmedent/32.6.882; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; Schlein Y, 2008, J MED ENTOMOL, V45, P384, DOI 10.1603/0022-2585(2008)45[384:AATMCU]2.0.CO;2; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Team RDC, 2019, R LANG ENV STAT COMP; Tracy CR, 2006, INTEGR COMP BIOL, V46, P1191, DOI 10.1093/icb/icl054; VANHANDE.E, 1972, MOSQ NEWS, V32, P458; VANHANDEL E, 1968, ANAL BIOCHEM, V22, P280, DOI 10.1016/0003-2697(68)90317-5; *WHO, 2004, WHOCDSCPEPVC20041011; World Health Organisation, 2008, WKLY EPIDEMIOL REC, V83, P177; Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150; ZAHAR AR, 1974, B WORLD HEALTH ORGAN, V50, P427; ZOHARY M., 1949, PALESTINE JOUR BOT JERUSALEM SER, V4, P177	36	85	87	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15996	10.1371/journal.pone.0015996	http://dx.doi.org/10.1371/journal.pone.0015996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283732	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200022
J	Brenet, F; Moh, M; Funk, P; Feierstein, E; Viale, AJ; Socci, ND; Scandura, JM				Brenet, Fabienne; Moh, Michelle; Funk, Patricia; Feierstein, Erika; Viale, Agnes J.; Socci, Nicholas D.; Scandura, Joseph M.			DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CYTOSINE-METHYLATION; GENE-EXPRESSION; X-CHROMOSOME; CPG ISLANDS; HUMAN-CELLS; CANCER; METHYLOME; REPRESSION; RESOLUTION	Tissue specific patterns of methylated cytosine residues vary with age, can be altered by environmental factors, and are often abnormal in human disease yet the cellular consequences of DNA methylation are incompletely understood. Although the bodies of highly expressed genes are often extensively methylated in plants, the relationship between intragenic methylation and expression is less clear in mammalian cells. We performed genome-wide analyses of DNA methylation and gene expression to determine how the pattern of intragenic methylation correlates with transcription and to assess the relationship between methylation of exonic and intronic portions of the gene body. We found that dense exonic methylation is far more common than previously recognized or expected statistically, yet first exons are relatively spared compared to more downstream exons and introns. Dense methylation surrounding the transcription start site (TSS) is uncoupled from methylation within more downstream regions suggesting that there are at least two classes of intragenic methylation. Whereas methylation surrounding the TSS is tightly linked to transcriptional silencing, methylation of more downstream regions is unassociated with the magnitude of gene expression. Notably, we found that DNA methylation downstream of the TSS, in the region of the first exon, is much more tightly linked to transcriptional silencing than is methylation in the upstream promoter region. These data provide direct evidence that DNA methylation is interpreted dissimilarly in different regions of the gene body and suggest that first exon methylation blocks transcript initiation, or vice versa. Our data also show that once initiated, downstream methylation is not a significant impediment to polymerase extension. Thus, the consequences of most intragenic DNA methylation must extend beyond the modulation of transcription magnitude. Sequencing data and gene expression microarray data have been submitted to the GEO online database (accession number SRA012081.1). Supporting information including expanded methods and ten additional figures in support of the manuscript is provided.	[Brenet, Fabienne; Moh, Michelle; Funk, Patricia; Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, Lab Mol Hematopoiesis, New York, NY USA; [Scandura, Joseph M.] Weill Cornell Med Coll, Leukemia Program, New York, NY USA; [Feierstein, Erika; Viale, Agnes J.] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Brenet, F (corresponding author), Weill Cornell Med Coll, Dept Med, Lab Mol Hematopoiesis, New York, NY USA.	jms2003@med.cornell.edu	Brenet, Fabienne/R-1881-2016	Brenet, Fabienne/0000-0003-4098-1096; Scandura, Joseph/0000-0002-9525-143X	Clinical and Translation Science Center at Weill Cornell Medical College [UL1RR024996]; Cornell Belfer Family Hematology-Oncology Division; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	Clinical and Translation Science Center at Weill Cornell Medical College; Cornell Belfer Family Hematology-Oncology Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant UL1RR024996 of the Clinical and Translation Science Center at Weill Cornell Medical College (JMS) and by Cornell Belfer Family Hematology-Oncology Division startup funds (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin SB, 1998, ADV CANCER RES, V72, P141; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1978, J MOL BIOL, V118, P49, DOI 10.1016/0022-2836(78)90243-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korshunova Y, 2008, GENOME RES, V18, P19, DOI 10.1101/gr.6883307; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Singal R, 1999, BLOOD, V93, P4059, DOI 10.1182/blood.V93.12.4059; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; [No title captured]	60	402	410	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14524	10.1371/journal.pone.0014524	http://dx.doi.org/10.1371/journal.pone.0014524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267076	gold, Green Submitted, Green Published			2022-12-27	WOS:000286519500006
J	Miyamoto, Y; Kitamura, N; Nakamura, Y; Futamura, M; Miyamoto, T; Yoshida, M; Ono, M; Ichinose, S; Arakawa, H				Miyamoto, Yuji; Kitamura, Noriaki; Nakamura, Yasuyuki; Futamura, Manabu; Miyamoto, Takafumi; Yoshida, Masaki; Ono, Masaya; Ichinose, Shizuko; Arakawa, Hirofumi			Possible Existence of Lysosome-Like Organella within Mitochondria and Its Role in Mitochondrial Quality Control	PLOS ONE			English	Article							PROTEIN-DEGRADATION; SOMATIC MUTATIONS; AAA PROTEASES; LON PROTEASE; AUTOPHAGY; CANCER; CELLS; DNA; MITOPHAGY; MAINTENANCE	The accumulation of unhealthy mitochondria results in mitochondrial dysfunction, which has been implicated in aging, cancer, and a variety of degenerative diseases. However, the mechanism by which mitochondrial quality is regulated remains unclear. Here, we show that Mieap, a novel p53-inducible protein, induces intramitochondrial lysosome-like organella that plays a critical role in mitochondrial quality control. Mieap expression is directly regulated by p53 and is frequently lost in human cancer as result of DNA methylation. Mieap dramatically induces the accumulation of lysosomal proteins within mitochondria and mitochondrial acidic condition without destroying the mitochondrial structure (designated MALM, for Mieap-induced accumulation of lysosome-like organelles within mitochondria) in response to mitochondrial damage. MALM was not related to canonical autophagy. MALM is involved in the degradation of oxidized mitochondrial proteins, leading to increased ATP synthesis and decreased reactive oxygen species generation. These results suggest that Mieap induces intramitochondrial lysosome-like organella that plays a critical role in mitochondrial quality control by eliminating oxidized mitochondrial proteins. Cancer cells might accumulate unhealthy mitochondria due to p53 mutations and/or Mieap methylation, representing a potential cause of the Warburg effect.	[Miyamoto, Yuji; Kitamura, Noriaki; Nakamura, Yasuyuki; Futamura, Manabu; Miyamoto, Takafumi; Yoshida, Masaki; Arakawa, Hirofumi] Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan; [Ono, Masaya] Natl Canc Ctr, Res Inst, Div Chemotherapy, Tokyo 104, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan.	harakawa@ncc.go.jp	Arakawa, Hirofumi/L-3459-2013; Miyamoto, Takafumi/T-6950-2019	Arakawa, Hirofumi/0000-0001-6077-0638; Miyamoto, Yuji/0000-0003-3948-5044; Miyamoto, Takafumi/0000-0001-9363-2864	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [23591966] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant support: a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Ministry of Health, Labor and Welfare for the 3rd-Term Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Assaily W, 2006, CANCER CELL, V10, P4, DOI 10.1016/j.ccr.2006.06.014; Baines CP, 2009, J MOL CELL CARDIOL, V46, P850, DOI 10.1016/j.yjmcc.2009.02.007; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Holtzman E., 1989, LYSOSOMES, P1, DOI [10.1007/978-1-4899-2540-4_1, DOI 10.1007/978-1-4899-2540-4_1]; Iida H, 2004, MOL REPROD DEV, V68, P385, DOI 10.1002/mrd.20101; Iiizumi M, 2002, CANCER RES, V62, P1246; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Luellmann-Rauch Renate, 2005, P1; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Masuda Yoshiko, 2006, J Hum Genet, V51, P652, DOI 10.1007/s10038-006-0004-6; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	48	54	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16054	10.1371/journal.pone.0016054	http://dx.doi.org/10.1371/journal.pone.0016054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264221	gold, Green Published, Green Submitted			2022-12-27	WOS:000286517600019
J	Chua, YS; Boh, BK; Ponyeam, W; Hagen, T				Chua, Yee Shin; Boh, Boon Kim; Ponyeam, Wanpen; Hagen, Thilo			Regulation of Cullin RING E3 Ubiquitin Ligases by CAND1 In Vivo	PLOS ONE			English	Article							COP9 SIGNALOSOME; PROTEIN; COMPLEX; CUL1; NEDD8; ARABIDOPSIS; SUBSTRATE; DENEDDYLATION; NEDDYLATION; CLEAVAGE	Cullin RING ligases are multi-subunit complexes consisting of a cullin protein which forms a scaffold onto which the RING protein Rbx1/2 and substrate receptor subunits assemble. CAND1, which binds to cullins that are not conjugated with Nedd8 and not associated with substrate receptors, has been shown to function as a positive regulator of Cullin ligases in vivo. Two models have been proposed to explain this requirement: (i) CAND1 sequesters cullin proteins and thus prevents autoubiquitination of substrate receptors, and (ii) CAND1 is required to promote the exchange of bound substrate receptors. Using mammalian cells, we show that CAND1 is predominantly cytoplasmically localized and that cullins are the major CAND1 interacting proteins. However, only small amounts of CAND1 bind to Cul1 in cells, despite low basal levels of Cul1 neddylation and approximately equal cytoplasmic endogenous protein concentrations of CAND1 and Cul1. Compared to F-box protein substrate receptors, binding of CAND1 to Cul1 in vivo is weak. Furthermore, preventing binding of F-box substrate receptors to Cul1 does not increase CAND1 binding. In conclusion, our study suggests that CAND1 does not function by sequestering cullins in vivo to prevent substrate receptor autoubiquitination and is likely to regulate cullin RING ligase activity via alternative mechanisms.	[Chua, Yee Shin; Boh, Boon Kim; Ponyeam, Wanpen; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Boh, Boon Kim; Hagen, Thilo] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	National University of Singapore; National University of Singapore	Chua, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Singapore Biomedical Research Council [07/1/21/19/500]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by a grant from the Singapore Biomedical Research Council (grant number 07/1/21/19/500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Cheng YF, 2004, PLANT PHYSIOL, V135, P1020, DOI 10.1104/pp.104.044495; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Feng SH, 2004, PLANT CELL, V16, P1870, DOI 10.1105/tpc.021949; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Min KW, 2005, BIOCHEM BIOPH RES CO, V334, P867, DOI 10.1016/j.bbrc.2005.06.188; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	25	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16071	10.1371/journal.pone.0016071	http://dx.doi.org/10.1371/journal.pone.0016071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249194	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000013
J	Yewhalaw, D; Wassie, F; Steurbaut, W; Spanoghe, P; Van Bortel, W; Denis, L; Tessema, DA; Getachew, Y; Coosemans, M; Duchateau, L; Speybroeck, N				Yewhalaw, Delenasaw; Wassie, Fantahun; Steurbaut, Walter; Spanoghe, Pieter; Van Bortel, Wim; Denis, Leen; Tessema, Dejene A.; Getachew, Yehenew; Coosemans, Marc; Duchateau, Luc; Speybroeck, Niko			Multiple Insecticide Resistance: An Impediment to Insecticide-Based Malaria Vector Control Program	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; KNOCKDOWN RESISTANCE; KDR MUTATION; CULEX-QUINQUEFASCIATUS; NATURAL-POPULATIONS; BURKINA-FASO; ARABIENSIS; DDT; SUSCEPTIBILITY; ACE-1(R)	Background: Indoor Residual Spraying (IRS), insecticide-treated nets (ITNs) and long-lasting insecticidal nets (LLINs) are key components in malaria prevention and control strategy. However, the development of resistance by mosquitoes to insecticides recommended for IRS and/or ITNs/LLINs would affect insecticide-based malaria vector control. We assessed the susceptibility levels of Anopheles arabiensis to insecticides used in malaria control, characterized basic mechanisms underlying resistance, and evaluated the role of public health use of insecticides in resistance selection. Methodology/Principal findings: Susceptibility status of An. arabiensis was assessed using WHO bioassay tests to DDT, permethrin, deltamethrin, malathion and propoxur in Ethiopia from August to September 2009. Mosquito specimens were screened for knockdown resistance (kdr) and insensitive acetylcholinesterase (ace-1(R)) mutations using AS-PCR and PCR-RFLP, respectively. DDT residues level in soil from human dwellings and the surrounding environment were determined by Gas Chromatography with Electron Capture Detector. An. arabiensis was resistant to DDT, permethrin, deltamethrin and malathion, but susceptible to propoxur. The West African kdr allele was found in 280 specimens out of 284 with a frequency ranged from 95% to 100%. Ace-1(R) mutation was not detected in all specimens scored for the allele. Moreover, DDT residues were found in soil samples from human dwellings but not in the surrounding environment. Conclusion: The observed multiple-resistance coupled with the occurrence of high kdr frequency in populations of An. arabiensis could profoundly affect the malaria vector control programme in Ethiopia. This needs an urgent call for implementing rational resistance management strategies and integrated vector control intervention.	[Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Jimma, Ethiopia; [Wassie, Fantahun] Jimma Univ, Dept Environm Hlth, Jimma, Ethiopia; [Tessema, Dejene A.] Jimma Univ, Dept Chem, Jimma, Ethiopia; [Getachew, Yehenew] Jimma Univ, Dept Plant Sci, Jimma, Ethiopia; [Steurbaut, Walter; Spanoghe, Pieter] Univ Ghent, Dept Crop Protect Chem, B-9000 Ghent, Belgium; [Van Bortel, Wim; Denis, Leen; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Duchateau, Luc] Univ Ghent, Dept Physiol & Biometr, B-9000 Ghent, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Sch Publ Hlth, Inst Hlth & Soc, B-1200 Brussels, Belgium	Jimma University; Jimma University; Jimma University; Jimma University; Ghent University; Institute of Tropical Medicine (ITM); Ghent University; Universite Catholique Louvain	Yewhalaw, D (corresponding author), Jimma Univ, Dept Biol, Jimma, Ethiopia.	delenasaw.yewhalaw@ju.edu.et	Spanoghe, Pieter/B-9440-2015; Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021	Spanoghe, Pieter/0000-0002-8158-4401; Van Bortel, Wim/0000-0002-6644-518X; Speybroeck, Niko/0000-0003-3322-3502	Flemish Interuniversity Council (Council of Flemish Universities, VLIR-IUC)	Flemish Interuniversity Council (Council of Flemish Universities, VLIR-IUC)	This work received financial support from the Flemish Interuniversity Council (Programme of Institutional University Cooperation of the Council of Flemish Universities, VLIR-IUC). The funders had no role in study design, data collection, decision to publish and preparation of the manuscript.	Abdalla H, 2008, T ROY SOC TROP MED H, V102, P263, DOI 10.1016/j.trstmh.2007.10.008; ABOSE Y, 1998, WHOMAL1998, P19; AHMED A, 2004, B MED J, V328, P1378; Akogbeto MC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-204; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2001, ETH DEM HLTH SURV 20; [Anonymous], 2007, INS TREAT MOSQ NETS; [Anonymous], 2006, IND RES SPRAYING US; Balkew M., 2003, Parassitologia (Rome), V45, P1; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Biscoe ML., 2004, CURRENT POLICY STATU; BROGDON WG, 1988, J AM MOSQUITO CONTR, V4, P152; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Daddi Jima, 2005, Ethiopian Journal of Health Development, V19, P16; Dalton JP, 2009, TRENDS PARASITOL, V25, P59, DOI 10.1016/j.pt.2008.11.002; DAVIDSON G, 1982, P INT WORK RES INS U, P137; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; ELGADDAL AA, 1985, J TROP MED HYG, V88, P153; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Fanello C, 2003, MED VET ENTOMOL, V17, P333, DOI 10.1046/j.1365-2915.2003.00450.x; Fettene M, 2004, AFR ENTOMOL, V12, P83; Gilles MT, 1987, ANOPHELINAE AFRICA S, P55; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; HEMINGWAY J, 1983, T ROY SOC TROP MED H, V77, P477, DOI 10.1016/0035-9203(83)90118-9; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; *INS RES ACT COMM, 2006, PREV MAN INS RES VEC; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Mandavilli A, 2006, NATURE, V443, P250, DOI 10.1038/443250b; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; *ROLL BACK MAL, 2004, ETH ROLL BACK MAL CO; Sadasivaiah S, 2007, AM J TROP MED HYG, V77, P249, DOI 10.4269/ajtmh.2007.77.249; Schapira A, 2006, LANCET, V368, P2111, DOI 10.1016/S0140-6736(06)69812-7; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tripet F, 2007, AM J TROP MED HYG, V76, P81; Tulu NA, 1993, ECOLOGY HLTH DIS ETH, P341; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; VERHAEGHEN K, 2009, THESIS ANTWERP U ANT, P127; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weissmann G, 2006, FASEB J, V20, P2427, DOI 10.1096/fj.06-1201ufm; WHO, 1998, WHOCDSCPCMAL9812; *WHO, 2002, MAN IND RES SPRAYING; World Health Organization, 2004, WHOCDSCPEPVC200410; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	65	102	106	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16066	10.1371/journal.pone.0016066	http://dx.doi.org/10.1371/journal.pone.0016066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264325	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514300006
J	Golovina, TN; Mikheeva, T; Brusko, TM; Blazar, BR; Bluestone, JA; Riley, JL				Golovina, Tatiana N.; Mikheeva, Tatiana; Brusko, Todd M.; Blazar, Bruce R.; Bluestone, Jeffrey A.; Riley, James L.			Retinoic Acid and Rapamycin Differentially Affect and Synergistically Promote the Ex Vivo Expansion of Natural Human T Regulatory Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; DE-NOVO GENERATION; TGF-BETA; TRANSPLANTATION TOLERANCE; INFECTIOUS TOLERANCE; PERIPHERAL-BLOOD; FOXP3 EXPRESSION; CUTTING EDGE; IN-VIVO	Natural T regulatory cells (Tregs) are challenging to expand ex vivo, and this has severely hindered in vivo evaluation of their therapeutic potential. All trans retinoic acid (ATRA) plays an important role in mediating immune homeostasis in vivo, and we investigated whether ATRA could be used to promote the ex vivo expansion of Tregs purified from adult human peripheral blood. We found that ATRA helped maintain FOXP3 expression during the expansion process, but this effect was transient and serum-dependent. Furthermore, natural Tregs treated with rapamycin, but not with ATRA, suppressed cytokine production in co-cultured effector T cells. This suppressive activity correlated with the ability of expanded Tregs to induce FOXP3 expression in non-Treg cell populations. Examination of CD45RA+ and CD45RA- Treg subsets revealed that ATRA failed to maintain suppressive activity in either population, but interestingly, Tregs expanded in the presence of both rapamycin and ATRA displayed more suppressive activity and had a more favorable epigenetic status of the FOXP3 gene than Tregs expanded in the presence of rapamycin only. We conclude that while the use of ATRA as a single agent to expand Tregs for human therapy is not warranted, its use in combination with rapamycin may have benefit.	[Golovina, Tatiana N.; Mikheeva, Tatiana; Riley, James L.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Golovina, Tatiana N.; Mikheeva, Tatiana; Riley, James L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Brusko, Todd M.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Blazar, Bruce R.; Bluestone, Jeffrey A.] Univ Minnesota, Ctr Canc, Minneapolis, MN USA; [Blazar, Bruce R.; Bluestone, Jeffrey A.] Univ Minnesota, Dept Pediat, Div Bone Marrow Transplant, Minneapolis, MN 55455 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Golovina, TN (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	rileyj@exchange.upenn.edu		Brusko, Todd/0000-0003-2878-9296; Riley, James/0000-0002-1057-576X	Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy; JDRF Center on Cord Blood Therapies for Type 1 Diabetes, Leukemia and Lymphoma Translational Research [R6029-07];  [P01 CA067493]; NATIONAL CANCER INSTITUTE [F32CA067493, P01CA142106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy; JDRF Center on Cord Blood Therapies for Type 1 Diabetes, Leukemia and Lymphoma Translational Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy and the JDRF Center on Cord Blood Therapies for Type 1 Diabetes, Leukemia and Lymphoma Translational Research (grant R6029-07) and P01 CA067493. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bonewald LF, 1997, ENDOCRINOLOGY, V138, P657, DOI 10.1210/en.138.2.657; Chai JG, 2005, TRANSPLANTATION, V79, P1310, DOI 10.1097/01.TP.0000159147.56408.9C; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2006, BLOOD, V108, p903A, DOI 10.1182/blood.V108.11.3163.3163; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim CH, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/416910; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moore C, 2009, TRANSPL P, V41, P2670, DOI 10.1016/j.transproceed.2009.06.130; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; RACKE MK, 1995, J IMMUNOL, V154, P450; Reifen R, 2002, J NUTR, V132, P2743, DOI 10.1093/jn/132.9.2743; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Taylor P, 2004, BLOOD, V104, p16A; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002; Zunino SJ, 2007, J NUTR, V137, P1216, DOI 10.1093/jn/137.5.1216	55	106	113	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15868	10.1371/journal.pone.0015868	http://dx.doi.org/10.1371/journal.pone.0015868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253593	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900018
J	Real, S; Meo-Evoli, N; Espada, L; Tauler, A				Real, Sebastian; Meo-Evoli, Nathalie; Espada, Lilia; Tauler, Albert			E2F1 Regulates Cellular Growth by mTORC1 Signaling	PLOS ONE			English	Article							TUBEROUS SCLEROSIS; ACTIVATION; EXPRESSION; RHEB; TSC2; PHOSPHORYLATION; PROLIFERATION; TARGET; GENES; LIFE	During cell proliferation, growth must occur to maintain homeostatic cell size. Here we show that E2F1 is capable of inducing growth by regulating mTORC1 activity. The activation of cell growth and mTORC1 by E2F1 is dependent on both E2F1's ability to bind DNA and to regulate gene transcription, demonstrating that a gene induction expression program is required in this process. Unlike E2F1, E2F3 is unable to activate mTORC1, suggesting that growth activity could be restricted to individual E2F members. The effect of E2F1 on the activation of mTORC1 does not depend on Akt. Furthermore, overexpression of TSC2 does not interfere with the effect of E2F1, indicating that the E2F1-induced signal pathway can compensate for the inhibitory effect of TSC2 on Rheb. Immunolocalization studies demonstrate that E2F1 induces the translocation of mTORC1 to the late endosome vesicles, in a mechanism dependent of leucine. E2F1 and leucine, or insulin, together affect the activation of S6K stronger than alone suggesting that they are complementary in activating the signal pathway. From these studies, E2F1 emerges as a key protein that integrates cell division and growth, both of which are essential for cell proliferation.	[Real, Sebastian; Meo-Evoli, Nathalie; Espada, Lilia; Tauler, Albert] Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain	University of Barcelona	Real, S (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain.	tauler@ub.edu	Tauler, Albert/D-5183-2014	Tauler, Albert/0000-0003-0193-0667; Espada, Lilia/0000-0002-6218-7785	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain [BFU2009-099339]; MAE; University Barcelona	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MAE(Ministry of Foreign Affairs and International Cooperation (Italy)); University Barcelona	This work was supported by Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain (BFU2009-099339), and the publication cost was provided by Vicerectorat de Politica Docent i Cientifica de la Universitat de Barcelona. Sebastian Real and Lilia Espada were the recipients of a fellowship from MAE and University Barcelona, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke Maurice, 2010, BMC Res Notes, V3, P58, DOI 10.1186/1756-0500-3-58; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hlaing M, 2002, J BIOL CHEM, V277, P23794, DOI 10.1074/jbc.M201980200; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Korotayev K, 2008, CELL SIGNAL, V20, P1221, DOI 10.1016/j.cellsig.2008.02.012; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; LI L, 2009, GEF MOL CELL, V35, P563; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	35	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16163	10.1371/journal.pone.0016163	http://dx.doi.org/10.1371/journal.pone.0016163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283628	gold, Green Published, Green Submitted			2022-12-27	WOS:000286523400024
J	Matsumaru, D; Haraguchi, R; Miyagawa, S; Motoyama, J; Nakagata, N; Meijlink, F; Yamada, G				Matsumaru, Daisuke; Haraguchi, Ryuma; Miyagawa, Shinichi; Motoyama, Jun; Nakagata, Naomi; Meijlink, Frits; Yamada, Gen			Genetic Analysis of Hedgehog Signaling in Ventral Body Wall Development and the Onset of Omphalocele Formation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; TAMOXIFEN-INDUCIBLE FORM; SONIC-HEDGEHOG; LIMB DEVELOPMENT; VERTEBRATE LIMB; ABDOMINAL-WALL; EXTERNAL GENITALIA; CRANIOFACIAL DEVELOPMENT; RECOMBINASE ACTIVITY; POLARIZING ACTIVITY	Background: An omphalocele is one of the major ventral body wall malformations and is characterized by abnormally herniated viscera from the body trunk. It has been frequently found to be associated with other structural malformations, such as genitourinary malformations and digit abnormalities. In spite of its clinical importance, the etiology of omphalocele formation is still controversial. Hedgehog (Hh) signaling is one of the essential growth factor signaling pathways involved in the formation of the limbs and urogenital system. However, the relationship between Hh signaling and ventral body wall formation remains unclear. Methodology/Principal Findings: To gain insight into the roles of Hh signaling in ventral body wall formation and its malformation, we analyzed phenotypes of mouse mutants of Sonic hedgehog (Shh), GLI-Kruppel family member 3 (Gli3) and Aristaless-like homeobox 4 (Alx4). Introduction of additional Alx4(Lst) mutations into the Gli3(Xt/Xt) background resulted in various degrees of severe omphalocele and pubic diastasis. In addition, loss of a single Shh allele restored the omphalocele and pubic symphysis of Gli3(Xt/+); Alx4(Lst/Lst) embryos. We also observed ectopic Hh activity in the ventral body wall region of Gli3(Xt/Xt) embryos. Moreover, tamoxifen-inducible gain-of-function experiments to induce ectopic Hh signaling revealed Hh signal dose-dependent formation of omphaloceles. Conclusions/Significance: We suggest that one of the possible causes of omphalocele and pubic diastasis is ectopically-induced Hh signaling. To our knowledge, this would be the first demonstration of the involvement of Hh signaling in ventral body wall malformation and the genetic rescue of omphalocele phenotypes.	[Matsumaru, Daisuke; Haraguchi, Ryuma; Miyagawa, Shinichi; Yamada, Gen] Kumamoto Univ, IMEG, Dept Organ Format, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Motoyama, Jun] Doshisha Univ, Dept Med Life Syst, Kyoto 602, Japan; [Nakagata, Naomi] Kumamoto Univ, CARD, Kumamoto, Japan; [Meijlink, Frits] Univ Med Ctr, Utrecht, Netherlands; [Meijlink, Frits] KNAW, Hubrecht Inst, Utrecht, Netherlands	Kumamoto University; Doshisha University; Kumamoto University; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Matsumaru, D (corresponding author), Kumamoto Univ, IMEG, Dept Organ Format, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan.	gensan@gpo.kumamoto-u.ac.jp		Matsumaru, Daisuke/0000-0002-1832-624X; Yamada, Gen/0000-0001-6160-2660; Nakagata, Naomi/0000-0002-5737-9993	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22132006]; Ministry of Health, Labor, and Welfare, Japan [20-3]; National Institutes of Health [R01ES016597]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Grant-in-Aid for Scientific Research B, for Scientific Research on Innovative Areas; Molecular mechanisms for establishment of sex differences (22132006), and the Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a grant for Child Health and Development (20-3) and Health Sciences Research Grant from the Ministry of Health, Labor, and Welfare, Japan. This work was also supported by National Institutes of Health Grant R01ES016597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIRON R, 1995, ULTRASOUND OBST GYN, V6, P256, DOI 10.1046/j.1469-0705.1995.06040256.x; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aspelund G, 2006, CURR PAEDIAT, V16, P192; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bassett EA, 2010, HUM MOL GENET, V19, P1791, DOI 10.1093/hmg/ddq060; Bohring A, 2002, AM J MED GENET, V107, P72, DOI 10.1002/ajmg.10084; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Brewer S, 2004, DEV BIOL, V267, P399, DOI 10.1016/j.ydbio.2003.11.021; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Carey JC, 2001, AM J MED GENET, V99, P270, DOI 10.1002/ajmg.1211; Chan KK, 2005, DEV DYNAM, V233, P473, DOI 10.1002/dvdy.20347; Chan KK, 2003, J CELL BIOCHEM, V90, P573, DOI 10.1002/jcb.10656; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Ebert AK, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-23; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feldkamp ML, 2007, AM J MED GENET A, V143A, P639, DOI 10.1002/ajmg.a.31578; Gage PJ, 1999, DEVELOPMENT, V126, P4643; GLASSER JG, 2009, OMPHALOCELE GASTROSC; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Habib Hasina, 2007, Congenital Anomalies, V47, P53, DOI 10.1111/j.1741-4520.2007.00143.x; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; Hilton T, 2010, J BIOL CHEM, V285, P11129, DOI 10.1074/jbc.M109.087429; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Katz LA, 2004, AM J MED GENET A, V130A, P277, DOI 10.1002/ajmg.a.30329; KAUFMAN MH, 1992, ATLAS MOUSE DEV, pR16; KAWAMURA DM, 1997, ABDOMEN SUPERFICIAL, pR15; Kim PCW, 2001, J PEDIATR SURG, V36, P381, DOI 10.1053/jpsu.2001.20722; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Langer JC, 2003, WORLD J SURG, V27, P117, DOI 10.1007/s00268-002-6746-1; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Ludwig M, 2009, BIRTH DEFECTS RES A, V85, P509, DOI 10.1002/bdra.20557; Malashichev Y, 2008, CELL TISSUE RES, V331, P595, DOI 10.1007/s00441-007-0556-6; Mann S, 2008, PRENATAL DIAG, V28, P626, DOI 10.1002/pd.2008; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; McGlinn E, 2006, CURR OPIN GENET DEV, V16, P426, DOI 10.1016/j.gde.2006.06.013; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Mingin GC, 2002, PEDIATRICS, V110, P1193, DOI 10.1542/peds.110.6.1193; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; NOVICK C, 2009, POLYDACTYLY FOOT; Ogi H, 2005, ANAT REC PART A, V284A, P424, DOI 10.1002/ar.a.20180; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Panman L, 2005, INT J DEV BIOL, V49, P443, DOI 10.1387/ijdb.051984lp; Perovic S. V., 1999, ATLAS CONGENITAL ANO; Pomikal C, 2010, J MORPHOL, V271, P116, DOI 10.1002/jmor.10785; Qu SM, 1997, DEVELOPMENT, V124, P3999; Qu SM, 1998, DEVELOPMENT, V125, P2711; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sadler TW, 2010, SEMIN PEDIATR SURG, V19, P209, DOI 10.1053/j.sempedsurg.2010.03.006; SADLER TW, 2006, LANGMANS MED EMBRYOL, pR13; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; SNELL RS, 1992, CLIN ANATOMY MED STU, pR10; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPONSELLER PD, 1995, J BONE JOINT SURG AM, V77A, P177, DOI 10.2106/00004623-199502000-00003; Stepan H, 1999, ULTRASOUND OBST GYN, V13, P207, DOI 10.1046/j.1469-0705.1999.13030207.x; Sun J, 2007, BIOCHEM BIOPH RES CO, V360, P238, DOI 10.1016/j.bbrc.2007.06.049; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; TAEUSCH HW, 2005, AVERYS DIS NEWBORN, pR21; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Weber TR, 2002, CURR OPIN PEDIATR, V14, P491, DOI 10.1097/00008480-200208000-00023; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Williams T, 2008, AM J MED GENET C, V148C, P186, DOI 10.1002/ajmg.c.30179; YAZBECK S, 1986, J PEDIATR SURG, V21, P761, DOI 10.1016/S0022-3468(86)80360-8; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	98	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16260	10.1371/journal.pone.0016260	http://dx.doi.org/10.1371/journal.pone.0016260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283718	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200045
J	Burggraaf, S; Bingham, J; Payne, J; Kimpton, WG; Lowenthal, JW; Bean, AGD				Burggraaf, Simon; Bingham, John; Payne, Jean; Kimpton, Wayne G.; Lowenthal, John W.; Bean, Andrew G. D.			Increased Inducible Nitric Oxide Synthase Expression in Organs Is Associated with a Higher Severity of H5N1 Influenza Virus Infection	PLOS ONE			English	Article							SERUM-AMYLOID-A; VIRAL REPLICATION; MAMMALIAN-CELLS; PATHOGENICITY; CHICKENS; DUCKS; GAMMA; MACROPHAGES; DISEASE; PROTEIN	Background: The mechanisms of disease severity caused by H5N1 influenza virus infection remain somewhat unclear. Studies have indicated that a high viral load and an associated hyper inflammatory immune response are influential during the onset of infection. This dysregulated inflammatory response with increased levels of free radicals, such as nitric oxide (NO), appears likely to contribute to disease severity. However, enzymes of the nitric oxide synthase (NOS) family such as the inducible form of NOS (iNOS) generate NO, which serves as a potent anti-viral molecule to combat infection in combination with acute phase proteins and cytokines. Nevertheless, excessive production of iNOS and subsequent high levels of NO during H5N1 infection may have negative effects, acting with other damaging oxidants to promote excessive inflammation or induce apoptosis. Methodology/Principal Findings: There are dramatic differences in the severity of disease between chickens and ducks following H5N1 influenza infection. Chickens show a high level of mortality and associated pathology, whilst ducks show relatively minor symptoms. It is not clear how this varying pathogenicty comes about, although it has been suggested that an overactive inflammatory immune response to infection in the chicken, compared to the duck response, may be to blame for the disparity in observed pathology. In this study, we identify and investigate iNOS gene expression in ducks and chickens during H5N1 influenza infection. Infected chickens show a marked increase in iNOS expression in a wide range of organs. Contrastingly, infected duck tissues have lower levels of tissue related iNOS expression. Conclusions/Significance: The differences in iNOS expression levels observed between chickens and ducks during H5N1 avian influenza infection may be important in the inflammatory response that contributes to the pathology. Understanding the regulation of iNOS expression and its role during H5N1 influenza infection may provide insights for the development of new therapeutic strategies in the treatment of avian influenza infection.	[Burggraaf, Simon; Bingham, John; Payne, Jean; Lowenthal, John W.; Bean, Andrew G. D.] CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia; [Burggraaf, Simon; Kimpton, Wayne G.] Univ Melbourne, Sch Vet Sci, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne	Burggraaf, S (corresponding author), CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia.	simon.burggraaf@csiro.au	Bingham, John/H-8591-2013; burggraaf, simon/H-3879-2011; Bean, Andrew G/H-8664-2013; Bean, Andy GD/D-1198-2011; lowenthal, john w/G-4459-2010	Bingham, John/0000-0003-2360-3827; Bean, Andrew G/0000-0002-4585-3811; lowenthal, john w/0000-0002-0548-2497; Kimpton, Wayne/0000-0002-1518-2316	CSIRO (Commonwealth Science and Industrial Research Organisation); ACIAR (Australian Centre for International Agricultural Research)	CSIRO (Commonwealth Science and Industrial Research Organisation)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); ACIAR (Australian Centre for International Agricultural Research)(Australian Ctr Intl Agr Res)	This work was funded by CSIRO (Commonwealth Science and Industrial Research Organisation) and in part by ACIAR (Australian Centre for International Agricultural Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 1998, NITRIC OXIDE-BIOL CH, V2, P242, DOI 10.1006/niox.1998.0184; Ahmed KA, 2007, INT J IMMUNOGENET, V34, P445, DOI 10.1111/j.1744-313X.2007.00722.x; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bingham J, 2009, AVIAN PATHOL, V38, P267, DOI 10.1080/03079450903055371; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; BURGGRAAF S, 2011, INVESTIGATI IN PRESS; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen JJ, 2009, VIRUS RES, V146, P19, DOI 10.1016/j.virusres.2009.08.010; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DIGBY MR, 1995, J INTERF CYTOK RES, V15, P939, DOI 10.1089/jir.1995.15.939; EVANS CH, 1995, AGENT ACTION SUPPL, V47, P107; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Isoda N, 2006, ARCH VIROL, V151, P1267, DOI 10.1007/s00705-005-0723-6; Kacergius T, 2006, PHARMACOL REP, V58, P924; KARPALA AJ, 2010, J INTERFERO IN PRESS; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kishida N, 2005, ARCH VIROL, V150, P1383, DOI 10.1007/s00705-004-0473-x; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Kobayashi Y, 1996, AVIAN PATHOL, V25, P285, DOI 10.1080/03079459608419142; KONE BC, 1995, AM J PHYSIOL-RENAL, V269, pF718, DOI 10.1152/ajprenal.1995.269.5.F718; Kreil TR, 1996, VIROLOGY, V219, P304, DOI 10.1006/viro.1996.0252; Kwon YK, 2005, AVIAN PATHOL, V34, P367, DOI 10.1080/03079450500181257; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Lin AW, 1996, J BIOL CHEM, V271, P11911, DOI 10.1074/jbc.271.20.11911; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mase M, 2005, AVIAN DIS, V49, P582, DOI 10.1637/7364-041105R.1; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; MIWATA H, 1993, ARCH DIS CHILD, V68, P210, DOI 10.1136/adc.68.2.210; Mo IP, 1997, AVIAN DIS, V41, P125, DOI 10.2307/1592452; Moncada S, 1993, Schweiz Rundsch Med Prax, V82, P1154; Moran JM, 2005, J VIROL, V79, P10226, DOI 10.1128/JVI.79.16.10226-10236.2005; Nakamura K, 2008, AVIAN DIS, V52, P8, DOI 10.1637/8027-060607-Reg; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NATHAN C, 1994, J BIOL CHEM, V269, P13725; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; OKADA NY, 2009, NAT PREC; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Park CS, 1996, LIFE SCI, V59, P219, DOI 10.1016/0024-3205(96)00287-1; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Reiss CS, 1998, J VIROL, V72, P4547, DOI 10.1128/JVI.72.6.4547-4551.1998; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; STUEHR DJ, 1992, ADV ENZYMOL RAMB, V65, P287; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; Wasilenko JL, 2009, ARCH VIROL, V154, P969, DOI 10.1007/s00705-009-0399-4; WILDHIRT SM, 1995, INT J CARDIOL, V50, P253, DOI 10.1016/0167-5273(95)02385-A	52	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14561	10.1371/journal.pone.0014561	http://dx.doi.org/10.1371/journal.pone.0014561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283521	Green Published, gold			2022-12-27	WOS:000286520600007
J	Colon, M; Hernandez, F; Lopez, K; Quezada, H; Gonzalez, J; Lopez, G; Aranda, C; Gonzalez, A				Colon, Maritrini; Hernandez, Fabiola; Lopez, Karla; Quezada, Hector; Gonzalez, James; Lopez, Geovani; Aranda, Cristina; Gonzalez, Alicia			Saccharomyces cerevisiae Bat1 and Bat2 Aminotransferases Have Functionally Diverged from the Ancestral-Like Kluyveromyces lactis Orthologous Enzyme	PLOS ONE			English	Article							AMINO-ACID TRANSAMINASES; FUSEL ALCOHOL PRODUCTION; GLUTAMATE SYNTHASE; ESCHERICHIA-COLI; GENE DUPLICATION; SHUTTLE VECTORS; YEAST GENOME; MITOCHONDRIAL; METABOLISM; EXPRESSION	Background: Gene duplication is a key evolutionary mechanism providing material for the generation of genes with new or modified functions. The fate of duplicated gene copies has been amply discussed and several models have been put forward to account for duplicate conservation. The specialization model considers that duplication of a bifunctional ancestral gene could result in the preservation of both copies through subfunctionalization, resulting in the distribution of the two ancestral functions between the gene duplicates. Here we investigate whether the presumed bifunctional character displayed by the single branched chain amino acid aminotransferase present in K. lactis has been distributed in the two paralogous genes present in S. cerevisiae, and whether this conservation has impacted S. cerevisiae metabolism. Principal Findings: Our results show that the KlBat1 orthologous BCAT is a bifunctional enzyme, which participates in the biosynthesis and catabolism of branched chain aminoacids (BCAAs). This dual role has been distributed in S. cerevisiae Bat1 and Bat2 paralogous proteins, supporting the specialization model posed to explain the evolution of gene duplications. BAT1 is highly expressed under biosynthetic conditions, while BAT2 expression is highest under catabolic conditions. Bat1 and Bat2 differential relocalization has favored their physiological function, since biosynthetic precursors are generated in the mitochondria (Bat1), while catabolic substrates are accumulated in the cytosol (Bat2). Under respiratory conditions, in the presence of ammonium and BCAAs the bat1 Delta bat2 Delta double mutant shows impaired growth, indicating that Bat1 and Bat2 could play redundant roles. In K. lactis wild type growth is independent of BCAA degradation, since a Klbat1 Delta mutant grows under this condition. Conclusions: Our study shows that BAT1 and BAT2 differential expression and subcellular relocalization has resulted in the distribution of the biosynthetic and catabolic roles of the ancestral BCAT in two isozymes improving BCAAs metabolism and constituting an adaptation to facultative metabolism.	[Colon, Maritrini; Hernandez, Fabiola; Lopez, Karla; Gonzalez, James; Lopez, Geovani; Aranda, Cristina; Gonzalez, Alicia] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Quezada, Hector] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Colon, M (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	amanjarr@ifc.unam.mx	López-Ortiz, Geovani/AAV-4009-2021; Lopez-Ortiz, Geovani/AAX-8420-2021; Quezada, Hector/AAJ-8486-2021	Lopez-Ortiz, Geovani/0000-0003-0280-0012; Quezada, Hector/0000-0003-2663-4696; Gonzalez, Alicia/0000-0002-1276-5719; Gonzalez, James/0000-0002-7329-4025; Colon-Gonzalez, Maritrini/0000-0001-6821-1726	Direccion General de Asuntos del Personal Academico, UNAM [IN210706-3, N2042093]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [49970]; Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico [PIFUTP08-1654]; Macroproyecto de Tecnologias de la Informacion y La Computacion, UNAM	Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico; Macroproyecto de Tecnologias de la Informacion y La Computacion, UNAM(Universidad Nacional Autonoma de Mexico)	This study was funded by Direccion General de Asuntos del Personal Academico, UNAM, grant IN210706-3 and N2042093 (http://dgapa.unam.mx); Consejo Nacional de Ciencia y Tecnologia (CONACYT), grant 49970 (http://www.conacyt.gob.mx/Paginas/default.aspx); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico, grant PIFUTP08-1654 (http://www.icyt.df.gob.mx) and Macroproyecto de Tecnologias de la Informacion y La Computacion, UNAM (http://www.mtuic.unam.mx). MC was recipient of a PhD Fellowship from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano A, 2005, MOL MICROBIOL, V57, P291, DOI 10.1111/j.1365-2958.2005.04689.x; BELTZER JP, 1988, J BIOL CHEM, V263, P368; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COGONI C, 1995, J BACTERIOL, V177, P792, DOI 10.1128/jb.177.3.792-798.1995; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Eden A, 2001, APPL MICROBIOL BIOT, V55, P296, DOI 10.1007/s002530000506; Force A, 1999, GENETICS, V151, P1531; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kispal G, 1996, J BIOL CHEM, V271, P24458, DOI 10.1074/jbc.271.40.24458; LEEPENG FC, 1979, J BACTERIOL, V139, P339, DOI 10.1128/JB.139.2.339-345.1979; Lilly M, 2006, FEMS YEAST RES, V6, P726, DOI 10.1111/j.1567-1364.2006.00057.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch M, 2000, GENETICS, V154, P459; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Navarro-Olmos R, 2010, MOL BIOL CELL, V21, P489, DOI 10.1091/mbc.E09-06-0472; Okada K, 2001, BIOCHEMISTRY-US, V40, P7453, DOI 10.1021/bi010384l; Prohl C, 2000, METHOD ENZYMOL, V324, P365; Quezada H, 2008, MICROBIOL-SGM, V154, P1656, DOI 10.1099/mic.0.2008/017103-0; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RYAN ED, 1973, J BACTERIOL, V116, P222, DOI 10.1128/JB.116.1.222-225.1973; Sambrook J., 2002, MOL CLONING LAB MANU; Schoondermark-Stolk SA, 2005, FEMS YEAST RES, V5, P757, DOI 10.1016/j.femsyr.2005.02.005; SIKORSKI RS, 1989, GENETICS, V122, P19; STRUHL K, 1981, J MOL BIOL, V152, P535, DOI 10.1016/0022-2836(81)90267-9; TAYLOR EJ, MOL BIOL CELL, V21, P2202; Valenzuela L, 2001, J BACTERIOL, V183, P2331, DOI 10.1128/JB.183.7.2331-2334.2001; Valenzuela L, 1998, J BACTERIOL, V180, P3533, DOI 10.1128/JB.180.14.3533-3540.1998; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yennawar N, 2001, ACTA CRYSTALLOGR D, V57, P506, DOI 10.1107/S0907444901001925	37	45	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16099	10.1371/journal.pone.0016099	http://dx.doi.org/10.1371/journal.pone.0016099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267457	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500038
J	Poravuth, Y; Socheat, D; Rueangweerayut, R; Uthaisin, C; Phyo, AP; Valecha, N; Rao, BHK; Tjitra, E; Purnama, A; Borghini-Fuhrer, I; Duparc, S; Shin, CS; Fleckenstein, L				Poravuth, Yi; Socheat, Duong; Rueangweerayut, Ronnatrai; Uthaisin, Chirapong; Phyo, Aung Pyae; Valecha, Neena; Rao, B. H. Krishnamoorthy; Tjitra, Emiliana; Purnama, Asep; Borghini-Fuhrer, Isabelle; Duparc, Stephan; Shin, Chang-Sik; Fleckenstein, Lawrence			Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; ANTIMALARIAL-DRUGS; ARTEMISININ; RESISTANCE; EFFICACY; SUSCEPTIBILITY; RESPONSES; PATTERNS	Background: New antimalarials are needed for P. vivax and P. falciparum malaria. This study compared the efficacy and safety of pyronaridine-artesunate with that of chloroquine for the treatment of uncomplicated P. vivax malaria. Methods and Findings: This phase III randomized, double-blind, non-inferiority trial included five centers across Cambodia, Thailand, India, and Indonesia. In a double-dummy design, patients (aged >3-<= 60 years) with microscopically confirmed P. vivax mono-infection were randomized (1:1) to receive pyronaridine-artesunate (target dose 7.2:2.4 mg/kg to 13.8:4.6 mg/kg) or chloroquine (standard dose) once daily for three days. Each treatment group included 228 randomized patients. Outcomes for the primary endpoint, Day-14 cure rate in the per-protocol population, were 99.5%, (217/218; 95%CI 97.5, 100) with pyronaridine-artesunate and 100% (209/209; 95%CI 98.3, 100) with chloroquine. Pyronaridine was non-inferior to chloroquine: treatment difference -0.5% (95%CI -2.6, 1.4), i.e., the lower limit of the 2-sided 95%CI for the treatment difference was greater than -10%. Pyronaridine-artesunate cure rates were non-inferior to chloroquine for Days 21, 28, 35 and 42. Parasite clearance time was shorter with pyronaridine-artesunate (median 23.0 h) versus chloroquine (32.0 h; p<0.0001), as was fever clearance time (median 15.9 h and 23.8 h, respectively; p = 0.0017). Kaplan-Meier estimates of post-baseline P. falciparum infection incidence until Day 42 were 2.5% with pyronaridine-artesunate, 6.1% with chloroquine (p = 0.048, log-rank test). Post-baseline P. vivax or P. falciparum infection incidence until Day 42 was 6.8% and 12.4%, respectively (p = 0.022, log rank test). There were no deaths. Adverse events occurred in 92/228 (40.4%) patients with pyronaridine-artesunate and 72/228 (31.6%) with chloroquine. Mild and transient increases in hepatic enzymes were observed for pyronaridine-artesunate. Conclusion: Pyronaridine-artesunate efficacy in acute uncomplicated P. vivax malaria was at least that of chloroquine. As pyronaridine-artesunate is also efficacious against P. falciparum malaria, this combination has potential utility as a global antimalarial drug. Trial registration: Clinicaltrials.gov NCT00440999	[Poravuth, Yi; Socheat, Duong] Natl Malaria Ctr, Phnom Penh, Cambodia; [Rueangweerayut, Ronnatrai] Mae Sot Gen Hosp, Dept Internal Med, Mae Sot, Thailand; [Uthaisin, Chirapong] Mae Ramat Hosp, Dept Internal Med, Mae Ramat, Thailand; [Phyo, Aung Pyae] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Valecha, Neena] Natl Inst Malaria Res, Delhi, India; [Rao, B. H. Krishnamoorthy] Wenlock Dist Hosp, Kasturba Med Coll, Mangalore, India; [Tjitra, Emiliana] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Purnama, Asep] TC Hillers Gen Hosp, Dept Internal Med, Maumere, Indonesia; [Borghini-Fuhrer, Isabelle; Duparc, Stephan] Med Malaria Venture, Geneva, Switzerland; [Shin, Chang-Sik] Shin Poong Pharmaceut Co, Seoul, South Korea; [Fleckenstein, Lawrence] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA	Mahidol University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; University of Iowa	Poravuth, Y (corresponding author), Natl Malaria Ctr, Phnom Penh, Cambodia.	borghinii@mmv.org	Phyo, Aung Pyae/GYU-6181-2022; Valecha, Neena/B-9830-2011; Duparc, Stephan/AAH-8758-2020; Phyo, Aung Pyae/K-2413-2019	Phyo, Aung Pyae/0000-0002-0383-9624; Duparc, Stephan/0000-0002-9649-4847; Phyo, Aung Pyae/0000-0002-0383-9624; Fleckenstein, Lawrence/0000-0001-5320-4531				Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Batty KT, 1998, AM J TROP MED HYG, V59, P823, DOI 10.4269/ajtmh.1998.59.823; Chai Jong-Yil, 1999, Korean Journal of Parasitology, V37, P129, DOI 10.3347/kjp.1999.37.3.129; deVries PJ, 1996, DRUGS, V52, P818, DOI 10.2165/00003495-199652060-00004; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; FU S, 1991, PARASITOL TODAY, V7, P310, DOI 10.1016/0169-4758(91)90267-R; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hamedi Y., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P570; Krudsood Srivicha, 2007, Korean Journal of Parasitology, V45, P111, DOI 10.3347/kjp.2007.45.2.111; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P205, DOI 10.4269/ajtmh.1996.54.205; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Parakh A, 2009, ANN TROP PAEDIATR, V29, P253, DOI 10.1179/027249309X12547917868844; Park JW, 2009, KOREAN J PARASITOL, V47, pS39, DOI 10.3347/kjp.2009.47.S.S39; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Price RN, 2010, ANTIMICROB AGENTS CH, V54, P5146, DOI 10.1128/AAC.00801-10; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000; Ramharter M, 2008, J INFECT DIS, V198, P911, DOI 10.1086/591096; Ribeiro I R, 1998, Med Trop (Mars), V58, P50; Ringwald P, 1998, CLIN INFECT DIS, V26, P946, DOI 10.1086/513942; Ringwald P, 1996, LANCET, V347, P24, DOI 10.1016/S0140-6736(96)91558-5; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SHAO BR, 1990, CHINESE MED J-PEKING, V103, P428; Sleigh AC, 1998, B WORLD HEALTH ORGAN, V76, P265; Sutanto I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-52; Sutanto I, 2009, AM J TROP MED HYG, V81, P338, DOI 10.4269/ajtmh.2009.81.338; Suwandittakul N, 2009, KOREAN J PARASITOL, V47, P139, DOI 10.3347/kjp.2009.47.2.139; Syafruddin D, 2005, AM J TROP MED HYG, V72, P174, DOI 10.4269/ajtmh.2005.72.174; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tshefu AK, 2010, LANCET, V375, P1457, DOI 10.1016/S0140-6736(10)60322-4; Valecha N, 2009, ACTA TROP, V111, P21, DOI 10.1016/j.actatropica.2009.01.013; Valecha N, 2006, T ROY SOC TROP MED H, V100, P831, DOI 10.1016/j.trstmh.2005.11.012; Valecha N, 2009, AM J TROP MED HYG, V81, P758, DOI 10.4269/ajtmh.2009.09-0348; Vathsala PG, 2004, AM J TROP MED HYG, V70, P256; WHO, 2002, MON ANT DRUG RES REP; WHO, 2010, GUID TREATM MAL, V2nd; *WHO REG OFF W PAC, 2004, INT WORKSH CONTR VIV; Woitsch B, 2007, WIEN KLIN WOCHENSCHR, V119, P76, DOI 10.1007/s00508-007-0872-6	44	66	68	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14501	10.1371/journal.pone.0014501	http://dx.doi.org/10.1371/journal.pone.0014501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267072	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500003
J	Wan, QH; Zhang, P; Ni, XW; Wu, HL; Chen, YY; Kuang, YY; Ge, YF; Fang, SG				Wan, Qiu-Hong; Zhang, Pei; Ni, Xiao-Wei; Wu, Hai-Long; Chen, Yi-Yan; Kuang, Ye-Ye; Ge, Yun-Fa; Fang, Sheng-Guo			A Novel HURRAH Protocol Reveals High Numbers of Monomorphic MHC Class II Loci and Two Asymmetric Multi-Locus Haplotypes in the Pere David's Deer	PLOS ONE			English	Article							DRB GENES; MATE CHOICE; IDENTIFICATION; SEQUENCE; DNA; ORGANIZATION; POLYMORPHISM; EXPRESSION; DIVERSITY; SOFTWARE	The Pere David's deer is a highly inbred, but recovered, species, making it interesting to consider their adaptive molecular evolution from an immunological perspective. Prior to this study, genomic sequencing was the only method for isolating all functional MHC genes within a certain species. Here, we report a novel protocol for isolating MHC class II loci from a species, and its use to investigate the adaptive evolution of this endangered deer at the level of multi-locus haplotypes. This protocol was designated "HURRAH" based on its various steps and used to estimate the total number of MHC class II loci. We confirmed the validity of this novel protocol in the giant panda and then used it to examine the Pere David's deer. Our results revealed that the Pere David's deer possesses nine MHC class II loci and therefore has more functional MHC class II loci than the eight genome-sequenced mammals for which full MHC data are currently available. This could potentially account at least in part for the strong survival ability of this species in the face of severe bottlenecking. The results from the HURRAH protocol also revealed that: (1) All of the identified MHC class II loci were monomorphic at their antigen-binding regions, although DRA was dimorphic at its cytoplasmic tail; and (2) these genes constituted two asymmetric functional MHC class II multi-locus haplotypes: DRA1*01, DRB1 similar to DRB3 similar to DQA1 similar to DQB2 (H1) and DRA1*02 similar to DRB2 similar to DRB4 similar to DQA2 similar to DQB1 (H2). The latter finding indicates that the current members of the deer species have lost the powerful ancestral MHC class II haplotypes of nine or more loci, and have instead fixed two relatively weak haplotypes containing five genes. As a result, the Pere David's deer are currently at risk for increased susceptibility to infectious pathogens.	[Wan, Qiu-Hong; Zhang, Pei; Ni, Xiao-Wei; Wu, Hai-Long; Chen, Yi-Yan; Kuang, Ye-Ye; Ge, Yun-Fa; Fang, Sheng-Guo] Zhejiang Univ, State Conservat Ctr Gene Resources Endangered Wil, Key Lab Conservat Biol Endangered Wildlife, Minist Educ,Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Hai-Long] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China	Zhejiang University; Anhui Normal University	Wan, QH (corresponding author), Zhejiang Univ, State Conservat Ctr Gene Resources Endangered Wil, Key Lab Conservat Biol Endangered Wildlife, Minist Educ,Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	sgfanglab@zju.edu.cn			National Basic Research Program of China (973 program) [2007CB411600]; State Forestry Administration; Fundamental Research Funds for the Central Universities of P. R. China	National Basic Research Program of China (973 program)(National Basic Research Program of China); State Forestry Administration; Fundamental Research Funds for the Central Universities of P. R. China	This work was supported by a grant from the National Basic Research Program of China (the 973 program; grant no. 2007CB411600), a special grant from the State Forestry Administration, and the Fundamental Research Funds for the Central Universities of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 2006, ANIM SCI J, V77, P127, DOI 10.1111/j.1740-0929.2006.00331.x; Babik W, 2005, MOL ECOL, V14, P4249, DOI 10.1111/j.1365-294X.2005.02751.x; Ballingall KT, 1997, IMMUNOGENETICS, V46, P237, DOI 10.1007/s002510050268; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BEIDLER JL, 1982, ANAL BIOCHEM, V126, P374, DOI 10.1016/0003-2697(82)90530-9; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Bowen L, 2002, IMMUNOGENETICS, V54, P332, DOI 10.1007/s00251-002-0472-6; Childers CP, 2006, ANIM GENET, V37, P121, DOI 10.1111/j.1365-2052.2005.01395.x; Croisetiere S, 2008, MOL IMMUNOL, V45, P3107, DOI 10.1016/j.molimm.2008.03.007; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Ding Y-H, 2004, CHINESE MILU RES; Ellis SA, 1999, IMMUNOL REV, V167, P159, DOI 10.1111/j.1600-065X.1999.tb01389.x; Fernandes CA, 2008, CONSERV GENET, V9, P681, DOI 10.1007/s10592-007-9364-5; Gutierrez-Espeleta GA, 2001, HEREDITY, V86, P439, DOI 10.1046/j.1365-2540.2001.00853.x; Heimeier D, 2009, MAR MAMMAL SCI, V25, P68, DOI 10.1111/j.1748-7692.2008.00244.x; Heinzelmann L, 2009, J MAR BIOL ASSOC UK, V89, P1009, DOI 10.1017/S0025315409003245; Herrmann-Hoesing LM, 2008, IMMUNOGENETICS, V60, P167, DOI 10.1007/s00251-008-0275-5; Jager I, 2007, J EVOLUTION BIOL, V20, P2005, DOI 10.1111/j.1420-9101.2007.01366.x; Jiang ZG, 2000, WILDLIFE SOC B, V28, P681; Jiao Y, 2008, CONSERV GENET, V9, P771, DOI 10.1007/s10592-007-9388-x; JONES ML, 1983, BIOL MANAGEMENT EXTI; KLEIN J, 1986, NATURAL HIST MAJOR H; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lancaster Alex, 2003, Pac Symp Biocomput, P514; Loiseau C, 2008, ECOL LETT, V11, P258, DOI 10.1111/j.1461-0248.2007.01141.x; Marsh S. G. E., 2000, HLA FACTSBOOK; Meyer-Lucht Y, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-39; Mikko S, 1999, IMMUNOL REV, V167, P169, DOI 10.1111/j.1600-065X.1999.tb01390.x; Niranjan SK, 2009, VET IMMUNOL IMMUNOP, V130, P268, DOI 10.1016/j.vetimm.2009.02.006; OHTAISHI N, 1990, MAMMAL REV, V20, P125, DOI 10.1111/j.1365-2907.1990.tb00108.x; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWEN L, 1998, SEQUENCE MOUSE MAJOR; Sambrook J, 2001, MOL CLONING LAB MANU; Schaschl H, 2004, DEV COMP IMMUNOL, V28, P265, DOI 10.1016/j.dci.2003.08.003; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Swarbrick PA, 1997, ANIM GENET, V28, P49, DOI 10.1111/j.1365-2052.1997.00063.x; SWARBRICK PA, 1995, IMMUNOGENETICS, V42, P1, DOI 10.1007/BF00164981; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Takada T, 1998, IMMUNOGENETICS, V48, P408, DOI 10.1007/s002510050452; Vage D. I., 1994, Animal Biotechnology, V5, P65, DOI 10.1080/10495399409525804; WALLACE AJ, 2002, METHODS MOL BIOL, V187; Wan QH, 2003, ANIM REPROD SCI, V77, P1, DOI 10.1016/S0378-4320(02)00249-X; Wan QH, 2003, FORENSIC SCI INT, V131, P75, DOI 10.1016/S0379-0738(02)00398-5; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; Wu HL, 2008, CONSERV GENET, V9, P1679, DOI 10.1007/s10592-008-9523-3; Yang WC, 2007, ZOOL STUD, V46, P664; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zhang Lin-yuan, 2010, Sichuan Journal of Zoology, V29, P505	55	25	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14518	10.1371/journal.pone.0014518	http://dx.doi.org/10.1371/journal.pone.0014518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267075	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500005
J	Aziz, A; Harrop, SP; Bishop, NE				Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.			DIA1R Is an X-Linked Gene Related to Deleted In Autism-1	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MENTAL-RETARDATION; INTERSTITIAL DELETION; MICRODELETION SYNDROMES; LONG ARM; INTELLECTUAL DISABILITY; FUNCTIONAL ANNOTATION; ENDOPLASMIC-RETICULUM; ASPERGER-SYNDROME; CHILDHOOD AUTISM	Background: Autism spectrum disorders (ASDs) are frequently occurring disorders diagnosed by deficits in three core functional areas: social skills, communication, and behaviours and/or interests. Mental retardation frequently accompanies the most severe forms of ASDs, while overall ASDs are more commonly diagnosed in males. Most ASDs have a genetic origin and one gene recently implicated in the etiology of autism is the Deleted-In-Autism-1 (DIA1) gene. Methodology/Principal Findings: Using a bioinformatics-based approach, we have identified a human gene closely related to DIA1, we term DIA1R (DIA1-Related). While DIA1 is autosomal (chromosome 3, position 3q24), DIA1R localizes to the X chromosome at position Xp11.3 and is known to escape X-inactivation. The gene products are of similar size, with DIA1 encoding 430, and DIA1R 433, residues. At the amino acid level, DIA1 and DIA1R are 62% similar overall (28% identical), and both encode signal peptides for targeting to the secretory pathway. Both genes are ubiquitously expressed, including in fetal and adult brain tissue. Conclusions/Significance: Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR. Together, these results support a model where the DIA1 and DIA1R gene products regulate molecular traffic through the cellular secretory pathway or affect the function of secreted factors, and functional deficits cause disorders with ASD-like symptoms and/or mental retardation.	[Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia	La Trobe University	Aziz, A (corresponding author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia.	N.Bishop@latrobe.edu.au			La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	NEB and SPH were supported by La Trobe University and AA by La Trobe University, the Malaysian Ministry of Higher Education, and the Islamic Science University of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; *ADDMNSYPI, 2009, MMWR-MORBID MORTAL W, V58, P1; ALBERCH P, 1991, GENETICA, V84, P5, DOI 10.1007/BF00123979; ALMATEEN M, 1986, AM J DIS CHILD, V140, P761, DOI 10.1001/archpedi.1986.02140220043029; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALVARADO M, 1987, AM J MED GENET, V27, P781, DOI 10.1002/ajmg.1320270406; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; AZIZ A, 2010, PLOS ONE IN PRESS; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bishop L, 1998, GASTROENTEROLOGY, V115, P1154, DOI 10.1016/S0016-5085(98)70086-1; Bonaglia MC, 2010, EUR J HUM GENET, V18, P1302, DOI 10.1038/ejhg.2010.115; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brito AR, 2009, J NEUROIMAGING, V19, P337, DOI 10.1111/j.1552-6569.2009.00366.x; Bryson SE, 2008, CAN J PSYCHIAT, V53, P449, DOI 10.1177/070674370805300710; Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088; Castellani ML, 2009, INT J IMMUNOPATH PH, V22, P15, DOI 10.1177/039463200902200103; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Cederlund M, 2008, J AUTISM DEV DISORD, V38, P72, DOI 10.1007/s10803-007-0364-6; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chiorino G, 2008, J BIOL REG HOMEOS AG, V22, P7; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Coury D, 2009, CURR OPIN PEDIATR, V21, P828, DOI 10.1097/MOP.0b013e328331eaaa; Creswell CS, 1999, NEUROCASE, V5, P511, DOI 10.1080/13554799908402746; Emanuele E, 2010, CLIN BIOCHEM, V43, P317, DOI 10.1016/j.clinbiochem.2009.10.005; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engstrom I, 2003, AUTISM, V7, P99, DOI 10.1177/1362361303007001008; Feenstra I, 2007, AM J MED GENET A, V143A, P1858, DOI 10.1002/ajmg.a.31850; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; FOMBONNE E, 1992, SOC PSYCH PSYCH EPID, V27, P203, DOI 10.1007/BF00789007; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; GILLBERG C, 1991, BRIT J PSYCHIAT, V158, P403, DOI 10.1192/bjp.158.3.403; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grafodatskaya D, 2010, J AM ACAD CHILD PSY, V49, P794, DOI 10.1016/j.jaac.2010.05.005; Groen W, 2010, J AM ACAD CHILD PSY, V49, P552, DOI 10.1016/j.jaac.2009.12.023; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Hayashi S, 2008, AM J MED GENET A, V146A, P2145, DOI 10.1002/ajmg.a.32433; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hoekstra RA, 2009, BRIT J PSYCHIAT, V195, P531, DOI 10.1192/bjp.bp.108.060889; Hoekstra RA, 2010, AM J MED GENET B, V153B, P994, DOI 10.1002/ajmg.b.31066; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Honda H, 2005, DEV MED CHILD NEUROL, V47, P10, DOI 10.1017/S0012162205000034; Hong D, 2009, DEV DISABIL RES REV, V15, P270, DOI 10.1002/ddrr.79; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2000, J ROY SOC MED, V93, P351, DOI 10.1177/014107680009300704; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Jensen LR, 2007, EUR J HUM GENET, V15, P68, DOI 10.1038/sj.ejhg.5201714; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kates WR, 2004, AM J PSYCHIAT, V161, P539, DOI 10.1176/appi.ajp.161.3.539; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Ko WT, 2003, AM J MED GENET A, V120A, P413, DOI 10.1002/ajmg.a.20149; KONSTANTAREAS MM, 1987, J AUTISM DEV DISORD, V17, P585, DOI 10.1007/BF01486973; Kooy R Frank, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-11; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Lee SN, 2006, J BIOL CHEM, V281, P3312, DOI 10.1074/jbc.M506635200; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lim DJ, 2000, VACCINE, V19, pS17, DOI 10.1016/S0264-410X(00)00273-5; Losh M, 2008, J NEUROPATH EXP NEUR, V67, P829, DOI 10.1097/NEN.0b013e318184482d; Lotter V., 1966, SOC PSYCHIATR, V1, P124, DOI [10.1007/BF00584048, https://doi.org/10.1007/BF00584048]; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mayes SD, 2004, J DEV PHYS DISABIL, V16, P257, DOI 10.1023/B:JODD.0000032301.07550.0e; McDougle CJ, 2005, J CLIN PSYCHIAT, V66, P9; McMahon HE, 2008, ENDOCRINOLOGY, V149, P812, DOI 10.1210/en.2007-1439; Meacock SL, 2000, ESSAYS BIOCHEM, V36, P1; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; National Center for Health Statistics, 2007, NAT SURV CHILDR HLTH; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Nishiyama T, 2009, J HUM GENET, V54, P56, DOI 10.1038/jhg.2008.3; Nordin V, 1996, DEV MED CHILD NEUROL, V38, P314; Nordin V, 1998, ACTA PSYCHIAT SCAND, V97, P99, DOI 10.1111/j.1600-0447.1998.tb09970.x; O'Hare A, 2009, ARCH DIS CHILDHOOD-E, V94, P161, DOI 10.1136/adc.2008.150490; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ortiz-Mantilla S, 2010, NEUROIMAGE, V49, P2791, DOI 10.1016/j.neuroimage.2009.10.029; Passmore M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-72; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PIVEN J, 1991, J AUTISM DEV DISORD, V21, P51, DOI 10.1007/BF02206997; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptak Carolyn, 2010, Dialogues Clin Neurosci, V12, P25; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Renty J, 2006, AUTISM, V10, P511, DOI 10.1177/1362361306066604; Reyniers E, 1999, AM J HUM GENET, V65, pA340; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; ROBIN NH, 1993, CLIN GENET, V44, P335; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Rosenhall U, 1999, J AUTISM DEV DISORD, V29, P349, DOI 10.1023/A:1023022709710; Rutter M, 2000, J ABNORM CHILD PSYCH, V28, P3, DOI 10.1023/A:1005113900068; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2010, NEUROSCI RES, V67, P197, DOI 10.1016/j.neures.2010.03.006; Sadakata T, 2009, CEREBELLUM, V8, P312, DOI 10.1007/s12311-009-0097-5; SANDEN MWN, 2003, NEUROSCI BIOBEHAV R, V27, P329; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Santos M, 2009, J CHILD NEUROL, V24, P49, DOI 10.1177/0883073808321043; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sbacchi S, 2010, CURR GENOMICS, V11, P136, DOI 10.2174/138920210790886880; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Shaffer LG, 2007, AM J MED GENET C, V145C, P335, DOI 10.1002/ajmg.c.30152; Shaffer LG, 2007, GENET MED, V9, P607, DOI 10.1097/GIM.0b013e3181484b49; Shapira Stuart K., 1998, Current Opinion in Pediatrics, V10, P622; Shi LM, 2004, EXPERT REV MOL DIAGN, V4, P761, DOI 10.1586/14737159.4.6.761; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Sivaswamy L, 2010, J CHILD NEUROL, V25, P1223, DOI 10.1177/0883073809358765; Skrzypski M, 2008, LUNG CANCER, V59, P147, DOI 10.1016/j.lungcan.2007.11.008; Slavotinek AM, 1997, J MED GENET, V34, P430, DOI 10.1136/jmg.34.5.430; Slavotinek AM, 2008, HUM GENET, V124, P1, DOI 10.1007/s00439-008-0513-9; SMITH DEP, 1988, J AUTISM DEV DISORD, V18, P53, DOI 10.1007/BF02211818; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takatalo M, 2008, DEV DYNAM, V237, P2243, DOI 10.1002/dvdy.21646; Takatalo MS, 2006, PROTEOMICS, V6, P3502, DOI 10.1002/pmic.200500516; Tang BL, 2008, BBA-MOL CELL RES, V1783, P169, DOI 10.1016/j.bbamcr.2007.11.011; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuchiya KJ, 2007, BIOL PSYCHIAT, V62, P1056, DOI 10.1016/j.biopsych.2006.12.018; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Verhoeven JS, 2010, NEURORADIOLOGY, V52, P3, DOI 10.1007/s00234-009-0583-y; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VORSTMAN JA, 2010, MOL PSYCHIA IN PRESS; WARING R, 2001, SULPHATION AUTISM WH; WARING R, 2001, Patent No. 2001077681; Wilkes T, 2007, OMICS, V11, P1, DOI 10.1089/omi.2006.0001; Wilkins MR, 1999, METH MOL B, V112, P531; World Health Organisation, 2007, INT STAT CLASS DIS R; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yen KH, 2009, BIOINFORMATICS, V25, P845, DOI 10.1093/bioinformatics/btn649; Zhang XY, 2004, AM J MED GENET A, V129A, P286, DOI 10.1002/ajmg.a.30121; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zweier C, 2005, EUR J MED GENET, V48, P360, DOI 10.1016/j.ejmg.2005.04.016	172	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14534	10.1371/journal.pone.0014534	http://dx.doi.org/10.1371/journal.pone.0014534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264219	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600009
J	Fucile, G; Di Biase, D; Nahal, H; La, G; Khodabandeh, S; Chen, YN; Easley, K; Christendat, D; Kelley, L; Provart, NJ				Fucile, Geoffrey; Di Biase, David; Nahal, Hardeep; La, Garon; Khodabandeh, Shokoufeh; Chen, Yani; Easley, Kante; Christendat, Dinesh; Kelley, Lawrence; Provart, Nicholas J.			ePlant and the 3D Data Display Initiative: Integrative Systems Biology on the World Wide Web	PLOS ONE			English	Article							GENE-EXPRESSION MAP; MULTIPLE SEQUENCE ALIGNMENT; MODEL DATA-ANALYSIS; DATA SETS; E-CELL; ARABIDOPSIS; VISUALIZATION; NETWORK; KNOWLEDGEBASE; ANNOTATION	Visualization tools for biological data are often limited in their ability to interactively integrate data at multiple scales. These computational tools are also typically limited by two-dimensional displays and programmatic implementations that require separate configurations for each of the user's computing devices and recompilation for functional expansion. Towards overcoming these limitations we have developed "ePlant" (http://bar.utoronto.ca/eplant) - a suite of open-source world wide web-based tools for the visualization of large-scale data sets from the model organism Arabidopsis thaliana. These tools display data spanning multiple biological scales on interactive three-dimensional models. Currently, ePlant consists of the following modules: a sequence conservation explorer that includes homology relationships and single nucleotide polymorphism data, a protein structure model explorer, a molecular interaction network explorer, a gene product subcellular localization explorer, and a gene expression pattern explorer. The ePlant's protein structure explorer module represents experimentally determined and theoretical structures covering >70% of the Arabidopsis proteome. The ePlant framework is accessed entirely through a web browser, and is therefore platform-independent. It can be applied to any model organism. To facilitate the development of three-dimensional displays of biological data on the world wide web we have established the "3D Data Display Initiative" (http://3ddi.org).	[Fucile, Geoffrey; Di Biase, David; Nahal, Hardeep; La, Garon; Khodabandeh, Shokoufeh; Chen, Yani; Christendat, Dinesh; Provart, Nicholas J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Nahal, Hardeep; Christendat, Dinesh; Provart, Nicholas J.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Easley, Kante] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Kelley, Lawrence] Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, Div Mol Biosci, Dept Life Sci, London, England	University of Toronto; University of Toronto; University of Toronto; Imperial College London	Fucile, G (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	nicholas.provart@utoronto.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an NSERC Discovery Grant to NJP. Open access publication costs were defrayed by the Ontario Genomics Institute Genomics Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, ECONOMIST, V392, P32; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Behr J., 2009, P 14 INT C 3D WEB TE, P127, DOI DOI 10.1145/1559764.1559784; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2009, PLANT CELL, V21, P1034, DOI 10.1105/tpc.109.066050; Card S. K., 1999, READINGS INFORM VISU; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coruzzi G, 2006, DEV BIOL, V295, P327, DOI 10.1016/j.ydbio.2006.04.025; de Tayrac M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-32; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Fucile G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000292; Garcia Castro Alexander, 2005, Appl Bioinformatics, V4, P157; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gehlenborg N, 2009, BIOINFORMATICS, V25, P682, DOI 10.1093/bioinformatics/btp005; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; *JMOL PROJ, JMOL OP SOURC JAV VI; Kahlem P, 2007, ANN NY ACAD SCI, V1115, P23, DOI 10.1196/annals.1407.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McDermott J, 2003, NUCLEIC ACIDS RES, V31, P3736, DOI 10.1093/nar/gkg550; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Merico D, 2009, NAT BIOTECHNOL, V27, P921, DOI 10.1038/nbt.1567; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Neerincx PBT, 2005, BRIEF BIOINFORM, V6, P178, DOI 10.1093/bib/6.2.178; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; O'Donoghue SI, 2010, NAT METHODS, V7, pS2, DOI 10.1038/nmeth.f.301; Paananen J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-26; Pavlopoulos GA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-104; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Sagotsky JA, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.39; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stephens SM, 2006, CURR OPIN DRUG DISC, V9, P240; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tsesmetzis N, 2008, PLANT CELL, V20, P1426, DOI 10.1105/tpc.108.057976; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wolfram Research Inc., 2008, MATH VERS 7 0; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Zhong W, 2007, DEVELOPMENT, V134, P3227, DOI 10.1242/dev.001073	72	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15237	10.1371/journal.pone.0015237	http://dx.doi.org/10.1371/journal.pone.0015237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249219	Green Submitted, Green Published, gold			2022-12-27	WOS:000286513100003
J	Hinchey, J; Jeon, BY; Alley, H; Chen, B; Goldberg, M; Derrick, S; Morris, S; Jacobs, WR; Porcelli, SA; Lee, S				Hinchey, Joseph; Jeon, Bo Y.; Alley, Holly; Chen, Bing; Goldberg, Michael; Derrick, Steven; Morris, Sheldon; Jacobs, William R., Jr.; Porcelli, Steven A.; Lee, Sunhee			Lysine Auxotrophy Combined with Deletion of the SecA2 Gene Results in a Safe and Highly Immunogenic Candidate Live Attenuated Vaccine for Tuberculosis	PLOS ONE			English	Article							CD8(+) T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL IMPAIRMENT; IMMUNE-RESPONSE; VIRAL-INFECTION; BCG; SMEGMATIS; DIAMINOPIMELATE; GENERATION; EFFECTOR	Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a major global health problem, despite the widespread use of the M. bovis Bacille Calmette-Guerin (BCG) vaccine and the availability of drug therapies. In recent years, the high incidence of coinfection of M. tuberculosis and HIV, as well as escalating problems associated with drug resistance, has raised ominous concerns with regard to TB control. Vaccination with BCG has not proven highly effective in controlling TB, and also has been associated with increasing concerns about the potential for the vaccine to cause disseminated mycobacterial infection in HIV infected hosts. Thus, the development of an efficacious and safe TB vaccine is generally viewed as a critical to achieving control of the ongoing global TB pandemic. In the current study, we have analyzed the vaccine efficacy of an attenuated M. tuberculosis strain that combines a mutation that enhances T cell priming (Delta secA2) with a strongly attenuating lysine auxotrophy mutation (Delta lysA). The Delta secA2 mutant was previously shown to be defective in the inhibition of apoptosis and markedly increased priming of antigen-specific CD8(+) T cells in vivo. Similarly, the Delta secA2 Delta lysA strain retained enhanced apoptosis and augmented CD8+ T cell stimulatory effects, but with a noticeably improved safety profile in immunosuppressed mice. Thus, the M. tuberculosis Delta secA2 Delta lysA mutant represents a live attenuated TB vaccine strain with the potential to deliver increased protection and safety compared to standard BCG vaccination.	[Hinchey, Joseph; Chen, Bing; Goldberg, Michael; Jacobs, William R., Jr.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Jeon, Bo Y.] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Alley, Holly; Lee, Sunhee] Duke Human Vaccine Inst, Durham, NC USA; [Derrick, Steven; Morris, Sheldon] US FDA, Ctr Biol Evaluat, Bethesda, MD 20014 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA; [Porcelli, Steven A.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yonsei University; Yonsei University Health System; US Food & Drug Administration (FDA); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Hinchey, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	sunhee.lee@duke.edu		Jacobs, William/0000-0003-3321-3080	NIH [U54 AI057157, AI063537]; Einstein Cancer Center (NIH/NCI) [NIH/NCI CA013330]; Einstein Center for AIDS Research (NIH) [NIH AI-51519]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063537, R21AI090434, R37AI026170, U54AI057157, P30AI051519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Center (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Center for AIDS Research (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SL was supported by NIH grant U54 AI057157. SAP and WRJ were supported by NIH Program Project Grant AI063537. Flow cytometry studies were carried out using core facilities supported by the Einstein Cancer Center (NIH/NCI CA013330) and the Einstein Center for AIDS Research (NIH AI-51519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Behar SM, 2007, EXPERT REV VACCINES, V6, P441, DOI 10.1586/14760584.6.3.441; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Consaul SA, 2003, FEMS MICROBIOL LETT, V225, P131, DOI 10.1016/S0378-1097(03)00502-0; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Ha SJ, 2008, IMMUNOL REV, V223, P317, DOI 10.1111/j.1600-065X.2008.00638.x; Hesseling AC, 2003, CLIN INFECT DIS, V37, P1226, DOI 10.1086/378298; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; KAUFMANN SH, LANCET, V375, P2110; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Serbina NV, 2001, INFECT IMMUN, V69, P4320, DOI 10.1128/IAI.69.7.4320-4328.2001; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Villarreal-Ramos B, 2009, EXPERT REV VACCINES, V8, P1531, DOI 10.1586/ERV.09.109; Vogel TU, 2001, J VIROL, V75, P2458, DOI 10.1128/JVI.75.5.2458-2461.2001; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Winau F, 2005, APOPTOSIS, V10, P707, DOI 10.1007/s10495-005-2940-6	32	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15857	10.1371/journal.pone.0015857	http://dx.doi.org/10.1371/journal.pone.0015857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264335	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100014
J	Efimova, O; Szankasi, P; Kelley, TW				Efimova, Olga; Szankasi, Philippe; Kelley, Todd W.			Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+Effector T Cells	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; REDUCED OXIDATIVE BURST; TGF-BETA; NADPH OXIDASE; RECEPTOR STIMULATION; AUTOIMMUNE-DISEASE; HYDROGEN-PEROXIDE; ARTHRITIS; MICE; PROLIFERATION	Background: Multiple mechanisms have been advanced to account for CD4+FOXP3+ regulatory T cell (Treg)-mediated suppression of CD4+ effector T cells (Teffs) but none appear to completely explain suppression. Previous data indicates that Tregs may affect the microenvironment redox state. Given the inherent redox sensitivity of T cells, we tested the hypothesis that oxidants may mediate the direct suppression of Teffs by Tregs. Methodology/Principal Findings: Tregs and Teffs were isolated from the spleens of wild type (WT) C57BL/6 mice or Ncf1(p47phox)-deficient C57BL/6 mice which lack NADPH oxidase function. Teffs were labeled with CFSE and co-cultured with unlabeled Tregs at varying Treg:Teff ratios in the presence of anti-CD3/CD28 coated beads for 3 days in suppression assays. Treg-mediated suppression was quantified by flow cytometric analysis of CFSE dilution in Teffs. The presence of the antioxidants n-acetylcysteine (NAC) or 2-mercaptoethanol or inhibitors of NADPH oxidase (diphenyleneiodonium and VAS-2870) resulted in reduced WT Treg-mediated suppression. The observed suppression was in part dependent upon TGF beta as it was partially blocked with neutralizing antibodies. The suppression of Teff proliferation induced by exogenous TGF beta treatment could be overcome with NAC. Ncf1-deficient Teff were slightly but significantly less sensitive than WT Teff to suppression by exogenous TGF beta. Ncf1-deficient Tregs suppressed Ncf1-deficient Teff very poorly compared to wild type controls. There was partial but incomplete reconstitution of suppression in assays with WT Tregs and Ncf1-deficient Teff. Conclusions/Significance: We present evidence that NADPH oxidase derived ROS plays a role in the direct Treg mediated suppression of CD4+ effector T cells in a process that is blocked by thiol-containing antioxidants, NADPH oxidase inhibitors or a lack of Ncf1 expression in Tregs and Teffs. Oxidants may represent a potential new target for therapeutic modulation of Treg function.	[Efimova, Olga; Kelley, Todd W.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Szankasi, Philippe; Kelley, Todd W.] ARUP Labs, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Efimova, O (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	todd.kelley@path.utah.edu			University of Utah	University of Utah	This work was supported by funds provided to the principle investigator by the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; CHRIST M, 1994, J IMMUNOL, V153, P1936; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Edinger AL, 2002, P NATL ACAD SCI USA, V99, P1107, DOI 10.1073/pnas.042707999; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hagenow K, 2009, J IMMUNOL, V183, P874, DOI 10.4049/jimmunol.0900966; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Huang A, 2006, COLORECTAL DIS, V8, P637, DOI 10.1111/j.1463-1318.2006.01030.x; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Itoh M, 1999, J IMMUNOL, V162, P5317; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kwon J, 2003, FREE RADICAL BIO MED, V35, P406, DOI 10.1016/S0891-5849(03)00318-6; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Meurer SK, 2005, BIOCHEM PHARMACOL, V70, P1026, DOI 10.1016/j.bcp.2005.07.001; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; YAN Z, 2010, J BIOL CHEM     1030; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	46	76	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16013	10.1371/journal.pone.0016013	http://dx.doi.org/10.1371/journal.pone.0016013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253614	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900035
J	Efroni, S; Ben-Hamo, R; Edmonson, M; Greenblum, S; Schaefer, CF; Buetow, KH				Efroni, Sol; Ben-Hamo, Rotem; Edmonson, Michael; Greenblum, Sharon; Schaefer, Carl F.; Buetow, Kenneth H.			Detecting Cancer Gene Networks Characterized by Recurrent Genomic Alterations in a Population	PLOS ONE			English	Article							DNA COPY-NUMBER; UBIQUITIN-PROTEASOME PATHWAY; HIGH-RESOLUTION ANALYSIS; HUMAN BREAST-TUMORS; PATIENT SURVIVAL; P53 STATUS; HYBRIDIZATION; EXPRESSION; MICROARRAYS; REVEALS	High resolution, system-wide characterizations have demonstrated the capacity to identify genomic regions that undergo genomic aberrations. Such research efforts often aim at associating these regions with disease etiology and outcome. Identifying the corresponding biologic processes that are responsible for disease and its outcome remains challenging. Using novel analytic methods that utilize the structure of biologic networks, we are able to identify the specific networks that are highly significantly, nonrandomly altered by regions of copy number amplification observed in a systems-wide analysis. We demonstrate this method in breast cancer, where the state of a subset of the pathways identified through these regions is shown to be highly associated with disease survival and recurrence.	[Efroni, Sol; Ben-Hamo, Rotem] Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel; [Schaefer, Carl F.; Buetow, Kenneth H.] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Edmonson, Michael; Greenblum, Sharon; Buetow, Kenneth H.] NIH, Lab Populat Genet, Bethesda, MD 20892 USA	Bar Ilan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Efroni, S (corresponding author), Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel.	buetowk@nih.gov	Efroni, Sol/I-6752-2012	Efroni, Sol/0000-0001-7927-6349	European Union; NATIONAL CANCER INSTITUTE [ZIHCO020005, ZIHBC010470] Funding Source: NIH RePORTER	European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SE is funded by the European Union through its International Reintegration Grants (IRG) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barlund M, 2000, CANCER RES, V60, P5340; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Buetow KH, 2002, CANCER CELL, V1, P315, DOI 10.1016/S1535-6108(02)00065-X; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cowell JK, 2003, ADV CANCER RES, V90, P91, DOI 10.1016/S0065-230X(03)90003-0; Edelman E, 2006, BIOINFORMATICS, V22, pE108, DOI 10.1093/bioinformatics/btl231; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fisher RA, 1932, STAT METHODS RES WOR, p[xiii, 11]; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; ISOLA JJ, 1995, AM J PATHOL, V147, P905; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Jeffrey SS, 2003, BREAST CANCER RES, V5, P320, DOI 10.1186/bcr655; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Schaefer C. F., 2007, PATHWAY INTERACTION; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Strausberg RL, 2002, CANCER INVEST, V20, P1038, DOI 10.1081/CNV-120005922; TANNER MM, 1994, CANCER RES, V54, P4257; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011	48	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14437	10.1371/journal.pone.0014437	http://dx.doi.org/10.1371/journal.pone.0014437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21283511	Green Submitted, Green Published, gold			2022-12-27	WOS:000286510500003
J	Xie, LS; Qiao, XH; Wu, YF; Tang, J				Xie, Lishi; Qiao, Xiaohang; Wu, Yanfang; Tang, Jie			beta-Arrestin1 Mediates the Endocytosis and Functions of Macrophage Migration Inhibitory Factor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR MIF; BETA-ARRESTIN; CYCLIN D1; MAP KINASE; ERK ACTIVATION; RECEPTOR; EXPRESSION; ANGIOGENESIS; CLATHRIN	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine, regulating inflammatory and immune responses. MIF binds to cell surface receptor CD74, resulting in both rapid and sustained ERK activation. It was reported that MIF-induced rapid ERK activation requires its co-receptor CD44. But the exact mechanism underlying sustained ERK activation is not well understood. In the current study, we described a detailed mechanism of MIF mediated sustained ERK activation. We found that beta-arrestin1, a scaffold protein involved in the activation of the MAPK cascade, interacts with CD74 upon MIF stimulation, resulting in CD74-mediated MIF endocytosis in a chlorpromazine (CPZ)-sensitive manner. beta-arrestin1 is also involved in endocytotic MIF signaling, leading to sustained ERK activation. Therefore beta-arrestin1 plays a central role in coupling MIF endocytosis to sustained ERK activation.	[Xie, Lishi; Qiao, Xiaohang; Wu, Yanfang; Tang, Jie] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China; [Xie, Lishi; Qiao, Xiaohang] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, LS (corresponding author), Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China.	jtang@ibp.ac.cn	Xie, Lishi/C-2334-2019	Xie, Lishi/0000-0003-2376-6685	Ministry of Science and Technololgy of China [2006CB504304]; Ministry of Health of China [008ZX10002-008]	Ministry of Science and Technololgy of China; Ministry of Health of China	This work was supported by grants from Ministry of Science and Technololgy of China (2006CB504304) and Ministry of Health of China (008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; COOPERSTOCK MS, 1974, ANTIMICROB AGENTS CH, V6, P422, DOI 10.1128/AAC.6.4.422; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; GEORGE M, 1962, P SOC EXP BIOL MED, V111, P514; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Kleemann R, 2002, J INTERF CYTOK RES, V22, P351, DOI 10.1089/107999002753675785; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Liang Wei, 2004, Current Drug Delivery, V1, P1, DOI 10.2174/1567201043480063; Liao H, 2003, J BIOL CHEM, V278, P76, DOI 10.1074/jbc.M208820200; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; MELOCHE S, 1992, FASEB J, V6, pA1852; Meyer-Siegler KL, 2002, CANCER-AM CANCER SOC, V94, P1449, DOI 10.1002/cncr.10354; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Santos LL, 2008, CLIN EXP IMMUNOL, V152, P372, DOI 10.1111/j.1365-2249.2008.03639.x; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; Wadgaonkar R, 2005, J CELL BIOCHEM, V95, P849, DOI 10.1002/jcb.20472; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	39	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16428	10.1371/journal.pone.0016428	http://dx.doi.org/10.1371/journal.pone.0016428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283538	Green Submitted, gold, Green Published			2022-12-27	WOS:000286661400051
J	Ghatak, P; Karmakar, K; Kasetty, S; Chatterji, D				Ghatak, Payel; Karmakar, Kajari; Kasetty, Sanjay; Chatterji, Dipankar			Unveiling the Role of Dps in the Organization of Mycobacterial Nucleoid	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL CHROMATIN; DNA CONDENSATION; SMEGMATIS DPS; PROTECTS DNA; SURVIVAL; STRESS; MICROSCOPY; MOLECULES; PROTEINS	In order to preserve genetic information in stress conditions, bacterial DNA is organized into higher order nucleoid structure. In this paper, with the help of Atomic Force Microscopy, we show the different structural changes in mycobacterial nucleoid at different points of growth in the presence of different concentrations of glucose in the medium. We also observe that in Mycobacterium smegmatis, two different Dps proteins (Dps1 and Dps2) promote two types of nucleoid organizations. At the late stationary phase, under low glucose availability, Dps1 binds to DNA to form a very stable toroid structure. On the other hand, under the same condition, Dps2-DNA complex forms an incompletely condensed toroid and finally forms a further stable coral reef structure in the presence of RNA. This coral reef structure is stable in high concentration of bivalent ion like Mg2+.	[Ghatak, Payel; Karmakar, Kajari; Kasetty, Sanjay; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Karmakar, Kajari] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Indian Institute of Science (IISC) - Bangalore; Friedrich Miescher Institute for Biomedical Research	Ghatak, P (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in		Chatterji, Dipankar/0000-0002-9985-0632	Department of Science and Technology (DST), Government of India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	The work was funded by the Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1997, NUCLEIC ACIDS RES, V25, P2221, DOI 10.1093/nar/25.11.2221; ALLISON SA, 1981, BIOPOLYMERS, V20, P469, DOI 10.1002/bip.1981.360200305; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Basu D, 2009, NUCLEIC ACIDS RES, V37, P4944, DOI 10.1093/nar/gkp502; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Cunha S, 2001, BIOCHIMIE, V83, P149, DOI 10.1016/S0300-9084(01)01245-7; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Fang Y, 1999, NUCLEIC ACIDS RES, V27, P1943, DOI 10.1093/nar/27.8.1943; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Frenkiel-Krispin D, 2002, ASM NEWS, V68, P277; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; HECHT RM, 1976, NUCLEIC ACIDS RES, V3, P767, DOI 10.1093/nar/3.3.767; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; KLEPPE K, 1979, J GEN MICROBIOL, V112, P1; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Minsky A, 2002, NAT REV MOL CELL BIO, V3, P50, DOI 10.1038/nrm700; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Mukherjee A, 2009, FEMS MICROBIOL LETT, V291, P232, DOI 10.1111/j.1574-6968.2008.01458.x; Ohniwa RL, 2007, GENES CELLS, V12, P1141, DOI 10.1111/j.1365-2443.2007.01125.x; Ojha AK, 2002, MICROBIOL-SGM, V148, P3039, DOI 10.1099/00221287-148-10-3039; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Sambrook J., 2002, MOL CLONING LAB MANU; Saraswathi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008017; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Yoshikawa Y, 1999, LANGMUIR, V15, P4085, DOI 10.1021/la981159g; Yoshimura SH, 2003, J ELECTRON MICROSC, V52, P415, DOI 10.1093/jmicro/52.4.415; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	48	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16019	10.1371/journal.pone.0016019	http://dx.doi.org/10.1371/journal.pone.0016019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283627	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000286523400011
J	Orwig, SD; Lieberman, RL				Orwig, Susan D.; Lieberman, Raquel L.			Biophysical Characterization of the Olfactomedin Domain of Myocilin, an Extracellular Matrix Protein Implicated in Inherited Forms of Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; HUMAN TRABECULAR MESHWORK; CIRCULAR-DICHROISM; CHONDROITIN SULFATE; SECONDARY STRUCTURE; DISEASE PHENOTYPE; BINDING; IDENTIFICATION; STABILITY; LOCALIZATION	Myocilin is an eye protein found in the trabecular extracellular matrix (TEM), within the anatomic region that controls fluid flow. Variants of myocilin, localized to its olfactomedin (OLF) domain, have been linked to inherited forms of glaucoma, a disease associated with elevated intraocular pressure. OLF domains have also been implicated in psychiatric diseases and cancers by their involvement in signaling, neuronal growth, and development. However, molecular characterization of OLFs has been hampered by challenges in recombinant expression, a hurdle we have recently overcome for the myocilin OLF domain (myoc-OLF). Here, we report the first detailed solution biophysical characterization of myoc-OLF to gain insight into its structure and function. Myoc-OLF is stable in the presence of glycosaminoglycans, as well as in a wide pH range in buffers with functional groups reminiscent of such glycosaminoglycans. Circular dichroism (CD) reveals significant beta-sheet and beta-turn secondary structure. Unexpectedly, the CD signature is reminiscent of alpha-chymotrypsin as well as another ocular protein family, the beta gamma-crystallins. At neutral pH, intrinsic tryptophan fluorescence and CD melts indicate a highly cooperative transition with a melting temperature of similar to 55 degrees C. Limited proteolysis combined with mass spectrometry reveals that the compact core structural domain of OLF consists of approximately residues 238-461, which retains the single disulfide bond and is as stable as the full myoc-OLF construct. The data presented here inform new testable hypotheses for interactions with specific TEM components, and will assist in design of therapeutic agents for myocilin glaucoma.	[Orwig, Susan D.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Orwig, SD (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	raquel.lieberman@chemistry.gatech.edu			Glaucoma Research Foundation; American Health Assistance Foundation; United States Department of Education [P200A060188]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER	Glaucoma Research Foundation; American Health Assistance Foundation(BrightFocus Foundation); United States Department of Education(US Department of Education); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants to R.L.L. from the Glaucoma Research Foundation and American Health Assistance Foundation. S.D.O. was supported in part by a United States Department of Education Graduate Assistance in Areas of National Need program P200A060188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Evans P, 2007, EXP EYE RES, V84, P1001, DOI 10.1016/j.exer.2007.01.016; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; Furutani Y, 2005, BIOCHEM J, V389, P675, DOI 10.1042/BJ20050120; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Hillier BJ, 2007, BIOCHEM CELL BIOL, V85, P552, DOI 10.1139/O07-055; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; JOHNSON PM, 1974, IMMUNOLOGY, V27, P27; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Knepper PA, 2005, INVEST OPHTH VIS SCI, V46, P2829, DOI 10.1167/iovs.04-1472; Knepper PA, 2005, J GLAUCOMA, V14, P230, DOI 10.1097/01.ijg.0000159130.00710.78; Kuleshova ON, 2007, B EXP BIOL MED+, V143, P381, DOI 10.1007/s10517-007-0117-8; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, pS30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liton PB, 2009, EXP EYE RES, V88, P724, DOI 10.1016/j.exer.2008.11.002; MANDAL K, 1987, J BIOL CHEM, V262, P8096; Mertts M, 1999, LAB INVEST, V79, P1237; MORRISETT JD, 1971, J AM CHEM SOC, V93, P7297, DOI 10.1021/ja00755a030; Nagy I, 2003, BIOCHEM BIOPH RES CO, V302, P554, DOI 10.1016/S0006-291X(03)00198-0; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pace CN, 2010, PROTEIN SCI, V19, P929, DOI 10.1002/pro.370; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tawara A, 2000, CURR EYE RES, V21, P934, DOI 10.1076/ceyr.21.6.934.6988; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Wentz-Hunter K, 2004, J CELL PHYSIOL, V200, P45, DOI 10.1002/jcp.10478; WU J, 1992, ANAL BIOCHEM, V200, P359, DOI 10.1016/0003-2697(92)90479-Q; Xu D, 1998, FOLD DES, V3, P11, DOI 10.1016/S1359-0278(98)00004-2; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com	53	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16347	10.1371/journal.pone.0016347	http://dx.doi.org/10.1371/journal.pone.0016347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283635	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400031
J	Thaipadunpanit, J; Chierakul, W; Wuthiekanun, V; Limmathurotsakul, D; Amornchai, P; Boonslip, S; Smythe, LD; Limpaiboon, R; Hoffmaster, AR; Day, NPJ; Peacock, SJ				Thaipadunpanit, Janjira; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Amornchai, Premjit; Boonslip, Siriphan; Smythe, Lee D.; Limpaiboon, Roongrueng; Hoffmaster, Alex R.; Day, Nicholas P. J.; Peacock, Sharon J.			Diagnostic Accuracy of Real-Time PCR Assays Targeting 16S rRNA and lipl32 Genes for Human Leptospirosis in Thailand: A Case-Control Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PATHOGENIC LEPTOSPIRA; TAQMAN ASSAY; CULTURE	Background: Rapid PCR-based tests for the diagnosis of leptospirosis can provide information that contributes towards early patient management, but these have not been adopted in Thailand. Here, we compare the diagnostic sensitivity and specificity of two real-time PCR assays targeting rrs or lipL32 for the diagnosis of leptospirosis in northeast Thailand. Methods/Principal Findings: A case-control study of 266 patients (133 cases of leptospirosis and 133 controls) was constructed to evaluate the diagnostic sensitivity and specificity (DSe & DSp) of both PCR assays. The median duration of illness prior to admission of cases was 4 days (IQR 2-5 days; range 1-12 days). DSe and DSp were determined using positive culture and/or microscopic agglutination test (MAT) as the gold standard. The DSe was higher for the rrs assay than the lipL32 assay (56%, (95% CI 47-64%) versus 43%, (95% CI 34-52%), p < 0.001). No cases were positive for the lipL32 assay alone. There was borderline evidence to suggest that the DSp of the rrs assay was lower than the lipL32 assay (90% (95% CI 83-94%) versus 93%, (95% CI 88-97%), p = 0.06). Nine controls gave positive reactions for both assays and 5 controls gave a positive reaction for the rrs assay alone. The DSe of the rrs and lipL32 assays were high in the subgroup of 39 patients who were culture positive for Leptospira spp. (95% and 87%, respectively, p = 0.25). Conclusions/Significance: Early detection of Leptospira using PCR is possible for more than half of patients presenting with leptospirosis and could contribute to individual patient care.	[Thaipadunpanit, Janjira; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Amornchai, Premjit; Boonslip, Siriphan; Day, Nicholas P. J.; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Thaipadunpanit, Janjira] Siriraj Hosp, Med Prote Unit, Off Res & Dev, Fac Med, Bangkok, Thailand; [Chierakul, Wirongrong] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Smythe, Lee D.] Queensland Hlth Forens & Sci Serv, Communicable Dis Unit, WHO FAO OIE Collaborating Ctr Reference & Res Lep, Brisbane, Qld, Australia; [Limpaiboon, Roongrueng] Udon Thani Reg Hosp, Udon Thani, Thailand; [Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Day, Nicholas P. J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Churchill Hosp, Oxford, England; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Food & Agriculture Organization of the United Nations (FAO); Queensland Health; Centers for Disease Control & Prevention - USA; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Thaipadunpanit, J (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	janjira@tropmedres.ac	Thaipadungpanit, Janjira/ABF-9857-2021; Peacock, Sharon J/ABE-6331-2020	Thaipadungpanit, Janjira/0000-0002-6184-3381; Limmathurotsakul, Direk/0000-0001-7240-5320; Chierakul, Wirongrong/0000-0003-2103-9425; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust (http://www.wellcome.ac.uk) funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Kawabata H, 2001, MICROBIOL IMMUNOL, V45, P491, DOI 10.1111/j.1348-0421.2001.tb02649.x; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; MERIEN F, 1995, J INFECT DIS, V172, P281, DOI 10.1093/infdis/172.1.281; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Reitstetter RE, 2006, FEMS MICROBIOL LETT, V264, P31, DOI 10.1111/j.1574-6968.2006.00431.x; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Slack A, 2007, DIAGN MICR INFEC DIS, V57, P361, DOI 10.1016/j.diagmicrobio.2006.10.004; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; STALLMAN ND, 1984, INT J SYST BACTERIOL, V34, P258; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Watt G, 2003, AM J TROP MED HYG, V68, P89, DOI 10.4269/ajtmh.2003.68.89; Wuthiekanun V, 2007, J CLIN MICROBIOL, V45, P1363, DOI 10.1128/JCM.02430-06; Wuthiekanun V, 2007, EMERG INFECT DIS, V13, P124, DOI 10.3201/eid1301.060718	24	76	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16236	10.1371/journal.pone.0016236	http://dx.doi.org/10.1371/journal.pone.0016236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283633	gold, Green Published, Green Submitted			2022-12-27	WOS:000286523400027
J	Moccand, C; Kaufmann, M; Fitzpatrick, TB				Moccand, Cyril; Kaufmann, Markus; Fitzpatrick, Teresa B.			It Takes Two to Tango: Defining an Essential Second Active Site in Pyridoxal 5 '-Phosphate Synthase	PLOS ONE			English	Article							VITAMIN-B-6 BIOSYNTHESIS; ESCHERICHIA-COLI; CHROMOPHORIC INTERMEDIATE; PHOSPHATE SYNTHASE; BACILLUS-SUBTILIS; ARGININE FINGER; PLP SYNTHASE; GENE; PATHWAY; BINDING	The prevalent de novo biosynthetic pathway of vitamin B6 involves only two enzymes (Pdx1 and Pdx2) that form an ornate multisubunit complex functioning as a glutamine amidotransferase. The synthase subunit, Pdx1, utilizes ribose 5-phosphate and glyceraldehyde 3-phosphate, as well as ammonia derived from the glutaminase activity of Pdx2 to directly form the cofactor vitamer, pyridoxal 5'-phosphate. Given the fact that a single enzyme performs the majority of the chemistry behind this reaction, a complicated mechanism is anticipated. Recently, the individual steps along the reaction co-ordinate are beginning to be unraveled. In particular, the binding of the pentose substrate and the first steps of the reaction have been elucidated but it is not known if the latter part of the chemistry, involving the triose sugar, takes place in the same or a disparate site. Here, we demonstrate through the use of enzyme assays, enzyme kinetics, and mutagenesis studies that indeed a second site is involved in binding the triose sugar and moreover, is the location of the final vitamin product, pyridoxal 5'-phosphate. Furthermore, we show that product release is triggered by the presence of a PLP-dependent enzyme. Finally, we provide evidence that a single arginine residue of the C terminus of Pdx1 is responsible for coordinating co-operativity in this elaborate protein machinery.	[Moccand, Cyril; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland	University of Geneva	Moccand, C (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland.	theresa.fitzpatrick@unige.ch			Swiss National Science Foundation [PPOOA_119186]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Financial support is gratefully acknowledged from the Swiss National Science Foundation (Grant PPOOA_119186) to T.B.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER DA, 1989, EUR J CLIN NUTR, V43, P289; Biesebeke RT, 2001, BIOCHEMISTRY-US, V40, P7474, DOI 10.1021/bi010027a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Cane DE, 1999, J AM CHEM SOC, V121, P7722, DOI 10.1021/ja9914947; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Fitzpatrick TB, 2010, CHEMBIOCHEM, V11, P1185, DOI 10.1002/cbic.201000084; Hanes JW, 2008, NAT CHEM BIOL, V4, P425, DOI 10.1038/nchembio.93; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; HANES JW, 2008, ANGEW CHEM, V120, P2132; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; KAYA SJ, 1994, J BIOL CHEM, V269, P7419; Komatsu S, 2003, BBA-PROTEINS PROTEOM, V1647, P127, DOI 10.1016/S1570-9639(03)00076-1; Laber B, 1999, FEBS LETT, V449, P45, DOI 10.1016/S0014-5793(99)00393-2; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Mahon MM, 1999, BBA-PROTEIN STRUCT M, V1434, P191, DOI 10.1016/S0167-4838(99)00181-8; Matxain JM, 2009, J PHYS CHEM B, V113, P9629, DOI 10.1021/jp903023c; MIDDLETON SA, 1988, BIOCHEMISTRY-US, V27, P8653, DOI 10.1021/bi00423a022; Mozzarelli A, 2006, CHEM REC, V6, P275, DOI 10.1002/tcr.20094; Muller IB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001815; Neuwirth M, 2009, FEBS LETT, V583, P2179, DOI 10.1016/j.febslet.2009.06.009; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Raschle T, 2009, J BIOL CHEM, V284, P7706, DOI 10.1074/jbc.M804728200; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; Sakai A, 2002, J BIOSCI BIOENG, V93, P309, DOI 10.1263/jbb.93.309; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; TAZUYA K, 1995, BBA-GEN SUBJECTS, V1244, P113, DOI 10.1016/0304-4165(94)00205-C; Titiz O, 2006, PLANT J, V48, P933, DOI 10.1111/j.1365-313X.2006.02928.x; Vacca Rosa A., 2008, BMC Biochemistry, V9, P17, DOI 10.1186/1471-2091-9-17; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609; Zhang XA, 2010, BIOCHEM J, V432, P445, DOI 10.1042/BJ20101241; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	44	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16042	10.1371/journal.pone.0016042	http://dx.doi.org/10.1371/journal.pone.0016042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283685	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300015
J	Srivastava, K; Srivastava, A; Kumar, A; Mittal, B				Srivastava, Kshitij; Srivastava, Anvesha; Kumar, Ashok; Mittal, Balraj			Gallbladder Cancer Predisposition: A Multigenic Approach to DNA-Repair, Apoptotic and Inflammatory Pathway Genes	PLOS ONE			English	Article							HOGG1 SER326CYS POLYMORPHISM; SQUAMOUS-CELL-CARCINOMA; BILIARY-TRACT CANCER; BREAST-CANCER; RAS GENE; RISK; CYCLOOXYGENASE-2; ASSOCIATION; POPULATION; EXPRESSION	Gallbladder cancer (GBC) is a multifactorial disease with complex interplay between multiple genetic variants. We performed Classification and Regression Tree Analysis (CART) and Grade of Membership (GoM) analysis to identify combinations of alleles among the DNA repair, inflammatory and apoptotic pathway genetic variants in modifying the risk for GBC. We analyzed 16 polymorphisms in 8 genes involved in DNA repair, apoptotic and inflammatory pathways to find out combinations of genetic variants contributing to GBC risk. The genes included in the study were XRCC1, OGG1, ERCC2, MSH2, CASP8, TLR2, TLR4 and PTGS2. Single locus analysis by logistic regression showed association of MSH2 IVS1+9G>C (rs2303426), ERCC2 Asp312Asn (rs1799793), OGG1 Ser326Cys (rs1052133), OGG1 IVS4-15C>G (rs2072668), CASP8 -652 6N ins/del (rs3834129), PTGS2 -1195G>A (rs689466), PTGS2 -765G>C (rs20417), TLR4 Ex4+936C>T (rs4986791) and TLR2 -196 to -174del polymorphisms with GBC risk. The CART analysis revealed OGG1 Ser326Cys, and OGG1 IVS4-15C>G polymorphisms as the best polymorphic signature for discriminating between cases and controls. In the GoM analysis, the data was categorized into six sets representing risk for GBC with respect to the investigated polymorphisms. Sets I, II and III described low intrinsic risk (controls) characterized by multiple protective alleles while sets IV, V and VI represented high intrinsic risk groups (GBC cases) characterized by the presence of multiple risk alleles. The CART and GoM analyses also showed the importance of PTGS2 -1195G>A polymorphism in susceptibility to GBC risk. In conclusion, the present multigenic approach can be used to define individual risk profiles for gallbladder cancer in North Indian population.	[Srivastava, Kshitij; Srivastava, Anvesha; Mittal, Balraj] Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Kumar, Ashok] Sanjay Gandhi Post Grad Inst Med Sci, Dept Surg Gastroenterol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Srivastava, K (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	balraj@sgpgi.ac.in	Srivastava, Kshitij/AAB-4468-2021	Srivastava, Kshitij/0000-0002-3658-0815	Counsel of Scientific and Industrial Research (CSIR), Govt. of India [09/590(0135)/2007-EMR-I]	Counsel of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by grants from Counsel of Scientific and Industrial Research (CSIR), Govt. of India (09/590(0135)/2007-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiki T, 1996, GUT, V38, P426, DOI 10.1136/gut.38.3.426; Arizono K, 2008, JPN J CLIN ONCOL, V38, P186, DOI 10.1093/jjco/hym176; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bernard-Gallon D, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-36; Breiman L., 1984, CLASSIFICATION REGRE; Cai QY, 2006, CANCER EPIDEM BIOMAR, V15, P403, DOI 10.1158/1055-9965.EPI-05-0868; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Corder EH, 2008, REJUV RES, V11, P667, DOI 10.1089/rej.2008.0742; Davis JN, 2005, CANCER RES, V65, P3633, DOI 10.1158/0008-5472.CAN-04-3129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Fan CY, 2001, MODERN PATHOL, V14, p149A; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fujita H, 2002, PROSTATE, V53, P232, DOI 10.1002/pros.10152; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hanada K, 1997, EUR J CANCER, V33, P1136, DOI 10.1016/S0959-8049(97)00080-4; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Jiao XY, 2007, INT J CANCER, V121, P501, DOI 10.1002/ijc.22748; KAMIYA H, 1995, CARCINOGENESIS, V16, P883, DOI 10.1093/carcin/16.4.883; Kim JI, 2003, WORLD J GASTROENTERO, V9, P956; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Liu F, 2006, GASTROENTEROLOGY, V130, P1975, DOI 10.1053/j.gastro.2006.03.021; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Manton K.G., 1994, STAT APPL USING FUZZ; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Park J, 2004, PHARMACOGENETICS, V14, P103, DOI 10.1097/00008571-200402000-00004; Ramsay RG, 2003, EXPERT OPIN THER TAR, V7, P235; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sakoda LC, 2006, CARCINOGENESIS, V27, P1251, DOI 10.1093/carcin/bgi314; Sanguansin S, 2006, J EXP CLIN CANC RES, V25, P251; Sobin LH, 2002, TNM CLASSIFICATION M, P184; Srivastava A, 2009, ANN SURG ONCOL, V16, P1695, DOI 10.1245/s10434-009-0354-3; SRIVASTAVA K, 2010, CANCER IN PRESS; Srivastava K, 2010, LIVER INT, V30, P1067, DOI 10.1111/j.1478-3231.2010.02268.x; Srivastava K, 2010, CANCER-AM CANCER SOC, V116, P3160, DOI 10.1002/cncr.25063; Srivastava K, 2009, J GASTROENTEROL, V44, P774, DOI 10.1007/s00535-009-0071-5; Steinberg D., 1995, CART TREE STRUCTURED; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; WOODBURY MA, 1982, METHOD INFORM MED, V21, P210; Xing D, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P377; YOSHIDA S, 1995, CANCER RES, V55, P2756; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	49	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16449	10.1371/journal.pone.0016449	http://dx.doi.org/10.1371/journal.pone.0016449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283657	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300048
J	Tredwell, GD; Edwards-Jones, B; Leak, DJ; Bundy, JG				Tredwell, Gregory D.; Edwards-Jones, Bryn; Leak, David J.; Bundy, Jacob G.			The Development of Metabolomic Sampling Procedures for Pichia pastoris, and Baseline Metabolome Data	PLOS ONE			English	Article							ESCHERICHIA-COLI; YEAST; EXTRACTION; QUANTIFICATION; SPECTROSCOPY; SPECTROMETRY; MIXTURES; PROFILES; BACTERIA; H-1-NMR	Metabolic profiling is increasingly being used to investigate a diverse range of biological questions. Due to the rapid turnover of intracellular metabolites it is important to have reliable, reproducible techniques for sampling and sample treatment. Through the use of non-targeted analytical techniques such as NMR and GC-MS we have performed a comprehensive quantitative investigation of sampling techniques for Pichia pastoris. It was clear that quenching metabolism using solutions based on the standard cold methanol protocol caused some metabolite losses from P. pastoris cells. However, these were at a low level, with the NMR results indicating metabolite increases in the quenching solution below 5% of their intracellular level for 75% of metabolites identified; while the GC-MS results suggest a slightly higher level with increases below 15% of their intracellular values. There were subtle differences between the four quenching solutions investigated but broadly, they all gave similar results. Total culture extraction of cells + broth using high cell density cultures typical of P. pastoris fermentations, was an efficient sampling technique for NMR analysis and provided a gold standard of intracellular metabolite levels; however, salts in the media affected the GC-MS analysis. Furthermore, there was no benefit in including an additional washing step in the quenching process, as the results were essentially identical to those obtained just by a single centrifugation step. We have identified the major high-concentration metabolites found in both the extra- and intracellular locations of P. pastoris cultures by NMR spectroscopy and GC-MS. This has provided us with a baseline metabolome for P. pastoris for future studies. The P. pastoris metabolome is significantly different from that of Saccharomyces cerevisiae, with the most notable difference being the production of high concentrations of arabitol by P. pastoris.	[Tredwell, Gregory D.; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Edwards-Jones, Bryn; Leak, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London; Imperial College London	Tredwell, GD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	j.bundy@imperial.ac.uk	Bundy, Jacob G/C-2131-2008; Tredwell, Greg/L-2294-2015	Bundy, Jacob G/0000-0002-1164-8465; Tredwell, Greg/0000-0002-0020-5626	Bioprocessing Research Industry Club (BRIC); BBSRC; EPSRC;  [BBF0049071]; BBSRC [BB/F004907/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004907/1] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	Bioprocessing Research Industry Club (BRIC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was wholly funded by the Bioprocessing Research Industry Club (BRIC), a partnership between BBSRC, EPSRC and a consortium of leading companies (http://www.bbsrc.ac.uk/business/collaborative-research/industry-clubs/bric/background.aspx, grant reference BBF0049071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canelas AB, 2008, METABOLOMICS, V4, P226, DOI 10.1007/s11306-008-0116-4; Castrillo JI, 2003, PHYTOCHEMISTRY, V62, P929, DOI 10.1016/S0031-9422(02)00713-6; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Curvers S, 2001, BIOTECHNOL PROGR, V17, P495, DOI 10.1021/bp000164j; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; DIETMAIR S, 2010, ANAL BIOCH; FAN TWM, 1986, BIOCHIM BIOPHYS ACTA, V882, P154, DOI 10.1016/0304-4165(86)90150-9; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fredlund E, 2004, APPL MICROBIOL BIOT, V64, P403, DOI 10.1007/s00253-003-1464-7; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; Jensen NBS, 1999, BIOTECHNOL BIOENG, V63, P356, DOI 10.1002/(SICI)1097-0290(19990505)63:3&lt;356::AID-BIT12&gt;3.0.CO;2-1; Kayingo G, 2001, ARCH MICROBIOL, V177, P29, DOI 10.1007/s00203-001-0358-2; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Letisse F, 2000, BIOTECHNOL LETT, V22, P1673, DOI 10.1023/A:1005663526753; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Mergler M, 2001, ACTA BIOL HUNG, V52, P265; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d	33	44	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16286	10.1371/journal.pone.0016286	http://dx.doi.org/10.1371/journal.pone.0016286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283710	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522300031
J	Yao, JG; Gao, X; Yan, HM; Li, CY				Yao, Jian-Gao; Gao, Xin; Yan, Hong-Mei; Li, Chao-Yi			Field of Attention for Instantaneous Object Recognition	PLOS ONE			English	Article							VISUAL-SEARCH; SELECTIVE ATTENTION; VISION; CORTEX; CATEGORIZATION; PERCEPTION; PICTURES; CONJUNCTIONS; ORIENTATION; ASYMMETRIES	Background: Instantaneous object discrimination and categorization are fundamental cognitive capacities performed with the guidance of visual attention. Visual attention enables selection of a salient object within a limited area of the visual field; we referred to as "field of attention'' (FA). Though there is some evidence concerning the spatial extent of object recognition, the following questions still remain unknown: (a) how large is the FA for rapid object categorization, (b) how accuracy of attention is distributed over the FA, and (c) how fast complex objects can be categorized when presented against backgrounds formed by natural scenes. Methodology/Principal Findings: To answer these questions, we used a visual perceptual task in which subjects were asked to focus their attention on a point while being required to categorize briefly flashed (20 ms) photographs of natural scenes by indicating whether or not these contained an animal. By measuring the accuracy of categorization at different eccentricities from the fixation point, we were able to determine the spatial extent and the distribution of accuracy over the FA, as well as the speed of categorizing objects using stimulus onset asynchrony (SOA). Our results revealed that subjects are able to rapidly categorize complex natural images within about 0.1 s without eye movement, and showed that the FA for instantaneous image categorization covers a visual field extending 20 degrees x24 degrees, and accuracy was highest (>90%) at the center of FA and declined with increasing eccentricity. Conclusions/Significance: In conclusion, human beings are able to categorize complex natural images at a glance over a large extent of the visual field without eye movement.	[Yao, Jian-Gao; Gao, Xin; Yan, Hong-Mei; Li, Chao-Yi] Univ Elect Sci & Technol China, Minist Educ China, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Life Sci, Shanghai, Peoples R China	Ministry of Education, China; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yao, JG (corresponding author), Univ Elect Sci & Technol China, Minist Educ China, Key Lab Neuroinformat, Chengdu 610054, Peoples R China.	cyli@sibs.ac.cn			Major State Basic Research Program [2007CB311001]; Natural Science Foundations of China [90820301, 60835005]; Shanghai Municipal Committee of Science and Technology [088014158, 098014026]	Major State Basic Research Program(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the Major State Basic Research Program (2007CB311001 to CYL), the Natural Science Foundations of China (90820301, 60835005 to CYL), and the Shanghai Municipal Committee of Science and Technology (088014158, 098014026 to CYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J., 1983, HUMAN MACHINE VISION, P1; CHRISTOPHER GH, 2005, PERCEPTION VISUALIZA; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DOWNING CJ, 1985, ATTENTION PERFORMANC, V40; DRIVER J, 1992, J EXP PSYCHOL HUMAN, V18, P22, DOI 10.1037/0096-1523.18.1.22; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Healey CG., 1996, ACM T COMPUT-HUM INT, V3, P107, DOI [10.1145/230562.230563, DOI 10.1145/230562.230563]; HOFFMAN JE, 1981, PERCEPT PSYCHOPHYS, V30, P283, DOI 10.3758/BF03214284; JULESZ B, 1983, BELL SYST TECH J, V62, P1619, DOI 10.1002/j.1538-7305.1983.tb03502.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; LOFTUS GR, 1978, J EXP PSYCHOL HUMAN, V4, P565, DOI 10.1037/0096-1523.4.4.565; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; NELSON WW, 1980, J EXP PSYCHOL-HUM L, V6, P391, DOI 10.1037/0278-7393.6.4.391; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POTTER MC, 1975, NATURE, V253, P437, DOI 10.1038/253437a0; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; Subramaniam S, 2000, VIS COGN, V7, P511, DOI 10.1080/135062800394630; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WOLFE JM, 1992, J EXP PSYCHOL HUMAN, V18, P34, DOI 10.1037/0096-1523.18.1.34	36	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16343	10.1371/journal.pone.0016343	http://dx.doi.org/10.1371/journal.pone.0016343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OY	21283690	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300036
J	Izzotti, A; Longobardi, M; Cartiglia, C; Sacca, SC				Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina; Sacca, Sergio Claudio			Mitochondrial Damage in the Trabecular Meshwork Occurs Only in Primary Open-Angle Glaucoma and in Pseudoexfoliative Glaucoma	PLOS ONE			English	Article							OXIDATIVE STRESS; CONGENITAL GLAUCOMA; JUVENILE GLAUCOMA; OUTFLOW PATHWAY; AQUEOUS OUTFLOW; DNA-DAMAGE; CELLS; PIGMENTARY; TISSUES; EXFOLIATION	Background: Open-angle glaucoma appears to be induced by the malfunction of the trabecular meshwork cells due to injury induced by oxidative damage and mitochondrial impairment. Here, we report that, in fact, we have detected mitochondrial damage only in primary open-angle glaucoma and pseudo-exfoliation glaucoma, among several glaucoma types compared. Methodology/Principal Findings: Mitochondrial damage was evaluated by analyzing the common mitochondrial DNA deletion by real-time PCR in trabecular meshwork specimens collected at surgery from glaucomatous patients and controls. Glaucomatous patients included 38 patients affected by various glaucoma types: primary open-angle, pigmented, juvenile, congenital, pseudoexfoliative, acute, neovascular, and chronic closed-angle glaucoma. As control samples, we used 16 specimens collected from glaucoma-free corneal donors. Only primary open-angle glaucoma (3.0-fold) and pseudoexfoliative glaucoma (6.3-fold) showed significant increases in the amount of mitochondrial DNA deletion. In all other cases, deletion was similar to controls. Conclusions/Significance: Despite the fact that the trabecular meshwork is the most important tissue in the physiopathology of aqueous humor outflow in all glaucoma types, the present study provides new information regarding basic physiopathology of this tissue: only in primary open-angle and pseudoexfoliative glaucomas oxidative damage arising from mitochondrial failure play a role in the functional decay of trabecular meshwork.	[Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Sacca, Sergio Claudio] St Martino Hosp, Ophthalmol Unit, Dept Head Neck Pathol, Genoa, Italy	University of Genoa	Izzotti, A (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	sergio.sacca@hsanmartino.it	Sacca, Sergio/D-5118-2018; Saccà, Sergio/AAG-3335-2019	Sacca, Sergio/0000-0001-6973-5978; Saccà, Sergio/0000-0001-6973-5978; izzotti, alberto/0000-0002-8588-0347	United States Glaucoma Foundation (New York, NY)	United States Glaucoma Foundation (New York, NY)	This study was supported by the United States Glaucoma Foundation (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Alvarado Jorge A, 2005, Trans Am Ophthalmol Soc, V103, P148; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; Bakunowicz-Lazarczyk A., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P17; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Brusini P, 2003, J GLAUCOMA, V12, P417, DOI 10.1097/00061198-200310000-00004; Caprioli J, 1994, Trans Am Ophthalmol Soc, V92, P589; DiMauro S, 1998, NEUROSCIENTIST, V4, P53, DOI 10.1177/107385849800400113; Ehlers JP, 2008, RETINA-J RET VIT DIS, V28, P696, DOI 10.1097/IAE.0b013e3181679c0b; Furuyoshi N, 1997, OPHTHALMOLOGICA, V211, P140, DOI 10.1159/000310781; Gottanka JY, 2006, J GLAUCOMA, V15, P142, DOI 10.1097/00061198-200604000-00011; Gupta N, 2007, EXP EYE RES, V84, P176, DOI 10.1016/j.exer.2006.09.013; HAMBLET NS, 1995, BIOCHEM BIOPH RES CO, V207, P839, DOI 10.1006/bbrc.1995.1262; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Konstas AGP, 1997, ARCH OPHTHALMOL-CHIC, V115, P182, DOI 10.1001/archopht.1997.01100150184006; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Li GR, 2007, MOL VIS, V13, P2282; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268; MAUL E, 1980, AM J OPHTHALMOL, V89, P667, DOI 10.1016/0002-9394(80)90286-X; MURPHY CG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1779, DOI 10.1001/archopht.1992.01080240119043; PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342; Ramamurthy B, 2007, CORNEA, V26, P647, DOI 10.1097/ICO.0b013e31804e4579; Ritch R, 2003, PROG RETIN EYE RES, V22, P253, DOI 10.1016/S1350-9462(02)00014-9; RITCH R, 1995, NEW DEV GLAUCOMA OPH, P281; Sacca S C, 1996, Eur J Ophthalmol, V6, P421; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; SCHLOTZERSCHREHARDT U, 1995, INVEST OPHTH VIS SCI, V36, P1750; Shieds M. B., 1996, GLAUCOMAS, P717; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; Takahashi A, 2004, BRAIN RES BULL, V62, P497, DOI 10.1016/j.brainresbull.2003.07.009; Tane N, 2007, EXP EYE RES, V84, P832, DOI 10.1016/j.exer.2007.01.002; TAWARA A, 1994, AM J OPHTHALMOL, V117, P741, DOI 10.1016/S0002-9394(14)70317-4; TAWARA A, 1984, AM J OPHTHALMOL, V98, P82, DOI 10.1016/0002-9394(84)90193-4; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Waring G O 3rd, 1975, Surv Ophthalmol, V20, P3, DOI 10.1016/0039-6257(75)90034-X; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0	51	60	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14567	10.1371/journal.pone.0014567	http://dx.doi.org/10.1371/journal.pone.0014567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283745	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200008
J	Seabury, CM; Bhattarai, EK; Taylor, JF; Viswanathan, GG; Cooper, SM; Davis, DS; Dowd, SE; Lockwood, ML; Seabury, PM				Seabury, Christopher M.; Bhattarai, Eric K.; Taylor, Jeremy F.; Viswanathan, Ganesh G.; Cooper, Susan M.; Davis, Donald S.; Dowd, Scot E.; Lockwood, Mitch L.; Seabury, Paul M.			Genome-Wide Polymorphism and Comparative Analyses in the White-Tailed Deer (Odocoileus virginianus): A Model for Conservation Genomics	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; MITOCHONDRIAL GENOME; TUBERCULOSIS; CERVIDAE; GENE; RNA; SUSCEPTIBILITY; EVOLUTION; DISCOVERY; DIAGNOSIS	The white-tailed deer (Odocoileus virginianus) represents one of the most successful and widely distributed large mammal species within North America, yet very little nucleotide sequence information is available. We utilized massively parallel pyrosequencing of a reduced representation library (RRL) and a random shotgun library (RSL) to generate a complete mitochondrial genome sequence and identify a large number of putative single nucleotide polymorphisms (SNPs) distributed throughout the white-tailed deer nuclear and mitochondrial genomes. A SNP validation study designed to test specific classes of putative SNPs provides evidence for as many as 10,476 genome-wide SNPs in the current dataset. Based on cytogenetic evidence for homology between cow (Bos taurus) and white-tailed deer chromosomes, we demonstrate that a divergent genome may be used for estimating the relative distribution and density of de novo sequence contigs as well as putative SNPs for species without draft genome assemblies. Our approach demonstrates that bioinformatic tools developed for model or agriculturally important species may be leveraged to support next-generation research programs for species of biological, ecological and evolutionary importance. We also provide a functional annotation analysis for the de novo sequence contigs assembled from white-tailed deer pyrosequencing reads, a mitochondrial phylogeny involving 13,722 nucleotide positions for 10 unique species of Cervidae, and a median joining haplotype network as a putative representation of mitochondrial evolution in O. virginianus. The results of this study are expected to provide a detailed template enabling genome-wide sequence-based studies of threatened, endangered or conservationally important non-model organisms.	[Seabury, Christopher M.; Bhattarai, Eric K.; Viswanathan, Ganesh G.; Davis, Donald S.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Taylor, Jeremy F.] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Cooper, Susan M.] Texas A&M Univ Syst, Uvalde, TX USA; [Dowd, Scot E.] SpiroStat Technol, Res & Testing Labs, Med Biofilm Res Inst, Lubbock, TX USA; [Lockwood, Mitch L.] Texas Parks & Wildlife Dept, Kerrville, TX USA; [Seabury, Paul M.] ElanTech Inc, Greenbelt, MD USA	Texas A&M University System; Texas A&M University College Station; University of Missouri System; University of Missouri Columbia; Texas A&M University System	Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427	Texas AgriLife Research, Department of Veterinary Pathobiology, College of Veterinary Medicine, and Texas AM University	Texas AgriLife Research, Department of Veterinary Pathobiology, College of Veterinary Medicine, and Texas AM University	The authors acknowledge the financial support of Texas AgriLife Research, Department of Veterinary Pathobiology, College of Veterinary Medicine, and Texas A&M University. DNA used in the validation study was partially enabled by Texas Parks and Wildlife Department grant #183260 to C.M.S. ElanTech, Inc. provided no funding for research, but allows Paul M. Seabury to participate as a collaborator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the following exceptions: Mitch L. Lockwood (TPWD Biologist) provided suggested revisions and references regarding white-tailed deer biology; Paul M. Seabury (ElanTech) provided and deployed custom scripts to parse data, as directed by Christopher M. Seabury.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Anderson JD, 2002, J WILDLIFE MANAGE, V66, P67, DOI 10.2307/3802872; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Baker R.H., 1984, P1; Baker SV, 1997, WILDLIFE SOC B, V25, P404; Blanchong JA, 2009, INFECT GENET EVOL, V9, P1329, DOI 10.1016/j.meegid.2009.08.010; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Bubenik GA, 1999, COMP BIOCHEM PHYS C, V122, P173, DOI 10.1016/S0742-8413(98)10101-9; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; DeYoung RW, 2003, WILDLIFE SOC B, V31, P220; DeYoung RW, 2002, J MAMMAL, V83, P884, DOI 10.1644/1545-1542(2002)083&lt;0884:MPIWTD&gt;2.0.CO;2; Douzery E, 1997, MOL BIOL EVOL, V14, P1154, DOI 10.1093/oxfordjournals.molbev.a025725; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ernest HB, 2010, CAN J VET RES, V74, P153; Everts-van der Wind A, 2005, P NATL ACAD SCI USA, V102, P18526, DOI 10.1073/pnas.0509285102; GALLAGHER DS, 1994, J HERED, V85, P204, DOI 10.1093/oxfordjournals.jhered.a111436; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Griffin JFT, 2000, VET J, V160, P202, DOI 10.1053/tvjl.2000.0514; Guha S, 2007, MOL PHYLOGENET EVOL, V42, P585, DOI 10.1016/j.ympev.2006.06.020; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joly DO, 2009, J WILDLIFE DIS, V45, P989, DOI 10.7589/0090-3558-45.4.989; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keane D, 2009, J CLIN MICROBIOL, V47, P1412, DOI 10.1128/JCM.02209-08; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Locke SL, 2007, J WILDLIFE DIS, V43, P726, DOI 10.7589/0090-3558-43.4.726; Lopez RR, 2003, J WILDLIFE MANAGE, V67, P34, DOI 10.2307/3803059; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; NOWAK RM, 1999, WALKERS MAMMALS WORL, V2, P1114; O'Brien DJ, 2009, J WILDLIFE DIS, V45, P153, DOI 10.7589/0090-3558-45.1.153; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pang H, 2008, MITOCHONDR DNA, V19, P411, DOI 10.1080/19401730802389517; Peterson MN, 2003, WILDLIFE SOC B, V31, P1198; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wada K, 2007, SMALL RUMINANT RES, V69, P46, DOI 10.1016/j.smallrumres.2005.12.002; Warren RJ, 1997, WILDLIFE SOC B, V25, P213; Waters WR, 2008, VET REC, V162, P203, DOI 10.1136/vr.162.7.203; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; WILSON DE, 2005, MAMMAL SPECIES WORLD, P657; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264; Wobeser G, 2009, CAN VET J, V50, P1169	55	35	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15811	10.1371/journal.pone.0015811	http://dx.doi.org/10.1371/journal.pone.0015811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283515	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600014
J	Pifer, PM; Yates, EA; Legleiter, J				Pifer, Phillip M.; Yates, Elizabeth A.; Legleiter, Justin			Point Mutations in A beta Result in the Formation of Distinct Polymorphic Aggregates in the Presence of Lipid Bilayers	PLOS ONE			English	Article							AMYLOID ION CHANNELS; ALZHEIMERS-DISEASE; IN-VITRO; SECONDARY STRUCTURE; PRECURSOR PROTEIN; WILD-TYPE; PEPTIDE; FIBRILLOGENESIS; OLIGOMERIZATION; TOXICITY	A hallmark of Alzheimer's disease (AD) is the rearrangement of the beta-amyloid (A beta) peptide to a non-native conformation that promotes the formation of toxic, nanoscale aggregates. Recent studies have pointed to the role of sample preparation in creating polymorphic fibrillar species. One of many potential pathways for A beta toxicity may be modulation of lipid membrane function on cellular surfaces. There are several mutations clustered around the central hydrophobic core of A beta near the alpha-secretase cleavage site (E22G Arctic mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish mutation). These point mutations are associated with hereditary diseases ranging from almost pure cerebral amyloid angiopathy (CAA) to typical Alzheimer's disease pathology with plaques and tangles. We investigated how these point mutations alter A beta aggregation in the presence of supported lipid membranes comprised of total brain lipid extract. Brain lipid extract bilayers were used as a physiologically relevant model of a neuronal cell surface. Intact lipid bilayers were exposed to predominantly monomeric preparations of Wild Type or different mutant forms of A beta, and atomic force microscopy was used to monitor aggregate formation and morphology as well as bilayer integrity over a 12 hour period. The goal of this study was to determine how point mutations in A beta, which alter peptide charge and hydrophobic character, influence interactions between A beta and the lipid surface. While fibril morphology did not appear to be significantly altered when mutants were prepped similarly and incubated under free solution conditions, aggregation in the lipid membranes resulted in a variety of polymorphic aggregates in a mutation dependent manner. The mutant peptides also had a variable ability to disrupt bilayer integrity.	[Pifer, Phillip M.; Yates, Elizabeth A.; Legleiter, Justin] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Legleiter, Justin] W Virginia Univ, WVnano Initiat, Morgantown, WV 26506 USA; [Legleiter, Justin] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Pifer, PM (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	justin.legleiter@mail.wvu.edu		Yates, Elizabeth A./0000-0002-7141-306X	West Virginia University	West Virginia University	The research was funded by a start-up fund provided by West Virginia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Clements A, 1996, J NEUROCHEM, V66, P740; CLEMENTS A, 1993, NEUROSCI LETT, V161, P17, DOI 10.1016/0304-3940(93)90129-9; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; Demeester N, 2001, EUR J NEUROSCI, V13, P2015, DOI 10.1046/j.0953-816x.2001.01579.x; Fernandes F, 2003, BIOPHYS J, V85, P2430, DOI 10.1016/S0006-3495(03)74666-9; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han X, 2000, J MOL BIOL, V304, P953, DOI 10.1006/jmbi.2000.4251; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jass J, 2000, BIOPHYS J, V79, P3153, DOI 10.1016/S0006-3495(00)76549-0; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2004, J MOL BIOL, V335, P997, DOI 10.1016/j.jmb.2003.11.019; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lindstrom F, 2002, PHYS CHEM CHEM PHYS, V4, P5524, DOI 10.1039/b206351d; Lins L, 2002, PROTEIN ENG, V15, P513, DOI 10.1093/protein/15.6.513; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Pastor MT, 2008, J MOL BIOL, V375, P695, DOI 10.1016/j.jmb.2007.08.012; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; ROTH GS, 1995, TRENDS NEUROSCI, V18, P203, DOI 10.1016/0166-2236(95)93902-A; Sennvik K, 2002, NEUROSCI LETT, V326, P51, DOI 10.1016/S0304-3940(02)00305-1; Sian AK, 2000, BIOCHEM J, V349, P299, DOI 10.1042/0264-6021:3490299; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; STATHOPULOS PB, 2003, P NAT ACAD SCI US, V100; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; VANNOSTRAND WE, 2001, J BIOL CHEM, V376, P32680; Verbeek MM, 1997, J NEUROPATH EXP NEUR, V56, P751; WALLIN A, 1989, ACTA NEUROL SCAND, V80, P319, DOI 10.1111/j.1600-0404.1989.tb03886.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zameer A, 2006, BIOCHEMISTRY-US, V45, P11532, DOI 10.1021/bi060601o; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	67	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16248	10.1371/journal.pone.0016248	http://dx.doi.org/10.1371/journal.pone.0016248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267410	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500048
J	Yoon, MY; Lee, KM; Park, Y; Yoon, SS				Yoon, Mi Young; Lee, Kang-Mu; Park, Yongjin; Yoon, Sang Sun			Contribution of Cell Elongation to the Biofilm Formation of Pseudomonas aeruginosa during Anaerobic Respiration	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; CYSTIC-FIBROSIS; NITRIC-OXIDE; ESCHERICHIA-COLI; RESISTANCE; NITRATE; METABOLISM; DIVISION; CARBENICILLIN; INFECTIONS	Pseudomonas aeruginosa, a gram-negative bacterium of clinical importance, forms more robust biofilm during anaerobic respiration, a mode of growth presumed to occur in abnormally thickened mucus layer lining the cystic fibrosis (CF) patient airway. However, molecular basis behind this anaerobiosis-triggered robust biofilm formation is not clearly defined yet. Here, we identified a morphological change naturally accompanied by anaerobic respiration in P. aeruginosa and investigated its effect on the biofilm formation in vitro. A standard laboratory strain, PAO1 was highly elongated during anaerobic respiration compared with bacteria grown aerobically. Microscopic analysis demonstrated that cell elongation likely occurred as a consequence of defective cell division. Cell elongation was dependent on the presence of nitrite reductase (NIR) that reduces nitrite (NO2-) to nitric oxide (NO) and was repressed in PAO1 in the presence of carboxy-PTIO, a NO antagonist, demonstrating that cell elongation involves a process to respond to NO, a spontaneous byproduct of the anaerobic respiration. Importantly, the non-elongated NIR-deficient mutant failed to form biofilm, while a mutant of nitrate reductase (NAR) and wild type PAO1, both of which were highly elongated, formed robust biofilm. Taken together, our data reveal a role of previously undescribed cell biological event in P. aeruginosa biofilm formation and suggest NIR as a key player involved in such process.	[Yoon, Mi Young; Lee, Kang-Mu; Park, Yongjin; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, MY (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea.	sangsun_yoon@yuhs.ac		Yoon, Sang Sun/0000-0003-2979-365X	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A090951]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea, A090951 to SSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.202001; Acosta D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.131801; Benkert B, 2008, MICROBIOL-SGM, V154, P3053, DOI 10.1099/mic.0.2008/018929-0; BHATTI AR, 1976, J BACTERIOL, V126, P400, DOI 10.1128/JB.126.1.400-409.1976; BURTON P, 1983, MOL GEN GENET, V190, P128, DOI 10.1007/BF00330334; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; GORETSKI J, 1990, J BIOL CHEM, V265, P11535; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; HASSETT DJ, 1995, J BACTERIOL, V177, P6330, DOI 10.1128/jb.177.22.6330-6337.1995; Hassett DJ, 1999, METHOD ENZYMOL, V310, P599; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; JAGGER KN, 1983, J CLIN MICROBIOL, V17, P55, DOI 10.1128/JCM.17.1.55-59.1983; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; O'May CY, 2006, FEMS IMMUNOL MED MIC, V48, P373, DOI 10.1111/j.1574-695X.2006.00157.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ojoo JC, 2005, THORAX, V60, P22, DOI 10.1136/thx.2003.017327; PHAIR JP, 1969, APPL MICROBIOL, V18, P303, DOI 10.1128/AEM.18.3.303-306.1969; RELLA M, 1982, ANTIMICROB AGENTS CH, V22, P242, DOI 10.1128/AAC.22.2.242; RICO AI, 2010, MOL MICROBIOL; ROLINSON GN, 1980, J GEN MICROBIOL, V120, P317; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; SHEARER BG, 1983, EUR J CLIN MICROBIOL, V2, P148, DOI 10.1007/BF02001581; Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Wong KKY, 1997, ANTIMICROB AGENTS CH, V41, P2009, DOI 10.1128/AAC.41.9.2009; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	49	81	82	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16105	10.1371/journal.pone.0016105	http://dx.doi.org/10.1371/journal.pone.0016105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267455	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500039
J	Meadows, E; Flynn, JM; Klein, WH				Meadows, Eric; Flynn, Jesse M.; Klein, William H.			Myogenin Regulates Exercise Capacity but Is Dispensable for Skeletal Muscle Regeneration in Adult mdx Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NITRIC-OXIDE SYNTHASE; MUTANT MICE; MOUSE; EXPRESSION; GENE; MYOD; METABOLISM; ADAPTATION; GLYCOLYSIS	Duchenne muscular dystrophy (DMD) is the most prevalent inherited childhood muscle disorder in humans. mdx mice exhibit a similar pathophysiology to the human disorder allowing for an in-depth investigation of DMD. Myogenin, a myogenic regulatory factor, is best known for its role in embryonic myogenesis, but its role in adult muscle maintenance and regeneration is still poorly understood. Here, we generated an mdx:Myog(flox/flox) mouse harboring a tamoxifen-inducible Cre recombinase transgene, which was used to conditionally delete Myog during adult life. After tamoxifen treatment, three groups of mice were created to study the effects of Myog deletion: mdx:Myog(flox/flox) mice (mdx), Myog(flox/flox) mice (wildtype), and mdx:Myog(flox Delta/flox Delta):Cre-ER mice (mdx:Myog-deleted). mdx: Myog-deleted mice exhibited no adverse phenotype and behaved normally. When run to exhaustion, mdx:Myog-deleted mice demonstrated an enhanced capacity for exercise compared to mdx mice, running nearly as far as wild-type mice. Moreover, these mice showed the same signature characteristics of muscle regeneration as mdx mice. Unexpectedly, we found that myogenin was dispensable for muscle regeneration. Factors associated with muscle fatigue, metabolism, and proteolysis were significantly altered in mdx: Myogdeleted mice, and this might contribute to their increased exercise capacity. Our results reveal novel functions for myogenin in adult muscle and suggest that reducing Myog expression in other muscle disease models may partially restore muscle function.	[Meadows, Eric; Flynn, Jesse M.; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meadows, Eric; Flynn, Jesse M.] Univ Texas Houston, Sch Biomed Sci Houston, Grad Training Program Genes & Dev, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Meadows, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	whklein@mdanderson.org			Muscular Dystrophy Association [MDA4289]; Robert A. Welch Foundation [G-0010]	Muscular Dystrophy Association(Muscular Dystrophy Association); Robert A. Welch Foundation(The Welch Foundation)	The work was supported by grants to W.H.K. from the Muscular Dystrophy Association (MDA4289) and from the Robert A. Welch Foundation (G-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2004, SCIENCE, V305, P1112, DOI 10.1126/science.1103078; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BULFIELD G, 1978, GENETICS, V89, P551; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; Ciafaloni E, 2008, CURR TREAT OPTION N, V10, P86, DOI 10.1007/s11940-008-0010-4; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; De la Porte S, 1999, INT REV CYTOL, V191, P99, DOI 10.1016/S0074-7696(08)60158-8; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; ENGEL A, 2004, MED PUB DIVISION, P2; Flynn JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013535; Gladden LB, 2008, MED SCI SPORT EXER, V40, P477, DOI [10.1249/mss.0b013e31815fa580, 10.1249/MSS.0b013e31815fa580]; GLESBY MJ, 1988, MUSCLE NERVE, V11, P852, DOI 10.1002/mus.880110809; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hamilton MT, 2000, J APPL PHYSIOL, V88, P327, DOI 10.1152/jappl.2000.88.1.327; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jin Y, 2000, ACTA NEUROPATHOL, V99, P619, DOI 10.1007/s004010051172; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Muir LA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001100; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Wehling-Henricks M, 2009, HUM MOL GENET, V18, P3439, DOI 10.1093/hmg/ddp288; Zhu XP, 2006, MUSCLE NERVE, V33, P104, DOI 10.1002/mus.20445	48	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16184	10.1371/journal.pone.0016184	http://dx.doi.org/10.1371/journal.pone.0016184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264243	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500034
J	Zhang, J; Wu, ZQ; Zhou, LL; Li, HL; Teng, HJ; Dai, W; Wang, YQ; Sun, ZS				Zhang, Jing; Wu, Zhouqiao; Zhou, Linglin; Li, Huili; Teng, Huajing; Dai, Wei; Wang, Yongqing; Sun, Zhong Sheng			Deficiency of Antinociception and Excessive Grooming Induced by Acute Immobilization Stress in Per1 Mutant Mice	PLOS ONE			English	Article							INDUCED ANALGESIA; ANALYSIS ALGORITHM; HPA AXIS; BEHAVIOR; MPER2; VASOPRESSIN; OXYTOCIN; NEUROENDOCRINE; STIMULATION; RELEASE	Acute stressors induce changes in numerous behavioral parameters through activation of the hypothalamic-pituitary-adrenal (HPA) axis. Several important hormones in paraventricular nucleus of the hypothalamus (PVN) play the roles in these stress-induced reactions. Corticotropin-releasing hormone (CRH), arginine-vasopressin (AVP) and corticosterone are considered as molecular markers for stress-induced grooming behavior. Oxytocin in PVN is an essential modulator for stress-induced antinociception. The clock gene, Per1, has been identified as an effecter response to the acute stresses, but its function in neuroendocrine stress systems remains unclear. In the present study we observed the alterations in grooming and nociceptive behaviors induced by acute immobilization stress in Per1 mutant mice and other genotypes (wild types and Per2 mutant). The results displayed that stress elicited a more robust effect on grooming behavior in Per1 mutant mice than in other genotypes. Subsequently, the obvious stress-induced antinociception was observed in the wild-type and Per2 mutant mice, however, in Per1 mutant, this antinociceptive effects were partially-reversed (mechanical sensitivity), or over-reversed to hyperalgesia (thermal sensitivity). The real-time qPCR results showed that in PVN, there were stress-induced up-regulations of Crh, Avp and c-fos in all of genotypes; moreover, the expression change of Crh in Per1 mutant mice was much larger than in others. Another hormonal gene, Oxt, was up-regulated induced by stress in wild-type and Per2 mutant but not in Per1 mutant. In addition, the stress significantly elevated the serum corticosterone levels without genotype-dependent differences, and accordingly the glucocorticoid receptor gene, Nr3c1, expressed with a similar pattern in PVN of all strains. Taken together, the present study indicated that in acute stress treated Per1 mutant mice, there are abnormal hormonal responses in PVN, correlating with the aberrant performance of stress-induced behaviors. Therefore, our findings suggest a novel functional role of Per1 in neuroendocrine stress system, which further participates in analgesic regulation.	[Zhang, Jing; Teng, Huajing; Dai, Wei; Wang, Yongqing; Sun, Zhong Sheng] Chinese Acad Sci, Behav Genet Ctr, Beijing, Peoples R China; [Zhang, Jing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wu, Zhouqiao] Peking Univ, Hosp 3, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zhou, Linglin] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Li, Huili] Capital Inst Pediat, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Wenzhou Medical University; Capital Institute of Pediatrics (CIP)	Zhang, J (corresponding author), Chinese Acad Sci, Behav Genet Ctr, Beijing, Peoples R China.	zsunusa@yahoo.com	Li, Huili/AAP-9120-2020; Huajing, Teng/AAF-4040-2020; Sun, Zhongsheng/AAS-4883-2020	Huajing, Teng/0000-0001-9952-3618; Sun, Zhongsheng/0000-0002-7640-5026; Li, Huili/0000-0002-9248-0720	National Natural Science Foundation of China [31071133]; Major State Basic Research Development Program of China [2007CB512302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31071133) and Major State Basic Research Development Program of China (2007CB512302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antonijevic I, 2008, STRESS, V11, P15, DOI 10.1080/10253890701378967; BARROS HMT, 1994, PHARMACOL TOXICOL, V74, P339, DOI 10.1111/j.1600-0773.1994.tb01370.x; BUWALDA B, 1993, PHYSIOL BEHAV, V54, P947, DOI 10.1016/0031-9384(93)90307-2; CALDWELL JD, 1986, REGUL PEPTIDES, V14, P261, DOI 10.1016/0167-0115(86)90009-1; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Condes-Lara M, 2008, NEUROSCI LETT, V444, P199, DOI 10.1016/j.neulet.2008.08.027; Condes-Lara M, 2009, EUR J NEUROSCI, V30, P1056, DOI 10.1111/j.1460-9568.2009.06899.x; DAMORE A, 1992, J PHARMACOL TOXICOL, V27, P197, DOI 10.1016/1056-8719(92)90041-X; DeLaTorre S, 2009, PAIN, V144, P320, DOI 10.1016/j.pain.2009.05.002; Eguibar JR, 2003, PHARMACOL BIOCHEM BE, V74, P827, DOI 10.1016/S0091-3057(02)01082-1; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Fediuc S, 2006, J APPL PHYSIOL, V100, P1867, DOI 10.1152/japplphysiol.01416.2005; Ford GK, 2008, PAIN, V140, P3, DOI 10.1016/j.pain.2008.09.023; Jezova D, 1995, ANN NY ACAD SCI, V771, P192, DOI 10.1111/j.1749-6632.1995.tb44681.x; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Korzeniewska Iwona, 1995, Polish Journal of Pharmacology, V47, P381; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; LaBuda CJ, 2000, BRAIN RES, V869, P1, DOI 10.1016/S0006-8993(00)02196-X; Lumley LA, 2001, PHYSIOL BEHAV, V73, P451, DOI 10.1016/S0031-9384(01)00501-7; Ma S, 2005, J NEUROENDOCRINOL, V17, P22, DOI 10.1111/j.1365-2826.2005.01279.x; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; MOODY TW, 1988, ANN NY ACAD SCI, V525, P281, DOI 10.1111/j.1749-6632.1988.tb38613.x; Nishioka T, 1998, BRAIN RES, V781, P57, DOI 10.1016/S0006-8993(97)01159-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Robinson DA, 2002, J PHYSIOL-LONDON, V540, P593, DOI 10.1113/jphysiol.2001.013492; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Seo YJ, 2006, BRAIN RES BULL, V71, P279, DOI 10.1016/j.brainresbull.2006.09.012; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Tavakoli-Nezhad M, 2007, J BIOL RHYTHM, V22, P81, DOI 10.1177/0748730406296717; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	36	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16212	10.1371/journal.pone.0016212	http://dx.doi.org/10.1371/journal.pone.0016212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264262	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500040
J	Ramshini, H; Parrini, C; Relini, A; Zampagni, M; Mannini, B; Pesce, A; Saboury, AA; Nemat-Gorgani, M; Chiti, F				Ramshini, Hassan; Parrini, Claudia; Relini, Annalisa; Zampagni, Mariagioia; Mannini, Benedetta; Pesce, Alessandra; Saboury, Ali Akbar; Nemat-Gorgani, Mohsen; Chiti, Fabrizio			Large Proteins Have a Great Tendency to Aggregate but a Low Propensity to Form Amyloid Fibrils	PLOS ONE			English	Article							FORMATION IN-VITRO; HYPF-N; DOMAIN; FIBRILLATION; LYSOZYME; BETA(2)-MICROGLOBULIN; TOXICITY; DISEASE; STATE; PH	The assembly of soluble proteins into ordered fibrillar aggregates with cross-beta structure is an essential event of many human diseases. The polypeptides undergoing aggregation are generally small in size. To explore if the small size is a primary determinant for the formation of amyloids under pathological conditions we have created two databases of proteins, forming amyloid-related and non-amyloid deposits in human diseases, respectively. The size distributions of the two protein populations are well separated, with the systems forming non-amyloid deposits appearing significantly larger. We have then investigated the propensity of the 486-residue hexokinase-B from Saccharomyces cerevisiae (YHKB) to form amyloid-like fibrils in vitro. This size is intermediate between the size distributions of amyloid and non-amyloid forming proteins. Aggregation was induced under conditions known to be most effective for amyloid formation by normally globular proteins: (i) low pH with salts, (ii) pH 5.5 with trifluoroethanol. In both situations YHKB aggregated very rapidly into species with significant beta-sheet structure, as detected using circular dichroism and X-ray diffraction, but a weak Thioflavin T and Congo red binding. Moreover, atomic force microscopy indicated a morphology distinct from typical amyloid fibrils. Both types of aggregates were cytotoxic to human neuroblastoma cells, as indicated by the MTT assay. This analysis indicates that large proteins have a high tendency to form toxic aggregates, but low propensity to form regular amyloid in vivo and that such a behavior is intrinsically determined by the size of the protein, as suggested by the in vitro analysis of our sample protein.	[Ramshini, Hassan; Zampagni, Mariagioia; Mannini, Benedetta; Chiti, Fabrizio] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Ramshini, Hassan; Saboury, Ali Akbar; Nemat-Gorgani, Mohsen] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Parrini, Claudia; Relini, Annalisa; Pesce, Alessandra] Univ Genoa, Dipartimento Fis, Genoa, Italy	University of Florence; University of Tehran; University of Genoa	Ramshini, H (corresponding author), Sabzevar Payam Noor Univ, Dept Biol, Sabzevar, Iran.	fabrizio.chiti@unifi.it	Ramshini(fazelinejad), hassan/GQQ-9129-2022; Pesce, Alessandra/A-3660-2015; Mannini, Benedetta/GLV-6007-2022; Relini, Annalisa/AHC-3105-2022; Saboury, Ali Akbar/L-6136-2019; Mannini, Benedetta/ABC-4854-2020	Mannini, Benedetta/0000-0001-6812-7348; RELINI, ANNALISA/0000-0002-4040-9279	Research Council of the University of Tehran; Iranian National Science Foundation (INSF); Italian Ministry of University, Research and Instruction (MIUR); European Community (EC)	Research Council of the University of Tehran(University of Tehran); Iranian National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Italian Ministry of University, Research and Instruction (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Community (EC)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Research Council of the University of Tehran, the Iranian National Science Foundation (INSF), the Italian Ministry of University, Research and Instruction (MIUR) and the European Community (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; Campioni S, 2008, J MOL BIOL, V379, P554, DOI 10.1016/j.jmb.2008.04.002; Castiglioni E, 2007, CHIRALITY, V19, P642, DOI 10.1002/chir.20436; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Desai A, 2006, BIOCHIMIE, V88, P1435, DOI 10.1016/j.biochi.2006.05.008; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Gast K, 2003, EUR BIOPHYS J BIOPHY, V32, P710, DOI 10.1007/s00249-003-0336-5; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; KARUPPIAH N, 1995, BIOCHEM BIOPH RES CO, V211, P60, DOI 10.1006/bbrc.1995.1778; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; McGowan DP, 2000, NEUROSCIENCE, V100, P677, DOI 10.1016/S0306-4522(00)00391-2; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; SCHMIDT JJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P458, DOI 10.1016/0003-9861(73)90537-7; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zerovnik E, 2002, BIOCHEM SOC T, V30, P543	37	45	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16075	10.1371/journal.pone.0016075	http://dx.doi.org/10.1371/journal.pone.0016075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249193	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000014
J	Shih, DQ; Barrett, R; Zhang, XL; Yeager, N; Koon, HW; Phaosawasdi, P; Song, YH; Ko, B; Wong, MH; Michelsen, KS; Martins, G; Pothoulakis, C; Targan, SR				Shih, David Q.; Barrett, Robert; Zhang, Xiaolan; Yeager, Nicole; Koon, Hon Wai; Phaosawasdi, Piangwarin; Song, Yahui; Ko, Brian; Wong, Michelle H.; Michelsen, Kathrin S.; Martins, Gislaine; Pothoulakis, Charalabos; Targan, Stephan R.			Constitutive TL1A (TNFSF15) Expression on Lymphoid or Myeloid Cells Leads to Mild Intestinal Inflammation and Fibrosis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR 9; IFN-GAMMA PRODUCTION; T-CELL; CROHNS-DISEASE; DENDRITIC CELLS; BOWEL-DISEASE; COLITIS; MICE; LYMPHOCYTES; ILEITIS	TL1A is a member of the TNF superfamily and its expression is increased in the mucosa of inflammatory bowel disease patients. Moreover, a subset of Crohn's disease (CD) patients with the risk TL1A haplotype is associated with elevated TL1A expression and a more severe disease course. To investigate the in vivo role of elevated TL1A expression, we generated two transgenic (Tg) murine models with constitutive Tl1a expression in either lymphoid or myeloid cells. Compared to wildtype (WT) mice, constitutive expression of Tl1a in either lymphoid or myeloid cells showed mild patchy inflammation in the small intestine, which was more prominent in the ileum. In addition, mice with constitutive Tl1a expression exhibited enhanced intestinal and colonic fibrosis compared to WT littermates. The percentage of T cells expressing the gut homing chemokine receptors CCR9 and CCR10 was higher in the Tl1a Tg mice compared to WT littermates. Sustained expression of Tl1A in T cells also lead to increased Foxp3+ Treg cells. T cells or antigen presenting cells (APC) with constitutive expression of Tl1a were found to have a more activated phenotype and mucosal mononuclear cells exhibit enhanced Th1 cytokine activity. These results indicated an important role of TL1A in mucosal T cells and APC function and showed that up-regulation of TL1A expression can promote mucosal inflammation and gut fibrosis.	[Shih, David Q.; Barrett, Robert; Zhang, Xiaolan; Yeager, Nicole; Phaosawasdi, Piangwarin; Ko, Brian; Wong, Michelle H.; Michelsen, Kathrin S.; Martins, Gislaine; Targan, Stephan R.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Zhang, Xiaolan] Hebei Med Univ, Hosp 2, Dept Gastroenterol, Shijianzuang, Peoples R China; [Koon, Hon Wai; Song, Yahui; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Hebei Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shih, DQ (corresponding author), Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	targans@cshs.org	Barrett, Robert/AAG-1941-2021		USPHS [DK056328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, R01DK056328] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	USPHS grant DK056328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Biener-Ramanujan E, 2010, FEBS LETT, V584, P2376, DOI 10.1016/j.febslet.2010.04.030; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Di Sabatino A, 2009, GUT, V58, P777, DOI 10.1136/gut.2008.149096; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kang YJ, 2005, CYTOKINE, V29, P229, DOI 10.1016/j.cyto.2004.12.001; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Koon HW, 2010, AM J PATHOL, V177, P2300, DOI 10.2353/ajpath.2010.100314; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Marsal J, 2002, EUR J IMMUNOL, V32, P3488, DOI 10.1002/1521-4141(200212)32:12<3488::AID-IMMU3488>3.0.CO;2-E; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; MEYLAN F, 2010, MUCOSAL IMMUNOL; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, FASEB J, V18, pA465; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rachmilewitz D, 2006, INFLAMM BOWEL DIS, V12, P339, DOI 10.1097/01.MIB.0000217335.30689.77; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Shih David Q, 2009, Curr Gastroenterol Rep, V11, P473; Shih DQ, 2009, EUR J IMMUNOL, V39, P3239, DOI 10.1002/eji.200839087; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Shinoda M, 2010, J GASTROENTEROL, V45, P608, DOI 10.1007/s00535-010-0210-z; Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; STAPPENBACK TS, 2010, AUTOPHAGY, V7; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; TARABAN VY, 2010, MUCOSAL IMMUNOL; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	52	132	143	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16090	10.1371/journal.pone.0016090	http://dx.doi.org/10.1371/journal.pone.0016090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264313	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000021
J	Orozovic, G; Orozovic, K; Lennerstrand, J; Olsen, B				Orozovic, Goran; Orozovic, Kanita; Lennerstrand, Johan; Olsen, Bjorn			Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds	PLOS ONE			English	Article							NEURAMINIDASE ACTIVE-SITE; COMBINATION CHEMOTHERAPY; GENETIC-CHARACTERIZATION; REDUCED SENSITIVITY; DRUG-RESISTANCE; IN-VITRO; INHIBITORS; H5N1; SUSCEPTIBILITY; EVOLUTION	The neuraminidase (NA) inhibitors oseltamivir and zanamivir are the first-line of defense against potentially fatal variants of influenza A pandemic strains. However, if resistant virus strains start to arise easily or at a high frequency, a new anti-influenza strategy will be necessary. This study aimed to investigate if and to what extent NA inhibitor-resistant mutants exist in the wild population of influenza A viruses that inhabit wild birds. NA sequences of all NA subtypes available from 5490 avian, 379 swine and 122 environmental isolates were extracted from NCBI databases. In addition, a dataset containing 230 virus isolates from mallard collected at Ottenby Bird Observatory (Oland, Sweden) was analyzed. Isolated NA RNA fragments from Ottenby were transformed to cDNA by RT-PCR, which was followed by sequencing. The analysis of genotypic profiles for NAs from both data sets in regard to antiviral resistance mutations was performed using bioinformatics tools. All 6221 sequences were scanned for oseltamivir- (I117V, E119V, D198N, I222V, H274Y, R292K, N294S and I314V) and zanamivir-related mutations (V116A, R118K, E119G/A/D, Q136K, D151E, R152K, R224K, E276D, R292K and R371K). Of the sequences from the avian NCBI dataset, 132 (2.4%) carried at least one, or in two cases even two and three, NA inhibitor resistance mutations. Swine and environmental isolates from the same data set had 18 (4.75%) and one (0.82%) mutant, respectively, with at least one mutation. The Ottenby sequences carried at least one mutation in 15 cases (6.52%). Therefore, resistant strains were more frequently found in Ottenby samples than in NCBI data sets. However, it is still uncertain if these mutations are the result of natural variations in the viruses or if they are induced by the selective pressure of xenobiotics (e.g., oseltamivir, zanamivir).	[Orozovic, Goran] Linneaus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Orozovic, Goran; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Sect Zoonot Ecol & Epidemiol, Uppsala, Sweden; [Orozovic, Kanita] Linneaus Univ, Sect Bioorgan & Biophys Chem Lab, Kalmar, Sweden; [Lennerstrand, Johan] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden	Linnaeus University; Uppsala University; Linnaeus University; Uppsala University	Orozovic, G (corresponding author), Linneaus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden.	goran.orozovic@lnu.se		Olsen, Bjorn/0000-0002-4646-691X; Tripp, Ralph/0000-0002-2924-9956	Swedish Research Council; Swedish Research Council Formas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was financially supported by the Swedish Research Council and the Swedish Research Council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, ANTIVIR RES, V77, P163, DOI 10.1016/j.antiviral.2007.08.008; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baigent SJ, 1999, VIROLOGY, V263, P323, DOI 10.1006/viro.1999.9931; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Deshpande J. D., 2009, Pravara Medical Review, V4, P4; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferraris O, 2005, ANTIVIR RES, V68, P43, DOI 10.1016/j.antiviral.2005.07.004; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Govorkova EA, 2010, VIRUSES-BASEL, V2, P1510, DOI 10.3390/v2081510; Gubareva LV, 2004, INT CONGR SER, V1263, P126, DOI 10.1016/j.ics.2004.01.048; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Harvala H, 2010, EUROSURVEILLANCE, V15, P2; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006; Ho HT, 2007, ANTIVIR RES, V76, P263, DOI 10.1016/j.antiviral.2007.08.002; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ilyushina N, 2006, ANTIVIR RES, V70, pA29; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Jhee SS, 2008, ANTIMICROB AGENTS CH, V52, P3687, DOI 10.1128/AAC.00327-08; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li JL, 2010, VIRUS RES, V147, P40, DOI 10.1016/j.virusres.2009.10.002; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; Okomo-Adhiambo M, 2010, ANTIVIR RES, V85, P381, DOI 10.1016/j.antiviral.2009.11.005; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2010, J VIROL METHODS, V170, P94, DOI 10.1016/j.jviromet.2010.09.006; Oshitani Hitoshi, 2006, Journal of Infection and Chemotherapy, V12, P167, DOI 10.1007/s10156-006-0453-z; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Richard M, 2008, J CLIN VIROL, V41, P20, DOI 10.1016/j.jcv.2007.10.021; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024	62	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16028	10.1371/journal.pone.0016028	http://dx.doi.org/10.1371/journal.pone.0016028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253602	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900036
J	Del Giudice, M				Del Giudice, Marco			Reduced Fertility in Patients' Families Is Consistent with the Sexual Selection Model of Schizophrenia and Schizotypy	PLOS ONE			English	Article							EPIDEMIOLOGY; PREVALENCE; CREATIVITY; RELATIVES; SIBLINGS; FITNESS; SUCCESS; COHORT; BIRTH	Background: Schizophrenia is a mental disorder marked by an evolutionarily puzzling combination of high heritability, reduced reproductive success, and a remarkably stable prevalence. Recently, it has been proposed that sexual selection may be crucially involved in the evolution of schizophrenia. In the sexual selection model (SSM) of schizophrenia and schizotypy, schizophrenia represents the negative extreme of a sexually selected indicator of genetic fitness and condition. Schizotypal personality traits are hypothesized to increase the sensitivity of the fitness indicator, thus conferring mating advantages on high-fitness individuals but increasing the risk of schizophrenia in low-fitness individuals; the advantages of successful schzotypy would be mediated by enhanced courtship-related traits such as verbal creativity. Thus, schizotypy-increasing alleles would be maintained by sexual selection, and could be selectively neutral or even beneficial, at least in some populations. However, most empirical studies find that the reduction in fertility experienced by schizophrenic patients is not compensated for by increased fertility in their unaffected relatives. This finding has been interpreted as indicating strong negative selection on schizotypy-increasing alleles, and providing evidence against sexual selection on schizotypy. Methodology: A simple mathematical model is presented, showing that reduced fertility in the families of schizophrenic patients can coexist with selective neutrality of schizotypy-increasing alleles, or even with positive selection on schizotypy in the general population. If the SSM is correct, studies of patients' families can be expected to underestimate the true fertility associated with schizotypy. Significance: This paper formally demonstrates that reduced fertility in the families of schizophrenic patients does not constitute evidence against sexual selection on schizotypy-increasing alleles. Futhermore, it suggests that the fertility estimates derived from extant studies may be biased to an unknown extent. These results have important implications for the evolutionary genetics of psychosis.	Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy	University of Turin	Del Giudice, M (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.	marco.delgiudice@unito.it	Del Giudice, Marco/F-7007-2010	Del Giudice, Marco/0000-0001-8526-1573	Regione Piemonte (Piedmont regional administration, Italy); bando Scienze Umane e Sociali [4/2006]	Regione Piemonte (Piedmont regional administration, Italy)(Regione Piemonte); bando Scienze Umane e Sociali	The study was supported by a grant from the Regione Piemonte (Piedmont regional administration, Italy). The grant title is: "bando Scienze Umane e Sociali 2008, L.R. n. 4/2006". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila M, 2001, SCHIZOPHR RES, V47, P233, DOI 10.1016/S0920-9964(00)00062-1; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; Brune M, 2004, NEUROSCI BIOBEHAV R, V28, P41, DOI 10.1016/j.neubiorev.2003.10.002; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Del Giudice M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00041; Doi N, 2009, PLOS ONE, V4, pA208, DOI 10.1371/journal.pone.0007799; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Haukka J, 2003, AM J PSYCHIAT, V160, P460, DOI 10.1176/appi.ajp.160.3.460; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; Kinney DK, 2000, CREATIVITY RES J, V13, P17; MacCabe JH, 2009, PSYCHOL MED, V39, P1667, DOI 10.1017/S0033291709005431; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 1999, ACTA PSYCHIAT SCAND, V99, P441, DOI 10.1111/j.1600-0447.1999.tb00990.x; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; NANKO S, 1993, ACTA PSYCHIAT SCAND, V87, P400, DOI 10.1111/j.1600-0447.1993.tb03395.x; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D., 2001, STRONG IMAGINATION M; Nettle D, 2006, BEHAV BRAIN SCI, V29, P418, DOI 10.1017/S0140525X06359092; Nettle D, 2006, J RES PERS, V40, P876, DOI 10.1016/j.jrp.2005.09.004; Nimgaonkar VL, 1998, ACTA PSYCHIAT SCAND, V98, P348, DOI 10.1111/j.1600-0447.1998.tb10097.x; PERUSSE D, 1993, BEHAV BRAIN SCI, V16, P267, DOI 10.1017/S0140525X00029939; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schretlen DJ, 2010, SCHIZOPHR RES, V118, P224, DOI 10.1016/j.schres.2010.01.008; Shaner A, 2004, SCHIZOPHR RES, V70, P101, DOI 10.1016/j.schres.2003.09.014; Srinivasan TN, 1997, ACTA PSYCHIAT SCAND, V96, P260, DOI 10.1111/j.1600-0447.1997.tb10161.x; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011	28	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e16040	10.1371/journal.pone.0016040	http://dx.doi.org/10.1371/journal.pone.0016040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21253008	gold, Green Published			2022-12-27	WOS:000285793200079
J	Gomez, JM; Perfectti, F; Jordano, P				Gomez, Jose M.; Perfectti, Francisco; Jordano, Pedro			The Functional Consequences of Mutualistic Network Architecture	PLOS ONE			English	Article							COEVOLUTIONARY NETWORKS; METABOLIC NETWORK; NESTEDNESS; SPECIALIZATION; COMPETITION	The architecture and properties of many complex networks play a significant role in the functioning of the systems they describe. Recently, complex network theory has been applied to ecological entities, like food webs or mutualistic plant-animal interactions. Unfortunately, we still lack an accurate view of the relationship between the architecture and functioning of ecological networks. In this study we explore this link by building individual-based pollination networks from eight Erysimum mediohispanicum (Brassicaceae) populations. In these individual-based networks, each individual plant in a population was considered a node, and was connected by means of undirected links to conspecifics sharing pollinators. The architecture of these unipartite networks was described by means of nestedness, connectivity and transitivity. Network functioning was estimated by quantifying the performance of the population described by each network as the number of per-capita juvenile plants produced per population. We found a consistent relationship between the topology of the networks and their functioning, since variation across populations in the average per-capita production of juvenile plants was positively and significantly related with network nestedness, connectivity and clustering. Subtle changes in the composition of diverse pollinator assemblages can drive major consequences for plant population performance and local persistence through modifications in the structure of the inter-plant pollination networks.	[Gomez, Jose M.] Univ Granada, Dept Ecol, Granada, Spain; [Perfectti, Francisco] Univ Granada, Dept Genet, Granada, Spain; [Jordano, Pedro] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain	University of Granada; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gomez, JM (corresponding author), Univ Granada, Dept Ecol, Granada, Spain.	jmgreyes@ugr.es	Perfectti, Francisco/C-5087-2008; Gómez, José M/K-8061-2017; Jordano, Pedro/A-5162-2008	Perfectti, Francisco/0000-0002-5551-213X; Gómez, José M/0000-0002-2487-4664; Jordano, Pedro/0000-0003-2142-9116	MARM [078/2007]; CYTED [409AC0369]; Consolider-Ingenio Montes [CSD2008-00040]; Spanish Ministry of Education and Science [CGL2009-07015, CGL2006-00373]; Junta de Andalucia [RNM220, CV165, P07-RNM2824]; Unidad Asociada CSIC-UGR "Grupo de Ecologia, Genetica y Coevolucion"	MARM; CYTED; Consolider-Ingenio Montes; Spanish Ministry of Education and Science(Spanish Government); Junta de Andalucia(Junta de Andalucia); Unidad Asociada CSIC-UGR "Grupo de Ecologia, Genetica y Coevolucion"	This work was supported by MARM grant (078/2007), CYTED (409AC0369), and Consolider-Ingenio Montes (CSD2008-00040) to JMG, the Spanish Ministry of Education and Science (CGL2009-07015 to FP and CGL2006-00373 to PJ), and by the Junta de Andalucia (RNM220 to JMG, CV165 to FP, P07-RNM2824 to PJ). Our collaborative work is supported by the Unidad Asociada CSIC-UGR "Grupo de Ecologia, Genetica y Coevolucion." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; CEDER A, 1986, TRANSPORT RES B-METH, V20, P331, DOI 10.1016/0191-2615(86)90047-0; Colwell RK, ESTIMATES STAT ESTIM; Dalsgaard B, 2008, OIKOS, V117, P789, DOI 10.1111/j.0030-1299.2008.16537.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fortuna MA, 2008, ECOL LETT, V11, P490, DOI 10.1111/j.1461-0248.2008.01167.x; FU BY, 2006, ORYZAE P NATL ACAD S, V103, P7994; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Gomez JM, 2007, OECOLOGIA, V153, P597, DOI 10.1007/s00442-007-0758-3; Greenberg AJ, 2008, MOL BIOL EVOL, V25, P2537, DOI 10.1093/molbev/msn205; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; HAINING R, 2002, SPATIAL DATA ANAL; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nooy De W., 2005, EXPLORATORY NETWORK; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pardalos P.M., 1997, NETWORK OPTIMIZATION; Parker D, 2006, PHILOS T R SOC B, V361, P81, DOI 10.1098/rstb.2005.1779; R Core Team, 2018, R LANG ENV STAT COMP; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	39	51	54	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16143	10.1371/journal.pone.0016143	http://dx.doi.org/10.1371/journal.pone.0016143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283583	Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400028
J	Rowe, M; Pruett-Jones, S				Rowe, Melissah; Pruett-Jones, Stephen			Sperm Competition Selects for Sperm Quantity and Quality in the Australian Maluridae	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; RELATIVE TESTIS SIZE; EJACULATE QUALITY; FAIRY-WRENS; ARTIFICIAL-INSEMINATION; INTERSPECIFIC VARIATION; SEMEN CHARACTERISTICS; OXIDATIVE STRESS; JAPANESE QUAIL; SEMINAL FLUID	When ejaculates from rival males compete for fertilization, there is strong selection for sperm traits that enhance fertilization success. Sperm quantity is one such trait, and numerous studies have demonstrated a positive association between sperm competition and both testes size and the number of sperm available for copulations. Sperm competition is also thought to favor increases in sperm quality and changes in testicular morphology that lead to increased sperm production. However, in contrast to sperm quantity, these hypotheses have received considerably less empirical support and remain somewhat controversial. In a comparative study using the Australian Maluridae (fairy-wrens, emu-wrens, grasswrens), we tested whether increasing levels of sperm competition were associated with increases in both sperm quantity and quality, as well as an increase in the relative amount of seminiferous tubule tissue contained within the testes. After controlling for phylogeny, we found positive associations between sperm competition and sperm numbers, both in sperm reserves and in ejaculate samples. Additionally, as sperm competition level increased, the proportion of testicular spermatogenic tissue also increased, suggesting that sperm competition selects for greater sperm production per unit of testicular tissue. Finally, we also found that sperm competition level was positively associated with multiple sperm quality traits, including the proportion of motile sperm in ejaculates and the proportion of both viable and morphologically normal sperm in sperm reserves. These results suggest multiple ejaculate traits, as well as aspects of testicular morphology, have evolved in response to sperm competition in the Australian Maluridae. Furthermore, our findings emphasize the importance of postcopulatory sexual selection as an evolutionary force shaping macroevolutionary differences in sperm phenotype.	[Rowe, Melissah; Pruett-Jones, Stephen] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Rowe, Melissah] Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, Oslo, Norway	University of Chicago; University of Oslo	Rowe, M (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	melissah.rowe@nhm.uio.no	Rowe, Melissah/G-3905-2015	Rowe, Melissah/0000-0001-9747-041X	National Science Foundation [IOB-051697]; University of Chicago	National Science Foundation(National Science Foundation (NSF)); University of Chicago(University of Chicago)	This work was supported by a grant to SP-J from the National Science Foundation (IOB-051697, 2005-2008) and by a grant to MR from the Hinds Fund from the University of Chicago (2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2008, OXID MED CELL LONGEV, V1, P15, DOI 10.4161/oxim.1.1.6843; ALLEN TE, 1958, AUST J AGR RES, V8, P788; AMANN RP, 1981, J ANDROL, V2, P37; Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; BAKST MR, 1997, TECHNIQUES SEMEN EVA, V3, P29; Balshine S, 2001, BEHAV ECOL, V12, P726, DOI 10.1093/beheco/12.6.726; BIRKHEAD TR, 1995, P ROY SOC B-BIOL SCI, V261, P153, DOI 10.1098/rspb.1995.0130; BIRKHEAD TR, 1993, BEHAV ECOL SOCIOBIOL, V32, P85, DOI 10.1007/BF00164040; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1995, NATURE, V377, P422, DOI 10.1038/377422a0; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; BLUMENSTIEL JP, 2010, J THEO BIOL, V249, P624; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; BRISKIE JV, 1993, AUK, V110, P875, DOI 10.2307/4088641; BROOKER MG, 1990, BEHAV ECOL SOCIOBIOL, V26, P191; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Christidis L, 1997, AUST J ZOOL, V45, P113, DOI 10.1071/ZO96068; Christidis L, 1999, AUST J ZOOL, V47, P113, DOI 10.1071/ZO98054; Ciereszko A, 2010, ANIM REPROD SCI, V122, P222, DOI 10.1016/j.anireprosci.2010.08.014; CLULOW J, 1982, J REPROD FERTIL, V64, P259, DOI 10.1530/jrf.0.0640259; COHEN J, 1967, NATURE, V215, P862, DOI 10.1038/215862a0; COHEN J, 1973, HEREDITY, V31, P408, DOI 10.1038/hdy.1973.96; COOPER DM, 1958, POULTRY SCI, V37, P699, DOI 10.3382/ps.0370699; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Denk AG, 2005, BEHAV ECOL, V16, P825, DOI 10.1093/beheco/ari065; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; DRISKELL AC, 2011, MOL PHYLO E IN PRESS; Dunn PO, 2001, EVOLUTION, V55, P161; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Firman RC, 2010, EVOLUTION, V64, P1245, DOI 10.1111/j.1558-5646.2009.00894.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 2006, BIOL REPROD, V74, P487, DOI 10.1095/biolreprod.105.046755; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; FUJIHARA N, 1978, POULTRY SCI, V57, P1766, DOI 10.3382/ps.0571766; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Gee GF, 2004, AVIAN POULT BIOL REV, V15, P47, DOI 10.3184/147020604783637435; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; HARRISON CJO, 1969, AMYTORNIS EMU, V69, P1; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Immler S, 2007, P ROY SOC B-BIOL SCI, V274, P561, DOI 10.1098/rspb.2006.3752; Karubian J, 2002, EVOLUTION, V56, P1673; Kingma Sjouke A., 2009, BMC Ecology, V9, P15, DOI 10.1186/1472-6785-9-15; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Lake P.E., 1975, Symposia Zool Soc Lond, VNo. 35, P225; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIN M, 1990, J REPROD FERTIL, V88, P481, DOI 10.1530/jrf.0.0880481; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Maguire GS, 2008, AUST J ZOOL, V56, P79, DOI 10.1071/ZO08047; Maguire GS, 2004, AUST J ZOOL, V52, P583, DOI 10.1071/ZO04043; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; MARTIN PA, 1974, J REPROD FERTIL, V39, P251, DOI 10.1530/jrf.0.0390251; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MOLLER AP, 1988, BIOL J LINN SOC, V33, P273, DOI 10.1111/j.1095-8312.1988.tb00812.x; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; MULDER RA, 1993, AUK, V110, P588, DOI 10.2307/4088422; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Noirault K, 2006, THERIOGENOLOGY, V65, P845, DOI 10.1016/j.theriogenology.2005.01.012; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parapanov R, 2008, REPROD FERT DEVELOP, V20, P431, DOI 10.1071/RD07207; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peirce EJ, 2001, REPRODUCTION, V121, P239, DOI 10.1530/rep.0.1210239; Penfold LM, 2000, REPROD FERT DEVELOP, V12, P229, DOI 10.1071/RD00093; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pizzari T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-332; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; Reviers M. de, 1984, Reproductive biology. Proceedings of the 17th Poultry Science Symposium, 1982., P183; Rowe M, 2006, AVIAN POULT BIOL REV, V17, P21, DOI 10.3184/147020606783437949; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rowe M, 2008, CONDOR, V110, P694, DOI 10.1525/cond.2008.8604; Rowley I., 1997, FAIRY WRENS GRASSWRE; Schultz AH, 1938, ANAT REC, V72, P387, DOI 10.1002/ar.1090720310; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Sontakke SD, 2004, THERIOGENOLOGY, V62, P139, DOI 10.1016/j.theriogenology.2003.08.018; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Tuttle EM, 1996, P ROY SOC B-BIOL SCI, V263, P1359, DOI 10.1098/rspb.1996.0199; Tuttle EM, 2004, ANIM BEHAV, V68, P541, DOI 10.1016/j.anbehav.2003.09.014; Webster MS, 2008, BEHAV ECOL, V19, P517, DOI 10.1093/beheco/arn015; Webster MS, 2004, BEHAV ECOL, V15, P907, DOI 10.1093/beheco/arh093; Westneat DF, 1998, BEHAV ECOL SOCIOBIOL, V43, P161, DOI 10.1007/s002650050477; WISHART GJ, 1984, J REPROD FERTIL, V71, P113, DOI 10.1530/jrf.0.0710113; Wishart GJ, 2002, REPROD FERT DEVELOP, V14, P401, DOI 10.1071/RD02014; WISHART GJ, 1997, TECHNIQUES SEMEN EVA; Wolfson A., 1952, Bird-Banding, V23, P159; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	105	67	68	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15720	10.1371/journal.pone.0015720	http://dx.doi.org/10.1371/journal.pone.0015720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283577	gold, Green Published			2022-12-27	WOS:000286661400013
J	Alimirah, F; Peng, XJ; Murillo, G; Mehta, RG				Alimirah, Fatouma; Peng, Xinjian; Murillo, Genoveva; Mehta, Rajendra G.			Functional Significance of Vitamin D Receptor FokI Polymorphism in Human Breast Cancer Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; UP-REGULATION; KAPPA-B; PROTEIN; RISK; GENE; D-3; DEGRADATION; METASTASIS; THERAPY	Background: The FokI vitamin D receptor (VDR) polymorphism results in different translation initiation sites on VDR. In the VDRff variant, initiation of translation occurs at the first ATG site, giving rise to a full length VDR protein of 427 amino acids. Conversely, in the VDRFF variant, translation begins at the second ATG site, resulting in a truncated protein with three less amino acids. Epidemiological studies have paradoxically implicated this polymorphism with increased breast cancer risk. 1 alpha,25 (OH)(2)D-3, the active metabolite of vitamin D, is known to inhibit cell proliferation, induce apoptosis and potentiate differentiation in human breast cancer cells. It is well documented that 1 alpha,25 (OH)(2)D-3 downregulates estrogen receptor alpha expression and inhibits estrogen mediated signaling in these cells. The functional significance of the VDR FokI polymorphism in vitamin D action is undefined. Methods/Findings: To elucidate the functional role of FokI polymorphism in breast cancer, MCF-7-Vector, MCF-7-VDRff and MCF-7-VDRFF stable cell lines were established from parental MCF-7 cells as single-cell clones. In response to 1 alpha,25 (OH)(2)D-3 treatments, cell growth was inhibited by 60% in VDRFF cells compared to 28% in VDRff cells. The induction of the vitamin D target gene CYP24A1 mRNA was 1.8 fold higher in VDRFF cells than in VDRff cells. Estrogen receptor-a protein expression was downregulated by 62% in VDRFF cells compared to 25% in VDRff cells. VDR protein stability was greater in MCF-7-VDRFF cells in the presence of cycloheximide. PCR array analyses of VDRff and VDRFF cells revealed increased basal expression levels of pro-inflammatory genes Cyclooxygenase-2, Interleukin-8 and Chemokine (C-C Motif) Ligand 2 in MCF-7-VDRff cells by 14, 52.7 and 5 fold, respectively. Conclusions/Significance: These results suggest that a VDRff genotype may play a role in amplifying aggressive breast cancer, paving the way for understanding why some breast cancer cells respond inefficiently to vitamin D treatment.	[Alimirah, Fatouma; Peng, Xinjian; Murillo, Genoveva; Mehta, Rajendra G.] IIT, IIT Res Inst, Div Canc Biol, Chicago, IL 60616 USA; [Alimirah, Fatouma; Murillo, Genoveva; Mehta, Rajendra G.] IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Alimirah, F (corresponding author), IIT, IIT Res Inst, Div Canc Biol, Chicago, IL 60616 USA.	rmehta@iitri.org			NCI [1F31CA132619]; Illinois State DFI [NCI RO3 CA12136-02]; NATIONAL CANCER INSTITUTE [F31CA132619] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Illinois State DFI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by NCI Predoctoral Fellowship 1F31CA132619 (FA), Illinois State DFI Predoctoral Fellowship (FA) NCI RO3 CA12136-02 (XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P1659, DOI 10.1016/j.febslet.2006.02.015; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Crew KD, 2009, J CLIN ONCOL, V27, P2151, DOI 10.1200/JCO.2008.19.6162; Dalloul A, 2009, AUTOIMMUN REV, V8, P349, DOI 10.1016/j.autrev.2008.11.007; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Hussain EA, 2003, RECENT RESULTS CANC, V164, P393; Jensen SS, 2002, J STEROID BIOCHEM, V81, P123, DOI 10.1016/S0960-0760(02)00057-2; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Kang JX, 2005, CARCINOGENESIS, V26, P1934, DOI 10.1093/carcin/bgi154; Kemmis CM, 2006, J NUTR, V136, P887, DOI 10.1093/jn/136.4.887; Li XY, 1999, MOL ENDOCRINOL, V13, P1686, DOI 10.1210/me.13.10.1686; Lima RT, 2004, CANCER GENE THER, V11, P309, DOI 10.1038/sj.cgt.7700706; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; McCullough ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1642; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Peng XJ, 2007, CARCINOGENESIS, V28, P1000, DOI 10.1093/carcin/bgl230; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Reichrath J, 2007, CANCER BIOL THER, V6, P48, DOI 10.4161/cbt.6.1.3493; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Sinotte M, 2008, ENDOCR-RELAT CANCER, V15, P975, DOI 10.1677/ERC-08-0056; Swami S, 2000, CLIN CANCER RES, V6, P3371; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	39	52	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16024	10.1371/journal.pone.0016024	http://dx.doi.org/10.1371/journal.pone.0016024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283672	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400012
J	Lamers, RP; Stinnett, JW; Muthukrishnan, G; Parkinson, CL; Cole, AM				Lamers, Ryan P.; Stinnett, Jason W.; Muthukrishnan, Gowrishankar; Parkinson, Christopher L.; Cole, Alexander M.			Evolutionary Analyses of Staphylococcus aureus Identify Genetic Relationships between Nasal Carriage and Clinical Isolates	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLUMPING FACTOR; HUMAN INFECTIONS; REPEAT REGION; CLONAL GROUPS; SPA; DIVERSITY; EMERGENCE; COAGULASE; INFERENCE	Nasal carriage of Staphylococcus aureus has long been hypothesized to be a major vector for the transmission of virulent strains throughout the community. To address this hypothesis, we have analyzed the relatedness between a cohort of nasal carriage strains and clinical isolates to understand better the genetic conformity therein. To assess the relatedness between nasal carriage and clinical isolates of S. aureus, a genetic association study was conducted using multilocus sequence typing (MLST) and typing of the hypervariable regions of clumping factor and fibronectin binding protein genes. At all loci analyzed, genetic associations between both nasal carriage and clinical isolates were observed. Computational analyses of MLST data indicate that nasal carriage and clinical isolates belong to the same genetic clusters (clades), despite differences in sequence type assignments. Genetic analyses of the hypervariable regions from the clumping factor and fibronectin binding protein genes revealed that not only do clinically relevant strains belong to identical genetic lineages as the nasal carriage isolates within our cohort, but they also exhibit 100% sequence similarity within these regions. The findings of this report indicate that strains of S. aureus being carried asymptomatically throughout the community via nasal colonization are genetically related to those responsible for high levels of morbidity and mortality.	[Lamers, Ryan P.; Muthukrishnan, Gowrishankar; Cole, Alexander M.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Stinnett, Jason W.] Univ Cent Florida, Sch Elect Engn & Comp Sci, Orlando, FL 32816 USA; [Parkinson, Christopher L.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Lamers, RP (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	acole@mail.ucf.edu	Parkinson, Christopher L./AAV-9370-2021; Muthukrishnan, Gowrishankar/H-3031-2019	Muthukrishnan, Gowrishankar/0000-0001-7521-6154	National Institutes of Health [AI060753]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded in part by grant #AI060753 from the National Institutes of Health (to A.M.C.) and from a doctoral postgraduate scholarship (PGS-D) from the Natural Sciences and Engineering Research Council of Canada (to R.P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos DH, 2005, DEV COMP IMMUNOL, V29, P211, DOI 10.1016/j.dci.2004.07.007; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; De Lencastre H, 2000, MICROB DRUG RESIST, V6, P1, DOI 10.1089/mdr.2000.6.1; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gomes AR, 2005, ANTIMICROB AGENTS CH, V49, P366, DOI 10.1128/AAC.49.1.366-379.2005; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koreen L, 2005, J CLIN MICROBIOL, V43, P3985, DOI 10.1128/JCM.43.8.3985-3994.2005; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kuhn G, 2007, J CLIN MICROBIOL, V45, P54, DOI 10.1128/JCM.01457-06; Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Said KB, 2010, J CLIN MICROBIOL, V48, P375, DOI 10.1128/JCM.01768-09; Said KB, 2010, FOODBORNE PATHOG DIS, V7, P111, DOI 10.1089/fpd.2009.0334; Said KB, 2009, DIAGN MICR INFEC DIS, V63, P24, DOI 10.1016/j.diagmicrobio.2008.09.004; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shopsin B, 2000, J CLIN MICROBIOL, V38, P3453, DOI 10.1128/JCM.38.9.3453-3456.2000; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; VanBelkum A, 1997, J MED MICROBIOL, V46, P222, DOI 10.1099/00222615-46-3-222; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	46	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16426	10.1371/journal.pone.0016426	http://dx.doi.org/10.1371/journal.pone.0016426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283661	gold, Green Published			2022-12-27	WOS:000286522300047
J	Twine, NA; Janitz, K; Wilkins, MR; Janitz, M				Twine, Natalie A.; Janitz, Karolina; Wilkins, Marc R.; Janitz, Michal			Whole Transcriptome Sequencing Reveals Gene Expression and Splicing Differences in Brain Regions Affected by Alzheimer's Disease	PLOS ONE			English	Article							RNA-SEQ; APOLIPOPROTEIN-E; MESSENGER-RNA; ADULT BRAIN; PROTEIN; CELLS; MICROARRAY; DISORDERS; RECEPTOR; NEURONS	Recent studies strongly indicate that aberrations in the control of gene expression might contribute to the initiation and progression of Alzheimer's disease (AD). In particular, alternative splicing has been suggested to play a role in spontaneous cases of AD. Previous transcriptome profiling of AD models and patient samples using microarrays delivered conflicting results. This study provides, for the first time, transcriptomic analysis for distinct regions of the AD brain using RNA-Seq next-generation sequencing technology. Illumina RNA-Seq analysis was used to survey transcriptome profiles from total brain, frontal and temporal lobe of healthy and AD post-mortem tissue. We quantified gene expression levels, splicing isoforms and alternative transcript start sites. Gene Ontology term enrichment analysis revealed an overrepresentation of genes associated with a neuron's cytological structure and synapse function in AD brain samples. Analysis of the temporal lobe with the Cufflinks tool revealed that transcriptional isoforms of the apolipoprotein E gene, APOE-001, -002 and -005, are under the control of different promoters in normal and AD brain tissue. We also observed differing expression levels of APOE-001 and -002 splice variants in the AD temporal lobe. Our results indicate that alternative splicing and promoter usage of the APOE gene in AD brain tissue might reflect the progression of neurodegeneration.	[Twine, Natalie A.; Wilkins, Marc R.; Janitz, Michal] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Twine, Natalie A.; Wilkins, Marc R.] Univ New S Wales, New S Wales Syst Biol Initiat, Sydney, NSW, Australia; [Janitz, Karolina; Wilkins, Marc R.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Twine, NA (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	m.janitz@unsw.edu.au	Twine, Natalie A/AAH-7966-2021; Twine, Natalie/R-6441-2018; Janitz, Michael/E-9823-2015; Twine, Natalie/AAM-5043-2021	Janitz, Michael/0000-0002-4878-0259; Twine, Natalie/0000-0002-2051-8275	UNSW Science Faculty [2010]; New South Wales Office for Science and Medical Research; Australian Government's Super Science Initiative	UNSW Science Faculty; New South Wales Office for Science and Medical Research; Australian Government's Super Science Initiative(Australian GovernmentDepartment of Industry, Innovation and Science)	MJ acknowledges support from a UNSW Science Faculty Research Grant 2010. MW and the NSW Systems Biology Initiative acknowledge support from the New South Wales Office for Science and Medical Research and the Australian Government's Super Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Bales KR, 2010, NEUROPHARMACOLOGY, V59, P295, DOI 10.1016/j.neuropharm.2010.01.005; Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GEULA C, 1995, ALZ DIS ASSOC DIS, V9, P23, DOI 10.1097/00002093-199501002-00005; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Guo H, 2002, MOL CELL NEUROSCI, V21, P546, DOI 10.1006/mcne.2002.1198; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Ishunina TA, 2009, NEUROENDOCRINOLOGY, V89, P187, DOI 10.1159/000158573; Janitz M., 2008, NEXT GENERATION GENO, V1st; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maruszak A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-115; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; SUTHERLAND GT, 2010, J NEUROCHEM; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	50	213	216	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16266	10.1371/journal.pone.0016266	http://dx.doi.org/10.1371/journal.pone.0016266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283692	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300025
J	Yang, C; Zhang, MJ; Niu, WP; Yang, RJ; Zhang, YH; Qiu, ZY; Sun, BX; Zhao, ZH				Yang, Chun; Zhang, Mingjun; Niu, Weiping; Yang, Runjun; Zhang, Yonghong; Qiu, Zhengyan; Sun, Boxing; Zhao, Zhihui			Analysis of DNA Methylation in Various Swine Tissues	PLOS ONE			English	Article							CYTOSINE METHYLATION; GENE-EXPRESSION; AFLP; RICE; AMPLIFICATION; PATTERNS; METHYLTRANSFERASES; HYBRIDIZATION; SEQUENCE; CHICKEN	DNA methylation is known to play an important role in regulating gene expression during biological development and tissue differentiation in eukaryotes. In this study, we used the fluorescence-labeled methylation-sensitive amplified polymorphism (F-MSAP) method to assess the extent and pattern of cytosine methylation in muscle, heart, liver, spleen, lung, kidney and stomach from the swine strain Laiwu, and we also examined specific methylation patterns in the seven tissues. In total, 96,371 fragments, each representing a recognition site cleaved by either or both EcoRI + HpaII and EcoRI + MspI, the HpaII and MspI are isoschizomeric enzymes, were amplified using 16 pairs of selective primers. A total of 50,094 sites were found to be methylated at cytosines in seven tissues. The incidence of DNA methylation was approximately 53.99% in muscle, 51.24% in the heart, 50.18% in the liver, 53.31% in the spleen, 51.97% in the lung, 51.15% in the kidney and 53.39% in the stomach, as revealed by the incidence of differential digestion. Additionally, differences in DNA methylation levels imply that such variations may be related to specific gene expression during tissue differentiation, growth and development. Three types of bands were generated in the F-MSAP profile, the total numbers of these three types of bands in the seven tissues were 46,277, 24,801 and 25,293, respectively. In addition, different methylation patterns were observed in seven tissues from pig, and almost all of the methylation patterns detected by F-MSAP could be confirmed by Southern analysis using the isolated amplified fragments as probes. The results clearly demonstrated that the F-MSAP technique can be adapted for use in large-scale DNA methylation detection in the pig genome.	[Yang, Chun; Zhang, Mingjun; Niu, Weiping; Yang, Runjun; Zhang, Yonghong; Qiu, Zhengyan; Sun, Boxing; Zhao, Zhihui] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China	Jilin University	Yang, C (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China.	sbx@jlu.edu.cn; zhzhao@jlu.edu.cn	Yang, Runjun/ABA-5056-2021	Yang, Runjun/0000-0003-1401-4318; siva, Vinu/0000-0003-4252-5211	National Natural Science Foundation [30771543]; National High-Tech Research and Development Program [2008AA10Z136]; Jilin Scientific and Technological Development Program [20070567]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China); Jilin Scientific and Technological Development Program	This work was supported by the National Natural Science Foundation (30771543), National High-Tech Research and Development Program (2008AA10Z136) and Jilin Scientific and Technological Development Program (20070567). We thank Professor Yunliang Jiang of Shandong Agricultural University for providing experimental samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; CHEN B, 1976, CHEM-BIOL INTERACT, V14, P101, DOI 10.1016/0009-2797(76)90028-4; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; De Montera B, 2004, CLONING STEM CELLS, V6, P133, DOI 10.1089/1536230041372382; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Eggermann T, 2009, HORM RES, V71, P30, DOI 10.1159/000192433; Finnegan E J, 1993, EXS, V64, P218; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Gurrieri F, 2009, ENDOCRIN DEV, V14, P20, DOI 10.1159/000207473; Huang J, 1999, BIOTECHNOL TECH, V13, P277, DOI 10.1023/A:1008970618252; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; JOST J, 1993, DNA METHYLATION MOLE; Labra M, 2004, CHEMOSPHERE, V54, P1049, DOI 10.1016/j.chemosphere.2003.10.024; LI X, 2002, PLANT PHYSL, V159; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MANDEL JL, 1979, NUCLEIC ACIDS RES, V7, P2081, DOI 10.1093/nar/7.8.2081; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sasaki H., 1993, Experientia Supplementum (Basel), V64, P469; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Terefework Z, 2001, J BIOTECHNOL, V91, P169, DOI 10.1016/S0168-1656(01)00338-8; Vanyushin BF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P488, DOI 10.1007/s10541-005-0143-y; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P4631, DOI 10.1093/nar/5.12.4631; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang X, 2008, CANCER LETT, V270, P132, DOI 10.1016/j.canlet.2008.04.053; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2004, THEOR APPL GENET, V109, P899, DOI 10.1007/s00122-004-1717-6; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Xu Q, 2005, CHINESE SCI BULL, V50, P2039, DOI 10.1360/982005-834; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Yeivin A, 1993, EXS, V64, P523; Zhao SH, 2000, MICROBES INFECT, V2, P107, DOI 10.1016/S1286-4579(00)00278-1	46	113	124	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16229	10.1371/journal.pone.0016229	http://dx.doi.org/10.1371/journal.pone.0016229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283691	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300021
J	Resnik-Docampo, M; de Celis, JF				Resnik-Docampo, Martin; de Celis, Jose F.			MAP4K3 Is a Component of the TORC1 Signalling Complex that Modulates Cell Growth and Viability in Drosophila melanogaster	PLOS ONE			English	Article							AMINO-ACIDS; PATTERN-FORMATION; GENE-EXPRESSION; RAG GTPASES; S6 KINASE; TARGET; SIZE; MTOR; REGULATOR; PATHWAY	Background: MAP4K3 is a conserved Ser/Thr kinase that has being found in connection with several signalling pathways, including the Imd, EGFR, TORC1 and JNK modules, in different organisms and experimental assays. We have analyzed the consequences of changing the levels of MAP4K3 expression in the development of the Drosophila wing, a convenient model system to characterize gene function during epithelial development. Methodology and Principal Findings: Using loss-of-function mutants and over-expression conditions we find that MAP4K3 activity affects cell growth and viability in the Drosophila wing. These requirements are related to the modulation of the TORC1 and JNK signalling pathways, and are best detected when the larvae grow in a medium with low protein concentration (TORC1) or are exposed to irradiation (JNK). We also show that MAP4K3 display strong genetic interactions with different components of the InR/Tor signalling pathway, and can interact directly with the GTPases RagA and RagC and with the multi-domain kinase Tor. Conclusions and Significance: We suggest that MAP4K3 has two independent functions during wing development, one related to the activation of the JNK pathway in response to stress and other in the assembling or activation of the TORC1 complex, being critical to modulate cellular responses to changes in nutrient availability.	[Resnik-Docampo, Martin] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Resnik-Docampo, M (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jfdecelis@cbm.uam.es	resnik-docampo, martin/B-7671-2019; de+Celis, Jose/AAE-8142-2019	resnik-docampo, martin/0000-0001-7016-9061; de Celis, Jose F./0000-0003-4808-9844	Fundacin Ramn Areces;  [BFU2009-09403];  [CSD2007-00008]	Fundacin Ramn Areces; ; 	Grants BFU2009-09403 and CSD2007-00008 were given to J.F.dC., and an institutional grant from Fundacin Ramn Areces to the Centro de Biologia Molecular Severo Ochoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bryk B, 2010, DEV BIOL, V344, P150, DOI 10.1016/j.ydbio.2010.04.027; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Cohen S. M., 1993, IMAGINAL DISC DEV; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cook Simon J, 2007, Biochem J, V403, pe1; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gelbart WM, 1997, NUCLEIC ACIDS RES, V25, P63, DOI 10.1093/nar/25.1.63; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito K, 1997, DEVELOPMENT, V124, P761; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lam D, 2009, CELL CYCLE, V8, P3248, DOI 10.4161/cc.8.20.9572; Lam D, 2009, P NATL ACAD SCI USA, V106, P11978, DOI 10.1073/pnas.0900608106; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Molnar C, 2006, GENETICS, V174, P1635, DOI 10.1534/genetics.106.061283; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Stewart MJ, 1996, P NATL ACAD SCI USA, V93, P10791, DOI 10.1073/pnas.93.20.10791; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zinke I, 1999, DEVELOPMENT, V126, P5275	56	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14528	10.1371/journal.pone.0014528	http://dx.doi.org/10.1371/journal.pone.0014528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267071	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500007
J	Rubins, KH; Hensley, LE; Relman, DA; Brown, PO				Rubins, Kathleen H.; Hensley, Lisa E.; Relman, David A.; Brown, Patrick O.			Stunned Silence: Gene Expression Programs in Human Cells Infected with Monkeypox or Vaccinia Virus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BROAD SPECIES-SPECIFICITY; DEPENDENT PROTEIN-KINASE; HUMAN HELA-CELLS; E3L GENE; OLIGONUCLEOTIDE ARRAYS; INTERFERON-ALPHA; BINDING-PROTEINS; ANKARA INFECTION; IMMUNE EVASION	Poxviruses use an arsenal of molecular weapons to evade detection and disarm host immune responses. We used DNA microarrays to investigate the gene expression responses to infection by monkeypox virus (MPV), an emerging human pathogen, and Vaccinia virus (VAC), a widely used model and vaccine organism, in primary human macrophages, primary human fibroblasts and HeLa cells. Even as the overwhelmingly infected cells approached their demise, with extensive cytopathic changes, their gene expression programs appeared almost oblivious to poxvirus infection. Although killed (gamma-irradiated) MPV potently induced a transcriptional program characteristic of the interferon response, no such response was observed during infection with either live MPV or VAC. Moreover, while the gene expression response of infected cells to stimulation with ionomycin plus phorbol 12-myristate 13-acetate (PMA), or poly (I-C) was largely unimpaired by infection with MPV, a cluster of pro-inflammatory genes were a notable exception. Poly(I-C) induction of genes involved in alerting the innate immune system to the infectious threat, including TNF-alpha, IL-1 alpha and beta, CCL5 and IL-6, were suppressed by infection with live MPV. Thus, MPV selectively inhibits expression of genes with critical roles in cell-signaling pathways that activate innate immune responses, as part of its strategy for stealthy infection.	[Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; [Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; [Rubins, Kathleen H.; Brown, Patrick O.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Hensley, Lisa E.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Brown, Patrick O.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Howard Hughes Medical Institute; Stanford University	Rubins, KH (corresponding author), Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA.	pbrown@stanford.edu		Relman, David A./0000-0001-8331-1354; Hensley, Lisa/0000-0003-1188-4342	Howard Hughes Medical Institute; National Institutes of Health [CA77097, AI54922]; Thomas C. and Joan M. Merigan Endowment at Stanford University; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054922] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas C. and Joan M. Merigan Endowment at Stanford University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was supported by the Howard Hughes Medical Institute (POB), National Institutes of Health Grants CA77097 (POB) and AI54922 (DAR); and the Thomas C. and Joan M. Merigan Endowment at Stanford University (DAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 1996, COMP IMMUNOL MICROB, V19, P305, DOI 10.1016/0147-9571(96)00013-6; ALCAMI A, 1995, J VIROL, V69, P4633; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alkhalil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-173; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; CARROLL K, 1993, J BIOL CHEM, V268, P12837; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Cunnion KM, 1999, MOL GENET METAB, V67, P278, DOI 10.1006/mgme.1999.2878; DAVIES MV, 1992, J VIROL, V66, P1943, DOI 10.1128/JVI.66.4.1943-1950.1992; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; ESPOSITO JJ, 2001, VIROLOGY, P2885; Guerra S, 2004, J VIROL, V78, P5820, DOI 10.1128/JVI.78.11.5820-5834.2004; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Jahrling PB, 1996, ARCH VIROL, P135; JEZEK Z, 1988, HUMAN MONKEYPOX, P1; Jezek Z, 1988, HUMAN MONKEYPOX; Kim YG, 2004, P NATL ACAD SCI USA, V101, P1514, DOI 10.1073/pnas.0308260100; Liu Y, 2001, VIROLOGY, V289, P378, DOI 10.1006/viro.2001.1154; Ludwig H, 2005, J VIROL, V79, P2584, DOI 10.1128/JVI.79.4.2584-2596.2005; MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288; MOSSMAN K, 1995, VIROLOGY, V208, P762, DOI 10.1006/viro.1995.1208; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rasschaert J, 2003, DIABETOLOGIA, V46, pA48; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072; Rubins KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002628; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Shchelkunov SN, 2002, VIROLOGY, V297, P172, DOI 10.1006/viro.2002.1446; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Weaver JR, 2008, IMMUNOL REV, V225, P96, DOI 10.1111/j.1600-065X.2008.00691.x; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	60	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15615	10.1371/journal.pone.0015615	http://dx.doi.org/10.1371/journal.pone.0015615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267444	Green Submitted, Green Published, gold			2022-12-27	WOS:000286519500024
J	Strauss, R; Li, ZY; Liu, Y; Beyer, I; Persson, J; Sova, P; Moller, T; Pesonen, S; Hemminki, A; Hamerlik, P; Drescher, C; Urban, N; Bartek, J; Lieber, A				Strauss, Robert; Li, Zong-Yi; Liu, Ying; Beyer, Ines; Persson, Jonas; Sova, Pavel; Moeller, Thomas; Pesonen, Sari; Hemminki, Akseli; Hamerlik, Petra; Drescher, Charles; Urban, Nicole; Bartek, Jiri; Lieber, Andre			Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity	PLOS ONE			English	Article							STEM-CELL PROPERTIES; E-CADHERIN; PROSPECTIVE IDENTIFICATION; TUMOR PROGRESSION; EXPRESSION; TRANSITION; CARCINOMA; CD133; SUBPOPULATION; GLIOBLASTOMA	In our studies of ovarian cancer cells we have identified subpopulations of cells that are in a transitory E/M hybrid stage, i.e. cells that simultaneously express epithelial and mesenchymal markers. E/M cells are not homogenous but, in vitro and in vivo, contain subsets that can be distinguished based on a number of phenotypic features, including the subcellular localization of E-cadherin, and the expression levels of Tie2, CD133, and CD44. A cellular subset (E/M-MP) (membrane E-cadherin(low)/cytoplasmic E-cadherin(high)/CD133(high), CD44(high), Tie2(low)) is highly enriched for tumor-forming cells and displays features which are generally associated with cancer stem cells. Our data suggest that E/M-MP cells are able to differentiate into different lineages under certain conditions, and have the capacity for self-renewal, i.e. to maintain a subset of undifferentiated E/M-MP cells during differentiation. Trans-differentiation of E/M-MP cells into mesenchymal or epithelial cells is associated with a loss of stem cell markers and tumorigenicity. In vivo xenograft tumor growth is driven by E/M-MP cells, which give rise to epithelial ovarian cancer cells. In contrast, in vitro, we found that E/M-MP cells differentiate into mesenchymal cells, in a process that involves pathways associated with an epithelial-to-mesenchymal transition. We also detected phenotypic plasticity that was dependent on external factors such as stress created by starvation or contact with either epithelial or mesenchymal cells in co-cultures. Our study provides a better understanding of the phenotypic complexity of ovarian cancer and has implications for ovarian cancer therapy.	[Strauss, Robert; Li, Zong-Yi; Liu, Ying; Beyer, Ines; Persson, Jonas; Lieber, Andre] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Sova, Pavel; Lieber, Andre] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Pesonen, Sari; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Helsinki, Finland; [Pesonen, Sari; Hemminki, Akseli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Drescher, Charles; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Strauss, Robert; Hamerlik, Petra; Bartek, Jiri] Ctr Genotox Stress Res, Danish Canc Soc, Dept Cell Cycle & Canc, Copenhagen, Denmark; [Hamerlik, Petra; Bartek, Jiri] Palacky Univ, Lab Genom Integr, CR-77147 Olomouc, Czech Republic; [Hamerlik, Petra; Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Fred Hutchinson Cancer Center; Danish Cancer Society; Palacky University Olomouc; Palacky University Olomouc	Strauss, R (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	lieber00@u.washington.edu	Bartek, Jiri/G-5870-2014; , Petra/U-2260-2019; Beyer, Ines/Q-3236-2017	, Petra/0000-0002-5856-0161; Beyer, Ines/0000-0001-7468-4466; Lieber, Andre/0000-0001-6742-6266	NIH [R01 CA080192, R01 HLA078836]; Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer [P50 CA83636]; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA136487, R01CA144057, R01CA080192] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported by NIH grants R01 CA080192, R01 HLA078836, and Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer Grant P50 CA83636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnoux V, 2005, MOL B INT U, P111; Auersperg N, 2002, INT J GYNECOL CANCER, V12, P691, DOI 10.1046/j.1525-1438.2002.01152.x; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fong MY, 2010, HISTOL HISTOPATHOL, V25, P113, DOI 10.14670/HH-25.113; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Imai T, 2004, HUM PATHOL, V35, P1469, DOI 10.1016/j.humpath.2004.09.014; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li ZY, 2004, MOL THER, V9, P650, DOI 10.1016/j.ymthe.2004.01.021; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; Martin V, 2009, ONCOGENE, V28, P2358, DOI 10.1038/onc.2009.103; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Thiery JP, 2005, DEV CELL, V8, P456, DOI 10.1016/j.devcel.2005.03.002; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; TURLEY EA, 2008, NAT CLIN PRACT ONCOL; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wong Alice S T, 2002, Cancer Treat Res, V107, P161; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	47	148	154	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16186	10.1371/journal.pone.0016186	http://dx.doi.org/10.1371/journal.pone.0016186			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264259	gold, Green Submitted, Green Published			2022-12-27	WOS:000286516500035
J	Zhang, J; Alcaide, P; Liu, L; Sun, JS; He, AN; Luscinskas, FW; Shi, GP				Zhang, Jie; Alcaide, Pilar; Liu, Li; Sun, Jiusong; He, Aina; Luscinskas, Francis W.; Shi, Guo-Ping			Regulation of Endothelial Cell Adhesion Molecule Expression by Mast Cells, Macrophages, and Neutrophils	PLOS ONE			English	Article							E-DEFICIENT MICE; P-SELECTIN; ATHEROSCLEROTIC LESIONS; UNSTABLE ANGINA; UP-REGULATION; VCAM-1; ICAM-1; ATHEROGENESIS; INFILTRATION; CYTOKINES	Background: Leukocyte adhesion to the vascular endothelium and subsequent transendothelial migration play essential roles in the pathogenesis of cardiovascular diseases such as atherosclerosis. The leukocyte adhesion is mediated by localized activation of the endothelium through the action of inflammatory cytokines. The exact proinflammatory factors, however, that activate the endothelium and their cellular sources remain incompletely defined. Methods and Results: Using bone marrow-derived mast cells from wild-type, Tnf(-/-), Ifng(-/-), Il6(-/-) mice, we demonstrated that all three of these pro-inflammatory cytokines from mast cells induced the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), P-selectin, and E-selectin in murine heart endothelial cells (MHEC) at both mRNA and protein levels. Compared with TNF-alpha and IL6, IFN-gamma appeared weaker in the induction of the mRNA levels, but at protein levels, both IL6 and IFN-gamma were weaker inducers than TNF-alpha. Under physiological shear flow conditions, mast cell-derived TNF-alpha and IL6 were more potent than IFN-gamma in activating MHEC and in promoting neutrophil adhesion. Similar observations were made when neutrophils or macrophages were used. Neutrophils and macrophages produced the same sets of pro-inflammatory cytokines as did mast cells to induce MHEC adhesion molecule expression, with the exception that macrophage-derived IFN-gamma showed negligible effect in inducing VCAM-1 expression in MHEC. Conclusion: Mast cells, neutrophils, and macrophages release pro-inflammatory cytokines such as TNF-alpha, IFN-gamma, and IL6 that induce expression of adhesion molecules in endothelium and recruit of leukocytes, which is essential to the pathogenesis of vascular inflammatory diseases.	[Zhang, Jie; Liu, Li; Sun, Jiusong; He, Aina; Shi, Guo-Ping] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Alcaide, Pilar; Luscinskas, Francis W.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol,Med Sch, Boston, MA 02115 USA; [Liu, Li] Huzhou Teachers Coll, Sch Life Sci, Huzhou, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Huzhou University	Zhang, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu		Luscinskas, Francis/0000-0001-7100-4103	National Institutes of Health (NIH) [HL60942, HL81090, HL88547, HL094706, HL36028, HL53993]; American Heart Association [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060942, R01HL088547, R00HL094706, K99HL094706, P01HL036028, R01HL053993, R01HL081090] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institutes of Health (NIH) grants HL60942, HL81090, HL88547 (GPS); HL094706 (PA), HL36028 and HL53993 (FWL) and American Heart Association EIA award 0840118N (GPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JB, 1985, HUM PATHOL, V16, P562, DOI 10.1016/S0046-8177(85)80105-2; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; de Vries IJM, 1998, J ALLERGY CLIN IMMUN, V102, P461, DOI 10.1016/S0091-6749(98)70136-8; Dong ZM, 2000, CIRCULATION, V101, P2290, DOI 10.1161/01.CIR.101.19.2290; DUSTIN ML, 1986, J IMMUNOL, V137, P245; EBISAWA M, 1992, J IMMUNOL, V149, P4021; Gerszten RE, 1998, CIRC RES, V82, P871; Grabie N, 2003, AM J PATHOL, V163, P2413, DOI 10.1016/S0002-9440(10)63596-1; JOHNSONTIDEY RR, 1994, AM J PATHOL, V144, P952; Kneilling M, 2009, BLOOD, V114, P1696, DOI 10.1182/blood-2008-11-187682; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; MENG H, 1995, J CELL PHYSIOL, V165, P40, DOI 10.1002/jcp.1041650106; Miyamoto S, 2008, HEART, V94, P1002, DOI 10.1136/hrt.2007.121640; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Piqueras L, 2000, CIRCULATION, V102, P2118, DOI 10.1161/01.CIR.102.17.2118; POSTON RN, 1992, AM J PATHOL, V140, P665; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Rotzius P, 2009, ATHEROSCLEROSIS, V202, P111, DOI 10.1016/j.atherosclerosis.2008.04.009; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Tenaglia AN, 1997, AM J CARDIOL, V79, P742, DOI 10.1016/S0002-9149(96)00861-2; Torres R, 2002, IMMUNOL CELL BIOL, V80, P170, DOI 10.1046/j.1440-1711.2002.01069.x; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	37	203	212	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14525	10.1371/journal.pone.0014525	http://dx.doi.org/10.1371/journal.pone.0014525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264293	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500006
J	Kang, HJ; Coulibaly, F; Proft, T; Baker, EN				Kang, Hae Joo; Coulibaly, Fasseli; Proft, Thomas; Baker, Edward N.			Crystal Structure of Spy0129, a Streptococcus pyogenes Class B Sortase Involved in Pilus Assembly	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; GRAM-POSITIVE BACTERIA; SORTING SIGNAL BINDING; CELL-WALL; SURFACE-PROTEINS; ACTIVE-SITE; GROUP-A; CORYNEBACTERIUM-DIPHTHERIAE; BACILLUS-ANTHRACIS; IN-VITRO	Sortase enzymes are cysteine transpeptidases that mediate the covalent attachment of substrate proteins to the cell walls of Gram-positive bacteria, and thereby play a crucial role in virulence, infection and colonisation by pathogens. Many cell-surface proteins are anchored by the housekeeping sortase SrtA but other more specialised sortases exist that attach subsets of proteins or function in pilus assembly. The sortase Spy0129, or SrtC1, from the M1 SF370 strain of Streptococcus pyogenes is responsible for generating the covalent linkages between the pilin subunits in the pili of this organism. The crystal structure of Spy0129 has been determined at 2.3 angstrom resolution (R = 20.4%, Rfree = 26.0%). The structure shows that Spy0129 is a class B sortase, in contrast to other characterised pilin polymerases, which belong to class C. Spy0129 lacks a flap believed to function in substrate recognition in class C enzymes and instead has an elaborated beta 6/beta 7 loop. The two independent Spy0129 molecules in the crystal show differences in the positions and orientations of the catalytic Cys and His residues, Cys221 and His126, correlated with movements of the beta 7/beta 8 and beta 4/beta 5 loops that respectively follow these residues. Bound zinc ions stabilise these alternative conformations in the crystal. This conformational variability is likely to be important for function although there is no evidence that zinc is involved in vivo.	[Kang, Hae Joo; Coulibaly, Fasseli; Proft, Thomas; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Kang, Hae Joo; Coulibaly, Fasseli; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Proft, Thomas] Univ Auckland, Sch Med Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Kang, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosceinces, London, England.	ted.baker@auckland.ac.nz	Proft, Thomas/H-4686-2019	Proft, Thomas/0000-0002-9275-5042; Baker, Edward/0000-0003-2456-7661; Coulibaly, Fasseli/0000-0003-3380-2117	Health Research Council of New Zealand; Foundation for Research, Science and Technology of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery	Health Research Council of New Zealand(Health Research Council of New Zealand); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Maurice Wilkins Centre for Molecular Biodiscovery	This work was supported by the Health Research Council of New Zealand, the Foundation for Research, Science and Technology of New Zealand, and the Maurice Wilkins Centre for Molecular Biodiscovery. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Holm SE, 1996, NEW ENGL J MED, V335, P590, DOI 10.1056/NEJM199608223350811; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	61	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15969	10.1371/journal.pone.0015969	http://dx.doi.org/10.1371/journal.pone.0015969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264317	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514000013
J	Murthy, S; Hayward, GS; Wheelan, S; Forman, MS; Ahn, JH; Pass, RF; Arav-Boger, R				Murthy, Suchetha; Hayward, Gary S.; Wheelan, Sarah; Forman, Michael S.; Ahn, Jin-Hyun; Pass, Robert F.; Arav-Boger, Ravit			Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; POLYMORPHISMS; RECEPTOR; ALPHA; BLOOD	Background: Infection with multiple CMV strains is common in immunocompromised hosts, but its occurrence in normal hosts has not been well-studied. Methods: We analyzed CMV strains longitudinally in women who acquired CMV while enrolled in a CMV glycoprotein B (gB) vaccine trial. Sequencing of four variable genes was performed in samples collected from seroconversion and up to 34 months thereafter. Results: 199 cultured isolates from 53 women and 65 original fluids from a subset of 19 women were sequenced. 51 women were infected with one strain each without evidence for genetic drift; only two women shed multiple strains. Genetic variability among strains increased with the number of sequenced genetic loci. Nevertheless, 13 of 53 women proved to be infected with an identical CMV strain based on sequencing at all four variable genes. CMV vaccine did not alter the degree of genetic diversity amongst strains. Conclusions: Primary CMV infection in healthy women nearly always involves shedding of one strain that remains stable over time. Immunization with CMVgB-1 vaccine strain is not selective against specific strains. Although 75% of women harbored their unique strain, or a strain shared with only one other woman, 25% shared a single common strain, suggesting that this predominant strain with a particular combination of genetic loci is advantageous in this large urban area.	[Murthy, Suchetha; Arav-Boger, Ravit] Johns Hopkins Med Inst, Dept Pediat, Div Infect Dis, Baltimore, MD 21205 USA; [Hayward, Gary S.] Johns Hopkins Med Inst, Sidney Kimmel Canc Res Ctr, Baltimore, MD 21205 USA; [Wheelan, Sarah] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Forman, Michael S.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ahn, Jin-Hyun] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea; [Pass, Robert F.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); University of Alabama System; University of Alabama Birmingham	Murthy, S (corresponding author), Johns Hopkins Med Inst, Dept Pediat, Div Infect Dis, Baltimore, MD 21205 USA.	boger@jhmi.edu		Pass, Robert/0000-0003-2029-0247	NIH KO8 [1K08AI074907-01A1]; Sanofi-Pasteur [CMEO1, U01-AI063565]; NIH Center for Research Resources [5UL1 RR025777]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI063565, K08AI074907] Funding Source: NIH RePORTER	NIH KO8(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi-Pasteur; NIH Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH KO8 (1K08AI074907-01A1), Sanofi-Pasteur CMEO1 to RAB, and U01-AI063565 to RFP. This project was also supported by 5UL1 RR025777 to the University of Alabama at Birmingham from the NIH Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; Arav-Boger R, 2005, VIRUS GENES, V31, P65, DOI 10.1007/s11262-005-2201-3; Arav-Boger R, 2006, J INFECT DIS, V194, P464, DOI 10.1086/505427; Baldanti F, 1998, ARCH VIROL, V143, P1701, DOI 10.1007/s007050050410; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; BALE JF, 1993, J CLIN MICROBIOL, V31, P2433, DOI 10.1128/JCM.31.9.2433-2438.1993; Benedict CA, 1999, J IMMUNOL, V162, P6967; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; CHANDLER SH, 1987, J INFECT DIS, V155, P655, DOI 10.1093/infdis/155.4.655; CHOU SW, 1986, NEW ENGL J MED, V314, P1418, DOI 10.1056/NEJM198605293142205; CHOU SW, 1989, J INFECT DIS, V160, P11, DOI 10.1093/infdis/160.1.11; DAL MP, 2001, J HUMAN VIROL, V4, P26; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Lurain NS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-4; Novak Z, 2008, J CLIN MICROBIOL, V46, P882, DOI 10.1128/JCM.01079-07; Novak Z, 2009, CLIN VACCINE IMMUNOL, V16, P288, DOI 10.1128/CVI.00281-08; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pignatelli S, 2004, REV MED VIROL, V14, P383, DOI 10.1002/rmv.438; Pignatelli S, 2010, CLIN INFECT DIS, V51, P33, DOI 10.1086/653423; Puchhammer-Stockl E, 2006, TRANSPLANTATION, V81, P187, DOI 10.1097/01.tp.0000194858.50812.cb; Rasmussen L, 2003, J INFECT DIS, V187, P809, DOI 10.1086/367900; Revello MG, 2008, J MED VIROL, V80, P1415, DOI 10.1002/jmv.21243; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Stanton R, 2005, J MED VIROL, V75, P42, DOI 10.1002/jmv.20235; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrago D, 2003, J CLIN MICROBIOL, V41, P2872, DOI 10.1128/JCM.41.7.2872-2877.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trincado DE, 2000, J MED VIROL, V61, P481, DOI 10.1002/1096-9071(200008)61:4&lt;481::AID-JMV11&gt;3.0.CO;2-H; Verbraak FD, 1998, AIDS, V12, P713, DOI 10.1097/00002030-199807000-00007	32	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15949	10.1371/journal.pone.0015949	http://dx.doi.org/10.1371/journal.pone.0015949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264339	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100020
J	Coskun, AF; Sencan, I; Su, TW; Ozcan, A				Coskun, Ahmet F.; Sencan, Ikbal; Su, Ting-Wei; Ozcan, Aydogan			Lensfree Fluorescent On-Chip Imaging of Transgenic Caenorhabditis elegans Over an Ultra-Wide Field-of-View	PLOS ONE			English	Article							SIGNAL RECOVERY; C. ELEGANS	We demonstrate lensfree on-chip fluorescent imaging of transgenic Caenorhabditis elegans (C. elegans) over an ultra-wide field-of-view (FOV) of e. g., >2-8 cm(2) with a spatial resolution of similar to 10 mu m. This is the first time that a lensfree on-chip platform has successfully imaged fluorescent C. elegans samples. In our wide-field lensfree imaging platform, the transgenic samples are excited using a prism interface from the side, where the pump light is rejected through total internal reflection occurring at the bottom facet of the substrate. The emitted fluorescent signal from C. elegans samples is then recorded on a large area opto-electronic sensor-array over an FOV of e. g., >2-8 cm(2), without the use of any lenses, thin-film interference filters or mechanical scanners. Because fluorescent emission rapidly diverges, such lensfree fluorescent images recorded on a chip look blurred due to broad point-spread-function of our platform. To combat this resolution challenge, we use a compressive sampling algorithm to uniquely decode the recorded lensfree fluorescent patterns into higher resolution images, demonstrating similar to 10 mm resolution. We tested the efficacy of this compressive decoding approach with different types of opto-electronic sensors to achieve a similar resolution level, independent of the imaging chip. We further demonstrate that this wide FOV lensfree fluorescent imaging platform can also perform sequential bright-field imaging of the same samples using partially-coherent lensfree digital in-line holography that is coupled from the top facet of the same prism used in fluorescent excitation. This unique combination permits ultra-wide field dual-mode imaging of C. elegans on a chip which could especially provide a useful tool for high-throughput screening applications in biomedical research.	[Coskun, Ahmet F.; Sencan, Ikbal; Su, Ting-Wei; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Calif NanoSyst Inst CNSI, Los Angeles, CA USA	University of California System; University of California Los Angeles	Coskun, AF (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	ozcan@ucla.edu	Ozcan, Aydogan/I-2608-2013; Sencan-Egilmez, Ikbal/GCE-9253-2022; Coskun, Ahmet F./K-2084-2013	Ozcan, Aydogan/0000-0002-0717-683X; Sencan-Egilmez, Ikbal/0000-0002-2903-041X; Coskun, Ahmet F./0000-0002-5797-1524	NSF [0754880, 0930501]; Office of Naval Research (ONR); Office of the Director, National Institutes of Health [DP2OD006427]; Okawa Foundation; Vodafone Americas Foundation; DARPA DSO [56556-MS-DRP]; NIH [1R21EB009222-01]; AFOSR [08NE255]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009222] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006427] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0954482, 0930501, 0754880] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Okawa Foundation; Vodafone Americas Foundation; DARPA DSO(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	A. Ozcan gratefully acknowledges the support of NSF (CAREER Award on BioPhotonics), the Office of Naval Research (ONR) under the Young Investigator Award 2009 and the NIH Director's New Innovator Award - Award Number DP2OD006427 from the Office of the Director, National Institutes of Health. The authors also acknowledge the support of the Okawa Foundation, Vodafone Americas Foundation, DARPA DSO (under 56556-MS-DRP), NSF BISH program (under Awards # 0754880 and 0930501), NIH (under 1R21EB009222-01), and AFOSR (under Project #08NE255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs DSC, 1997, APPL OPTICS, V36, P1766, DOI 10.1364/AO.36.001766; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; CHOKSHI TV, 2010, AUTOMATED MICROFLUID; Coskun AF, 2010, OPT EXPRESS, V18, P10510, DOI 10.1364/OE.18.010510; Coskun AF, 2010, LAB CHIP, V10, P824, DOI 10.1039/b926561a; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Isikman SO, 2010, LAB CHIP, V10, P1109, DOI 10.1039/c001200a; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kural C, 2009, BIOCHEMISTRY-US, V48, P4663, DOI 10.1021/bi8023477; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pulak Rock, 2006, V351, P275; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Richard C, 2009, LAB CHIP, V9, P1371, DOI 10.1039/b819080a; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Semple JI, 2010, NAT METHODS, V7, P725, DOI 10.1038/nmeth.1495; Seo S, 2010, ANAL CHEM, V82, P4621, DOI 10.1021/ac1007915; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Su TW, 2010, OPT EXPRESS, V18, P9690, DOI 10.1364/OE.18.009690; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	33	61	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15955	10.1371/journal.pone.0015955	http://dx.doi.org/10.1371/journal.pone.0015955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253611	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900031
J	Gu, TL; Deng, XX; Huang, FZ; Tucker, M; Crosby, K; Rimkunas, V; Wang, Y; Deng, G; Zhu, L; Tan, ZP; Hu, YR; Wu, CL; Nardone, J; MacNeill, J; Ren, JM; Reeves, C; Innocenti, G; Norris, B; Yuan, J; Yu, JA; Haack, H; Shen, BY; Peng, CH; Li, HW; Zhou, XM; Liu, XY; Rush, J; Comb, MJ				Gu, Ting-Lei; Deng, Xiaxing; Huang, Feizhou; Tucker, Meghan; Crosby, Katherine; Rimkunas, Victoria; Wang, Yi; Deng, Gang; Zhu, Lei; Tan, Zhiping; Hu, Yerong; Wu, Chunlin; Nardone, Julie; MacNeill, Joan; Ren, Jianmin; Reeves, Cynthia; Innocenti, Gregory; Norris, Brett; Yuan, Jin; Yu, Jian; Haack, Herbert; Shen, Baiyong; Peng, Chenghong; Li, Hongwei; Zhou, Xinmin; Liu, Xunyang; Rush, John; Comb, Michael J.			Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma	PLOS ONE			English	Article							LIVER-REGENERATION; CANCER; GLIOBLASTOMA; EXPRESSION; PHOSPHORYLATION; PATHOGENESIS; PATHWAY; PROTEIN; GENES	Cholangiocarcinoma, also known as bile duct cancer, is the second most common primary hepatic carcinoma with a median survival of less than 2 years. The molecular mechanisms underlying the development of this disease are not clear. To survey activated tyrosine kinases signaling in cholangiocarcinoma, we employed immunoaffinity profiling coupled to mass spectrometry and identified DDR1, EPHA2, EGFR, and ROS tyrosine kinases, along with over 1,000 tyrosine phosphorylation sites from about 750 different proteins in primary cholangiocarcinoma patients. Furthermore, we confirmed the presence of ROS kinase fusions in 8.7% (2 out of 23) of cholangiocarcinoma patients. Expression of the ROS fusions in 3T3 cells confers transforming ability both in vitro and in vivo, and is responsive to its kinase inhibitor. Our data demonstrate that ROS kinase is a promising candidate for a therapeutic target and for a diagnostic molecular marker in cholangiocarcinoma. The identification of ROS tyrosine kinase fusions in cholangiocarcinoma, along with the presence of other ROS kinase fusions in lung cancer and glioblastoma, suggests that a more broadly based screen for activated ROS kinase in cancer is warranted.	[Gu, Ting-Lei; Tucker, Meghan; Crosby, Katherine; Rimkunas, Victoria; Wang, Yi; Nardone, Julie; MacNeill, Joan; Ren, Jianmin; Reeves, Cynthia; Innocenti, Gregory; Norris, Brett; Yuan, Jin; Yu, Jian; Haack, Herbert; Rush, John; Comb, Michael J.] Cell Signaling Technol, Danvers, MA USA; [Deng, Xiaxing; Shen, Baiyong; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Ctr Organ Transplantat, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Huang, Feizhou; Deng, Gang; Zhu, Lei; Liu, Xunyang] Cent S Univ, Xiangya Hosp 3, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Tan, Zhiping; Hu, Yerong; Wu, Chunlin; Zhou, Xinmin] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Shanghai Jiao Tong University; Central South University; Central South University	Gu, TL (corresponding author), Cell Signaling Technol, Danvers, MA USA.	tgu@cellsignal.com; mcomb@cellsignal.com		Peng, Chenghong/0000-0002-5573-7873				Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Eom M, 2008, PATHOL INT, V58, P226, DOI 10.1111/j.1440-1827.2008.02215.x; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Hertl M, 2005, ONCOLOGIST, V10, P269, DOI 10.1634/theoncologist.10-4-269; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Seki E, 2008, J HEPATOL, V48, P237, DOI 10.1016/j.jhep.2007.08.020	23	230	259	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15640	10.1371/journal.pone.0015640	http://dx.doi.org/10.1371/journal.pone.0015640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253578	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900007
J	Dama, MS; Singh, NMP; Rajender, S				Dama, Madhukar Shivajirao; Singh, Negi Mahendra Pal; Rajender, Singh			High Fat Diet Prevents Over-Crowding Induced Decrease of Sex Ratio in Mice	PLOS ONE			English	Article							HAMSTER MESOCRICETUS-AURATUS; GOLDEN-HAMSTER; MATERNAL DIET; POPULATION-DENSITY; LITTER DEFICITS; RED DEER; STRESS; CORTICOSTERONE; PROGESTERONE; ENVIRONMENT	Adaptive theory predicts that mothers would be advantaged by adjusting the sex ratio of their offspring in relation to their offspring's future reproductive success. In the present study, we tested the effect of housing mice under crowded condition on the sex ratio and whether the fat content of the diet has any influence on the outcome of pregnancies. Three-week-old mice were placed on the control diet (NFD) for 3 weeks. Thereafter the mice were allotted randomly to two groups of 7 cages each with 4, 6, 8, 10, 12, 14, and 16 mice in every cage to create increasing crowding gradient and fed either NFD or high fat diet (HFD). After 4 weeks, dams were bred and outcomes of pregnancy were analyzed. The average dam body weight (DBW) at conception, litter size (LS) and SR were significantly higher in HFD fed dams. Further, male biased litters declined with increasing crowding in NFD group but not in HFD. The LS and SR in NFD declined significantly with increasing crowding, whereas only LS was reduced in HFD group. We conclude that female mice housed under overcrowding conditions shift offspring SR in favor of daughters in consistent with the TW hypothesis and high fat diet reduces this influence of overcrowding.	[Dama, Madhukar Shivajirao; Rajender, Singh] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Singh, Negi Mahendra Pal] CSIR, Cent Drug Res Inst, Biometry & Stat Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Dama, MS (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	rajender_singh@cdri.res.in	Singh, Rajender/ABE-3512-2020; Dama, Madhukar/H-9945-2012	Rajender, Singh/0000-0002-4592-6566; Dama, Madhukar/0000-0002-8361-1530	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	MSD is grateful to Dr. Pramod Kulkarni for fruitful discussions on the sex ratio adjustments over the years. MSD would like to thank Council of Scientific and Industrial Research, India for research fellowship. We are thankful to Dr. Naibedya Chattopadhay and Dr. Nagarajan Perumal for helpful suggestions on designing and conducting the experiments. We are grateful to Dr. Srinidhi KP and his team at Tetragon Chemie PVT, LTD. Bangalore, for generously formulating experimental diet for the present study. We thank an anonymous reviewer, Dr. Fumihito Shibata, Dr. Takeo Kawamachi and the academic editor Dr. Amit Singh for their constructive comments. The CDRI communication number of this article is 7766.	Aioi A, 2001, J DERMATOL SCI, V25, P189, DOI 10.1016/S0923-1811(00)00133-X; Alexenko AP, 2007, BIOL REPROD, V77, P599, DOI 10.1095/biolreprod.107.062174; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Correa SM, 2005, BIOL LETTERS, V1, P215, DOI 10.1098/rsbl.2004.0283; Denda M, 1998, BRIT J DERMATOL, V138, P780; Flint APF, 1997, GEN COMP ENDOCR, V106, P374, DOI 10.1006/gcen.1997.6879; Fountain ED, 2008, BIOL REPROD, V78, P211, DOI 10.1095/biolreprod.107.065003; GEIRINGER E, 1961, P SOC EXP BIOL MED, V106, P752, DOI 10.3181/00379727-106-26464; GOERLICH VC, PHYSL BIOCH ZOOL, V83, P490; GRANT VJ, 1994, BRIT J MED PSYCHOL, V67, P343, DOI 10.1111/j.2044-8341.1994.tb01802.x; Hotchkiss AK, 2005, CONTEMP TOP LAB ANIM, V44, P46; Ideta A, 2009, J REPROD DEVELOP, V55, P529, DOI 10.1262/jrd.20209; Kimura K, 2005, MOL REPROD DEV, V72, P201, DOI 10.1002/mrd.20342; Komdeur J, 2002, P ROY SOC B-BIOL SCI, V269, P1067, DOI 10.1098/rspb.2002.1965; Krackow S, 1997, J REPROD FERTIL, V110, P87, DOI 10.1530/jrf.0.1100087; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; LANE EA, 1973, J ABNORM PSYCHOL, V82, P78, DOI 10.1037/h0034851; Larson MA, 2001, P NATL ACAD SCI USA, V98, P9677, DOI 10.1073/pnas.171305398; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; MORIYA K, 1978, INT J BIOMETEOROL, V22, P312, DOI 10.1007/BF01552813; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; PENG X, 1989, LAB ANIM, V23, P302, DOI 10.1258/002367789780746042; Pike TW, 2005, BIOL LETTERS, V1, P204, DOI 10.1098/rsbl.2005.0295; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; PRATT NC, 1991, J REPROD FERTIL, V92, P139, DOI 10.1530/jrf.0.0920139; PRATT NC, 1990, BEHAV NEURAL BIOL, V54, P1, DOI 10.1016/0163-1047(90)91201-L; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Veiga JP, 2004, HORM BEHAV, V46, P47, DOI 10.1016/j.yhbeh.2004.01.007; von Engelhardt N, 2004, HORM BEHAV, V45, P306, DOI 10.1016/j.yhbeh.2003.12.009; Wang HB, 2005, P NATL ACAD SCI USA, V102, P9960, DOI 10.1073/pnas.0501632102; Whyte JJ, 2007, J ENDOCRINOL, V192, P75, DOI 10.1677/JOE-06-0095; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16296	10.1371/journal.pone.0016296	http://dx.doi.org/10.1371/journal.pone.0016296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283594	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400041
J	Fan, XJ; Ren, PG; Dhal, S; Bejerano, G; Goodman, SB; Druzin, ML; Gambhir, SS; Nayak, NR				Fan, Xiujun; Ren, Peigen; Dhal, Sabita; Bejerano, Gill; Goodman, Stuart B.; Druzin, Maurice L.; Gambhir, Sanjiv S.; Nayak, Nihar R.			Noninvasive Monitoring of Placenta-Specific Transgene Expression by Bioluminescence Imaging	PLOS ONE			English	Article							REPORTER GENE-EXPRESSION; IN-VIVO; MANIPULATION; LENTIVIRUS	Background: Placental dysfunction underlies numerous complications of pregnancy. A major obstacle to understanding the roles of potential mediators of placental pathology has been the absence of suitable methods for tissue-specific gene manipulation and sensitive assays for studying gene functions in the placentas of intact animals. We describe a sensitive and noninvasive method of repetitively tracking placenta-specific gene expression throughout pregnancy using lentivirus-mediated transduction of optical reporter genes in mouse blastocysts. Methodology/Principal Findings: Zona-free blastocysts were incubated with lentivirus expressing firefly luciferase (Fluc) and Tomato fluorescent fusion protein for trophectoderm-specific infection and transplanted into day 3 pseudopregnant recipients (GD3). Animals were examined for Fluc expression by live bioluminescence imaging (BLI) at different points during pregnancy, and the placentas were examined for tomato expression in different cell types on GD18. In another set of experiments, blastocysts with maximum photon fluxes in the range of 2.0E+4 to 6.0E+4 p/s/cm(2)/sr were transferred. Fluc expression was detectable in all surrogate dams by day 5 of pregnancy by live imaging, and the signal increased dramatically thereafter each day until GD12, reaching a peak at GD16 and maintaining that level through GD18. All of the placentas, but none of the fetuses, analyzed on GD18 by BLI showed different degrees of Fluc expression. However, only placentas of dams transferred with selected blastocysts showed uniform photon distribution with no significant variability of photon intensity among placentas of the same litter. Tomato expression in the placentas was limited to only trophoblast cell lineages. Conclusions/Significance: These results, for the first time, demonstrate the feasibility of selecting lentivirally-transduced blastocysts for uniform gene expression in all placentas of the same litter and early detection and quantitative analysis of gene expression throughout pregnancy by live BLI. This method may be useful for a wide range of applications involving trophoblast-specific gene manipulations in utero.	[Fan, Xiujun; Dhal, Sabita; Druzin, Maurice L.; Nayak, Nihar R.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Ren, Peigen; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA USA; [Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Radiol,Bio X Program, Stanford, CA USA; [Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Bioengn,Bio X Program, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Fan, XJ (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	nayakn@stanford.edu	Ren, Pei-Gen/A-4099-2009; Goodman, Stuart/AAZ-7499-2020	Druzin, Maurice/0000-0001-7185-6664; Goodman, Stuart/0000-0002-1919-3717; Fan, Xiujun/0000-0003-3322-1857	Children's Health Initiative at Stanford	Children's Health Initiative at Stanford	This work was supported by the Children's Health Initiative at Stanford (to NRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CT, 2009, MOL IMAGING BIOL, V11, P144, DOI 10.1007/s11307-008-0187-7; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Deroose CM, 2006, MOL THER, V14, P423, DOI 10.1016/j.ymthe.2006.05.007; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Germeyer A, 2005, J CLIN ENDOCR METAB, V90, P1783, DOI 10.1210/jc.2004-1769; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Lee DS, 2009, GENESIS, V47, P433, DOI 10.1002/dvg.20518; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malashicheva A, 2007, GENESIS, V45, P456, DOI 10.1002/dvg.20313; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Marino Michael P, 2003, Methods Mol Biol, V229, P43; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Morioka Y, 2009, GENESIS, V47, P793, DOI 10.1002/dvg.20563; Nagy A, 2003, MANIPULATING MOUSE E, P268; Nayak NR, 2002, J CLIN ENDOCR METAB, V87, P1845, DOI 10.1210/jc.87.4.1845; Niu G, 2007, MOL IMAGING BIOL, V9, P126, DOI 10.1007/s11307-007-0079-2; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Reid Susan W., 2009, V530, P269, DOI 10.1007/978-1-59745-471-1_14; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Yoshimitsu M, 2004, P NATL ACAD SCI USA, V101, P16909, DOI 10.1073/pnas.0407572101; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	27	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16348	10.1371/journal.pone.0016348	http://dx.doi.org/10.1371/journal.pone.0016348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283713	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300037
J	Miller, PM; Saltz, JB; Cochrane, VA; Marcinkowski, CM; Mobin, R; Turner, TL				Miller, Paige M.; Saltz, Julia B.; Cochrane, Veronica A.; Marcinkowski, Caitlin M.; Mobin, Raisa; Turner, Thomas L.			Natural Variation in Decision-Making Behavior in Drosophila melanogaster	PLOS ONE			English	Article							OVIPOSITION SITE PREFERENCE; QUANTITATIVE GENETIC-VARIATION; LIFE-HISTORY; ACETIC-ACID; SELECTION; POPULATION; EVOLUTION; SEQUENCE	There has been considerable recent interest in using Drosophila melanogaster to investigate the molecular basis of decision-making behavior. Deciding where to place eggs is likely one of the most important decisions for a female fly, as eggs are vulnerable and larvae have limited motility. Here, we show that many natural genotypes of D. melanogaster prefer to lay eggs near nutritious substrate, rather than in nutritious substrate. These preferences are highly polymorphic in both degree and direction, with considerable heritability (0.488) and evolvability. Relative preferences are modulated by the distance between options and the overall concentration of ethanol, suggesting Drosophila integrate many environmental factors when making oviposition decisions. As oviposition-related decisions can be efficiently assessed by simply counting eggs, oviposition behavior is an excellent model for understanding information processing in insects. Associating natural genetic polymorphisms with decision-making variation will shed light on the molecular basis of host choice behavior, the evolutionary maintenance of genetic variation, and the mechanistic nature of preference variation in general.	[Miller, Paige M.; Cochrane, Veronica A.; Marcinkowski, Caitlin M.; Mobin, Raisa; Turner, Thomas L.] Univ Calif Santa Barbara, Ecol Evolut & Marine Biol Dept, Santa Barbara, CA 93106 USA; [Saltz, Julia B.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Saltz, Julia B.] Univ So Calif, Mol & Computat Biol Dept, Los Angeles, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Davis; University of Southern California	Miller, PM (corresponding author), Univ Calif Santa Barbara, Ecol Evolut & Marine Biol Dept, Santa Barbara, CA 93106 USA.	tturner@lifesci.ucsb.edu	Saltz, Julia/AAJ-4869-2020	Miller, Paige/0000-0002-5419-8601	University of California, Santa Barbara	University of California, Santa Barbara(University of California System)	This work was supported by the University of California, Santa Barbara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBORNOZ J, 1987, BEHAV GENET, V17, P257, DOI 10.1007/BF01065505; [Anonymous], 2006, SAS MIXED MODELS; Barker JSF, 1999, HEREDITAS, V130, P145, DOI 10.1111/j.1601-5223.1999.00145.x; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Courtney SP, 1988, FUNCT ECOL, V2, P521, DOI 10.2307/2389395; COYNE JA, 1982, AM NAT, V119, P589, DOI 10.1086/283936; DELSOLAR E, 1968, GENETICS, V58, P275; Eisses KT, 1997, BEHAV GENET, V27, P171, DOI 10.1023/A:1025697627556; Evans AT, 1916, J ECON ENTOMOL, V9, P354, DOI 10.1093/jee/9.3.354; FOGLEMAN JC, 1979, BEHAV GENET, V9, P407, DOI 10.1007/BF01066978; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; GARCIADORADO A, 1991, HEREDITY, V66, P313, DOI 10.1038/hdy.1991.40; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GONZALEZ D, 1989, BEHAV GENET, V19, P301, DOI 10.1007/BF01065912; GONZALEZ D, 1990, BEHAV GENET, V20, P675, DOI 10.1007/BF01065878; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HOFFMANN AA, 1991, EVOLUTION, V45, P1000, DOI 10.1111/j.1558-5646.1991.tb04366.x; HOFFMANN AA, 1985, AM NAT, V126, P41, DOI 10.1086/284394; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; JAENIKE J, 1982, AM NAT, V119, P784, DOI 10.1086/283955; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; LUTZ F. E., 1914, J NEW YORK ENTOMOL S, V22, P134; MACKAY TF, 2008, PROPOSAL SEQUENCE DR; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Possidente B, 1999, BEHAV GENET, V29, P193, DOI 10.1023/A:1021696019426; RUIZDUBREUIL G, 1994, HEREDITY, V73, P103, DOI 10.1038/hdy.1994.105; SCHAALJE GB, 2001, 26262 SUGI SAS I; SCHABENBERGER O, 2007, 19630 SUGI SAS I; Tatum EL, 1939, P NATL ACAD SCI USA, V25, P490, DOI 10.1073/pnas.25.9.490; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; VANDELDEN W, 1990, BEHAV GENET, V20, P661, DOI 10.1007/BF01065877; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	34	38	38	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16436	10.1371/journal.pone.0016436	http://dx.doi.org/10.1371/journal.pone.0016436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283727	Green Published, gold			2022-12-27	WOS:000286522200063
J	Erez, Y; Tischler, H; Belelovsky, K; Bar-Gad, I				Erez, Yaara; Tischler, Hadass; Belelovsky, Katya; Bar-Gad, Izhar			Dispersed Activity during Passive Movement in the Globus Pallidus of the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Primate	PLOS ONE			English	Article							BASAL GANGLIA; SUBTHALAMIC NUCLEUS; PARKINSONIAN MONKEYS; NEURONAL-ACTIVITY; LIMB MOVEMENT; DISCHARGE; ORGANIZATION; CIRCUITS; DISEASE; MODEL	Parkinson's disease is a neurodegenerative disorder manifesting in debilitating motor symptoms. This disorder is characterized by abnormal activity throughout the cortico-basal ganglia loop at both the single neuron and network levels. Previous neurophysiological studies have suggested that the encoding of movement in the parkinsonian state involves correlated activity and synchronized firing patterns. In this study, we used multi-electrode recordings to directly explore the activity of neurons from the globus pallidus of parkinsonian primates during passive limb movements and to determine the extent to which they interact and synchronize. The vast majority (80/103) of the recorded pallidal neurons responded to periodic flexion-extension movements of the elbow. The response pattern was sinusoidal-like and the timing of the peak response of the neurons was uniformly distributed around the movement cycle. The interaction between the neuronal activities was analyzed for 123 simultaneously recorded pairs of neurons. Movement-based signal correlation values were diverse and their mean was not significantly different from zero, demonstrating that the neurons were not activated synchronously in response to movement. Additionally, the difference in the peak responses phase of pairs of neurons was uniformly distributed, showing their independent firing relative to the movement cycle. Our results indicate that despite the widely distributed activity in the globus pallidus of the parkinsonian primate, movement encoding is dispersed and independent rather than correlated and synchronized, thus contradicting current views that posit synchronous activation during Parkinson's disease.	[Erez, Yaara; Tischler, Hadass; Belelovsky, Katya; Bar-Gad, Izhar] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel; [Bar-Gad, Izhar] Bar Ilan Univ, Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Erez, Y (corresponding author), Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel.	bargadi@mail.biu.ac.il		Bar-Gad, Izhar/0000-0002-2999-4083; Erez, Yaara/0000-0001-9563-816X	Israel Science Foundation (ISF) [1000/05, 327/09]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported in part by Israel Science Foundation (ISF, http://www.isf.org.il/english/default.asp) grants 1000/05 and 327/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BAKER KB, 2010, EXP NEUROL; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Boraud T, 2000, J NEUROPHYSIOL, V83, P1760, DOI 10.1152/jn.2000.83.3.1760; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; DELONG MR, 1985, J NEUROPHYSIOL, V53, P530, DOI 10.1152/jn.1985.53.2.530; Erez Y, 2009, J NEUROSCI, V29, P7797, DOI 10.1523/JNEUROSCI.0401-09.2009; FILION M, 1988, BRAIN RES, V444, P165, DOI 10.1016/0006-8993(88)90924-9; Gdowski MJ, 2001, J NEUROPHYSIOL, V85, P998, DOI 10.1152/jn.2001.85.2.998; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; HAMADA I, 1990, J NEUROPHYSIOL, V64, P1892, DOI 10.1152/jn.1990.64.6.1892; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Heimer G, 2002, J NEUROSCI, V22, P7850; IANSEK R, 1980, J PHYSIOL-LONDON, V301, P439, DOI 10.1113/jphysiol.1980.sp013216; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Leblois A, 2006, EUR J NEUROSCI, V24, P1201, DOI 10.1111/j.1460-9568.2006.04984.x; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Levy R, 2000, J NEUROSCI, V20, P7766; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Schneider JS, 2003, BRAIN RES, V990, P38, DOI 10.1016/S0006-8993(03)03382-1; STERIO D, 1994, ANN NEUROL, V35, P586, DOI 10.1002/ana.410350512; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Taha JM, 1996, J NEUROSURG, V85, P1005, DOI 10.3171/jns.1996.85.6.1005; Turner RS, 1997, J NEUROPHYSIOL, V77, P1051, DOI 10.1152/jn.1997.77.3.1051; Vitek JL, 1998, J NEUROSURG, V88, P1027, DOI 10.3171/jns.1998.88.6.1027	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16293	10.1371/journal.pone.0016293	http://dx.doi.org/10.1371/journal.pone.0016293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267415	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500050
J	Xu, ZP; Zheng, YF; Zhu, YF; Kong, XY; Hu, LD				Xu, Zhongping; Zheng, Yufang; Zhu, Yufei; Kong, Xiangyin; Hu, Landian			Evidence for OTUD-6B Participation in B Lymphocytes Cell Cycle after Cytokine Stimulation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA; DEUBIQUITINATING ENZYME; GENE-EXPRESSION; D2 EXPRESSION; REGULATOR; IDENTIFICATION; TRANSITION; FAMILY; MEMBER	Deubiquitinating enzymes (DUBs) are important regulators of cell proliferation. Here we identified a functional deubiquitinating enzyme, ovarian tumor domain-containing 6B (OTUD-6B). Mutation of the conserved Cys residue abolished its deubiquitinating activity in vitro. Otud-6b expression was induced with cytokine stimulation in both mouse Ba/F3 cells and primary B lymphocytes followed a rapid decrease. This rapid decrease was partially facilitated by tristetraprolin (TTP) destabilization of Otud-6b mRNA through AU-rich motifs. Enforced expression of OTUD-6B in Ba/F3 cells could block cell proliferation by arresting cells in G1 phase. In addition, cyclin D2 level was down-regulated when OTUD-6B WT was overexpressed. Therefore, down-regulation of Otud-6b expression after prolonged cytokine stimulation may be required for cell proliferation in B lymphocytes.	[Xu, Zhongping; Zhu, Yufei; Kong, Xiangyin; Hu, Landian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Zhongping; Zhu, Yufei; Kong, Xiangyin; Hu, Landian] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Yufang] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Kong, Xiangyin; Hu, Landian] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Xu, Zhongping; Zhu, Yufei; Kong, Xiangyin; Hu, Landian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, ZP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xiangyinster@gmail.com; ldhu2005@gmail.com	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624	National High Technology Research and Development Program of China [2006AA02Z330, 2006AA02A301]; Chinese Academy of Sciences [KSCX1-YW-R-74, KSCX1-YW-22]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National High Technology Research and Development Program of China (2006AA02Z330, 2006AA02A301), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-74, KSCX1-YW-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, CYTOKINE GROWTH F R, V18, P73, DOI 10.1016/j.cytogfr.2007.01.007; Almeida S, 2008, J INVEST DERMATOL, V128, P587, DOI 10.1038/sj.jid.5701045; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Buzzeo MP, 2007, EXP HEMATOL, V35, P1456, DOI 10.1016/j.exphem.2007.06.001; CaligarisCappio F, 1996, IMMUNOL TODAY, V17, P206, DOI 10.1016/0167-5699(96)30008-X; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; DeSalle LM, 2001, FEBS LETT, V490, P179, DOI 10.1016/S0014-5793(01)02121-4; Dey A, 2000, MOL BIOL CELL, V11, P3835, DOI 10.1091/mbc.11.11.3835; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KLUG G, 1993, MOL MICROBIOL, V9, P1, DOI 10.1111/j.1365-2958.1993.tb01663.x; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu Yong-Yu, 2004, Methods Mol Biol, V249, P177; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Vicari L, 2006, LEUKEMIA, V20, P2208, DOI 10.1038/sj.leu.2404447; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275; Zhu Y, 1996, MOL CELL BIOL, V16, P4808; Zhu YA, 1997, J BIOL CHEM, V272, P51	45	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14514	10.1371/journal.pone.0014514	http://dx.doi.org/10.1371/journal.pone.0014514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267069	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500004
J	Ringvall, M; Thulin, AA; Zhang, L; Cedervall, J; Tsuchida-Straeten, N; Jahnen-Dechent, W; Siegbahn, A; Olsson, AK				Ringvall, Maria; Thulin, Asa; Zhang, Lei; Cedervall, Jessica; Tsuchida-Straeten, Nobuko; Jahnen-Dechent, Willi; Siegbahn, Agneta; Olsson, Anna-Karin			Enhanced Platelet Activation Mediates the Accelerated Angiogenic Switch in Mice Lacking Histidine-Rich Glycoprotein	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TUMOR-GROWTH; COAGULATION; INHIBITORS; FRAGMENT; ADHESION	Background: The heparin-binding plasma protein histidine-rich glycoprotein (HRG; alternatively, HRGP/HPRG) can suppress tumor angiogenesis and growth in vitro and in vivo. Mice lacking the HRG gene are viable and fertile, but have an enhanced coagulation resulting in decreased bleeding times. In addition, the angiogenic switch is significantly enhanced in HRG-deficient mice. Methodology/Principal Findings: To address whether HRG deficiency affects tumor development, we have crossed HRG knockout mice with the RIP1-Tag2 mouse, a well established orthotopic model of multistage carcinogenesis. RIP1-Tag2 HRG(-/-) mice display significantly larger tumor volume compared to their RIP1-Tag2 HRG(+/+) littermates, supporting a role for HRG as an endogenous regulator of tumor growth. In the present study we also demonstrate that platelet activation is increased in mice lacking HRG. To address whether this elevated platelet activation contributes to the increased pathological angiogenesis in HRG-deficient mice, they were rendered thrombocytopenic before the onset of the angiogenic switch by injection of the anti-platelet antibody GP1b alpha. Interestingly, this treatment suppressed the increase in angiogenic neoplasias seen in HRG knockout mice. However, if GP1b alpha treatment was initiated at a later stage, after the onset of the angiogenic switch, no suppression of tumor growth was detected in HRG-deficient mice. Conclusions: Our data show that increased platelet activation mediates the accelerated angiogenic switch in HRG-deficient mice. Moreover, we conclude that platelets play a crucial role in the early stages of tumor development but are of less significance for tumor growth once angiogenesis has been initiated.	[Ringvall, Maria; Thulin, Asa; Zhang, Lei; Cedervall, Jessica; Olsson, Anna-Karin] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Tsuchida-Straeten, Nobuko; Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Dept Biomed Engn, Biointerface Lab, Aachen, Germany; [Siegbahn, Agneta] Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Uppsala University; RWTH Aachen University; Uppsala University; Uppsala University Hospital	Ringvall, M (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	zhang, lei/AAI-7464-2021; Zhang, Lei/N-7913-2016; Jahnen-Dechent, Willi/A-7608-2011	zhang, lei/0000-0001-7438-0489; Zhang, Lei/0000-0001-7438-0489; Jahnen-Dechent, Willi/0000-0003-1315-4407	Swedish Research Council [K2007-64X-20571-01-4, K2007-64P-20570-01-4]; Swedish Cancer Society [08 0375]; Swedish Society of Medicine [SLS-101361]; Jeanssons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medicine; Jeanssons Foundation; Ake Wiberg Foundation	Financial support was provided by the Swedish Research Council (www.vr.se) grant nr: K2007-64X-20571-01-4, K2007-64P-20570-01-4, the Swedish Cancer Society (www.cancerfonden.se) grant nr: 08 0375, the Swedish Society of Medicine (www.sls.se) grant nr: SLS-101361, Jeanssons Foundation (www.jeanssonsstiftelser.se) and Ake Wiberg Foundation (www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, LAB ANIM-UK, V22, P195; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Chiodoni C, 2006, J EXP MED, V203, P2441, DOI 10.1084/jem.20060844; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hulett MD, 2000, IMMUNOL CELL BIOL, V78, P280, DOI 10.1046/j.1440-1711.2000.00940.x; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Juarez JC, 2002, CANCER RES, V62, P5344; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; Jurk K, 2005, SEMIN THROMB HEMOST, V31, P381, DOI 10.1055/s-2005-916671; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LEUNG LLK, 1983, BLOOD, V62, P1016; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Olsson AK, 2004, CANCER RES, V64, P599, DOI 10.1158/0008-5472.CAN-03-1941; Pipili-Synetos E, 1998, BRIT J PHARMACOL, V125, P1252, DOI 10.1038/sj.bjp.0702191; POON IK, 2010, BLOOD; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Staton CA, 2005, J CELL MOL MED, V9, P286, DOI 10.1111/j.1582-4934.2005.tb00356.x; Thulin A, 2009, MOL CANCER RES, V7, P1792, DOI 10.1158/1541-7786.MCR-09-0094; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; Verheul HMW, 2000, BLOOD, V96, P4216, DOI 10.1182/blood.V96.13.4216	28	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14526	10.1371/journal.pone.0014526	http://dx.doi.org/10.1371/journal.pone.0014526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264222	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600007
J	Anderson, JL; Shearer, CA				Anderson, Jennifer L.; Shearer, Carol A.			Population Genetics of the Aquatic Fungus Tetracladium marchalianum over Space and Time	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; LEAF-LITTER; HYPHOMYCETE CONIDIA; TAPESIA-YALLUNDAE; LEAVES; STREAM; BREAKDOWN; DYNAMICS; COLONIZATION; DIVERSITY	Aquatic hyphomycete fungi are fundamental mediators of energy flow and nutrient spiraling in rivers. These microscopic fungi are primarily dispersed in river currents, undergo substantial annual fluctuations in abundance, and reproduce either predominantly or exclusively asexually. These aspects of aquatic hyphomycete biology are expected to influence levels and distributions of genetic diversity over both spatial and temporal scales. In this study, we investigated the spatiotemporal distribution of genotypic diversity in the representative aquatic hyphomycete Tetracladium marchalianum. We sampled populations of this fungus from seven sites, three sites each in two rivers in Illinois, USA, and one site in a Wisconsin river, USA, and repeatedly sampled one population over two years to track population genetic parameters through two seasonal cycles. The resulting fungal isolates (N = 391) were genotyped at eight polymorphic microsatellite loci. In spite of seasonal reductions in the abundance of this species, genotypic diversity was consistently very high and allele frequencies remarkably stable over time. Likewise, genotypic diversity was very high at all sites. Genetic differentiation was only observed between the most distant rivers (similar to 450 km). Clear evidence that T. marchalianum reproduces sexually in nature was not observed. Additionally, we used phylogenetic analysis of partial beta-tubulin gene sequences to confirm that the fungal isolates studied here represent a single species. These results suggest that populations of T. marchalianum may be very large and highly connected at local scales. We speculate that large population sizes and colonization of alternate substrates in both terrestrial and aquatic environments may effectively buffer the aquatic populations from in-stream population fluctuations and facilitate stability in allele frequencies over time. These data also suggest that overland dispersal is more important for structuring populations of T. marchalianum over geographic scales than expected.	[Anderson, Jennifer L.; Shearer, Carol A.] Univ Illinois, Dept Plant Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Anderson, JL (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	jennia@uoregon.edu	Anderson, Jennifer L/I-5435-2012	Anderson, Jennifer L/0000-0002-0713-6897	Research Board at the University of Illinois at Urbana-Champaign	Research Board at the University of Illinois at Urbana-Champaign	The Research Board at the University of Illinois at Urbana-Champaign funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raheem AM, 1997, MYCOPATHOLOGIA, V138, P163, DOI 10.1023/A:1006860011208; Abelho M, 1998, HYDROBIOLOGIA, V386, P147, DOI 10.1023/A:1003532921432; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; AIMER RD, 1985, BOT J LINN SOC, V91, P61, DOI 10.1111/j.1095-8339.1985.tb01135.x; Anderson JL, 2006, MOL ECOL NOTES, V6, P703, DOI 10.1111/j.1471-8286.2006.01316.x; ANDERSON JL, 2004, PLANT BIOL; ARSUFFI TL, 1984, OIKOS, V42, P144, DOI 10.2307/3544786; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; BALDY V, 1995, OIKOS, V74, P93, DOI 10.2307/3545678; BANDONI RJ, 1972, CAN J BOTANY, V50, P2283, DOI 10.1139/b72-297; BARLOCHER F, 1983, ECOLOGY, V64, P1266, DOI 10.2307/1937834; BARLOCHER F, 1981, T BRIT MYCOL SOC, V76, P160; BARLOCHER F, 1992, FRESHWATER BIOL, V28, P1, DOI 10.1111/j.1365-2427.1992.tb00556.x; BARLOCHER F, 1982, OECOLOGIA, V52, P1, DOI 10.1007/BF00349003; BARLOCHER F, 1974, J ECOL, V62, P761, DOI 10.2307/2258954; Baschien C, 2006, NOVA HEDWIGIA, V83, P311, DOI 10.1127/0029-5035/2006/0083-0311; Berbee ML, 2003, MYCOL RES, V107, P169, DOI 10.1017/S0953756203007263; Bergemann SE, 2002, NEW PHYTOL, V156, P313, DOI 10.1046/j.1469-8137.2002.00507.x; Burnett JH., 2003, FUNGAL POPULATIONS S; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Carbone I, 1999, EVOLUTION, V53, P11, DOI [10.1111/j.1558-5646.1999.tb05329.x, 10.2307/2640916]; CHAMIER AC, 1985, BOT J LINN SOC, V91, P67, DOI 10.1111/j.1095-8339.1985.tb01136.x; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; CHAUVET E, 1992, NOVA HEDWIGIA, V54, P379; CHAUVET E, 1988, Revue des Sciences de l'Eau, V1, P203; CHERGUI H, 1990, ARCH HYDROBIOL, V118, P341; CHERGUI H, 1991, FRESHWATER BIOL, V26, P97, DOI 10.1111/j.1365-2427.1991.tb00512.x; DESCALS E, 1995, NOVA HEDWIGIA, V60, P551; Douhan GW, 2002, MOL ECOL, V11, P2229, DOI 10.1046/j.1365-294X.2002.01607.x; Douhan GW, 2002, PHYTOPATHOLOGY, V92, P703, DOI 10.1094/PHYTO.2002.92.7.703; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Fabre E, 1997, MYCOL RES, V101, P908, DOI 10.1017/S0953756297003948; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FIRDAUSEBAREEN, 1994, CAN J BOT, V72, P1316, DOI 10.1139/b94-161; FISHER PJ, 1989, MYCOL RES, V92, P367, DOI 10.1016/S0953-7562(89)80081-4; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Garnett H, 2000, MYCOLOGIA, V92, P29, DOI 10.2307/3761447; GESSNER MO, 1993, MYCOL RES, V97, P163, DOI 10.1016/S0953-7562(09)80238-4; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Gessner MO, 1998, J N AM BENTHOL SOC, V17, P403, DOI 10.2307/1468362; Gonczol J, 1999, ARCH HYDROBIOL, V144, P495; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulis V, 2004, MYCOLOGIA, V96, P57, DOI 10.2307/3761988; Gulis V, 2008, APPL ENVIRON MICROB, V74, P1094, DOI 10.1128/AEM.01903-07; Hurst LD, 1996, TRENDS ECOL EVOL, V11, pA46; INGOLD CT, 1979, AM J BOT, V66, P218, DOI 10.2307/2442527; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Laitung B, 2004, MOL ECOL, V13, P1679, DOI 10.1111/j.1365-294X.2004.02135.x; Letourneau A, 2010, FUNGAL DIVERS, V40, P51, DOI 10.1007/s13225-009-0006-8; Linde CC, 2003, FUNGAL GENET BIOL, V40, P115, DOI 10.1016/S1087-1845(03)00110-5; McGlashan DJ, 2001, CAN J FISH AQUAT SCI, V58, P1842, DOI 10.1139/cjfas-58-9-1842; Meffe G. K., 1994, PRINCIPLES CONSERVAT; MICHOD RE, 1987, EVOLUTION SEX EXAMIN; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Miller AN, 2005, MOL PHYLOGENET EVOL, V35, P60, DOI 10.1016/j.ympev.2005.01.007; MINSHALL GW, 1967, ECOLOGY, V48, P139; MotheJeanLouis AM, 1997, CAN J BOT, V75, P155, DOI 10.1139/b97-018; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; NILSSON SVEN, 1964, SYMBOLAE BOT UPSALIENSIS, V18, P1; Pelaez F, 1996, MYCOL RES, V100, P831, DOI 10.1016/S0953-7562(96)80030-X; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; RANZONI FV, 1979, MYCOLOGIA, V71, P786, DOI 10.2307/3759189; ROLDAN A, 1989, MYCOL RES, V93, P452, DOI 10.1016/S0953-7562(89)80039-5; SANDERS PF, 1978, T BRIT MYCOL SOC, V71, P231, DOI 10.1016/S0007-1536(78)80103-X; SANDERS PF, 1979, T BRIT MYCOL SOC, V73, P103, DOI 10.1016/S0007-1536(79)80079-0; Sati SC, 2005, MYCOLOGIA, V97, P45, DOI 10.3852/mycologia.97.1.45; Seena S, 2010, FUNGAL DIVERS, V44, P77, DOI 10.1007/s13225-010-0056-y; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; Shearer C.A., 1992, ECOLOGY AQUATIC HYPH, P77, DOI DOI 10.1007/978-3-642-76855-2_4; Sivichai S, 2003, FUNG DIVERS RES SER, V10, P259; SRIDHAR KR, 1993, MYCOL RES, V97, P1530, DOI 10.1016/S0953-7562(09)80229-3; SRIDHAR KR, 1992, MYCOL RES, V96, P305, DOI 10.1016/S0953-7562(09)80942-8; SUBERKROPP K, 1980, CAN J BOT, V58, P1025, DOI 10.1139/b80-126; Suberkropp K, 1997, FRESHWATER BIOL, V38, P169, DOI 10.1046/j.1365-2427.1997.00203.x; SUBERKROPP K, 1991, MYCOL RES, V95, P843, DOI 10.1016/S0953-7562(09)80048-8; Suberkropp K, 2001, APPL ENVIRON MICROB, V67, P5063, DOI 10.1128/AEM.67.11.5063-5068.2001; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THAKUR SB, 1977, MYCOLOGIA, V69, P843, DOI 10.2307/3758877; Vandenkoornhuyse P, 2001, HEREDITY, V87, P243, DOI 10.1046/j.1365-2540.2001.00941.x; Viji G, 2002, PLANT DIS, V86, P827, DOI 10.1094/PDIS.2002.86.8.827; WEBSTER J, 1981, BIOL CONIDIAL FUNGI, P295; Webster JR, 1999, FRESHWATER BIOL, V41, P687, DOI 10.1046/j.1365-2427.1999.00409.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weyers HS, 1996, J N AM BENTHOL SOC, V15, P408, DOI 10.2307/1467795; Wright S., 1978, EVOLUTION GENETIC PO; YUN T, 1996, PLANT BIOL; Zeigler RS, 1998, ANNU REV PHYTOPATHOL, V36, P249, DOI 10.1146/annurev.phyto.36.1.249	93	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15908	10.1371/journal.pone.0015908	http://dx.doi.org/10.1371/journal.pone.0015908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264239	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500015
J	Mullins, JI; Heath, L; Hughes, JP; Kicha, J; Styrchak, S; Wong, KG; Rao, U; Hansen, A; Harris, KS; Laurent, JP; Li, D; Simpson, JH; Essigmann, JM; Loeb, LA; Parkins, J				Mullins, James I.; Heath, Laura; Hughes, James P.; Kicha, Jessica; Styrchak, Sheila; Wong, Kim G.; Rao, Ushnal; Hansen, Alexis; Harris, Kevin S.; Laurent, Jean-Pierre; Li, Deyu; Simpson, Jeffrey H.; Essigmann, John M.; Loeb, Lawrence A.; Parkins, Jeffrey			Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIRUS TYPE-1 REPLICATION; LETHAL MUTAGENESIS; ERROR CATASTROPHE; IN-VIVO; SEQUENCE ALIGNMENT; WEB SERVER; RIBAVIRIN; RNA; RECOMBINATION	The deoxycytidine analog KP1212, and its prodrug KP1461, are prototypes of a new class of antiretroviral drugs designed to increase viral mutation rates, with the goal of eventually causing the collapse of the viral population. Here we present an extensive analysis of viral sequences from HIV-1 infected volunteers from the first "mechanism validation'' phase II clinical trial of a mutagenic base analog in which individuals previously treated with antiviral drugs received 1600 mg of KP1461 twice per day for 124 days. Plasma viral loads were not reduced, and overall levels of viral mutation were not increased during this short-term study, however, the mutation spectrum of HIV was altered. A large number (N = 105 per sample) of sequences were analyzed, each derived from individual HIV-1 RNA templates, after 0, 56 and 124 days of therapy from 10 treated and 10 untreated control individuals (>7.1 million base pairs of unique viral templates were sequenced). We found that private mutations, those not found in more than one viral sequence and likely to have occurred in the most recent rounds of replication, increased in treated individuals relative to controls after 56 (p = 0.038) and 124 (p = 0.002) days of drug treatment. The spectrum of mutations observed in the treated group showed an excess of A to G and G to A mutations (p = 0.01), and to a lesser extent T to C and C to T mutations (p = 0.09), as predicted by the mechanism of action of the drug. These results validate the proposed mechanism of action in humans and should spur development of this novel antiretroviral approach.	[Mullins, James I.; Heath, Laura; Wong, Kim G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Loeb, Lawrence A.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA USA; [Kicha, Jessica; Styrchak, Sheila; Rao, Ushnal; Hansen, Alexis; Harris, Kevin S.; Laurent, Jean-Pierre; Parkins, Jeffrey] Koronis Pharmaceut, Redmond, WA USA; [Li, Deyu; Simpson, Jeffrey H.; Essigmann, John M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Li, Deyu; Essigmann, John M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Mullins, JI (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu			Koronis Pharmaceuticals (KP); NATIONAL CANCER INSTITUTE [R01CA115802, R37CA080024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER	Koronis Pharmaceuticals (KP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Koronis Pharmaceuticals (KP) funded this work. Employees of KP participated in the experimental design, carried out a portion of the experimental work and commented on and approved the manuscript. The funders had no role in data analysis or decision to publish.	Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Chung DH, 2007, J VIROL, V81, P11722, DOI 10.1128/JVI.00874-07; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dapp MJ, 2009, J VIROL, V83, P11950, DOI 10.1128/JVI.01406-09; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Domingo E, 2005, VIRUS RES, V107, P129, DOI 10.1016/j.virusres.2004.11.003; Domingo E., 2006, QUASISPECIES CONCEPT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; FELSENSTEIN J, 1974, GENETICS, V78, P737; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gerrish PJ, 2003, LANCET INFECT DIS, V3, P28, DOI 10.1016/S1473-3099(03)00485-7; Gilbert PB, 2005, BIOMETRICS, V61, P106, DOI 10.1111/j.0006-341X.2005.020719.x; Graci JD, 2007, J VIROL, V81, P11256, DOI 10.1128/JVI.01028-07; Harris KS, 2005, ANTIVIR RES, V67, P1, DOI 10.1016/j.antiviral.2005.03.004; Hatano H, 2000, AIDS, V14, P1357, DOI 10.1097/00002030-200007070-00008; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; KamathLoeb AS, 1997, EUR J BIOCHEM, V250, P492, DOI 10.1111/j.1432-1033.1997.0492a.x; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Murakami E, 2005, ANTIVIR RES, V67, P10, DOI 10.1016/j.antiviral.2004.12.004; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schrager LK, 1998, JAMA-J AM MED ASSOC, V280, P67, DOI 10.1001/jama.280.1.67; Sedaghat AR, 2007, PLOS PATHOG, V3, P1165, DOI 10.1371/journal.ppat.0030122; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; Smith RA, 2005, VIRUS RES, V107, P215, DOI 10.1016/j.virusres.2004.11.011; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; WRIN T, 2001, ANTIVIR THER, V6; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1; Zhu T, 2002, J ANTIMICROB CHEMOTH, V50, P309, DOI 10.1093/jac/dkf143; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	49	50	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15135	10.1371/journal.pone.0015135	http://dx.doi.org/10.1371/journal.pone.0015135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264288	gold, Green Published, Green Submitted			2022-12-27	WOS:000286516500010
J	Tyan, SW; Kuo, WH; Huang, CK; Pan, CC; Shew, JY; Chang, KJ; Lee, EYHP; Lee, WH				Tyan, Shiaw-Wei; Kuo, Wen-Hung; Huang, Chun-Kai; Pan, Chi-Chun; Shew, Jin-Yuh; Chang, King-Jen; Lee, Eva Y. -H. P.; Lee, Wen-Hwa			Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis	PLOS ONE			English	Article							TUMOR-STROMAL INTERACTIONS; MICROENVIRONMENT; HETEROGENEITY; METASTASIS; CARCINOMAS; BETA; MET	It has been well documented that microenvironment consisting of stroma affects breast cancer progression. However, the mechanisms by which cancer cells and fibroblasts, the major cell type in stroma, interact with each other during tumor development remains to be elucidated. Here, we show that the human cancer-associated fibroblasts (CAFs) had higher activity in enhancing breast tumorigenecity compared to the normal tissue-associated fibroblasts (NAFs) isolated from the same patients. The expression level of hepatocyte growth factor (HGF) in these fibroblasts was positively correlated with their ability to enhance breast tumorigenesis in mice. Deprivation of HGF using a neutralizing antibody reduced CAF-mediated colony formation of human breast cancer cells, indicating that CAFs enhanced cancer cell colony formation mainly through HGF secretion. Co-culture with human breast cancer MDA-MB-468 cells in a transwell system enhanced NAFs to secret HGF as well as promote tumorigenecity. The newly gained ability of these "educated'' NAFs became irreversible after continuing this process till fourth passage. These results suggested that breast cancer cells could alter the nature of its surrounding fibroblasts to secrete HGF to support its own progression through paracrine signaling.	[Tyan, Shiaw-Wei; Huang, Chun-Kai; Pan, Chi-Chun; Shew, Jin-Yuh; Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Irvine; University of California System; University of California Irvine	Tyan, SW (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	kingjen@ntu.edu.tw; elee@uci.edu; whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014	KUO, WEN-HUNG/0000-0002-9881-4605; Chang, King jen/0000-0001-9811-3422	Academia Sinica [2371, 4012]; biotech company; GeneTex; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); biotech company; GeneTex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Academia Sinica Peak Project (grant number 2371, 4012, http://www.sinica.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Based on University of California Irvine policy, WHL and EL declare that they have financial interests of a biotech company, GeneTex, which distributes research reagents globally and owns stock from Schering-Plough, a publicly traded pharmaceutical company, like any stockholder. WHL is on the board of directors, and EL is a consultant. GeneTex did not support this work in any way. These data and material will be distributed freely following the policies of PLoS ONE. It is the authors' recognition that these financial interests could not generate any bias toward this work, and do not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakamura T, 1997, CANCER RES, V57, P3305; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Wurtz SO, 2005, ENDOCR-RELAT CANCER, V12, P215, DOI 10.1677/erc.1.00719	24	130	136	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15313	10.1371/journal.pone.0015313	http://dx.doi.org/10.1371/journal.pone.0015313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249190	Green Published, gold			2022-12-27	WOS:000286515000004
J	Lukoye, D; Cobelens, FGJ; Ezati, N; Kirimunda, S; Adatu, FE; Lule, JK; Nuwaha, F; Joloba, ML				Lukoye, Deus; Cobelens, Frank G. J.; Ezati, Nicholas; Kirimunda, Samuel; Adatu, Francis E.; Lule, Joseph K.; Nuwaha, Fred; Joloba, Moses L.			Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection	PLOS ONE			English	Article							TUBERCULOSIS	Background: Drug resistance among tuberculosis patients in sub-Saharan Africa is increasing, possibly due to association with HIV infection. We studied drug resistance and HIV infection in a representative sample of 533 smear-positive tuberculosis patients diagnosed in Kampala, Uganda. Methods/Principal Findings: Among 473 new patients, multidrug resistance was found in 5 (1.1%, 95% CI 0.3-2.5) and resistance to any drug in 57 (12.1%, 9.3-15.3). Among 60 previously treated patients this was 7 (11.7%, 4.8-22.6) and 17 (28.3%; 17.5-41.4), respectively. Of 517 patients with HIV results, 165 (31.9%, 27.9-36.1) tested positive. Neither multidrug (adjusted odds ratio (ORadj) 0.7; 95% CI 0.19-2.6) nor any resistance (ORadj 0.7; 0.43-1.3) was associated with HIV status. Primary resistance to any drug was more common among patients who had worked in health care (ORadj 3.5; 1.0-12.0). Conclusion/Significance: Anti-tuberculosis drug resistance rates in Kampala are low and not associated with HIV infection, but may be associated with exposure during health care.	[Lukoye, Deus] Kampala City Council, Dept Publ Hlth, Kampala, Uganda; [Cobelens, Frank G. J.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Lukoye, Deus; Ezati, Nicholas; Adatu, Francis E.; Joloba, Moses L.] Natl TB & Leprosy Programme, Kampala, Uganda; [Kirimunda, Samuel; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Lule, Joseph K.; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	University of Amsterdam; Academic Medical Center Amsterdam; Makerere University; Makerere University	Lukoye, D (corresponding author), Kampala City Council, Dept Publ Hlth, Kampala, Uganda.	moses.joloba@case.edu		Lukoye, Deus/0000-0002-5362-9924; Joloba, Moses/0000-0002-0334-9983; Cobelens, Frank/0000-0002-4367-1133; kirimunda, Samuel/0000-0002-8769-5516	Netherlands Government (NACCAP) European Union (Europe AID) through CPCD Uganda [SANTE/2006/105-316]; INTERACT program	Netherlands Government (NACCAP) European Union (Europe AID) through CPCD Uganda(European Commission); INTERACT program	This study was funded by the Netherlands Government (NACCAP) European Union (Europe AID) grant SANTE/2006/105-316 through CPCD Uganda and the INTERACT program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretzel G, 1999, INT J TUBERC LUNG D, V3, P810; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P189; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; *WHO, 2003, GLOB PROJ ANT DRUG R; *WHO, 2001, GUID SUSC TEST 2 LIN; *WHO IUATLD WIT, 2004, GLOB PROJ ANT DRUG R; World Health Organization, 2008, 4 WHOHTMTB, P394; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	14	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16130	10.1371/journal.pone.0016130	http://dx.doi.org/10.1371/journal.pone.0016130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249225	Green Submitted, Green Published, gold			2022-12-27	WOS:000286513100028
J	Mitchell, MD; McCormick, MI; Ferrari, MCO; Chivers, DP				Mitchell, Matthew D.; McCormick, Mark I.; Ferrari, Maud C. O.; Chivers, Douglas P.			Coral Reef Fish Rapidly Learn to Identify Multiple Unknown Predators upon Recruitment to the Reef	PLOS ONE			English	Article							CHEMICAL ALARM CUES; FATHEAD MINNOWS; PIMEPHALES-PROMELAS; ANTIPREDATOR BEHAVIOR; ACQUIRED RECOGNITION; PREY ANIMALS; RISK; PROSPECTUS; AVOIDANCE; SUBSTANCE	Organisms often undergo shifts in habitats as their requirements change with ontogeny. Upon entering a new environment, it is vitally important to be able to rapidly assess predation risk. Predation pressure should selectively promote mechanisms that enable the rapid identification of novel predators. Here we tested the ability of a juvenile marine fish to simultaneously learn the identity of multiple previously unknown predators. Individuals were conditioned with a 'cocktail' of novel odours (from two predators and two non-predators) paired with either a conspecific alarm cue or a saltwater control and then tested for recognition of the four odours individually and two novel odours (one predator and one non-predator) the following day. Individuals conditioned with the 'cocktail' and alarm cue responded to the individual 'cocktail' odours with an antipredator response compared to controls. These results demonstrate that individuals acquire recognition of novel odours and that the responses were not due to innate recognition of predators or due to a generalised response to novel odours. Upon entering an unfamiliar environment prey species are able to rapidly assess the risk of predation, enhancing their chances of survival, through the assessment of chemical stimuli.	[Mitchell, Matthew D.; McCormick, Mark I.] James Cook Univ, Australia Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Mitchell, Matthew D.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Ferrari, Maud C. O.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	James Cook University; James Cook University; University of California System; University of California Davis; University of Saskatchewan	Mitchell, MD (corresponding author), James Cook Univ, Australia Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	matthew.mitchell1@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645; Chivers, Douglas/0000-0002-9497-4329	Australian Research Council; ARC Centre of Excellence for Coral Reef Studies [CE0561432]; Natural Sciences and Engineering Council of Canada	Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was supplied by the Australian Research Council (www.arc.gov.au), ARC Centre of Excellence for Coral Reef Studies (Grant No. CE0561432, www.coralcoe.org.au) and the Natural Sciences and Engineering Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquistapace P, 2003, J CRUSTACEAN BIOL, V23, P364, DOI 10.1651/0278-0372(2003)023[0364:UPALOP]2.0.CO;2; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); Booth DJ, 2004, OECOLOGIA, V140, P289, DOI 10.1007/s00442-004-1608-1; BROWN GE, 1995, BEHAV ECOL SOCIOBIOL, V36, P105, DOI 10.1007/s002650050130; Brown GE, 2001, ETHOLOGY, V107, P401, DOI 10.1046/j.1439-0310.2001.00671.x; Brown Grant E., 2005, P34; CHIVERS DP, 1994, J FISH BIOL, V44, P273, DOI 10.1006/jfbi.1994.1026; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Darwish TL, 2005, ANIM BEHAV, V70, P83, DOI 10.1016/j.anbehav.2004.09.017; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2006, ANIM BEHAV, V71, P19, DOI 10.1016/j.anbehav.2005.02.016; Ferrari MCO, 2006, CAN J ZOOL, V84, P505, DOI 10.1139/Z06-027; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Fievet V, 2008, OIKOS, V117, P1380, DOI 10.1111/j.0030-1299.2008.16629.x; Goldman B, 1976, P125; Golub JL, 2005, J FISH BIOL, V66, P1073, DOI 10.1111/j.0022-1112.2005.00658.x; Griffen BD, 2006, OECOLOGIA, V146, P608, DOI 10.1007/s00442-005-0211-4; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hazlett BA, 2003, ETHOLOGY, V109, P765, DOI 10.1046/j.1439-0310.2003.00916.x; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Jachner A, 1999, ENVIRON BIOL FISH, V54, P433, DOI 10.1023/A:1007523732293; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kristensen EA, 2004, J FISH BIOL, V64, P643, DOI 10.1111/j.1095-8649.2004.00328.x; Larson JK, 2005, ANIM BEHAV, V69, P51, DOI 10.1016/j.anbehav.2004.04.005; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGURRAN AE, 1989, ETHOLOGY, V82, P216, DOI 10.1111/j.1439-0310.1989.tb00501.x; Mathis A, 1996, ANIM BEHAV, V51, P185, DOI 10.1006/anbe.1996.0016; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; McCormick MI, 2008, CORAL REEFS, V27, P105, DOI 10.1007/s00338-007-0296-9; Meekan MG, 2001, MAR BIOL, V139, P373; Mirza RS, 2001, BEHAVIOUR, V138, P1249, DOI 10.1163/15685390152822201; Mirza RS, 2003, CAN J ZOOL, V81, P88, DOI 10.1139/Z02-216; Montgomery John C., 2008, P3; Randall JE, 1997, FISHES GREAT BARRIER; SANO M, 1984, FOOD HABITS TELEOSTE; SAVINO JF, 1989, ENVIRON BIOL FISH, V24, P287, DOI 10.1007/BF00001402; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SMITH RJF, 1989, ETHOLOGY, V83, P19; SWIHART RK, 1991, J CHEM ECOL, V17, P767, DOI 10.1007/BF00994199; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065; VAIL A, 2009, THESIS J COOK U TOWN; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; Wisenden Brian D., 2006, P259; Wisenden Brian D., 2003, P236, DOI 10.1007/978-0-387-22628-6_12	51	59	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15764	10.1371/journal.pone.0015764	http://dx.doi.org/10.1371/journal.pone.0015764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249216	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000286513100011
J	Clark, MS; Thorne, MAS; Toullec, JY; Meng, Y; Guan, LL; Peck, LS; Moore, S				Clark, Melody S.; Thorne, Michael A. S.; Toullec, Jean-Yves; Meng, Yan; Guan, Le Luo; Peck, Lloyd S.; Moore, Stephen			Antarctic Krill 454 Pyrosequencing Reveals Chaperone and Stress Transcriptome	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GLUCAN BINDING-PROTEIN; SUPEROXIDE-DISMUTASE; EUPHAUSIA-SUPERBA; MOLECULAR-CLONING; SOUTHERN-OCEAN; BETA-GLUCAN; CLIMATE-CHANGE; RIMICARIS-EXOCULATA; AMINO-ACID	Background: The Antarctic krill Euphausia superba is a keystone species in the Antarctic food chain. Not only is it a significant grazer of phytoplankton, but it is also a major food item for charismatic megafauna such as whales and seals and an important Southern Ocean fisheries crop. Ecological data suggest that this species is being affected by climate change and this will have considerable consequences for the balance of the Southern Ocean ecosystem. Hence, understanding how this organism functions is a priority area and will provide fundamental data for life history studies, energy budget calculations and food web models. Methodology/Principal Findings: The assembly of the 454 transcriptome of E. superba resulted in 22,177 contigs with an average size of 492bp (ranging between 137 and 8515bp). In depth analysis of the data revealed an extensive catalogue of the cellular chaperone systems and the major antioxidant proteins. Full length sequences were characterised for the chaperones HSP70, HSP90 and the super-oxide dismutase antioxidants, with the discovery of potentially novel duplications of these genes. The sequence data contained 41,470 microsatellites and 17,776 Single Nucleotide Polymorphisms (SNPs/INDELS), providing a resource for population and also gene function studies. Conclusions: This paper details the first 454 generated data for a pelagic Antarctic species or any pelagic crustacean globally. The classical "stress proteins'', such as HSP70, HSP90, ferritin and GST were all highly expressed. These genes were shown to be over expressed in the transcriptomes of Antarctic notothenioid fish and hypothesized as adaptations to living in the cold, with the associated problems of decreased protein folding efficiency and increased vulnerability to damage by reactive oxygen species. Hence, these data will provide a major resource for future physiological work on krill, but in particular a suite of "stress'' genes for studies understanding marine ectotherms' capacities to cope with environmental change.	[Clark, Melody S.; Thorne, Michael A. S.; Peck, Lloyd S.] British Antarctic Survey, NERC, Cambridge, England; [Toullec, Jean-Yves] Univ Paris 06, UPMC, CNRS, UMR 7144,Stn Biol Roscoff, Roscoff, France; [Meng, Yan; Guan, Le Luo; Moore, Stephen] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of Alberta	Clark, MS (corresponding author), British Antarctic Survey, NERC, Cambridge, England.	mscl@bas.ac.uk	Clark, Melody S/D-7371-2014	Clark, Melody S/0000-0002-3442-3824; Moore, Stephen/0000-0002-9758-166X; Thorne, Michael/0000-0001-7759-612X	Livestock Gentech: an Alberta Ingenuity Centre at the University of Alberta; la Region Bretagne (France); l'Institut Paul-Emile Victor (IPEV); Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Livestock Gentech: an Alberta Ingenuity Centre at the University of Alberta; la Region Bretagne (France)(Region Bretagne); l'Institut Paul-Emile Victor (IPEV); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for the 454 run provided by Livestock Gentech: an Alberta Ingenuity Centre at the University of Alberta. JYT benefits from funding provided by la Region Bretagne (France) and also l'Institut Paul-Emile Victor (IPEV). The analyses were completed by the team from the British Antarctic Survey within the Ecosystems Adaptations and Physiology Work Package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Agianian B, 2003, J MOL BIOL, V326, P151, DOI 10.1016/S0022-2836(02)01327-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Batlle M, 2011, BBA-GENE REGUL MECH, V1809, P46, DOI 10.1016/j.bbagrm.2010.10.005; Beck G, 2002, DEV COMP IMMUNOL, V26, P11, DOI 10.1016/S0145-305X(01)00051-9; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Buchholz F, 2003, MAR FRESHW BEHAV PHY, V36, P229, DOI 10.1080/10236240310001623376; BUCHHOLZ F, 1991, MAR ECOL PROG SER, V69, P217, DOI 10.3354/meps069217; *CBS, CBS PRED SERV PRED N; *CBS, CBS PRED SERV ON LIN; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Cheng WT, 2006, FISH SHELLFISH IMMUN, V21, P453, DOI 10.1016/j.fsi.2006.02.005; Cheng WT, 2006, FISH SHELLFISH IMMUN, V21, P102, DOI 10.1016/j.fsi.2005.10.009; Cheng WT, 2006, FISH SHELLFISH IMMUN, V20, P438, DOI 10.1016/j.fsi.2005.05.016; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark MS, 2008, CELL STRESS CHAPERON, V13, P39, DOI 10.1007/s12192-008-0014-8; Clark MS, 2008, CELL STRESS CHAPERON, V13, P51, DOI 10.1007/s12192-008-0015-7; Clark MS, 2008, POLAR BIOL, V31, P171, DOI 10.1007/s00300-007-0344-5; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Clark MS, 2009, CELL STRESS CHAPERON, V14, P649, DOI 10.1007/s12192-009-0117-x; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Clarke A., 1976, Bulletin Br Antarct Surv, VNo. 43, P111; *CLC, CLC MAINWORKBENCH SO; Costantino E, 2009, CANCER LETT, V279, P39, DOI 10.1016/j.canlet.2009.01.018; Cottin D, 2010, J EXP MAR BIOL ECOL, V393, P9, DOI 10.1016/j.jembe.2010.06.008; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; De Pitta C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-45; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dodson RE, 1997, J BIOL CHEM, V272, P12249, DOI 10.1074/jbc.272.19.12249; ENGMAN DM, 1990, J IMMUNOL, V144, P3987; Everson I, 2000, KRILL BIOL ECOLOGY F; Falk-Petersen S, 2000, CAN J FISH AQUAT SCI, V57, P178, DOI 10.1139/cjfas-57-S3-178; FAO, 2005, 457 FAO; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Fraser KPP, 2007, J EXP BIOL, V210, P2691, DOI 10.1242/jeb.003715; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Gross M, 2004, CURR PROTEIN PEPT SC, V5, P213, DOI 10.2174/1389203043379684; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hagen W, 2001, MAR BIOL, V139, P95, DOI 10.1007/s002270000527; Hagen W, 1999, INVERTEBR REPROD DEV, V36, P25, DOI 10.1080/07924259.1999.9652674; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hofmann GE, 2000, J EXP BIOL, V203, P2331; Huang TS, 1996, EUR J BIOCHEM, V236, P450, DOI 10.1111/j.1432-1033.1996.00450.x; Jarman SN, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-S3-51; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jiang SG, 2009, MOL BIOL REP, V36, P127, DOI 10.1007/s11033-007-9160-9; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Korcsmaros T, 2007, J BIOSCIENCES, V32, P441, DOI 10.1007/s12038-007-0043-y; Larade K, 2004, J EXP BIOL, V207, P1353, DOI 10.1242/jeb.00872; Lin YC, 2008, MOL IMMUNOL, V45, P1346, DOI 10.1016/j.molimm.2007.09.005; Liu J, 2004, CELL STRESS CHAPERON, V9, P313, DOI 10.1379/CSC-40R.1; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; MACAULAY MC, 1984, J CRUSTACEAN BIOL, V4, P16, DOI 10.1163/1937240X84X00480; Machida RJ, 2004, MAR BIOTECHNOL, V6, P238, DOI 10.1007/s10126-003-0016-6; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; MAYER C, PHOBOS 3 3 10 2006 2; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; MURPHY EJ, 2010, SO OC FOOD WEB MOD W; Nebert Daniel W., 2004, Human Genomics, V1, P460; NICOL S, 1994, ANTARCTIC SCI GLOBAL, V33, P144; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Obermuller BE, 2010, MAR ECOL PROG SER, V415, P109, DOI 10.3354/meps08735; PACHAURI RK, 2007, IPCC CLIMATE CHANGE; Pantzartzi CN, 2009, GENE, V431, P47, DOI 10.1016/j.gene.2008.10.028; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; Peck LS, 2006, BIOL REV, V81, P75, DOI 10.1017/S1464793105006871; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Place S, 2005, POLAR BIOL, V28, P261, DOI 10.1007/s00300-004-0697-y; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quetin LB, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P285, DOI 10.5479/si.097884601X.21; QUETIN LB, 1991, AM ZOOL, V31, P49; Ravaux J, 2007, GENE, V386, P162, DOI 10.1016/j.gene.2006.09.001; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ritz DA, 2003, J MAR BIOL ASSOC UK, V83, P329, DOI 10.1017/S002531540300715Xh; Romo-Figueroa MG, 2004, DEV COMP IMMUNOL, V28, P713, DOI 10.1016/j.dci.2003.11.008; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; SCHININA ME, 1989, ARCH BIOCHEM BIOPHYS, V272, P507, DOI 10.1016/0003-9861(89)90246-4; Schram FR, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P233; Seear P, 2009, J EXP MAR BIOL ECOL, V381, P57, DOI 10.1016/j.jembe.2009.09.010; Shen X, 2010, MOL BIOL REP, V37, P771, DOI 10.1007/s11033-009-9602-7; Siegel V, 2005, POLAR BIOL, V29, P1, DOI 10.1007/s00300-005-0058-5; Sorensen JG, 2007, J BIOSCIENCES, V32, P447, DOI 10.1007/s12038-007-0044-x; Tarling GA, 2009, DEEP-SEA RES PT I, V56, P1994, DOI 10.1016/j.dsr.2009.07.004; Teschke M, 2008, MAR BIOL, V154, P315, DOI 10.1007/s00227-008-0925-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorne MAS, 2010, MAR GENOM, V3, P35, DOI 10.1016/j.margen.2010.02.002; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Trathan PN, 2010, ANTARCT SCI, V22, P387, DOI 10.1017/S0954102010000222; Truebano M, 2010, J EXP MAR BIOL ECOL, V391, P65, DOI 10.1016/j.jembe.2010.06.011; Vargas-Albores F, 2000, AQUACULTURE, V191, P13, DOI 10.1016/S0044-8486(00)00416-6; Vayssier M, 1999, PARASITOLOGY, V119, P81, DOI 10.1017/S0031182099004461; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; Wu LT, 2008, MOL REPROD DEV, V75, P952, DOI 10.1002/mrd.20817; Yamaguchi H, 2005, EXP CELL RES, V303, P415, DOI 10.1016/j.yexcr.2004.10.005; Yepiz-Plascencia G, 1998, COMP BIOCHEM PHYS B, V121, P309, DOI 10.1016/S0305-0491(98)10104-9; Zhang JQ, 2006, J BIOTECHNOL, V125, P173, DOI 10.1016/j.jbiotec.2006.03.010; Zhang XY, 2009, COMP BIOCHEM PHYS C, V150, P465, DOI 10.1016/j.cbpc.2009.07.002; Zhao DX, 2010, FISH SHELLFISH IMMUN, V29, P698, DOI 10.1016/j.fsi.2010.06.002; NEWBLER ASSEMBLY SOF	127	64	69	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15919	10.1371/journal.pone.0015919	http://dx.doi.org/10.1371/journal.pone.0015919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253607	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900023
J	Costa, TP; Brown, JD; Howerth, EW; Stallknecht, DE; Swayne, DE				Costa, Taiana P.; Brown, Justin D.; Howerth, Elizabeth W.; Stallknecht, David E.; Swayne, David E.			Homo- and Heterosubtypic Low Pathogenic Avian Influenza Exposure on H5N1 Highly Pathogenic Avian Influenza Virus Infection in Wood Ducks (Aix sponsa)	PLOS ONE			English	Article							A-VIRUSES; WILD BIRDS; HONG-KONG; ASIAN LINEAGE; CHICKENS; SUSCEPTIBILITY; PROTECTION; WATERFOWL; OUTBREAKS; IMMUNITY	Wild birds in the Orders Anseriformes and Charadriiformes are the natural reservoirs for avian influenza (AI) viruses. Although they are often infected with multiple AI viruses, the significance and extent of acquired immunity in these populations is not understood. Pre-existing immunity to AI virus has been shown to modulate the outcome of a highly pathogenic avian influenza (HPAI) virus infection in multiple domestic avian species, but few studies have addressed this effect in wild birds. In this study, the effect of pre-exposure to homosubtypic (homologous hemagglutinin) and heterosubtypic (heterologous hemagglutinin) low pathogenic avian influenza (LPAI) viruses on the outcome of a H5N1 HPAI virus infection in wood ducks (Aix sponsa) was evaluated. Pre- exposure of wood ducks to different LPAI viruses did not prevent infection with H5N1 HPAI virus, but did increase survival associated with H5N1 HPAI virus infection. The magnitude of this effect on the outcome of the H5N1 HPAI virus infection varied between different LPAI viruses, and was associated both with efficiency of LPAI viral replication in wood ducks and the development of a detectable humoral immune response. These observations suggest that in naturally occurring outbreaks of H5N1 HPAI, birds with pre-existing immunity to homologous hemagglutinin or neuraminidase subtypes of AI virus may either survive H5N1 HPAI virus infection or live longer than naive birds and, consequently, could pose a greater risk for contributing to viral transmission and dissemination. The mechanisms responsible for this protection and/or the duration of this immunity remain unknown. The results of this study are important for surveillance efforts and help clarify epidemiological data from outbreaks of H5N1 HPAI virus in wild bird populations.	[Costa, Taiana P.; Howerth, Elizabeth W.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Costa, Taiana P.; Brown, Justin D.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA 30602 USA; [Swayne, David E.] ARS, SE Poultry Res Lab, USDA, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Costa, TP (corresponding author), Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA.	dstall@uga.edu	Costa, Taiana/O-9469-2019; Costa, Taiana/HHS-5800-2022; Swayne, David/AAP-7166-2020	Costa, Taiana/0000-0002-5010-4188; Costa, Taiana/0000-0002-5010-4188; Swayne, David/0000-0001-7472-1992	Southeast Poultry Research Laboratory [58-6612-2-0220]; Southeastern Cooperative Wildlife Disease Study (SCWDS) [58-6612-2-0220]; Current Research Information System project [6612-32000-048-00D]	Southeast Poultry Research Laboratory; Southeastern Cooperative Wildlife Disease Study (SCWDS); Current Research Information System project	Funding for this work was provided through specific Cooperative Agreement #58-6612-2-0220 between the Southeast Poultry Research Laboratory (http://www.ars.usda.gov/main/site_main.htm?modecode = 66-12-07-00) and the Southeastern Cooperative Wildlife Disease Study (SCWDS) (http://scwds.org/), through the continued sponsorship of SCWDS member state and federal agencies, and Current Research Information System project 6612-32000-048-00D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; BROWN DW, 1992, AVIAN DIS, V36, P515, DOI 10.2307/1591743; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; CHAMBERS TM, 1988, VIROLOGY, V167, P414, DOI 10.1016/0042-6822(88)90103-1; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; HINSHAW VS, 1980, VIROLOGY, V102, P412, DOI 10.1016/0042-6822(80)90108-7; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pantin-Jackwood Mary J., 2008, V436, P77, DOI 10.1007/978-1-59745-279-3_10; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6	39	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15987	10.1371/journal.pone.0015987	http://dx.doi.org/10.1371/journal.pone.0015987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253608	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900034
J	Wallace, BP; DiMatteo, AD; Hurley, BJ; Finkbeiner, EM; Bolten, AB; Chaloupka, MY; Hutchinson, BJ; Abreu-Grobois, FA; Amorocho, D; Bjorndal, KA; Bourjea, J; Bowen, BW; Duenas, RB; Casale, P; Choudhury, BC; Costa, A; Dutton, PH; Fallabrino, A; Girard, A; Girondot, M; Godfrey, MH; Hamann, M; Lopez-Mendilaharsu, M; Marcovaldi, MA; Mortimer, JA; Musick, JA; Nel, R; Pilcher, NJ; Seminoff, JA; Troeng, S; Witherington, B; Mast, RB				Wallace, Bryan P.; DiMatteo, Andrew D.; Hurley, Brendan J.; Finkbeiner, Elena M.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Alberto Abreu-Grobois, F.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Girard, Alexandre; Girondot, Marc; Godfrey, Matthew H.; Hamann, Mark; Lopez-Mendilaharsu, Milagros; Marcovaldi, Maria Angela; Mortimer, Jeanne A.; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Seminoff, Jeffrey A.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.			Regional Management Units for Marine Turtles: A Novel Framework for Prioritizing Conservation and Research across Multiple Scales	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; EVOLUTIONARILY-SIGNIFICANT-UNITS; CHELONIA-MYDAS; MITOCHONDRIAL-DNA; CARETTA-CARETTA; POPULATION-STRUCTURE; GENETIC-STRUCTURE; SATELLITE TRACKING; PROTECTED AREAS; PACIFIC	Background: Resolving threats to widely distributed marine megafauna requires definition of the geographic distributions of both the threats as well as the population unit(s) of interest. In turn, because individual threats can operate on varying spatial scales, their impacts can affect different segments of a population of the same species. Therefore, integration of multiple tools and techniques - including site-based monitoring, genetic analyses, mark-recapture studies and telemetry - can facilitate robust definitions of population segments at multiple biological and spatial scales to address different management and research challenges. Methodology/Principal Findings: To address these issues for marine turtles, we collated all available studies on marine turtle biogeography, including nesting sites, population abundances and trends, population genetics, and satellite telemetry. We georeferenced this information to generate separate layers for nesting sites, genetic stocks, and core distributions of population segments of all marine turtle species. We then spatially integrated this information from fine-to coarse-spatial scales to develop nested envelope models, or Regional Management Units (RMUs), for marine turtles globally. Conclusions/Significance: The RMU framework is a solution to the challenge of how to organize marine turtles into units of protection above the level of nesting populations, but below the level of species, within regional entities that might be on independent evolutionary trajectories. Among many potential applications, RMUs provide a framework for identifying data gaps, assessing high diversity areas for multiple species and genetic stocks, and evaluating conservation status of marine turtles. Furthermore, RMUs allow for identification of geographic barriers to gene flow, and can provide valuable guidance to marine spatial planning initiatives that integrate spatial distributions of protected species and human activities. In addition, the RMU framework - including maps and supporting metadata - will be an iterative, user-driven tool made publicly available in an online application for comments, improvements, download and analysis.	[Wallace, Bryan P.; DiMatteo, Andrew D.; Hurley, Brendan J.; Finkbeiner, Elena M.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Alberto Abreu-Grobois, F.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Girard, Alexandre; Girondot, Marc; Godfrey, Matthew H.; Hamann, Mark; Lopez-Mendilaharsu, Milagros; Marcovaldi, Maria Angela; Mortimer, Jeanne A.; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Seminoff, Jeffrey A.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.] IUCN, SSC Marine Turtle Specialist Grp, Burning Issues Working Grp, Arlington, VA USA; [Wallace, Bryan P.; Hurley, Brendan J.; Hutchinson, Brian J.; Troeng, Sebastian; Mast, Roderic B.] Conservat Int, Global Marine Div, Arlington, VA USA; [Wallace, Bryan P.; Finkbeiner, Elena M.] Duke Univ, Ctr Marine Conservat, Beaufort, NC USA; [DiMatteo, Andrew D.] Duke Univ, Marine Geospatial Ecol Lab, Durham, NC USA; [Bolten, Alan B.; Bjorndal, Karen A.] Univ Florida, Dept Biol, Archie Carr Ctr Sea Turtle Res, Gainesville, FL USA; [Chaloupka, Milani Y.] Univ Queensland, Ecol Modelling Serv Pty Ltd, Brisbane, Qld, Australia; [Alberto Abreu-Grobois, F.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Sinaloa, Mexico; [Amorocho, Diego] Ctr Invest Medio Ambiente & Desarrollo, Cali, Colombia; [Bourjea, Jerome] IFREMER, Lab Ressources Halieut, Le Port, Reunion, France; [Bowen, Brian W.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Briseno Duenas, Raquel] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Mazatlan, Banco Informac Tortugas Marinas BITMAR, Mazatlan, Sinaloa, Mexico; [Casale, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Casale, Paolo] World Wildlife Fund Italy, World Wildlife Fund Mediterranean Turtle Programm, Rome, Italy; [Choudhury, B. C.] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Costa, Alice] World Wildlife Fund Mozambique, Maputo, Mozambique; [Fallabrino, Alejandro] Karumbe, Montevideo, Uruguay; [Girard, Alexandre] Assoc RENATURA, Albens, France; [Girondot, Marc] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France; [Godfrey, Matthew H.] N Carolina Wildlife Resources Commiss, Beaufort, NC USA; [Hamann, Mark] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Lopez-Mendilaharsu, Milagros; Marcovaldi, Maria Angela] Fundacao Pro Tamar, Projeto Tamar ICMBio, Salvador, BA, Brazil; [Lopez-Mendilaharsu, Milagros] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Musick, John A.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Sch Environm Sci, Port Elizabeth, South Africa; [Pilcher, Nicolas J.] Marine Res Fdn, Sabah, Malaysia; [Seminoff, Jeffrey A.] NOAA, Marine Turtle Ecol & Assessment Program, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Troeng, Sebastian] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Troeng, Sebastian] Sea Turtle Conservancy, Sci Advisory Comm, Gainesville, FL USA; [Witherington, Blair] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL USA	Conservation International; Duke University; Duke University; State University System of Florida; University of Florida; University of Queensland; Universidad Nacional Autonoma de Mexico; Ifremer; Universidad Nacional Autonoma de Mexico; Sapienza University Rome; Wildlife Institute of India; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; James Cook University; Universidade do Estado do Rio de Janeiro; William & Mary; Virginia Institute of Marine Science; Nelson Mandela University; National Oceanic Atmospheric Admin (NOAA) - USA; Lund University; Florida Fish & Wildlife Conservation Commission	Wallace, BP (corresponding author), IUCN, SSC Marine Turtle Specialist Grp, Burning Issues Working Grp, Arlington, VA USA.	b.wallace@conservation.org	Grobois, Alberto Abreu/A-3560-2017; Girondot, Marc/A-7663-2010	Grobois, Alberto Abreu/0000-0002-7350-757X; CASALE, PAOLO/0000-0003-2534-6158; Bourjea, Jerome/0000-0001-7149-3648; Hamann, Mark/0000-0003-4588-7955; Girard, Alexandre/0000-0002-2973-5137; Bolten, Alan/0000-0002-4834-2742; Bjorndal, Karen/0000-0002-6286-1901; Girondot, Marc/0000-0001-6645-8530; Mortimer, Jeanne A./0000-0001-6318-2890	National Fish and Wildlife Foundation; Offield Family Foundation; National Fish and Wildlife Foundation; Offield Family Foundation	National Fish and Wildlife Foundation; Offield Family Foundation; National Fish and Wildlife Foundation; Offield Family Foundation	This study was funded by the National Fish and Wildlife Foundation and the Offield Family Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MYC is employed by a commercial company that provides ecological modelling services, and his involvement in this study was partially supported by this company. However, this support in no way biased his contributions to all aspects of this study, the overall process or resulting products generated by this study.	ABREUGROBOIS FA, 2007, IUCN RED LIST STATUS, P39; Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Bass AL, 2004, CONSERV GENET, V5, P783, DOI 10.1007/s10592-004-1979-1; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Bjorndal KA, 2005, MAR BIOL, V147, P1449, DOI 10.1007/s00227-005-0045-y; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal KA, 2008, MOL ECOL, V17, P2185, DOI 10.1111/j.1365-294X.2008.03752.x; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 1998, ECOL APPL, V8, P1; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 1999, MOL ECOL, V8, pS5, DOI 10.1046/j.1365-294X.1999.00798.x; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Bowen BW, 2004, MOL ECOL, V13, P3797, DOI 10.1111/j.1365-294X.2004.02356.x; BOWEN BW, 1995, P NAT ACAD SCI, V92, P3371; Boyle MC, 2009, P R SOC B, V276, P1993, DOI 10.1098/rspb.2008.1931; Calix M., 2018, EUROPEAN RED LIST SA; Carreras C, 2007, CONSERV GENET, V8, P761, DOI 10.1007/s10592-006-9224-8; Carreras C, 2006, MAR BIOL, V149, P1269, DOI 10.1007/s00227-006-0282-8; Conant TA., 2009, LOGGERHEAD SEA TURTL; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dow W., 2007, 6 WIDECAST, P267; Dryden J, 2008, WILDLIFE RES, V35, P477, DOI 10.1071/WR07087; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; FitzSimmons NN, 1997, GENETICS, V147, P1843; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Formia Angela, 2007, Endangered Species Research, V3, P145, DOI 10.3354/esr003145; FRAZIER J, 1985, J HERPETOL, V19, P1, DOI 10.2307/1564414; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; KARL SA, 1992, GENETICS, V131, P163; LAHANAS PN, 1994, GENETICA, V94, P57, DOI 10.1007/BF01429220; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; LIMPUS CJ, 2008, BIOL REV AUSTR MARIN, P96; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Martien Karen K., 2003, Journal of Cetacean Research and Management, V5, P213; MEYLAN AB, 1990, SCIENCE, V248, P724, DOI 10.1126/science.2333522; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mrosovsky N, 2003, PREDICTING EXTINCTIO; Musick John A., 1997, P137; Seminoff JA, 2008, J EXP MAR BIOL ECOL, V356, P52, DOI 10.1016/j.jembe.2007.12.007; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Suryan RM, 2009, PROG OCEANOGR, V81, P214, DOI 10.1016/j.pocean.2009.04.012; Taylor BL, 1999, MOL ECOL, V8, pS11, DOI 10.1046/j.1365-294X.1999.00797.x; Wallace Bryan P., 2009, Endangered Species Research, V7, P11, DOI 10.3354/esr00177; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 1995, AM FISH S S, V17, P8; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Yorio P, 2009, CONSERV LETT, V2, P171, DOI 10.1111/j.1755-263X.2009.00062.x; 1996, FED RED, V61, P4722	59	378	407	1	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15465	10.1371/journal.pone.0015465	http://dx.doi.org/10.1371/journal.pone.0015465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21253007	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000285572900021
J	Holdo, RM; Fryxell, JM; Sinclair, ARE; Dobson, A; Holt, RD				Holdo, Ricardo M.; Fryxell, John M.; Sinclair, Anthony R. E.; Dobson, Andrew; Holt, Robert D.			Predicted Impact of Barriers to Migration on the Serengeti Wildebeest Population	PLOS ONE			English	Article							HETEROGENEITY; FRAGMENTATION; VIABILITY; RAINFALL; FORAGE; SCALE	The Serengeti wildebeest migration is a rare and spectacular example of a once-common biological phenomenon. A proposed road project threatens to bisect the Serengeti ecosystem and its integrity. The precautionary principle dictates that we consider the possible consequences of a road completely disrupting the migration. We used an existing spatially-explicit simulation model of wildebeest movement and population dynamics to explore how placing a barrier to migration across the proposed route (thus creating two disjoint but mobile subpopulations) might affect the long-term size of the wildebeest population. Our simulation results suggest that a barrier to migration-even without causing habitat loss-could cause the wildebeest population to decline by about a third. The driver of this decline is the effect of habitat fragmentation (even without habitat loss) on the ability of wildebeest to effectively track temporal shifts in high-quality forage resources across the landscape. Given the important role of the wildebeest migration for a number of key ecological processes, these findings have potentially important ramifications for ecosystem biodiversity, structure, and function in the Serengeti.	[Holdo, Ricardo M.] Univ Missouri, Div Biol, Columbia, MO 65211 USA; [Fryxell, John M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Sinclair, Anthony R. E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Dobson, Andrew] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Holt, Robert D.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA	University of Missouri System; University of Missouri Columbia; University of Guelph; University of British Columbia; Princeton University; State University System of Florida; University of Florida	Holdo, RM (corresponding author), Univ Missouri, Div Biol, Columbia, MO 65211 USA.	holdor@missouri.edu			National Science Foundation [DEB 0308486]	National Science Foundation(National Science Foundation (NSF))	The authors would like to acknowledge financial support from the National Science Foundation Biocomplexity Program (DEB 0308486) for supporting development of the Savanna Dynamics model. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Boone RB, 2006, HUM ECOL, V34, P809, DOI 10.1007/s10745-006-9031-3; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; CAMPBELL BM, 1995, SERENGETI, V2, P534; Coughenour M., 1993, SAVANNA LANDSCAPE RE; Dobson A, 2010, NATURE, V467, P272, DOI 10.1038/467272a; Fryxell JM, 2004, ECOLOGY, V85, P2429, DOI 10.1890/04-0147; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; FRYXELL JM, 1988, AFR J ECOL, V26, P17, DOI 10.1111/j.1365-2028.1988.tb01125.x; FYNN RWS, 2010, AFRICAN J ECOLOGY, P1; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hilborn Ray, 1997, V28; Hobbs NT, 2008, GLOBAL ENVIRON CHANG, V18, P776, DOI 10.1016/j.gloenvcha.2008.07.011; Holdo RM, 2010, ECOL APPL, V20, P381, DOI 10.1890/08-0780.1; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; McNaughton SJ., 1979, SERENGETI DYNAMICS E, P46; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Pascual MA, 1997, CONSERV BIOL, V11, P966, DOI 10.1046/j.1523-1739.1997.95437.x; Searle KR, 2010, OECOLOGIA, V163, P815, DOI 10.1007/s00442-010-1610-8; Talbot L.M., 1963, WILDLIFE MONOGR, V12, P1; WILCOVE DS, 2008, NO WAY BACK DECLINE; Wilmshurst JE, 1999, ECOLOGY, V80, P2338, DOI 10.1890/0012-9658(1999)080[2338:WCDIIT]2.0.CO;2; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223	30	71	71	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16370	10.1371/journal.pone.0016370	http://dx.doi.org/10.1371/journal.pone.0016370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283536	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400046
J	Mamo, G; Bayleyegn, G; Tessema, TS; Legesse, M; Medhin, G; Bjune, G; Abebe, F; Ameni, G				Mamo, Gezahegne; Bayleyegn, Gizachew; Tessema, Tesfaye Sisay; Legesse, Mengistu; Medhin, Girmay; Bjune, Gunnar; Abebe, Fekadu; Ameni, Gobena			Pathology of Camel Tuberculosis and Molecular Characterization of Its Causative Agents in Pastoral Regions of Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; RISK-FACTORS; CATTLE HUSBANDRY; TUBERCLE-BACILLI; IDENTIFICATION; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS; PREVALENCE; DIAGNOSIS	A cross sectional study was conducted on 906 apparently healthy camels slaughtered at Akaki and Metehara abattoirs to investigate the pathology of camel tuberculosis (TB) and characterize its causative agents using postmortem examination, mycobacteriological culturing, and multiplex polymerase chain reaction (PCR), region of difference-4 (RD4)-based PCR and spoligotyping. The prevalence of camel TB was 10.04% (91/906) on the basis of pathology and it was significantly higher in females (chi(2) = 4.789; P = 0.029). The tropism of TB lesions was significantly different among the lymph nodes (chi(2) = 22.697; P = 0.002) and lung lobes (chi(2) = 17.901; P = 0.006). Mycobacterial growth was observed in 34% (31/91) of camels with grossly suspicious TB lesions. Upon further molecular characterization using multiplex PCR, 68% (21/31) of the colonies showed a positive signal for the genus Mycobacterium, of which two were confirmed Mycobacterium bovis (M. bovis) by RD4 deletion typing. Further characterization of the two M. bovis at strains level revealed that one of the strains was SB0133 while the other strain was new and had not been reported to the M. bovis database prior to this study. Hence, it has now been reported to the database, and designated as SB1953. In conclusion, the results of the present study have shown that the majority of camel TB lesions are caused by mycobacteria other than Mycobacterium tuberculosis complex. And hence further identification and characterization of these species would be useful towards the efforts made to control TB in camels.	[Mamo, Gezahegne; Bayleyegn, Gizachew; Tessema, Tesfaye Sisay] Univ Addis Ababa, Fac Vet Med, Debre Zeit, Ethiopia; [Legesse, Mengistu; Medhin, Girmay; Ameni, Gobena] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Mamo, Gezahegne; Legesse, Mengistu; Bjune, Gunnar; Abebe, Fekadu] Univ Oslo, Inst Hlth & Soc, Fac Med, Dept Gen Practice & Community Med, Oslo, Norway	Addis Ababa University; Addis Ababa University; University of Oslo	Mamo, G (corresponding author), Univ Addis Ababa, Fac Vet Med, Debre Zeit, Ethiopia.	gezahegnemamo@yahoo.com	Tessema, Tesfaye Sisay/AAD-6230-2020; Ameni, Gobena/AAR-4201-2020; Kassa, Gezahegne Mamo/AAN-2144-2020	Ameni, Gobena/0000-0003-3987-0671; Kassa, Gezahegne Mamo/0000-0002-4200-884X; Medhin, Girmay/0000-0003-2146-4261	Norwegian Programme for Development, Research and Education (NUFU) [PRO-2007/10198]	Norwegian Programme for Development, Research and Education (NUFU)	This study was financially supported by the Norwegian Programme for Development, Research and Education (NUFU), PRO-2007/10198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, VET REC, V161, P782; Ameni G, 2010, VET REC, V167, P138, DOI 10.1136/vr.b4881; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Biffa D, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-28; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; *CSA, 2008, STAT B, V2, P16; ELMOSSALAMI E, 1971, Zentralblatt fuer Veterinaermedizin Reihe B, V18, P253; GETAHUN T, 2002, NOMADIC PEOPLES, V6, P155; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; HUSSEN N, 2009, THESIS ADDIS ABABA U; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kazwala RR, 2001, VET RES COMMUN, V25, P609, DOI 10.1023/A:1012757011524; KINNE J, 2006, TROP ANIM HLTH PROD, V38, P38; MAMO G, 2009, B ANIM HLTH PROD AFR, V57, P1; Manefield GW, 1997, CAMELS COMPENDIUM C; Markakis John., 2004, PASTORALISM MARGIN; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Munyeme M, 2009, TROP ANIM HEALTH PRO, V41, P345, DOI 10.1007/s11250-008-9195-5; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; NORI M, 2005, SUSTAINABLE CAMEL MI; *OIE, 2004, OIE MAN STAND DIAGN, P451; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Ozygit MO, 2007, VET REC, V160, P307, DOI 10.1136/vr.160.9.307; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Refai M, 1992, P 1 INT CAM C; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; UNDP (United Nations Development Programme), 2007, ROCK HARD PLAC ARM V; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wernery U, 2002, INFECT DIS CAMELIDS, p[23, 33]; Wilton S, 1992, PCR Methods Appl, V1, P269; Zubair R., 2004, J CAMEL SCI, V1, P103	37	35	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15862	10.1371/journal.pone.0015862	http://dx.doi.org/10.1371/journal.pone.0015862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283668	Green Submitted, Green Published, gold			2022-12-27	WOS:000286523400007
J	Pedroso, DCS; Tellechea, A; Moura, L; Fidalgo-Carvalho, I; Duarte, J; Carvalho, E; Ferreira, L				Pedroso, Dora C. S.; Tellechea, Ana; Moura, Liane; Fidalgo-Carvalho, Isabel; Duarte, Joao; Carvalho, Eugenia; Ferreira, Lino			Improved Survival, Vascular Differentiation and Wound Healing Potential of Stem Cells Co-Cultured with Endothelial Cells	PLOS ONE			English	Article							CORD BLOOD-CELLS; PROGENITOR CELLS; HEMATOPOIETIC PROGENITOR; CYTOKINE; ANGIOGENESIS; PROMOTE; FIBRIN; EXPRESSION; IL-10	In this study, we developed a methodology to improve the survival, vascular differentiation and regenerative potential of umbilical cord blood (UCB)-derived hematopoietic stem cells (CD34(+) cells), by co-culturing the stem cells in a 3D fibrin gel with CD34(+)-derived endothelial cells (ECs). ECs differentiated from CD34(+) cells appear to have superior angiogenic properties to fully differentiated ECs, such as human umbilical vein endothelial cells (HUVECs). Our results indicate that the pro-survival effect of CD34(+)-derived ECs on CD34(+) cells is mediated, at least in part, by bioactive factors released from ECs. This effect likely involves the secretion of novel cytokines, including interleukin-17 (IL-17) and interleukin-10 (IL-10), and the activation of the ERK 1/2 pathway in CD34(+) cells. We also show that the endothelial differentiation of CD34(+) cells in co-culture with CD34(+)-derived ECs is mediated by a combination of soluble and insoluble factors. The regenerative potential of this co-culture system was demonstrated in a chronic wound diabetic animal model. The co-transplantation of CD34(+) cells with CD34(+)-derived ECs improved the wound healing relatively to controls, by decreasing the inflammatory reaction and increasing the neovascularization of the wound.	[Pedroso, Dora C. S.; Tellechea, Ana; Moura, Liane; Carvalho, Eugenia; Ferreira, Lino] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Pedroso, Dora C. S.; Ferreira, Lino] Ctr Inovacao Biotecnol, Cantanhede, Portugal; [Fidalgo-Carvalho, Isabel] Inst Biol Mol & Celular, Oporto, Portugal; [Duarte, Joao] Crioestaminal, Cantanhede, Portugal	Universidade de Coimbra; Universidade do Porto	Pedroso, DCS (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	lino@biocant.pt	Tellechea, Ana/C-4900-2013; Moura, Liane IF/F-6534-2015; iMed.ULisboa, InTraCellADD/B-4826-2014; Tellechea, Ana/O-8325-2019; Fidalgo-Carvalho, Isabel/E-1335-2011; Carvalho, Eugenia/AAV-6868-2021; Fidalgo-Carvalho, Isabel SS/P-5192-2015	Moura, Liane IF/0000-0003-4264-6865; Tellechea, Ana/0000-0001-9387-7706; Carvalho, Eugenia/0000-0001-6264-3632; Fidalgo-Carvalho, Isabel SS/0000-0002-7882-3555; Pedroso, Dora/0000-0002-5735-5094; ferreira, lino/0000-0001-8985-9302	Crioestaminal S.A.; Crioestaminal; Associacao Viver a Ciencia; MIT- Portugal Program; Marie Curie Reintegration Grant; EFSD/JDRF/Novo Nordisk European Programme; Fundacao para a Ciencia e Tecnologia [PTDC/CTM/099659/2008, PTDC/SAU-MII/098567/2008, SFRH/BD/48624/2008, SFRH/BD/60837/2009, BPD 000081/CMIT]	Crioestaminal S.A.; Crioestaminal; Associacao Viver a Ciencia; MIT- Portugal Program; Marie Curie Reintegration Grant(European Commission); EFSD/JDRF/Novo Nordisk European Programme(Juvenile Diabetes Research Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Crioestaminal S.A. (project reference: INJECTCORD), Crioestaminal (LF), Associacao Viver a Ciencia (LF), MIT- Portugal Program (LF) and a Marie Curie Reintegration Grant (LF), EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research (EC), and Fundacao para a Ciencia e Tecnologia (PTDC/CTM/099659/2008 (LF), PTDC/SAU-MII/098567/2008 (EC), SFRH/BD/48624/2008 (AT), SFRH/BD/60837/2009 (LM), and BPD 000081/CMIT (DP)). Joao Duarte is an employee of Crioestaminal, a Portuguese cryobanking stem cell company. He contributed for the characterization of stem cells and their progenies. Crioestaminal had no other role in the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Behringer D, 1997, BRIT J HAEMATOL, V97, P9, DOI 10.1046/j.1365-2141.1997.d01-2143.x; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Geest CR, 2009, BLOOD, V114, P3402, DOI 10.1182/blood-2008-08-175141; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Henning RJ, 2006, CELL TRANSPLANT, V15, P647, DOI 10.3727/000000006783981611; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Leor J, 2005, CYTOTHERAPY, V7, P251, DOI 10.1080/14653240510027163; Lozito TP, 2009, J CELL BIOCHEM, V107, P714, DOI 10.1002/jcb.22167; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Parada Y, 2001, J BIOL CHEM, V276, P23572, DOI 10.1074/jbc.M101885200; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Ratajczak J, 1998, LEUKEMIA, V12, P371, DOI 10.1038/sj.leu.2400927; Romagnani P, 2005, CIRC RES, V97, P314, DOI 10.1161/01.RES.0000177670.72216.9b; SCHEUBEL RJ, 2008, INT J CARDIOL; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Smadja DM, 2008, J CELL MOL MED, V12, P975, DOI 10.1111/j.1582-4934.2008.00161.x; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Valbonesi M, 2004, TRANSFUS APHER SCI, V30, P153, DOI 10.1016/j.transci.2003.11.006; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; WeberNordt RM, 1996, BLOOD, V88, P2549, DOI 10.1182/blood.V88.7.2549.bloodjournal8872549; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226	38	78	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16114	10.1371/journal.pone.0016114	http://dx.doi.org/10.1371/journal.pone.0016114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283630	Green Published, gold			2022-12-27	WOS:000286523400018
J	Petrella, S; Gelus-Ziental, N; Maudry, A; Laurans, C; Boudjelloul, R; Sougakoff, W				Petrella, Stephanie; Gelus-Ziental, Nathalie; Maudry, Arnaud; Laurans, Caroline; Boudjelloul, Rachid; Sougakoff, Wladimir			Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide	PLOS ONE			English	Article							DRUG PYRAZINAMIDE; TUBERCLE-BACILLI; PNCA MUTATIONS; GENE; IDENTIFICATION; NICOTINAMIDASE; MECHANISM; DYNAMICS; STRAINS; BINDING	Pyrazinamidase (PncA) activates the first-line antituberculous drug pyrazinamide into pyrazinoic acid. The crystal structure of the Mycobacterium tuberculosis PncA protein has been determined, showing significant differences in the substrate binding cavity when compared to the pyrazinamidases from Pyrococcus horikoshii and Acinetobacter baumanii. In M. tuberculosis, this region was found to hold a Fe2+ ion coordinated by one aspartate and three histidines, one of them corresponding to His57 which is replaced by Asp in Mycobacterium bovis, a species naturally resistant to pyrazinamide. The binding cavity also contains a Cys138-Asp8-Lys96 motif evocating a cysteine-based catalytic mechanism. Mutants have been constructed and investigated by kinetic and thermal shift assays, highlighting the importance of protein folding and thermal stability in the pyrazinamidase activity.	[Petrella, Stephanie; Gelus-Ziental, Nathalie; Maudry, Arnaud; Laurans, Caroline; Boudjelloul, Rachid; Sougakoff, Wladimir] Univ Paris 06, UPMC, Fac Med Pitie Salpetriere, ER Bacteriol Hyg EA1541 5, Paris, France; [Gelus-Ziental, Nathalie] Univ Lille 1, INSERM, U908, F-59655 Villeneuve Dascq, France; [Gelus-Ziental, Nathalie] Univ Lille 1, CNRS, FRE3249, F-59655 Villeneuve Dascq, France; [Laurans, Caroline] Ctr Hosp Victor Provo, Equipe Operat Hyg & Infectiol, Roubaix, France; [Sougakoff, Wladimir] INSERM, LRMA, UMRS Pitie Salpetriere 872 12, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Petrella, S (corresponding author), Univ Paris 06, UPMC, Fac Med Pitie Salpetriere, ER Bacteriol Hyg EA1541 5, Paris, France.	wladimir.sougakoff@upmc.fr	SOUGAKOFF, Wladimir/O-9754-2017	SOUGAKOFF, Wladimir/0000-0002-2447-517X; Petrella, Stephanie/0000-0001-6641-5901	Ministere de la Recherche [UPRES EA1541]	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by a grant from the Ministere de la Recherche (program grant UPRES EA1541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doustdar F, 2009, MICROB DRUG RESIST, V15, P251, DOI 10.1089/mdr.2009.0066; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KONNO K, 1967, AM REV RESPIR DIS, V95, P461; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lemaitre N, 1999, ANTIMICROB AGENTS CH, V43, P1761, DOI 10.1128/AAC.43.7.1761; Lemaitre N, 2001, BIOCHEM J, V353, P453, DOI 10.1042/0264-6021:3530453; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCCOY AJ, 2007, J APPL CRYSTALLOGR, V40, P1297; McDonnell PA, 2009, ANAL BIOCHEM, V392, P59, DOI 10.1016/j.ab.2009.05.044; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pandey S, 2009, PATHOLOGY, V41, P582, DOI 10.1080/00313020903071587; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scorpio A, 1997, J CLIN MICROBIOL, V35, P106, DOI 10.1128/JCM.35.1.106-110.1997; Seiner DR, 2010, BIOCHEMISTRY-US, V49, P9613, DOI 10.1021/bi1011157; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P2802, DOI 10.1128/JCM.00352-07; Sheen P, 2009, TUBERCULOSIS, V89, P109, DOI 10.1016/j.tube.2009.01.004; Unissa AN, 2009, BIOINFORMATION, V4, P24, DOI 10.6026/97320630004024; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Zhang H, 2009, J INT MED RES, V37, P1430, DOI 10.1177/147323000903700517; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zimic M, 2010, INFECT GENET EVOL, V10, P346, DOI 10.1016/j.meegid.2009.11.016	31	99	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15785	10.1371/journal.pone.0015785	http://dx.doi.org/10.1371/journal.pone.0015785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283666	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400005
J	Getz, WM; Owen-Smith, N				Getz, Wayne M.; Owen-Smith, Norman			Consumer-Resource Dynamics: Quantity, Quality, and Allocation	PLOS ONE			English	Article								Background: The dominant paradigm for modeling the complexities of interacting populations and food webs is a system of coupled ordinary differential equations in which the state of each species, population, or functional trophic group is represented by an aggregated numbers-density or biomass-density variable. Here, using the metaphysiological approach to model consumer-resource interactions, we formulate a two-state paradigm that represents each population or group in a food web in terms of both its quantity and quality. Methodology and Principal Findings: The formulation includes an allocation function controlling the relative proportion of extracted resources to increasing quantity versus elevating quality. Since lower quality individuals senesce more rapidly than higher quality individuals, an optimal allocation proportion exists and we derive an expression for how this proportion depends on population parameters that determine the senescence rate, the per-capita mortality rate, and the effects of these rates on the dynamics of the quality variable. We demonstrate that oscillations do not arise in our model from quantity-quality interactions alone, but require consumer-resource interactions across trophic levels that can be stabilized through judicious resource allocation strategies. Analysis and simulations provide compelling arguments for the necessity of populations to evolve quality-related dynamics in the form of maternal effects, storage or other appropriate structures. They also indicate that resource allocation switching between investments in abundance versus quality provide a powerful mechanism for promoting the stability of consumer-resource interactions in seasonally forcing environments. Conclusions/Significance: Our simulations show that physiological inefficiencies associated with this switching can be favored by selection due to the diminished exposure of inefficient consumers to strong oscillations associated with the well-known paradox of enrichment. Also our results demonstrate how allocation switching can explain observed growth patterns in experimental microbial cultures and discuss how our formulation can address questions that cannot be answered using the quantity-only paradigms that currently predominate.	[Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa; [Owen-Smith, Norman] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa	University of California System; University of California Berkeley; Stellenbosch University; University of Witwatersrand	Getz, WM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	wgetz@berkeley.edu	Owen-Smith, Norman/ABI-5113-2020; Getz, Wayne/I-4521-2013	Owen-Smith, Norman/0000-0001-8429-1201; Getz, Wayne/0000-0001-8784-9354	NIH [GM083863]; James S. McDonnell Foundation; South African NRF; Stellenbosch Institute for Advanced Study, Stellenbosch, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; South African NRF(National Research Foundation - South Africa); Stellenbosch Institute for Advanced Study, Stellenbosch, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported with funding from NIH Grant GM083863 (WMG), the James S. McDonnell Foundation (WMG), the South African NRF (NOS), and the Stellenbosch Institute for Advanced Study, Stellenbosch, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AANES R, 2002, ECOL LETT, P445; Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Abrams PA, 2005, J EVOLUTION BIOL, V18, P1162, DOI 10.1111/j.1420-9101.2004.00843.x; ABRAMS PA, 1988, ECOLOGY, V69, P1418, DOI 10.2307/1941639; ABRAMS PA, 1994, ECOLOGY, V75, P1118, DOI 10.2307/1939435; ABRAMS PA, 1994, EVOLUTIONARY ECOLOGY, P150; ABRAMS PA, 2009, AM NAT, P321; ABRAMS PA, 2004, EVOLUTIONARY ECOLOGY, V8, P150; AKCAKAYA HR, 1988, B MATH BIOL, V50, P503, DOI 10.1007/BF02458849; ALLEN AP, 2009, ECOL LETT, P369; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; ANDERSEN T, 2004, ECOL LETT, P884; ARDITI R, 1992, ECOLOGY, V73, P1544, DOI 10.2307/1940007; BALTENSWEILER W, 1977, ANNU REV ENTOMOL, V22, P79, DOI 10.1146/annurev.en.22.010177.000455; BARBOSA PA, 1997, PLANT RESOURCE ALLOC; Batzli GO, 1999, TRENDS ECOL EVOL, V14, P129, DOI 10.1016/S0169-5347(98)01581-X; BAXTER PWJ, 2005, ECOLOGICAL APPL, P1331; BEDDINGTON JR, 1975, J ANIM ECOL, V44, P331, DOI 10.2307/3866; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bullock JM, 2008, J ECOL, V96, P567, DOI 10.1111/j.1365-2745.2008.01382.x; Caswell H., 2001, MATRIX POPULATION MO; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; De Roos AM, 2001, OIKOS, V94, P51, DOI 10.1034/j.1600-0706.2001.11313.x; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; DEMETRIUS L, 2009, PHYSICA A, P651; ELLNER SP, 2006, AM NAT, P410; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; FESTABIANCHET M, 2003, J ANIM ECOL, P640; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GAUZE GF, 1934, STRUGGLE EXISTENCE, pR9; Getz W. M., 1989, Population harvesting: demographic models of fish, forest, and animal resources.; Getz Wayne M., 1999, Natural Resource Modeling, V12, P197; Getz WM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000209; Getz Wayne M., 1994, Lecture Notes in Biomathematics, V100, P411; Getz WM, 1999, ANN ZOOL FENN, V36, P11; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; Getz WM, 1998, BIOSCIENCE, V48, P540, DOI 10.2307/1313316; GETZ WM, 1991, NAT RESOUR MODEL, V5, P623; GETZ WM, 1993, EVOLUTIONARY ECOLOGY, P287; GETZ WM, 1984, J THEOR BIOL, P623; GETZ WM, 2010, ECOLOGY LETT; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; Ginzburg LR, 2010, BIOL LETTERS, V6, P850, DOI 10.1098/rsbl.2010.0452; GINZBURG LR, 1986, J THEOR BIOL, P385; GINZBURG LR, 1998, J ANIM ECOL, P325; Gross J. E., 2010, DYNAMICS LARGE HERBI, P117; GROVER JP, 2003, AM NAT, P29; GURNEY WSC, 1998, ECOLOGICAL DYNAMICS, pR13; Gutierrez A. P., 1996, Applied population ecology: a supply-demand approach.; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; Haque M, 2009, B MATH BIOL, V71, P430, DOI 10.1007/s11538-008-9368-4; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; HILKER FM, 2008, J THEOR BIOL, P299; Hobbs N. T., 2010, DYNAMICS LARGE HERBI, P141; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; INCHAUSTI P, 1998, J ANIM ECOL, P180; Inchausti P, 2009, PHILOS T R SOC B, V364, P1117, DOI 10.1098/rstb.2008.0292; IVES AR, 1985, J THEOR BIOL, P65; JOHST K, 2008, POPULATION ECOLOGY, P79; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; KOOIJMAN SALM, 1989, FUNCT ECOL, V3, P325, DOI 10.2307/2389373; KOT M, 1984, THEORETICAL POPULATI, P340; Kuwamura M, 2009, J MATH BIOL, V58, P459, DOI 10.1007/s00285-008-0203-1; LAMBIN X, 2006, J ANIM ECOL, P340; LANDE R, 2003, STOCHASTIC POPULATIO, pR10; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LINDSTROM J, 2002, ECOL LETT, P338; Lotka A. J., 1925, P460; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1973, STABILITY COMPLEXITY, pR9; McGill BJ, 2007, ANNU REV ECOL EVOL S, V38, P403, DOI 10.1146/annurev.ecolsys.36.091704.175517; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MOUGI A, 2009, THEORETICAL ECOLOGY, P33; MOYES K, 2009, J ANIM ECOL, P406; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Murdoch W. W., 2003, CONSUMER RESOURCE DY, p[xiii, 462]; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; NICHOLSON A. J., 1935, Proceedings of the Zoological Society of London, P551; NICHOLSON AJ, 1933, J ANIM ECOL, P132; NISBET RM, 2000, J ANIM ECOL, P913; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; Owen-Smith N., 2008, RESOURCE ECOLOGY SPA, P159, DOI DOI 10.1007/978-1-4020-6850-8_14; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Owens IPF, 2006, TRENDS ECOL EVOL, V21, P356, DOI 10.1016/j.tree.2006.03.014; OWENSMITH N, 1987, ECOLOGY, V68, P319, DOI 10.2307/1939263; OWENSMITH N, 2002, ECOLOGICAL MODELLING, P153; PARKER KL, 2009, FUNCTIONAL ECOLOGY, P57; PONTRYAGIN LS, 1964, MATH THEORY OPTIMAL, V340, pR7; Power ME, 2002, ECOL RES, V17, P451, DOI 10.1046/j.1440-1703.2002.00503.x; RAMOSJILIBERTO R, 2000, ECOLOGICAL MODELLING, P221; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; SCHULTZ JC, 1983, ACS SYM SER, V208, P37; SIMARD MA, 2008, J ANIM ECOL, P678; STREIFER W, 1973, ECOLOGY, V54, P392, DOI 10.2307/1934347; THOMPSON W. R., 1929, PARASILOLOGY, V21, P180, DOI 10.1017/S0031182000022885; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; VADASZ P, 2010, MICROB ECOL, P233; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; WILMERS CC, 2004, ECOLOGICAL MODELLING, P193; WILMERS CC, 2003, J ANIM ECOL, P909; WILMERS CC, 2003, ECOL LETT, P996; Wilmers CC, 2007, J ANIM ECOL, V76, P1037, DOI 10.1111/j.1365-2656.2007.01289.x; WILSON DS, 1977, AM NAT, V111, P157, DOI 10.1086/283146; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	121	3	3	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14539	10.1371/journal.pone.0014539	http://dx.doi.org/10.1371/journal.pone.0014539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283752	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522200002
J	Santiago, C; Ruiz, JR; Rodriguez-Romo, G; Fiuza-Luces, C; Yvert, T; Gonzalez-Freire, M; Gomez-Gallego, F; Moran, M; Lucia, A				Santiago, Catalina; Ruiz, Jonatan R.; Rodriguez-Romo, Gabriel; Fiuza-Luces, Carmen; Yvert, Thomas; Gonzalez-Freire, Marta; Gomez-Gallego, Felix; Moran, Maria; Lucia, Alejandro			The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men	PLOS ONE			English	Article							JUMP PERFORMANCE; VERTICAL JUMP; STRENGTH; GENOTYPE; GROWTH; SARCOPENIA; REGULATOR; HUMANS; CATTLE; MICE	The Lys(K) 153Arg(R) polymorphism in exon 2 (rs1805086, 2379 A>G replacement) of the myostatin (MSTN) gene is a candidate to influence skeletal muscle phenotypes. We examined the association between the MSTN K153R polymorphism and 'explosive' leg power, assessed during sprint (30 m) and stationary jumping tests [squat (SJ) and counter-movement jumps (CMJ)] in non-athletic young adults (University students) [n = 281 (214 men); age: 21-32 years]. We also genotyped the MSTN exonic variants E164K (rs35781413), I225T, and P198A, yet no subject carried any of these variant MSTN alleles. As for the K153R polymorphism, we found only one woman with the KR genotype; thus, we presented the results only for men. The results of a one-way ANCOVA (with age, weight and height entered as covariates) showed that men with the KR genotype (n = 15) had a worse performance in vertical jumps compared with those with the KK genotype [SJ: vertical displacement of center of gravity (CG) of 35.17 +/- 1.42 vs. 39.06 +/- 0.39 cm, respectively, P = 0.009; CMJ: vertical displacement of CG of 36.44 +/- 1.50 vs. 40.63 +/- 0.41 cm, respectively, P = 0.008]. The results persisted after adjusting for multiple comparisons according to Bonferroni. Performance in 30 m sprint tests did however not differ by K153R genotypes. In summary, the MSTN K153R polymorphism is associated with the ability to produce 'peak' power during muscle contractions, as assessed with vertical jump tests, in young non-athletic men. Although more research is still needed, this genetic variation is among the numerous candidates to explain, alone or in combination with other polymorphisms, individual variations in muscle phenotypes.	[Santiago, Catalina; Fiuza-Luces, Carmen; Yvert, Thomas; Gonzalez-Freire, Marta; Gomez-Gallego, Felix; Lucia, Alejandro] Univ Europea Madrid, Dept Biomed, Madrid, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Unit Prevent Nutr, Dept Biosci & Nutr, Novum, Stockholm, Sweden; [Rodriguez-Romo, Gabriel] Univ Politecn Madrid, INEF, Madrid, Spain; [Moran, Maria] Hosp Univ 12 Octubre, Madrid, Spain	European University of Madrid; Karolinska Institutet; Universidad Politecnica de Madrid; Facultad de Ciencias de la Actividad Fisica del Deporte (INEF); Hospital Universitario 12 de Octubre	Santiago, C (corresponding author), Univ Europea Madrid, Dept Biomed, Madrid, Spain.	alejandro.lucia@uem.es	Santiago, Catalina/P-8177-2019; Lucia, Alejandro/M-2759-2014; Gonzalez-Freire, Marta/ABG-1197-2020; Gomez-Gallego, Felix/H-6925-2013; Gomez-Gallego, Felix/AAD-9617-2020; Rodriguez-Romo, Gabriel/AAD-1603-2022; Moran, Maria/HHS-1798-2022; RUIZ, JONATAN R/M-1338-2015; Santiago, Catalina/K-6803-2014	Santiago, Catalina/0000-0003-3852-8217; Lucia, Alejandro/0000-0002-3025-2060; Gomez-Gallego, Felix/0000-0002-1968-1761; Rodriguez-Romo, Gabriel/0000-0003-3111-6340; RUIZ, JONATAN R/0000-0002-7548-7138; Santiago, Catalina/0000-0003-3852-8217; Gonzalez-Freire, Marta/0000-0001-9741-2826; Lucia, Alejandro/0000-0002-5565-0997; Fiuza-Luces, Carmen/0000-0001-8131-7007; Yvert, Thomas/0000-0002-9451-9799	Consejo Superior de Deportes (CSD) [UPR10/08]; Fondo de Investigaciones Sanitarias (FIS) [PS09/00194]; Swedish Council for Working Life and Social Research (FAS)	Consejo Superior de Deportes (CSD); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Consejo Superior de Deportes (CSD, ref # UPR10/08), Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194), and the Swedish Council for Working Life and Social Research (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz PE, 2009, J STRENGTH COND RES, V23, P480, DOI 10.1519/JSC.0b013e318198f92c; Ashley C.D., 1994, J STRENGTH CONDITION, V1, P5, DOI [10.1519/1533-4287(1994)0082.3.CO;2, DOI 10.1519/1533-4287(1994)0082.3.CO;2]; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P357, DOI 10.1007/BF00429072; Brown LE, 2001, J EXERC PHYSL ONLINE, V4, DOI DOI 10.4236/JEP.2013.46A001; Cavagna G A, 1977, Exerc Sport Sci Rev, V5, P89; Corsi AM, 2002, J AM GERIATR SOC, V50, P1463, DOI 10.1046/j.1532-5415.2002.50376.x; Fedoruk MN, 2008, SCAND J MED SCI SPOR, V18, P123, DOI 10.1111/j.1600-0838.2007.00759.x; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Gonzalez-Freire M, 2010, AGE, V32, P405, DOI 10.1007/s11357-010-9139-7; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Ham DJ, 2007, J STRENGTH COND RES, V21, P967; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; HOLM S, 1979, SCAND J STAT, V6, P65; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Ivey FM, 2000, J GERONTOL A-BIOL, V55, pB152, DOI 10.1093/gerona/55.3.B152; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Juffer P, 2009, INT J SPORTS MED, V30, P387, DOI 10.1055/s-0028-1105931; Kostek MA, 2009, MED SCI SPORT EXER, V41, P1063, DOI 10.1249/MSS.0b013e3181930337; Kubo K, 1999, J APPL PHYSIOL, V87, P2090, DOI 10.1152/jappl.1999.87.6.2090; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; SANTIAGO C, 2009, SCAND J MED SCI SPOR; Saunders MA, 2006, AM J HUM GENET, V79, P1089, DOI 10.1086/509707; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seibert MJ, 2001, J AM GERIATR SOC, V49, P1093, DOI 10.1046/j.1532-5415.2001.49214.x; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Young WB, 2001, J STRENGTH COND RES, V15, P6	37	36	37	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16323	10.1371/journal.pone.0016323	http://dx.doi.org/10.1371/journal.pone.0016323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283721	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522200050
J	Ward, JR; Heath, PR; Catto, JW; Whyte, MKB; Milo, M; Renshaw, SA				Ward, Jon R.; Heath, Paul R.; Catto, James W.; Whyte, Moira K. B.; Milo, Marta; Renshaw, Stephen A.			Regulation of Neutrophil Senescence by MicroRNAs	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; CELL-DEATH; APOPTOSIS; CANCER; SURVIVAL; INFLAMMATION; ACTIVATION	Neutrophils are rapidly recruited to sites of tissue injury or infection, where they protect against invading pathogens. Neutrophil functions are limited by a process of neutrophil senescence, which renders the cells unable to respond to chemoattractants, carry out respiratory burst, or degranulate. In parallel, aged neutrophils also undergo spontaneous apoptosis, which can be delayed by factors such as GMCSF. This is then followed by their subsequent removal by phagocytic cells such as macrophages, thereby preventing unwanted inflammation and tissue damage. Neutrophils translate mRNA to make new proteins that are important in maintaining functional longevity. We therefore hypothesised that neutrophil functions and lifespan might be regulated by microRNAs expressed within human neutrophils. Total RNA from highly purified neutrophils was prepared and subjected to microarray analysis using the Agilent human miRNA microarray V3. We found human neutrophils expressed a selected repertoire of 148 microRNAs and that 6 of these were significantly upregulated after a period of 4 hours in culture, at a time when the contribution of apoptosis is negligible. A list of predicted targets for these 6 microRNAs was generated from http://mirecords.biolead.org and compared to mRNA species downregulated over time, revealing 83 genes targeted by at least 2 out of the 6 regulated microRNAs. Pathway analysis of genes containing binding sites for these microRNAs identified the following pathways: chemokine and cytokine signalling, Ras pathway, and regulation of the actin cytoskeleton. Our data suggest that microRNAs may play a role in the regulation of neutrophil senescence and further suggest that manipulation of microRNAs might represent an area of future therapeutic interest for the treatment of inflammatory disease.	[Ward, Jon R.; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, Sch Med & Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Ward, Jon R.; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, Sch Med & Biomed Sci, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Heath, Paul R.] Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield, S Yorkshire, England; [Milo, Marta] Univ Sheffield, Sch Med & Biomed Sci, NIHR Cardiovasc Biomed Res Unit, Sheffield, S Yorkshire, England; [Catto, James W.] Univ Sheffield, Sch Med & Biomed Sci, Dept Oncol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Ward, JR (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	s.a.renshaw@sheffield.ac.uk	Heath, Paul/B-4778-2009; Renshaw, Steve/E-6192-2010	Renshaw, Steve/0000-0003-1790-1641; catto, james/0000-0003-2787-8828	MRC [G0701932]; MRC [G108/595] Funding Source: UKRI; Medical Research Council [G0701932, G108/595] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an MRC Senior Clinical Fellowship to SAR (reference number: G0701932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; COLOTTA F, 1992, BLOOD, V80, P2012; COWBURN AS, 2010, AM J RESP CELL MOL B; CRONKITE EP, 1964, NEW ENGL J MED, V270, P1347, DOI 10.1056/NEJM196406182702506; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Slezak S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-39; Stringer RE, 1996, BRIT J HAEMATOL, V92, P169, DOI 10.1046/j.1365-2141.1996.00307.x; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Ward JR, 2009, IMMUNOLOGY, V128, P58, DOI 10.1111/j.1365-2567.2009.03071.x; Watson RWG, 1996, J IMMUNOL, V156, P3986; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Whyte MKB, 1997, J LEUKOCYTE BIOL, V62, P195, DOI 10.1002/jlb.62.2.195; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	54	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15810	10.1371/journal.pone.0015810	http://dx.doi.org/10.1371/journal.pone.0015810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283524	gold, Green Accepted, Green Published			2022-12-27	WOS:000286520600013
J	McMaster, A; Jangani, M; Sommer, P; Han, N; Brass, A; Beesley, S; Lu, WQ; Berry, A; Loudon, A; Donn, R; Ray, DW				McMaster, Andrew; Jangani, Maryam; Sommer, Paula; Han, Namshik; Brass, Andy; Beesley, Stephen; Lu, Weiqun; Berry, Andrew; Loudon, Andrew; Donn, Rachelle; Ray, David W.			Ultradian Cortisol Pulsatility Encodes a Distinct, Biologically Important Signal	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; PROMOTER; STRESS; GENE; TRANSCRIPTION; MODULATION; RELEASE; RHYTHM; ADRENOCORTICOTROPIN; CORTICOTROPIN	Context: Cortisol is released in ultradian pulses. The biological relevance of the resulting fluctuating cortisol concentration has not been explored. Objective: Determination of the biological consequences of ultradian cortisol pulsatility. Design: A novel flow through cell culture system was developed to deliver ultradian pulsed or continuous cortisol to cells. The effects of cortisol dynamics on cell proliferation and survival, and on gene expression were determined. In addition, effects on glucocorticoid receptor (GR) expression levels and phosphorylation, as a potential mediator, were measured. Results: Pulsatile cortisol caused a significant reduction in cell survival compared to continuous exposure of the same cumulative dose, due to increased apoptosis. Comprehensive analysis of the transcriptome response by microarray identified genes with a differential response to pulsatile versus continuous glucocorticoid delivery. These were confirmed with qRT-PCR. Several transcription factor binding sites were enriched in these differentially regulated target genes, including CCAAT-displacement protein (CDP). A CDP regulated reporter gene (MMTV-luc) was, as predicted, also differentially regulated by pulsatile compared to continuous cortisol delivery. Importantly there was no effect of cortisol delivery kinetics on either GR expression, or activation (GR phosphoSer(211)). Conclusions: Cortisol oscillations exert important effects on target cell gene expression, and phenotype. This is not due to differences in cumulative cortisol exposure, or either expression, or activation of the GR. This suggests a novel means to regulate GR function.	[McMaster, Andrew; Jangani, Maryam; Sommer, Paula; Lu, Weiqun; Berry, Andrew; Ray, David W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Endocrine Sci Res Grp, Manchester, Lancs, England; [McMaster, Andrew; Jangani, Maryam; Berry, Andrew; Donn, Rachelle] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Han, Namshik; Brass, Andy; Beesley, Stephen; Lu, Weiqun; Loudon, Andrew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Life Sci, Manchester, Lancs, England; [Han, Namshik; Brass, Andy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Comp Sci, Manchester, Lancs, England; [Sommer, Paula] Univ Kwa Zulu, Sch Biol Sci, Durban, South Africa	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Kwazulu Natal	McMaster, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Endocrine Sci Res Grp, Manchester, Lancs, England.	Rachelle.donn@manchester.ac.uk; David.w.ray@manchester.ac.uk	Sommer, Paula/E-9454-2010; beesley, stephen/B-4841-2017	Sommer, Paula/0000-0001-6810-5587; Loudon, Andrew/0000-0003-3648-445X; Donn, Rachelle/0000-0001-6976-9828; Han, Namshik/0000-0002-7741-6384; Ray, David/0000-0002-4739-6773; Brass, Andrew/0000-0002-0389-7058; beesley, stephen/0000-0001-6010-124X	Arthritis Research UK; NIHR Manchester Biomedical Research Centre	Arthritis Research UK(Versus Arthritis); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	The authors are grateful to Arthritis Research UK for support (RD, AB, AMcM), BBSRC (WL, AL), and Wellcome Trust (PS, DWR). The authors acknowledge support from the NIHR Manchester Biomedical Research Centre (MJ, DWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergendahl M, 2000, J CLIN ENDOCR METAB, V85, P2203, DOI 10.1210/jc.85.6.2203; Bijlsma JWJ, 2005, RHEUM DIS CLIN N AM, V31, pXIII, DOI 10.1016/j.rdc.2004.11.001; Chrousos GP, 1998, ENDOCRINOLOGY, V139, P437, DOI 10.1210/endo.139.2.5857; Cutolo M, 2005, RHEUM DIS CLIN N AM, V31, P115, DOI 10.1016/j.rdc.2004.09.005; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Invitti C, 1998, METABOLISM, V47, P143, DOI 10.1016/S0026-0495(98)90210-4; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KERRIGAN JR, 1993, J CLIN ENDOCR METAB, V76, P1505, DOI 10.1210/jc.76.6.1505; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Lightman S L, 2000, Novartis Found Symp, V227, P244; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Muglia LJ, 1997, J CLIN INVEST, V99, P2923, DOI 10.1172/JCI119487; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; SARNYAI Z, 1995, J CLIN ENDOCR METAB, V80, P54, DOI 10.1210/jc.80.1.54; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sommer P, 2007, ONCOGENE, V26, P7111, DOI 10.1038/sj.onc.1210524; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; VELDHUIS JD, 1990, J CLIN ENDOCR METAB, V71, P452, DOI 10.1210/jcem-71-2-452; VELDHUIS JD, 1989, AM J PHYSIOL, V257, pE5, DOI 10.1152/ajpendo.1989.257.1.E6; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Windle RJ, 2001, J NEUROENDOCRINOL, V13, P905, DOI 10.1046/j.1365-2826.2001.00715.x; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001; Zhu Q, 2002, J VIROL, V76, P2168, DOI 10.1128/JVI.76.5.2168-2179.2002	38	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15766	10.1371/journal.pone.0015766	http://dx.doi.org/10.1371/journal.pone.0015766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267416	Green Submitted, gold, Green Published			2022-12-27	WOS:000286519500027
J	Francis, J; Lin, WC; Rozenblatt-Rosen, O; Meyerson, M				Francis, Joshua; Lin, Wenchu; Rozenblatt-Rosen, Orit; Meyerson, Matthew			The Menin Tumor Suppressor Protein Is Phosphorylated in Response to DNA Damage	PLOS ONE			English	Article							ENDOCRINE NEOPLASIA TYPE-1; HISTONE METHYLTRANSFERASE COMPLEX; EXPRESSION ANALYSIS; TARGET GENES; CELL-LINES; CHROMATIN; IDENTIFICATION; MUTATIONS; REPAIR; FANCD2	Background: Multiple endocrine neoplasia type 1 (MEN1) is a heritable cancer syndrome characterized by tumors of the pituitary, pancreas and parathyroid. Menin, the product of the MEN1 gene, is a tumor suppressor protein that functions in part through the regulation of transcription mediated by interactions with chromatin modifying enzymes. Principal Findings: Here we show menin association with the 5' regions of DNA damage response genes increases after DNA damage and is correlated with RNA polymerase II association but not with changes in histone methylation. Furthermore, we were able to detect significant levels of menin at the 3' regions of CDKN1A and GADD45A under conditions of enhanced transcription following DNA damage. We also demonstrate that menin is specifically phosphorylated at Ser394 in response to several forms of DNA damage, Ser487 is dynamically phosphorylated and Ser543 is constitutively phosphorylated. Phosphorylation at these sites however does not influence the ability to interact with histone methyltransferase activity. In contrast, the interaction between menin and RNA polymerase II is influenced by phosphorylation, whereby a phospho-deficient mutant had a higher affinity for the elongating form of RNA polymerase compared to wild type. Additionally, a subset of MEN1-associated missense point mutants, fail to undergo DNA damage dependent phosphorylation. Conclusion: Together, our findings suggest that the menin tumor suppressor protein undergoes DNA damage induced phosphorylation and participates in the DNA damage transcriptional response.	[Francis, Joshua; Lin, Wenchu; Rozenblatt-Rosen, Orit; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Francis, Joshua; Lin, Wenchu; Rozenblatt-Rosen, Orit; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Francis, J (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Rozenblatt-Rosen, Orit/HDN-4182-2022	Meyerson, Matthew/0000-0002-9133-8108	Caring for Carcinoid Foundation; Ruth L. Kirschstein National Research Service [F32DK77424]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077424] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Caring for Carcinoid Foundation (M.M.) and a Ruth L. Kirschstein National Research Service Award Post-Doctoral fellowship F32DK77424 (J.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2004, ANN NY ACAD SCI, V1014, P189, DOI 10.1196/annals.1294.020; Agarwal SK, 2007, NEOPLASIA, V9, P101, DOI 10.1593/neo.06706; Bazzi W, 2008, GASTROENTEROLOGY, V135, P1698, DOI 10.1053/j.gastro.2008.07.031; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dreijerink KMA, 2009, J INTERN MED, V266, P53, DOI 10.1111/j.1365-2796.2009.02115.x; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Farley SM, 2006, J SURG RES, V133, P29, DOI 10.1016/j.jss.2006.02.021; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; Guru SC, 1999, MAMM GENOME, V10, P592, DOI 10.1007/s003359901051; Guru SC, 2001, GENE, V263, P31, DOI 10.1016/S0378-1119(00)00562-X; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heppner C, 1997, NAT GENET, V16, P375, DOI 10.1038/ng0897-375; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kottemann MC, 2009, DNA REPAIR, V8, P944, DOI 10.1016/j.dnarep.2009.06.001; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; MacConaill LE, 2006, MOL CANCER RES, V4, P793, DOI 10.1158/1541-7786.MCR-06-0123; Marek LR, 2008, DNA REPAIR, V7, P476, DOI 10.1016/j.dnarep.2007.12.009; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wautot V, 2000, INT J CANCER, V85, P877, DOI 10.1002/(SICI)1097-0215(20000315)85:6<877::AID-IJC23>3.0.CO;2-F; Wu Xinjiang, 2008, Curr Mol Med, V8, P805, DOI 10.2174/156652408786733702; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zhuang ZP, 1997, CANCER RES, V57, P4682	39	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16119	10.1371/journal.pone.0016119	http://dx.doi.org/10.1371/journal.pone.0016119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264250	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500029
J	Mateo, R; Baos, AR; Vidal, D; Camarero, PR; Martinez-Haro, M; Taggart, MA				Mateo, Rafael; Baos, Ana R.; Vidal, Dolors; Camarero, Pablo R.; Martinez-Haro, Monica; Taggart, Mark A.			Bioaccessibility of Pb from Ammunition in Game Meat Is Affected by Cooking Treatment	PLOS ONE			English	Article							VITRO DIGESTION MODELS; LEAD-EXPOSURE; NORTHERN ONTARIO; HUMAN DIET; SHOT; BIOAVAILABILITY; GREENLAND; CADMIUM; MERCURY; HEALTH	Background: The presence of lead (Pb) ammunition residues in game meat has been widely documented, yet little information exists regarding the bioaccessibility of this Pb contamination. We study how cooking treatment (recipe) can affect Pb bioaccessibility in meat of animals hunted with Pb ammunition. Methodology/Principal Findings: We used an in vitro gastrointestinal simulation to study bioaccessibility. The simulation was applied to meat from red-legged partridge (Alectoris rufa) hunted with Pb shot pellets and cooked using various traditional Spanish game recipes involving wine or vinegar. Total Pb concentrations in the meat were higher in samples with visible Pb ammunition by X-ray (mean +/- SE: 3.29 +/- 1.12 mu g/g w.w.) than in samples without this evidence (1.28 +/- 0.61 mu g/g). The percentage of Pb that was bioaccessible within the simulated intestine phase was far higher in meat cooked with vinegar (6.75%) and wine (4.51%) than in uncooked meat (0.7%). Risk assessment simulations using our results transformed to bioavailability and the Integrated Exposure Uptake Biokinetic model (IEUBK; US EPA) show that the use of wine instead of vinegar in cooking recipes may reduce the percentage of children that would be expected to have >10 mu g/dl of Pb in blood from 2.08% to 0.26% when game meat represents 50% of the meat in diet. Conclusions/Significance: Lead from ammunition in game meat is more bioaccessible after cooking, especially when using highly acidic recipes. These results are important because existing theoretical models regarding Pb uptake and subsequent risk in humans should take such factors into account.	[Mateo, Rafael; Baos, Ana R.; Vidal, Dolors; Camarero, Pablo R.; Martinez-Haro, Monica; Taggart, Mark A.] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Mateo, R (corresponding author), CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain.	rafael.mateo@uclm.es	Martinez-Haro, Mónica/B-8363-2015; Vidal, Dolo/AAF-2431-2020; Mateo, Rafael/A-3117-2011; Vidal, M Dolors/K-2192-2012; Mateo, Rafael/AAU-1480-2020	Martinez-Haro, Mónica/0000-0002-4326-5805; Vidal, Dolo/0000-0002-8671-6960; Mateo, Rafael/0000-0003-1307-9152; Vidal, M Dolors/0000-0002-8671-6960; Mateo, Rafael/0000-0003-1307-9152; Taggart, Mark/0000-0002-0649-8490; Camarero Abella, Pablo R/0000-0002-2047-6554	Spanish Ministry of Science and Innovation (MICINN) [CGL2007-62797]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by the Spanish Ministry of Science and Innovation (MICINN) under CGL2007-62797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLTROP D, 1975, POSTGRAD MED J, V51, P805, DOI 10.1136/pgmj.51.601.805; Bjerregaard P, 2004, ENVIRON HEALTH PERSP, V112, P1496, DOI 10.1289/ehp.7083; Burger J, 1997, ENVIRON RES, V75, P173, DOI 10.1006/enrs.1997.3789; Carlisle JC, 2009, J ENVIRON SCI HEAL A, V44, P1200, DOI 10.1080/10934520903139829; CUADRADO C, 1995, FOOD ADDIT CONTAM, V12, P107, DOI 10.1080/02652039509374285; *EUR COMM, 2001, OFF J EUR COMM; Falco G, 2005, FOOD CHEM TOXICOL, V43, P1713, DOI 10.1016/j.fct.2005.05.014; *FAO WHO, 2000, TECHN REP SER WHO, V896; Ferrandis P, 2008, ENVIRON SCI TECHNOL, V42, P6271, DOI 10.1021/es800215y; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hanning RM, 2003, J ENVIRON MONITOR, V5, P241, DOI 10.1039/b208220a; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Johansen P, 2001, ENVIRON POLLUT, V112, P501, DOI 10.1016/S0269-7491(00)00130-5; Juhasz AL, 2009, ENVIRON SCI TECHNOL, V43, P4503, DOI 10.1021/es803238u; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693; Llobett JM, 2003, J AGR FOOD CHEM, V51, P838, DOI 10.1021/jf020734q; Martinez-Haro M, 2009, ENVIRON SCI TECHNOL, V43, P9480, DOI 10.1021/es901960e; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; MOREIRAS O, 1993, NUTR RES, V13, P851, DOI 10.1016/S0271-5317(05)80588-3; Mushak P, 1998, ENVIRON HEALTH PERSP, V106, P1467, DOI 10.1289/ehp.98106s61467; Oomen AG, 2002, ENVIRON SCI TECHNOL, V36, P3326, DOI 10.1021/es010204v; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P116, DOI 10.1007/s00244-002-1226-z; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; RUBIO C, 2004, REV TOXICOL, V21, P72, DOI DOI 10.1590/S0036-36342010000200010; Ruby MV, 1996, ENVIRON SCI TECHNOL, V30, P422, DOI 10.1021/es950057z; Ryan JA, 2004, ENVIRON SCI TECHNOL, V38, p18A, DOI 10.1021/es040337r; Scheuhammer AM, 1998, ENVIRON POLLUT, V102, P251, DOI 10.1016/S0269-7491(98)00083-9; Schroder JL, 2004, J ENVIRON QUAL, V33, P513, DOI 10.2134/jeq2004.0513; Taggart MA, 2011, ENVIRON INT, V37, P18, DOI 10.1016/j.envint.2010.06.007; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; Tsuji LJS, 2001, J ENVIRON MONITOR, V3, P702, DOI 10.1039/b106163c; U.S. EPA, 2007, US GUID INT EXP UPT; *US EPA, 1994, GUID MAN INT EXP UPT; Van de Wiele TR, 2007, J ENVIRON SCI HEAL A, V42, P1203, DOI 10.1080/10934520701434919	37	41	42	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15892	10.1371/journal.pone.0015892	http://dx.doi.org/10.1371/journal.pone.0015892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264290	Green Published, gold			2022-12-27	WOS:000286516500014
J	Trognitz, B; Scheldeman, X; Hansel-Hohl, K; Kuant, A; Grebe, H; Hermann, M				Trognitz, Bodo; Scheldeman, Xavier; Hansel-Hohl, Karin; Kuant, Aldo; Grebe, Hans; Hermann, Michael			Genetic Population Structure of Cacao Plantings within a Young Production Area in Nicaragua	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; THEOBROMA-CACAO; GERMPLASM; DIVERSITY; INFERENCE; L.	Significant cocoa production in the municipality of Waslala, Nicaragua, began in 1961. Since the 1980s, its economic importance to rural smallholders increased, and the region now contributes more than 50% of national cocoa bean production. This research aimed to assist local farmers to develop production of high-value cocoa based on optimal use of cacao biodiversity. Using microsatellite markers, the allelic composition and genetic structure of cacao was assessed from 44 representative plantings and two unmanaged trees. The population at Waslala consists of only three putative founder genotype spectra (lineages). Two (B and R) were introduced during the past 50 years and occur in >95% of all trees sampled, indicating high rates of outcrossing. Based on intermediate allelic diversity, there was large farm-to-farm multilocus genotypic variation. GIS analysis revealed unequal distribution of the genotype spectra, with R being frequent within a 2 km corridor along roads, and B at more remote sites with lower precipitation. The third lineage, Y, was detected in the two forest trees. For explaining the spatial stratification of the genotype spectra, both human intervention and a combination of management and selection driven by environmental conditions, appear responsible. Genotypes of individual trees were highly diverse across plantings, thus enabling selection for farm-specific qualities. On-farm populations can currently be most clearly recognized by the degree of the contribution of the three genotype spectra. Of two possible strategies for future development of cacao in Waslala, i.e. introducing more unrelated germplasm, or working with existing on-site diversity, the latter seems most appropriate. Superior genotypes could be selected by their specific composite genotype spectra as soon as associations with desired quality traits are established, and clonally multiplied. The two Y trees from the forest share a single multilocus genotype, possibly representing the Mayan, 'ancient Criollo' cacao.	[Trognitz, Bodo; Hansel-Hohl, Karin] Austrian Inst Technol, Seibersdorf, Austria; [Scheldeman, Xavier] Biovers Int, Cali, Colombia; [Kuant, Aldo; Grebe, Hans] Pro Mundo Humano, Managua, Nicaragua; [Hermann, Michael] Crops Future, Serdang, Selangor, Malaysia	Austrian Institute of Technology (AIT); Alliance; Bioversity International	Trognitz, B (corresponding author), Austrian Inst Technol, Seibersdorf, Austria.	bodo.trognitz@ait.ac.at	Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361	Austrian Development Agency, ADA; Austrian Institute of Technology, AIT [1.U4.00077]	Austrian Development Agency, ADA; Austrian Institute of Technology, AIT	Funded by the Austrian Development Agency, ADA (NICACAO Project), (http://www.entwicklung.at/en/) and the Austrian Institute of Technology, AIT (1.U4.00077) (http://www.ait.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication content is solely the responsibility of the authors and does not necessarily represent the official views of ADA nor AIT.	Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Irish BM, 2010, CROP SCI, V50, P656, DOI 10.2135/cropsci2009.06.0299; Johnson ES, 2009, CROP SCI, V49, P564, DOI 10.2135/cropsci2008.03.0128; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; LANAUD C, 1987, CAFE CACAO THE, V31, P267; Li YC, 2002, HEREDITY, V89, P127, DOI 10.1038/sj.hdy.6800115; *MARENA, 2005, ATL RES BIOSF BOS; Merrill T., 1994, NICARAGUA COUNTRY ST; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; MOTILAL LA, 2008, TROPICAL PLANT BIOL, V2; Motilal LA, 2010, PLANT GENET RESOUR-C, V8, P106, DOI 10.1017/S1479262109990232; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT, P15; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Saunders JA, 2004, THEOR APPL GENET, V110, P41, DOI 10.1007/s00122-004-1762-1; Wood G.A.R., 1985, COCOA, V4th; Zhang D, 2008, CONSERV GENET, V9, P327, DOI 10.1007/s10592-007-9345-8; Zhang DP, 2006, ANN BOT-LONDON, V98, P647, DOI 10.1093/aob/mcl146; Zhang DP, 2006, CROP SCI, V46, P2084, DOI 10.2135/cropsci2006.01.0004; Zhang DP, 2009, TREE GENET GENOMES, V5, P1, DOI 10.1007/s11295-008-0163-z	27	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16056	10.1371/journal.pone.0016056	http://dx.doi.org/10.1371/journal.pone.0016056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264251	Green Published, gold			2022-12-27	WOS:000286516500025
J	Lee, YJ; Wang, SX; Slone, SR; Yacoubian, TA; Witt, SN				Lee, Yong Joo; Wang, Shaoxiao; Slone, Sunny R.; Yacoubian, Talene A.; Witt, Stephan N.			Defects in Very Long Chain Fatty Acid Synthesis Enhance Alpha-Synuclein Toxicity in a Yeast Model of Parkinson's Disease	PLOS ONE			English	Article							PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; GENE; NEURODEGENERATION; PATHWAYS; MUTATION; CLONING; SPHINGOLIPIDS; BIOSYNTHESIS; ELONGATION	We identified three S. cerevisiae lipid elongase null mutants (elo1D, elo2D, and elo3D) that enhance the toxicity of alpha-synuclein (alpha-syn). These elongases function in the endoplasmic reticulum (ER) to catalyze the elongation of medium chain fatty acids to very long chain fatty acids, which is a component of sphingolipids. Without alpha-syn expression, the various elo mutants showed no growth defects, no reactive oxygen species (ROS) accumulation, and a modest decrease in survival of aged cells compared to wild-type cells. With (WT, A53T or E46K) alpha-syn expression, the various elo mutants exhibited severe growth defects (although A30P had a negligible effect on growth), ROS accumulation, aberrant protein trafficking, and a dramatic decrease in survival of aged cells compared to wild-type cells. Inhibitors of ceramide synthesis, myriocin and FB1, were extremely toxic to wild-type yeast cells expressing (WT, A53T, or E46K) alpha-syn but much less toxic to cells expressing A30P. The elongase mutants and ceramide synthesis inhibitors enhance the toxicity of WT alpha-syn, A53T and E46K, which transit through the ER, but have a negligible effect on A30P, which does not transit through the ER. Disruption of ceramide-sphingolipid homeostasis in the ER dramatically enhances the toxicity of alpha-syn (WT, A53T, and E46K).	[Lee, Yong Joo; Wang, Shaoxiao; Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Slone, Sunny R.; Yacoubian, Talene A.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Alabama System; University of Alabama Birmingham	Lee, YJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.	switt1@lsuhsc.edu	wang, shaoxiao/N-7126-2013; Witt, Stephan N/M-7922-2013	wang, shaoxiao/0000-0002-0195-6210; Witt, Stephan N/0000-0002-6462-2840	National Institutes of Health [NS057656]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant NS057656 (S.N.W.) from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2004, CELL TISSUE RES, V318, P185, DOI 10.1007/s00441-004-0922-6; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Bras JM, 2009, BBA-MOL BASIS DIS, V1792, P597, DOI 10.1016/j.bbadis.2008.11.008; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Carratu MR, 2003, TOXICOL LETT, V140, P459, DOI 10.1016/S0378-4274(03)00042-0; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Flower TR, 2007, J CELL BIOL, V177, P1091, DOI 10.1083/jcb.200610071; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mielke MM, 2010, NEUROBIOL AGING, V31, P17, DOI 10.1016/j.neurobiolaging.2008.03.011; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponnusamy S, 2008, J BIOL CHEM, V283, P27514, DOI 10.1074/jbc.M802980200; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stevens VL, 1997, J BIOL CHEM, V272, P18020, DOI 10.1074/jbc.272.29.18020; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	61	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15946	10.1371/journal.pone.0015946	http://dx.doi.org/10.1371/journal.pone.0015946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264320	Green Published, gold, Green Submitted			2022-12-27	WOS:000286514000011
J	Baratchi, S; Kanwar, RK; Kanwar, JR				Baratchi, Sara; Kanwar, Rupinder K.; Kanwar, Jagat R.			Survivin Mutant Protects Differentiated Dopaminergic SK-N-SH Cells Against Oxidative Stress	PLOS ONE			English	Article							PARKINSONS-DISEASE; GLUTATHIONE-PEROXIDASE; EXPRESSION; APOPTOSIS; PROTEINS; ANTAGONISTS; CHECKPOINT; BRAIN; IAP	Oxidative stress is due to an imbalance of antioxidant/pro-oxidant homeostasis and is associated with the progression of several neurological diseases, including Parkinson's and Alzheimer's disease and amyotrophic lateral sclerosis. Furthermore, oxidative stress is responsible for the neuronal loss and dysfunction associated with disease pathogenesis. Survivin is a member of the inhibitors of the apoptosis (IAP) family of proteins, but its neuroprotective effects have not been studied. Here, we demonstrate that SurR9-C84A, a survivin mutant, has neuroprotective effects against H2O2-induced neurotoxicity. Our results show that H2O2 toxicity is associated with an increase in cell death, mitochondrial membrane depolarisation, and the expression of cyclin D1 and caspases 9 and 3. In addition, pre-treatment with SurR9-C84A reduces cell death by decreasing both the level of mitochondrial depolarisation and the expression of cyclin D1 and caspases 9 and 3. We further show that SurR9-C84A increases the antioxidant activity of GSH-peroxidase and catalase, and effectively counteracts oxidant activity following exposure to H2O2. These results suggest for the first time that SurR9-C84A is a promising treatment to protect neuronal cells against H2O2-induced neurotoxicity.	[Baratchi, Sara; Kanwar, Rupinder K.; Kanwar, Jagat R.] Deakin Univ, Lab Immunol & Mol Biomed Res, Ctr Biotechnol & Interdisciplinary Biosci, Inst Technol Res & Innovat, Waurn Ponds, Vic, Australia	Deakin University	Baratchi, S (corresponding author), Deakin Univ, Lab Immunol & Mol Biomed Res, Ctr Biotechnol & Interdisciplinary Biosci, Inst Technol Res & Innovat, Waurn Ponds, Vic, Australia.	jagat.kanwar@deakin.edu.au	Baratchi, Sara/V-2683-2019	Baratchi, Sara/0000-0003-3588-7951	Deakin University	Deakin University	The study was supported by postgraduate fellowship from Deakin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATCHI S, 2010, J NEUROIMMUNOLOGY; Baratchi S, 2010, CRIT REV BIOCHEM MOL, V45, P535, DOI 10.3109/10409238.2010.516740; Baratchi S, 2010, J NEUROIMMUNOL, V227, P120, DOI 10.1016/j.jneuroim.2010.06.024; Baratchi S, 2009, CURR NANOSCI, V5, P15, DOI 10.2174/157341309787314665; Barone P, 2010, EUR J NEUROL, V17, P364, DOI 10.1111/j.1468-1331.2009.02900.x; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Chang PA, 2005, MOL BRAIN RES, V141, P30, DOI 10.1016/j.molbrainres.2005.07.012; Cheung CHA, 2006, EJC SUPPL, V4, P149, DOI 10.1016/S1359-6349(06)70493-1; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; del Rio M. Jimenez, 2004, Current Medicinal Chemistry - Central Nervous System Agents, V4, P279; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Donnini S, 2009, CELL CYCLE, V8, P1271, DOI 10.4161/cc.8.8.8301; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JOHANNSEN P, 1991, J NEUROL NEUROSUR PS, V54, P679, DOI 10.1136/jnnp.54.8.679; Jordan-Sciutto KL, 2002, J NEUROSCI, V22, P2185, DOI 10.1523/JNEUROSCI.22-06-02185.2002; Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155; Kanwar JR, 2004, CANCER GENE THER, V11, P853; Kanwar JR, 2001, J NATL CANCER I, V93, P1541, DOI 10.1093/jnci/93.20.1541; Kanwar RK, 2010, CURR MED CHEM, V17, P1509, DOI 10.2174/092986710790979935; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Morris MC, 2000, CURR OPIN BIOTECH, V11, P461, DOI 10.1016/S0958-1669(00)00128-2; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005	33	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15865	10.1371/journal.pone.0015865	http://dx.doi.org/10.1371/journal.pone.0015865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249229	gold, Green Published, Green Submitted			2022-12-27	WOS:000286513100016
J	Krall, JA; Beyer, EM; MacBeath, G				Krall, Jordan A.; Beyer, Elsa M.; MacBeath, Gavin			High- and Low-Affinity Epidermal Growth Factor Receptor-Ligand Interactions Activate Distinct Signaling Pathways	PLOS ONE			English	Article							BREAST-CANCER CELLS; EGF-RECEPTOR; NEGATIVE COOPERATIVITY; FACTOR BINDING; APOPTOSIS; SURFACE; TRANSDUCTION; EXPRESSION; INTEGRIN; SYSTEM	Signaling mediated by the Epidermal Growth Factor Receptor (EGFR) is crucial in normal development, and aberrant EGFR signaling has been implicated in a wide variety of cancers. Here we find that the high- and low-affinity interactions between EGFR and its ligands activate different signaling pathways. While high-affinity ligand binding is sufficient for activation of most canonical signaling pathways, low-affinity binding is required for the activation of the Signal transducers and activators of transcription (Stats) and Phospholipase C-gamma 1 (PLC gamma 1). As the Stat proteins are involved in many cellular responses including proliferation, migration and apoptosis, these results assign a function to low-affinity interactions that has been omitted from computational models of EGFR signaling. The existence of receptors with distinct signaling properties provides a way for EGFR to respond to different concentrations of the same ligand in qualitatively different ways.	[Krall, Jordan A.; MacBeath, Gavin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Beyer, Elsa M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Krall, JA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	gavin_macbeath@harvard.edu		MacBeath, Gavin/0000-0003-2585-6772	WM Keck Foundation; Camille and Henry Dreyfus Foundation; National Institutes of Health [R33 CA128726, R21 CA126720, P50 GM068762]; NATIONAL CANCER INSTITUTE [R21CA126720, R33CA128726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); Camille and Henry Dreyfus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by awards from the WM Keck Foundation and the Camille and Henry Dreyfus Foundation, and by grants from the National Institutes of Health (R33 CA128726, R21 CA126720, and P50 GM068762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Colomiere M, 2009, INT J BIOCHEM CELL B, V41, P1034, DOI 10.1016/j.biocel.2008.09.018; Danielsen AJ, 2002, GROWTH FACTORS, V20, P1, DOI 10.1080/08977190290022185; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Garcia R, 2006, CELL CYCLE, V5, P1840; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Hendriks BS, 2003, CANCER RES, V63, P1130; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mayawala K, 2005, FEBS LETT, V579, P3043, DOI 10.1016/j.febslet.2005.04.059; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Rezgui SS, 2000, INT J CANCER, V87, P360, DOI 10.1002/1097-0215(20000801)87:3<360::AID-IJC8>3.0.CO;2-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43	30	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15945	10.1371/journal.pone.0015945	http://dx.doi.org/10.1371/journal.pone.0015945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264347	Green Published, Green Submitted, gold			2022-12-27	WOS:000286513100019
J	de la Garza-Rodea, AS; Verweij, MC; Boersma, H; van der Velde-van Dijke, I; de Vries, AAF; Hoeben, RC; van Bekkum, DW; Wiertz, EJHJ; Knaan-Shanzer, S				de la Garza-Rodea, Anabel S.; Verweij, Marieke C.; Boersma, Hester; van der Velde-van Dijke, Ietje; de Vries, Antoine A. F.; Hoeben, Rob C.; van Bekkum, Dirk W.; Wiertz, Emmanuel J. H. J.; Knaan-Shanzer, Shoshan			Exploitation of Herpesvirus Immune Evasion Strategies to Modify the Immunogenicity of Human Mesenchymal Stem Cell Transplants	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; MARROW STROMAL CELLS; I HEAVY-CHAINS; CYTOMEGALOVIRUS-ENCODED US2; VERSUS-HOST-DISEASE; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; MEMBRANE-PROTEIN; DENDRITIC CELLS	Background: Mesenchymal stem cells (MSCs) are multipotent cells residing in the connective tissue of many organs and holding great potential for tissue repair. In culture, human MSCs (hMSCs) are capable of extensive proliferation without showing chromosomal aberrations. Large numbers of hMSCs can thus be acquired from small samples of easily obtainable tissues like fat and bone marrow. MSCs can contribute to regeneration indirectly by secretion of cytokines or directly by differentiation into specialized cell types. The latter mechanism requires their long-term acceptance by the recipient. Although MSCs do not elicit immune responses in vitro, animal studies have revealed that allogeneic and xenogeneic MSCs are rejected. Methodology/Principal Findings: We aim to overcome MSC immune rejection through permanent down-regulation of major histocompatibility complex (MHC) class I proteins on the surface of these MHC class II-negative cells through the use of viral immune evasion proteins. Transduction of hMSCs with a retroviral vector encoding the human cytomegalovirus US11 protein resulted in strong inhibition of MHC class I surface expression. When transplanted into immunocompetent mice, persistence of the US11-expressing and HLA-ABC-negative hMSCs at levels resembling those found in immunodeficient (i.e., NOD/SCID) mice could be attained provided that recipients' natural killer (NK) cells were depleted prior to cell transplantation. Conclusions/Significance: Our findings demonstrate the potential utility of herpesviral immunoevasins to prevent rejection of xenogeneic MSCs. The observation that down-regulation of MHC class I surface expression renders hMSCs vulnerable to NK cell recognition and cytolysis implies that multiple viral immune evasion proteins are likely required to make hMSCs non-immunogenic and thereby universally transplantable.	[de la Garza-Rodea, Anabel S.; Boersma, Hester; van der Velde-van Dijke, Ietje; de Vries, Antoine A. F.; Hoeben, Rob C.; van Bekkum, Dirk W.; Knaan-Shanzer, Shoshan] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Verweij, Marieke C.; Wiertz, Emmanuel J. H. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	de la Garza-Rodea, AS (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	s.knaan@lumc.nl	de Vries, Antoine/ABG-5787-2021; Hoeben, Rob C./A-5771-2008	Hoeben, Rob C./0000-0001-9443-8377	Universidad Autonoma de Nuevo Leon, Monterrey, Mexico; Diabetes Research Foundation [DFN 2005.00.0212, DFN 2007.00.015]; Association Francaise contre les Myopathies (AFM) [12259-SR-GROUPE E]; Leiden University [7207/5-3-06\Kk]	Universidad Autonoma de Nuevo Leon, Monterrey, Mexico; Diabetes Research Foundation; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Leiden University	This study was supported by a Scholarship to ASdlGR from the Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, and by research grants from the Diabetes Research Foundation (DFN 2005.00.0212 and DFN 2007.00.015), the Association Francaise contre les Myopathies (AFM; 12259-SR-GROUPE E) and the Leiden University Fund (LUF pilot study 7207/5-3-06\Kk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barel MT, 2006, MOL IMMUNOL, V43, P1258, DOI 10.1016/j.molimm.2005.07.005; Barel MT, 2006, INT IMMUNOL, V18, P173, DOI 10.1093/intimm/dxh362; Barel MT, 2003, J IMMUNOL, V171, P6757, DOI 10.4049/jimmunol.171.12.6757; Barel MT, 2003, EUR J IMMUNOL, V33, P1707, DOI 10.1002/eji.200323912; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Chen GY, 2010, ANN THORAC SURG, V90, P190, DOI 10.1016/j.athoracsur.2010.02.074; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Daga A, 2002, GENE THER, V9, P915, DOI 10.1038/sj.gt.3301727; DELAGARZARODEA AS, 2010, CELL TRANSP IN PRESS; Dewan MZ, 2005, BIOMED PHARMACOTHER, V59, pS375, DOI 10.1016/S0753-3322(05)80082-4; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duan WM, 2001, EXP NEUROL, V167, P108, DOI 10.1006/exnr.2000.7537; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Eliopoulos N, 2003, GENE THER, V10, P478, DOI 10.1038/sj.gt.3301919; Eppens EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FAUSTMAN D, 1991, SCIENCE, V252, P1700, DOI 10.1126/science.1710828; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Goncalves MAFV, 2001, VIROLOGY, V288, P236, DOI 10.1006/viro.2001.1073; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Horst D, 2009, J IMMUNOL, V182, P2313, DOI 10.4049/jimmunol.0803218; Hsieh CL, 2002, TRANSPL IMMUNOL, V9, P111, DOI 10.1016/S0966-3274(02)00033-3; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Knaan-Shanzer S, 2005, STEM CELLS, V23, P1598, DOI 10.1634/stemcells.2005-0016; Knaan-Shanzer S, 2008, STEM CELLS, V26, P3210, DOI 10.1634/stemcells.2007-0117; Kojaoghlanian T, 2009, GENE THER, V16, P340, DOI 10.1038/gt.2008.172; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Leong CC, 1998, J EXP MED, V187, P1681, DOI 10.1084/jem.187.10.1681; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Lipinska AD, 2006, J VIROL, V80, P5822, DOI 10.1128/JVI.02707-05; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Machold RP, 1997, J EXP MED, V185, P363, DOI 10.1084/jem.185.2.363; MONTOLIU L, 1995, P NATL ACAD SCI USA, V92, P4244, DOI 10.1073/pnas.92.10.4244; Morandi F, 2008, STEM CELLS, V26, P1275, DOI 10.1634/stemcells.2007-0878; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; PAKZABAN P, 1995, NEUROSCIENCE, V65, P983, DOI 10.1016/0306-4522(94)00626-G; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prigozhina TB, 2008, EXP HEMATOL, V36, P1370, DOI 10.1016/j.exphem.2008.04.022; Radosevich TJ, 2003, HUM GENE THER, V14, P1765, DOI 10.1089/104303403322611773; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rasmusson I, 2007, SCAND J IMMUNOL, V65, P336, DOI 10.1111/j.1365-3083.2007.01905.x; Rehm A, 2002, J VIROL, V76, P5043, DOI 10.1128/JVI.76.10.5043-5050.2002; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; SWIFT S, 1999, CURR PROTOC IMMUNOL, V10; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; van Tuyn J, 2007, FASEB J, V21, P3369, DOI 10.1096/fj.07-8211com; Viswanathan K, 2005, P NATL ACAD SCI USA, V102, P5808, DOI 10.1073/pnas.0501650102; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Wang Y, 2007, J ORTHOP RES, V25, P926, DOI 10.1002/jor.20385; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wiertz EJ, 2007, J VIROL, V81, P4389, DOI 10.1128/JVI.01525-06; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Xia Z, 2006, J CELL BIOCHEM, V98, P966, DOI 10.1002/jcb.20730; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zdoroveac A, 2008, J SURG RES, V145, P161, DOI 10.1016/j.jss.2007.08.031; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018	78	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14493	10.1371/journal.pone.0014493	http://dx.doi.org/10.1371/journal.pone.0014493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253016	gold, Green Submitted, Green Published			2022-12-27	WOS:000286511900002
J	Keller, MJ; Madan, RP; Torres, NM; Fazzari, MJ; Cho, S; Kalyoussef, S; Shust, G; Mesquita, PMM; Louissaint, N; Chen, JM; Cohen, HW; Diament, EC; Lee, AC; Soto-Torres, L; Hendrix, CW; Herold, BC				Keller, Marla J.; Madan, Rebecca P.; Torres, N. Merna; Fazzari, Melissa J.; Cho, Sylvia; Kalyoussef, Sabah; Shust, Gail; Mesquita, Pedro M. M.; Louissaint, Nicolette; Chen, Jianmeng; Cohen, Hillel W.; Diament, Erin C.; Lee, Anna C.; Soto-Torres, Lydia; Hendrix, Craig W.; Herold, Betsy C.			A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel	PLOS ONE			English	Article							SIMPLEX-VIRUS INFECTION; VAGINAL FLUID; MICROBICIDE; TRANSMISSION; LAMIVUDINE; ADHERENCE; SAFETY; ASSAY	Background: Preclinical and early phase clinical microbicide studies have not consistently predicted the outcome of efficacy trials. To address this gap, candidate biomarkers of microbicide pharmacodynamics and safety were evaluated in a double-blind, placebo-controlled trial of tenofovir gel, the first microbicide to demonstrate significant protection against HIV acquisition. Methods: 30 women were randomized to apply a single daily dose of tenofovir or placebo gel for 14 consecutive days. Anti-HIV activity was measured in cervicovaginal lavage (CVL) on Days 0, 3, 7, 14 and 21 by luciferase assay as a surrogate marker of pharmacodynamics. Endogenous activity against E. coli and HSV-2 and concentrations of immune mediators were quantified in CVL as candidate biomarkers of safety. Tenofovir levels were measured in CVL and blood. Results: A significant increase in anti-HIV activity was detected in CVL from women who applied tenofovir gel compared to their endogenous anti-HIV activity in genital tract secretions on Day 0 and compared to activity in CVL from women in the placebo group. The activity correlated significantly with CVL concentration of tenofovir (r = 0.6, p, 0.001) and fit a sigmoid E-max pharmacodynamic model. Anti-HIV activity in CVL from women who applied tenofovir persisted when virus was introduced in semen, whereas endogenous anti-HIV activity decreased. Tenofovir did not trigger an inflammatory response or induce sustained loss in endogenous antimicrobial activity or immune mediators. Conclusions: Tenofovir gel had no deleterious impact on soluble mucosal immunity. The increased anti-HIV activity in CVL, which persisted in the presence of semen and correlated with tenofovir concentration, is consistent with the efficacy observed in a recent clinical trial. These results promote quantified CVL anti-HIV activity as a surrogate of tissue pharmacodynamics and as a potential biomarker of adherence to product. This simple, feasible and inexpensive bioassay may promote the development of models more predictive of microbicide efficacy.	[Keller, Marla J.; Diament, Erin C.; Lee, Anna C.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Keller, Marla J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, New York, NY USA; [Madan, Rebecca P.; Torres, N. Merna; Cho, Sylvia; Kalyoussef, Sabah; Shust, Gail; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Fazzari, Melissa J.; Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Mesquita, Pedro M. M.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Louissaint, Nicolette; Chen, Jianmeng; Hendrix, Craig W.] Johns Hopkins Univ, Sch Med, Dept Med Clin Pharmacol, Baltimore, MD USA; [Soto-Torres, Lydia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Keller, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, New York, NY USA.	marla.keller@einstein.yu.edu	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Herold, Betsy/0000-0001-9974-0786; Cohen, Hillel/0000-0002-4524-0898; Fazzari, Melissa/0000-0002-5674-3589; Mesquita, Pedro/0000-0002-6591-4896	National Institutes of Health [U01 AI069551, UL1 RR025750, UL1 RR025005, U01 AI068633, P60 MD00514]; Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center [NIH AI-51519]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, U01AI069551, U01AI068633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (U01 AI069551, UL1 RR025750, UL1 RR025005, U01 AI068633, and P60 MD00514) and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, DIVISION AIDS TABLE; Austin MN, 2009, SEX TRANSM DIS, V36, P368, DOI 10.1097/OLQ.0b013e3181972397; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Delaney WE, 2006, ANTIMICROB AGENTS CH, V50, P2471, DOI 10.1128/AAC.00138-06; GARCIALERMA G, 2010, EFFICACY INTERMITTEN; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; Hillier SL, 2008, SAFETY ACCEPTABILITY; Hogarty K, 2007, SEX TRANSM DIS, V34, P1000, DOI 10.1097/OLQ.0b013e3180f62f81; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Pruvost A, 2009, ANTIMICROB AGENTS CH, V53, P1937, DOI 10.1128/AAC.01064-08; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Shust GF, 2010, AM J REPROD IMMUNOL, V63, P110, DOI 10.1111/j.1600-0897.2009.00768.x; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wallace A, 2004, SEX TRANSM DIS, V31, P465, DOI 10.1097/01.olq.0000135986.35216.ba; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463	30	72	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16475	10.1371/journal.pone.0016475	http://dx.doi.org/10.1371/journal.pone.0016475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283552	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400055
J	Lee, G; Origanti, S; White, LS; Sun, JW; Stappenbeck, TS; Piwnica-Worms, H				Lee, Gwanghee; Origanti, Sofia; White, Lynn S.; Sun, Jinwu; Stappenbeck, Thaddeus S.; Piwnica-Worms, Helen			Contributions Made by CDC25 Phosphatases to Proliferation of Intestinal Epithelial Stem and Progenitor Cells	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; CANCER; DEPHOSPHORYLATION; ACTIVATION; MICE; RECOMBINATION; EXPRESSION; MATURATION; IRINOTECAN; P34CDC2	The CDC25 protein phosphatases drive cell cycle advancement by activating cyclin-dependent protein kinases (CDKs). Humans and mice encode three family members denoted CDC25A, -B and -C and genes encoding these family members can be disrupted individually with minimal phenotypic consequences in adult mice. However, adult mice globally deleted for all three phosphatases die within one week after Cdc25 disruption. A severe loss of absorptive villi due to a failure of crypt epithelial cells to proliferate was observed in the small intestines of these mice. Because the Cdc25s were globally deleted, the small intestinal phenotype and loss of animal viability could not be solely attributed to an intrinsic defect in the inability of small intestinal stem and progenitor cells to divide. Here, we report the consequences of deleting different combinations of Cdc25s specifically in intestinal epithelial cells. The phenotypes arising in these mice were then compared with those arising in mice globally deleted for the Cdc25s and in mice treated with irinotecan, a chemotherapeutic agent commonly used to treat colorectal cancer. We report that the phenotypes arising in mice globally deleted for the Cdc25s are due to the failure of small intestinal stem and progenitor cells to proliferate and that blocking cell division by inhibiting the cell cycle engine (through Cdc25 loss) versus by inducing DNA damage (via irinotecan) provokes a markedly different response of small intestinal epithelial cells. Finally, we demonstrate that CDC25A and CDC25B but not CDC25C compensate for each other to maintain the proliferative capacity of intestinal epithelial stem and progenitor cells.	[Lee, Gwanghee; Origanti, Sofia; White, Lynn S.; Sun, Jinwu; Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Origanti, Sofia; White, Lynn S.; Piwnica-Worms, Helen] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO USA; [Sun, Jinwu] Washington Univ, Sch Med, Mol Imaging Ctr, St Louis, MO USA; [Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Origanti, Sofia; White, Lynn S.; Piwnica-Worms, Helen] Howard Hughes Med Inst, Chevy Chase, MD USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Lee, G (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA USA.	hpiwnica@wustl.edu	Piwnica-Worms, Helen/C-5214-2012	Origanti, Sofia/0000-0002-6953-0160	Cancer Biology Pathway program; National Cancer Institute Cancer Center [P30 CA91842]; Pew Scholars Program in the Biomedical Sciences; Crohn's Colitis Fund of America; National Institutes of Health;  [P50 CA94056]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER	Cancer Biology Pathway program; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Scholars Program in the Biomedical Sciences; Crohn's Colitis Fund of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	G.L. was supported in part by the Cancer Biology Pathway program administered through the Siteman Cancer Center. The Siteman Cancer Center is supported in part by an National Cancer Institute Cancer Center Support Grant P30 CA91842. This work was supported by grants from the Pew Scholars Program in the Biomedical Sciences and the Crohn's Colitis Fund of America to T.S.S. and from the National Institutes of Health to H.P.-W. S.O. is an Associate and H.P.-W. is an Investigator of the Howard Hughes Medical Institute. J.S. was supported in part by P50 CA94056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2008, PLOS BIOL, V6, P1746, DOI 10.1371/journal.pbio.0060191; Alimonti A, 2004, CANCER TREAT REV, V30, P555, DOI 10.1016/j.ctrv.2004.05.002; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; HONDA R, 1993, FEBS LETT, V318, P331, DOI 10.1016/0014-5793(93)80540-B; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; LEE MS, 1992, MOL BIOL CELL, V3, pA188; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Zamboni WC, 1998, CLIN CANCER RES, V4, P743	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15561	10.1371/journal.pone.0015561	http://dx.doi.org/10.1371/journal.pone.0015561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283624	gold, Green Published, Green Submitted			2022-12-27	WOS:000286661400008
J	Li, XW; Yang, Y; Zhou, F; Zhang, YZ; Lu, HZ; Jin, Q; Gao, L				Li, XiangWei; Yang, Yu; Zhou, Feng; Zhang, Yunzhi; Lu, Hongzhou; Jin, Qi; Gao, Lei			SLC11A1 (NRAMP1) Polymorphisms and Tuberculosis Susceptibility: Updated Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; PULMONARY TUBERCULOSIS; INFECTIOUS-DISEASES; FORMERLY NRAMP1; HOST SUSCEPTIBILITY; 3'UTR POLYMORPHISMS; ASSOCIATION; POPULATION; RESISTANCE; IRON	Background: Natural resistance associated macrophage protein 1 (NRAMP1), encoded by the SLC11A1 gene, has been described to regulate macrophage activation and be associated with infectious and autoimmune diseases. The relation between SLC11A1 polymorphisms and tuberculosis susceptibility has been studied in different populations. Methods: We systematically reviewed published studies on SLC11A1 polymorphisms and tuberculosis susceptibility until September 15, 2010 and quantitatively summarized associations of the most widely studied polymorphisms using meta-analysis. Results: In total, 36 eligible articles were included in this review. In Meta-analysis, significant associations were observed between tuberculosis risk and widely studied SLC11A1 polymorphisms with summarized odds ratio of 1.35 (95% CI, 1.17-1.54), 1.25 (95% CI, 1.04-1.50), 1.23 (95% CI, 1.04-1.44), 1.31 (95% CI, 1.08-1.59) for 3' UTR, D543N, INT4, and 5' (GT)n, respectively. Heterogeneity between studies was not pronounced, and the associations did not remarkably vary in the stratified analysis with respect to study population and study base. Conclusions: The association between SLC11A1 polymorphisms and tuberculosis susceptibility observed in our analyses supports the hypothesis that NRAMP1 might play an important role in the host defense to the development of tuberculosis.	[Li, XiangWei; Yang, Yu; Zhou, Feng; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Li, XiangWei; Yang, Yu; Zhou, Feng; Jin, Qi; Gao, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Yunzhi; Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Fudan University	Li, XW (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China.	jinqi@ipbcams.ac.cn; gaolei@ipbcams.ac.cn	Jin, Qi/B-5379-2009	Yang, Yu/0000-0002-5611-8951	Ministry of Science and Technology, the People's Republic of China [2008ZX10003-005, 2008ZX10001-006]	Ministry of Science and Technology, the People's Republic of China(Ministry of Science and Technology, China)	The work was supported by Eleven Fifth Key Research grant from the Ministry of Science and Technology, the People's Republic of China (NO: 2008ZX10003-005,2008ZX10001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J INFECTION, V46, P215, DOI 10.1053/jinf.2002.1064; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Ates O, 2009, INT J IMMUNOGENET, V36, P15, DOI 10.1111/j.1744-313X.2008.00814.x; Awomoyi AA, 2002, J INFECT DIS, V186, P1808, DOI 10.1086/345920; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Canonne-Hergaux F, 1999, P ASSOC AM PHYSICIAN, V111, P283, DOI 10.1046/j.1525-1381.1999.99236.x; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Druszczynska Magdalena, 2006, Polish Journal of Microbiology, V55, P7; DUAN HF, 2003, STUDY ASS 3 UTR POLY, P28; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Farnia P., 2008, TANAFFOS - Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, V7, P19; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Gao PS, 2000, CLIN GENET, V58, P74, DOI 10.1034/j.1399-0004.2000.580113.x; Hatta M, 2010, SE ASIAN J TROP MED, V41, P386; Hsu YH, 2006, J FORMOS MED ASSOC, V105, P363, DOI 10.1016/S0929-6646(09)60131-5; Jin J, 2009, CLIN INFECT DIS, V48, P733, DOI 10.1086/597034; Leung KH, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-19; [李春柱 LI Chun-zhu], 2010, [生命科学研究, Life Science Research], V14, P125; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Liaw YS, 2002, INT J TUBERC LUNG D, V6, P454; LIN R, 2008, J CLIN MED PRACTIC, V12, P61; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; LIU ZB, 2008, J TONGJI UNI MED SCI, V29, P19; Ma X, 2002, INT J TUBERC LUNG D, V6, P818; McDermid JM, 2006, CLIN SCI, V110, P503, DOI 10.1042/CS20050273; Meng Xian-jie, 2009, Zhonghua Weishengwuxue He Mianyixue Zazhi, V29, P420, DOI 10.3760/cma.j.issn.0254-5101.2009.05.009; Merza M, 2009, BRAZ J INFECT DIS, V13, P252, DOI 10.1590/S1413-86702009000400002; Motsinger AA, 2007, J INFECT DIS, V195, P1737, DOI 10.1086/518247; Nino-Moreno P, 2007, CLIN EXP IMMUNOL, V148, P469, DOI 10.1111/j.1365-2249.2007.03359.x; Pacheco AG, 2009, DIS MARKERS, V27, P173, DOI [10.1155/2009/685618, 10.3233/DMA-2009-0654]; Puzyrev VP, 2002, MOL BIOL+, V36, P634, DOI 10.1023/A:1020611111205; Qu YB, 2007, INT J HYG ENVIR HEAL, V210, P679, DOI 10.1016/j.ijheh.2006.11.010; Ryu S, 2000, INT J TUBERC LUNG D, V4, P577; Sahiratmadja E, 2007, BRIT J NUTR, V98, P684, DOI 10.1017/S0007114507742691; Satomi A, 2008, INFECT DIS CLIN PRAC, V16, P230, DOI [DOI 10.1097/IPC.0B013E318173F6AE, 10.1097/IPC.0b013e318173f6ae]; SELVARAJ P, 2002, CURR SCI, V82, P4; Soborg C, 2002, J INFECT DIS, V186, P517, DOI 10.1086/341775; Soborg C, 2007, MOL IMMUNOL, V44, P2213, DOI 10.1016/j.molimm.2006.11.002; Su BH, 2008, NINGXIA MED, V30, P303; Taype CA, 2006, INFECT GENET EVOL, V6, P361, DOI 10.1016/j.meegid.2006.01.002; Vejbaesya S, 2007, RESPIROLOGY, V12, P202, DOI 10.1111/j.1440-1843.2006.01037.x; WU JD, 2009, J NONGKAN MED, V31, P16; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zhang WH, 2005, CLIN INFECT DIS, V40, P1232, DOI 10.1086/428726	46	52	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15831	10.1371/journal.pone.0015831	http://dx.doi.org/10.1371/journal.pone.0015831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283567	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400014
J	Friberg, U; Miller, PM; Stewart, AD; Rice, WR				Friberg, Urban; Miller, Paige M.; Stewart, Andrew D.; Rice, William R.			Mechanisms Promoting the Long-Term Persistence of a Wolbachia Infection in a Laboratory-Adapted Population of Drosophila melanogaster	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; UNIDIRECTIONAL INCOMPATIBILITY; ANTAGONISTIC COEVOLUTION; SIMULANS; DYNAMICS; EVOLUTION; MOSQUITOS; SELECTION; INSECTS; STRAINS	Intracellular bacteria of the genus Wolbachia are widespread endosymbionts across diverse insect taxa. Despite this prevalence, our understanding of how Wolbachia persists within populations is not well understood. Cytoplasmic incompatibility (CI) appears to be an important phenotype maintaining Wolbachia in many insects, but it is believed to be too weak to maintain Wolbachia in Drosophila melanogaster, suggesting that Wolbachia must also have other effects on this species. Here we estimate the net selective effect of Wolbachia on its host in a laboratory-adapted population of D. melanogaster, to determine the mechanisms leading to its persistence in the laboratory environment. We found i) no significant effects of Wolbachia infection on female egg-to-adult survival or adult fitness, ii) no reduced juvenile survival in males, iii) substantial levels of CI, and iv) a vertical transmission rate of Wolbachia higher than 99%. The fitness of cured females was, however, severely reduced (a decline of 37%) due to CI in offspring. Taken together these findings indicate that Wolbachia is maintained in our laboratory environment due to a combination of a nearly perfect transmission rate and substantial CI. Our results show that there would be strong selection against females losing their infection and producing progeny free from Wolbachia.	[Friberg, Urban] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden; [Friberg, Urban; Miller, Paige M.; Stewart, Andrew D.; Rice, William R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Uppsala University; University of California System; University of California Santa Barbara	Friberg, U (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden.	Urban.Friberg@ebc.uu.se	Friberg, Urban/C-9412-2015	Friberg, Urban/0000-0001-6112-9586; Miller, Paige/0000-0002-5419-8601	National Science Foundation [DEB-0128780, DEB-0111613]; National Institutes of Health [1R01HD057974-01]; Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057974] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was funded by the National Science Foundation [DEB-0128780 and DEB-0111613]; National Institutes of Health [1R01HD057974-01]; the Wenner-Gren Foundations (http://www.swgc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bourtzis K, 1996, GENETICS, V144, P1063; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7; Friberg U, 2008, J EVOLUTION BIOL, V21, P1798, DOI 10.1111/j.1420-9101.2008.01581.x; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Harcombe W, 2004, J INVERTEBR PATHOL, V87, P45, DOI 10.1016/j.jip.2004.07.003; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1988, GENETICS, V119, P435; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOFFMANN AA, 1994, GENETICS, V136, P993; Hoffmann AA, 1998, GENETICS, V148, P221; HOFFMANN AA, 1990, GENETICS, V126, P933; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Montenegro H, 2006, GENETICA, V127, P207, DOI 10.1007/s10709-005-3766-4; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; PROUT T, 1994, EVOLUTION, V48, P909, DOI 10.1111/j.1558-5646.1994.tb01371.x; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Rice WR, 2006, PHILOS T R SOC B, V361, P287, DOI 10.1098/rstb.2005.1787; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; TURELLI M, 1992, GENETICS, V132, P713; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	42	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16448	10.1371/journal.pone.0016448	http://dx.doi.org/10.1371/journal.pone.0016448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283625	gold, Green Submitted, Green Published			2022-12-27	WOS:000286523400037
J	Capilla, A; Pazo-Alvarez, P; Darriba, A; Campo, P; Gross, J				Capilla, Almudena; Pazo-Alvarez, Paula; Darriba, Alvaro; Campo, Pablo; Gross, Joachim			Steady-State Visual Evoked Potentials Can Be Explained by Temporal Superposition of Transient Event-Related Responses	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; RESONANCE PHENOMENA; BRAIN DYNAMICS; EEG RESPONSES; STIMULI; GENERATION; FREQUENCY; FLICKER; OSCILLATIONS; HABITUATION	Background: One common criterion for classifying electrophysiological brain responses is based on the distinction between transient (i.e. event-related potentials, ERPs) and steady-state responses (SSRs). The generation of SSRs is usually attributed to the entrainment of a neural rhythm driven by the stimulus train. However, a more parsimonious account suggests that SSRs might result from the linear addition of the transient responses elicited by each stimulus. This study aimed to investigate this possibility. Methodology/Principal Findings: We recorded brain potentials elicited by a checkerboard stimulus reversing at different rates. We modeled SSRs by sequentially shifting and linearly adding rate-specific ERPs. Our results show a strong resemblance between recorded and synthetic SSRs, supporting the superposition hypothesis. Furthermore, we did not find evidence of entrainment of a neural oscillation at the stimulation frequency. Conclusions/Significance: This study provides evidence that visual SSRs can be explained as a superposition of transient ERPs. These findings have critical implications in our current understanding of brain oscillations. Contrary to the idea that neural networks can be tuned to a wide range of frequencies, our findings rather suggest that the oscillatory response of a given neural network is constrained within its natural frequency range.	[Capilla, Almudena; Gross, Joachim] Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging CCNi, Glasgow, Lanark, Scotland; [Capilla, Almudena] Univ Autonoma Madrid, Dept Biol & Hlth Psychol, Madrid, Spain; [Pazo-Alvarez, Paula; Darriba, Alvaro] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain; [Campo, Pablo] Univ Complutense Madrid, Ctr Magnetoencephalog Dr Perez Modrego, Madrid, Spain; [Campo, Pablo] Univ Politecn Madrid, Univ Complutense Madrid, Ctr Biomed Technol, Lab Cognit & Computat Neurosci, Madrid, Spain; [Campo, Pablo] Univ Autonoma Madrid, Dept Basic Psychol, Madrid, Spain; [Gross, Joachim] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Glasgow; Autonomous University of Madrid; Universidade de Santiago de Compostela; Complutense University of Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Autonomous University of Madrid; University of Glasgow	Capilla, A (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging CCNi, Glasgow, Lanark, Scotland.	almudena.capilla@uam.es	Capilla, Almudena/B-9387-2011; Darriba, Álvaro/M-5417-2015; Gross, Joachim/C-5886-2009; Darriba, Alvaro/E-6641-2013; Campo, Pablo/M-3317-2019; Pazo-Alvarez, Paula/K-6537-2014; Campo, Pablo/I-8156-2012	Capilla, Almudena/0000-0002-4181-4284; Darriba, Álvaro/0000-0001-5425-5752; Gross, Joachim/0000-0002-3994-1006; Campo, Pablo/0000-0003-4539-6857; Pazo-Alvarez, Paula/0000-0001-8144-9536; Campo, Pablo/0000-0003-4539-6857	Spanish Ministry of Science and Innovation [2008-0168]; Spanish Ministry of Science and Innovation (Ramon y Cajal) [RYC-2010-05748]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation (Ramon y Cajal)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (2008-0168 Postdoctoral Fellowship to A. Capilla; and RYC-2010-05748 Ramon y Cajal Fellowship to P. Campo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P138; AZZENA GB, 1995, HEARING RES, V83, P1, DOI 10.1016/0378-5955(94)00184-R; BACAR E, 1980, EEG BRAIN DYNAMICS R; BASAR E, 1987, INT J NEUROSCI, V33, P103; Bohorquez J, 2007, P ANN INT IEEE EMBS, P2444, DOI 10.1109/IEMBS.2007.4352822; Bohorquez J, 2008, CLIN NEUROPHYSIOL, V119, P2598, DOI 10.1016/j.clinph.2008.08.002; Boutros NN, 1999, PSYCHIAT RES, V88, P119, DOI 10.1016/S0165-1781(99)00074-8; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; CELESIA GG, 1982, ANN NY ACAD SCI, V388, P290, DOI 10.1111/j.1749-6632.1982.tb50797.x; Conti G, 1999, CLIN NEUROPHYSIOL, V110, P62, DOI 10.1016/S0168-5597(98)00045-8; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; ERWIN RJ, 1986, ELECTROEN CLIN NEURO, V64, P417, DOI 10.1016/0013-4694(86)90075-1; Fuentemilla LI, 2006, NEUROIMAGE, V30, P909, DOI 10.1016/j.neuroimage.2005.10.036; GALAMBOS R, 1982, ANN NY ACAD SCI, V388, P722, DOI 10.1111/j.1749-6632.1982.tb50841.x; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Heinrich S P, 2001, Doc Ophthalmol, V102, P141, DOI 10.1023/A:1017509717071; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; HILLYARD SA, 1985, TRENDS NEUROSCI, V8, P400, DOI 10.1016/0166-2236(85)90142-0; JERVIS BW, 1983, IEEE T BIO-MED ENG, V30, P43, DOI 10.1109/TBME.1983.325165; Kerr CC, 2008, BIOL CYBERN, V98, P171, DOI 10.1007/s00422-007-0201-1; Klimesch W, 2006, NEUROIMAGE, V29, P808, DOI 10.1016/j.neuroimage.2005.08.041; KLIMESCH W, 2009, NEUROIMAGE; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Martinez-Montes E, 2008, STAT MED, V27, P2922, DOI 10.1002/sim.3132; McEvoy L, 1997, PSYCHOPHYSIOLOGY, V34, P308, DOI 10.1111/j.1469-8986.1997.tb02401.x; Moratti S, 2007, HUM BRAIN MAPP, V28, P1318, DOI 10.1002/hbm.20342; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; PICTON TW, 1992, ELECTROEN CLIN NEURO, V84, P90, DOI 10.1016/0168-5597(92)90071-I; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; REGAN D, 1982, ANN NY ACAD SCI, V388, P45, DOI 10.1111/j.1749-6632.1982.tb50784.x; Regan D, 2009, VISION RES, V49, pV, DOI 10.1016/S0042-6989(09)00142-4; Regan D., 1989, HUMAN BRAIN ELECTROP; Rennie CJ, 2002, BIOL CYBERN, V86, P457, DOI 10.1007/s00422-002-0310-9; Risner ML, 2009, NEUROIMAGE, V45, P463, DOI 10.1016/j.neuroimage.2008.12.031; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Ross B, 2005, J NEUROPHYSIOL, V94, P4082, DOI 10.1152/jn.00469.2005; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Sable JJ, 2004, PSYCHOPHYSIOLOGY, V41, P636, DOI 10.1111/j.1469-8986.2004.00192.x; SANTARELLI R, 1995, HEARING RES, V83, P9, DOI 10.1016/0378-5955(94)00185-S; Santarelli R, 1999, SCAND AUDIOL, V28, P23; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; SPEKREIJSE H, 1977, VISUAL EVOKED POTENT; Srinivasan R, 2006, BRAIN TOPOGR, V18, P167, DOI 10.1007/s10548-006-0267-4; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; STAPELLS DR, 1988, ELECTROEN CLIN NEURO, V71, P289, DOI 10.1016/0168-5597(88)90029-9; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wilcox RR, 2003, PSYCHOL METHODS, V8, P254, DOI 10.1037/1082-989X.8.3.254; Zaehle T, 2010, EXP BRAIN RES, V203, P629, DOI 10.1007/s00221-010-2265-8	58	128	130	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14543	10.1371/journal.pone.0014543	http://dx.doi.org/10.1371/journal.pone.0014543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267081	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000286519500013
J	Feikin, DR; Olack, B; Bigogo, GM; Audi, A; Cosmas, L; Aura, B; Burke, H; Njenga, MK; Williamson, J; Breiman, RF				Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Williamson, John; Breiman, Robert F.			The Burden of Common Infectious Disease Syndromes at the Clinic and Household Level from Population-Based Surveillance in Rural and Urban Kenya	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PERIPHERAL HEALTH FACILITIES; WESTERN KENYA; COTRIMOXAZOLE PROPHYLAXIS; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; RISK-FACTORS; MORBIDITY SURVEILLANCE; INTEGRATED MANAGEMENT; PNEUMOCOCCAL DISEASE	Background: Characterizing infectious disease burden in Africa is important for prioritizing and targeting limited resources for curative and preventive services and monitoring the impact of interventions. Methods: From June 1, 2006 to May 31, 2008, we estimated rates of acute lower respiratory tract illness (ALRI), diarrhea and acute febrile illness (AFI) among >50,000 persons participating in population-based surveillance in impoverished, rural western Kenya (Asembo) and an informal settlement in Nairobi, Kenya (Kibera). Field workers visited households every two weeks, collecting recent illness information and performing limited exams. Participants could access free high-quality care in a designated referral clinic in each site. Incidence and longitudinal prevalence were calculated and compared using Poisson regression. Results: Incidence rates resulting in clinic visitation were the following: ALRI - 0.36 and 0.51 episodes per year for children <5 years and 0.067 and 0.026 for persons >= 5 years in Asembo and Kibera, respectively; diarrhea - 0.40 and 0.71 episodes per year for children <5 years and 0.09 and 0.062 for persons >= 5 years in Asembo and Kibera, respectively; AFI - 0.17 and 0.09 episodes per year for children <5 years and 0.03 and 0.015 for persons >= 5 years in Asembo and Kibera, respectively. Annually, based on household visits, children <5 years in Asembo and Kibera had 60 and 27 cough days, 10 and 8 diarrhea days, and 37 and 11 fever days, respectively. Household-based rates were higher than clinic rates for diarrhea and AFI, this difference being several-fold greater in the rural than urban site. Conclusions: Individuals in poor Kenyan communities still suffer from a high burden of infectious diseases, which likely hampers their development. Urban slum and rural disease incidence and clinic utilization are sufficiently disparate in Africa to warrant data from both settings for estimating burden and focusing interventions.	[Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Breiman, Robert F.] Ctr Dis Control & Prevent Nairobi, Int Emerging Infect Program Kenya, Nairobi, Kenya; [Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Breiman, Robert F.] Ctr Dis Control & Prevent Kisumu, Int Emerging Infect Program Kenya, Kisumu, Kenya; [Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Williamson, John; Breiman, Robert F.] CDC Publ Hlth & Res Collaborat, Kenya Med Res Inst, Kisumu, Kenya; [Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Williamson, John; Breiman, Robert F.] CDC Publ Hlth & Res Collaborat, Kenya Med Res Inst, Nairobi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute	Feikin, DR (corresponding author), Ctr Dis Control & Prevent Nairobi, Int Emerging Infect Program Kenya, Nairobi, Kenya.	dfeikin@ke.cdc.gov	Bigogo, Godfrey/W-3591-2019	Audi, Allan/0000-0003-1683-554X	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded through core funding of CDC's International Emerging Infections Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bickel P.J., 2001, MATH STAT BASIC IDEA; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BREIMAN RF, J HLTH POPU IN PRESS; Breman JG, 2001, AM J TROP MED HYG, V64, pI; BURTON DC, J HLTH POPU IN PRESS; CAMPBELL H, 1989, LANCET, V1, P297, DOI 10.1016/S0140-6736(89)91308-1; *CENTR BUR STAT, 2001, POP DISTR ADM AR URB, P2; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; FAGBULE D, 1994, J TROP PEDIATRICS, V40, P279, DOI 10.1093/tropej/40.5.279; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Hayes J A, 1990, Health Care Strateg Manage, V8, P12; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; MANUNEBO MN, 1994, J TROP MED HYG, V97, P31; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; McElroy PD, 2001, AM J TROP MED HYG, V64, P18, DOI 10.4269/ajtmh.2001.64.18; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; *MIN HLTH KEN CBS, 2004, KEN DEM HLTH SURV 20; Mirza NM, 1997, AM J EPIDEMIOL, V146, P776, DOI 10.1093/oxfordjournals.aje.a009354; Molbak K, 1997, AM J EPIDEMIOL, V146, P273, DOI 10.1093/oxfordjournals.aje.a009263; Morris SS, 1998, AM J EPIDEMIOL, V147, P1087, DOI 10.1093/oxfordjournals.aje.a009403; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; MURRAY CJL, 1996, GLOBAL HLTH STAT, P286; Ngongo CJ, 2008, INT Q COMMUNITY HEAL, V28, P33, DOI 10.2190/IQ.28.1.d; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; OYEJIDE CO, 1990, REV INFECT DIS, V12, pS1042; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P38; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Schmidt WP, 2007, EPIDEMIOLOGY, V18, P537, DOI 10.1097/EDE.0b013e318093f3ce; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Syagga P. M., 2001, SLUM UPGRADING LESSO; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; Van Hemelrijck MJJ, 2009, TROP MED INT HEALTH, V14, P62, DOI 10.1111/j.1365-3156.2008.02184.x; WAFULA EM, 1990, REV INFECT DIS, V12, pS1035; WHO, 2010, WORLD HLTH STAT; WHO, 2008, INT MAN CHILDH ILLN; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; World Health Organization, 2010, WHO STAT INF SYST; Wright JA, 2006, J HEALTH POPUL NUTR, V24, P8	65	124	125	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16085	10.1371/journal.pone.0016085	http://dx.doi.org/10.1371/journal.pone.0016085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267459	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500037
J	Tanner, MJ; Welliver, RC; Chen, MQ; Shtutman, M; Godoy, A; Smith, G; Mian, BM; Buttyan, R				Tanner, Matthew J.; Welliver, R. Charles, Jr.; Chen, Mengqian; Shtutman, Michael; Godoy, Alejandro; Smith, Gary; Mian, Badar M.; Buttyan, Ralph			Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells	PLOS ONE			English	Article							REGULATED GENES; MOLECULAR REGULATION; LNCAP CELLS; IN-VIVO; IDENTIFICATION; PROGRESSION; MICROENVIRONMENT; CARCINOGENESIS	The androgen receptor (AR) is expressed in a subset of prostate stromal cells and functional stromal cell AR is required for normal prostate developmental and influences the growth of prostate tumors. Although we are broadly aware of the specifics of the genomic actions of AR in prostate cancer cells, relatively little is known regarding the gene targets of functional AR in prostate stromal cells. Here, we describe a novel human prostate stromal cell model that enabled us to study the effects of AR on gene expression in these cells. The model involves a genetically manipulated variant of immortalized human WPMY-1 prostate stromal cells that overexpresses wildtype AR (WPMY-AR) at a level comparable to LNCaP cells and is responsive to dihydrotestosterone (DHT) stimulation. Use of WPMY-AR cells for gene expression profiling showed that the presence of AR, even in the absence of DHT, significantly altered the gene expression pattern of the cells compared to control (WPMY-Vec) cells. Treatment of WPMY-AR cells, but not WPMY-Vec control cells, with DHT resulted in further changes that affected the expression of 141 genes by 2-fold or greater compared to vehicle treated WPMY-AR cells. Remarkably, DHT significantly downregulated more genes than were upregulated but many of these changes reversed the initial effects of AR overexpression alone on individual genes. The genes most highly effected by DHT treatment were categorized based upon their role in cancer pathways or in cell signaling pathways (transforming growth factor-beta, Wnt, Hedgehog and MAP Kinase) thought to be involved in stromal-epithelial crosstalk during prostate or prostate cancer development. DHT treatment of WPMY-AR cells was also sufficient to alter their paracrine potential for prostate cancer cells as conditioned medium from DHT-treated WPMY-AR significantly increased growth of LNCaP cells compared to DHT-treated WPMY-Vec cell conditioned medium.	[Tanner, Matthew J.; Chen, Mengqian; Shtutman, Michael; Buttyan, Ralph] Ordway Res Inst, Albany, NY USA; [Welliver, R. Charles, Jr.; Mian, Badar M.; Buttyan, Ralph] Albany Med Coll, Dept Surg, Div Urol, Albany, NY 12208 USA; [Welliver, R. Charles, Jr.; Mian, Badar M.] Stratton Vet Affairs Med Ctr, Albany, NY USA; [Godoy, Alejandro; Smith, Gary] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA	Ordway Research Institute; Albany Medical College; Roswell Park Cancer Institute	Tanner, MJ (corresponding author), Ordway Res Inst, Albany, NY USA.	rbuttyan@ordwayresearch.org	Godoy, Alejandro/GPS-4942-2022; Shtutman, Michael/AAB-8391-2020; Mian, Badar M/GYJ-4637-2022	Shtutman, Michael/0000-0002-2458-3226; Mian, Badar M/0000-0002-1698-9525; Tanner, Matthew/0000-0002-4392-5535; Giannakakou, Paraskevi/0000-0001-7378-262X; Chen, Mengqian/0000-0003-1706-9509; Welliver, Charles/0000-0001-8520-3218	Equinox Foundation; Medical Research Foundation of Albany, New York; Department of Defense (DoD) [W81XWH-10-100125, W81XWH-09-1-0330]	Equinox Foundation; Medical Research Foundation of Albany, New York; Department of Defense (DoD)(United States Department of Defense)	This work was funded by the Equinox Foundation and the Medical Research Foundation of Albany, New York. MT was an American Urological Association (URA) Foundation Research Fellow. MC and AG are recipients of Department of Defense (DoD) Prostate Cancer Research Program (PCRP) Postdoctoral Research Fellowships (W81XWH-10-100125 [to MC] and W81XWH-09-1-0330 [to AG]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basanta D, 2009, CANCER RES, V69, P7111, DOI 10.1158/0008-5472.CAN-08-3957; Cano P, 2007, CANCER RES, V67, P511, DOI 10.1158/0008-5472.CAN-06-1478; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; GLEAVE M, 1991, CANCER RES, V51, P3753; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Hu P, 2006, CANCER INFORM, V2, P289; Imperato-McGinley J, 2002, MOL CELL ENDOCRINOL, V198, P51, DOI 10.1016/S0303-7207(02)00368-4; IWAMURA M, 1994, J HISTOCHEM CYTOCHEM, V42, P783, DOI 10.1177/42.6.8189040; Jariwala U, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-39; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Liu AY, 1997, PROSTATE, V30, P145, DOI 10.1002/(SICI)1097-0045(19970215)30:3<145::AID-PROS1>3.0.CO;2-L; Mechlin CW, 2010, J UROLOGY, V184, P344, DOI 10.1016/j.juro.2010.03.007; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mohler JL, 1996, CLIN CANCER RES, V2, P889; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Price DT, 2000, J UROLOGY, V164, P2145, DOI 10.1016/S0022-5347(05)66987-X; Rostad K, 2007, INT J ONCOL, V30, P19; SAR M, 1990, ENDOCRINOLOGY, V127, P3180, DOI 10.1210/endo-127-6-3180; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; SULTAN C, 1993, J STEROID BIOCHEM, V46, P519, DOI 10.1016/0960-0760(93)90178-Y; Thompson IM, 2009, J UROLOGY, V182, P499, DOI 10.1016/j.juro.2009.04.015; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Xu LL, 2001, INT J CANCER, V92, P322, DOI 10.1002/ijc.1196	35	44	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16027	10.1371/journal.pone.0016027	http://dx.doi.org/10.1371/journal.pone.0016027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267466	Green Submitted, Green Published, gold			2022-12-27	WOS:000286519500036
J	Jankowska, EA; Filippatos, GS; von Haehling, S; Papassotiriou, J; Morgenthaler, NG; Cicoira, M; Schefold, JC; Rozentryt, P; Ponikowska, B; Doehner, W; Banasiak, W; Hartmann, O; Struck, J; Bergmann, A; Anker, SD; Ponikowski, P				Jankowska, Ewa A.; Filippatos, Gerasimos S.; von Haehling, Stephan; Papassotiriou, Jana; Morgenthaler, Nils G.; Cicoira, Mariantonietta; Schefold, Joerg C.; Rozentryt, Piotr; Ponikowska, Beata; Doehner, Wolfram; Banasiak, Waldemar; Hartmann, Oliver; Struck, Joachim; Bergmann, Andreas; Anker, Stefan D.; Ponikowski, Piotr			Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; MIDREGIONAL PRO-ADRENOMEDULLIN; PROGNOSTIC VALUE; BIG ENDOTHELIN-1; PREDICTING SURVIVAL; MARKERS; VASOCONSTRICTION; DIAGNOSIS	Objectives: We hypothesised that assessment of plasma C-terminal pro-endothelin-1 (CT-proET-1), a stable endothelin-1 precursor fragment, is of prognostic value in patients with chronic heart failure (CHF), beyond other prognosticators, including N-terminal pro-B-type natriuretic peptide (NT-proBNP). Methods: We examined 491 patients with systolic CHF (age: 63 +/- 11 years, 91% men, New York Heart Association [NYHA] class [I/II/III/IV]: 9%/45%/38%/8%, 69% ischemic etiology). Plasma CT-proET-1 was detected using a chemiluminescence immunoassay. Results: Increasing CT-proET-1 was a predictor of increased cardiovascular mortality at 12-months of follow-up (standardized hazard ratio 1.42, 95% confidence interval [CI] 1.04-1.95, p = 0.03) after adjusting for NT-proBNP, left ventricular ejection fraction (LVEF), age, creatinine, NYHA class. In receiver operating characteristic curve analysis, areas under curve for 12-month follow-up were similar for CT-proET-1 and NT-proBNP (p = 0.40). Both NT-proBNP and CT-proET-1 added prognostic value to a base model that included LVEF, age, creatinine, and NYHA class. Adding CT-proET-1 to the base model had stronger prognostic power (p<0.01) than adding NT-proBNP (p<0.01). Adding CT-proET-1 to NT-proBNP in this model yielded further prognostic information (p = 0.02). Conclusions: Plasma CT-proET-1 constitutes a novel predictor of increased 12-month cardiovascular mortality in patients with CHF. High CT-proET-1 together with high NT-proBNP enable to identify patients with CHF and particularly unfavourable outcomes.	[Jankowska, Ewa A.; Ponikowski, Piotr] Wroclaw Mil Hosp, Dept Heart Dis, Wroclaw, Poland; [Jankowska, Ewa A.; Banasiak, Waldemar; Ponikowski, Piotr] Mil Hosp, Dept Cardiol, Wroclaw, Poland; [Filippatos, Gerasimos S.] Atticon Univ Hosp, Dept Cardiol, Athens, Greece; [von Haehling, Stephan; Doehner, Wolfram; Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany; [von Haehling, Stephan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Clin Cardiol, London, England; [Papassotiriou, Jana; Morgenthaler, Nils G.; Hartmann, Oliver; Struck, Joachim; Bergmann, Andreas] Biotechnol Ctr Hennigsdorf Berlin, BRAHMS AG, Res Dept, Hennigsdorf, Germany; [Cicoira, Mariantonietta] Univ Verona, Dept Biomed & Surg Sci, Cardiol Sect, I-37100 Verona, Italy; [Schefold, Joerg C.] Charite, Dept Nephrol & Intens Care Med, Berlin, Germany; [Rozentryt, Piotr] Silesian Ctr Heart Dis, Dept Cardiol 3, Zabrze, Poland; [Ponikowska, Beata] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland; [Doehner, Wolfram] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Anker, Stefan D.] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy	University Hospital Attikon; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; Thermo Fisher Scientific; Brahms AG; University of Verona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Silesian Center for Heart Diseases; Wroclaw Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Jankowska, EA (corresponding author), Wroclaw Mil Hosp, Dept Heart Dis, Wroclaw, Poland.	Ewa.Jankowska@antro.pan.wroc.pl	Jankowska, Ewa A/AAY-3040-2020; Ponikowski, Piotr/O-6454-2015; Filippatos, Gerasimos/ABA-4656-2021; Jankowska, Ewa A/O-6358-2015; Jankowska, Ewa A/G-7960-2011; Jankowska, Ewa/ABD-4073-2021	Jankowska, Ewa A/0000-0002-9202-432X; Ponikowski, Piotr/0000-0002-3391-7064; Jankowska, Ewa A/0000-0002-9202-432X; Doehner, Wolfram/0000-0001-7598-708X; Ponikowska, Beata/0000-0002-6044-5322; Rozentryt, Piotr/0000-0002-8979-2205; Schefold, Joerg C./0000-0001-9162-5724	B.R.A.H.M.S AG	B.R.A.H.M.S AG	Stephan von Haehling has received speaker's fees from B.R.A.H.M.S AG for giving presentations on biomarkers produced and marketed by B.R.A.H.M.S. AG. Nils G. Morgenthaler, Jana Papassotiriou, Joachim Struck, Oliver Hartmann, and Andreas Bergmann are employed by B.R.A.H.M.S. AG, which is a biotech company that developed the CT-proET-1 assay. The funder B.R.A.H.M.S. AG was involved in data collection and analysis and reviewed the manuscript before submission. Andreas Bergmann is a member of the board of directors and shareholder of B.R.A.H.M.S. AG. Stefan D. Anker has received consultant honoraria from B.R.A.H.M.S. AG.	Adlbrecht C, 2009, EUR J HEART FAIL, V11, P361, DOI 10.1093/eurjhf/hfp004; Behnes M, 2008, CLIN CHEM LAB MED, V46, P204, DOI 10.1515/CCLM.2008.040; Berger R, 2003, J HEART LUNG TRANSPL, V22, P1037, DOI 10.1016/S1053-2498(02)00560-0; Brunner F, 2006, PHARMACOL THERAPEUT, V111, P508, DOI 10.1016/j.pharmthera.2005.11.001; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Dieplinger B, 2010, CLIN BIOCHEM, V43, P714, DOI 10.1016/j.clinbiochem.2010.02.002; Ferro CJ, 1998, CIRCULATION, V97, P2323, DOI 10.1161/01.CIR.97.23.2323; Gardner RS, 2005, EUR J HEART FAIL, V7, P253, DOI 10.1016/j.ejheart.2004.06.002; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Harrell FE, 2001, REGRESSION MODELING; Hulsmann M, 1998, J AM COLL CARDIOL, V32, P1695, DOI 10.1016/S0735-1097(98)00437-9; Isnard R, 2000, AM J CARDIOL, V86, P417, DOI 10.1016/S0002-9149(00)00957-7; Khan SQ, 2007, AM HEART J, V154, P736, DOI 10.1016/j.ahj.2007.06.016; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Marasciulo FL, 2006, CURR MED CHEM, V13, P1655, DOI 10.2174/092986706777441968; Masson S, 2006, J CARD FAIL, V12, P375, DOI 10.1016/j.cardfail.2006.02.013; Masson S, 2010, EUR J HEART FAIL, V12, P338, DOI 10.1093/eurjhf/hfp206; Pacher R, 1996, J AM COLL CARDIOL, V27, P633, DOI 10.1016/0735-1097(95)00520-X; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Pousset F, 1997, EUR HEART J, V18, P254; Rossi GP, 2000, ANN CLIN BIOCHEM, V37, P608, DOI 10.1258/0004563001899906; Selvais PL, 2000, J CARD FAIL, V6, P201, DOI 10.1054/jcaf.2000.8833; Stanek B, 1997, TRANSPL P, V29, P595, DOI 10.1016/S0041-1345(96)00097-8; Stanek B, 2001, J AM COLL CARDIOL, V38, P436, DOI 10.1016/S0735-1097(01)01383-3; Struck J, 2005, PEPTIDES, V26, P2482, DOI 10.1016/j.peptides.2005.05.010; Sugden Peter H., 2005, Current Vascular Pharmacology, V3, P343, DOI 10.2174/157016105774329390; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tsutamoto T, 1999, EUR HEART J, V20, P1799, DOI 10.1053/euhj.1999.1746; TSUTAMOTO T, 1995, AM J CARDIOL, V76, P803, DOI 10.1016/S0002-9149(99)80231-8; van Beneden R, 2004, J CARD FAIL, V10, P490, DOI 10.1016/j.cardfail.2004.04.001; von Haehling S, 2007, J AM COLL CARDIOL, V50, P1973, DOI 10.1016/j.jacc.2007.08.012; von Haehling S, 2010, EUR J HEART FAIL, V12, P484, DOI 10.1093/eurjhf/hfq031; WEITZBERG E, 1991, BIOCHEM BIOPH RES CO, V180, P1298, DOI 10.1016/S0006-291X(05)81336-1	33	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14506	10.1371/journal.pone.0014506	http://dx.doi.org/10.1371/journal.pone.0014506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264211	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600002
J	Marsolier-Kergoat, MC				Marsolier-Kergoat, Marie-Claude			A Simple Model for the Influence of Meiotic Conversion Tracts on GC Content	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; RECOMBINATION HOT-SPOTS; SACCHAROMYCES-CEREVISIAE; HUMAN GENOME; GENE CONVERSION; DNA REVEALS; HOTSPOTS; YEAST; EVOLUTION; SITES	A strong correlation between GC content and recombination rate is observed in many eukaryotes, which is thought to be due to conversion events linked to the repair of meiotic double-strand breaks. In several organisms, the length of conversion tracts has been shown to decrease exponentially with increasing distance from the sites of meiotic doublestrand breaks. I show here that this behavior leads to a simple analytical model for the evolution and the equilibrium state of the GC content of sequences devoid of meiotic double-strand break sites. In the yeast Saccharomyces cerevisiae, meiotic double-strand breaks are practically excluded from protein-coding sequences. A good fit was observed between the predictions of the model and the variations of the average GC content of the third codon position (GC3) of S. cerevisiae genes. Moreover, recombination parameters that can be extracted by fitting the data to the model coincide with experimentally determined values. These results thus indicate that meiotic recombination plays an important part in determining the fluctuations of GC content in yeast coding sequences. The model also accounted for the different patterns of GC variations observed in the genes of Candida species that exhibit a variety of sexual lifestyles, and hence a wide range of meiotic recombination rates. Finally, the variations of the average GC3 content of human and chicken coding sequences could also be fitted by the model. These results suggest the existence of a widespread pattern of GC variation in eukaryotic genes due to meiotic recombination, which would imply the generality of two features of meiotic recombination: its association with GC-biased gene conversion and the quasi-exclusion of meiotic double-strand breaks from coding sequences. Moreover, the model points out to specific constraints on protein fragments encoded by exon terminal sequences, which are the most affected by the GC bias.	CEA Saclay, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Marsolier-Kergoat, MC (corresponding author), CEA Saclay, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France.	mcmk@cea.fr			ARC (Association pour la Recherche sur le Cancer) [4917, ANR-07-BLAN-0091 - CSD 8]	ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from the ARC (Association pour la Recherche sur le Cancer, fixed subvention # 4917; http://www.arc-cancer.net/) and from the ANR (Agence Nationale de la Recherche, ANR-07-BLAN-0091 - CSD 8; http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; HILLIKER AJ, 1994, GENETICS, V137, P1019; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Noor MAF, 2008, MOL BIOL EVOL, V25, P2439, DOI 10.1093/molbev/msn186; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; R Core Team, 2020, R LANG ENV STAT COMP; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107; Webster MT, 2006, MOL BIOL EVOL, V23, P1203, DOI 10.1093/molbev/msk008; Wu ZK, 2010, NUCLEIC ACIDS RES, V38, P2346, DOI 10.1093/nar/gkp1251	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16109	10.1371/journal.pone.0016109	http://dx.doi.org/10.1371/journal.pone.0016109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249197	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000019
J	Baumgartner, A; Coleman, S; Swanson, B				Baumgartner, Alex; Coleman, Seth; Swanson, Brook			The Cost of the Sword: Escape Performance in Male Swordtails	PLOS ONE			English	Article							XIPHOPHORUS; PREFERENCE; PREDATORS; SELECTION; SIGNALS; BIAS	The handicap theory of sexual selection posits that male display traits that are favored in mate choice come at a significant cost to performance. We tested one facet of this hypothesis in the green swordtail (Xiphophorus helleri). In this species, the lower ray of male caudal fin is extended into a 'sword', which serves to attract potential mates. However, bearing a long sword may increase drag and thus compromise a male's ability to swim effectively. We tested escape performance in this species by eliciting C-start escape responses, an instinctive escape behavior, in males with various sword lengths. We then removed males' swords and retested escape performance. We found no relationship between escape performance and sword length and no effect of sword removal on escape performance. While having a large sword may attract a predator's attention, our results suggest that sword size does not compromise a male's escape performance.	[Baumgartner, Alex; Coleman, Seth; Swanson, Brook] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA	Gonzaga University	Baumgartner, A (corresponding author), Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA.	swansonb@gonzaga.edu		Baumgartner, Alexander/0000-0002-0009-2756	Howard Hughes Medical Institute; Gonzaga University; MJ Murdock Charitable Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gonzaga University; MJ Murdock Charitable Trust	This study was funded by grants from the Howard Hughes Medical Institute (www.hhmi.org), Gonzaga University (www.gonzaga.edu), and the MJ Murdock Charitable Trust (www.murdock-trust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; BASOLO AL, 1995, ANIM BEHAV, V50, P365, DOI 10.1006/anbe.1995.0252; Basolo AL, 2003, P ROY SOC B-BIOL SCI, V270, P1631, DOI 10.1098/rspb.2003.2388; Domenici P, 1997, J EXP BIOL, V200, P1165; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; GARCIA CM, 1994, BEHAV ECOL SOCIOBIOL, V35, P253, DOI 10.1007/s002650050096; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Houde A.E., 1997, SEX COLOR MATE CHOIC; KATZIR G, 1993, COPEIA, P549; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Marcus JM, 1999, SYST BIOL, V48, P491, DOI 10.1080/106351599260111; MOLLER AP, 1994, EVOLUTION, V48, P1676, DOI 10.1111/j.1558-5646.1994.tb02204.x; Morris MR, 2001, COPEIA, P65, DOI 10.1643/0045-8511(2001)001[0065:PRAPON]2.0.CO;2; NISSANOV J, 1989, AM ZOOL, V29, P103; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Royle NJ, 2006, FUNCT ECOL, V20, P662, DOI 10.1111/j.1365-2435.2006.01147.x; Wakeling JM, 2006, FISH PHYSIOL, V23, P333, DOI 10.1016/S1546-5098(05)23009-1; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WEIHS D, 1989, AM ZOOL, V29, P151; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	26	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15837	10.1371/journal.pone.0015837	http://dx.doi.org/10.1371/journal.pone.0015837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253013	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900011
J	Goldstein-Daruech, N; Cope, EK; Zhao, KQ; Vukovic, K; Kofonow, JM; Doghramji, L; Gonzalez, B; Chiu, AG; Kennedy, DW; Palmer, JN; Leid, JG; Kreindler, JL; Cohen, NA				Goldstein-Daruech, Natalia; Cope, Emily K.; Zhao, Ke-Qing; Vukovic, Katarina; Kofonow, Jennifer M.; Doghramji, Laurel; Gonzalez, Bernardo; Chiu, Alexander G.; Kennedy, David W.; Palmer, James N.; Leid, Jeffery G.; Kreindler, James L.; Cohen, Noam A.			Tobacco Smoke Mediated Induction of Sinonasal Microbial Biofilms	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS; BACTERIAL BIOFILMS; EPITHELIAL-CELLS; STAPHYLOCOCCUS-EPIDERMIDIS; COTININE LEVELS; AIRWAY; LIPOPOLYSACCHARIDE; ACTIVATION; EXPRESSION	Cigarette smokers and those exposed to second hand smoke are more susceptible to life threatening infection than nonsmokers. While much is known about the devastating effect tobacco exposure has on the human body, less is known about the effect of tobacco smoke on the commensal and commonly found pathogenic bacteria of the human respiratory tract, or human respiratory tract microbiome. Chronic rhinosinusitis (CRS) is a common medical complaint, affecting 16% of the US population with an estimated aggregated cost of $6 billion annually. Epidemiologic studies demonstrate a correlation between tobacco smoke exposure and rhinosinusitis. Although a common cause of CRS has not been defined, bacterial presence within the nasal and paranasal sinuses is assumed to be contributory. Here we demonstrate that repetitive tobacco smoke exposure induces biofilm formation in a diverse set of bacteria isolated from the sinonasal cavities of patients with CRS. Additionally, bacteria isolated from patients with tobacco smoke exposure demonstrate robust in vitro biofilm formation when challenged with tobacco smoke compared to those isolated from smoke naive patients. Lastly, bacteria from smoke exposed patients can revert to a non-biofilm phenotype when grown in the absence of tobacco smoke. These observations support the hypothesis that tobacco exposure induces sinonasal biofilm formation, thereby contributing to the conversion of a transient and medically treatable infection to a persistent and therapeutically recalcitrant condition.	[Goldstein-Daruech, Natalia; Zhao, Ke-Qing; Kofonow, Jennifer M.; Doghramji, Laurel; Chiu, Alexander G.; Kennedy, David W.; Palmer, James N.; Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Goldstein-Daruech, Natalia] Pontificia Univ Catolica Chile, PhD Program Med Sci, Santiago, Chile; [Goldstein-Daruech, Natalia; Gonzalez, Bernardo] Univ Adolfo Ibanez, Fac Ingn & Ciencia, Santiago, Chile; [Cope, Emily K.; Leid, Jeffery G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Zhao, Ke-Qing] Fudan Univ, Dept Otorhinolaryngol Head & Neck Surg, Eye & ENT Hosp, Sch Shanghai Med, Shanghai 200433, Peoples R China; [Vukovic, Katarina] Univ Hosp Ctr, Dept Otorhonolaryngol Head & Neck Surg, Zagreb, Croatia; [Kreindler, James L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kreindler, James L.] Univ Penn, Sch Med, Dept Pediat, Div Pulm Med, Philadelphia, PA 19104 USA; [Cohen, Noam A.] Philadelphia Vet Affairs Med Ctr, Surg Serv, Philadelphia, PA USA	University of Pennsylvania; Pontificia Universidad Catolica de Chile; Universidad Adolfo Ibanez; Northern Arizona University; Fudan University; University of Zagreb; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Goldstein-Daruech, N (corresponding author), Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA.	cohenn@uphs.upenn.edu	Chiu, Alexander G/J-1230-2014; González, Bernardo/AAW-9578-2021	Chiu, Alexander G/0000-0002-7592-6575; Cohen, Noam/0000-0002-9462-3932	Flight Attendants Medical Research Institute; Comision Nacional de investigacion cientifica y tecnologica de Chile (CONICYT); Cotutela/Codireccion 2009-2010 Pontificia Universidad Catolica de Chile	Flight Attendants Medical Research Institute; Comision Nacional de investigacion cientifica y tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Cotutela/Codireccion 2009-2010 Pontificia Universidad Catolica de Chile	This work was funded by the Flight Attendants Medical Research Institute as well as training fellowship grants from Comision Nacional de investigacion cientifica y tecnologica de Chile (CONICYT), and Cotutela/Codireccion 2009-2010 Pontificia Universidad Catolica de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MB, 2007, CURR OPIN ALLERGY CL, V7, P5, DOI 10.1097/ACI.0b013e3280114eef; APSELOFF G, 1994, CLIN PHARMACOL THER, V56, P460, DOI 10.1038/clpt.1994.161; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bagaitkar J, 2009, ENVIRON MICROBIOL, V11, P1242, DOI 10.1111/j.1462-2920.2008.01852.x; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Bertrand B., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P227; Bhattacharyya N, 1999, ARCH OTOLARYNGOL, V125, P1117; Briggs RD, 2004, LARYNGOSCOPE, V114, P126, DOI 10.1097/00005537-200401000-00022; Brook I, 2008, ANN OTO RHINOL LARYN, V117, P727, DOI 10.1177/000348940811701003; Brook I, 2010, INT J PEDIATR OTORHI, V74, P447, DOI 10.1016/j.ijporl.2010.01.006; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Cherry Donald K, 2002, Adv Data, P1; CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982; COHEN NA, 2009, LARYNGOSCOPE; Cohen NA, 2006, ANN OTO RHINOL LARYN, V115, P20; Colman G, 1976, Aust Dent J, V21, P111; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Daines SM, 2010, CURR OPIN OTOLARYNGO, V18, P187, DOI 10.1097/MOO.0b013e328338206a; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Ebbert JO, 2007, ENVIRON HEALTH-GLOB, V6, P1, DOI 10.1186/1476-069X-6-28; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Fullmer SC, 2009, J DENT RES, V88, P524, DOI 10.1177/0022034509338676; GLIKLICH RE, 1995, OTOLARYNG HEAD NECK, V113, P104, DOI 10.1016/S0194-5998(95)70152-4; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamilos Daniel L, 2010, Proc Am Thorac Soc, V7, P245, DOI 10.1513/pats.200909-098AL; Heyder J, 1975, Inhaled Part, V4 Pt 1, P107; Jorissen M., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P219; Kennedy D W, 1992, Laryngoscope, V102, P1; Kennedy DW, 2004, ANN OTO RHINOL LARYN, V113, P6, DOI 10.1177/00034894041130S503; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Lan MY, 2007, AM J RHINOL, V21, P218, DOI 10.2500/ajr.2007.21.2966; Lane AP, 2009, CURR ALLERGY ASTHM R, V9, P205, DOI 10.1007/s11882-009-0030-5; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Lee WK, 2007, AM J RHINOL, V21, P658, DOI 10.2500/ajr.2007.21.3094; Lewis SJ, 2003, BIOMARKERS, V8, P218, DOI 10.1080/1354750031000120125; Lieu JEC, 2000, ARCH OTOLARYNGOL, V126, P940, DOI 10.1001/archotol.126.8.940; Ly Nghi, 2002, Adv Data, P1; Mackay J, 2002, TOBACCO ATLAS; McMaster SK, 2008, BRIT J PHARMACOL, V153, P536, DOI 10.1038/sj.bjp.0707595; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Mirza N, 1999, OTOLARYNG CLIN N AM, V32, P243, DOI 10.1016/S0030-6665(05)70128-6; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Palmer J, 2006, ANN OTO RHINOL LARYN, V115, P35; Palmer JN, 2005, OTOLARYNG CLIN N AM, V38, P1193, DOI 10.1016/j.otc.2005.07.004; Perloff JR, 2004, AM J RHINOL, V18, P377, DOI 10.1177/194589240401800607; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Ramadan HH, 2005, OTOLARYNG HEAD NECK, V132, P414, DOI 10.1016/j.otohns.2004.11.011; Ramadan HH, 2002, OTOLARYNG HEAD NECK, V127, P546, DOI 10.1067/mhn.2002.129816; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; Savitski AN, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-120; Smith TL, 2005, LARYNGOSCOPE, V115, P2199, DOI 10.1097/01.mlg.0000182825.82910.80; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Trevino RJ, 1996, OTOLARYNG HEAD NECK, V114, P239, DOI 10.1016/S0194-5998(96)70174-2; Zurak K, 2009, J MED MICROBIOL, V58, P1231, DOI 10.1099/jmm.0.010579-0	59	64	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15700	10.1371/journal.pone.0015700	http://dx.doi.org/10.1371/journal.pone.0015700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253587	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900008
J	Li, MY; Shen, QA; Xu, HY; Wong, FM; Cui, JZ; Li, ZD; Hong, N; Wang, L; Zhao, HB; Ma, B; Hong, YH				Li, Mingyou; Shen, Qian; Xu, Hongyan; Wong, Foong Mei; Cui, Jianzhou; Li, Zhendong; Hong, Ni; Wang, Li; Zhao, Haobin; Ma, Bo; Hong, Yunhan			Differential Conservation and Divergence of Fertility Genes boule and dazl in the Rainbow Trout	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; VASA-LIKE GENE; CAENORHABDITIS-ELEGANS HOMOLOG; GREEN FLUORESCENT PROTEIN; MALE-STERILITY GENE; RNA LOCALIZATION; EXPRESSION; SPERMATOGENESIS; PLASM; GAMETOGENESIS	Background: The genes boule and dazl are members of the DAZ (Deleted in Azoospermia) family encoding RNA binding proteins essential for germ cell development. Although dazl exhibits bisexual expression in mitotic and meiotic germ cells in diverse animals, boule shows unisexual meiotic expression in invertebrates and mammals but a bisexual mitotic and meiotic expression in medaka. How boule and dazl have evolved different expression patterns in diverse organisms has remained unknown. Methodology and Principal Findings: Here we chose the fish rainbow trout (Oncorhynchus mykiss) as a second lower vertebrate model to investigate the expression of boule and dazl. By molecular cloning and sequence comparison, we identified cDNAs encoding the trout Boule and Dazl proteins, which have a conserved RNA-recognition motif and a maximal similarity to their homologs. By RT-PCR analysis, adult RNA expression of trout boule and dazl is restricted to the gonads of both sexes. By chromogenic and two-color fluorescence in situ hybridization, we revealed bisexual and germline-specific expression of boule and dazl. We found that dazl displays conserved expression throughout gametogenesis and concentrates in the Balbinani's body of early oocytes and the chromatoid body of sperm. Surprisingly, boule exhibits mitotic and meiotic expression in the male but meiosis-specific expression in the female. Conclusions: Our data underscores differential conservation and divergence of DAZ family genes during vertebrate evolution. We propose a model in which the diversity of boule expression in sex and stage specificity might have resulted from selective loss or gain of its expression in one sex and mitotic germ cells.	[Li, Mingyou; Shen, Qian; Xu, Hongyan; Wong, Foong Mei; Cui, Jianzhou; Li, Zhendong; Hong, Ni; Wang, Li; Zhao, Haobin; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ma, Bo] Heilongjiang Fisheries Res Inst, Haerbin City, Peoples R China; [Hong, Yunhan] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Jinzhou, Peoples R China	National University of Singapore; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS	Li, MY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009; Hong, Ni/Y-6114-2018; Cui, Jianzhou/AAU-7765-2020	Hong, Ni/0000-0002-9404-3110; Cui, Jianzhou/0000-0003-1666-4082; Li, Mingyou/0000-0002-8729-7964	Biomedical Research Council of Singapore [R-08-1-21-19-585, SBIC-SSCC C-002-2007]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of Singapore (R-08-1-21-19-585 & SBIC-SSCC C-002-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng MH, 1998, DEV BIOL, V204, P567, DOI 10.1006/dbio.1998.9098; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Elis S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-110; Houston DW, 1998, DEVELOPMENT, V125, P171; IWAMATSU T, 1988, ZOOL SCI, V5, P20; Johnson AD, 2001, DEV BIOL, V234, P402, DOI 10.1006/dbio.2001.0264; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; KITO G, J REPROD DEV, V56, P341; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Liu WS, 2007, CYTOGENET GENOME RES, V116, P65, DOI 10.1159/000097419; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Otori M, 2006, MOL BIOL CELL, V17, P3147, DOI 10.1091/mbc.E05-11-1067; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; TIMMERMANS LPM, 1985, CELL BIOL INT REP, V9, P518, DOI 10.1016/0309-1651(85)90005-0; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Xu HY, 2007, GENE EXPR PATTERNS, V7, P332, DOI 10.1016/j.modgep.2006.08.001; Xu HY, 2010, SCI CHINA LIFE SCI, V53, P435, DOI 10.1007/s11427-010-0058-8; Xu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006097; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323; Yoshizaki G, 2000, MOL REPROD DEV, V55, P364, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;364::AID-MRD2&gt;3.0.CO;2-8	37	42	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15910	10.1371/journal.pone.0015910	http://dx.doi.org/10.1371/journal.pone.0015910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253610	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900022
J	Galopier, A; Hermann-Le Denmat, S				Galopier, Aurelie; Hermann-Le Denmat, Sylvie			Mitochondria of the Yeasts Saccharomyces cerevisiae and Kluyveromyces lactis Contain Nuclear rDNA-Encoded Proteins	PLOS ONE			English	Article							RNA-POLYMERASE-II; INNER-MEMBRANE; TRANSCRIPTION TERMINATION; SHUTTLE VECTORS; RIBOSOMAL-RNA; COENZYME-Q; DNA; SEQUENCES; SIGNALS; SPACER	In eukaryotes, the nuclear ribosomal DNA (rDNA) is the source of the structural 18S, 5.8S and 25S rRNAs. In hemiascomycetous yeasts, the 25S rDNA sequence was described to lodge an antisense open reading frame (ORF) named TAR1 for Transcript Antisense to Ribosomal RNA. Here, we present the first immuno-detection and sub-cellular localization of the authentic product of this atypical yeast gene. Using specific antibodies against the predicted amino-acid sequence of the Saccharomyces cerevisiae TAR1 product, we detected the endogenous Tar1p polypeptides in S. cerevisiae (Sc) and Kluyveromyces lactis (Kl) species and found that both proteins localize to mitochondria. Protease and carbonate treatments of purified mitochondria further revealed that endogenous Sc Tar1p protein sub-localizes in the inner membrane in a N(in)-C(out) topology. Plasmid-versions of 5` end or 3` end truncated TAR1 ORF were used to demonstrate that neither the N-terminus nor the C-terminus of Sc Tar1p were required for its localization. Also, Tar1p is a presequence-less protein. Endogenous Sc Tar1p was found to be a low abundant protein, which is expressed in fermentable and non-fermentable growth conditions. Endogenous Sc TAR1 transcripts were also found low abundant and consistently 5` flanking regions of TAR1 ORF exhibit modest promoter activity when assayed in a luciferase-reporter system. Using rapid amplification of cDNA ends (RACE) PCR, we also determined that endogenous Sc TAR1 transcripts possess heterogeneous 5` and 3` ends probably reflecting the complex expression of a gene embedded in actively transcribed rDNA sequence. Altogether, our results definitively ascertain that the antisense yeast gene TAR1 constitutes a functional transcription unit within the nuclear rDNA repeats.	[Galopier, Aurelie] Univ Paris 11, Orsay, France; [Galopier, Aurelie; Hermann-Le Denmat, Sylvie] CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Hermann-Le Denmat, Sylvie] Ecole Normale Super, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Galopier, A (corresponding author), Univ Paris 11, Orsay, France.	sylvie.hermann-ledenmat@igmors.u-psud.fr			CNRS-ATIP; FRM-INE [INE20071110914]	CNRS-ATIP(Centre National de la Recherche Scientifique (CNRS)); FRM-INE	This work was supported by research projects granted by the CNRS-ATIP Program 2006 (to S.H.L.D) and the FRM-INE Program 2007 (to S.H.L.D; code INE20071110914). (http://www.cnrs.fr/ http://www.frm.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Baba SW, 2004, J BIOL CHEM, V279, P10052, DOI 10.1074/jbc.M313712200; BALDARI C, 1985, GENE, V35, P27, DOI 10.1016/0378-1119(85)90154-4; Bonawitz ND, 2008, CURR GENET, V54, P83, DOI 10.1007/s00294-008-0203-0; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CIGAN AM, 1987, GENE, V59, P1; COEHLO PS, 2002, GENE DEV, V16, P2755; COLLART MA, 1997, CURRENT PROTOCOLS MO; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Ge JH, 2010, RNA, V16, P1078, DOI 10.1261/rna.2060210; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Grentzmann G, 1998, RNA, V4, P479; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; PARIKH VS, 1989, MOL CELL BIOL, V9, P1897, DOI 10.1128/MCB.9.5.1897; PARKIH VS, 1987, SCIENCE, V235, P576; SANTANGELO GM, 1988, MOL CELL BIOL, V8, P4217, DOI 10.1128/MCB.8.10.4217; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Torchet C, 1998, RNA, V4, P1636, DOI 10.1017/S1355838298981511; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WALLIS MG, 1994, EUR J BIOCHEM, V222, P27, DOI 10.1111/j.1432-1033.1994.tb18837.x; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhao XL, 2008, NAT METHODS, V5, P95, DOI 10.1038/NMETH1142	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16325	10.1371/journal.pone.0016325	http://dx.doi.org/10.1371/journal.pone.0016325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283537	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400043
J	Molokhia, M; Nitsch, D; Patrick, AL; McKeigue, P				Molokhia, Mariam; Nitsch, Dorothea; Patrick, Alan Leslie; McKeigue, Paul			30 Year Patterns of Mortality in Tobago, West Indies, 1976-2005: Impact of Glucose Intolerance and Alcohol Intake	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; RISK; MEN; OBESITY; WOMEN	Objectives: To determine the main predictors of all-cause and cardiovascular (CV) mortality in a rural West Indian population in Plymouth, Tobago over 30 years. Methods: Questionnaire survey for CV risk factors and alcohol consumption patterns administered at baseline in 1976 with 92.5% response rate. 831/832 patients were followed up until 2005 or death. Results: Hypertension (>140/90 mm Hg) was prevalent in 48% of men and 44% of women, and 21% of men and 17% of women had diabetes. Evidence showed most predictors for all cause and cardiovascular mortality having the main effects at ages <60 years, (p-value for interaction<0.01) but no risk factors having sex-specific effects on mortality. The main predictors of all-cause mortality at age <60 years in the fully adjusted model were high sessional alcohol intake (hazard ratio (HR) 2.04, 95% CI 1.10-3.80), severe hypertension >160/95 mm Hg (HR 1.68, 95% CI 1.09-2.60), diabetes (HR 3.28, 95% CI 1.89-5.69), and BMI (HR 1.04, 95% CI 1.00-1.07). The main predictors of cardiovascular mortality were similar in the fully adjusted model: high sessional alcohol intake (HR 2.47 95% CI 1.10-5.57), severe hypertension (HR 2.78 95% CI 1.56-4.95), diabetes (HR 3.68 95% CI 1.77-7.67) and additionally LVH, (HR 5.54 95% CI 1.38-22.26), however BMI did not show independent effects. For men, high sessional alcohol intake explains 27% of all cause mortality, and 40% of cardiovascular mortality at age <60 yrs. In adults aged <60 years, the attributable risk fraction for IGT/Diabetes and all cause mortality and cardiovascular mortality is 28% in women vs. 11% in men, and 22% in women vs. 6% in men respectively. Conclusions: In this Afro-Caribbean population we found that a major proportion of deaths are attributable to high sessional alcohol intake (in males), diabetes, and hypertension and these risk factors primarily operate in those below 60 years.	[Molokhia, Mariam; Nitsch, Dorothea] London Sch Hyg & Trop Med, Div Epidemiol & Populat Hlth, London WC1, England; [Patrick, Alan Leslie] Kavanagh St Med Ctr, Port of Spain, Trinidad, Trinidad Tobago; [McKeigue, Paul] Univ Edinburgh, Publ Hlth Sci Mol Med Ctr, Edinburgh, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh	Molokhia, M (corresponding author), London Sch Hyg & Trop Med, Div Epidemiol & Populat Hlth, London WC1, England.	mariam.molokhia@lshtm.ac.uk		Nitsch, Dorothea/0000-0001-5767-248X	Commonwealth Research Council; National Institutes of Health	Commonwealth Research Council; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The original study was supported by a grant from the Commonwealth Health Research Council, formerly the Commonwealth Research Council. MM is supported by a National Institutes of Health Research postdoctoral fellowship and is an investigator for the FP7 ARITMO project: Investigating Arrhythmogenic Potential of Drugs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM HEART ASS, 2008, AFR AM CARD DIS STAT, P1; Austin M, 2004, W INDIAN MED J, V53, P387; *CENTR STAT OFF GO, 2004, POP VIT STAT REP; Chalmers J, 2008, J HYPERTENS, V26, pS11, DOI 10.1097/01.hjh.0000320754.38732.46; CHATURVEDI N, 1994, DIABETOLOGIA, V37, P765, DOI 10.1007/s001250050177; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Glynn RJ, 2002, HYPERTENSION, V39, P105, DOI 10.1161/hy1201.097199; He J, 1999, J HYPERTENS, V17, pS7; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; LACKLAND DT, 1995, CLIN EXP HYPERTENS, V17, P1091, DOI 10.3109/10641969509033654; MILLER GJ, 1988, INT J EPIDEMIOL, V17, P62, DOI 10.1093/ije/17.1.62; Mourad JJ, 2008, J HYPERTENS, V26, pS257; PATRICK AL, 1985, W INDIAN MED J, V34, P158; PATRICK AL, 1986, W INDIAN MED J, V35, P76; PATRICK AL, 1980, THESIS U LONDON LOND; PATRICK AL, 1995, 3 EUR C CARD; Price GM, 2006, AM J CLIN NUTR, V84, P449; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Shkolnikov VM, 2002, J EPIDEMIOL COMMUN H, V56, P171, DOI 10.1136/jech.56.3.171; Sull JW, 2009, STROKE, V40, P2953, DOI 10.1161/STROKEAHA.109.556027; Wilks R, 1996, CIBA F SYMP, V201, P37	22	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14588	10.1371/journal.pone.0014588	http://dx.doi.org/10.1371/journal.pone.0014588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283617	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000286661400005
J	Thepparit, C; Sunyakumthorn, P; Guillotte, ML; Popov, VL; Foil, LD; Macaluso, KR				Thepparit, Chutima; Sunyakumthorn, Piyanate; Guillotte, Mark L.; Popov, Vsevolod L.; Foil, Lane D.; Macaluso, Kevin R.			Isolation of a Rickettsial Pathogen from a Non-Hematophagous Arthropod	PLOS ONE			English	Article							CTENOCEPHALIDES-FELIS BOUCHE; LIPOSCELIS-BOSTRYCHOPHILA PSOCOPTERA; SPOTTED-FEVER GROUP; CAT FLEAS; CELL-LINE; TICK; MYCETOME; TYPHUS; GENE; PEST	Rickettsial diversity is intriguing in that some species are transmissible to vertebrates, while others appear exclusive to invertebrate hosts. Of particular interest is Rickettsia felis, identifiable in both stored product insect pests and hematophagous disease vectors. To understand rickettsial survival tactics in, and probable movement between, both insect systems will explicate the determinants of rickettsial pathogenicity. Towards this objective, a population of Liposcelis bostrychophila, common booklice, was successfully used for rickettsial isolation in ISE6 (tick-derived cells). Rickettsiae were also observed in L. bostrychophila by electron microscopy and in paraffin sections of booklice by immunofluorescence assay using anti-R. felis polyclonal antibody. The isolate, designated R. felis strain LSU-Lb, resembles typical rickettsiae when examined by microscopy. Sequence analysis of portions of the Rickettsia specific 17-kDa antigen gene, citrate synthase (gltA) gene, rickettsial outer membrane protein A (ompA) gene, and the presence of the R. felis plasmid in the cell culture isolate confirmed the isolate as R. felis. Variable nucleotide sequences from the isolate were obtained for R. felis-specific pRF-associated putative tldD/pmbA. Expression of rickettsial outer membrane protein B (OmpB) was verified in R. felis (LSU-Lb) using a monoclonal antibody. Additionally, a quantitative real-time PCR assay was used to identify a significantly greater median rickettsial load in the booklice, compared to cat flea hosts. With the potential to manipulate arthropod host biology and infect vertebrate hosts, the dual nature of R. felis provides an excellent model for the study of rickettsial pathogenesis and transmission. In addition, this study is the first isolation of a rickettsial pathogen from a non-hematophagous arthropod.	[Thepparit, Chutima; Sunyakumthorn, Piyanate; Guillotte, Mark L.; Macaluso, Kevin R.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Popov, Vsevolod L.] Univ Texas Med Branch, WHO Collaborating Ctr Trop Dis, Dept Pathol, Galveston, TX USA; [Foil, Lane D.] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of Texas System; University of Texas Medical Branch Galveston; Louisiana State University System; Louisiana State University	Thepparit, C (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	kmacaluso@vetmed.lsu.edu	Thepparit, Chutima/GLN-5662-2022	Guillotte, Mark/0000-0002-1826-8879; Thepparit, Chutima/0000-0002-8355-269X	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI069248, AI069248-S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077784, R21AI069248] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (www.nih.gov; AI069248 and AI069248-S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; CHANG KP, 1973, CAN J MICROBIOL, V19, P1075, DOI 10.1139/m73-171; Fournier PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002289; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; HAYES SF, 1979, J BACTERIOL, V137, P605, DOI 10.1128/JB.137.1.605-613.1979; HENDERSON G, 1993, J MED ENTOMOL, V30, P619, DOI 10.1093/jmedent/30.3.619; HINDE R, 1971, J INSECT PHYSIOL, V17, P1791, DOI 10.1016/0022-1910(71)90076-X; Horta MC, 2006, APPL ENVIRON MICROB, V72, P1705, DOI 10.1128/AEM.72.2.1705-1707.2006; ITO S, 1981, RICKETTSIAE RICKETTS, P213; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; Lawrence W, 2000, J VECTOR ECOL, V25, P98; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061; MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; Pornwiroon W, 2007, ISME J, V1, P394, DOI 10.1038/ismej.2007.38; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Raoult D, 2001, EMERG INFECT DIS, V7, P73, DOI 10.3201/eid0701.010112; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Reif KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002805; REIF KE, 2010, VECTOR BORN IN PRESS; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Sunyakumthorn P, 2008, APPL ENVIRON MICROB, V74, P3151, DOI 10.1128/AEM.00025-08; TURNER BD, 1994, INT J PEST MANAGE, V40, P179, DOI 10.1080/09670879409371879; VAUGHAN JA, 1990, ANN NY ACAD SCI, V590, P70, DOI 10.1111/j.1749-6632.1990.tb42209.x; Walker DH, 1997, LAB INVEST, V76, P129; Wedincamp J, 2000, J VECTOR ECOL, V25, P123; Wedincamp J, 2002, J VECTOR ECOL, V27, P96; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Yusuf M, 2004, J STORED PROD RES, V40, P207, DOI 10.1016/S0022-474X(02)00098-X; Zavala-Castro JE, 2005, AM J TROP MED HYG, V73, P662, DOI 10.4269/ajtmh.2005.73.662; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	45	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16396	10.1371/journal.pone.0016396	http://dx.doi.org/10.1371/journal.pone.0016396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283549	gold, Green Submitted, Green Published			2022-12-27	WOS:000286661400047
J	Dixit, P; Mukherjee, PK; Ramachandran, V; Eapen, S				Dixit, Prachy; Mukherjee, Prasun K.; Ramachandran, V.; Eapen, Susan			Glutathione Transferase from Trichoderma virens Enhances Cadmium Tolerance without Enhancing Its Accumulation in Transgenic Nicotiana tabacum	PLOS ONE			English	Article							HEAVY-METAL TOLERANCE; LIPID-PEROXIDATION; S-TRANSFERASES; STRESS; PLANTS; EXPRESSION; GENE; CHLOROPLASTS; SEEDLINGS; ENZYMES	Background: Cadmium (Cd) is a major heavy metal pollutant which is highly toxic to plants and animals. Vast agricultural areas worldwide are contaminated with Cd. Plants take up Cd and through the food chain it reaches humans and causes toxicity. It is ideal to develop plants tolerant to Cd, without enhanced accumulation in the edible parts for human consumption. Glutathione transferases (GST) are a family of multifunctional enzymes known to have important roles in combating oxidative stresses induced by various heavy metals including Cd. Some GSTs are also known to function as glutathione peroxidases. Overexpression/heterologous expression of GSTs is expected to result in plants tolerant to heavy metals such as Cd. Results: Here, we report cloning of a glutathione transferase gene from Trichoderma virens, a biocontrol fungus and introducing it into Nicotiana tabacum plants by Agrobacterium-mediated gene transfer. Transgenic nature of the plants was confirmed by Southern blot hybridization and expression by reverse transcription PCR. Transgene (TvGST) showed single gene Mendelian inheritance. When transgenic plants expressing TvGST gene were exposed to different concentrations of Cd, they were found to be more tolerant compared to wild type plants, with transgenic plants showing lower levels of lipid peroxidation. Levels of different antioxidant enzymes such as glutathione transferase, superoxide dismutase, ascorbate peroxidase, guiacol peroxidase and catalase showed enhanced levels in transgenic plants expressing TvGST compared to control plants, when exposed to Cd. Cadmium accumulation in the plant biomass in transgenic plants were similar or lower than wild-type plants. Conclusion: The results of the present study suggest that transgenic tobacco plants expressing a Trichoderma virens GST are more tolerant to Cd, without enhancing its accumulation in the plant biomass. It should be possible to extend the present results to crop plants for developing Cd tolerance and in limiting Cd availability in the food chain.	[Dixit, Prachy; Mukherjee, Prasun K.; Ramachandran, V.; Eapen, Susan] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Dixit, P (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	eapenhome@yahoo.com	Ramachandran, Vidhya/HGA-8671-2022					AEBI H, 1984, METHOD ENZYMOL, V105, P121; Apse MP, 2002, CURR OPIN BIOTECH, V13, P146, DOI 10.1016/S0958-1669(02)00298-7; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARTLING D, 1993, EUR J BIOCHEM, V216, P579, DOI 10.1111/j.1432-1033.1993.tb18177.x; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; CURTIS CR, 1971, CAN J BOTANY, V49, P333, DOI 10.1139/b71-056; DEGRAEVE N, 1981, MUTAT RES, V86, P115, DOI 10.1016/0165-1110(81)90035-X; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dominguez-Solis JR, 2004, PLANT BIOTECHNOL J, V2, P469, DOI 10.1111/j.1467-7652.2004.00092.x; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Farinati S, 2010, NEW PHYTOL, V185, P964, DOI 10.1111/j.1469-8137.2009.03132.x; Gasic K, 2007, PLANT MOL BIOL, V64, P361, DOI 10.1007/s11103-007-9158-7; HABIG WH, 1981, METHOD ENZYMOL, V77, P735; HALLIWELL B, 1987, CHEM PHYS LIPIDS, V44, P327, DOI 10.1016/0009-3084(87)90056-9; Halliwell B., 1993, FREE RADICALS BIOL M; Hasegawa I, 1997, PLANT SOIL, V196, P277, DOI 10.1023/A:1004222612602; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hegedus A, 2001, PLANT SCI, V160, P1085, DOI 10.1016/S0168-9452(01)00330-2; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KATO M, 1987, CAN J BOT, V65, P729, DOI 10.1139/b87-097; Kawashima CG, 2004, BIOTECHNOL LETT, V26, P153, DOI 10.1023/B:BILE.0000012895.60773.ff; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ning HX, 2010, BIOTECHNOL LETT, V32, P557, DOI 10.1007/s10529-009-0178-z; Payton P, 1997, PHOTOSYNTH RES, V52, P233, DOI 10.1023/A:1005873105596; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Ranieri A, 2005, PLANT PHYSIOL BIOCH, V43, P45, DOI 10.1016/j.plaphy.2004.12.004; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sanita di Toppi L, 1999, J PLANT PHYSIOL, V154, P385, DOI 10.1016/S0176-1617(99)80185-0; SENGUPTA A, 1993, PLANT PHYSIOL, V103, P1067, DOI 10.1104/pp.103.4.1067; Shah Mamta R., 2010, Physiology and Molecular Biology of Plants, V16, P39, DOI 10.1007/s12298-010-0006-x; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; WILLIAMSON G, 1987, BIOCHEM SOC T, V15, P1103, DOI 10.1042/bst0151103; Wu Q, 2011, J PLANT PHYSIOL, V168, P167, DOI 10.1016/j.jplph.2010.06.005; Zhao F, 2006, J AGR SCI-CAMBRIDGE, V144, P547, DOI 10.1017/S0021859606006411; Zhao FY, 2009, J INTEGR PLANT BIOL, V51, P942, DOI 10.1111/j.1744-7909.2009.00865.x	46	76	80	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16360	10.1371/journal.pone.0016360	http://dx.doi.org/10.1371/journal.pone.0016360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283689	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300040
J	Etchuuya, R; Ito, M; Kitano, S; Shigi, F; Sobue, R; Maeda, S				Etchuuya, Rika; Ito, Miki; Kitano, Seiko; Shigi, Fukiko; Sobue, Rina; Maeda, Sumio			Cell-to-Cell Transformation in Escherichia coli: A Novel Type of Natural Transformation Involving Cell-Derived DNA and a Putative Promoting Pheromone	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; PLASMID TRANSFORMATION; NONCONJUGATIVE PLASMIDS; HORIZONTAL TRANSFER; COLONY BIOFILM; COMPETENCE; COMPLEMENTATION; EXPRESSION; RESISTANCE; SECRETION	Escherichia coli is not assumed to be naturally transformable. However, several recent reports have shown that E. coli can express modest genetic competence in certain conditions that may arise in its environment. We have shown previously that spontaneous lateral transfer of non-conjugative plasmids occurs in a colony biofilm of mixed E. coli strains (a set of a donor strain harbouring a plasmid and a plasmid-free recipient strain). In this study, with high-frequency combinations of strains and a plasmid, we constructed the same lateral plasmid transfer system in liquid culture. Using this system, we demonstrated that this lateral plasmid transfer was DNase-sensitive, indicating that it is a kind of transformation in which DNase-accessible extracellular naked DNA is essential. However, this transformation did not occur with purified plasmid DNA and required a direct supply of plasmid from co-existing donor cells. Based on this feature, we have termed this transformation type as 'cell-to-cell transformation'. Analyses using medium conditioned with the high-frequency strain revealed that this strain released a certain factor(s) that promoted cell-to-cell transformation and arrested growth of the other strains. This factor is heat-labile and protease-sensitive, and its roughly estimated molecular mass was between similar to 9 kDa and similar to 30 kDa, indicating that it is a polypeptide factor. Interestingly, this factor was effective even when the conditioned medium was diluted 10(-5)-10(-6), suggesting that it acts like a pheromone with high bioactivity. Based on these results, we propose that cell-to-cell transformation is a novel natural transformation mechanism in E. coli that requires cell-derived DNA and is promoted by a peptide pheromone. This is the first evidence that suggests the existence of a peptide pheromone-regulated transformation mechanism in E. coli and in Gram-negative bacteria.	[Etchuuya, Rika; Ito, Miki; Kitano, Seiko; Shigi, Fukiko; Sobue, Rina; Maeda, Sumio] Nara Womens Univ, Fac Human Life & Environm, Nara 630, Japan	Nara Womens University	Etchuuya, R (corresponding author), Nara Womens Univ, Fac Human Life & Environm, Nara 630, Japan.	smaeda@cc.nara-wu.ac.jp			Japan Society for the Promotion of Science [19580089]; Institute for Fermentation, Osaka, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO))	This work was supported by a Grant-In-Aid for Scientific Research (no. 19580089) from the Japan Society for the Promotion of Science and in part by a grant from the Institute for Fermentation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2009, WORLD J MICROB BIOT, V25, P1865, DOI 10.1007/s11274-009-0070-y; Averhoff B, 2003, ARCH MICROBIOL, V180, P385, DOI 10.1007/s00203-003-0616-6; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bauer F, 1999, SYST APPL MICROBIOL, V22, P161, DOI 10.1016/S0723-2020(99)80061-7; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Bushman F., 2002, LATERAL DNA TRANSFER; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Carmen John C., 2004, Journal of Infection and Chemotherapy, V10, P193; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; DANNER DB, 1980, GENE, V11, P311, DOI 10.1016/0378-1119(80)90071-2; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Duggan PS, 2000, FEMS MICROBIOL LETT, V191, P71, DOI 10.1111/j.1574-6968.2000.tb09321.x; EKINS C, 1991, J BACTERIOL, V173, P3911; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; FOUTS KE, 1982, J BACTERIOL, V149, P106, DOI 10.1128/JB.149.1.106-113.1982; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hong XK, 1996, MOL MICROBIOL, V21, P953, DOI 10.1046/j.1365-2958.1996.591419.x; Ishimoto Y, 2008, WORLD J MICROB BIOT, V24, P2731, DOI 10.1007/s11274-008-9761-z; Keese Paul, 2008, Environmental Biosafety Research, V7, P123, DOI 10.1051/ebr:2008014; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P969, DOI 10.1016/j.fct.2008.02.007; Koch B, 2005, MICROBIOL-SGM, V151, P3589, DOI 10.1099/mic.0.27954-0; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maeda S, 2006, FEMS MICROBIOL LETT, V255, P115, DOI 10.1111/j.1574-6968.2005.00072.x; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; Maeda S., 2003, MICROBES ENV, V18, P100, DOI 10.1264/jsme2.18.100; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Manen D, 1997, GENE, V186, P197, DOI 10.1016/S0378-1119(96)00702-0; Neidhardt, 1996, ESCHERICHIA COLIAND, V2, P2460; Panja S, 2008, BIOMACROMOLECULES, V9, P2501, DOI 10.1021/bm8005215; Perez-Conesa D, 2006, J FOOD PROTECT, V69, P2947, DOI 10.4315/0362-028X-69.12.2947; Pontiroli A, 2009, APPL ENVIRON MICROB, V75, P3314, DOI 10.1128/AEM.02632-08; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Sambrook J, 1989, MOL CLONING LABORATO; SINGER M, 1989, MICROBIOL REV, V53, P1; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; Wang XJ, 2007, CURR MICROBIOL, V54, P450, DOI 10.1007/s00284-006-0617-1; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002; Zahrl D, 2006, J BACTERIOL, V188, P6611, DOI 10.1128/JB.00632-06	60	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16355	10.1371/journal.pone.0016355	http://dx.doi.org/10.1371/journal.pone.0016355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283723	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200055
J	Song, JM; Wang, BZ; Park, KM; Van Rooijen, N; Quan, FS; Kim, MC; Jin, HT; Pekosz, A; Compans, RW; Kang, SM				Song, Jae-Min; Wang, Bao-Zhong; Park, Kyoung-Mi; Van Rooijen, Nico; Quan, Fu-Shi; Kim, Min-Chul; Jin, Hyun-Tak; Pekosz, Andrew; Compans, Richard W.; Kang, Sang-Moo			Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; A VIRUS; EXTRACELLULAR DOMAIN; CONJUGATE VACCINES; RESPONSES; ANTIBODY; IMMUNOGENICITY; ECTODOMAIN; MICE; MACROPHAGES	Background: Current influenza vaccines based on the hemagglutinin protein are strain specific and do not provide good protection against drifted viruses or emergence of new pandemic strains. An influenza vaccine that can confer cross-protection against antigenically different influenza A strains is highly desirable for improving public health. Methodology/Principal Findings: To develop a cross protective vaccine, we generated influenza virus-like particles containing the highly conserved M2 protein in a membrane-anchored form (M2 VLPs), and investigated their immunogenicity and breadth of cross protection. Immunization of mice with M2 VLPs induced anti-M2 antibodies binding to virions of various strains, M2 specific T cell responses, and conferred long-lasting cross protection against heterologous and heterosubtypic influenza viruses. M2 immune sera were found to play an important role in providing cross protection against heterosubtypic virus and an antigenically distinct 2009 pandemic H1N1 virus, and depletion of dendritic and macrophage cells abolished this cross protection, providing new insight into cross-protective immune mechanisms. Conclusions/Significance: These results suggest that presenting M2 on VLPs in a membrane-anchored form is a promising approach for developing broadly cross protective influenza vaccines.	[Song, Jae-Min; Wang, Bao-Zhong; Park, Kyoung-Mi; Quan, Fu-Shi; Kim, Min-Chul; Jin, Hyun-Tak; Compans, Richard W.; Kang, Sang-Moo] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Song, Jae-Min; Wang, Bao-Zhong; Park, Kyoung-Mi; Quan, Fu-Shi; Kim, Min-Chul; Jin, Hyun-Tak; Compans, Richard W.; Kang, Sang-Moo] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Van Rooijen, Nico] Vrije Univ Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Pekosz, Andrew] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Emory University; Emory University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University	Song, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu; skang2@emory.edu	Quan, Fu-Shi/V-1826-2019; Van Rooijen, Nico/Z-1578-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X; Park, Kyoung-Mi/0000-0001-7548-8432; Wang, Bao-Zhong/0000-0002-1561-4318; Pekosz, Andrew/0000-0003-3248-1761	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI0680003]; Georgia Research Alliance; Korea Research Foundation [KRF-2007-357-C00088]	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance; Korea Research Foundation(National Research Foundation of Korea)	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant AI0680003 (R.W.C.) and partially by funds from the Georgia Research Alliance (S.M.K.) and the Korea Research Foundation Grant KRF-2007-357-C00088 (J.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Grantham ML, 2010, J VIROL, V84, P8765, DOI 10.1128/JVI.00853-10; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HEUSSER CH, 1977, J EXP MED, V145, P1316, DOI 10.1084/jem.145.5.1316; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Misplon JA, 2010, VACCINE, V28, P5817, DOI 10.1016/j.vaccine.2010.06.069; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009161; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Skountzou I, 2007, J VIROL, V81, P1083, DOI 10.1128/JVI.01692-06; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; THEPEN T, 1991, EUR J IMMUNOL, V21, P2845, DOI 10.1002/eji.1830211128; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yao QZ, 2004, J IMMUNOL, V173, P1951, DOI 10.4049/jimmunol.173.3.1951; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	53	89	97	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14538	10.1371/journal.pone.0014538	http://dx.doi.org/10.1371/journal.pone.0014538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267073	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500011
J	Yu, H; Li, Q				Yu, Hong; Li, Qi			Mutation and Selection on the Wobble Nucleotide in tRNA Anticodons in Marine Bivalve Mitochondrial Genomes	PLOS ONE			English	Article							GENETIC-CODE; EVOLUTION; POSITION; CODONS; 7-METHYLGUANOSINE; METAZOA; BIAS; DNA	Background: Animal mitochondrial genomes typically encode one tRNA for each synonymous codon family, so that each tRNA anticodon essentially has to wobble to recognize two or four synonymous codons. Several factors have been hypothesized to determine the nucleotide at the wobble site of a tRNA anticodon in mitochondrial genomes, such as the codon-anticodon adaptation hypothesis, the wobble versatility hypothesis, the translation initiation and elongation conflict hypothesis, and the wobble cost hypothesis. Principal Findings: In this study, we analyzed codon usage and tRNA anticodon wobble sites of 29 marine bivalve mitochondrial genomes to evaluate features of the wobble nucleotides in tRNA anticodons. The strand-specific mutation bias favors G and T on the H strand in all the 29 marine bivalve mitochondrial genomes. A bias favoring G and T is also visible in the third codon positions of protein-coding genes and the wobble sites of anticodons, rejecting that codon usage bias drives the wobble sites of tRNA anticodons or tRNA anticodon bias drives the evolution of codon usage. Almost all codon families (98.9%) from marine bivalve mitogenomes support the wobble versatility hypothesis. There are a few interesting exceptions involving tRNA(Trp) with an anticodon CCA fixed in Pectinoida species, tRNA(Ser) with a GCU anticodon fixed in Mytiloida mitogenomes, and the uniform anticodon CAU of tRNA(Met) translating the AUR codon family. Conclusions/Significance: These results demonstrate that most of the nucleotides at the wobble sites of tRNA anticodons in marine bivalve mitogenomes are determined by wobble versatility. Other factors such as the translation initiation and elongation conflict, and the cost of wobble translation may contribute to the determination of the wobble nucleotide in tRNA anticodons. The finding presented here provides valuable insights into the previous hypotheses of the wobble nucleotide in tRNA anticodons by adding some new evidence.	[Yu, Hong; Li, Qi] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China	Ocean University of China	Yu, H (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	qili66@ouc.edu.cn			973 Program [2010CB126406]; National Marine Public Welfare Research Program [200905020]	973 Program(National Basic Research Program of China); National Marine Public Welfare Research Program	This study was supported by research grants from 973 Program (2010CB126406), and National Marine Public Welfare Research Program (200905020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; BONITZ SG, 1980, P NATL ACAD SCI-BIOL, V77, P3167, DOI 10.1073/pnas.77.6.3167; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1991, GENETICS, V129, P897; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Kondow A, 1999, NUCLEIC ACIDS RES, V27, P2554, DOI 10.1093/nar/27.12.2554; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; Min XJ, 2007, DNA RES, V14, P201, DOI 10.1093/dnares/dsm019; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Scouras A, 2006, MOL PHYLOGENET EVOL, V39, P323, DOI 10.1016/j.ympev.2005.11.004; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; TOMITA K, 1999, CODON READING PATTER; Tomita Kozo, 1997, Nucleic Acids Symposium Series, V37, P197; Tong KL, 2004, GENE, V333, P169, DOI 10.1016/j.gene.2004.02.028; Wang XZ, 2007, GENE, V399, P11, DOI 10.1016/j.gene.2007.04.019; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2007, PLOS ONE, V2, pNIL82; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Yokobori S, 2001, J MOL EVOL, V53, P314, DOI 10.1007/s002390010221; Yokoyama Shigeyuki, 1995, P207	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16147	10.1371/journal.pone.0016147	http://dx.doi.org/10.1371/journal.pone.0016147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267462	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500042
J	Lu, Y; Bedard, N; Chevalier, S; Wing, SS				Lu, Yu; Bedard, Nathalie; Chevalier, Simone; Wing, Simon S.			Identification of Distinctive Patterns of USP19-Mediated Growth Regulation in Normal and Malignant Cells	PLOS ONE			English	Article							CDK INHIBITOR P27; UBIQUITIN LIGASE; DEUBIQUITINATING ENZYMES; PROSTATE-CANCER; MICE LACKING; G(1) PHASE; P27(KIP1); DEGRADATION; HYPERPLASIA; PROTEOLYSIS	We previously reported that the USP19 deubiquitinating enzyme positively regulates proliferation in fibroblasts by stabilizing KPC1, a ubiquitin ligase for p27(Kip1). To explore whether this role of USP19 extends to other cellular systems, we tested the effects of silencing of USP19 in several human prostate and breast models, including carcinoma cell lines. Depletion of USP19 inhibited proliferation in prostate cancer DU145, PC-3 and 22RV1 cells, which was similar to the pattern established in fibroblasts in that it was due to decreased progression from G1 to S phase and associated with a stabilization of the cyclin-dependent kinase inhibitor p27(Kip1). However, in contrast to previous findings in fibroblasts, the stabilization of p27(Kip1) upon USP19 depletion was not associated with changes in the levels of the KPC1 ligase. USP19 could also regulate the growth of immortalized MCF10A breast epithelial cells through a similar mechanism. This regulatory pattern was lost, though, in breast cancer MCF7 and MDA-MB-231 cells and in prostate carcinoma LNCaP cells. Of interest, the transformation of fibroblasts through overexpression of an oncogenic form of Ras disrupted the USP19-mediated regulation of cell growth and of levels of p27(Kip1) and KPC1. Thus, the cell context appears determinant for the ability of USP19 to regulate cell proliferation and p27(Kip1) levels. This may occur through both KPC1 dependent and independent mechanisms. Moreover, a complete loss of USP19 function on cell growth may arise as a result of oncogenic transformation of cells.	[Lu, Yu; Bedard, Nathalie; Wing, Simon S.] McGill Univ, Ctr Hlth, Res Inst, Polypeptide Lab,Dept Med, Montreal, PQ, Canada; [Chevalier, Simone] McGill Univ, Ctr Hlth, Res Inst, Div Urol,Dept Surg, Montreal, PQ, Canada	McGill University; McGill University	Lu, Y (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Polypeptide Lab,Dept Med, Montreal, PQ, Canada.	simon.wing@mcgill.ca	Wing, Simon/D-2589-2012	Wing, Simon/0000-0001-8394-7563	National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Fonds de la recherche en sante du Quebec	National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the National Cancer Institute of Canada/Canadian Cancer Society Research Institute to SSW. SSW was the recipient of a Chercheur National salary award from the Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GUAN X, 2009, J CELL MOL MED; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MCFARLANE C, 2001, CANCER RES, V70, P3329; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimada M, 2009, CANCER SCI, V100, P866, DOI 10.1111/j.1349-7006.2009.01122.x; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5	26	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15936	10.1371/journal.pone.0015936	http://dx.doi.org/10.1371/journal.pone.0015936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264218	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600013
J	Starkey, DJ; Smith, TD; Barnard, M				Starkey, David J.; Smith, Tim D.; Barnard, Michaela			Fisheries and Marine Animal Populations: Learning from the Long Term	PLOS ONE			English	Editorial Material							IMPACTS; HISTORY; SIZE		[Starkey, David J.; Barnard, Michaela] Univ Hull, Dept Hist, Kingston Upon Hull HU6 7RX, N Humberside, England; [Smith, Tim D.] Hist Marine Anim Populat, Redding, CA USA	University of Hull	Starkey, DJ (corresponding author), Univ Hull, Dept Hist, Kingston Upon Hull HU6 7RX, N Humberside, England.	d.j.starkey@hull.ac.uk						Alexander KE, 2009, FISH FISH, V10, P428, DOI 10.1111/j.1467-2979.2009.00334.x; ALLISON C, 2004, SC56O27 INT WHAL COM; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Ausubel J. H., 2008, OCEANS MANAGEMENT IN, pxix; Bannister J. L., 1981, REPORTS IWC, V31, P821; Bannister John L., 2008, P109; BARNARD MG, 2010, HMAP DATA PAGES; Barrett J, 2008, J ARCHAEOL SCI, V35, P850, DOI 10.1016/j.jas.2007.06.004; BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Bolster WJ, 2006, ENVIRON HIST-US, V11, P567; CLAESSON S, 2010, HIST ATLAS MARINE EC; Eddy TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013670; Eero M, 2007, ICES J MAR SCI, V64, P1257, DOI 10.1093/icesjms/fsm114; Enghoff IB, 2007, FISH RES, V87, P167, DOI 10.1016/j.fishres.2007.03.004; Enghoff Inge Bodker, 1999, Archaeofauna, V8, P41; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; FRANCIS RC, 2001, EXPLOITED SEAS NEW D, P123; Gaumiga R, 2007, FISH RES, V87, P120, DOI 10.1016/j.fishres.2007.04.003; Goode G., 1887, FISHERIES FISHERY IN, P3; HOLM P, 1998, N ATLANTIC FISHERIES; HOLM P, 1999, HIST MARINE ANIMAL P; HOLM P, 1999, SJOEKLEN, V1998, P9; HOLM P, 1999, TECHNOLOGICAL CHANGE; HOLM P, 1996, N ATLANTIC FISHERIES; Holm Poul, 2001, EXPLOITED SEAS NEW D; Hope P. L., 1991, REPORTS INT WHALING, V41, P273; HUTCHINGS JA, 1995, ISL LIV SER, V3, P37; Jackson J, 2009, TAKING STOCK H UNPUB, P1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Josephson E, 2008, FISH FISH, V9, P155, DOI 10.1111/j.1467-2979.2008.00275.x; Josephson Elizabeth A., 2008, P133; Kingsland S. E., 1985, MODELING NATURE EPIS; Laake J., 2009, NMFSAFSC203 NOAA DEP; Lajus J, 2007, FISH RES, V87, P126, DOI 10.1016/j.fishres.2007.07.004; LUND JN, 2010, AM OFFSHORE WHALING; MACKENZIE BR, 2010, PLOS ONE HM IN PRESS; Manez KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011346; MARBOE AH, 2010, HMAP IMAGE GALLERY; MARGALEF R, 1960, P WORLD M BIOL SARD, P1265; Marquardt Ole, 1999, SEALING FISHING SOCI; MUNIZ AM, 1996, ARCHAEOFAUNA, V5, P13; O'Dor R.K., 2003, Gayana (Concepc.), V67, P145; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; POULSEN B, 2008, DUTCH HERRING HIST A; Poulsen B, 2007, FISH RES, V87, P181, DOI 10.1016/j.fishres.2007.07.014; Poulsen R. T., 2007, ENV HIST N SEA LING; Punt Andre E., 2006, Journal of Cetacean Research and Management, V8, P145; Reeves R. R., 2010, US NMFS MAR FISH REV, V72, P26; Reeves R. R., 2010, MAR FISH REV, V72, P1; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; Reeves Randall R., 2007, P39; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Rozwadowski H. M., 2002, SEA KNOWS BOUNDARIES; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; Smith T. D., 1994, SCALING FISHERIES SC; SMITH TD, COMPILERS WHALE CHAR; SMITH TD, 2010, WHALING HIST, V3, P85; Smith TD, 2010, MAR FISH REV, V72, P1; Smith Tim D., 2008, P149; Smith Tim D., 2009, NAMMCO Scientific Publications, V7, P161; SOUTAR A, 1969, CALIFORNIA COOPERATI, V13, P63; Starkey David J, 2000, ENGLANDS SEA FISHERI; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; TILLMAN M, 1983, HIST WHALING RECORDS; VICKERS D, 1995, MARINE RESOURCES HUM; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295	70	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16011	10.1371/journal.pone.0016011	http://dx.doi.org/10.1371/journal.pone.0016011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249209	Green Published, Green Submitted, gold			2022-12-27	WOS:000286512900017
J	Sugawara, M; Ohye, H; Tomoda, C; Kogai, T; Kamata, Y; Pezeshkpour, GH; Moatamed, F				Sugawara, Masahiro; Ohye, Hidemi; Tomoda, Chisato; Kogai, Takahiko; Kamata, Yoshimasa; Pezeshkpour, Gholam H.; Moatamed, Farhad			A Novel Role for Niemann-Pick Disease Type 2C Protein in Papillae Formation	PLOS ONE			English	Article							APOPTOSIS; NPC2	Background: Despite the presence of papillary structures and papillary tumors in humans, the mechanism of papillae formation is unknown. We describe herein a novel role for Niemann-Pick disease type 2C (NPC2) protein, a cholesterol binding protein in the lysosome, in papillae formation. Methodology/Principal Finding: We examined NPC2 protein expression in surgical samples of papillary tissues by immunohistochemical stain, and all papillary tissues expressed NPC2 protein in the epithelium. To examine our hypothesis of NPC2 protein-mediated papillae formation, we carried out xenograft experiments using wild H460 cells (large cell lung carcinoma cell line) that constitutively expressed abundant NPC2 protein and NPC2 protein-depleted H460 cells by NPC2 shRNA. The xenografts of wild H460 cells and empty shRNA vector cells showed distinct papillae formation, whereas NPC2 protein-depleted H460 cells displayed markedly reduced or no papillae. Since all papillary tissues have open spaces we examined whether NPC2 protein might also contribute to the creation of open spaces. The TUNEL assay in the xenografts of wild and empty shRNA vector H460 cells showed massive cell death, and NPC2 protein-depleted cells displayed minimal cell death. Measurement of caspase 3/7 activities in cultured H460 cells supported NPC2 protein-mediated apoptotic cell death. The presence of excess NPC2 protein, however, did not always produce papillae as seen in the xenografts of CHO cells that were stably transfected with NPC2. Conclusions/Significance: The NPC2 protein of certain cells forms papillae coupled with apoptosis that creates open space. This protein may have future applications to modulate papillae formation and papillary growth in tumor tissues.	[Sugawara, Masahiro; Ohye, Hidemi; Tomoda, Chisato; Kogai, Takahiko] Univ Calif Los Angeles, David Geffen Sch Med, Endocrinol & Diabet Div, Dept Med,Vet Affairs Greater Los Angeles Hlth Car, Los Angeles, CA 90095 USA; [Sugawara, Masahiro] Univ Calif Los Angeles, David Geffen Sch Med, Primary Care Serv, Dept Med,Vet Affairs Greater Los Angeles Hlth Car, Los Angeles, CA 90095 USA; [Kamata, Yoshimasa] Hirosaki Univ, Sch Med, Dept Pathol, Hirosaki, Aomori 036, Japan; [Pezeshkpour, Gholam H.; Moatamed, Farhad] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hirosaki University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Sugawara, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Endocrinol & Diabet Div, Dept Med,Vet Affairs Greater Los Angeles Hlth Car, Los Angeles, CA 90095 USA.	msugawar@ucla.edu			Veterans Affairs	Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Veterans Affairs Merit Review grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asakawa JI, 2002, ENDOCRINOLOGY, V143, P4422, DOI 10.1210/en.2002-220550; Kurz T, 2010, ANTIOXID REDOX SIGN, V13, P511, DOI 10.1089/ars.2009.3005; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Willenborg M, 2005, J LIPID RES, V46, P2559, DOI 10.1194/jlr.M500131-JLR200	8	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15777	10.1371/journal.pone.0015777	http://dx.doi.org/10.1371/journal.pone.0015777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253586	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900010
J	Evans, D; McGreevy, P				Evans, David; McGreevy, Paul			An Investigation of Racing Performance and Whip Use by Jockeys in Thoroughbred Races	PLOS ONE			English	Article								Concerns have been expressed concerning animal-welfare issues associated with whip use during Thoroughbred races. However, there have been no studies of relationships between performance and use of whips in Thoroughbred racing. Our aim was to describe whip use and the horses' performance during races, and to investigate associations between whip use and racing performance. Under the Australian Racing Board (ARB) rules, only horses that are in contention can be whipped, so we expected that whippings would be associated with superior performance, and those superior performances would be explained by an effect of whipping on horse velocities in the final 400 m of the race. We were also interested to determine whether performance in the latter sections of a race was associated with performance in the earlier sections of a race. Measurements of whip strikes and sectional times during each of the final three 200 metre (m) sections of five races were analysed. Jockeys in more advanced placings at the final 400 and 200 m positions in the races whipped their horses more frequently. Horses, on average, achieved highest speeds in the 600 to 400 m section when there was no whip use, and the increased whip use was most frequent in the final two 200 m sections when horses were fatigued. This increased whip use was not associated with significant variation in velocity as a predictor of superior placing at the finish.	[Evans, David; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Evans, D (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	paul.mcgreevy@sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378				Australian Racing Board, 2009, AUSTR RUL RAC; Brisbane Racing Club, 2010, TRACK RAT; British Horseracing Authority, 2009, RAC MAN B SCH 6 CAUS; Deuel N.R., 1987, P EQ NUTR PHYS S, V10, P487; HARRIS RC, 1987, J APPL PHYSIOL, V63, P12, DOI 10.1152/jappl.1987.63.1.12; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; McGreevy PD, 2007, J VET BEHAV, V2, P108, DOI 10.1016/j.jveb.2007.05.003; McLean A., 2008, ACAD HORSE TRAINING; Racing Victoria, 2009, PADD WHIP SPEC	9	33	33	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15622	10.1371/journal.pone.0015622	http://dx.doi.org/10.1371/journal.pone.0015622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21283587	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900015
J	Dwivedi, P; Thompson, A; Xie, ZH; Kashleva, H; Ganguly, S; Mitchell, AP; Dongari-Bagtzoglou, A				Dwivedi, Prabhat; Thompson, Angela; Xie, Zhihong; Kashleva, Helena; Ganguly, Shantanu; Mitchell, Aaron P.; Dongari-Bagtzoglou, Anna			Role of Bcr1-Activated Genes Hwp1 and Hyr1 in Candida Albicans Oral Mucosal Biofilms and Neutrophil Evasion	PLOS ONE			English	Article							TRANSGLUTAMINASE SUBSTRATE; MODEL; MANIFESTATIONS; RESPONSES; ADHESIN; GOVERN; THRUSH; ALS3P	Candida albicans triggers recurrent infections of the oropharyngeal mucosa that result from biofilm growth. Prior studies have indicated that the transcription factor Bcr1 regulates biofilm formation in a catheter model, both in vitro and in vivo. We thus hypothesized that Bcr1 plays similar roles in the formation of oral mucosal biofilms and tested this hypothesis in a mouse model of oral infection. We found that a bcr1/bcr1 mutant did not form significant biofilm on the tongues of immunocompromised mice, in contrast to reference and reconstituted strains that formed pseudomembranes covering most of the tongue dorsal surface. Overexpression of HWP1, which specifies an epithelial adhesin that is under the transcriptional control of Bcr1, partly but significantly rescued the bcr1/bcr1 biofilm phenotype in vivo. Since HWP1 overexpression only partly reversed the biofilm phenotype, we investigated whether additional mechanisms, besides adhesin down-regulation, were responsible for the reduced virulence of this mutant. We discovered that the bcr1/bcr1 mutant was more susceptible to damage by human leukocytes when grown on plastic or on the surface of a human oral mucosa tissue analogue. Overexpression of HYR1, but not HWP1, significantly rescued this phenotype. Furthermore a hyr1/hyr1 mutant had significantly attenuated virulence in the mouse oral biofilm model of infection. These discoveries show that Bcr1 is critical for mucosal biofilm infection via regulation of epithelial cell adhesin and neutrophil function.	[Dwivedi, Prabhat] Univ Texas, Dept Microbiol, Houston, TX 77030 USA; [Thompson, Angela; Xie, Zhihong; Kashleva, Helena; Dongari-Bagtzoglou, Anna] Univ Connecticut, Sch Dent Med, Div Periodontol, Farmington, CT 06032 USA; [Ganguly, Shantanu; Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	University of Texas System; University of Connecticut; Carnegie Mellon University	Dwivedi, P (corresponding author), Univ Texas, Dept Microbiol, Houston, TX 77030 USA.	adongari@uchc.edu	XIE, Zhihong/B-2968-2011	Mitchell, Aaron/0000-0002-0868-4000	National Institutes of Health [RO1DE013986, RO1DE013986-08S1, R01AI067703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported by National Institutes of Health grants RO1DE013986, RO1DE013986-08S1 (ADB) and R01AI067703 (APM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Brent NB, 2001, CLIN PEDIATR, V40, P503, DOI 10.1177/000992280104000905; Cheng SJ, 2003, MOL MICROBIOL, V48, P1275, DOI 10.1046/j.1365-2958.2003.03521.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coogan M M, 2006, Adv Dent Res, V19, P130; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Deconinck S, 2003, BRIT J GEN PRACT, V53, P130; Dongari-Bagtzoglou A, 2005, MED MYCOL, V43, P545, DOI 10.1080/13693780500064557; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Fonseca R, 2000, QUINTESSENCE INT, V31, P419; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Green CB, 2004, MICROBIOL-SGM, V150, P267, DOI 10.1099/mic.0.26699-0; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; HOLMSTRUP P, 1990, ACTA ODONTOL SCAND, V48, P57, DOI 10.3109/00016359009012734; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Nicolatou-Galitis O, 2001, J ORAL PATHOL MED, V30, P471, DOI 10.1034/j.1600-0714.2001.030008471.x; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Ricicova M, 2010, MICROBIOL-SGM, V156, P909, DOI 10.1099/mic.0.033530-0; Scaramuzzino DA, 2000, INFECT IMMUN, V68, P2880, DOI 10.1128/IAI.68.5.2880-2887.2000; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836; THOMAS D, 2006, PROTEOMICS, V6, P1; Tsuchimori N, 2000, INFECT IMMUN, V68, P1997, DOI 10.1128/IAI.68.4.1997-2002.2000; Villar CC, 2004, ORAL MICROBIOL IMMUN, V19, P262, DOI 10.1111/j.1399-302X.2004.00150.x; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	39	66	70	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16218	10.1371/journal.pone.0016218	http://dx.doi.org/10.1371/journal.pone.0016218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283544	gold, Green Published, Green Submitted			2022-12-27	WOS:000286661400035
J	Sarup, P; Sorensen, JG; Kristensen, TN; Hoffmann, AA; Loeschcke, V; Paige, KN; Sorensen, P				Sarup, Pernille; Sorensen, Jesper G.; Kristensen, Torsten N.; Hoffmann, Ary A.; Loeschcke, Volker; Paige, Ken N.; Sorensen, Peter			Candidate Genes Detected in Transcriptome Studies Are Strongly Dependent on Genetic Background	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; EXPRESSION; RESISTANCE; IDENTIFICATION; VALIDATION	Whole genome transcriptomic studies can point to potential candidate genes for organismal traits. However, the importance of potential candidates is rarely followed up through functional studies and/or by comparing results across independent studies. We have analysed the overlap of candidate genes identified from studies of gene expression in Drosophila melanogaster using similar technical platforms. We found little overlap across studies between putative candidate genes for the same traits in the same sex. Instead there was a high degree of overlap between different traits and sexes within the same genetic backgrounds. Putative candidates found using transcriptomics therefore appear very sensitive to genetic background and this can mask or override effects of treatments. The functional importance of putative candidate genes emerging from transcriptome studies needs to be validated through additional experiments and in future studies we suggest a focus on the genes, networks and pathways affecting traits in a consistent manner across backgrounds.	[Sarup, Pernille; Kristensen, Torsten N.; Loeschcke, Volker] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark; [Sorensen, Jesper G.] Aarhus Univ, Dept Terr Ecol, Natl Environm Res Inst, Silkeborg, Denmark; [Kristensen, Torsten N.; Sorensen, Peter] Aarhus Univ, Dept Genet & Biotechnol, Danish Inst Agr Sci, Tjele, Denmark; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Hoffmann, Ary A.] Univ Melbourne, Ctr Environm Stress & Adaptat Res, Melbourne, Vic, Australia; [Paige, Ken N.] Univ Illinois, Dept Anim Biol, Sch Integrat Biol, Urbana, IL 61801 USA	Aarhus University; Aarhus University; Aarhus University; University of Melbourne; University of Melbourne; University of Illinois System; University of Illinois Urbana-Champaign	Sarup, P (corresponding author), Aarhus Univ, Dept Biol Sci, Aarhus, Denmark.	pernille.sarup@biology.au.dk	Hoffmann, Ary/C-2961-2011; Sørensen, Jesper Givskov/J-3190-2013; Kristensen, Torsten N/C-5031-2015; Sarup, Pernille/B-8632-2014; Hoffmann, Ary/R-2972-2019; Sarup, Pernille/AAY-2230-2020; Loeschcke, Volker/J-2527-2013	Sørensen, Jesper Givskov/0000-0002-9149-3626; Kristensen, Torsten N/0000-0001-6204-8753; Sarup, Pernille/0000-0002-5838-1251; Hoffmann, Ary/0000-0001-9497-7645; Loeschcke, Volker/0000-0003-1450-0754	Danish Natural Research Council; Villum Foundation; Carlsberg Foundation	Danish Natural Research Council(Danish Natural Science Research Council); Villum Foundation(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation)	Funding was provided by The Danish Natural Research Council (VL, TNK), the Villum Foundation (VL), and the Carlsberg Foundation (JGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroles JF, 2009, CONSERV BIOL, V23, P920, DOI 10.1111/j.1523-1739.2009.01186.x; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Edwards AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r76; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Hughes KA, 2006, GENETICS, V173, P1347, DOI 10.1534/genetics.105.051474; Jumbo-Lucioni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-297; Kottapalli KR, 2007, MOL CELLS, V24, P394; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Morozova TV, 2009, GENETICS, V183, P733, DOI 10.1534/genetics.109.107490; Paige KN, 2010, BIOSCIENCE, V60, P267, DOI 10.1525/bio.2010.60.4.5; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Schweiger W, 2010, MOL PLANT MICROBE IN, V23, P977, DOI 10.1094/MPMI-23-7-0977; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Williams LM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-282; Williams NS, 2003, CLIN CANCER RES, V9, P931; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b	24	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15644	10.1371/journal.pone.0015644	http://dx.doi.org/10.1371/journal.pone.0015644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283582	gold, Green Published			2022-12-27	WOS:000286661400010
J	Waller, RG; Scanlon, KM; Robinson, LF				Waller, Rhian G.; Scanlon, Kathryn M.; Robinson, Laura F.			Cold-Water Coral Distributions in the Drake Passage Area from Towed Camera Observations - Initial Interpretations	PLOS ONE			English	Article							BIOLOGY; DEEP; REGION; REEFS	Seamounts are unique deep-sea features that create habitats thought to have high levels of endemic fauna, productive fisheries and benthic communities vulnerable to anthropogenic impacts. Many seamounts are isolated features, occurring in the high seas, where access is limited and thus biological data scarce. There are numerous seamounts within the Drake Passage (Southern Ocean), yet high winds, frequent storms and strong currents make seafloor sampling particularly difficult. As a result, few attempts to collect biological data have been made, leading to a paucity of information on benthic habitats or fauna in this area, particularly those on primarily hard-bottom seamounts and ridges. During a research cruise in 2008 six locations were examined (two on the Antarctic margin, one on the Shackleton Fracture Zone, and three on seamounts within the Drake Passage), using a towed camera with onboard instruments to measure conductivity, temperature, depth and turbidity. Dominant fauna and bottom type were categorized from 200 randomized photos from each location. Cold-water corals were present in high numbers in habitats both on the Antarctic margin and on the current swept seamounts of the Drake Passage, though the diversity of orders varied. Though the Scleractinia (hard corals) were abundant on the sedimented margin, they were poorly represented in the primarily hard-bottom areas of the central Drake Passage. The two seamount sites and the Shackleton Fracture Zone showed high numbers of stylasterid (lace) and alcyonacean (soft) corals, as well as large numbers of sponges. Though data are preliminary, the geological and environmental variability (particularly in temperature) between sample sites may be influencing cold-water coral biogeography in this region. Each area observed also showed little similarity in faunal diversity with other sites examined for this study within all phyla counted. This manuscript highlights how little is understood of these isolated features, particularly in Polar regions.	[Waller, Rhian G.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Scanlon, Kathryn M.] US Geol Survey, Woods Hole, MA 02543 USA; [Robinson, Laura F.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; United States Geological Survey; Woods Hole Oceanographic Institution	Waller, RG (corresponding author), Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA.	rhian.waller@maine.edu		Robinson, Laura/0000-0001-6811-0140	National Science Foundation [ANT0636787]; CenSeam; University of Hawaii at Manoa; Office of Polar Programs (OPP) [1127582] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); CenSeam; University of Hawaii at Manoa; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the National Science Foundation's Antarctic Earth Sciences Program (ANT0636787 awarded to LFR and RGW) and a CenSeam minigrant (awarded to RGW), and RGW is supported by a SOEST Young Investigator Fellowship from the University of Hawaii at Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; CAIRNS SD, 1990, SYNOPSIS ANTARCTIC B, V1; Cairns Stephen D., 1992, Scientia Marina, V56, P125; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; CLARKE A, 1989, GEOLOGICAL SOC SPECI, V47, P253; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; Daniel J., 2003, EOS T AM GEOPHYS UN, V84, P69, DOI [DOI 10.1029/2003E0080001, 10.1029/2003EO080001, DOI 10.1029/2003EO080001]; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; Haussermann V, 2007, POLAR BIOL, V30, P487, DOI 10.1007/s00300-006-0207-5; HEIFETZ J, 2007, DEEP SEA CORAL DISTR; Huber Brian T., 1992, Antarctic Research Series, V56, P31; Kleypas J., 2006, IMPACTS OCEAN ACIDIF; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Lipps J., 1982, ENV DEEP SEA, P324; Livermore R, 2005, EARTH PLANET SC LETT, V236, P459, DOI 10.1016/j.epsl.2005.03.027; MacIntyre I.G., 2000, ATOLL RES BULL, V466, P1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROGERS AD, 2007, SEAMOUNTS ECOLOGY FI, P141; Rutzler K., 2002, Acta Geologica Hispanica, V37, P61; Stocks K. I., 2007, SEAMOUNTS ECOLOGY FI, P255; STOCKS KI, 2004, P COL OC DAT S BRUSS, P77; Thomson MRA, 2004, DEEP-SEA RES PT II, V51, P1467, DOI 10.1016/j.dsr2.2004.06.021; Wilson RR, 1987, GEOPHYS MONOGR SER, P355, DOI DOI 10.1029/GM043P0355	26	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16153	10.1371/journal.pone.0016153	http://dx.doi.org/10.1371/journal.pone.0016153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283585	gold, Green Published, Green Submitted			2022-12-27	WOS:000286661400030
J	Bilalic, M; Kiesel, A; Pohl, C; Erb, M; Grodd, W				Bilalic, Merim; Kiesel, Andrea; Pohl, Carsten; Erb, Michael; Grodd, Wolfgang			It Takes Two-Skilled Recognition of Objects Engages Lateral Areas in Both Hemispheres	PLOS ONE			English	Article							ANTERIOR INFEROTEMPORAL CORTEX; EXPERT CHESS PLAYERS; NEURAL BASIS; DELIBERATE PRACTICE; MEMORY; PARIETAL; MECHANISMS; KNOWLEDGE; REGIONS; TASK	Our object recognition abilities, a direct product of our experience with objects, are fine-tuned to perfection. Left temporal and lateral areas along the dorsal, action related stream, as well as left infero-temporal areas along the ventral, object related stream are engaged in object recognition. Here we show that expertise modulates the activity of dorsal areas in the recognition of man-made objects with clearly specified functions. Expert chess players were faster than chess novices in identifying chess objects and their functional relations. Experts' advantage was domain-specific as there were no differences between groups in a control task featuring geometrical shapes. The pattern of eye movements supported the notion that experts' extensive knowledge about domain objects and their functions enabled superior recognition even when experts were not directly fixating the objects of interest. Functional magnetic resonance imaging (fMRI) related exclusively the areas along the dorsal stream to chess specific object recognition. Besides the commonly involved left temporal and parietal lateral brain areas, we found that only in experts homologous areas on the right hemisphere were also engaged in chess specific object recognition. Based on these results, we discuss whether skilled object recognition does not only involve a more efficient version of the processes found in non-skilled recognition, but also qualitatively different cognitive processes which engage additional brain areas.	[Bilalic, Merim; Erb, Michael] Univ Tubingen, Dept Neuroradiol, D-7400 Tubingen, Germany; [Kiesel, Andrea; Pohl, Carsten] Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [Grodd, Wolfgang] Univ Aachen, Clin Psychiat & Psychotherapy, D-5100 Aachen, Germany	Eberhard Karls University of Tubingen; University of Wurzburg; RWTH Aachen University	Bilalic, M (corresponding author), Univ Tubingen, Dept Neuroradiol, D-7400 Tubingen, Germany.	merim.bilalic@med.uni-tuebingen.de	Kiesel, Andrea/G-3840-2016; Steyaert, Tine/ABC-5521-2021; Kiesel, Andrea/AAX-5703-2020	Kiesel, Andrea/0000-0001-5564-010X; Kiesel, Andrea/0000-0001-5564-010X; Erb, Michael/0000-0002-9311-4693; Lauwereyns, Jan/0000-0003-0551-2550	Deutsche Forschungsgemeinschaft [DFG-Gr 833/8-1, Bi 1450/1-2, Ki-1388/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG-Gr 833/8-1, Bi 1450/1-2, and Ki-1388/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; Bilalic M, 2008, COGNITION, V108, P652, DOI 10.1016/j.cognition.2008.05.005; Bilalic M, 2008, COGNITIVE PSYCHOL, V56, P73, DOI 10.1016/j.cogpsych.2007.02.001; Bilalic M, 2007, INTELLIGENCE, V35, P457, DOI 10.1016/j.intell.2006.09.005; Bilalic M, 2010, J EXP PSYCHOL GEN, V139, P728, DOI 10.1037/a0020756; Bilalic M, 2009, COGNITIVE SCI, V33, P1117, DOI 10.1111/j.1551-6709.2009.01030.x; Boronat CB, 2005, COGNITIVE BRAIN RES, V23, P361, DOI 10.1016/j.cogbrainres.2004.11.001; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Brambati SM, 2006, J COGNITIVE NEUROSCI, V18, P1644, DOI 10.1162/jocn.2006.18.10.1644; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Campitelli G, 2008, INT J NEUROSCI, V118, P191, DOI 10.1080/00207450701668053; Campitelli G, 2007, INT J NEUROSCI, V117, P1641, DOI 10.1080/00207450601041955; Campitelli G, 2005, SPAN J PSYCHOL, V8, P238, DOI 10.1017/S1138741600005126; Campitelli G, 2008, LEARN INDIVID DIFFER, V18, P446, DOI 10.1016/j.lindif.2007.11.006; Canessa N, 2008, CEREB CORTEX, V18, P740, DOI 10.1093/cercor/bhm110; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Charness N, 2005, APPL COGNITIVE PSYCH, V19, P151, DOI 10.1002/acp.1106; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Elo A. E., 1978, RATING CHESSPLAYERS; Ericsson KA, 2009, ANN NY ACAD SCI, V1172, P199, DOI 10.1196/annals.1393.001; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gobet F, 2001, TRENDS COGN SCI, V5, P236, DOI 10.1016/S1364-6613(00)01662-4; Gobet F, 1998, MEMORY, V6, P225, DOI 10.1080/741942359; Gobet F, 2004, MOVES IN MIND: THE PSYCHOLOGY OF BOARD GAMES; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Groot de, 1978, THOUGHT CHOICE CHESS; Helton WS, 2010, NEUROPSYCHOLOGIA, V48, P1683, DOI 10.1016/j.neuropsychologia.2010.02.014; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Henson R, 2006, CORTEX, V42, P387, DOI 10.1016/S0010-9452(08)70365-4; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kellenbach ML, 2003, J COGNITIVE NEUROSCI, V15, P30, DOI 10.1162/089892903321107800; Kiesel A, 2009, J EXP PSYCHOL LEARN, V35, P292, DOI 10.1037/a0014499; Levy I, 2004, HUM BRAIN MAPP, V22, P15, DOI 10.1002/hbm.20010; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Liederman J, 1998, BRAIN COGNITION, V36, P193, DOI 10.1006/brcg.1997.0952; LUCK SJ, 1989, NATURE, V342, P543, DOI 10.1038/342543a0; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McGregor SJ, 2002, MEM COGNITION, V30, P707, DOI 10.3758/BF03196427; Miceli G, 2001, NAT NEUROSCI, V4, P662, DOI 10.1038/88497; Mill JS., 1884, SYSTEM LOGIC, V1; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Noppeney U, 2006, CEREB CORTEX, V16, P437, DOI 10.1093/cercor/bhi123; Noppeney U, 2008, J PHYSIOL-PARIS, V102, P40, DOI 10.1016/j.jphysparis.2008.03.009; Palmeri TJ, 2004, NAT REV NEUROSCI, V5, P291, DOI 10.1038/nrn1364; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; Poldrack RA, 2009, SOC COGN AFFECT NEUR, V4, P208, DOI 10.1093/scan/nsp011; Popper K., 1968, SYST ZOOL; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Reingold EM, 2001, PSYCHON B REV, V8, P504, DOI 10.3758/BF03196185; REINGOLD EM, OXFORD HDB E INPRESS; Reingold EM, 2005, COGNITIVE PROCESS, P325, DOI DOI 10.1093/ACPR0F:0S0/9780198566816.003.0014; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; SAARILUOMA P, 1990, LINES OF THINKING : REFLECTIONS ON THE PSYCHOLOGY OF THOUGHT, VOL 2, P41; Saariluoma P., 1995, CHESS PLAYERS THINKI; Saleem KS, 2000, J NEUROSCI, V20, P5083; Scalf PE, 2007, J EXP PSYCHOL HUMAN, V33, P298, DOI 10.1037/0096-1523.33.2.298; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Tranel D, 2005, BRAIN LANG, V92, P288, DOI 10.1016/j.bandl.2004.01.011; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VANKLEECK MH, 1989, NEUROPSYCHOLOGIA, V27, P1179, DOI 10.1016/0028-3932(89)90100-0; VANKLEECK MH, 1989, NEUROPSYCHOLOGIA, V27, P1165, DOI 10.1016/0028-3932(89)90099-7; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Weissman DH, 2000, NEUROPSYCHOLOGY, V14, P41, DOI 10.1037/0894-4105.14.1.41; Zhong YM, 2003, CEREB CORTEX, V13, P527, DOI 10.1093/cercor/13.5.527	78	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16202	10.1371/journal.pone.0016202	http://dx.doi.org/10.1371/journal.pone.0016202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710PJ	21283683	Green Published, gold			2022-12-27	WOS:000286523400026
J	Ho, MCW; Schiller, BJ; Akbari, OS; Bae, E; Drewell, RA				Ho, Margaret C. W.; Schiller, Benjamin J.; Akbari, Omar S.; Bae, Esther; Drewell, Robert A.			Disruption of the Abdominal-B Promoter Tethering Element Results in a Loss of Long-Range Enhancer-Directed Hox Gene Expression in Drosophila	PLOS ONE			English	Article							BITHORAX-COMPLEX; ANTENNAPEDIA COMPLEX; REGULATORY LANDSCAPE; MELANOGASTER; BOUNDARIES; EMBRYO; REGION; DOMAIN; LOCUS; DNA	There are many examples within gene complexes of transcriptional enhancers interacting with only a subset of target promoters. A number of molecular mechanisms including promoter competition, insulators and chromatin looping are thought to play a role in regulating these interactions. At the Drosophila bithorax complex (BX-C), the IAB5 enhancer specifically drives gene expression only from the Abdominal-B (Abd-B) promoter, even though the enhancer and promoter are 55 kb apart and are separated by at least three insulators. In previous studies, we discovered that a 255 bp cis-regulatory module, the promoter tethering element (PTE), located 59 of the Abd-B transcriptional start site is able to tether IAB5 to the Abd-B promoter in transgenic embryo assays. In this study we examine the functional role of the PTE at the endogenous BX-C using transposon-mediated mutagenesis. Disruption of the PTE by P element insertion results in a loss of enhancer-directed Abd-B expression during embryonic development and a homeotic transformation of abdominal segments. A partial deletion of the PTE and neighboring upstream genomic sequences by imprecise excision of the P element also results in a similar loss of Abd-B expression in embryos. These results demonstrate that the PTE is an essential component of the regulatory network at the BX-C and is required in vivo to mediate specific long-range enhancer-promoter interactions.	[Ho, Margaret C. W.; Schiller, Benjamin J.; Akbari, Omar S.; Drewell, Robert A.] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Bae, Esther] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA	Claremont Colleges; Harvey Mudd College; Western University of Health Sciences	Ho, MCW (corresponding author), Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA.	drewell@hmc.edu		Akbari, Omar/0000-0002-6853-9884; Ho, Margaret/0000-0002-2007-2226	National Institutes of Health [NIH-HD54977]; National Science Foundation [IOS-0845103]; Howard Hughes Medical Institute [520051213]; Merck-American Association for the Advancement of Science (AAAS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD054977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Merck-American Association for the Advancement of Science (AAAS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research in this paper was supported by funding to R.A.D. from the National Institutes of Health (NIH-HD54977) and the National Science Foundation (IOS-0845103) and a Howard Hughes Medical Institute Undergraduate Science Education Program grant (520051213) to the Biology department at Harvey Mudd College. M.C.W.H. received support from the Merck-American Association for the Advancement of Science (AAAS) Undergraduate Science Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari OS, 2007, FLY, V1, P337, DOI 10.4161/fly.5607; Akbari OS, 2008, DEVELOPMENT, V135, P123, DOI 10.1242/dev.010744; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BOULET AM, 1991, DEVELOPMENT, V111, P393; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Cande JD, 2009, DEVELOPMENT, V136, P3153, DOI 10.1242/dev.038034; CAPLAN AI, 1978, SCIENCE, V201, P120, DOI 10.1126/science.351805; CASANOVA J, 1986, CELL, V47, P627, DOI 10.1016/0092-8674(86)90627-6; Celniker SE, 2007, BIOESSAYS, V29, P7, DOI 10.1002/bies.20520; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; de Navas L, 2006, MECH DEVELOP, V123, P860, DOI 10.1016/j.mod.2006.07.010; DELORENZI M, 1990, DEVELOPMENT, V108, P323; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Estrada B, 2002, DEVELOPMENT, V129, P5195; Fujioka M, 2009, DEVELOPMENT, V136, P3077, DOI 10.1242/dev.036467; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; Kwon D, 2009, DEVELOPMENT, V136, P3067, DOI 10.1242/dev.036426; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin O, 2003, DEVELOPMENT, V130, P519, DOI 10.1242/dev.00227; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3237, DOI 10.1073/pnas.0605730104; MACIAS A, 1990, DEVELOPMENT, V110, P1197; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; Mihaly J, 1998, CELL MOL LIFE SCI, V54, P60, DOI 10.1007/s000180050125; Mihaly J, 2006, DEVELOPMENT, V133, P2983, DOI 10.1242/dev.02451; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Perez-Lluch S, 2008, NUCLEIC ACIDS RES, V36, P6926, DOI 10.1093/nar/gkn818; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; SANCHEZHERRERO E, 1988, EMBO J, V7, P2163, DOI 10.1002/j.1460-2075.1988.tb03055.x; Sipos L, 2005, FEBS J, V272, P3253, DOI 10.1111/j.1742-4658.2005.04757.x; Sipos L, 1998, GENETICS, V149, P1031; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; ZELLER RW, 1995, P NATL ACAD SCI USA, V92, P2989, DOI 10.1073/pnas.92.7.2989; Zhou JM, 1999, DEVELOPMENT, V126, P3057	48	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16283	10.1371/journal.pone.0016283	http://dx.doi.org/10.1371/journal.pone.0016283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283702	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522300030
J	Tang, CSM; Tang, WK; So, MT; Miao, XP; Leung, BMC; Yip, BHK; Leon, TYY; Ngan, ESW; Lui, VCH; Chen, Y; Chan, IHY; Chung, PHY; Liu, XL; Wu, XZ; Wong, KKY; Sham, PC; Cherny, SS; Tam, PKH; Garcia-Barcelo, MM				Tang, Clara Sze-Man; Tang, Wai-Kiu; So, Man-Ting; Miao, Xiao-Ping; Leung, Brian Man-Chun; Yip, Benjamin Hon-Kei; Leon, Thomas Yuk-Yu; Ngan, Elly Sau-Wai; Lui, Vincent Chi-Hang; Chen, Yan; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Wu, Xuan-Zhao; Wong, Kenneth Kak-Yuen; Sham, Pak-Chung; Cherny, Stacey S.; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce			Fine Mapping of the NRG1 Hirschsprung's Disease Locus	PLOS ONE			English	Article							RET PROTOONCOGENE; NERVOUS-SYSTEM; MUTATIONS; GENE; NEUREGULIN-1; EXPRESSION; SCHIZOPHRENIA; ASSOCIATION; MAINTENANCE; COMMON	The primary pathology of Hirschsprung's disease (HSCR, colon aganglionosis) is the absence of ganglia in variable lengths of the hindgut, resulting in functional obstruction. HSCR is attributed to a failure of migration of the enteric ganglion precursors along the developing gut. RET is a key regulator of the development of the enteric nervous system (ENS) and the major HSCR-causing gene. Yet the reduced penetrance of RET DNA HSCR-associated variants together with the phenotypic variability suggest the involvement of additional genes in the disease. Through a genome-wide association study, we uncovered a similar to 350 kb HSCR-associated region encompassing part of the neuregulin-1 gene (NRG1). To identify the causal NRG1 variants contributing to HSCR, we genotyped 243 SNPs variants on 343 ethnic Chinese HSCR patients and 359 controls. Genotype analysis coupled with imputation narrowed down the HSCR-associated region to 21 kb, with four of the most associated SNPs (rs10088313, rs10094655, rs4624987, and rs3884552) mapping to the NRG1 promoter. We investigated whether there was correlation between the genotype at the rs10088313 locus and the amount of NRG1 expressed in human gut tissues (40 patients and 21 controls) and found differences in expression as a function of genotype. We also found significant differences in NRG1 expression levels between diseased and control individuals bearing the same rs10088313 risk genotype. This indicates that the effects of NRG1 common variants are likely to depend on other alleles or epigenetic factors present in the patients and would account for the variability in the genetic predisposition to HSCR.	[Tang, Clara Sze-Man; Yip, Benjamin Hon-Kei; Sham, Pak-Chung; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Tang, Clara Sze-Man; Tang, Wai-Kiu; So, Man-Ting; Leung, Brian Man-Chun; Yip, Benjamin Hon-Kei; Leon, Thomas Yuk-Yu; Ngan, Elly Sau-Wai; Lui, Vincent Chi-Hang; Chen, Yan; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Wong, Kenneth Kak-Yuen; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Ngan, Elly Sau-Wai; Lui, Vincent Chi-Hang; Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Wu, Xuan-Zhao] Guiyang Med Coll Affiliated Hosp, Dept Surg, Guiyang, Peoples R China; [Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Minist Educ Key Lab Envi, Wuhan 430074, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Guizhou Medical University; Huazhong University of Science & Technology	Tang, CSM (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	cherny@hku.hk; mmgarcia@hku.hk	Yip, Benjamin/AAC-7845-2019; Chen, Yan/C-4228-2009; Wong, Kenneth K. Y./B-9920-2008; YIP, Benjamin HK/I-2336-2013; Chen, Yan/N-7489-2019; Ngan, Elly/N-1543-2019; Cherny, Stacey S/B-3315-2008; miao, xiaoping/C-4336-2011; /C-4405-2009; /C-4359-2009	Yip, Benjamin/0000-0002-4749-7611; Chen, Yan/0000-0002-2354-230X; Chen, Yan/0000-0002-2354-230X; Ngan, Elly/0000-0002-0022-7999; Cherny, Stacey S/0000-0002-0269-3352; miao, xiaoping/0000-0002-6818-9722; /0000-0001-6231-3035; /0000-0002-1758-8854; CHUNG, Patrick Ho Yu/0000-0003-2382-5681; Tang, Clara/0000-0003-0265-2638	Hong Kong Research Grants Council [HKU 765609M]; University of Hong Kong [200911159071, 200811159006]; University of Hong Kong Genomics Strategic Research Theme	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); University of Hong Kong Genomics Strategic Research Theme	This work was supported by research grants from the Hong Kong Research Grants Council HKU 765609M to MGB and from The University of Hong Kong Seed Funding 200911159071 and 200811159006 to PT and MGB respectively. Support was also obtained from The University of Hong Kong Genomics Strategic Research Theme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Ao SI, 2005, BIOINFORMATICS, V21, P1735, DOI 10.1093/bioinformatics/bti201; Britsch S, 2007, V190; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Crone SA, 2003, NEURON, V37, P29, DOI 10.1016/S0896-6273(02)01128-5; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; TANG CS, 2010, HUM GENET; Torfs C., 1998, EPIDEMIOLOGICAL STUD; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012	31	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16181	10.1371/journal.pone.0016181	http://dx.doi.org/10.1371/journal.pone.0016181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283760	Green Published, gold			2022-12-27	WOS:000286522200033
J	Kantomaa, MT; Purtsi, J; Taanila, AM; Remes, J; Viholainen, H; Rintala, P; Ahonen, T; Tammelin, TH				Kantomaa, Marko T.; Purtsi, Jarno; Taanila, Anja M.; Remes, Jouko; Viholainen, Helena; Rintala, Pauli; Ahonen, Timo; Tammelin, Tuija H.			Suspected Motor Problems and Low Preference for Active Play in Childhood Are Associated with Physical Inactivity and Low Fitness in Adolescence	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; DEVELOPMENTAL COORDINATION DISORDER; SEDENTARY BEHAVIORS; PRESCHOOL-CHILDREN; PROFICIENCY; COMPETENCE; EVOLUTION; YOUTH	Background: This prospective longitudinal study investigates whether suspected motor problems and low preference for active play in childhood are associated with physical inactivity and low cardiorespiratory fitness in adolescence. Methodology/Principal Findings: The study sample consisted of the Northern Finland Birth Cohort 1986 (NFBC 1986) composed of 5,767 children whose parents responded to a postal inquiry concerning their children's motor skills at age 8 years and who themselves reported their physical activity at age 16 years. Cardiorespiratory fitness was measured with a cycle ergometer test at age 16 years. Odds ratios (OR) and their 95% confidence intervals (95% CI) for the level of physical activity and fitness were obtained from multinomial logistic regression and adjusted for socio-economic position and body mass index. Low preference for active play in childhood was associated with physical inactivity (boys: OR 3.31, 95% CI 2.42-4.53; girls: OR 1.79, 95% CI 1.36-2.36) and low cardiorespiratory fitness (boys: OR 1.87, 95% CI 1.27-2.74; girls: OR 1.52, 95% CI 1.09-2.11) in adolescence. Suspected gross (OR 2.16, 95% CI 1.33-3.49) and fine (OR 1.88, 95% CI 1.35-2.60) motor problems were associated with physical inactivity among boys. Children with suspected motor problems and low preference for active play tended to have an even higher risk of physical inactivity in adolescence. Conclusions/Significance: Low preference for active play in childhood was associated with physical inactivity and low cardiorespiratory fitness in adolescence. Furthermore, children with suspected motor problems and low preference for active play tended to have an even higher risk of physical inactivity in adolescence. Identification of children who do not prefer active play and who have motor problems may allow targeted interventions to support their motor learning and participation in active play and thereby promote their physical activity and fitness in later life.	[Kantomaa, Marko T.; Purtsi, Jarno; Tammelin, Tuija H.] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Kantomaa, Marko T.; Purtsi, Jarno; Viholainen, Helena] Finnish CP Assoc, Helsinki, Finland; [Taanila, Anja M.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Taanila, Anja M.] Univ Hosp Oulu, Unit Gen Practice, Oulu, Finland; [Remes, Jouko] Finnish Inst Occupat Hlth, Oulu, Finland; [Viholainen, Helena] Univ Jyvaskyla, Dept Educ, Jyvaskyla, Finland; [Rintala, Pauli] Univ Jyvaskyla, Dept Sport Sci, Jyvaskyla, Finland; [Ahonen, Timo] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Oulu; Finnish Institute of Occupational Health; University of Jyvaskyla; University of Jyvaskyla; University of Jyvaskyla	Kantomaa, MT (corresponding author), LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland.	marko.kantomaa@likes.fi	Rintala, Pauli/O-2507-2017	Rintala, Pauli/0000-0002-3405-8169; Kantomaa, Marko/0000-0002-5937-3456; Viholainen, Helena/0000-0002-8164-9180	Academy of Finland; European Union; National Institutes of Health (US); Wellcome Trust (UK); Nordic Academy for Advanced Study (NorFA); Ministry of Education and Culture, Finland	Academy of Finland(Academy of Finland); European Union(European Commission); National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust (UK)(Wellcome Trust); Nordic Academy for Advanced Study (NorFA); Ministry of Education and Culture, Finland	This study was funded by the Academy of Finland, the European Union, the National Institutes of Health (US), the Wellcome Trust (UK), the Nordic Academy for Advanced Study (NorFA) and the Ministry of Education and Culture, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barnett LM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-48; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Barnett LM, 2008, MED SCI SPORT EXER, V40, P2137, DOI 10.1249/MSS.0b013e31818160d3; Bateson Patrick, 2005, P13; Bjorklund D. F., 2005, ORIGINS SOCIAL MIND, P76; Bjorklund DF, 2006, DEV REV, V26, P213, DOI 10.1016/j.dr.2006.02.007; Cairney J, 2007, PEDIATR EXERC SCI, V19, P20, DOI 10.1123/pes.19.1.20; Cantell M, 2008, HUM MOVEMENT SCI, V27, P344, DOI 10.1016/j.humov.2008.02.007; Cliff DP, 2009, PEDIATR EXERC SCI, V21, P436, DOI 10.1123/pes.21.4.436; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Faught BE, 2008, HUM MOVEMENT SCI, V27, P177, DOI 10.1016/j.humov.2008.02.001; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; FOGELHOLM M, 2007, PHYS ACTIVITY POSSIB; Geuze RH, 2001, HUM MOVEMENT SCI, V20, P7, DOI 10.1016/S0167-9457(01)00027-6; Gottlieb G, 2003, HUM DEV, V46, P337, DOI 10.1159/000073306; Graf C, 2004, INT J OBESITY, V28, P22, DOI 10.1038/sj.ijo.0802428; Haga M, 2008, CHILD CARE HLTH DEV, V34, P329, DOI 10.1111/j.1365-2214.2008.00814.x; Haga M, 2009, PHYS THER, V89, P1089, DOI 10.2522/ptj.20090052; Hands B., 2002, DEV COORDINATION DIS, P172; Hands B, 2008, J SCI MED SPORT, V11, P155, DOI 10.1016/j.jsams.2007.02.012; Hay JA, 2004, J ADOLESCENT HEALTH, V34, P308, DOI 10.1016/j.jadohealth.2003.07.004; Jaakkola T, 2009, PERCEPT MOTOR SKILL, V108, P97, DOI 10.2466/PMS.108.1.97-111; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Pellegrini AD, 1998, CHILD DEV, V69, P577, DOI 10.2307/1132187; Pellegrini AD, 2007, DEV REV, V27, P261, DOI 10.1016/j.dr.2006.09.001; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Saakslahti A, 1999, PEDIATR EXERC SCI, V11, P327, DOI 10.1123/pes.11.4.327; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Santtila M, 2006, MED SCI SPORT EXER, V38, P1990, DOI 10.1249/01.mss.0000232023.28984.78; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Statistics Finland, 1989, STAT FINL HANDB, V17; Tammelin T, 2007, MED SCI SPORT EXER, V39, P1067, DOI 10.1249/mss.0b13e318058a603; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Whitt-Glover MC, 2009, J PUBLIC HEALTH POL, V30, pS309, DOI 10.1057/jphp.2008.46; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214; Wilson BN, 2000, AM J OCCUP THER, V54, P484, DOI 10.5014/ajot.54.5.484; World Health Organization, 2010, OB OV; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742	42	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14554	10.1371/journal.pone.0014554	http://dx.doi.org/10.1371/journal.pone.0014554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267447	Green Submitted, Green Published, gold			2022-12-27	WOS:000286519500021
J	Kumar, S; Kumar, S; Rajendran, M; Alam, SM; Lin, FF; Cheng, PW; Lin, MF				Kumar, Santosh; Kumar, Satyendra; Rajendran, Mythilypriya; Alam, Syed Mahfuzul; Lin, Fen-Fen; Cheng, Pi-Wan; Lin, Ming-Fong			Steroids Up-Regulate p66Shc Longevity Protein in Growth Regulation by Inhibiting Its Ubiquitination	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; MOLECULAR-WEIGHT PROTEASES; SIGNALING PATHWAY; OXIDATIVE STRESS; BREAST-CANCER; ANDROGEN RECEPTOR; ADAPTER PROTEINS; ACID-PHOSPHATASE; P66(SHC) ISOFORM; SHC	Background: p66Shc, an isoform of Shc adaptor proteins, mediates diverse signals, including cellular stress and mouse longevity. p66Shc protein level is elevated in several carcinomas and steroid-treated human cancer cells. Several lines of evidence indicate that p66Shc plays a critical role in steroid-related carcinogenesis, and steroids play a role in its elevated levels in those cells without known mechanism. Methods and Findings: In this study, we investigated the molecular mechanism by which steroid hormones up-regulate p66Shc protein level. In steroid-treated human prostate and ovarian cancer cells, p66Shc protein levels were elevated, correlating with increased cell proliferation. These steroid effects on p66Shc protein and cell growth were competed out by the respective antagonist. Further, actinomycin D and cyclohexamide could only partially block the elevated p66Shc protein level by steroids. Treatment with proteasomal inhibitors, but not lysosomal protease inhibitor, resulted in elevated p66Shc protein levels, even higher than that by steroids. Using prostate cancer cells as a model, immunoprecipitation revealed that androgens and proteasomal inhibitors reduce the ubiquitinated p66Shc proteins. Conclusions: The data collectively indicate that functional steroid receptors are required in steroid up-regulation of p66Shc protein levels in prostate and ovarian cancer cells, correlating with cell proliferation. In these steroid-treated cells, elevated p66Shc protein level is apparently in part due to inhibiting its ubiquitination. The results may lead to an impact on advanced cancer therapy via the regulation of p66Shc protein by up-regulating its ubiquitination pathway.	[Kumar, Santosh; Kumar, Satyendra; Rajendran, Mythilypriya; Alam, Syed Mahfuzul; Lin, Fen-Fen; Cheng, Pi-Wan; Lin, Ming-Fong] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE USA; [Cheng, Pi-Wan; Lin, Ming-Fong] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kumar, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE USA.	mlin@unmc.edu			National Institutes of Health [R01 CA88184]; Department of Defense [PC074289, PC050769]; Nebraska Research Initiative;  [NE LB506]; NATIONAL CANCER INSTITUTE [R01CA088184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Nebraska Research Initiative; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported in part by National Institutes of Health Grant (R01 CA88184), Department of Defense (PC074289 and PC050769), Nebraska Research Initiative (Cancer Glycobiology Program) and NE LB506 (#2010-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, BIOCHEM BIOPH RES CO, V307, P188, DOI 10.1016/S0006-291X(03)01140-9; Alam SM, 2009, ENDOCR-RELAT CANCER, V16, P1, DOI 10.1677/ERC-08-0179; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Davol PA, 2003, CANCER RES, V63, P6772; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; Eissa NT, 1998, P NATL ACAD SCI USA, V95, P7625, DOI 10.1073/pnas.95.13.7625; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Grossman SR, 2007, CLIN CANCER RES, V13, P5798, DOI 10.1158/1078-0432.CCR-07-0073; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Lee MS, 2004, INT J CANCER, V108, P672, DOI 10.1002/ijc.11621; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2004, J BIOL CHEM, V279, P43900, DOI 10.1074/jbc.M403936200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Park YJ, 2005, ENDOCRINOLOGY, V146, P2473, DOI 10.1210/en.2004-1588; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Stevenson LE, 1998, BREAST CANCER RES TR, V49, P119, DOI 10.1023/A:1006007227747; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; Ventura A, 2002, J BIOL CHEM, V277, P22370, DOI 10.1074/jbc.M200280200; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; Xie YM, 1996, BIOCHEM BIOPH RES CO, V221, P140, DOI 10.1006/bbrc.1996.0559	44	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15942	10.1371/journal.pone.0015942	http://dx.doi.org/10.1371/journal.pone.0015942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264241	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500019
J	Morton, CO; Varga, JJ; Hornbach, A; Mezger, M; Sennefelder, H; Kneitz, S; Kurzai, O; Krappmann, S; Einsele, H; Nierman, WC; Rogers, TR; Loeffler, J				Morton, Charles O.; Varga, John J.; Hornbach, Anke; Mezger, Markus; Sennefelder, Helga; Kneitz, Susanne; Kurzai, Oliver; Krappmann, Sven; Einsele, Hermann; Nierman, William C.; Rogers, Thomas R.; Loeffler, Juergen			The Temporal Dynamics of Differential Gene Expression in Aspergillus fumigatus Interacting with Human Immature Dendritic Cells In Vitro	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TRANSCRIPTIONAL ACTIVATOR CPCA; HUMAN MONOCYTES; INVASIVE ASPERGILLOSIS; HOST-DEFENSE; PROTEINS; VIRULENCE; FUNGI; INFECTION; APOPTOSIS	Dendritic cells (DC) are the most important antigen presenting cells and play a pivotal role in host immunity to infectious agents by acting as a bridge between the innate and adaptive immune systems. Monocyte-derived immature DCs (iDC) were infected with viable resting conidia of Aspergillus fumigatus (Af293) for 12 hours at an MOI of 5; cells were sampled every three hours. RNA was extracted from both organisms at each time point and hybridised to microarrays. iDC cell death increased at 6 h in the presence of A. fumigatus which coincided with fungal germ tube emergence; >80% of conidia were associated with iDC. Over the time course A. fumigatus differentially regulated 210 genes, FunCat analysis indicated significant up-regulation of genes involved in fermentation, drug transport, pathogenesis and response to oxidative stress. Genes related to cytotoxicity were differentially regulated but the gliotoxin biosynthesis genes were down regulated over the time course, while Aspf1 was up-regulated at 9 h and 12 h. There was an up-regulation of genes in the subtelomeric regions of the genome as the interaction progressed. The genes up-regulated by iDC in the presence of A. fumigatus indicated that they were producing a pro-inflammatory response which was consistent with previous transcriptome studies of iDC interacting with A. fumigatus germ tubes. This study shows that A. fumigatus adapts to phagocytosis by iDCs by utilising genes that allow it to survive the interaction rather than just up-regulation of specific virulence genes.	[Morton, Charles O.; Rogers, Thomas R.] Trinity Coll Dublin, Dept Clin Microbiol, Dublin, Ireland; [Varga, John J.; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Hornbach, Anke; Mezger, Markus; Sennefelder, Helga; Einsele, Hermann; Loeffler, Juergen] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany; [Kneitz, Susanne] Interdisziplinares Zentrum Klin Forsch, Labor Microarray Anwendungen, Wurzburg, Germany; [Kurzai, Oliver] Univ Jena, Sept Res Ctr, Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Jena, Germany; [Krappmann, Sven] Univ Wurzburg, Zentrum Infekt Forsch, Wurzburg, Germany	Trinity College Dublin; J. Craig Venter Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); University of Wurzburg	Morton, CO (corresponding author), Trinity Coll Dublin, Dept Clin Microbiol, Dublin, Ireland.	Loeffler_J@medizin.uni-wuerzburg.de	Varga, John J/I-8130-2012; Morton, Charles O/H-4000-2012; Krappmann, Sven/K-2615-2012	Varga, John J/0000-0002-4868-1971; Rogers, Thomas/0000-0003-4336-7729; Mezger, Markus/0000-0002-0211-2343; Kurzai, Oliver/0000-0002-7277-2646; Morton, Charles Oliver/0000-0003-1702-0545; Krappmann, Sven/0000-0002-8299-7777	European Union; US Institutes of Health [1R21AI052236]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052236] Funding Source: NIH RePORTER	European Union(European Commission); US Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a European Union Framework 6 grant as part of a project entitled Development of Novel Management Strategies for Invasive Aspergillosis "MANASP''. Support for the Aspergillus fumigatus microarray work was funded by the US Institutes of Health grant 1R21AI052236 to WCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Braus GH, 2006, MED MYCOL, V44, pS91, DOI 10.1080/13693780600898029; Brown JS, 2000, MOL MICROBIOL, V36, P1371, DOI 10.1046/j.1365-2958.2000.01953.x; Burns S, 2004, CURR BIOL, V14, pR965, DOI 10.1016/j.cub.2004.10.044; Chignard M, 2007, CLIN IMMUNOL, V124, P238, DOI 10.1016/j.clim.2007.05.004; Cortez KJ, 2006, INFECT IMMUN, V74, P2353, DOI 10.1128/IAI.74.4.2353-2365.2006; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; de Gouvea PF, 2008, FUNGAL GENET BIOL, V45, P1135, DOI 10.1016/j.fgb.2008.04.001; Gafa V, 2006, INFECT IMMUN, V74, P1480, DOI 10.1128/IAI.74.3.1480-1489.2006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAHL N, 2009, MED MYCOL, P1; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Hope WW, 2009, MED MYCOL, V47, pS291, DOI 10.1080/13693780802510232; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Kamei K, 2005, MED MYCOL, V43, pS95, DOI 10.1080/13693780500051547; Kang MW, 2008, CELL PHYSIOL BIOCHEM, V21, P215, DOI 10.1159/000113763; Krappmann S, 2004, MOL MICROBIOL, V52, P785, DOI 10.1111/j.1365-2958.2004.04015.x; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Lacadena J, 2007, FEMS MICROBIOL REV, V31, P212, DOI 10.1111/j.1574-6976.2006.00063.x; Lamarre C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-417; LAMBOU K, MOL MICROBIOL; Langfelder K, 2001, INFECT IMMUN, V69, P6411, DOI 10.1128/IAI.69.10.6411-6418.2001; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Li SM, 2006, PLANTA MED, V72, P1117, DOI 10.1055/s-2006-947195; Loeffler J, 2009, J MED MICROBIOL, V58, P49, DOI 10.1099/jmm.0.003293-0; Luther K, 2006, MED MYCOL, V44, pS219, DOI 10.1080/13693780600892972; Malicev E, 2007, MED MYCOL, V45, P123, DOI 10.1080/13693780601039615; Martinez-Ruiz A, 1999, TOXICON, V37, P1549, DOI 10.1016/S0041-0101(99)00103-8; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Mezger M, 2008, BLOOD, V111, P534, DOI 10.1182/blood-2007-05-090928; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ok M, 2009, CLIN VACCINE IMMUNOL, V16, P1485, DOI 10.1128/CVI.00175-08; Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Phadke AP, 2005, MED MYCOL, V43, pS173, DOI 10.1080/13693780500052099; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Romani L, 2002, TRENDS MICROBIOL, V10, P508, DOI 10.1016/S0966-842X(02)02460-5; Romani L, 2009, MED MYCOL, V47, pS154, DOI 10.1080/13693780802139867; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasse C, 2008, FUNGAL GENET BIOL, V45, P693, DOI 10.1016/j.fgb.2007.12.008; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Serrano-Gomez D, 2005, IMMUNOBIOLOGY, V210, P175, DOI 10.1016/j.imbio.2005.05.011; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Shibuya Kazutoshi, 2006, Nihon Ishinkin Gakkai Zasshi, V47, P249, DOI 10.3314/jjmm.47.249; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Watts C, 2006, CELL, V126, P17, DOI 10.1016/j.cell.2006.06.031; Willger S, 2009, MED MYCOL, V47, pS72, DOI 10.1080/13693780802455313; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xie DX, 2009, INT IMMUNOL, V21, P1251, DOI 10.1093/intimm/dxp087	80	50	146	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16016	10.1371/journal.pone.0016016	http://dx.doi.org/10.1371/journal.pone.0016016			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264256	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500022
J	Lee, CH; Wang, JD; Chen, PC				Lee, Chang-Hsing; Wang, Jung-Der; Chen, Pau-Chung			Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639,779 Patients with Hepatitis B Virus Infection	PLOS ONE			English	Article							AUTOIMMUNE HEPATITIS; MEDICINE; TAIWAN	Background: Chinese herbal products (CHPs) containing Radix bupleuri are often prescribed for chronic hepatitis. There have been no epidemiological studies in populations with hepatitis B virus (HBV) infection. Our study was conducted to determine the association between the use of CHPs containing Radix bupleuri and the risk of hospitalisation related to liver injury among HBV-infected patients in Taiwan. Methods: From a total of 639,779 patients with diagnoses related to HBV infection, we included hospitalised adult cases with a primary diagnosis of liver injury in the database of Taiwan's national health insurance during the period 1997-2004. Case-control and case-crossover designs were used to assess the risk of hospitalisation with conditional logistic regression models constructed and adjusted for 270 conventionally hepatotoxic drugs. Cumulative doses of these CHPs and Radix bupleuri were assessed for any dose-response relationship. Findings: In total, we collected 1,080 cases fulfilled the inclusion criteria. In the case-control design, the adjusted odds ratio was 1.90 (95% confidence interval [CI]: 1.30 to 2.77). The risks from prescribing the CHPs Xiao-Chai-Hu-Tang and Long-Dan-Xie-Gan-Tang were significantly high, and dose-response relationships were found. The risk of adding each 19 gm dose of Radix bupleuri was 2.19 (95% CI: 1.66 to 2.89). The results using the case-crossover design remained similar. Conclusions: Prescribing Xiao-Chai-Hu-Tang, Long-Dan-Xie-Gan-Tang, or CHPs containing more than 19 gram of Radix bupleuri in HBV-infected patients might increase their risks of liver injury. Further studies are indicated to corroborate the above findings.	[Lee, Chang-Hsing; Wang, Jung-Der; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Lee, Chang-Hsing] Ton Yen Gen Hosp, Dept Occupat Med, Hsinchu, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan	National Taiwan University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital	Lee, CH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan.	pchen@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974	National Science Council, Taiwan [NSC98-2314-B-002-129]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by the National Science Council (NSC98-2314-B-002-129), Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN BR, 1990, LANCET, V336, P177, DOI 10.1016/0140-6736(90)91696-8; Borum ML, 2001, AM J GASTROENTEROL, V96, P1654, DOI 10.1111/j.1572-0241.2001.03827.x; *CDCP, 2008, GUID COMM DIS SURV; Centers for Disease Control and Prevention, 1979, INT CLASS DIS 9 REV; Chen CJ, 2004, HEPATOLOGY, V39, P1196, DOI 10.1002/hep.20222; Chen FP, 2008, J ETHNOPHARMACOL, V117, P84, DOI 10.1016/j.jep.2008.01.018; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Haller CA, 2002, WESTERN J MED, V176, P39, DOI 10.1136/ewjm.176.1.39; Hsu Li-Ming, 2006, J Chin Med Assoc, V69, P86, DOI 10.1016/S1726-4901(09)70119-4; Ikegami F, 2006, HUM EXP TOXICOL, V25, P481, DOI 10.1191/0960327106het654oa; ITOH S, 1995, DIGEST DIS SCI, V40, P1845, DOI 10.1007/BF02212712; Kamiyama T, 1997, AM J GASTROENTEROL, V92, P703; KANE JA, 1995, GUT, V36, P146, DOI 10.1136/gut.36.1.146; Larrey D, 2002, SEMIN LIVER DIS, V22, P145, DOI 10.1055/s-2002-30101; Lee CH, 2006, J ALTERN COMPLEM MED, V12, P233, DOI 10.1089/acm.2006.12.233; Mantani N, 2002, PHYTOMEDICINE, V9, P280, DOI 10.1078/0944-7113-00141; Melchart D, 1999, JAMA-J AM MED ASSOC, V282, P28, DOI 10.1001/jama.282.1.28; Modi AA, 2007, ANTIVIR THER, V12, P285; National Health Research Institutes, 2003, NAT HLTH INS RES DAT; OKA H, 1995, CANCER-AM CANCER SOC, V76, P743, DOI 10.1002/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V; Park GJH, 2001, J GASTROEN HEPATOL, V16, P115, DOI 10.1046/j.1440-1746.2001.02309.x; *THOMS HEALTHC, 2006, MICROMEDEX HEALTHC S, V127; *WHO, 1999, WHO MON MED PLANTS R; Wong VWS, 2005, COMPLEMENT THER MED, V13, P175, DOI 10.1016/j.ctim.2005.04.006; Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x; 2000, J FOOD DRUG ANAL, V8, P270	26	36	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16064	10.1371/journal.pone.0016064	http://dx.doi.org/10.1371/journal.pone.0016064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264326	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514300005
J	Keatley, BE; Bennett, EM; MacDonald, GK; Taranu, ZE; Gregory-Eaves, I				Keatley, Bronwyn E.; Bennett, Elena M.; MacDonald, Graham K.; Taranu, Zofia E.; Gregory-Eaves, Irene			Land-Use Legacies Are Important Determinants of Lake Eutrophication in the Anthropocene	PLOS ONE			English	Article							GLOBAL POPULATION; SURFACE WATERS; PHOSPHORUS; PALEOLIMNOLOGY; AGRICULTURE; CROPLANDS; SOILS	Background: A hallmark of the latter half of the 20(th) century is the widespread, rapid intensification of a variety of anthropogenically-driven environmental changes-a "Great Acceleration." While there is evidence of a Great Acceleration in a variety of factors known to be linked to water quality degradation, such as conversion of land to agriculture and intensification of fertilizer use, it is not known whether there has been a similar acceleration of freshwater eutrophication. Methodology/Principal Findings: Using quantitative reconstructions of diatom-inferred total phosphorus (DI-TP) as a proxy for lake trophic state, we synthesized results from 67 paleolimnological studies from across Europe and North America to evaluate whether most lakes showed a pattern of eutrophication with time and whether this trend was accelerated after 1945 CE, indicative of a Great Acceleration. We found that European lakes have experienced widespread increases in DI-TP over the 20(th) century and that 33% of these lakes show patterns consistent with a post-1945 CE Great Acceleration. In North America, the proportion of lakes that increased in DI-TP over time is much lower and only 9% exhibited a Great Acceleration of eutrophication. Conclusions/Significance: The longer and more widespread history of anthropogenic influence in Europe, the leading cause for the relatively pervasive freshwater eutrophication, provides an important cautionary tale; our current path of intensive agriculture around the world may lead to an acceleration of eutrophication in downstream lakes that could take centuries from which to recover.	[Keatley, Bronwyn E.; Bennett, Elena M.; MacDonald, Graham K.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Keatley, Bronwyn E.; Bennett, Elena M.; MacDonald, Graham K.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Keatley, Bronwyn E.; Taranu, Zofia E.; Gregory-Eaves, Irene] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University; McGill University	Keatley, BE (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.	irene.gregory-eaves@mcgill.ca	MacDonald, Graham/L-5648-2019; Bennett, Elena/A-9553-2008; Gregory-Eaves, Irene/U-9325-2019	MacDonald, Graham/0000-0002-7120-1366; Gregory-Eaves, Irene/0000-0002-0380-5061; Bennett, Elena/0000-0003-3944-2925	Natural Sciences and Engineering Research Council (NSERC) Discovery; Canadian Foundation for Innovation; McGill School of Environment Interdisciplinary Research Seed Fund; Tomlinson Fellowshi; Le Fonds Quebecois de la Recherche sur la Nature et les Technologies	Natural Sciences and Engineering Research Council (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); McGill School of Environment Interdisciplinary Research Seed Fund; Tomlinson Fellowshi; Le Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	The authors acknowledge funding from Natural Sciences and Engineering Research Council (NSERC) Discovery, Canadian Foundation for Innovation, and McGill School of Environment Interdisciplinary Research Seed Fund grants awarded to IG-E and EMB; a Tomlinson Fellowship awarded to BEK; and NSERC and Le Fonds Quebecois de la Recherche sur la Nature et les Technologies Scholarships awarded to GKM and ZET, respectively. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; [Anonymous], 1995, PHOSPHORUS GLOBAL EN; Assessment M.E., 2005, ECOSYSTEMS HUMAN WEL; BATTARBEE R, 2010, J PALEOLIMNOLOGY; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; D'Arcy P, 1997, CAN J FISH AQUAT SCI, V54, P2215, DOI 10.1139/cjfas-54-10-2215; DILLON PJ, 1975, WATER RES, V9, P135, DOI 10.1016/0043-1354(75)90002-0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Hall R.I., 2010, DIATOMS APPL ENV EAR; Hall RI, 1999, LIMNOL OCEANOGR, V44, P739, DOI 10.4319/lo.1999.44.3_part_2.0739; HECKRATH G, 1995, J ENVIRON QUAL, V24, P904, DOI 10.2134/jeq1995.00472425002400050018x; Hesketh N, 2000, J ENVIRON QUAL, V29, P105, DOI 10.2134/jeq2000.00472425002900010013x; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Lotter AF, 2001, J PALEOLIMNOL, V25, P65, DOI 10.1023/A:1008140122230; McDowell RW, 2001, J ENVIRON QUAL, V30, P508, DOI 10.2134/jeq2001.302508x; Miettinen J, 2002, J PALEOLIMNOL, V27, P29, DOI 10.1023/A:1013550811858; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ramankutty N, 2002, AMBIO, V31, P251, DOI 10.1639/0044-7447(2002)031[0251:POTLCI]2.0.CO;2; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Smol J.P., 2009, POLLUTION LAKES RIVE; Steffen W., 2004, IGBP BOOK SERIES; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Taranu ZE, 2008, ECOSYSTEMS, V11, P715, DOI 10.1007/s10021-008-9153-0; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261	30	38	38	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15913	10.1371/journal.pone.0015913	http://dx.doi.org/10.1371/journal.pone.0015913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264341	Green Published, Green Submitted, gold			2022-12-27	WOS:000286513100017
J	Peiris, PM; Schmidt, E; Calabrese, M; Karathanasis, E				Peiris, Pubudu M.; Schmidt, Erik; Calabrese, Michael; Karathanasis, Efstathios			Assembly of Linear Nano-Chains from Iron Oxide Nanospheres with Asymmetric Surface Chemistry	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; GOLD NANOPARTICLES; FUNCTIONALIZATION; NANOTECHNOLOGY; PARTICLES; NANOWORMS; TRANSPORT; MOTION	Besides the multifunctionality, another equally important aspect of nanoparticles is their engineerability to control the geometrical and chemical properties during fabrication. In this work, we exploited this aspect to define asymmetric surface chemistry of an iron oxide nanosphere by controlling the topology of ligand expression on its surface resulting in a particle with two faces, one displaying only amines and the other only thiols. Specifically, amine-functionalized iron oxide nanospheres were attached on a solid support via a crosslinker containing a disulfide bridge. Liberation of the nanosphere using thiolytic cleavage created thiols on the portion of the particle's surface that interacted with the solid support. Employing a solid-phase strategy and a step-by-step addition of particles, the two unique faces on the same nanosphere served as fittings to assemble them into linear nano-chains. Assembly of chains with various lengths and aspect ratios was controlled by the size and number of the added nanospheres. The characteristics of those chains showed a high degree of uniformity indicating the exceptional control of the synthetic process. Notably, one of the unique properties of the iron oxide nano-chains was an increased magnetic relaxivity, indicating their potential use as contrast agents for magnetic resonance imaging.	[Peiris, Pubudu M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Radiol, Case Ctr Imaging Res, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Peiris, PM (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	stathis@case.edu		Karathanasis, Efstathios/0000-0001-7484-7552	Case Western Reserve University	Case Western Reserve University	This study was supported by a discretionary fund provided by Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2005, ADV MATER, V17, P1949, DOI 10.1002/adma.200401904; Dai Q, 2005, J AM CHEM SOC, V127, P8008, DOI 10.1021/ja042610v; Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024; Decuzzi P, 2006, ANN BIOMED ENG, V34, P633, DOI 10.1007/s10439-005-9072-6; Decuzzi P, 2008, BIOMATERIALS, V29, P377, DOI 10.1016/j.biomaterials.2007.09.025; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gavze E, 1998, J FLUID MECH, V371, P59, DOI 10.1017/S0022112098002109; Gentile F, 2008, ANN BIOMED ENG, V36, P254, DOI 10.1007/s10439-007-9423-6; Ghaghada KB, 2005, J CONTROL RELEASE, V104, P113, DOI 10.1016/j.jconrel.2005.01.012; GHAGHADA KB, 2006, THESIS U HOUSTON HOU; Gossuin Y, 2010, CONTRAST MEDIA MOL I, V5, P318, DOI 10.1002/cmmi.387; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jeppesen C, 2001, SCIENCE, V293, P465, DOI 10.1126/science.293.5529.465; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Lasic DD, 1996, NATURE, V380, P561, DOI 10.1038/380561a0; LI B, 2007, J AM CHEM SOC, V129; Liu X, 2006, SMALL, V2, P1126, DOI 10.1002/smll.200600162; Lu J, 2009, BIOMATERIALS, V30, P2919, DOI 10.1016/j.biomaterials.2009.02.001; LUDWIG FR, 1985, EUR J BIOCHEM, V151, P83, DOI 10.1111/j.1432-1033.1985.tb09071.x; Maus L, 2009, LANGMUIR, V25, P7910, DOI 10.1021/la900545t; Park JH, 2008, ADV MATER, V20, P1630, DOI 10.1002/adma.200800004; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Pegg EC, 2009, J BIOMED MATER RES A, V90A, P947, DOI 10.1002/jbm.a.32155; Sardar R, 2008, NANO LETT, V8, P731, DOI 10.1021/nl073154m; Sardar R, 2007, J AM CHEM SOC, V129, P5356, DOI 10.1021/ja070933w; Service RF, 2005, SCIENCE, V310, P1132, DOI 10.1126/science.310.5751.1132; Simard J, 2000, CHEM COMMUN, P1943, DOI 10.1039/b004162i; Socrates G, 1994, INFRARED CHARACTERIS; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Sung KM, 2004, J AM CHEM SOC, V126, P5064, DOI 10.1021/ja049578p; Worden JG, 2004, CHEM COMMUN, P518, DOI 10.1039/b312819a; YANG L, 2008, SMALL, V133, P154; Yang LL, 2009, CLIN CANCER RES, V15, P4722, DOI 10.1158/1078-0432.CCR-08-3289; Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8; Yuet KP, 2010, LANGMUIR, V26, P4281, DOI 10.1021/la903348s	38	36	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15927	10.1371/journal.pone.0015927	http://dx.doi.org/10.1371/journal.pone.0015927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253600	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900026
J	Chou, CS; Nie, Q; Yi, TM				Chou, Ching-Shan; Nie, Qing; Yi, Tau-Mu			Modeling Robustness Tradeoffs in Yeast Cell Polarization Induced by Spatial Gradients	PLOS ONE			English	Article							EXCHANGE FACTOR CDC24; PROTEINS; DIFFUSION; CHEMOTAXIS; GROWTH; MOVEMENT; POLARITY	Cells localize (polarize) internal components to specific locations in response to external signals such as spatial gradients. For example, yeast cells form a mating projection toward the source of mating pheromone. There are specific challenges associated with cell polarization including amplification of shallow external gradients of ligand to produce steep internal gradients of protein components (e. g. localized distribution), response over a broad range of ligand concentrations, and tracking of moving signal sources. In this work, we investigated the tradeoffs among these performance objectives using a generic model that captures the basic spatial dynamics of polarization in yeast cells, which are small. We varied the positive feedback, cooperativity, and diffusion coefficients in the model to explore the nature of this tradeoff. Increasing the positive feedback gain resulted in better amplification, but also produced multiple steady-states and hysteresis that prevented the tracking of directional changes of the gradient. Feedforward/ feedback coincidence detection in the positive feedback loop and multi-stage amplification both improved tracking with only a modest loss of amplification. Surprisingly, we found that introducing lateral surface diffusion increased the robustness of polarization and collapsed the multiple steady-states to a single steady-state at the cost of a reduction in polarization. Finally, in a more mechanistic model of yeast cell polarization, a surface diffusion coefficient between 0.01 and 0.001 mu m(2)/s produced the best polarization performance, and this range is close to the measured value. The model also showed good gradient-sensitivity and dynamic range. This research is significant because it provides an in-depth analysis of the performance tradeoffs that confront biological systems that sense and respond to chemical spatial gradients, proposes strategies for balancing this tradeoff, highlights the critical role of lateral diffusion of proteins in the membrane on the robustness of polarization, and furnishes a framework for future spatial models of yeast cell polarization.	[Chou, Ching-Shan; Nie, Qing] Univ Calif Irvine, Dept Math, Ctr Math & Computat Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA; [Yi, Tau-Mu] Univ Calif Irvine, Ctr Complex Biol Syst, Dept Dev & Cell Biol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Chou, CS (corresponding author), Univ Calif Irvine, Dept Math, Ctr Math & Computat Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	tmy@uci.edu			NIH [R01GM75309, P50GM76516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM075309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH grants R01GM75309 (through the joint NSF/NIGMS initiative to support research in the area of mathematical biology) to QN and TMY, and P50GM76516 to QN and TMY.	ANDREWS BW, 2006, PLOS COMP BIOL, V2; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; [Anonymous], 2004, SYSTEMS BIOL, V1, P54, DOI 10.1049/sb:20045001; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Briggs WL, 2000, MULTIGRID TUTORIAL; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Haugh JM, 2004, BIOPHYS J, V86, P589, DOI 10.1016/S0006-3495(04)74137-5; Horowitz P., 2015, ART ELECT; Iglesias Pablo A, 2002, Sci STKE, V2002, pre12, DOI 10.1126/stke.2002.148.re12; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; MALY VI, 2004, BIOPHYS J, V86; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Meinhardt H, 1999, J CELL SCI, V112, P2867; Meinhardt H., 1982, MODELS BIOL PATTERN; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Pruyne D, 2000, J CELL SCI, V113, P365; Skupsky R, 2005, BIOPHYS J, V89, P2806, DOI 10.1529/biophysj.105.061564; Thompson D.W., 1961, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Yi TM, 2007, J STAT PHYS, V128, P193, DOI 10.1007/s10955-007-9285-1; Yi TM, 2007, METHOD ENZYMOL, V422, P123, DOI 10.1016/S0076-6879(06)22006-8	34	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3103	10.1371/journal.pone.0003103	http://dx.doi.org/10.1371/journal.pone.0003103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	21267054	Green Published, Green Submitted, gold			2022-12-27	WOS:000264416600003
J	De Neys, W; Cromheeke, S; Osman, M				De Neys, Wim; Cromheeke, Sofie; Osman, Magda			Biased but in Doubt: Conflict and Decision Confidence	PLOS ONE			English	Article							DUAL-PROCESS THEORIES; CONJUNCTION FALLACY; 2 SYSTEMS; JUDGMENT; THINKING; RATIONALITY; ADOLESCENT; RESOLUTION; ACCOUNTS; MEMORY	Human reasoning is often biased by intuitive heuristics. A central question is whether the bias results from a failure to detect that the intuitions conflict with traditional normative considerations or from a failure to discard the tempting intuitions. The present study addressed this unresolved debate by using people's decision confidence as a nonverbal index of conflict detection. Participants were asked to indicate how confident they were after solving classic base-rate (Experiment 1) and conjunction fallacy (Experiment 2) problems in which a cued intuitive response could be inconsistent or consistent with the traditional correct response. Results indicated that reasoners showed a clear confidence decrease when they gave an intuitive response that conflicted with the normative response. Contrary to popular belief, this establishes that people seem to acknowledge that their intuitive answers are not fully warranted. Experiment 3 established that younger reasoners did not yet show the confidence decrease, which points to the role of improved bias awareness in our reasoning development. Implications for the long standing debate on human rationality are discussed.	[De Neys, Wim] Univ Toulouse, CNRS, Toulouse, France; [Cromheeke, Sofie] Katholieke Univ Leuven, Dept Psychol, Leuven, Belgium; [Osman, Magda] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; KU Leuven; University of London; Queen Mary University London	De Neys, W (corresponding author), Univ Toulouse, CNRS, Toulouse, France.	wim.deneys@univ-tlse2.fr		osman, magda/0000-0003-1480-6657	Centre National de la Recherche Scientifique (CNRS); Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO); Engineering and Physical Sciences Research Council (EPSRC) [EP/F069421/1]; Engineering and Physical Sciences Research Council [EP/F069421/1] Funding Source: researchfish; EPSRC [EP/F069421/1] Funding Source: UKRI	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by grants from the Centre National de la Recherche Scientifique (CNRS), Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO), and Engineering and Physical Sciences Research Council (EPSRC - EP/F069421/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner C, 2010, MEM COGNITION, V38, P186, DOI 10.3758/MC.38.2.186; Brainerd CJ, 2008, PSYCHOL BULL, V134, P343, DOI 10.1037/0033-2909.134.3.343; Davies PL, 2004, DEV NEUROPSYCHOL, V25, P355, DOI 10.1207/s15326942dn2503_6; de Neys W, 2006, PSYCHOL SCI, V17, P428, DOI 10.1111/j.1467-9280.2006.01723.x; De Neys W, 2008, PSYCHOL SCI, V19, P483, DOI 10.1111/j.1467-9280.2008.02113.x; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; De Neys W, 2010, COGN AFFECT BEHAV NE, V10, P208, DOI 10.3758/CABN.10.2.208; De Neys W, 2009, COGNITION, V113, P45, DOI 10.1016/j.cognition.2009.07.009; De Neys W, 2009, BEHAV BRAIN SCI, V32, P87, DOI 10.1017/S0140525X09000326; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Evans J., 1996, RATIONALITY REASONIN; Evans Jonathan, 2009, 2 MINDS DUAL PROCESS; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JSBT, 2007, THINK REASONING, V13, P321, DOI 10.1080/13546780601008825; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Fitzgerald KD, 2010, NEUROIMAGE, V49, P3463, DOI 10.1016/j.neuroimage.2009.11.004; Franssens S, 2009, THINK REASONING, V15, P105, DOI 10.1080/13546780802711185; GIGERENZER G, 1988, J EXP PSYCHOL HUMAN, V14, P513, DOI 10.1037/0096-1523.14.3.513; Gigerenzer G, 1996, PSYCHOL REV, V103, P592, DOI 10.1037/0033-295X.103.3.592; Hertwig R, 1999, J BEHAV DECIS MAKING, V12, P275, DOI 10.1002/(SICI)1099-0771(199912)12:4<275::AID-BDM323>3.0.CO;2-M; Hoffrage U, 2000, BEHAV BRAIN SCI, V23, P679, DOI 10.1017/S0140525X00373435; Houde O, 2007, THINK REASONING, V13, P81, DOI 10.1080/13546780500450599; Jacobs JE, 2005, DEV JUDGMENT DECISIO; Kahneman D, 2000, BEHAV BRAIN SCI, V23, P681, DOI 10.1017/S0140525X00403432; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kahneman D., 2011, THINKING FAST SLOW; Koehler JJ, 1996, BEHAV BRAIN SCI, V19, P1, DOI 10.1017/S0140525X00041157; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Markovits H, 2004, THINK REASONING, V10, P113, DOI 10.1080/13546780442000006; Oaksford M., 2007, BAYSIAN RATIONALITY; Osman M, 2004, PSYCHON B REV, V11, P988, DOI 10.3758/BF03196730; Quayle JD, 2000, Q J EXP PSYCHOL-A, V53, P1202, DOI 10.1080/02724980050156362; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; REYNA VF, 2003, EMERGING PERSPECTIVE; Santesso DL, 2008, DEV PSYCHOL, V44, P205, DOI 10.1037/0012-1649.44.1.205; Shynkaruk JM, 2006, MEM COGNITION, V34, P619, DOI 10.3758/BF03193584; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stanovich KE, 2008, J PERS SOC PSYCHOL, V94, P672, DOI 10.1037/0022-3514.94.4.672; Stein E., 1996, GOOD REASON RATIONAL; Stupple EJN, 2008, THINK REASONING, V14, P168, DOI 10.1080/13546780701739782; TEPPERS E, 2009, ONTWIKKELING CONFLIC; Thompson VA., 2009, ARIEL-REV INT ENGL, V137, P51; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; WASON PC, 1968, Q J EXP PSYCHOL, V20, P273, DOI 10.1080/14640746808400161; WASON PC, 1975, COGNITION, V3, P141, DOI 10.1016/0010-0277(74)90017-1; WASON PC, 1983, THINK REASONING, P45	48	99	100	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15954	10.1371/journal.pone.0015954	http://dx.doi.org/10.1371/journal.pone.0015954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283574	Green Published, gold			2022-12-27	WOS:000286661400018
J	Van Hout, AJM; Eens, M; Pinxten, R				Van Hout, Alain J. -M.; Eens, Marcel; Pinxten, Rianne			Carotenoid Supplementation Positively Affects the Expression of a Non-Visual Sexual Signal	PLOS ONE			English	Article							MALE EUROPEAN STARLINGS; OXIDATION HANDICAP HYPOTHESIS; STURNUS-VULGARIS; TESTOSTERONE; AVAILABILITY; ANTIOXIDANTS; SONG; STRESS; COLORATION; PERFORMANCE	Carotenoids are a class of pigments which are widely used by animals for the expression of yellow-to-red colour signals, such as bill or plumage colour. Since they also have been shown to promote immunocompetence and to function as antioxidants, many studies have investigated a potential allocation trade-off with respect to carotenoid-based signals within the context of sexual selection. Although an effect of carotenoids on non-visual (e.g. acoustic) signals involved in sexual selection has been hypothesized, this has to date not been investigated. First, we examined a potential effect of dietary carotenoid supplementation on overall song rate during the non-breeding season in captive male European starlings (Sturnus vulgaris). After only 3-7 days, we found a significant (body-mass independent) positive effect of carotenoid availability on overall song rate. Secondly, as a number of studies suggest that carotenoids could affect the modulation of sexual signals by plasma levels of the steroid hormone testosterone (T), we used the same birds to subsequently investigate whether carotenoid availability affects the increase in (nestbox-oriented) song rate induced by experimentally elevated plasma T levels. Our results suggest that carotenoids may enhance the positive effect of elevated plasma T levels on nestbox-oriented song rate. Moreover, while non-supplemented starlings responded to T-implantation with an increase in both overall song rate and nestbox-oriented song, carotenoid-supplemented starlings instead shifted song production towards (reproductively relevant) nestbox-oriented song, without increasing overall song rate. Given that song rate is an acoustic signal rather than a visual signal, our findings therefore indicate that the role of carotenoids in (sexual) signalling need not be dependent on their function as pigments.	[Van Hout, Alain J. -M.; Eens, Marcel; Pinxten, Rianne] Univ Antwerp, Res Grp Ethol, Antwerp, Belgium	University of Antwerp	Van Hout, AJM (corresponding author), Univ Antwerp, Res Grp Ethol, Antwerp, Belgium.	alain.vanhout@ua.ac.be	Eens, Marcel/AAC-8466-2020		FWO Flanders (Belgium) [G.0130.07]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); University of Antwerp; FWO-Flanders	FWO Flanders (Belgium)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University of Antwerp; FWO-Flanders(FWO)	This study was supported by a research project (G.0130.07) to ME from FWO Flanders (Belgium). Alain Van Hout was funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). Marcel Eens and Rianne Pinxten were funded by the University of Antwerp and supported by FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2003, BEHAV BRAIN RES, V143, P15, DOI 10.1016/S0166-4328(03)00006-8; Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Barnett CA, 2007, BEHAV ECOL SOCIOBIOL, V61, P579, DOI 10.1007/s00265-006-0286-x; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Catchpole CK, 1995, BIRD SONG BIOL THEME; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2007, J COMP PHYSIOL B, V177, P723, DOI 10.1007/s00360-007-0169-0; De Ridder E, 2000, BEHAV ECOL SOCIOBIOL, V49, P24, DOI 10.1007/s002650000266; Duffy DL, 2002, P ROY SOC B-BIOL SCI, V269, P847, DOI 10.1098/rspb.2002.1956; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; Eens M, 1996, ANIM BEHAV, V51, P1141, DOI 10.1006/anbe.1996.0115; Hasselquist D, 2008, J AVIAN BIOL, V39, P384, DOI 10.1111/j.0908-8857.2008.04427.x; Hill GE, 2009, J EXP BIOL, V212, P1225, DOI 10.1242/jeb.026963; Huggins KA, 2010, NATURWISSENSCHAFTEN, V97, P637, DOI 10.1007/s00114-010-0679-6; Larcombe SD, 2008, J EXP BIOL, V211, P2859, DOI 10.1242/jeb.017970; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Martinez-Padilla J, 2010, J EVOLUTION BIOL, V23, P902, DOI 10.1111/j.1420-9101.2010.01956.x; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; MOUNTJOY DJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P97; Navarro C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1057, DOI 10.1007/s00265-010-0920-5; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; ONeill CA, 1996, J APPL PHYSIOL, V81, P1197, DOI 10.1152/jappl.1996.81.3.1197; Perez C, 2008, BEHAV ECOL, V19, P967, DOI 10.1093/beheco/arn053; Pike TW, 2007, BEHAV ECOL, V18, P1100, DOI 10.1093/beheco/arm084; Pike TW, 2007, BIOL LETTERS, V3, P353, DOI 10.1098/rsbl.2007.0072; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Van Hout AJM, 2009, HORM BEHAV, V56, P564, DOI 10.1016/j.yhbeh.2009.09.010; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Wikelski M, 1999, J COMP PHYSIOL A, V185, P463, DOI 10.1007/s003590050407	37	18	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16326	10.1371/journal.pone.0016326	http://dx.doi.org/10.1371/journal.pone.0016326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283591	Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400044
J	Goler-Baron, V; Assaraf, YG				Goler-Baron, Vicky; Assaraf, Yehuda G.			Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance	PLOS ONE			English	Article							HEREDITARY FOLATE MALABSORPTION; INTRACELLULAR TRAFFICKING; PROTEIN BCRP/ABCG2; ABC TRANSPORTERS; MOLECULAR-BASIS; TIGHT JUNCTION; CELL-LINE; CANCER; MEMBRANE; BCRP	Multidrug resistance (MDR) is a major impediment to curative cancer chemotherapy. The ATP-Binding Cassette transporters ABCG2, ABCB1 and ABCC2 form a unique defense network against multiple structurally and functionally distinct chemotherapeutics, thereby resulting in MDR. Thus, deciphering novel mechanisms of MDR and their overcoming is a major goal of cancer research. Recently we have shown that overexpression of ABCG2 in the membrane of novel extracellular vesicles (EVs) in breast cancer cells results in mitoxantrone resistance due to its dramatic sequestration in EVs. However, nothing is known about EVs structure, biogenesis and their ability to concentrate multiple antitumor agents. To this end, we here found that EVs are structural and functional homologues of bile canaliculi, are apically localized, sealed structures reinforced by an actin-based cytoskeleton and secluded from the extracellular milieu by the tight junction proteins occludin and ZO-1. Apart from ABCG2, ABCB1 and ABCC2 were also selectively targeted to the membrane of EVs. Moreover, Ezrin-Radixin-Moesin protein complex selectively localized to the border of the EVs membrane, suggesting a key role for the tethering of MDR pumps to the actin cytoskeleton. The ability of EVs to concentrate and sequester different antitumor drugs was also explored. Taking advantage of the endogenous fluorescence of anticancer drugs, we found that EVs-forming breast cancer cells display high level resistance to topotecan, imidazoacridinones and methotrexate via efficient intravesicular drug concentration hence sequestering them away from their cellular targets. Thus, we identified a new modality of anticancer drug compartmentalization and resistance in which multiple chemotherapeutics are actively pumped from the cytoplasm and highly concentrated within the lumen of EVs via a network of MDR transporters differentially targeted to the EVs membrane. We propose a composite model for the structure and function of MDR pump-rich EVs in cancer cells and their ability to confer multiple anticancer drug resistance.	[Goler-Baron, Vicky; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Goler-Baron, V (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Assaraf, Yehuda G./0000-0001-6692-8221	Fred Wyszkowski Cancer Research Fund	Fred Wyszkowski Cancer Research Fund	This study was supported by the Fred Wyszkowski Cancer Research Fund to Y.G.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Delacour D, 2006, CELL MOL LIFE SCI, V63, P2491, DOI 10.1007/s00018-006-6210-8; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; Ifergan I, 2009, BIOCHEM BIOPH RES CO, V380, P5, DOI 10.1016/j.bbrc.2008.12.168; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kipp H, 2000, SEMIN LIVER DIS, V20, P339, DOI 10.1055/s-2000-9388; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Li N, 2009, MOL PHARMACEUT, V6, P1180, DOI 10.1021/mp900044x; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Mohrmann K, 2005, CANCER CHEMOTH PHARM, V56, P344, DOI 10.1007/s00280-005-1004-5; Nelson WJ, 2004, NAT CELL BIOL, V6, P282, DOI 10.1038/ncb0404-282; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Rodrigues AC, 2006, BBA-GEN SUBJECTS, V1760, P1866, DOI 10.1016/j.bbagen.2006.08.003; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; STJOHNSTON D, CELL, V141, P757; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; Tian X, 2007, ANTIMICROB AGENTS CH, V51, P3230, DOI 10.1128/AAC.00082-07; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wakabayashi Y, 2006, J BIOL CHEM, V281, P27669, DOI 10.1074/jbc.R600013200; Zegers MMP, 1998, MOL BIOL CELL, V9, P1939, DOI 10.1091/mbc.9.7.1939	40	67	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16007	10.1371/journal.pone.0016007	http://dx.doi.org/10.1371/journal.pone.0016007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283667	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400010
J	Skrlj, N; Vranac, T; Popovic, M; Serbec, VC; Dolinar, M				Skrlj, Nives; Vranac, Tanja; Popovic, Mara; Serbec, Vladka Curin; Dolinar, Marko			Specific Binding of the Pathogenic Prion Isoform: Development and Characterization of a Humanized Single-Chain Variable Antibody Fragment	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PRPSC REPLICATION; PROTEIN PEPTIDE; IN-VITRO; DISEASE; IMMUNOTHERAPY; DOMAINS; SCRAPIE; CELLS; MOUSE	Murine monoclonal antibody V5B2 which specifically recognizes the pathogenic form of the prion protein represents a potentially valuable tool in diagnostics or therapy of prion diseases. As murine antibodies elicit immune response in human, only modified forms can be used for therapeutic applications. We humanized a single-chain V5B2 antibody using variable domain resurfacing approach guided by computer modelling. Design based on sequence alignments and computer modelling resulted in a humanized version bearing 13 mutations compared to initial murine scFv. The humanized scFv was expressed in a dedicated bacterial system and purified by metal-affinity chromatography. Unaltered binding affinity to the original antigen was demonstrated by ELISA and maintained binding specificity was proved by Western blotting and immunohistochemistry. Since monoclonal antibodies against prion protein can antagonize prion propagation, humanized scFv specific for the pathogenic form of the prion protein might become a potential therapeutic reagent.	[Skrlj, Nives; Serbec, Vladka Curin; Dolinar, Marko] Univ Ljubljana, Chair Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Vranac, Tanja; Serbec, Vladka Curin] Blood Transfus Ctr Slovenia, Dept Prod Diagnost Reagents & Res, Ljubljana, Slovenia; [Popovic, Mara] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Skrlj, N (corresponding author), Univ Ljubljana, Chair Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia.	marko.dolinar@fkkt.uni-lj.si		Dolinar, Marko/0000-0002-4726-8077	Slovenian Research Agency [L3-0206]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency Ph.D. grant for NS and grant L3-0206 to VCS, MD, and TV. DiaMed Benelux (http://diamed.be/) was co-financing the project L3-0206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrenne C, 2009, J NEUROIMMUNOL, V209, P50, DOI 10.1016/j.jneuroim.2009.01.025; Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boado RJ, 2010, MOL PHARMACEUT, V7, P237, DOI 10.1021/mp900235k; Caldas C, 2003, MOL IMMUNOL, V39, P941, DOI 10.1016/S0161-5890(03)00022-1; Campana V, 2009, BIOCHEM J, V418, P507, DOI 10.1042/BJ20081541; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Delagrave S, 1999, PROTEIN ENG, V12, P357, DOI 10.1093/protein/12.4.357; Donofrio G, 2005, J VIROL, V79, P8330, DOI 10.1128/JVI.79.13.8330-8338.2005; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Flego M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-38; Furrer E, 2009, J NEUROIMMUNOL, V215, P65, DOI 10.1016/j.jneuroim.2009.08.005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Jones M, 2009, BRAIN PATHOL, V19, P293, DOI 10.1111/j.1750-3639.2008.00181.x; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KNAPPIK A, 1995, PROTEIN ENG, V8, P81, DOI 10.1093/protein/8.1.81; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Koren S, 2008, APPL MICROBIOL BIOT, V78, P1071, DOI 10.1007/s00253-008-1386-5; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li BH, 2007, BIOCHEM BIOPH RES CO, V357, P951, DOI 10.1016/j.bbrc.2007.04.039; Ludewigs H, 2007, EXPERT REV ANTI-INFE, V5, P613, DOI 10.1586/14787210.5.4.613; Luo GX, 2003, J IMMUNOL METHODS, V275, P31, DOI 10.1016/S0022-1759(02)00542-2; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Mirick GR, 2004, Q J NUCL MED MOL IM, V48, P251; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Muzard J, 2009, FEBS J, V276, P4207, DOI 10.1111/j.1742-4658.2009.07129.x; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; PEDERSEN JT, 1994, J MOL BIOL, V235, P959, DOI 10.1006/jmbi.1994.1050; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Roguska MA, 1996, PROTEIN ENG, V9, P895, DOI 10.1093/protein/9.10.895; Sadowski MJ, 2009, NEUROBIOL DIS, V34, P267, DOI 10.1016/j.nbd.2009.01.013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Serbec VC, 2004, J BIOL CHEM, V279, P3694, DOI 10.1074/jbc.M310868200; Sigurdsson EM, 2003, NEUROSCI LETT, V336, P185, DOI 10.1016/S0304-3940(02)01192-8; Skrlj N, 2010, APPL BIOCHEM BIOTECH, V160, P1808, DOI 10.1007/s12010-009-8699-4; Skrlj N, 2009, PROTEIN EXPRES PURIF, V64, P198, DOI 10.1016/j.pep.2008.10.019; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Ulrih NP, 2006, BIOCHEM BIOPH RES CO, V344, P1320, DOI 10.1016/j.bbrc.2006.04.046; Venturini AC, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-16; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Vranac T, 2006, PEPTIDES, V27, P2695, DOI 10.1016/j.peptides.2006.05.026; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Wuertzer CA, 2008, MOL THER, V16, P481, DOI 10.1038/sj.mt.6300387; Zhang W, 2005, MOL IMMUNOL, V42, P1445, DOI 10.1016/j.molimm.2005.01.015	57	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15783	10.1371/journal.pone.0015783	http://dx.doi.org/10.1371/journal.pone.0015783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283753	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200013
J	White, BR; Bauer, AQ; Snyder, AZ; Schlaggar, BL; Lee, JM; Culver, JP				White, Brian R.; Bauer, Adam Q.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Lee, Jin-Moo; Culver, Joseph P.			Imaging of Functional Connectivity in the Mouse Brain	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; RESTING-STATE; DEFAULT NETWORK; VISUAL-CORTEX; BLOOD-FLOW; NEURODEGENERATIVE DISEASES; HEMOGLOBIN CONCENTRATION; STRUCTURAL CONNECTIVITY; HEMODYNAMIC-RESPONSE; NEURONAL-ACTIVITY	Functional neuroimaging (e.g., with fMRI) has been difficult to perform in mice, making it challenging to translate between human fMRI studies and molecular and genetic mechanisms. A method to easily perform large-scale functional neuroimaging in mice would enable the discovery of functional correlates of genetic manipulations and bridge with mouse models of disease. To satisfy this need, we combined resting-state functional connectivity mapping with optical intrinsic signal imaging (fcOIS). We demonstrate functional connectivity in mice through highly detailed fcOIS mapping of resting-state networks across most of the cerebral cortex. Synthesis of multiple network connectivity patterns through iterative parcellation and clustering provides a comprehensive map of the functional neuroarchitecture and demonstrates identification of the major functional regions of the mouse cerebral cortex. The method relies on simple and relatively inexpensive camera-based equipment, does not require exogenous contrast agents and involves only reflection of the scalp (the skull remains intact) making it minimally invasive. In principle, fcOIS allows new paradigms linking human neuroscience with the power of molecular/genetic manipulations in mouse models.	[White, Brian R.; Culver, Joseph P.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [White, Brian R.; Bauer, Adam Q.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Culver, Joseph P.] Washington Univ, Dept Radiol, St Louis, MO USA; [Snyder, Abraham Z.; Schlaggar, Bradley L.; Lee, Jin-Moo] Washington Univ, Dept Neurol, St Louis, MO USA; [Schlaggar, Bradley L.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Schlaggar, Bradley L.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Culver, Joseph P.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	White, BR (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	culverj@mir.wustl.edu	White, Brian/C-8269-2019; Bullmore, Ed/C-1706-2012; Schlaggar, Bradley/AAZ-4153-2020; Lee, Jin-Moo/K-2024-2015	White, Brian/0000-0001-5196-2339; Bullmore, Ed/0000-0002-8955-8283; Lee, Jin-Moo/0000-0002-3979-0906	NIH [R01-EB008085, R01-EB009233, T90-DA022871, P01-NS32636]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009233, R01EB008085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032636, R01NS084028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by NIH grants R01-EB008085 (J.P.C.), R01-EB009233 (J.P.C.), T90-DA022871 (Imaging Science Fellowship, B.R.W.), and P01-NS32636 (L.J-M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2007, NMR BIOMED, V20, P200, DOI 10.1002/nbm.1167; ARRIDGE SR, 1992, PHYS MED BIOL, V37, P1531, DOI 10.1088/0031-9155/37/7/005; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bouchard MB, 2009, OPT EXPRESS, V17, P15670, DOI 10.1364/OE.17.015670; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Culver JP, 2005, NEUROIMAGE, V27, P947, DOI 10.1016/j.neuroimage.2005.05.052; Culver JP, 2003, J CEREBR BLOOD F MET, V23, P911, DOI 10.1097/01.WCB.0000076703.71231.BB; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Prahl S, 2002, OPTICAL ABSORPTION H; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; SMYSER CD, 2010, CEREBRAL CO IN PRESS; Strome EM, 2007, MOL IMAGING BIOL, V9, P186, DOI 10.1007/s11307-007-0093-4; TALARAICH J, 1988, COPLANAR STEREOTACTI; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	60	161	164	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16322	10.1371/journal.pone.0016322	http://dx.doi.org/10.1371/journal.pone.0016322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283729	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522200049
J	Luque, RM; Lin, Q; Cordoba-Chacon, J; Subbaiah, PV; Buch, T; Waisman, A; Vankelecom, H; Kineman, RD				Luque, Raul M.; Lin, Qing; Cordoba-Chacon, Jose; Subbaiah, Papasani V.; Buch, Thorsten; Waisman, Ari; Vankelecom, Hugo; Kineman, Rhonda D.			Metabolic Impact of Adult-Onset, Isolated, Growth Hormone Deficiency (AOiGHD) Due to Destruction of Pituitary Somatotropes	PLOS ONE			English	Article							INCREASED INSULIN SENSITIVITY; DIET-INDUCED OBESITY; RECEPTOR GENE; FACTOR-I; HYPOTHALAMIC EXPRESSION; REPLACEMENT THERAPY; GLUCOSE; INHIBITION; MOUSE; LIVER	Growth hormone (GH) inhibits fat accumulation and promotes protein accretion, therefore the fall in GH observed with weight gain and normal aging may contribute to metabolic dysfunction. To directly test this hypothesis a novel mouse model of adult onset-isolated GH deficiency (AOiGHD) was generated by cross breeding rat GH promoter-driven Cre recombinase mice (Cre) with inducible diphtheria toxin receptor mice (iDTR) and treating adult Cre(+/-), iDTR(+/-) offspring with DT to selectively destroy the somatotrope population of the anterior pituitary gland, leading to a reduction in circulating GH and IGF-I levels. DT-treated Cre(-/-), iDTR(+/-) mice were used as GH-intact controls. AOiGHD improved whole body insulin sensitivity in both low-fat and high-fat fed mice. Consistent with improved insulin sensitivity, indirect calorimetry revealed AOiGHD mice preferentially utilized carbohydrates for energy metabolism, as compared to GH-intact controls. In high-fat, but not low-fat fed AOiGHD mice, fat mass increased, hepatic lipids decreased and glucose clearance and insulin output were impaired. These results suggest the age-related decline in GH helps to preserve systemic insulin sensitivity, and in the context of moderate caloric intake, prevents the deterioration in metabolic function. However, in the context of excess caloric intake, low GH leads to impaired insulin output, and thereby could contribute to the development of diabetes.	[Luque, Raul M.; Lin, Qing; Kineman, Rhonda D.] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA; [Luque, Raul M.; Lin, Qing; Subbaiah, Papasani V.; Kineman, Rhonda D.] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL USA; [Luque, Raul M.; Cordoba-Chacon, Jose] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Luque, Raul M.; Cordoba-Chacon, Jose] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain; [Buch, Thorsten] Univ Zurich Hosp, Dept Pathol, Inst Expt Immunol, Neuroimmunol Div, CH-8091 Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Biol, Mainz, Germany; [Vankelecom, Hugo] Katholieke Univ Leuven, Lab Tissue Plast, Dept Mol Cell Biol, Leuven, Belgium	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zurich; University Zurich Hospital; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; KU Leuven	Luque, RM (corresponding author), Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA.	Kineman@uic.edu	Cordoba-Chacon, Jose/AAH-5753-2019; Waisman, Ari/C-7383-2015; Subbaiah, Papasani/U-1104-2019; Kineman, Rhonda D/H-2221-2011; Buch, Thorsten/P-1659-2019; Raul, Luque Huertas/M-6948-2018	Cordoba-Chacon, Jose/0000-0001-8787-2706; Waisman, Ari/0000-0003-4304-8234; Kineman, Rhonda D/0000-0001-7322-1152; Buch, Thorsten/0000-0002-2236-9074; Vankelecom, Hugo/0000-0002-2251-7284; Luque, Raul M./0000-0002-7585-1913	Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; NIH [AG-031465, HL68585, DK78165]; Programa Ramon y Cajal [RYC-2007-00186]; del Ministerio de Educacion y Ciencia e Innovacion [JC2008-00220, BFU2008-01136/BFI]; Fondo de Investigacion sanitaria del, Spain [ISCIII FI06/00804]; Fund for Scientific Research (F.W.O.)-Flanders (Belgium); Research Fund of the K.U.Leuven; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL068585, R01HL068585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088133, R21DK078165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031465] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programa Ramon y Cajal(Spanish Government); del Ministerio de Educacion y Ciencia e Innovacion(German Research Foundation (DFG)); Fondo de Investigacion sanitaria del, Spain; Fund for Scientific Research (F.W.O.)-Flanders (Belgium)(FWO); Research Fund of the K.U.Leuven; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Merit Award and NIH AG-031465 (to RDK); Grants from Programa Ramon y Cajal RYC-2007-00186, Programa Jose Castillejo JC2008-00220 and BFU2008-01136/BFI del Ministerio de Educacion y Ciencia e Innovacion (to RML) and Fondo de Investigacion sanitaria del ISCIII FI06/00804 (to JCC), Spain; NIH HL68585 and DK78165 (to PVS); Fund for Scientific Research (F.W.O.)-Flanders (Belgium) and the Research Fund of the K.U.Leuven (to HV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attallah H, 2006, GROWTH HORM IGF RES, V16, pS62, DOI 10.1016/j.ghir.2006.03.004; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE PJ, 1992, DIABETOLOGIA, V35, P372, DOI 10.1007/BF00401205; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Christ ER, 2003, CLIN ENDOCRINOL, V58, P309, DOI 10.1046/j.1365-2265.2003.01714.x; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; DELEHAYEZERVAS MC, 1994, J CLIN ENDOCR METAB, V78, P1473; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Frick F, 2001, AM J PHYSIOL-ENDOC M, V281, pE1230, DOI 10.1152/ajpendo.2001.281.6.E1230; Giovannini S, 2008, MECH AGEING DEV, V129, P593, DOI 10.1016/j.mad.2008.08.001; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Groop L, 2005, HORM RES, V64, P45, DOI 10.1159/000089317; Guo YB, 2005, ENDOCRINOLOGY, V146, P2602, DOI 10.1210/en.2004-1203; Hersch EC, 2008, CLIN INTERV AGING, V3, P121; Imrie H, 2009, ENDOCRINOLOGY, V150, P4575, DOI 10.1210/en.2008-1641; Jensen J, 2005, J ENDOCRINOL, V187, P25, DOI 10.1677/joe.1.06086; Jorgensen JOL, 2004, HORM RES, V62, P51, DOI 10.1159/000080499; Kanety H, 2009, EUR J ENDOCRINOL, V161, P837, DOI 10.1530/EJE-09-0419; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Lanes Roberto, 2004, Pediatr Endocrinol Rev, V2, P209; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Liu JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE405, DOI 10.1152/ajpendo.00423.2003; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Luque RM, 2007, ENDOCRINOLOGY, V148, P300, DOI 10.1210/en.2006-0592; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Luque RM, 2007, ENDOCRINOLOGY, V148, P1946, DOI 10.1210/en.2006-1542; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P1686, DOI 10.1210/jc.85.4.1686; Oliveira JLM, 2006, J CLIN ENDOCR METAB, V91, P2093, DOI 10.1210/jc.2005-2571; NIELSEN JH, 1989, MOL ENDOCRINOL, V3, P165, DOI 10.1210/mend-3-1-165; NIELSEN JH, 1990, BIOMED BIOCHIM ACTA, V49, P1151; Pereira RMC, 2007, J CLIN ENDOCR METAB, V92, P2353, DOI 10.1210/jc.2007-0092; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Rosenfalck AM, 2000, J CLIN ENDOCR METAB, V85, P4173, DOI 10.1210/jc.85.11.4173; Sasaki-Suzuki N, 2009, J BIOL CHEM, V284, P6061, DOI 10.1074/jbc.M808282200; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Segerlantz M, 2003, EUR J ENDOCRINOL, V149, P511, DOI 10.1530/eje.0.1490511; Short KR, 2008, J CLIN ENDOCR METAB, V93, P597, DOI 10.1210/jc.2007-1814; TRIMBLE ER, 1980, J CLIN ENDOCR METAB, V51, P626, DOI 10.1210/jcem-51-3-626; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venken K, 2007, J BONE MINER RES, V22, P72, DOI 10.1359/JBMR.060911; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yuen KCJ, 2007, DIABETES OBES METAB, V9, P11, DOI 10.1111/j.1463-1326.2006.00591.x; Yuen KCJ, 2006, GROWTH HORM IGF RES, V16, pS55, DOI 10.1016/j.ghir.2006.03.001	50	60	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15767	10.1371/journal.pone.0015767	http://dx.doi.org/10.1371/journal.pone.0015767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283519	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000286520600011
J	Chen, TJ; Wang, JQ; Yang, R; Li, JC; Lin, M; Lin, ZL				Chen, Tingjian; Wang, Jianqing; Yang, Rong; Li, Jicong; Lin, Min; Lin, Zhanglin			Laboratory-Evolved Mutants of an Exogenous Global Regulator, IrrE from Deinococcus radiodurans, Enhance Stress Tolerances of Escherichia coli	PLOS ONE			English	Article							ETHANOL-PRODUCTION; TRANSCRIPTION MACHINERY; OXIDATIVE STRESS; GAF DOMAINS; IMPROVEMENT; GENE; RADIORESISTANCE; EXPRESSION; MICROBES; PROTEOME	Background: The tolerance of cells toward different stresses is very important for industrial strains of microbes, but difficult to improve by the manipulation of single genes. Traditional methods for enhancing cellular tolerances are inefficient and time-consuming. Recently, approaches employing global transcriptional or translational engineering methods have been increasingly explored. We found that an exogenous global regulator, irrE from an extremely radiation-resistant bacterium, Deinococcus radiodurans, has the potential to act as a global regulator in Escherichia coli, and that laboratory-evolution might be applied to alter this regulator to elicit different phenotypes for E. coli. Methodology/Principal Findings: To extend the methodology for strain improvement and to obtain higher tolerances toward different stresses, we here describe an approach of engineering irrE gene in E. coli. An irrE library was constructed by randomly mutating the gene, and this library was then selected for tolerance to ethanol, butanol and acetate stresses. Several mutants showing significant tolerances were obtained and characterized. The tolerances of E. coli cells containing these mutants were enhanced 2 to 50-fold, based on cell growth tests using different concentrations of alcohols or acetate, and enhanced 10 to 100-fold based on ethanol or butanol shock experiments. Intracellular reactive oxygen species (ROS) assays showed that intracellular ROS levels were sharply reduced for cells containing the irrE mutants. Sequence analysis of the mutants revealed that the mutations distribute cross all three domains of the protein. Conclusions: To our knowledge, this is the first time that an exogenous global regulator has been artificially evolved to suit its new host. The successes suggest the possibility of improving tolerances of industrial strains by introducing and engineering exogenous global regulators, such as those from extremophiles. This new approach can be applied alone or in combination with other global methods, such as global transcriptional machinery engineering (gTME) for strain improvements.	[Chen, Tingjian; Wang, Jianqing; Yang, Rong; Li, Jicong; Lin, Zhanglin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China; [Lin, Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Minist Agr, Key Lab Crop Biotechnol, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, TJ (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.	linmin57@vip.163.com; zhanglinlin@mail.tsinghua.edu.cn	min, lin/AAJ-7325-2020; Chen, Tingjian/L-2659-2013; Lin, Zhanglin/A-7232-2011; Yang, Rong/J-3718-2014	Chen, Tingjian/0000-0002-4458-4269; Yang, Rong/0000-0001-6427-026X	National Basic Research (973) Program of China [2007CB707804, 2009CB724704]	National Basic Research (973) Program of China(National Basic Research Program of China)	This work was supported by grants from the National Basic Research (973) Program of China (No. 2007CB707804 and No. 2009CB724704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Atsumi S, 2008, CURR OPIN BIOTECH, V19, P414, DOI 10.1016/j.copbio.2008.08.008; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bauermeister A, 2009, ARCH MICROBIOL, V191, P913, DOI 10.1007/s00203-009-0522-7; Bore E, 2007, MICROBIOL-SGM, V153, P935, DOI 10.1099/mic.0.29288-0; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Ghim CM, 2010, BIOTECHNOL BIOPROC E, V15, P11, DOI 10.1007/s12257-009-3065-5; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Jarboe LR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/761042; Jin Y, 2005, P NATL ACAD SCI USA, V102, P18992, DOI 10.1073/pnas.0509653102; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Klein-Marcuschamer D, 2009, APPL ENVIRON MICROB, V75, P2705, DOI 10.1128/AEM.01888-08; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Liu SQ, 2009, NEW BIOTECHNOL, V26, P117, DOI 10.1016/j.nbt.2009.06.984; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; Ochi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1373, DOI 10.1271/bbb.70007; OHTA K, 1991, APPL ENVIRON MICROB, V57, P893, DOI 10.1128/AEM.57.4.893-900.1991; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Patnaik R, 2002, NAT BIOTECHNOL, V20, P707, DOI 10.1038/nbt0702-707; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Van Duy N, 2007, PROTEOMICS, V7, P698, DOI 10.1002/pmic.200600706; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang ZC, 2008, BIOTECHNOL LETT, V30, P657, DOI 10.1007/s10529-007-9597-x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yan Y, 2009, J IND MICROBIOL BIOT, V36, P471, DOI 10.1007/s10295-009-0532-0; Yeh CH, 1997, P NATL ACAD SCI USA, V94, P10967, DOI 10.1073/pnas.94.20.10967; Yomano LP, 2008, BIOTECHNOL LETT, V30, P2097, DOI 10.1007/s10529-008-9821-3; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhang Y, 2010, J MICROBIOL BIOTECHN, V20, P1156, DOI 10.4014/jmb.0912.12036; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a; Zheng YN, 2009, J IND MICROBIOL BIOT, V36, P1127, DOI 10.1007/s10295-009-0609-9; Zhou S, 2008, BIOTECHNOL LETT, V30, P335, DOI 10.1007/s10529-007-9544-x	44	51	61	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16228	10.1371/journal.pone.0016228	http://dx.doi.org/10.1371/journal.pone.0016228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267412	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500046
J	Nihonmatsu-Kikuchi, N; Hashimoto, R; Hattori, S; Matsuzaki, S; Shinozaki, T; Miura, H; Ohota, S; Tohyama, M; Takeda, M; Tatebayashi, Y				Nihonmatsu-Kikuchi, Naomi; Hashimoto, Ryota; Hattori, Satoko; Matsuzaki, Shinsuke; Shinozaki, Takiko; Miura, Haruka; Ohota, Shigeru; Tohyama, Masaya; Takeda, Masatoshi; Tatebayashi, Yoshitaka			Reduced Rate of Neural Differentiation in the Dentate Gyrus of Adult Dysbindin Null (Sandy) Mouse	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; DTNBP1; SCHIZOPHRENIA; BRAIN; NEUROGENESIS; MUTANT; 6P22.3; ABNORMALITIES	Genetic variations in the gene encoding dysbindin has consistently been associated with schizophrenia and bipolar disorder, although little is known about the neural functions carried out by dysbindin. To gain some insight into this area, we took advantage of the readily available dysbindin-null mouse sandy (sdy-/-) and studied hippocampal neurogenesis using thymidine analogue bromodeoxuridine (BrdU). No significant differences were found in the proliferation (4 hours) or survival (1, 4 and 8 weeks after the last BrdU injection) of progenitors in the subgranular regions of the dentate gyrus between sdy-/- and sdy+/+ (control) mice. However, 4 weeks after the last BrdU injection, a significant reduction was observed in the ratio of neuronal differentiation in sdy-/- when compared to that of sdy+/+ (sdy+/+ = 87.0+/-5.3% vs. sdy-/- = 71.3+/-8.3%, p = 0.01). These findings suggest that dysbindin plays a role during differentiation process in the adult hippocampal neurogenesis and that its deficit may negatively affect neurogenesis-related functions such as cognition and mood.	[Nihonmatsu-Kikuchi, Naomi; Shinozaki, Takiko; Miura, Haruka; Tatebayashi, Yoshitaka] Tokyo Inst Psychiat, Mood Disorders Res Team, Tokyo, Japan; [Nihonmatsu-Kikuchi, Naomi; Ohota, Shigeru] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Hashimoto, Ryota; Matsuzaki, Shinsuke; Tohyama, Masaya; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota; Hattori, Satoko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Matsuzaki, Shinsuke; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Matsuzaki, Shinsuke; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Osaka, Japan; [Matsuzaki, Shinsuke; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan	Tokyo Institute of Psychiatry; Hiroshima University; Osaka University; Osaka University; National Center for Neurology & Psychiatry - Japan; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Nihonmatsu-Kikuchi, N (corresponding author), Tokyo Inst Psychiat, Mood Disorders Res Team, Tokyo, Japan.	tatebayashi-ys@igakuken.or.jp	Hashimoto, Ryota/P-8572-2014; Hashimoto, Ryota/AAE-3200-2019; Hattori, Satoko/AAE-6873-2022	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Hattori, Satoko/0000-0002-1047-6454	Japanese Society for the Promotion of Science [KAKENHI 20390317]; Japanese Ministry of Education, Culture, Sports, Science and Technology; CREST of JST; MEXT [18023045]; Japanese Society for the Promotion of Science; Health and Labour Sciences Research Grants, Japan	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST of JST(Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grants, Japan	Y.T. was supported by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science (KAKENHI 20390317). http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm. R.H. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, CREST of JST, and by a Grant-in-Aid for Scientific Research on Priority Areas (Research on the Pathomechanisms of Brain Disorders) from the MEXT (18023045). http://www.jst.go.jp/kisoken/crest/. http://www.mext.go.jp/english/. S. M. was supported by a Grant-in-Aid for Young Scientists (B) from the Japanese Society for the Promotion of Science. http://www.jsps.go.jp/j-grantsinaid/index.html. M. T. was supported by Health and Labour Sciences Research Grants, Japan. http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Breen G, 2006, AM J PSYCHIAT, V163, P1636, DOI 10.1176/appi.ajp.163.9.1636; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fallgatter AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2002, DOI 10.1038/sj.npp.1301003; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; Guo AY, 2009, MOL PSYCHIATR, V14, P18, DOI 10.1038/mp.2008.88; Hashimoto R, 2010, WORLD J BIOL PSYCHIA, V11, P431, DOI [10.3109/15622970902736503, 10.1080/15622970902736503]; Hashimoto R, 2009, PSYCHIAT CLIN NEUROS, V63, P550, DOI 10.1111/j.1440-1819.2009.01985.x; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Murotani T, 2007, NEUROSCI LETT, V421, P47, DOI 10.1016/j.neulet.2007.05.019; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Straub RE, 2003, BIOL PSYCHIAT, V53, p167S; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15886	10.1371/journal.pone.0015886	http://dx.doi.org/10.1371/journal.pone.0015886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267465	Green Submitted, gold, Green Published			2022-12-27	WOS:000286519500030
J	Smale, DA; Wernberg, T; Peck, LS; Barnes, DKA				Smale, Dan A.; Wernberg, Thomas; Peck, Lloyd S.; Barnes, David K. A.			Turning on the Heat: Ecological Response to Simulated Warming in the Sea	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROCOSM EXPERIMENTS; TEMPERATURE; RECRUITMENT; COMMUNITIES; DISTURBANCE; IMPACTS; GROWTH	Significant warming has been observed in every ocean, yet our ability to predict the consequences of oceanic warming on marine biodiversity remains poor. Experiments have been severely limited because, until now, it has not been possible to manipulate seawater temperature in a consistent manner across a range of marine habitats. We constructed a "hot-plate'' system to directly examine ecological responses to elevated seawater temperature in a subtidal marine system. The substratum available for colonisation and overlying seawater boundary layer were warmed for 36 days, which resulted in greater biomass of marine organisms and a doubling of space coverage by a dominant colonial ascidian. The "hot-plate'' system will facilitate complex manipulations of temperature and multiple stressors in the field to provide valuable information on the response of individuals, populations and communities to environmental change in any aquatic habitat.	[Smale, Dan A.; Wernberg, Thomas] Univ Western Australia, Sch Plant Biol, Oceans Inst, Perth, WA 6009, Australia; [Wernberg, Thomas] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Perth, WA 6009, Australia; [Peck, Lloyd S.; Barnes, David K. A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Western Australia; Australian Institute of Marine Science; University of Western Australia; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Smale, DA (corresponding author), Univ Western Australia, Sch Plant Biol, Oceans Inst, Perth, WA 6009, Australia.	daniel.smale@uwa.edu.au	Wernberg, Thomas/B-4172-2010; Smale, Daniel/Y-2909-2019	Wernberg, Thomas/0000-0003-1185-9745; Smale, Daniel/0000-0003-4157-541X	University of Western Australia [AUD 30K]; NERC [dml011000, bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish	University of Western Australia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was sourced from the University of Western Australia's postdoctoral development award to DS (AUD 30K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius BP, 2007, J EXP MAR BIOL ECOL, V342, P30, DOI 10.1016/j.jembe.2006.10.012; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Convey P, 2002, ECOLOGY, V83, P3130, DOI 10.1890/0012-9658(2002)083[3130:ROATMT]2.0.CO;2; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Keser M, 2005, J SEA RES, V54, P211, DOI 10.1016/j.seares.2005.05.001; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Maughan BC, 2001, J EXP MAR BIOL ECOL, V256, P59, DOI 10.1016/S0022-0981(00)00304-X; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; POLOCZANSKA ES, 2010, BIOFOULING; Rao TS, 2010, AQUAT ECOL, V44, P463, DOI 10.1007/s10452-009-9304-1; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; RUSS GR, 1980, J EXP MAR BIOL ECOL, V42, P55, DOI 10.1016/0022-0981(80)90166-5; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sugden H, 2008, J ANIM ECOL, V77, P24, DOI 10.1111/j.1365-2656.2007.01323.x; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; UNDERWOOD AJ, EXPT ECOLOGY THEIR L; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Wilson SK, 2010, J EXP BIOL, V213, P894, DOI 10.1242/jeb.037895; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	27	30	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16050	10.1371/journal.pone.0016050	http://dx.doi.org/10.1371/journal.pone.0016050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264244	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000286516500024
J	Roth, C; Kang, SM; Batty, M; Barthelemy, M				Roth, Camille; Kang, Soong Moon; Batty, Michael; Barthelemy, Marc			Structure of Urban Movements: Polycentric Activity and Entangled Hierarchical Flows	PLOS ONE			English	Article								The spatial arrangement of urban hubs and centers and how individuals interact with these centers is a crucial problem with many applications ranging from urban planning to epidemiology. We utilize here in an unprecedented manner the large scale, real-time 'Oyster' card database of individual person movements in the London subway to reveal the structure and organization of the city. We show that patterns of intraurban movement are strongly heterogeneous in terms of volume, but not in terms of distance travelled, and that there is a polycentric structure composed of large flows organized around a limited number of activity centers. For smaller flows, the pattern of connections becomes richer and more complex and is not strictly hierarchical since it mixes different levels consisting of different orders of magnitude. This new understanding can shed light on the impact of new urban projects on the evolution of the polycentric configuration of a city and the dense structure of its centers and it provides an initial approach to modeling flows in an urban system.	[Roth, Camille; Barthelemy, Marc] CNRS EHESS, CAMS, Paris, France; [Roth, Camille] ISC PIF, Paris, France; [Kang, Soong Moon] UCL, Dept Management Sci & Innovat, London, England; [Batty, Michael] UCL, CASA, London, England; [Barthelemy, Marc] URA 2306, IPhT CNRS, CEA, Inst Phys Theor, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); University of London; University College London; University of London; University College London; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Roth, C (corresponding author), CNRS EHESS, CAMS, Paris, France.	marc.barthelemy@cea.fr	Roth, Camille/AFB-9056-2022; Batty, Michael/I-5638-2014; Batty, Michael/D-4422-2011; barthelemy, marc/B-3942-2008	Roth, Camille/0000-0003-3925-7957; Batty, Michael/0000-0002-9931-1305; 				Alexander Christopher, 1965, ARCHIT FORUM, V122, P58; Anas A, 1998, J ECON LIT, V36, P1426; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Batty M., 2005, CITIES COMPLEXITY; Batty M, 2006, METHODS SER, V3, P143; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FRIEDMANN J, 1965, J AM I PLANNERS, V31, P312, DOI 10.1080/01944366508978185; Fujita M., 2001, SPATIAL EC; Geddes P., 1915, CITIES EVOLUTION; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GUTTIEREZ J, 2006, J TRANSP GEOGR, V15, P18; Hall P., 1984, WORLD CITIES; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Kloosterman RC, 2001, URBAN STUD, V38, P623, DOI 10.1080/00420980120035259; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Thurstain-Goodwin M., 2000, T GIS, V4, P305, DOI [10.1111/1467-9671.00058, DOI 10.1111/1467-9671.00058]; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Wilson A., 2000, COMPLEX SPATIAL SYST	21	267	294	8	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15923	10.1371/journal.pone.0015923	http://dx.doi.org/10.1371/journal.pone.0015923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LJ	21249210	Green Submitted, Green Published, gold			2022-12-27	WOS:000286512900012
J	Rizkallah, R; Alexander, KE; Kassardjian, A; Luscher, B; Hurt, MM				Rizkallah, Raed; Alexander, Karen E.; Kassardjian, Ari; Luescher, Bernhard; Hurt, Myra M.			The Transcription Factor YY1 Is a Substrate for Polo-Like Kinase 1 at the G2/M Transition of the Cell Cycle	PLOS ONE			English	Article							FACTOR YIN-YANG-1; GENE-EXPRESSION; REGULATOR YIN-YANG-1; PROTEIN-KINASE; MESSENGER-RNA; BOX DOMAIN; IN-VIVO; PLK1; CANCER; PHOSPHORYLATION	Yin-Yang 1 (YY1) is an essential multifunctional zinc-finger protein. It has been shown over the past two decades to be a critical regulator of a vast array of biological processes, including development, cell proliferation and differentiation, DNA repair, and apoptosis. YY1 exerts its functions primarily as a transcription factor that can activate or repress gene expression, dependent on its spatial and temporal context. YY1 regulates a large number of genes involved in cell cycle transitions, many of which are oncogenes and tumor-suppressor genes. YY1 itself has been classified as an oncogene and was found to be upregulated in many cancer types. Unfortunately, our knowledge of what regulates YY1 is very minimal. Although YY1 has been shown to be a phosphoprotein, no kinase has ever been identified for the phosphorylation of YY1. Polo-like kinase 1 (Plk1) has emerged in the past few years as a major cell cycle regulator, particularly for cell division. Plk1 has been shown to play important roles in the G/M transition into mitosis and for the proper execution of cytokinesis, processes that YY1 has been shown to regulate also. Here, we present evidence that Plk1 directly phosphorylates YY1 in vitro and in vivo at threonine 39 in the activation domain. We show that this phosphorylation is cell cycle regulated and peaks at G2/M. This is the first report identifying a kinase for which YY1 is a substrate.	[Rizkallah, Raed; Alexander, Karen E.; Kassardjian, Ari; Hurt, Myra M.] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Kassardjian, Ari] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Luescher, Bernhard] Rheinisch Westfalische Tech Hsch Aachen Univ, Inst Biochem & Mol Biol, Aachen, Germany	State University System of Florida; Florida State University; State University System of Florida; Florida State University; RWTH Aachen University	Rizkallah, R (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	myra.hurt@med.fsu.edu	; Luscher, Bernhard/A-7330-2011	Rizkallah, Raed/0000-0001-8114-4935; Luscher, Bernhard/0000-0002-9622-8709	Florida State University, College of Medicine	Florida State University, College of Medicine	This work was supported by Florida State University, College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 1998, J CELL SCI, V111, P1751; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Arai T, 2008, CELL CYCLE, V7, P3556, DOI 10.4161/cc.7.22.7072; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Baritaki S, 2007, INT J ONCOL, V31, P69; Baritaki S, 2009, CANCER INVEST, V27, P184, DOI 10.1080/07357900802210760; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chinnappan D, 2009, INT J ONCOL, V34, P1417, DOI 10.3892/ijo_00000270; Dalle S, 2009, CLIN CANCER RES, V15, P851, DOI 10.1158/1078-0432.CCR-08-1685; de Nigris F, 2006, EUR J CANCER, V42, P2420, DOI 10.1016/j.ejca.2006.06.008; Delehouzee S, 2005, GENES CELLS, V10, P717, DOI 10.1111/j.1365-2443.2005.00873.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Furlong EEM, 1996, MOL CELL BIOL, V16, P5933; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Grubach L, 2008, EUR J HAEMATOL, V81, P112, DOI 10.1111/j.1600-0609.2008.01083.x; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Libra M, 2008, J HEPATOL, V49, P170, DOI 10.1016/j.jhep.2008.03.031; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Lowery DM, 2004, CELL CYCLE, V3, P128; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Reagan-Shaw S, 2005, IUBMB LIFE, V57, P677, DOI 10.1080/15216540500305910; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Schmit TL, 2009, CELL CYCLE, V8, P2697, DOI 10.4161/cc.8.17.9413; Seligson D, 2005, INT J ONCOL, V27, P131; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; WANG C, 2010, EUR J CELL BIOL; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yakovleva T, 2004, BIOCHEM BIOPH RES CO, V318, P615, DOI 10.1016/j.bbrc.2004.04.065; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308	71	27	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15928	10.1371/journal.pone.0015928	http://dx.doi.org/10.1371/journal.pone.0015928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253604	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900027
J	Pernice, M; Dunn, SR; Miard, T; Dufour, S; Dove, S; Hoegh-Guldberg, O				Pernice, Mathieu; Dunn, Simon R.; Miard, Thomas; Dufour, Sylvie; Dove, Sophie; Hoegh-Guldberg, Ove			Regulation of Apoptotic Mediators Reveals Dynamic Responses to Thermal Stress in the Reef Building Coral Acropora millepora	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; GENE-EXPRESSION; CELL-DEATH; OXIDATIVE STRESS; BCL-2; MECHANISMS; EVOLUTION; RELEASE; SUSCEPTIBILITY; BIOCHEMISTRY	Background: Mass coral bleaching is increasing in scale and frequency across the world's coral reefs and is being driven primarily by increased levels of thermal stress arising from global warming. In order to understand the impacts of projected climate change upon corals reefs, it is important to elucidate the underlying cellular mechanisms that operate during coral bleaching and subsequent mortality. In this respect, increased apoptotic cell death activity is an important cellular process that is associated with the breakdown of the mutualistic symbiosis between the cnidarian host and their dinoflagellate symbionts. Methodology/Principal Findings: The present study reports the impacts of different stressors (colchicine and heat stress) on three phases of apoptosis: (i) the potential initiation by differential expression of Bcl-2 members, (ii) the execution of apoptotic events by activation of caspase 3-like proteases and (iii) and finally, the cell disposal indicated by DNA fragmentation in the reef building coral Acropora millepora. In corals incubated with colchicine, an increase in caspase 3-like activity and DNA fragmentation was associated with a relative down-regulation of Bcl-2, suggesting that the initiation of apoptosis may be mediated by the suppression of an anti-apoptotic mechanism. In contrast, in the early steps of heat stress, the induction of caspase-dependent apoptosis was related to a relative up-regulation of Bcl-2 consecutively followed by a delayed decrease in apoptosis activity. Conclusions/Significance: In the light of these results, we propose a model of heat stress in coral hosts whereby increasing temperatures engage activation of caspase 3-dependent apoptosis in cells designated for termination, but also the onset of a delayed protective response involving overexpression of Bcl-2 in surviving cells. This mitigating response to thermal stress could conceivably be an important regulatory mechanism for cell survival in corals exposed to sudden environmental changes.	[Pernice, Mathieu; Dunn, Simon R.; Miard, Thomas; Dove, Sophie; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Global Change Inst, Coral Reef Ecosyst Lab, St Lucia, Qld, Australia; [Pernice, Mathieu; Dufour, Sylvie] UMR 7208 Biol Organismes & Ecosyst Aquat MNHN CNR, Paris, France	University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Pernice, M (corresponding author), Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Global Change Inst, Coral Reef Ecosyst Lab, St Lucia, Qld, Australia.	m.pernice@uq.edu.au	Pernice, Mathieu/AAU-9285-2020; Hoegh-Guldberg, Ove/ABA-5420-2020; Dove, Sophie/I-7873-2013; Hoegh-Guldberg, Ove/H-6169-2011	Pernice, Mathieu/0000-0002-3431-2104; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Dove, Sophie/0000-0003-1823-8634; Hoegh-Guldberg, Ove/0000-0001-7510-6713	Marie Curie International Outgoing Fellowship; Australian Research Council Centre for Excellence for Coral Reef Studies	Marie Curie International Outgoing Fellowship(European Commission); Australian Research Council Centre for Excellence for Coral Reef Studies(Australian Research Council)	This work was supported by a Marie Curie International Outgoing Fellowship and the Australian Research Council Centre for Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; D'Alessio M, 2004, FASEB J, V18, P1609, DOI 10.1096/fj.04-1813fje; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2007, BIOL BULL-US, V212, P250, DOI 10.2307/25066607; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; DUNN SR, 2002, P 9 INT COR REEF S B, V1, P145; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Gorman AM, 1999, EUR J NEUROSCI, V11, P1067, DOI 10.1046/j.1460-9568.1999.00512.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kowaltowski AJ, 2005, ANTIOXID REDOX SIGN, V7, P508, DOI 10.1089/ars.2005.7.508; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Middlebrook R, 2010, J EXP BIOL, V213, P1026, DOI 10.1242/jeb.031633; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plantivaux A, 2004, FREE RADICAL BIO MED, V37, P1170, DOI 10.1016/j.freeradbiomed.2004.06.043; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sandau KB, 2000, CELL DEATH DIFFER, V7, P118, DOI 10.1038/sj.cdd.4400615; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Setroikromo R, 2007, CELL STRESS CHAPERON, V12, P320, DOI 10.1379/CSC-279.1; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Sunagawa S, 2008, COMP BIOCHEM PHYS B, V151, P133, DOI 10.1016/j.cbpb.2008.06.007; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiens M, 2000, J MOL EVOL, V50, P520, DOI 10.1007/s002390010055; Wiens M, 2001, CELL DEATH DIFFER, V8, P887, DOI 10.1038/sj.cdd.4400906; Zmasek CM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r226	62	61	61	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16095	10.1371/journal.pone.0016095	http://dx.doi.org/10.1371/journal.pone.0016095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283671	Green Published, gold			2022-12-27	WOS:000286523400017
J	Yoon, M; Kopp, SJ; Taylor, JM; Storti, CS; Spear, PG; Muller, WJ				Yoon, Miri; Kopp, Sarah J.; Taylor, Joann M.; Storti, Christopher S.; Spear, Patricia G.; Muller, William J.			Functional Interaction between Herpes Simplex Virus Type 2 gD and HVEM Transiently Dampens Local Chemokine Production after Murine Mucosal Infection	PLOS ONE			English	Article							T-LYMPHOCYTE ATTENUATOR; 3-O-SULFATED HEPARAN-SULFATE; NECROSIS-FACTOR-ALPHA; FEMALE GENITAL-TRACT; ENTRY MEDIATOR; GLYCOPROTEIN-D; B-LYMPHOCYTE; CELL ENTRY; KAPPA-B; PSEUDORABIES VIRUS	Herpes virus entry mediator (HVEM) is one of two principal receptors mediating herpes simplex virus (HSV) entry into murine and human cells. It functions naturally as an immune signaling co-receptor, and may participate in enhancing or repressing immune responses depending on the natural ligand used. To investigate whether engagement of HVEM by HSV affects the in vivo response to HSV infection, we generated recombinants of HSV-2(333) that expressed wild-type gD (HSV-2/gD) or mutant gD able to bind to nectin-1 (the other principal entry receptor) but not HVEM. Replication kinetics and yields of the recombinant strains on Vero cells were indistinguishable from those of wild-type HSV-2(333). After intravaginal inoculation with mutant or wild-type virus, adult female C57BL/6 mice developed vaginal lesions and mortality in similar proportions, and mucosal viral titers were similar or lower for mutant strains at different times. Relative to HSV-2/gD, percentages of HSV-specific CD8(+) T-cells were similar or only slightly reduced after infection with the mutant strain HSV-2/gD-Delta 7-15, in all tissues up to 9 days after infection. Levels of HSV-specific CD4(+) T-cells five days after infection also did not differ after infection with either strain. Levels of the cytokine IL-6 and of the chemokines CXCL9, CXCL10, and CCL4 were significantly lower in vaginal washes one day after infection with HSV-2/gD compared with HSV-2/gD-Delta 7-15. We conclude that the interaction of HSV gD with HVEM may alter early innate events in the murine immune response to infection, without significantly affecting acute mortality, morbidity, or initial T-cell responses after lethal challenge.	[Yoon, Miri; Kopp, Sarah J.; Taylor, Joann M.; Spear, Patricia G.] Northwestern Univ, Dept Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kopp, Sarah J.; Storti, Christopher S.; Muller, William J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Yoon, M (corresponding author), Northwestern Univ, Dept Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA.	wjmuller@northwestern.edu		Muller, William J/0000-0001-7690-0695	Midwest Sexually Transmitted Infections and Topical Microbicides (STI-TM) Cooperative Research Center [U19 AI031494]; Midwest STI-TM Cooperative Research Center; Department of Pediatrics, Feinberg School of Medicine; Children's Memorial Research Center at Northwestern University; Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089942, U19AI031494] Funding Source: NIH RePORTER	Midwest Sexually Transmitted Infections and Topical Microbicides (STI-TM) Cooperative Research Center; Midwest STI-TM Cooperative Research Center; Department of Pediatrics, Feinberg School of Medicine; Children's Memorial Research Center at Northwestern University; Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants through the Midwest Sexually Transmitted Infections and Topical Microbicides (STI-TM) Cooperative Research Center U19 AI031494 (to PGS), a Midwest STI-TM Cooperative Research Center Developmental Award (to MY), and from a Child Health Research Career Development Award through the Department of Pediatrics, Feinberg School of Medicine, and Children's Memorial Research Center at Northwestern University (to WJM), a Midwest STI-TM Cooperative Research Center Developmental Award (to WJM), and an Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases Young Investigator Award (to WJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Connolly SA, 2003, J VIROL, V77, P8127, DOI 10.1128/JVI.77.14.8127-8140.2003; Croft M, 2005, TRENDS IMMUNOL, V26, P292, DOI 10.1016/j.it.2005.03.010; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gierynska M, 2002, J VIROL, V76, P6568, DOI 10.1128/JVI.76.13.6568-6576.2002; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Harrop JA, 1998, J IMMUNOL, V161, P1786; Hosokawa Y, 2010, MOL IMMUNOL, V47, P666, DOI 10.1016/j.molimm.2009.10.018; Kovacs SK, 2009, CURR EYE RES, V34, P896, DOI 10.3109/02713680903184250; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; LeBlanc RA, 1999, J VIROL, V73, P8145, DOI 10.1128/JVI.73.10.8145-8151.1999; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; MacLeod IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009560; Manoj S, 2004, P NATL ACAD SCI USA, V101, P12414, DOI 10.1073/pnas.0404211101; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; MILLIGAN GN, 1995, VIROLOGY, V206, P234, DOI 10.1016/S0042-6822(95)80038-7; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nicola AV, 1998, J VIROL, V72, P3595, DOI 10.1128/JVI.72.5.3595-3601.1998; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PAPAIOANNOU VE, 1993, LAB ANIM SCI, V43, P189; PARR MB, 1994, LAB INVEST, V70, P369; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Salazar-Mather TP, 2006, CURR TOP MICROBIOL, V303, P29, DOI 10.1007/978-3-540-33397-5_2; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shukla D, 1999, J VIROL, V73, P4493, DOI 10.1128/JVI.73.5.4493-4497.1999; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Sun YL, 2009, J IMMUNOL, V183, P1946, DOI 10.4049/jimmunol.0801866; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Taylor JM, 2007, CELL HOST MICROBE, V2, P19, DOI 10.1016/j.chom.2007.06.005; Thapa M, 2008, J VIROL, V82, P10295, DOI 10.1128/JVI.00931-08; Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WESTMORELAND D, 1976, J VIROL, V18, P92, DOI 10.1128/JVI.18.1.92-102.1976; Yoon M, 2004, P NATL ACAD SCI USA, V101, P17252, DOI 10.1073/pnas.0407892101; Yoon M, 2003, J VIROL, V77, P9221, DOI 10.1128/JVI.77.17.9221-9231.2003; Zago A, 2003, J VIROL, V77, P9695, DOI 10.1128/JVI.77.17.9695-9699.2003	64	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16122	10.1371/journal.pone.0016122	http://dx.doi.org/10.1371/journal.pone.0016122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283640	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400020
J	Jeong, JH; Bhatia, A; Toth, Z; Oh, S; Inn, KS; Liao, CP; Roy-Burman, P; Melamed, J; Coetzee, GA; Jung, JU				Jeong, Joseph H.; Bhatia, Ayesha; Toth, Zsolt; Oh, Soohwan; Inn, Kyung-Soo; Liao, Chun-Peng; Roy-Burman, Pradip; Melamed, Jonathan; Coetzee, Gerhard A.; Jung, Jae U.			TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; MOUSE MODEL; TYROSINE PHOSPHORYLATION; RECEPTOR PHOSPHORYLATION; TUMOR PROGRESSION; NF-KAPPA-B1 P105; BREAST-CANCER; EXPRESSION; CELLS	Background: Despite its initial positive response to hormone ablation therapy, prostate cancers invariably recur in more aggressive, treatment resistant forms. The lack of our understanding of underlying genetic alterations for the transition from androgen-dependent (AD) to ADI prostate cancer growth hampers our ability to develop target-driven therapeutic strategies for the efficient treatment of ADI prostate cancer. Methodology/Principal Findings: By screening a library of activated human kinases, we have identified TPL2, encoding a serine/threonine kinase, as driving ADI prostate cancer growth. TPL2 activation by over-expressing either wild-type or a constitutively activated form of TPL2 induced ADI growth, whereas the suppression of TPL2 expression and its kinase activity in ADI prostate cancer cells inhibited cell proliferation under androgen-depleted conditions. Most importantly, TPL2 is upregulated in ADI prostate cancers of both the Pten deletion mouse model and the clinical prostate cancer specimens. Conclusions/Significance: Together these data suggest that TPL2 kinase plays a critical role in the promotion of ADI prostate cancer progression. Furthermore, the suppression of TPL2 diminishes ADI prostate cancer growth and a high frequency of TPL2 overexpression in human ADI prostate cancer samples validates TPL2 as a target for the treatment of this deadly disease.	[Jeong, Joseph H.; Bhatia, Ayesha; Toth, Zsolt; Oh, Soohwan; Inn, Kyung-Soo; Jung, Jae U.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Liao, Chun-Peng; Roy-Burman, Pradip] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Melamed, Jonathan] NYU, Dept Pathol, NYU Prostate Canc Tissue Resource, New York, NY 10016 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Urol & Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; New York University; University of Southern California	Jeong, JH (corresponding author), Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	hyeongnj@usc.edu; jaeujung@usc.edu	Melamed, Jonathan/AAV-3769-2020; Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020; Inn, Kyung-Soo/AAJ-4118-2020	Melamed, Jonathan/0000-0003-2844-7990; Coetzee, Gerhard/0000-0001-8820-8364; Liao, Chun-Peng/0000-0001-8920-4322	DoD [060868]; ACS [IRG-58-007-48]; NIH [CA 109147, R01 CA 136924, CA 59705, CA 113392, CA082057, CA31363, CA115284, AI083025, DE019085, CA148616]; Hastings Foundation; Fletcher Jones Foundation; NATIONAL CANCER INSTITUTE [R01CA109147, R01CA082057, RC2CA148616, R01CA115284, R01CA059705, R01CA031363, R01CA113392, R01CA136924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	DoD(United States Department of Defense); ACS(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; Fletcher Jones Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded and supported by DoD 060868 and ACS grant IRG-58-007-48 to JHJ, NIH grants CA 109147 and R01 CA 136924 to GAC, NIH grants CA 59705 and CA 113392 to PRB, and CA082057, CA31363, CA115284, AI083025, DE019085, CA148616, Hastings Foundation, and Fletcher Jones Foundation to JUJ. (http://cdmrp.army.mil/, http://www.cancer.org/, http://www.nih.gov/, http://www.fletcherjonesfdn.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; COFFEY DS, 1993, CANCER, V71, P880, DOI 10.1002/1097-0142(19930201)71:3+<880::AID-CNCR2820711403>3.0.CO;2-6; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gatti G, 2009, PROSTATE, V69, P1387, DOI 10.1002/pros.20984; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gioeli D, 1999, CANCER RES, V59, P279; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Jia L, 2003, MOL CANCER RES, V1, P385; Koivisto P, 1997, CANCER RES, V57, P314; Lee KM, 2009, CANCER RES, V69, P8043, DOI 10.1158/0008-5472.CAN-09-2316; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P44, DOI 10.1007/s12672-009-0005-y; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; THALMANN GN, 1994, CANCER RES, V54, P2577; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yeung F, 2000, J BIOL CHEM, V275, P40846, DOI 10.1074/jbc.M002755200; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	51	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16205	10.1371/journal.pone.0016205	http://dx.doi.org/10.1371/journal.pone.0016205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267413	gold, Green Submitted, Green Published			2022-12-27	WOS:000286519500045
J	Xu, X; Jackson, PL; Tanner, S; Hardison, MT; Roda, MA; Blalock, JE; Gaggar, A				Xu, Xin; Jackson, Patricia L.; Tanner, Scott; Hardison, Matthew T.; Roda, Mojtaba Abdul; Blalock, James Edwin; Gaggar, Amit			A Self-Propagating Matrix Metalloprotease-9 (MMP-9) Dependent Cycle of Chronic Neutrophilic Inflammation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CYSTIC-FIBROSIS; GELATINASE-B; SIGNALING PATHWAYS; PROTEIN-KINASES; TNF-ALPHA; P38 MAPK; KAPPA-B; MATRIX-METALLOPROTEINASE-9; CHEMOATTRACTANT	Background: Chronic neutrophilic inflammation is a poorly understood feature in a variety of diseases with notable worldwide morbidity and mortality. We have recently characterized N-acetyl Pro-Gly-Pro (Ac-PGP) as an important neutrophil (PMN) chemoattractant in chronic inflammation generated from the breakdown of collagen by the actions of MMP-9. MMP-9 is present in the granules of PMNs and is differentially released during inflammation but whether Ac-PGP contributes to this ongoing proteolytic activity in chronic neutrophilic inflammation is currently unknown. Methodology/Principal Findings: Utilizing isolated primary blood PMNs from human donors, we found that Ac-PGP induces significant release of MMP-9 and concurrently activates the ERK1/2 MAPK pathway. This MMP-9 release is attenuated by an inhibitor of ERK1/2 MAPK and upstream blockade of CXCR1 and CXCR2 receptors with repertaxin leads to decreased MMP-9 release and ERK 1/2 MAPK activation. Supernatants obtained from PMNs stimulated by Ac-PGP generate more Ac-PGP when incubated with intact collagen ex vivo; this effect is inhibited by an ERK1/2 pathway inhibitor. Finally, clinical samples from individuals with CF demonstrate a notable correlation between Ac-PGP (as measured by liquid chromatography-tandem mass spectrometry) and MMP-9 levels even when accounting for total PMN burden. Conclusions/Significance: These data indicate that ECM-derived Ac-PGP could result in a feed-forward cycle by releasing MMP-9 from activated PMNs through the ligation of CXCR1 and CXCR2 and subsequent activation of the ERK1/2 MAPK, highlighting for the first time a matrix-derived chemokine (matrikine) augmenting its generation through a discrete receptor/intracellular signaling pathway. These findings have notable implications to the development unrelenting chronic PMN inflammation in human disease.	[Xu, Xin; Jackson, Patricia L.; Hardison, Matthew T.; Blalock, James Edwin; Gaggar, Amit] Univ Alabama, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Xu, Xin; Jackson, Patricia L.; Blalock, James Edwin; Gaggar, Amit] Univ Alabama, Gregory Fleming James CF Ctr, Birmingham, AL 35294 USA; [Tanner, Scott] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Roda, Mojtaba Abdul] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands; [Gaggar, Amit] Birmingham VA Med Ctr, Pulm Serv, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Utrecht University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Xu, X (corresponding author), Univ Alabama, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	agaggar@uab.edu		Blalock, J. Edwin/0000-0001-5303-8123; Tanner, Scott/0000-0002-7717-5293	University of Alabama; Cystic Fibrosis Foundation [GAGGAR07A0]; NIH/NHLBI [HL07783, HL090999, HL087824, HL102371-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090999, R01HL087824, R01HL102371] Funding Source: NIH RePORTER	University of Alabama; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Alabama Clinical Investigator Fellowship Award, the Cystic Fibrosis Foundation (Grant GAGGAR07A0 to AG) and NIH/NHLBI (HL07783, HL090999, and HL087824 (to JEB) and HL102371-01A1 (to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagoe K, 1998, J IMMUNOL, V160, P4518; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Boyd D, 1996, CANCER METAST REV, V15, P77, DOI 10.1007/BF00049488; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; DEKRUIJF P, EUR J PHARM, V643, P29; Finlay GA, 1997, THORAX, V52, P502, DOI 10.1136/thx.52.6.502; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; GERNEZ Y, EUR RESP J, V35, P467; GREENE CM, AM J RESP CRIT CARE, V181, P31; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Haddox JL, 1999, INVEST OPHTH VIS SCI, V40, pS687; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hii CST, 1999, INFECT IMMUN, V67, P1297, DOI 10.1128/IAI.67.3.1297-1302.1999; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; LU DJ, 1993, BLOOD CELLS, V19, P343; Ludwig A, 1997, BLOOD, V90, P4588; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; McCawley LJ, 1998, J CELL PHYSIOL, V176, P255, DOI 10.1002/(SICI)1097-4652(199808)176:2<255::AID-JCP4>3.0.CO;2-N; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Petrich BG, 2004, TRENDS CARDIOVAS MED, V14, P50, DOI 10.1016/j.tcm.2003.11.002; PFISTER RR, 1995, INVEST OPHTH VIS SCI, V36, pS701; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Strniskova M, 2002, GEN PHYSIOL BIOPHYS, V21, P231; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; VANDAMME J, 1988, J EXP MED, V167, P1364, DOI 10.1084/jem.167.4.1364; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WEATHINGTON NM, 2005, BIOL CXC CHEMOKINES, P49	46	135	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15781	10.1371/journal.pone.0015781	http://dx.doi.org/10.1371/journal.pone.0015781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249198	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000008
J	Zschenderlein, C; Gebhardt, C; Halbach, OVU; Kulisch, C; Albrecht, D				Zschenderlein, Carsten; Gebhardt, Christine; Halbach, Oliver von Bohlen und; Kulisch, Christoph; Albrecht, Doris			Capsaicin-Induced Changes in LTP in the Lateral Amygdala Are Mediated by TRPV1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; THALAMIC INPUT SYNAPSES; SYNAPTIC PLASTICITY; BASOLATERAL AMYGDALA; VANILLOID RECEPTORS; MEMORY CONSOLIDATION; NMDA RECEPTOR; ION-CHANNEL; RAT; NEURONS	The transient receptor potential vanilloid type 1 (TRPV1) channel is a well recognized polymodal signal detector that is activated by painful stimuli such as capsaicin. Here, we show that TRPV1 is expressed in the lateral nucleus of the amygdala (LA). Despite the fact that the central amygdala displays the highest neuronal density, the highest density of TRPV1 labeled neurons was found within the nuclei of the basolateral complex of the amygdala. Capsaicin specifically changed the magnitude of long-term potentiation (LTP) in the LA in brain slices of mice depending on the anesthetic (ether, isoflurane) used before euthanasia. After ether anesthesia, capsaicin had a suppressive effect on LA-LTP both in patch clamp and in extracellular recordings. The capsaicin-induced reduction of LTP was completely blocked by the nitric oxide synthase (NOS) inhibitor L-NAME and was absent in neuronal NOS as well as in TRPV1 deficient mice. The specific antagonist of cannabinoid receptor type 1 (CB1), AM 251, was also able to reduce the inhibitory effect of capsaicin on LA-LTP, suggesting that stimulation of TRPV1 provokes the generation of anandamide in the brain which seems to inhibit NO synthesis. After isoflurane anesthesia before euthanasia capsaicin caused a TRPV1-mediated increase in the magnitude of LA-LTP. Therefore, our results also indicate that the appropriate choice of the anesthetics used is an important consideration when brain plasticity and the action of endovanilloids will be evaluated. In summary, our results demonstrate that TRPV1 may be involved in the amygdala control of learning mechanisms.	[Zschenderlein, Carsten; Gebhardt, Christine; Kulisch, Christoph; Albrecht, Doris] Charite, Inst Neurophysiol, CVK, D-13353 Berlin, Germany; [Halbach, Oliver von Bohlen und] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Greifswald, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ernst Moritz Arndt Universitat Greifswald	Zschenderlein, C (corresponding author), Charite, Inst Neurophysiol, CVK, D-13353 Berlin, Germany.	doris.albrecht@charite.de	von Bohlen und Halbach, Oliver/R-3464-2019; von Bohlen und Halbach, Oliver/A-1060-2008	von Bohlen und Halbach, Oliver/0000-0002-6265-9156; von Bohlen und Halbach, Oliver/0000-0002-2613-2517; Kulisch, Christoph/0000-0001-6689-1107	Deutsche Forschungsgemeinschaft (DFG) [AI 342/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (DFG) (AI 342/12-1). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hayani A, 2001, NEUROPHARMACOLOGY, V41, P1000, DOI 10.1016/S0028-3908(01)00145-9; Alter BJ, 2008, NEURON, V57, P629, DOI 10.1016/j.neuron.2008.02.023; Alvares LD, 2006, BRAIN RES, V1075, P60, DOI 10.1016/j.brainres.2005.11.101; Aroniadou-Anderjaska V, 2001, NEUROREPORT, V12, P635, DOI 10.1097/00001756-200103050-00041; Azad SC, 2003, LEARN MEMORY, V10, P116, DOI 10.1101/lm.53303; Baryshnikova LM, 2006, MICROSC RES TECHNIQ, V69, P738, DOI 10.1002/jemt.20345; Benko R, 2005, LIFE SCI, V76, P2773, DOI 10.1016/j.lfs.2004.07.033; Bieda MC, 2009, ANESTH ANALG, V108, P484, DOI 10.1213/ane.0b013e3181904571; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; CHAPMAN PF, 1992, SYNAPSE, V11, P310, DOI 10.1002/syn.890110406; CHAVES AE, 2008, SOC NEUR ABSTR; Chen A, 2003, NEUROSCIENCE, V119, P53, DOI 10.1016/S0306-4522(03)00076-9; Chen Y, 2008, NEUROPEPTIDES, V42, P551, DOI 10.1016/j.npep.2008.08.001; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; de Olmos J.S., 1985, RAT NERVOUS SYSTEM, VI, P223; Derbenev AV, 2006, J NEUROSCI, V26, P9666, DOI 10.1523/JNEUROSCI.1591-06.2006; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Fendt M, 2002, EUR J NEUROSCI, V15, P1535, DOI 10.1046/j.1460-9568.2002.01988.x; Ferrini F, 2007, PAIN, V129, P195, DOI 10.1016/j.pain.2007.01.009; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; Harrison N, 2008, MOL PHARMACOL, V74, P1180, DOI 10.1124/mol.108.051615; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Immke DC, 2006, SEMIN CELL DEV BIOL, V17, P582, DOI 10.1016/j.semcdb.2006.09.004; Johnson LR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.003.2008; Johnston D., 1995, FDN CELLULAR NEUROPH; Kofalvi A, 2006, NEUROSCI LETT, V403, P151, DOI 10.1016/j.neulet.2006.04.030; Kotaria N, 2005, CELL TISSUE RES, V322, P503, DOI 10.1007/s00441-005-0023-1; Lamprecht R, 2006, NEUROSCIENCE, V139, P821, DOI 10.1016/j.neuroscience.2005.12.055; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Li H, 1998, J NEUROSCI, V18, P1662; Li HB, 2008, ACTA CRYSTALLOGR E, V64, pO465, DOI 10.1107/S1600536808001293; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Marinelli S, 2003, J NEUROSCI, V23, P3136; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; MCDONALD AJ, 1984, J COMP NEUROL, V222, P589, DOI 10.1002/cne.902220410; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Muller T, 2009, LEARN MEMORY, V16, P395, DOI 10.1101/lm.1398709; MULLER W, 1988, EXP BRAIN RES, V72, P287; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Okere CO, 2000, J COMP NEUROL, V423, P670, DOI 10.1002/1096-9861(20000807)423:4<670::AID-CNE11>3.0.CO;2-S; Pan BX, 2009, NEURON, V61, P917, DOI 10.1016/j.neuron.2009.01.029; Pitkanen A, 2003, ANN NY ACAD SCI, V985, P34; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Pollandt S, 2003, NEUROREPORT, V14, P895, DOI 10.1097/00001756-200305060-00025; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Roberts Louise A, 2006, Recent Pat CNS Drug Discov, V1, P65, DOI 10.2174/157488906775245309; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rossi S, 2008, J NEUROSCI, V28, P7284, DOI 10.1523/JNEUROSCI.5346-07.2008; Samson RD, 2003, J NEUROSCI, V23, P1966; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schubert M, 2008, NEUROPSYCHOPHARMACOL, V33, P2524, DOI 10.1038/sj.npp.1301633; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; Trevisani M, 2004, J PHARMACOL EXP THER, V309, P1167, DOI 10.1124/jpet.103.064162; von Bohlen und Halbach O, 2005, CELL TISSUE RES, V322, P201, DOI 10.1007/s00441-005-0004-4; von Bohlen und Halbach O, 1998, PEPTIDES, V19, P1031, DOI 10.1016/S0196-9781(98)00044-8; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Westphalen RI, 2006, J PHARMACOL EXP THER, V316, P208, DOI 10.1124/jpet.105.090647; Zechel S, 2007, CELL TISSUE RES, V328, P651, DOI 10.1007/s00441-007-0388-4; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	82	63	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16116	10.1371/journal.pone.0016116	http://dx.doi.org/10.1371/journal.pone.0016116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249195	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000020
J	Ouwe-Missi-Oukem-Boyer, O; Ndouo, FST; Ollomo, B; Mezui-Me-Ndong, J; Noulin, F; Lachard, I; Ndong-Atome, GR; Makuwa, M; Roques, P; Branger, M; Preux, PM; Mazier, D; Bisser, S				Ouwe-Missi-Oukem-Boyer, Odile; Ndouo, Fousseyni S. Toure; Ollomo, Benjamin; Mezui-Me-Ndong, Jerome; Noulin, Florian; Lachard, Isabelle; Ndong-Atome, Guy-Roger; Makuwa, Maria; Roques, Pierre; Branger, Michel; Preux, Pierre-Marie; Mazier, Dominique; Bisser, Sylvie			Hepatitis C Virus Infection May Lead to Slower Emergence of P. falciparum in Blood	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; B-VIRUS; MALARIA INFECTION; RURAL GABON; PREVALENCE; TRANSMISSION; RESISTANCE; POPULATION; PROTECTION	Background: Areas endemic for Plasmodium falciparum, hepatitis B virus (HBV) and hepatitis C virus (HCV) overlap in many parts of sub-Saharan Africa. HBV and HCV infections develop in the liver, where takes place the first development stage of P. falciparum before its further spread in blood. The complex mechanisms involved in the development of hepatitis may potentially influence the development of the liver stage of malaria parasites. Understanding the molecular mechanisms of these interactions could provide new pathophysiological insights for treatment strategies in Malaria. Methodology: We studied a cohort of 319 individuals living in a village where the three infections are prevalent. The patients were initially given a curative antimalarial treatment and were then monitored for the emergence of asexual P. falciparum forms in blood, fortnightly for one year, by microscopy and polymerase chain reaction. Principal Findings: At inclusion, 65 (20.4%) subjects had detectable malaria parasites in blood, 36 (11.3%) were HBV chronic carriers, and 61 (18.9%) were HCV chronic carriers. During follow-up, asexual P. falciparum forms were detected in the blood of 203 patients. The median time to P. falciparum emergence in blood was respectively 140 and 120 days in HBV- and HBV+ individuals, and 135 and 224 days in HCV- and HCV+ individuals. HCV carriage was associated with delayed emergence of asexual P. falciparum forms in blood relative to patients without HCV infection. Conclusions: This pilot study represents first tentative evidence of a potential epidemiological interaction between HBV, HCV and P. falciparum infections. Age is an important confounding factor in this setting however multivariate analysis points to an interaction between P. falciparum and HCV at the hepatic level with a slower emergence of P. falciparum in HCV chronic carriers. More in depth analysis are necessary to unravel the basis of hepatic interactions between these two pathogens, which could help in identifying new therapeutic approaches against malaria.	[Ouwe-Missi-Oukem-Boyer, Odile; Ndouo, Fousseyni S. Toure; Ollomo, Benjamin; Mezui-Me-Ndong, Jerome; Noulin, Florian; Lachard, Isabelle; Ndong-Atome, Guy-Roger; Makuwa, Maria; Roques, Pierre; Bisser, Sylvie] Ctr Int Rech Med Franceville, Franceville, Gabon; [Branger, Michel] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Preux, Pierre-Marie; Bisser, Sylvie] Univ Limoges, IFR GEIST 145, Inst Neurol Trop, EA NeuroEpidemiol Trop & Comparee 3174, Limoges, France; [Mazier, Dominique] INSERM, U945, Paris, France; [Mazier, Dominique] Univ Paris 06, UMR S945, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Roques, Pierre] CEA, Div ImmunoVirol SIV, Inst Emerging Dis & Innovat Therapies IMETI, Fontenay Aux Roses, France; [Roques, Pierre] Univ Paris 11, UMR E1, Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ouwe-Missi-Oukem-Boyer, O (corresponding author), Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.	ooukem@yahoo.fr	PREUX, Pierre-Marie/B-8393-2014; noulin, florian/J-3809-2013; Roques, Pierre/M-2212-2013; Preux, Pierre-Marie/N-3538-2019	PREUX, Pierre-Marie/0000-0002-2171-2977; noulin, florian/0000-0001-7430-8073; Roques, Pierre/0000-0003-1825-1054; Preux, Pierre-Marie/0000-0002-2171-2977	Total Gabon; Gabonese government; French Foreign Ministry	Total Gabon(Total SA); Gabonese government; French Foreign Ministry	This study was supported by Centre International de Recherche Medicale de Franceville (CIRMF), which is jointly funded by Total Gabon, the Gabonese government, and the French Foreign Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; BRABIN L, 1989, ANN TROP MED PARASIT, V83, P365, DOI 10.1080/00034983.1989.11812359; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; Daubersies P, 1996, AM J TROP MED HYG, V54, P18, DOI 10.4269/ajtmh.1996.54.18; DAZZA MC, 1993, T ROY SOC TROP MED H, V87, P539, DOI 10.1016/0035-9203(93)90078-5; DELAPORTE E, 1993, T ROY SOC TROP MED H, V87, P636, DOI 10.1016/0035-9203(93)90269-V; Deloron P, 1999, AM J TROP MED HYG, V61, P99, DOI 10.4269/ajtmh.1999.61.99; Dieye A, 1997, PARASITOL TODAY, V13, P48, DOI 10.1016/S0169-4758(96)20062-6; Domarle O, 1999, AM J TROP MED HYG, V61, P926, DOI 10.4269/ajtmh.1999.61.926; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; DUPONT A, 1988, ANN SOC BELG MED TR, V68, P157; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Guidotti LG, 1996, P NATL ACAD SCI USA, V93, P4589, DOI 10.1073/pnas.93.10.4589; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Mayengue PI, 2004, TROP MED INT HEALTH, V9, P949, DOI 10.1111/j.1365-3156.2004.01294.x; Mazier D, 1993, Parassitologia, V35 Suppl, P59; Migot-Nabias F, 1999, TISSUE ANTIGENS, V53, P580, DOI 10.1034/j.1399-0039.1999.530610.x; Migot-Nabias F, 1999, AM J TROP MED HYG, V61, P488; Morel CM, 2002, SCIENCE, V298, P79, DOI 10.1126/science.1078047; MOUNT DL, 1989, B WORLD HEALTH ORGAN, V67, P295; Ndong-Atome GR, 2008, J MED VIROL, V80, P1581, DOI 10.1002/jmv.21252; Njouom R, 2003, J MED VIROL, V71, P219, DOI 10.1002/jmv.10473; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Ouwe-Missi-Oukem-Boyer O N, 2005, Bull Soc Pathol Exot, V98, P343; Oyedeji SI, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-112; Pasquetto V, 2000, J EXP MED, V192, P529, DOI 10.1084/jem.192.4.529; Perraut R, 2003, J INFECT DIS, V188, P1940, DOI 10.1086/379838; Pied S, 2000, J IMMUNOL, V164, P1463, DOI 10.4049/jimmunol.164.3.1463; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; RICHARDLENOBLE D, 1995, AM J TROP MED HYG, V53, P338, DOI 10.4269/ajtmh.1995.53.338; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna CS, 2001, AM J TROP MED HYG, V65, P167, DOI 10.4269/ajtmh.2001.65.167; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Taylor-Robinson, 2000, Parasitol Today, V16, P509, DOI 10.1016/S0169-4758(00)01833-0; TAYLORROBINSON A, 2000, J EXP MED, V192, P529; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Toure FS, 2006, CLIN MED RES, V4, P175, DOI [10.3121/cmr.4.3.175, 10.3121/cmr.4.1.1]; WHO, 2006, GUID TREATM MAL; World Health Organization, 2002, WKLY EPIDEMIOL REC, V77, P45; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013	48	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16034	10.1371/journal.pone.0016034	http://dx.doi.org/10.1371/journal.pone.0016034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249226	gold, Green Submitted, Green Published			2022-12-27	WOS:000286513100024
J	Sukenik, S; Politi, R; Ziserman, L; Danino, D; Friedler, A; Harries, D				Sukenik, Shahar; Politi, Regina; Ziserman, Lior; Danino, Dganit; Friedler, Assaf; Harries, Daniel			Crowding Alone Cannot Account for Cosolute Effect on Amyloid Aggregation	PLOS ONE			English	Article							RAMAN OPTICAL-ACTIVITY; EXCLUDED SURFACE-AREA; PROTEIN AGGREGATION; FIBRIL FORMATION; II CONFORMATION; HEAT-CAPACITIES; BETA-PEPTIDE; WATER; STABILITY; DISEASE	Amyloid fiber formation is a specific form of protein aggregation, often resulting from the misfolding of native proteins. Aimed at modeling the crowded environment of the cell, recent experiments showed a reduction in fibrillation halftimes for amyloid-forming peptides in the presence of cosolutes that are preferentially excluded from proteins and peptides. The effect of excluded cosolutes has previously been attributed to the large volume excluded by such inert cellular solutes, sometimes termed "macromolecular crowding". Here, we studied a model peptide that can fold to a stable monomeric beta-hairpin conformation, but under certain solution conditions aggregates in the form of amyloid fibrils. Using Circular Dichroism spectroscopy (CD), we found that, in the presence of polyols and polyethylene glycols acting as excluded cosolutes, the monomeric beta-hairpin conformation was stabilized with respect to the unfolded state. Stabilization free energy was linear with cosolute concentration, and grew with molecular volume, as would also be predicted by crowding models. After initiating the aggregation process with a pH jump, fibrillation in the presence and absence of cosolutes was followed by ThT fluorescence, transmission electron microscopy, and CD spectroscopy. Polyols (glycerol and sorbitol) increased the lag time for fibril formation and elevated the amount of aggregated peptide at equilibrium, in a cosolute size and concentration dependent manner. However, fibrillation rates remained almost unaffected by a wide range of molecular weights of soluble polyethylene glycols. Our results highlight the importance of other forces beyond the excluded volume interactions responsible for crowding that may contribute to the cosolute effects acting on amyloid formation.	[Sukenik, Shahar; Politi, Regina; Friedler, Assaf; Harries, Daniel] Hebrew Univ Jerusalem, Fritz Haber Res Ctr, Inst Chem, IL-91904 Jerusalem, Israel; [Ziserman, Lior; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Russell Berrie Nanotechnol Inst, Haifa, Israel	Hebrew University of Jerusalem; Technion Israel Institute of Technology	Sukenik, S (corresponding author), Hebrew Univ Jerusalem, Fritz Haber Res Ctr, Inst Chem, Edmund J Safra Campus, IL-91904 Jerusalem, Israel.	daniel@fh.huji.ac.il	Danino, Dganit/D-6832-2016; Sukenik, Shahar/J-4438-2013; Harries, Daniel/F-7016-2012	Danino, Dganit/0000-0002-9782-4940; Sukenik, Shahar/0000-0003-3855-9574; Harries, Daniel/0000-0002-3057-9485	Israel Science Foundation (ISF) [1011/07]; European Research Council under the European Community [203413]; Minerva Foundation, Munich, Germany	Israel Science Foundation (ISF)(Israel Science Foundation); European Research Council under the European Community(European Research Council (ERC)); Minerva Foundation, Munich, Germany	DH has received financial support from the Israel Science Foundation (ISF grant No. 1011/07). AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 203413. The Fritz Haber Research Center is supported by the Minerva Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Athawale MV, 2005, BIOPHYS J, V89, P858, DOI 10.1529/biophysj.104.056671; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Blodgett MB, 2007, J CHEM THERMODYN, V39, P627, DOI 10.1016/j.jct.2006.08.009; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Capp MW, 2009, BIOCHEMISTRY-US, V48, P10372, DOI 10.1021/bi901273r; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; DIPAOLA G, 1977, CAN J CHEM, V55, P3825, DOI 10.1139/v77-540; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eker F, 2004, BIOCHEMISTRY-US, V43, P6893, DOI 10.1021/bi049542+; Eliassi A, 1998, J CHEM ENG DATA, V43, P719, DOI 10.1021/je970228a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gee MB, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253299; GIBBS JW, 1993, EQUILIBRIUM HETEROGE; GLENNER GG, 1980, NEW ENGL J MED, V302, P1333, DOI 10.1056/NEJM198006123022403; Griffiths-Jones SR, 1999, J MOL BIOL, V292, P1051, DOI 10.1006/jmbi.1999.3119; Guo F, 2009, J PHYS CHEM B, V113, P16632, DOI 10.1021/jp9072284; Gurnev PA, 2009, CHEMPHYSCHEM, V10, P1445, DOI 10.1002/cphc.200900312; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamley IW, 2010, MACROMOL BIOSCI, V10, P40, DOI 10.1002/mabi.200900217; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harries D, 2008, METHOD CELL BIOL, V84, P679, DOI 10.1016/S0091-679X(07)84022-2; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; IZHACK C, 2008, ANGEW CHEM, V47, P4062; Kuffel A, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3464768; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu FF, 2009, J PHYS CHEM B, V113, P11320, DOI 10.1021/jp905580j; Maynard AJ, 1998, J AM CHEM SOC, V120, P1996, DOI 10.1021/ja9726769; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Minton AP, 2000, BIOPHYS CHEM, V86, P239, DOI 10.1016/S0301-4622(00)00151-4; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Minton AP, 2001, BIOPHYS J, V80, P1641, DOI 10.1016/S0006-3495(01)76136-X; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; PARSEGIAN VA, 2002, INT REV CYTOLOGY SUR, P1; PARSEGIAN VA, 1995, MACROMOLECULES WATER, P43; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; PERCZEL A, 1991, PROTEIN ENG, V4, P669, DOI 10.1093/protein/4.6.669; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Politi R, 2010, CHEM COMMUN, V46, P6449, DOI 10.1039/c0cc01763a; Politi R, 2009, J PHYS CHEM A, V113, P7548, DOI 10.1021/jp9010026; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Rosgen J, 2007, PROTEIN SCI, V16, P733, DOI 10.1110/ps.062671607; Rudan-Tasic D, 2003, J MOL LIQ, V103, P187, DOI 10.1016/S0167-7322(02)00139-3; SHI Z, 2002, IS POLYPROLINE 2 MAJ, P163; Sidorova NY, 2000, BIOPOLYMERS, V53, P363, DOI 10.1002/(SICI)1097-0282(20000415)53:5<363::AID-BIP1>3.0.CO;2-Q; SILIGARDI G, 1995, BIOPOLYMERS, V37, P281, DOI 10.1002/bip.360370406; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Stanley CB, 2008, BIOPHYS J, V94, P4427, DOI 10.1529/biophysj.107.122705; Sun J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789434; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; WYMAN J, 1964, LINKED FUNCTIONS REC, P223; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	71	46	46	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15608	10.1371/journal.pone.0015608	http://dx.doi.org/10.1371/journal.pone.0015608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249221	gold, Green Published			2022-12-27	WOS:000286513100007
J	Benagli, C; Rossi, V; Dolina, M; Tonolla, M; Petrini, O				Benagli, Cinzia; Rossi, Viviana; Dolina, Marisa; Tonolla, Mauro; Petrini, Orlando			Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for the Identification of Clinically Relevant Bacteria	PLOS ONE			English	Article							DESORPTION/IONIZATION-TIME; DIFFERENTIATION; STREPTOCOCCI; SEQUENCE; STRAINS	Background: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) allows rapid and reliable identification of microorganisms, particularly clinically important pathogens. Methodology/Principal Findings: We compared the identification efficiency of MALDI-TOF MS with that of Phoenix (R), API (R) and 16S ribosomal DNA sequence analysis on 1,019 strains obtained from routine diagnostics. Further, we determined the agreement of MALDI-TOF MS identifications as compared to 16S gene sequencing for additional 545 strains belonging to species of Enterococcus, Gardnerella, Staphylococcus, and Streptococcus. For 94.7% of the isolates MALDI-TOF MS results were identical with those obtained with conventional systems. 16S sequencing confirmed MALDI-TOF MS identification in 63% of the discordant results. Agreement of identification of Gardnerella, Enterococcus, Streptococcus and Staphylococcus species between MALDI-TOF MS and traditional method was high (Crohn's kappa values: 0.9 to 0.93). Conclusions/Significance: MALDI-TOF MS represents a rapid, reliable and cost-effective identification technique for clinically relevant bacteria.	[Benagli, Cinzia; Rossi, Viviana; Dolina, Marisa; Tonolla, Mauro; Petrini, Orlando] Cantonal Inst Microbiol, Bellinzona, Switzerland; [Tonolla, Mauro] Univ Geneva, Dept Plant Biol, Microbiol Unit, CH-1211 Geneva 4, Switzerland	University of Geneva	Benagli, C (corresponding author), Cantonal Inst Microbiol, Bellinzona, Switzerland.	cinzia.benagli@ti.ch	Petrini, Orlando/G-4392-2010	Petrini, Orlando/0000-0002-1234-7832; Tonolla, Mauro/0000-0002-8861-7763				Bernardo K, 2002, PROTEOMICS, V2, P747, DOI 10.1002/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Glazunova OO, 2009, INT J SYST EVOL MICR, V59, P2317, DOI 10.1099/ijs.0.005488-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Majcherczyk PA, 2006, FEMS MICROBIOL LETT, V255, P233, DOI 10.1111/j.1574-6968.2005.00060.x; Marinach C, 2009, PROTEOMICS, V9, P4627, DOI 10.1002/pmic.200900152; Marinach-Patrice C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008862; Moura H, 2008, FEMS IMMUNOL MED MIC, V53, P333, DOI 10.1111/j.1574-695X.2008.00428.x; Rupf S, 2005, ORAL MICROBIOL IMMUN, V20, P267, DOI 10.1111/j.1399-302X.2005.00223.x; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; Wilkins CL, 2006, CHEM ANAL SERIES MON, V169, P1	17	111	116	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16424	10.1371/journal.pone.0016424	http://dx.doi.org/10.1371/journal.pone.0016424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283545	gold, Green Submitted, Green Published			2022-12-27	WOS:000286661400050
J	Lerdsamran, H; Pittayawonganon, C; Pooruk, P; Mungaomklang, A; Iamsirithaworn, S; Thongcharoen, P; Kositanont, U; Auewarakul, P; Chokephaibulkit, K; Oota, S; Pongkankham, W; Silaporn, P; Komolsiri, S; Noisumdaeng, P; Chotpitayasunondh, T; Sangsajja, C; Wiriyarat, W; Louisirirotchanakul, S; Puthavathana, P				Lerdsamran, Hatairat; Pittayawonganon, Chakrarat; Pooruk, Phisanu; Mungaomklang, Anek; Iamsirithaworn, Sopon; Thongcharoen, Prasert; Kositanont, Uraiwan; Auewarakul, Prasert; Chokephaibulkit, Kulkanya; Oota, Sineenat; Pongkankham, Warin; Silaporn, Patummal; Komolsiri, Supaloek; Noisumdaeng, Pirom; Chotpitayasunondh, Tawee; Sangsajja, Chariya; Wiriyarat, Witthawat; Louisirirotchanakul, Suda; Puthavathana, Pilaipan			Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population	PLOS ONE			English	Article							H5N1 VIRUS; HA2 GLYCOPOLYPEPTIDE; ANTIBODY-RESPONSES; VACCINE; HEMAGGLUTININ; INHIBITION; PROTECTION; STRAIN	Background: Individuals infected with the 2009 pandemic virus A(H1N1) developed serological response which can be measured by hemagglutination-inhibition (HI) and microneutralization (microNT) assays. Methodology/Principal Findings: MicroNT and HI assays for specific antibody to the 2009 pandemic virus were conducted in serum samples collected at the end of the first epidemic wave from various groups of Thai people: laboratory confirmed cases, blood donors and health care workers (HCW) in Bangkok and neighboring province, general population in the North and the South, as well as archival sera collected at pre- and post-vaccination from vaccinees who received influenza vaccine of the 2006 season. This study demonstrated that goose erythrocytes yielded comparable HI antibody titer as compared to turkey erythrocytes. In contrast to the standard protocol, our investigation found out the necessity to eliminate nonspecific inhibitor present in the test sera by receptor destroying enzyme (RDE) prior to performing microNT assay. The investigation in pre-pandemic serum samples showed that HI antibody was more specific to the 2009 pandemic virus than NT antibody. Based on data from pre-pandemic sera together with those from the laboratory confirmed cases, HI antibody titers >= 40 for adults and > 20 for children could be used as the cut-off level to differentiate between the individuals with or without past infection by the 2009 pandemic virus. Conclusions/Significance: Based on the cut-off criteria, the infection rates of 7 and 12.8% were estimated in blood donors and HCW, respectively after the first wave of the 2009 influenza pandemic. Among general population, the infection rate of 58.6% was found in children versus 3.1% in adults.	[Lerdsamran, Hatairat; Pooruk, Phisanu; Thongcharoen, Prasert; Kositanont, Uraiwan; Auewarakul, Prasert; Komolsiri, Supaloek; Noisumdaeng, Pirom; Louisirirotchanakul, Suda; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Pittayawonganon, Chakrarat; Iamsirithaworn, Sopon; Silaporn, Patummal] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Nonthaburi, Thailand; [Mungaomklang, Anek] Minist Publ Hlth, Maharat Nakhonratchasima Hosp, Nakhon Ratchasima, Thailand; [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat, Bangkok 10700, Thailand; [Oota, Sineenat] Thai Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand; [Pongkankham, Warin] Royal Thai Navy, Naval Med Dept, Div Prevent Med, Chon Buri, Thailand; [Chotpitayasunondh, Tawee] Minist Publ Hlth, Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Sangsajja, Chariya] Minist Publ Hlth, Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Wiriyarat, Witthawat] Mahidol Univ, Fac Vet Sci, Nakhon Pathom, Thailand	Mahidol University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University; Thai Red Cross Society; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University	Lerdsamran, H (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.	siput@mahidol.ac.th	Auewarakul, Prasert/D-6015-2011	Tripp, Ralph/0000-0002-2924-9956; Auewarakul, Prasert/0000-0002-4745-4291	National Science and Technology Development Agency; Thailand Research Fund for Senior Research Scholar; Mahidol University	National Science and Technology Development Agency; Thailand Research Fund for Senior Research Scholar; Mahidol University	This study was supported by the National Science and Technology Development Agency, the Thailand Research Fund for Senior Research Scholar and the Mahidol University Research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auewarakul P, 2007, VACCINE, V25, P659, DOI 10.1016/j.vaccine.2006.08.026; Chan M., WORLD NOW START 2009; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; Gocnik M, 2007, J GEN VIROL, V88, P951, DOI 10.1099/vir.0.82563-0; HAJJAR LA, 2010, ANN ONCOL; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Kositanont U, 2010, VIRAL IMMUNOL, V23, P329, DOI 10.1089/vim.2009.0082; Louisirirotchanakul S, 2007, J CLIN MICROBIOL, V45, P2284, DOI 10.1128/JCM.00921-07; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; WHO, 2009, CDC PROT REALT RT PC; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2009, ASS SEV INFL PAND	34	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16164	10.1371/journal.pone.0016164	http://dx.doi.org/10.1371/journal.pone.0016164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283570	gold, Green Submitted, Green Published			2022-12-27	WOS:000286661400031
J	Zuniga, L; Marquez, V; Gonzalez-Nilo, FD; Chipot, C; Cid, LP; Sepulveda, FV; Niemeyer, MI				Zuniga, Leandro; Marquez, Valeria; Gonzalez-Nilo, Fernando D.; Chipot, Christophe; Pablo Cid, L.; Sepulveda, Francisco V.; Isabel Niemeyer, Maria			Gating of a pH-Sensitive K-2P Potassium Channel by an Electrostatic Effect of Basic Sensor Residues on the Selectivity Filter	PLOS ONE			English	Article							DOMAIN K+ CHANNELS; MOLECULAR-DYNAMICS SIMULATIONS; 2-PORE DOMAIN; FUNCTIONAL-CHARACTERISTICS; EXTRACELLULAR HISTIDINE; CRYSTAL-STRUCTURE; PORE; MECHANISM; TASK2; INACTIVATION	K+ channels share common selectivity characteristics but exhibit a wide diversity in how they are gated open. Leak K-2P K+ channels TASK-2, TALK-1 and TALK-2 are gated open by extracellular alkalinization. The mechanism for this alkalinization-dependent gating has been proposed to be the neutralization of the side chain of a single arginine (lysine in TALK-2) residue near the pore of TASK-2, which occurs with the unusual pK(a) of 8.0. We now corroborate this hypothesis by transplanting the TASK-2 extracellular pH (pH(o)) sensor in the background of a pH(o)-insensitive TASK-3 channel, which leads to the restitution of pH(o)-gating. Using a concatenated channel approach, we also demonstrate that for TASK-2 to open, pH(o) sensors must be neutralized in each of the two subunits forming these dimeric channels with no apparent cross-talk between the sensors. These results are consistent with adaptive biasing force analysis of K+ permeation using a model selectivity filter in wild-type and mutated channels. The underlying free-energy profiles confirm that either a doubly or a singly charged pH(o) sensor is sufficient to abolish ion flow. Atomic detail of the associated mechanism reveals that, rather than a collapse of the pore, as proposed for other K-2P channels gated at the selectivity filter, an increased height of the energetic barriers for ion translocation accounts for channel blockade at acid pHo. Our data, therefore, strongly suggest that a cycle of protonation/deprotonation of pH(o)-sensing arginine 224 side chain gates the TASK-2 channel by electrostatically tuning the conformational stability of its selectivity filter.	[Zuniga, Leandro; Pablo Cid, L.; Sepulveda, Francisco V.; Isabel Niemeyer, Maria] Ctr Estudios Cient, Valdivia, Chile; [Sepulveda, Francisco V.] CECS CIN, Ctr Ingn Innovac, Valdivia, Chile; [Marquez, Valeria; Gonzalez-Nilo, Fernando D.] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Chipot, Christophe] Univ Illinois, Beckman Inst, Urbana, IL USA; [Chipot, Christophe] Univ Nancy, Unite Mixte Rech CNRS UHP 7565, Equipe Dynam Assemblages Membranaires, Vandoeuvre Les Nancy, France	Universidad de Talca; University of Illinois System; University of Illinois Urbana-Champaign; Universite de Lorraine	Zuniga, L (corresponding author), Univ Concepcion, Dept Fisiol, Concepcion, Chile.	fsepulveda@cecs.cl	González Nilo, Fernando Danilo/M-5368-2017; González-Nilo, Fernando/M-5671-2016	González Nilo, Fernando Danilo/0000-0001-6857-3575; González-Nilo, Fernando/0000-0001-6857-3575; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598; Cid, Pablo/0000-0003-0394-0498	Fondecyt [1090478]; Conicyt [ACT/24]; Conicyt Base Financing Program; Gobierno Regional de Los Rios; Conicyt fund CIN	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Conicyt Base Financing Program; Gobierno Regional de Los Rios; Conicyt fund CIN	Supported by grants Fondecyt (http://www.conicyt.cl/573/propertyvalue-2229.html) 1090478 and Conicyt (http://www.conicyt.cl/573/channel.html) ACT/24. CECS is funded by Conicyt Base Financing Program. The Gobierno Regional de Los Rios (http://www.goredelosrios.cl/) and Conicyt fund CIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; DIAZ M, 1995, PFLUG ARCH EUR J PHY, V430, P168, DOI 10.1007/BF00374647; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Niemeyer MI, 2010, J BIOL CHEM, V285, P16467, DOI 10.1074/jbc.M110.107060; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Morton MJ, 2005, P NATL ACAD SCI USA, V102, P16102, DOI 10.1073/pnas.0506870102; Niemeyer M. I., 2006, BIOCHEM SOC T, V34, P903; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2003, MOL MEMBR BIOL, V20, P185, DOI 10.1080/0968768031000084181; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	52	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16141	10.1371/journal.pone.0016141	http://dx.doi.org/10.1371/journal.pone.0016141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283586	Green Published, gold			2022-12-27	WOS:000286661400027
J	Kim, JH; Karpyak, VM; Biernacka, JM; Nam, HW; Lee, MR; Preuss, UW; Zill, P; Yoon, G; Colby, C; Mrazek, DA; Choi, DS				Kim, Jeong-Hyun; Karpyak, Victor M.; Biernacka, Joanna M.; Nam, Hyung Wook; Lee, Moonnoh R.; Preuss, Ulrich W.; Zill, Peter; Yoon, Gihyun; Colby, Colin; Mrazek, David A.; Choi, Doo-Sup			Functional Role of the Polymorphic 647 T/C Variant of ENT1 (SLC29A1) and Its Association with Alcohol Withdrawal Seizures	PLOS ONE			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; REGULATES ETHANOL INTOXICATION; INDUCED MOTOR INCOORDINATION; KINASE-C-EPSILON; GLUTAMATERGIC NEUROTRANSMISSION; EXTRACELLULAR ADENOSINE; SENSITIVITY; MICE; RECEPTORS; DETERMINANTS	Background: Adenosine is involved in several neurological and behavioral disorders including alcoholism. In cultured cell and animal studies, type 1 equilibrative nucleoside transporter (ENT1, slc29a1), which regulates adenosine levels, is known to regulate ethanol sensitivity and preference. Interestingly, in humans, the ENT1 (SLC29A1) gene contains a non-synonymous single nucleotide polymorphism (647 T/C; rs45573936) that might be involved in the functional change of ENT1. Principal Findings: Our functional analysis showed that prolonged ethanol exposure increased adenosine uptake activity of mutant cells (ENT1-216Thr) compared to wild-type (ENT1-216Ile) transfected cells, which might result in reduced extracellular adenosine levels. We found that mice lacking ENT1 displayed increased propensity to ethanol withdrawal seizures compared to wild-type littermates. We further investigated a possible association of the 647C variant with alcoholism and the history of alcohol withdrawal seizures in subjects of European ancestry recruited from two independent sites. Analyses of the combined data set showed an association of the 647C variant and alcohol dependence with withdrawal seizures at the nominally significant level. Conclusions: Together with the functional data, our findings suggest a potential contribution of a genetic variant of ENT1 to the development of alcoholism with increased risk of alcohol withdrawal-induced seizures in humans.	[Kim, Jeong-Hyun; Nam, Hyung Wook; Lee, Moonnoh R.; Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Karpyak, Victor M.; Biernacka, Joanna M.; Mrazek, David A.; Choi, Doo-Sup] Mayo Clin, Dept Psychiat, Coll Med, Rochester, MN USA; [Biernacka, Joanna M.; Colby, Colin] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA; [Preuss, Ulrich W.] Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat, Halle, Germany; [Zill, Peter] Univ Munich, Sect Psychiat Genet & Neurochem, Munich, Germany; [Yoon, Gihyun] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Martin Luther University Halle Wittenberg; University of Munich; University of Minnesota System; University of Minnesota Twin Cities	Kim, JH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	choids@mayo.edu	Karpyak, Victor M./AGJ-2595-2022; Choi, Doo-Sup/G-9474-2012	Karpyak, Victor M./0000-0002-9552-6130; Choi, Doo-Sup/0000-0002-6796-9938	Mayo Clinic; National Institutes of Health [AA015164, AA018779, AA017830-Project 1]; Ludwig-Maximilians-University, Munich, Germany; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017830, R01AA015164, R01AA018779] Funding Source: NIH RePORTER	Mayo Clinic; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig-Maximilians-University, Munich, Germany; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Samuel Johnson Genomics of Addiction Program at Mayo Clinic (VMK, JMB, DAM, DSC), and in part by the National Institutes of Health grant AA015164, AA018779, and AA017830-Project 1 (DSC). The study in Germany was supported by the FoFoLe Program of the Ludwig-Maximilians-University, Munich, Germany (UWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Becker HC, 1997, PHARMACOL BIOCHEM BE, V57, P179, DOI 10.1016/S0091-3057(96)00303-6; Boison D, 2005, NEUROSCIENTIST, V11, P25, DOI 10.1177/1073858404269112; Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; Boison D, 2006, TRENDS PHARMACOL SCI, V27, P652, DOI 10.1016/j.tips.2006.10.008; Bone DBJ, 2007, MOL MEMBR BIOL, V24, P294, DOI 10.1080/09687860701210617; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Chen JH, 2010, BEHAV BRAIN RES, V208, P636, DOI 10.1016/j.bbr.2010.01.011; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Choi DS, 2002, J NEUROSCI, V22, P9905; CHOI DS, 2009, PHARMACOL THERAPEUT, P817; Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4; Coe IR, 1996, J PHARMACOL EXP THER, V276, P365; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; DAR MS, 1990, PHARMACOL BIOCHEM BE, V37, P747, DOI 10.1016/0091-3057(90)90558-Y; DAR MS, 1990, J PHARMACOL EXP THER, V255, P1202; DRAGUNOW M, 1991, ANN NEUROL, V29, P575, DOI 10.1002/ana.410290524; Duka T, 2004, ALCOHOL CLIN EXP RES, V28, P233, DOI 10.1097/01.ALC.0000113780.41701.81; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; Hammond JR, 2000, N-S ARCH PHARMACOL, V361, P373, DOI 10.1007/s002100000214; Harwood HJ, 1998, RECENT DEV ALCOHOL, V14, P307, DOI 10.1007/0-306-47148-5_14; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kaplan GB, 1999, ALCOHOL, V19, P157, DOI 10.1016/S0741-8329(99)00033-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Levran O, 2009, GENES BRAIN BEHAV, V8, P531, DOI 10.1111/j.1601-183X.2009.00501.x; LISKOW BI, 1987, J STUD ALCOHOL, V48, P356, DOI 10.15288/jsa.1987.48.356; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MESSING RO, 1991, J BIOL CHEM, V266, P23428; Nagel J, 2002, BEHAV BRAIN RES, V134, P485, DOI 10.1016/S0166-4328(02)00062-1; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Nam HW, 2010, NEUROSCI LETT, V479, P277, DOI 10.1016/j.neulet.2010.05.079; Osato DH, 2003, PHARMACOGENETICS, V13, P297, DOI 10.1097/00008571-200305000-00010; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K; SAPRU MK, 1994, J PHARMACOL EXP THER, V271, P542; Schmidt LG, 2000, EUR PSYCHIAT, V15, P135, DOI 10.1016/S0924-9338(00)00220-0; Schork NJ, 1998, ALCOHOL, V16, P71, DOI 10.1016/S0741-8329(97)00179-1; SCHUCKIT MA, 1995, ADDICTION, V90, P1335, DOI 10.1046/j.1360-0443.1995.901013355.x; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Tsai GC, 1998, ANNU REV MED, V49, P173; Tsai GCE, 1998, AM J PSYCHIAT, V155, P726; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Wu JH, 2010, ALCOHOL CLIN EXP RES, V34, P1110, DOI 10.1111/j.1530-0277.2010.01187.x	51	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16331	10.1371/journal.pone.0016331	http://dx.doi.org/10.1371/journal.pone.0016331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283641	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400030
J	Martinez-Marignac, VL; Rodrigue, A; Davidson, D; Couillard, M; Al-Moustafa, AE; Abramovitz, M; Foulkes, WD; Masson, JY; Aloyz, R				Martinez-Marignac, Veronica L.; Rodrigue, Amelie; Davidson, David; Couillard, Martin; Al-Moustafa, Ala-Eddin; Abramovitz, Mark; Foulkes, William D.; Masson, Jean-Yves; Aloyz, Raquel			The Effect of a DNA Repair Gene on Cellular Invasiveness: Xrcc3 Over-Expression in Breast Cancer Cells	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATIONAL REPAIR; MATRIX-METALLOPROTEINASE; CISPLATIN RESISTANCE; LUNG-CANCER; PROTEIN KU; NUDE-MICE; METASTASIS; CARCINOMA; MIGRATION; INVASION	Over-expression of DNA repair genes has been associated with resistance to radiation and DNA-damage induced by chemotherapeutic agents such as cisplatin. More recently, based on the analysis of genome expression profiling, it was proposed that over-expression of DNA repair genes enhances the invasive behaviour of tumour cells. In this study we present experimental evidence utilizing functional assays to test this hypothesis. We assessed the effect of the DNA repair proteins known as X-ray complementing protein 3 (XRCC3) and RAD51, to the invasive behavior of the MCF-7 luminal epithelial-like and BT20 basal-like triple negative human breast cancer cell lines. We report that stable or transient overexpression of XRCC3 but not RAD51 increased invasiveness in both cell lines in vitro. Moreover, XRCC3 over-expressing MCF7 cells also showed a higher tumorigenesis in vivo and this phenotype was associated with increased activity of the metalloproteinase MMP-9 and the expression of known modulators of cell-cell adhesion and metastasis such as CD44, ID-1, DDR1 and TFF1. Our results suggest that in addition to its' role in facilitating repair of DNA damage, XRCC3 affects invasiveness of breast cancer cell lines and the expression of genes associated with cell adhesion and invasion.	[Martinez-Marignac, Veronica L.; Davidson, David; Couillard, Martin; Al-Moustafa, Ala-Eddin; Abramovitz, Mark; Aloyz, Raquel] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Martinez-Marignac, Veronica L.; Davidson, David; Couillard, Martin; Al-Moustafa, Ala-Eddin; Abramovitz, Mark; Aloyz, Raquel] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Foulkes, William D.; Aloyz, Raquel] McGill Univ, Fac Med, Program Canc Genet, Montreal, PQ H3T 1E2, Canada; [Aloyz, Raquel] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Rodrigue, Amelie; Masson, Jean-Yves] Univ Laval, Genome Stabil Lab, Canc Res Ctr, Hotel Dieu Quebec, Quebec City, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Laval University	Aloyz, R (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.; Aloyz, R (corresponding author), McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada.; Aloyz, R (corresponding author), McGill Univ, Fac Med, Program Canc Genet, Montreal, PQ H3T 1E2, Canada.; Aloyz, R (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	raquel.aloyz@mcgill.ca	Aloyz, Raquel S/N-6606-2013; Foulkes, William D./AAR-9586-2021	Aloyz, Raquel S/0000-0002-6812-497X; Foulkes, William D./0000-0001-7427-4651; Rodrigue, Amelie/0000-0001-9883-7084; Masson, Jean Yves/0000-0002-4403-7169	Weekend to End Breast Cancer-Jewish General Hospital Foundation; CIHR [MOP-86519]; Canadian Breast Cancer Research Alliance	Weekend to End Breast Cancer-Jewish General Hospital Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance	This work was funded by the Weekend to End Breast Cancer-Jewish General Hospital Foundation grant to Raquel Aloyz, a grant from the CIHR (MOP-86519) to Jean Yves Masson. Preliminary results were obtained with funding from the Canadian Breast Cancer Research Alliance to Raquel Aloyz and William D Foulkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloyz R, 2002, CANCER RES, V62, P5457; Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; *CAN CANC SOC STEE, CAN CANC STAT 2010; Crosier M, 2001, AM J PATHOL, V159, P215, DOI 10.1016/S0002-9440(10)61687-2; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Ganguly A, 2010, MOL VIS, V16, P1292; HARRIS AL, 1985, INT J RADIAT BIOL, V48, P675, DOI 10.1080/09553008514551781; Honrado E, 2005, J CLIN ONCOL, V23, P7503, DOI 10.1200/JCO.2005.01.3698; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Hussain S, 2006, DNA REPAIR, V5, P629, DOI 10.1016/j.dnarep.2006.02.007; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KUBOTA T, 1993, SURG TODAY, V23, P375, DOI 10.1007/BF00309059; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu CY, 2007, LUNG CANCER, V55, P303, DOI 10.1016/j.lungcan.2006.10.019; Loignon M, 2007, CELL CYCLE, V6, P606, DOI 10.4161/cc.6.5.3923; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Mimeault M, 2010, DRUG DISCOV TODAY, V15, P354, DOI 10.1016/j.drudis.2010.03.009; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Park HS, 2007, ONCOL REP, V18, P1435; Paupert J, 2007, EMBO REP, V8, P583, DOI 10.1038/sj.embor.7400976; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Sarasin A, 2010, CURR MOL MED, V10, P413, DOI 10.2174/156652410791317011; Sarasin A, 2008, MUTAT RES-REV MUTAT, V659, P49, DOI 10.1016/j.mrrev.2007.12.002; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; THEUNISSEN PHMH, 1992, HISTOPATHOLOGY, V20, P251, DOI 10.1111/j.1365-2559.1992.tb00964.x; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZM, 2001, J NATL CANCER I, V93, P1473, DOI 10.1093/jnci/93.19.1473; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Xu ZY, 2005, J PHARMACOL EXP THER, V314, P495, DOI 10.1124/jpet.105.084053; Xu ZY, 2002, ANTI-CANCER DRUG, V13, P511, DOI 10.1097/00001813-200206000-00010; YOSHIDA K, 1995, CANCER RES, V55, P4273; Yu Q, 2000, GENE DEV, V14, P163; ZHAI YF, 1992, CANCER IMMUNOL IMMUN, V35, P237, DOI 10.1007/BF01789329	48	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16394	10.1371/journal.pone.0016394	http://dx.doi.org/10.1371/journal.pone.0016394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283680	Green Submitted, Green Published, gold			2022-12-27	WOS:000286523400032
J	Tubio, JMC; Tojo, M; Bassaganyas, L; Escaramis, G; Sharakhov, IV; Sharakhova, MV; Tornador, C; Unger, MF; Naveira, H; Costas, J; Besansky, NJ				Tubio, Jose Manuel C.; Tojo, Marta; Bassaganyas, Laia; Escaramis, Georgia; Sharakhov, Igor V.; Sharakhova, Maria V.; Tornador, Cristian; Unger, Maria F.; Naveira, Horacio; Costas, Javier; Besansky, Nora J.			Evolutionary Dynamics of the Ty3/Gypsy LTR Retrotransposons in the Genome of Anopheles gambiae	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; GENE ASSOCIATIONS; MDG1 LINEAGE; DNA; RECOMBINATION; SEQUENCE; POPULATION; CHROMOSOME; SELECTION; FIXATION	Ty3/gypsy elements represent one of the most abundant and diverse LTR-retrotransposon ( LTRr) groups in the Anopheles gambiae genome, but their evolutionary dynamics have not been explored in detail. Here, we conduct an in silico analysis of the distribution and abundance of the full complement of 1045 copies in the updated AgamP3 assembly. Chromosomal distribution of Ty3/gypsy elements is inversely related to arm length, with densities being greatest on the X, and greater on the short versus long arms of both autosomes. Taking into account the different heterochromatic and euchromatic compartments of the genome, our data suggest that the relative abundance of Ty3/gypsy LTRrs along each chromosome arm is determined mainly by the different proportions of heterochromatin, particularly pericentric heterochromatin, relative to total arm length. Additionally, the breakpoint regions of chromosomal inversion 2La appears to be a haven for LTRrs. These elements are underrepresented more than 7-fold in euchromatin, where 33% of the Ty3/gypsy copies are associated with genes. The euchromatin on chromosome 3R shows a faster turnover rate of Ty3/gypsy elements, characterized by a deficit of proviral sequences and the lowest average sequence divergence of any autosomal region analyzed in this study. This probably reflects a principal role of purifying selection against insertion for the preservation of longer conserved syntenyc blocks with adaptive importance located in 3R. Although some Ty3/gypsy LTRrs show evidence of recent activity, an important fraction are inactive remnants of relatively ancient insertions apparently subject to genetic drift. Consistent with these computational predictions, an analysis of the occupancy rate of putatively older insertions in natural populations suggested that the degenerate copies have been fixed across the species range in this mosquito, and also are shared with the sibling species Anopheles arabiensis.	[Tubio, Jose Manuel C.; Bassaganyas, Laia; Escaramis, Georgia; Tornador, Cristian] Ctr Genom Regulat, Genes & Dis Programme, Barcelona, Spain; [Tubio, Jose Manuel C.; Tojo, Marta] Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain; [Tojo, Marta] Ctr Nacl Genotipado CEGEN, Barcelona, Spain; [Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Unger, Maria F.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Naveira, Horacio] Univ A Coruna, Dept Biol Celular & Mol, La Coruna, Spain; [Costas, Javier] Complexo Hosp Univ Santiago, Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Complexo Hospitalario Universitario de Santiago de Compostela; Virginia Polytechnic Institute & State University; University of Notre Dame; Universidade da Coruna; Complexo Hospitalario Universitario de Santiago de Compostela	Tubio, JMC (corresponding author), Ctr Genom Regulat, Genes & Dis Programme, Barcelona, Spain.	nbesansk@nd.edu	Sharakhov, Igor/B-1972-2008; Tubio, Jose M.C./H-5076-2015; Costas, Javier/B-5016-2008; Tornador, Cristian/S-2197-2018; Naveira, Horacio/I-7802-2019; Escaramis, Georgia/AAR-5586-2020; Naveira, Horacio/H-7249-2014; Escaramis, Georgia/B-2997-2015	Sharakhov, Igor/0000-0003-0752-3747; Tubio, Jose M.C./0000-0003-3540-2459; Costas, Javier/0000-0003-0306-3990; Tornador, Cristian/0000-0002-6437-9270; Naveira, Horacio/0000-0002-3840-1569; Naveira, Horacio/0000-0002-3840-1569; Escaramis, Georgia/0000-0002-5416-3177; BASSAGANYAS, LAIA/0000-0002-4575-0214	National Institutes of Health [AI63508]; Xunta de Galicia (Spain); FSE European funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xunta de Galicia (Spain)(Xunta de Galicia); FSE European funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grant AI63508 to NJB. JMCT was in part supported by a fellowship from Xunta de Galicia (Spain) and FSE European funds. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bae YA, 2001, MOL BIOL EVOL, V18, P1474, DOI 10.1093/oxfordjournals.molbev.a003933; Bartolome C, 2004, GENET RES, V83, P91, DOI 10.1017/S0016672304006755; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Blumenstiel JP, 2002, MOL BIOL EVOL, V19, P2211, DOI 10.1093/oxfordjournals.molbev.a004045; BOEKE JD, 1998, 7 ICTV; Caceres M, 2001, GENOME RES, V11, P1353, DOI 10.1101/gr.174001; Charlesworth B, 1997, GENETICS, V147, P1993; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Costas J, 2001, J MOL EVOL, V53, P165, DOI 10.1007/s002390010206; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Finnegan DJ, 1992, CURR OPIN GENET DEV, V2, P861, DOI 10.1016/S0959-437X(05)80108-X; Franchini LF, 2004, MOL BIOL EVOL, V21, P1323, DOI 10.1093/molbev/msh116; Ganko EW, 2006, J MOL EVOL, V62, P111, DOI 10.1007/s00239-004-0312-4; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hua-Van A, 2005, CYTOGENET GENOME RES, V110, P426, DOI 10.1159/000084975; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Jordan IK, 1999, J MOL EVOL, V49, P352, DOI 10.1007/PL00006558; Jordan IK, 1999, GENETICA, V107, P3, DOI 10.1023/A:1004022704701; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lehmann T, 2000, J HERED, V91, P165, DOI 10.1093/jhered/91.2.165; Lerat E, 2003, GENOME RES, V13, P1889, DOI 10.1101/gr.827603; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Maside X, 2005, GENET RES, V85, P195, DOI 10.1017/S0016672305007548; McDonald JF, 1997, GENETICA, V100, P3, DOI 10.1023/A:1018392117410; MCLAIN DK, 1989, HEREDITY, V62, P257, DOI 10.1038/hdy.1989.36; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Navarro A, 1997, GENETICS, V146, P695; Nuzhdin SV, 1999, GENETICA, V107, P129, DOI 10.1023/A:1003957323876; Petrov DA, 2003, MOL BIOL EVOL, V20, P880, DOI 10.1093/molbev/msg102; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-459; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stump AD, 2007, INSECT MOL BIOL, V16, P703, DOI 10.1111/j.1365-2583.2007.00764.x; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; Tubio JMC, 2004, GENE, V330, P123, DOI [10.1016/S0378-1119(04)00039-3, 10.1016/j.gene.2004.01.012]; Xia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010592	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16328	10.1371/journal.pone.0016328	http://dx.doi.org/10.1371/journal.pone.0016328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283637	Green Submitted, gold, Green Published			2022-12-27	WOS:000286523400029
J	Coyle, DE; Li, J; Baccei, M				Coyle, Dennis E.; Li, Jie; Baccei, Mark			Regional Differentiation of Retinoic Acid-Induced Human Pluripotent Embryonic Carcinoma Stem Cell Neurons	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; RADIAL GLIAL-CELLS; NTERA-2 CELLS; TRANSCRIPTION FACTORS; ECTOPIC EXPRESSION; HNT NEURONS; ES CELLS; TRANSPLANTATION; SPECIFICATION; NEUROGENESIS	The NTERA2 cl D1 (NT2) cell line, derived from human teratocarcinoma, exhibits similar properties as embryonic stem (ES) cells or very early neuroepitheial progenitors. NT2 cells can be induced to become postmitotic central nervous system neurons (NT2N) with retinoic acid. Although neurons derived from pluripotent cells, such as NT2N, have been characterized for their neurotransmitter phenotypes, their potential suitability as a donor source for neural transplantation also depends on their ability to respond to localized environmental cues from a specific region of the CNS. Therefore, our study aimed to characterize the regional transcription factors that define the rostocaudal and dorsoventral identity of NT2N derived from a monolayer differentiation paradigm using quantitative PCR (qPCR). Purified NT2N mainly expressed both GABAergic and glutamatergic phenotypes and were electrically active but did not form functional synapses. The presence of immature astrocytes and possible radial glial cells was noted. The NT2N expressed a regional transcription factor code consistent with forebrain, hindbrain and spinal cord neural progenitors but showed minimal expression of midbrain phenotypes. In the dorsoventral plane NT2N expressed both dorsal and ventral neural progenitors. Of major interest was that even under the influence of retinoic acid, a known caudalization factor, the NT2N population maintained a rostral phenotype subpopulation which expressed cortical regional transcription factors. It is proposed that understanding the regional differentiation bias of neurons derived from pluripotent stem cells will facilitate their successful integration into existing neuronal networks within the CNS.	[Coyle, Dennis E.; Li, Jie; Baccei, Mark] Univ Cincinnati, Dept Anesthesiol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Coyle, DE (corresponding author), Univ Cincinnati, Dept Anesthesiol, Cincinnati, OH 45221 USA.	dennis.coyle@uc.edu			Department of Anesthesiology of the University of Cincinnati	Department of Anesthesiology of the University of Cincinnati	The authors gratefully acknowledge that this work was supported by funding from the Department of Anesthesiology of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1996, DEVELOPMENT, V122, P735; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bliss TM, 2006, J NEUROSCI RES, V83, P1004, DOI 10.1002/jnr.20800; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Diez del Corral R, 2003, NEURON, V40, P65; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Guillemain I, 2000, J COMP NEUROL, V422, P380, DOI 10.1002/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; HARDY M, 1994, J NEUROCHEM, V63, P482; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jain M, 2003, EXP NEUROL, V182, P113, DOI 10.1016/S0014-4886(03)00055-4; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; KOCH P, 2009, PROCNATLACADSCIUSA; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Krizbai IA, 2000, NEUROREPORT, V11, P791, DOI 10.1097/00001756-200003200-00027; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Li YQ, 2010, CELL REPROGRAM, V12, P3, DOI 10.1089/cell.2009.0033; Looijenga LHJ, 2007, ANN NY ACAD SCI, V1120, P187, DOI 10.1196/annals.1411.000; Marin O, 2000, J NEUROSCI, V20, P6063; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Misiuta IE, 2006, J NEUROSCI RES, V83, P668, DOI 10.1002/jnr.20718; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Piper DR, 2000, J NEUROPHYSIOL, V84, P534, DOI 10.1152/jn.2000.84.1.534; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Przyborski SA, 2000, EUR J NEUROSCI, V12, P3521, DOI 10.1046/j.1460-9568.2000.00230.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Serra M, 2007, J NEUROSCI RES, V85, P3557, DOI 10.1002/jnr.21451; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Simoes PD, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-5; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Squires PE, 1996, EUR J NEUROSCI, V8, P783, DOI 10.1111/j.1460-9568.1996.tb01263.x; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; TIESMAN J, 1988, IN VITRO CELL DEV B, V24, P1209; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	77	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16174	10.1371/journal.pone.0016174	http://dx.doi.org/10.1371/journal.pone.0016174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283767	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200031
J	Palande, KK; Beekman, R; van der Meeren, LE; Beverloo, HB; Valk, PJM; Touw, IP				Palande, Karishma K.; Beekman, Renee; van der Meeren, Lotte E.; Beverloo, H. Berna; Valk, Peter J. M.; Touw, Ivo P.			The Antioxidant Protein Peroxiredoxin 4 Is Epigenetically Down Regulated in Acute Promyelocytic Leukemia	PLOS ONE			English	Article							COLONY-STIMULATING-FACTOR; ACUTE MYELOID-LEUKEMIA; GENE; METHYLATION; EXPRESSION; MUTATIONS; RECEPTOR; TARGET; PRDX4; RAR	The antioxidant peroxiredoxin (PRDX) protein family comprises 6 members, which are implicated in a variety of cellular responses, including growth factor signal transduction. PRDX4 resides in the endoplasmic reticulum (ER), where it locally controls oxidative stress by reducing H2O2 levels. We recently provided evidence for a regulatory function of PRDX4 in signal transduction from a myeloid growth factor receptor, the granulocyte colony-stimulating factor receptor (G-CSFR). Upon activation, the ligand-induced G-CSFR undergoes endocytosis and routes via the early endosomes where it physically interacts with ER-resident PRDX4. PRDX4 negatively regulates G-CSFR mediated signaling. Here, we investigated whether PRDX4 is affected in acute myeloid leukemia (AML); genomic alterations and expression levels of PRDX4 were investigated. We show that genomic abnormalities involving PRDX4 are rare in AML. However, we find a strong reduction in PRDX4 expression levels in acute promyelocytic leukemia (APL) compared to normal promyelocytes and different molecular subtypes of AML. Subsequently, the possible role of DNA methylation and histone modifications in silencing of PRDX4 in APLs was investigated. We show that the reduced expression is not due to methylation of the CpG island in the promoter region of PRDX4 but correlates with increased trimethylation of histone 3 lysine residue 27 (H3K27me3) and lysine residue 4 (H3K4me3) at the transcriptional start site (TSS) of PRDX4, indicative of a bivalent histone code involved in transcriptional silencing. These findings suggest that the control of G-CSF responses by the antioxidant protein PRDX4 may be perturbed in APL.	[Palande, Karishma K.; Beekman, Renee; van der Meeren, Lotte E.; Valk, Peter J. M.; Touw, Ivo P.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Beverloo, H. Berna] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Palande, KK (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands.	i.touw@erasmusmc.nl	Beekman, Renée/AAF-2088-2020; Valk, Peter/AAX-2823-2020	Beekman, Renée/0000-0001-7081-7874; van der Meeren, Lotte Elisabeth/0000-0002-4537-5645	Dutch Cancer Society "KWF kankerbestrijding"; Center for Translational Molecular Medicine (CTMM)	Dutch Cancer Society "KWF kankerbestrijding"(KWF Kankerbestrijding); Center for Translational Molecular Medicine (CTMM)	This work was supported by grants from the Dutch Cancer Society "KWF kankerbestrijding" and by the Center for Translational Molecular Medicine (CTMM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Freedman MH, 2002, SEMIN HEMATOL, V39, P128, DOI 10.1053/shem.2002.31912; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Irandoust MI, 2007, EMBO J, V26, P1782, DOI 10.1038/sj.emboj.7601640; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; PEBUSQUE MJ, 1988, BLOOD, V72, P257; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; Verhaak RGW, 2010, CANCER TREAT RES, V145, P67, DOI 10.1007/978-0-387-69259-3_5; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Wolfler A, 2009, TRAFFIC, V10, P1168, DOI 10.1111/j.1600-0854.2009.00928.x; Zhang YM, 2004, GENE CHROMOSOME CANC, V40, P365, DOI 10.1002/gcc.20050; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612	26	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16340	10.1371/journal.pone.0016340	http://dx.doi.org/10.1371/journal.pone.0016340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283726	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200052
J	Hu, LL; Huang, T; Shi, XH; Lu, WC; Cai, YD; Chou, KC				Hu, Lele; Huang, Tao; Shi, Xiaohe; Lu, Wen-Cong; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Functions of Proteins in Mouse Based on Weighted Protein-Protein Interaction Network and Protein Hybrid Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SECONDARY STRUCTURE; GENE ONTOLOGY; ANNOTATION; DATABASE; CLASSIFICATION; BIOINFORMATICS; MODEL	Background: With the huge amount of uncharacterized protein sequences generated in the post-genomic age, it is highly desirable to develop effective computational methods for quickly and accurately predicting their functions. The information thus obtained would be very useful for both basic research and drug development in a timely manner. Methodology/Principal Findings: Although many efforts have been made in this regard, most of them were based on either sequence similarity or protein-protein interaction (PPI) information. However, the former often fails to work if a query protein has no or very little sequence similarity to any function-known proteins, while the latter had similar problem if the relevant PPI information is not available. In view of this, a new approach is proposed by hybridizing the PPI information and the biochemical/physicochemical features of protein sequences. The overall first-order success rates by the new predictor for the functions of mouse proteins on training set and test set were 69.1% and 70.2%, respectively, and the success rate covered by the results of the top-4 order from a total of 24 orders was 65.2%. Conclusions/Significance: The results indicate that the new approach is quite promising that may open a new avenue or direction for addressing the difficult and complicated problem.	[Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Lele; Lu, Wen-Cong] Shanghai Univ, Dept Chem, Coll Sci, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Shi, Xiaohe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiaohe] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]	National Basic Research Program of China(National Basic Research Program of China)	This research is supported by the National Basic Research Program of China 2011CB510102, 2011CB510101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Afjehi-Sadat L, 2007, NAT PROTOC, V2, P2318, DOI 10.1038/nprot.2007.317; Aguero-Chapin G, 2008, J CHEM INF MODEL, V48, P2265, DOI 10.1021/ci8001809; Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Ashburner M, 2002, NOVART FDN SYMP, V247, P66; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Brun C, 2004, GENOME BIOL, V5; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cai YD, 2004, BIOINFORMATICS, V20, P1292, DOI 10.1093/bioinformatics/bth085; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Chen Y, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P471; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Chua HN, 2006, LECT NOTES COMPUT SC, V3916, P1; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Maciag K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100045; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Mucchielli-Giorgi MH, 1999, BIOINFORMATICS, V15, P176, DOI 10.1093/bioinformatics/15.2.176; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; NISHIKAWA K, 1982, J BIOCHEM-TOKYO, V91, P1821, DOI 10.1093/oxfordjournals.jbchem.a133877; Ofran Y, 2005, DRUG DISCOV TODAY, V10, P1475, DOI 10.1016/S1359-6446(05)03621-4; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Renugopalakrishnan V, 1999, BIOCHEM BIOPH RES CO, V258, P653, DOI 10.1006/bbrc.1999.0667; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruepp A, 2006, NUCLEIC ACIDS RES, V34, pD568, DOI 10.1093/nar/gkj074; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen H.-B., 2009, J BIOMED SCI ENG, V2, DOI DOI 10.4236/JBISE.2009.23024; Shen H.B., 2009, OPEN BIOINFORM J, V3, P31, DOI DOI 10.2174/1875036200903010031; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Sleator RD, 2010, ARCH MICROBIOL, V192, P151, DOI 10.1007/s00203-010-0549-9; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vlahovicek K, 2002, NUCLEIC ACIDS RES, V30, P273, DOI 10.1093/nar/30.1.273; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xiao X, 2009, J APPL CRYSTALLOGR, V42, P169, DOI 10.1107/S0021889809002751; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; ZHOU GP, 2009, BIOCH BIOPHYSICAL RE, DOI DOI 10.1016/J.BBRC.2009.1009.1084; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	69	237	237	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14556	10.1371/journal.pone.0014556	http://dx.doi.org/10.1371/journal.pone.0014556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283518	gold, Green Submitted, Green Published			2022-12-27	WOS:000286520600003
J	de Torres, JP; Casanova, C; Pinto-Plata, V; Varo, N; Restituto, P; Cordoba-Lanus, E; Baz-Davila, R; Aguirre-Jaime, A; Celli, BR				de Torres, Juan P.; Casanova, Ciro; Pinto-Plata, Victor; Varo, Nerea; Restituto, Patricia; Cordoba-Lanus, Elizabeth; Baz-Davila, Rebeca; Aguirre-Jaime, Armando; Celli, Bartolome R.			Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC INFLAMMATION; SERUM BIOMARKERS; SEX-DIFFERENCES; LUNG-CANCER; DIAGNOSIS; MASS	Rationale: Little is known about gender differences in plasma biomarker levels in patients with chronic obstructive pulmonary disease (COPD). Hypothesis: There are differences in serum biomarker levels between women and men with COPD. Objective: Explore gender differences in plasma biomarker levels in patients with COPD and smokers without COPD. Methods: We measured plasma levels of IL-6, IL-8, IL-16, MCP-1, MMP-9, PARC and VEGF in 80 smokers without COPD (40 males, 40 females) and 152 stable COPD patients (76 males, 76 females) with similar airflow obstruction. We determined anthropometrics, smoking history, lung function, exercise tolerance, body composition, BODE index, co-morbidities and quality of life. We then explored associations between plasma biomarkers levels and the clinical characteristics of the patients and also with the clinical and physiological variables known to predict outcome in COPD. Results: The plasma biomarkers level explored were similar in men and women without COPD. In contrast, in patients with COPD the median value in pg/mL of IL-6 (6.26 vs 8.0, p = 0.03), IL-16 (390 vs 321, p = 0.009) and VEGF (50 vs 87, p = 0.02) differed between women and men. Adjusted for smoking history, gender was independently associated with IL-16, PARC and VEGF levels. There were also gender differences in the associations between IL-6, IL-16 and VEGF and physiologic variables that predict outcomes. Conclusions: In stable COPD patients with similar airflow obstruction, there are gender differences in plasma biomarker levels and in the association between biomarker levels and important clinical or physiological variables. Further studies should confirm our findings.	[de Torres, Juan P.] Univ Navarra Clin, Dept Pulm, Pamplona, Spain; [Casanova, Ciro] Hosp Univ Nuestra Senora de Candelaria, Dept Pulm, Santa Cruz De Tenerife, Spain; [Pinto-Plata, Victor] St Elizabeths Med Ctr, Pulm & Crit Care Dept, Boston, MA USA; [Varo, Nerea; Restituto, Patricia] Univ Navarra Clin, Biochem Anal Dept, Pamplona, Spain; [Casanova, Ciro; Cordoba-Lanus, Elizabeth; Baz-Davila, Rebeca; Aguirre-Jaime, Armando] Hosp Univ Nuestra Senora de Candelaria, Resp Res Unit, Santa Cruz De Tenerife, Spain; [Celli, Bartolome R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pulm, Boston, MA 02115 USA	University of Navarra; St. Elizabeth's Medical Center; University of Navarra; Harvard University; Brigham & Women's Hospital; Harvard Medical School	de Torres, JP (corresponding author), Univ Navarra Clin, Dept Pulm, Pamplona, Spain.	jupa65@hotmail.com	Córdoba-Lanús, Elizabeth/B-8573-2014; Varo, Nerea/AAB-3569-2019	Varo, Nerea/0000-0002-2362-9472; de Torres, Juan Pablo/0000-0003-1231-4894; Cordoba-Lanus, Elizabeth/0000-0001-5534-8280				Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bolton CE, 2004, AM J RESP CRIT CARE, V170, P1286, DOI 10.1164/rccm.200406-754OC; Brooks SM, 1982, ATS NEWS, V8, P12; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cohen SBZ, 2007, AM J RESP CRIT CARE, V176, P113, DOI 10.1164/rccm.20011-1655PP; Conti P, 2002, ALLERGY ASTHMA PROC, V23, P103; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; de Torres JP, 2006, EUR RESPIR J, V27, P902, DOI 10.1183/09031936.06.00109605; Di Marco F, 2006, RESP MED, V100, P1767, DOI 10.1016/j.rmed.2006.01.026; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; MANNINO DM, 2002, MMWR-MORBID MORTAL W, V51, pSS6; Marwick JA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-11; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477	27	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16021	10.1371/journal.pone.0016021	http://dx.doi.org/10.1371/journal.pone.0016021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267454	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500035
J	Dye, TD; Apondi, R; Lugada, E				Dye, Timothy De Ver; Apondi, Rose; Lugada, Eric			A Qualitative Assessment of Participation in a Rapid Scale-Up, Diagonally-Integrated MDG-Related Disease Prevention Campaign in Rural Kenya	PLOS ONE			English	Article							HEALTH-CARE; PUBLIC-HEALTH; GLOBAL HEALTH; HIV; DISCLOSURE; SCIENCE; EVENTS; WOMEN	Background: Many countries face severe scale-up barriers toward achievement of MDGs. We ascertained motivational and experiential dimensions of participation in a novel, rapid, "diagonal" Integrated Prevention Campaign (IPC) in rural Kenya that provided prevention goods and services to 47,000 people within one week, aimed at rapidly moving the region toward MDG achievement. Specifically, the IPC provided interventions and commodities targeting disease burden reduction in HIV/AIDS, malaria, and water-borne illness. Methods: Qualitative in-depth interviews (IDI) were conducted with 34 people (18 living with HIV/AIDS and 16 not HIV-infected) randomly selected from IPC attendees consenting to participate. Interviews were examined for themes and patterns to elucidate participant experience and motivation with IPC. Findings: Participants report being primarily motivated to attend IPC to learn of their HIV status (through voluntary counseling and testing), and with receipt of prevention commodities (bednets, water filters, and condoms) providing further incentive. Participants reported that they were satisfied with the IPC experience and offered suggestions to improve future campaigns. Interpretation: Learning their HIV status motivated participants along with the incentive of a wider set of commodities that were rapidly deployed through IPC in this challenging region. The critical role of wanting to know their HIV status combined with commodity incentives may offer a new model for rapid scaled-up of prevention strategies that are wider in scope in rural Africa.	[Dye, Timothy De Ver] SUNY Upstate Med Univ, Syracuse, NY USA; [Apondi, Rose] Uganda Virus Res Inst, Entebbe, Uganda; [Lugada, Eric] CHF Int, Nairobi, Kenya	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Uganda Virus Research Institute	Dye, TD (corresponding author), SUNY Upstate Med Univ, Syracuse, NY USA.	dyet@upstate.edu	Dye, Timothy/HHY-9965-2022		Vestergaard-Frandsen, Lausanne, Switzerland	Vestergaard-Frandsen, Lausanne, Switzerland	This research was supported by Vestergaard-Frandsen, Lausanne, Switzerland. The funders developed the intervention in partnership with other stakeholders, though they had no role in qualitative assessment study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than to provide technical clarification as required.	Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], 2004, COCHRANE DB SYST REV; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Bhattacharya S, 2008, B WORLD HEALTH ORGAN, V86, P163, DOI 10.2471/BLT.08.051979; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Cisse B, 2007, HEALTH POLICY, V80, P51, DOI 10.1016/j.healthpol.2006.02.011; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Gielen AC, 2000, J URBAN HEALTH, V77, P480, DOI 10.1007/BF02386755; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Magnussen L, 2004, HEALTH AFFAIR, V23, P167, DOI 10.1377/hlthaff.23.3.167; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; McCannon CJ, 2007, JAMA-J AM MED ASSOC, V298, P1937, DOI 10.1001/jama.298.16.1937; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Rothman AJ, 2007, HDB MOTIVATION SCI, P494; Ryan G. W., 2003, COLLECTING INTERPRET; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UN, 2008, MILL DEV GOALS 2008; *UN DEV GROUP, 2009, GOOD PRACT SCAL MDG; UNAIDS, 2004, 4 UNAIDS; *WHO, 2008, VCT EV COUNTR CAS ST; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2009, PUBL HLTH CAMP GETT	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14551	10.1371/journal.pone.0014551	http://dx.doi.org/10.1371/journal.pone.0014551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267452	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500019
J	Clouser, CL; Holtz, CM; Mullett, M; Crankshaw, DL; Briggs, JE; Chauhan, J; VanHoutan, IM; Patterson, SE; Mansky, LM				Clouser, Christine L.; Holtz, Colleen M.; Mullett, Mary; Crankshaw, Duane L.; Briggs, Jacquie E.; Chauhan, Jay; VanHoutan, Ilze Matise; Patterson, Steven E.; Mansky, Louis M.			Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine	PLOS ONE			English	Article							RETROVIRUS-INDUCED IMMUNODEFICIENCY; RIBONUCLEOTIDE REDUCTASE INHIBITORS; DEFECTIVE VIRUS; SYNDROME MAIDS; BONE-MARROW; MURINE AIDS; CELL-LINES; MICE; DISEASE; INDUCTION	Replication of retroviral and host genomes requires ribonucleotide reductase to convert rNTPs to dNTPs, which are then used as substrates for DNA synthesis. Inhibition of ribonucleotide reductase by hydroxyurea (HU) has been previously used to treat cancers as well as HIV. However, the use of HU as an antiretroviral is limited by its associated toxicities such as myelosuppression and hepatotoxicity. In this study, we examined the ribonucleotide reductase inhibitor, gemcitabine, both in cell culture and in C57Bl/6 mice infected with LP-BM5 murine leukemia virus (LP-BM5 MuLV, a murine AIDS model). Gemcitabine decreased infectivity of MuLV in cell culture with an EC50 in the low nanomolar range with no detectable cytotoxicity. Similarly, gemcitabine significantly decreased disease progression in mice infected with LP-BM5. Specifically, gemcitabine treatment decreased spleen size, plasma IgM, and provirus levels compared to LP-BM5 MuLV infected, untreated mice. Gemcitabine efficacy was observed at doses as low as 1 mg/kg/day in the absence of toxicity. Higher doses of gemcitabine (3 mg/kg/day and higher) were associated with toxicity as determined by a loss in body mass. In summary, our findings demonstrate that gemcitabine has antiretroviral activity ex vivo and in vivo in the LP-BM5 MuLV model. These observations together with a recent ex vivo study with HIV-1[1], suggest that gemcitabine has broad antiretroviral activity and could be particularly useful in vivo when used in combination drug therapy.	[Clouser, Christine L.; Holtz, Colleen M.; Patterson, Steven E.; Mansky, Louis M.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Holtz, Colleen M.; Mansky, Louis M.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, MinnCResT Program, Minneapolis, MN 55455 USA; [Chauhan, Jay; Patterson, Steven E.; Mansky, Louis M.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN USA; [Mansky, Louis M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [VanHoutan, Ilze Matise] Univ Minnesota, Masonic Canc Ctr Comparat Pathol Shared Resource, Minneapolis, MN USA; [Mullett, Mary; Crankshaw, Duane L.; Briggs, Jacquie E.] VA Med Ctr, Dept Food Sci & Nutr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Clouser, CL (corresponding author), Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA.	mansky@umn.edu			Academic Health Center; NIH [GM56615, T32 CA009138, T32 DE07288]; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056615, R01GM056615] Funding Source: NIH RePORTER	Academic Health Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported from a Center for Drug Design Funding Agreement, an Academic Health Center Translational Research Grant, and NIH grants GM56615, T32 CA009138 (Cancer Biology Training Grant, to C. L. C.) and T32 DE07288 (MinnCResT Program, to C. M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Bender DM, 2009, J MED CHEM, V52, P6958, DOI 10.1021/jm901181h; Casabianca A, 2004, J CLIN MICROBIOL, V42, P4361, DOI 10.1128/JCM.42.9.4361-4364.2004; CHATTOPADHYAY SK, 1989, P NATL ACAD SCI USA, V86, P3862, DOI 10.1073/pnas.86.10.3862; CHATTOPADHYAY SK, 1991, J VIROL, V65, P4232, DOI 10.1128/JVI.65.8.4232-4241.1991; Clouser CL, 2010, J VIROL, V84, P9301, DOI 10.1128/JVI.01006-10; Dias ASP, 2006, CURR HIV RES, V4, P431; HARRINGTON RD, 1993, J VIROL, V67; HARTLEY JW, 1989, J VIROL, V63, P1223, DOI 10.1128/JVI.63.3.1223-1231.1989; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lori F, 1999, ANTIVIR THER, V4, P101; Mayhew C, 1997, CELL MOL BIOL, V43, P1019; Mayhew CN, 2002, ANTIVIR RES, V56, P167, DOI 10.1016/S0166-3542(02)00108-0; MORSE HC, 1992, AIDS, V6, P607, DOI 10.1097/00002030-199207000-00001; MORSE HC, 1994, SYMP SOC GEN MICROBI, V51, P265; MOSIER DE, 1987, J EXP MED, V165, P1737, DOI 10.1084/jem.165.6.1737; NOZAKI A, 2010, ARCH VIROL, V45, P66; OHNOTA H, 1990, ANTIMICROB AGENTS CH, V34, P605, DOI 10.1128/AAC.34.4.605; PATTENGALE PK, 1982, AM J PATHOL, V107, P362; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rossi L, 2002, J ANTIMICROB CHEMOTH, V50, P639, DOI 10.1093/jac/dkf205; Sakamoto H, 2006, J GASTROENTEROL, V41, P70, DOI 10.1007/s00535-005-1724-7; SIMARD C, 1995, VIROLOGY, V206, P555, DOI 10.1016/S0042-6822(95)80072-7; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; YETTER RA, 1988, J EXP MED, V168, P623, DOI 10.1084/jem.168.2.623	30	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15840	10.1371/journal.pone.0015840	http://dx.doi.org/10.1371/journal.pone.0015840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264291	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500013
J	Chertov, O; Zhang, N; Chen, X; Oppenheim, JJ; Lubkowski, J; McGrath, C; Sowder, RC; Crise, BJ; Malyguine, A; Kutzler, MA; Steele, AD; Henderson, EE; Rogers, TJ				Chertov, Oleg; Zhang, Ning; Chen, Xin; Oppenheim, Joost J.; Lubkowski, Jacek; McGrath, Connor; Sowder, Raymond C., II; Crise, Bruce J.; Malyguine, Anatoli; Kutzler, Michele A.; Steele, Amber D.; Henderson, Earl E.; Rogers, Thomas J.			Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; V3 LOOP; RECEPTOR-BINDING; LIGAND-BINDING; CC-CHEMOKINE; R5 HIV-1; CXCR4; CORECEPTOR; IDENTIFICATION	The sequential interaction of the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1) with CD4 and certain chemokine coreceptors initiates host cell entry of the virus. The appropriate chemokines have been shown to inhibit viral replication by blocking interaction of the gp120 envelope protein with the coreceptors. We considered the possibility that this interaction involves a motif of the gp120 that may be structurally homologous to the chemokines. In the amino acid sequences of most chemokines there is a Trp residue located at the beginning of the C-terminal a-helix, which is separated by six residues from the fourth Cys residue. The gp120 of all HIV-1 isolates have a similar motif, which includes the C-terminal part of a variable loop 3 (V3) and N-terminal part of a conserved region 3 (C3). Two synthetic peptides, derived from the relevant gp120 sequence inhibited HIV-1 replication in macrophages and T lymphocytes in sequence-dependent manner. The peptides also prevented binding of anti-CXCR4 antibodies to CXCR4, and inhibited the intracellular Ca(2+) influx in response to CXCL12/SDF-1 alpha. Thus these peptides can be used to dissect gp120 interactions with chemokine receptors and could serve as leads for the design of new inhibitors of HIV-1.	[Chertov, Oleg] NCI, Prot Chem Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Zhang, Ning; Chen, Xin; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Frederick, MD 21701 USA; [Lubkowski, Jacek] NCI, Ctr Macromol Crystallog, Frederick, MD 21701 USA; [McGrath, Connor] Target Struct Based Drug Discovery Grp, Frederick, MD USA; [Sowder, Raymond C., II; Crise, Bruce J.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick, MD USA; [Malyguine, Anatoli] SAIC Frederick Inc, Clin Serv Program, Frederick, MD USA; [Kutzler, Michele A.; Steele, Amber D.; Henderson, Earl E.; Rogers, Thomas J.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Fels Inst Canc Res & Mol Biol,Dept Pharmacol, Philadelphia, PA 19122 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Chertov, O (corresponding author), NCI, Prot Chem Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	rogerst@temple.edu	Chen, Xin n/a/I-6601-2015	Chen, Xin n/a/0000-0002-2628-4027; Chertov, Oleg/0000-0002-0426-2521; Kutzler, Michele/0000-0001-5692-5617	National Cancer Institute, National Institutes of Health (NIH) [N01-CO-12400]; NIH, National Cancer Institute, Center for Cancer Research; United States Public Health Service [DA-14230, DA-25532, P01DA-23860, P30DA-13429, F31 DA-05894]; National Institute on Drug Abuse [DA-06650]; NATIONAL CANCER INSTITUTE [ZIABC009369] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract N01-CO-12400. It was also supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This work was also supported by United States Public Health Service Grants DA-14230, DA-25532, P01DA-23860, P30DA-13429, and F31 DA-05894 (to M. K.), and grant DA-06650 from the National Institute on Drug Abuse. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; CAPON DJ, 1991, ANNU REV IMMUNOL, V9, P649, DOI 10.1146/annurev.iy.09.040191.003245; CHERTOV O, Patent No. 0205063; Choe W, 2001, J VIROL, V75, P10738, DOI 10.1128/JVI.75.22.10738-10745.2001; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLAYTON LK, 1989, NATURE, V339, P548, DOI 10.1038/339548a0; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; Cole SW, 2001, P NATL ACAD SCI USA, V98, P12695, DOI 10.1073/pnas.221134198; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Grainger DJ, 2003, BIOCHEM PHARMACOL, V65, P1027, DOI 10.1016/S0006-2952(02)01626-X; HAGLER AT, 1974, J AM CHEM SOC, V96, P5319, DOI 10.1021/ja00824a004; HAGLER AT, 1985, SCIENCE, V227, P1309, DOI 10.1126/science.3975616; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; Howard OMZ, 1999, J BIOL CHEM, V274, P16228, DOI 10.1074/jbc.274.23.16228; Hoxie JA, 1998, J REPROD IMMUNOL, V41, P197, DOI 10.1016/S0165-0378(98)00059-X; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Korber B.T., 1998, HUMAN RETROVIRUSES A; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; Moulard M, 1999, J PEPT RES, V53, P647, DOI 10.1034/j.1399-3011.1999.00062.x; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Sakaida H, 1998, J VIROL, V72, P9763, DOI 10.1128/JVI.72.12.9763-9770.1998; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wetzel MA, 2002, VIROLOGY, V292, P6, DOI 10.1006/viro.2001.1249; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e14474	10.1371/journal.pone.0014474	http://dx.doi.org/10.1371/journal.pone.0014474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264298	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000001
J	Marcu, O; Lera, MP; Sanchez, ME; Levic, E; Higgins, LA; Shmygelska, A; Fahlen, TF; Nichol, H; Bhattacharya, S				Marcu, Oana; Lera, Matthew P.; Sanchez, Max E.; Levic, Edina; Higgins, Laura A.; Shmygelska, Alena; Fahlen, Thomas F.; Nichol, Helen; Bhattacharya, Sharmila			Innate Immune Responses of Drosophila melanogaster Are Altered by Spaceflight	PLOS ONE			English	Article							HUMORAL STRESS-RESPONSE; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEIN; SYSTEM DYSREGULATION; SCAVENGER RECEPTOR; APOPTOTIC CELLS; LYSOZYME LOCUS; EXPRESSION; RECOGNITION; SPACE	Alterations and impairment of immune responses in humans present a health risk for space exploration missions. The molecular mechanisms underpinning innate immune defense can be confounded by the complexity of the acquired immune system of humans. Drosophila (fruit fly) innate immunity is simpler, and shares many similarities with human innate immunity at the level of molecular and genetic pathways. The goals of this study were to elucidate fundamental immune processes in Drosophila affected by spaceflight and to measure host-pathogen responses post-flight. Five containers, each containing ten female and five male fruit flies, were housed and bred on the space shuttle (average orbit altitude of 330.35 km) for 12 days and 18.5 hours. A new generation of flies was reared in microgravity. In larvae, the immune system was examined by analyzing plasmatocyte number and activity in culture. In adults, the induced immune responses were analyzed by bacterial clearance and quantitative real-time polymerase chain reaction (qPCR) of selected genes following infection with E. coli. The RNA levels of relevant immune pathway genes were determined in both larvae and adults by microarray analysis. The ability of larval plasmatocytes to phagocytose E. coli in culture was attenuated following spaceflight, and in parallel, the expression of genes involved in cell maturation was downregulated. In addition, the level of constitutive expression of pattern recognition receptors and opsonins that specifically recognize bacteria, and of lysozymes, antimicrobial peptide (AMP) pathway and immune stress genes, hallmarks of humoral immunity, were also reduced in larvae. In adults, the efficiency of bacterial clearance measured in vivo following a systemic infection with E. coli post-flight, remained robust. We show that spaceflight altered both cellular and humoral immune responses in Drosophila and that the disruption occurs at multiple interacting pathways.	[Marcu, Oana; Lera, Matthew P.; Levic, Edina; Higgins, Laura A.; Shmygelska, Alena; Bhattacharya, Sharmila] NASA, Space Biosci Div, Ames Res Ctr, Mountain View, CA USA; [Marcu, Oana] SETI Inst, Carl Sagan Ctr, Mountain View, CA USA; [Shmygelska, Alena] Carnegie Mellon Univ, NASA, Ames Res Ctr, Mountain View, CA USA; [Nichol, Helen] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Carnegie Mellon University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Saskatchewan	Marcu, O (corresponding author), NASA, Space Biosci Div, Ames Res Ctr, Mountain View, CA USA.	sharmila.bhattacharya@nasa.gov			NASA [FSB-FIT-2005]	NASA(National Aeronautics & Space Administration (NASA))	This study work was supported by a NASA grant to SB for "Fungal Pathogenesis, Tumorigenesis, and Effects of Host Immunity in the Space Environment" (FSB-FIT-2005). The funder had a role in study design and in supporting data collection.	Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; ARMSTRONG JW, 1995, EXP CELL RES, V216, P160, DOI 10.1006/excr.1995.1020; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2004, J APPL PHYSIOL, V97, P1437, DOI 10.1152/japplphysiol.00259.2004; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; BERRY WD, 1991, J INTERFERON RES, V11, P243, DOI 10.1089/jir.1991.11.243; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Busse MS, 2007, EMBO J, V26, P3826, DOI 10.1038/sj.emboj.7601798; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Fahlen T.F., 2006, GRAVITATIONAL SP BIO, V19, P133; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; KNIBIEHLER B, 1987, ROUX ARCH DEV BIOL, V196, P243, DOI 10.1007/BF00376348; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kumei Y, 1996, J BIOTECHNOL, V47, P313, DOI 10.1016/0168-1656(96)01412-5; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; KYLSTEN P, 1992, MOL GEN GENET, V232, P335, DOI 10.1007/BF00266235; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Licato LL, 1999, IMMUNOPHARMACOLOGY, V44, P273, DOI 10.1016/S0162-3109(99)00123-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Marco R, 1996, J BIOTECHNOL, V47, P179, DOI 10.1016/0168-1656(96)01408-3; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Persson C, 2007, INSECT BIOCHEM MOLEC, V37, P1309, DOI 10.1016/j.ibmb.2007.08.003; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Qiu P, 1998, DEVELOPMENT, V125, P1909; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Sackton TB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000797; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shearer WT, 2009, J ALLERGY CLIN IMMUN, V123, P900, DOI 10.1016/j.jaci.2008.12.016; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; STEINER H, 2004, IMMUNOL REV, P83; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tokusumi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006429; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; VERNOS I, 1989, International Journal of Developmental Biology, V33, P213; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Yasothornsrikul S, 1997, GENE, V198, P17, DOI 10.1016/S0378-1119(97)00274-6	102	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15361	10.1371/journal.pone.0015361	http://dx.doi.org/10.1371/journal.pone.0015361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264297	Green Published, gold, Green Submitted			2022-12-27	WOS:000286514000005
J	Plummer, P; Zhu, JE; Akiba, M; Pei, DH; Zhang, QJ				Plummer, Paul; Zhu, Jinge; Akiba, Masato; Pei, Dehua; Zhang, Qijing			Identification of a Key Amino Acid of LuxS Involved in AI-2 Production in Campylobacter jejuni	PLOS ONE			English	Article							S-RIBOSYLHOMOCYSTEINASE LUXS; ESCHERICHIA-COLI; GENE-EXPRESSION; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; CLOSTRIDIUM-DIFFICILE; BIOFILM FORMATION; BACTERIAL; AUTOINDUCER-2; VIRULENCE	Autoinducer-2 (AI-2) mediated quorum sensing has been associated with the expression of virulence factors in a number of pathogenic organisms and has been demonstrated to play a role in motility and cytolethal distending toxin (cdt) production in Campylobacter jejuni. We have initiated the work to determine the molecular basis of AI-2 synthesis and the biological functions of quorum sensing in C. jejuni. In this work, two naturally occurring variants of C. jejuni 81116 were identified, one producing high-levels of AI-2 while the other is defective in AI-2 synthesis. Sequence analysis revealed a G92D mutation in the luxS gene of the defective variant. Complementation of the AI-2 2 variant with a plasmid encoded copy of the wild-type luxS gene or reversion of the G92D mutation by site-directed mutagenesis fully restored AI-2(-) production by the variant. These results indicate that the G92D mutation alone is responsible for the loss of AI-2 activity in C. jejuni. Kinetic analyses showed that the G92D LuxS has a similar to 100-fold reduced catalytic activity relative to the wild-type enzyme. Findings from this study identify a previously undescribed amino acid that is essential for AI-2 production by LuxS and provide a unique isogenic pair of naturally occurring variants for us to dissect the functions of AI-2 mediated quorum sensing in Campylobacter.	[Plummer, Paul; Akiba, Masato; Zhang, Qijing] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA; [Plummer, Paul] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Zhu, Jinge; Pei, Dehua] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	Iowa State University; Iowa State University; University System of Ohio; Ohio State University	Plummer, P (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA.	pplummer@iastate.edu	Pei, Dehua/P-4594-2016	Pei, Dehua/0000-0002-2057-6934	National Institute for Allergy and Infectious Disease [K08AI070523-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI070523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by Grant Number K08AI070523-03 from the National Institute for Allergy and Infectious Disease (http://www.niaid.nih.gov). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute for Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JF, 2004, ORG LETT, V6, P3043, DOI 10.1021/ol049182i; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Belval SC, 2006, APPL ENVIRON MICROB, V72, P2644, DOI 10.1128/AEM.72.4.2644-2650.2006; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Carter GP, 2005, J MED MICROBIOL, V54, P119, DOI 10.1099/jmm.0.45817-0; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cloak OM, 2002, APPL ENVIRON MICROB, V68, P4666, DOI 10.1128/AEM.68.9.4666-4671.2002; DAWSON RMC, 1989, DATA BIOCHEMICAL RES; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104; He YP, 2008, FOODBORNE PATHOG DIS, V5, P399, DOI 10.1089/fpd.2008.0106; Heurlier K, 2009, J BACTERIOL, V191, P1293, DOI 10.1128/JB.01170-08; Holmgren K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-73; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jeon B, 2005, MICROBIOL IMMUNOL, V49, P599, DOI 10.1111/j.1348-0421.2005.tb03651.x; Jeon B, 2003, MICROBIOL IMMUNOL, V47, P833, DOI 10.1111/j.1348-0421.2003.tb03449.x; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Lynch SV, 2008, CURR OPIN CRIT CARE, V14, P593, DOI 10.1097/MCC.0b013e32830f1dd5; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; OHTANI K, 2009, J BACTERIOL; Olson CK, 2008, CAMPYLOBACTER, 3RD EDITION, P163; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pei DH, 2004, CURR OPIN CHEM BIOL, V8, P492, DOI 10.1016/j.cbpa.2004.08.003; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Raffa RB, 2005, J PHARMACOL EXP THER, V312, P417, DOI 10.1124/jpet.104.075150; Rajan R, 2005, BIOCHEMISTRY-US, V44, P3745, DOI 10.1021/bi0477384; Ren DC, 2004, APPL ENVIRON MICROB, V70, P2038, DOI 10.1128/AEM.70.4.2038-2043.2004; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Ruzheinikov SN, 2001, J MOL BIOL, V313, P111, DOI 10.1006/jmbi.2001.5027; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Sperondio V, 2007, EXPERT REV ANTI-INFE, V5, P271, DOI 10.1586/14787210.5.2.271; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Zhu J, 2004, BIOCHEMISTRY-US, V43, P10166, DOI 10.1021/bi0491088; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j; Zhu JG, 2008, ACS CHEM BIOL, V3, P110, DOI 10.1021/cb7002048	49	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15876	10.1371/journal.pone.0015876	http://dx.doi.org/10.1371/journal.pone.0015876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264316	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514000009
J	Fox, NJ; White, PCL; McClean, CJ; Marion, G; Evans, A; Hutchings, MR				Fox, Naomi J.; White, Piran C. L.; McClean, Colin J.; Marion, Glenn; Evans, Andy; Hutchings, Michael R.			Predicting Impacts of Climate Change on Fasciola hepatica Risk	PLOS ONE			English	Article							GEOGRAPHIC INFORMATION-SYSTEM; SPATIAL-DISTRIBUTION; ANNUAL PREVALENCE; DISEASE RISK; DAIRY HERDS; CATTLE; MODEL; LOUISIANA; ENGLAND	Fasciola hepatica (liver fluke) is a physically and economically devastating parasitic trematode whose rise in recent years has been attributed to climate change. Climate has an impact on the free-living stages of the parasite and its intermediate host Lymnaea truncatula, with the interactions between rainfall and temperature having the greatest influence on transmission efficacy. There have been a number of short term climate driven forecasts developed to predict the following season's infection risk, with the Ollerenshaw index being the most widely used. Through the synthesis of a modified Ollerenshaw index with the UKCP09 fine scale climate projection data we have developed long term seasonal risk forecasts up to 2070 at a 25 km square resolution. Additionally UKCIP gridded datasets at 5 km square resolution from 1970-2006 were used to highlight the climate-driven increase to date. The maps show unprecedented levels of future fasciolosis risk in parts of the UK, with risk of serious epidemics in Wales by 2050. The seasonal risk maps demonstrate the possible change in the timing of disease outbreaks due to increased risk from overwintering larvae. Despite an overall long term increase in all regions of the UK, spatio-temporal variation in risk levels is expected. Infection risk will reduce in some areas and fluctuate greatly in others with a predicted decrease in summer infection for parts of the UK due to restricted water availability. This forecast is the first approximation of the potential impacts of climate change on fasciolosis risk in the UK. It can be used as a basis for indicating where active disease surveillance should be targeted and where the development of improved mitigation or adaptation measures is likely to bring the greatest benefits.	[Fox, Naomi J.; Evans, Andy; Hutchings, Michael R.] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Fox, Naomi J.; White, Piran C. L.; McClean, Colin J.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Fox, Naomi J.; Marion, Glenn] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	Scottish Agricultural College; University of York - UK; James Hutton Institute	Fox, NJ (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	mike.hutchings@sac.ac.uk	White, Piran C.L./F-5091-2010; Hutchings, Mike/P-6836-2019; White, Piran Crawfurd Limond/AAH-6851-2021; Evans, Andy/AAL-9072-2021; Marion, Glenn/J-4738-2013; guillermo, andres/AAW-4702-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775; Evans, Andy/0000-0002-0272-9941; Hutchings, Mike/0000-0003-3338-471X; Marion, Glenn/0000-0002-0454-9338	Scottish Government	Scottish Government	SAC and BioSS receive funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ASRAT M, 2007, ETHIOPIA VET J, V11, P41; de Waal T., 2007, MAKING SCI WORK FARM, P60; Droogers P., 2002, Irrigation and Drainage Systems, V16, P33, DOI 10.1023/A:1015508322413; Fuentes MV, 2001, ACTA TROP, V79, P87, DOI 10.1016/S0001-706X(01)00106-1; GETTINBY G, 1974, INT J BIOMETEOROL, V18, P319, DOI 10.1007/BF01463722; GOODALL EA, 1991, AGR SYST, V36, P231, DOI 10.1016/0308-521X(91)90026-7; GOODALL EA, 1995, IMA J MATH APPL BUSI, V5, P337; Harle KJ, 2007, AGR SYST, V93, P61, DOI 10.1016/j.agsy.2006.04.003; Kenyon F, 2009, VET PARASITOL, V163, P293, DOI 10.1016/j.vetpar.2009.03.027; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; LUZONPENA M, 1994, VET PARASITOL, V55, P143, DOI 10.1016/0304-4017(94)90065-5; Mader TL, 2004, J ANIM SCI, V82, P3077; Malone JB, 1998, VET PARASITOL, V78, P87, DOI 10.1016/S0304-4017(98)00137-X; MALONE JB, 1992, PARASITOL TODAY, V8, P266, DOI 10.1016/0169-4758(92)90138-R; Malone JB, 1999, FASCIOLOSIS, P151; MALONE JB, 1987, AM J VET RES, V48, P1167; Mas-Coma S, 2009, VET PARASITOL, V163, P264, DOI 10.1016/j.vetpar.2009.03.024; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009; MCILROY SG, 1990, PREV VET MED, V9, P27, DOI 10.1016/0167-5877(90)90039-K; Nardone A, 2006, VET RES COMMUN, V30, P75, DOI 10.1007/s11259-006-0016-x; OLLERENSHAW C. B., 1966, AGR METEOROL, V3, P35, DOI 10.1016/0002-1571(66)90004-5; Ollerenshaw C. B., 1959, Veterinary Record, V71, P591; Pritchard GC, 2005, VET REC, V157, P578, DOI 10.1136/vr.157.19.578; Rapsch C, 2008, VET PARASITOL, V154, P242, DOI 10.1016/j.vetpar.2008.03.030; Rivington M, 2007, ENVIRON MODELL SOFTW, V22, P202, DOI 10.1016/j.envsoft.2005.07.018; van Dijk J, 2008, VET PARASITOL, V158, P73, DOI 10.1016/j.vetpar.2008.08.006; van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991; *VET LAB AG, VET INV SURV REP VID; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Yilma JM, 1998, VET PARASITOL, V78, P103, DOI 10.1016/S0304-4017(98)00136-8; ZUKOWSKI SH, 1993, VET PARASITOL, V47, P51, DOI 10.1016/0304-4017(93)90175-M; Zuur AF, 2007, STAT BIOL HEALTH, pVII	36	146	150	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16126	10.1371/journal.pone.0016126	http://dx.doi.org/10.1371/journal.pone.0016126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249228	Green Submitted, Green Published, gold			2022-12-27	WOS:000286513100027
J	Eisenhauer, N; Milcu, A; Sabais, ACW; Bessler, H; Brenner, J; Engels, C; Klarner, B; Maraun, M; Partsch, S; Roscher, C; Schonert, F; Temperton, VM; Thomisch, K; Weigelt, A; Weisser, WW; Scheu, S				Eisenhauer, Nico; Milcu, Alexandru; Sabais, Alexander C. W.; Bessler, Holger; Brenner, Johanna; Engels, Christof; Klarner, Bernhard; Maraun, Mark; Partsch, Stephan; Roscher, Christiane; Schonert, Felix; Temperton, Vicky M.; Thomisch, Karolin; Weigelt, Alexandra; Weisser, Wolfgang W.; Scheu, Stefan			Plant Diversity Surpasses Plant Functional Groups and Plant Productivity as Driver of Soil Biota in the Long Term	PLOS ONE			English	Article							SPECIES-DIVERSITY; EXPERIMENTAL GRASSLAND; MICROBIAL COMMUNITIES; BIODIVERSITY EXPERIMENT; TERRESTRIAL ECOSYSTEMS; NITROGEN DEPOSITION; CURRENT KNOWLEDGE; ELEVATED CO2; BIOMASS; LEGUMES	Background: One of the most significant consequences of contemporary global change is the rapid decline of biodiversity in many ecosystems. Knowledge of the consequences of biodiversity loss in terrestrial ecosystems is largely restricted to single ecosystem functions. Impacts of key plant functional groups on soil biota are considered to be more important than those of plant diversity; however, current knowledge mainly relies on short-term experiments. Methodology/Principal Findings: We studied changes in the impacts of plant diversity and presence of key functional groups on soil biota by investigating the performance of soil microorganisms and soil fauna two, four and six years after the establishment of model grasslands. The results indicate that temporal changes of plant community effects depend on the trophic affiliation of soil animals: plant diversity effects on decomposers only occurred after six years, changed little in herbivores, but occurred in predators after two years. The results suggest that plant diversity, in terms of species and functional group richness, is the most important plant community property affecting soil biota, exceeding the relevance of plant above-and belowground productivity and the presence of key plant functional groups, i.e. grasses and legumes, with the relevance of the latter decreasing in time. Conclusions/Significance: Plant diversity effects on biota are not only due to the presence of key plant functional groups or plant productivity highlighting the importance of diverse and high-quality plant derived resources, and supporting the validity of the singular hypothesis for soil biota. Our results demonstrate that in the long term plant diversity essentially drives the performance of soil biota questioning the paradigm that belowground communities are not affected by plant diversity and reinforcing the importance of biodiversity for ecosystem functioning.	[Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Milcu, Alexandru] Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England; [Sabais, Alexander C. W.; Partsch, Stephan; Schonert, Felix] Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany; [Bessler, Holger; Engels, Christof] Humboldt Univ, Dept Plant Nutr & Fertilizat, Berlin, Germany; [Brenner, Johanna; Klarner, Bernhard; Maraun, Mark; Thomisch, Karolin; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Temperton, Vicky M.] Forschungszentrum Juelich GmbH, IBG Plant Sci 2, Julich, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Bot & Funct Biodivers, Inst Biol 1, Leipzig, Germany; [Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany	University of Minnesota System; University of Minnesota Twin Cities; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Technical University of Darmstadt; Humboldt University of Berlin; University of Gottingen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Research Center Julich; Leipzig University; Friedrich Schiller University of Jena	Eisenhauer, N (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	nico.eisenhauer@web.de	Eisenhauer, Nico/I-3191-2019; Scheu, Stefan/H-7049-2015; Eisenhauer, Nico/I-5932-2012; Weisser, Wolfgang W/B-9718-2014; Milcu, Alexandru/X-6267-2018	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Weisser, Wolfgang W/0000-0002-2757-8959; Klarner, Bernhard/0000-0003-1867-4911; Temperton, Vicky/0000-0003-0543-4521; Milcu, Alexandru/0000-0002-2889-1234; Thomisch, Karolin/0000-0002-7144-8369	German Science Foundation [FOR 456, Ei 862/1-1]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	German Science Foundation(German Research Foundation (DFG)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	German Science Foundation (FOR 456), German Science Foundation (Ei 862/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; BAHRMANN R, 1995, BESTIMMUNG WIRBELLOS; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P2430, DOI 10.1016/j.soilbio.2009.09.001; Fjellberg A, 1980, IDENTIFICATION KEYS; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Haase S, 2007, PLANT SOIL, V301, P151, DOI 10.1007/s11104-007-9431-1; Habekost M, 2008, SOIL BIOL BIOCHEM, V40, P2588, DOI 10.1016/j.soilbio.2008.06.019; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hedlund K, 2003, OIKOS, V103, P45, DOI 10.1034/j.1600-0706.2003.12511.x; HEIMER K, 1991, SPINNEN MITTELEUROPA; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Hopkin C., 1969, KEY SPRINGTAILS COLL; Hopkin S. P., 1997, BIOL SPRINGTAILS COL; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kempson D., 1963, Pedobiologia, V3, P1; KLAUSNITZER B, 2005, STRESEMANN EXKURSION, V2; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kulmatiski A, 2008, SOIL BIOL BIOCHEM, V40, P1059, DOI 10.1016/j.soilbio.2007.11.020; Lau JA, 2008, ECOLOGY, V89, P226, DOI 10.1890/07-0423.1; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Milcu A, 2006, OIKOS, V112, P513, DOI 10.1111/j.0030-1299.2006.14292.x; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mulder CPH, 2002, OECOLOGIA, V133, P412, DOI 10.1007/s00442-002-1043-0; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; SABAIS ACW, 2010, REV IN PRESS; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaefer M, 2009, BROHMER FAUNA DEUTSC; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sulkava P, 1998, OECOLOGIA, V116, P390, DOI 10.1007/s004420050602; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Putten Wim H., 2005, P250, DOI 10.1017/CBO9780511541926.015; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Viketoft M, 2009, ECOLOGY, V90, P90, DOI 10.1890/08-0382.1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Weigelt A, 2010, ECOLOGY, V91, P929; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zaller JG, 1999, PLANT SOIL, V208, P1, DOI 10.1023/A:1004424720523	80	109	124	16	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16055	10.1371/journal.pone.0016055	http://dx.doi.org/10.1371/journal.pone.0016055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249208	Green Published, gold			2022-12-27	WOS:000286512900020
J	Kulkarni, AA; Thatcher, TH; Olsen, KC; Maggirwar, SB; Phipps, RP; Sime, PJ				Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Maggirwar, Sanjay B.; Phipps, Richard P.; Sime, Patricia J.			PPAR-gamma Ligands Repress TGF beta-Induced Myofibroblast Differentiation by Targeting the PI3K/Akt Pathway: Implications for Therapy of Fibrosis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR-BETA; NF-KAPPA-B; PULMONARY-FIBROSIS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; SIGNALING PATHWAY; LUNG FIBROBLASTS; GENE-TRANSFER	Transforming growth factor beta (TGF beta) induced differentiation of human lung fibroblasts to myofibroblasts is a key event in the pathogenesis of pulmonary fibrosis. Although the typical TGF beta signaling pathway involves the Smad family of transcription factors, we have previously reported that peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands inhibit TGF beta-mediated differentiation of human lung fibroblasts to myofibroblasts via a Smad-independent pathway. TGF beta also activates the phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) pathway leading to phosphorylation of Akt(S473). Here, we report that PPAR-gamma ligands, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and 15-deoxy-(12,14)-15d-prostaglandin J(2) (15d-PGJ(2)), inhibit human myofibroblast differentiation of normal and idiopathic pulmonary fibrotic (IPF) fibroblasts, by blocking Akt phosphorylation at Ser473 by a PPAR-gamma-independent mechanism. The PI3K inhibitor LY294002 and a dominant-negative inactive kinase-domain mutant of Akt both inhibited TGF beta-stimulated myofibroblast differentiation, as determined by Western blotting for alpha-smooth muscle actin and calponin. Prostaglandin A(1) (PGA(1)), a structural analogue of 15d-PGJ(2) with an electrophilic center, also reduced TGF beta-driven phosphorylation of Akt, while CAY10410, another analogue that lacks an electrophilic center, did not; implying that the activity of 15d-PGJ(2) and CDDO is dependent on their electrophilic properties. PPAR-gamma ligands inhibited TGF beta-induced Akt phosphorylation via both post-translational and post-transcriptional mechanisms. This inhibition is independent of MAPK-p38 and PTEN but is dependent on TGF beta-induced phosphorylation of FAK, a kinase that acts upstream of Akt. Thus, PPAR-gamma ligands inhibit TGF beta signaling by affecting two pro-survival pathways that culminate in myofibroblast differentiation. Further studies of PPAR-gamma ligands and small electrophilic molecules may lead to a new generation of anti-fibrotic therapeutics.	[Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Olsen, Keith C.; Maggirwar, Sanjay B.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kulkarni, AA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA.	Patricia_Sime@urmc.rochester.edu		Thatcher, Thomas/0000-0001-7177-3041	National Institutes of Health [HL075432, HL075432-04S1, HL075432-04S2, HL095402-02, T32 HL66988, F30 HL097596, T32 ES07026, P30 ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R03HL095402, R01HL075432, F30HL097596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health Grants: HL075432, HL075432-04S1, HL075432-04S2, HL095402-02, T32 HL66988, F30 HL097596, T32 ES07026 and P30 ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assinder SJ, 2009, BIOCHEM J, V417, P411, DOI 10.1042/BJ20081610; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; Deeb Dorrah, 2008, J Exp Ther Oncol, V7, P31; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Ferguson HE, 2009, AM J PHYSIOL-LUNG C, V297, pL912, DOI 10.1152/ajplung.00148.2009; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Han H, 2007, APOPTOSIS, V12, P2101, DOI 10.1007/s10495-007-0124-2; Hart CM, 2008, J INVEST MED, V56, P515, DOI 10.2310/JIM.0b013e318165e89d; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kalantari P, 2009, FASEB J, V23, P2366, DOI 10.1096/fj.08-124982; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kilter H, 2009, DIABETES OBES METAB, V11, P1060, DOI 10.1111/j.1463-1326.2009.01097.x; Kim DH, 2010, ONCOGENE, V29, P2560, DOI 10.1038/onc.2010.8; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Mimura Y, 2005, J INVEST DERMATOL, V124, P886, DOI 10.1111/j.0022-202X.2005.23701.x; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Pitha-Rowe I, 2009, INVEST OPHTH VIS SCI, V50, P5339, DOI 10.1167/iovs.09-3648; Roman J, 2008, J INVEST MED, V56, P528, DOI 10.2310/JIM.0b013e3181659932; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; TAN X, RESP RES, V11, P21; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Vinals F, 2001, MOL CELL BIOL, V21, P7218, DOI 10.1128/MCB.21.21.7218-7230.2001; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yamada KM, 2001, J CELL SCI, V114, P2375	59	137	161	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15909	10.1371/journal.pone.0015909	http://dx.doi.org/10.1371/journal.pone.0015909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253589	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900021
J	Treleaven, CM; Tamsett, T; Fidler, JA; Taksir, TV; Cheng, SH; Shihabuddin, LS; Dodge, JC				Treleaven, Christopher M.; Tamsett, Thomas; Fidler, Jonathan A.; Taksir, Tatyana V.; Cheng, Seng H.; Shihabuddin, Lamya S.; Dodge, James C.			Comparative Analysis of Acid Sphingomyelinase Distribution in the CNS of Rats and Mice Following Intracerebroventricular Delivery	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; LYSOSOMAL STORAGE PATHOLOGY; PICK-A MOUSE; NIEMANN-PICK; CEREBROSPINAL-FLUID; INTRACEREBRAL TRANSPLANTATION; DISEASE; MODEL; BRAIN; CELLS	Niemann-Pick A (NPA) disease is a lysosomal storage disorder (LSD) caused by a deficiency in acid sphingomyelinase (ASM) activity. Previously, we reported that biochemical and functional abnormalities observed in ASM knockout (ASMKO) mice could be partially alleviated by intracerebroventricular (ICV) infusion of hASM. We now show that this route of delivery also results in widespread enzyme distribution throughout the rat brain and spinal cord. However, enzyme diffusion into CNS parenchyma did not occur in a linear dose-dependent fashion. Moreover, although the levels of hASM detected in the rat CNS were determined to be within the range shown to be therapeutic in ASMKO mice, the absolute amounts represented less than 1% of the total dose administered. Finally, our results also showed that similar levels of enzyme distribution are achieved across rodent species when the dose is normalized to CNS weight as opposed to whole body weight. Collectively, these data suggest that the efficacy observed following ICV delivery of hASM in ASMKO mice could be scaled to CNS of the rat.	[Treleaven, Christopher M.; Tamsett, Thomas; Fidler, Jonathan A.; Taksir, Tatyana V.; Cheng, Seng H.; Shihabuddin, Lamya S.; Dodge, James C.] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Treleaven, CM (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	jim.dodge@genzyme.com	Cheng, Seng H/AAC-6564-2022		Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	Genzyme Corporation funded all experiments reported in the manuscript. Study design, data collection, analysis and manuscript preparation was conducted by Genzyme employees. Genzyme Corporation owns all patents and products related to findings reported in the manuscript.	Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Anderson VC, 1999, NEUROSURGERY, V44, P289, DOI 10.1097/00006123-199902000-00026; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Cook AM, 2009, PHARMACOTHERAPY, V29, P832, DOI 10.1592/phco.29.7.832; DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Dodge JC, 2005, P NATL ACAD SCI USA, V102, P17822, DOI 10.1073/pnas.0509062102; Haines SJ, 1998, CRIT REV NEUROSURG, V8, P169, DOI 10.1007/s003290050074; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Jin HK, 2003, MOL THER, V8, P876, DOI 10.1016/j.ymthe.2003.07.008; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kapoor KG, 2008, BRAIN RES BULL, V77, P327, DOI 10.1016/j.brainresbull.2008.08.009; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; LUER MS, 1993, ANN PHARMACOTHER, V27, P912, DOI 10.1177/106002809302700720; Mufson EJ, 1999, PROG NEUROBIOL, V57, P451, DOI 10.1016/S0301-0082(98)00059-8; OBBENS EAMT, 1985, NEUROLOGY, V35, P1274, DOI 10.1212/WNL.35.9.1274; Passini MA, 2005, MOL THER, V11, P754, DOI 10.1016/j.ymthe.2005.01.011; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schuchman EH, 2001, METABOLIC MOL BASES, V3, P3589; Shihabuddin LS, 2004, J NEUROSCI, V24, P10642, DOI 10.1523/JNEUROSCI.3584-04.2004; Slusarczyk K, 1996, Folia Morphol (Warsz), V55, P453; Smith DE, 2004, ADV DRUG DELIVER REV, V56, P1765, DOI 10.1016/j.addr.2004.07.008; TRIPATHI R, 1974, BRAIN RES, V80, P503, DOI 10.1016/0006-8993(74)91033-6; Yang WW, 2007, EXP NEUROL, V207, P258, DOI 10.1016/j.expneurol.2007.06.017	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16313	10.1371/journal.pone.0016313	http://dx.doi.org/10.1371/journal.pone.0016313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283548	Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400042
J	King, KY; Lew, JD; Ha, NP; Lin, JS; Ma, X; Graviss, EA; Goodell, MA				King, Katherine Y.; Lew, Justin D.; Ha, Ngan P.; Lin, Jeffery S.; Ma, Xin; Graviss, Edward A.; Goodell, Margaret A.			Polymorphic Allele of Human IRGM1 Is Associated with Susceptibility to Tuberculosis in African Americans	PLOS ONE			English	Article							INTRACELLULAR PATHOGENS; CROHNS-DISEASE; IMMUNITY; GENE; RESISTANCE; GTPASES	An ancestral polymorphic allele of the human autophagy-related gene IRGM1 is associated with altered gene expression and a genetic risk for Crohn's Disease (CD). We used the single nucleotide polymorphism rs10065172C/T as a marker of this polymorphic allele and genotyped 370 African American and 177 Caucasian tuberculosis (TB) cases and 180 African American and 110 Caucasian controls. Among African Americans, the TB cases were more likely to carry the CD-related T allele of rs10065172 (odds ratio of 1.54; 95% confidence interval, 1.17-2.02; P<0.01) compared to controls. Our finding suggests that this CD-related IRGM1 polymorphic allele is also associated with human susceptibility to TB disease among African Americans.	[King, Katherine Y.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Lew, Justin D.; Ha, Ngan P.; Ma, Xin; Graviss, Edward A.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Lin, Jeffery S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of California System; University of California Berkeley; Baylor College of Medicine	King, KY (corresponding author), Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.	kyk@bcm.edu	King, Katherine/AAI-2436-2021	Goodell, Margaret A./0000-0003-1111-2932; King, Katherine/0000-0002-5093-6005	Simmons Foundation	Simmons Foundation	This work was supported by the Simmons Foundation Collaborative Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CM, 2008, J INFECT DIS, V197, P1713, DOI 10.1086/588384; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; CHE N, 2010, CLIN CHIM ACTA, P1; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Ma X, 2002, INT J TUBERC LUNG D, V6, P818; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475; McCarroll SA, 2008, NAT GENET; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x	16	64	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16317	10.1371/journal.pone.0016317	http://dx.doi.org/10.1371/journal.pone.0016317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283700	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522300034
J	Shi, M; Liu, ZR; Lv, YG; Zheng, MH; Du, F; Zhao, G; Huang, Y; Chen, JY; Han, H; Ding, YQ				Shi, Ming; Liu, Zhirong; Lv, Yonggang; Zheng, Minhua; Du, Fang; Zhao, Gang; Huang, Ying; Chen, Jiayin; Han, Hua; Ding, Yuqiang			Forced Notch Signaling Inhibits Commissural Axon Outgrowth in the Developing Chick Central Nerve System	PLOS ONE			English	Article							NEURITE OUTGROWTH; SPINAL-CORD; NEURAL DEVELOPMENT; SONIC HEDGEHOG; MOUSE-BRAIN; FLOOR PLATE; GUIDANCE; NEURONS; CELLS; OVEREXPRESSION	Background: A collection of in vitro evidence has demonstrated that Notch signaling plays a key role in the growth of neurites in differentiated neurons. However, the effects of Notch signaling on axon outgrowth in an in vivo condition remain largely unknown. Methodology/Principal Findings: In this study, the neural tubes of HH10-11 chick embryos were in ovo electroporated with various Notch transgenes of activating or inhibiting Notch signaling, and then their effects on commissural axon outgrowth across the floor plate midline in the chick developing central nerve system were investigated. Our results showed that forced expression of Notch intracellular domain, constitutively active form of RBPJ, or full-length Hes1 in the rostral hindbrain, diencephalon and spinal cord at stage HH10-11 significantly inhibited commissural axon outgrowth. On the other hand, inhibition of Notch signaling by ectopically expressing a dominant-negative form of RBPJ promoted commissural axonal growth along the circumferential axis. Further results revealed that these Notch signaling-mediated axon outgrowth defects may be not due to the alteration of axon guidance since commissural axon marker TAG1 was present in the axons in floor plate midline, and also not result from the changes in cell fate determination of commissural neurons since the expression of postmitotic neuron marker Tuj1 and specific commissural markers TAG1 and Pax7 was unchanged. Conclusions/Significance: We first used an in vivo system to provide evidence that forced Notch signaling negatively regulates commissural axon outgrowth.	[Shi, Ming; Liu, Zhirong; Du, Fang; Zhao, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Lv, Yonggang] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Vasc & Endocrine Surg, Xian 710032, Peoples R China; [Zheng, Minhua; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China; [Huang, Ying; Chen, Jiayin; Ding, Yuqiang] Tongji Univ, Sch Med, Dept Anat & Neurobiol, Shanghai 200092, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Tongji University	Shi, M (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China.	biomidas@163.com; dingyuqiang@gmail.com	Shi, Ming/B-7829-2012	Ding, Yu-Qiang/0000-0003-1202-4635	Ministry of Science and Technology of China [2006CB943903, 2009ZX09501-030]; National Natural Science Foundation of China [31030034]; Shaanxi Provincial Science and Technology Program, China [2009K01-59]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Science and Technology Program, China	This work was supported by grants from the Ministry of Science and Technology of China (2006CB943903, 2009ZX09501-030), National Natural Science Foundation of China (31030034) and Shaanxi Provincial Science and Technology Program, China (2009K01-59). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Bhat KMR, 2006, NUCLEIC ACIDS RES, V34, P3819, DOI 10.1093/nar/gkl476; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Ferrari-Toninelli G, 2008, NEUROSCIENCE, V154, P946, DOI 10.1016/j.neuroscience.2008.04.025; Ferrari-Toninelli G, 2009, DEV NEUROBIOL, V69, P378, DOI 10.1002/dneu.20710; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Guthrie S, 2004, CURR BIOL, V14, pR166, DOI 10.1016/j.cub.2004.01.050; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Jessen U, 2003, J NEUROSCI RES, V71, P1, DOI 10.1002/jnr.10433; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maddodi N, 2010, J BIOL CHEM, V285, P242, DOI 10.1074/jbc.M109.068668; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Murakami F, 1997, CELL TISSUE RES, V290, P323, DOI 10.1007/s004410050937; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Otto A, 2006, ANAT EMBRYOL, V211, P293, DOI 10.1007/s00429-006-0083-3; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Saba R, 2003, J NEUROSCI, V23, P1987; Salinas PC, 2003, TRENDS NEUROSCI, V26, P641, DOI 10.1016/j.tins.2003.09.006; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shi M, 2008, MOL CELL NEUROSCI, V39, P529, DOI 10.1016/j.mcn.2008.07.023; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Zhu Y, 2006, DEVELOPMENT, V133, P3837, DOI 10.1242/dev.02564	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14570	10.1371/journal.pone.0014570	http://dx.doi.org/10.1371/journal.pone.0014570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283742	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522300008
J	Wang, GP; Ye, Y; Yang, XQ; Liao, HY; Zhao, CG; Liang, SA				Wang, Guiping; Ye, Yun; Yang, Xiaoqin; Liao, Hongying; Zhao, Canguo; Liang, Shuang			Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma	PLOS ONE			English	Article							CELL-CYCLE ARREST; GENE-EXPRESSION; CANCER CELLS; INHIBITION; APOPTOSIS; AKT; GROWTH; HSP90; PROTEIN; CHINA	Background: Lung adenocarcinom (AC) is the most common form of lung cancer. Currently, the number of medical options to deal with lung cancer is very limited. In this study, we aimed to investigate potential therapeutic compounds for lung adenocarcinoma based on integrative analysis. Methodology/Principal Findings: The candidate therapeutic compounds were identified in a two-step process. First, a meta-analysis of two published microarray data was conducted to obtain a list of 343 differentially expressed genes specific to lung AC. In the next step, expression profiles of these genes were used to query the Connectivity-Map (C-MAP) database to identify a list of compounds whose treatment reverse expression direction in various cancer cells. Several compounds in the categories of HSP90 inhibitor, HDAC inhibitor, PPAR agonist, PI3K inhibitor, passed our screening to be the leading candidates. On top of the list, three HSP90 inhibitors, i.e. 17-AAG (also known as tanespimycin), monorden, and alvespimycin, showed significant negative enrichment scores. Cytotoxicity as well as effects on cell cycle regulation and apoptosis were evaluated experimentally in lung adenocarcinoma cell line (A549 or GLC-82) with or without treatment with 17-AAG. In vitro study demonstrated that 17-AAG alone or in combination with cisplatin (DDP) can significantly inhibit lung adenocarcinoma cell growth by inducing cell cycle arrest and apoptosis. Conclusions/Significance: We have used an in silico screening to identify compounds for treating lung cancer. One such compound 17-AAG demonstrated its anti-lung AC activity by inhibiting cell growth and promoting apoptosis and cell cycle arrest.	[Wang, Guiping; Ye, Yun; Yang, Xiaoqin; Liang, Shuang] So Med Univ, Inst Genet Engn, Bioinformat Grp, Guangzhou, Guangdong, Peoples R China; [Wang, Guiping; Zhao, Canguo] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China; [Ye, Yun] Guangxi Univ Technol, Dept Biol & Chem Engn, Liuzhou, Peoples R China; [Liao, Hongying] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Guangxi University of Science & Technology; Sun Yat Sen University	Wang, GP (corresponding author), So Med Univ, Inst Genet Engn, Bioinformat Grp, Guangzhou, Guangdong, Peoples R China.	itshuang@gmail.com			Higher Education Agency of GuangDong province	Higher Education Agency of GuangDong province	This research was funded by a special grant from the Higher Education Agency of GuangDong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Crocetti E, 2002, LUNG CANCER-J IASLC, V35, P215, DOI 10.1016/S0169-5002(01)00335-X; Crowell JA, 2003, J NATL CANCER I, V95, P252, DOI 10.1093/jnci/95.4.252; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Ebi H, 2009, CANCER RES, V69, P4027, DOI 10.1158/0008-5472.CAN-08-3403; Georgakis GV, 2006, BRIT J HAEMATOL, V135, P68, DOI 10.1111/j.1365-2141.2006.06247.x; Han H, 2007, APOPTOSIS, V12, P2101, DOI 10.1007/s10495-007-0124-2; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn610; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mukhopadhyay NK, 2006, ANN THORAC SURG, V81, P1034, DOI 10.1016/j.athoracsur.2005.06.059; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Okamoto J, 2008, J THORAC ONCOL, V3, P1089, DOI 10.1097/JTO.0b013e3181839693; Pitt SC, 2009, J AM COLL SURGEONS, V209, P82, DOI 10.1016/j.jamcollsurg.2009.03.006; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Rahman KMW, 2006, CANCER RES, V66, P4952, DOI 10.1158/0008-5472.CAN-05-3918; Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Senju M, 2006, J CANCER RES CLIN, V132, P150, DOI 10.1007/s00432-005-0047-7; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Solit DB, 2003, CANCER RES, V63, P2139; Solit DB, 2002, CLIN CANCER RES, V8, P986; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Watanabe G, 2009, CANCER CHEMOTH PHARM, V64, P433, DOI 10.1007/s00280-008-0888-2; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Yang L, 2005, EUR J CANCER PREV, V14, P329, DOI 10.1097/00008469-200508000-00004; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Yang Ling, 2003, Asian Pac J Cancer Prev, V4, P23; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	36	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14573	10.1371/journal.pone.0014573	http://dx.doi.org/10.1371/journal.pone.0014573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283735	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300010
J	Azadniv, M; Bowers, WJ; Topham, DJ; Crispe, IN				Azadniv, Mitra; Bowers, William J.; Topham, David J.; Crispe, Ian N.			CD4+T Cell Effects on CD8+T Cell Location Defined Using Bioluminescence	PLOS ONE			English	Article							CD4(+) T-CELLS; DENDRITIC CELLS; ACUTE INFECTION; NAIVE CELLS; MEMORY; HELP; EXPRESSION; TISSUE; LYMPHOCYTES; RESPONSES	T lymphocytes of the CD8+ class are critical in delivering cytotoxic function and in controlling viral and intracellular infections. These cells are "helped'' by T lymphocytes of the CD4+ class, which facilitate their activation, clonal expansion, full differentiation and the persistence of memory. In this study we investigated the impact of CD4+ T cells on the location of CD8+ T cells, using antibody-mediated CD4+ T cell depletion and imaging the antigen-driven redistribution of bioluminescent CD8+ T cells in living mice. We documented that CD4+ T cells influence the biodistribution of CD8+ T cells, favoring their localization to abdominal lymph nodes. Flow cytometric analysis revealed that this was associated with an increase in the expression of specific integrins. The presence of CD4+ T cells at the time of initial CD8+ T cell activation also influences their biodistribution in the memory phase. Based on these results, we propose the model that one of the functions of CD4+ T cell "help'' is to program the homing potential of CD8+ T cells.	[Azadniv, Mitra; Topham, David J.] Univ Rochester, Med Ctr, David H Smith Ctr Microbiol & Immunol, Aab Inst Biomed Res, Rochester, NY 14642 USA; [Bowers, William J.] Univ Rochester, Med Ctr, Ctr Aging & Dev Biol, Aab Inst Biomed Res,Dept Neurol, Rochester, NY 14642 USA; [Crispe, Ian N.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Rochester; University of Rochester; Center for Infectious Disease Research	Azadniv, M (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Microbiol & Immunol, Aab Inst Biomed Res, Rochester, NY 14642 USA.	nick.crispe@seattlebiomed.org			NIH [AI056356, AI057998]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057998, P01AI056356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grants AI056356 to William Bowers, PhD and AI057998 to Ian N. Crispe, MB BS PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azadniv M, 2007, INT IMMUNOL, V19, P1165, DOI 10.1093/intimm/dxm086; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bowers WJ, 2000, MOL THER, V1, P294, DOI 10.1006/mthe.2000.0039; Bowers WJ, 2006, MOL THER, V13, P580, DOI 10.1016/j.ymthe.2005.11.011; Bowers WJ, 2001, GENE THER, V8, P111, DOI 10.1038/sj.gt.3301340; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chewning JH, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-44; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; de Herve MGD, 2008, J IMMUNOL, V181, P5974, DOI 10.4049/jimmunol.181.9.5974; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mosmann TR, 2004, NAT IMMUNOL, V5, P564, DOI 10.1038/ni0604-564; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; REES MA, 1990, P NATL ACAD SCI USA, V87, P2765, DOI 10.1073/pnas.87.7.2765; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Santos K, 2007, VACCINE, V25, P1634, DOI 10.1016/j.vaccine.2006.11.004; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuhbauer DMS, 2000, EUR J IMMUNOL, V30, P1255; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Shoukry NH, 2004, J IMMUNOL, V172, P483, DOI 10.4049/jimmunol.172.1.483; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Willis RA, 2001, HUM GENE THER, V12, P1867, DOI 10.1089/104303401753153929; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16222	10.1371/journal.pone.0016222	http://dx.doi.org/10.1371/journal.pone.0016222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283759	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200039
J	Kettern, N; Rogon, C; Limmer, A; Schild, H; Hohfeld, J				Kettern, Nadja; Rogon, Christian; Limmer, Andreas; Schild, Hansjoerg; Hoehfeld, Joerg			The Hsc/Hsp70 Co-Chaperone Network Controls Antigen Aggregation and Presentation during Maturation of Professional Antigen Presenting Cells	PLOS ONE			English	Article							PROTEIN-QUALITY CONTROL; TRANSMEMBRANE CONDUCTANCE REGULATOR; MOLECULAR CHAPERONES; IN-VIVO; UBIQUITINATED PROTEINS; DENDRITIC CELLS; DEGRADATION; PROTEASOME; AUTOPHAGY; CHIP	The maturation of mouse macrophages and dendritic cells involves the transient deposition of ubiquitylated proteins in the form of dendritic cell aggresome-like induced structures (DALIS). Transient DALIS formation was used here as a paradigm to study how mammalian cells influence the formation and disassembly of protein aggregates through alterations of their proteostasis machinery. Co-chaperones that modulate the interplay of Hsc70 and Hsp70 with the ubiquitin-proteasome system (UPS) and the autophagosome-lysosome pathway emerged as key regulators of this process. The chaperone-associated ubiquitin ligase CHIP and the ubiquitin-domain protein BAG-1 are essential for DALIS formation in mouse macrophages and bone-marrow derived dendritic cells (BMDCs). CHIP also cooperates with BAG-3 and the autophagic ubiquitin adaptor p62 in the clearance of DALIS through chaperone-assisted selective autophagy (CASA). On the other hand, the co-chaperone HspBP1 inhibits the activity of CHIP and thereby attenuates antigen sequestration. Through a modulation of DALIS formation CHIP, BAG-1 and HspBP1 alter MHC class I mediated antigen presentation in mouse BMDCs. Our data show that the Hsc/Hsp70 co-chaperone network controls transient protein aggregation during maturation of professional antigen presenting cells and in this way regulates the immune response. Similar mechanisms may modulate the formation of aggresomes and aggresome-like induced structures (ALIS) in other mammalian cell types.	[Kettern, Nadja; Rogon, Christian; Hoehfeld, Joerg] Univ Bonn, Inst Cell Biol, D-5300 Bonn, Germany; [Limmer, Andreas] Univ Hosp Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany; [Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Inst Immunol, D-6500 Mainz, Germany	University of Bonn; University of Bonn; Johannes Gutenberg University of Mainz	Kettern, N (corresponding author), Univ Bonn, Inst Cell Biol, D-5300 Bonn, Germany.	hoehfeld@uni-bonn.de			Deutsche Forschungsgemeinschaft [SFB 704, SFB 635, DIP K.5.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (SFB 704; SFB 635 and DIP K.5.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Fassbender M, 2008, MED MICROBIOL IMMUN, V197, P185, DOI 10.1007/s00430-008-0091-4; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schweichel D, 2006, J GENE MED, V8, P1243, DOI 10.1002/jgm.952; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	47	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16398	10.1371/journal.pone.0016398	http://dx.doi.org/10.1371/journal.pone.0016398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283720	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200060
J	Trompeter, HI; Abbad, H; Iwaniuk, KM; Hafner, M; Renwick, N; Tuschl, T; Schira, J; Muller, HW; Wernet, P				Trompeter, Hans-Ingo; Abbad, Hassane; Iwaniuk, Katharina M.; Hafner, Markus; Renwick, Neil; Tuschl, Thomas; Schira, Jessica; Mueller, Hans Werner; Wernet, Peter			MicroRNAs MiR-17, MiR-20a, and MiR-106b Act in Concert to Modulate E2F Activity on Cell Cycle Arrest during Neuronal Lineage Differentiation of USSC	PLOS ONE			English	Article							SOMATIC STEM-CELL; CORD BLOOD; DISTINCT ROLES; CDK INHIBITORS; FEEDBACK LOOP; EXPRESSION; PROLIFERATION; CANCER; PROGRESSION; APOPTOSIS	Background: MicroRNAs are short (similar to 22 nt) non-coding regulatory RNAs that control gene expression at the post-transcriptional level. Here the functional impact of microRNAs on cell cycle arrest during neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood (USSC) was analyzed. Methodology/Principal Findings: Expression profiling revealed downregulation of microRNAs miR-17, -20a, and -106b in USSC differentiated into neuronal lineage but not in USSC differentiated into osteogenic lineage. Transfection experiments followed by Ki67 immunostainings demonstrated that each of these microRNAs was able to promote proliferation of native USSC and to prevent in part cell cycle arrest during neuronal lineage differentiation of USSC. Bioinformatic target gene predictions followed by experimental target gene validations revealed that miR-17, -20a, and -106b act in a common manner by downregulating an overlapping set of target genes mostly involved in regulation and execution of G(1)/S transition. Pro-proliferative target genes cyclinD1 (CCND1) and E2F1 as well as anti-proliferative targets CDKN1A (p21), PTEN, RB1, RBL1 (p107), RBL2 (p130) were shown as common targets for miR-17, -20a, and -106b. Furthermore, these microRNAs also downregulate WEE1 which is involved in G(2)/M transition. Most strikingly, miR-17, -20a, and -106b were found to promote cell proliferation by increasing the intracellular activity of E2F transcription factors, despite the fact that miR-17, 20a, and -106b directly target the transcripts that encode for this protein family. Conclusions/Significance: Mir-17, -20a, and -106b downregulate a common set of pro-and anti-proliferative target genes to impact cell cycle progression of USSC and increase intracellular activity of E2F transcription factors to govern G(1)/S transition.	[Trompeter, Hans-Ingo; Abbad, Hassane; Iwaniuk, Katharina M.; Wernet, Peter] Univ Dusseldorf, Fac Med, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany; [Hafner, Markus; Renwick, Neil; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; [Schira, Jessica; Mueller, Hans Werner] Univ Dusseldorf, Dept Neurol, Fac Med, Mol Neurobiol Lab, D-4000 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; Rockefeller University; Heinrich Heine University Dusseldorf	Trompeter, HI (corresponding author), Univ Dusseldorf, Fac Med, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany.	peter.wernet@uni-duesseldorf.de	Hafner, Markus/O-7100-2018; Renwick, Neil/V-3980-2019; Renwick, Neil M/A-3744-2012	Hafner, Markus/0000-0002-4336-6518; Renwick, Neil/0000-0001-6695-8236; Renwick, Neil M/0000-0001-6695-8236; Schira-Heinen, Jessica/0000-0002-2184-9746	Deutsche Forschungsgemeinschaft (DFG) [FOR717: WE 505/2-1, MU630/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by peer-reviewed grants from the Deutsche Forschungsgemeinschaft (DFG research group FOR717: WE 505/2-1, MU630/10-1) given to Peter Wernet and Hans Werner Muller (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHEN D, 2010, J CELL PHYSL; Chen H, 2010, NEUROL RES, V32, P603, DOI 10.1179/174313209X455691; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; CZECH B, NAT REV GENET; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Demir O, 2009, ANAT REC, V292, P1953, DOI 10.1002/ar.20980; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Greschat S, 2008, STEM CELLS DEV, V17, P221, DOI 10.1089/scd.2007.0118; Hafner M., J VIS EXP; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; HARPER JW, 1993, CELL, V75, P805; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; IWANIUK KM, 2010, STEM CELLS IN PRESS; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; RUIZ EJ, 2010, CURR BIOL; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wernet P, 2010, EXP HEMATOL, V38, P1099, DOI 10.1016/j.exphem.2010.09.006; Wong P, CANC RES, V70, P3833; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079	66	104	109	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16138	10.1371/journal.pone.0016138	http://dx.doi.org/10.1371/journal.pone.0016138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283765	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200029
J	Gao, SB; Babu, R; Lu, YL; Martinez, C; Hao, ZF; Krivanek, AF; Wang, JK; Rong, TZ; Crouch, J; Xu, YB				Gao, Shibin; Babu, Raman; Lu, Yanli; Martinez, Carlos; Hao, Zhuanfang; Krivanek, Alan F.; Wang, Jiankang; Rong, Tingzhao; Crouch, Jonathan; Xu, Yunbi			Revisiting the Hetero-Fertilization Phenomenon in Maize	PLOS ONE			English	Article							SINGLE FERTILIZATION; HETEROFERTILIZATION	Development of a seed DNA-based genotyping system for marker-assisted selection (MAS) has provided a novel opportunity for understanding aberrant reproductive phenomena such as hetero-fertilization (HF) by observing the mismatch of endosperm and leaf genotypes in monocot species. In contrast to conventional approaches using specific morphological markers, this approach can be used for any population derived from diverse parental genotypes. A large-scale experiment was implemented using seven F(2) populations and four three-way cross populations, each with 534 to 1024 individuals. The frequency of HF within these populations ranged from 0.14% to 3.12%, with an average of 1.46%. The highest frequency of HF in both types of population was contributed by the pollen gametes. Using three-way crosses allowed, for the first time, detection of the HF contributed by maternal gametes, albeit at very low frequency (0.14%-0.65%). Four HF events identified from each of two F(2) populations were tested and confirmed using 1032 single nucleotide polymorphic markers. This analysis indicated that only 50% of polymorphic markers can detect a known HF event, and thus the real HF frequency can be inferred by doubling the estimate obtained from using only one polymorphic marker. As expected, 99% of the HF events can be detected by using seven independent markers in combination. Although seed DNA-based analysis may wrongly predict plant genotypes due to the mismatch of endosperm and leaf DNA caused by HF, the relatively low HF frequencies revealed with diverse germplasm in this study indicates that the effect on the accuracy of MAS is limited. In addition, comparative endosperm and leaf DNA analysis of specific genetic stocks could be useful for revealing the relationships among various aberrant fertilization phenomena including haploidy and apomixis.	[Gao, Shibin; Lu, Yanli; Hao, Zhuanfang; Rong, Tingzhao] Sichuan Agr Univ, Maize Res Inst, Yaan, Peoples R China; [Gao, Shibin; Babu, Raman; Lu, Yanli; Martinez, Carlos; Krivanek, Alan F.; Crouch, Jonathan; Xu, Yunbi] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico; [Wang, Jiankang; Xu, Yunbi] Chinese Acad Agr Sci, Natl Key Facil Crop Genet Resources & Improvement, Int Maize & Wheat Improvement Ctr CIMMYT, Inst Crop Sci, Beijing, Peoples R China	Sichuan Agricultural University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Gao, SB (corresponding author), Sichuan Agr Univ, Maize Res Inst, Yaan, Peoples R China.	y.xu@cgiar.org			Rockefeller Foundation; Bill and Melinda Gates Foundation; Generation Challenge Programme; European Community	Rockefeller Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Generation Challenge Programme; European Community(European Commission)	This research was supported by the Rockefeller Foundation, the Bill and Melinda Gates Foundation, the Generation Challenge Programme, and the European Community. These funders provided financial support to the experiments and research related to this report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belicuas PR, 2007, EUPHYTICA, V156, P95, DOI 10.1007/s10681-007-9356-z; CHANG MT, 1989, GENOME, V32, P232, DOI 10.1139/g89-434; *CIMMYT APPL MOL G, 2003, LAB PROT, P7; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Ford RH, 2000, AM BIOL TEACH, V62, P181, DOI 10.1662/0002-7685(2000)062[0181:IOKCIC]2.0.CO;2; GAO S, 2008, MOL BREEDING, V22, P77; Guignard M.L., 1899, REV G N BOT, V11, P129; Kato A, 1999, J HERED, V90, P276, DOI 10.1093/jhered/90.2.276; Kato A, 1997, SEX PLANT REPROD, V10, P96, DOI 10.1007/s004970050073; Kato A, 2001, GENOME, V44, P1114, DOI 10.1139/gen-44-6-1114; Kiesselbach TA, 1949, RES B, V161; Kraptchev B, 2003, MAYDICA, V48, P271; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; ROBERTSON DS, 1984, J HERED, V75, P457, DOI 10.1093/oxfordjournals.jhered.a109985; SARKAR KR, 1971, J HERED, V62, P118, DOI 10.1093/oxfordjournals.jhered.a108136; Sprague GF, 1929, SCIENCE, V69, P526, DOI 10.1126/science.69.1794.526-a; Sprague GF, 1932, GENETICS, V17, P0358; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2	21	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16101	10.1371/journal.pone.0016101	http://dx.doi.org/10.1371/journal.pone.0016101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283522	Green Published, gold			2022-12-27	WOS:000286520600023
J	Pham, T; Mero, P; Booth, JW				Pham, Theodore; Mero, Patricia; Booth, James W.			Dynamics of Macrophage Trogocytosis of Rituximab-Coated B Cells	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; TARGET-CELLS; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; CUTTING EDGE; NK CELLS; T-CELLS; MECHANISM; ENDOCYTOSIS	Macrophages can remove antigen from the surface of antibody-coated cells by a process termed trogocytosis. Using live cell microscopy and flow cytometry, we investigated the dynamics of trogocytosis by RAW264.7 macrophages of Ramos B cells opsonized with the anti-CD20 monoclonal antibody rituximab. Spontaneous and reversible formation of uropods was observed on Ramos cells, and these showed a strong enrichment in rituximab binding. RAW-Ramos conjugate interfaces were highly enriched in rituximab, and transfer of rituximab to the RAW cells in submicron-sized puncta occurred shortly after cell contact. Membrane from the target cells was concomitantly transferred along with rituximab to a variable extent. We established a flow cytometry-based approach to follow the kinetics of transfer and internalization of rituximab. Disruption of actin polymerization nearly eliminated transfer, while blocking phosphatidylinositol 3-kinase activity only resulted in a delay in its acquisition. Inhibition of Src family kinase activity both slowed acquisition and reduced the extent of trogocytosis. The effects of inhibiting these kinases are likely due to their role in efficient formation of cell-cell conjugates. Selective pre-treatment of Ramos cells with phenylarsine oxide blocked uropod formation, reduced enrichment of rituximab at cell-cell interfaces, and reduced the efficiency of trogocytic transfer of rituximab. Our findings highlight that dynamic changes in target cell shape and surface distribution of antigen may significantly influence the progression and extent of trogocytosis. Understanding the mechanistic determinants of macrophage trogocytosis will be important for optimal design of antibody therapies.	[Pham, Theodore; Mero, Patricia; Booth, James W.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Pham, Theodore; Mero, Patricia; Booth, James W.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Pham, T (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	james.booth@utoronto.ca			Canadian Institutes of Health Research [MOP84475]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP84475 from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Beum PV, 2008, J IMMUNOL, V181, P2916, DOI 10.4049/jimmunol.181.4.2916; Beum PV, 2008, J IMMUNOL, V181, P8120, DOI 10.4049/jimmunol.181.11.8120; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Daubeuf S, 2010, J IMMUNOL, V184, P1897, DOI 10.4049/jimmunol.0901570; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; GRIFFIN FM, 1976, J EXP MED, V144, P788, DOI 10.1084/jem.144.3.788; HoWangYin KY, 2010, CELL MOL LIFE SCI, V67, P1133, DOI 10.1007/s00018-009-0239-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; McCann FE, 2007, J IMMUNOL, V178, P3418, DOI 10.4049/jimmunol.178.6.3418; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Perosa F, 2007, J IMMUNOL, V179, P7967, DOI 10.4049/jimmunol.179.11.7967; Petrie RJ, 2002, J IMMUNOL, V169, P2886, DOI 10.4049/jimmunol.169.6.2886; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Taylor RP, 2007, NAT CLIN PRACT RHEUM, V3, P86, DOI 10.1038/ncprheum0424; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Williams ME, 2006, J IMMUNOL, V177, P7435, DOI 10.4049/jimmunol.177.10.7435; Zhang QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003097	33	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14498	10.1371/journal.pone.0014498	http://dx.doi.org/10.1371/journal.pone.0014498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264210	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600001
J	Xie, P; Sayers, JR				Xie, Ping; Sayers, Jon R.			A Model for Transition of 5 '-Nuclease Domain of DNA Polymerase I from Inert to Active Modes	PLOS ONE			English	Article							OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; EXONUCLEASE ACTIVITY; CRYSTAL-STRUCTURE; KLENOW FRAGMENT; NUCLEASE DOMAIN; ENDONUCLEASE; REPLICATION; MECHANISM	Bacteria contain DNA polymerase I (PolI), a single polypeptide chain consisting of similar to 930 residues, possessing DNA-dependent DNA polymerase, 3'-5' proofreading and 5'-3' exonuclease (also known as flap endonuclease) activities. PolI is particularly important in the processing of Okazaki fragments generated during lagging strand replication and must ultimately produce a double-stranded substrate with a nick suitable for DNA ligase to seal. PolI's activities must be highly coordinated both temporally and spatially otherwise uncontrolled 5'-nuclease activity could attack a nick and produce extended gaps leading to potentially lethal double-strand breaks. To investigate the mechanism of how PolI efficiently produces these nicks, we present theoretical studies on the dynamics of two possible scenarios or models. In one the flap DNA substrate can transit from the polymerase active site to the 5'-nuclease active site, with the relative position of the two active sites being kept fixed; while the other is that the 5'-nuclease domain can transit from the inactive mode, with the 5'-nuclease active site distant from the cleavage site on the DNA substrate, to the active mode, where the active site and substrate cleavage site are juxtaposed. The theoretical results based on the former scenario are inconsistent with the available experimental data that indicated that the majority of 5'-nucleolytic processing events are carried out by the same PolI molecule that has just extended the upstream primer terminus. By contrast, the theoretical results on the latter model, which is constructed based on available structural studies, are consistent with the experimental data. We thus conclude that the latter model rather than the former one is reasonable to describe the cooperation of the PolI's polymerase and 5'-3' exonuclease activities. Moreover, predicted results for the latter model are presented.	[Xie, Ping] Chinese Acad Sci, Key Lab Soft Matter Phys, Beijing, Peoples R China; [Xie, Ping] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China; [Sayers, Jon R.] Univ Sheffield, Sch Med, Krebs Inst, Dept Infect & Immun, Sheffield, S Yorkshire, England	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; University of Sheffield	Xie, P (corresponding author), Chinese Acad Sci, Key Lab Soft Matter Phys, Beijing, Peoples R China.	j.r.sayers@sheffield.ac.uk	Sayers, Jon R/I-8974-2012; Sayers, Jon R/AAP-6179-2020	Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443	National Natural Science Foundation of China [10834014, 10974248]; Biotechnology and Biological Research Council [50/B19466]; Biotechnology and Biological Sciences Research Council [B19466] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm, Grant Nos. 10834014 and 10974248). Work in the Sayers' laboratory is supported by the Biotechnology and Biological Research Council (grant no 50/B19466; http://www.bbsrc.ac.uk) and benefits from infrastructure provided by the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LM, 2009, BIOCHEM J, V418, P285, DOI 10.1042/BJ20081637; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Datta K, 2006, BIOPHYS J, V90, P1739, DOI 10.1529/biophysj.105.071837; DEGENNES PG, 1979, SCALING CONCEPTS POL, pCH3; Delagoutte E, 2003, J BIOL CHEM, V278, P25435, DOI 10.1074/jbc.M303370200; DIAZ A, 1992, MOL MICROBIOL, V6, P3009, DOI 10.1111/j.1365-2958.1992.tb01759.x; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; Gardiner C. W., 1983, HDB STOCHASTIC METHO; Garforth SJ, 1997, NUCLEIC ACIDS RES, V25, P3801, DOI 10.1093/nar/25.19.3801; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Ho DL, 2004, J BIOL CHEM, V279, P39146, DOI 10.1074/jbc.M404565200; Hodskinson MRG, 2007, NUCLEIC ACIDS RES, V35, P4094, DOI 10.1093/nar/gkm396; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HONEYCUTT RL, 1992, PHYS REV A, V45, P600, DOI 10.1103/PhysRevA.45.600; Imai M, 2007, MOL GENET GENOMICS, V278, P211, DOI 10.1007/s00438-007-0239-8; JOYCE CM, 1987, TRENDS BIOCHEM SCI, V12, P288, DOI 10.1016/0968-0004(87)90143-5; KAMPMEYER PM, 1952, J APPL PHYS, V23, P99, DOI 10.1063/1.1701986; KELLEY WS, 1983, J MOL BIOL, V164, P529, DOI 10.1016/0022-2836(83)90049-9; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KUROSAWA Y, 1975, J MOL BIOL, V96, P653, DOI 10.1016/0022-2836(75)90144-8; Kutyavin IV, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1138; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; LUNDQUIST RC, 1982, CELL, V31, P53, DOI 10.1016/0092-8674(82)90404-4; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Makiela-Dzbenska K, 2009, MOL MICROBIOL, V74, P1114, DOI 10.1111/j.1365-2958.2009.06921.x; Nagata Y, 2002, GENETICS, V160, P13; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; Orlando C, 1998, CLIN CHEM LAB MED, V36, P255, DOI 10.1515/CCLM.1998.045; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Risken H., 1984, FOKKER PLANK EQUATIO; ROBINS P, 1994, J BIOL CHEM, V269, P28535; SAYERS JR, 1994, J THEOR BIOL, V170, P415, DOI 10.1006/jtbi.1994.1202; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SAYERS JR, 1991, NUCLEIC ACIDS RES, V19, P4127, DOI 10.1093/nar/19.15.4127; SETLOW P, 1972, J BIOL CHEM, V247, P232; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c; Urs UK, 1999, ACTA CRYSTALLOGR D, V55, P1971; Xie P, 2008, BBA-BIOENERGETICS, V1777, P1195, DOI 10.1016/j.bbabio.2008.04.040; Xie P, 2007, ARCH BIOCHEM BIOPHYS, V457, P73, DOI 10.1016/j.abb.2006.09.019; Xie P, 2009, J THEOR BIOL, V259, P434, DOI 10.1016/j.jtbi.2009.04.009; Xu Y, 2000, J BIOL CHEM, V275, P20949, DOI 10.1074/jbc.M909135199; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zietlow L, 2008, BIOCHEMISTRY-US, V47, P5460, DOI 10.1021/bi702343y	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16213	10.1371/journal.pone.0016213	http://dx.doi.org/10.1371/journal.pone.0016213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264264	gold, Green Published, Green Accepted			2022-12-27	WOS:000286516500041
J	Baruch-Mordo, S; Breck, SW; Wilson, KR; Broderick, J				Baruch-Mordo, Sharon; Breck, Stewart W.; Wilson, Kenneth R.; Broderick, John			The Carrot or the Stick? Evaluation of Education and Enforcement as Management Tools for Human-Wildlife Conflicts	PLOS ONE			English	Article							AMERICAN BLACK BEAR; CONSERVATION; CARNIVORES; PREDATION; PROGRAMS; LAW	Evidence-based decision-making is critical for implementing conservation actions, especially for human-wildlife conflicts, which have been increasing worldwide. Conservation practitioners recognize that long-term solutions should include altering human behaviors, and public education and enforcement of wildlife-related laws are two management actions frequently implemented, but with little empirical evidence evaluating their success. We used a system where human-black bear conflicts were common, to experimentally test the efficacy of education and enforcement in altering human behavior to better secure attractants (garbage) from bears. We conducted 3 experiments in Aspen CO, USA to evaluate: 1) on-site education in communal dwellings and construction sites, 2) Bear Aware educational campaign in residential neighborhoods, and 3) elevated law enforcement at two levels in the core business area of Aspen. We measured human behaviors as the response including: violation of local wildlife ordinances, garbage availability to bears, and change in use of bear-resistance refuse containers. As implemented, we found little support for education, or enforcement in the form of daily patrolling in changing human behavior, but found more support for proactive enforcement, i.e., dispensing warning notices. More broadly we demonstrated the value of gathering evidence before and after implementing conservation actions, and the dangers of measuring responses in the absence of ecological knowledge. We recommend development of more effective educational methods, application of proactive enforcement, and continued evaluation of tools by directly measuring change in human behavior. We provide empirical evidence adding to the conservation managers' toolbox, informing policy makers, and promoting solutions to human-wildlife conflicts.	[Baruch-Mordo, Sharon; Wilson, Kenneth R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Breck, Stewart W.] USDA WS Natl Wildlife Res Ctr, Ft Collins, CO USA; [Broderick, John] Colorado Div Wildlife, Ft Collins, CO 80526 USA	Colorado State University; United States Department of Agriculture (USDA)	Baruch-Mordo, S (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	Sharon.Baruch-Mordo@colostate.edu	Breck, Stewart/GWC-5825-2022; Wilson, Kenneth R./P-8692-2019		United States Department of Agriculture - National Wildlife Research Center; city of Aspen [5353530]; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	United States Department of Agriculture - National Wildlife Research Center; city of Aspen; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	This study was funded by the United States Department of Agriculture - National Wildlife Research Center (SWB) (http://www.aphis.usda.gov/wildlife_damage/nwrc/). Additional funds awarded by the city of Aspen to KRW (CSU account no. 5353530). Fellowship and scholarship support given to SBM by Aspen Field Biology Lab, Jack H. Berryman Institute, Rocky Mountain Goats Foundation, and the Colorado Chapter of The Wildlife Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, RESOLVING HUMAN WILD; *ASP CHAMB RES ASS, 2009, ASP DEM PROF REP; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; BARUCHMORDO S, 2000, 1 US CENS BUR AM FAC; BARUCHMORDO S, 2000, PROFILE SELECTED EC; Beckmann JP, 2004, WILDLIFE SOC B, V32, P1141, DOI 10.2193/0091-7648(2004)032[1141:EODTAD]2.0.CO;2; Cameron AC, 1997, J ECONOMETRICS, V77, P329; *CO STAT DEM OFF, 2009, POP TOT COL MUN; Conover MR, 1997, WILDLIFE SOC B, V25, P306; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Don Carlos Andrew W., 2009, Human Dimensions of Wildlife, V14, P174; Dunn WC, 2008, URSUS, V19, P43, DOI 10.2192/1537-6176(2008)19[43:SEIBCA]2.0.CO;2; Fall MW, 2002, INT BIODETER BIODEGR, V49, P87, DOI 10.1016/S0964-8305(01)00107-X; FEIGHERY E, 1991, JAMA-J AM MED ASSOC, V266, P3168; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; George SL, 2006, SOUTHWEST NAT, V51, P240, DOI 10.1894/0038-4909(2006)51[240:EACOTU]2.0.CO;2; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gore ML, 2006, URSUS, V17, P75, DOI 10.2192/1537-6176(2006)17[75:EPFRAB]2.0.CO;2; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; *INT ASS FISH WILD, 2005, POT COSTS LOS HUNT T; Jachmann H, 1997, J APPL ECOL, V34, P233, DOI 10.2307/2404861; Jachmann H, 2008, BIOL CONSERV, V141, P1906, DOI 10.1016/j.biocon.2008.05.009; Jacobson S.K., 2006, CONSERVATION ED OUTR; JACOBSON SK, 2009, WILDLIFE SOC SCI HUM, P301; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Knarrum V, 2006, URSUS, V17, P67, DOI 10.2192/1537-6176(2006)17[67:BBPODS]2.0.CO;2; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Manfredo M., 2008, WHO CARES WILDLIFE S, Vfirst, DOI [10.1007/978-0-387-77040-6, DOI 10.1007/978-0-387-77040-6]; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; McCleery RA, 2009, SOC NATUR RESOUR, V22, P353, DOI 10.1080/08941920802064414; Messmer Terry A., 2009, Human-Wildlife Conflicts, V3, P10; *NAT AGR IM PROGR, 2005, NAIP IM; Ott RL, 2001, INTRO STAT METHODS D; Peine John D., 2001, Human Dimensions of Wildlife, V6, P223, DOI 10.1080/108712001753461301; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; *SAS I, 2002, SAS SYST WIND V 9 2; Shivik JA, 2006, BIOSCIENCE, V56, P253, DOI 10.1641/0006-3568(2006)056[0253:TFTEWN]2.0.CO;2; Shults RA, 2009, AM J PREV MED, V37, P360, DOI 10.1016/j.amepre.2009.07.005; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Tchamba MN, 1996, BIOL CONSERV, V75, P35, DOI 10.1016/0006-3207(95)00040-2; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vasudevan V, 2009, TRAFFIC INJ PREV, V10, P330, DOI 10.1080/15389580902995190; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Woodroffe R., 2005, CONSERV BIOL	51	74	75	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e15681	10.1371/journal.pone.0015681	http://dx.doi.org/10.1371/journal.pone.0015681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264267	gold, Green Submitted, Green Published			2022-12-27	WOS:000286514300001
J	Calabrese, A; Schumacher, JW; Schneider, DM; Paninski, L; Woolley, SMN				Calabrese, Ana; Schumacher, Joseph W.; Schneider, David M.; Paninski, Liam; Woolley, Sarah M. N.			A Generalized Linear Model for Estimating Spectrotemporal Receptive Fields from Responses to Natural Sounds	PLOS ONE			English	Article							ZEBRA FINCHES; NEURAL ENSEMBLE; NONLINEARITIES; NEURONS; SONG; DISCRIMINATION; REPRESENTATION; SHRINKAGE; CORTEX	In the auditory system, the stimulus-response properties of single neurons are often described in terms of the spectrotemporal receptive field (STRF), a linear kernel relating the spectrogram of the sound stimulus to the instantaneous firing rate of the neuron. Several algorithms have been used to estimate STRFs from responses to natural stimuli; these algorithms differ in their functional models, cost functions, and regularization methods. Here, we characterize the stimulus-response function of auditory neurons using a generalized linear model (GLM). In this model, each cell's input is described by: 1) a stimulus filter (STRF); and 2) a post-spike filter, which captures dependencies on the neuron's spiking history. The output of the model is given by a series of spike trains rather than instantaneous firing rate, allowing the prediction of spike train responses to novel stimuli. We fit the model by maximum penalized likelihood to the spiking activity of zebra finch auditory midbrain neurons in response to conspecific vocalizations (songs) and modulation limited (ml) noise. We compare this model to normalized reverse correlation (NRC), the traditional method for STRF estimation, in terms of predictive power and the basic tuning properties of the estimated STRFs. We find that a GLM with a sparse prior predicts novel responses to both stimulus classes significantly better than NRC. Importantly, we find that STRFs from the two models derived from the same responses can differ substantially and that GLM STRFs are more consistent between stimulus classes than NRC STRFs. These results suggest that a GLM with a sparse prior provides a more accurate characterization of spectrotemporal tuning than does the NRC method when responses to complex sounds are studied in these neurons.	[Calabrese, Ana; Schumacher, Joseph W.; Schneider, David M.; Paninski, Liam; Woolley, Sarah M. N.] Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA; [Calabrese, Ana; Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY USA; [Woolley, Sarah M. N.] Columbia Univ, Dept Psychol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Calabrese, A (corresponding author), Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA.	sw2277@columbia.edu			Gatsby Initiative in Brain Circuitry, National Institutes of Health [HD007430-11]; National Institutes of Health, National Research Service Award (NRSA) [DC010301-01A110]; National Institutes of Health [R01 DC009810]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009810, F31DC010301] Funding Source: NIH RePORTER	Gatsby Initiative in Brain Circuitry, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Gatsby Initiative in Brain Circuitry, National Institutes of Health training grant HD007430-11, National Institutes of Health, National Research Service Award (NRSA) grant DC010301-01A110, and National Institutes of Health R01 DC009810. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMADIAN Y, 2009, EFFICIENT MARKOV CHA; Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Ahrens MB, 2008, J NEUROSCI, V28, P1929, DOI 10.1523/JNEUROSCI.3377-07.2008; BRILLINGER DR, 1988, BIOL CYBERN, V59, P189, DOI 10.1007/BF00318010; CARVALHO CM, HORSESHOE ESTIMATOR; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Covey E, 1996, J NEUROSCI, V16, P3009; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1368, DOI 10.1073/pnas.89.4.1368; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; Dent ML, 2009, J COMP PSYCHOL, V123, P357, DOI 10.1037/a0016898; DONOHO DL, 1995, J ROY STAT SOC B MET, V57, P301; Eldawlatly S, 2009, NEURAL COMPUT, V21, P450, DOI 10.1162/neco.2008.09-07-606; Escabi MA, 2003, BIOL CYBERN, V89, P350, DOI 10.1007/S00422-003-0440-8; Friedman J., 2008, REGULARIZATION PATHS; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kouh M, 2009, NETWORK-COMP NEURAL, V20, P49, DOI 10.1080/09548980902950891; Lewi J, 2009, NEURAL COMPUT, V21, P619, DOI 10.1162/neco.2008.08-07-594; MACHENS C, 2003, NIPS, V15, P149; Mesgarani N, 2009, J NEUROPHYSIOL, V102, P3329, DOI 10.1152/jn.91128.2008; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; RAMIREZ A, 2010, J NEUROSCI; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; SAHANI M, 2003, NIPS, V15, P317; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Schmidt M., 2007, EUR C MACH LEARN ECM; SCHNEIDER DM, 2010, J NEUROPHYS IN PRESS; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2008, J NEUROPHYSIOL, V99, P2496, DOI 10.1152/jn.01397.2007; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smyth D, 2003, J NEUROSCI, V23, P4746; Snyder Donald Lee, 1991, RANDOM POINT PROCESS, DOI DOI 10.1007/978-1-4612-3166-0; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Woolley SMN, 2004, J NEUROPHYSIOL, V91, P136, DOI 10.1152/jn.00633.2003; Zevin JD, 2004, J NEUROSCI, V24, P5849, DOI 10.1523/JNEUROSCI.1891-04.2004; Zhang T, 2005, ANN STAT, V33, P1538, DOI 10.1214/009053605000000255; ZHAO M, 2010, NEURAL COMPUT, V22, P1; [No title captured]	52	70	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16104	10.1371/journal.pone.0016104	http://dx.doi.org/10.1371/journal.pone.0016104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264310	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514000022
J	Zhang, B; Chen, BB; Wu, T; Tan, YL; Qiu, SA; Xuan, ZY; Zhu, XP; Chen, RS				Zhang, Bo; Chen, Beibei; Wu, Tao; Tan, Yuliang; Qiu, Shuang; Xuan, Zhenyu; Zhu, Xiaopeng; Chen, Runsheng			Estimating the Quality of Reprogrammed Cells Using ES Cell Differentiation Expression Patterns	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; DISEASE; MICE	Somatic cells can be reprogrammed to a pluripotent state by over-expression of defined factors, and pluripotency has been confirmed by the tetraploid complementation assay. However, especially in human cells, estimating the quality of Induced Pluripotent Stem Cell(iPSC) is still difficult. Here, we present a novel supervised method for the assessment of the quality of iPSCs by estimating the gene expression profile using a 2-D "Differentiation-index coordinate", which consists of two "developing lines" that reflects the directions of ES cell differentiation and the changes of cell states during differentiation. By applying a novel liner model to describe the differentiation trajectory, we transformed the ES cell differentiation time-course expression profiles to linear "developing lines"; and use these lines to construct the 2-D "Differentiation-index coordinate" of mouse and human. We compared the published gene expression profiles of iPSCs, ESCs and fibroblasts in mouse and human "Differentiation-index coordinate". Moreover, we defined the Distance index to indicate the qualities of iPS cells, which based on the projection distance of iPSCs-ESCs and iPSCs-fibroblasts. The results indicated that the "Differentiation-index coordinate" can distinguish differentiation states of the different cells types. Furthermore, by applying this method to the analysis of expression profiles in the tetraploid complementation assay, we showed that the Distance index which reflected spatial distributions correlated the pluripotency of iPSCs. We also analyzed the significantly changed gene sets of "developing lines". The results suggest that the method presented here is not only suitable for the estimation of the quality of iPS cells based on expression profiles, but also is a new approach to analyze time-resolved experimental data.	[Zhang, Bo; Chen, Beibei; Wu, Tao; Tan, Yuliang; Qiu, Shuang; Zhu, Xiaopeng; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhang, Bo; Chen, Beibei; Tan, Yuliang; Qiu, Shuang] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China; [Xuan, Zhenyu] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75083 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Texas System; University of Texas Dallas	Zhang, B (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	nimezhu@gmail.com; crs@sun5.ibp.ac.cn	Chen, Runsheng/S-9834-2017; xiaopeng, zhu/A-6755-2011; Wu, Tao/A-1063-2013; zb, aber/A-6874-2011	Chen, Runsheng/0000-0001-6049-8347; xiaopeng, zhu/0000-0003-2007-9820; Wu, Tao/0000-0002-9859-4534; zb, aber/0000-0003-2962-5314; Xuan, Zhenyu/0000-0001-9344-8493	National Program on Key Basic Research Project (973 Program) [2009CB825401]; National Natural Science Foundation of China [60933009]; Chinese Academy of Sciences [KSCX2-YW-R-124]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Program on Key Basic Research Project (973 Program Grant 2009CB825401), the National Natural Science Foundation of China (60933009), and the Innovation Projects (KSCX2-YW-R-124) from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r240; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Nord AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000617; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pewsey E, 2009, MOL CELL PROTEOMICS, V8, P1401, DOI 10.1074/mcp.M800478-MCP200; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Treff NR, 2006, STEM CELLS, V24, P2529, DOI 10.1634/stemcells.2006-0082; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weng J, 2009, J VIROL, V83, P7467, DOI 10.1128/JVI.00163-09; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15336	10.1371/journal.pone.0015336	http://dx.doi.org/10.1371/journal.pone.0015336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21283513	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514000004
J	Chen, CYC				Chen, Calvin Yu-Chian			TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico	PLOS ONE			English	Article							PHARMACOINFORMATICS APPROACH; DESIGN	Rapid advancing computational technologies have greatly speeded up the development of computer-aided drug design (CADD). Recently, pharmaceutical companies have increasingly shifted their attentions toward traditional Chinese medicine (TCM) for novel lead compounds. Despite the growing number of studies on TCM, there is no free 3D small molecular structure database of TCM available for virtual screening or molecular simulation. To address this shortcoming, we have constructed TCM Database@Taiwan (http://tcm.cmu.edu.tw/) based on information collected from Chinese medical texts and scientific publications. TCM Database@Taiwan is currently the world's largest non-commercial TCM database. This web-based database contains more than 20,000 pure compounds isolated from 453 TCM ingredients. Both cdx (2D) and Tripos mol2 (3D) formats of each pure compound in the database are available for download and virtual screening. The TCM database includes both simple and advanced web-based query options that can specify search clauses, such as molecular properties, substructures, TCM ingredients, and TCM classification, based on intended drug actions. The TCM database can be easily accessed by all researchers conducting CADD. Over the last eight years, numerous volunteers have devoted their time to analyze TCM ingredients from Chinese medical texts as well as to construct structure files for each isolated compound. We believe that TCM Database@Taiwan will be a milestone on the path towards modernizing traditional Chinese medicine.	[Chen, Calvin Yu-Chian] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Bioinformat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA	China Medical University Taiwan; Asia University Taiwan; Massachusetts Institute of Technology (MIT)	Chen, CYC (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	ycc@mail.cmu.edu.tw	; Chen, Calvin Yu-Chian/E-9402-2010	Chen, Calvin Yu-Chian/0000-0001-9213-9832; Chen, Calvin Yu-Chian/0000-0003-3306-250X	National Science Council of Taiwan [NSC 99-2221-E-039-013-]; China Medical University [CMU99-S-02]; Asia University [CMU98-ASIA-09]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH99-TD-C-111-005]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence	The research was supported by grants from the National Science Council of Taiwan (NSC 99-2221-E-039-013-), China Medical University (CMU99-S-02) and Asia University (CMU98-ASIA-09). This study is also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (DOH99-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CYC, 2010, J TAIWAN INST CHEM E, V41, P143, DOI 10.1016/j.jtice.2009.08.007; Chen CYC, 2010, J BIOMOL STRUCT DYN, V27, P627, DOI 10.1080/07391102.2010.10508577; Chen CYC, 2009, J MOL GRAPH MODEL, V28, P261, DOI 10.1016/j.jmgm.2009.08.004; Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P55, DOI 10.1016/j.jtice.2008.06.001; Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P36, DOI 10.1016/j.jtice.2008.07.011; Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P155, DOI 10.1016/j.jtice.2008.07.010; Chen CY, 2010, J MOL GRAPH MODEL, V29, P21, DOI 10.1016/j.jmgm.2010.04.002; Chen CY, 2010, J TAIWAN INST CHEM E, V41, P8, DOI 10.1016/j.jtice.2009.06.007; Chen CY, 2009, J BIOMOL STRUCT DYN, V27, P171, DOI 10.1080/07391102.2009.10507307; CHEN G, 1992, BEN CAO GANG MU TONG; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; FANG Y, 1991, SHANG HAN LUN TIAO B, P2; Fang YC, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-58; Haider N, 2010, MOLECULES, V15, P5079, DOI 10.3390/molecules15085079; He M, 2001, J CHEM INF COMP SCI, V41, P273, DOI 10.1021/ci0003101; Huang HJ, 2010, J TAIWAN INST CHEM E, V41, P623, DOI 10.1016/j.jtice.2010.03.017; Huang HJ, 2010, J BIOMOL STRUCT DYN, V28, P23, DOI 10.1080/07391102.2010.10507341; Huang HJ, 2010, J TAIWAN INST CHEM E, V41, P352, DOI 10.1016/j.jtice.2009.09.002; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; LU X, 2002, ZHONG YAO JIAN BIE D, P2; MIAO X, 2002, SHENNONG BEN CAO JIN; Qiao XB, 2002, J CHEM INF COMP SCI, V42, P481, DOI 10.1021/ci010113h; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; SHEN L, 1998, BEN CAO GANG MU CAI, P4; Yang S., 1998, DIVINE FARMERS MAT M, V1st, pxvi; YAO D, GUANGZHOU SHI GUANGD, P3; ZHONG N, 2006, ZHONG YAO DA CI DIAN	27	639	694	9	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15939	10.1371/journal.pone.0015939	http://dx.doi.org/10.1371/journal.pone.0015939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253603	Green Submitted, gold, Green Published			2022-12-27	WOS:000286511900028
J	Fousteri, G; Dave, A; Juedes, A; Juntti, T; Morin, B; Togher, L; Farber, DL; von Herrath, M				Fousteri, Georgia; Dave, Amy; Juedes, Amy; Juntti, Therese; Morin, Bret; Togher, Lisa; Farber, Donna L.; von Herrath, Matthias			Increased Memory Conversion of Naive CD8 T Cells Activated during Late Phases of Acute Virus Infection Due to Decreased Cumulative Antigen Exposure	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VIRAL-INFECTION; PROTECTIVE IMMUNITY; DISTINCT ROLES; CUTTING EDGE; EFFECTOR; DIFFERENTIATION; SURVIVAL; PROLIFERATION; EXPRESSION	Background: Memory CD8 T cells form an essential part of protective immunity against viral infections. Antigenic load, costimulation, CD4-help, cytokines and chemokines fluctuate during the course of an antiviral immune response thus affecting CD8 T cell activation and memory conversion. Methodology/Principal Findings: In the present study, naive TCR transgenic LCMV-specific P14 CD8 T cells engaged at a late stage during the acute antiviral LCMV response showed reduced expansion kinetics but greater memory conversion in the spleen. Such late activated cells displayed a memory precursor effector phenotype already at the peak of the systemic antiviral response, suggesting that the environment determined their fate during antigen encounter. In the spleen, the majority of late transferred cells exhibited a central memory phenotype compared to the effector memory displayed by the early transferred cells. Increasing the inflammatory response by exogenous administration of IFN gamma, PolyI:C or CpG did not affect memory conversion in the late transferred group, suggesting that the diverging antigen load early versus later during acute infection had determined their fate. In agreement, reduction in the LCMV antigenic load after ribavirin treatment enhanced the contribution of early transferred cells to the long lasting memory pool. Conclusions/Significance: Our results show that naive CD8 cells, exposed to reduced duration or concentration of antigen during viral infection convert into memory more efficiently, an observation that could have significant implications for vaccine design.	[Fousteri, Georgia; Dave, Amy; Juedes, Amy; Juntti, Therese; Morin, Bret; Togher, Lisa; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA	La Jolla Institute for Immunology; Columbia University	Fousteri, G (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA USA.	matthias@liai.org	Fousteri, Georgia/B-1226-2012	Fousteri, Georgia/0000-0001-7745-7517; Farber, Donna/0000-0001-8236-9183; Jhatakia, Amy/0000-0001-6855-5342	Brehm coalition; National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) [AI68818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068818] Funding Source: NIH RePORTER	Brehm coalition; National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the Brehm coalition and National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) grant # AI68818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 2004, J IMMUNOL, V173, P2217, DOI 10.4049/jimmunol.173.4.2217; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; CERNY A, 1988, J VIROL, V62, P1803, DOI 10.1128/JVI.62.5.1803-1807.1988; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Seiler P, 2000, J VIROL, V74, P5896, DOI 10.1128/JVI.74.13.5896-5901.2000; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Takamura S, 2010, J EXP MED, V207, P1153, DOI 10.1084/jem.20090283; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14502	10.1371/journal.pone.0014502	http://dx.doi.org/10.1371/journal.pone.0014502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253594	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900005
J	Kofler, R; Orozco-terWengel, P; De Maio, N; Pandey, RV; Nolte, V; Futschik, A; Kosiol, C; Schlotterer, C				Kofler, Robert; Orozco-terWengel, Pablo; De Maio, Nicola; Pandey, Ram Vinay; Nolte, Viola; Futschik, Andreas; Kosiol, Carolin; Schloetterer, Christian			PoPoolation: A Toolbox for Population Genetic Analysis of Next Generation Sequencing Data from Pooled Individuals	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; RECOMBINATION RATES; DNA POLYMORPHISM; EVOLUTION; ALIGNMENT; MUTATION; SAMPLES; SEQ	Recent statistical analyses suggest that sequencing of pooled samples provides a cost effective approach to determine genome-wide population genetic parameters. Here we introduce PoPoolation, a toolbox specifically designed for the population genetic analysis of sequence data from pooled individuals. PoPoolation calculates estimates of theta(Watterson), theta(p), and Tajima's D that account for the bias introduced by pooling and sequencing errors, as well as divergence between species. Results of genome-wide analyses can be graphically displayed in a sliding window plot. PoPoolation is written in Perl and R and it builds on commonly used data formats. Its source code can be downloaded from http://code.google.com/p/popoolation/. Furthermore, we evaluate the influence of mapping algorithms, sequencing errors, and read coverage on the accuracy of population genetic parameter estimates from pooled data.	[Kofler, Robert; Orozco-terWengel, Pablo; De Maio, Nicola; Pandey, Ram Vinay; Nolte, Viola; Kosiol, Carolin; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria; [Futschik, Andreas] Univ Vienna, Dept Stat, Vienna, Austria	University of Veterinary Medicine Vienna; University of Vienna	Kofler, R (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Orozco-terWengel, Pablo Andres/D-1527-2011; Schlötterer, Christian/G-6326-2010; Futschik, Andreas/G-3697-2010; Pandey, Ram Vinay/AAA-3544-2022; Schlötterer, Christian/Q-5264-2019; Pandey, Ram Vinay/AAL-1701-2021	Orozco-terWengel, Pablo Andres/0000-0002-7951-4148; Schlötterer, Christian/0000-0003-4710-6526; Futschik, Andreas/0000-0002-7980-0304; Schlötterer, Christian/0000-0003-4710-6526; Pandey, Ram Vinay/0000-0002-2533-8687; De Maio, Nicola/0000-0002-1776-8564; Kofler, Robert/0000-0001-9960-7248	Austrian Science Funds (FWF) [P19467-B11]; Austrian Science Fund (FWF) [P 19467] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been supported by grants of the Austrian Science Funds (FWF) to Christian Schlotterer (P19467-B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; FUTSCHIK A, 2010, GENETICS IN PRESS; Haubold B, 2010, MOL ECOL, V19, P277, DOI 10.1111/j.1365-294X.2009.04482.x; HU Y, 2010, BIOINFORMATICS; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; TAJIMA F, 1989, GENETICS, V123, P585; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TURNER TL, 2010, NAT GENET; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	351	354	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15925	10.1371/journal.pone.0015925	http://dx.doi.org/10.1371/journal.pone.0015925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253599	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900025
J	Xu, B; Hua, JA; Zhang, YW; Jiang, XH; Zhang, HA; Ma, TL; Zheng, W; Sun, R; Shen, W; Sha, JH; Cooke, HJ; Shi, QH				Xu, Bo; Hua, Juan; Zhang, Yuanwei; Jiang, Xiaohua; Zhang, Huan; Ma, Tieliang; Zheng, Wei; Sun, Rui; Shen, Wei; Sha, Jiahao; Cooke, Howard J.; Shi, Qinghua			Proliferating Cell Nuclear Antigen (PCNA) Regulates Primordial Follicle Assembly by Promoting Apoptosis of Oocytes in Fetal and Neonatal Mouse Ovaries	PLOS ONE			English	Article							GERM-CELL; IN-VITRO; GENE-EXPRESSION; RAT OVARY; GROWTH; MICE; INITIATION; DIFFERENTIATION; SURVIVAL; BCL-2	Primordial follicles, providing all the oocytes available to a female throughout her reproductive life, assemble in perinatal ovaries with individual oocytes surrounded by granulosa cells. In mammals including the mouse, most oocytes die by apoptosis during primordial follicle assembly, but factors that regulate oocyte death remain largely unknown. Proliferating cell nuclear antigen (PCNA), a key regulator in many essential cellular processes, was shown to be differentially expressed during these processes in mouse ovaries using 2D-PAGE and MALDI-TOF/TOF methodology. A V-shaped expression pattern of PCNA in both oocytes and somatic cells was observed during the development of fetal and neonatal mouse ovaries, decreasing from 13.5 to 18.5 dpc and increasing from 18.5 dpc to 5 dpp. This was closely correlated with the meiotic prophase I progression from pre-leptotene to pachytene and from pachytene to diplotene when primordial follicles started to assemble. Inhibition of the increase of PCNA expression by RNA interference in cultured 18.5 dpc mouse ovaries strikingly reduced the apoptosis of oocytes, accompanied by down-regulation of known pro-apoptotic genes, e. g. Bax, caspase-3, and TNF alpha and TNFR2, and up-regulation of Bcl-2, a known anti-apoptotic gene. Moreover, reduced expression of PCNA was observed to significantly increase primordial follicle assembly, but these primordial follicles contained fewer guanulosa cells. Similar results were obtained after down-regulation by RNA interference of Ing1b, a PCNA-binding protein in the UV-induced apoptosis regulation. Thus, our results demonstrate that PCNA regulates primordial follicle assembly by promoting apoptosis of oocytes in fetal and neonatal mouse ovaries.	[Xu, Bo; Hua, Juan; Zhang, Yuanwei; Jiang, Xiaohua; Zhang, Huan; Ma, Tieliang; Zheng, Wei; Sun, Rui; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shen, Wei] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, Lab Reprod Med, Nanjing, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Guelph; Nanjing Medical University; University of Edinburgh; University of Edinburgh	Xu, B (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Zhang, Yuanwei/C-7695-2016; Shi, Qinghua/N-2950-2013	Zhang, Yuanwei/0000-0002-2814-8061; 	National Basic Research Program of China (973) [2006CB504003, 2007CB947401]; Chinese Academy of Sciences [KSCX1-YW-R-51, KSCX2-EW-R-07]	National Basic Research Program of China (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program (2006CB504003, 2007CB947401) of China (973), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-51, KSCX2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla M, 2008, TISSUE CELL, V40, P373, DOI 10.1016/j.tice.2008.03.006; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; BORUM K, 1967, EXP CELL RES, V45, P39, DOI 10.1016/0014-4827(67)90110-3; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; De Felici M, 2004, HUM REPROD UPDATE, V10, P197, DOI 10.1093/humupd/dmh020; De Felici M, 1999, CELL DEATH DIFFER, V6, P908, DOI 10.1038/sj.cdd.4400561; De Felici M, 2008, AUTOPHAGY, V4, P240, DOI 10.4161/auto.5410; De Pol A, 1997, HUM REPROD, V12, P2235, DOI 10.1093/humrep/12.10.2235; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; Dissen GA, 2001, ENDOCRINOLOGY, V142, P2078, DOI 10.1210/en.142.5.2078; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Flaws JA, 2001, BIOL REPROD, V64, P1153, DOI 10.1095/biolreprod64.4.1153; Flaws JA, 2006, TOXICOL APPL PHARM, V215, P51, DOI 10.1016/j.taap.2006.03.003; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; GAPIENKO E F, 1976, Arkhiv Anatomii Gistologii i Embriologii, V70, P30; Garcia-Rudaz C, 2007, DEVELOPMENT, V134, P945, DOI 10.1242/dev.02795; Greenfeld CR, 2007, REPRODUCTION, V133, P865, DOI 10.1530/REP-06-0270; Greenfeld CR, 2007, BIOL REPROD, V76, P224, DOI 10.1095/biolreprod.106.055509; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hutt KJ, 2006, CELL TISSUE RES, V326, P809, DOI 10.1007/s00441-006-0223-3; Kamat A, 1999, P NATL ACAD SCI USA, V96, P4575, DOI 10.1073/pnas.96.8.4575; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Kezele P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1990, DOI 10.2741/kezele; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Korfsmeier KH, 2002, ACTA HISTOCHEM, V104, P73, DOI 10.1078/0065-1281-00632; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Lobascio AM, 2007, REPRODUCTION, V134, P241, DOI 10.1530/REP-07-0141; Marcinkiewicz JL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1997, DOI 10.2741/marcin; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Muskhelishvili L, 2005, TOXICOL PATHOL, V33, P365, DOI 10.1080/01926230590930164; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Picut CA, 2008, TOXICOL PATHOL, V36, P674, DOI 10.1177/0192623308317428; Pinon-Lataillade G, 2004, J CELL SCI, V117, P3691, DOI 10.1242/jcs.01226; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scott M, 2001, J CELL SCI, V114, P3455; Shen W, 2007, REPRODUCTION, V134, P223, DOI 10.1530/REP-06-0378; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tomanek M, 2006, FOLIA HISTOCHEM CYTO, V44, P269; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wandji SA, 1996, BIOL REPROD, V55, P942, DOI 10.1095/biolreprod55.5.942; Wandji SA, 1997, HUM REPROD, V12, P1993, DOI 10.1093/humrep/12.9.1993; Wang C, 2006, ENDOCRINOLOGY, V147, P1725, DOI 10.1210/en.2005-1208; WANG C, 2010, ENDOCRINOLOGY; Wang NL, 2009, PROTEOMICS, V9, P3425, DOI 10.1002/pmic.200800822; Wen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007372; Zhang ZP, 2010, DNA CELL BIOL, V29, P163, DOI 10.1089/dna.2009.0958	76	87	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16046	10.1371/journal.pone.0016046	http://dx.doi.org/10.1371/journal.pone.0016046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253613	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900038
J	Zhou, LA; Chen, JH; Li, ZZ; Li, XX; Hu, XD; Huang, Y; Zhao, XK; Liang, CZ; Wang, Y; Sun, LA; Shi, M; Xu, XH; Shen, F; Chen, MS; Han, ZJ; Peng, ZY; Zhai, QN; Chen, J; Zhang, ZF; Yang, RL; Ye, JX; Guan, ZC; Yang, HM; Gui, YT; Wang, J; Cai, ZM; Zhang, XQ				Zhou, Liang; Chen, Jiahao; Li, Zhizhong; Li, Xianxin; Hu, Xueda; Huang, Yi; Zhao, Xiaokun; Liang, Chaozhao; Wang, Yong; Sun, Liang; Shi, Min; Xu, Xiaohong; Shen, Feng; Chen, Maoshan; Han, Zujing; Peng, Zhiyu; Zhai, Qingna; Chen, Jing; Zhang, Zhongfu; Yang, Ruilin; Ye, Jiongxian; Guan, Zhichen; Yang, Huanming; Gui, Yaoting; Wang, Jun; Cai, Zhiming; Zhang, Xiuqing			Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; REPRESSORS ZEB1; CANCER; HYPOXIA; PHENOTYPE; SIGNATURE; PROGNOSIS; TUMORS; CLASSIFICATION; CYTOSCAPE	Background: With the advent of second-generation sequencing, the expression of gene transcripts can be digitally measured with high accuracy. The purpose of this study was to systematically profile the expression of both mRNA and miRNA genes in clear cell renal cell carcinoma (ccRCC) using massively parallel sequencing technology. Methodology: The expression of mRNAs and miRNAs were analyzed in tumor tissues and matched normal adjacent tissues obtained from 10 ccRCC patients without distant metastases. In a prevalence screen, some of the most interesting results were validated in a large cohort of ccRCC patients. Principal Findings: A total of 404 miRNAs and 9,799 mRNAs were detected to be differentially expressed in the 10 ccRCC patients. We also identified 56 novel miRNA candidates in at least two samples. In addition to confirming that canonical cancer genes and miRNAs (including VEGFA, DUSP9 and ERBB4; miR-210, miR-184 and miR-206) play pivotal roles in ccRCC development, promising novel candidates (such as PNCK and miR-122) without previous annotation in ccRCC carcinogenesis were also discovered in this study. Pathways controlling cell fates (e. g., cell cycle and apoptosis pathways) and cell communication (e. g., focal adhesion and ECM-receptor interaction) were found to be significantly more likely to be disrupted in ccRCC. Additionally, the results of the prevalence screen revealed that the expression of a miRNA gene cluster located on Xq27.3 was consistently downregulated in at least 76.7% of similar to 50 ccRCC patients. Conclusions: Our study provided a two-dimensional map of the mRNA and miRNA expression profiles of ccRCC using deep sequencing technology. Our results indicate that the phenotypic status of ccRCC is characterized by a loss of normal renal function, downregulation of metabolic genes, and upregulation of many signal transduction genes in key pathways. Furthermore, it can be concluded that downregulation of miRNA genes clustered on Xq27.3 is associated with ccRCC.	[Zhou, Liang; Li, Xianxin; Huang, Yi; Wang, Yong; Sun, Liang; Shi, Min; Zhai, Qingna; Chen, Jing; Zhang, Zhongfu; Yang, Ruilin; Ye, Jiongxian; Guan, Zhichen; Gui, Yaoting; Cai, Zhiming] Peking Univ, Key Lab Stem Cell Biol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen Hosp,Shenzhen PKU HKUST Med Ct, Shenzhen, Peoples R China; [Chen, Jiahao; Li, Zhizhong; Hu, Xueda; Xu, Xiaohong; Shen, Feng; Chen, Maoshan; Han, Zujing; Peng, Zhiyu; Yang, Huanming; Wang, Jun; Zhang, Xiuqing] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Chen, Jiahao; Li, Zhizhong] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhao, Xiaokun] Cent So Univ, Dept Urosurg, Hosp 2, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Dept Urosurg, Hosp 1, Hefei, Peoples R China; [Yang, Ruilin] Shantou Univ, Coll Med, Shantou, Peoples R China	Hong Kong University of Science & Technology; Peking University; Beijing Genomics Institute (BGI); South China University of Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central South University; Anhui Medical University; Shantou University	Zhou, LA (corresponding author), Peking Univ, Key Lab Stem Cell Biol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen Hosp,Shenzhen PKU HKUST Med Ct, Shenzhen, Peoples R China.	caizhiming2000@yahoo.com.cn; zhangxq@genomics.org.cn	gui, yaoting/GLT-3684-2022; Peng, Zhiyu/GXV-5301-2022; Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	CHEN, MAOSHAN/0000-0002-3827-4969; Wang, Jun/0000-0002-2113-5874; Chen, Jiahao/0000-0001-7719-3216; Wang, Jun/0000-0002-8540-8931	Ministry of Science and Technology of China [2006AA02A302, 2009AA022707]; National Natural Science Foundation of China [30725008, 30811130531, 30900817, 30972992, 30971636]; Shenzhen Municipal Government of China [CXB200903110066A, JC200903190768A, ZD200806180054A]; Renovation Project of Shenzhen and Hong Kong [ZYB200907080110A]; Danish Natural Science Research Council [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Renovation Project of Shenzhen and Hong Kong; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Shenzhen Key Laboratory, Shenzhen, China	This work was supported by the Ministry of Science and Technology of China, 863 program [2006AA02A302; 2009AA022707]; the National Natural Science Foundation of China [30725008; 30811130531, 30900817, 30972992, 30971636]; the Shenzhen Municipal Government of China [CXB200903110066A; JC200903190768A; ZD200806180054A]; the Renovation Project of Shenzhen and Hong Kong [ZYB200907080110A]; the Danish Natural Science Research Council, the Solexa project [272-07-0196]; the Danish Strategic Research Council [2106-07-0021] and the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A to Z.M.-C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Deb TB, 2008, AM J PHYSIOL-CELL PH, V295, pC365, DOI 10.1152/ajpcell.00449.2007; Gardner HP, 2000, CANCER RES, V60, P5571; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosari F, 2005, CLIN CANCER RES, V11, P5128, DOI 10.1158/1078-0432.CCR-05-0073; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Mizuno N, 2007, DRUG METAB DISPOS, V35, P1429, DOI 10.1124/dmd.106.013912; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; SEIFERT G, 1990, PATHOL RES PRACT, V186, P555, DOI 10.1016/S0344-0338(11)80220-7; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTHERLAND GR, 1979, HUM GENET, V53, P23, DOI 10.1007/BF00289445; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Torres AM, 2008, WORLD J GASTROENTERO, V14, P6616, DOI 10.3748/wjg.14.6616; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Verkman A, 2000, EXPT NEPHROLOGY, V10, P235; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	68	391	415	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15224	10.1371/journal.pone.0015224	http://dx.doi.org/10.1371/journal.pone.0015224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21253009	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600014
J	Hibbert, B; Ma, XL; Pourdjabbar, A; Simard, T; Rayner, K; Sun, JF; Chen, YX; Filion, L; O'Brien, ER				Hibbert, Benjamin; Ma, Xiaoli; Pourdjabbar, Ali; Simard, Trevor; Rayner, Katey; Sun, Jiangfeng; Chen, Yong-Xiang; Filion, Lionel; O'Brien, Edward R.			Pre-Procedural Atorvastatin Mobilizes Endothelial Progenitor Cells: Clues to the Salutary Effects of Statins on Healing of Stented Human Arteries	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RE-ENDOTHELIALIZATION; INCREASE; THERAPY; DISEASE; NUMBER; NEOVASCULARIZATION; OUTCOMES; REPAIR	Objectives: Recent clinical trials suggest an LDL-independent superiority of intensive statin therapy in reducing target vessel revascularization and peri-procedural myocardial infarctions in patients who undergo percutaneous coronary interventions (PCI). While animal studies demonstrate that statins mobilize endothelial progenitor cells (EPCs) which can enhance arterial repair and attenuate neointimal formation, the precise explanation for the clinical PCI benefits of high dose statin therapy remain elusive. Thus we serially assessed patients undergoing PCI to test the hypothesis that high dose Atorvastatin therapy initiated prior to PCI mobilizes EPCs that may be capable of enhancing arterial repair. Methods and Results: Statin naive male patients undergoing angiography for stent placement were randomized to standard therapy without Atorvastatin (n = 10) or treatment with Atorvastatin 80 mg (n = 10) beginning three days prior to stent implantation. EPCs were defined by flow cytometry (e.g., surface marker profile of CD45dim/34+/133+/117+). As well, we also enumerated cultured angiogenic cells (CACs) by standard in vitro culture assay. While EPC levels did not fluctuate over time for the patients free of Atorvastatin, there was a 3.5-fold increase in EPC levels with high dose Atorvastatin beginning within 3 days of the first dose (and immediately pre-PCI) which persisted at 4 and 24 hours post-PCI (p < 0.05). There was a similar rise in CAC levels as assessed by in vitro culture. CACs cultured in the presence of Atorvastatin failed to show augmented survival or VEGF secretion but displayed a 2-fold increase in adhesion to stent struts (p < 0.05). Conclusions: High dose Atorvastatin therapy pre-PCI improves EPC number and CAC number and function in humans which may in part explain the benefit in clinical outcomes seen in patients undergoing coronary interventions.	[Hibbert, Benjamin; Ma, Xiaoli; Pourdjabbar, Ali; Simard, Trevor; Rayner, Katey; Sun, Jiangfeng; Chen, Yong-Xiang; O'Brien, Edward R.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Filion, Lionel] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Hibbert, B (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	eobrien@ottawaheart.ca	O'Brien, Edward R/J-6621-2013; Rayner, Katey/K-8914-2012	O'Brien, Edward R/0000-0003-1039-9425; Rayner, Katey/0000-0001-6230-426X	Pfizer Canada; University of Ottawa Heart Institute Interventional Cardiology Group	Pfizer Canada(Pfizer); University of Ottawa Heart Institute Interventional Cardiology Group	This work was supported by grants from Pfizer Canada and The University of Ottawa Heart Institute Interventional Cardiology Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Egan CG, 2009, THROMB HAEMOSTASIS, V101, P1138, DOI 10.1160/TH08-11-0723; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gibson CM, 2009, J AM COLL CARDIOL, V54, P2290, DOI 10.1016/j.jacc.2009.09.010; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hibbert B, 2004, AM J PHYSIOL-HEART C, V287, pH518, DOI 10.1152/ajpheart.00002.2004; Hibbert B, 2003, TRENDS CARDIOVAS MED, V13, P322, DOI 10.1016/j.tcm.2003.09.002; Hibbert B, 2009, CARDIOVASC RES, V83, P16, DOI 10.1093/cvr/cvp156; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2007, ATHEROSCLEROSIS, V192, P413, DOI 10.1016/j.atherosclerosis.2006.05.031; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Ma XL, 2010, CARDIOVASC RES, V86, P338, DOI 10.1093/cvr/cvq047; Ma XL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001894; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Schroeter MR, 2009, ATHEROSCLEROSIS, V205, P63, DOI 10.1016/j.atherosclerosis.2008.11.013; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang CH, 2006, J MOL CELL CARDIOL, V41, P34, DOI 10.1016/j.yjmcc.2006.03.006; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Werner C, 2007, DIABETES, V56, P2609, DOI 10.2337/db07-0069; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215	40	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16413	10.1371/journal.pone.0016413	http://dx.doi.org/10.1371/journal.pone.0016413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283543	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400048
J	Loke, SC; Abdullah, SS; Chai, ST; Hamid, TA; Yahaya, N				Loke, Seng Cheong; Abdullah, Siti S.; Chai, Sen Tyng; Hamid, Tengku A.; Yahaya, Nurizan			Assessment of Factors Influencing Morale in the Elderly	PLOS ONE			English	Article							SCALE; DEPRESSION; DISABILITY; CHINESE; ADULTS; HEALTH	Background: We examined the relationship between morale measured by the Philadelphia Geriatric Morale Scale (PGC) and disability, social support, religiosity, and personality traits. Instruments predicting morale were then tested against PGC domains. Methods: The study utilized a cross-sectional survey with a multistage cluster sampling design. Instruments used were disability (disease burden; WHO Disability Score-II, WHODAS-II), social support (Duke Social Support Scale, DUSOCS; Lubben Social Network Scale, LSNS-6; Medical Outcomes Study Social Support Survey, MOS-SSS), religiosity (Revised Intrinsic-Extrinsic Religious Orientation Scale, I/E-R), and personality (Ten-Item Personality Inventory, TIPI). These were plotted as bar charts against PGC, resolved with one-way ANOVA and Kruskal-Wallis tests, then corrected for multiple comparisons. This process was repeated with PGC domains. Contribution of factors was modeled using population attributable risk (PAR) and odds ratios. Effect of confounders such as gender, age, and ethnicity were checked using binary logistic regression. Results: All instruments showed clear relationships with PGC, with WHODAS-II and DUSOCS performing well (ANOVA p, 0.001). For PGC domains, attitude toward aging and lonely dissatisfaction trended together, while agitation did not. PAR, odds ratios, and Exp(beta) were disability (WHODAS-II: 28.5%, 3.8, 2.8), social support (DUSOCS: 28.0%, 3.4, 2.2), religiosity (I/E-R: 21.6%, 3.2, 2.1), and personality (TIPI: 27.9%, 3.6, 2.4). Combined PAR was 70.9%. Conclusions: Disability, social support, religiosity, and personality strongly influence morale in the elderly. WHODAS-II and DUSOCS perform best in measuring disability and social support respectively.	[Loke, Seng Cheong; Abdullah, Siti S.; Chai, Sen Tyng; Hamid, Tengku A.] Univ Putra Malaysia, Inst Gerontol, Serdang, Selangor Darul, Malaysia; [Yahaya, Nurizan] Univ Putra Malaysia, Fac Human Ecol, Serdang, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Loke, SC (corresponding author), Univ Putra Malaysia, Inst Gerontol, Serdang, Selangor Darul, Malaysia.	lokesengcheong@yahoo.com.sg		Chai, Sen Tyng/0000-0001-5486-7759	Ministry of Science, Technology, and Innovation, Malaysia [06-01-04-SF0479]	Ministry of Science, Technology, and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The study is funded by the eScienceFund (grant number 06-01-04-SF0479), Ministry of Science, Technology, and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jawad M, 2007, Med J Malaysia, V62, P375; COLEMAN PG, 1995, AGE AGEING, V24, P416, DOI 10.1093/ageing/24.5.416; *DUK U, 1986, DUSOCS FORM A; Ellison CG, 2009, J NERV MENT DIS, V197, P568, DOI 10.1097/NMD.0b013e3181b08f45; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; GORSUCH RL, 1989, J SCI STUD RELIG, V28, P348, DOI 10.2307/1386745; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Grimby G, 2001, J REHABIL MED, V33, P193; Imran A, 2009, Med J Malaysia, V64, P134; Keyes CLM, 2007, AGING MENT HEALTH, V11, P434, DOI 10.1080/13607860601086371; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Louis ED, 2008, MOVEMENT DISORD, V23, P1435, DOI 10.1002/mds.22124; Lubben J., 2003, LUBBEN SOCIAL NETWOR; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; MORRIS JN, 1975, J GERONTOL, V30, P209, DOI 10.1093/geronj/30.2.209; Parkerson G R Jr, 1991, Fam Med, V23, P357; RAI GS, 1995, ARCH GERONTOL GERIAT, V20, P249, DOI 10.1016/0167-4943(94)00620-M; *RAND HLTH, 1992, MED OUTC STUD SOC SU; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; *WHO, 2001, WHO DIS ASS SCHED, V2; *WHO, 2010, STEPS SAMPL SIZ CALC; Wong E, 2004, GERONTOLOGIST, V44, P408, DOI 10.1093/geront/44.3.408; Woo J, 2005, INT J GERIATR PSYCH, V20, P1052, DOI 10.1002/gps.1394	24	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16490	10.1371/journal.pone.0016490	http://dx.doi.org/10.1371/journal.pone.0016490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283551	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400056
J	Teissier, E; Zandomeneghi, G; Loquet, A; Lavillette, D; Lavergne, JP; Montserret, R; Cosset, FL; Bockmann, A; Meier, BH; Penin, F; Pecheur, EI				Teissier, Elodie; Zandomeneghi, Giorgia; Loquet, Antoine; Lavillette, Dimitri; Lavergne, Jean-Pierre; Montserret, Roland; Cosset, Francois-Loic; Boeckmann, Anja; Meier, Beat H.; Penin, Francois; Pecheur, Eve-Isabelle			Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; MICELLE-BOUND PEPTIDES; TRYPTOPHAN-RICH MOTIF; STATE PROTON-TRANSFER; PHOSPHOLIPID BICELLES; ANTIOXIDANT ACTIVITY; MODEL MEMBRANES; IN-VITRO; B-VIRUS; PROTEIN	The broad-spectrum antiviral arbidol (Arb) inhibits cell entry of enveloped viruses by blocking viral fusion with host cell membrane. To better understand Arb mechanism of action, we investigated its interactions with phospholipids and membrane peptides. We demonstrate that Arb associates with phospholipids in the micromolar range. NMR reveals that Arb interacts with the polar head-group of phospholipid at the membrane interface. Fluorescence studies of interactions between Arb and either tryptophan derivatives or membrane peptides reconstituted into liposomes show that Arb interacts with tryptophan in the micromolar range. Interestingly, apparent binding affinities between lipids and tryptophan residues are comparable with those of Arb IC50 of the hepatitis C virus (HCV) membrane fusion. Since tryptophan residues of membrane proteins are known to bind preferentially at the membrane interface, these data suggest that Arb could increase the strength of virus glycoprotein's interactions with the membrane, due to a dual binding mode involving aromatic residues and phospholipids. The resulting complexation would inhibit the expected viral glycoprotein conformational changes required during the fusion process. Our findings pave the way towards the design of new drugs exhibiting Arb-like interfacial membrane binding properties to inhibit early steps of virus entry, i.e., attractive targets to combat viral infection.	[Teissier, Elodie; Loquet, Antoine; Lavergne, Jean-Pierre; Montserret, Roland; Boeckmann, Anja; Penin, Francois; Pecheur, Eve-Isabelle] Univ Lyon, Inst Biol & Chim Prot, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, Lyon, France; [Zandomeneghi, Giorgia; Meier, Beat H.] ETH, Zurich, Switzerland; [Lavillette, Dimitri; Cosset, Francois-Loic] Univ Lyon, UCB Lyon1, IFR128, Lyon, France; [Lavillette, Dimitri; Cosset, Francois-Loic] INSERM, U758, F-69008 Lyon, France; [Lavillette, Dimitri; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Swiss Federal Institutes of Technology Domain; ETH Zurich; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON)	Teissier, E (corresponding author), Univ Lyon, Inst Biol & Chim Prot, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, Lyon, France.	f.penin@ibcp.fr; e.pecheur@ibcp.fr	Böckmann, Anja/AAW-6276-2021; Meier, Beat H/K-4066-2016; Cosset, François-Loïc/M-5862-2019; Zandomeneghi, Giorgia/J-8124-2016; Loquet, Antoine/A-1465-2010	Böckmann, Anja/0000-0001-8149-7941; Meier, Beat H/0000-0002-9107-4464; Cosset, François-Loïc/0000-0001-8842-3726; Zandomeneghi, Giorgia/0000-0001-9452-8751; Loquet, Antoine/0000-0001-7176-7813; Pecheur, Eve/0000-0002-8613-862X; Lavillette, Dimitri/0000-0002-4706-1519	ANRS; European Research Council [ERC-2008-AdG-233130-HEPCENT]	ANRS(ANRSFrench National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	Funding was provided by ANRS to E-IP and FP (www.anrs.fr) and European Research Council (ERC-2008-AdG-233130-HEPCENT) to F-LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Angelova MI, 1999, EUR BIOPHYS J BIOPHY, V28, P142, DOI 10.1007/s002490050193; BERTINI I, 1996, COOR CHEM REV; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658; Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56; Bowles MR, 1997, ANAL BIOCHEM, V244, P133, DOI 10.1006/abio.1996.9888; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Broer R, 2006, J VIROL, V80, P1302, DOI 10.1128/JVI.80.3.1302-1310.2006; Brooks MJ, 2004, CURR OPIN PULM MED, V10, P197, DOI 10.1097/00063198-200405000-00009; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chai HF, 2006, BIOORGAN MED CHEM, V14, P911, DOI 10.1016/j.bmc.2005.08.041; Chaudhuri S, 2008, LUMINESCENCE, V23, P397, DOI 10.1002/bio.1052; Chaudhuri S, 2009, BIOPHYS CHEM, V139, P29, DOI 10.1016/j.bpc.2008.09.018; Chew CF, 2008, BIOPHYS J, V95, P5627, DOI 10.1529/biophysj.108.139477; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; Claessens MMAE, 2007, LANGMUIR, V23, P6315, DOI 10.1021/la0637622; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; de Foresta B, 1999, BIOPHYS J, V77, P3071, DOI 10.1016/S0006-3495(99)77138-9; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Harrison SC, 2008, J CELL BIOL, V183, P177, DOI 10.1083/jcb.200809175; HINMAN RL, 1964, J AM CHEM SOC, V86, P3796, DOI 10.1021/ja01072a040; Kliger Y, 2000, J MOL BIOL, V301, P905, DOI 10.1006/jmbi.2000.4004; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Komla-Soukha I, 2006, J VIROL, V80, P4648, DOI 10.1128/JVI.80.10.4648-4655.2006; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Marcellin P, 2009, LIVER INT, V29, P1, DOI 10.1111/j.1478-3231.2008.01947.x; Meanwell NA, 2006, CURR OPIN INVEST DR, V7, P727; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; MONTSERRET R, 2010, J BIOL CHEM; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Perrault M, 2009, BIOCHEM J, V423, P303, DOI 10.1042/BJ20091000; Petersen FNR, 2005, BIOPHYS J, V89, P3985, DOI 10.1529/biophysj.105.061804; Pietschmann T, 2009, NATURE, V457, P797, DOI 10.1038/457797a; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sellitto G, 2010, BIOORGAN MED CHEM, V18, P6143, DOI 10.1016/j.bmc.2010.06.058; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; Villalain J, 2010, J PHYS CHEM B, V114, P8544, DOI 10.1021/jp102619w; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; Yang Jian-Ping, 2009, V510, P295, DOI 10.1007/978-1-59745-394-3_22; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zandomeneghi G, 2003, J BIOMOL NMR, V25, P125, DOI 10.1023/A:1022244025351; Zangger K, 2009, J PHYS CHEM B, V113, P4400, DOI 10.1021/jp808501x	69	94	106	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15874	10.1371/journal.pone.0015874	http://dx.doi.org/10.1371/journal.pone.0015874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283579	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400016
J	Gu, W; Yang, JK; Lou, ZY; Liang, LM; Sun, YN; Huang, JW; Li, XM; Cao, Y; Meng, ZH; Zhang, KQ				Gu, Wen; Yang, Jinkui; Lou, Zhiyong; Liang, Lianming; Sun, Yuna; Huang, Jingwen; Li, Xuemei; Cao, Yi; Meng, Zhaohui; Zhang, Ke-Qin			Structural Basis of Enzymatic Activity for the Ferulic Acid Decarboxylase (FADase) from Enterobacter sp Px6-4	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL ANALYSIS; GENE CLONING; PURIFICATION; 4-VINYLGUAIACOL; TRANSFORMATIONS; DEGRADATION; METABOLISM; EXPRESSION; VANILLIN	Microbial ferulic acid decarboxylase (FADase) catalyzes the transformation of ferulic acid to 4-hydroxy-3-methoxystyrene (4-vinylguaiacol) via non-oxidative decarboxylation. Here we report the crystal structures of the Enterobacter sp. Px6-4 FADase and the enzyme in complex with substrate analogues. Our analyses revealed that FADase possessed a half-opened bottom beta-barrel with the catalytic pocket located between the middle of the core beta-barrel and the helical bottom. Its structure shared a high degree of similarity with members of the phenolic acid decarboxylase (PAD) superfamily. Structural analysis revealed that FADase catalyzed reactions by an "open-closed'' mechanism involving a pocket of 868615 angstrom dimension on the surface of the enzyme. The active pocket could directly contact the solvent and allow the substrate to enter when induced by substrate analogues. Site-directed mutagenesis showed that the E134A mutation decreased the enzyme activity by more than 60%, and Y21A and Y27A mutations abolished the enzyme activity completely. The combined structural and mutagenesis results suggest that during decarboxylation of ferulic acid by FADase, Trp25 and Tyr27 are required for the entering and proper orientation of the substrate while Glu134 and Asn23 participate in proton transfer.	[Gu, Wen; Yang, Jinkui; Liang, Lianming; Huang, Jingwen; Cao, Yi; Meng, Zhaohui; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Peoples R China; [Lou, Zhiyong] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Sun, Yuna] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100080, Peoples R China; [Li, Xuemei] Yunnan Acad Tobacco Sci, Kunming, Peoples R China; [Cao, Yi] Guizhou Tobacco Res Inst, Guiyang, Peoples R China; [Meng, Zhaohui] Kunming Med Coll, Affiliated Hosp 1, Dept Cardiol, Mol Cardiol Lab, Kunming, Peoples R China	Yunnan University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; China National Tobacco Corporation; China National Tobacco Corporation; Kunming Medical University	Gu, W (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Peoples R China.	zhhmeng@yahoo.cn; kqzhang111@yahoo.com.cn	Liang, Lian-Ming/AAL-3861-2021; zhang, ke/AAH-8217-2019	Yang, Jinkui/0000-0002-3106-2189	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [31060012]; Department of Science and Technology of Yunnan Province [2007C170M, 2007C0001R, 2006C0071M, 2009CI052]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	This work was supported by the National Basic Research Program of China (approved no. 2007CB411600), the National Natural Science Foundation of China (approved no. 31060012), and by projects from the Department of Science and Technology of Yunnan Province (approved no. 2007C170M, 2007C0001R, 2006C0071M and 2009CI052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFMANN HA, 1989, Z NATURFORSCH C, V44, P765; Barthelmebs L, 2001, APPL ENVIRON MICROB, V67, P1063, DOI 10.1128/AEM.67.3.1063-1069.2001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavin JF, 1998, APPL ENVIRON MICROB, V64, P1466; Cavin JF, 1997, APPL ENVIRON MICROB, V63, P1939, DOI 10.1128/AEM.63.5.1939-1944.1997; Cavin JF, 1997, FEMS MICROBIOL LETT, V147, P291, DOI 10.1016/S0378-1097(97)00004-9; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; DEGRASSI G, 1995, APPL ENVIRON MICROB, V61, P326, DOI 10.1128/AEM.61.1.326-332.1995; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HARTLEY RD, 1989, ACS SYM SER, V399, P137; Huang Z, 1994, J BIOL CHEM, V268, P23594; HUANG ZX, 1993, APPL ENVIRON MICROB, V59, P2244, DOI 10.1128/AEM.59.7.2244-2250.1993; Jurgen R, 1991, US Patent, Patent No. 5017388; Karmakar B, 2000, J BIOTECHNOL, V80, P195, DOI 10.1016/S0168-1656(00)00248-0; LABUDA I, 1992, Patent No. 512825; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XM, 2008, PROCESS BIOCHEM, V43, P1132, DOI 10.1016/j.procbio.2008.06.006; Lomascolo A, 1999, TRENDS BIOTECHNOL, V17, P282, DOI 10.1016/S0167-7799(99)01313-X; Mathew S, 2006, CRIT REV MICROBIOL, V32, P115, DOI 10.1080/10408410600709628; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muheim A, 1999, APPL MICROBIOL BIOT, V51, P456, DOI 10.1007/s002530051416; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAZARETH S, 1986, CAN J MICROBIOL, V32, P494, DOI 10.1139/m86-090; Nelson DL, 2004, LEHNINGER PRINCIPLES, P190; Nelson DL, 2004, LEHNINGER PRINCIPLES, P75; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; Prim N, 2001, CURR MICROBIOL, V42, P237, DOI 10.1007/s002840010210; RAHOUTI M, 1989, APPL ENVIRON MICROB, V55, P2391, DOI 10.1128/AEM.55.9.2391-2398.1989; Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009; Rodriguez H, 2010, PROTEINS, V78, P1662, DOI 10.1002/prot.22684; Rosazza JPN, 1995, J IND MICROBIOL, V15, P457, DOI 10.1007/BF01570016; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Walton NJ, 2000, CURR OPIN BIOTECH, V11, P490, DOI 10.1016/S0958-1669(00)00125-7; Washisu S., 1993, Patent Application, Patent No. [5227980, JP5227980]; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Yoshimoto T., 1990, Japanese Patent, Patent No. [2195871, 2(195) 871]; ZAGO A, 1995, APPL ENVIRON MICROB, V61, P4484, DOI 10.1128/AEM.61.12.4484-4486.1995	40	41	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16262	10.1371/journal.pone.0016262	http://dx.doi.org/10.1371/journal.pone.0016262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283705	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300024
J	McClatchy, DB; Liao, LJ; Park, SK; Xu, T; Lu, BW; Yates, JR				McClatchy, Daniel B.; Liao, Lujian; Park, Sung Kyu; Xu, Tao; Lu, Bingwen; Yates, John R., III			Differential Proteomic Analysis of Mammalian Tissues Using SILAM	PLOS ONE			English	Article							SCALE PHOSPHORYLATION ANALYSIS; SITE-SPECIFIC PHOSPHORYLATION; TANDEM MASS-SPECTRA; PROTEIN-KINASE CK2; QUANTITATIVE-ANALYSIS; PHOSPHOPROTEOMIC ANALYSIS; NUCLEAR PHOSPHOPROTEINS; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Differential expression of proteins between tissues underlies organ-specific functions. Under certain pathological conditions, this may also lead to tissue vulnerability. Furthermore, post-translational modifications exist between different cell types and pathological conditions. We employed SILAM (Stable Isotope Labeling in Mammals) combined with mass spectrometry to quantify the proteome between mammalian tissues. Using (15)N labeled rat tissue, we quantified 3742 phosphorylated peptides in nuclear extracts from liver and brain tissue. Analysis of the phosphorylation sites revealed tissue specific kinase motifs. Although these tissues are quite different in their composition and function, more than 500 protein identifications were common to both tissues. Specifically, we identified an up-regulation in the brain of the phosphoprotein, ZFHX1B, in which a genetic deletion causes the neurological disorder Mowat-Wilson syndrome. Finally, pathway analysis revealed distinct nuclear pathways enriched in each tissue. Our findings provide a valuable resource as a starting point for further understanding of tissue specific gene regulation and demonstrate SILAM as a useful strategy for the differential proteomic analysis of mammalian tissues.	[McClatchy, Daniel B.; Liao, Lujian; Park, Sung Kyu; Xu, Tao; Lu, Bingwen; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute	McClatchy, DB (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jyates@scripps.edu	Xu, Tao/A-9353-2009		National Institutes of Health [5R01 MH067880-08, P41 RR11823-14]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge financial support from the National Institutes of Health grants 5R01 MH067880-08 and P41 RR11823-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAMEDINA J, BIOGERONTOLOGY, V11, P703; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BENBROOK DM, 1990, ONCOGENE, V5, P295; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cantin GT, 2006, J PROTEOME RES, V5, P127, DOI 10.1021/pr050270m; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen KD, 1997, EUR J BIOCHEM, V248, P120, DOI 10.1111/j.1432-1033.1997.t01-1-00120.x; Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123; Conrads TP, 2001, ANAL CHEM, V73, P2132, DOI 10.1021/ac001487x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Goodlett DR, 2001, RAPID COMMUN MASS SP, V15, P1214, DOI 10.1002/rcm.362; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Haydon CE, 2003, MOL CELL PROTEOMICS, V2, P1055, DOI 10.1074/mcp.M300054-MCP200; HSU JC, 1991, P NATL ACAD SCI USA, V88, P3511, DOI 10.1073/pnas.88.9.3511; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liao LJ, 2008, J PROTEOME RES, V7, P4743, DOI 10.1021/pr8003198; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; MacCoss MJ, 2005, ANAL CHEM, V77, p295A; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; MATSUDA S, 1991, J BIOL CHEM, V266, P18188; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; STUURMAN N, 1990, J BIOL CHEM, V265, P5460; TAKEDA J, 1991, ONCOGENE, V6, P1009; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	70	26	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16039	10.1371/journal.pone.0016039	http://dx.doi.org/10.1371/journal.pone.0016039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283754	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200024
J	Sysi-Aho, M; Koikkalainen, J; Seppanen-Laakso, T; Kaartinen, M; Kuusisto, J; Peuhkurinen, K; Karkkainen, S; Antila, M; Lauerma, K; Reissell, E; Jurkko, R; Lotjonen, J; Helio, T; Oresic, M				Sysi-Aho, Marko; Koikkalainen, Juha; Seppanen-Laakso, Tuulikki; Kaartinen, Maija; Kuusisto, Johanna; Peuhkurinen, Keijo; Karkkainen, Satu; Antila, Margareta; Lauerma, Kirsi; Reissell, Eeva; Jurkko, Raija; Lotjonen, Jyrki; Helio, Tiina; Oresic, Matej			Serum Lipidomics Meets Cardiac Magnetic Resonance Imaging: Profiling of Subjects at Risk of Dilated Cardiomyopathy	PLOS ONE			English	Article							LAMIN-A/C GENE; VARIABLE SELECTION; MUTATIONS; HEART	Dilated cardiomyopathy (DCM), characterized by left ventricular dilatation and systolic dysfunction, constitutes a significant cause for heart failure, sudden cardiac death or need for heart transplantation. Lamin A/C gene (LMNA) on chromosome 1p12 is the most significant disease gene causing DCM and has been reported to cause 7-9% of DCM leading to cardiac transplantation. We have previously performed cardiac magnetic resonance imaging (MRI) to LMNA carriers to describe the early phenotype. Clinically, early recognition of subjects at risk of developing DCM would be important but is often difficult. Thus we have earlier used the MRI findings of these LMNA carriers for creating a model by which LMNA carriers could be identified from the controls at an asymptomatic stage. Some LMNA mutations may cause lipodystrophy. To characterize possible effects of LMNA mutations on lipid profile, we set out to apply global serum lipidomics using Ultra Performance Liquid Chromatography coupled to mass spectrometry in the same LMNA carriers, DCM patients without LMNA mutation and controls. All DCM patients, with or without LMNA mutation, differed from controls in regard to distinct serum lipidomic profile dominated by diminished odd-chain triglycerides and lipid ratios related to desaturation. Furthermore, we introduce a novel approach to identify associations between the molecular lipids from serum and the MR images from the LMNA carriers. The association analysis using dependency network and regression approaches also helped us to obtain novel insights into how the affected lipids might relate to cardiac shape and volume changes. Our study provides a framework for linking serum derived molecular markers not only with clinical endpoints, but also with the more subtle intermediate phenotypes, as derived from medical imaging, of potential pathophysiological relevance.	[Sysi-Aho, Marko; Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Lauerma, Kirsi] Univ Helsinki, Cent Hosp, Helsinki Med Imaging Ctr, FIN-00170 Helsinki, Finland; [Kuusisto, Johanna; Peuhkurinen, Keijo; Karkkainen, Satu] Kuopio Univ Hosp, SF-70210 Kuopio, Finland	VTT Technical Research Center Finland; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Sysi-Aho, M (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Oresic, Matej/0000-0002-2856-9165; Helio, Tiina/0000-0002-9640-9040	Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; special governmental subsidy for health sciences research [TYH 7106, TYH2009121]; European Commission [201668]	Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; special governmental subsidy for health sciences research; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors were supported by grants from the Finnish Foundation for Cardiovascular Research (TH), Finnish Medical Foundation (TH), the special governmental subsidy for health sciences research TYH 7106 and TYH2009121 (TH), and the European Commission (ATHEROREMO project, FP7-HEALTH-2007-A contract number 201668) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Karkkainen S, 2006, HEART, V92, P524, DOI 10.1136/hrt.2004.056721; Karkkainen S, 2004, EUR HEART J, V25, P885, DOI 10.1016/j.ehj.2004.01.020; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Koikkalainen JR, 2008, RADIOLOGY, V249, P88, DOI 10.1148/radiol.2491071584; LIN F, 1993, J BIOL CHEM, V268, P16321; Lotjonen J, 2004, MED IMAGE ANAL, V8, P371, DOI 10.1016/j.media.2004.06.013; Malhotra R, 2009, CURR OPIN CARDIOL, V24, P203, DOI 10.1097/HCO.0b013e32832a11c6; Mestroni L, 2008, J AM COLL CARDIOL, V52, P1261, DOI 10.1016/j.jacc.2008.07.021; Nadeau M, 2010, METABOLISM, V59, P1106, DOI 10.1016/j.metabol.2009.09.034; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Warensjo E, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-21; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yamashita T, 2007, COMMUN STAT-THEOR M, V36, P2395, DOI 10.1080/03610920701215639; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	21	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15744	10.1371/journal.pone.0015744	http://dx.doi.org/10.1371/journal.pone.0015744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283746	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200012
J	Cohen, M; Yossef, R; Erez, T; Kugel, A; Welt, M; Karpasas, MM; Bones, J; Rudd, PM; Taieb, J; Boissin, H; Harats, D; Noy, K; Tekoah, Y; Lichtenstein, RG; Rubin, E; Porgador, A				Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Karpasas, Mark M.; Bones, Jonathan; Rudd, Pauline M.; Taieb, Julien; Boissin, Herve; Harats, Dror; Noy, Karin; Tekoah, Yoram; Lichtenstein, Rachel G.; Rubin, Eitan; Porgador, Angel			Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROSTATE-CANCER; PLASMA PROTEOME; BIOMARKER; TOF; SURFACE; IDENTIFICATION; VALIDATION; DISCOVERY; CARCINOMA	Finding new peptide biomarkers for stomach cancer in human sera that can be implemented into a clinically practicable prediction method for monitoring of stomach cancer. We studied the serum peptidome from two different biorepositories. We first employed a C8-reverse phase liquid chromatography approach for sample purification, followed by mass-spectrometry analysis. These were applied onto serum samples from cancer-free controls and stomach cancer patients at various clinical stages. We then created a bioinformatics analysis pipeline and identified peptide signature discriminating stomach adenocarcinoma patients from cancer-free controls. Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) results from 103 samples revealed 9 signature peptides; with prediction accuracy of 89% in the training set and 88% in the validation set. Three of the discriminating peptides discovered were fragments of Apolipoproteins C-I and C-III (apoC-I and C-III); we further quantified their serum levels, as well as CA19-9 and CRP, employing quantitative commercial-clinical assays in 142 samples. ApoC-I and apoC-III quantitative results correlated with the MS results. We then employed apoB-100-normalized apoC-I and apoC-III, CA19-9 and CRP levels to generate rules set for stomach cancer prediction. For training, we used sera from one repository, and for validation, we used sera from the second repository. Prediction accuracies of 88.4% and 74.4% were obtained in the training and validation sets, respectively. Serum levels of apoC-I and apoC-III combined with other clinical parameters can serve as a basis for the formulation of a diagnostic score for stomach cancer patients.	[Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Rubin, Eitan; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Karpasas, Mark M.] Ben Gurion Univ Negev, Analyt Res Serv, IL-84105 Beer Sheva, Israel; [Karpasas, Mark M.] Ben Gurion Univ Negev, Instrumentat Unit, IL-84105 Beer Sheva, Israel; [Bones, Jonathan; Rudd, Pauline M.] Univ Coll Dublin, Conway Inst, NIBRT, Oxford Glycobiol Lab, Dublin 2, Ireland; [Taieb, Julien; Boissin, Herve] RNTech SAS France, Paris, France; [Tekoah, Yoram; Lichtenstein, Rachel G.] Ben Gurion Univ Negev, Avram & Stella Goren Goldstein Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Harats, Dror] Sheba Med Ctr, Bert Stassburger Lipid Ctr, Ramat Gan, Israel; [Noy, Karin] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Rubin, Eitan; Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; University College Dublin; Ben Gurion University; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University	Cohen, M (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	angel@bgu.ac.il	Rubin, Eitan/E-5256-2011; Yoseph, Rami/L-6823-2019; Yossef, Rami/K-5740-2019	Rubin, Eitan/0000-0002-7807-4005; Porgador, Angel/0000-0003-1540-4449; Lichtenstein, Rachel/0000-0002-2225-1068	European Community [GLYFDIS 037661]	European Community(European Commission)	Funding was provided by the European Community (FP6 GLYFDIS 037661). RNTech SAS France is stated as funder due to the fact that JT and HB are/were employees of this company; the contributions of JT and HB are defined as Final approval of the version to be published, and they were not involved in contribution to conception and design, or acquisition of data, or analysis and interpretation of data or drafting the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Bergen HR, 2003, DIS MARKERS, V19, P239; Bidart JM, 1999, CLIN CHEM, V45, P1695; Check E, 2004, NATURE, V429, P496, DOI 10.1038/429496a; Chen JZ, 2007, J CHROMATOGR A, V1162, P117, DOI 10.1016/j.chroma.2007.03.096; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200; Engwegen JYMN, 2006, WORLD J GASTROENTERO, V12, P1536, DOI 10.3748/wjg.v12.i10.1536; Gerber Y, 2002, PREV MED, V35, P42, DOI 10.1006/pmed.2002.1045; Gobel T, 2006, WORLD J GASTROENTERO, V12, P7604; Grizzle WE, 2003, DIS MARKERS, V19, P185, DOI 10.1155/2004/546293; Hortin GL, 2006, CLIN CHEM, V52, P1218, DOI 10.1373/clinchem.2006.067280; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Koomen JM, 2005, J PROTEOME RES, V4, P972, DOI 10.1021/pr050046x; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Lustgarten JL, 2008, BIOINFORMATICS, V24, P1418, DOI 10.1093/bioinformatics/btn125; Marshall J, 2003, J PROTEOME RES, V2, P361, DOI 10.1021/pr030003l; McComb ME, 2007, RAPID COMMUN MASS SP, V21, P44, DOI 10.1002/rcm.2805; McLerran D, 2008, CLIN CHEM, V54, P53, DOI 10.1373/clinchem.2007.091496; McLerran D, 2008, CLIN CHEM, V54, P44, DOI 10.1373/clinchem.2007.091470; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rai AJ, 2004, ANN NY ACAD SCI, V1022, P286, DOI 10.1196/annals.1318.044; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Swartz M, 2009, ANAL METHOD VALIDATI; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2007, NAT PROTOC, V2, P588, DOI 10.1038/nprot.2007.57; Villanueva J, 2006, NAT PROTOC, V1, P880, DOI 10.1038/nprot.2006.128; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Yamamoto-Ishikawa K, 2009, ASIAN J ANDROL, V11, P299, DOI 10.1038/aja.2008.38; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	36	36	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14540	10.1371/journal.pone.0014540	http://dx.doi.org/10.1371/journal.pone.0014540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267442	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500012
J	Jeffers, ES; Bonsall, MB; Willis, KJ				Jeffers, Elizabeth S.; Bonsall, Michael B.; Willis, Kathy J.			Stability in Ecosystem Functioning across a Climatic Threshold and Contrasting Forest Regimes	PLOS ONE			English	Article							NITROGEN; REGENERATION; PERSPECTIVE; FRAMEWORK; DYNAMICS; TREES	Classical ecological theory predicts that changes in the availability of essential resources such as nitrogen should lead to changes in plant community composition due to differences in species-specific nutrient requirements. What remains unknown, however, is the extent to which climate change will alter the relationship between plant communities and the nitrogen cycle. During intervals of climate change, do changes in nitrogen cycling lead to vegetation change or do changes in community composition alter the nitrogen dynamics? We used long-term ecological data to determine the role of nitrogen availability in changes of forest species composition under a rapidly changing climate during the early Holocene (16k to 8k cal. yrs. BP). A statistical computational analysis of ecological data spanning 8,000 years showed that secondary succession from a coniferous to deciduous forest occurred independently of changes in the nitrogen cycle. As oak replaced pine under a warming climate, nitrogen cycling rates increased. Interestingly, the mechanism by which the species interacted with nitrogen remained stable across this threshold change in climate and in the dominant tree species. This suggests that changes in tree population density over successional time scales are not driven by nitrogen availability. Thus, current models of forest succession that incorporate the effects of available nitrogen may be over-estimating tree population responses to changes in this resource, which may result in biased predictions of future forest dynamics under climate warming.	[Jeffers, Elizabeth S.; Willis, Kathy J.] Univ Oxford, Sch Geog, Oxford OX1 3TB, England; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Willis, Kathy J.] Univ Bergen, Dept Biol, Bergen, Norway	University of Oxford; University of Oxford; University of Bergen	Jeffers, ES (corresponding author), Univ Oxford, Sch Geog, Mansfield Rd, Oxford OX1 3TB, England.	michael.bonsall@zoo.ox.ac.uk	Jeffers, Elizabeth S./D-4021-2013	Jeffers, Elizabeth S./0000-0001-9679-5909; Willis, Katherine/0000-0002-6763-2489; Bonsall, Michael/0000-0003-0250-0423	Royal Society; Natural Environment Research Council; NERC [NE/G010730/1] Funding Source: UKRI; Natural Environment Research Council [NE/G010730/1] Funding Source: researchfish	Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the Royal Society and the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bennett KD, 2001, TRACKING ENV CHANGE, V3, P5, DOI DOI 10.1007/0-306-47668-1_2; BERGLUND BE, 1986, HDB HOLOCENE PALAEOE, V24; Bonsall MB, 2004, J ANIM ECOL, V73, P1043, DOI 10.1111/j.0021-8790.2004.00874.x; BUCK CE, 1999, BCAL ON LINE BAYESIA; Burnham KP, 2002, MODEL SELECTION MULT, VXXVI; Catovsky S, 2002, ECOL APPL, V12, P1611, DOI 10.2307/3099926; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; Clark BR, 2005, AM NAT, V165, P609, DOI 10.1086/430074; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DELCOURT HR, 1991, QUATERNARY ECOLOGY P, V10; Eckstein RL, 1999, NEW PHYTOL, V143, P177, DOI 10.1046/j.1469-8137.1999.00429.x; GREEN DG, 1983, NEW PHYTOL, V94, P459, DOI 10.1111/j.1469-8137.1983.tb03459.x; GREEN DG, 1981, QUATERNARY RES, V15, P265, DOI 10.1016/0033-5894(81)90030-2; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Karolewski P, 2005, WATER AIR SOIL POLL, V160, P95, DOI 10.1007/s11270-005-3941-3; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; Menge DNL, 2009, AM NAT, V173, P164, DOI 10.1086/595749; MORGAN BJT, 1999, APPL STOCHASTIC MODE, V9; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; PRENTICE IC, 1988, TRENDS ECOL EVOL, V3, P343; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Talbot MR, 2002, DEV PALEOENVIRON RES, V2, P401; Tilman David, 2007, P84; Wallace ZP, 2007, FOREST ECOL MANAG, V243, P210, DOI 10.1016/j.foreco.2007.02.015; Willis KJ, 1997, ECOLOGY, V78, P740, DOI 10.1890/0012-9658(1997)078[0740:DSCCVC]2.0.CO;2; Wolfe BB, 1999, HOLOCENE, V9, P215, DOI 10.1191/095968399669823431; Xu-Ri, 2008, GLOBAL CHANGE BIOL, V14, P1745, DOI 10.1111/j.1365-2486.2008.01625.x	33	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16134	10.1371/journal.pone.0016134	http://dx.doi.org/10.1371/journal.pone.0016134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267469	gold, Green Submitted, Green Published			2022-12-27	WOS:000286519500040
J	Ren, XF; Lim, S; Ji, ZY; Yuh, J; Peng, V; Smith, MT; Zhang, LP				Ren, Xuefeng; Lim, Sophia; Ji, Zhiying; Yuh, Jessica; Peng, Vivian; Smith, Martyn T.; Zhang, Luoping			Comparison of Proliferation and Genomic Instability Responses to WRN Silencing in Hematopoietic HL60 and TK6 Cells	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; RECQ FAMILY HELICASES; BENZENE METABOLITE HYDROQUINONE; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; DNA-DAMAGE; FUNCTIONAL INTERACTION; REPLICATION ARREST; CYCLE CHECKPOINTS; CHROMOSOMAL INSTABILITY	Background: Werner syndrome (WS) results from defects in the RecQ helicase (WRN) and is characterized by premature aging and accelerated tumorigenesis. Contradictorily, WRN deficient human fibroblasts derived from WS patients show a characteristically slower cell proliferation rate, as do primary fibroblasts and human cancer cell lines with WRN depletion. Previous studies reported that WRN silencing in combination with deficiency in other genes led to significantly accelerated cellular proliferation and tumorigenesis. The aim of the present study was to examine the effects of silencing WRN in p53 deficient HL60 and p53 wild-type TK6 hematopoietic cells, in order to further the understanding of WRN-associated tumorigenesis. Methodology/Principal Findings: We found that silencing WRN accelerated the proliferation of HL60 cells and decreased the cell growth rate of TK6 cells. Loss of WRN increased DNA damage in both cell types as measured by COMET assay, but elicited different responses in each cell line. In HL60 cells, but not in TK6 cells, the loss of WRN led to significant increases in levels of phosphorylated RB and numbers of cells progressing from G1 phase to S phase as shown by cell cycle analysis. Moreover, WRN depletion in HL60 cells led to the hyper-activation of homologous recombination repair via up-regulation of RAD51 and BLM protein levels. This resulted in DNA damage disrepair, apparent by the increased frequencies of both spontaneous and chemically induced structural chromosomal aberrations and sister chromatid exchanges. Conclusions/Significance: Together, our data suggest that the effects of WRN silencing on cell proliferation and genomic instability are modulated probably by other genetic factors, including p53, which might play a role in the carcinogenesis induced by WRN deficiency.	[Ren, Xuefeng; Lim, Sophia; Ji, Zhiying; Yuh, Jessica; Peng, Vivian; Smith, Martyn T.; Zhang, Luoping] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Genes & Environm Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ren, XF (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Social & Prevent Med, Buffalo, NY 14260 USA.	luoping@berkeley.edu			National Institutes of Health; National Institute of Environmental Health Sciences [R01 ES01896, P42 ES04705]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896, P42ES004705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (http://nih.gov/) and National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) [R01 ES01896 and P42 ES04705 to Dr. Martyn Smith]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Ariyoshi K, 2007, J RADIAT RES, V48, P219, DOI 10.1269/jrr.07017; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Bishop AJR, 2000, HUM MOL GENET, V9, P2427, DOI 10.1093/hmg/9.16.2427; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Bohr VA, 2005, MUTAT RES-FUND MOL M, V577, P252, DOI 10.1016/j.mrfmmm.2005.03.021; Brosh RM, 2002, EXP GERONTOL, V37, P491, DOI 10.1016/S0531-5565(01)00227-3; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chakraverty RK, 1999, BIOESSAYS, V21, P286; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chen LS, 2003, AGING CELL, V2, P191, DOI 10.1046/j.1474-9728.2003.00052.x; CHU WK, 2009, NAT REV CANC; Collins Andrew R, 2002, Methods Mol Biol, V203, P163; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Ding SL, 2007, CANCER EPIDEM BIOMAR, V16, P263, DOI 10.1158/1055-9965.EPI-06-0678; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Franchitto A, 2004, CELL CYCLE, V3, P1331, DOI 10.4161/cc.3.10.1185; Furuichi Y, 2001, ANN NY ACAD SCI, V928, P121; GEBHART E, 1988, HUM GENET, V80, P135, DOI 10.1007/BF00702855; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Gowans ID, 2005, CANCER RES, V65, P3527, DOI 10.1158/0008-5472.CAN-04-4242; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Khayat AS, 2005, CLIN EXP MED, V5, P161, DOI 10.1007/s10238-005-0081-4; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kusumoto R, 2008, BIOCHEMISTRY-US, V47, P7548, DOI 10.1021/bi702325t; Lan Q, 2009, CARCINOGENESIS, V30, P50, DOI 10.1093/carcin/bgn249; Lavoie J, 2005, CANCER GENET CYTOGEN, V156, P134, DOI 10.1016/j.cancergencyto.2004.05.005; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2001, CANCER RES, V61, P1816; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Lu XB, 2003, MUTAT RES-FUND MOL M, V522, P69, DOI 10.1016/S0027-5107(02)00261-0; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Nakayama R, 2008, CANCER SCI, V99, P333, DOI 10.1111/j.1349-7006.2007.00692.x; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Oshima J, 2000, BIOESSAYS, V22, P894, DOI 10.1002/1521-1878(200010)22:10<894::AID-BIES4>3.0.CO;2-B; Otterlei M, 2006, J CELL SCI, V119, P5137, DOI 10.1242/jcs.03291; Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Reliene R, 2007, ADV GENET, V58, P67, DOI 10.1016/S0065-2660(06)58003-4; Ren XF, 2009, TOXICOL SCI, V107, P367, DOI 10.1093/toxsci/kfn254; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Saintigny Y, 1999, ONCOGENE, V18, P3553, DOI 10.1038/sj.onc.1202941; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; SALK D, 1985, ADV EXP MED BIOL, V190, P305; SCAPPATICCI S, 1982, HUM GENET, V62, P16, DOI 10.1007/BF00295599; Shen M, 2006, CARCINOGENESIS, V27, P2083, DOI 10.1093/carcin/bgl061; Shibuya H, 2005, J DERMATOL, V32, P737, DOI 10.1111/j.1346-8138.2005.tb00835.x; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sommers JA, 2005, CANCER RES, V65, P1223, DOI 10.1158/0008-5472.CAN-03-0231; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Szekely AM, 2005, MOL CELL BIOL, V25, P10492, DOI 10.1128/MCB.25.23.10492-10506.2005; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; WANG Z, 2009, BREAST CANC RES TREA; Yamamoto A, 1996, MOL GEN GENET, V251, P1	71	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14546	10.1371/journal.pone.0014546	http://dx.doi.org/10.1371/journal.pone.0014546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267443	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500016
J	Chen, LA; Meng, QH; Kao, W; Xia, Y				Chen, Liang; Meng, Qinghang; Kao, Winston; Xia, Ying			I kappa B Kinase beta Regulates Epithelium Migration during Corneal Wound Healing	PLOS ONE			English	Article							P38 MAP KINASE; INFLAMMATORY SKIN-DISEASE; IKK-BETA; CELL-MIGRATION; GROWTH-FACTORS; ACTIVATION; PROLIFERATION; EXPRESSION; DELETION; APOPTOSIS	The IKK beta is known to regulate transcription factor NF-kappa B activation leading to inflammatory responses. Recent gene knockout studies have shown that IKK beta can orchestrate local inflammatory responses and regulate homeostasis of epithelial tissues. To investigate whether IKK beta has an intrinsic role in epithelial cells, we established an in vivo system in the immune privileged corneal epithelium. We generated triple transgenic Krt12(rtTA/rtTAt)/tet-O-Cre/Ikk beta(F/F) (Ikk beta(Delta CE/Delta CE)) mice by crossing the Krt12-rtTA knock-in mice, which express the reverse tetracycline transcription activator in corneal epithelial cells, with the tet-O-Cre and Ikk beta(F/F) mice. Doxcycline-induced IKK beta ablation occurred in corneal epithelial cells of triple transgenic Ikk beta(Delta CE/Delta CE) mice, but loss of IKK beta did not cause ocular abnormalities in fetal development and postnatal maintenance. Instead, loss of IKK beta significantly delayed healing of corneal epithelial debridement without affecting cell proliferation, apoptosis or macrophage infiltration. In vitro studies with human corneal epithelial cells (HCEpi) also showed that IKK beta was required for cytokine-induced cell migration and wound closure but was dispensable for cell proliferation. In both in vivo and in vitro settings, IKK beta was required for optimal activation of NF-kappa B and p38 signaling in corneal epithelial cells, and p38 activation is likely mediated through formation of an IKK beta-p38 protein complex. Thus, our studies in corneal epithelium reveal a previously un-recognized role for IKK beta in the control of epithelial cell motility and wound healing.	[Chen, Liang; Meng, Qinghang; Xia, Ying] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Kao, Winston] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Chen, LA (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.	ying.xia@uc.edu	Chen, Liang/G-2990-2013	Chen, Liang/0000-0002-6748-9416; Xia, Ying/0000-0001-9532-9527	National Institutes of Health [NIH EY 15227]; Ryan Fellowship; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryan Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work is supported in part by funding from National Institutes of Health (NIH EY 15227) and the Ryan Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anstead G M, 1998, Adv Wound Care, V11, P277; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Bockhart V, 2009, J NEUROSCI, V29, P12919, DOI 10.1523/JNEUROSCI.1496-09.2009; Busti AJ, 2005, PHARMACOTHERAPY, V25, P1566, DOI 10.1592/phco.2005.25.11.1566; Chae S, 2006, J IMMUNOL, V177, P1214, DOI 10.4049/jimmunol.177.2.1214; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen LW, 2007, CRIT CARE MED, V35, P1332, DOI 10.1097/01.CCM.0000261891.30360.F0; Chikama TI, 2005, INVEST OPHTH VIS SCI, V46; Deng MX, 2006, MOL BIOL CELL, V17, P3446, DOI 10.1091/mbc.E06-02-0102; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Hara Y, 2001, EXP EYE RES, V72, P107, DOI 10.1006/exer.2000.0938; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hori Junko, 2008, J Ocul Biol Dis Infor, V1, P94, DOI 10.1007/s12177-008-9010-6; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Koch KS, 2009, BIOCHEM BIOPH RES CO, V380, P349, DOI 10.1016/j.bbrc.2009.01.085; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIU CY, 1994, J BIOL CHEM, V269, P24627; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Qiao H, 2009, J INVEST DERMATOL, V129, pS37; Rasoulpour RJ, 2007, BIOL REPROD, V76, P279, DOI 10.1095/biolreprod.106.054924; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2007, CORNEA, V26, pS70, DOI 10.1097/ICO.0b013e31812f6d14; Sastre AP, 2008, J BIOL CHEM, V283, P25871, DOI 10.1074/jbc.M800949200; Schalnus R, 2003, OPHTHALMOLOGICA, V217, P89, DOI 10.1159/000068563; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WANG XG, 1994, INVEST OPHTH VIS SCI, V35, P4001; Wilson SE, 2009, EXP EYE RES, V89, P124, DOI 10.1016/j.exer.2009.02.011; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xie WJ, 2009, BIOCHEM BIOPH RES CO, V379, P1027, DOI 10.1016/j.bbrc.2009.01.009; Yamada N, 2006, INVEST OPHTH VIS SCI, V47, P3286, DOI 10.1167/iovs.05-1205; Yanai R, 2006, EXP EYE RES, V83, P76, DOI 10.1016/j.exer.2005.10.033; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	61	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16132	10.1371/journal.pone.0016132	http://dx.doi.org/10.1371/journal.pone.0016132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264230	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600022
J	Milling, A; Babujee, L; Allen, C				Milling, Annett; Babujee, Lavanya; Allen, Caitilyn			Ralstonia solanacearum Extracellular Polysaccharide Is a Specific Elicitor of Defense Responses in Wilt-Resistant Tomato Plants	PLOS ONE			English	Article							BACTERIAL WILT; PSEUDOMONAS-SOLANACEARUM; TRANSPOSON MUTAGENESIS; ARABIDOPSIS-THALIANA; PATHOGENIC BACTERIA; GENE-EXPRESSION; RACE-3 BIOVAR-2; SALICYLIC-ACID; IMMUNE-SYSTEM; VIRULENCE	Ralstonia solanacearum, which causes bacterial wilt of diverse plants, produces copious extracellular polysaccharide (EPS), a major virulence factor. The function of EPS in wilt disease is uncertain. Leading hypotheses are that EPS physically obstructs plant water transport, or that EPS cloaks the bacterium from host plant recognition and subsequent defense. Tomato plants infected with R. solanacearum race 3 biovar 2 strain UW551 and tropical strain GMI1000 upregulated genes in both the ethylene (ET) and salicylic acid (SA) defense signal transduction pathways. The horizontally wilt-resistant tomato line Hawaii7996 activated expression of these defense genes faster and to a greater degree in response to R. solanacearum infection than did susceptible cultivar Bonny Best. However, EPS played different roles in resistant and susceptible host responses to R. solanacearum. In susceptible plants the wild-type and eps(-) mutant strains induced generally similar defense responses. But in resistant Hawaii7996 tomato plants, the wild-type pathogens induced significantly greater defense responses than the eps(-) mutants, suggesting that the resistant host recognizes R. solanacearum EPS. Consistent with this idea, purified EPS triggered significant SA pathway defense gene expression in resistant, but not in susceptible, tomato plants. In addition, the eps(-) mutant triggered noticeably less production of defense-associated reactive oxygen species in resistant tomato stems and leaves, despite attaining similar cell densities in planta. Collectively, these data suggest that bacterial wilt-resistant plants can specifically recognize EPS from R. solanacearum.	[Milling, Annett; Babujee, Lavanya; Allen, Caitilyn] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Milling, A (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	cza@plantpath.wisc.edu			Deutsche Forschungsgemeinschaft (DFG); United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Plant Biosecurity [2006-04560]; USDA-Agricultural Research Service Floral and Nursery Crops Research Initiative; University of Wisconsin College of Agricultural and Life Sciences	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Plant Biosecurity(United States Department of Agriculture (USDA)); USDA-Agricultural Research Service Floral and Nursery Crops Research Initiative; University of Wisconsin College of Agricultural and Life Sciences	This research was supported by a Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship to AM and by United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Plant Biosecurity project 2006-04560, the USDA-Agricultural Research Service Floral and Nursery Crops Research Initiative and by the University of Wisconsin College of Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; BOUCHER CA, 1985, J GEN MICROBIOL, V131, P2449; Chen YY, 2009, PHYSIOL PLANTARUM, V136, P324, DOI 10.1111/j.1399-3054.2009.01226.x; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; DANHASH N, 1993, PLANT MOL BIOL, V22, P1017, DOI 10.1007/BF00028974; de Pinto MC, 2003, PLANT CELL PHYSIOL, V44, P803, DOI 10.1093/pcp/pcg105; Denny T., 2006, PLANT ASS BACTERIA; DENNY TP, 1991, MOL PLANT MICROBE IN, V4, P198, DOI 10.1094/MPMI-4-198; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Genin S, 2002, MOL PLANT PATHOL, V3, P111, DOI 10.1046/j.1364-3703.2002.00102.x; Giovanini MP, 2006, MOL PLANT MICROBE IN, V19, P1023, DOI 10.1094/MPMI-19-1023; GRIMAULT V, 1993, PLANT PATHOL, V42, P589, DOI 10.1111/j.1365-3059.1993.tb01539.x; Hanson PM, 1996, HORTSCIENCE, V31, P143, DOI 10.21273/HORTSCI.31.1.143; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hirsch J, 2002, PHYTOPATHOLOGY, V92, P1142, DOI 10.1094/PHYTO.2002.92.10.1142; Ho FI, 2009, BOT STUD, V50, P413; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Katagiri F, 2004, CURR OPIN PLANT BIOL, V7, P506, DOI 10.1016/j.pbi.2004.07.013; LEVVY GA, 1959, BIOCHEM J, V73, P127, DOI 10.1042/bj0730127; Lin YM, 2008, MOL PLANT MICROBE IN, V21, P1261, DOI 10.1094/MPMI-21-9-1261; Makino S, 2006, J DAIRY SCI, V89, P2873, DOI 10.3168/jds.S0022-0302(06)72560-7; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; McGarvey JA, 1999, PHYTOPATHOLOGY, V89, P1233, DOI 10.1094/PHYTO.1999.89.12.1233; Milling A, 2009, PHYTOPATHOLOGY, V99, P1127, DOI 10.1094/PHYTO-99-10-1127; ORGAMBIDE G, 1991, J BIOL CHEM, V266, P8312; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Pfund C, 2004, MOL PLANT MICROBE IN, V17, P696, DOI 10.1094/MPMI.2004.17.6.696; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Romanenko AS, 2003, J PHYTOPATHOL, V151, P1, DOI 10.1046/j.1439-0434.2003.00667.x; Romeiro RS, 1997, J PHYTOPATHOL, V145, P495, DOI 10.1111/j.1439-0434.1997.tb00356.x; Saile E, 1997, PHYTOPATHOLOGY, V87, P1264, DOI 10.1094/PHYTO.1997.87.12.1264; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Smart CD, 2003, MOL PLANT MICROBE IN, V16, P141, DOI 10.1094/MPMI.2003.16.2.141; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; Tans-Kersten J, 1998, APPL ENVIRON MICROB, V64, P4918; Thoquet P, 1996, MOL PLANT MICROBE IN, V9, P826, DOI 10.1094/MPMI-9-0826; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JF, 1998, BACTERIAL WILT DISEASE, P269; Wang JF, 2000, MOL PLANT MICROBE IN, V13, P6, DOI 10.1094/MPMI.2000.13.1.6; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	56	118	128	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15853	10.1371/journal.pone.0015853	http://dx.doi.org/10.1371/journal.pone.0015853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253019	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511900015
J	Zhong, CY; Peng, DH; Ye, WX; Chai, LJ; Qi, JL; Yu, ZN; Ruan, LF; Sun, M				Zhong, Chunying; Peng, Donghai; Ye, Weixing; Chai, Lujun; Qi, Junliang; Yu, Ziniu; Ruan, Lifang; Sun, Ming			Determination of Plasmid Copy Number Reveals the Total Plasmid DNA Amount Is Greater than the Chromosomal DNA Amount in Bacillus thuringiensis YBT-1520	PLOS ONE			English	Article							REAL-TIME PCR; INSECTICIDAL CRYSTAL PROTEIN; ESCHERICHIA-COLI; SEQUENCE-ANALYSIS; GENETIC ELEMENTS; STRAIN YBT-1520; REPLICATION; CEREUS; QUANTIFICATION; GERMINATION	Bacillus thuringiensis is the most widely used bacterial bio-insecticide, and most insecticidal crystal protein-coding genes are located on plasmids. Most strains of B. thuringiensis harbor numerous diverse plasmids, although the plasmid copy numbers (PCNs) of all native plasmids in this host and the corresponding total plasmid DNA amount remains unknown. In this study, we determined the PCNs of 11 plasmids (ranging from 2 kb to 416 kb) in a sequenced B. thuringiensis subsp. kurstaki strain YBT-1520 using real-time qPCR. PCNs were found to range from 1.38 to 172, and were negatively correlated to plasmid size. The amount of total plasmid DNA (similar to 8.7 Mbp) was 1.62-fold greater than the amount of chromosomal DNA (similar to 5.4 Mbp) at the mid-exponential growth stage (OD(600) = 2.0) of the organism. Furthermore, we selected three plasmids with different sizes and replication mechanisms to determine the PCNs over the entire life cycle. We found that the PCNs dynamically shifted at different stages, reaching their maximum during the mid-exponential growth or stationary phases and remaining stable and close to their minimum after the prespore formation stage. The PCN of pBMB2062, which is the smallest plasmid (2062 bp) and has the highest PCN of those tested, varied in strain YBT-1520, HD-1, and HD-136 (172, 115, and 94, respectively). These findings provide insight into both the total plasmid DNA amount of B. thuringiensis and the strong ability of the species to harbor plasmids.	[Zhong, Chunying; Peng, Donghai; Ye, Weixing; Chai, Lujun; Qi, Junliang; Yu, Ziniu; Ruan, Lifang; Sun, Ming] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhong, CY (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015; Peng, donghai/O-7259-2016	Ming, Sun/0000-0001-5465-5983; Peng, donghai/0000-0002-4918-2357	National High Technology Research and Development Program (863 Program) of China [2011AA10A203, 2006AA02Z174]; National Basic Research Program (973) of China [2009CB118902]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; Ministry of Agriculture [2011]; Ministry of Forestry [2006-4-41]; National Natural Science Foundation of China [30870066, 30470026]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); Genetically Modified Organisms Breeding Major Projects of China; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Forestry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program (863 Program) of China Grants (2011AA10A203, 2006AA02Z174), and the National Basic Research Program (973) of China (2009CB118902), and Genetically Modified Organisms Breeding Major Projects of China Grant (2009ZX08009-032B), and China 948 Program of Ministry of Agriculture (2011) and Ministry of Forestry (2006-4-41), and National Natural Science Foundation of China (30870066, 30470026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis Luis A., 1999, Frontiers in Bioscience, V4, pD43, DOI 10.2741/Actis; AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; ARONSON AI, 1993, MOL MICROBIOL, V7, P489, DOI 10.1111/j.1365-2958.1993.tb01139.x; Asano K, 1998, EMBO J, V17, P5201, DOI 10.1093/emboj/17.17.5201; BAUM JA, 1995, MOL MICROBIOL, V18, P1, DOI 10.1111/j.1365-2958.1995.mmi_18010001.x; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; BRANTL S, 1994, MOL MICROBIOL, V14, P473, DOI 10.1111/j.1365-2958.1994.tb02182.x; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; del Solar G, 2000, MOL MICROBIOL, V37, P492, DOI 10.1046/j.1365-2958.2000.02005.x; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dobrzhanskaya E. O., 2000, Mikrobiologiya, V69, P796; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grabherr R, 2002, TRENDS BIOTECHNOL, V20, P257, DOI 10.1016/S0167-7799(02)01950-9; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hu HJ, 2007, FEMS MICROBIOL LETT, V272, P245, DOI 10.1111/j.1574-6968.2007.00766.x; KALMAN S, 1993, APPL ENVIRON MICROB, V59, P1131, DOI 10.1128/AEM.59.4.1131-1137.1993; KIESELBURG MK, 1984, NAT BIOTECHNOL, V2, P6; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee SJ, 2002, APPL ENVIRON MICROB, V68, P3919, DOI 10.1128/AEM.68.8.3919-3924.2002; Liu C, 2007, PLASMID, V57, P44, DOI 10.1016/j.plasmid.2006.06.002; Liu XJ, 2008, J MICROBIOL BIOTECHN, V18, P1630; MARIN R, 1992, FEMS MICROBIOL LETT, V73, P263; MCDOWELL DG, 1991, PLASMID, V25, P113, DOI 10.1016/0147-619X(91)90022-O; NAKAMURA LK, 1994, INT J SYST BACTERIOL, V44, P125, DOI 10.1099/00207713-44-1-125; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Providenti MA, 2006, J MICROBIOL METH, V65, P476, DOI 10.1016/j.mimet.2005.09.007; Qiu N, 2010, FEMS MICROBIOL LETT, V310, P9, DOI 10.1111/j.1574-6968.2010.02033.x; Reyes-Ramirez A, 2008, APPL ENVIRON MICROB, V74, P125, DOI 10.1128/AEM.02133-07; Rowland SL, 1997, MOL MICROBIOL, V23, P295, DOI 10.1046/j.1365-2958.1997.2141580.x; Schmidt T, 1996, J BIOTECHNOL, V49, P219, DOI 10.1016/0168-1656(96)01519-2; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sedlak M, 2000, J BACTERIOL, V182, P734, DOI 10.1128/JB.182.3.734-741.2000; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smajs D, 2008, PLASMID, V59, P1, DOI 10.1016/j.plasmid.2007.08.002; Summers D, 1998, MOL MICROBIOL, V29, P1137, DOI 10.1046/j.1365-2958.1998.01012.x; Sun M, 2000, Wei Sheng Wu Xue Bao, V40, P365; Sun M, 2000, Yi Chuan Xue Bao, V27, P932; Turgeon N, 2008, PLASMID, V60, P118, DOI 10.1016/j.plasmid.2008.05.001; Verheust C, 2003, MICROBIOL-SGM, V149, P2083, DOI 10.1099/mic.0.26307-0; Wagner EGH, 2002, ADV GENET, V46, P361; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; YOSHIKAWA H, 1964, P NATL ACAD SCI USA, V52, P973, DOI 10.1073/pnas.52.4.973	47	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16025	10.1371/journal.pone.0016025	http://dx.doi.org/10.1371/journal.pone.0016025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283584	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400021
J	Ganusov, VV; Barber, DL; De Boer, RJ				Ganusov, Vitaly V.; Barber, Daniel L.; De Boer, Rob J.			Killing of Targets by CD8(+) T Cells in the Mouse Spleen Follows the Law of Mass Action	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEDIATED CYTO-TOXICITY; IN-VIVO; IMMUNODEFICIENCY-VIRUS; VIRAL-INFECTION; CUTTING EDGE; EFFECTOR FUNCTION; RHESUS-MONKEYS; CTL ACTIVITY; LYMPH-NODES	It has been difficult to correlate the quality of CD8(+) T cell responses with protection against viral infections. To investigate the relationship between efficacy and magnitude of T cell responses, we quantify the rate at which individual CD8(+) effector and memory T cells kill target cells in the mouse spleen. Using mathematical modeling, we analyze recent data on the loss of target cells pulsed with three different peptides from the mouse lymphocytic choriomeningitis virus (LCMV) in mouse spleens with varying numbers of epitope-specific CD8(+) T cells. We find that the killing of targets follows the law of mass-action, i.e., the death rate of individual target cells remains proportional to the frequency (or the total number) of specific CD8(+) T cells in the spleen despite the fact that effector cell densities and effector to target ratios vary about a 1000-fold. The killing rate of LCMV-specific CD8(+) T cells is largely independent of T cell specificity and differentiation stage. Our results thus allow one to calculate the critical T cell concentration at which growth of a virus with a given replication rate can be prevented from the start of infection by memory CD8(+) T cell response.	[Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Barber, Daniel L.] NIH, Bethesda, MD 20892 USA; [De Boer, Rob J.] Univ Utrecht, Utrecht, Netherlands	University of Tennessee System; University of Tennessee Knoxville; National Institutes of Health (NIH) - USA; Utrecht University	Ganusov, VV (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	vitaly.ganusov@gmail.com	Barber, Daniel L./V-1190-2019; de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X; Ganusov, Vitaly/0000-0001-6572-1691	NWO [016.048.603]; Marie Curie Incoming International Fellowship (FP6); U.S. Department of Energy; University of Tennessee; Russian Ministry of Education [NK-550P/2]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009222] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006427] Funding Source: NIH RePORTER	NWO(Netherlands Organization for Scientific Research (NWO)); Marie Curie Incoming International Fellowship (FP6)(European Commission); U.S. Department of Energy(United States Department of Energy (DOE)); University of Tennessee; Russian Ministry of Education(Ministry of Education and Science, Russian Federation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the VICI grant 016.048.603 from NWO, Marie Curie Incoming International Fellowship (FP6), the U.S. Department of Energy through the LANL/LDRD Program, start-up funds from the University of Tennessee and in part by a grant from the Russian Ministry of Education (NK-550P/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; Althaus CL, 2007, J IMMUNOL, V179, P2944, DOI 10.4049/jimmunol.179.5.2944; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Berger DP, 2000, VIROLOGY, V266, P257, DOI 10.1006/viro.1999.0074; Blancou P, 2001, P NATL ACAD SCI USA, V98, P13237, DOI 10.1073/pnas.231348598; Bocharov G, 2004, J VIROL, V78, P2247, DOI 10.1128/JVI.78.5.2247-2254.2004; Borghans JAM, 1996, B MATH BIOL, V58, P43, DOI 10.1016/0092-8240(95)00306-1; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; De Boer RJ, 2007, J VIROL, V81, P2838, DOI 10.1128/JVI.01914-06; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ehl S, 1997, EUR J IMMUNOL, V27, P3404, DOI 10.1002/eji.1830271240; Ganusov VV, 2007, J IMMUNOL, V179, P5006, DOI 10.4049/jimmunol.179.8.5006; Ganusov VV, 2008, J VIROL, V82, P11749, DOI 10.1128/JVI.01128-08; Graw F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000466; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; Jenkins MR, 2009, CELL DEATH DIFFER, V16, P537, DOI 10.1038/cdd.2008.176; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kim SK, 2004, J IMMUNOL, V172, P3139, DOI 10.4049/jimmunol.172.5.3139; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MERRILL SJ, 1982, MATH BIOSCI, V62, P219, DOI 10.1016/0025-5564(82)90084-0; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oehen S, 1998, J IMMUNOL, V161, P5338; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PERELSON AS, 1984, J IMMUNOL, V132, P2190; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Yates A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001301	51	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15959	10.1371/journal.pone.0015959	http://dx.doi.org/10.1371/journal.pone.0015959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283669	Green Submitted, gold, Green Published			2022-12-27	WOS:000286523400009
J	Dua, R; Zhang, JH; Parry, G; Penuel, E				Dua, Rajiv; Zhang, Jianhuan; Parry, Gordon; Penuel, Elicia			Detection of Hepatocyte Growth Factor (HGF) Ligand-c-MET Receptor Activation in Formalin-Fixed Paraffin Embedded Specimens by a Novel Proximity Assay	PLOS ONE			English	Article							TYROSINE KINASE; LUNG ADENOCARCINOMA; EXPRESSION; CANCER; BREAST; QUANTITATION; INHIBITION; OVEREXPRESSION; MUTATIONS; SURVIVAL	Aberrant activation of membrane receptors frequently occurs in human carcinomas. Detection of phosphorylated receptors is commonly used as an indicator of receptor activation in formalin-fixed paraffin embedded (FFPE) tumor specimens. FFPE is a standard method of specimen preparation used in the histological analysis of solid tumors. Due to variability in FFPE preparations and the labile nature of protein phosphorylation, measurements of phospho-proteins are unreliable and create ambiguities in clinical interpretation. Here, we describe an alternative, novel approach to measure receptor activation by detecting and quantifying ligand-receptor complexes in FFPE specimens. We used hepatocyte growth factor (HGF)-c-MET as our model ligand-receptor system. HGF is the only known ligand of the c-MET tyrosine kinase receptor and HGF binding triggers c-MET phosphorylation. Novel antibody proximity-based assays were developed and used to detect and quantify total c-MET, total HGF, and HGF-c-MET ligand-receptor interactions in FFPE cell line and tumor tissue. In glioma cells, autocrine activation of c-MET by HGF-c-MET increased basal levels of c-MET phosphorylation at tyrosine (Tyr) 1003. Furthermore, HGF-c-MET activation in glioma cell lines was verified by Surface Protein-Protein Interaction by Crosslinking ELISA (SPPICE) assay in corresponding soluble cell lysates. Finally, we profiled levels of c-MET, HGF, and HGF-c-MET complexes in FFPE specimens of human Non-Small Cell Lung Cancer (NSCLC), Gastric Cancer, Head and Neck Squamous Cell, and Head and Neck Non-Squamous Cell carcinomas. This report describes a novel approach for the detection and quantification of ligand-receptor interactions that can be widely applied to measure receptor activation in FFPE preclinical models and archived FFPE human tissue specimens.	[Dua, Rajiv; Zhang, Jianhuan; Parry, Gordon; Penuel, Elicia] Monogram Biosci Inc, Res & Dev, Oncol, San Francisco, CA USA		Dua, R (corresponding author), Monogram Biosci Inc, Res & Dev, Oncol, San Francisco, CA USA.	rdua@monogrambio.com			Monogram Biosciences, Inc.	Monogram Biosciences, Inc.	The study was funded by Monogram Biosciences, Inc. Monogram Biosciences played role in study design, data collection and analysis, preparation of manuscript, and decision to publish this work. No outside funding was received for performing this research work.	Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; CHISTENSEN JG, 2003, CANCER RES, V63, P7345; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Desmedt C, 2009, DIAGN MOL PATHOL, V18, P22, DOI 10.1097/PDM.0b013e31818ebc69; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Gotte M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1641; Gordon MS, 2010, CLIN CANCER RES, V16, P699, DOI 10.1158/1078-0432.CCR-09-1365; Gupta A, 2008, CLIN CANCER RES, V14, P7385, DOI 10.1158/1078-0432.CCR-07-5110; Jain A, 2010, CANCER RES, V70, P1989, DOI 10.1158/0008-5472.CAN-09-3326; Jones RJ, 2008, CANCER CHEMOTH PHARM, V61, P23, DOI 10.1007/s00280-007-0440-9; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Kong DS, 2009, CANCER-AM CANCER SOC, V115, P140, DOI 10.1002/cncr.23972; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Koochekpour S, 1997, CANCER RES, V57, P5391; Larson JS, 2010, PATHOLOG RES INT; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Nakamura T, 1997, CANCER RES, V57, P3305; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Pozner-Moulis S, 2007, LAB INVEST, V87, P251, DOI 10.1038/labinvest.3700515; SALGIA R, 2008, P 20 ANN AACR NCI EO; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Siegfried JM, 1997, CANCER RES, V57, P433; Sperinde J, 2010, CLIN CANCER RES, V16, P4226, DOI 10.1158/1078-0432.CCR-10-0410; Toschi L, 2008, CLIN CANCER RES, V14, P5941, DOI 10.1158/1078-0432.CCR-08-0071; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yap TA, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3584; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	34	20	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e15932	10.1371/journal.pone.0015932	http://dx.doi.org/10.1371/journal.pone.0015932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283737	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300014
J	Kaess, BM; Tomaszewski, M; Braund, PS; Stark, K; Rafelt, S; Fischer, M; Hardwick, R; Nelson, CP; Debiec, R; Huber, F; Kremer, W; Kalbitzer, HR; Rose, LM; Chasman, DI; Hopewell, J; Clarke, R; Burton, PR; Tobin, MD; Hengstenberg, C; Samani, NJ				Kaess, Bernhard M.; Tomaszewski, Maciej; Braund, Peter S.; Stark, Klaus; Rafelt, Suzanne; Fischer, Marcus; Hardwick, Robert; Nelson, Christopher P.; Debiec, Radoslaw; Huber, Fritz; Kremer, Werner; Kalbitzer, Hans Robert; Rose, Lynda M.; Chasman, Daniel I.; Hopewell, Jemma; Clarke, Robert; Burton, Paul R.; Tobin, Martin D.; Hengstenberg, Christian; Samani, Nilesh J.			Large-Scale Candidate Gene Analysis of HDL Particle Features	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CORONARY-ARTERY-DISEASE; MACULAR DEGENERATION; COMMON VARIANTS; BINDING-PROTEIN; SMOOTH-MUSCLE; LIPID-LEVELS; LIPOPROTEIN; FIBULIN-5; LOCI	Background: HDL cholesterol (HDL-C) is an established marker of cardiovascular risk with significant genetic determination. However, HDL particles are not homogenous, and refined HDL phenotyping may improve insight into regulation of HDL metabolism. We therefore assessed HDL particles by NMR spectroscopy and conducted a large-scale candidate gene association analysis. Methodology/Principal Findings: We measured plasma HDL-C and determined mean HDL particle size and particle number by NMR spectroscopy in 2024 individuals from 512 British Caucasian families. Genotypes were 49,094 SNPs in >2,100 cardiometabolic candidate genes/loci as represented on the HumanCVD BeadChip version 2. False discovery rates (FDR) were calculated to account for multiple testing. Analyses on classical HDL-C revealed significant associations (FDR<0.05) only for CETP (cholesteryl ester transfer protein; lead SNP rs3764261: p = 5.6*10(-15)) and SGCD (sarcoglycan delta; rs6877118: p = 8.6*10(-6)). In contrast, analysis with HDL mean particle size yielded additional associations in LIPC (hepatic lipase; rs261332: p = 6.1*10(-9)), PLTP (phospholipid transfer protein, rs4810479: p = 1.7*10(-8)) and FBLN5 (fibulin-5; rs2246416: p = 6.2*10(-6)). The associations of SGCD and Fibulin-5 with HDL particle size could not be replicated in PROCARDIS (n = 3,078) and/or the Women's Genome Health Study (n = 23,170). Conclusions: We show that refined HDL phenotyping by NMR spectroscopy can detect known genes of HDL metabolism better than analyses on HDL-C.	[Kaess, Bernhard M.; Tomaszewski, Maciej; Braund, Peter S.; Rafelt, Suzanne; Hardwick, Robert; Nelson, Christopher P.; Debiec, Radoslaw; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Kaess, Bernhard M.; Stark, Klaus; Fischer, Marcus; Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Huber, Fritz; Kremer, Werner; Kalbitzer, Hans Robert] LipoFIT Analyt GmbH, Regensburg, Germany; [Kremer, Werner; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-8400 Regensburg, Germany; [Rose, Lynda M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Prevent Med, Boston, MA 02115 USA; [Hopewell, Jemma; Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester; University of Regensburg; University of Regensburg; Harvard University; Brigham & Women's Hospital; University of Oxford; University of Leicester	Kaess, BM (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	christian.hengstenberg@klinik.uni-regensburg.de; njs@le.ac.uk	Hengstenberg, Christian/U-5485-2019; Stark, Klaus/L-7367-2013; Stark, Klaus/D-3813-2009	Stark, Klaus/0000-0002-7832-1942; Stark, Klaus/0000-0002-7832-1942; Hopewell, Jemma/0000-0002-3870-8018; Tomaszewski, Maciej/0000-0001-8215-6567; Debiec, Radoslaw/0000-0003-2292-467X; Tobin, Martin/0000-0002-3596-7874; Kalbitzer, Hans Robert/0000-0002-6514-2355; Nelson, Christopher/0000-0001-8025-2897	British Heart Foundation; National Genome Network (NGFNplus) [01GS0832]; European Union [LSH-2005-037593]; Medical Research Council [G0501942]; Leicester National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease; Medical Research Council [MC_U137686857] Funding Source: researchfish; MRC [MC_U137686857, G0501942] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); National Genome Network (NGFNplus); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leicester National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Recruitment and genotyping of the GRAPHIC cohort was funded by the British Heart Foundation. Phenotyping and BK's fellowship in Leicester were supported by grants from the National Genome Network (NGFNplus, 01GS0832) and the European Union-sponsored project Cardiogenics (LSH-2005-037593). NJS holds a British Heart Foundation Chair of Cardiology and MDT holds a Medical Research Council Clinician Scientist Fellowship (G0501942). NJS, MT and PRB are supported by the Leicester National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease. NMR spectroscopy was performed at LipoFIT GmbH. WK and HRK are employed by the University of Regensburg and co-founders of LipoFIT GmbH; FH is co-founder and CEO of LipoFIT GmbH. With the exception of this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalain JH, 2002, CLIN CHIM ACTA, V326, P97, DOI 10.1016/S0009-8981(02)00288-7; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ARSENAULT BJ, 2009, ATHEROSCLEROSIS; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; de Souza JA, 2008, ATHEROSCLEROSIS, V197, P84, DOI 10.1016/j.atherosclerosis.2007.08.009; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Kaess B, 2008, J LIPID RES, V49, P715, DOI 10.1194/jlr.M700338-JLR200; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Mora S, 2009, CIRCULATION, V119, pE385, DOI 10.1161/CIRCULATIONAHA.108.835587; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; OCONNELL DL, 1988, GENET EPIDEMIOL, V5, P323, DOI 10.1002/gepi.1370050504; OTVOS JD, 1991, CLIN CHEM, V37, P377; Pietilainen KH, 2009, OBESITY, V17, P1208, DOI 10.1038/oby.2008.675; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Superko HR, 2009, CIRCULATION, V119, P2383, DOI 10.1161/CIRCULATIONAHA.108.809582; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Vekic J, 2007, EUR J CLIN INVEST, V37, P715, DOI 10.1111/j.1365-2362.2007.01849.x; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	36	32	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14529	10.1371/journal.pone.0014529	http://dx.doi.org/10.1371/journal.pone.0014529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283740	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522300002
J	Lorenzo, MN; Ramos, AM; Taboada, JJ; Gimeno, L				Lorenzo, Maria N.; Ramos, Alexandre M.; Taboada, Juan J.; Gimeno, Luis			Changes in Present and Future Circulation Types Frequency in Northwest Iberian Peninsula	PLOS ONE			English	Article							ATMOSPHERIC CIRCULATION; ATLANTIC OSCILLATION; WINTER CLIMATE; WEATHER-TYPE; CLASSIFICATION; TEMPERATURE; PATTERNS; IMPACT; PRECIPITATION; SIMULATIONS	The aim of the work described herein was to study projection scenarios in order to find changes in the synoptic variability of the northwest Iberian Peninsula in the 21st century. To this end, we investigated the changes in the frequency of the different circulation types computed for the study area using three different models used in the IPCC 4(th) assessment report. The circulation types were computed using the procedure known as Lamb circulation types. The control simulation for the late 20th century was evaluated objectively from the results obtained using data from the NCEP/NCAR reanalysis, as to evaluate the ability of the model to reproduce the present climate. We have compared not only seasonal mean sea level pressure fields but also the mean seasonal frequency of circulation types. The results for the end of the 21st century show a decrease in the frequency of cyclonic, W, and SW circulation types in the spring and summer months. This trend also appears in the autumn, with a concomitant increase in the anticyclonic types.	[Lorenzo, Maria N.; Ramos, Alexandre M.; Gimeno, Luis] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain; [Taboada, Juan J.] Xunta de Galicia, Meteogalicia, Santiago De Compostela, Spain	Universidade de Vigo	Lorenzo, MN (corresponding author), Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain.	alexramos@uvigo.es	GIMENO, LUIS/B-8137-2008; Ramos, Alexandre M./A-1998-2009; de las Nieves Lorenzo, María/B-9924-2011	Ramos, Alexandre M./0000-0003-3129-7233; de las Nieves Lorenzo, María/0000-0001-5302-8312; Taboada, Juan/0000-0001-9023-473X; GIMENO, LUIS/0000-0002-0778-3605	Xunta de Galicia [PGIDIT06PXIB383288PR]; Portuguese Science Foundation (FCT) [BD/46000/2008]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by 'Xunta de Galicia' under project PGIDIT06PXIB383288PR. Alexandre M. Ramos was supported by the Portuguese Science Foundation (FCT) through Grant BD/46000/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004744; Anagnostopouloua CHR, 2008, INT J CLIMATOL, V28, P185, DOI 10.1002/joc.1521; Buchanan CM, 2002, ATMOS ENVIRON, V36, P5343, DOI 10.1016/S1352-2310(02)00579-4; Cahynova M, 2009, THEOR APPL CLIMATOL, V96, P57, DOI 10.1007/s00704-008-0097-2; Cassou C, 2004, J CLIMATE, V17, P1055, DOI 10.1175/1520-0442(2004)017<1055:NAWCRS>2.0.CO;2; deCastro M, 2008, CLIM RES, V36, P169, DOI 10.3354/cr00742; Demuzere M, 2009, INT J CLIMATOL, V29, P1796, DOI 10.1002/joc.1821; Demuzere M, 2009, ATMOS CHEM PHYS, V9, P2695, DOI 10.5194/acp-9-2695-2009; Fowler HJ, 2002, J HYDROL, V262, P177, DOI 10.1016/S0022-1694(02)00034-3; Garcia-Herrera R, 2007, J HYDROMETEOROL, V8, P483, DOI 10.1175/JHM578.1; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; GOMEZGESTEIRA M, 2011, CLIMATE RES IN PRESS; Goodess CM, 2002, INT J CLIMATOL, V22, P1593, DOI 10.1002/joc.810; Hipel K.W., 2005, TIME SERIES MODELLIN; Hope PK, 2006, CLIM DYNAM, V26, P765, DOI 10.1007/s00382-006-0116-x; HULME M, 1993, CLIM DYNAM, V9, P95, DOI 10.1007/BF00210012; Huth R, 2000, THEOR APPL CLIMATOL, V67, P1, DOI 10.1007/s007040070012; Huth R, 2001, INT J CLIMATOL, V21, P135, DOI 10.1002/joc.605; Huth R, 2008, ANN NY ACAD SCI, V1146, P105, DOI 10.1196/annals.1446.019; James PM, 2008, USE SYNOPTIC REGIME; JONES PD, 1993, INT J CLIMATOL, V13, P655, DOI 10.1002/joc.3370130606; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karl TR, 2000, GEOPHYS RES LETT, V27, P719, DOI 10.1029/1999GL010877; Kendall M. G., 1975, RANK CORRELATION MET; Kysely J, 2008, GLOBAL PLANET CHANGE, V62, P147, DOI 10.1016/j.gloplacha.2008.01.003; Laaidi K, 2001, INT J BIOMETEOROL, V45, P124, DOI 10.1007/s004840100096; Lamb H.H., 1972, METEOROLOGICAL OFFIC, VXVI, P85; Lopez-Moreno JI, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037956; Lorenzo MN, 2008, INT J CLIMATOL, V28, P1493, DOI 10.1002/joc.1646; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Philipp A, 2010, PHYS CHEM EARTH, V35, P360, DOI 10.1016/j.pce.2009.12.010; Ramos AM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012194; Santos J, 2009, J APPL STAT, V36, P323, DOI 10.1080/02664760802449159; Schoof JT, 2003, INT J CLIMATOL, V23, P1725, DOI 10.1002/joc.969; Siegismund F, 2001, CLIMATE RES, V18, P39, DOI 10.3354/cr018039; Solomon S., 2007, 2007 CLIMATE CHANGE; Stefan S, 2010, PHYS CHEM EARTH, V35, P523, DOI 10.1016/j.pce.2009.12.008; Stephenson DB, 2006, CLIM DYNAM, V27, P401, DOI 10.1007/s00382-006-0140-x; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; Trigo RM, 2008, ANN NY ACAD SCI, V1146, P212, DOI 10.1196/annals.1446.014; van Ulden AP, 2006, ATMOS CHEM PHYS, V6, P863, DOI 10.5194/acp-6-863-2006; Walter K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000850	42	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16201	10.1371/journal.pone.0016201	http://dx.doi.org/10.1371/journal.pone.0016201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283703	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300019
J	Tepper, N; Shlomi, T				Tepper, Naama; Shlomi, Tomer			Computational Design of Auxotrophy-Dependent Microbial Biosensors for Combinatorial Metabolic Engineering Experiments	PLOS ONE			English	Article							GLUCOSE-LIMITED GROWTH; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; COMPUTER-MODEL; SINGLE-CELL; GENE; RECONSTRUCTION; FRAMEWORK; PATHWAY; CAPABILITIES	Combinatorial approaches in metabolic engineering work by generating genetic diversity in a microbial population followed by screening for strains with improved phenotypes. One of the most common goals in this field is the generation of a high rate chemical producing strain. A major hurdle with this approach is that many chemicals do not have easy to recognize attributes, making their screening expensive and time consuming. To address this problem, it was previously suggested to use microbial biosensors to facilitate the detection and quantification of chemicals of interest. Here, we present novel computational methods to: (i) rationally design microbial biosensors for chemicals of interest based on substrate auxotrophy that would enable their high-throughput screening; (ii) predict engineering strategies for coupling the synthesis of a chemical of interest with the production of a proxy metabolite for which high-throughput screening is possible via a designed bio-sensor. The biosensor design method is validated based on known genetic modifications in an array of E. coli strains auxotrophic to various amino-acids. Predicted chemical production rates achievable via the biosensor-based approach are shown to potentially improve upon those predicted by current rational strain design approaches. (A Matlab implementation of the biosensor design method is available via http://www.cs.technion.ac.il/similar to tomersh/tools).	[Tepper, Naama; Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Tepper, N (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	naamat@cs.technion.ac.il; tomersh@cs.technion.ac.il						Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Baez-Viveros JL, 2004, BIOTECHNOL BIOENG, V87, P516, DOI 10.1002/bit.20159; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Bailey JE, 1996, BIOTECHNOL BIOENG, V52, P109, DOI 10.1002/(SICI)1097-0290(19961005)52:1<109::AID-BIT11>3.3.CO;2-1; BERG CM, 1979, GENETICS, V93, P309; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; BURKHOLDER PR, 1951, SCIENCE, V114, P459, DOI 10.1126/science.114.2966.459; Chalova VI, 2007, APPL MICROBIOL BIOT, V76, P91, DOI 10.1007/s00253-007-0989-6; Chotani G, 2000, BBA-PROTEIN STRUCT M, V1543, P434, DOI 10.1016/S0167-4838(00)00234-X; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; DIAMONT YCE, 2009, MOL BIOSYST, V5, P1732; DOMACH MM, 1984, BIOTECHNOL BIOENG, V26, P203, DOI 10.1002/bit.260260303; Domach MM, 2000, BIOTECHNOL BIOENG, V67, P827, DOI 10.1002/(SICI)1097-0290(20000320)67:6<827::AID-BIT18>3.0.CO;2-N; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; FELL D, 1996, UNDERSTANDING CONTRO; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; HANI EK, 1994, J BACTERIOL, V176, P1865, DOI 10.1128/jb.176.7.1865-1871.1994; HEATWOLE VM, 1991, J BACTERIOL, V173, P108, DOI 10.1128/jb.173.1.108-115.1991; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JIN YSS, 2007, METAB ENG, V9; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kim MI, 2010, ANAL CHEM, V82, P4072, DOI 10.1021/ac100087r; Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x; LEI WCY, 2006, ANAL CHIMICA ACTA, V568; LEWIS NEH, 2010, MOL SYSTEMS BIOL, V6; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Okamoto K, 1997, BIOSCI BIOTECH BIOCH, V61, P1877, DOI 10.1271/bbb.61.1877; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; PATIL KR, 2005, BMC BIOINFORMATICS, V6, DOI DOI 10.1186/1471-2105-1186-1308; PAYNE JW, 1977, J APPL BACTERIOL, V42, P165, DOI 10.1111/j.1365-2672.1977.tb00682.x; Pfleger BF, 2007, METAB ENG, V9, P30, DOI 10.1016/j.ymben.2006.08.002; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; VARMA A, 1993, BIOTECHNOL BIOENG, V42, P59, DOI 10.1002/bit.260420109; Wright BE, 1997, MICROBIOL-UK, V143, P847, DOI 10.1099/00221287-143-3-847	55	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16274	10.1371/journal.pone.0016274	http://dx.doi.org/10.1371/journal.pone.0016274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283695	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522300027
J	Farke, AA				Farke, Andrew A.			Anatomy and Taxonomic Status of the Chasmosaurine Ceratopsid Nedoceratops hatcheri from the Upper Cretaceous Lance Formation of Wyoming, USA	PLOS ONE			English	Article							WESTERN CANADA; TRICERATOPS; DINOSAURS; ONTOGENY; SKULL; ORNITHISCHIA; ALBERTA	Background: The validity of Nedoceratops hatcheri, a chasmosaurine ceratopsid dinosaur known from a single skull recovered in the Lance Formation of eastern Wyoming, U.S.A., has been debated for over a century. Some have argued that the taxon is an aberrant Triceratops, and most recently it was proposed that N. hatcheri represents an intermediate ontogenetic stage between "young adult'' and "old adult'' forms of a single taxon previously split into Triceratops and Torosaurus. Methodology/Principal Findings: The holotype skull of Nedoceratops hatcheri was reexamined in order to map reconstructed areas and compare the specimen with other ceratopsids. Although squamosal fenestrae are almost certainly not of taxonomic significance, some other features are unique to N. hatcheri. These include a nasal lacking a recognizable horn, nearly vertical postorbital horncores, and relatively small parietal fenestrae. Thus, N. hatcheri is tentatively considered valid, and closely related to Triceratops spp. The holotype of N. hatcheri probably represents an "old adult,'' based upon bone surface texture and the shape of the horns and epiossifications on the frill. In this study, Torosaurus is maintained as a genus distinct from Triceratops and Nedoceratops. Synonymy of the three genera as ontogenetic stages of a single taxon would require cranial changes otherwise unknown in ceratopsids, including additions of ossifications to the frill and repeated alternation of bone surface texture between juvenile and adult morphotypes. Conclusions/Significance: Triceratops, Torosaurus, and likely Nedoceratops, are all distinct taxa, indicating that species richness for chasmosaurine ceratopsids in the Lance Formation just prior to the Cretaceous-Paleocene extinction was roughly equivalent to that earlier in the Cretaceous.	Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA		Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA.	afarke@webb.org		Farke, Andrew/0000-0002-6930-2002	National Science Foundation [EAR 0819953]; Division Of Earth Sciences [0819953] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a grant from the National Science Foundation (EAR 0819953; http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; COBABE EA, 1987, J PALEONTOL, V61, P148, DOI 10.1017/S0022336000028298; COLBERT EDWIN H., 1947, PROC ACAD NAT SCI PHILADELPHIA, V99, P93; DODSON P, 1988, CAN J EARTH SCI, V25, P926, DOI 10.1139/e88-090; Dodson P, 1997, ENCY DINOSAURS, P473; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Farke Andrew A., 2007, P235; Farke AA, 2010, J VERTEBR PALEONTOL, V30, P1486, DOI 10.1080/02724634.2010.501436; Forster A., 1869, VERHANDLUNGEN NATURH, V25, P135; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P246, DOI 10.1080/02724634.1996.10011312; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Forster Catherine A., 1993, Journal of Vertebrate Paleontology, V13, P161; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Goodwin Mark B., 2010, P551; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hatcher JB, 1905, AM J SCI, V20, P413; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Kirkland James I., 2010, P117; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lehman TM, 1998, J PALEONTOL, V72, P894, DOI 10.1017/S0022336000027220; Loewen Mark A., 2010, P99; Longrich NR, 2010, J PALEONTOL, V84, P681, DOI 10.1666/09-114.1; LULL RS, 1933, YALE PEABODY MUSEUM, V3, P1; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; MARSH OC, 1898, AM J SCI 4, V6, P92; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Mateus O, 2008, J PALEONTOL, V82, P423, DOI 10.1666/07-069.1; Ostrom J.H., 1986, Zitteliana, V14, P111; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PADIAN K, 1993, NEW MEXICO MUSEUM NA, V3, P379; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Tanke Darren H., 2007, P319; Tsuihiji T, 2010, ANAT REC, V293, P1360, DOI 10.1002/ar.21191; Tumarkin-Deratzian Allison R., 2010, P251; Ukrainsky A.S., 2007, Zoosystematica Rossica, V16, P292; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011	44	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16196	10.1371/journal.pone.0016196	http://dx.doi.org/10.1371/journal.pone.0016196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283763	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200036
J	Kissner, TL; Ruthel, G; Alam, S; Ulrich, RG; Fernandez, S; Saikh, KU				Kissner, Teri L.; Ruthel, Gordon; Alam, Shahabuddin; Ulrich, Robert G.; Fernandez, Stefan; Saikh, Kamal U.			Activation of MyD88 Signaling upon Staphylococcal Enterotoxin Binding to MHC Class II Molecules	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; BRUTONS-TYROSINE KINASE; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; FACTOR-ALPHA GENES; HUMAN-MONOCYTES; T-CELLS; HLA-DR; TRANSCRIPTIONAL ACTIVATION; CYTOKINE EXPRESSION	Ligands binding to Toll-like receptor (TLR), interleukin 1 receptor (IL-1R), or IFN-gamma R1 are known to trigger MyD88-mediated signaling, which activates pro-inflammatory cytokine responses. Recently we reported that staphylococcal enterotoxins (SEA or SEB), which bind to MHC class II molecules on APCs and cross link T cell receptors, activate MyD88-mediated proinflammatory cytokine responses. We also reported that MyD88(-/-) mice were resistant to SE-induced toxic shock and had reduced levels of serum cytokines. In this study, we investigated whether MHC class II-SE interaction by itself is sufficient to activate MyD88 in MHC class II(+) cells and induce downstream pro-inflammatory signaling and production of cytokines such as TNF-alpha and IL-1 beta. Here we report that human monocytes treated with SEA, SEB, or anti-MHC class II monoclonal antibodies up regulated MyD88 expression, induced activation of NF-kB, and increased expression of IL-1R1 accessory protein, TNF-alpha and IL-1 beta. MyD88 immunoprecipitated from cell extracts after SEB stimulation showed a greater proportion of MyD88 phosphorylation compared to unstimulated cells indicating that MyD88 was a component of intracellular signaling. MyD88 downstream proteins such as IRAK4 and TRAF6 were also up regulated in monocytes after SEB stimulation. In addition to monocytes, primary B cells up regulated MyD88 in response to SEA or SEB stimulation. Importantly, in contrast to primary B cells, MHC class II deficient T2 cells had no change of MyD88 after SEA or SEB stimulation, whereas MHC class II-independent activation of MyD88 was elicited by CpG or LPS. Collectively, these results demonstrate that MHC class II utilizes a MyD88-mediated signaling mechanism when in contact with ligands such as SEs to induce pro-inflammatory cytokines.	[Kissner, Teri L.; Ruthel, Gordon; Alam, Shahabuddin; Ulrich, Robert G.; Fernandez, Stefan; Saikh, Kamal U.] USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD 21702 USA		Kissner, TL (corresponding author), USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD 21702 USA.	kamal.saikh@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022	Ruthel, Gordon/0000-0001-9193-5589	Defense Threat Reduction Agency (DTRA) [CBM.THRTOX.03.10.RD.006]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency (DTRA; WWW.jpras.us) Grant CBM.THRTOX.03.10.RD.006 to Kamal U. Saikh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alugupalli KR, 2007, J IMMUNOL, V178, P3740, DOI 10.4049/jimmunol.178.6.3740; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Becart S, 2003, J CELL SCI, V116, P2565, DOI 10.1242/jcs.00449; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Buatois V, 2003, J IMMUNOL, V171, P5812, DOI 10.4049/jimmunol.171.11.5812; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; CAMBIER JC, 1987, NATURE, V327, P629, DOI 10.1038/327629a0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FAASSEN AE, 1995, J IMMUNOL, V155, P1737; FISCHER H, 1989, J IMMUNOL, V142, P3151; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GORGA JC, 1986, CELL IMMUNOL, V103, P160, DOI 10.1016/0008-8749(86)90077-8; Graves DT, 2000, INFECT IMMUN, V68, P4746, DOI 10.1128/IAI.68.8.4746-4751.2000; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; HAUSCHILDT S, 1993, EUR J IMMUNOL, V23, P2988, DOI 10.1002/eji.1830231139; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kissner TL, 2010, IMMUNOLOGY, V130, P516, DOI 10.1111/j.1365-2567.2010.03249.x; KISSNER TL, 2010, INNATE IMMU IN PRESS; LANE PJL, 1990, J IMMUNOL, V144, P3684; MATSUYAMA S, 1993, EUR J IMMUNOL, V23, P3194, DOI 10.1002/eji.1830231223; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MOURAD W, 1990, J EXP MED, V172, P1513, DOI 10.1084/jem.172.5.1513; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; PALKAMA T, 1989, SCAND J IMMUNOL, V29, P609; PALKAMA T, 1993, HUM IMMUNOL, V36, P259, DOI 10.1016/0198-8859(93)90133-L; Rich T, 1997, J IMMUNOL, V159, P3792; Saikh KU, 2004, J IMMUNOL, V173, P7426, DOI 10.4049/jimmunol.173.12.7426; Saikh KU, 2003, J INFECT DIS, V188, P1562, DOI 10.1086/379196; Saikh KU, 2001, CLIN EXP IMMUNOL, V126, P447, DOI 10.1046/j.1365-2249.2001.01672.x; SCHOLL P, 1989, P NATL ACAD SCI USA, V86, P4210, DOI 10.1073/pnas.86.11.4210; SPERTINI F, 1992, J IMMUNOL, V149, P65; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TREDE NS, 1991, J IMMUNOL, V146, P2310; Ulrich RG, 1995, TRENDS MICROBIOL, V3, P463, DOI 10.1016/S0966-842X(00)89011-3; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094	48	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15985	10.1371/journal.pone.0015985	http://dx.doi.org/10.1371/journal.pone.0015985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283748	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522200021
J	Zhou, XA; Takatoh, J; Wang, F				Zhou, Xiang; Takatoh, Jun; Wang, Fan			The Mammalian Class 3 PI3K (PIK3C3) Is Required for Early Embryogenesis and Cell Proliferation	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; EARLY EMBRYONIC LETHALITY; DAB2 ADAPTER PROTEIN; HEART TUBE FORMATION; TRANSCRIPTION FACTOR; VISCERAL ENDODERM; MOUSE EMBRYO; PHOSPHOINOSITIDE 3-KINASE; SACCHAROMYCES-CEREVISIAE; VENTRAL MORPHOGENESIS	The Pik3c3 gene encodes an 887 amino acid lipid kinase, phosphoinositide-3-kinase class 3 (PIK3C3). PIK3C3 is known to regulate various intracellular membrane trafficking events. However, little is known about its functions during early embryogenesis in mammals. To investigate the function of PIK3C3 in vivo, we generated Pik3c3 null mice. We show here that Pik3c3 heterozygous are normal and fertile. In contrast, Pik3c3 homozygous mutants are embryonic lethal and die between E7.5 and E8.5 of embryogenesis. Mutant embryos are poorly developed with no evidence of mesoderm formation, and suffer from severely reduced cell proliferations. Cell proliferation defect is also evident in vitro, where mutant blastocysts in culture fail to give rise to typical colonies formed by inner cell mass. Electron microscopic analysis revealed that epiblast cells in mutant embryos appear normal, whereas the visceral endoderm cells contain larger vesicles inside the lipid droplets. Finally, we provide evidence that mTOR signaling is drastically reduced in Pik3c3 null embryos, which could be a major contributor to the observed proliferation and embryogenesis defects.	[Zhou, Xiang; Takatoh, Jun; Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zhou, Xiang; Wang, Fan] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Zhou, XA (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	f.wang@cellbio.duke.edu		Takatoh, Jun/0000-0002-0976-7684	McKnight Scholar Award; Wings for Life Foundation	McKnight Scholar Award; Wings for Life Foundation	This work is supported by the McKnight Scholar Award and the Wings for Life Foundation to F.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; GWATKIN RBL, 1966, ANN MED EXP BIOL FEN, V44, P125; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; NAESLUND G, 1979, UPSALA J MED SCI, V84, P9, DOI 10.3109/03009737909179136; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POWER MA, 1993, ANAT EMBRYOL, V187, P493; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104; Zhou XA, 2010, AUTOPHAGY, V6, P798, DOI 10.4161/auto.6.6.12511; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	66	61	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16358	10.1371/journal.pone.0016358	http://dx.doi.org/10.1371/journal.pone.0016358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283715	Green Published, gold			2022-12-27	WOS:000286522200056
J	Gee, JE; Glass, MB; Lackner, G; Helsel, LO; Daneshvar, M; Hollis, DG; Jordan, J; Morey, R; Steigerwalt, A; Hertweck, C				Gee, Jay E.; Glass, Mindy B.; Lackner, Gerald; Helsel, Leta O.; Daneshvar, Maryam; Hollis, Dannie G.; Jordan, Jean; Morey, Roger; Steigerwalt, Arnold; Hertweck, Christian			Characterization of Burkholderia rhizoxinica and B. endofungorum Isolated from Clinical Specimens	PLOS ONE			English	Article							FUNGUS RHIZOPUS-MICROSPORUS; BACTERIAL ENDOSYMBIONTS; BAYESIAN-INFERENCE; SP-NOV.; EVOLUTIONARY; RHIZONIN; TOXIN; PSEUDOMALLEI	Eight isolates submitted to CDC from 1989 to 2006 from clinical specimens were initially identified as members of the genus Burkholderia based on preliminary cellular fatty acid analysis and/or 16S rRNA gene sequencing. With the recent descriptions of the new species B. rhizoxinica and B. endofungorum, which are considered endosymbiotic bacteria in Rhizopus microsporus fungi, we now identify seven of these clinical isolates as B. rhizoxinica and one as B. endofungorum based on biochemical testing, 16s rRNA, and DNA-DNA hybridization results. We also further characterize these isolates by assessing toxin production and/or by multiple locus sequence typing.	[Gee, Jay E.; Glass, Mindy B.; Helsel, Leta O.; Daneshvar, Maryam; Hollis, Dannie G.; Jordan, Jean; Morey, Roger; Steigerwalt, Arnold] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Lackner, Gerald; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hertweck, Christian] Univ Jena, Jena, Germany	Centers for Disease Control & Prevention - USA; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Gee, JE (corresponding author), Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	JGee1@cdc.gov	Hertweck, Christian/G-1896-2014; Hertweck, Christian/AAZ-8452-2021	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X; Lackner, Gerald/0000-0002-0307-8319; Gee, Jay/0000-0003-4308-1659				BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ibrahim AS, 2008, J INFECT DIS, V198, P1083, DOI 10.1086/591461; IWASAKI S, 1984, J ANTIBIOT, V37, P354, DOI 10.7164/antibiotics.37.354; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lackner G, 2009, TRENDS MICROBIOL, V17, P570, DOI 10.1016/j.tim.2009.09.003; Lackner G, 2009, APPL ENVIRON MICROB, V75, P2982, DOI 10.1128/AEM.01765-08; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Partida-Martinez LP, 2008, MYCOSES, V51, P266, DOI 10.1111/j.1439-0507.2007.01477.x; Partida-Martinez LP, 2007, INT J SYST EVOL MICR, V57, P2583, DOI 10.1099/ijs.0.64660-0; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2007, CURR BIOL, V17, P773, DOI 10.1016/j.cub.2007.03.039; Partida-Martinez LP, 2007, APPL ENVIRON MICROB, V73, P793, DOI 10.1128/AEM.01784-06; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Sato Z., 1983, ANN PHYTOPATHOL SOC, V49, P128; Scherlach K, 2006, J AM CHEM SOC, V128, P11529, DOI 10.1021/ja062953o; STEYN PS, 1983, J CHEM SOC CHEM COMM, P47, DOI 10.1039/c39830000047; Weyant RS, 1995, IDENTIFICATION UNUSU, V2nd; WILSON T, 1984, FOOD CHEM TOXICOL, V22, P275, DOI 10.1016/0278-6915(84)90006-1; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x	27	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15731	10.1371/journal.pone.0015731	http://dx.doi.org/10.1371/journal.pone.0015731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267449	gold, Green Published			2022-12-27	WOS:000286519500026
J	Jin, K; Zheng, XL; Xia, YX				Jin, Kai; Zheng, Xiaoli; Xia, Yuxian			Gene Expression Profiling via Multigene Concatemers	PLOS ONE			English	Article							GENOME SEQUENCE; DNA MICROARRAYS; SERIAL ANALYSIS; PCR; CANCER; DISCOVERY; PATTERNS; DESIGN	We established a novel method, Gene Expression Profiling via Multigene Concatemers (MgC-GEP), to study multigene expression patterns simultaneously. This method consists of the following steps: (1) cDNA was obtained using specific reverse primers containing an adaptor. (2) During the initial 1-3 cycles of polymerase chain reaction (PCR), the products containing universal adaptors with digestion sites at both termini were amplified using specific forward and reverse primers containing the adaptors. (3) In the subsequent 4-28 cycles, the universal adaptors were used as primers to yield products. (4) The products were digested and ligated to produce concatemers. (5) The concatemers were cloned into the vector and sequenced. Then, the occurrence of each gene tag was determined. To validate MgC-GEP, we analyzed 20 genes in Saccharomyces cerevisiae induced by weak acid using MgC-GEP combined with real-time reverse transcription (RT)-PCR. Compared with the results of real-time RT-PCR and the previous reports of microarray analysis, MgC-GEP can precisely determine the transcript levels of multigenes simultaneously. Importantly, MgC-GEP is a cost effective strategy that can be widely used in most laboratories without specific equipment. MgC-GEP is a potentially powerful tool for multigene expression profiling, particularly for moderate-throughput analysis.	[Jin, Kai; Zheng, Xiaoli; Xia, Yuxian] Chongqing Univ, Sch Bioengn, Genet Engn Res Ctr, Chongqing 630044, Peoples R China; [Jin, Kai; Zheng, Xiaoli; Xia, Yuxian] Chongqing Engn Res Ctr Fungal Insecticide, Chongqing, Peoples R China; [Jin, Kai; Zheng, Xiaoli; Xia, Yuxian] Chongqing Municipal Educ Commiss, Key Lab Gene Funct & Regulat Technol, Chongqing, Peoples R China	Chongqing University	Jin, K (corresponding author), Chongqing Univ, Sch Bioengn, Genet Engn Res Ctr, Chongqing 630044, Peoples R China.	yuxianxia@cqu.edu.cn		Zheng, Xiaoli/0000-0003-0350-6560	Foundation of Chongqing Municipal Education Committee [KJ08A04]; Natural Science Foundation of China [30971913]	Foundation of Chongqing Municipal Education Committee; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Project Foundation of Chongqing Municipal Education Committee (KJ08A04) and the Natural Science Foundation of China (30971913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Cebeci O, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/505701; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Edelman LB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-583; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Gunson R, 2003, J CLIN VIROL, V26, P369, DOI 10.1016/S1386-6532(03)00006-4; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ji RR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000512; Kuo WP, 2002, ORAL ONCOL, V38, P650; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liang P, 2007, NAT BIOTECHNOL, V25, P27, DOI 10.1038/nbt0107-27; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Matsumura H, 2006, NAT METHODS, V3, P469, DOI 10.1038/NMETH882; Nagel MA, 2009, J VIROL METHODS, V157, P62, DOI 10.1016/j.jviromet.2008.11.019; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Rai AJ, 2009, ANAL BIOANAL CHEM, V393, P1505, DOI 10.1007/s00216-008-2436-7; Reinartz Jeannette, 2002, Briefings in Functional Genomics & Proteomics, V1, P95, DOI 10.1093/bfgp/1.1.95; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schoske R, 2003, ANAL BIOANAL CHEM, V375, P333, DOI 10.1007/s00216-002-1683-2; Schuller C, 2004, MOL BIOL CELL, V15, P706, DOI 10.1091/mbc.E03-05-0322; Smith GW, 2007, J ANIM SCI, V85, pE20, DOI 10.2527/jas.2006-479; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang SM, 2006, PROTEOMICS, V6, P4765, DOI 10.1002/pmic.200500881; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Yamamoto M, 2001, J IMMUNOL METHODS, V250, P45, DOI 10.1016/S0022-1759(01)00305-2; Zarlenga DS, 2001, VET PARASITOL, V101, P215, DOI 10.1016/S0304-4017(01)00568-4; Zembutsu H, 2002, CANCER RES, V62, P518	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15711	10.1371/journal.pone.0015711	http://dx.doi.org/10.1371/journal.pone.0015711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267445	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500025
J	Rajoria, S; Suriano, R; George, A; Shanmugam, A; Schantz, SP; Geliebter, J; Tiwari, RK				Rajoria, Shilpi; Suriano, Robert; George, Andrea; Shanmugam, Arulkumaran; Schantz, Stimson P.; Geliebter, Jan; Tiwari, Raj K.			Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3 '-Diindolylmethane in Thyroid Cancer	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; PROSTATE-CANCER; MOLECULAR TARGETS; CELL INVASION; MUSCLE-CELLS; RECEPTOR; INDOLE-3-CARBINOL; PATHWAY; ACTIVATION	Background: Thyroid cancer is the most common endocrine related cancer with increasing incidences during the past five years. Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significant recurrence rates of thyroid cancer, new preventive modalities are needed. The present study investigates the property of a natural dietary compound found in cruciferous vegetables, 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of thyroid cancer cells through a functional estrogen receptor. Methodology/Principal Findings: Thyroid cancer cell lines were treated with estrogen and/or DIM and subjected to in vitro adhesion, migration and invasion assays to investigate the anti-metastatic and anti-estrogenic effects of DIM. We observed that DIM inhibits estrogen mediated increase in thyroid cell migration, adhesion and invasion, which is also supported by ER-a downregulation (siRNA) studies. Western blot and zymography analyses provided direct evidence for this DIM mediated inhibition of E-2 enhanced metastasis associated events by virtue of targeting essential proteolytic enzymes, namely MMP-2 and MMP-9. Conclusion/Significance: Our data reports for the first time that DIM displays anti-estrogenic like activity by inhibiting estradiol enhanced thyroid cancer cell proliferation and in vitro metastasis associated events, namely adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were determined to be targets of DIM. This anti-estrogen like property of DIM may lead to the development of a novel preventive and/or therapeutic dietary supplement for thyroid cancer patients by targeting progression of the disease.	[Rajoria, Shilpi; Suriano, Robert; George, Andrea; Shanmugam, Arulkumaran; Geliebter, Jan; Tiwari, Raj K.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Schantz, Stimson P.] New York Eye & Ear Infirm, Dept Otolaryngol, New York, NY 10003 USA	New York Medical College; New York Eye & Ear Infirmary of Mount Sinai	Rajoria, S (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	raj_tiwari@nymc.edu			National Cancer Institute [1R01CA131946]; New York Eye and Ear Infirmary, New York, New York; NATIONAL CANCER INSTITUTE [R01CA131946] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York Eye and Ear Infirmary, New York, New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute 1R01CA131946 and clinical funding from the New York Eye and Ear Infirmary, New York, New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Ashok B. T., 2004, Recent Research Developments in Nutrition, Vol. 6, P83; Ashok BT, 2002, EUR J CANCER PREV, V11, pS86; Bode AM, 2009, NAT REV CANCER, V9, P508, DOI 10.1038/nrc2646; Bradlow HL, 2002, ANN NY ACAD SCI, V963, P247; Ciocca DR, 1997, TRENDS ENDOCRIN MET, V8, P313, DOI 10.1016/S1043-2760(97)00122-7; Dalessandri KM, 2004, NUTR CANCER, V50, P161, DOI 10.1207/s15327914nc5002_5; Fitzgibbons SC, 2008, AM SURGEON, V74, P389; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Garikapaty VPS, 2006, PROSTATE, V66, P453, DOI 10.1002/pros.20350; Garikapaty VPS, 2006, BIOCHEM BIOPH RES CO, V340, P718, DOI 10.1016/j.bbrc.2005.12.059; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Hua KQ, 2008, INT J ONCOL, V33, P959, DOI 10.3892/ijo_00000083; Husain S, 2005, INVEST OPHTH VIS SCI, V46, P1706, DOI 10.1167/iovs.04-0993; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamel H, 2010, J OBSTET GYNAECOL CA, V32, P580, DOI 10.1016/S1701-2163(16)34527-3; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Leibelt DA, 2003, TOXICOL SCI, V74, P10, DOI 10.1093/toxsci/kfg103; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Manavathi B, 2006, J CELL PHYSIOL, V207, P594, DOI 10.1002/jcp.20551; Marquez DC, 2006, MOL CELL ENDOCRINOL, V246, P91, DOI 10.1016/j.mce.2005.11.020; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Nikiforov YE, 2008, MODERN PATHOL, V21, pS37, DOI 10.1038/modpathol.2008.10; Nilsson UW, 2007, BREAST CANCER RES TR, V102, P253, DOI 10.1007/s10549-006-9335-4; Noujaim D, 2002, ONCOGENE, V21, P4549, DOI 10.1038/sj.onc.1205552; O-charoenrat P, 2000, CANCER RES, V60, P1121; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Pietras Richard J, 2003, Breast J, V9, P361, DOI 10.1046/j.1524-4741.2003.09510.x; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Rajoria S, 2010, THYROID, V20, P33, DOI 10.1089/thy.2009.0296; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Smith S, 2008, J NUTR, V138, P2379, DOI 10.3945/jn.108.090993; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Sun M, 2001, CANCER RES, V61, P5985; Suriano R, 2008, CANCER RES, V68, P6038, DOI 10.1158/0008-5472.CAN-08-1009; TIWARI RK, 1994, J NATL CANCER I, V86, P126, DOI 10.1093/jnci/86.2.126; Tuttle RM, 2008, ENDOCRIN METAB CLIN, V37, P419, DOI 10.1016/j.ecl.2008.02.008; Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Yeh MW, 2006, ENDOCR-RELAT CANCER, V13, P1173, DOI 10.1677/erc.1.01226	50	61	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15879	10.1371/journal.pone.0015879	http://dx.doi.org/10.1371/journal.pone.0015879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267453	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500029
J	Hwang, GM; DiCarlo, AA; Lin, GC				Hwang, Grace M.; DiCarlo, Anthony A.; Lin, Gene C.			An Analysis on the Detection of Biological Contaminants Aboard Aircraft	PLOS ONE			English	Article							LEICESTER-COUGH-MONITOR; AIR-FLOW; SUBJECTIVE ASSESSMENTS; PARTICLE-TRANSPORT; TRANSMISSION; FREQUENCY; VIRUS; INFECTION; SYSTEM; CABIN	The spread of infectious disease via commercial airliner travel is a significant and realistic threat. To shed some light on the feasibility of detecting airborne pathogens, a sensor integration study has been conducted and computational investigations of contaminant transport in an aircraft cabin have been performed. Our study took into consideration sensor sensitivity as well as the time-to-answer, size, weight and the power of best available commercial off-the-shelf (COTS) devices. We conducted computational fluid dynamics simulations to investigate three types of scenarios: (1) nominal breathing (up to 20 breaths per minute) and coughing (20 times per hour); (2) nominal breathing and sneezing (4 times per hour); and (3) nominal breathing only. Each scenario was implemented with one or seven infectious passengers expelling air and sneezes or coughs at the stated frequencies. Scenario 2 was implemented with two additional cases in which one infectious passenger expelled 20 and 50 sneezes per hour, respectively. All computations were based on 90 minutes of sampling using specifications from a COTS aerosol collector and biosensor. Only biosensors that could provide an answer in under 20 minutes without any manual preparation steps were included. The principal finding was that the steady-state bacteria concentrations in aircraft would be high enough to be detected in the case where seven infectious passengers are exhaling under scenarios 1 and 2 and where one infectious passenger is actively exhaling in scenario 2. Breathing alone failed to generate sufficient bacterial particles for detection, and none of the scenarios generated sufficient viral particles for detection to be feasible. These results suggest that more sensitive sensors than the COTS devices currently available and/or sampling of individual passengers would be needed for the detection of bacteria and viruses in aircraft.	[Hwang, Grace M.] Mitre Corp, Dept Off Chief Engineer, Mclean, VA USA; [DiCarlo, Anthony A.] Mitre Corp, Dept Mech & Reliabil Engn, Bedford, MA 01730 USA; [Lin, Gene C.] Mitre Corp, Dept W & Int Redesign, Mclean, VA USA	MITRE Corporation; MITRE Corporation; MITRE Corporation	Hwang, GM (corresponding author), Mitre Corp, Dept Off Chief Engineer, Mclean, VA USA.	gmhwang@mitre.org	Hwang, Grace/L-6096-2019	Hwang, Grace/0000-0002-3335-8688	MITRE Corporation	MITRE Corporation	All three authors work for the funders (i.e., the MITRE Corporation). MITRE is a not-for-profit Corporation that operates four federally funded research and development centers. MITRE has an annual budget allocated to research and development. This work was conducted under the internal R&D program, and the program is run by a set of chief engineers who provide management and financial oversight for the study. Management had no direct role in study design, data collection and analysis. The authors have the discretion to publish their research in the public domain after approval from management is obtained. This work was funded by The MITRE Corporation via the Bio-Threat Aircraft Warning System (BTAWS) research project. The contents of this document reflect the views of the author and The MITRE Corporation and do not necessarily reflect the views of the FAA or the DOT or any other government entities that MITRE supports.	Aboosaidi F., 1991, P SOC AUTOMOTIVE ENG, V246, P249; Armendariz AJ, 2002, J AEROSOL SCI, V33, P133, DOI 10.1016/S0021-8502(01)00152-5; BAKER AJ, 2006, ADA455914 CIV AER I; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Bischoff WE, 2006, J INFECT DIS, V194, P1119, DOI 10.1086/507908; Coyle Michael A, 2005, Cough, V1, P3, DOI 10.1186/1745-9974-1-3; Decalmer SC, 2007, THORAX, V62, P329, DOI 10.1136/thx.2006.067413; DUGUID JP, 1946, J HYG, V4, P471; Emanuel P.A., 2007, BIOL DETECTORS MARKE; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; GARNER RP, 2004, DOTFAAAM047 OFF AER, P1; GERENCHER C, 2010, RES TRANSMISSION DIS, P28; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; Hunt E.H., 1994, AIRPLANE CABIN ENV I; HWANG GM, 2009, TECHNOLOGIES HOMELAN, P477; KESAVAN JS, 2006, ECBCTN028; Key Angela L, 2010, Cough, V6, P4, DOI 10.1186/1745-9974-6-4; Li AM, 2003, THORAX, V58, P974, DOI 10.1136/thorax.58.11.974; Lin CH, 2006, HVAC&R RES, V12, P935, DOI 10.1080/10789669.2006.10391218; Liu X, 2007, INDOOR BUILT ENVIRON, V16, P322, DOI 10.1177/1420326X06079890; LOUDON RG, 1967, AM REV RESPIR DIS, V96, P1137; LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Matos S, 2007, IEEE T BIO-MED ENG, V54, P1472, DOI 10.1109/TBME.2007.900811; Mazumdar S, 2008, J ENVIRON MONITOR, V10, P71, DOI 10.1039/b713187a; MIZUNO T, 1992, ASHRAE TRAN, V98, P329; MO H, 2003, ASHRAE T, V109, P101; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; *NAT RES COUNC, 2006, DEF US AIR TRANSP SY; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; OTTA J, 2009, J CLIN MICROBIOL, V1, P205; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; SAYWELL T, 2003, D JONES FAR E EC REV; Singh A., 2002, ASHRAE T, V108, P13; Smith JA, 2006, THORAX, V61, P425, DOI 10.1136/thx.2005.050963; Smith J, 2006, CHEST, V130, P379, DOI 10.1016/S0012-3692(15)51851-5; Smith Jaclyn A, 2006, Cough, V2, P1, DOI 10.1186/1745-9974-2-1; Staub N.C., 1991, BASIC RESP PHYSL; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Sun YG, 2005, ASHRAE TRAN, V111, P45; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Zhai Z, 2007, HVAC&R RES, V2007, P853, DOI DOI 10.1080/10789669.2007.10391459; Zhang T, 2007, HVAC&R RES, V13, P683, DOI 10.1080/10789669.2007.10390980; Zhang Z, 2007, ATMOS ENVIRON, V41, P5236, DOI 10.1016/j.atmosenv.2006.05.086; Zhang Z, 2006, ATMOS ENVIRON, V40, P3396, DOI 10.1016/j.atmosenv.2006.01.014; Zhang Z, 2009, BUILD ENVIRON, V44, P85, DOI 10.1016/j.buildenv.2008.01.012; Zhang Z, 2007, HVAC&R RES, V13, P871, DOI 10.1080/10789669.2007.10391460; Zihlif N, 2005, PEDIATR PULM, V39, P551, DOI 10.1002/ppul.20202; CLIN INFECT DIS, V51, P1033	55	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14520	10.1371/journal.pone.0014520	http://dx.doi.org/10.1371/journal.pone.0014520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264266	gold, Green Published, Green Submitted			2022-12-27	WOS:000286517600004
J	Shapira, A; Gal-Tanamy, M; Nahary, L; Litvak-Greenfeld, D; Zemel, R; Tur-Kaspa, R; Benhar, I				Shapira, Assaf; Gal-Tanamy, Meital; Nahary, Limor; Litvak-Greenfeld, Dana; Zemel, Romy; Tur-Kaspa, Ran; Benhar, Itai			Engineered Toxins "Zymoxins'' Are Activated by the HCV NS3 Protease by Removal of an Inhibitory Protein Domain	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RICIN-A-CHAIN; RIBOSOME-INACTIVATING PROTEIN; AERUGINOSA EXOTOXIN-A; SHIGA-LIKE TOXIN-1; PSEUDOMONAS EXOTOXIN; SERINE-PROTEASE; MEMBRANE ASSOCIATION; DELETION ANALYSIS; REPLICATION	The synthesis of inactive enzyme precursors, also known as "zymogens,'' serves as a mechanism for regulating the execution of selected catalytic activities in a desirable time and/or site. Zymogens are usually activated by proteolytic cleavage. Many viruses encode proteases that execute key proteolytic steps of the viral life cycle. Here, we describe a proof of concept for a therapeutic approach to fighting viral infections through eradication of virally infected cells exclusively, thus limiting virus production and spread. Using the hepatitis C virus (HCV) as a model, we designed two HCV NS3 protease-activated "zymogenized'' chimeric toxins (which we denote "zymoxins''). In these recombinant constructs, the bacterial and plant toxins diphtheria toxin A (DTA) and Ricin A chain (RTA), respectively, were fused to rationally designed inhibitor peptides/domains via an HCV NS3 protease-cleavable linker. The above toxins were then fused to the binding and translocation domains of Pseudomonas exotoxin A in order to enable translocation into the mammalian cells cytoplasm. We show that these toxins exhibit NS3 cleavage dependent increase in enzymatic activity upon NS3 protease cleavage in vitro. Moreover, a higher level of cytotoxicity was observed when zymoxins were applied to NS3 expressing cells or to HCV infected cells, demonstrating a potential therapeutic window. The increase in toxin activity correlated with NS3 protease activity in the treated cells, thus the therapeutic window was larger in cells expressing recombinant NS3 than in HCV infected cells. This suggests that the "zymoxin'' approach may be most appropriate for application to life-threatening acute infections where much higher levels of the activating protease would be expected.	[Shapira, Assaf; Nahary, Limor; Litvak-Greenfeld, Dana; Benhar, Itai] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran] Tel Aviv Univ, Mol Hepatol Res Lab, Felsenstein Med Res Ctr, Sackler Sch Med, Petah Tiqwa, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Shapira, A (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel.	benhar@post.tau.ac.il		Benhar, Itai/0000-0002-0824-7177	Israel Science Foundation (ISF) [397/08]; Recanati Foundation, Israel [0601242231]; Ministry of Health, Israel [3-4179]	Israel Science Foundation (ISF)(Israel Science Foundation); Recanati Foundation, Israel; Ministry of Health, Israel	This research was supported by grants from the Israel Science Foundation (ISF) (grant No. 397/08), the Recanati Foundation (grant No 0601242231), Israel and by grant No. 3-4179 of the "Ezvonot'' Fund from the Ministry of Health, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; BASS HW, 1992, PLANT CELL, V4, P225, DOI 10.1105/tpc.4.2.225; Berdichevsky Y, 2003, J VIROL METHODS, V107, P245, DOI 10.1016/S0166-0934(02)00255-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Brass Volker, 2006, Int J Med Sci, V3, P29; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; COLLIER RJ, 1971, J BIOL CHEM, V246, P1496; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; DEBINSKI W, 1994, BIOCONJUGATE CHEM, V5, P40, DOI 10.1021/bc00025a006; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dimasi N, 1998, PROTEIN ENG, V11, P1257, DOI 10.1093/protein/11.12.1257; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Falnes PO, 1999, BIOCHEM J, V343, P199, DOI 10.1042/0264-6021:3430199; FitzGerald D, 1991, Semin Cell Biol, V2, P31; Frelin L, 2003, GENE THER, V10, P686, DOI 10.1038/sj.gt.3301933; Gal-Tanamy M, 2005, J MOL BIOL, V347, P991, DOI 10.1016/j.jmb.2005.02.020; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; GUIDIRONTANI C, 1992, MOL MICROBIOL, V6, P1281, DOI 10.1111/j.1365-2958.1992.tb00849.x; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hsu JTA, 2006, CURR PHARM DESIGN, V12, P1301, DOI 10.2174/138161206776361110; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; IGLEWSKI BH, 1977, INFECT IMMUN, V15, P138, DOI 10.1128/IAI.15.1.138-144.1977; Jackson ME, 1999, J CELL SCI, V112, P467; Johnson RJ, 2006, FEBS J, V273, P5457, DOI 10.1111/j.1742-4658.2006.05536.x; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jucovic M, 2008, PROTEIN ENG DES SEL, V21, P631, DOI 10.1093/protein/gzn038; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; KREITMAN RJ, 1995, BIOCHEM J, V307, P29, DOI 10.1042/bj3070029; LAW SK, 2010, NUCL ACIDS RES  0617; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mansfield E, 1996, BIOCONJUGATE CHEM, V7, P557, DOI 10.1021/bc960043y; MAY MJ, 1989, EMBO J, V8, P301, DOI 10.1002/j.1460-2075.1989.tb03377.x; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McGivern DR, 2009, J VIROL, V83, P7422, DOI 10.1128/JVI.00262-09; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Munishkin A, 1995, J BIOL CHEM, V270, P30581, DOI 10.1074/jbc.270.51.30581; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Parikh BA, 2004, MINI-REV MED CHEM, V4, P523, DOI 10.2174/1389557043403800; Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; PITCHER C, 1995, BIOCONJUGATE CHEM, V6, P624, DOI 10.1021/bc00035a018; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Ratts R, 2005, TOP CURR GENET, V11, P1, DOI 10.1007/b102267; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Rychlowska M, 2007, ACTA BIOCHIM POL, V54, P703; Shaki-Loewenstein S, 2005, J IMMUNOL METHODS, V303, P19, DOI 10.1016/j.jim.2005.05.004; Steinkuhler C, 1996, J VIROL, V70, P6694; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; Turcotte RF, 2008, AIDS RES HUM RETROV, V24, P1357, DOI 10.1089/aid.2008.0146; Varshavsky A, 1995, COLD SPRING HARB SYM, V60, P461, DOI 10.1101/SQB.1995.060.01.051; VATER CA, 1995, J BIOL CHEM, V270, P12933, DOI 10.1074/jbc.270.21.12933; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WALSH TA, 1991, J BIOL CHEM, V266, P23422; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Zemel R, 2004, J HEPATOL, V40, P1000, DOI 10.1016/j.jhep.2004.02.026; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	76	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15916	10.1371/journal.pone.0015916	http://dx.doi.org/10.1371/journal.pone.0015916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264238	gold, Green Published, Green Submitted			2022-12-27	WOS:000286516500016
J	Freitas, MS; Follmer, C; Costa, LT; Vilani, C; Bianconi, ML; Achete, CA; Silva, JL				Freitas, Monica S.; Follmer, Cristian; Costa, Lilian T.; Vilani, Cecilia; Bianconi, M. Lucia; Achete, Carlos Alberto; Silva, Jerson L.			Measuring the Strength of Interaction between the Ebola Fusion Peptide and Lipid Rafts: Implications for Membrane Fusion and Virus Infection	PLOS ONE			English	Article							FOLATE RECEPTOR-ALPHA; CELLULAR ENTRY; GLYCOPROTEIN; CAVEOLAE; MECHANISM; PROTEINS; CYCLODEXTRINS; TRAFFICKING; ASSOCIATION; INVOLVEMENT	The Ebola fusion peptide (EBO(16)) is a hydrophobic domain that belongs to the GP2 membrane fusion protein of the Ebola virus. It adopts a helical structure in the presence of mimetic membranes that is stabilized by the presence of an aromatic-aromatic interaction established by Trp8 and Phe12. In spite of its infectious cycle becoming better understood recently, several steps still remain unclear, a lacuna that makes it difficult to develop strategies to block infection. In order to gain insight into the mechanism of membrane fusion, we probed the structure, function and energetics of EBO(16) and its mutant W8A, in the absence or presence of different lipid membranes, including isolated domain-resistant membranes (DRM), a good experimental model for lipid rafts. The depletion of cholesterol from living mammalian cells reduced the ability of EBO(16) to induce lipid mixing. On the other hand, EBO(16) was structurally sensitive to interaction with lipid rafts (DRMs), but the same was not observed for W8A mutant. In agreement with these data, W8A showed a poor ability to promote membrane aggregation in comparison to EBO(16). Single molecule AFM experiments showed a high affinity force pattern for the interaction of EBO(16) and DRM, which seems to be a complex energetic event as observed by the calorimetric profile. Our study is the first to show a strong correlation between the initial step of Ebola virus infection and cholesterol, thus providing a rationale for Ebola virus proteins being co-localized with lipid-raft domains. In all, the results show how small fusion peptide sequences have evolved to adopt highly specific and strong interactions with membrane domains. Such features suggest these processes are excellent targets for therapeutic and vaccine approaches to viral diseases.	[Freitas, Monica S.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Ciencias & Tecnol Biol Estrutural & Bio, Rio De Janeiro, Brazil; [Follmer, Cristian] Univ Fed Rio de Janeiro, Inst Quim, Dept Quim Fis, Rio De Janeiro, Brazil; [Costa, Lilian T.; Vilani, Cecilia; Achete, Carlos Alberto] Inmetro, Div Metrol Mat DIMAT, Rio De Janeiro, Brazil; [Bianconi, M. Lucia] Univ Fed Rio de Janeiro, Inst Bioqum Med, Lab Biocalorimetria, Rio De Janeiro, Brazil; [Achete, Carlos Alberto] Univ Fed Rio de Janeiro, COPPE, Programa Engn Met & Mat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Freitas, MS (corresponding author), FMP, Leibniz Inst Mol Pharmakol, Berlin, Germany.	jerson@bioqmed.ufrj.br	Inomat, Inct/H-9989-2013; Follmer, Cristian/O-6134-2016; Silva, Jerson/J-8984-2014; Vilani, Cecilia/AAG-8988-2021; Achete, carlos/AAS-5843-2021; de Freitas, Mônica Santos/E-8540-2015; SILVA, JERSON Lima/GRF-1442-2022	Follmer, Cristian/0000-0001-6178-0432; Silva, Jerson/0000-0001-9523-9441; de Freitas, Mônica Santos/0000-0003-3105-7918; SILVA, JERSON Lima/0000-0001-9523-9441	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT); Departatmento de Ciencia e Tecnologia/Ministerio da Saude; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT); Departatmento de Ciencia e Tecnologia/Ministerio da Saude; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the following public Brazilian funding agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program), Departatmento de Ciencia e Tecnologia/Ministerio da Saude, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The grants supported the acquisition of consumables and equipments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MA, 2001, J CELL SCI, V114, P3957; Aman MJ, 2003, MICROBES INFECT, V5, P639, DOI 10.1016/S1286-4579(03)00095-9; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; Biswas S, 2008, J GEN PHYSIOL, V131, P503, DOI 10.1085/jgp.200709932; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Gomara MJ, 2004, FEBS LETT, V569, P261, DOI 10.1016/j.febslet.2004.06.006; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Maia LF, 2006, J BIOL CHEM, V281, P29278, DOI 10.1074/jbc.M604689200; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; OSTROWSKY N, 1981, OPT ACTA, V28, P1059, DOI 10.1080/713820704; Ruiz-Arguello MB, 1998, J VIROL, V72, P1775; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Suarez T, 2003, FEBS LETT, V535, P23, DOI 10.1016/S0014-5793(02)03847-4; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Vilani C, 2007, APPL SURF SCI, V254, P131, DOI 10.1016/j.apsusc.2007.07.060; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Volynsky PE, 2005, BIOCHEMISTRY-US, V44, P14626, DOI 10.1021/bi0514562; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	39	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15756	10.1371/journal.pone.0015756	http://dx.doi.org/10.1371/journal.pone.0015756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249196	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000007
J	Ignatiadis, M; Rothe, F; Chaboteaux, C; Durbecq, V; Rouas, G; Criscitiello, C; Metallo, J; Kheddoumi, N; Singhal, SK; Michiels, S; Veys, I; Rossari, J; Larsimont, D; Carly, B; Pestrin, M; Bessi, S; Buxant, F; Liebens, F; Piccart, M; Sotiriou, C				Ignatiadis, Michail; Rothe, Francoise; Chaboteaux, Carole; Durbecq, Virginie; Rouas, Ghizlane; Criscitiello, Carmen; Metallo, Jessica; Kheddoumi, Naima; Singhal, Sandeep K.; Michiels, Stefan; Veys, Isabelle; Rossari, Jose; Larsimont, Denis; Carly, Birgit; Pestrin, Marta; Bessi, Silvia; Buxant, Frederic; Liebens, Fabienne; Piccart, Martine; Sotiriou, Christos			HER2-Positive Circulating Tumor Cells in Breast Cancer	PLOS ONE			English	Article							HER2 STATUS; STAGE-I; PREDICTS; RECOMMENDATIONS; EXPRESSION; SURVIVAL; BLOOD	Purpose: Circulating Tumor Cells (CTCs) detection and phenotyping are currently evaluated in Breast Cancer (BC). Tumor cell dissemination has been suggested to occur early in BC progression. To interrogate dissemination in BC, we studied CTCs and HER2 expression on CTCs across the spectrum of BC staging. Methods: Spiking experiments with 6 BC cell lines were performed and blood samples from healthy women and women with BC were analyzed for HER2-positive CTCs using the CellSearch (R). Results: Based on BC cell lines experiments, HER2-positive CTCs were defined as CTCs with HER2 immunofluoresence intensity that was at least 2.5 times higher than the background. No HER2-positive CTC was detected in 42 women without BC (95% confidence interval (CI) 0-8.4%) whereas 4.1% (95% CI 1.4-11.4%) of 73 patients with ductal/lobular carcinoma in situ (DCIS/LCIS) had 1 HER2-positive CTC/22.5 mL, 7.9%, (95% CI 4.1-14.9%) of 101 women with non metastatic (M0) BC had >= 1 HER2-positive CTC/22.5 mL (median 1 cell, range 1-3 cells) and 35.9% (95% CI 22.7-51.9%) of 39 patients with metastatic BC had >= 1 HER2-positive CTC/7.5 mL (median 1.5 cells, range 1-42 cells). In CTC-positive women with DCIS/LCIS or M0 BC, HER2-positive CTCs were more commonly detected in HER2-positive (5 of 5 women) than HER2-negative BC (5 of 12 women) (p = 0.03). Conclusion: HER2-positive CTCs were detected in DCIS/LCIS or M0 BC irrespective of the primary tumor HER2 status. Nevertheless, their presence was more common in women with HER2-positive disease. Monitoring of HER2 expression on CTCs might be useful in trials with anti-HER2 therapies.	[Ignatiadis, Michail; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium; [Ignatiadis, Michail; Rothe, Francoise; Chaboteaux, Carole; Durbecq, Virginie; Rouas, Ghizlane; Criscitiello, Carmen; Metallo, Jessica; Kheddoumi, Naima; Singhal, Sandeep K.; Michiels, Stefan; Rossari, Jose; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Breast Canc Translat Res Lab, B-1000 Brussels, Belgium; [Veys, Isabelle] Inst Jules Bordet, Dept Surg Oncol & Gynecol, B-1000 Brussels, Belgium; [Larsimont, Denis] Inst Jules Bordet, Dept Pathol, B-1000 Brussels, Belgium; [Carly, Birgit; Liebens, Fabienne] Hop St Pierre & Erasme, Dept Gynecol, Brussels, Belgium; [Pestrin, Marta; Bessi, Silvia] Hosp Prato, Translat Res Unit, Prato, Italy; [Buxant, Frederic] Hop Erasme, Dept Gynecol, Brussels, Belgium	Institut Jules Bordet; Institut Jules Bordet; Institut Jules Bordet; Institut Jules Bordet; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Prato Hospital; Universite Libre de Bruxelles	Ignatiadis, M (corresponding author), Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium.	Michail.Ignatiadis@bordet.be	Michiels, Stefan/L-1516-2013	Michiels, Stefan/0000-0002-6963-2968	La Fondation Fournier Majoie pour l'innovation; Fonds de la Recherche Scientifique -FNRS; MEDIC Foundation	La Fondation Fournier Majoie pour l'innovation; Fonds de la Recherche Scientifique -FNRS(Fonds de la Recherche Scientifique - FNRS); MEDIC Foundation	Michail Ignatiadis and Christos Sotiriou have received funding for research on Circulating Tumor Cells from "La Fondation Fournier Majoie pour l'innovation", from "Fonds de la Recherche Scientifique -FNRS" and from "MEDIC Foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Braun S, 2001, CANCER RES, V61, P1890; Criscitiello C, 2010, CURR OPIN ONCOL, V22, P552, DOI 10.1097/CCO.0b013e32833de186; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fehm T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1783; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hayes DF, 2002, INT J ONCOL, V21, P1111; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Lang JE, 2009, BREAST CANCER RES TR, V113, P501, DOI 10.1007/s10549-008-9951-2; Leake R, 2000, J CLIN PATHOL, V53, P634, DOI 10.1136/jcp.53.8.634; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Pachmann K, 2005, CLIN CHEM LAB MED, V43, P617, DOI 10.1515/CCLM.2005.107; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030; Riethdorf S, 2010, CLIN CANCER RES, V16, P2634, DOI 10.1158/1078-0432.CCR-09-2042; Sandri MT, 2010, ANN SURG ONCOL, V17, P1539, DOI 10.1245/s10434-010-0918-2; Solomayer EF, 2006, BREAST CANCER RES TR, V98, P179, DOI 10.1007/s10549-005-9147-y; Tibbe AGJ, 2001, CYTOMETRY, V43, P31, DOI 10.1002/1097-0320(20010101)43:1<31::AID-CYTO1016>3.0.CO;2-F; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087	25	148	151	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15624	10.1371/journal.pone.0015624	http://dx.doi.org/10.1371/journal.pone.0015624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264346	Green Submitted, Green Published, gold			2022-12-27	WOS:000286513100008
J	Pluta, RM; Oldfield, EH; Bakhtian, KD; Fathi, AR; Smith, RK; DeVroom, HL; Nahavandi, M; Woo, S; Figg, WD; Lonser, RR				Pluta, Ryszard M.; Oldfield, Edward H.; Bakhtian, Kamran D.; Fathi, Ali Reza; Smith, Rene K.; DeVroom, Hetty L.; Nahavandi, Masoud; Woo, Sukyung; Figg, William D.; Lonser, Russell R.			Safety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy Volunteers	PLOS ONE			English	Article							VIVO ISCHEMIA-REPERFUSION; CEREBRAL VASOSPASM; IN-VIVO; CIRCULATING NITRITE; CEREBROSPINAL-FLUID; OXIDE METABOLITES; PLASMA NITRITE; PRIMATE MODEL; BLOOD-FLOW; NITRATE	Background: Infusion of sodium nitrite could provide sustained therapeutic concentrations of nitric oxide (NO) for the treatment of a variety of vascular disorders. The study was developed to determine the safety and feasibility of prolonged sodium nitrite infusion. Methodology: Healthy volunteers, aged 21 to 60 years old, were candidates for the study performed at the National Institutes of Health (NIH; protocol 05-N-0075) between July 2007 and August 2008. All subjects provided written consent to participate. Twelve subjects (5 males, 7 females; mean age, 38.8 +/- 9.2 years (range, 21-56 years)) were intravenously infused with increasing doses of sodium nitrite for 48 hours (starting dose at 4.2 mu g/kg/hr; maximal dose of 533.8 mu g/kg/hr). Clinical, physiologic and laboratory data before, during and after infusion were analyzed. Findings: The maximal tolerated dose for intravenous infusion of sodium nitrite was 267 mu g/kg/hr. Dose limiting toxicity occurred at 446 mu g/kg/hr. Toxicity included a transient asymptomatic decrease of mean arterial blood pressure (more than 15 mmHg) and/or an asymptomatic increase of methemoglobin level above 5%. Nitrite, nitrate, S-nitrosothiols concentrations in plasma and whole blood increased in all subjects and returned to preinfusion baseline values within 12 hours after cessation of the infusion. The mean half-life of nitrite estimated at maximal tolerated dose was 45.3 minutes for plasma and 51.4 minutes for whole blood. Conclusion: Sodium nitrite can be safely infused intravenously at defined concentrations for prolonged intervals. These results should be valuable for developing studies to investigate new NO treatment paradigms for a variety of clinical disorders, including cerebral vasospasm after subarachnoid hemorrhage, and ischemia of the heart, liver, kidney and brain, as well as organ transplants, blood-brain barrier modulation and pulmonary hypertension. Information:	[Pluta, Ryszard M.; Oldfield, Edward H.; Bakhtian, Kamran D.; Fathi, Ali Reza; Smith, Rene K.; DeVroom, Hetty L.; Nahavandi, Masoud; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Oldfield, Edward H.] Univ Virginia, Hlth Sci Ctr, Dept Neurol Surg, Charlottesville, VA 22908 USA; [Fathi, Ali Reza] Kantonsspital Aarau AG, Dept Neurosurg, Aarau, Switzerland; [Woo, Sukyung; Figg, William D.] NCI, Mol Pharmacol Sect, NIH, Bethesda, MD 20892 USA; [Woo, Sukyung; Figg, William D.] NCI, Clin Pharmacol Program, Med Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Virginia; Kantonsspital Aarau AG (KSA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pluta, RM (corresponding author), NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	rysiek@ninds.nih.gov	Figg, William D/M-2411-2016		National Institute of Neurological Disorders and Stroke at the NIH; Swiss National Science Foundation [PBSKP3-123454]; NATIONAL CANCER INSTITUTE [ZICBC010548, ZICSC006537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003054] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the NIH. Ali Reza Fathi, M.D. was supported by a grant from the Swiss National Science Foundation (PBSKP3-123454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSHAR JKB, 1995, J NEUROSURG, V83, P118, DOI 10.3171/jns.1995.83.1.0118; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; EGEMEN N, 1993, NEUROL RES, V15, P310; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gladwin M, 2005, NAT CHEM BIOL, V1, P1; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; HASHI K, 1972, J NEUROL SCI, V17, P1, DOI 10.1016/0022-510X(72)90016-0; Hon YY, 2010, DRUG METAB DISPOS, V38, P1707, DOI 10.1124/dmd.110.034355; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; Iida S, 2005, AM J PHYSIOL-HEART C, V289, pH525, DOI 10.1152/ajpheart.00108.2005; Jung KH, 2006, STROKE, V37, P2744, DOI 10.1161/01.STR.0000245116.40163.1c; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; Khaldi A, 2001, NEUROSURGERY, V49, P33; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; Mason RB, 2000, J NEUROSURG, V93, P99, DOI 10.3171/jns.2000.93.1.0099; Nagasaka Y, 2008, ANESTHESIOLOGY, V109, P675, DOI 10.1097/ALN.0b013e318186316e; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Pluta RM, 1998, J NEUROSURG, V88, P557, DOI 10.3171/jns.1998.88.3.0557; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; Pluta RM, 2001, NEUROSURGERY, V48, P884, DOI 10.1097/00006123-200104000-00039; Pluta RM, 1997, J NEUROSURG, V87, P746, DOI 10.3171/jns.1997.87.5.0746; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; Sadamitsu D, 2001, CRIT CARE MED, V29, P77, DOI 10.1097/00003246-200101000-00018; Schatlo B, 2008, J CEREBR BLOOD F MET, V28, P482, DOI 10.1038/sj.jcbfm.9600542; Sinha SS, 2008, TRENDS CARDIOVAS MED, V18, P163, DOI 10.1016/j.tcm.2008.05.001; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Suzuki M, 1999, NEUROSURG REV, V22, P96, DOI 10.1007/s101430050038; Thomas JE, 1999, NEUROSURGERY, V44, P48, DOI 10.1097/00006123-199901000-00026; Tsikas Dimitrios, 2004, V279, P81; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Weyerbrock A, 2003, J NEUROSURG, V99, P728, DOI 10.3171/jns.2003.99.4.0728; Woszczyk A, 2003, ACTA NEUROCHIR, V145, P257, DOI 10.1007/s00701-003-0004-7	51	84	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e14504	10.1371/journal.pone.0014504	http://dx.doi.org/10.1371/journal.pone.0014504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249218	gold, Green Submitted, Green Published			2022-12-27	WOS:000286513100001
J	Hugler, M; Petersen, JM; Dubilier, N; Imhoff, JF; Sievert, SM				Huegler, Michael; Petersen, Jillian M.; Dubilier, Nicole; Imhoff, Johannes F.; Sievert, Stefan M.			Pathways of Carbon and Energy Metabolism of the Epibiotic Community Associated with the Deep-Sea Hydrothermal Vent Shrimp Rimicaris exoculata	PLOS ONE			English	Article							INORGANIC SULFUR-COMPOUNDS; TRICARBOXYLIC-ACID CYCLE; MICROBIAL COMMUNITIES; CO2 FIXATION; ULTRAMAFIC ROCKS; TROPHIC ECOLOGY; GILL CHAMBER; BACTERIA; DIVERSITY; FIELD	Background: The shrimp Rimicaris exoculata dominates the faunal biomass at many deep-sea hydrothermal vent sites at the Mid-Atlantic Ridge. In its enlarged gill chamber it harbors a specialized epibiotic bacterial community for which a nutritional role has been proposed. Methodology/Principal Findings: We analyzed specimens from the Snake Pit hydrothermal vent field on the Mid-Atlantic Ridge by complementing a 16S rRNA gene survey with the analysis of genes involved in carbon, sulfur and hydrogen metabolism. In addition to Epsilon-and Gammaproteobacteria, the epibiotic community unexpectedly also consists of Deltaproteobacteria of a single phylotype, closely related to the genus Desulfocapsa. The association of these phylogenetic groups with the shrimp was confirmed by fluorescence in situ hybridization. Based on functional gene analyses, we hypothesize that the Gamma-and Epsilonproteobacteria are capable of autotrophic growth by oxidizing reduced sulfur compounds, and that the Deltaproteobacteria are also involved in sulfur metabolism. In addition, the detection of proteobacterial hydrogenases indicates the potential for hydrogen oxidation in these communities. Interestingly, the frequency of these phylotypes in 16S rRNA gene clone libraries from the mouthparts differ from that of the inner lining of the gill chamber, indicating potential functional compartmentalization. Conclusions: Our data show the specific association of autotrophic bacteria with Rimicaris exoculata from the Snake Pit hydrothermal vent field, and suggest that autotrophic carbon fixation is contributing to the productivity of the epibiotic community with the reductive tricarboxylic acid cycle as one important carbon fixation pathway. This has not been considered in previous studies of carbon fixation and stable carbon isotope composition of the shrimp and its epibionts. Furthermore, the co-occurrence of sulfur-oxidizing and sulfur-reducing epibionts raises the possibility that both may be involved in the syntrophic exchange of sulfur compounds, which could increase the overall efficiency of this epibiotic community.	[Huegler, Michael; Sievert, Stefan M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Huegler, Michael; Imhoff, Johannes F.] IFM GEOMAR, Leibniz Inst Marine Sci, Kiel, Germany; [Petersen, Jillian M.; Dubilier, Nicole] Max Planck Inst Marine Microbiol, Bremen, Germany	Woods Hole Oceanographic Institution; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society	Hugler, M (corresponding author), Technol Ctr TZW, Karlsruhe, Germany.	ssievert@whoi.edu	Imhoff, Johannes F./D-2515-2010; Imhoff, Johannes F./AAB-8765-2022; Hügler, Michael/A-9155-2018; Dubilier, Nicole/I-8203-2018; Petersen, Jillian/GVU-6351-2022; Petersen, Jillian/K-6066-2015	Imhoff, Johannes F./0000-0001-8789-0728; Imhoff, Johannes F./0000-0001-8789-0728; Hügler, Michael/0000-0002-2820-0333; Dubilier, Nicole/0000-0002-9394-825X; Petersen, Jillian/0000-0002-9852-3445; Sievert, Stefan/0000-0002-9541-2707	NSF [OCE-0452333]; Alfried Krupp Wissenschaftskolleg Greifswald, Germany; Max Planck Society; German Research Foundation (DFG) Cluster of Excellence at Marum; MOMARnet; IFM-GEOMAR	NSF(National Science Foundation (NSF)); Alfried Krupp Wissenschaftskolleg Greifswald, Germany; Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation (DFG) Cluster of Excellence at Marum(German Research Foundation (DFG)); MOMARnet; IFM-GEOMAR	Funding was provided through NSF grant OCE-0452333 and the Alfried Krupp Wissenschaftskolleg Greifswald, Germany (SMS), the Max Planck Society, the German Research Foundation (DFG) Cluster of Excellence at Marum, and MOMARnet (ND, JMP), and IFM-GEOMAR (MH, JFI).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; BIEBL H, 1977, ARCH MICROBIOL, V112, P115, DOI 10.1007/BF00446664; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; CAMPBELL AC, 1988, NATURE, V335, P514, DOI 10.1038/335514a0; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; CASANOVA B, 1993, CAH BIOL MAR, V34, P573; Cavanaugh CM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P285; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Corbari L, 2008, AQUAT BIOL, V1, P225, DOI 10.3354/ab00024; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Finster K, 1998, APPL ENVIRON MICROB, V64, P119; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; GALCHENKO VF, 1989, DOKL AKAD NAUK SSSR+, V308, P1478; GEBRUK AV, 1993, MAR ECOL PROG SER, V98, P247, DOI 10.3354/meps098247; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Grabovich MY, 1999, FEMS MICROBIOL LETT, V178, P155, DOI 10.1111/j.1574-6968.1999.tb13772.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hugler M, 2010, FEMS MICROBIOL ECOL, V73, P526, DOI 10.1111/j.1574-6941.2010.00919.x; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; JANNASCH HW, 1991, RIDGE EVENTS, V19; Janssen PH, 1996, ARCH MICROBIOL, V166, P184, DOI 10.1007/s002030050374; KARSON JA, 1989, MAR GEOPHYS RES, V10, P91; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lopez-Garcia P, 2003, ENVIRON MICROBIOL, V5, P961, DOI 10.1046/j.1462-2920.2003.00495.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Peduzzi S, 2003, FEMS MICROBIOL ECOL, V45, P29, DOI 10.1016/S0168-6496(03)00107-7; Perner M, 2007, FEMS MICROBIOL ECOL, V61, P97, DOI 10.1111/j.1574-6941.2007.00325.x; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Petri R, 2001, FEMS MICROBIOL LETT, V197, P171, DOI 10.1111/j.1574-6968.2001.tb10600.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Rieley G, 1999, MAR BIOL, V133, P495, DOI 10.1007/s002270050489; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; Robinson JL, 1995, LIMNOL OCEANOGR, V40, P1496, DOI 10.4319/lo.1995.40.8.1496; Schmidt C, 2009, GEOBIOLOGY, V7, P454, DOI 10.1111/j.1472-4669.2009.00209.x; Schmidt C, 2008, MAR CHEM, V108, P18, DOI 10.1016/j.marchem.2007.09.009; Schmidt C, 2008, J SHELLFISH RES, V27, P79, DOI 10.2983/0730-8000(2008)27[79:IODVIW]2.0.CO;2; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Sievert SM, 2008, MICROBIAL SULFUR METABOLISM, P238, DOI 10.1007/978-3-540-72682-1_19; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; Suzuki Y, 2005, APPL ENVIRON MICROB, V71, P5440, DOI 10.1128/AEM.71.9.5440-5450.2005; Suzuki Y, 2009, J MAR BIOL ASSOC UK, V89, P727, DOI 10.1017/S0025315409000459; Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005; THOMPSON G, 1988, CAN MINERAL, V26, P697; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; WIRSEN CO, 1993, J GEOPHYS RES-SOL EA, V98, P9693, DOI 10.1029/92JB01556; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	67	59	62	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16018	10.1371/journal.pone.0016018	http://dx.doi.org/10.1371/journal.pone.0016018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249205	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000286512900018
J	Hain, D; Bettencourt, B; Okamura, K; Csorba, T; Meyer, W; Jin, ZG; Biggerstaff, J; Siomi, H; Hutvagner, G; Lai, EC; Welte, M; Muller, HAJ				Hain, Daniel; Bettencourt, Brian; Okamura, Katsutomo; Csorba, Tibor; Meyer, Wibke; Jin, Zhigang; Biggerstaff, Jason; Siomi, Haruhiko; Hutvagner, Gyorgy; Lai, Eric C.; Welte, Michael; Mueller, H. -Arno J.			Natural Variation of the Amino-Terminal Glutamine-Rich Domain in Drosophila Argonaute2 Is Not Associated with Developmental Defects	PLOS ONE			English	Article							RNA INTERFERENCE; ANTIVIRAL IMMUNITY; MESSENGER-RNAS; PROTEIN; GENE; MELANOGASTER; PATHWAY; HETEROCHROMATIN; EVOLUTION; ARMADILLO	The Drosophila argonaute2 (ago2) gene plays a major role in siRNA mediated RNA silencing pathways. Unlike mammalian Argonaute proteins, the Drosophila protein has an unusual amino-terminal domain made up largely of multiple copies of glutamine-rich repeats (GRRs). We report here that the ago2 locus produces an alternative transcript that encodes a putative short isoform without this amino-terminal domain. Several ago2 mutations previously reported to be null alleles only abolish expression of the long, GRR-containing isoform. Analysis of drop out (dop) mutations had previously suggested that variations in GRR copy number result in defects in RNAi and embryonic development. However, we find that dop mutations genetically complement transcript-null alleles of ago2 and that ago2 alleles with variant GRR copy numbers support normal development. In addition, we show that the assembly of the central RNAi machinery, the RISC (RNA induced silencing complex), is unimpaired in embryos when GRR copy number is altered. In fact, we find that GRR copy number is highly variable in natural D. melanogaster populations as well as in laboratory strains. Finally, while many other insects share an extensive, glutamine-rich Ago2 amino-terminal domain, its primary sequence varies drastically between species. Our data indicate that GRR variation does not modulate an essential function of Ago2 and that the amino-terminal domain of Ago2 is subject to rapid evolution.	[Hain, Daniel; Mueller, H. -Arno J.] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland; [Bettencourt, Brian] Alnylam Pharmaceut, Cambridge, MA USA; [Okamura, Katsutomo; Jin, Zhigang; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, New York, NY USA; [Csorba, Tibor; Hutvagner, Gyorgy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland; [Meyer, Wibke] Univ Dusseldorf, Inst Genet, Dusseldorf, Germany; [Biggerstaff, Jason] Boston Univ, Boston, MA 02215 USA; [Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Welte, Michael] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Dundee; Memorial Sloan Kettering Cancer Center; University of Dundee; Heinrich Heine University Dusseldorf; Boston University; Keio University; University of Rochester	Hain, D (corresponding author), Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland.	h.j.muller@dundee.ac.uk	Welte, Michael/AAH-5589-2019; Müller, Hans-Arno/G-5753-2012; Lai, Eric/AAO-1143-2021; Muller, Hans-Arno/Q-2864-2019; Siomi, Haruhiko/A-7020-2015; Lai, Eric C/A-3412-2008; Csorba, Tibor/A-2359-2014	Welte, Michael/0000-0001-5741-4720; Müller, Hans-Arno/0000-0002-7525-6874; Lai, Eric/0000-0002-8432-5851; Muller, Hans-Arno/0000-0002-7525-6874; Siomi, Haruhiko/0000-0001-8690-3822; Csorba, Tibor/0000-0003-4185-1496; Hutvagner, Gyorgy/0000-0002-7231-9446	European Molecular Biology Organisation (EMBO); Commonwealth of Massachusetts; Wellcome Trust; European Union; Burroughs Wellcome Fund; Alfred Bressler Scholars Fund; National Institutes of Health [R01-GM083300]; National Institute of General Medical Sciences [GM64687]; Deutsche Forschungsgemeinshaft (DFG) [MU1168/5-1, MU1168/5-2, MU1168/5-3]; College of Life Sciences, University of Dundee, Scotland; MRC [G0501679] Funding Source: UKRI; Medical Research Council [G0501679] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064687, R01GM083300] Funding Source: NIH RePORTER	European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Commonwealth of Massachusetts; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alfred Bressler Scholars Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Deutsche Forschungsgemeinshaft (DFG)(German Research Foundation (DFG)); College of Life Sciences, University of Dundee, Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TC was supported by a European Molecular Biology Organisation (EMBO) short term fellowship, BRB received support from the Commonwealth of Massachusetts, and GH was supported by a Wellcome Trust Career Development Fellowship and European Union Framework 6 programme SIROCCO (Silencing RNAs: organisers and coordinators of complexity in eukaryotic organisms). ZJ is a fellow of the National Cancer Institute of Canada Terry Fox Foundation (#700132). KO is a fellow of the Japan Society for the Promotion of Science. ECL was supported by the Burroughs Wellcome Fund, the Alfred Bressler Scholars Fund, and the National Institutes of Health R01-GM083300. MAW was supported by National Institute of General Medical Sciences grant GM64687, DH was a graduate student fellow of the Biotechnological and Biological Sciences Research Council (BBSRC, UK) and HAM was supported by Deutsche Forschungsgemeinshaft (DFG) grant MU1168/5-1, 5-2, 5-3 of the DFG priority programme 'Cell polarity', and funds of the College of Life Sciences, University of Dundee, Scotland. During the time that Dr. Bettencourt performed data analysis and prepared the manuscript he was also serving as an employee of and receiving a regular salary of Alnylam Pharmaceuticals, Inc. Alnylam did not directly or indirectly fund the research that was conducted and Dr. Bettencourt's research and work on the manuscript was not done in his capacity as an employee of Alnylam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bettencourt BR, 2007, J BIOSCIENCES, V32, P537, DOI 10.1007/s12038-007-0053-9; Bettencourt BR, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-5; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; EISEN M, 2007, ASSEMBLY ALIGNEMENT; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; Lazzaro BP, 2001, GENETICS, V159, P659; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Murphy D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-92; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998c; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Pepper ASR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007618; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Sainz A, 2003, HEREDITY, V91, P28, DOI 10.1038/sj.hdy.6800275; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Shi HF, 2009, J BIOL CHEM, V284, P36511, DOI 10.1074/jbc.M109.073072; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang RL, 1997, GENETICS, V147, P1091; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	57	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15264	10.1371/journal.pone.0015264	http://dx.doi.org/10.1371/journal.pone.0015264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21253006	Green Published, gold, Green Submitted			2022-12-27	WOS:000285381200020
J	Biersmith, B; Liu, Z; Bauman, K; Geisbrecht, ER				Biersmith, Bridget; Liu, Ze (Cindy); Bauman, Kenneth; Geisbrecht, Erika R.			The DOCK Protein Sponge Binds to ELMO and Functions in Drosophila Embryonic CNS Development	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE; MYOBLAST FUSION; TYROSINE KINASE; CELL-MIGRATION; RAC ACTIVATION; PH DOMAIN; IDENTIFICATION; GEF; PATHWAY; GTPASE	Cell morphogenesis, which requires rearrangement of the actin cytoskeleton, is essential to coordinate the development of tissues such as the musculature and nervous system during normal embryonic development. One class of signaling proteins that regulate actin cytoskeletal rearrangement is the evolutionarily conserved CDM (C. elegans Ced-5, human DOCK180, Drosophila Myoblast city, or Mbc) family of proteins, which function as unconventional guanine nucleotide exchange factors for the small GTPase Rac. This CDM-Rac protein complex is sufficient for Rac activation, but is enhanced upon the association of CDM proteins with the ELMO/Ced-12 family of proteins. We identified and characterized the role of Drosophila Sponge (Spg), the vertebrate DOCK3/DOCK4 counterpart as an ELMO-interacting protein. Our analysis shows Spg mRNA and protein is expressed in the visceral musculature and developing nervous system, suggesting a role for Spg in later embryogenesis. As maternal null mutants of spg die early in development, we utilized genetic interaction analysis to uncover the role of Spg in central nervous system (CNS) development. Consistent with its role in ELMO-dependent pathways, we found genetic interactions with spg and elmo mutants exhibited aberrant axonal defects. In addition, our data suggests Ncad may be responsible for recruiting Spg to the membrane, possibly in CNS development. Our findings not only characterize the role of a new DOCK family member, but help to further understand the role of signaling downstream of N-cadherin in neuronal development.	[Biersmith, Bridget; Liu, Ze (Cindy); Bauman, Kenneth; Geisbrecht, Erika R.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [Biersmith, Bridget; Liu, Ze (Cindy)] Univ Missouri, Sch Biol Sci, PhD Program, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Biersmith, B (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.	geisbrechte@umkc.edu			University of Missouri Research Board (UMRB) Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053027] Funding Source: NIH RePORTER	University of Missouri Research Board (UMRB) Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the University of Missouri Research Board (UMRB) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Balagopalan L, 2006, MOL CELL BIOL, V26, P9442, DOI 10.1128/MCB.00016-06; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Chen Q, 2005, J NEUROSCI, V25, P281, DOI 10.1523/JNEUROSCI.3692-04.2005; Chen Q, 2001, AM J PATHOL, V159, P1597, DOI 10.1016/S0002-9440(10)63005-2; Chen Q, 2009, J NEUROSCI, V29, P118, DOI 10.1523/JNEUROSCI.3985-08.2009; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harris TJC, 2009, CURR TOP DEV BIOL, V89, P55, DOI 10.1016/S0070-2153(09)89003-0; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; LU MRK, 2005, ACTIVATION GTPASES D, P73; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; POSTNER MA, 1992, J CELL BIOL, V119, P1205, DOI 10.1083/jcb.119.5.1205; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; RICE TB, 1975, DEV BIOL, V43, P277, DOI 10.1016/0012-1606(75)90027-5; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Starz-Gaiano M, 2004, CURR OPIN GENET DEV, V14, P86, DOI 10.1016/j.gde.2003.12.001; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; UEDA S, 2008, J NEUROSCI RES; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yan D, 2006, J MOL BIOL, V357, P755, DOI 10.1016/j.jmb.2006.01.017; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	66	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16120	10.1371/journal.pone.0016120	http://dx.doi.org/10.1371/journal.pone.0016120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283588	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400026
J	Selman, C; Partridge, L; Withers, DJ				Selman, Colin; Partridge, Linda; Withers, Dominic J.			Replication of Extended Lifespan Phenotype in Mice with Deletion of Insulin Receptor Substrate 1	PLOS ONE			English	Article							NUTRIENT HOMEOSTASIS; CALORIC RESTRICTION; HUMAN LONGEVITY; DWARF MICE; EXTENSION; RAPAMYCIN; PATHWAY	We previously reported that global deletion of insulin receptor substrate protein 1 (Irs1) extends lifespan and increases resistance to several age-related pathologies in female mice. However, no effect on lifespan was observed in male Irs1 null mice. We suggested at the time that the lack of any effect in males might have been due to a sample size issue. While such lifespan studies are essential to our understanding of the aging process, they are generally based on survival curves derived from single experiments, primarily due to time and economic constraints. Consequently, the robustness of such findings as a basis for further investigation has been questioned. We have therefore measured lifespan in a second, separate cohort of Irs1 null female mice, and show that, consistent with our previous finding, global deletion of Irs1 significantly extends lifespan in female mice. In addition, an augmented and completed study demonstrates lifespan extension in male Irs1 null mice. Therefore, we show that reduced IRS1-dependent signalling is a robust mechanism through which mammalian lifespan can be modulated.	[Selman, Colin] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland; [Partridge, Linda] UCL, Dept Genet Evolut & Environm, Inst Healthy Ageing, London, England; [Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, Metab Signaling Grp, London, England	University of Aberdeen; University of London; University College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Selman, C (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland.	c.selman@abdn.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010; Withers, Dominic J/D-7671-2014	Withers, Dominic J/0000-0002-8009-7521; Selman, Colin/0000-0002-8727-0593; Partridge, Linda/0000-0001-9615-0094	Wellcome Trust; Medical Research Council [MC_U120097114] Funding Source: researchfish; MRC [MC_U120097114] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust (Functional Genomics and Strategic) awards to L.P. and D.J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austad S, 2008, AGING CELL, V7, P119, DOI 10.1111/j.1474-9726.2008.00374.x; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; PARTRIDGE L, 2010, EXP GERONTOL; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; SELMAN C, 2010, PHILOS T R IN PRESS; Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244	26	68	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16144	10.1371/journal.pone.0016144	http://dx.doi.org/10.1371/journal.pone.0016144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283571	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400029
J	Shah, ND; Mason, J; Kurt, M; Denton, BT; Schaefer, AJ; Montori, VM; Smith, SA				Shah, Nilay D.; Mason, Jennifer; Kurt, Murat; Denton, Brian T.; Schaefer, Andrew J.; Montori, Victor M.; Smith, Steven A.			Comparative Effectiveness of Guidelines for the Management of Hyperlipidemia and Hypertension for Type 2 Diabetes Patients	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; STATIN TREATMENT; RISK; CHOLESTEROL; PREVENTION; STROKE	Background: Several guidelines to reduce cardiovascular risk in diabetes patients exist in North America, Europe, and Australia. Their ability to achieve this goal efficiently is unclear. Methods and Findings: Decision analysis was used to compare the efficiency and effectiveness of international contemporary guidelines for the management of hypertension and hyperlipidemia for patients aged 40-80 with type 2 diabetes. Measures of comparative effectiveness included the expected probability of a coronary or stroke event, incremental medication costs per event, and number-needed-to-treat (NNT) to prevent an event. All guidelines are equally effective, but they differ significantly in their medication costs. The range of NNT to prevent an event was small across guidelines (6.5-7.6 for males and 6.5-7.5 for females); a larger range of differences were observed for expected cost per event avoided (ranges,$117,269-$157,186 for males and $115,999-$163,775 for females). Australian and U.S. guidelines result in the highest and lowest expected costs, respectively. Conclusions: International guidelines based on the same evidence and seeking the same goal are similar in their effectiveness; however, there are large differences in expected medication costs.	[Shah, Nilay D.; Denton, Brian T.; Montori, Victor M.; Smith, Steven A.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA; [Shah, Nilay D.; Montori, Victor M.; Smith, Steven A.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN USA; [Kurt, Murat; Schaefer, Andrew J.] N Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA; [Mason, Jennifer; Denton, Brian T.] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA USA; [Montori, Victor M.; Smith, Steven A.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic	Shah, ND (corresponding author), Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA.	shah.nilay@mayo.edu	Smith, Steven/HDM-9496-2022	Montori, Victor/0000-0003-0595-2898	Agency for Healthcare Research and Quality (AHRQ) [1R21HS017628]; National Science Foundation (NSF) [CMMI-0844511, CMMI-0546960]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS017628] Funding Source: NIH RePORTER; Directorate For Engineering [1258323, 0844511] Funding Source: National Science Foundation	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This project was funded in part by the Agency for Healthcare Research and Quality (AHRQ) under R21 Grant 1R21HS017628 (Shah) and National Science Foundation (NSF) under grants CMMI-0844511 (Denton) and -CMMI-0546960 (Schaefer). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2005, J AM BOARD FAM PRACT, V18, P414, DOI 10.3122/jabfm.18.5.414; *AM DIAB ASS, 2008, DIABETES CARE, V31, P1, DOI DOI 10.2337/DC07-2052; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Barter P.B.J., 2001, MED J AUSTR S, V175, pS57; Bhattacharyya OK, 2008, CAN MED ASSOC J, V179, P920, DOI 10.1503/cmaj.080554; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Collins R, 2003, LANCET, V361, P2005; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Davidson MH, 2006, AM J MANAG CARE, V12, pS405; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; FLEMING T, 2007, RED BOOK 2007 PHARM; GENEST J, 2003, CANADIAN MEDICAL ASS, P921; Gold MR, 1996, COST EFFECTIVENESS H; GOLD MR, 2007, STUDY FEDERAL SPENDI; Gorman CA, 2000, COMPUT METH PROG BIO, V62, P127, DOI 10.1016/S0169-2607(99)00054-1; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARRIS P, 2009, DIABETES AUSTR PUBLI, V1005; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; MUNTNER P, 2002, HYPERTENSION AM HEAR, P897; PANEL E, 1993, JAMA-J AM MED ASSOC, V269, P3015; Stevens R, 2004, DIABETES CARE, V27, P201, DOI 10.2337/diacare.27.1.201; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Timbie JW, 2010, ARCH INTERN MED, V170, P1037, DOI 10.1001/archinternmed.2010.150; WARNICK GR, 1990, CLIN CHEM, V36, P15; WIERINGA NF, 2000, PHARMACOEPIDEMIOLOGY, V9; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; World Health Organization, 2009, GLOB HLTH RISKS MOR; N ENGL J MED, V362, P1563; 1975, N ENGL J MED, V362, P1575	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16170	10.1371/journal.pone.0016170	http://dx.doi.org/10.1371/journal.pone.0016170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283569	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000286661400032
J	Xie, SS; Li, XY; Liu, T; Cao, JH; Zhong, QA; Zhao, SH				Xie, Sheng-Song; Li, Xin-Yun; Liu, Teng; Cao, Jian-Hua; Zhong, Qiang; Zhao, Shu-Hong			Discovery of Porcine microRNAs in Multiple Tissues by a Solexa Deep Sequencing Approach	PLOS ONE			English	Article							EXPRESSION; GENES; RNAS; IDENTIFICATION; MIR-122; ENCODES; SYSTEM	The domestic pig (Sus scrofa) is an important economic animal for meat production and as a suitable model organism for comparative genomics and biomedical studies. In an effort to gain further identification of miRNAs in the pig, we have applied the Illumina Solexa sequencing technology to carry out an in-depth analysis of the miRNA transcriptome in a pool of equal amounts of RNA from 16 different porcine tissues. From this data set, we identified 437 conserved and 86 candidate novel miRNA/miRNA* in the pig, corresponding to 329 miRNA genes. Compared with all the reported porcine miRNAs, the result showed that 112 conserved and 61 candidate novel porcine miRNA were first reported in this study. Further analysis revealed extensive sequence variations (isomiRs) of porcine miRNAs, including terminal isomiRs at both the 5` and 3` ends and nucleotide variants. Read counts of individual porcine miRNA spanned from a few reads to approximately 405541 reads, confirming the different level of expression of porcine miRNAs. Subsequently, the tissue expression patterns of 8 miRNAs were characterized by Northern blotting. The results showed that miR-145, miR-423-5p, miR-320, miR-26a, and miR-191 are ubiquitously expressed in diverse tissues, while miR-92, miR-200a, and miR-375 were selectively enriched and expressed in special tissues. Meanwhile, the expression of 8 novel porcine-specific miRNAs was validated by stem-loop RT-PCR, and one of these was detected by Northern blotting. Using the porcine miRNA array designed according to our Solexa results, 123 miRNAs were detected expression in porcine liver tissues. A total of 58 miRNAs showed differential expression between the Tongcheng (a Chinese indigenous fatty breed) and Large White pig breeds (a lean type pig). Taken together, our results add new information to existing data on porcine miRNAs and should be useful for investigating the biological functions of miRNAs in pig and other species.	[Xie, Sheng-Song] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; Huazhong Agr Univ, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Xie, SS (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China.	shzhao@mail.hzau.edu.cn			National High Science and Technology Foundation of China [2010AA10A104, 2008AA101008]; NSFC [U0631005]; National Key Basic Research and Development Program of China [2006CB102105]; Chinese Ministry of Education [IRT0831]	National High Science and Technology Foundation of China; NSFC(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China)	This study was supported by a grant from the the National High Science and Technology Foundation of China "863" (2010AA10A104 and 2008AA101008), the NSFC-Guangdong Key Project (U0631005), National Key Basic Research and Development Program of China (2006CB102105), and the creative team project of the Chinese Ministry of Education (IRT0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; CHO IS, MOL BIOL REP; Critser John K, 2009, ILAR J, V50, P89; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; FORMAN JJ, CELL CYCLE, V9; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	59	66	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16235	10.1371/journal.pone.0016235	http://dx.doi.org/10.1371/journal.pone.0016235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283541	Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400037
J	Hu, J; De Barro, P; Zhao, H; Wang, J; Nardi, F; Liu, SS				Hu, Jian; De Barro, Paul; Zhao, Hua; Wang, Jia; Nardi, Francesco; Liu, Shu-Sheng			An Extensive Field Survey Combined with a Phylogenetic Analysis Reveals Rapid and Widespread Invasion of Two Alien Whiteflies in China	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; MITOCHONDRIAL-DNA MARKERS; POLYMERASE CHAIN-REACTION; BIOTYPE-B; HOMOPTERA ALEYRODIDAE; GENNADIUS HEMIPTERA; SHANDONG PROVINCE; GENETIC DIVERSITY; SPECIES COMPLEX; RIBOSOMAL ITS1	Background: To understand the processes of invasions by alien insects is a pre-requisite for improving management. The whitefly Bemisia tabaci is a cryptic species complex that contains some of the most invasive pests worldwide. However, extensive field data to show the geographic distribution of the members of this species complex as well as the invasion by some of its members are scarce. Methodology/Principal Findings: We used field surveys and published data to assess the current diversity and distribution of B. tabaci cryptic species in China and relate the indigenous members to other Asian and Australian members of the complex. The survey covered the 16 provinces where indigenous B. tabaci occur and extends this with published data for the whole of China. We used molecular markers to identify cryptic species. The evolutionary relationships between the different Asian B. tabaci were reconstructed using Bayesian methods. We show that whereas in the past the exotic invader Middle East-Asia Minor 1 was predominant across China, another newer invader Mediterranean is now the dominant species in the Yangtze River Valley and eastern coastal areas, and Middle East-Asia Minor 1 is now predominant only in the south and south eastern coastal areas. Based on mtCO1 we identified four new cryptic species, and in total we have recorded 13 indigenous and two invasive species from China. Diversity was highest in the southern and southeastern provinces and declined to north and west. Only the two invasive species were found in the northern part of the country where they occur primarily in protected cropping. By 2009, indigenous species were mainly found in remote mountainous areas and were mostly absent from extensive agricultural areas. Conclusions/Significance: Invasions by some members of the whitefly B. tabaci species complex can be rapid and widespread, and indigenous species closely related to the invaders are replaced.	[Hu, Jian; Zhao, Hua; Wang, Jia; Liu, Shu-Sheng] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [De Barro, Paul] CSIRO Ecosyst Sci, Indooroopilly, Qld, Australia; [Nardi, Francesco] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Ministry of Agriculture & Rural Affairs; Zhejiang University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Siena	Hu, J (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shshliu@zju.edu.cn	De Barro, Paul J/C-1724-2008; Nardi, Francesco/E-5516-2011; Liu, Shu-Sheng/D-2300-2013	Nardi, Francesco/0000-0003-0271-9855; 	National Basic Research Programme of China [2009CB119203]; National Nature Science Foundation of China [30730061]; Earmarked Fund for Modern Agro-Industry Technology Research System in China	National Basic Research Programme of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-Industry Technology Research System in China	Financial support from the National Basic Research Programme of China (2009CB119203) (http://www.most.gov.cn/), the National Nature Science Foundation of China (30730061) (http://www.nsfc.gov.cn), and the Earmarked Fund for Modern Agro-Industry Technology Research System in China is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Muhammad Z., 2009, Acta Entomologica Sinica, V52, P1132; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Chu D, 2007, ENVIRON ENTOMOL, V36, P1290, DOI 10.1603/0046-225X(2007)36[1290:BSADOB]2.0.CO;2; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; DeBarro PJ, 1997, AUST J ENTOMOL, V36, P149; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Guirao P, 1997, B ENTOMOL RES, V87, P587, DOI 10.1017/S0007485300038682; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Horowitz AR, 2003, PHYTOPARASITICA, V31, P94, DOI 10.1007/BF02979772; Hsieh CH, 2006, ANN ENTOMOL SOC AM, V99, P768, DOI 10.1603/0013-8746(2006)99[768:AOBTHA]2.0.CO;2; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Lima LHC, 2000, GENET MOL BIOL, V23, P781, DOI 10.1590/S1415-47572000000400012; Lin K, 2007, CROP PROT, V26, P1831, DOI 10.1016/j.cropro.2007.04.002; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Lockwood J.L., 2007, INVASION ECOLOGY, P304; Luan JB, 2008, ENTOMOL EXP APPL, V129, P316, DOI 10.1111/j.1570-7458.2008.00777.x; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Ma DY, 2007, CROP PROT, V26, P612, DOI 10.1016/j.cropro.2006.04.027; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Moya A, 2001, MOL ECOL, V10, P891, DOI 10.1046/j.1365-294X.2001.01221.x; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pascual S, 2004, B ENTOMOL RES, V94, P369, DOI 10.1079/BER2003307; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu BL, 2007, PROG NAT SCI-MATER, V17, P645; Rao Q, 2011, B ENTOMOL RES, V101, P81, DOI 10.1017/S0007485310000428; Roques A., 2006, Bulletin OEPP, V36, P490; Rosell RC, 1997, ANN ENTOMOL SOC AM, V90, P575, DOI 10.1093/aesa/90.5.575; Simon B, 2003, B ENTOMOL RES, V93, P259, DOI 10.1079/BER2003233; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda S, 2009, J APPL ENTOMOL, V133, P355, DOI 10.1111/j.1439-0418.2008.01379.x; WANG P, 2011, INSECT SCI IN PRESS, V18, DOI DOI 10.1017/S0007485310000416; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilson M, 2007, PEST MANAG SCI, V63, P761, DOI 10.1002/ps.1403; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Xu J., 2009, THESIS ZHEJIANG U HA; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhou FuCai, 2003, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V24, P71	58	263	331	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16061	10.1371/journal.pone.0016061	http://dx.doi.org/10.1371/journal.pone.0016061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283707	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300016
J	Mills, EJ; Ghement, I; O'Regan, C; Thorlund, K				Mills, Edward J.; Ghement, Isabella; O'Regan, Christopher; Thorlund, Kristian			Estimating the Power of Indirect Comparisons: A Simulation Study	PLOS ONE			English	Article							METAANALYSIS; TRIALS	Background: Indirect comparisons are becoming increasingly popular for evaluating medical treatments that have not been compared head-to-head in randomized clinical trials (RCTs). While indirect methods have grown in popularity and acceptance, little is known about the fragility of confidence interval estimations and hypothesis testing relying on this method. Methods: We present the findings of a simulation study that examined the fragility of indirect confidence interval estimation and hypothesis testing relying on the adjusted indirect method. Findings: Our results suggest that, for the settings considered in this study, indirect confidence interval estimation suffers from under-coverage while indirect hypothesis testing suffers from low power in the presence of moderate to large between-study heterogeneity. In addition, the risk of overestimation is large when the indirect comparison of interest relies on just one trial for one of the two direct comparisons. Interpretation: Indirect comparisons typically suffer from low power. The risk of imprecision is increased when comparisons are unbalanced.	[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Ghement, Isabella] Ghement Stat Consulting Co, Richmond, BC, Canada; [O'Regan, Christopher] London Sch Hyg & Trop Med, Dept Epidemiol, London WC1, England; [Thorlund, Kristian] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; McMaster University	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.	Edward.mills@uottawa.ca			Canadian Institutes of Health Research; Pfizer Canada Incorporated; Pfizer Ltd (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Canada Incorporated(Pfizer); Pfizer Ltd (Canada)(Pfizer)	Edward Mills is supported by a Canada Research Chair from the Canadian Institutes of Health Research. This work was supported by an unrestricted educational grant from Pfizer Canada Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Edward Mills received unrestricted support from Pfizer Ltd (Canada) to conduct this study as part of a New Investigator award (partnered with the Canadian Institutes of Health Research). Chris O'Regan is an employee of Merck. However, Merck has had no involvement in this study and his participation is solely from his own interest. Isabella Ghement runs a consulting firm and received compensation to assist with this analysis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2010, R LANG ENV STAT COMP; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; O'Regan C, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-86; Pocock SJ, 2007, LANCET, V370, P2099, DOI 10.1016/S0140-6736(07)61898-4; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sanchez-Meca J, 2008, PSYCHOL METHODS, V13, P31, DOI 10.1037/1082-989X.13.1.31; Sidik K, 2007, STAT MED, V26, P1964, DOI 10.1002/sim.2688; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Wells GA, 2009, INDIRECT EVIDENCE IN	14	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16237	10.1371/journal.pone.0016237	http://dx.doi.org/10.1371/journal.pone.0016237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283698	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522300023
J	Jang, Y				Jang, Yikweon			Male Responses to Conspecific Advertisement Signals in the Field Cricket Gryllus rubens (Orthoptera: Gryllidae)	PLOS ONE			English	Article							ALTERNATIVE MATING TACTICS; IN-HOUSE CRICKETS; CALLING-SONG; WING DIMORPHISM; BODY-SIZE; ACOUSTIC COMMUNICATION; ALLOPATRIC POPULATIONS; INTERMALE COMPETITION; FULTONI ORTHOPTERA; FEMALE PREFERENCE	In many species males aggregate and produce long-range advertisement signals to attract conspecific females. The majority of the receivers of these signals are probably other males most of the time, and male responses to competitors' signals can structure the spatial and temporal organization of the breeding aggregation and affect male mating tactics. I quantified male responses to a conspecific advertisement stimulus repeatedly over three age classes in Gryllus rubens (Orthoptera: Gryllidae) in order to estimate the type and frequency of male responses to the broadcast stimulus and to determine the factors affecting them. Factors tested included body size, wing dimorphism, age, and intensity of the broadcast stimulus. Overall, males employed acoustic response more often than positive phonotactic response. As males aged, the frequency of positive phonotactic response decreased but that of the acoustic response increased. That is, males may use positive phonotaxis in the early stages of their adult lives, possibly to find suitable calling sites or parasitize calling males, and then later in life switch to acoustic responses in response to conspecific advertisement signals. Males with smaller body size more frequently exhibited acoustic responses. This study suggests that individual variation, more than any factors measured, is critical for age-dependent male responses to conspecific advertisement signals.	[Jang, Yikweon] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Jang, Y (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul, South Korea.	jangy@ewha.ac.kr			National Research Foundation of Korea [371-2009-1-C00001]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported financially by a National Research Foundation of Korea grant (371-2009-1-C00001). Funder's website: http://www.nrf.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; ALEXANDER RD, 1962, EVOLUTION, V16, P443, DOI 10.1111/j.1558-5646.1962.tb03236.x; Andersson Malte, 1994; ARAK A, 1988, ANIM BEHAV, V36, P416, DOI 10.1016/S0003-3472(88)80012-5; ARAK A, 1990, BEHAV ECOL SOCIOBIOL, V26, P1, DOI 10.1007/BF00174019; Beck CW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000939; Beck CW, 2002, EVOL ECOL RES, V4, P275; Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Bee MA, 2002, BEHAV ECOL, V13, P109, DOI 10.1093/beheco/13.1.109; Bee MA, 2007, BEHAV ECOL SOCIOBIOL, V61, P955, DOI 10.1007/s00265-006-0324-8; Bell W.J, 1991, SEARCHING BEHAV; Bertram SM, 2000, ANIM BEHAV, V60, P333, DOI 10.1006/anbe.2000.1473; Bertram SM, 2006, ETHOLOGY, V112, P850, DOI 10.1111/j.1439-0310.2006.01234.x; BOAKE CRB, 1994, QUANTITATIVE GENETIC, P3; Bosch J, 1996, ETHOLOGY, V102, P841; Bosch J, 2002, HERPETOLOGICA, V58, P95, DOI 10.1655/0018-0831(2002)058[0095:RTVICF]2.0.CO;2; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Crnokrak P, 1998, EVOLUTION, V52, P1111, DOI 10.1111/j.1558-5646.1998.tb01838.x; Crnokrak P, 1998, ANIM BEHAV, V56, P433, DOI 10.1006/anbe.1998.0741; CRUMP ML, 1988, ANIM BEHAV, V36, P1064, DOI 10.1016/S0003-3472(88)80066-6; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; DOHERTY JA, 1991, J INSECT BEHAV, V4, P67, DOI 10.1007/BF01092552; Falconer D. S., 1996, Introduction to quantitative genetics.; Farris HE, 1997, J INSECT BEHAV, V10, P639, DOI 10.1007/BF02765384; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRAFE TU, 1995, ETHOLOGY, V101, P67; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; GREENFIELD MD, 1993, ETHOLOGY, V95, P309, DOI 10.1111/j.1439-0310.1993.tb00480.x; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; GREENFIELD MD, 1993, NATURE, V364, P618, DOI 10.1038/364618a0; Greenfield MD, 2002, SIGNALERS RECEIVERS; HISSMANN K, 1991, J INSECT BEHAV, V4, P675, DOI 10.1007/BF01048078; Huang Y, 2000, MOL PHYLOGENET EVOL, V17, P48, DOI 10.1006/mpev.2000.0815; Humfeld SC, 2008, ANIM BEHAV, V75, P205, DOI 10.1016/j.anbehav.2007.05.015; Humfeld SC, 2009, ANIM BEHAV, V78, P915, DOI 10.1016/j.anbehav.2009.06.028; Jacot A, 2007, ETHOLOGY, V113, P615, DOI 10.1111/j.1439-0310.2007.01360.x; Jang Y, 2006, J EVOLUTION BIOL, V19, P459, DOI 10.1111/j.1420-9101.2005.01014.x; Jang Y, 1997, J INSECT BEHAV, V10, P87, DOI 10.1007/BF02765476; Jang Y, 2008, BEHAV ECOL SOCIOBIOL, V62, P1397, DOI 10.1007/s00265-008-0568-6; Jang Y, 2007, ETHOLOGY, V113, P87, DOI 10.1111/j.1439-0310.2006.01304.x; Jang Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P150, DOI 10.1007/s00265-005-0151-3; Kiflawi M, 2000, P ROY SOC B-BIOL SCI, V267, P2157, DOI 10.1098/rspb.2000.1263; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; Leary CJ, 2005, ANIM BEHAV, V70, P663, DOI 10.1016/j.anbehav.2004.12.013; Leonard AS, 2009, BEHAV ECOL, V20, P1175, DOI 10.1093/beheco/arp115; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; Lucas JR, 1996, ANIM BEHAV, V51, P501, DOI 10.1006/anbe.1996.0056; Marshall VT, 2003, ANIM BEHAV, V65, P1223, DOI 10.1006/anbe.2003.2134; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; Morris GK, 2002, CAN J ZOOL, V80, P271, DOI 10.1139/z02-003; MURRAY AM, 1995, CAN J ZOOL, V73, P1207, DOI 10.1139/z95-144; Naguib M, 1996, BEHAV PROCESS, V38, P163, DOI 10.1016/0376-6357(95)00077-1; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NICKLE D A, 1974, Florida Entomologist, V57, P8, DOI 10.2307/3493822; Pfennig KS, 2000, BEHAV ECOL SOCIOBIOL, V48, P69, DOI 10.1007/s002650000205; Prosser MR, 1997, J INSECT BEHAV, V10, P437, DOI 10.1007/BF02765609; RITCHIE MG, 1995, P ROY SOC B-BIOL SCI, V262, P21, DOI 10.1098/rspb.1995.0171; ROMER H, 1986, J COMP PHYSIOL A, V159, P627, DOI 10.1007/BF00612036; Schul J, 2002, P ROY SOC B-BIOL SCI, V269, P1847, DOI 10.1098/rspb.2002.2092; SHELLY TE, 1989, BEHAVIOUR, V109, P200, DOI 10.1163/156853989X00231; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SIMMONS LW, 1992, ANIM BEHAV, V44, P1145, DOI 10.1016/S0003-3472(05)80326-4; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SIMMONS LW, 1993, BEHAV ECOL, V4, P364, DOI 10.1093/beheco/4.4.364; Simmons LW, 1995, BEHAV ECOL, V6, P376, DOI 10.1093/beheco/6.4.376; SMITH CJ, 1987, CAN J ZOOL, V65, P2390, DOI 10.1139/z87-359; Snedden WA, 1998, BEHAV ECOL SOCIOBIOL, V43, P59, DOI 10.1007/s002650050466; SNEDDEN WA, 1992, ANIM BEHAV, V44, P633, DOI 10.1016/S0003-3472(05)80291-X; SOLYMAR BD, 1990, BEHAV ECOL SOCIOBIOL, V26, P73, DOI 10.1007/BF00171576; STOUT J, 1989, NEURAL MECH BEHAV; Tarano Z, 2002, J HERPETOL, V36, P615, DOI 10.1670/0022-1511(2002)036[0615:VRTCCV]2.0.CO;2; Tarano Z, 2002, ANIM BEHAV, V64, P599, DOI 10.1006/anbe.2002.3080; Tarano Z, 2009, ETHOLOGY, V115, P747, DOI 10.1111/j.1439-0310.2009.01664.x; WAGNER WE, 1989, ANIM BEHAV, V38, P1025, DOI 10.1016/S0003-3472(89)80141-1; WAGNER WE, 1989, BEHAV ECOL SOCIOBIOL, V25, P429, DOI 10.1007/BF00300189; Walker TJ, 2000, ANN ENTOMOL SOC AM, V93, P565, DOI 10.1603/0013-8746(2000)093[0565:PRITSO]2.0.CO;2; Walker TJ, 1998, ANN ENTOMOL SOC AM, V91, P175, DOI 10.1093/aesa/91.2.175; WALKER TJ, 1986, ANN ENTOMOL SOC AM, V79, P84, DOI 10.1093/aesa/79.1.84; WALKER TJ, 1987, ANN ENTOMOL SOC AM, V80, P547, DOI 10.1093/aesa/80.5.547; WELLS KD, 1978, ANIM BEHAV, V26, P1051, DOI 10.1016/0003-3472(78)90094-5; ZERA AJ, 1989, OECOLOGIA, V80, P249, DOI 10.1007/BF00380159; ZUK M, 1988, EVOLUTION, V42, P969, DOI 10.1111/j.1558-5646.1988.tb02515.x	87	29	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16063	10.1371/journal.pone.0016063	http://dx.doi.org/10.1371/journal.pone.0016063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283758	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522200027
J	Dimitrov, NB; Goll, S; Hupert, N; Pourbohloul, B; Meyers, LA				Dimitrov, Nedialko B.; Goll, Sebastian; Hupert, Nathaniel; Pourbohloul, Babak; Meyers, Lauren Ancel			Optimizing Tactics for Use of the US Antiviral Strategic National Stockpile for Pandemic Influenza	PLOS ONE			English	Article							OSELTAMIVIR; VIRUS; TRANSMISSIBILITY	In 2009, public health agencies across the globe worked to mitigate the impact of the swine-origin influenza A (pH1N1) virus. These efforts included intensified surveillance, social distancing, hygiene measures, and the targeted use of antiviral medications to prevent infection (prophylaxis). In addition, aggressive antiviral treatment was recommended for certain patient subgroups to reduce the severity and duration of symptoms. To assist States and other localities meet these needs, the U.S. Government distributed a quarter of the antiviral medications in the Strategic National Stockpile within weeks of the pandemic's start. However, there are no quantitative models guiding the geo-temporal distribution of the remainder of the Stockpile in relation to pandemic spread or severity. We present a tactical optimization model for distributing this stockpile for treatment of infected cases during the early stages of a pandemic like 2009 pH1N1, prior to the wide availability of a strain-specific vaccine. Our optimization method efficiently searches large sets of intervention strategies applied to a stochastic network model of pandemic influenza transmission within and among U.S. cities. The resulting optimized strategies depend on the transmissability of the virus and postulated rates of antiviral uptake and wastage (through misallocation or loss). Our results suggest that an aggressive community-based antiviral treatment strategy involving early, widespread, pro-rata distribution of antivirals to States can contribute to slowing the transmission of mildly transmissible strains, like pH1N1. For more highly transmissible strains, outcomes of antiviral use are more heavily impacted by choice of distribution intervals, quantities per shipment, and timing of shipments in relation to pandemic spread. This study supports previous modeling results suggesting that appropriate antiviral treatment may be an effective mitigation strategy during the early stages of future influenza pandemics, increasing the need for systematic efforts to optimize distribution strategies and provide tactical guidance for public health policy-makers.	[Dimitrov, Nedialko B.] Univ Texas Austin, ORIE Program, Austin, TX 78712 USA; [Hupert, Nathaniel] US Ctr Dis Control & Prevent, Preparedness Modeling Unit, Atlanta, GA USA; [Hupert, Nathaniel] Weill Cornell Med Coll, New York, NY USA; [Pourbohloul, Babak] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Texas System; University of Texas Austin; Centers for Disease Control & Prevention - USA; Cornell University; The Santa Fe Institute	Dimitrov, NB (corresponding author), Univ Texas Austin, ORIE Program, Austin, TX 78712 USA.	ned@alumni.cs.utexas.edu		Meyers, Lauren/0000-0002-5828-8874	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation; NIGMS NIH HHS [U01-GM087719-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Azadivar F., 1999, WSC'99. 1999 Winter Simulation Conference Proceedings. `Simulation - A Bridge to the Future' (Cat. No.99CH37038), P93, DOI 10.1109/WSC.1999.823057; Bajardi P, 2009, Emerg Health Threats J, V2, pe11, DOI 10.3134/ehtj.09.011; Ball F, 1997, ANN APPL PROBAB, V7, P46; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Barnes B, 2007, MATH BIOSCI, V209, P403, DOI 10.1016/j.mbs.2007.02.008; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; *BUR TRANSP STAT, 2008, AIRP MAST COORD DAT; *BUR TRANSP STAT, 2007, OR DEST SURV ALL QUA; COQUELIN P, 2007, ABSCS0703062 COMP RE; Danon L, 2009, EPIDEMICS-NETH, V1, P250, DOI 10.1016/j.epidem.2009.11.002; Doyle A, 2006, J EPIDEMIOL COMMUN H, V60, P399, DOI 10.1136/jech.2005.034082; Even-Dar E., 2002, Computational Learning Theory. 15th Annual Conference on Computational Learning Theory, COLT 2002. Proceedings (Lecture Notes in Artificial Intelligence Vol.2375), P255; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gelly S, 2006, P NIPS NEUR INT PROC; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghani AC, 2009, PLOS CURR INFLUENZA, V1, DOI [10.1371/currents.RRN1130, DOI 10.1371/CURRENTS.RRN1130]; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Hota S, 2007, CLIN INFECT DIS, V45, P1362, DOI 10.1086/522661; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mannor S, 2004, J MACH LEARN RES, V5, P623; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; SCHUCHAT A, 2009, CDC TELEBRIEFING INV; *US BUR CENS, 2000, COUNT COUNT WORK FLO; *US BUR CENS, 2000, METR MICR STAT AR; *US CDC, 2009, CDC EST 2009 H1N1 IN; *US CDC, 2009, CDC HLTH UPD SWIN IN; *US CDC, 2009, QUEST ANSW ANT DRUGS; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; *WHIT HOUS NAT SEC, 2009, NAT FRAM 2009 H1N1 I; Wu JT, 2007, P ROY SOC B-BIOL SCI, V274, P2811, DOI 10.1098/rspb.2007.0893; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779	48	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16094	10.1371/journal.pone.0016094	http://dx.doi.org/10.1371/journal.pone.0016094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283514	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600021
J	Rouleau, M; Saxena, V; Rodrigue, A; Paquet, ER; Gagnon, A; Hendzel, MJ; Masson, JY; Ekker, M; Poirier, GG				Rouleau, Michele; Saxena, Vishal; Rodrigue, Amelie; Paquet, Eric R.; Gagnon, Abbie; Hendzel, Michael J.; Masson, Jean-Yves; Ekker, Marc; Poirier, Guy G.			A Key Role for Poly(ADP-Ribose) Polymerase 3 in Ectodermal Specification and Neural Crest Development	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; TARGET GENES; DNA-REPAIR; POLYCOMB; PARP-3; EXPRESSION; BINDING; REST; PLURIPOTENT; ASSOCIATION	Background: The PARP family member poly(ADP-ribose) polymerase 3 (PARP3) is structurally related to the well characterized PARP1 that orchestrates cellular responses to DNA strand breaks and cell death by the synthesis of poly(ADPribose). In contrast to PARP1 and PARP2, the functions of PARP3 are undefined. Here, we reveal critical functions for PARP3 during vertebrate development. Principal Findings: We have used several in vitro and in vivo approaches to examine the possible functions of PARP3 as a transcriptional regulator, a function suggested from its previously reported association with several Polycomb group (PcG) proteins. We demonstrate that PARP3 gene occupancy in the human neuroblastoma cell line SK-N-SH occurs preferentially with developmental genes regulating cell fate specification, tissue patterning, craniofacial development and neurogenesis. Addressing the significance of this association during zebrafish development, we show that morpholino oligonucleotide-directed inhibition of parp3 expression in zebrafish impairs the expression of the neural crest cell specifier sox9a and of dlx3b/dlx4b, the formation of cranial sensory placodes, inner ears and pectoral fins. It delays pigmentation and severely impedes the development of the median fin fold and tail bud. Conclusion: Our findings demonstrate that Parp3 is crucial in the early stages of zebrafish development, possibly by exerting its transcriptional regulatory functions as early as during the specification of the neural plate border.	[Rouleau, Michele; Poirier, Guy G.] CHU Laval, CHUQ Res Ctr, Canc Res Lab, Laval, PQ, Canada; [Rouleau, Michele; Masson, Jean-Yves; Poirier, Guy G.] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada; [Saxena, Vishal; Gagnon, Abbie; Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Rodrigue, Amelie; Paquet, Eric R.; Masson, Jean-Yves] Univ Laval, Hotel Dieu Quebec, Canc Res Ctr, Genome Stabil Lab, Quebec City, PQ G1K 7P4, Canada; [Hendzel, Michael J.] Univ Alberta, Fac Med, Dept Oncol, Edmonton, AB, Canada; [Hendzel, Michael J.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	Laval University; Laval University; University of Ottawa; Laval University; University of Alberta; University of Alberta	Rouleau, M (corresponding author), CHU Laval, CHUQ Res Ctr, Canc Res Lab, Laval, PQ, Canada.	guy.poirier@crchul.ulaval.ca	Hendzel, Michael/C-3391-2009; saxena, vishal/GRJ-5665-2022	Hendzel, Michael/0000-0002-9603-7945; Poirier, Guy/0000-0002-4869-1424; Masson, Jean Yves/0000-0002-4403-7169; Rodrigue, Amelie/0000-0001-9883-7084; Paquet, Eric/0000-0001-9194-1655	Cancer Research Society Inc.; CIHR	Cancer Research Society Inc.; CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by the Cancer Research Society Inc. AR was the recipient of a CIHR doctoral fellowship. JYM is a FRSQ Senior scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Elsalini OA, 2003, DEV BIOL, V263, P67, DOI 10.1016/S0012-1606(03)00436-6; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Esterberg R, 2009, DEV BIOL, V325, P189, DOI 10.1016/j.ydbio.2008.10.017; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hermanson O, 2008, PLOS BIOL, V6, P2094, DOI 10.1371/journal.pbio.0060271; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Johansson M, 1999, GENOMICS, V57, P442, DOI 10.1006/geno.1999.5799; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Loseva O, 2010, J BIOL CHEM, V285, P8054, DOI 10.1074/jbc.M109.077834; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rohr KB, 2001, NEURON, V29, P341, DOI 10.1016/S0896-6273(01)00210-0; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Rouleau M, 2009, J HISTOCHEM CYTOCHEM, V57, P675, DOI 10.1369/jhc.2009.953380; RULTEN SL, 2011, MOL CELL IN PRESS; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Selvaraj V, 2009, J BIOL CHEM, V284, P26070, DOI 10.1074/jbc.M109.013474; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Solomon KS, 2002, DEVELOPMENT, V129, P3127; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003	58	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15834	10.1371/journal.pone.0015834	http://dx.doi.org/10.1371/journal.pone.0015834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264220	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600012
J	Blank, K; Hensel, M; Gerlach, RG				Blank, Kathrin; Hensel, Michael; Gerlach, Roman G.			Rapid and Highly Efficient Method for Scarless Mutagenesis within the Salmonella enterica Chromosome	PLOS ONE			English	Article							ESCHERICHIA-COLI; SECRETION SYSTEM; GENE; TYPHIMURIUM; VIRULENCE; PHOP; IDENTIFICATION; RECOMBINATION; PATHOGENICITY; PURIFICATION	Direct manipulation of bacterial chromosomes by recombination-based techniques has become increasingly important for both cognitive and applied research. Here we demonstrate, for the first time, the combination of the Red recombinase system with I-SceI endonuclease-based selection of successful recombinants after electroporation with short synthetic olignucleotides. We show the generation of scarless gene knockouts as well as site-directed mutagenesis using the Salmonella virulence-associated two component signaling system PhoPQ. The presented approach is very versatile for generating in-frame deletions, point mutations or insertions within bacterial chromosomes.	[Blank, Kathrin; Gerlach, Roman G.] Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany; [Hensel, Michael] Univ Osnabruck, Div Microbiol, Sch Biol Chem, Osnabruck, Germany	Robert Koch Institute; University Osnabruck	Blank, K (corresponding author), Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany.	GerlachR@rki.de		Hensel, Michael/0000-0001-6604-6253; Gerlach, Roman/0000-0002-5718-4758	Robert Koch Institute; Deutsche Forschungsgemeinschaft [MH1964]	Robert Koch Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by an intramural research grant from the Robert Koch Institute (http://www.rki.de) to RGG and grants MH1964 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox MM, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gerlach RG, 2007, APPL ENVIRON MICROB, V73, P4234, DOI 10.1128/AEM.00509-07; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; Gunn JS, 1996, J BACTERIOL, V178, P6369, DOI 10.1128/jb.178.21.6369-6373.1996; Hansen-Wester I, 2002, INFECT IMMUN, V70, P2351, DOI 10.1128/IAI.70.5.2351-2360.2002; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; KIER LD, 1979, J BACTERIOL, V138, P155, DOI 10.1128/JB.138.1.155-161.1979; KIER LD, 1977, J BACTERIOL, V130, P399, DOI 10.1128/JB.130.1.399-410.1977; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Maloy SR., 1996, GENETIC ANAL PATHOGE; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Ranallo RT, 2006, FEMS IMMUNOL MED MIC, V47, P462, DOI 10.1111/j.1574-695X.2006.00118.x; Rivero-Muller A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm250; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359	26	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15763	10.1371/journal.pone.0015763	http://dx.doi.org/10.1371/journal.pone.0015763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264289	Green Published, gold			2022-12-27	WOS:000286516500011
J	Nichols, LA; Adang, LA; Kedes, DH				Nichols, Lisa A.; Adang, Laura A.; Kedes, Dean H.			Rapamycin Blocks Production of KSHV/HHV8: Insights into the Anti-Tumor Activity of an Immunosuppressant Drug	PLOS ONE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; MULTICENTRIC CASTLEMAN-DISEASE; KAPOSIS-SARCOMA; LYTIC REPLICATION; ENDOTHELIAL-CELLS; PERIPHERAL-BLOOD; MAMMALIAN TARGET; GENE-EXPRESSION; PROTEIN; VIRUS	Background: Infection with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) often results in the development of fatal tumors in immunocompromised patients. Studies of renal transplant recipients show that use of the immunosuppressant drug rapamycin, an mTOR inhibitor, both prevents and can induce the regression of Kaposi's sarcoma (KS), an opportunistic tumor that arises within a subset of this infected population. In light of rapamycin's marked anti-KS activity, we tested whether the drug might directly inhibit the KSHV life cycle. We focused on the molecular switch that triggers this predominantly latent virus to enter the lytic (productive) replication phase, since earlier work links this transition to viral persistence and tumorigenesis. Methods and Findings: In latently infected human B cell lines, we found that rapamycin inhibited entry of the virus into the lytic replication cycle, marked by a loss of expression of the lytic switch protein, replication and transcription activator (RTA). To test for viral-specific effects of rapamycin, we focused our studies on a B cell line with resistance to rapamycin-mediated growth inhibition. Using this line, we found that the drug had minimal effect on cell cycle profiles, cellular proliferation, or the expression of other cellular or latent viral proteins, indicating that the RTA suppression was not a result of global cellular dysregulation. Finally, treatment with rapamycin blocked the production of progeny virions. Conclusions: These results indicate that mTOR plays a role in the regulation of RTA expression and, therefore, KSHV production, providing a potential molecular explanation for the marked clinical success of rapamycin in the treatment and prevention of post-transplant Kaposi's sarcoma. The striking inhibition of rapamycin on KSHV lytic replication, thus, helps explain the apparent paradox of an immunosuppressant drug suppressing the pathogenesis of an opportunistic viral infection.	[Nichols, Lisa A.; Adang, Laura A.; Kedes, Dean H.] Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22903 USA; [Nichols, Lisa A.; Adang, Laura A.; Kedes, Dean H.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kedes, Dean H.] Univ Virginia, Dept Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Nichols, LA (corresponding author), Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22903 USA.	kedes@virginia.edu			National Institutes of Health [DHK: R-01CA88768, 1 RC2 CA148038, T32 GM07267, T32 AI007046]; University of Virginia Cancer Center [P30 CA44579]; NATIONAL CANCER INSTITUTE [R01CA088768, P30CA044579, RC2CA148038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health (DHK: R-01CA88768 and 1 RC2 CA148038) and through the University of Virginia Cancer Center (P30 CA44579). LAA received support from the NIH Medical Scientist Training Grant (T32 GM07267). LAN received supported from NIH Infectious Disease Training Grant (T32 AI007046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Barozzi P, 2009, TRANSPLANTATION, V88, P597, DOI 10.1097/TP.0b013e3181b15d56; Bottero V, 2009, VIROLOGY, V392, P34, DOI 10.1016/j.virol.2009.07.002; BUBMAN D, 2007, ONCOGENE; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Cai QI, 2006, J VIROL, V80, P7965, DOI 10.1128/JVI.00689-06; Casper C, 2004, BLOOD, V103, P1632, DOI 10.1182/blood-2003-05-1721; Charfi S, 2007, SAUDI J KIDNEY DIS T, V18, P617; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Davis MA, 1997, J NATL CANCER I, V89, P1868, DOI 10.1093/jnci/89.24.1868; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Garcia VD, 2003, TRANSPL INT, V16, P202, DOI 10.1111/j.1432-2277.2003.tb00287.x; Gonzalez-Lopez MA, 2006, DERMATOLOGY, V213, P30, DOI 10.1159/000092834; Grandadam M, 1997, J INFECT DIS, V175, P1198, DOI 10.1086/593567; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Gutierrez-Dalmau A, 2005, TRANSPL P, V37, P3836, DOI 10.1016/j.transproceed.2005.10.076; Hornstein E, 1999, J BIOL CHEM, V274, P1708, DOI 10.1074/jbc.274.3.1708; Jham BC, 2010, J CELL BIOCHEM, V110, P1, DOI 10.1002/jcb.22524; Kolhe N, 2006, INT J CLIN PRACT, V60, P1509, DOI 10.1111/j.1742-1241.2006.00815.x; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LACOMBE F, 1988, CYTOMETRY, V9, P245, DOI 10.1002/cyto.990090310; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Merimsky Ofer, 2008, Sarcoma, V2008, P825093, DOI 10.1155/2008/825093; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Moody CA, 2005, J VIROL, V79, P5499, DOI 10.1128/JVI.79.9.5499-5506.2005; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nepomuceno RR, 2003, CANCER RES, V63, P4472; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Rose NJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-24; Rose NJ, 2001, J GEN VIROL, V82, P435, DOI 10.1099/0022-1317-82-2-435; Roy J, 2002, ANTIMICROB AGENTS CH, V46, P3447, DOI 10.1128/AAC.46.11.3447-3455.2002; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Shaw RN, 2000, AIDS, V14, P899, DOI 10.1097/00002030-200005050-00021; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Tomescu C, 2003, J VIROL, V77, P9669, DOI 10.1128/JVI.77.17.9669-9684.2003; Vaysberg M, 2007, TRANSPLANTATION, V83, P1114, DOI 10.1097/01.tp.0000260142.38619.9c; Wang L, 2006, CANCER RES, V66, P3658, DOI 10.1158/0008-5472.CAN-05-3680; Wanner K, 2006, BRIT J HAEMATOL, V134, P475, DOI 10.1111/j.1365-2141.2006.06210.x; Wasywich CA, 2006, J HEART LUNG TRANSPL, V25, P726, DOI 10.1016/j.healun.2006.01.010; Watanabe T, 2003, J VIROL, V77, P6188, DOI 10.1128/JVI.77.11.6188-6196.2003; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; YATSCOFF RW, 1995, THER DRUG MONIT, V17, P666, DOI 10.1097/00007691-199512000-00020; Yilmaz R, 2007, RENAL FAILURE, V29, P103, DOI 10.1080/08860220601039528; Yu YM, 1999, J GEN VIROL, V80, P83, DOI 10.1099/0022-1317-80-1-83; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	68	61	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14535	10.1371/journal.pone.0014535	http://dx.doi.org/10.1371/journal.pone.0014535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264294	gold, Green Submitted, Green Published			2022-12-27	WOS:000286516500008
J	Thie, H; Toleikis, L; Li, JD; von Wasielewski, R; Bastert, G; Schirrmann, T; Esteves, IT; Behrens, CK; Fournes, B; Fournier, N; de Romeuf, C; Hust, M; Dubel, S				Thie, Holger; Toleikis, Lars; Li, Jiandong; von Wasielewski, Reinhard; Bastert, Gunther; Schirrmann, Thomas; Esteves, Isabel Tourais; Behrens, Christian K.; Fournes, Benedict; Fournier, Nathalie; de Romeuf, Christophe; Hust, Michael; Duebel, Stefan			Rise and Fall of an Anti-MUC1 Specific Antibody	PLOS ONE			English	Article							O-LINKED POLYLACTOSAMINOGLYCANS; POLYMORPHIC EPITHELIAL MUCIN; PHAGE DISPLAY LIBRARIES; TUMOR-ASSOCIATED MUCIN; SKIM MILK MUCINS; AFFINITY MATURATION; RECOMBINANT ANTIBODIES; IN-VITRO; ESCHERICHIA-COLI; GENE LIBRARIES	Background: So far, human antibodies with good affinity and specificity for MUC1, a transmembrane protein overexpressed on breast cancers and ovarian carcinomas, and thus a promising target for therapy, were very difficult to generate. Results: A human scFv antibody was isolated from an immune library derived from breast cancer patients immunised with MUC1. The anti-MUC1 scFv reacted with tumour cells in more than 80% of 228 tissue sections of mamma carcinoma samples, while showing very low reactivity with a large panel of non-tumour tissues. By mutagenesis and phage display, affinity of scFvs was increased up to 500fold to 5,7x10(-10) M. Half-life in serum was improved from below 1 day to more than 4 weeks and was correlated with the dimerisation tendency of the individual scFvs. The scFv bound to T47D and MCF-7 mammalian cancer cell lines were recloned into the scFv-Fc and IgG format resulting in decrease of affinity of one binder. The IgG variants with the highest affinity were tested in mouse xenograft models using MCF-7 and OVCAR tumour cells. However, the experiments showed no significant decrease in tumour growth or increase in the survival rates. To study the reasons for the failure of the xenograft experiments, ADCC was analysed in vitro using MCF-7 and OVCAR3 target cells, revealing a low ADCC, possibly due to internalisation, as detected for MCF-7 cells. Conclusions: Antibody phage display starting with immune libraries and followed by affinity maturation is a powerful strategy to generate high affinity human antibodies to difficult targets, in this case shown by the creation of a highly specific antibody with subnanomolar affinity to a very small epitope consisting of four amino acids. Despite these "best in class'' binding parameters, the therapeutic success of this antibody was prevented by the target biology.	[Thie, Holger; Toleikis, Lars; Li, Jiandong; Schirrmann, Thomas; Hust, Michael; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-3300 Braunschweig, Germany; [von Wasielewski, Reinhard] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany; [Bastert, Gunther] Univ Frauenklin Heidelberg, Heidelberg, Germany; [Esteves, Isabel Tourais; Behrens, Christian K.; Fournes, Benedict; Fournier, Nathalie; de Romeuf, Christophe] LFB Biotechnol Res Dept, Lille, France	Braunschweig University of Technology; Hannover Medical School; Ruprecht Karls University Heidelberg	Thie, H (corresponding author), Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.	s.duebel@tu-bs.de		Hust, Michael/0000-0003-3418-6045; Dubel, Stefan/0000-0001-8811-7390	BMBF, SMP; LFB	BMBF, SMP(Federal Ministry of Education & Research (BMBF)); LFB	The initial experiments were financed by the BMBF, SMP "Antibody Factory" in the NGFN2 program. The BMBF (Bundesministerium fur Bildung und Forschung) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was partly financed by LFB. LFB was also involved in the study design, data collection, analysis and decision to publish the data.	Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Albrecht H, 2007, Q J NUCL MED MOL IM, V51, P304; Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Arndt MAE, 2004, FEBS LETT, V578, P257, DOI 10.1016/j.febslet.2004.11.011; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Beatty PL, 2010, CANCER PREV RES, V3, P438, DOI 10.1158/1940-6207.CAPR-09-0194; Blockzjil A, 1998, TUMOR BIOL, V19, P46, DOI 10.1159/000056504; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; BRIGGS S, 1993, EUR J CANCER, V29A, P230, DOI 10.1016/0959-8049(93)90181-E; BURCHELL J, 1989, INT J CANCER, V44, P691, DOI 10.1002/ijc.2910440423; Cardoso DF, 2000, SCAND J IMMUNOL, V51, P337; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; DESHPAPNDE S, 1996, ENZYME IMMUNOASSAYS; DUBEL S, 1992, CELL BIOPHYS, V21, P69; Dubel S, 2007, APPL MICROBIOL BIOT, V74, P723, DOI 10.1007/s00253-006-0810-y; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; FAN X, 2010, PATHOL RES PRACT; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; Gerber HP, 2009, MABS-AUSTIN, V1, P247, DOI 10.4161/mabs.1.3.8515; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; Hanisch FG, 2000, GLYCOBIOLOGY, V10, P439, DOI 10.1093/glycob/10.5.439; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HANISCH FG, 1990, GLYCOCONJUGATE J, V7, P525, DOI 10.1007/BF01189075; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Henderikx P, 2002, AM J PATHOL, V160, P1597, DOI 10.1016/S0002-9440(10)61107-8; Henderikx P, 1998, CANCER RES, V58, P4324; HILKENS J, 1986, CANCER RES, V46, P2582; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang XM, 2004, PROSTATE, V61, P1, DOI 10.1002/pros.20074; Hull S R, 1989, Cancer Commun, V1, P261; HUST M, 2007, HDB THERAPEUTIC ANTI, P45; HUST M, 2010, J BIOTECHNOL; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Hust M, 2009, NEW BIOTECHNOL, V25, P424, DOI 10.1016/j.nbt.2009.03.004; Irving RA, 1996, IMMUNOTECHNOLOGY, V2, P127, DOI 10.1016/1380-2933(96)00044-9; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Karanikas V, 1998, TUMOR BIOL, V19, P71, DOI 10.1159/000056507; Kim SJ, 2008, J IMMUNOL METHODS, V329, P176, DOI 10.1016/j.jim.2007.10.009; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Krebs B, 2001, J IMMUNOL METHODS, V254, P67, DOI 10.1016/S0022-1759(01)00398-2; Kuroda K, 2010, PROSTATE, V70, P1286, DOI 10.1002/pros.21164; Kurtenkov O, 2007, ACTA ONCOL, V46, P316, DOI 10.1080/02841860601055441; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; Lee YC, 2002, J MOL BIOL, V320, P107, DOI 10.1016/S0022-2836(02)00403-5; Lepisto Andrew J, 2008, Cancer Ther, V6, P955; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; Mabry R, 2010, PROTEIN ENG DES SEL, V23, P115, DOI 10.1093/protein/gzp073; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Menzel C, 2008, BLOOD, V111, P3830, DOI 10.1182/blood-2007-04-082768; Meyer T, 2011, VET MICROBIOL, V147, P162, DOI 10.1016/j.vetmic.2010.06.023; Mollova S, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P3, DOI 10.1007/978-3-642-01147-4_1; Mukherjee P, 2001, GLYCOCONJUGATE J, V18, P931, DOI 10.1023/A:1022260711583; Muzard J, 2009, FEBS J, V276, P4207, DOI 10.1111/j.1742-4658.2009.07129.x; Park SG, 2000, BIOCHEM BIOPH RES CO, V275, P553, DOI 10.1006/bbrc.2000.3336; PARRY G, 1990, EXP CELL RES, V188, P302, DOI 10.1016/0014-4827(90)90174-9; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MINI-REV MED CHEM, V9, P1633, DOI 10.2174/138955709791012283; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Pericleous LM, 2005, BRIT J CANCER, V93, P1257, DOI 10.1038/sj.bjc.6602847; Pietersz GA, 1997, CANCER IMMUNOL IMMUN, V44, P323, DOI 10.1007/s002620050389; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; SAFI F, 1991, CANCER-AM CANCER SOC, V68, P574, DOI 10.1002/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B; Sambrook J, 2001, MOL CLONING LAB MANU; Schirrmann T, 2010, METHODS MOL BIOL, V651, P177, DOI 10.1007/978-1-60761-786-0_11; Schirrmann T, 2009, EXPERT OPIN BIOL TH, V9, P79, DOI [10.1517/14712590802631862, 10.1517/14712590802631862 ]; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Schoonooghe S, 2010, PROTEIN ENG DES SEL, V23, P721, DOI 10.1093/protein/gzq044; Schutte M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006625; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Singh R, 2007, CANCER BIOL THER, V6, P481, DOI 10.4161/cbt.6.4.4201; Skrlj N, 2010, APPL BIOCHEM BIOTECH, V160, P1808, DOI 10.1007/s12010-009-8699-4; SPICER AP, 1991, J BIOL CHEM, V266, P15099; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; SWALLOW DM, 1987, NATURE, V328, P82, DOI 10.1038/328082a0; TAYLORPAPADIMITRIOU J, 1981, INT J CANCER, V28, P17, DOI 10.1002/ijc.2910280104; Teicher BA, 2009, CURR CANCER DRUG TAR, V9, P982, DOI 10.2174/156800909790192365; Thie H, 2008, CURR PHARM BIOTECHNO, V9, P439, DOI 10.2174/138920108786786349; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Trahtenherts A, 2009, HYBRIDOMA, V28, P225, DOI 10.1089/hyb.2009.0019; VERHOEYEN ME, 1993, IMMUNOLOGY, V78, P364; Vimal D, 2000, MOL CELL BIOCHEM, V204, P107, DOI 10.1023/A:1007015312036; vonWasielewski R, 1997, J HISTOCHEM CYTOCHEM, V45, P1455, DOI 10.1177/002215549704501102; Wang ZR, 2007, BIOCONJUGATE CHEM, V18, P947, DOI 10.1021/bc0603438; WELSCHOF M, 1995, J IMMUNOL METHODS, V179, P203, DOI 10.1016/0022-1759(94)00286-6; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; Williamson P, 1999, FEMS IMMUNOL MED MIC, V23, P313, DOI 10.1016/S0928-8244(98)00151-5; Yau KYF, 2005, J IMMUNOL METHODS, V297, P213, DOI 10.1016/j.jim.2004.12.005; Zhao XL, 2009, J BIOTECHNOL, V144, P253, DOI 10.1016/j.jbiotec.2009.09.022; Zielinski R, 2009, J IMMUNOTHER, V32, P817, DOI 10.1097/CJI.0b013e3181ad4d5d; ZOTTER S, 1988, INT J CANCER, P38	108	55	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15921	10.1371/journal.pone.0015921	http://dx.doi.org/10.1371/journal.pone.0015921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264246	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500017
J	Fan, XH; Shao, L; Fang, H; Tong, WD; Cheng, YY				Fan, Xiaohui; Shao, Li; Fang, Hong; Tong, Weida; Cheng, Yiyu			Cross-Platform Comparison of Microarray-Based Multiple-Class Prediction	PLOS ONE			English	Article							DNA MICROARRAYS; QUALITY-CONTROL; OLIGONUCLEOTIDE; CLASSIFIERS; CONSISTENCY; CALIBRATION; PROGNOSIS; GENES	High-throughput microarray technology has been widely applied in biological and medical decision-making research during the past decade. However, the diversity of platforms has made it a challenge to re-use and/or integrate datasets generated in different experiments or labs for constructing array-based diagnostic models. Using large toxicogenomics datasets generated using both Affymetrix and Agilent microarray platforms, we carried out a benchmark evaluation of cross-platform consistency in multiple-class prediction using three widely-used machine learning algorithms. After an initial assessment of model performance on different platforms, we evaluated whether predictive signature features selected in one platform could be directly used to train a model in the other platform and whether predictive models trained using data from one platform could predict datasets profiled using the other platform with comparable performance. Our results established that it is possible to successfully apply multiple-class prediction models across different commercial microarray platforms, offering a number of important benefits such as accelerating the possible translation of biomarkers identified with microarrays to clinically-validated assays. However, this investigation focuses on a technical platform comparison and is actually only the beginning of exploring cross-platform consistency. Further studies are needed to confirm the feasibility of microarray-based cross-platform prediction, especially using independent datasets.	[Fan, Xiaohui; Shao, Li; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Hong] Z Tech Corp, Jefferson, AZ USA; [Tong, Weida] US FDA, Natl Ctr Toxicol Res, Jefferson, AZ USA	Zhejiang University; US Food & Drug Administration (FDA)	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	weida.tong@fda.hhs.gov; chengyy@zju.edu.cn	FAN, Xiaohui/F-6458-2010	FAN, Xiaohui/0000-0002-6336-3007	National Science Foundation of China [30801556]; Higher Education of China [20090101110126]; Science Foundation of Chinese University [2009QNA7031]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (No. 30801556), the Research Fund for the Doctoral Program of Higher Education of China (No. 20090101110126), and Science Foundation of Chinese University (No. 2009QNA7031). The funders or the sponsor (Z-Tech Corporation) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biganzoli E, 2005, LANCET, V365, P1683, DOI 10.1016/S0140-6736(05)66537-3; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fan X, 2010, PHARMACOGENOMICS J, V10, P247, DOI 10.1038/tpj.2010.34; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Gallagher WM, 2009, DRUG DISCOV TODAY, V14, P337, DOI 10.1016/j.drudis.2009.02.001; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Huang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-288; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Lobenhofer EK, 2006, TOXICOL PATHOL, V34, P921, DOI 10.1080/01926230601072319; Lobenhofer EK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r100; Mao Shihong, 2009, Journal of Bioinformatics and Computational Biology, V7, P157, DOI 10.1142/S0219720009004011; Peter EH., 2000, PATTERN CLASSIFICATI; Pollack JR, 2007, AM J PATHOL, V171, P375, DOI 10.2353/ajpath.2007.070342; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Shi LM, 2008, CURR OPIN BIOTECH, V19, P10, DOI 10.1016/j.copbio.2007.11.003; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S11; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steiner G, 2004, ENVIRON HEALTH PERSP, V112, P1236, DOI 10.1289/txg.7036; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Yauk CL, 2007, ENVIRON MOL MUTAGEN, V48, P380, DOI 10.1002/em.20290; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	30	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16067	10.1371/journal.pone.0016067	http://dx.doi.org/10.1371/journal.pone.0016067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264309	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000019
J	Thiel, A; Kesselring, R; Pries, R; Puzik, A; Wittkopf, N; Wollenberg, B				Thiel, Annette; Kesselring, Rebecca; Pries, Ralph; Puzik, Alexander; Wittkopf, Nadine; Wollenberg, Barbara			Expression of the T Cell Receptor alpha beta on a CD123+BDCA2+HLA-DR+ Subpopulation in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; HUMAN PERIPHERAL-BLOOD; SPI-B; CANCER; INTERLEUKIN-6; CYTOKINES; TUMOR; SURVIVAL; CPG; IDENTIFICATION	Human Plasmacytoid Dendritic Cells (PDCs) infiltrating solid tumor tissues and draining lymph nodes of Head and Neck Squamous Cell Carcinoma (HNSCC) show an impaired immune response. In addition to an attenuated secretion of IFN-alpha little is known about other HNSCC-induced functional alterations in PDCs. Particular objectives in this project were to gain new insights regarding tumor-induced phenotypical and functional alterations in the PDC population. We showed by FACS analysis and RT-PCR that HNSCC orchestrates an as yet unknown subpopulation exhibiting functional autonomy in-vitro and in-vivo besides bearing phenotypical resemblance to PDCs and T cells. A subset, positive for the PDC markers CD123, BDCA2, HLA-DR and the T cell receptor alpha beta (TCR-alpha beta) was significantly induced subsequent to stimulation with HNSCC in-vitro (p = 0.009) and also present in metastatic lymph nodes in-vivo. This subgroup could be functionally distinguished due to an enhanced production of IL-2 (p = 0.02), IL-6 (p = 0.0007) and TGF-beta (not significant). Furthermore, after exposure to HNSCC cells, mRNA levels revealed a D-J-beta rearrangement of the TCR-beta chain besides a strong enhancement of the CD3 epsilon chain in the PDC population. Our data indicate an interface between the PDC and T cell lineage. These findings will improve our understanding of phenotypical and functional intricacies concerning the very heterogeneous PDC population in-vivo.	[Thiel, Annette; Kesselring, Rebecca; Pries, Ralph; Wittkopf, Nadine; Wollenberg, Barbara] Univ Schleswig Holstein, Dept Otorhinolaryngol, Lubeck, Germany; [Puzik, Alexander] Univ Freiburg, Dept Pediat, D-7800 Freiburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Freiburg	Thiel, A (corresponding author), Univ Schleswig Holstein, Dept Otorhinolaryngol, Campus Lubeck, Lubeck, Germany.	annettethiel@yahoo.de	Wollenberg, Barbara/AAK-7272-2020; Wollenberg, Barbara/E-7435-2010	Puzik, Alexander/0000-0003-1432-5183	Mildred Scheel-Stiftung (Deutsche Krebshilfe); Werner-and-Klara-Kreitz-Stiftung; Monika-Kutzner-Stiftung; Rudolf-Bartling-Stiftung	Mildred Scheel-Stiftung (Deutsche Krebshilfe)(Deutsche Krebshilfe); Werner-and-Klara-Kreitz-Stiftung; Monika-Kutzner-Stiftung; Rudolf-Bartling-Stiftung	This work was supported by grants from the Mildred Scheel-Stiftung (Deutsche Krebshilfe), the Werner-and-Klara-Kreitz-Stiftung, the Monika-Kutzner-Stiftung and the Rudolf-Bartling-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarstad HJ, 2006, ACTA OTO-LARYNGOL, V126, P1326, DOI 10.1080/00016480600702092; Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Bose Anamika, 2008, Cancer Immun, V8, P10; Bruno L, 1997, J EXP MED, V185, P875, DOI 10.1084/jem.185.5.875; Busch A, 2008, J IMMUNOL, V181, P3965, DOI 10.4049/jimmunol.181.6.3965; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Chin D, 2004, BRIT J PLAST SURG, V57, P595, DOI 10.1016/j.bjps.2004.06.010; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Dasgupta S, 2006, J CELL BIOCHEM, V97, P1036, DOI 10.1002/jcb.20647; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Douglas JG, 2000, HEAD NECK-J SCI SPEC, V22, P826, DOI 10.1002/1097-0347(200012)22:8<826::AID-HED13>3.0.CO;2-P; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; FACCHETTI F, 1989, AM J CLIN PATHOL, V92, P42, DOI 10.1093/ajcp/92.1.42; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Hartmann E, 2003, CANCER RES, V63, P6478; Hartmann G, 1996, ANTISENSE NUCLEIC A, V6, P291, DOI 10.1089/oli.1.1996.6.291; Heimdal JH, 2000, LARYNGOSCOPE, V110, P402, DOI 10.1097/00005537-200003000-00013; Heimdal JH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-34; Kanazawa T, 2007, EUR ARCH OTO-RHINO-L, V264, P815, DOI 10.1007/s00405-007-0264-6; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lathers DMR, 2003, HUM IMMUNOL, V64, P1160, DOI 10.1016/j.humimm.2003.08.024; Legrand F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005926; Li YY, 2009, HUM IMMUNOL, V70, P151, DOI 10.1016/j.humimm.2009.01.004; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Pries R, 2006, IN VIVO, V20, P45; Pries R, 2006, CYTOKINE GROWTH F R, V17, P141, DOI 10.1016/j.cytogfr.2006.02.001; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Riedel F, 2005, ANTICANCER RES, V25, P2761; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Scales D, 2001, J IMMUNOL, V166, P6437, DOI 10.4049/jimmunol.166.10.6437; Schotte R, 2003, BLOOD, V101, P1015, DOI 10.1182/blood-2002-02-0438; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Sparano A, 2004, OTOLARYNG HEAD NECK, V131, P573, DOI 10.1016/j.otohns.2004.03.016; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Tel J, 2010, J IMMUNOL, V184, P4276, DOI 10.4049/jimmunol.0903286; Thiel A, 2009, ANTICANCER RES, V29, P3019; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Wilkins-Port CE, 2007, CELLS TISSUES ORGANS, V185, P116, DOI 10.1159/000101312; Zitvogel L, 2008, M S-MED SCI, V24, P525, DOI 10.1051/medsci/2008245525	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15997	10.1371/journal.pone.0015997	http://dx.doi.org/10.1371/journal.pone.0015997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264308	Green Published, gold, Green Submitted			2022-12-27	WOS:000286514000014
J	Cawood, R; Wong, SL; Di, Y; Baban, DF; Seymour, LW				Cawood, Ryan; Wong, Suet-Ling; Di, Ying; Baban, Dilair F.; Seymour, Leonard W.			MicroRNA Controlled Adenovirus Mediates Anti-Cancer Efficacy without Affecting Endogenous MicroRNA Activity	PLOS ONE			English	Article							TRANSGENE EXPRESSION; ONCOLYTIC ADENOVIRUS; GENE-THERAPY; IN-VIVO; VIRUS; VECTORS; CANCER; E1A; HEPATOTOXICITY; REPLICATION	MicroRNAs are small non-coding RNA molecules that regulate mRNA translation and stability by binding to complementary sequences usually within the 39 un-translated region (UTR). We have previously shown that the hepatic toxicity caused by wild-type Adenovirus 5 (Ad5WT) in mice can be prevented by incorporating 4 binding sites for the liver-specific microRNA, mir122, into the 3' UTR of E1A mRNA. This virus, termed Ad5mir122, is a promising virotherapy candidate and causes no obvious liver pathology. Herein we show that Ad5mir122 maintains wild-type lytic activity in cancer cells not expressing mir122 and assess any effects of possible mir122 depletion in host cells. Repeat administration of 2 x 10(10) viral particles of Admir122 to HepG2 tumour bearing mice showed significant anti-cancer efficacy. RT-QPCR showed that E1A mRNA was down-regulated 29-fold in liver when compared to Ad5WT. Western blot for E1A confirmed that all protein variants were knocked down. RT-QPCR for mature mir122 in infected livers showed that quantity of mir122 remained unaffected. Genome wide mRNA microarray profiling of infected livers showed that although the transcript level of >3900 different mRNAs changed more than 2-fold following Ad5WT infection, less than 600 were changed by Ad5mir122. These were then filtered to select mRNAs that were only altered by Ad5mir122 and the remaining 21 mRNAs were compared to predicted mir122 targets. No mir122 target mRNAs were affected by Ad5 mir122. These results demonstrate that the exploitation of microRNA regulation to control virus replication does not necessarily affect the level of the microRNA or the endogenous mRNA targets.	[Cawood, Ryan; Wong, Suet-Ling; Di, Ying; Seymour, Leonard W.] Univ Oxford, Dept Clin Pharmacol, Med Virol Res Grp, Oxford, England; [Baban, Dilair F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Genom Grp, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Cawood, R (corresponding author), Univ Oxford, Dept Clin Pharmacol, Med Virol Res Grp, Oxford, England.	len.seymour@clinpharm.ox.ac.uk		Felce, Ling/0000-0001-8534-1629	Cancer Research UK; Medical Research Council; Wellcome Trust; Cancer Research UK [11339] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	RC and YD are supported by Cancer Research UK (http://www.cancer.org.uk/), SLW is funded by a research studentship from the Medical Research Council (www.mrc.ac.uk). The microarray core facility is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bazan-Peregrino M, 2008, HUM GENE THER, V19, P873, DOI 10.1089/hum.2008.047; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Engler H, 2004, VIROLOGY, V328, P52, DOI 10.1016/j.virol.2004.06.043; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fabani MM, 2008, RNA, V14, P336, DOI 10.1261/rna.844108; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; KAMRUD KI, 2010, J VIROLOGY; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KELLY EJ, J VIROLOGY, V84, P1550; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; LEE TC, BIOCH BIOPHYSICAL RE, V396, P596; Lichtenstein DL, 2004, CANCER GENE THER, V11, P819, DOI 10.1038/sj.cgt.7700765; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Majem M, 2006, CANCER GENE THER, V13, P696, DOI 10.1038/sj.cgt.7700940; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Msaouel P, 2009, PROSTATE, V69, P82, DOI 10.1002/pros.20857; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHAEFER A, 2001, EUROPEAN UROLOGY, V57, P919; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Suzuki T, 2008, MOL THER, V16, P1719, DOI 10.1038/mt.2008.159; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08	34	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16152	10.1371/journal.pone.0016152	http://dx.doi.org/10.1371/journal.pone.0016152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264344	gold, Green Published, Green Submitted			2022-12-27	WOS:000286513100029
J	Davies, P; Moualla, D; Brown, DR				Davies, Paul; Moualla, Dima; Brown, David R.			Alpha-Synuclein Is a Cellular Ferrireductase	PLOS ONE			English	Article							METAL-BINDING; COPPER(II) BINDING; IRON; INSIGHTS; PATHOGENESIS; MUTATIONS; DISEASE; CU(II); CU2+	alpha-synuclein (alpha S) is a cellular protein mostly known for the association of its aggregated forms with a variety of diseases that include Parkinson's disease and Dementia with Lewy Bodies. While the role of alpha S in disease is well documented there is currently no agreement on the physiological function of the normal isoform of the protein. Here we provide strong evidence that alpha S is a cellular ferrireductase, responsible for reducing iron (III) to bio available iron (II). The recombinant form of the protein has a V-Max of 2.72 nmols/min/mg and K-m 23 mu M. This activity is also evident in lysates from neuronal cell lines overexpressing alpha S. This activity is dependent on copper bound to alpha S as a cofactor and NADH as an electron donor. Overexpression of alpha-synuclein by cells significantly increases the percentage of iron (II) in cells. The common disease mutations associated with increased susceptibility to PD show differences in activity or iron (II) levels. This discovery may well provide new therapeutic targets for PD and Lewy body dementias.	[Davies, Paul; Moualla, Dima; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Davies, P (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Davies, Paul/0000-0001-8022-2719				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Beyer K, 2009, INT J MOL SCI, V10, P724, DOI 10.3390/ijms10030724; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Bharathi, 2007, BIOCHEM BIOPH RES CO, V359, P115, DOI 10.1016/j.bbrc.2007.05.060; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Brown DR, 2009, BIOCHEM BIOPH RES CO, V380, P377, DOI 10.1016/j.bbrc.2009.01.103; Burke RE, 2004, NEUROLOGIST, V10, P75, DOI 10.1097/01.nrl.0000117822.90759.83; Charkoudian LK, 2006, INORG CHEM, V45, P3657, DOI 10.1021/ic060014r; Davies P, 2009, BIOCHEMISTRY-US, V48, P2610, DOI 10.1021/bi900170n; Drew SC, 2008, J AM CHEM SOC, V130, P7766, DOI 10.1021/ja800708x; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Hong L, 2009, J PHYS CHEM B, V113, P9551, DOI 10.1021/jp809773y; Kienzl E, 1999, LIFE SCI, V65, P1973, DOI 10.1016/S0024-3205(99)00458-0; Lee EN, 2003, J NEUROCHEM, V84, P1128, DOI 10.1046/j.1471-4159.2003.01612.x; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; MASSERANO JM, 1983, MOL CELL BIOCHEM, V53-4, P129; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Simovich MJ, 2002, AM J HEMATOL, V69, P164, DOI 10.1002/ajh.10052; Sung YH, 2006, BBA-PROTEINS PROTEOM, V1764, P5, DOI 10.1016/j.bbapap.2005.11.003; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Wolozin B, 2002, NEUROSCIENTIST, V8, P22, DOI 10.1177/107385840200800107; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Yu S, 2005, MOL NEUROBIOL, V31, P243, DOI 10.1385/MN:31:1-3:243; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118	30	140	145	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15814	10.1371/journal.pone.0015814	http://dx.doi.org/10.1371/journal.pone.0015814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249223	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100012
J	Pandya, GA; McEllistrem, MC; Venepally, P; Holmes, MH; Jarrahi, B; Sanka, R; Liu, J; Karamycheva, SA; Bai, Y; Fleischmann, RD; Peterson, SN				Pandya, Gagan A.; McEllistrem, M. Catherine; Venepally, Pratap; Holmes, Michael H.; Jarrahi, Behnam; Sanka, Ravi; Liu, Jia; Karamycheva, Svetlana A.; Bai, Yun; Fleischmann, Robert D.; Peterson, Scott N.			Monitoring the Long-Term Molecular Epidemiology of the Pneumococcus and Detection of Potential 'Vaccine Escape' Strains	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; UNITED-STATES; SEQUENCE-ANALYSIS; INVASIVE DISEASE; GENOME SEQUENCE; DIVERSITY; PSPA; RECOMBINATION; VIRULENCE	Background: While the pneumococcal protein conjugate vaccines reduce the incidence in invasive pneumococcal disease (IPD), serotype replacement remains a major concern. Thus, serotype-independent protection with vaccines targeting virulence genes, such as PspA, have been pursued. PspA is comprised of diverse clades that arose through recombination. Therefore, multi-locus sequence typing (MLST)-defined clones could conceivably include strains from multiple PspA clades. As a result, a method is needed which can both monitor the long-term epidemiology of the pneumococcus among a large number of isolates, and analyze vaccine-candidate genes, such as pspA, for mutations and recombination events that could result in 'vaccine escape' strains. Methodology: We developed a resequencing array consisting of five conserved and six variable genes to characterize 72 pneumococcal strains. The phylogenetic analysis of the 11 concatenated genes was performed with the MrBayes program, the single nucleotide polymorphism (SNP) analysis with the DNA Sequence Polymorphism program (DnaSP), and the recombination event analysis with the recombination detection package (RDP). Results: The phylogenetic analysis correlated with MLST, and identified clonal strains with unique PspA clades. The DnaSP analysis correlated with the serotype-specific diversity detected using MLST. Serotypes associated with more than one ST complex had a larger degree of sequence polymorphism than a serotype associated with one ST complex. The RDP analysis confirmed the high frequency of recombination events in the pspA gene. Conclusions: The phylogenetic tree correlated with MLST, and detected multiple PspA clades among clonal strains. The genetic diversity of the strains and the frequency of recombination events in the mosaic gene, pspA were accurately assessed using the DnaSP and RDP programs, respectively. These data provide proof-of-concept that resequencing arrays could play an important role within research and clinical laboratories in both monitoring the molecular epidemiology of the pneumococcus and detecting 'vaccine escape' strains among vaccine-candidate genes.	[Pandya, Gagan A.; Venepally, Pratap; Holmes, Michael H.; Jarrahi, Behnam; Sanka, Ravi; Liu, Jia; Karamycheva, Svetlana A.; Bai, Yun; Fleischmann, Robert D.; Peterson, Scott N.] J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD USA; [McEllistrem, M. Catherine] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	J. Craig Venter Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Pandya, GA (corresponding author), J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD USA.	scottp@jcvi.org			NIAID [N01-AI-15447];  [K23 AI01788-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001788] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID contract No. N01-AI-15447 to Pathogen Functional Genomics Resource Center and K23 AI01788-05 (MCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Beall B, 2000, J CLIN MICROBIOL, V38, P3663, DOI 10.1128/JCM.38.10.3663-3669.2000; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Chen Y, 2007, J CLIN MICROBIOL, V45, P835, DOI 10.1128/JCM.01575-06; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Do T, 2009, MICROBIOL-SGM, V155, P2593, DOI 10.1099/mic.0.027284-0; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feavers IM, 1999, J CLIN MICROBIOL, V37, P3883, DOI 10.1128/JCM.37.12.3883-3887.1999; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; McEllistrem MC, 2009, FUTURE MICROBIOL, V4, P857, DOI 10.2217/FMB.09.58; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mitchell TJ, 2004, PNEUMOCCOCUS, P61; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Nei M., 1987, MOL EVOLUTIONARY GEN; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pandya GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm918; Rehm SJ, 2009, POSTGRAD MED, V121, P101, DOI 10.3810/pgm.2009.11.2069; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Roche H, 2003, INFECT IMMUN, V71, P4498, DOI 10.1128/IAI.71.8.4498-4505.2003; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Snel B, 2005, ANNU REV MICROBIOL, V59, P191, DOI 10.1146/annurev.micro.59.030804.121233; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1983, GENETICS, V105, P437; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Xin W, 2009, INFECT IMMUN, V77, P4518, DOI 10.1128/IAI.00486-09; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994	62	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15950	10.1371/journal.pone.0015950	http://dx.doi.org/10.1371/journal.pone.0015950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264340	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100021
J	Wen, XY; Abe, T; Kukihara, H; Taguwa, S; Mori, Y; Tani, H; Kato, N; Suzuki, T; Tatsumi, M; Moriishi, K; Matsuura, Y				Wen, Xiaoyu; Abe, Takayuki; Kukihara, Hiroshi; Taguwa, Shuhei; Mori, Yoshio; Tani, Hideki; Kato, Nobuyuki; Suzuki, Tetsuro; Tatsumi, Masashi; Moriishi, Kohji; Matsuura, Yoshiharu			Elimination of Hepatitis C Virus from Hepatocytes by a Selective Activation of Therapeutic Molecules	PLOS ONE			English	Article							RIG-I; ADAPTER PROTEIN; INTERFERON; EXPRESSION; CELLS; IFN; ESTABLISHMENT; PATHOGENESIS; CLEAVAGE; PATHWAY	To eliminate hepatitis C virus (HCV) from infected hepatocytes, we generated two therapeutic molecules specifically activated in cells infected with HCV. A dominant active mutant of interferon (IFN) regulatory factor 7 (IRF7) and a negative regulator of HCV replication, VAP-C (Vesicle-associated membrane protein-associated protein subtype C), were fused with the C-terminal region of IPS-1 (IFN beta promoter stimulator-1), which includes an HCV protease cleavage site that was modified to be localized on the ER membrane, and designated cIRF7 and cVAP-C, respectively. In cells expressing the HCV protease, cIRF7 was cleaved and the processed fragment was migrated into the nucleus, where it activated various IFN promoters, including promoters of IFN alpha 6, IFN beta, and IFN stimulated response element. Activation of the IFN promoters and suppression of viral RNA replication were observed in the HCV replicon cells and in cells infected with the JFH1 strain of HCV (HCVcc) by expression of cIRF7. Suppression of viral RNA replication was observed even in the IFN-resistant replicon cells by the expression of cIRF7. Expression of the cVAP-C also resulted in suppression of HCV replication in both the replicon and HCVcc infected cells. These results suggest that delivery of the therapeutic molecules into the liver of hepatitis C patients, followed by selective activation of the molecules in HCV-infected hepatocytes, is a feasible method for eliminating HCV.	[Wen, Xiaoyu; Abe, Takayuki; Kukihara, Hiroshi; Taguwa, Shuhei; Mori, Yoshio; Tani, Hideki; Moriishi, Kohji; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan; [Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama 7008530, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4312102, Japan; [Tatsumi, Masashi] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	Osaka University; Okayama University; Hamamatsu University School of Medicine; National Institute of Infectious Diseases (NIID)	Wen, XY (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan.	matsuura@biken.osaka-u.ac.jp	Moriishi, Kohji/I-4173-2019	Moriishi, Kohji/0000-0002-9542-5188	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; Osaka University Global Center of Excellence; Foundation for Biomedical Research and Innovation	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Biomedical Research and Innovation(Foundation for Biomedical Research and Innovation, Kobe, Japan)	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare; the Ministry of Education, Culture, Sports, Science, and Technology; the Osaka University Global Center of Excellence Program; and the Foundation for Biomedical Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; Cerny A, 1999, HEPATOLOGY, V30, P595, DOI 10.1002/hep.510300312; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kukihara H, 2009, J VIROL, V83, P7959, DOI 10.1128/JVI.00889-09; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Naka K, 2005, J GEN VIROL, V86, P2787, DOI 10.1099/vir.0.81124-0; Namba K, 2004, BIOCHEM BIOPH RES CO, V323, P299, DOI 10.1016/j.bbrc.2004.08.091; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Soriano V, 2008, EXPERT OPIN EMERG DR, V13, P1, DOI 10.1517/14728214.13.1.1 ; Tanaka Y, 2010, MICROBIOL IMMUNOL, V54, P206, DOI 10.1111/j.1348-0421.2010.00209.x; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vilasco M, 2006, HEPATOLOGY, V44, P1635, DOI 10.1002/hep.21432; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854; Zhu HZ, 2005, J INTERF CYTOK RES, V25, P528, DOI 10.1089/jir.2005.25.528	41	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15967	10.1371/journal.pone.0015967	http://dx.doi.org/10.1371/journal.pone.0015967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253612	Green Submitted, gold, Green Published			2022-12-27	WOS:000286511900032
J	Xu, P; Wu, XH; Wang, BG; Liu, YH; Ehlers, JD; Close, TJ; Roberts, PA; Diop, NN; Qin, DH; Hu, TT; Lu, ZF; Li, GJ				Xu, Pei; Wu, Xiaohua; Wang, Baogen; Liu, Yonghua; Ehlers, Jeffery D.; Close, Timothy J.; Roberts, Philip A.; Diop, Ndeye-Ndack; Qin, Dehui; Hu, Tingting; Lu, Zhongfu; Li, Guojing			A SNP and SSR Based Genetic Map of Asparagus Bean (Vigna. unguiculata ssp sesquipedialis) and Comparison with the Broader Species	PLOS ONE			English	Article							SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; LINKAGE MAP; MARKERS; COWPEA; DIVERSITY; REGIONS; CROSSES; LEGUME; MAIZE	Asparagus bean (Vigna. unguiculata ssp. sesquipedialis) is a distinctive subspecies of cowpea [Vigna. unguiculata (L.) Walp.] that apparently originated in East Asia and is characterized by extremely long and thin pods and an aggressive climbing growth habit. The crop is widely cultivated throughout Asia for the production of immature pods known as 'long beans' or 'asparagus beans'. While the genome of cowpea ssp. unguiculata has been characterized recently by high-density genetic mapping and partial sequencing, little is known about the genome of asparagus bean. We report here the first genetic map of asparagus bean based on SNP and SSR markers. The current map consists of 375 loci mapped onto 11 linkage groups (LGs), with 191 loci detected by SNP markers and 184 loci by SSR markers. The overall map length is 745 cM, with an average marker distance of 1.98 cM. There are four high marker-density blocks distributed on three LGs and three regions of segregation distortion (SDRs) identified on two other LGs, two of which co-locate in chromosomal regions syntenic to SDRs in soybean. Synteny between asparagus bean and the model legume Lotus. japonica was also established. This work provides the basis for mapping and functional analysis of genes/QTLs of particular interest in asparagus bean, as well as for comparative genomics study of cowpea at the subspecies level.	[Xu, Pei; Wu, Xiaohua; Wang, Baogen; Liu, Yonghua; Qin, Dehui; Hu, Tingting; Lu, Zhongfu; Li, Guojing] Zhejiang Acad Agr Sci, Inst Vegetables, Hangzhou, Zhejiang, Peoples R China; [Ehlers, Jeffery D.; Close, Timothy J.; Roberts, Philip A.; Diop, Ndeye-Ndack] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Zhejiang Academy of Agricultural Sciences; University of California System; University of California Riverside	Xu, P (corresponding author), Zhejiang Acad Agr Sci, Inst Vegetables, Hangzhou, Zhejiang, Peoples R China.	Guojing_li@Yahoo.com.cn	Xu, Pei/H-4904-2019		National Science Foundation of China [30871711, 30900985]; Science Foundation of Zhejiang Province [Y3090146]; CGIAR	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); CGIAR(CGIAR)	This study was partially supported by the National Science Foundation of China (No. 30871711, No. 30900985, http://www.nsfc.gov.cn) and the Science Foundation of Zhejiang Province (No. Y3090146, http://www.zjnsf.net) to the Zejiang Academy of Agricultural Sciences and by the CGIAR Generation Challenge Program's Tropical Legumes I (http://www.generationcp.org) to the University of California Riverside. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Chen LR, 2008, PLANT CELL REP, V27, P535, DOI 10.1007/s00299-007-0488-3; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Ehlers JD, 1997, FIELD CROP RES, V53, P187, DOI 10.1016/S0378-4290(97)00031-2; Fang JG, 2007, GENET RESOUR CROP EV, V54, P1197, DOI 10.1007/s10722-006-9101-9; Faris JD, 1998, GENETICS, V149, P319; FATMI A, 1993, THEOR APPL GENET, V86, P859, DOI 10.1007/BF00212613; FATOKUN CA, 1992, GENETICS, V132, P841; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li CD, 2001, CROP SCI, V41, P189, DOI 10.2135/cropsci2001.411189x; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Maguire T. L., 1994, Plant Molecular Biology Reporter, V12, P106, DOI 10.1007/BF02668371; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Nayak SN, 2010, THEOR APPL GENET, V120, P1415, DOI 10.1007/s00122-010-1265-1; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Qi X, 2004, THEOR APPL GENET, V109, P1485, DOI 10.1007/s00122-004-1765-y; Roder MS, 1998, GENETICS, V149, P2007; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Singh B.B., 2002, CHALLENGES OPPORTUNI, P3; Timko M.P., 2007, PULSES SUGAR TUBER C, V3, P49, DOI DOI 10.1007/978-3-540-34516-9_3; WILLIAMS CG, 1995, GENETICS, V141, P1573; Xu P, 2010, MOL BREEDING, V25, P675, DOI 10.1007/s11032-009-9364-x; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Yamanaka N, 2001, DNA RES, V8, P61, DOI 10.1093/dnares/8.2.61	33	39	42	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15952	10.1371/journal.pone.0015952	http://dx.doi.org/10.1371/journal.pone.0015952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253606	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900030
J	Chansard, M; Wang, JA; Hong, CT; Neumayer, G; Shim, SY; Park, YU; Belzil, C; Hoa, TL; Park, SK; Minh, DN				Chansard, Mathieu; Wang, Jian; Hong Chi Tran; Neumayer, Gernot; Shim, Su Yeon; Park, Young-Un; Belzil, Camille; Hoa Thi Le; Park, Sang Ki; Minh Dang Nguyen			The Cytoskeletal Protein Ndel1 Regulates Dynamin 2 GTPase Activity	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; RECEPTOR-MEDIATED ENDOCYTOSIS; CYTOPLASMIC DYNEIN; NEURONAL MIGRATION; NEURITE OUTGROWTH; MEMBRANE FISSION; MAMMALIAN-CELLS; HOMOLOGY DOMAIN; ACTIN; LIS1	Cytoskeleton dynamics, membranes trafficking and positioning are essential for the proper functioning of any mammalian cell. The identification of the molecules and mechanisms that allow these cellular processes to interface is vital for understanding cell behaviors. Ndel1, the mammalian homolog of the Aspergillus nidulans NudE, organizes the cytoskeleton and regulates molecular motors, thereby impacting on the positioning of membranes. Hypothetically, Ndel1 can act in concert with enzymes controlling membrane trafficking (vesicle-mediated transport) per se, but this idea has never been investigated. We now report that a pool of Ndel1 associates directly with Dynamin 2 (Dyn2), a large cytosolic GTPase involved in the trafficking of the AMPA receptor subunit GluR1. In vitro, Ndel1 enhances Dyn2 GTPase activity in its unassembled and assembled forms, without promoting oligomerization of the enzyme. In cells, gain and loss of function of Ndel1 recapitulate the effects of overexpression of Dyn2 and Dyn2 dominant negative with reduced GTPase activity on the intracellular localization of GluR1, respectively, without affecting the stability of microtubules. Together, these results indicate that Ndel1 regulates Dyn2 GTPase activity and impacts GluR1-containing membranes distribution in a manner reminiscent of Dyn2.	[Chansard, Mathieu; Wang, Jian; Hong Chi Tran; Neumayer, Gernot; Shim, Su Yeon; Belzil, Camille; Hoa Thi Le; Minh Dang Nguyen] Univ Calgary, Dept Clin Neurosci Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada; [Chansard, Mathieu; Wang, Jian; Hong Chi Tran; Neumayer, Gernot; Shim, Su Yeon; Belzil, Camille; Hoa Thi Le; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Park, Young-Un; Park, Sang Ki] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang, South Korea; [Park, Young-Un] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	University of Calgary; University of Calgary; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Chansard, M (corresponding author), Univ Calgary, Dept Clin Neurosci Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada.	mdnguyen@ucalgary.ca	wang, jian/GVS-0711-2022		Canadian Institutes of Health Research (CIHR) [733371]; Alberta Heritage Foundation for Medical Research (AHFMR) [732626]; Multiple Sclerosis Society of Canada; Brain Research Center [2010K000812]; Korean Ministry of Education, Science and Technology [331-2007-1-C00213, 3-200900000001605, 20090076351]; Human Frontier Science Program Organization (HFSPO); Brenda Strafford Foundation Chair in Alzheimer research [791959]; Hotchkiss Brain Institute (HBI); Austrian Academy of Sciences at the Institute of Biochemistry and Molecular Biology/University of Calgary	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Multiple Sclerosis Society of Canada; Brain Research Center; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Brenda Strafford Foundation Chair in Alzheimer research; Hotchkiss Brain Institute (HBI); Austrian Academy of Sciences at the Institute of Biochemistry and Molecular Biology/University of Calgary	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR, 733371), the Alberta Heritage Foundation for Medical Research (AHFMR, 732626), the Multiple Sclerosis Society of Canada (to MDN), a grant from the Brain Research Center of the 21C Frontier Research Program (2010K000812) and the grants 331-2007-1-C00213, 3-200900000001605 and 20090076351 from the Korean Ministry of Education, Science and Technology (to SKP). MDN holds a Career Development Award from the Human Frontier Science Program Organization (HFSPO), a New Investigator Award from the CIHR, a scholarship from the AHFMR and the Brenda Strafford Foundation Chair in Alzheimer research (791959). MC is supported by a Hotchkiss Brain Institute (HBI) post-doctoral fellowship. GN is a recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Institute of Biochemistry and Molecular Biology/University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Hinshaw JE, 2006, NAT CELL BIOL, V8, P432, DOI 10.1038/ncb0506-432; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LIU JP, 1995, ENDOCR REV, V16, P590, DOI 10.1210/er.16.5.590; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; TOOZE SA, 1992, METHOD ENZYMOL, V219, P81; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	61	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14583	10.1371/journal.pone.0014583	http://dx.doi.org/10.1371/journal.pone.0014583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283621	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400002
J	Fontainhas, AM; Wang, MH; Liang, KJ; Chen, S; Mettu, P; Damani, M; Fariss, RN; Li, W; Wong, WT				Fontainhas, Aurora M.; Wang, Minhua; Liang, Katharine J.; Chen, Shan; Mettu, Pradeep; Damani, Mausam; Fariss, Robert N.; Li, Wei; Wong, Wai T.			Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission	PLOS ONE			English	Article							IN-VIVO; PANNEXIN HEMICHANNELS; CULTURED MICROGLIA; CELL COMMUNICATION; RETINAL MICROGLIA; EXTRACELLULAR ATP; P2Y RECEPTORS; MOUSE RETINA; TASTE-BUDS; BRAIN	Purpose: Microglia represent the primary resident immune cells in the CNS, and have been implicated in the pathology of neurodegenerative diseases. Under basal or "resting'' conditions, microglia possess ramified morphologies and exhibit dynamic surveying movements in their processes. Despite the prominence of this phenomenon, the function and regulation of microglial morphology and dynamic behavior are incompletely understood. We investigate here whether and how neurotransmission regulates "resting'' microglial morphology and behavior. Methods: We employed an ex vivo mouse retinal explant system in which endogenous neurotransmission and dynamic microglial behavior are present. We utilized live-cell time-lapse confocal imaging to study the morphology and behavior of GFP-labeled retinal microglia in response to neurotransmitter agonists and antagonists. Patch clamp electrophysiology and immunohistochemical localization of glutamate receptors were also used to investigate direct-versus-indirect effects of neurotransmission by microglia. Results: Retinal microglial morphology and dynamic behavior were not cell-autonomously regulated but are instead modulated by endogenous neurotransmission. Morphological parameters and process motility were differentially regulated by different modes of neurotransmission and were increased by ionotropic glutamatergic neurotransmission and decreased by ionotropic GABAergic neurotransmission. These neurotransmitter influences on retinal microglia were however unlikely to be directly mediated; local applications of neurotransmitters were unable to elicit electrical responses on microglia patch-clamp recordings and ionotropic glutamatergic receptors were not located on microglial cell bodies or processes by immunofluorescent labeling. Instead, these influences were mediated indirectly via extracellular ATP, released in response to glutamatergic neurotransmission through probenecid-sensitive pannexin hemichannels. Conclusions: Our results demonstrate that neurotransmission plays an endogenous role in regulating the morphology and behavior of "resting'' microglia in the retina. These findings illustrate a mode of constitutive signaling between the neural and immune compartments of the CNS through which immune cells may be regulated in concert with levels of neural activity.	[Fontainhas, Aurora M.; Wang, Minhua; Liang, Katharine J.; Mettu, Pradeep; Damani, Mausam; Wong, Wai T.] NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA; [Chen, Shan; Li, Wei] NEI, Unit Retinal Neurophysiol, Bethesda, MD 20892 USA; [Fariss, Robert N.] NEI, Off Sci Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Fontainhas, AM (corresponding author), NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA.	wongw@nei.nih.gov	Fariss, Robert/ABI-1771-2020; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016; Fariss, Robert/0000-0003-3227-7170	National Eye Institute; Prevention of Blindness Society of Metropolitan Washington; NATIONAL EYE INSTITUTE [ZICEY000459, ZIAEY000463] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Prevention of Blindness Society of Metropolitan Washington; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work has been supported by the National Eye Institute Intramural Research Program and a grant from the Prevention of Blindness Society of Metropolitan Washington (www.youreyes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Eter N, 2008, INVEST OPHTH VIS SCI, V49, P3649, DOI 10.1167/iovs.07-1322; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Gottlieb M, 1997, J CEREBR BLOOD F MET, V17, P290, DOI 10.1097/00004647-199703000-00006; Hagino Y, 2004, GLIA, V47, P68, DOI 10.1002/glia.20034; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kurth-Nelson ZL, 2009, J NEUROSCI, V29, P11339, DOI 10.1523/JNEUROSCI.2493-09.2009; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Li W, 2002, J COMP NEUROL, V448, P230, DOI 10.1002/cne.10189; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Liu GJ, 2009, EUR J NEUROSCI, V29, P1108, DOI 10.1111/j.1460-9568.2009.06659.x; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Newman EA, 2004, GLIA, V47, P268, DOI 10.1002/glia.20030; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noda M, 2000, J NEUROSCI, V20, P251, DOI 10.1523/JNEUROSCI.20-01-00251.2000; NORENBERG W, 1994, J PHYSIOL-LONDON, V475, P15; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Paques M, 2010, GLIA, V58, P1663, DOI 10.1002/glia.21037; Perez-Leon J, 2003, INVEST OPHTH VIS SCI, V44, P1376, DOI 10.1167/iovs.02-0702; PERRY VH, 1989, NEUROSCIENCE, V31, P453, DOI 10.1016/0306-4522(89)90387-4; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; POW DV, 1989, NEUROSCIENCE, V33, P567, DOI 10.1016/0306-4522(89)90409-0; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wollmer MA, 2001, J NEUROIMMUNOL, V115, P19, DOI 10.1016/S0165-5728(01)00257-0; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Wu LJ, 2008, J NEUROPHYSIOL, V99, P2026, DOI 10.1152/jn.01210.2007; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Xiang ZH, 2006, J NEUROSCI RES, V83, P91, DOI 10.1002/jnr.20709; Yamada J, 2006, BIOCHEM BIOPH RES CO, V349, P913, DOI 10.1016/j.bbrc.2006.08.126	56	227	231	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15973	10.1371/journal.pone.0015973	http://dx.doi.org/10.1371/journal.pone.0015973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283568	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400019
J	An, HB; Lu, XY; Liu, D; Yarbrough, WG				An, Hanbing; Lu, Xinyuan; Liu, Dan; Yarbrough, Wendell G.			LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE CHECKPOINTS; NF-KAPPA-B; TUMOR-SUPPRESSOR; BINDING PROTEIN; BAX TRANSLOCATION; INDUCED APOPTOSIS; UV-RADIATION; EXPRESSION; PATHWAY	LZAP (Cdk5rap3, C53) is a putative tumor suppressor that inhibits RelA, Chk1 and Chk2 and activates p53. LZAP is lost in a portion of human head and neck squamous cell carcinoma and experimental loss of LZAP expression is associated with enhanced invasion, xenograft tumor growth and angiogenesis. p38 MAPK can increase or decrease proliferation and cell death depending on cellular context. LZAP has no known enzymatic activity, implying that its biological functions are likely mediated by its protein-protein interactions. To gain further insight into LZAP activities, we searched for LZAP-associated proteins (LAPs). Here we show that the LZAP binds p38, alters p38 cellular localization, and inhibits basal and cytokine-stimulated p38 activity. Expression of LZAP inhibits p38 phosphorylation in a dose-dependent fashion while loss of LZAP enhances phosphorylation and activation with resultant phosphorylation of p38 downstream targets. Mechanistically, the ability of LZAP to alter p38 phosphorylation depended, at least partially, on the p38 phosphatase, Wip1. Expression of LZAP increased both LZAP and Wip1 binding to p38. Taken together, these data suggest that LZAP activity includes inhibition of p38 phosphorylation and activation.	[An, Hanbing; Yarbrough, Wendell G.] Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA; [Lu, Xinyuan; Liu, Dan; Yarbrough, Wendell G.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA; [An, Hanbing; Lu, Xinyuan; Liu, Dan; Yarbrough, Wendell G.] Vanderbilt Univ, Barry Baker Lab Head & Neck Oncol, Nashville, TN USA; [Yarbrough, Wendell G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	An, HB (corresponding author), Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA.	wendell.yarbrough@vanderbilt.edu			NIH/NIDCR; Ingram Professorship; Vanderbilt Ingram Cancer Center; Department of Otolaryngology; Vanderbilt Bill Wilkerson Center; National Institute of Dental and Craniofacial Research [2R01 DE013173];  [2R56 DE013173-10];  [09/01/10]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013173] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ingram Professorship; Vanderbilt Ingram Cancer Center; Department of Otolaryngology; Vanderbilt Bill Wilkerson Center; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was funded by 2R56 DE013173-10, 09/01/10 to 08/31/11, NIH/NIDCR: "Tumor suppressor qualities and mechanisms of LZAP activity. Identify molecular differences in HNSCC related to HPV status." (http://www.nidcr.nih.gov/.) These studies are supported by an endowment to the Barry Baker Laboratories for Head and Neck Oncology, by funds supplied through the Ingram Professorship (WGY), and through funds supplied by the Vanderbilt Ingram Cancer Center, the Department of Otolaryngology, and the Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences and through grant # 2R01 DE013173 from the National Institute of Dental and Craniofacial Research to Dr. Yarbrough. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fu J, 2006, J CELL SCI, V119, P115, DOI 10.1242/jcs.02699; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Ishikawa Y, 2003, MOL CELL NEUROSCI, V24, P451, DOI 10.1016/S1044-7431(03)00203-3; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pomerance M, 2006, J PATHOL, V209, P298, DOI 10.1002/path.1975; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	41	18	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16427	10.1371/journal.pone.0016427	http://dx.doi.org/10.1371/journal.pone.0016427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283629	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400034
J	Jain, A; McKeon, RJ; Brady-Kalnay, SM; Bellamkonda, RV				Jain, Anjana; McKeon, Robert J.; Brady-Kalnay, Susann M.; Bellamkonda, Ravi V.			Sustained Delivery of Activated Rho GTPases and BDNF Promotes Axon Growth in CSPG-Rich Regions Following Spinal Cord Injury	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; NERVOUS-SYSTEM; GLIAL SCAR; ADULT-RAT; REGENERATION; REPAIR; INHIBITION	Background: Spinal cord injury (SCI) often results in permanent functional loss. This physical trauma leads to secondary events, such as the deposition of inhibitory chondroitin sulfate proteoglycan (CSPG) within astroglial scar tissue at the lesion. Methodology/Principal Findings: We examined whether local delivery of constitutively active (CA) Rho GTPases, Cdc42 and Rac1 to the lesion site alleviated CSPG-mediated inhibition of regenerating axons. A dorsal over-hemisection lesion was created in the rat spinal cord and the resulting cavity was conformally filled with an in situ gelling hydrogel combined with lipid microtubes that slowly released constitutively active (CA) Cdc42, Rac1, or Brain-derived neurotrophic factor (BDNF). Treatment with BDNF, CA-Cdc42, or CA-Rac1 reduced the number of GFAP-positive astrocytes, as well as CSPG deposition, at the interface of the implanted hydrogel and host tissue. Neurofilament 160kDa positively stained axons traversed the glial scar extensively, entering the hydrogel-filled cavity in the treatments with BDNF and CA-Rho GTPases. The treated animals had a higher percentage of axons from the corticospinal tract that traversed the CSPG-rich regions located proximal to the lesion site. Conclusion: Local delivery of CA-Cdc42, CA-Rac1, and BDNF may have a significant therapeutic role in overcoming CSPG-mediated regenerative failure after SCI.	[Jain, Anjana; Bellamkonda, Ravi V.] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [McKeon, Robert J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Brady-Kalnay, Susann M.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Brady-Kalnay, Susann M.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Case Western Reserve University; Case Western Reserve University	Jain, A (corresponding author), Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.	ravi@gatech.edu			National Institutes of Health (NINDS) [R01 NS43486]; GTEC an NSF Engineering Research Center based at Georgia Tech/Emory [EEC - 9731643]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043486] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GTEC an NSF Engineering Research Center based at Georgia Tech/Emory; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from National Institutes of Health R01 NS43486 (NINDS, R.V.B.) and GTEC an NSF Engineering Research Center based at Georgia Tech/Emory, (EEC - 9731643, Nerem). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; DAVID S, 2003, ANN REV NEUROSCI; Dergham P, 2002, J NEUROSCI, V22, P6570; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 1999, BRIT J CANCER, V80, P25; Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jin Z, 1997, J NEUROSCI, V17, P6256; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; Kosako H, 1997, J BIOL CHEM, V272, P10333; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Major DL, 2007, MOL CELL NEUROSCI, V34, P453, DOI 10.1016/j.mcn.2006.11.022; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5; Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost B, 2002, J NEUROSCI, V22, P10368; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Zhou LJ, 2003, J NEUROSCI RES, V74, P221, DOI 10.1002/jnr.10718; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922	32	57	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16135	10.1371/journal.pone.0016135	http://dx.doi.org/10.1371/journal.pone.0016135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283639	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400023
J	Magbanua, ZV; Ozkan, S; Bartlett, BD; Chouvarine, P; Saski, CA; Liston, A; Cronn, RC; Nelson, CD; Peterson, DG				Magbanua, Zenaida V.; Ozkan, Seval; Bartlett, Benjamin D.; Chouvarine, Philippe; Saski, Christopher A.; Liston, Aaron; Cronn, Richard C.; Nelson, C. Dana; Peterson, Daniel G.			Adventures in the Enormous: A 1.8 Million Clone BAC Library for the 21.7 Gb Genome of Loblolly Pine	PLOS ONE			English	Article							ARTIFICIAL CHROMOSOME LIBRARIES; REPEAT TRANSPOSABLE ELEMENTS; WOOD PROPERTY TRAITS; TAEDA L.; HIGH-THROUGHPUT; WATER-DEFICIT; CONSTRUCTION; GENE; IDENTIFICATION; INTEGRATION	Loblolly pine (LP; Pinus taeda L.) is the most economically important tree in the U. S. and a cornerstone species in southeastern forests. However, genomics research on LP and other conifers has lagged behind studies on flowering plants due, in part, to the large size of conifer genomes. As a means to accelerate conifer genome research, we constructed a BAC library for the LP genotype 7-56. The LP BAC library consists of 1,824,768 individually-archived clones making it the largest single BAC library constructed to date, has a mean insert size of 96 kb, and affords 7.6X coverage of the 21.7 Gb LP genome. To demonstrate the efficacy of the library in gene isolation, we screened macroarrays with overgos designed from a pine EST anchored on LP chromosome 10. A positive BAC was sequenced and found to contain the expected full-length target gene, several gene-like regions, and both known and novel repeats. Macroarray analysis using the retrotransposon IFG-7 (the most abundant repeat in the sequenced BAC) as a probe indicates that IFG-7 is found in roughly 210,557 copies and constitutes about 5.8% or 1.26 Gb of LP nuclear DNA; this DNA quantity is eight times the Arabidopsis genome. In addition to its use in genome characterization and gene isolation as demonstrated herein, the BAC library should hasten whole genome sequencing of LP via next-generation sequencing strategies/technologies and facilitate improvement of trees through molecular breeding and genetic engineering. The library and associated products are distributed by the Clemson University Genomics Institute (www.genome.clemson.edu).	[Magbanua, Zenaida V.; Ozkan, Seval; Bartlett, Benjamin D.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Mississippi Genome Explorat Lab, Mississippi State, MS 39762 USA; [Magbanua, Zenaida V.; Ozkan, Seval; Bartlett, Benjamin D.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA; [Magbanua, Zenaida V.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Magbanua, Zenaida V.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA; [Saski, Christopher A.] Clemson Univ, Clemson Univ Genom Inst, Clemson, SC USA; [Liston, Aaron; Cronn, Richard C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Cronn, Richard C.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Nelson, C. Dana] US Forest Serv, So Inst Forest Genet, Saucier, MS USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University; Clemson University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Magbanua, ZV (corresponding author), Mississippi State Univ, Mississippi Genome Explorat Lab, Mississippi State, MS 39762 USA.	zvm2@msstate.edu		Cronn, Richard/0000-0001-5342-3494; Peterson, Daniel/0000-0002-0274-5968	National Science Foundation [DBI-0421717, MCB-0841821]; U.S. Department of Agriculture [ARS-58-6402-7-241, CSREES-2009-34609-20222]; Div Of Molecular and Cellular Bioscience [0841821] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DBI-0421717 to DGP and CDN; MCB-0841821 to DGP) and U.S. Department of Agriculture (ARS-58-6402-7-241 to DGP; CSREES-2009-34609-20222 to ZVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auckland L, 2002, CONIFER MICROSATELLI; Baig MNR, 2009, GENOME, V52, P484, DOI [10.1139/G09-017, 10.1139/g09-017]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennett M. D., 2003, PLANT DNA C VALUES D; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berube Y, 2007, TREE GENET GENOMES, V3, P251, DOI 10.1007/s11295-006-0061-1; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Brown GR, 2003, GENETICS, V164, P1537; Brown GR, 2001, GENETICS, V159, P799; Cairney J, 2006, PLANT MOL BIOL, V62, P485, DOI 10.1007/s11103-006-9035-9; CAPEL J, 1993, NUCLEIC ACIDS RES, V21, P2369, DOI 10.1093/nar/21.10.2369; Cavagnaro PF, 2009, MOL GENET GENOMICS, V281, P273, DOI 10.1007/s00438-008-0411-9; Chagne D, 2003, MOL BREEDING, V12, P185, DOI 10.1023/A:1026318327911; Chester M, 2010, CYTOGENET GENOME RES, V129, P35, DOI 10.1159/000312959; Coyne CJ, 2007, GENOME, V50, P871, DOI 10.1139/G07-063; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farjon A., 2008, NATURAL HIST CONIFER; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Frederick WJ, 2008, BIORESOURCE TECHNOL, V99, P5051, DOI 10.1016/j.biortech.2007.08.086; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gough CM, 2004, TREE PHYSIOL, V24, P845, DOI 10.1093/treephys/24.7.845; Guimaraes PM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-14; Gutman W, 2008, CELL MOL BIOL LETT, V13, P74, DOI 10.2478/s11658-007-0038-6; Hawkins JS, 2008, PLANT SCI, V174, P557, DOI 10.1016/j.plantsci.2008.03.015; Hoekstra FA, 2001, CRYOBIOLOGY, V43, P140, DOI 10.1006/cryo.2001.2358; HOLST L, 1971, ANN MATH STAT, V42, P1671, DOI 10.1214/aoms/1177693165; Islam-Faridi MN, 2007, GENOME, V50, P241, DOI 10.1139/G06-153; Jacobs G, 2009, GENETICA, V135, P157, DOI 10.1007/s10709-008-9265-7; Kaufmann H, 2003, MOL GENET GENOMICS, V268, P666, DOI 10.1007/s00438-002-0784-0; Kossack DS, 1999, PLANT MOL BIOL, V39, P417, DOI 10.1023/A:1006115732620; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; LORENZ WW, 2006, TREE PHYSL, V26; Luo MZ, 2001, GENOME, V44, P154, DOI 10.1139/gen-44-2-154; McKeand S, 2003, J FOREST, V101, P32; MURRAY B, 2003, GYMNOSPERM DNA C VAL; NEALE DB, 1996, GENOME MAPPING PLANT, P309; Nilmalgoda SD, 2003, GENOME, V46, P870, DOI 10.1139/G03-067; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Peterson DG, 2000, J AGR GENOMICS, V5; Philippe C, 2008, ANAL BIOCHEM, V373, P78, DOI 10.1016/j.ab.2007.08.008; Plomion C., 2007, V7, P29; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; Sambrook J., 1999, MOL CLONING LAB MANU; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sewell MM, 1999, GENETICS, V151, P321; Shan XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S9; Shi BJ, 2009, THEOR APPL GENET, V119, P695, DOI 10.1007/s00122-009-1080-8; SMITH AM, 2010, NUCL ACIDS RES ADV; Steuernagel B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-547; Talia P, 2010, GENOME, V53, P172, DOI [10.1139/G09-097, 10.1139/g09-097]; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Yu Q, 2005, CAN J FOREST RES, V35, P1723, DOI 10.1139/X05-103; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HB, 2001, PLANT PHYSIOL BIOCH, V39, P195, DOI 10.1016/S0981-9428(00)01236-5	62	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16214	10.1371/journal.pone.0016214	http://dx.doi.org/10.1371/journal.pone.0016214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283709	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300020
J	Chan, M; Lim, PL; Chow, A; Win, MK; Barkham, TM				Chan, Monica; Lim, Poh Lian; Chow, Angela; Win, Mar Kyaw; Barkham, Timothy M.			Surveillance for Clostridium difficile Infection: ICD-9 Coding Has Poor Sensitivity Compared to Laboratory Diagnosis in Hospital Patients, Singapore	PLOS ONE			English	Article							DISEASE; CODES	Introduction: Clostridium difficile infection (CDI) is an increasingly recognized nosocomial infection in Singapore. Surveillance methods include laboratory reporting of Clostridium difficile toxin assays (CDTA) or use of International Classification of Diseases, 9(th) Revision (ICD-9) discharge code 008.45. Previous US studies showed good correlation between CDTA and ICD-9 codes. However, the use of ICD-9 codes for CDI surveillance has not been validated in other healthcare settings. Methods: We compared CDI rates based on CDTA to ICD-9 codes for all discharges in 2007 from our hospital to determine sensitivity and specificity of ICD-9 codes. Demographic and hospitalization data were analyzed to determine predictors for missing ICD-9 codes. Results: During 2007, there were 56,352 discharges. Of these, 268 tested CDTA-positive but only 133 were assigned the CDI ICD-9 code. A total of 141 discharges had the ICD-9 code; 8 were CDTA-negative, the rest were CDTA-positive. Community-acquired CDI accounted for only 3.2% of cases. The sensitivity and specificity of ICD-9 codes compared to CDTA were 49.6% and 100% respectively. Concordance between CDTA and ICD-9 codes was 0.649 (p<.001). Comparing concordant patients (CDTA+/ICD9+) to discordant patients (CDTA+/ICD9-), concordant patients were more likely to be over 50 years of age (OR 3.49, 95% CI 1.66-7.34, p = .001) and have shorter time from admission to testing (OR 0.98, 95% CI 0.97-0.99, p = .009). Discussion: Unlike previous studies in the US, ICD-9 codes substantially underestimate CDI in Singapore compared to microbiological data. Older patients with shorter time to testing were less likely to have missing ICD-9 codes.	[Chan, Monica; Lim, Poh Lian] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Chow, Angela; Win, Mar Kyaw] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Barkham, Timothy M.] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital	Chan, M (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	pllim@post.harvard.edu		Chow, Angela/0000-0002-4063-736X				Alcala L, 2008, J CLIN MICROBIOL, V46, P3833, DOI 10.1128/JCM.01060-08; Alfa MJ, 1998, J CLIN MICROBIOL, V36, P2076, DOI 10.1128/JCM.36.7.2076-2080.1998; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dubberke ER, 2006, EMERG INFECT DIS, V12, P1576, DOI 10.3201/eid1210.060016; Dubberke ER, 2010, INFECT CONT HOSP EP, V31, P262, DOI 10.1086/650447; Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013; HACEK DM, 2004, J CLIN MICROBIOL, V32, P232; Lim PL, 2008, EMERG INFECT DIS, V14, P1487, DOI 10.3201/eid1409.070043; Madsen KM, 1998, INFECT CONT HOSP EP, V19, P175; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; Scheurer DB, 2007, EPIDEMIOL INFECT, V135, P1010, DOI 10.1017/S0950268806007655; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572; Zilberberg MD, 2010, EMERG INFECT DIS, V16, P604, DOI 10.3201/eid1604.090680	14	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15603	10.1371/journal.pone.0015603	http://dx.doi.org/10.1371/journal.pone.0015603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283751	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200009
J	Fujioka, Y; Tsuda, M; Hattori, T; Sasaki, J; Sasaki, T; Miyazaki, T; Ohba, Y				Fujioka, Yoichiro; Tsuda, Masumi; Hattori, Tomoe; Sasaki, Junko; Sasaki, Takehiko; Miyazaki, Tadaaki; Ohba, Yusuke			The Ras-PI3K Signaling Pathway Is Involved in Clathrin-Independent Endocytosis and the Internalization of Influenza Viruses	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; A-VIRUS; NS1 PROTEIN; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL-3-KINASE PI3K; TRANSCRIPTION FACTOR-8; MEDIATED ENDOCYTOSIS; NEGATIVE REGULATION; DENGUE VIRUS; RAS BINDING	Background: Influenza virus infection causes highly contagious, severe respiratory disorders and gives rise to thousands of deaths every year; however, the efficacy of currently approved defense strategies, including vaccines and neuraminidase inhibitors, is limited because the virus frequently acquires resistance via antigen drift and reassortment. It is therefore important to establish a novel, effective therapeutic strategy that is effective irrespective of viral subtype. Methodology/Principal Findings: Here, we identify the Ras-phosphoinositide 3-kinase (PI3K) signaling pathway as a host-cell regulatory mechanism for influenza virus entry. The binding of Ras to PI3K is specifically involved in clathrinin-dependent endocytosis, endosomal maturation, and intracellular transport of viruses, which result in decreased infectious efficacy of different subtypes of influenza viruses in cells lacking the Ras-PI3K interaction. Moreover, influenza virus infection indeed triggered Ras activation and subsequent PI3K activation in early endosomes. Conclusions/Significance: Taken together, these results demonstrate that the Ras-PI3K signaling axis acts as a host-oriented mechanism for viral internalization. Given that virus incorporation is a process conserved among virus subtypes and species, this signaling pathway may provide a target for potent, well-tolerated prophylactics and therapeutics against a broad range of viruses.	[Fujioka, Yoichiro; Tsuda, Masumi; Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan; [Hattori, Tomoe; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Sch Med, Div Microbiol, Dept Pathol & Immunol, Akita 010, Japan	Hokkaido University; Hokkaido University; Akita University	Fujioka, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan.	yohba@med.hokudai.ac.jp	Ohba, Yusuke/E-7944-2011; Fujioka, Yoichiro/AAF-3313-2019; Miyazaki, Tadaaki/D-9368-2012	Fujioka, Yoichiro/0000-0002-5760-9357; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Japan Science and Technology Agency; Takeda Science Foundation; Akiyama Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Akiyama Foundation	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Society for the Promotion of Science and by grants from the Japan Science and Technology Agency, the Takeda Science Foundation, and the Akiyama Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Ehrhardt C, 2007, J VIROL, V81, P12097, DOI 10.1128/JVI.01216-07; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Inuzuka T, 2009, CANCER RES, V69, P1678, DOI 10.1158/0008-5472.CAN-08-3620; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Li Y, 2008, J BIOL CHEM, V283, P23397, DOI 10.1074/jbc.M802737200; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Tsutsumi K, 2009, CELL SIGNAL, V21, P1672, DOI 10.1016/j.cellsig.2009.07.004; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	50	53	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16324	10.1371/journal.pone.0016324	http://dx.doi.org/10.1371/journal.pone.0016324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283725	Green Published, gold			2022-12-27	WOS:000286522200051
J	Sousa, AGP; Lopes, NH; Hueb, WA; Krieger, JE; Pereira, AC				Sousa, Andre Gustavo P.; Lopes, Neuza H.; Hueb, Whady A.; Krieger, Jose Eduardo; Pereira, Alexandre C.			Genetic Variants of Diabetes Risk and Incident Cardiovascular Events in Chronic Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONTROLLED CLINICAL-TRIAL; 3 THERAPEUTIC STRATEGIES; MASS-II; FOLLOW-UP; ANGIOPLASTY; SURGERY; LOCI; MEDICINE; REPLICATION	Objective: To determine whether information from genetic risk variants for diabetes is associated with cardiovascular events incidence. Methods: From the about 30 known genes associated with diabetes, we genotyped single-nucleotide polymorphisms at the 10 loci most associated with type-2 diabetes in 425 subjects from the MASS-II Study, a randomized study in patients with multi-vessel coronary artery disease. The combined genetic information was evaluated by number of risk alleles for diabetes. Performance of genetic models relative to major cardiovascular events incidence was analyzed through Kaplan-Meier curve comparison and Cox Hazard Models and the discriminatory ability of models was assessed for cardiovascular events by calculating the area under the ROC curve. Results: Genetic information was able to predict 5-year incidence of major cardiovascular events and overall-mortality in non-diabetic individuals, even after adjustment for potential confounders including fasting glycemia. Non-diabetic individuals with high genetic risk had a similar incidence of events then diabetic individuals (cumulative hazard of 33.0 versus 35.1% of diabetic subjects). The addition of combined genetic information to clinical predictors significantly improved the AUC for cardiovascular events incidence (AUC = 0.641 versus 0.610). Conclusions: Combined information of genetic variants for diabetes risk is associated to major cardiovascular events incidence, including overall mortality, in non-diabetic individuals with coronary artery disease.	[Sousa, Andre Gustavo P.; Krieger, Jose Eduardo; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Sousa, Andre Gustavo P.] Univ Fed Rio Grande do Norte, Dept Clin Med, BR-59072970 Natal, RN, Brazil; [Lopes, Neuza H.; Hueb, Whady A.] Univ Sao Paulo, Sch Med, Inst Heart, Coronary Artery Dis Serv, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo	Sousa, AGP (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	agpsousa@ig.com.br	Krieger, Jose E/C-3117-2011; Pereira, Alexandre/HHN-1038-2022; Hueb, Whady/A-7919-2013	Krieger, Jose E/0000-0001-5464-1792; Hueb, Whady/0000-0002-3166-6054	FAPESP [2007/54138-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (www.fapesp.br) grant number 2007/54138-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman EL, 1996, NEW ENGL J MED, V335, P217; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; *IDF, 2004, INT DIAB FED DIAB AT; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Pereira AC, 2006, J AM COLL CARDIOL, V48, P948, DOI 10.1016/j.jacc.2005.11.094; Qiao Q, 2003, DIABETES CARE, V26, P688; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schettert IT, 2006, THROMB RES, V118, P679, DOI 10.1016/j.thromres.2005.11.009; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16341	10.1371/journal.pone.0016341	http://dx.doi.org/10.1371/journal.pone.0016341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283728	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200053
J	Oruc, I; Guo, XYM; Barton, JJS				Oruc, Ipek; Guo, Xiaoyue M.; Barton, Jason J. S.			Gender in Facial Representations: A Contrast-Based Study of Adaptation within and between the Sexes	PLOS ONE			English	Article							HUMAN VISUAL-SYSTEM; CATEGORICAL PERCEPTION; FACE-SPACE; FEMALE FACES; ORIENTATION; RECOGNITION; MOTION; TILT; DISTINCTIVENESS; THRESHOLDS	Face aftereffects are proving to be an effective means of examining the properties of face-specific processes in the human visual system. We examined the role of gender in the neural representation of faces using a contrast-based adaptation method. If faces of different genders share the same representational face space, then adaptation to a face of one gender should affect both same- and different-gender faces. Further, if these aftereffects differ in magnitude, this may indicate distinct gender-related factors in the organization of this face space. To control for a potential confound between physical similarity and gender, we used a Bayesian ideal observer and human discrimination data to construct a stimulus set in which pairs of different-gender faces were equally dissimilar as same- gender pairs. We found that the recognition of both same-gender and different-gender faces was suppressed following a brief exposure of 100ms. Moreover, recognition was more suppressed for test faces of a different-gender than those of the same-gender as the adaptor, despite the equivalence in physical and psychophysical similarity. Our results suggest that male and female faces likely occupy the same face space, allowing transfer of aftereffects between the genders, but that there are special properties that emerge along gender-defining dimensions of this space.	[Oruc, Ipek; Guo, Xiaoyue M.; Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Oruc, Ipek; Guo, Xiaoyue M.; Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Guo, Xiaoyue M.] Wellesley Coll, Dept Neurosci, Wellesley, MA 02181 USA	University of British Columbia; University of British Columbia; University of British Columbia; Wellesley College	Oruc, I (corresponding author), Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada.	ipor@interchange.ubc.ca	Barton, Jason JS/A-6362-2012; Oruc, Ipek/C-8719-2013	Guo, Xiaoyue Mona/0000-0002-5922-272X	Natural Sciences and Engineering Research Council [RGPIN 355879-08]; University of British Columbia; Canada Research Chair; Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by Discovery Grant RGPIN 355879-08 from the Natural Sciences and Engineering Research Council. MG was supported by a Canadian Institutes of Health Research Summer Studentship from the University of British Columbia graduate program in neuroscience. JB was also supported by a Canada Research Chair and Senior Scholar Award from the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bestelmeyer PEG, 2008, COGNITION, V107, P353, DOI 10.1016/j.cognition.2007.07.018; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; BLAKEMORE C, 1971, J PHYSIOL-LONDON, V213, P157, DOI 10.1113/jphysiol.1971.sp009374; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bulthoff I, 2004, VIS COGN, V11, P823, DOI 10.1080/13506280444000012; Campanella S, 2001, VIS COGN, V8, P237, DOI 10.1080/13506280042000072; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Fox CJ, 2008, J VISION, V8, DOI 10.1167/8.3.11; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Green DM, 1988, SIGNAL DETECTION THE; Guo XYM, 2009, VISION RES, V49, P2254, DOI 10.1016/j.visres.2009.06.012; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Huber DE, 2003, COGNITIVE SCI, V27, P403, DOI 10.1016/S0364-0213(03)00012-0; Jaquet E, 2008, J EXP PSYCHOL HUMAN, V34, P101, DOI 10.1037/0096-1523.34.1.101; Johnston RA, 1997, VIS COGN, V4, P59, DOI 10.1080/713756748; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; Little AC, 2005, P ROY SOC B-BIOL SCI, V272, P2283, DOI 10.1098/rspb.2005.3220; LUNDQVIST D, 1998, AVERAGED KAROLINKSA; MAGNUSSEN S, 1986, VISION RES, V26, P661, DOI 10.1016/0042-6989(86)90014-3; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Ng M, 2008, J VISION, V8, DOI 10.1167/8.1.1; Oruc I, 2010, VISION RES, V50, P1845, DOI 10.1016/j.visres.2010.06.005; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rostamirad S, 2009, NEUROREPORT, V20, P1177, DOI 10.1097/WNR.0b013e32832f078d; SEKULER RW, 1968, J OPT SOC AM, V58, P1146, DOI 10.1364/JOSA.58.001146; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; TJAN BS, 1995, VISION RES, V35, P3053, DOI 10.1016/0042-6989(95)00070-G; VALENTINE T, 1992, Q J EXP PSYCHOL-A, V44, P671, DOI 10.1080/14640749208401305; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Valentine T, 2001, SCI PSYCH S, P83; Valentine T., 1995, ACCOUNT OWN RACE BIA; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	48	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16251	10.1371/journal.pone.0016251	http://dx.doi.org/10.1371/journal.pone.0016251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267414	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500049
J	Sinakevitch, I; Mustard, JA; Smith, BH				Sinakevitch, Irina; Mustard, Julie A.; Smith, Brian H.			Distribution of the Octopamine Receptor AmOA1 in the Honey Bee Brain	PLOS ONE			English	Article							UNPAIRED MEDIAN NEURONS; COCKROACH PERIPLANETA-AMERICANA; FLY DROSOPHILA-MELANOGASTER; DIVISION-OF-LABOR; APIS-MELLIFERA L; MUSHROOM BODIES; SUBESOPHAGEAL GANGLION; VISUAL-SYSTEM; CENTRAL COMPLEX; ANTENNAL LOBES	Octopamine plays an important role in many behaviors in invertebrates. It acts via binding to G protein coupled receptors located on the plasma membrane of responsive cells. Several distinct subtypes of octopamine receptors have been found in invertebrates, yet little is known about the expression pattern of these different receptor subtypes and how each subtype may contribute to different behaviors. One honey bee (Apis mellifera) octopamine receptor, AmOA1, was recently cloned and characterized. Here we continue to characterize the AmOA1 receptor by investigating its distribution in the honey bee brain. We used two independent antibodies produced against two distinct peptides in the carboxyl-terminus to study the distribution of the AmOA1 receptor in the honey bee brain. We found that both anti-AmOA1 antibodies revealed labeling of cell body clusters throughout the brain and within the following brain neuropils: the antennal lobes; the calyces, pedunculus, vertical (alpha, gamma) and medial (beta) lobes of the mushroom body; the optic lobes; the subesophageal ganglion; and the central complex. Double immunofluorescence staining using anti-GABA and anti-AmOA1 receptor antibodies revealed that a population of inhibitory GABAergic local interneurons in the antennal lobes express the AmOA1 receptor in the cell bodies, axons and their endings in the glomeruli. In the mushroom bodies, AmOA1 receptors are expressed in a subpopulation of inhibitory GABAergic feedback neurons that ends in the visual (outer half of basal ring and collar regions) and olfactory (lip and inner basal ring region) calyx neuropils, as well as in the collar and lip zones of the vertical and medial lobes. The data suggest that one effect of octopamine via AmOA1 in the antennal lobe and mushroom body is to modulate inhibitory neurons.	[Sinakevitch, Irina; Mustard, Julie A.; Smith, Brian H.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sinakevitch, I (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	brian.h.smith@asu.edu		Mustard, Julie A/0000-0002-1412-1140	National Institutes of Health National Center for Research Resources [RR014166]; National Institute on Deafness and Other Communication Disorders [DC007997]; National Institute on Drug Abuse [DA017694]; Fondation pour Recherche Medicale [UFM20060306548]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA017694] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Fondation pour Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institutes of Health National Center for Research Resources grant RR014166 and National Institute on Deafness and Other Communication Disorders grant DC007997 to BHS; National Institute on Drug Abuse grant DA017694 to JAM; and Fondation pour Recherche Medicale grant UFM20060306548 to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Bacon JP, 1995, J NEUROPHYSIOL, V74, P2739, DOI 10.1152/jn.1995.74.6.2739; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Bornhauser BC, 1997, CELL TISSUE RES, V287, P211, DOI 10.1007/s004410050747; Braunig P, 2004, ACTA BIOL HUNG, V55, P13, DOI 10.1556/ABiol.55.2004.1-4.3; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brown SM, 2006, J COMP NEUROL, V496, P556, DOI 10.1002/cne.20943; Busch S, 2010, J COMP NEUROL, V518, P2355, DOI 10.1002/cne.22337; CANDY DJ, 1978, INSECT BIOCHEM, V8, P177, DOI 10.1016/0020-1790(78)90070-7; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; DAVENPORT AP, 1984, INSECT BIOCHEM, V14, P135, DOI 10.1016/0020-1790(84)90021-0; Dierick HA, 2008, CURR BIOL, V18, pR161, DOI 10.1016/j.cub.2007.12.026; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; ERBER J, 1995, J COMP PHYSIOL A, V176, P111, DOI 10.1007/BF00197757; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Farooqui T, 2003, J NEUROSCI, V23, P5370; Farris SM, 2004, J COMP NEUROL, V474, P325, DOI 10.1002/cne.20146; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; GEFFARD M, 1984, BRAIN RES, V294, P161, DOI 10.1016/0006-8993(84)91323-4; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Grunewald B, 1999, J COMP NEUROL, V404, P114; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Han KA, 1998, J NEUROSCI, V18, P3650; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HOMBERG U, 1985, J INSECT PHYSIOL, V31, P251, DOI 10.1016/0022-1910(85)90127-1; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; KLOPPENBURG P, 1995, J COMP PHYSIOL A, V176, P119, DOI 10.1007/BF00197758; KONINGS PNM, 1988, CELL TISSUE RES, V251, P371, DOI 10.1007/BF00215846; KREISSL S, 1994, J COMP NEUROL, V348, P583, DOI 10.1002/cne.903480408; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Matheson T, 1997, J EXP BIOL, V200, P1317; Mentel T, 2003, J NEUROSCI, V23, P1109, DOI 10.1523/JNEUROSCI.23-04-01109.2003; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; REHDER V, 1988, PROC R SOC SER B-BIO, V235, P179, DOI 10.1098/rspb.1988.0071; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; ROWELL CHF, 1971, J EXP BIOL, V55, P727; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; RYBAK J, 2001, 6 INT C NEUR 29 JUL; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SEGUELA P, 1984, P NATL ACAD SCI-BIOL, V81, P3888, DOI 10.1073/pnas.81.12.3888; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Sinakevitch I, 2001, J COMP NEUROL, V439, P352, DOI 10.1002/cne.1355; Sinakevitch IG, 1996, J COMP NEUROL, V367, P147; SINAKEVITCH IG, 1994, CELL TISSUE RES, V276, P15, DOI 10.1007/BF00354779; Smith BH, 2006, BIOLOGY OF FLORAL SCENT, P263; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Stern M, 1999, MICROSC RES TECHNIQ, V45, P135, DOI 10.1002/(SICI)1097-0029(19990501)45:3<135::AID-JEMT1>3.0.CO;2-G; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; WATSON AHD, 1984, J NEUROCYTOL, V13, P303, DOI 10.1007/BF01148121; Wicher Dieter, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P304, DOI 10.2174/187153007782794290; Widmer A, 2005, J NEUROSCI, V25, P1588, DOI 10.1523/JNEUROSCI.4505-04.2005; Yamagata N, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.016.2009; Zhukovskaya MI, 2006, J INSECT PHYSIOL, V52, P76, DOI 10.1016/j.jinsphys.2005.09.005	81	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14536	10.1371/journal.pone.0014536	http://dx.doi.org/10.1371/journal.pone.0014536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267078	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500010
J	Liu, FY; Hu, XL; Zimmerman, M; Waller, JL; Wu, P; Hayes-Jordan, A; Lev, D; Liu, KB				Liu, Feiyan; Hu, Xiaolin; Zimmerman, Mary; Waller, Jennifer L.; Wu, Ping; Hayes-Jordan, Andrea; Lev, Dina; Liu, Kebin			TNF alpha Cooperates with IFN-gamma to Repress Bcl-xL Expression to Sensitize Metastatic Colon Carcinoma Cells to TRAIL-mediated Apoptosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; LIGAND-INDUCED APOPTOSIS; BREAST-CANCER CELLS; DOWN-REGULATION; COLORECTAL-CANCER; DEATH RECEPTORS; HEPATOCELLULAR-CARCINOMA; INITIATED APOPTOSIS; PROTEIN EXPRESSION	Background: TNF-related apoptosis-inducing ligand (TRAIL) is an immune effector molecule that functions as a selective anti-tumor agent. However, tumor cells, especially metastatic tumor cells often exhibit a TRAIL-resistant phenotype, which is currently a major impediment in TRAIL therapy. The aim of this study is to investigate the synergistic effect of TNF alpha and IFN-gamma in sensitizing metastatic colon carcinoma cells to TRAIL-mediated apoptosis. Methodology/Principal Findings: The efficacy and underlying molecular mechanism of cooperation between TNF alpha and IFN-gamma in sensitizing metastatic colon carcinoma cells to TRAIL-mediated apoptosis were examined. The functional significance of TNF alpha- and IFN-gamma-producing T lymphocyte immunotherapy in combination with TRAIL therapy in suppression of colon carcinoma metastasis was determined in an experimental metastasis mouse model. We observed that TNF alpha or IFN-gamma alone exhibits minimal sensitization effects, but effectively sensitized metastatic colon carcinoma cells to TRAIL-induced apoptosis when used in combination. TNF alpha and IFN-gamma cooperate to repress Bcl-xL expression, whereas TNF alpha represses Survivin expression in the metastatic colon carcinoma cells. Silencing Bcl-xL expression significantly increased the metastatic colon carcinoma cell sensitivity to TRAIL-induced apoptosis. Conversely, overexpression of Bcl-xL significantly decreased the tumor cell sensitivity to TRAIL-induced apoptosis. Furthermore, TNF alpha and IFN-gamma also synergistically enhanced TRAIL-induced caspase-8 activation. TNF alpha and IFN-gamma was up-regulated in activated primary and tumor-specific T cells. TRAIL was expressed in tumor-infiltrating immune cells in vivo, and in tumor-specific cytotoxic T lymphocytes (CTL) ex vivo. Consequently, TRAIL therapy in combination with TNF alpha/IFN-gamma-producing CTL adoptive transfer immunotherapy effectively suppressed colon carcinoma metastasis in vivo. Conclusions/Significance: TNF alpha and IFN-gamma cooperate to overcome TRAIL resistance at least partially through enhancing caspase 8 activation and repressing Bcl-xL expression. Combined CTL immunotherapy and TRAIL therapy hold great promise for further development for the treatment of metastatic colorectal cancer.	[Liu, Feiyan; Wu, Ping] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Feiyan; Hu, Xiaolin; Zimmerman, Mary; Liu, Kebin] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Waller, Jennifer L.] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biostat, Augusta, GA USA; [Hayes-Jordan, Andrea] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Hayes-Jordan, Andrea] Univ Texas MD Anderson Canc Ctr, Dept Pediat Oncol, Houston, TX 77030 USA; [Lev, Dina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Liu, Kebin] Univ Texas MD Anderson Canc Ctr, Sarcoma Res Ctr, Houston, TX 77030 USA	Zhejiang University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, FY (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	Kliu@mcg.edu		Liu, Kebin/0000-0003-1965-7240	National Institutes of Health [CA133085, CA138345]; American Cancer Society [RSG-09-209-01-TBG]; National High Technology Research and Development Program of China [2007AA021504]; NATIONAL CANCER INSTITUTE [R01CA138345, R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support from the National Institutes of Health (CA133085 to KL and CA138345 to DL), the American Cancer Society (RSG-09-209-01-TBG to K.L.), and the National High Technology Research and Development Program of China (2007AA021504 to FL and PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EY, 2002, INT J CANCER, V100, P445, DOI 10.1002/ijc.10516; Ammann JU, 2009, INT J CANCER, V124, P1301, DOI 10.1002/ijc.24068; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bhat UG, 2008, INT J CANCER, V122, P1426, DOI 10.1002/ijc.23239; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Chawla-Sarkar M, 2003, J BIOL CHEM, V278, P39461, DOI 10.1074/jbc.M306111200; Darvas K, 2010, INT J CANCER, V127, P1384, DOI 10.1002/ijc.25170; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Elrod HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012178; Fulda S, 2006, ONCOGENE, V25, P5125, DOI 10.1038/sj.onc.1209518; Gagiannis S, 2009, INT J CANCER, V125, P1551, DOI 10.1002/ijc.24471; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Haynes NM, 2010, J IMMUNOL, V185, P532, DOI 10.4049/jimmunol.0903624; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Jalving M, 2006, CLIN CANCER RES, V12, P4350, DOI 10.1158/1078-0432.CCR-05-2487; Jani TS, 2010, J BIOL CHEM, V285, P19162, DOI 10.1074/jbc.M109.091645; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045; Karlsson M, 2010, ANN SURG ONCOL, V17, P1747, DOI 10.1245/s10434-010-0920-8; Kauh J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010376; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lacour S, 2001, CANCER RES, V61, P1645; Li FZ, 2006, AM J PATHOL, V169, P1, DOI 10.2353/ajpath.2006.060121; Li FZ, 2005, ONCOGENE, V24, P1385, DOI 10.1038/sj.onc.1208330; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Lippa MS, 2007, APOPTOSIS, V12, P1465, DOI 10.1007/s10495-007-0076-6; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Panner A, 2009, CANCER RES, V69, P7911, DOI 10.1158/0008-5472.CAN-09-1287; Psahoulia FH, 2007, MOL CANCER THER, V6, P2591, DOI 10.1158/1535-7163.MCT-07-0001; Ravi R, 2006, CANCER RES, V66, P1730, DOI 10.1158/0008-5472.CAN-05-3377; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Seol DW, 2001, CANCER RES, V61, P1138; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Sinicrope FA, 2005, MOL CANCER THER, V4, P1475, DOI 10.1158/1535-7163.MCT-05-0137; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Tillman DM, 2003, CANCER RES, V63, P5118; van der Most RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006982; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Xu J, 2006, CANCER RES, V66, P10092, DOI 10.1158/0008-5472.CAN-06-1633; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang DF, 2008, INT J CANCER, V122, P350, DOI 10.1002/ijc.23090; Yang DF, 2007, J IMMUNOL, V179, P4775, DOI 10.4049/jimmunol.179.7.4775; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhou Y, 2008, J INTERF CYTOK RES, V28, P65, DOI 10.1089/jir.2007.0025; Zimmerman M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014076	73	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16241	10.1371/journal.pone.0016241	http://dx.doi.org/10.1371/journal.pone.0016241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264227	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600023
J	Rivera-Gutierrez, HF; Pinxten, R; Eens, M				Rivera-Gutierrez, Hector F.; Pinxten, Rianne; Eens, Marcel			Difficulties when Assessing Birdsong Learning Programmes under Field Conditions: A Re-Evaluation of Song Repertoire Flexibility in the Great Tit	PLOS ONE			English	Article							PARUS-MAJOR; SEXUAL SELECTION; ACQUISITION; SIMILARITY; SPARROWS; BEHAVIOR; OVERLAP; CHOICE; SIZE; MATE	There is a remarkable diversity of song-learning strategies in songbirds. Establishing whether a species is closed-or open-ended is important to be able to interpret functional and evolutionary consequences of variation in repertoire size. Most of our knowledge regarding the timing of vocal learning is based on laboratory studies, despite the fact that these may not always replicate the complex ecological and social interactions experienced by birds in the wild. Given that field studies cannot provide the experimental control of laboratory studies, it may not be surprising that species such as the great tit that were initially assumed to be closed-ended learners have later been suggested to be open-ended learners. By using an established colour-ringed population, by following a standardized recording protocol, and by taking into account the species' song ecology (using only recordings obtained during peak of singing at dawn), we replicated two previous studies to assess song repertoire learning and flexibility in adult wild great tits elicited by social interactions. First, we performed a playback experiment to test repertoire plasticity elicited by novel versus own songs. Additionally, in a longitudinal study, we followed 30 males in two consecutive years and analysed whether new neighbours influenced any change in the repertoire. Contrary to the previous studies, song repertoire size and composition were found to be highly repeatable both between years and after confrontation with a novel song. Our results suggest that great tits are closed-ended learners and that their song repertoire probably does not change during adulthood. Methodological differences that may have led to an underestimation of the repertoires or population differences may explain the discrepancy in results with previous studies. We argue that a rigorous and standardized assessment of the repertoire is essential when studying age-or playback-induced changes in repertoire size and composition under field conditions.	[Rivera-Gutierrez, Hector F.; Pinxten, Rianne; Eens, Marcel] Univ Antwerp, Ethol Grp, Antwerp, Belgium	University of Antwerp	Rivera-Gutierrez, HF (corresponding author), Univ Antwerp, Ethol Grp, Antwerp, Belgium.	HectorFabio.RiveraGutierrez@ua.ac.be	Eens, Marcel/AAC-8466-2020; Rivera-Gutierrez, Hector/AAE-7879-2020	Rivera-Gutierrez, Hector/0000-0001-6025-3470	University of Antwerp; FWO-Flanders [G.0130.07, G.0280.10N]	University of Antwerp; FWO-Flanders(FWO)	Financial support was provided by the University of Antwerp and FWO-Flanders (Research Projects G.0130.07 and G.0280.10N) to ME and RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2002, ANIM BEHAV, V64, P939, DOI 10.1006/anbe.2002.1974; Beecher MD, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 1: A-G, P164; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Beecher MD, 1996, ECOLOGY EVOLUTION AC; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CHAIKEN M, 1994, BEHAVIOUR, V128, P25, DOI 10.1163/156853994X00037; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; EENS M, 1992, IBIS, V134, P72, DOI 10.1111/j.1474-919X.1992.tb07233.x; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; FALLS JB, 1982, ANIM BEHAV, V30, P997, DOI 10.1016/S0003-3472(82)80188-7; Foote JR, 2009, WILSON J ORNITHOL, V121, P819, DOI 10.1676/08-137.1; Forstmeier W, 2006, BEHAV ECOL SOCIOBIOL, V59, P634, DOI 10.1007/s00265-005-0090-z; Franco P, 2009, ANIM BEHAV, V77, P261, DOI 10.1016/j.anbehav.2008.09.023; Gorissen L, 2005, OECOLOGIA, V145, P504, DOI 10.1007/s00442-005-0091-7; Gorissen L, 2004, AUK, V121, P184, DOI 10.1642/0004-8038(2004)121[0184:ICBMAF]2.0.CO;2; Gosler A, 1993, GREAT TIT; HINDE R, 1952, BEHAVIOUR S2, V1, P1; Holland J, 2001, BEHAVIOUR, V138, P189, DOI 10.1163/15685390151074375; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; KREBS J, 1978, NATURE, V271, P539, DOI 10.1038/271539a0; KREBS JR, 1977, ANIM BEHAV, V25, P475, DOI 10.1016/0003-3472(77)90022-7; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; KREBS JR, 1976, BEHAV ECOL SOCIOBIOL, V1, P215, DOI 10.1007/BF00299198; KROODSMA DE, 1991, AM ZOOL, V31, P318; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; MACE R, 1987, NATURE, V330, P745, DOI 10.1038/330745a0; MACE R, 1987, ARDEA, V75, P123; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; MCGREGOR PK, 1982, BEHAVIOUR, V79, P126, DOI 10.1163/156853982X00210; MCGREGOR PK, 1981, AM NAT, V118, P149, DOI 10.1086/283811; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Nordby JC, 2002, ETHOLOGY, V108, P39, DOI 10.1046/j.1439-0310.2002.00752.x; Nordeen KW, 2004, ANN NY ACAD SCI, V1016, P416, DOI 10.1196/annals.1298.018; NOTTEBOHM F, 1984, CONDOR, V86, P227, DOI 10.2307/1366988; Nowicki S, 1998, AM ZOOL, V38, P179; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; PETERS SS, 1980, ANIM BEHAV, V28, P393, DOI 10.1016/S0003-3472(80)80048-0; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; Rivera-Gutierrez HF, 2010, ETHOLOGY, V116, P951, DOI 10.1111/j.1439-0310.2010.01813.x; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; SEARCY WA, 1992, AM ZOOL, V32, P71; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Trillo PA, 2005, ANIM BEHAV, V70, P921, DOI 10.1016/j.anbehav.2005.02.004; Van Duyse E, 2005, HORM BEHAV, V48, P243, DOI 10.1016/j.yhbeh.2005.02.013; Van Duyse E, 2003, GEN COMP ENDOCR, V134, P1, DOI 10.1016/S0016-6480(03)00213-2	49	15	15	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16003	10.1371/journal.pone.0016003	http://dx.doi.org/10.1371/journal.pone.0016003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264212	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600016
J	Kanakaraj, I; Jewell, DL; Murphy, JC; Fox, GE; Willson, RC				Kanakaraj, Indhu; Jewell, David L.; Murphy, Jason C.; Fox, George E.; Willson, Richard C.			Removal of PCR Error Products and Unincorporated Primers by Metal-Chelate Affinity Chromatography	PLOS ONE			English	Article							PLASMID DNA; NUCLEIC-ACIDS; POLYMERASE; RNA; PURIFICATION; SEPARATION; IONS	Immobilized Metal Affinity Chromatography (IMAC) has been used for decades to purify proteins on the basis of amino acid content, especially surface-exposed histidines and "histidine tags'' genetically added to recombinant proteins. We and others have extended the use of IMAC to purification of nucleic acids via interactions with the nucleotide bases, especially purines, of single-stranded RNA and DNA. We also have demonstrated the purification of plasmid DNA from contaminating genomic DNA by IMAC capture of selectively-denatured genomic DNA. Here we describe an efficient method of purifying PCR products by specifically removing error products, excess primers, and unincorporated dNTPs from PCR product mixtures using flow-through metal-chelate affinity adsorption. By flowing a PCR product mixture through a Cu(2+)-iminodiacetic acid (IDA) agarose spin column, 94-99% of the dNTPs and nearly all the primers can be removed. Many of the error products commonly formed by Taq polymerase also are removed. Sequencing of the IMAC-processed PCR product gave base-calling accuracy comparable to that obtained with a commercial PCR product purification method. The results show that IMAC matrices (specifically Cu(2+)-IDA agarose) can be used for the purification of PCR products. Due to the generality of the base-specific mechanism of adsorption, IMAC matrices may also be used in the purification of oligonucleotides, cDNA, mRNA and micro RNAs.	[Kanakaraj, Indhu; Fox, George E.; Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Jewell, David L.; Murphy, Jason C.; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Kanakaraj, I (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	willson@uh.edu	Willson, richard/AAD-4832-2019		National Space Biomedical Research Institute (NASA) [NCC 9-58]; Robert A. Welch Foundation [E-1264, E-1451]	National Space Biomedical Research Institute (NASA)(National Aeronautics & Space Administration (NASA)); Robert A. Welch Foundation(The Welch Foundation)	This research was funded by grants to RCW and GEF from the National Space Biomedical Research Institute (NASA Cooperative Agreement NCC 9-58), and from the Robert A. Welch Foundation (Grants E-1264 and E-1451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan S, 2003, BIOTECHNOL LETT, V25, P1111, DOI 10.1023/A:1024148316322; Cano T, 2005, BIOTECHNOL PROGR, V21, P1472, DOI 10.1021/bp050155g; DUSTERHOFT A, 1998, QIAGEN GUIDE TEMPLAT; Eckert K A, 1991, PCR Methods Appl, V1, P17; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FANOUAYI L, 1983, ANN NY ACAD SCI, V413, P300, DOI 10.1111/j.1749-6632.1983.tb47904.x; Fu JY, 2006, J MOL RECOGNIT, V19, P348, DOI 10.1002/jmr.789; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUBERT P, 1980, J CHROMATOGR, V198, P247, DOI 10.1016/S0021-9673(00)84764-0; LUO RG, 2002, Patent No. 6365147; Marzilli L.G, 1980, NUCL ACID METAL ION, P179; Murphy JC, 2003, BIOTECHNOL PROGR, V19, P982, DOI 10.1021/bp025563o; Nastasijevic B, 2008, BIOCHEM BIOPH RES CO, V366, P420, DOI 10.1016/j.bbrc.2007.11.169; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Potty ASR, 2006, J CHROMATOGR A, V1115, P88, DOI 10.1016/j.chroma.2006.02.077; Smith J, 1997, P NATL ACAD SCI USA, V94, P6847, DOI 10.1073/pnas.94.13.6847; SULKOWSKI E, 1989, BIOESSAYS, V10, P170, DOI 10.1002/bies.950100508; Tan LH, 2007, CHEM ENG SCI, V62, P5809, DOI 10.1016/j.ces.2007.06.019; Tan LH, 2007, J CHROMATOGR A, V1141, P226, DOI 10.1016/j.chroma.2006.12.023	20	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14512	10.1371/journal.pone.0014512	http://dx.doi.org/10.1371/journal.pone.0014512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264292	gold, Green Published, Green Submitted			2022-12-27	WOS:000286516500003
J	Kostyak, JC; Naik, UP				Kostyak, John C.; Naik, Ulhas P.			Calcium- and Integrin-Binding Protein 1 Regulates Endomitosis and Its Interaction with Polo-Like Kinase 3 Is Enhanced in Endomitotic Dami Cells	PLOS ONE			English	Article							MEGAKARYOCYTIC DIFFERENTIATION; CLEAVAGE FURROW; ACTIN REORGANIZATION; CONTRACTILE RING; TUMOR-SUPPRESSOR; DROSOPHILA-POLO; MITOTIC KINASES; CYCLE ARREST; DNA-DAMAGE; PLK3	Endomitosis is a form of mitosis in which both karyokinesis and cytokinesis are interrupted and is a hallmark of megakaryocyte differentiation. Very little is known about how such a dramatic alteration of the cell cycle in a physiological setting is achieved. Thrombopoietin-induced signaling is essential for induction of endomitosis. Here we show that calcium- and integrin-binding protein 1 (CIB1), a known regulator of platelet integrin alpha(IIb)beta(3) outside-in signaling, regulates endomitosis. We observed that CIB1 expression is increased in primary mouse megakaryocytes compared to mononuclear bone marrow cells as determined by Western blot analysis. Following PMA treatment of Dami cells, a megakaryoblastic cell line, we found that CIB1 protein expression increased concomitant with cell ploidy. Overexpression of CIB1 in Dami cells resulted in multilobated nuclei and led to increased time for a cell to complete cytokinesis as well as increased incidence of furrow regression as observed by time-lapse microscopy. Additionally, we found that surface expression of integrin alpha(IIb)beta(3), an important megakaryocyte marker, was enhanced in CIB1 overexpressing cells as determined by flow cytometry. Furthermore, PMA treatment of CIB1 overexpressing cells led to increased ploidy compared to PMA treated control cells. Interestingly, expression of Polo-like kinase 3 (Plk3), an established CIB1-interacting protein and a key regulator of the mitotic process, decreased upon PMA treatment of Dami cells. Furthermore, PMA treatment augmented the interaction between CIB1 and Plk3, which depended on the duration of treatment. These data suggest that CIB1 is involved in regulating endomitosis, perhaps through its interaction with Plk3.	[Kostyak, John C.; Naik, Ulhas P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Naik, Ulhas P.] Univ Delaware, Dept Chem Engn, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Naik, Ulhas P.] Univ Delaware, Delaware Cardiovasc Res Ctr, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware; University of Delaware; University of Delaware	Kostyak, JC (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	unaik@udel.edu			National Heart Lung and Blood Institute [HL57630]; National Center for Research Resources [P20RR15588]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057630, R01HL057630] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute Grant HL57630 and National Center for Research Resources Grant P20RR15588 (to U.P.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRYSIK Z, NUCL ACIDS RES, V38, P2931; Bahassi ELM, 2004, ONCOGENE, V23, P2658, DOI 10.1038/sj.onc.1207425; Bahassi EM, 2006, MUTAT RES-FUND MOL M, V596, P166, DOI 10.1016/j.mrfmmm.2005.12.002; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Conn CW, 2000, CANCER RES, V60, P6826; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fuhrken PG, 2008, J BIOL CHEM, V283, P15589, DOI 10.1074/jbc.M801923200; Geddis AE, 2004, BLOOD, V104, P1017, DOI 10.1182/blood-2004-02-0419; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Geddis AE, 2006, CELL CYCLE, V5, P538, DOI 10.4161/cc.5.5.2537; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; GREENBERG SM, 1988, BLOOD, V72, P1968; Huang X, 2004, CELL CYCLE, V3, P946; Huebner-Chan D, 2001, MODERN PATHOL, V14, P1000, DOI 10.1038/modpathol.3880425; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jalagadugula G, 2008, THROMB HAEMOSTASIS, V100, P821, DOI 10.1160/TH08-07-0496; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Lepage A, 2000, BLOOD, V96, P4169, DOI 10.1182/blood.V96.13.4169.h8004169_4169_4177; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Myer DL, 2005, ONCOGENE, V24, P299, DOI 10.1038/sj.onc.1208278; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Naik MU, 2006, J CELL SCI, V119, P490, DOI 10.1242/jcs.02771; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; NAIK MU, INT J CANC; NAIK MU, 2009, J THROMB HAEMOST; NAIK MU, INT J BIOCH CELL BIO; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nakano K, 2006, MOL BIOL CELL, V17, P1933, DOI 10.1091/mbc.E05-09-0900; Papadantonakis N, 2008, CELL CYCLE, V7, P2352, DOI 10.4161/cc.6325; Rojnuckarin P, 2001, BLOOD, V97, P154, DOI 10.1182/blood.V97.1.154; Sang MX, 2009, GENES CELLS, V14, P775, DOI 10.1111/j.1365-2443.2009.01309.x; Strober W, 2001, CURR PROTOC IMMUNOL, V3; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; van de Weerdt BCM, 2008, BBA-MOL CELL RES, V1783, P1015, DOI 10.1016/j.bbamcr.2008.02.019; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yang F, 2007, J CELL SCI, V120, P4060, DOI 10.1242/jcs.014795; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06	47	9	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14513	10.1371/journal.pone.0014513	http://dx.doi.org/10.1371/journal.pone.0014513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264284	gold, Green Submitted, Green Published			2022-12-27	WOS:000286516500004
J	Shao, YZ; Hu, WY; Zhong, WR; Li, L				Shao, Yuanzhi; Hu, Wenyong; Zhong, Weirong; Li, Li			Scaling Dynamic Response and Destructive Metabolism in an Immunosurveillant Anti-Tumor System Modulated by Different External Periodic Interventions	PLOS ONE			English	Article							MODEL; PREDATORS; SIZE; LAWS	On the basis of two universal power-law scaling laws, i.e. the scaling dynamic hysteresis in physics and the allometric scaling metabolism in biosystem, we studied the dynamic response and the evolution of an immunosurveillant anti-tumor system subjected to a periodic external intervention, which is equivalent to the scheme of a radiotherapy or chemotherapy, within the framework of the growth dynamics of tumor. Under the modulation of either an abrupt or a gradual change external intervention, the population density of tumors exhibits a dynamic hysteresis to the intervention. The area of dynamic hysteresis loop characterizes a sort of dissipative-therapeutic relationship of the dynamic responding of treated tumors with the dose consumption of accumulated external intervention per cycle of therapy. Scaling the area of dynamic hysteresis loops against the intensity of an external intervention, we deduced a characteristic quantity which was defined as the theoretical therapeutic effectiveness of treated tumor and related with the destructive metabolism of tumor under treatment. The calculated dose-effectiveness profiles, namely the dose cumulant per cycle of intervention versus the therapeutic effectiveness, could be well scaled into a universal quadratic formula regardless of either an abrupt or a gradual change intervention involved. We present a new concept, i.e., the therapy-effect matrix and the dose cumulant matrix, to expound the new finding observed in the growth and regression dynamics of a modulated anti-tumor system.	[Shao, Yuanzhi; Hu, Wenyong] Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhong, Weirong] Jinan Univ, Dept Phys, Guangzhou, Guangdong, Peoples R China; [Li, Li] Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University; Sun Yat Sen University	Shao, YZ (corresponding author), Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China.	stssyz@mail.sysu.edu.cn	zhong, wei-rong/AAO-8565-2020; zhong, wei-rong/F-6365-2012	zhong, wei-rong/0000-0003-3708-2911	National Natural Science Foundation of China [10875178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 10875178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano R, 2006, P NATL ACAD SCI USA, V103, P1639, DOI 10.1073/pnas.0510567103; Chakrabarti BK, 1999, REV MOD PHYS, V71, P847, DOI 10.1103/RevModPhys.71.847; Dreyer O, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.038101; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Garland JM, 1997, J BIOL CHEM, V272, P4680, DOI 10.1074/jbc.272.8.4680; Gillooly JF, 2007, BIOL LETTERS, V3, P99, DOI 10.1098/rsbl.2006.0576; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HE YL, 1993, PHYS REV LETT, V70, P2336, DOI 10.1103/PhysRevLett.70.2336; Head DA, 1997, PHYS REV E, V55, P3312, DOI 10.1103/PhysRevE.55.3312; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; KURZ H, 1998, SCIENCE, V281, pA751; Lefever R., 1978, BIOMATHEMATICS CELL, P333; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; LIU JM, 2001, PHYS REV B, V65; Maimon R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.255502; Mankin R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061106; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; Marquet PA, 2002, SCIENCE, V295, P2229, DOI 10.1126/science.1070587; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; SAVAGE VM, 2008, PLOS COMPUTATIONAL E; Sides SW, 1998, PHYS REV LETT, V81, P834, DOI 10.1103/PhysRevLett.81.834; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; Uchiyama S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061912; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16115	10.1371/journal.pone.0016115	http://dx.doi.org/10.1371/journal.pone.0016115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264252	Green Published, Green Submitted, gold			2022-12-27	WOS:000286516500028
J	Cross, A; Collard, M				Cross, Alan; Collard, Mark			Estimating Surface Area in Early Hominins	PLOS ONE			English	Article							BODY; PROPORTIONS; HEIGHT	Height and weight-based methods of estimating surface area have played an important role in the development of the current consensus regarding the role of thermoregulation in human evolution. However, such methods may not be reliable when applied to early hominins because their limb proportions differ markedly from those of humans. Here, we report a study in which this possibility was evaluated by comparing surface area estimates generated with the best-known height and weight-based method to estimates generated with a method that is sensitive to proportional differences. We found that the two methods yield indistinguishable estimates when applied to taxa whose limb proportions are similar to those of humans, but significantly different results when applied to taxa whose proportions differ from those of humans. We also found that the discrepancy between the estimates generated by the two methods is almost entirely attributable to inter-taxa differences in limb proportions. One corollary of these findings is that we need to reassess hypotheses about the role of thermoregulation in human evolution that have been developed with the aid of height and weight-based methods of estimating body surface area. Another is that we need to use other methods in future work on fossil hominin body surface areas.	[Cross, Alan; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada; [Collard, Mark] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	Simon Fraser University; University of Missouri System; University of Missouri Columbia	Cross, A (corresponding author), Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada.	agc6@sfu.ca		Collard, Mark/0000-0002-2725-4989	SSHRC-CGS [766-2004-0723, 767-2006-1902]; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University	SSHRC-CGS; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University	This work was supported by SSHRC-CGS 766-2004-0723, SSHRC-CGS 767-2006-1902, the Canada Research Chairs Program, Canada Foundation for Innovation, British Columbia Knowledge Development Fund, Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey BJR, 1996, STAT MED, V15, P1325; Churchill SE, 2007, VERTEBR PALEOBIOL PA, P113; Collard Mark, 2007, P1575, DOI 10.1007/978-3-540-33761-4_51; Crompton RH, 1996, AM J PHYS ANTHROPOL, V99, P547, DOI 10.1002/(SICI)1096-8644(199604)99:4<547::AID-AJPA3>3.0.CO;2-R; Cross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002464; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Haeusler M, 2004, J HUM EVOL, V46, P433, DOI 10.1016/j.jhevol.2004.01.004; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Ruff Christopher B., 1993, Evolutionary Anthropology, V2, P53, DOI 10.1002/evan.1360020207; Trinkaus E., 1981, ASPECTS HUMAN EVOLUT, P187; WHEELER PE, 1993, J HUM EVOL, V24, P13, DOI 10.1006/jhev.1993.1003; WHEELER PE, 1984, J HUM EVOL, V13, P91, DOI 10.1016/S0047-2484(84)80079-2; Yu CY, 2003, APPL ERGON, V34, P273, DOI 10.1016/S0003-6870(03)00007-3	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16107	10.1371/journal.pone.0016107	http://dx.doi.org/10.1371/journal.pone.0016107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710ME	21249191	Green Published, gold			2022-12-27	WOS:000286515000018
J	Minutolo, C; Nadra, AD; Fernandez, C; Taboas, M; Buzzalino, N; Casali, B; Belli, S; Charreau, EH; Alba, L; Dain, L				Minutolo, Carolina; Nadra, Alejandro D.; Fernandez, Cecilia; Taboas, Melisa; Buzzalino, Noemi; Casali, Barbara; Belli, Susana; Charreau, Eduardo H.; Alba, Liliana; Dain, Liliana			Structure-Based Analysis of Five Novel Disease-Causing Mutations in 21-Hydroxylase-Deficient Patients	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; STEROID 21-HYDROXYLASE; MISSENSE MUTATIONS; GENE CONVERSION; MUTATED ALLELES; DEFICIENCY; GENOTYPE; CYP21; PHENOTYPE; ASSOCIATION	Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is the most frequent inborn error of metabolism, and accounts for 90-95% of CAH cases. The affected enzyme, P450C21, is encoded by the CYP21A2 gene, located together with a 98% nucleotide sequence identity CYP21A1P pseudogene, on chromosome 6p21.3. Even though most patients carry CYP21A1P-derived mutations, an increasing number of novel and rare mutations in disease causing alleles were found in the last years. In the present work, we describe five CYP21A2 novel mutations, p.R132C, p.149C, p.M283V, p.E431K and a frameshift g.2511_2512delGG, in four non-classical and one salt wasting patients from Argentina. All novel point mutations are located in CYP21 protein residues that are conserved throughout mammalian species, and none of them were found in control individuals. The putative pathogenic mechanisms of the novel variants were analyzed in silico. A three-dimensional CYP21 structure was generated by homology modeling and the protein design algorithm FoldX was used to calculate changes in stability of CYP21A2 protein. Our analysis revealed changes in protein stability or in the surface charge of the mutant enzymes, which could be related to the clinical manifestation found in patients.	[Minutolo, Carolina; Fernandez, Cecilia; Taboas, Melisa; Buzzalino, Noemi; Casali, Barbara; Alba, Liliana; Dain, Liliana] ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina; [Minutolo, Carolina; Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Fernandez, Cecilia; Charreau, Eduardo H.; Dain, Liliana] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Belli, Susana] Hosp Durand, Div Endocrinol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Minutolo, C (corresponding author), ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina.	ldain@fbmc.fcen.uba.ar	; Nadra, Alejandro/A-5668-2009	DAIN, Liliana/0000-0002-2155-4999; Nadra, Alejandro/0000-0002-7860-3245	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT 2006-00208, 2007-00732]; Universidad de Buenos Aires, Ciencia y Tecnica (UBACYT) [X059]; Roemmers Foundation	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Universidad de Buenos Aires, Ciencia y Tecnica (UBACYT)(University of Buenos Aires); Roemmers Foundation	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT): PICT 2006-00208 (LD), 2007-00732 (ADN) (www.agencia.gov.ar, link Foncyt), Universidad de Buenos Aires, Ciencia y Tecnica (UBACYT) X059 (LD) (http://www.uba.ar/secyt/proyectosencurso/fxuba.php), Roemmers Foundation (LD) (http://www.roemmers.com.ar/acerca/funda/apoyo.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanche H, 1997, HUM GENET, V101, P56, DOI 10.1007/s004390050586; Bleicken C, 2009, HUM MUTAT, V30, pE443, DOI 10.1002/humu.20926; DAIN L, 2006, HUM GENET, V119, P359; Dain LB, 2002, CLIN ENDOCRINOL, V56, P237; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dolzan V, 2005, EUR J ENDOCRINOL, V153, P99, DOI 10.1530/eje.1.01944; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; Ezquieta B, 2002, ACTA PAEDIATR, V91, P892, DOI 10.1080/080352502760148595; Gomes LG, 2008, J CLIN ENDOCR METAB, V93, P2913, DOI 10.1210/jc.2008-0304; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Jaaskelainen J, 1997, J CLIN ENDOCR METAB, V82, P3293, DOI 10.1210/jc.82.10.3293; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Loidi L, 2006, CLIN ENDOCRINOL, V64, P330, DOI 10.1111/j.1365-2265.2006.02465.x; Menassa R, 2008, J CLIN ENDOCR METAB, V93, P1901, DOI 10.1210/jc.2007-2701; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; MILLER WL, 1994, J CLIN ENDOCR METAB, V78, P241, DOI 10.1210/jc.78.2.241; NEW MI, 1989, METABOLIC BASIS INHE, P1881; Nikoshkov A, 1997, J CLIN ENDOCR METAB, V82, P194, DOI 10.1210/jc.82.1.194; Nimkarn S, 1999, J CLIN ENDOCR METAB, V84, P378, DOI 10.1210/jc.84.1.378; OWERBACH D, 1992, J CLIN ENDOCR METAB, V74, P553, DOI 10.1210/jc.74.3.553; Pang Songya, 1997, Current Opinion in Pediatrics, V9, P419, DOI 10.1097/00008480-199708000-00018; Pasqualini T, 2007, MEDICINA-BUENOS AIRE, V67, P253; Pey AL, 2007, AM J HUM GENET, V81, P1006, DOI 10.1086/521879; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; SPEISER PW, 1985, AM J HUM GENET, V37, P650; Tardy V, 2010, J CLIN ENDOCR METAB, V95, P1288, DOI 10.1210/jc.2009-1202; Therrell BL, 2001, ENDOCRIN METAB CLIN, V30, P15, DOI 10.1016/S0889-8529(08)70017-3; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; van der Kamp HJ, 2004, EUR J ENDOCRINOL, V151, pU71, DOI 10.1530/eje.0.151U071; WATANABE N, 1993, EUR J BIOCHEM, V214, P521, DOI 10.1111/j.1432-1033.1993.tb17950.x; WEDELL A, 1993, HUM MOL GENET, V2, P499, DOI 10.1093/hmg/2.5.499; WEDELL A, 1992, P NATL ACAD SCI USA, V89, P7232, DOI 10.1073/pnas.89.15.7232; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; Wijesuriya SD, 1999, J BIOL CHEM, V274, P38097, DOI 10.1074/jbc.274.53.38097; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P2322, DOI 10.1210/jc.80.8.2322; WU DA, 1991, J CLIN INVEST, V88, P519, DOI 10.1172/JCI115334	41	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15899	10.1371/journal.pone.0015899	http://dx.doi.org/10.1371/journal.pone.0015899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264314	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000010
J	Ferreira, KS; Maranhao, AQ; Garcia, MCC; Brigido, MM; Santos, SS; Lopes, JD; Almeida, SR				Ferreira, Karen S.; Maranhao, Andrea Q.; Garcia, Maria C. C.; Brigido, Marcelo M.; Santos, Suelen S.; Lopes, Jose D.; Almeida, Sandro R.			Dendritic Cells Transfected with scFv from Mab 7.B12 Mimicking Original Antigen gp43 Induces Protection against Experimental Paracoccidioidomycosis	PLOS ONE			English	Article							SINGLE-CHAIN FV; CYTOTOXIC T-LYMPHOCYTES; PLASMID DNA; ANTIIDIOTYPIC ANTIBODIES; IDIOTYPIC ANTIBODIES; DISPLAY LIBRARY; INTERNAL IMAGE; GENE GUN; CLASS-I; PROTEIN	Paracoccidioidomycosis (PCM), endemic in Latin America, is a progressive systemic mycosis caused by Paracoccidioides brasiliensis (P. brasiliensis), which primarily attacks lung tissue. Dendritic cells (DCs) are able to initiate a response in naive T cells, and they also participate in Th-cell education. Furthermore, these cells have been used for therapy in several disease models. Here we transfected DCs with a plasmid (pMAC/PS-scFv) encoding a single chain variable fragment (scFv) of an anti-Id antibody that is capable of mimicking gp43, the main antigenic component of P. brasiliensis. First, Balb/c mice were immunized subcutaneously with pMAC/PS-scFv and, after seven days, scFv protein was presented to the regional lymph nodes cells. Moreover, we showed that the DCs transfected with scFv were capable of efficiently activating proliferation of total lymph node cells and inducing a decrease in lung infection. Therefore, our results suggested that the use of scFv-transfected DCs may be a promising therapy in the paracoccidioidomycosis (PCM) model.	[Ferreira, Karen S.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Dept Ciencias Biol, Sao Paulo, Brazil; [Maranhao, Andrea Q.; Brigido, Marcelo M.] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Garcia, Maria C. C.; Santos, Suelen S.; Almeida, Sandro R.] Univ Sao Paulo, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Lopes, Jose D.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Brasilia; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Ferreira, KS (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Dept Ciencias Biol, Sao Paulo, Brazil.	karenspadari@gmail.com	Brigido, Marcelo Macedo/A-1972-2015; Maranhão, Andrea Q/L-4474-2013; Ferreira, Karen/AAA-4363-2022; Maranhão, Andrea Queiroz/S-8696-2019; Brigido, Marcelo/H-2718-2019; almeida, sandro r/F-5816-2012; Santos, Suelen/F-3048-2014; Ferreira/Spadari, Karen SF/D-4437-2013; Maranhão, Andrea/AAC-3560-2019	Brigido, Marcelo Macedo/0000-0002-7136-7059; Maranhão, Andrea Q/0000-0002-1946-7191; Brigido, Marcelo/0000-0002-7136-7059; almeida, sandro r/0000-0002-0562-1610; Maranhão, Andrea/0000-0002-1946-7191; Spadari, Karen/0000-0003-2832-5942	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/57594-9, 07/50568-2]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Process: 07/57594-9)(scholarship to K.S.F. process: 07/50568-2) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, research fellowships to S.R.A. and J.D.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, ANTICANCER RES, V22, P1575; Beninati C, 2006, J EXP MED, V203, P111, DOI 10.1084/jem.20051540; Beninati C, 2000, NAT BIOTECHNOL, V18, P1060, DOI 10.1038/80250; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bona CA, 1996, P SOC EXP BIOL MED, V213, P32; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGIDO MM, 1993, J IMMUNOL, V150, P469; Caldas C, 2000, PROTEIN ENG, V13, P353, DOI 10.1093/protein/13.5.353; Campos-Da-Paz M, 2008, MOL BIOTECHNOL, V39, P155, DOI 10.1007/s12033-008-9055-6; Chang JT, 2000, J IMMUNOL, V164, P100, DOI 10.4049/jimmunol.164.1.100; COLOMA MJ, 1991, BIOTECHNIQUES, V11, P152; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Corr M, 1996, J EXP MED, V184, P1555, DOI 10.1084/jem.184.4.1555; DECAMARGO ZP, 1988, J CLIN MICROBIOL, V26, P2147, DOI 10.1128/JCM.26.10.2147-2151.1988; Depetris M, 2008, J IMMUNOL METHODS, V334, P104, DOI 10.1016/j.jim.2008.02.003; Doe B, 1996, P NATL ACAD SCI USA, V93, P8578, DOI 10.1073/pnas.93.16.8578; Erlandsson A, 2006, MOL IMMUNOL, V43, P599, DOI 10.1016/j.molimm.2005.04.019; Feltquate DM, 1997, J IMMUNOL, V158, P2278; Franco MF., 1989, BAILLIERE CLIN TROP, V4, P185, DOI DOI 10.1590/S0036-46651994000100017; Gesztesi JL, 1996, HYBRIDOMA, V15, P415, DOI 10.1089/hyb.1996.15.415; He FT, 2002, WORLD J GASTROENTERO, V8, P258; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 1997, J IMMUNOL, V159, P11; JERNE NK, 1982, EMBO J, V1, P243, DOI 10.1002/j.1460-2075.1982.tb01154.x; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Juvenale M, 2001, J MED MICROBIOL, V50, P127, DOI 10.1099/0022-1317-50-2-127; Kawano Y, 1996, IMMUNOLOGY, V88, P40, DOI 10.1046/j.1365-2567.1996.d01-634.x; KITANI A, 1993, J IMMUNOL, V151, P3478; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; MENEZES VM, 2006, COCHRANE DB SYST REV, V2; Moll H, 2001, IMMUNOBIOLOGY, V204, P659, DOI 10.1078/0171-2985-00105; NISONOFF A, 1981, CLIN IMMUNOL IMMUNOP, V21, P397, DOI 10.1016/0090-1229(81)90228-2; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5; PAN Y, 1995, FASEB J, V9, P43, DOI 10.1096/fasebj.9.1.7821758; Pignatari GC, 2007, J BIOTECHNOL, V127, P615, DOI 10.1016/j.jbiotec.2006.08.007; Pokorna Dana, 2008, Genet Vaccines Ther, V6, P4, DOI 10.1186/1479-0556-6-4; RESTREPO A, 2005, PRINCIPLES PRACTICE, P3062; Schwegler C, 2005, CANCER RES, V65, P1925, DOI 10.1158/0008-5472.CAN-04-3591; Shibagaki N, 2003, EUR J IMMUNOL, V33, P850, DOI 10.1002/eji.200323709; Shibagaki N, 2002, J IMMUNOL, V168, P2393, DOI 10.4049/jimmunol.168.5.2393; Souza AR, 1998, CLIN EXP IMMUNOL, V114, P40; Souza EB, 2004, CLIN EXP IMMUNOL, V137, P123, DOI 10.1111/j.1365-2249.2004.02507.x; Torres CAT, 1997, J IMMUNOL, V158, P4529; Ulmer JB, 1996, IMMUNOLOGY, V89, P59, DOI 10.1046/j.1365-2567.1996.d01-718.x; WARRENS AN, 1994, INT IMMUNOL, V6, P847, DOI 10.1093/intimm/6.6.847; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; ZAGHOUANI H, 1993, EUR J IMMUNOL, V23, P2746, DOI 10.1002/eji.1830231104; ZHOU H, 1994, NUCLEIC ACIDS RES, V22, P888, DOI 10.1093/nar/22.5.888	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15935	10.1371/journal.pone.0015935	http://dx.doi.org/10.1371/journal.pone.0015935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249212	Green Submitted, Green Published, gold			2022-12-27	WOS:000286512900013
J	Podolska, A; Kaczkowski, B; Busk, PK; Sokilde, R; Litman, T; Fredholm, M; Cirera, S				Podolska, Agnieszka; Kaczkowski, Bogumil; Busk, Peter Kamp; Sokilde, Rolf; Litman, Thomas; Fredholm, Merete; Cirera, Susanna			MicroRNA Expression Profiling of the Porcine Developing Brain	PLOS ONE			English	Article							IDENTIFICATION; DIFFERENTIATION; REVEALS; GROWTH; RNAS	Background: MicroRNAs are small, non-coding RNA molecules that regulate gene expression at the post-transcriptional level and play an important role in the control of developmental and physiological processes. In particular, the developing brain contains an impressive diversity of microRNAs. Most microRNA expression profiling studies have been performed in human or rodents and relatively limited knowledge exists in other mammalian species. The domestic pig is considered to be an excellent, alternate, large mammal model for human-related neurological studies, due to its similarity in both brain development and the growth curve when compared to humans. Considering these similarities, studies examining microRNA expression during porcine brain development could potentially be used to predict the expression profile and role of microRNAs in the human brain. Methodology/Principal Findings: MicroRNA expression profiling by use of microRNA microarrays and qPCR was performed on the porcine developing brain. Our results show that microRNA expression is regulated in a developmentally stage-specific, as well as a tissue-specific manner. Numerous developmental stage or tissue-specific microRNAs including, miR-17, miR-18a, miR-29c, miR-106a, miR-135a and b, miR-221 and miR-222 were found by microarray analysis. Expression profiles of selected candidates were confirmed by qPCR. Conclusions/Significance: The differential expression of specific microRNAs in fetal versus postnatal samples suggests that they likely play an important role in the regulation of developmental and physiological processes during brain development. The data presented here supports the notion that microRNAs act as post-transcriptional switches which may regulate gene expression when required.	[Podolska, Agnieszka; Fredholm, Merete; Cirera, Susanna] Univ Copenhagen, Fac Life Sci, Sect Genet & Bioinformat, Dept Basic Anim & Vet Sci, Copenhagen, Denmark; [Kaczkowski, Bogumil] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Kaczkowski, Bogumil] Univ Copenhagen, Biotech Res & Innovat Ctr, Bioinformat Ctr, Copenhagen, Denmark; [Busk, Peter Kamp] Exiqon AS, Mol Biol, Vedbaek, Denmark; [Sokilde, Rolf; Litman, Thomas] Exiqon AS, Biomarker Discovery, Vedbaek, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Exiqon; Exiqon	Podolska, A (corresponding author), Univ Copenhagen, Fac Life Sci, Sect Genet & Bioinformat, Dept Basic Anim & Vet Sci, Copenhagen, Denmark.	scs@life.ku.dk	Søkilde, Rolf/F-5138-2015; Busk, Peter/Q-8145-2016; Kaczkowski, Bogumil/D-5336-2017; Cirera, Susanna/K-8540-2017	Søkilde, Rolf/0000-0003-3010-3599; Busk, Peter/0000-0003-1920-636X; Kaczkowski, Bogumil/0000-0001-6554-5608; Fredholm, Merete/0000-0002-3563-7648; Cirera, Susanna/0000-0001-8105-1579; Litman, Thomas/0000-0002-6068-901X	Danish National Advanced Technology Foundation; Faculty of Life Sciences, University of Copenhagen	Danish National Advanced Technology Foundation; Faculty of Life Sciences, University of Copenhagen	PKB and TL were employed by Exiqon A/S during the conduct of the study. As such, Exiqon A/S has provided economic support and know how for the project. Study design, data analysis and decision to publish was the responsibility of the academic partners. This study was supported by a grant from the Danish National Advanced Technology Foundation for the project "Pigs and Health", and from a grant from Faculty of Life Sciences, University of Copenhagen for a Ph.D. scholarship to Agnieszka Podolska. These founders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P114, DOI 10.1016/j.mrgentox.2010.05.007; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LARSELL O, 1954, ANAT REC, V118, P73, DOI 10.1002/ar.1091180106; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Xiao B, 2009, J GENET GENOMICS, V36, P695, DOI 10.1016/S1673-8527(08)60162-9; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Zhang CZ, 2009, INT J ONCOL, V34, P1653, DOI 10.3892/ijo_00000296; Zhou B, 2010, ANIM SCI J, V81, P290, DOI 10.1111/j.1740-0929.2010.00742.x	40	49	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14494	10.1371/journal.pone.0014494	http://dx.doi.org/10.1371/journal.pone.0014494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253018	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511900003
J	Long, QA; Jeffares, DC; Zhang, QR; Ye, K; Nizhynska, V; Ning, ZM; Tyler-Smith, C; Nordborg, M				Long, Quan; Jeffares, Daniel C.; Zhang, Qingrun; Ye, Kai; Nizhynska, Viktoria; Ning, Zemin; Tyler-Smith, Chris; Nordborg, Magnus			PoolHap: Inferring Haplotype Frequencies from Pooled Samples by Next Generation Sequencing	PLOS ONE			English	Article							CELLS; IDENTIFICATION; ISOFORMS	With the advance of next-generation sequencing (NGS) technologies, increasingly ambitious applications are becoming feasible. A particularly powerful one is the sequencing of polymorphic, pooled samples. The pool can be naturally occurring, as in the case of multiple pathogen strains in a blood sample, multiple types of cells in a cancerous tissue sample, or multiple isoforms of mRNA in a cell. In these cases, it's difficult or impossible to partition the subtypes experimentally before sequencing, and those subtype frequencies must hence be inferred. In addition, investigators may occasionally want to artificially pool the sample of a large number of individuals for reasons of cost-efficiency, e. g., when carrying out genetic mapping using bulked segregant analysis. Here we describe PoolHap, a computational tool for inferring haplotype frequencies from pooled samples when haplotypes are known. The key insight into why PoolHap works is that the large number of SNPs that come with genome-wide coverage can compensate for the uneven coverage across the genome. The performance of PoolHap is illustrated and discussed using simulated and real data. We show that PoolHap is able to accurately estimate the proportions of haplotypes with less than 2% error for 34-strain mixtures with 2X total coverage Arabidopsis thaliana whole genome polymorphism data. This method should facilitate greater biological insight into heterogeneous samples that are difficult or impossible to isolate experimentally. Software and users manual are freely available at http://arabidopsis.gmi.oeaw.ac.at/quan/poolhap/.	[Long, Quan; Zhang, Qingrun; Nizhynska, Viktoria; Nordborg, Magnus] Gregor Mendel Inst, Vienna, Austria; [Long, Quan; Jeffares, Daniel C.; Ning, Zemin; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge, England; [Jeffares, Daniel C.] UCL, Res Dept Genet Evolut & Environm, London, England; [Zhang, Qingrun] Chinese Acad Sci, Beijing Inst Gen, Beijing, Peoples R China; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Nordborg, Magnus] Univ So Calif, Los Angeles, CA USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Wellcome Trust Sanger Institute; University of London; University College London; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Southern California	Long, QA (corresponding author), Gregor Mendel Inst, Vienna, Austria.	quan.long@gmi.oeaw.ac.at	Ye, Kai/GSD-9856-2022; Jeffares, Daniel/N-2632-2018; Ning, Zemin/D-2411-2013; Ye, Kai/B-3640-2012	Ye, Kai/0000-0002-2851-6741; Jeffares, Daniel/0000-0001-7320-0706; Nordborg, Magnus/0000-0001-7178-9748; Ning, Zemin/0000-0003-4359-776X	Austrian Academy of Science; Wellcome Trust [085775/Z/08/Z]; National Natural Science Foundation of China [30700442, 30730057]	Austrian Academy of Science; Wellcome Trust(Wellcome TrustEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Austrian Academy of Science (http://www.oeaw.ac.at/english/home.html), the Wellcome Trust (grant 085775/Z/08/Z) (http://www.wellcome.ac.uk/) and National Natural Science Foundation of China (No. 30700442, 30730057) (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Fagotti A, 1998, NUCLEIC ACIDS RES, V26, P2031, DOI 10.1093/nar/26.8.2031; Fuhrman LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002882; Gorlov IP, 2002, ANAL BIOCHEM, V308, P401, DOI 10.1016/S0003-2697(02)00244-0; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIU HP, 2010, DEV COMP IMMUNOL; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; NANAK E, 1995, J MOL RECOGNIT, V8, P77, DOI 10.1002/jmr.300080114; NAVAS P, 1989, CANCER RES, V49, P2147; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Supabandhu J, 2008, MED MYCOL, V46, P41, DOI 10.1080/13693780701513840; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515	15	22	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15292	10.1371/journal.pone.0015292	http://dx.doi.org/10.1371/journal.pone.0015292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21264334	Green Submitted, gold, Green Published			2022-12-27	WOS:000286511200006
J	Meredith, JM; Basu, S; Nimmo, DD; Larget-Thiery, I; Warr, EL; Underhill, A; McArthur, CC; Carter, V; Hurd, H; Bourgouin, C; Eggleston, P				Meredith, Janet M.; Basu, Sanjay; Nimmo, Derric D.; Larget-Thiery, Isabelle; Warr, Emma L.; Underhill, Ann; McArthur, Clare C.; Carter, Victoria; Hurd, Hilary; Bourgouin, Catherine; Eggleston, Paul			Site-Specific Integration and Expression of an Anti-Malarial Gene in Transgenic Anopheles gambiae Significantly Reduces Plasmodium Infections	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MALARIA PARASITE; GERMLINE TRANSFORMATION; TRANSPOSABLE ELEMENT; BLOOD MEAL; VECTOR; FALCIPARUM; STEPHENSI; MOSQUITOS; DIPTERA	Diseases transmitted by mosquitoes have a devastating impact on global health and this is worsening due to difficulties with existing control measures and climate change. Genetically modified mosquitoes that are refractory to disease transmission are seen as having great potential in the delivery of novel control strategies. Historically the genetic modification of insects has relied upon transposable elements which have many limitations despite their successful use. To circumvent these limitations the Streptomyces phage phiC31 integrase system has been successfully adapted for site-specific transgene integration in insects. Here, we present the first site-specific transformation of Anopheles gambiae, the principal vector of human malaria. Mosquitoes were initially engineered to incorporate the phiC31 targeting site at a defined genomic location. A second phase of genetic modification then achieved site-specific integration of Vida3, a synthetic anti-malarial gene. Expression of Vida3, specifically in the midgut of bloodfed females, offered consistent and significant protection against Plasmodium yoelii nigeriensis, reducing average parasite intensity by 85%. Similar protection was observed against Plasmodium falciparum in some experiments, although protection was inconsistent. In the fight against malaria, it is imperative to establish a broad repertoire of both anti-malarial effector genes and tissue-specific promoters for their expression, enabling those offering maximum effect with minimum fitness cost to be identified. In the future, this technology will allow effective comparisons and informed choices to be made, potentially leading to complete transmission blockade.	[Meredith, Janet M.; Basu, Sanjay; Nimmo, Derric D.; Warr, Emma L.; Underhill, Ann; McArthur, Clare C.; Carter, Victoria; Hurd, Hilary; Eggleston, Paul] Keele Univ, Ctr Appl Entomol & Parasitol, Keele, Staffs, England; [Basu, Sanjay] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Nimmo, Derric D.] Oxitec Ltd, Oxford, England; [Larget-Thiery, Isabelle; Bourgouin, Catherine] Inst Pasteur, Ctr Prod & Infect Anopheles, Parasitol & Mycol Dept, Paris, France	Keele University; Virginia Polytechnic Institute & State University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meredith, JM (corresponding author), Keele Univ, Ctr Appl Entomol & Parasitol, Keele, Staffs, England.	p.eggleston@biol.keele.ac.uk	Bourgouin, Catherine/F-1253-2014	Bourgouin, Catherine/0000-0002-9209-845X	Wellcome Trust [077593, 069162]; UNICEF/UNDP/World Bank/WHO; EU [228421]; Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires)	Wellcome Trust(Wellcome TrustEuropean Commission); UNICEF/UNDP/World Bank/WHO(World Health Organization); EU(European Commission); Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires)(Sanofi-AventisMinistry of Research, France)	This investigation received financial support from the Wellcome Trust (grant numbers 077593 and 069162), the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) and from the EU:FP7 Infrastructures Programme (grant number 228421). The CEPIA received financial support from Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amenya DA, 2010, INSECT MOL BIOL, V19, P263, DOI 10.1111/j.1365-2583.2009.00986.x; Arrighi RBG, 2002, ANTIMICROB AGENTS CH, V46, P2104, DOI 10.1128/AAC.46.7.2104-2110.2002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Crampton A, 2001, INFECT GENET EVOL, V1, P131, DOI 10.1016/S1567-1348(01)00017-X; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jahan N, 1997, ANN TROP MED PARASIT, V91, P365, DOI 10.1080/00034989760987; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Lopes LF, 2007, EXP PARASITOL, V115, P259, DOI 10.1016/j.exppara.2006.09.007; Lorenzen MD, 2002, INSECT MOL BIOL, V11, P399, DOI 10.1046/j.1365-2583.2002.00349.x; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Mitri C, 2009, P ROY SOC B-BIOL SCI, V276, P3721, DOI 10.1098/rspb.2009.0962; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; SAKAI RK, 1992, J MED ENTOMOL, V29, P374, DOI 10.1093/jmedent/29.2.374; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192	38	77	79	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14587	10.1371/journal.pone.0014587	http://dx.doi.org/10.1371/journal.pone.0014587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283619	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000286661400004
J	Malinouski, M; Zhou, Y; Belousov, VV; Hatfield, DL; Gladyshev, VN				Malinouski, Mikalai; Zhou, You; Belousov, Vsevolod V.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Hydrogen Peroxide Probes Directed to Different Cellular Compartments	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; DISULFIDE RELAY SYSTEM; GLUTATHIONE-PEROXIDASE; FLUORESCENT-PROBES; MAMMALIAN-CELLS; DNA-DAMAGE; GENERATION; H2O2; PERMEABILITY; MITOCHONDRIA	Background: Controlled generation and removal of hydrogen peroxide play important roles in cellular redox homeostasis and signaling. We used a hydrogen peroxide biosensor HyPer, targeted to different compartments, to examine these processes in mammalian cells. Principal Findings: Reversible responses were observed to various redox perturbations and signaling events. HyPer expressed in HEK 293 cells was found to sense low micromolar levels of hydrogen peroxide. When targeted to various cellular compartments, HyPer occurred in the reduced state in the nucleus, cytosol, peroxisomes, mitochondrial intermembrane space and mitochondrial matrix, but low levels of the oxidized form of the biosensor were also observed in each of these compartments, consistent with a low peroxide tone in mammalian cells. In contrast, HyPer was mostly oxidized in the endoplasmic reticulum. Using this system, we characterized control of hydrogen peroxide in various cell systems, such as cells deficient in thioredoxin reductase, sulfhydryl oxidases or subjected to selenium deficiency. Generation of hydrogen peroxide could also be monitored in various compartments following signaling events. Conclusions: We found that HyPer can be used as a valuable tool to monitor hydrogen peroxide generated in different cellular compartments. The data also show that hydrogen peroxide generated in one compartment could translocate to other compartments. Our data provide information on compartmentalization, dynamics and homeostatic control of hydrogen peroxide in mammalian cells.	[Malinouski, Mikalai; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Malinouski, Mikalai; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Malinouski, Mikalai; Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Belousov, Vsevolod V.] Russian Acad Sci, Inst Bioorgan Chem, Moscow, Russia; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malinouski, M (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013; Belousov, Vsevolod V/G-5562-2016	Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health; National Institutes of Health, National Cancer Institute, Center for Cancer Research; Russian Federation [DoeDs.-3567.2009.4]; Russian Foundation for Basic Research [10-04-01561]; NATIONAL CANCER INSTITUTE [ZIABC010889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603, R37GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Federation(Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants (to VNG), the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (to DLH), a grant of the President of Russian Federation (DoeDs.-3567.2009.4) and the Russian Foundation for Basic Research (10-04-01561) (VVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bellomo G, 1997, MICROSC RES TECHNIQ, V36, P243, DOI 10.1002/(SICI)1097-0029(19970215)36:4<243::AID-JEMT3>3.0.CO;2-N; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Chen K, 2009, ANTIOXID REDOX SIGN, V11, P2467, DOI [10.1089/ars.2009.2594, 10.1089/ARS.2009.2594]; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GO YM, BIOCH BIOPH IN PRESS; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Go Young-Mi, 2008, V464, P303; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hansen JM, 2006, TOXICOL SCI, V91, P643, DOI 10.1093/toxsci/kfj175; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Isenberg JS, 2000, TOXICOL SCI, V53, P340, DOI 10.1093/toxsci/53.2.340; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Makino N, 2004, BBA-GEN SUBJECTS, V1673, P149, DOI 10.1016/j.bbagen.2004.04.011; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Markvicheva K. N., 2009, METHOD MOL BIOL, V476, P76; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Millonig G, 2009, FREE RADICAL BIO MED, V46, P182, DOI 10.1016/j.freeradbiomed.2008.09.043; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; SANDSTROM BE, 1990, BIOCHEM J, V271, P17, DOI 10.1042/bj2710017; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Souslova EA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P683, DOI 10.1134/S0006297907070012; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TACHIKAWA T, 2009, NEW TRENDS MOL BIOL, V18; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yoo MH, 2007, RNA, V13, P921, DOI 10.1261/rna.533007; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065	66	146	152	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14564	10.1371/journal.pone.0014564	http://dx.doi.org/10.1371/journal.pone.0014564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283738	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300004
J	Burgdorf, KS; Grarup, N; Justesen, JM; Harder, MN; Witte, DR; Jorgensen, T; Sandbaek, A; Lauritzen, T; Madsbad, S; Hansen, T; Pedersen, O				Burgdorf, Kristoffer Solvsten; Grarup, Niels; Justesen, Johanne Marie; Harder, Marie Neergaard; Witte, Daniel Rinse; Jorgensen, Torben; Sandbaek, Annelli; Lauritzen, Torsten; Madsbad, Sten; Hansen, Torben; Pedersen, Oluf		DIAGRAM Consortium	Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans	PLOS ONE			English	Article							BETA-CELL FUNCTION; POLYMORPHISM; GLUCOSE; HOMEOSTASIS; K121Q; GENE	Aims: A study of 222 candidate genes in type 2 diabetes reported association of variants in RAPGEF1, ENPP1, TP53, NRF1, SLC2A2, SLC2A4 and FOXC2 with type 2 diabetes in 4,805 Finnish individuals. We aimed to replicate these associations in a Danish case-control study and to substantiate any replicated associations in meta-analyses. Furthermore, we evaluated the impact on diabetes-related intermediate traits in a population-based sample of middle-aged Danes. Methods: We genotyped nine lead variants in the seven genes in 4,973 glucose-tolerant and 3,612 type 2 diabetes Danish individuals. In meta-analyses we combined case-control data from the DIAGRAM+ Consortium (n = 47,117) and the present genotyping results. The quantitative trait studies involved 5,882 treatment-naive individuals from the Danish Inter99 study. Results: None of the nine investigated variants were significantly associated with type 2 diabetes in the Danish samples. However, for all nine variants the estimate of increase in type 2 diabetes risk was observed for the same allele as previously reported. In a meta-analysis of published and online data including 55,521 Europeans the G-allele of rs1042522 in TP53 showed significant association with type 2 diabetes (OR = 1.06 95% CI 1.02-1.11, p = 0.0032). No substantial associations with diabetes-related intermediary phenotypes were found. Conclusion: The G-allele of TP53 rs1042522 is associated with an increased prevalence of type 2 diabetes in a combined analysis of 55,521 Europeans.	[Burgdorf, Kristoffer Solvsten; Grarup, Niels; Justesen, Johanne Marie; Harder, Marie Neergaard; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Copenhagen, Denmark; [Burgdorf, Kristoffer Solvsten; Madsbad, Sten] Hvidovre Univ Hosp, Copenhagen, Denmark; [Witte, Daniel Rinse] Steno Diabet Ctr, Copenhagen, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben; Madsbad, Sten; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, Copenhagen, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Aarhus Univ, Dept Gen Practice, Inst Publ Hlth, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark; Aarhus University	Burgdorf, KS (corresponding author), Hagedorn Res Inst, Copenhagen, Denmark.	krek@hagedorn.dk	Jørgensen, Torben/Z-1335-2018; Witte, Daniel/AAF-9535-2019; Pedersen, Oluf/AAG-8015-2020; Grarup, Niels/K-2807-2015; Meitinger, Thomas/O-1318-2015; Boehm, Bernhard Otto/F-8750-2015; Justesen, Johanne Marie/AAY-4210-2021; Pedersen, Oluf/Z-1731-2019; Witte, Daniel R/C-1722-2008; Justesen, Johanne Marie/L-6023-2015	Witte, Daniel/0000-0002-0769-2922; Grarup, Niels/0000-0001-5526-1070; Justesen, Johanne Marie/0000-0002-0484-8522; Pedersen, Oluf/0000-0002-3321-3972; Witte, Daniel R/0000-0002-0769-2922; Justesen, Johanne Marie/0000-0002-0484-8522; Burgdorf, Kristoffer/0000-0001-5814-6844; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830; Madsbad, Sten/0000-0002-5017-1815				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almeida LO, 2009, GENET MOL RES, V8, P8, DOI 10.4238/vol8-1gmr518; Baratta R, 2008, DIABETES, V57, pA332; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731; Gaulton KJ, 2007, BIOINFORMATICS, V23, P1132, DOI 10.1093/bioinformatics/btm001; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Han JY, 2008, CANCER-AM CANCER SOC, V113, P799, DOI 10.1002/cncr.23668; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAteer JB, 2008, DIABETES, V57, P1125, DOI 10.2337/db07-1336; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; R Development Core Team, 1999, R LANG ENV STAT COMP; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; *WHO STUD GROUP, 1999, TECH REP SER WHO, P36	23	42	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15813	10.1371/journal.pone.0015813	http://dx.doi.org/10.1371/journal.pone.0015813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283750	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200014
J	de Koning, JJ; Foster, C; Bakkum, A; Kloppenburg, S; Thiel, C; Joseph, T; Cohen, J; Porcari, JP				de Koning, Jos J.; Foster, Carl; Bakkum, Arjan; Kloppenburg, Sil; Thiel, Christian; Joseph, Trent; Cohen, Jacob; Porcari, John P.			Regulation of Pacing Strategy during Athletic Competition	PLOS ONE			English	Article							PERIPHERAL PHYSIOLOGICAL SYSTEMS; EXERCISE PERFORMANCE; PERCEIVED EXERTION; SIMULATED COMPETITION; HYPERTHERMIC FATIGUE; PROLONGED EXERCISE; MUSCLE GLYCOGEN; BRAIN ACTIVITY; PERCEPTION; HUMANS	Background: Athletic competition has been a source of interest to the scientific community for many years, as a surrogate of the limits of human ambulatory ability. One of the remarkable things about athletic competition is the observation that some athletes suddenly reduce their pace in the mid-portion of the race and drop back from their competitors. Alternatively, other athletes will perform great accelerations in mid-race (surges) or during the closing stages of the race (the endspurt). This observation fits well with recent evidence that muscular power output is regulated in an anticipatory way, designed to prevent unreasonably large homeostatic disturbances. Principal Findings: Here we demonstrate that a simple index, the product of the momentary Rating of Perceived Exertion (RPE) and the fraction of race distance remaining, the Hazard Score, defines the likelihood that athletes will change their velocity during simulated competitions; and may effectively represent the language used to allow anticipatory regulation of muscle power output. Conclusions: These data support the concept that the muscular power output during high intensity exercise performance is actively regulated in an anticipatory manner that accounts for both the momentary sensations the athlete is experiencing as well as the relative amount of a competition to be completed.	[de Koning, Jos J.; Foster, Carl; Bakkum, Arjan; Kloppenburg, Sil] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands; [de Koning, Jos J.; Foster, Carl; Joseph, Trent; Cohen, Jacob; Porcari, John P.] Univ Wisconsin La Crosse, Dept Exercise & Sport Sci, La Crosse, WI USA; [Thiel, Christian] Goethe Univ Frankfurt, Dept Sportmed, Frankfurt, Germany	Vrije Universiteit Amsterdam; University of Wisconsin System; University of Wisconsin La Crosse; Goethe University Frankfurt	de Koning, JJ (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands.	j.dekoning@fbw.vu.nl	Thiel, Christian/AAB-4695-2022	Thiel, Christian/0000-0003-4507-8787; de Koning, Jos J/0000-0002-5596-0282				Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheung SS, 2004, EXERC SPORT SCI REV, V32, P100, DOI 10.1097/00003677-200407000-00005; COYLE EF, 1983, J APPL PHYSIOL, V55, P230, DOI 10.1152/jappl.1983.55.1.230; DUGAS JP, 2010, INT J SPORT IN PRESS; Esteve-Lanao J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002943; Faulkner J, 2008, PSYCHOPHYSIOLOGY, V45, P977, DOI 10.1111/j.1469-8986.2008.00712.x; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; Foster C, 2009, BRIT J SPORT MED, V43, P765, DOI 10.1136/bjsm.2008.054841; FOSTER C, 1994, SPORTS MED, V17, P77, DOI 10.2165/00007256-199417020-00001; Gibson ASC, 2006, SPORTS MED, V36, P705; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Joseph T, 2008, MED SCI SPORT EXER, V40, P381, DOI 10.1249/mss.0b013e31815a83f6; KARLSSON J, 1970, J APPL PHYSIOL, V29, P598, DOI 10.1152/jappl.1970.29.5.598; KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Laursen PB, 2009, INT J SPORT PHYSIOL, V4, P533, DOI 10.1123/ijspp.4.4.533; Nielsen B, 2001, PFLUG ARCH EUR J PHY, V442, P41, DOI 10.1007/s004240100515; Noakes TD, 2004, J APPL PHYSIOL, V96, P1571, DOI 10.1152/japplphysiol.01124.2003; Nybo L, 2001, J APPL PHYSIOL, V91, P2017, DOI 10.1152/jappl.2001.91.5.2017; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Tucker R, 2009, BRIT J SPORT MED, V43, DOI 10.1136/bjsm.2009.057562; Tucker R, 2006, INT J SPORT PHYSIOL, V1, P233, DOI 10.1123/ijspp.1.3.233; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309	31	159	162	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15863	10.1371/journal.pone.0015863	http://dx.doi.org/10.1371/journal.pone.0015863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283744	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200016
J	Kalisya, LM; Justin, PL; Kimona, C; Nyavandu, K; Eugenie, KM; Jonathan, KML; Claude, KM; Hawkes, M				Kalisya, Luc Malemo; Justin, Paluku Lussy; Kimona, Christophe; Nyavandu, Kavira; Eugenie, Kamabu Mukekulu; Jonathan, Kasereka Muhindo Lusi; Claude, Kasereka Masumbuko; Hawkes, Michael			Sexual Violence toward Children and Youth in War-Torn Eastern Democratic Republic of Congo	PLOS ONE			English	Article							MORTALITY; INJURY; ABUSE	Background: The epidemic of gender-based violence in the Democratic Republic of the Congo (DRC) has garnered popular media attention, but is incompletely described in the medical literature to date. In particular, the relative importance of militarized compared to civilian rape and the impact on vulnerable populations merits further study. We describe a retrospective case series of sexual abuse among children and youth in eastern DRC. Methods: Medical records of patients treated for sexual assault at HEAL Africa Hospital, Goma, DRC between 2006 and 2008 were reviewed. Information extracted from the chart record was summarized using descriptive statistics, with comparative statistics to examine differences between pediatric (<= 18 yrs) and adult patients. Findings: 440 pediatric and 54 adult sexual abuse cases were identified. Children and youth were more often assaulted by someone known to the family (74% vs 30%, OR 6.7 [95% CI 3.6-12], p<0.001), and less frequently by military personnel (13% vs 48%, OR 0.14 [95% CI 0.075-0.26], p<0.001). Delayed presentation for medical care (. 72 hours after the assault) was more common in pediatric patients (53% vs 33%, OR 2.2 [95% CI 1.2-4.0], p = 0.007). Physical signs of sexual abuse, including lesions of the posterior fourchette, hymeneal tears, and anal lesions, were more commonly observed in children and youth (84% vs 69%, OR 2.3 [95% CI 1.3-4.4], p = 0.006). Nine (2.9%) pediatrics patients were HIV-positive at presentation, compared to 5.3% of adults (p = 0.34). Interpretation: World media attention has focused on violent rape as a weapon of war in the DRC. Our data highlight some neglected but important and distinct aspects of the ongoing epidemic of sexual violence: sexual abuse of children and youth.	[Kalisya, Luc Malemo; Justin, Paluku Lussy; Kimona, Christophe; Nyavandu, Kavira; Eugenie, Kamabu Mukekulu; Jonathan, Kasereka Muhindo Lusi; Claude, Kasereka Masumbuko] HEAL Africa, Goma, DEM REP CONGO; [Hawkes, Michael] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto	Kalisya, LM (corresponding author), HEAL Africa, Goma, DEM REP CONGO.	exo40mluc@yahoo.fr	, Michael/AAP-3049-2020	Hawkes, Michael/0000-0002-4122-0937; Kasereka, Masumbuko/0000-0003-1367-3426	UNICEF; USAID; IRC; KfW	UNICEF; USAID(United States Agency for International Development (USAID)); IRC; KfW	The funding sources (UNICEF, USAID, IRC, and KfW) finance the clinical management of sexual abuse victims at the authors' institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI KP, CONFL HLTH, V4, P17; BARTELS SA, CONFL HLTH, V4, P9; Brown L, 2006, STUD FAMILY PLANN, V37, P269, DOI 10.1111/j.1728-4465.2006.00105.x; Buambo-Bamanga S F, 2005, Sante, V15, P31; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Coghlan B, 2009, DISASTER MED PUBLIC, V3, P88, DOI 10.1097/DMP.0b013e3181a6e952; DERRICO NC, MED CONFL SURVIV, V26, P145; Faravelli C, 2004, AM J PSYCHIAT, V161, P1483, DOI 10.1176/appi.ajp.161.8.1483; *HARV HUM IN, INV SEX VIOL E DEM R; Hilden M, 2005, FORENSIC SCI INT, V154, P200, DOI 10.1016/j.forsciint.2004.10.010; Islam Muhammad Nurul, 2003, Leg Med (Tokyo), V5 Suppl 1, pS351, DOI 10.1016/S1344-6223(02)00170-0; Kassa A, 2005, ACCESS HEALTHCARE MO; Loncar M, 2006, CROAT MED J, V47, P67; Longombe AO, 2008, REPROD HEALTH MATTER, V16, P132, DOI 10.1016/S0968-8080(08)31350-0; Menick D M, 1998, Med Trop (Mars), V58, P249; Mukwege DM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000204; NDUATI RWK, 1992, E AFR MED J, V69, P350; Ononge Samuel, 2005, Afr Health Sci, V5, P50; Palmer Cheryn M, 2004, Sex Health, V1, P55, DOI 10.1071/SH03004; Ramsay S, 1999, LANCET, V354, P2018, DOI 10.1016/S0140-6736(99)00455-9; WESTCOTT DL, 1984, S AFR MED J, V65, P895	21	46	46	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15911	10.1371/journal.pone.0015911	http://dx.doi.org/10.1371/journal.pone.0015911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267467	gold, Green Published			2022-12-27	WOS:000286519500032
J	Schott, BH; Seidenbecher, CI; Richter, S; Wustenberg, T; Debska-Vielhaber, G; Schubert, H; Heinze, HJ; Richardson-Klavehn, A; Duzel, E				Schott, Bjoern H.; Seidenbecher, Constanze I.; Richter, Sylvia; Wuestenberg, Torsten; Debska-Vielhaber, Grazyna; Schubert, Heike; Heinze, Hans-Jochen; Richardson-Klavehn, Alan; Duezel, Emrah			Genetic Variation of the Serotonin 2a Receptor Affects Hippocampal Novelty Processing in Humans	PLOS ONE			English	Article							EPISODIC MEMORY; 5-HT2A RECEPTOR; HIS452TYR POLYMORPHISM; INTERNEURONS; RETRIEVAL; AMPLITUDE; BRAIN; AGE	Serotonin (5-hydroxytryptamine, 5-HT) is an important neuromodulator in learning and memory processes. A functional genetic polymorphism of the 5-HT 2a receptor (5-HTR2a His452Tyr), which leads to blunted intracellular signaling, has previously been associated with explicit memory performance in several independent cohorts, but the underlying neural mechanisms are thus far unclear. The human hippocampus plays a critical role in memory, particularly in the detection and encoding of novel information. Here we investigated the relationship of 5-HTR2a His452Tyr and hippocampal novelty processing in 41 young, healthy subjects using functional magnetic resonance imaging (fMRI). Participants performed a novelty/familiarity task with complex scene stimuli, which was followed by a delayed recognition memory test 24 hours later. Compared to His homozygotes, Tyr carriers exhibited a diminished hippocampal response to novel stimuli and a higher tendency to judge novel stimuli as familiar during delayed recognition. Across the cohort, the false alarm rate during delayed recognition correlated negatively with the hippocampal novelty response. Our results suggest that previously reported effects of 5-HTR2a on explicit memory performance may, at least in part, be mediated by alterations of hippocampal novelty processing.	[Schott, Bjoern H.; Seidenbecher, Constanze I.; Richter, Sylvia; Debska-Vielhaber, Grazyna; Schubert, Heike; Heinze, Hans-Jochen] Leibniz Inst Neurobiol, Magdeburg, Germany; [Schott, Bjoern H.; Debska-Vielhaber, Grazyna; Schubert, Heike; Heinze, Hans-Jochen; Richardson-Klavehn, Alan; Duezel, Emrah] Univ Hosp Magdeburg, Dept Neurol, Magdeburg, Germany; [Schott, Bjoern H.; Wuestenberg, Torsten] Charite, Dept Psychiat, Berlin, Germany; [Richter, Sylvia; Heinze, Hans-Jochen; Duezel, Emrah] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Duezel, Emrah] Univ Hosp Magdeburg, Inst Cognit Neurol & Dementia Res, Magdeburg, Germany; [Duezel, Emrah] UCL, Inst Cognit Neurosci, London, England	Leibniz Institut fur Neurobiologie (LIN); University Hospital Magdeburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University Hospital Magdeburg; University of London; University College London	Schott, BH (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	bjoern.schott@med.ovgu.de	Duzel, Emrah/A-1794-2010; Schott, Björn H/U-5626-2017; Schott, Björn H/B-9369-2012	Schott, Björn H/0000-0002-8237-4481; Wustenberg, Torsten/0000-0001-8408-2864; Seidenbecher, Constanze/0000-0002-7433-2716; Duzel, Emrah/0000-0002-0139-5388	Deutsche Forschungsgemeinschaft (DFG) [SFB 779, TP A7, TP A8]; State of Saxony-Anhalt	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); State of Saxony-Anhalt	This work was supported by Deutsche Forschungsgemeinschaft (DFG), SFB 779, TP A7 and A8 (http://www.dfg.de) and State of Saxony-Anhalt, State Research Award to Dr. Bjorn Schott (http://www.sachsen-anhalt.de/LPSA/index.php?id = 3564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner RL, 2000, ACTA PSYCHOL, V105, P127, DOI 10.1016/S0001-6918(00)00057-3; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Filippini N, 2006, EUR J HUM GENET, V14, P443, DOI 10.1038/sj.ejhg.5201573; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Hazelwood LA, 2004, MOL PHARMACOL, V66, P1293, DOI 10.1124/mol.66.5.1293; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MARCUSSON JO, 1984, BRAIN RES, V311, P51, DOI 10.1016/0006-8993(84)91397-0; Ohmura Y, 2010, NEUROPSYCHOPHARMACOL, V35, P1271, DOI 10.1038/npp.2009.229; Ozaki N, 1997, J NEUROCHEM, V68, P2186; Papassotiropoulos A, 2005, NEUROREPORT, V16, P839, DOI 10.1097/00001756-200505310-00012; Papp EC, 1999, NEUROSCIENCE, V90, P369, DOI 10.1016/S0306-4522(98)00455-2; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Serretti A, 2007, CURR MED CHEM, V14, P2053; Sheline YI, 2002, AM J PSYCHIAT, V159, P430, DOI 10.1176/appi.ajp.159.3.430; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner M, 2008, INT J NEUROPSYCHOPH, V11, P1163, DOI 10.1017/S146114570800905X; Wang RY, 1998, BRAIN RES, V779, P309, DOI 10.1016/S0006-8993(97)01174-8	28	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15984	10.1371/journal.pone.0015984	http://dx.doi.org/10.1371/journal.pone.0015984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267461	gold, Green Submitted, Green Published			2022-12-27	WOS:000286519500034
J	Izeddin, I; Specht, CG; Lelek, M; Darzacq, X; Triller, A; Zimmer, C; Dahan, M				Izeddin, Ignacio; Specht, Christian G.; Lelek, Mickael; Darzacq, Xavier; Triller, Antoine; Zimmer, Christophe; Dahan, Maxime			Super-Resolution Dynamic Imaging of Dendritic Spines Using a Low-Affinity Photoconvertible Actin Probe	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LOCALIZATION MICROSCOPY; FLUORESCENCE MICROSCOPY; 3-DIMENSIONAL STRUCTURE; GLUTAMATE RECEPTORS; F-ACTIN; PLASTICITY; PROTEIN; ORGANIZATION; DIFFUSION	The actin cytoskeleton of dendritic spines plays a key role in morphological aspects of synaptic plasticity. The detailed analysis of the spine structure and dynamics in live neurons, however, has been hampered by the diffraction-limited resolution of conventional fluorescence microscopy. The advent of nanoscopic imaging techniques thus holds great promise for the study of these processes. We implemented a strategy for the visualization of morphological changes of dendritic spines over tens of minutes at a lateral resolution of 25 to 65 nm. We have generated a low-affinity photoconvertible probe, capable of reversibly binding to actin and thus allowing long-term photoactivated localization microscopy of the spine cytoskeleton. Using this approach, we resolve structural parameters of spines and record their long-term dynamics at a temporal resolution below one minute. Furthermore, we have determined changes in the spine morphology in response to pharmacologically induced synaptic activity and quantified the actin redistribution underlying these changes. By combining PALM imaging with quantum dot tracking, we could also simultaneously visualize the cytoskeleton and the spine membrane, allowing us to record complementary information on the morphological changes of the spines at super-resolution.	[Izeddin, Ignacio; Dahan, Maxime] Univ Paris 06, CNRS, Ecole Normale Super, Dept Phys,Lab Kastler Brossel,UMR 8552, Paris, France; [Izeddin, Ignacio; Dahan, Maxime] Univ Paris 06, CNRS, Ecole Normale Super, Dept Biol,Lab Kastler Brossel,UMR 8552, Paris, France; [Specht, Christian G.; Triller, Antoine] Ecole Normale Super, INSERM, U1024, F-75231 Paris, France; [Lelek, Mickael; Zimmer, Christophe] Inst Pasteur, CNRS, Grp Imagerie & Modelisat, URA 2582, Paris, France; [Darzacq, Xavier] Ecole Normale Super, CNRS, UMR8541, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Izeddin, I (corresponding author), Univ Paris 06, CNRS, Ecole Normale Super, Dept Phys,Lab Kastler Brossel,UMR 8552, Paris, France.	triller@biologie.ens.fr; maxime.dahan@lkb.ens.fr	Izeddin, Ignacio/H-2628-2013; Dahan, Maxime/F-1740-2010; LELEK, Mickaël/AAW-8152-2021	Izeddin, Ignacio/0000-0002-8476-3915; Darzacq, Xavier/0000-0003-2537-8395; Dahan, Maxime/0000-0002-4943-2491; Specht, Christian G/0000-0001-6038-7735; TRILLER, Antoine/0000-0002-7530-1233	Fondation pour la Recherche Medicale (FRM); Fondation Pierre-Gilles de Gennes; C'Nano Ile de France; Netherlands Organisation for Scientific Research (NWO)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Pierre-Gilles de Gennes; C'Nano Ile de France(Region Ile-de-France); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is supported by the Fondation pour la Recherche Medicale (FRM), the Fondation Pierre-Gilles de Gennes, and C'Nano Ile de France. I.I. acknowledges the Netherlands Organisation for Scientific Research (NWO) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BLOMBERG F, 1977, J CELL BIOL, V74, P204, DOI 10.1083/jcb.74.1.204; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; GAETAN C, 2006, PROCESSUS PONCTUELS; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; MONTAGUE C, 1983, J MUSCLE RES CELL M, V4, P95, DOI 10.1007/BF00711960; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Wang XB, 2007, J NEUROSCI, V27, P12419, DOI 10.1523/JNEUROSCI.2015-07.2007; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; WILSON CJ, 1983, J NEUROSCI, V3, P383; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]	41	109	111	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15611	10.1371/journal.pone.0015611	http://dx.doi.org/10.1371/journal.pone.0015611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264214	gold, Green Published, Green Submitted			2022-12-27	WOS:000286517600010
J	Menke, C; Goncharov, T; Qamar, L; Korch, C; Ford, HL; Behbakht, K; Thorburn, A				Menke, Christina; Goncharov, Tatiana; Qamar, Lubna; Korch, Christopher; Ford, Heide L.; Behbakht, Kian; Thorburn, Andrew			TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; MEDIATED APOPTOSIS; R DEFICIENCY; DEATH DOMAIN; TUMOR; CELLS; METASTASIS; RESISTANCE; PATHWAY; ACTIVATION	Background: Signaling by Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) and Fas ligand (FasL) has been proposed to contribute to the chemosensitivity of tumor cells treated with various other anti-cancer agents. However, the importance of these effects and whether there are differences in vitro and in vivo is unclear. Methodology/Principal Findings: To assess the relative contribution of death receptor pathways to this sensitivity and to determine whether these effects are intrinsic to the tumor cells, we compared the chemosensitivity of isogenic BJAB human lymphoma cells where Fas and TRAIL receptors or just TRAIL receptors were inhibited using mutants of the adaptor protein FADD or by altering the expression of the homeobox transcription factor Six1. Inhibition of TRAIL receptors did not affect in vitro tumor cell killing by various anti-cancer agents indicating that chemosensitivity is not significantly affected by the tumor cell-intrinsic activation of death receptor signaling. However, selective inhibition of TRAIL receptor signaling caused reduced tumor regression and clearance in vivo when tested in a NOD/SCID mouse model. Conclusions: These data show that TRAIL receptor signaling in tumor cells can determine chemosensitivity in vivo but not in vitro and thus imply that TRAIL resistance makes tumors less susceptible to conventional cytotoxic anti-cancer drugs as well as drugs that directly target the TRAIL receptors.	[Menke, Christina; Goncharov, Tatiana; Thorburn, Andrew] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA; [Qamar, Lubna; Ford, Heide L.; Behbakht, Kian] Univ Colorado, Dept Obstet & Gynecol, Sch Med, Aurora, CO USA; [Korch, Christopher] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Menke, C (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA.	Andrew.Thorburn@ucdenver.edu		Behbakht, Kian/0000-0003-4793-9958	National Institutes of Health (NIH) [RO1CA 111421, RO1CA 124545]; Department of Defense [OC060143]; NIH-National Cancer Institute [P30 CA46934]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA124545, R01CA111421] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants RO1CA 111421 (A. T.), RO1CA 124545 (A. T., H. F. & K. B.) and Department of Defense OC060143 (K. B.) and core facilities supported by the NIH-National Cancer Institute Support Grant (P30 CA46934) to University of Colorado Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Fulda S, 1998, CELL DEATH DIFFER, V5, P884, DOI 10.1038/sj.cdd.4400419; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Igney FH, 2005, CANCER IMMUNOL IMMUN, V54, P1127, DOI 10.1007/s00262-005-0680-7; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; Seki N, 2003, CANCER RES, V63, P207; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Tourneur L, 2004, CANCER RES, V64, P8101, DOI 10.1158/0008-5472.CAN-04-2361; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wajant H, 2006, CANC TREAT, V130, P141; Wang SL, 2004, CANCER RES, V64, P6666, DOI 10.1158/0008-5472.CAN-04-1734; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	30	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14527	10.1371/journal.pone.0014527	http://dx.doi.org/10.1371/journal.pone.0014527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264287	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500007
J	Ohta, S; Imaizumi, Y; Okada, Y; Akamatsu, W; Kuwahara, R; Ohyama, M; Amagai, M; Matsuzaki, Y; Yamanaka, S; Okano, H; Kawakami, Y				Ohta, Shigeki; Imaizumi, Yoichi; Okada, Yohei; Akamatsu, Wado; Kuwahara, Reiko; Ohyama, Manabu; Amagai, Masayuki; Matsuzaki, Yumi; Yamanaka, Shinya; Okano, Hideyuki; Kawakami, Yutaka			Generation of Human Melanocytes from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; MELANOMA; VITILIGO; PATIENT; CANCER; NICHE; SKIN; MAINTENANCE; NEURONS; BIOLOGY	Epidermal melanocytes play an important role in protecting the skin from UV rays, and their functional impairment results in pigment disorders. Additionally, melanomas are considered to arise from mutations that accumulate in melanocyte stem cells. The mechanisms underlying melanocyte differentiation and the defining characteristics of melanocyte stem cells in humans are, however, largely unknown. In the present study, we set out to generate melanocytes from human iPS cells in vitro, leading to a preliminary investigation of the mechanisms of human melanocyte differentiation. We generated iPS cell lines from human dermal fibroblasts using the Yamanaka factors (SOX2, OCT3/4, and KLF4, with or without c-MYC). These iPS cell lines were subsequently used to form embryoid bodies (EBs) and then differentiated into melanocytes via culture supplementation with Wnt3a, SCF, and ET-3. Seven weeks after inducing differentiation, pigmented cells expressing melanocyte markers such as MITF, tyrosinase, SILV, and TYRP1, were detected. Melanosomes were identified in these pigmented cells by electron microscopy, and global gene expression profiling of the pigmented cells showed a high similarity to that of human primary foreskin-derived melanocytes, suggesting the successful generation of melanocytes from iPS cells. This in vitro differentiation system should prove useful for understanding human melanocyte biology and revealing the mechanism of various pigment cell disorders, including melanoma.	[Ohta, Shigeki; Kuwahara, Reiko; Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Imaizumi, Yoichi; Okada, Yohei; Akamatsu, Wado; Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Tokyo, Japan; [Ohyama, Manabu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan	Keio University; Keio University; Keio University; Keio University; Kyoto University; Kyoto University	Ohta, S (corresponding author), Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan.	hidokano@sc.itc.keio.ac.jp; yutakawa@sc.itc.keio.ac.jp	Ohyama, Manabu/J-5524-2014; Ohta, Shigeki/Y-4455-2019; Kawakami, Yutaka/E-7429-2013; Akamatsu, Wado/L-1214-2013; Okada, Yohei/L-1662-2013; Okano, Hideyuki/I-7584-2019; Ohta, shigeki/L-1677-2013; Amagai, Masayuki/K-5325-2013	Ohyama, Manabu/0000-0002-2662-5717; Ohta, Shigeki/0000-0003-2994-4278; Kawakami, Yutaka/0000-0003-4836-2855; Amagai, Masayuki/0000-0003-3314-7052; Imaizumi, Yoichi/0000-0002-8501-9792; Matsuzaki, Yumi/0000-0002-3729-2997	MEXT (Ministry of Education, Culture, Sports, Science and Technology)	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from MEXT, and a Grant-in-aid for the Global COE program to Keio University from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas O, 2009, BRIT J DERMATOL, V161, P228, DOI 10.1111/j.1365-2133.2009.09250.x; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Boiko AD, NATURE, V466, P133; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Czajkowski R, 2007, DERMATOL SURG, V33, P1027, DOI 10.1111/j.1524-4725.2007.33216.x; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Grichnik JM, 2008, J INVEST DERMATOL, V128, P2365, DOI 10.1038/jid.2008.166; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; KISKINIS E, J CLIN INVEST, V120, P51; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; LI L, J CELL SCI, V123, P853; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; NAKAGAWA M, P NATL ACAD SCI US, V107, P14152; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; NISHIMURA EK, CELL STEM CELL, V6, P130; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; QUINTANA E, CANC CELL, V18, P510; Sabatino M, 2009, CANCER LETT, V279, P119, DOI 10.1016/j.canlet.2008.10.039; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Geel N, 2001, DERMATOLOGY, V202, P162, DOI 10.1159/000051626; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Yamane T, 1999, DEV DYNAM, V216, P450, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0; YU H, J INVEST DERMATOL, V130, P1227; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	42	76	85	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16182	10.1371/journal.pone.0016182	http://dx.doi.org/10.1371/journal.pone.0016182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249204	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000028
J	Ahmad, S; Varagic, J; Westwood, BM; Chappell, MC; Ferrario, CM				Ahmad, Sarfaraz; Varagic, Jasmina; Westwood, Brian M.; Chappell, Mark C.; Ferrario, Carlos M.			Uptake and Metabolism of the Novel Peptide Angiotensin-(1-12) by Neonatal Cardiac Myocytes	PLOS ONE			English	Article							CULTURED HEART-CELLS; BLOOD-PRESSURE; CONVERTING ENZYME; EXPRESSION; CHYMASE; PLASMA; GROWTH; TISSUE; PROANGIOTENSIN-12; SYSTEM	Background: Angiotensin-(1-12) [Ang-(1-12)] functions as an endogenous substrate for the productions of Ang II and Ang( 1-7) by a non-renin dependent mechanism. This study evaluated whether Ang-(1-12) is incorporated by neonatal cardiac myocytes and the enzymatic pathways of I-125-Ang-(1-12) metabolism in the cardiac myocyte medium from WKY and SHR rats. Methodology/Principal Findings: The degradation of I-125-Ang-(1-12) (1 nmol/L) in the cultured medium of these cardiac myocytes was evaluated in the presence and absence of inhibitors for angiotensin converting enzymes 1 and 2, neprilysin and chymase. In both strains uptake of I-125-Ang-(1-12) by myocytes occurred in a time-dependent fashion. Uptake of intact Ang-(1-12) was significantly greater in cardiac myocytes of SHR as compared to WKY. In the absence of renin angiotensin system (RAS) enzymes inhibitors the hydrolysis of labeled Ang-(1-12) and the subsequent generation of smaller Ang peptides from Ang-(1-12) was significantly greater in SHR compared to WKY controls. I-125-Ang-(1-12) degradation into smaller Ang peptides fragments was significantly inhibited (90% in WKY and 71% in SHR) in the presence of all RAS enzymes inhibitors. Further analysis of peptide fractions generated through the incubation of Ang-(1-12) in the myocyte medium demonstrated a predominant hydrolytic effect of angiotensin converting enzyme and neprilysin in WKY and an additional role for chymase in SHR. Conclusions/Significance: These studies demonstrate that neonatal myocytes sequester angiotensin-(1-12) and revealed the enzymes involved in the conversion of the dodecapeptide substrate to biologically active angiotensin peptides.	[Ahmad, Sarfaraz; Varagic, Jasmina; Westwood, Brian M.; Chappell, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA; [Ahmad, Sarfaraz; Varagic, Jasmina; Chappell, Mark C.; Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC USA; [Varagic, Jasmina; Chappell, Mark C.; Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA; [Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Nephrol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Ahmad, S (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA.	cferrari@wfubmc.edu	Ferrario, Carlos/ABB-4165-2021; Chappell, Mark/AAX-9087-2021; Ferrario, Carlos/ABD-2791-2020	Ferrario, Carlos/0000-0003-0792-6239	National Heart, Lung and Blood Institutes of the National Institutes of Health [2PO1 HL-051952, RO1 HL-56973]; Farley-Hudson Foundation, Jacksonville, North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952, R01HL056973] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institutes of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Farley-Hudson Foundation, Jacksonville, North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Heart, Lung and Blood Institutes of the National Institutes of Health (2PO1 HL-051952 and RO1 HL-56973). We also acknowledge partial support provided by the Farley-Hudson Foundation, Jacksonville, North Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, FASEB J, V24; Axelband F, 2009, REGUL PEPTIDES, V158, P47, DOI 10.1016/j.regpep.2009.08.004; Bauer J, 1999, AM J PHYSIOL-REG I, V277, pR412, DOI 10.1152/ajpregu.1999.277.2.R412; BUMPUS FM, 1991, HYPERTENSION, V17, P720, DOI 10.1161/01.HYP.17.5.720; Cernucan Dana Luiza, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P717; CLUBB FJ, 1987, LAB INVEST, V56, P189; Cohen JA, 2010, AM J PHYSIOL-RENAL, V299, pF35, DOI 10.1152/ajprenal.00138.2010; Danser AHJ, 1996, HEART, V76, P28, DOI 10.1136/hrt.76.3_Suppl_3.28; Danser AHJ, 1996, MOL CELL BIOCHEM, V157, P211; ENGELMANN GL, 1988, J MOL CELL CARDIOL, V20, P169, DOI 10.1016/S0022-2828(88)80030-0; Ferrario CM, 2010, HYPERTENSION, V55, P445, DOI 10.1161/HYPERTENSIONAHA.109.145839; Ferrario CM, 2009, AM J PHYSIOL-HEART C, V296, pH1184, DOI 10.1152/ajpheart.01114.2008; Guo CY, 2001, J CLIN INVEST, V107, P703, DOI 10.1172/JCI9997; Ichihara Atsuhiro, 2009, Nihon Jinzo Gakkai Shi, V51, P433; Jessup JA, 2008, AM J PHYSIOL-HEART C, V294, pH2614, DOI 10.1152/ajpheart.91521.2007; Kirimura K, 2005, HYPERTENS RES, V28, P457, DOI 10.1291/hypres.28.457; KUZUO H, 1995, CLIN EXP PHARMACOL P, V22, P82, DOI 10.1111/j.1440-1681.1995.tb01960.x; MATSUSHIMA Y, 1988, J HYPERTENS, V6, P791; MINEO C, 1990, EXP CELL RES, V190, P99, DOI 10.1016/0014-4827(90)90149-5; Nagata S, 2006, BIOCHEM BIOPH RES CO, V350, P1026, DOI 10.1016/j.bbrc.2006.09.146; Nagata S, 2010, PEPTIDES, V31, P889, DOI 10.1016/j.peptides.2010.02.008; Pan N, 2006, CLIN CHIM ACTA, V373, P32, DOI 10.1016/j.cca.2006.04.021; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; Re RN, 2006, REGUL PEPTIDES, V133, P1, DOI 10.1016/j.regpep.2005.09.012; Sano H, 1998, MOL CELL BIOCHEM, V178, P51, DOI 10.1023/A:1006830401072; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; Shaltout HA, 2009, HYPERTENSION, V53, P404, DOI 10.1161/HYPERTENSIONAHA.108.124339; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; SUZUKI J, 1993, CIRC RES, V73, P439, DOI 10.1161/01.RES.73.3.439; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Trask AJ, 2008, AM J PHYSIOL-HEART C, V294, pH2242, DOI 10.1152/ajpheart.00175.2008; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; Wei CC, 2002, AM J PHYSIOL-HEART C, V282, pH2254, DOI 10.1152/ajpheart.00191.2001; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; YAMADA S, 1989, JPN CIRC J, V53, P1221, DOI 10.1253/jcj.53.1221; YAYAMA K, 1995, LIFE SCI, V57, P1791, DOI 10.1016/0024-3205(95)02157-E	37	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15759	10.1371/journal.pone.0015759	http://dx.doi.org/10.1371/journal.pone.0015759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249217	Green Submitted, gold, Green Published			2022-12-27	WOS:000286513100010
J	Mckay, SL; Johnson, TL				McKay, Susannah L.; Johnson, Tracy L.			An Investigation of a Role for U2 snRNP Spliceosomal Components in Regulating Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; CYCLIN-DEPENDENT KINASE; C-TERMINAL DOMAIN; SMALL NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; P-TEFB; ELONGATION-FACTOR; HIV-1 TAT; CTDK-I	There is mounting evidence to suggest that the synthesis of pre-mRNA transcripts and their subsequent splicing are coordinated events. Previous studies have implicated the mammalian spliceosomal U2 snRNP as having a novel role in stimulating transcriptional elongation in vitro through interactions with the elongation factors P-TEFb and Tat-SF1; however, the mechanism remains unknown [1]. These factors are conserved in Saccharomyces cerevisiae, a fact that suggests that a similar interaction may occur in yeast to stimulate transcriptional elongation in vivo. To address this possibility we have looked for evidence of a role for the yeast Tat-SF1 homolog, Cus2, and the U2 snRNA in regulating transcription. Specifically, we have performed a genetic analysis to look for functional interactions between Cus2 or U2 snRNA and the P-TEFb yeast homologs, the Bur1/2 and Ctk1/2/3 complexes. In addition, we have analyzed Cus2-deleted or -overexpressing cells and U2 snRNA mutant cells to determine if they show transcription-related phenotypes similar to those displayed by the P-TEFb homolog mutants. In no case have we been able to observe phenotypes consistent with a role for either spliceosomal factor in transcription elongation. Furthermore, we did not find evidence for physical interactions between the yeast U2 snRNP factors and the P-TEFb homologs. These results suggest that in vivo, S. cerevisiae do not exhibit functional or physical interactions similar to those exhibited by their mammalian counterparts in vitro. The significance of the difference between our in vivo findings and the previously published in vitro results remains unclear; however, we discuss the potential importance of other factors, including viral proteins, in mediating the mammalian interactions.	[McKay, Susannah L.; Johnson, Tracy L.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mckay, SL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	johnsont@ucsd.edu			NSF [MCB-0448010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085474] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF CAREER award to T.L.J. (MCB-0448010) and an NSF predoctoral fellowship to S.L.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Conrad NK, 2000, GENETICS, V154, P557; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Costa PJ, 2000, GENETICS, V156, P535; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Doonan JH, 2009, MOL BIOTECHNOL, V42, P14, DOI 10.1007/s12033-008-9126-8; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Ganem C, 2006, MOL GENET GENOMICS, V275, P136, DOI 10.1007/s00438-005-0071-y; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hautbergue G, 2001, J BIOL CHEM, V276, P8005, DOI 10.1074/jbc.M010162200; Hilliker AK, 2007, GENE DEV, V21, P821, DOI 10.1101/gad.1536107; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; IGEL AH, 1988, NATURE, V334, P450, DOI 10.1038/334450a0; Igel H, 1998, RNA, V4, P1; Jablonski JA, 2010, NUCLEIC ACIDS RES, V38, P1249, DOI 10.1093/nar/gkp1105; Jona G, 2001, GENE, V267, P31, DOI 10.1016/S0378-1119(01)00389-4; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kim D, 2003, GENES CELLS, V8, P371, DOI 10.1046/j.1365-2443.2003.00638.x; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lindstrom DL, 2001, GENETICS, V159, P487; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Miller HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005710; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Patturajan M, 1999, J BIOL CHEM, V274, P27823, DOI 10.1074/jbc.274.39.27823; Perriman R, 2003, P NATL ACAD SCI USA, V100, P13857, DOI 10.1073/pnas.2036312100; Perriman R, 2010, MOL CELL, V38, P416, DOI 10.1016/j.molcel.2010.02.036; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; PRELICH G, 1993, GENETICS, V135, P665; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Selth LA, 2009, COLD SPRING HARB PRO; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Wells SE, 1996, GENE DEV, V10, P220, DOI 10.1101/gad.10.2.220; Wilcox CB, 2004, GENETICS, V167, P93, DOI 10.1534/genetics.167.1.93; WINSTON F, 1984, GENETICS, V107, P179; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; XIAO B, 2001, MOL CELL BIOL, V27, P721; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; ZAVANELLI MI, 1994, MOL CELL BIOL, V14, P1689, DOI 10.1128/MCB.14.3.1689; ZAVANELLI MI, 1991, GENE DEV, V5, P2521, DOI 10.1101/gad.5.12b.2521; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	72	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16077	10.1371/journal.pone.0016077	http://dx.doi.org/10.1371/journal.pone.0016077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283673	Green Submitted, gold, Green Published			2022-12-27	WOS:000286523400014
J	Horch, RA; Gochberg, DF; Nyman, JS; Does, MD				Horch, R. Adam; Gochberg, Daniel F.; Nyman, Jeffry S.; Does, Mark D.			Non-invasive Predictors of Human Cortical Bone Mechanical Properties: T-2-Discriminated H-1 NMR Compared with High Resolution X-ray	PLOS ONE			English	Article							MINERAL DENSITY; WATER; TOUGHNESS; FRACTURES; CONTRAST; BMD	Recent advancements in magnetic resonance imaging (MRI) have enabled clinical imaging of human cortical bone, providing a potentially powerful new means for assessing bone health with molecular-scale sensitivities unavailable to conventional X-ray-based diagnostics. To this end, H-1 nuclear magnetic resonance (NMR) and high-resolution X-ray signals from human cortical bone samples were correlated with mechanical properties of bone. Results showed that H-1 NMR signals were better predictors of yield stress, peak stress, and pre-yield toughness than were the X-ray derived signals. These H-1 NMR signals can, in principle, be extracted from clinical MRI, thus offering the potential for improved clinical assessment of fracture risk.	[Horch, R. Adam; Nyman, Jeffry S.; Does, Mark D.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Horch, R. Adam; Gochberg, Daniel F.; Does, Mark D.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN USA; [Gochberg, Daniel F.; Does, Mark D.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA; [Nyman, Jeffry S.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA; [Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN USA; [Does, Mark D.] Vanderbilt Univ, Dept Elect Engn, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University	Horch, RA (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	jeffry.s.nyman@vanderbilt.edu; mark.does@vanderbilt.edu	Does, Mark/G-8975-2011; Nyman, Jeffry/L-5736-2013	Nyman, Jeffry/0000-0001-7403-7605	NIH [EB001744, EB001452]; Vanderbilt Discovery Grant program; NSF [0448915]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001452, R01EB001744, T32EB001628] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Discovery Grant program; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge financial support from NIH Grant # EB001744, #EB001452, the Vanderbilt Discovery Grant program, and NSF Grant #0448915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; CARTER DR, 1992, J BONE MINER RES, V7, P137; Du J, 2010, MAGN RESON MED, V63, P447, DOI 10.1002/mrm.22257; Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227; Horch RA, 2010, MAGN RESON MED, V64, P1652, DOI 10.1002/mrm.22558; Horch RA, 2010, MAGN RESON MED, V64, P680, DOI 10.1002/mrm.22459; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Larson PEZ, 2007, MAGN RESON MED, V58, P952, DOI 10.1002/mrm.21341; Majumdar S, 1998, BONE, V22, P445, DOI 10.1016/S8756-3282(98)00030-1; Majumdar S, 2008, SKELETAL RADIOL, V37, P95, DOI 10.1007/s00256-007-0412-5; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012; Nyman JS, 2005, MICRON, V36, P566, DOI 10.1016/j.micron.2005.07.004; Rahmer J, 2007, MAGN RESON MATER PHY, V20, P83, DOI 10.1007/s10334-007-0070-6; Robson MD, 2006, NMR BIOMED, V19, P765, DOI 10.1002/nbm.1100; Sigmund EE, 2008, MAGN RESON MED, V59, P28, DOI 10.1002/mrm.21281; SILVER MS, 1984, J MAGN RESON, V59, P347, DOI 10.1016/0022-2364(84)90181-1; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Wehrli FW, 2007, J MAGN RESON IMAGING, V25, P390, DOI 10.1002/jmri.20807; WHITTALL KP, 1989, J MAGN RESON, V84, P134, DOI 10.1016/0022-2364(89)90011-5	21	89	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16359	10.1371/journal.pone.0016359	http://dx.doi.org/10.1371/journal.pone.0016359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283693	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522300039
J	Kalghatgi, S; Kelly, CM; Cerchar, E; Torabi, B; Alekseev, O; Fridman, A; Friedman, G; Azizkhan-Clifford, J				Kalghatgi, Sameer; Kelly, Crystal M.; Cerchar, Ekaterina; Torabi, Behzad; Alekseev, Oleg; Fridman, Alexander; Friedman, Gary; Azizkhan-Clifford, Jane			Effects of Non-Thermal Plasma on Mammalian Cells	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; DNA-DAMAGE; BLOOD-COAGULATION; HISTONE H2AX; STERILIZATION; INACTIVATION; APOPTOSIS; BACTERIA; PHOSPHORYLATION; RADIATION	Thermal plasmas and lasers have been widely used in medicine to cut, ablate and cauterize tissues through heating; in contrast, non-thermal plasma produces no heat, so its effects can be selective. In order to exploit the potential for clinical applications, including wound healing, sterilization, blood coagulation, and cancer treatment, a mechanistic understanding of the interaction of non-thermal plasma with living tissues is required. Using mammalian cells in culture, it is shown here that non-thermal plasma created by dielectric barrier discharge (DBD) has dose-dependent effects that range from increasing cell proliferation to inducing apoptosis. It is also shown that these effects are primarily due to formation of intracellular reactive oxygen species (ROS). We have utilized gamma-H2AX to detect DNA damage induced by non-thermal plasma and found that it is initiated by production of active neutral species that most likely induce formation of organic peroxides in cell medium. Phosphorylation of H2AX following non-thermal plasma treatment is ATR dependent and ATM independent, suggesting that plasma treatment may lead to replication arrest or formation of single-stranded DNA breaks; however, plasma does not lead to formation of bulky adducts/thymine dimers.	[Kalghatgi, Sameer; Friedman, Gary] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Kelly, Crystal M.; Torabi, Behzad; Alekseev, Oleg; Azizkhan-Clifford, Jane] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA; [Cerchar, Ekaterina] Drexel Univ, Dept Surg, Coll Med, Philadelphia, PA 19104 USA; [Fridman, Alexander] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University; Drexel University	Azizkhan-Clifford, J (corresponding author), Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.	jc19072@gmail.com			Drexel University Major Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013011] Funding Source: NIH RePORTER	Drexel University Major Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Drexel University Major Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Ayan H, 2009, IEEE T PLASMA SCI, V37, P113, DOI 10.1109/TPS.2008.2006899; Coulombe S, 2006, PURE APPL CHEM, V78, P1147, DOI 10.1351/pac200678061147; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; ELIASSON B, 1994, PURE APPL CHEM, V66, pU1766; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Fitch ME, 2003, CARCINOGENESIS, V24, P843, DOI 10.1093/carcin/bgg031; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; FRIDMAN A, 2008, PLASMA BIOL PLASMA M; FRIDMAN A, 2008, PLASMA CHEM, P848; FRIDMAN A, 2008, PLASMA CHEM; FRIDMAN A, 2004, PLASMA PHYS ENG, P853; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; GEBICKI S, 1993, BIOCHEM J, V289, P743, DOI 10.1042/bj2890743; Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jiang C, 2008, IEEE INT POWER MODUL, P77, DOI 10.1109/IPMC.2008.4743581; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; KOGELSCHATZ U, 2004, NONEQUILIBRIUM AIR P; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899; Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lehnert BE, 2002, HUM EXP TOXICOL, V21, P65, DOI 10.1191/0960327102ht212oa; Lu XP, 2009, IEEE T PLASMA SCI, V37, P668, DOI 10.1109/TPS.2009.2015454; MAJNO G, 1995, AM J PATHOL, V146, P3; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shekhter AB, 2005, NITRIC OXIDE-BIOL CH, V12, P210, DOI 10.1016/j.niox.2005.03.004; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Siemens C. W., 1862, J FRANKLIN I, V74, P166, DOI DOI 10.1016/0016-0032(62)90468-4; Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012; Sladek REJ, 2004, IEEE T PLASMA SCI, V32, P1540, DOI 10.1109/TPS.2004.832636; STOFFELS E, 2008, ADV PLASMA TECHNOLOG, P301; Stoffels E, 2006, J PHYS D APPL PHYS, V39, DOI 10.1088/0022-3727/39/16/E01; Vargo JJ, 2004, GASTROINTEST ENDOSC, V59, P81, DOI 10.1016/S0016-5107(03)02296-X; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Weng CC, 2009, INT J RADIAT BIOL, V85, P362, DOI 10.1080/09553000902781105	49	379	394	6	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16270	10.1371/journal.pone.0016270	http://dx.doi.org/10.1371/journal.pone.0016270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283714	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300026
J	Rekha, RS; Kamal, SMM; Andersen, P; Rahim, Z; Hoq, MI; Ara, G; Andersson, J; Sack, D; Raqib, R				Rekha, Rokeya Sultana; Kamal, S. M. Mostafa; Andersen, Peter; Rahim, Zeaur; Hoq, Md Imranul; Ara, Gul; Andersson, Jan; Sack, David; Raqib, Rubhana			Validation of the ALS Assay in Adult Patients with Culture Confirmed Pulmonary Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LYMPHOCYTE SECRETIONS; COMPARATIVE GENOMICS; ANTIBODY-RESPONSES; RAPID DIAGNOSIS; INFECTION; CHILDREN; TESTS; PERFORMANCE; BOVIS	Background: We have earlier shown that Bacille Calmette-Guerin (BCG) vaccine-specific IgG Antibodies in Lymphocyte Supernatant (ALS) can be used for diagnosis of active tuberculosis (TB) in adults and children. Methodology/Principal Findings: The ALS method was validated in a larger cohort (n = 212) of patients with suspicion of pulmonary TB using multiple antigens (BCG, LAM, TB15.3, TB51A, CFP10-ESAT6-A, CFP, CW) from Mycobacterium tuberculosis. The sensitivity and specificity of the ALS assay was calculated using non-TB patients as controls. The sensitivity and the specificity were highest with BCG vaccine (90% and 88% respectively) followed by LAM (89% and 87% respectively). Simultaneous assessment of multiple antigen-specific antibodies increased sensitivity (91%) and specificity (88%). Using higher lymphocyte count in smaller volume of culture media increased detection and reduced the assay duration to similar to 30 hrs. Twenty one patients with clinical findings strongly suggestive of TB finally diagnosed as non-TB patients were positive by the ALS assay, of which 9 (43%) were positive for 7 antigens and 19 (90%) for at least 3 antigens. Conclusions/Significance: Our findings show that simultaneous detection of antigens improves the diagnostic potential of the ALS assay; the modified method increases sensitivity and can provide results in,48 hours, and enable detection of some cases of pulmonary TB that are not detectable by standard methods.	[Rekha, Rokeya Sultana; Rahim, Zeaur; Hoq, Md Imranul; Ara, Gul; Sack, David; Raqib, Rubhana] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Kamal, S. M. Mostafa] Natl Inst Dis Chest & Hosp NIDCH, Dhaka, Bangladesh; [Andersen, Peter] Statum Serum Inst, Copenhagen, Denmark; [Andersson, Jan] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden	International Centre for Diarrhoeal Disease Research (ICDDR); Statens Serum Institut; Karolinska Institutet; Karolinska University Hospital	Rekha, RS (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	rubhana@icddrb.org	Abrams, William R/A-5782-2008	Raqib, Rubhana/0000-0002-8116-4511; Andersen, Peter/0000-0002-5869-2551	WHO/TDR [C10/181/86, TDR-ID A40387]; US Agency for International Development (USAID) [HRN-A-00-96-90005-00]; International Center for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B)	WHO/TDR(World Health Organization); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); International Center for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B)	The study was funded by the WHO/TDR (C10/181/86; TDR-ID A40387) and the US Agency for International Development (USAID, grant HRN-A-00-96-90005-00) and International Center for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRERA L, 1989, PEDIATR INFECT DIS J, V8, P763, DOI 10.1097/00006454-198911000-00007; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; Davies MA, 2009, AIDS, V23, P961, DOI 10.1097/QAD.0b013e32832956ad; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; KALRA M, 2009, DIAGN MICROBIOL INFE; Kobashi Y, 2009, EUR RESPIR J, V33, P812, DOI 10.1183/09031936.00075008; Lewinsohn DA, 2004, INT J TUBERC LUNG D, V8, P658; Lodha Rakesh, 2004, Indian Journal of Pediatrics, V71, P221, DOI 10.1007/BF02724274; Mahadevan S., 1997, Indian Journal of Pediatrics, V64, P97, DOI 10.1007/BF02795786; McConkey SJ, 2002, INT J TUBERC LUNG D, V6, P246; Perkins MD, 2003, CHEST, V123, P107, DOI 10.1378/chest.123.1.107; Raqib R, 2004, CLIN DIAGN LAB IMMUN, V11, P1022, DOI 10.1128/CDLI.11.6.1022-1027.2004; Raqib R, 2003, J INFECT DIS, V188, P364, DOI 10.1086/376511; Raqib R, 2009, CLIN VACCINE IMMUNOL, V16, P521, DOI 10.1128/CVI.00391-08; Richeldi L, 2009, CHEST, V136, P198, DOI 10.1378/chest.08-2575; Samanich K, 2001, INFECT IMMUN, V69, P4600, DOI 10.1128/IAI.69.7.4600-4609.2001; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; Steingart KR, 2007, FUTURE MICROBIOL, V2, P355, DOI 10.2217/17460913.2.4.355; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Tan SH, 2001, ANN ACAD MED SINGAP, V30, P3; Tsukamura M., 1984, IDENTIFICATION MYCOB; Vordermeier HM, 2007, CLIN VACCINE IMMUNOL, V14, P1203, DOI 10.1128/CVI.00116-07; *WHO, 2008, SER WHO, V2; World Health Organization, 2009, GLOB TUB CONTR EP ST	28	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16425	10.1371/journal.pone.0016425	http://dx.doi.org/10.1371/journal.pone.0016425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283655	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300046
J	Cao, HB; Wu, J; Lam, S; Duan, RQ; Newnham, C; Molday, RS; Graziotto, JJ; Pierce, EA; Hu, J				Cao, Huibi; Wu, Jing; Lam, Simon; Duan, Rongqi; Newnham, Catherine; Molday, Robert S.; Graziotto, John J.; Pierce, Eric A.; Hu, Jim			Temporal and Tissue Specific Regulation of RP-Associated Splicing Factor Genes PRPF3, PRPF31 and PRPC8-Implications in the Pathogenesis of RP	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; MESSENGER-RNA; DISEASE MECHANISM; EPITHELIAL-CELLS; SNRNP; MUTATIONS; PROTEIN; EXPRESSION; COMPLEX; HPRP3P	Background: Genetic mutations in several ubiquitously expressed RNA splicing genes such as PRPF3, PRP31 and PRPC8, have been found to cause retina-specific diseases in humans. To understand this intriguing phenomenon, most studies have been focused on testing two major hypotheses. One hypothesis assumes that these mutations interrupt retina-specific interactions that are important for RNA splicing, implying that there are specific components in the retina interacting with these splicing factors. The second hypothesis suggests that these mutations have only a mild effect on the protein function and thus affect only the metabolically highly active cells such as retinal photoreceptors. Methodology/Principal Findings: We examined the second hypothesis using the PRPF3 gene as an example. We analyzed the spatial and temporal expression of the PRPF3 gene in mice and found that it is highly expressed in retinal cells relative to other tissues and its expression is developmentally regulated. In addition, we also found that PRP31 and PRPC8 as well as snRNAs are highly expressed in retinal cells. Conclusions/Significance: Our data suggest that the retina requires a relatively high level of RNA splicing activity for optimal tissue-specific physiological function. Because the RP18 mutation has neither a debilitating nor acute effect on protein function, we suggest that retinal degeneration is the accumulative effect of decades of suboptimal RNA splicing due to the mildly impaired protein.	[Cao, Huibi; Wu, Jing; Lam, Simon; Duan, Rongqi; Newnham, Catherine; Hu, Jim] Univ Toronto, Physiol & Expt Med Program, Toronto, ON, Canada; [Hu, Jim] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hu, Jim] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Graziotto, John J.; Pierce, Eric A.] Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of Pennsylvania; Pennsylvania Medicine	Cao, HB (corresponding author), Univ Toronto, Physiol & Expt Med Program, Toronto, ON, Canada.	jim.hu@utoronto.ca		Hu, Jim/0000-0001-9134-7103; Pierce, Eric/0000-0002-2354-4102	Canadian Institutes of Health Research [MOP-77750, CIHR RMF-92101]; Canadian Cystic Fibrosis Foundation; Foundation Fighting Blindness-Canada; NATIONAL EYE INSTITUTE [R01EY020902] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Foundation Fighting Blindness-Canada; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was partially supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (funding reference numbers MOP-77750, CIHR RMF-92101), the Canadian Cystic Fibrosis Foundation (http://www.cysticfibrosis.ca/en/index.php) (grants to JH) and Foundation Fighting Blindness-Canada (http://www.ffb.ca/research_ffb-funded.php?hc = 1) (grant to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; BOUGHMAN JA, 1983, BRIT J OPHTHALMOL, V67, P449, DOI 10.1136/bjo.67.7.449; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; Bujakowska K, 2009, INVEST OPHTH VIS SCI, V50, P5927, DOI 10.1167/iovs.08-3275; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Deery EC, 2002, HUM MOL GENET, V11, P3209, DOI 10.1093/hmg/11.25.3209; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gonzalez-Santos JM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni093; Gonzalez-Santos JM, 2002, J BIOL CHEM, V277, P23764, DOI 10.1074/jbc.M111461200; Gonzalez-Santos JM, 2008, HUM MOL GENET, V17, P225, DOI 10.1093/hmg/ddm300; GRAZIOTTO JJ, 2006, INVEST OPHTHALMOL VI, V47; GRAZIOTTO JJ, 2010, INVEST OPHTHALMOL VI; Graziotto JJ, 2008, INVEST OPHTH VIS SCI, V49, P3830, DOI 10.1167/iovs.07-1483; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hong WJ, 1997, NUCLEIC ACIDS RES, V25, P354, DOI 10.1093/nar/25.2.354; Horowitz DS, 1997, RNA, V3, P1374; Jin ZB, 2007, AM J MED GENET A, V143A, P2544, DOI 10.1002/ajmg.a.31984; Lauber J, 1997, RNA, V3, P926; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Little JT, 2008, J BIOL CHEM, V283, P8145, DOI 10.1074/jbc.M707984200; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Maita H, 2005, EXP CELL RES, V302, P61, DOI 10.1016/j.yexcr.2004.08.022; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Medenbach J, 2004, MOL CELL BIOL, V24, P7392, DOI 10.1128/MCB.24.17.7392-7401.2004; Mordes D, 2006, MOL VIS, V12, P1259; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Rivolta C, 2006, HUM MUTAT, V27, P644, DOI 10.1002/humu.20325; Schmidt-Kastner R, 2008, MOL VIS, V14, P125; STEINBERG RH, 1987, INVEST OPHTH VIS SCI, V28, P1888; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, pU333; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wang A, 1997, HUM MOL GENET, V6, P2117, DOI 10.1093/hmg/6.12.2117; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilkie SE, 2008, MOL VIS, V14, P683; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57	44	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15860	10.1371/journal.pone.0015860	http://dx.doi.org/10.1371/journal.pone.0015860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283520	gold, Green Published, Green Submitted			2022-12-27	WOS:000286520600015
J	Cifuentes-Diaz, C; Dubourg, O; Irinopoulou, T; Vigny, M; Lachkar, S; Decker, L; Charnay, P; Denisenko, N; Maisonobe, T; Leger, JM; Viala, K; Hauw, JJ; Girault, JA				Cifuentes-Diaz, Carmen; Dubourg, Odile; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Decker, Laurence; Charnay, Patrick; Denisenko, Natalia; Maisonobe, Thierry; Leger, Jean-Marc; Viala, Karine; Hauw, Jean-Jacques; Girault, Jean-Antoine			Nodes of Ranvier and Paranodes in Chronic Acquired Neuropathies	PLOS ONE			English	Article							INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; NERVE BIOPSY; MYELINATED AXONS; DIAGNOSTIC-VALUE; PROTEIN CASPR; POLYNEUROPATHY; LOCALIZATION; CHANNEL; RECOMMENDATIONS; MAINTENANCE	Chronic acquired neuropathies of unknown origin are classified as chronic inflammatory demyelinating polyneuropathies (CIDP) and chronic idiopathic axonal polyneuropathies (CIAP). The diagnosis can be very difficult, although it has important therapeutic implications since CIDP can be improved by immunomodulating treatment. The aim of this study was to examine the possible abnormalities of nodal and paranodal regions in these two types of neuropathies. Longitudinal sections of superficial peroneal nerves were obtained from biopsy material from 12 patients with CIDP and 10 patients with CIAP and studied by immunofluorescence and in some cases electron microscopy. Electron microscopy revealed multiple alterations in the nodal and paranodal regions which predominated in Schwann cells in CIDP and in axons in CIAP. In CIDP paranodin/Caspr immunofluorescence was more widespread than in control nerves, extending along the axon in internodes where it appeared intense. Nodal channels Nav and KCNQ2 were less altered but were also detected in the internodes. In CIAP paranodes, paranodin labeling was irregular and/or decreased. To test the consequences of acquired primary Schwann cells alteration on axonal proteins, we used a mouse model based on induced deletion of the transcription factor Krox-20 gene. In the demyelinated sciatic nerves of these mice we observed alterations similar to those found in CIDP by immunofluorescence, and immunoblotting demonstrated increased levels of paranodin. Finally we examined whether the alterations in paranodin immunoreactivity could have a diagnosis value. In a sample of 16 biopsies, the study of paranodin immunofluorescence by blind evaluators led to correct diagnosis in 70 +/- 4% of the cases. This study characterizes for the first time the abnormalities of nodes of Ranvier in CIAP and CIDP, and the altered expression and distribution of nodal and paranodal proteins. Marked differences were observed between CIDP and CIAP and the alterations in paranodin immunofluorescence may be an interesting tool for their differential diagnosis.	[Cifuentes-Diaz, Carmen; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Denisenko, Natalia; Girault, Jean-Antoine] INSERM, UMR S 839, Paris, France; [Cifuentes-Diaz, Carmen; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Denisenko, Natalia; Hauw, Jean-Jacques; Girault, Jean-Antoine] Univ Paris 06, Paris, France; [Cifuentes-Diaz, Carmen; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Denisenko, Natalia; Girault, Jean-Antoine] Inst Fer Moulin, Paris, France; [Dubourg, Odile; Maisonobe, Thierry; Hauw, Jean-Jacques] Hop La Pitie Salpetriere, AP HP, Lab Neuropathol Raymond Escourolle, Paris, France; [Dubourg, Odile; Leger, Jean-Marc] Hop La Pitie Salpetriere, AP HP, Ctr Reference Paris Est, Paris, France; [Decker, Laurence; Charnay, Patrick] Ecole Normale Super, CNRS, UMR 8197, IBENS,INSERM,U1024, F-75231 Paris, France; [Maisonobe, Thierry; Viala, Karine] Hop La Pitie Salpetriere, AP HP, Federat Neurophysiol Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cifuentes-Diaz, C (corresponding author), INSERM, UMR S 839, Paris, France.	jean-antoine.girault@inserm.fr	Girault, Jean-Antoine/F-7518-2013	Girault, Jean-Antoine/0000-0002-7900-1705; Cifuentes Diaz, Carmen/0000-0003-2563-2082; Charnay, Patrick/0000-0002-3847-6042	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique - Hopitaux de Paris (AP-HP)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique - Hopitaux de Paris (AP-HP)	The work was supported by funding from Institut National de la Sante et de la Recherche Medicale (Inserm) and from Assistance Publique - Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLT G, 1975, J NEUROCYTOL, V4, P63, DOI 10.1007/BF01099096; Antoine JC, 2008, POSTGRAD MED J, V84, P378, DOI 10.1136/jnnp.2006.109785; Arroyo EJ, 2002, J NEUROSCI, V22, P1726, DOI 10.1523/JNEUROSCI.22-05-01726.2002; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bosboom WMJ, 2001, BRAIN, V124, P2427, DOI 10.1093/brain/124.12.2427; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Devaux JJ, 2005, J NEUROSCI, V25, P1470, DOI 10.1523/JNEUROSCI.3328-04.2005; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ELLISMAN MH, 1982, P NATL ACAD SCI-BIOL, V79, P6707, DOI 10.1073/pnas.79.21.6707; England JD, 1996, MICROSC RES TECHNIQ, V34, P445, DOI 10.1002/(SICI)1097-0029(19960801)34:5<445::AID-JEMT4>3.0.CO;2-L; FOSTER RE, 1980, SCIENCE, V210, P661, DOI 10.1126/science.6159685; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7; Henry MA, 2006, PAIN, V124, P222, DOI 10.1016/j.pain.2006.05.028; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KOSKI CL, 2008, J NEUROL SCI; KRENDEL DA, 1989, MUSCLE NERVE, V12, P257, DOI 10.1002/mus.880120402; Kuitwaard K, 2009, DRUGS, V69, P987, DOI 10.2165/00003495-200969080-00004; Li J, 2005, BRAIN, V128, P1168, DOI 10.1093/brain/awh483; Magy L, 2008, REV NEUROL-FRANCE, V164, P1063, DOI 10.1016/j.neurol.2008.09.001; Maisonobe T, 2006, REV NEUROL-FRANCE, V162, P527; Mathis C, 2001, DEVELOPMENT, V128, P4881; MCLEOD JG, 1984, J NEUROL NEUROSUR PS, V47, P530, DOI 10.1136/jnnp.47.5.530; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; NOTERMANS NC, 1994, J NEUROL NEUROSUR PS, V57, P1525, DOI 10.1136/jnnp.57.12.1525; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Vallat JM, 2009, J NEUROPATH EXP NEUR, V68, P833, DOI 10.1097/NEN.0b013e3181af2b9c; Vallat JM, 2003, MUSCLE NERVE, V27, P478, DOI 10.1002/mus.10348; Viala K, 2010, J PERIPHER NERV SYST, V15, P50, DOI 10.1111/j.1529-8027.2010.00251.x; VRANCKEN AF, 2004, COCHRANE DB SYST REV; Wolswijk G, 2003, BRAIN, V126, P1638, DOI 10.1093/brain/awg151	39	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14533	10.1371/journal.pone.0014533	http://dx.doi.org/10.1371/journal.pone.0014533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267074	gold, Green Published, Green Submitted			2022-12-27	WOS:000286519500009
J	Billing, O; Kao, G; Naredi, P				Billing, Ola; Kao, Gautam; Naredi, Peter			Mitochondrial Function Is Required for Secretion of DAF-28/Insulin in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN IMPORT; INSULIN-SECRETION; OXIDATIVE STRESS; GENETIC-ANALYSIS; OUTER-MEMBRANE; LONGEVITY; DAF-16; NEMATODE; COMPLEX	While insulin signaling has been extensively studied in Caenorhabditis elegans in the context of ageing and stress response, less is known about the factors underlying the secretion of insulin ligands upstream of the insulin receptor. Activation of the receptor governs the decision whether to progress through the reproductive lifecycle or to arrest growth and enter hibernation. We find that animals with reduced levels of the mitochondrial outer membrane translocase homologue TOMM-40 arrest growth as larvae and have decreased insulin signaling strength. TOMM-40 acts as a mitochondrial translocase in C. elegans and in its absence animals fail to import a mitochondrial protein reporter across the mitochondrial membrane(s). Inactivation of TOMM-40 evokes the mitochondrial unfolded protein response and causes a collapse of the proton gradient across the inner mitochondrial membrane. Consequently these broadly dysfunctional mitochondria render an inability to couple food abundance to secretion of DAF-28/insulin. The secretion defect is not general in nature since two other neuropeptides, ANF::GFP and INS-22::VENUS, are secreted normally. RNAi against two other putative members of the TOMM complex give similar phenotypes, implying that DAF-28 secretion is sensitive to mitochondrial dysfunction in general. We conclude that mitochondrial function is required for C. elegans to secrete DAF-28/insulin when food is abundant. This modulation of secretion likely represents an additional level of control over DAF-28/insulin function.	[Billing, Ola; Kao, Gautam; Naredi, Peter] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University	Billing, O (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden.	gautam.kao@surgery.umu.se	Naredi, Peter/AAG-1504-2019	Billing, Ola/0000-0001-5824-6263; Naredi, Peter/0000-0002-5652-0422	Swedish Research Council [K2008-68X-20803-01-3]; Swedish Cancer Society [CAN2007/901]; Cancer Research Foundation in Northern Sweden; Vasterbottens County Council; National Institutes of Health National Center for Research Resources (NCRR)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundation in Northern Sweden; Vasterbottens County Council; National Institutes of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Swedish Research Council (K2008-68X-20803-01-3), the Swedish Cancer Society (CAN2007/901), the Cancer Research Foundation in Northern Sweden, and Vasterbottens County Council (ALF-means and Spjutspetsmedel). Some C. elegans strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Arkblad EL, 2002, COMP BIOCHEM PHYS B, V133, P13, DOI 10.1016/S1096-4959(02)00107-0; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collet J, 1998, GENETICS, V148, P187; Curran SP, 2004, J BIOL CHEM, V279, P54655, DOI 10.1074/jbc.M409618200; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Fares H, 2001, GENETICS, V159, P133; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gems D, 1998, GENETICS, V150, P129; Goudeau J, 2010, AGING CELL, V9, P991, DOI 10.1111/j.1474-9726.2010.00625.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HERMAN RK, 1978, GENETICS, V88, P49; Hu Patrick J, 2007, WormBook, P1; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; Kondo M, 2005, MECH AGEING DEV, V126, P637, DOI 10.1016/j.mad.2004.11.011; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Malone EA, 1996, GENETICS, V143, P1193; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Sherman EL, 2006, J BIOL CHEM, V281, P22554, DOI 10.1074/jbc.M601630200; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Tan FJ, 2007, CELL DEATH DIFFER, V14, P1925, DOI 10.1038/sj.cdd.4402215; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	53	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14507	10.1371/journal.pone.0014507	http://dx.doi.org/10.1371/journal.pone.0014507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264209	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600003
J	Nakamura, M; Ohki, S; Suzuki, A; Sakai, K				Nakamura, Masako; Ohki, Shun; Suzuki, Atsushi; Sakai, Kazuhiko			Coral Larvae under Ocean Acidification: Survival, Metabolism, and Metamorphosis	PLOS ONE			English	Article							CO2; SETTLEMENT; SEAWATER; GROWTH; DEPRESSION; STRESS; IMPACT; ENERGY; CARBON; REEFS	Ocean acidification may negatively impact the early life stages of some marine invertebrates including corals. Although reduced growth of juvenile corals in acidified seawater has been reported, coral larvae have been reported to demonstrate some level of tolerance to reduced pH. We hypothesize that the observed tolerance of coral larvae to low pH may be partly explained by reduced metabolic rates in acidified seawater because both calcifying and non-calcifying marine invertebrates could show metabolic depression under reduced pH in order to enhance their survival. In this study, after 3-d and 7-d exposure to three different pH levels (8.0, 7.6, and 7.3), we found that the oxygen consumption of Acropora digitifera larvae tended to be suppressed with reduced pH, although a statistically significant difference was not observed between pH conditions. Larval metamorphosis was also observed, confirming that successful recruitment is impaired when metamorphosis is disrupted, despite larval survival. Results also showed that the metamorphosis rate significantly decreased under acidified seawater conditions after both short (2 h) and long (7 d) term exposure. These results imply that acidified seawater impacts larval physiology, suggesting that suppressed metabolism and metamorphosis may alter the dispersal potential of larvae and subsequently reduce the resilience of coral communities in the near future as the ocean pH decreases.	[Nakamura, Masako; Ohki, Shun; Sakai, Kazuhiko] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Okinawa, Japan; [Suzuki, Atsushi] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki, Japan	University of the Ryukyus; National Institute of Advanced Industrial Science & Technology (AIST)	Nakamura, M (corresponding author), Okinawa Inst Sci & Technol, Okinawa, Japan.	m_coral29@yahoo.co.jp	Suzuki, Atsushi/L-6120-2018	Suzuki, Atsushi/0000-0002-0266-5765; Ohki, Shun/0000-0001-6301-8919; Sakai, Kazuhiko/0000-0003-1905-5952	Ministry of the Environment of Japan [B-084]; Grants-in-Aid for Scientific Research [21247006, 20121002] Funding Source: KAKEN	Ministry of the Environment of Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Acidification Impact on CALcifiers (AICAL) project, lead by Yukihiro Nojiri and funded by Global Environment Research Fund B-084 of the Ministry of the Environment of Japan. The funders has no role in study design, data collection and analysis, decision to publish, or perparation of the manuscript.	Albright R, 2008, CORAL REEFS, V27, P485, DOI 10.1007/s00338-008-0392-5; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; DEGNAN BM, 1995, AM ZOOL, V35, P391; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; Harrison P.L., 1990, CORAL REEFS, V25, P133; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Jackson D, 2002, INT J DEV BIOL, V46, P679; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Langenbuch M, 2004, AQUAT TOXICOL, V70, P55, DOI 10.1016/j.aquatox.2004.07.006; Leitz T, 1997, INVERTEBR REPROD DEV, V31, P109, DOI 10.1080/07924259.1997.9672569; Lewis E., 1998, PROGRAM DEV CO2 SYST; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; Okubo N, 2008, MAR ECOL PROG SER, V366, P305, DOI 10.3354/meps07562; Page LR, 1998, INVERTEBR BIOL, V117, P208, DOI 10.2307/3226987; Reipschlager A, 1996, J EXP BIOL, V199, P1801; RODRIGUEZ JL, 1990, MAR BIOL, V106, P109, DOI 10.1007/BF02114680; Sabine CL, 2007, GREENHOUSE GAS SINKS, P31, DOI 10.1079/9781845931896.0031; Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Shilling FM, 1996, BIOL BULL, V191, P402, DOI 10.2307/1543013; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; SUZUKI A, 1995, SEDIMENT GEOL, V99, P259, DOI 10.1016/0037-0738(95)00048-D; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690; WHEATLY MG, 1992, J EXP ZOOL, V263, P127, DOI 10.1002/jez.1402630204	49	108	112	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14521	10.1371/journal.pone.0014521	http://dx.doi.org/10.1371/journal.pone.0014521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264208	gold, Green Published, Green Submitted			2022-12-27	WOS:000286517600005
J	He, HQ; Liu, ZR; Dong, BQ; Zhang, JW; Shu, XQ; Zhou, JJ; Ji, YH				He, Huiqiong; Liu, Zhirui; Dong, Bangqian; Zhang, Jianwei; Shu, Xueqin; Zhou, Jingjing; Ji, Yonghua			Localization of Receptor Site on Insect Sodium Channel for Depressant beta-toxin BmK IT2	PLOS ONE			English	Article							BUTHUS-MARTENSI KARSCH; GATED NA+ CHANNELS; SCORPION TOXIN; MOLECULAR-CLONING; SELECTIVE TOXINS; VOLTAGE SENSOR; NERVOUS-SYSTEM; MESSENGER-RNAS; ALPHA-SUBUNIT; ION CHANNELS	Background: BmK IT2 is regarded as a receptor site-4 modulator of sodium channels with depressant insect toxicity. It also displays anti-nociceptive and anti-convulsant activities in rat models. In this study, the potency and efficacy of BmK IT2 were for the first time assessed and compared among four sodium channel isoforms expressed in Xenopus oocytes. Combined with molecular approach, the receptor site of BmK IT2 was further localized. Principal Findings: 2 mu M BmK IT2 strongly shifted the activation of DmNa(v)1, the sodium channel from Drosophila, to more hyperpolarized potentials; whereas it hardly affected the gating properties of rNa(v)1.2, rNa(v)1.3 and mNa(v)1.6, three mammalian central neuronal sodium channel subtypes. (1) Mutations of Glu(896), Leu(899), Gly(904) in extracellular loop Domain II S3-S4 of DmNa(v)1 abolished the functional action of BmK IT2. (2) BmK IT2-preference for DmNav1 could be conferred by Domain III. Analysis of subsequent DmNa(v)1 mutants highlighted the residues in Domain III pore loop, esp. Ile(1529) was critical for recognition and binding of BmK IT2. Conclusions/Significance: In this study, BmK IT2 displayed total insect-selectivity. Two binding regions, comprising domains II and III of DmNa(v)1, play separated but indispensable roles in the interaction with BmK IT2. The insensitivity of Na(v)1.2, Na(v)1.3 and Na(v)1.6 to BmK IT2 suggests other isoforms or mechanism might be involved in the suppressive activity of BmK IT2 in rat pathological models.	[He, Huiqiong; Liu, Zhirui; Dong, Bangqian; Zhang, Jianwei; Shu, Xueqin; Zhou, Jingjing; Ji, Yonghua] Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China; [He, Huiqiong] Chinese Acad Sci, Shanghai Inst Physiol, Shanghai Inst Biol Sci, Grad Sch, Shanghai 200031, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, HQ (corresponding author), Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China.	yhji@staff.shu.edu.cn	Ji, Yonghua/B-7769-2014		National Basic Research Program of China [2006CB500801, 2010CB529806]; Key discipline 'Molecular Physiology' of the Shanghai Education Committee	National Basic Research Program of China(National Basic Research Program of China); Key discipline 'Molecular Physiology' of the Shanghai Education Committee	This study was supported by National Basic Research Program of China (2006CB500801 and 2010CB529806) and Key discipline 'Molecular Physiology' of the Shanghai Education Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Borchani L, 1996, EUR J BIOCHEM, V241, P525, DOI 10.1111/j.1432-1033.1996.00525.x; Borges A, 2004, TOXICON, V43, P671, DOI 10.1016/j.toxicon.2004.02.022; Bosmans F, 2005, TOXICON, V45, P501, DOI 10.1016/j.toxicon.2004.12.010; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Cestele S, 1997, EUR J BIOCHEM, V243, P93, DOI 10.1111/j.1432-1033.1997.93_1a.x; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chai ZF, 2006, PHARMACOL RES, V54, P85, DOI 10.1016/j.phrs.2006.02.009; Cohen L, 2007, MOL PHARMACOL, V72, P1220, DOI 10.1124/mol.107.039057; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; De Lima ME, 2007, COMP BIOCHEM PHYS C, V146, P264, DOI 10.1016/j.cbpc.2006.10.010; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; GORDON D, 1992, BIOCHEMISTRY-US, V31, P7622, DOI 10.1021/bi00148a025; Gordon D, 2003, EUR J BIOCHEM, V270, P2663, DOI 10.1046/j.1432-1033.2003.03643.x; JI YH, 1994, CHINESE SCI BULL, V39, P945; JI YH, 1994, SCI CHINA SER B, V37, P955; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Li YJ, 2000, NEUROSCI RES, V38, P257, DOI 10.1016/S0168-0102(00)00164-4; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MOSKOWITZ H, 1994, INSECT BIOCHEM MOLEC, V24, P13, DOI 10.1016/0965-1748(94)90118-X; Peng F, 2002, EUR J BIOCHEM, V269, P4468, DOI 10.1046/j.1432-1033.2002.03136.x; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; Tan ZY, 2001, NEUROPHARMACOLOGY, V40, P352, DOI 10.1016/S0028-3908(00)00168-4; Tian CH, 2008, TOXICON, V51, P555, DOI 10.1016/j.toxicon.2007.11.010; Zhao R, 2008, BRIT J PHARMACOL, V154, P1116, DOI 10.1038/bjp.2008.156	33	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14510	10.1371/journal.pone.0014510	http://dx.doi.org/10.1371/journal.pone.0014510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264295	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500002
J	Weigand, MR; Tran, VN; Sundin, GW				Weigand, Michael R.; Tran, Vinh N.; Sundin, George W.			Growth Parameter Components of Adaptive Specificity during Experimental Evolution of the UVR-Inducible Mutator Pseudomonas cichorii 302959	PLOS ONE			English	Article							MUTAGENIC DNA-REPAIR; ESCHERICHIA-COLI; BACTERIAL EVOLUTION; ADAPTATION; FITNESS; POPULATIONS; RADIATION; SELECTION; OPERON; MUTABILITY	Background: Mutagenic DNA repair (MDR) transiently increases mutation rate through the activation of low-fidelity repair polymerases in response to specific, DNA-damaging environmental stress conditions such as ultraviolet radiation (UVR) exposure. These repair polymerases also confer UVR tolerance, intimately linking mutability and survival in bacteria that colone habitats subject to regular UVR exposure. Methodology/Principal Findings: Here, we investigate adaptive specificity in experimental lineages of the highly UVR-mutable epiphytic plant pathogen Pseudomonas cichorii 302959. Relative fitness measurements of isolates and population samples from replicate lineages indicated that adaptive improvements emerged early in all lineages of our evolution experiment and specific increases in relative fitness correlated with distinct improvements in doubling and lag times. Adaptive improvements gained under UVR and non-UVR conditions were acquired preferentially, and differentially contributed to relative fitness under varied growth conditions. Conclusions: These results support our earlier observations that MDR activation may contribute to gains in relative fitness without impeding normal patterns of adaptive specificity in P. cichorii 302959.	[Weigand, Michael R.; Sundin, George W.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Tran, Vinh N.; Sundin, George W.] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Sundin, George W.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Sundin, George W.] Michigan State Univ, Ctr Pathogenesis, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Weigand, MR (corresponding author), Michigan State Univ, Genet Program, E Lansing, MI 48824 USA.	sundin@msu.edu		Weigand, Michael/0000-0002-7278-0160	Michigan Agricultural Experiment Station	Michigan Agricultural Experiment Station	This work was funded by the Michigan Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BROCK BIOL MICROORGA; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Courcelle J, 2001, GENETICS, V158, P41; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; de Visser JAGM, 2002, MICROBIOL-SGM, V148, P1247, DOI 10.1099/00221287-148-5-1247; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Kim JJ, 2000, J BACTERIOL, V182, P6137, DOI 10.1128/JB.182.21.6137-6144.2000; KING EO, 1954, J LAB CLIN MED, V44, P310; Lenski RE, 1998, ANTON LEEUW INT J G, V73, P35, DOI 10.1023/A:1000675521611; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; Loh E, 2010, P NATL ACAD SCI USA, V107, P1154, DOI 10.1073/pnas.0912451107; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Sambrook J., 2002, MOL CLONING LAB MANU; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Sleight SC, 2007, PHYSIOL BIOCHEM ZOOL, V80, P370, DOI 10.1086/518013; Sundin GW, 2007, FEMS MICROBIOL LETT, V277, P11, DOI 10.1111/j.1574-6968.2007.00901.x; Sundin GW, 1999, ENVIRON MICROBIOL, V1, P75, DOI 10.1046/j.1462-2920.1999.00008.x; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Travisano M, 1996, GENETICS, V143, P15; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Weigand MR, 2009, GENETICS, V181, P199, DOI 10.1534/genetics.108.096131; Zhang S, 2004, CAN J MICROBIOL, V50, P29, DOI [10.1139/w03-105, 10.1139/W03-105]	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15975	10.1371/journal.pone.0015975	http://dx.doi.org/10.1371/journal.pone.0015975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264242	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500020
J	Hasson, CJ; Miller, RH; Caldwell, GE				Hasson, Christopher J.; Miller, Ross H.; Caldwell, Graham E.			Contractile and Elastic Ankle Joint Muscular Properties in Young and Older Adults	PLOS ONE			English	Article							POWER-VELOCITY CHARACTERISTICS; LENGTH-TENSION RELATIONSHIP; MUSCLE STRENGTH; MECHANICAL-PROPERTIES; TORQUE-VELOCITY; ELDERLY-MEN; GASTROCNEMIUS-MUSCLE; PLANTAR-FLEXION; KNEE EXTENSORS; TENDON	The purpose of this study was to investigate age-related differences in contractile and elastic properties of both dorsi-(DF) and plantarflexor (PF) muscles controlling the ankle joint in young and older adults. Experimental data were collected while twelve young and twelve older male and female participants performed maximal effort isometric and isovelocity contractions on a dynamometer. Equations were fit to the data to give torque-angle (T theta) and torque-angular velocity (T omega) relations. Muscle series-elasticity was measured during ramped dynamometer contractions using ultrasonography to measure aponeurosis extension as a function of torque; second order polynomials were used to characterize the torque-extension (T Delta L) relation. The results showed no age differences in DF maximal torque and none for female PF; however, older males had smaller maximal PF torques compared to young males. In both muscle groups and genders, older adults had decreased concentric force capabilities. Both DF and PF T Delta L relations were more nonlinear in the older adults. Older PF, but not DF muscles, were stiffer compared to young. A simple antagonism model suggested age-related differences in T theta and T omega relations would be magnified if antagonistic torque contributions were included. This assessment of static, dynamic, and elastic joint properties affords a comprehensive view of age-related modifications in muscle function. Although many clinical studies use maximal isometric strength as a marker of functional ability, the results demonstrate that there are also significant age-related modifications in ankle muscle dynamic and elastic properties.	[Hasson, Christopher J.; Miller, Ross H.; Caldwell, Graham E.] Univ Massachusetts Amherst, Dept Kinesiol, Biomech Lab, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Amherst	Hasson, CJ (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	cjhasson@neu.edu	Miller, Ross/K-9344-2015; Miller, Ross/I-7329-2012	Miller, Ross/0000-0002-2924-7993; Hasson, Christopher/0000-0002-9851-0919	National Institutes of Health [R03AG026281]; NATIONAL INSTITUTE ON AGING [R03AG026281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by National Institutes of Health Grant R03AG026281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2000, SCAND J MED SCI SPOR, V10, P58, DOI 10.1034/j.1600-0838.2000.010002058.x; Abbasi AA, 1998, AM J MED SCI, V315, P188, DOI 10.1097/00000441-199803000-00008; Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Bazzucchi I, 2006, MUSCLE NERVE, V33, P191, DOI 10.1002/mus.20462; Behm D G, 1996, Can J Appl Physiol, V21, P403; BELANGER AY, 1983, EUR J APPL PHYSIOL O, V51, P381, DOI 10.1007/BF00429075; Billot M, 2010, MUSCLE NERVE, V41, P511, DOI 10.1002/mus.21530; BLANPIED P, 1993, J GERONTOL, V48, pM58, DOI 10.1093/geronj/48.2.M58; BOBBERT MF, 1990, J BIOMECH, V23, P105, DOI 10.1016/0021-9290(90)90345-4; Bojsen-Moller J, 2004, J APPL PHYSIOL, V97, P1908, DOI 10.1152/japplphysiol.00084.2004; CALDWELL GE, 1993, CAN J APPL PHYSIOL, V18, P274, DOI 10.1139/h93-024; CALDWELL GE, 1995, J APPL BIOMECH, V11, P1; Carmeli E, 2000, GERONTOLOGY, V46, P249, DOI 10.1159/000022168; CHAPMAN AE, 1985, J APPL PHYSIOL, V59, P78, DOI 10.1152/jappl.1985.59.1.78; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Delgado-Lezama R, 1997, J NEUROSCI METH, V78, P125, DOI 10.1016/S0165-0270(97)00143-X; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Epstein M, 2006, J BIOMECH, V39, P2020, DOI 10.1016/j.jbiomech.2005.06.011; ETTEMA GJC, 1989, J BIOMECH, V22, P1209, DOI 10.1016/0021-9290(89)90223-6; Ferri A, 2003, ACTA PHYSIOL SCAND, V177, P69, DOI 10.1046/j.1365-201X.2003.01050.x; FITZHUGH R, 1977, J MATH BIOL, V4, P203, DOI 10.1007/BF00280973; Fukunaga T, 1996, J APPL PHYSIOL, V81, P1430, DOI 10.1152/jappl.1996.81.3.1430; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HARRIES UJ, 1990, EUR J APPL PHYSIOL, V60, P187, DOI 10.1007/BF00839157; HERZOG W, 1988, J BIOMECH, V21, P5, DOI 10.1016/0021-9290(88)90185-6; Hill A.V, 1970, 1 LAST EXPT MUSCLE M; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HORTOBAGYI T, 1995, J GERONTOL A-BIOL, V50, pB399, DOI 10.1093/gerona/50A.6.B399; Hubley-Kozey C, 2000, EUR J APPL PHYSIOL, V82, P289, DOI 10.1007/s004210000208; HYATT RH, 1990, AGE AGEING, V19, P330, DOI 10.1093/ageing/19.5.330; ITO M, 1998, J APPL PHYSIOL, V80, P1235; JAKOBSSON F, 1988, MUSCLE NERVE, V11, P1211, DOI 10.1002/mus.880111205; JOHNS RJ, 1962, J APPL PHYSIOL, V17, P824, DOI 10.1152/jappl.1962.17.5.824; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; Karamanidis K, 2006, J BIOMECH, V39, P406, DOI 10.1016/j.jbiomech.2004.12.017; Kawakami Y, 2002, EUR J APPL PHYSIOL, V87, P381, DOI 10.1007/s00421-002-0657-6; Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22, DOI 10.1152/jappl.1999.87.1.22; Klass M, 2005, J APPL PHYSIOL, V99, P31, DOI 10.1152/japplphysiol.01426.2004; Lanza IR, 2003, J APPL PHYSIOL, V95, P2361, DOI 10.1152/japplphysiol.00724.2002; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86, DOI 10.1152/ajpcell.1991.261.1.C86; Loram ID, 2004, J PHYSIOL-LONDON, V556, P683, DOI 10.1113/jphysiol.2004.062398; Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x; Maganaris CN, 1998, EXP PHYSIOL, V83, P843, DOI 10.1113/expphysiol.1998.sp004164; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; MARSH E, 1981, J APPL PHYSIOL, V51, P160, DOI 10.1152/jappl.1981.51.1.160; Muramatsu T, 2001, J APPL PHYSIOL, V90, P1671, DOI 10.1152/jappl.2001.90.5.1671; OBERG B, 1987, MED SCI SPORT EXER, V19, P318; Ochala J, 2005, EUR J APPL PHYSIOL, V94, P126, DOI 10.1007/s00421-004-1299-7; Ochala J, 2004, EXP GERONTOL, V39, P349, DOI 10.1016/j.exger.2003.11.004; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Porter M M, 1995, Can J Appl Physiol, V20, P429; Porter MM, 1997, J GERONTOL A-BIOL, V52, pB125, DOI 10.1093/gerona/52A.2.B125; POULIN MJ, 1992, CAN J SPORT SCI, V17, P3; Roy A, 2009, IEEE T ROBOT, V25, P569, DOI 10.1109/TRO.2009.2019783; SALE D, 1982, J APPL PHYSIOL, V52, P1636, DOI 10.1152/jappl.1982.52.6.1636; SCOTT SH, 1995, J MORPHOL, V224, P73, DOI 10.1002/jmor.1052240109; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; SIEGLER S, 1984, J BIOMECH, V17, P647, DOI 10.1016/0021-9290(84)90118-0; Simoneau E, 2005, J GERONTOL A-BIOL, V60, P439, DOI 10.1093/gerona/60.4.439; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; Simoneau EM, 2009, J ELECTROMYOGR KINES, V19, pE123, DOI 10.1016/j.jelekin.2007.11.006; TAYLOR NAS, 1991, EUR J APPL PHYSIOL O, V62, P116, DOI 10.1007/BF00626766; TAYLOR NAS, 1991, EUR J APPL PHYSIOL O, V62, P180, DOI 10.1007/BF00643739; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; Thom JM, 2007, EUR J APPL PHYSIOL, V100, P613, DOI 10.1007/s00421-007-0481-0; van Donkelaar CC, 1999, J BIOMECH, V32, P755, DOI 10.1016/S0021-9290(99)00073-1; VANDERVOORT AA, 1990, J GERONTOL, V45, pB125, DOI 10.1093/geronj/45.4.B125; VANDERVOORT AA, 1986, J APPL PHYSIOL, V61, P361, DOI 10.1152/jappl.1986.61.1.361; VANSCHAIK CS, 1994, J GERONTOL, V49, pB121, DOI 10.1093/geronj/49.3.B121; Winegard KJ, 1997, J GERONTOL A-BIOL, V52, pB337, DOI 10.1093/gerona/52A.6.B337; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211	81	21	21	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15953	10.1371/journal.pone.0015953	http://dx.doi.org/10.1371/journal.pone.0015953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264315	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000012
J	Chen, G; Rogers, AK; League, GP; Nam, SC				Chen, Geng; Rogers, Alicia K.; League, Garrett P.; Nam, Sang-Chul			Genetic Interaction of Centrosomin and Bazooka in Apical Domain Regulation in Drosophila Photoreceptor	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; RETINITIS-PIGMENTOSA; CRUMBS; CELLS; EYE; MORPHOGENESIS; POLARITY; LOCALIZATION; HOMOLOG	Background: Cell polarity genes including Crumbs (Crb) and Par complexes are essential for controlling photoreceptor morphogenesis. Among the Crb and Par complexes, Bazooka (Baz, Par-3 homolog) acts as a nodal component for other cell polarity proteins. Therefore, finding other genes interacting with Baz will help us to understand the cell polarity genes' role in photoreceptor morphogenesis. Methodology/Principal Findings: Here, we have found a genetic interaction between baz and centrosomin (cnn). Cnn is a core protein for centrosome which is a major microtubule-organizing center. We analyzed the effect of the cnn mutation on developing eyes to determine its role in photoreceptor morphogenesis. We found that Cnn is dispensable for retinal differentiation in eye imaginal discs during the larval stage. However, photoreceptors deficient in Cnn display dramatic morphogenesis defects including the mislocalization of Crumbs (Crb) and Bazooka (Baz) during mid-stage pupal eye development, suggesting that Cnn is specifically required for photoreceptor morphogenesis during pupal eye development. This role of Cnn in apical domain modulation was further supported by Cnn's gain-of-function phenotype. Cnn overexpression in photoreceptors caused the expansion of the apical Crb membrane domain, Baz and adherens junctions (AJs). Conclusions/Significance: These results strongly suggest that the interaction of Baz and Cnn is essential for apical domain and AJ modulation during photoreceptor morphogenesis, but not for the initial photoreceptor differentiation in the Drosophila photoreceptor.	[Chen, Geng; Rogers, Alicia K.; League, Garrett P.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X; Rogers, Alicia/0000-0001-5525-6095	Knights Templar Eye Foundation; University Research Committee of Baylor University	Knights Templar Eye Foundation; University Research Committee of Baylor University	This study was supported by grants from the Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef/), and University Research Committee of Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Brodu V, 2010, DEV CELL, V18, P790, DOI [10.1016/j.devcel.2010.03.015, 10.1016/j.devce1.2010.03.015]; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009480; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Eisman RC, 2009, GENETICS, V182, P979, DOI 10.1534/genetics.109.103887; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Guerin CM, 2009, DEVELOPMENT, V136, P1411, DOI 10.1242/dev.031823; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kumar JP, 1995, DEVELOPMENT, V121, P4359; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Malikov V, 2004, MOL BIOL CELL, V15, P2742, DOI 10.1091/mbc.E03-10-0770; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Moutinho-Pereira S, 2009, MOL BIOL CELL, V20, P2796, DOI 10.1091/mbc.E09-01-0011; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Newsome TP, 2000, DEVELOPMENT, V127, P851; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; STUURMAN N, 1995, J CELL SCI, V108, P3137; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; XU T, 1993, DEVELOPMENT, V117, P1223	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16127	10.1371/journal.pone.0016127	http://dx.doi.org/10.1371/journal.pone.0016127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253601	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511900040
J	Stollhoff, R; Jost, J; Elze, T; Kennerknecht, I				Stollhoff, Rainer; Jost, Juergen; Elze, Tobias; Kennerknecht, Ingo			Deficits in Long-Term Recognition Memory Reveal Dissociated Subtypes in Congenital Prosopagnosia	PLOS ONE			English	Article							VENTRAL VISUAL-CORTEX; HUMAN NEURAL SYSTEM; FUSIFORM FACE AREA; DEVELOPMENTAL PROSOPAGNOSIA; HEREDITARY PROSOPAGNOSIA; DETAILED EXPLORATION; COVERT RECOGNITION; UNFAMILIAR FACES; 1ST REPORT; PERCEPTION	The study investigates long-term recognition memory in congenital prosopagnosia (CP), a lifelong impairment in face identification that is present from birth. Previous investigations of processing deficits in CP have mostly relied on short-term recognition tests to estimate the scope and severity of individual deficits. We firstly report on a controlled test of long-term (one year) recognition memory for faces and objects conducted with a large group of participants with CP. Long-term recognition memory is significantly impaired in eight CP participants (CPs). In all but one case, this deficit was selective to faces and didn't extend to intra-class recognition of object stimuli. In a test of famous face recognition, long-term recognition deficits were less pronounced, even after accounting for differences in media consumption between controls and CPs. Secondly, we combined test results on long-term and short-term recognition of faces and objects, and found a large heterogeneity in severity and scope of individual deficits. Analysis of the observed heterogeneity revealed a dissociation of CP into subtypes with a homogeneous phenotypical profile. Thirdly, we found that among CPs self-assessment of real-life difficulties, based on a standardized questionnaire, and experimentally assessed face recognition deficits are strongly correlated. Our results demonstrate that controlled tests of long-term recognition memory are needed to fully assess face recognition deficits in CP. Based on controlled and comprehensive experimental testing, CP can be dissociated into subtypes with a homogeneous phenotypical profile. The CP subtypes identified align with those found in prosopagnosia caused by cortical lesions; they can be interpreted with respect to a hierarchical neural system for face perception.	[Stollhoff, Rainer; Jost, Juergen; Elze, Tobias] Max Planck Inst Math Sci, Leipzig, Germany; [Jost, Juergen] Santa Fe Inst Sci Complex, Santa Fe, NM USA; [Kennerknecht, Ingo] Univ Munster, Inst Human Genet, D-4400 Munster, Germany	Max Planck Society; The Santa Fe Institute; University of Munster	Stollhoff, R (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	rainer.stollhoff@mis.mpg.de		Elze, Tobias/0000-0002-2032-0496; Jost, Juergen/0000-0001-5258-6590				Ariel R, 1996, CORTEX, V32, P221, DOI 10.1016/S0010-9452(96)80048-7; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Baayen R., 2008, J MEMORY LANGUAGE; Barton JJS, 2005, NEUROLOGY, V65, P270, DOI 10.1212/01.wnl.0000168901.98616.1c; Barton JJS, 2003, NEUROPSYCHOLOGIA, V41, P1703, DOI 10.1016/S0028-3932(03)00115-5; Barton JJS, 2003, NEUROLOGY, V61, P220, DOI 10.1212/01.WNL.0000071229.11658.F8; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Barton JJS, 2001, NEUROLOGY, V57, P1161, DOI 10.1212/WNL.57.7.1161; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bobes MA, 2003, CORTEX, V39, P41, DOI 10.1016/S0010-9452(08)70073-X; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Breen N, 2000, COGNITIVE NEUROPSYCH, V17, P55, DOI 10.1080/026432900380481; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Crawford JR, 2006, NEUROPSYCHOLOGIA, V44, P666, DOI 10.1016/j.neuropsychologia.2005.06.001; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; de Haan M, 2002, DEV PSYCHOBIOL, V40, P200, DOI 10.1002/dev.10027; de Haan M, 2001, COGNITIVE DEV, V16, P659, DOI 10.1016/S0885-2014(01)00051-X; Della Sala S, 2003, CORTEX, V39, P533; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; DINKELACKER V, 2010, J NEUROLOGY IN PRESS; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine BC, 2003, NEUROPSYCHOLOGIA, V41, P713, DOI 10.1016/S0028-3932(02)00222-1; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine B, 2008, AM J MED GENET A, V146A, P2860, DOI 10.1002/ajmg.a.32548; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellis HD, 2001, TRENDS COGN SCI, V5, P149, DOI 10.1016/S1364-6613(00)01620-X; ELZE T, 2009, J VIS, V9, P58; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; FAUST C, 1947, PARTIELLE SEELENBLIN, P294; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Garrido L, 2009, BRAIN, V132, P3443, DOI 10.1093/brain/awp271; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GRUETER M, 2004, GENETIK KONGENITALEN; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; Hadfield J., 2009, MCMC METHODS MULTIRE; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HECAEN H, 1962, ARCH NEUROL-CHICAGO, V7, P92, DOI 10.1001/archneur.1962.04210020014002; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Humphreys K, 2007, EXP BRAIN RES, V176, P356, DOI 10.1007/s00221-006-0621-5; JANICKE C, 2001, THESIS; Kalbe E, 2008, NEUROCASE, V14, P15, DOI 10.1080/13554790801992735; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kennerknecht I, 2008, FRONT BIOSCI-LANDMRK, V13, P3150, DOI 10.2741/2916; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Lange J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007414; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Lissauer H., 1890, ARCH PSYCHIAT NERVEN, V21, P22; MAZZUCCHI A, 1983, CORTEX, V19, P509, DOI 10.1016/S0010-9452(83)80032-X; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Palmeri TJ, 2004, NAT REV NEUROSCI, V5, P291, DOI 10.1038/nrn1364; PASCALIS O, 1994, NEUROREPORT, V5, P1721, DOI 10.1097/00001756-199409080-00008; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; R Core Team, 2020, R LANG ENV STAT COMP; Riddoch JM, 1993, BORB BIRMINGHAM OBJE; Scherf KS, 2007, DEVELOPMENTAL SCI, V10, pF15, DOI 10.1111/j.1467-7687.2007.00595.x; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Schmalzl L, 2008, COGN NEUROPSYCHOL, V25, P704, DOI 10.1080/02643290802299350; Schwarzer G, 2007, PSYCHOL RES-PSYCH FO, V71, P583, DOI 10.1007/s00426-006-0068-0; Sperber S, 2003, CORTEX, V39, P57, DOI 10.1016/S0010-9452(08)70074-1; Stollhoff R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011482; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; TRANEL D, 1995, J COGNITIVE NEUROSCI, V7, P425, DOI 10.1162/jocn.1995.7.4.425; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; von Kriegstein K, 2006, CEREB CORTEX, V16, P1314, DOI 10.1093/cercor/bhj073; Warrington EK., 1991, VISUAL OBJECT SPACE; WILBRAND H, 1892, DTSCH Z NERVENHEILKD, V2, P361, DOI DOI 10.1007/BF01667704; Williams MA, 2007, CURR BIOL, V17, P1259, DOI 10.1016/j.cub.2007.06.042; Young AW, 1999, COGN NEUROPSYCHOL, V16, P1, DOI 10.1080/026432999380960	92	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15702	10.1371/journal.pone.0015702	http://dx.doi.org/10.1371/journal.pone.0015702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283572	gold, Green Published, Green Submitted			2022-12-27	WOS:000286661400011
J	van der Heide, T; van Nes, EH; van Katwijk, MM; Olff, H; Smolders, AJP				van der Heide, Tjisse; van Nes, Egbert H.; van Katwijk, Marieke M.; Olff, Han; Smolders, Alfons J. P.			Positive Feedbacks in Seagrass Ecosystems - Evidence from Large-Scale Empirical Data	PLOS ONE			English	Article							POSIDONIA-OCEANICA; ZOSTERA-MARINA; WATER; TOXICITY; NITROGEN; SHIFTS; FLOW	Positive feedbacks cause a nonlinear response of ecosystems to environmental change and may even cause bistability. Even though the importance of feedback mechanisms has been demonstrated for many types of ecosystems, their identification and quantification is still difficult. Here, we investigated whether positive feedbacks between seagrasses and light conditions are likely in seagrass ecosystems dominated by the temperate seagrass Zostera marina. We applied a combination of multiple linear regression and structural equation modeling (SEM) on a dataset containing 83 sites scattered across Western Europe. Results confirmed that a positive feedback between sediment conditions, light conditions and seagrass density is likely to exist in seagrass ecosystems. This feedback indicated that seagrasses are able to trap and stabilize suspended sediments, which in turn improves water clarity and seagrass growth conditions. Furthermore, our analyses demonstrated that effects of eutrophication on light conditions, as indicated by surface water total nitrogen, were on average at least as important as sediment conditions. This suggests that in general, eutrophication might be the most important factor controlling seagrasses in sheltered estuaries, while the seagrass-sediment-light feedback is a dominant mechanism in more exposed areas. Our study demonstrates the potentials of SEM to identify and quantify positive feedbacks mechanisms for ecosystems and other complex systems.	[van der Heide, Tjisse; Olff, Han] Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Haren, Netherlands; [van Nes, Egbert H.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, Dept Environm Sci, Wageningen, Netherlands; [van Katwijk, Marieke M.] Radboud Univ Nijmegen, Dept Environm Sci, Inst Wetland & Water Res, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Smolders, Alfons J. P.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, Inst Water & Wetland Res, Fac Sci, NL-6525 ED Nijmegen, Netherlands	University of Groningen; Wageningen University & Research; Radboud University Nijmegen; Radboud University Nijmegen	van der Heide, T (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Haren, Netherlands.	T.van.der.Heide@rug.nl	van Katwijk, Marieke M/B-1709-2012; van der Heide, Tjisse/M-3000-2013; Olff, Han/A-8516-2008; van Nes, Egbert H/F-2681-2011; Smolders, Alfons J.P./H-2583-2012	van Katwijk, Marieke M/0000-0002-4482-5835; Olff, Han/0000-0003-2154-3576; van Nes, Egbert/0000-0002-6345-104X	Netherlands Organization of Scientific Research - Earth and Life Sciences (NWO-ALW)	Netherlands Organization of Scientific Research - Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	The data presented in this study were collected as part of the project "Macrophytes in Estuarine Gradients (MEG)." This project was funded by the Netherlands Organization of Scientific Research - Earth and Life Sciences (NWO-ALW) as part of the framework "Land-Ocean Interactions in the Coastal Zone (LOICZ)." Website: http://www.nwo.nl/projecten.nsf/pages/1900121750. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2002, ESTUARIES, V25, P1205, DOI 10.1007/BF02692217; ARBUCKLE J. L., 2007, AMOS 16 0 USERS GUID; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barron C, 2006, LIMNOL OCEANOGR, V51, P1648, DOI 10.4319/lo.2006.51.4.1648; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter SR, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P357; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Koroleff F., 1983, METHODS SEAWATER ANA, V2nd, P205; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Moore KA, 2004, J COASTAL RES, P162, DOI 10.2112/SI45-162.1; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; van der Heide T, 2009, LIMNOL OCEANOGR, V54, P2018, DOI 10.4319/lo.2009.54.6.2018; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2010, ECOLOGY, V91, P362, DOI 10.1890/08-1567.1; van Katwijk MM, 2010, ESTUAR COAST SHELF S, V89, P175, DOI 10.1016/j.ecss.2010.06.008; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; WARD LG, 1984, MAR GEOL, V59, P85, DOI 10.1016/0025-3227(84)90089-6; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WOOD ED, 1967, J MAR BIOL ASSOC UK, V47, P23, DOI 10.1017/S002531540003352X	32	87	90	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16504	10.1371/journal.pone.0016504	http://dx.doi.org/10.1371/journal.pone.0016504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283684	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400039
J	Leon, A; Caceres, C; Fernandez, E; Chausa, P; Martin, M; Codina, C; Rousaud, A; Blanch, J; Mallolas, J; Martinez, E; Blanco, JL; Laguno, M; Larrousse, M; Milinkovic, A; Zamora, L; Canal, N; Miro, JM; Gatell, JM; Gomez, EJ; Garcia, F				Leon, Agathe; Caceres, Cesar; Fernandez, Emma; Chausa, Paloma; Martin, Maite; Codina, Carles; Rousaud, Araceli; Blanch, Jordi; Mallolas, Josep; Martinez, Esteban; Blanco, Jose L.; Laguno, Montserrat; Larrousse, Maria; Milinkovic, Ana; Zamora, Laura; Canal, Neus; Miro, Josep M.; Gatell, Josep M.; Gomez, Enrique J.; Garcia, Felipe			A New Multidisciplinary Home Care Telemedicine System to Monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized Study	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; HOSPITAL ANXIETY; HIV; MANAGEMENT; ADHERENCE; TELECARE; TRIAL; DEPRESSION; DISTANCE; IMPACT	Background: Antiretroviral therapy has changed the natural history of human immunodeficiency virus (HIV) infection in developed countries, where it has become a chronic disease. This clinical scenario requires a new approach to simplify follow-up appointments and facilitate access to healthcare professionals. Methodology: We developed a new internet-based home care model covering the entire management of chronic HIV-infected patients. This was called Virtual Hospital. We report the results of a prospective randomised study performed over two years, comparing standard care received by HIV-infected patients with Virtual Hospital care. HIV-infected patients with access to a computer and broadband were randomised to be monitored either through Virtual Hospital (Arm I) or through standard care at the day hospital (Arm II). After one year of follow up, patients switched their care to the other arm. Virtual Hospital offered four main services: Virtual Consultations, Telepharmacy, Virtual Library and Virtual Community. A technical and clinical evaluation of Virtual Hospital was carried out. Findings: Of the 83 randomised patients, 42 were monitored during the first year through Virtual Hospital (Arm I) and 41 through standard care (Arm II). Baseline characteristics of patients were similar in the two arms. The level of technical satisfaction with the virtual system was high: 85% of patients considered that Virtual Hospital improved their access to clinical data and they felt comfortable with the videoconference system. Neither clinical parameters [level of CD4(+) T lymphocytes, proportion of patients with an undetectable level of viral load (p = 0.21) and compliance levels >90% (p = 0.58)] nor the evaluation of quality of life or psychological questionnaires changed significantly between the two types of care. Conclusions: Virtual Hospital is a feasible and safe tool for the multidisciplinary home care of chronic HIV patients. Telemedicine should be considered as an appropriate support service for the management of chronic HIV infection.	[Leon, Agathe; Fernandez, Emma; Mallolas, Josep; Martinez, Esteban; Blanco, Jose L.; Laguno, Montserrat; Larrousse, Maria; Milinkovic, Ana; Zamora, Laura; Miro, Josep M.; Gatell, Josep M.; Garcia, Felipe] Univ Barcelona, Hosp Clin, Infect Dis Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Caceres, Cesar; Chausa, Paloma; Gomez, Enrique J.] Tech Univ Madrid, Bioengn & Telemed Unit, Madrid, Spain; [Martin, Maite; Codina, Carles] Univ Barcelona, Serv Pharm, Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Rousaud, Araceli; Blanch, Jordi] Univ Barcelona, Hosp Clin, Clin Inst Psychiat & Psychol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Canal, Neus] IMS Hlth Inc, Hlth Econ & Outcomes Res, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad Politecnica de Madrid; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Leon, A (corresponding author), Univ Barcelona, Hosp Clin, Infect Dis Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.	aleon@clinic.ub.es	Caceres, Cesar/AAP-5173-2021; Chausa, Paloma/AAT-5569-2021; Blanch, Jordi/I-9022-2012; , Felipe/F-4242-2014; Caceres, Cesar/K-5378-2012; Gomez, Enrique J/K-6698-2017; Leon, Agathe/K-9851-2015	Caceres, Cesar/0000-0002-1546-775X; Chausa, Paloma/0000-0002-6740-657X; Blanch, Jordi/0000-0003-2597-8454; , Felipe/0000-0001-7658-5832; Caceres, Cesar/0000-0002-1546-775X; Gomez, Enrique J/0000-0001-6998-1407; Leon, Agathe/0000-0002-1198-5090; Laguno Centeno, Montserrat/0000-0002-7798-6352; Mallolas Masferrer, Josep/0000-0002-8365-141X; Milinkovic, Ana/0000-0002-7732-9168	Institut de Investigacions Biomediques August Pi I Sunyer [CM06/00170]; Fundacio Clinic; Spanish Health Department; Abbott; Bristol-Myers Squibb; Gilead Sciences; MSD; GlaxoSmithKline; Tibotec; Roche; Boehringerngelheim; Pfizer	Institut de Investigacions Biomediques August Pi I Sunyer; Fundacio Clinic; Spanish Health Department; Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); MSD; GlaxoSmithKline(GlaxoSmithKline); Tibotec; Roche(Roche Holding); Boehringerngelheim; Pfizer(Pfizer)	Dr. Leon is supported by Contract CM06/00170 from the Institut de Investigacions Biomediques August Pi I Sunyer and Fundacio Clinic in collaboration with the Spanish Health Department. The role of Health Economics and Outcomes Research IMS Health in the study had been only to analyze the patients' quality of life data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A Leon, C Caceres, E Fernandez, P Chausa, M Martin, C Codina, A Rousaud, A Milinkovic, M Laguno, M Larrousse, L Zamora, and EJ Gomez have no potential conflicts of interests. Neus Canal is employed by a commercial company, Health Economics and Outcomes Research IMS Health. E Martinez, F Garcia, J Blanch and JL Blanco have received research grants from Abbott, Bristol-Myers Squibb, and Gilead Sciences. J Mallolas and JM Miro have received research grants from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences and Roche. JM Gatell has received honoraria or research grants from Bristol-Myers Squibb, MSD, GlaxoSmithKline, Gilead Sciences, Tibotec, Roche, Boehringerngelheim, Abbott and Pfizer. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials."	Balas EA, 1997, JAMA-J AM MED ASSOC, V278, P152, DOI 10.1001/jama.278.2.152; Barlow J, 2003, J TELEMED TELECARE, V9, pS1; Benatar D, 2003, ARCH INTERN MED, V163, P347, DOI 10.1001/archinte.163.3.347; Besch C Lynn, 2007, HIV Clin, V19, P4; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Caceres C, 2005, ST HEAL T, V114, P23; Caceres C, 2006, INT J MED INFORM, V75, P638, DOI 10.1016/j.ijmedinf.2006.04.010; Celler BG, 2003, MED J AUSTRALIA, V179, P242, DOI 10.5694/j.1326-5377.2003.tb05529.x; Clark RA, 2007, BMJ-BRIT MED J, V334, P942, DOI 10.1136/bmj.39156.536968.55; Cooper CB, 2009, THORAX, V64, P189, DOI 10.1136/thx.2008.104810; Cretin S, 2004, EVALUATION REV, V28, P28, DOI 10.1177/0193841X03256298; DEROGATIS LR, 1986, J PSYCHOSOM RES, V30, P77, DOI 10.1016/0022-3999(86)90069-3; Dunbar PJ, 2003, J AM MED INFORM ASSN, V10, P11, DOI 10.1197/jamia.M1047; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Eaton T, 1999, CHEST, V116, P416, DOI 10.1378/chest.116.2.416; Farmer A, 2005, DIABETIC MED, V22, P1372, DOI 10.1111/j.1464-5491.2005.01627.x; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; GOLDBERG DP, 1973, 1972 PSYCHOL MED, V3, P257; Goldschmidt Ronald H, 2003, J Natl Med Assoc, V95, p8S; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Jerant AF, 2001, MED CARE, V39, P1234, DOI 10.1097/00005650-200111000-00010; Kiviat AD, 2007, J INFECT DIS, V196, pS512, DOI 10.1086/521117; Lahtela JT, 2002, ANN MED, V34, P241, DOI 10.1080/078538902320322501; Larsen ME, 2010, J TELEMED TELECARE, V16, P433, DOI 10.1258/jtt.2010.100103; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Llibre JM, 2008, J ANTIMICROB CHEMOTH, V61, P206, DOI 10.1093/jac/dkm438; LOBO A, 1988, BRIT J PSYCHIAT, V152, P807, DOI 10.1192/bjp.152.6.807; Lobodzinski SS, 2010, CARDIOL J, V17, P200; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Mahoney MR, 2008, J ASSOC NURSE AIDS C, V19, P302, DOI 10.1016/j.jana.2008.05.002; Malacarne M, 2007, TELEMED J E-HEALTH, V13, P557, DOI 10.1089/tmj.2006.0092; Martin David J, 2003, J Occup Health Psychol, V8, P181, DOI 10.1037/1076-8998.8.3.181; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; McKee MB, 2006, AIDS EDUC PREV, V18, P116, DOI 10.1521/aeap.2006.18.2.116; Montori VM, 2004, DIABETES CARE, V27, P1088, DOI 10.2337/diacare.27.5.1088; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1, P1; Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3; Polisena J, 2009, DIABETES OBES METAB, V11, P913, DOI 10.1111/j.1463-1326.2009.01057.x; Polisena J, 2010, J TELEMED TELECARE, V16, P68, DOI 10.1258/jtt.2009.090406; Reiter G S, 2000, AIDS Clin Care, V12, P13; Shah NB, 1998, AM HEART J, V135, P373, DOI 10.1016/S0002-8703(98)70310-2; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stone RA, 2010, DIABETES CARE, V33, P478, DOI 10.2337/dc09-1012; Trepanier LL, 2005, J CLIN EXP NEUROPSYC, V27, P1, DOI 10.1080/138033990513546; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Whitten P, 2005, J Postgrad Med, V51, P294; Wiecha J, 2004, J MED INTERNET RES, V6, P113, DOI 10.2196/jmir.6.3.e22; Young M, 2001, CHEST, V119, P1565, DOI 10.1378/chest.119.5.1565; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; STATUS GLOBAL HIV EP	53	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14515	10.1371/journal.pone.0014515	http://dx.doi.org/10.1371/journal.pone.0014515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OY	21283736	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000286522300001
J	Omosa-Manyonyi, GS; Jaoko, W; Anzala, O; Ogutu, H; Wakasiaka, S; Malogo, R; Nyange, J; Njuguna, P; Ndinya-Achola, J; Bhatt, K; Farah, B; Oyaro, M; Schmidt, C; Priddy, F; Fast, P				Omosa-Manyonyi, Gloria S.; Jaoko, Walter; Anzala, Omu; Ogutu, Hilda; Wakasiaka, Sabina; Malogo, Roselyn; Nyange, Jacqueline; Njuguna, Pamela; Ndinya-Achola, Jeckoniah; Bhatt, Kirana; Farah, Bashir; Oyaro, Micah; Schmidt, Claudia; Priddy, Frances; Fast, Patricia			Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; VIRUS ANKARA MVA; GENETIC NEUTROPENIA; IMMUNOGENICITY; DOSAGE; SAFETY; DNA	Background: With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the Kenya AIDS Vaccine Initiative (KAVI) at the University of Nairobi has conducted HIV vaccine clinical trials since 2001. Methodology: Participants were recruited after an extensive informed consent process followed by screening to determine eligibility. Screening included an assessment of risk behavior, medical history and physical examination, and if clinically healthy, laboratory testing. In the absence of locally derived laboratory reference ranges, the ranges used in these trials were derived from populations in the West. Principal findings: Two hundred eighty-one participants were screened between 2003 and 2006 for two clinical trials. Of these, 167 (59.4%) met the inclusion/exclusion criteria. Overall, laboratory abnormalities based on the non-indigenous laboratory references used were the most frequent reasons (61.4%) for ineligibility. Medical abnormalities contributed 30.7% of the total reasons for ineligibility. Based on the laboratory reference intervals now developed from East and Southern Africa, those ineligible due to laboratory abnormalities would have been 46.3%. Of the eligible participants, 18.6% declined enrolment. Conclusions: Participant recruitment for HIV vaccine clinical trials is a rigorous and time-consuming exercise. Over 61% of the screening exclusions in clinically healthy people were due to laboratory abnormalities. It is essential that laboratory reference ranges generated from local populations for laboratory values be used in the conduct of clinical trials to avoid unnecessary exclusion of willing participants and to avoid over-reporting of adverse events for enrolled participants.	[Omosa-Manyonyi, Gloria S.; Jaoko, Walter; Anzala, Omu; Ogutu, Hilda; Wakasiaka, Sabina; Malogo, Roselyn; Nyange, Jacqueline; Njuguna, Pamela; Ndinya-Achola, Jeckoniah; Bhatt, Kirana; Farah, Bashir; Oyaro, Micah] Univ Nairobi, Kenya AIDS Vaccine Initiat KAVI, Nairobi, Kenya; [Schmidt, Claudia; Priddy, Frances; Fast, Patricia] Int AIDS Vaccine Initiat IAVI, New York, NY USA	University of Nairobi; International AIDS Vaccine Initiative	Omosa-Manyonyi, GS (corresponding author), Univ Nairobi, Kenya AIDS Vaccine Initiat KAVI, Nairobi, Kenya.	gomosa@kaviuon.org	Jaoko, Walter/AAN-5048-2020	Jaoko, Walter/0000-0002-7134-6581	International AIDS Vaccine initiative (IAVI), New York	International AIDS Vaccine initiative (IAVI), New York	All the studies whose data are analyzed in this manuscript were supported by the International AIDS Vaccine initiative (IAVI), New York. The funder was involved in the design of the studies whose data are analyzed. The funder was not involved in data collection, but participated in analysis and interpretation of data. The funder reviewed the manuscript and was involved in the decision to publish. Protocol V001 was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government.	[Anonymous], 2010, REP GLOB HIV AIDS EP; EZEILO GC, 1972, LANCET, V2, P1003; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kasili E G, 1969, East Afr Med J, V46, P676; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; OMOSA G, 2002, BALT MAR US 5 ANN C; OMOSAMANYONYI G, 2005, MONTR CAN AIDS VACC; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; SHAPER AG, 1971, LANCET, V2, P1021; Stevens W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002043; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999	15	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14580	10.1371/journal.pone.0014580	http://dx.doi.org/10.1371/journal.pone.0014580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283743	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300012
J	Guerrero, PA; Maggert, KA				Guerrero, Paola A.; Maggert, Keith A.			The CCCTC-Binding Factor (CTCF) of Drosophila Contributes to the Regulation of the Ribosomal DNA and Nucleolar Stability	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHROMATIN-STRUCTURE; RNA GENES; EPIGENETIC REGULATION; GENOME ORGANIZATION; ENHANCER BLOCKING; POLYMERASE PARP; RDNA; MELANOGASTER; INSULATOR	In the repeat array of ribosomal DNA (rDNA), only about half of the genes are actively transcribed while the others are silenced. In arthropods, transposable elements interrupt a subset of genes, often inactivating transcription of those genes. Little is known about the establishment or separation of juxtaposed active and inactive chromatin domains, or preferential inactivation of transposable element interrupted genes, despite identity in promoter sequences. CTCF is a sequence-specific DNA binding protein which is thought to act as a transcriptional repressor, block enhancer-promoter communication, and delimit juxtaposed domains of active and inactive chromatin; one or more of these activities might contribute to the regulation of this repeated gene cluster. In support of this hypothesis, we show that the Drosophila nucleolus contains CTCF, which is bound to transposable element sequences within the rDNA. Reduction in CTCF gene activity results in nucleolar fragmentation and reduced rDNA silencing, as does disruption of poly-ADP-ribosylation thought to be necessary for CTCF nucleolar localization. Our data establish a role for CTCF as a component necessary for proper control of transposable element-laden rDNA transcription and nucleolar stability.	[Guerrero, Paola A.] Texas A&M Univ, Dept Biochem Biophys, College Stn, TX 77843 USA; [Maggert, Keith A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Guerrero, PA (corresponding author), Texas A&M Univ, Dept Biochem Biophys, College Stn, TX 77843 USA.	kmaggert@tamu.edu		Maggert, Keith/0000-0002-9291-9481	National Institutes of Health [R01 GM076092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by National Institutes of Health R01 GM076092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGSHUMAN S, 2007, COLD SPRING HARB PRO; ASHBURNER M, 2005, DROSOPHILA LAB HDB, P1409; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; BOGART K, 2006, EXTRACTION TOTAL RNA; BROWNE MJ, 1984, NUCLEIC ACIDS RES, V12, P9111, DOI 10.1093/nar/12.23.9111; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; HAWLEY RS, 1985, GENETICS, V109, P691; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; JAKUBCZAK JL, 1992, GENETICS, V131, P129; JAMRICH M, 1984, EMBO J, V3, P1541, DOI 10.1002/j.1460-2075.1984.tb02008.x; KIDD SJ, 1980, CELL, V19, P103, DOI 10.1016/0092-8674(80)90392-X; Konev AY, 2003, GENETICS, V165, P2039; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Maggert KA, 2002, GENETICS, V162, P1245; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Ohlsson R, 2010, CHROMOSOMA; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Paredes S, 2009, GENETICS, V181, P1661, DOI 10.1534/genetics.108.099093; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Perrin L, 1998, J CELL SCI, V111, P2753; PLATA MP, 2008, CHROMOSOMA; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; STEFFENSEN DM, 1981, CHROMOSOMA, V82, P525, DOI 10.1007/BF00295011; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; VANDERNOBELEN S, 2008, TOUCHED CTCF ANAL MU, P175; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WINKLES JA, 1985, J BIOL CHEM, V260, P7716; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhou J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000386	59	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16401	10.1371/journal.pone.0016401	http://dx.doi.org/10.1371/journal.pone.0016401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283722	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200061
J	Opsteegh, M; Swart, A; Fonville, M; Dekkers, L; van der Giessen, J				Opsteegh, Marieke; Swart, Arno; Fonville, Manoj; Dekkers, Leo; van der Giessen, Joke			Age-Related Toxoplasma gondii Seroprevalence in Dutch Wild Boar Inconsistent with Lifelong Persistence of Antibodies	PLOS ONE			English	Article							RANGING DOMESTIC PIGS; SUS-SCROFA; NETHERLANDS; PREVALENCE; TESTS; INFECTION; ANIMALS; SYSTEMS; ISLAND; SPAIN	Toxoplasma gondii is an important zoonotic pathogen that is best known as a cause of abortion or abnormalities in the newborn after primary infection during pregnancy. Our aim was to determine the prevalence of T. gondii in wild boar to investigate the possible role of their meat in human infection and to get an indication of the environmental contamination with T. gondii. The presence of anti-T. gondii antibodies was determined by in-house ELISA in 509 wild boar shot in 2002/2003 and 464 wild boar shot in 2007. Most of the boar originated from the "Roerstreek'' (n = 673) or the "Veluwe'' (n = 241). A binormal mixture model was fitted to the log-transformed optical density values for wild boar up to 20 months old to estimate the optimal cut-off value (-0.685) and accompanying sensitivity (90.6%) and specificity (93.6%). The overall seroprevalence was estimated at 24.4% (95% CI: 21.1-27.7%). The prevalence did not show variation between sampling years or regions, indicating a stable and homogeneous infection pressure from the environment. The relation between age and seroprevalence was studied in two stages. Firstly, seroprevalence by age group was determined by fitting the binary mixture model to 200 animals per age category. The prevalence showed a steep increase until approximately 10 months of age but stabilized at approximately 35% thereafter. Secondly, we fitted the age-dependent seroprevalence data to several SIR-type models, with seropositives as infected (I) and seronegatives as either susceptible (S) or resistant (R). A model with a recovery rate (SIS) was superior to a model without a recovery rate (SI). This finding is not consistent with the traditional view of lifelong persistence of T. gondii infections. The high seroprevalence suggests that eating undercooked wild boar meat may pose a risk of infection with T. gondii.	[Opsteegh, Marieke; Swart, Arno; Fonville, Manoj; van der Giessen, Joke] Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Opsteegh, Marieke] Univ Utrecht, Fac Vet Med, IRAS, Utrecht, Netherlands; [Dekkers, Leo] Anim Hlth Serv GD, Deventer, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University	Opsteegh, M (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands.	marieke.opsteegh@rivm.nl			Dutch Food and Consumer Product Safety Authority (VWA)	Dutch Food and Consumer Product Safety Authority (VWA)	This work was financially supported by the Dutch Food and Consumer Product Safety Authority (VWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolova D, 2007, ANN AGR ENV MED, V14, P71; Bartova E, 2006, VET PARASITOL, V142, P150, DOI 10.1016/j.vetpar.2006.06.022; Canters Kees J., 2005, Lutra, V48, P67; Choi WY, 1997, J INFECT DIS, V175, P1280, DOI 10.1086/593702; Diderrich V, 1996, J EUKARYOT MICROBIOL, V43, pS122, DOI 10.1111/j.1550-7408.1996.tb05038.x; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dubey JP, 2009, VET PARASITOL, V164, P89, DOI 10.1016/j.vetpar.2009.05.018; Dubey JP, 1997, VET PARASITOL, V68, P41, DOI 10.1016/S0304-4017(96)01053-9; Dubey JP, 1997, J PARASITOL, V83, P839, DOI 10.2307/3284277; Edelhofer R, 1996, WIEN TIERARZTL MONAT, V83, P225; Elbers ARW, 2000, REV SCI TECH OIE, V19, P848, DOI 10.20506/rst.19.3.1254; Gauss CBL, 2005, VET PARASITOL, V131, P151, DOI 10.1016/j.vetpar.2005.04.023; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Hejlicek K, 1997, J WILDLIFE DIS, V33, P480, DOI 10.7589/0090-3558-33.3.480; Hofhuis A, 2010, EPIDEMIOL INFECT, V24, P1; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JENSEN P, 1989, APPL ANIM BEHAV SCI, V23, P49, DOI 10.1016/0168-1591(89)90006-3; JENSEN P, 1986, APPL ANIM BEHAV SCI, V16, P131, DOI 10.1016/0168-1591(86)90105-X; Kijlstra A, 2004, INVEST OPHTH VIS SCI, V45, P3165, DOI 10.1167/iovs.04-0326; MULDER JL, 2007, MET FOTOVAL SCHROEVE; Opsteegh M, 2010, PREV VET MED, V96, P232, DOI 10.1016/j.prevetmed.2010.06.009; Richomme C, 2010, EPIDEMIOL INFECT, V138, P1257, DOI 10.1017/S0950268810000117; Richomme C, 2009, VET PARASITOL, V164, P296, DOI 10.1016/j.vetpar.2009.06.014; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Ruiz-Fons F, 2006, THERIOGENOLOGY, V65, P731, DOI 10.1016/j.theriogenology.2005.07.001; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; van der Giessen J, 2007, VET PARASITOL, V148, P371, DOI 10.1016/j.vetpar.2007.06.009; VANKNAPEN F, 1982, VET QUART, V4, P101, DOI 10.1080/01652176.1982.9693848	29	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16240	10.1371/journal.pone.0016240	http://dx.doi.org/10.1371/journal.pone.0016240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283764	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200042
J	Kostallas, G; Lofdahl, PA; Samuelson, P				Kostallas, George; Lofdahl, Per-Ake; Samuelson, Patrik			Substrate Profiling of Tobacco Etch Virus Protease Using a Novel Fluorescence-Assisted Whole-Cell Assay	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRINUCLEOTIDE PHOSPHORAMIDITES; GENETIC-ANALYSIS; DEGRADATION; SPECIFICITY; EXPRESSION; PURIFICATION; PHAGE; IMMOBILIZATION; POLYPEPTIDES	Site-specific proteolysis of proteins plays an important role in many cellular functions and is often key to the virulence of infectious organisms. Efficient methods for characterization of proteases and their substrates will therefore help us understand these fundamental processes and thereby hopefully point towards new therapeutic strategies. Here, a novel whole-cell in vivo method was used to investigate the substrate preference of the sequence specific tobacco etch virus protease (TEVp). The assay, which utilizes protease-mediated intracellular rescue of genetically encoded short-lived fluorescent substrate reporters to enhance the fluorescence of the entire cell, allowed subtle differences in the processing efficiency of closely related substrate peptides to be detected. Quantitative screening of large combinatorial substrate libraries, through flow cytometry analysis and cell sorting, enabled identification of optimal substrates for TEVp. The peptide, ENLYFQG, identical to the protease's natural substrate peptide, emerged as a strong consensus cleavage sequence, and position P3 (tyrosine, Y) and P1 (glutamine, Q) within the substrate peptide were confirmed as being the most important specificity determinants. In position P19, glycine (G), serine (S), cysteine (C), alanine (A) and arginine (R) were among the most prevalent residues observed, all known to generate functional TEVp substrates and largely in line with other published studies stating that there is a strong preference for short aliphatic residues in this position. Interestingly, given the complex hydrogen-bonding network that the P6 glutamate (E) is engaged in within the substrate-enzyme complex, an unexpectedly relaxed residue preference was revealed for this position, which has not been reported earlier. Thus, in the light of our results, we believe that our assay, besides enabling protease substrate profiling, also may serve as a highly competitive platform for directed evolution of proteases and their substrates.	[Kostallas, George; Lofdahl, Per-Ake; Samuelson, Patrik] Royal Inst Technol KTH, Sch Biotechnol, Dept Mol Biotechnol, Stockholm, Sweden	Royal Institute of Technology	Kostallas, G (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Dept Mol Biotechnol, Stockholm, Sweden.	patrik@biotech.kth.se			Swedish Research Council [621-2004-4647]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grant 621-2004-4647 from the Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Bandmann N, 2000, J BIOTECHNOL, V79, P161, DOI 10.1016/S0168-1656(00)00224-8; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Boulware KT, 2010, BIOTECHNOL BIOENG, V106, P339, DOI 10.1002/bit.22693; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dautin N, 2000, J BACTERIOL, V182, P7060, DOI 10.1128/JB.182.24.7060-7066.2000; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Deperthes D, 2002, BIOL CHEM, V383, P1107, DOI 10.1515/BC.2002.119; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Doucet A, 2008, MOL ASPECTS MED, V29, P339, DOI 10.1016/j.mam.2008.04.003; DOUGHERTY WG, 1989, VIROLOGY, V172, P302, DOI 10.1016/0042-6822(89)90132-3; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hersch GL, 2004, P NATL ACAD SCI USA, V101, P12136, DOI 10.1073/pnas.0404733101; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kapust RB, 2002, PROTEIN EXPRES PURIF, V24, P61, DOI 10.1006/prep.2001.1545; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kayushin AL, 1996, NUCLEIC ACIDS RES, V24, P3748, DOI 10.1093/nar/24.19.3748; Larsson M, 2000, J BIOTECHNOL, V80, P143, DOI 10.1016/S0168-1656(00)00258-3; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Marnett AB, 2005, TRENDS BIOTECHNOL, V23, P59, DOI 10.1016/j.tibtech.2004.12.010; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; OHANA RF, 2009, PROTEIN EXPR PURIF; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Puhl AC, 2009, BIOTECHNOL APPL BIOC, V53, P165, DOI 10.1042/BA20080063; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; RUTHER U, 1982, NUCLEIC ACIDS RES, V10, P5765, DOI 10.1093/nar/10.19.5765; Scholle MD, 2006, CHEMBIOCHEM, V7, P834, DOI 10.1002/cbic.200500427; Sellamuthu S, 2008, BIOCHEM BIOPH RES CO, V371, P122, DOI 10.1016/j.bbrc.2008.04.026; Steen J, 2006, PROTEIN EXPRES PURIF, V46, P173, DOI 10.1016/j.pep.2005.12.010; STEERE AN, PROTEIN EXPR PURIF, V72, P32; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967	49	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16136	10.1371/journal.pone.0016136	http://dx.doi.org/10.1371/journal.pone.0016136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267463	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500041
J	Pitter, KL; Galban, CJ; Galban, S; Saeed-Tehrani, O; Li, F; Charles, N; Bradbury, MS; Becher, OJ; Chenevert, TL; Rehemtulla, A; Ross, BD; Holland, EC; Hambardzumyan, D				Pitter, Kenneth L.; Galban, Craig J.; Galban, Stefanie; Saeed-Tehrani, Omid; Li, Fei; Charles, Nikki; Bradbury, Michelle S.; Becher, Oren J.; Chenevert, Thomas L.; Rehemtulla, Alnawaz; Ross, Brian D.; Holland, Eric C.; Hambardzumyan, Dolores			Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; PHASE-II TRIAL; MALIGNANT GLIOMA; BRAIN-TUMORS; ALKYLPHOSPHOLIPID PERIFOSINE; IMAGING BIOMARKER; MAMMALIAN TARGET; LEUKEMIA-CELLS; EARLY RESPONSE; MTOR	Background: Platelet derived growth factor receptor (PDGFR) activity is deregulated in human GBM due to amplification and rearrangement of the PDGFR-alpha gene locus or overexpression of the PDGF ligand, resulting in the activation of downstream kinases such as phosphatidylinositol 3-kinase (PI3K), Akt, and mammalian target of rapamycin (mTOR). Aberrant PDGFR signaling is observed in approximately 25-30% of human GBMs, which are frequently molecularly classified as the proneural subclass. It would be valuable to understand how PDGFR driven GBMs respond to Akt and mTOR inhibition. Methodology/Principal Findings: Using genetically engineered PTEN-intact and PTEN-deficient PDGF-driven mouse models of GBM that closely mimic the histology and genetics of the human PDGF subgroup, we investigated the effect of inhibiting Akt and mTOR alone or in combination in vitro and in vivo. We used perifosine and CCI-779 to inhibit Akt and mTOR, respectively. Here, we show in vitro data demonstrating that the most effective inhibition of Akt and mTOR activity in both PTEN-intact and PTEN-null primary glioma cell cultures is obtained when using both inhibitors in combination. We next investigated if the effects we observed in culture could be duplicated in vivo by treating mice with gliomas for 5 days. The in vivo treatments with the combination of CCI-779 and perifosine resulted in decreased Akt and mTOR signaling, which correlated to decreased proliferation and increased cell death independent of PTEN status, as monitored by immunoblot analysis, histology and MRI. Conclusions/Significance: These findings underline the importance of simultaneously targeting Akt and mTOR to achieve significant down-regulation of the PI3K pathway and support the rationale for testing the perifosine and CCI-779 combination in the human PDGF-subgroup of GBM.	[Pitter, Kenneth L.; Charles, Nikki; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Pitter, Kenneth L.; Charles, Nikki; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Galban, Craig J.; Saeed-Tehrani, Omid; Li, Fei; Chenevert, Thomas L.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI USA; [Bradbury, Michelle S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Becher, Oren J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol & Surg, New York, NY 10021 USA; [Hambardzumyan, Dolores] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Duke University; Duke University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cleveland Clinic Foundation	Pitter, KL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	bdross@umich.edu; hollande@mskcc.org; hambard@ccf.org	Becher, Oren/AAI-7495-2020	Chenevert, Thomas/0000-0003-1476-4274; Becher, Oren/0000-0003-4016-8492; Pitter, Kenneth/0000-0002-9450-313X; Tehrani, Omid/0000-0001-6493-6391	National Institutes of Health (NIH) [U54 CA126518, U01 CA141502-01, P01CA85878, P50CA93990, MSTP GM07739]; Brain Tumor Center; NATIONAL CANCER INSTITUTE [U01CA141502, U54CA126518, P01CA085878, R01CA100688, P50CA093990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Tumor Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants U54 CA126518, U01 CA141502-01, P01CA85878, P50CA93990, MSTP GM07739 (KLP) and by the Brain Tumor Center (http://www.mskcc.org/mskcc/html/289.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Breslin EM, 2005, BRIT J PHARMACOL, V144, P791, DOI 10.1038/sj.bjp.0706061; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Chee KG, 2007, CLIN GENITOURIN CANC, V5, P433, DOI 10.3816/CGC.2007.n.031; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; de la Pena L, 2006, MOL CANCER THER, V5, P1504, DOI 10.1158/1535-7163.MCT-06-0091; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Ernst DS, 2005, INVEST NEW DRUG, V23, P569, DOI 10.1007/s10637-005-1157-4; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fumarola C, 2005, CELL DEATH DIFFER, V12, P1344, DOI 10.1038/sj.cdd.4401660; Galanis E, 2005, J CLIN ONCOL, V23, p115S; Geoerger B, 2001, CANCER RES, V61, P1527; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gonzalez J, 2008, EXPERT REV ANTICANC, V8, P1767, DOI 10.1586/14737140.8.11.1767; HAMBARDZUMYAN D, 2008, STEM CELL REV; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Marsh RD, 2007, AM J CLIN ONCOL-CANC, V30, P26, DOI 10.1097/01.coc.0000251235.46149.43; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Momota H, 2005, CANCER RES, V65, P7429, DOI 10.1158/0008-5472.CAN-05-1042; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Rasband W., 2006, IMAGEJ; Ross BD, 1998, P NATL ACAD SCI USA, V95, P7012, DOI 10.1073/pnas.95.12.7012; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vink SR, 2006, CLIN CANCER RES, V12, P1615, DOI 10.1158/1078-0432.CCR-05-2033	45	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14545	10.1371/journal.pone.0014545	http://dx.doi.org/10.1371/journal.pone.0014545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267448	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500015
J	Rudramurthy, SM; de Valk, HA; Chakrabarti, A; Meis, JFGM; Klaassen, CHW				Rudramurthy, Shivaprakash M.; de Valk, Hanneke A.; Chakrabarti, Arunaloke; Meis, Jacques F. G. M.; Klaassen, Corne H. W.			High Resolution Genotyping of Clinical Aspergillus flavus Isolates from India Using Microsatellites	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; IN-VITRO; SEXUAL REPRODUCTION; TANDEM REPEATS; FUMIGATUS; SUSCEPTIBILITY; PARASITICUS; OUTBREAK; DNA; ITRACONAZOLE	Background: Worldwide, Aspergillus flavus is the second leading cause of allergic, invasive and colonizing fungal diseases in humans. However, it is the most common species causing fungal rhinosinusitis and eye infections in tropical countries. Despite the growing challenges due to A. flavus, the molecular epidemiology of this fungus has not been well studied. We evaluated the use of microsatellites for high resolution genotyping of A. flavus from India and a possible connection between clinical presentation and genotype of the involved isolate. Methodology/Principal Findings: A panel of nine microsatellite markers were selected from the genome of A. flavus NRRL 3357. These markers were used to type 162 clinical isolates of A. flavus. All nine markers proved to be polymorphic displaying up to 33 alleles per marker. Thirteen isolates proved to be a mixture of different genotypes. Among the 149 pure isolates, 124 different genotypes could be recognized. The discriminatory power (D) for the individual markers ranged from 0.657 to 0.954. The D value of the panel of nine markers combined was 0.997. The multiplex multicolor approach was instrumental in rapid typing of a large number of isolates. There was no correlation between genotype and the clinical presentation of the infection. Conclusions/Significance: There is a large genotypic diversity in clinical A. flavus isolates from India. The presence of more than one genotype in clinical samples illustrates the possibility that persons may be colonized by multiple genotypes and that any isolate from a clinical specimen is not necessarily the one actually causing infection. Microsatellites are excellent typing targets for discriminating between A. flavus isolates from various origins.	[Rudramurthy, Shivaprakash M.; Chakrabarti, Arunaloke] Post Grad Inst Med Educ & Res, Dept Med Microbiol, Mycol Div, Chandigarh, India; [de Valk, Hanneke A.; Meis, Jacques F. G. M.; Klaassen, Corne H. W.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Canisius-Wilhelmina Hospital	Rudramurthy, SM (corresponding author), Post Grad Inst Med Educ & Res, Dept Med Microbiol, Mycol Div, Chandigarh, India.	c.klaassen@cwz.nl	Meis, Jacques F/A-9241-2010; Rudramurthy, Shivaprakash/ABH-6521-2020	Meis, Jacques F/0000-0003-3253-6080; Rudramurthy, Shivaprakash/0000-0002-9097-9253	Labland Clinical Microbiology	Labland Clinical Microbiology	MS received a travel grant from Labland Clinical Microbiology. The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2009, CLIN MICROBIOL INFEC, V15, P260, DOI 10.1111/j.1469-0691.2008.02661.x; Bagyalakshmi R, 2007, J MICROBIOL METH, V68, P1, DOI 10.1016/j.mimet.2006.05.021; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Bart-Delabesse E, 1998, J CLIN MICROBIOL, V36, P2413, DOI 10.1128/JCM.36.9.2413-2418.1998; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chakrabarti A, 2008, RETINA-J RET VIT DIS, V28, P1400, DOI 10.1097/IAE.0b013e318185e943; Chazalet V, 1998, J CLIN MICROBIOL, V36, P1494, DOI 10.1128/JCM.36.6.1494-1500.1998; De Hoog G. S., 2000, ATLAS CLIN FUNGI; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; de Valk HA, 2007, J CLIN MICROBIOL, V45, P1415, DOI 10.1128/JCM.02423-06; de Valk HA, 2007, J MICROBIOL METH, V69, P268, DOI 10.1016/j.mimet.2007.01.009; de Valk HA, 2009, J CYST FIBROS, V8, P110, DOI 10.1016/j.jcf.2008.10.003; Denning DW, 1997, J ANTIMICROB CHEMOTH, V40, P401, DOI 10.1093/jac/40.3.401; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Grubisha LC, 2010, MOL ECOL, V19, P269, DOI 10.1111/j.1365-294X.2009.04467.x; Hadrich I, 2010, J CLIN MICROBIOL, V48, P2396, DOI 10.1128/JCM.01269-09; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Heinemann S, 2004, J HOSP INFECT, V57, P149, DOI 10.1016/j.jhin.2004.02.007; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Horn BW, 2009, FUNGAL GENET BIOL, V46, P169, DOI 10.1016/j.fgb.2008.11.004; Johnson EM, 2000, J ANTIMICROB CHEMOTH, V45, P85, DOI 10.1093/jac/45.1.85; Klaassen CHW, 2007, STUD MYCOL, P47, DOI 10.3114/sim.2007.59.06; Klaassen CHW, 2009, MED MYCOL, V47, pS27, DOI 10.1080/13693780802382244; Midorikawa GEO, 2008, LETT APPL MICROBIOL, V47, P12, DOI 10.1111/j.1472-765X.2008.02377.x; Montiel D, 2003, MYCOL RES, V107, P1427, DOI 10.1017/S0953756203008797; MOODY SF, 1990, APPL ENVIRON MICROB, V56, P2441, DOI 10.1128/AEM.56.8.2441-2452.1990; Morgan J, 2005, MED MYCOL, V43, pS49, DOI 10.1080/13693780400020113; Mosquera J, 2001, ANTIMICROB AGENTS CH, V45, P1456, DOI 10.1128/AAC.45.5.1456-1462.2001; Pasqualotto AC, 2008, MED MYCOL, V46, P275, DOI 10.1080/13693780701624639; Pasqualotto AC, 2009, MED MYCOL, V47, pS261, DOI 10.1080/13693780802247702; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; Varga J, 2006, MED MYCOL, V44, pS149, DOI 10.1080/13693780600823266; Verweij PE, 1996, J CLIN MICROBIOL, V34, P2595, DOI 10.1128/JCM.34.10.2595-2597.1996; Vonberg RP, 2006, J HOSP INFECT, V63, P246, DOI 10.1016/j.jhin.2006.02.014	37	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16086	10.1371/journal.pone.0016086	http://dx.doi.org/10.1371/journal.pone.0016086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264229	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600021
J	Gonsalves, SE; Moses, AM; Razak, Z; Robert, F; Westwood, JT				Gonsalves, Sarah E.; Moses, Alan M.; Razak, Zak; Robert, Francois; Westwood, J. Timothy			Whole-Genome Analysis Reveals That Active Heat Shock Factor Binding Sites Are Mostly Associated with Non-Heat Shock Genes in Drosophila melanogaster	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ECDYSONE RECEPTOR; STRESS RESPONSES; RNA-POLYMERASE; WIDE ANALYSIS; EXPRESSION; MICROARRAY; HSF1; CELLS; PATTERNS	During heat shock (HS) and other stresses, HS gene transcription in eukaryotes is up-regulated by the transcription factor heat shock factor (HSF). While the identities of the major HS genes have been known for more than 30 years, it has been suspected that HSF binds to numerous other genes and potentially regulates their transcription. In this study, we have used a chromatin immunoprecipitation and microarray (ChIP-chip) approach to identify 434 regions in the Drosophila genome that are bound by HSF. We have also performed a transcript analysis of heat shocked Kc167 cells and third instar larvae and compared them to HSF binding sites. The heat-induced transcription profiles were quite different between cells and larvae and surprisingly only about 10% of the genes associated with HSF binding sites show changed transcription. There were also genes that showed changes in transcript levels that did not appear to correlate with HSF binding sites. Analysis of the locations of the HSF binding sites revealed that 57% were contained within genes with approximately 2/3rds of these sites being in introns. We also found that the insulator protein, BEAF, has enriched binding prior to HS to promoters of genes that are bound by HSF upon HS but that are not transcriptionally induced during HS. When the genes associated with HSF binding sites in promoters were analyzed for gene ontology terms, categories such as stress response and transferase activity were enriched whereas analysis of genes having HSF binding sites in introns identified those categories plus ones related to developmental processes and reproduction. These results suggest that Drosophila HSF may be regulating many genes besides the known HS genes and that some of these genes may be regulated during non-stress conditions.	[Gonsalves, Sarah E.; Razak, Zak; Westwood, J. Timothy] Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada; [Moses, Alan M.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Moses, Alan M.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Robert, Francois] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Robert, Francois] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University of Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Gonsalves, SE (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada.	t.westwood@utoronto.ca	Robert, Francois/D-2316-2012		Natural Sciences and Engineering Research Council (NSERC) Canada [138234-06]; NSERC	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Some of the procedures were performed at the Canadian Drosophila Microarray Centre which was supported by an Natural Sciences and Engineering Research Council (NSERC) Canada (http://www.nserc-crsng.gc.ca/) multi-user facility grant. J.T.W. is supported by an NSERC Canada Discovery Grant no. 138234-06. S. E. G. is a recipient of an NSERC Postgraduate Doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2008, P NATL ACAD SCI USA, V105, P11224, DOI 10.1073/pnas.0800620105; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Cahill CM, 1996, J BIOL CHEM, V271, P24874; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Cotto JJ, 1999, BIOCHEM SOC SYMP, P105; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ECHALIER G, 1970, IN VITRO CELL DEV B, V6, P162; Emberly E, 2008, PLOS BIOL, V6, P2896, DOI 10.1371/journal.pbio.0060327; Fernandes M., 1994, BIOL HEAT SHOCK PROT, P375; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; GREENLEAF AL, 1977, CHROMOSOMA, V65, P127; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HO JSL, 2002, CRC SER EXERC PHSIOL, P13; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JAMRICH M, 1977, P NATL ACAD SCI USA, V74, P2079, DOI 10.1073/pnas.74.5.2079; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Leemans R, 2000, P NATL ACAD SCI USA, V97, P12138, DOI 10.1073/pnas.210066997; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Neal SJ, 2006, PHYSIOL GENOMICS, V25, P493, DOI 10.1152/physiolgenomics.00195.2005; Neal SJ, 2003, GENOME, V46, P879, DOI 10.1139/G03-056; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu C., 1994, BIOL HEAT SHOCK PROT, P395; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Xie Y, 2002, BIOCHEM BIOPH RES CO, V291, P1071, DOI 10.1006/bbrc.2002.6562; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	72	56	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15934	10.1371/journal.pone.0015934	http://dx.doi.org/10.1371/journal.pone.0015934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264254	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500018
J	Timmers, S; de Vogel-van den Bosch, J; Hesselink, MKC; van Beurden, D; Schaart, G; Ferraz, MJ; Losen, M; Martinez-Martinez, P; De Baets, MH; Aerts, JMFG; Schrauwen, P				Timmers, Silvie; de Vogel-van den Bosch, Johan; Hesselink, Matthijs K. C.; van Beurden, Denis; Schaart, Gert; Ferraz, Maria Joao; Losen, Mario; Martinez-Martinez, Pilar; De Baets, Marc H.; Aerts, Johannes M. F. G.; Schrauwen, Patrick			Paradoxical Increase in TAG and DAG Content Parallel the Insulin Sensitizing Effect of Unilateral DGAT1 Overexpression in Rat Skeletal Muscle	PLOS ONE			English	Article							FATTY-ACID OXIDATION; DIFFERENTIATION-RELATED PROTEIN; INTRAMYOCELLULAR LIPID-CONTENT; ADIPOSE TRIGLYCERIDE LIPASE; UNCOUPLING PROTEIN-3; CERAMIDE SYNTHESIS; GLUCOSE-TOLERANCE; RESISTANCE; EXERCISE; SENSITIVITY	Background: The involvement of muscle triacylglycerol (TAG) storage in the onset of insulin resistance is questioned and the attention has shifted towards inhibition of insulin signalling by the lipid intermediate diacylglycerol (DAG). The enzyme 1,2-acylCoA:diacylglyceroltransferase-1 (DGAT1) esterifies a fatty acyl-CoA on DAG to form TAG. Therefore, the aim of the present study was to investigate if unilateral overexpression of DGAT1 in adult rat Tibialis anterior (TA) muscle will increase conversion of the lipid intermediate DAG into TAG, thereby improving muscle insulin sensitivity. Methodology/Principal Findings: The DGAT1 gene construct was injected in the left TA muscle of male rats on chow or high-fat (45% kcal) diet for three weeks, followed by application of one 800 V/cm and four 80 V/cm pulses, using the contralateral leg as sham-electroporated control. Seven days after electroporation, muscle specific insulin sensitivity was assessed with a hyperinsulinemic euglycemic clamp using 2-deoxy-[3H] glucose. Here, we provide evidence that unilateral overexpression of DGAT1 in TA muscle of male rats is associated with an increased rather than decreased DAG content. Strikingly, this increase in DAG content was accompanied by improved muscle insulin sensitivity. Interestingly, markers of muscle lipolysis and mitochondrial function were also increased in DGAT1 overexpressing muscle. Conclusions/Significance: We conclude that unilateral DGAT1 overexpression can rescue insulin sensitivity, possibly by increasing DAG and TAG turnover in skeletal muscle. In case of a proper balance between the supply and oxidation of fatty acids in skeletal muscle, the lipid intermediate DAG may not exert harmful effects on insulin signalling.	[Timmers, Silvie; de Vogel-van den Bosch, Johan; Schrauwen, Patrick] TIFN, Wageningen, Netherlands; [Timmers, Silvie; de Vogel-van den Bosch, Johan; van Beurden, Denis; Schrauwen, Patrick] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Hesselink, Matthijs K. C.; Schaart, Gert] Maastricht Univ, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Ferraz, Maria Joao; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Losen, Mario; Martinez-Martinez, Pilar; De Baets, Marc H.] Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Timmers, S (corresponding author), TIFN, Wageningen, Netherlands.	p.schrauwen@hb.unimaas.nl	Timmers, Silvie/A-9422-2016; Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Timmers, Silvie/0000-0003-2852-5274; De Vogel-van den Bosch, Johan/0000-0001-5249-3992; Martinez Martinez, Pilar/0000-0002-5990-3373; Ferraz, Maria Joao/0000-0002-5765-9645; Losen, Mario/0000-0002-9761-0002; schrauwen, patrick/0000-0002-0973-847X	Top Institute Food and Nutrition; Netherlands Organization for Scientific Research (NWO) [918.96.618, 917.66.359]	Top Institute Food and Nutrition; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by Top Institute Food and Nutrition. TI Food and Nutrition was formerly known as WCFS. Partners are major Dutch food companies and research organizations. A VICI (grant 918.96.618) and a VIDI (grant 917.66.359) for innovative research from the Netherlands Organization for Scientific Research (NWO) supports the work of P. Schrauwen and M. Hesselink, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Amati F, 2009, OBESITY, V17, pS71; Bachmann OP, 2001, DIABETES, V50, pA331; Bergman BC, 1999, AM J PHYSIOL-ENDOC M, V276, pE106, DOI 10.1152/ajpendo.1999.276.1.E106; Boden G, 2001, DIABETES, V50, pA319; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; COEN PM, DIABETES, V59, P80; Decombaz J, 2001, AM J PHYSIOL-REG I, V281, pR760, DOI 10.1152/ajpregu.2001.281.3.R760; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox AK, 2004, J APPL PHYSIOL, V97, P11, DOI 10.1152/japplphysiol.01398.2003; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hoeks J, 2003, FEBS LETT, V555, P631, DOI 10.1016/S0014-5793(03)01343-7; Itani S, 2002, DIABETES, V51, pA300; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; MEEX RC, 2009, DIABETES; Meex RCR, 2009, AM J PHYSIOL-REG I, V297, pR913, DOI 10.1152/ajpregu.91053.2008; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; MORRISON WR, 1964, J LIPID RES, V5, P600; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Schenk S, 2005, AM J PHYSIOL-ENDOC M, V288, pE519, DOI 10.1152/ajpendo.00401.2004; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Schrauwen P, 2003, FASEB J, V17, P2272, DOI 10.1096/fj.03-0515fje; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Watt MJ, 2008, MOL ENDOCRINOL, V22, P1200, DOI 10.1210/me.2007-0485; Watt MJ, 2009, CLIN EXP PHARMACOL P, V36, P5, DOI 10.1111/j.1440-1681.2008.05075.x; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	48	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14503	10.1371/journal.pone.0014503	http://dx.doi.org/10.1371/journal.pone.0014503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264296	Green Published, gold, Green Submitted			2022-12-27	WOS:000286516500001
J	Weiss, GE; Clark, EH; Li, SP; Traore, B; Kayentao, K; Ongoiba, A; Hernandez, JN; Doumbo, OK; Pierce, SK; Branch, OH; Crompton, PD				Weiss, Greta E.; Clark, Eva H.; Li, Shanping; Traore, Boubacar; Kayentao, Kassoum; Ongoiba, Aissata; Hernandez, Jean N.; Doumbo, Ogobara K.; Pierce, Susan K.; Branch, OraLee H.; Crompton, Peter D.			A Positive Correlation between Atypical Memory B Cells and Plasmodium falciparum Transmission Intensity in Cross-Sectional Studies in Peru and Mali	PLOS ONE			English	Article							MALARIA; EXPRESSION; IMMUNITY	Background: Antibodies that protect against Plasmodium falciparum (Pf) malaria are only acquired after years of repeated infections. The B cell biology that underlies this observation is poorly understood. We previously reported that "atypical'' memory B cells are increased in children and adults exposed to intense Pf transmission in Mali, similar to what has been observed in individuals infected with HIV. In this study we examined B cell subsets of Pf-infected adults in Peru and Mali to determine if Pf transmission intensity correlates with atypical memory B cell expansion. Methodology/Principal Findings: In this cross-sectional study venous blood was collected from adults in areas of zero (U. S., n = 10), low (Peru, n = 18) and high (Mali, n = 12) Pf transmission. Adults in Peru and Mali were infected with Pf at the time of blood collection. Thawed lymphocytes were analyzed by flow cytometry to quantify B cell subsets, including atypical memory B cells, defined by the cell surface markers CD19(+) CD20(+) CD21(-) CD27(-) CD10(-). In Peru, the mean level of atypical memory B cells, as a percent of total B cells, was higher than U. S. adults (Peru mean: 5.4% [95% CI: 3.61-7.28]; U. S. mean: 1.4% [95% CI: 0.92-1.81]; p<0.0001) but lower than Malian adults (Mali mean 13.1% [95% CI: 10.68-15.57]; p = 0.0001). In Peru, individuals self-reporting >= 1 prior malaria episodes had a higher percentage of atypical memory B cells compared to those reporting no prior episodes (>= 1 prior episodes mean: 6.6% [95% CI: 4.09-9.11]; no prior episodes mean: 3.1% [95% CI: 1.52-4.73]; p = 0.028). Conclusions/Significance: Compared to Pf-naive controls, atypical memory B cells were increased in Peruvian adults exposed to low Pf transmission, and further increased in Malian adults exposed to intense Pf transmission. Understanding the origin, function and antigen specificity of atypical memory B cells in the context of Pf infection could contribute to our understanding of naturally-acquired malaria immunity.	[Weiss, Greta E.; Li, Shanping; Pierce, Susan K.; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Clark, Eva H.; Branch, OraLee H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Clark, Eva H.; Hernandez, Jean N.; Branch, OraLee H.] Univ Nacl Amazonia Peruana, LIPNAA, Iquitos, Loreto, Peru; [Traore, Boubacar; Kayentao, Kassoum; Ongoiba, Aissata; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Branch, OraLee H.] NYU, Dept Med Parasitol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Alabama System; University of Alabama Birmingham; Universidad Nacional de la Amazonia Peruana; University of Bamako; New York University	Weiss, GE (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	pcrompton@niaid.nih.gov	Crompton, Peter/N-1130-2016		NIAID/NIH [R01AI064831]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001155, R01AI064831, ZIAAI001064] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID/NIH grant No. R01AI064831 and the Intramural Research Program of the NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; GOSLING RD, EXPERT REV ANTIINFEC, V8, P589; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	24	65	65	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15983	10.1371/journal.pone.0015983	http://dx.doi.org/10.1371/journal.pone.0015983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264245	Green Published, Green Submitted, gold			2022-12-27	WOS:000286516500021
J	Convertino, M; Elsner, JB; Munoz-Carpena, R; Kiker, GA; Martinez, CJ; Fischer, RA; Linkov, I				Convertino, Matteo; Elsner, James B.; Munoz-Carpena, Rafael; Kiker, Gregory A.; Martinez, Christopher J.; Fischer, Richard A.; Linkov, Igor			Do Tropical Cyclones Shape Shorebird Habitat Patterns? Biogeoclimatology of Snowy Plovers in Florida	PLOS ONE			English	Article							CHARADRIUS-ALEXANDRINUS; BIRD POPULATIONS; NATAL DISPERSAL; HURRICANES; FREQUENCY; AVIFAUNA; FOREST; IMPACT; BEACH	Background: The Gulf coastal ecosystems in Florida are foci of the highest species richness of imperiled shoreline dependent birds in the USA. However environmental processes that affect their macroecological patterns, like occupancy and abundance, are not well unraveled. In Florida the Snowy Plover (Charadrius alexandrinus nivosus) is resident along northern and western white sandy estuarine/ocean beaches and is considered a state-threatened species. Methodology/Principal Findings: Here we show that favorable nesting areas along the Florida Gulf coastline are located in regions impacted relatively more frequently by tropical cyclones. The odds of Snowy Plover nesting in these areas during the spring following a tropical cyclone impact are seven times higher compared to the odds during the spring following a season without a cyclone. The only intensity of a tropical cyclone does not appear to be a significant factor affecting breeding populations. Conclusions/Significance: Nevertheless a future climate scenario featuring fewer, but more extreme cyclones could result in a decrease in the breeding Snowy Plover population and its breeding range. This is because the spatio-temporal frequency of cyclone events was found to significantly affect nest abundance. Due to the similar geographic range and habitat suitability, and no decrease in nest abundance of other shorebirds in Florida after the cyclone season, our results suggest a common bioclimatic feedback between shorebird abundance and tropical cyclones in breeding areas which are affected by cyclones.	[Convertino, Matteo; Munoz-Carpena, Rafael; Kiker, Gregory A.; Martinez, Christopher J.] Univ Florida, IFAS, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Convertino, Matteo; Linkov, Igor] USA, Corps Engineers, Engn Res & Dev Ctr ERDC, Risk & Decis Sci Grp, Concord, MA USA; [Elsner, James B.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Fischer, Richard A.] USA, Corps Engineers, Environm Lab, Engn Res & Dev Ctr ERDC, Vicksburg, MS 39180 USA; [Linkov, Igor] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	State University System of Florida; University of Florida; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; State University System of Florida; Florida State University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Carnegie Mellon University	Convertino, M (corresponding author), Univ Florida, IFAS, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	mconvertino@ufl.edu	Convertino, Matteo/ABD-5828-2021; Linkov, Igor/AAH-5981-2019; Kiker, Gregory A/K-6149-2017; Convertino, Matteo/J-1365-2016; Munoz-Carpena, Rafael/A-7588-2010	Linkov, Igor/0000-0002-0823-8107; Kiker, Gregory A/0000-0001-6215-0686; Convertino, Matteo/0000-0001-7003-7587; Munoz-Carpena, Rafael/0000-0003-2838-1514; Elsner, James/0000-0001-6805-7431	United States Department of Defense [SI-1699, SI-1700]	United States Department of Defense(United States Department of Defense)	This research was supported by the United States Department of Defense, through the Strategic Environmental Research and Development Program (SERDP), Projects SI-1699 and SI-1700. Permission was granted to publish this material by the United States Army Corps of Engineers (USACE) Chief of Engineers. The views and opinions expressed in this paper are those of the individual authors and not those of the United States Army or other sponsor organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; CHUAGOR M, 2010, ENV MODELING SOFTWAR; CLAY R, 2010, LIFE EDGE TECHNICAL; Colwell MA, 2007, WILSON J ORNITHOL, V119, P378, DOI 10.1676/06-038.1; CONVERTINO M, 2010, ECOLOGICAL ENG UNPUB; CONVERTINO M, 2010, ECOLOGICAL MOD UNPUB; CONVERTINO M, 2010, COASTLINE FRAC UNPUB; Conway WC, 2005, J WILDLIFE MANAGE, V69, P174, DOI 10.2193/0022-541X(2005)069<0174:SHUANS>2.0.CO;2; Donoghue JosephF., 2006, 1 FLORIDIANS LAST MA, P31, DOI DOI 10.1007/978-1-4020-4694-0_2; ELSNER J, HURRICANES CLIMATE C; ELSNER J, 2010, HOURLY INTERPOLATED; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Elsner JB, 2001, J CLIMATE, V14, P4341, DOI 10.1175/1520-0442(2001)014<4341:BAOUSH>2.0.CO;2; ELSNER JB, 2001, WEATHER FORECAST, V21, P182; FAC-FWC, 2008, DES THREAT SPEC PROH; *FSA, 2010, TECHN REP; Funk WC, 2007, CONSERV GENET, V8, P1287, DOI 10.1007/s10592-006-9278-7; FWC, 2010, FLOR BEACH NEST BIRD; Godown ME, 2000, BIODIVERS CONSERV, V9, P1313, DOI 10.1023/A:1008924322405; GORNISH E, 2010, GLOBAL CHANGE BIOL, V316; Himes JG, 2006, STATUS DISTRIBUTION; HOUSER C, 2008, J COSTAL RES, V24; Houser C, 2009, EARTH SURF PROC LAND, V34, P613, DOI 10.1002/esp.1730; Keim BD, 2007, J CLIMATE, V20, P3498, DOI 10.1175/JCLI4187.1; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; KUPPER C, 1997, AUK, V126; LAMONTE KM, 2002, STATUS DISTRIBUTION; LEATHERMAN SP, 1979, J ENG GEOLOGY, V12, P281; LOTT CA, 2009, DISTRIBUTION ABUNDAN; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; *NOAA, 2010, HIST HURR TRACKS TEC; Otvos EG, 2004, J COASTAL RES, V20, P326, DOI 10.2112/1551-5036(2004)20[326:BAFHLI]2.0.CO;2; Page GW, 2009, BIRDS N AM ONLINE, DOI [10.2173/bna.154, DOI 10.2173/BNA.154]; Rittenhouse CD, 2010, GLOBAL CHANGE BIOL, V16, P905, DOI 10.1111/j.1365-2486.2009.02101.x; Sheikh P.A, 2005, IMPACT HURRICANE KAT; SHOWSTACK R, 2010, EOS T AGU; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stenzel LE, 2007, AUK, V124, P1023, DOI 10.1642/0004-8038(2007)124[1023:SANDOJ]2.0.CO;2; STONE G, 1996, J COSTAL RES, V12; Stone GW, 2004, MAR GEOL, V210, P63, DOI 10.1016/j.margeo.2004.05.021; Storch D, 2005, SCIENCE, V307, P684, DOI 10.1126/science.1106935; Tossas AG, 2006, CARIBB J SCI, V42, P81; Unitt, 2003, BIRDS SALTON SEA STA; *US FWS, 2007, REC PLAN PAC COAST P; USFWS, 2001, W SNOW PLOV NAT HIST; *USGS, 2009, DAT 2006 INT PIP PLO; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; Walshaw D, 2000, J R STAT SOC C-APPL, V49, P51, DOI 10.1111/1467-9876.00178; WAUER RH, 1992, WILSON BULL, V104, P656; WUNDERLE JM, 1992, AUK, V109, P148, DOI 10.2307/4088275; Xi WM, 2008, J PLANT ECOL-UK, V1, P43, DOI 10.1093/jpe/rtm003; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	53	20	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e15683	10.1371/journal.pone.0015683	http://dx.doi.org/10.1371/journal.pone.0015683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264268	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514300002
J	Bourassa, CV; Riviere, JB; Dion, PA; Bernard, G; Diab, S; Panisset, M; Chouinard, S; Dupre, N; Fournier, H; Raelson, J; Belouchi, M; Rouleau, GA				Bourassa, Cynthia V.; Riviere, Jean-Baptiste; Dion, Patrick A.; Bernard, Genevieve; Diab, Sabrina; Panisset, Michel; Chouinard, Sylvain; Dupre, Nicolas; Fournier, Helene; Raelson, John; Belouchi, Majid; Rouleau, Guy A.			LINGO1 Variants in the French-Canadian Population	PLOS ONE			English	Article							ESSENTIAL TREMOR; GENE; ASSOCIATION; LINKAGE; RISK	Essential tremor (ET) is a complex genetic disorder for which no causative gene has been found. Recently, a genome-wide association study reported that two variants in the LINGO1 locus were associated to this disease. The aim of the present study was to test if this specific association could be replicated using a French-Canadian cohort of 259 ET patients and 479 ethnically matched controls. Our genotyping results lead us to conclude that no association exists between the key variant rs9652490 and ET (P-corr = 1.00).	[Bourassa, Cynthia V.; Riviere, Jean-Baptiste; Dion, Patrick A.; Bernard, Genevieve; Diab, Sabrina; Rouleau, Guy A.] Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Montreal, PQ, Canada; [Bourassa, Cynthia V.; Riviere, Jean-Baptiste; Dion, Patrick A.; Bernard, Genevieve; Diab, Sabrina; Panisset, Michel; Chouinard, Sylvain; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Panisset, Michel; Chouinard, Sylvain] Univ Montreal, CHUM, Montreal, PQ H3C 3J7, Canada; [Dupre, Nicolas] Univ Laval, Fac Med, Dept Neurol Sci, Ctr Hosp Affilie Univ Quebec Enfant Jesus, Quebec City, PQ G1K 7P4, Canada; [Fournier, Helene; Raelson, John; Belouchi, Majid] Genizon BioSci, St Laurent, PQ, Canada; [Rouleau, Guy A.] St Justine Hosp, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Bourassa, CV (corresponding author), Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca	Dupre, Nicolas/Y-1828-2019; Bernard, Geneviève/AAU-7569-2020	Bernard, Geneviève/0000-0002-9634-2966	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	CVB is supported by CIHR-Frederick Banting and Charles Best Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genizon BioSciences Inc. had a role in the collection of some samples used in this study.	Clark LN, 2010, EUR J HUM GENET, V18, P838, DOI 10.1038/ejhg.2010.27; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Louis ED, 2001, NEW ENGL J MED, V345, P887, DOI 10.1056/NEJMcp010928; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Tan EK, 2009, NEUROLOGY, V73, P1161, DOI 10.1212/WNL.0b013e3181bacfc9; Thier S, 2010, MOVEMENT DISORD, V25, P717, DOI 10.1002/mds.22887; Vilarino-Guell C, 2010, NEUROGENETICS, V11, P401, DOI 10.1007/s10048-010-0241-x; Vilarino-Guell C, 2010, PARKINSONISM RELAT D, V16, P109, DOI 10.1016/j.parkreldis.2009.08.006; Zuo X, 2010, NEUROSCI LETT, V481, P69, DOI 10.1016/j.neulet.2010.06.041	13	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16254	10.1371/journal.pone.0016254	http://dx.doi.org/10.1371/journal.pone.0016254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264305	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000025
J	Cahalane, DJ; Clancy, B; Kingsbury, MA; Graf, E; Sporns, O; Finlay, BL				Cahalane, Diarmuid J.; Clancy, Barbara; Kingsbury, Marcy A.; Graf, Ethan; Sporns, Olaf; Finlay, Barbara L.			Network Structure Implied by Initial Axon Outgrowth in Rodent Cortex: Empirical Measurement and Models	PLOS ONE			English	Article							CELLULAR SCALING RULES; BRAIN NETWORKS; ORGANIZATION; PROJECTIONS; CONNECTIVITY; NEOCORTEX	The developmental mechanisms by which the network organization of the adult cortex is established are incompletely understood. Here we report on empirical data on the development of connections in hamster isocortex and use these data to parameterize a network model of early cortical connectivity. Using anterograde tracers at a series of postnatal ages, we investigate the growth of connections in the early cortical sheet and systematically map initial axon extension from sites in anterior (motor), middle (somatosensory) and posterior (visual) cortex. As a general rule, developing axons extend from all sites to cover relatively large portions of the cortical field that include multiple cortical areas. From all sites, outgrowth is anisotropic, covering a greater distance along the medial/lateral axis than along the anterior/posterior axis. These observations are summarized as 2-dimensional probability distributions of axon terminal sites over the cortical sheet. Our network model consists of nodes, representing parcels of cortex, embedded in 2-dimensional space. Network nodes are connected via directed edges, representing axons, drawn according to the empirically derived anisotropic probability distribution. The networks generated are described by a number of graph theoretic measurements including graph efficiency, node betweenness centrality and average shortest path length. To determine if connectional anisotropy helps reduce the total volume occupied by axons, we define and measure a simple metric for the extra volume required by axons crossing. We investigate the impact of different levels of anisotropy on network structure and volume. The empirically observed level of anisotropy suggests a good trade-off between volume reduction and maintenance of both network efficiency and robustness. Future work will test the model's predictions for connectivity in larger cortices to gain insight into how the regulation of axonal outgrowth may have evolved to achieve efficient and economical connectivity in larger brains.	[Cahalane, Diarmuid J.] Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA; [Clancy, Barbara] Univ Cent Arkansas, Conway, AR USA; [Clancy, Barbara] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Kingsbury, Marcy A.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Graf, Ethan] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Program Neurosci, Bloomington, IN USA; [Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Program Cognit Sci, Bloomington, IN USA; [Finlay, Barbara L.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Cornell University; University of Central Arkansas; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University Bloomington; Amherst College; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Cornell University	Cahalane, DJ (corresponding author), Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA.	djc338@cornell.edu	Sporns, Olaf/A-1667-2010	Sporns, Olaf/0000-0001-7265-4036; Clancy, Barbara/0000-0002-6882-2225	NIH [R01 19245, P20 RR-16460]; NIMH [T32 MN19389]; NSF [IBN 0138113]; National University of Ireland; JS McDonnell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); National University of Ireland; JS McDonnell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grant R01 19245 to Barbara Finlay, NIMH research fellowships under T32 MN19389 to Barbara Clancy and Marcy Kingsbury, NSF IBN 0138113 to B. Clancy and B. Finlay, and NIH Grant Number P20 RR-16460 to B. Clancy. D. Cahalane was supported by a Traveling Studentship from the National University of Ireland. OS acknowledges support from the JS McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ANDERSON ML, 2010, BEHAV BRAIN SCI, V33; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bayer S.A., 1991, NEOCORTICAL DEV; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burton H, 2003, J NEUROSCI, V23, P4005; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; DING SL, 1995, J NEUROSCI METH, V57, P67, DOI 10.1016/0165-0270(94)00127-3; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P7, DOI 10.1098/rstb.2000.0546; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Innocenti GM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.011.2010; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Kaiser M, 2009, CEREB CORTEX, V19, P3001, DOI 10.1093/cercor/bhp071; Kingsbury MA, 2000, J COMP NEUROL, V424, P165, DOI 10.1002/1096-9861(20000814)424:1<165::AID-CNE12>3.0.CO;2-U; LATORA V, 2001, EFFICIENT BEHAV SMAL, V87; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; LENT R, 1982, J COMP NEUROL, V206, P227, DOI 10.1002/cne.902060303; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; Molnar Z, 1998, J COMP NEUROL, V398, P491; MORIN LP, 2000, STEREOTAXIC ATLAS GO; MURRE JMJ, 1995, BIOL CYBERN, V73, P529, DOI 10.1007/BF00199545; Newman MEJ., 2006, STRUCTURE DYNAMICS N; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; OLSHAUSEN BA, 2005, NEURAL COMPUT, V17, P1; Pallas SL, 2001, TRENDS NEUROSCI, V24, P417, DOI 10.1016/S0166-2236(00)01853-1; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Reep RL, 2000, BRAIN BEHAV EVOLUT, V56, P212, DOI 10.1159/000047206; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; WINDREM MS, 1991, CEREBRAL CORTEX, V1; Wolfram Research Inc., 2008, MATH VERS 7 0; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhong YM, 2003, CEREB CORTEX, V13, P527, DOI 10.1093/cercor/13.5.527	56	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16113	10.1371/journal.pone.0016113	http://dx.doi.org/10.1371/journal.pone.0016113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264302	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514000023
J	Chandiramani, N; Wang, XH; Margeta, M				Chandiramani, Natasha; Wang, Xianhong; Margeta, Marta			Molecular Basis for Vulnerability to Mitochondrial and Oxidative Stress in a Neuroendocrine CRI-G1 Cell Line	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; GLUTATHIONE DISULFIDE; NRF2 ACTIVATION; MICE; RISK; DJ-1; SULFORAPHANE; METABOLISM; ASTROCYTES	Background: Many age-associated disorders (including diabetes, cancer, and neurodegenerative diseases) are linked to mitochondrial dysfunction, which leads to impaired cellular bioenergetics and increased oxidative stress. However, it is not known what genetic and molecular pathways underlie differential vulnerability to mitochondrial dysfunction observed among different cell types. Methodology/Principal Findings: Starting with an insulinoma cell line as a model for a neuronal/endocrine cell type, we isolated a novel subclonal line (named CRI-G1-RS) that was more susceptible to cell death induced by mitochondrial respiratory chain inhibitors than the parental CRI-G1 line (renamed CRI-G1-RR for clarity). Compared to parental RR cells, RS cells were also more vulnerable to direct oxidative stress, but equally vulnerable to mitochondrial uncoupling and less vulnerable to protein kinase inhibition-induced apoptosis. Thus, differential vulnerability to mitochondrial toxins between these two cell types likely reflects differences in their ability to handle metabolically generated reactive oxygen species rather than differences in ATP production/utilization or in downstream apoptotic machinery. Genome-wide gene expression analysis and follow-up biochemical studies revealed that, in this experimental system, increased vulnerability to mitochondrial and oxidative stress was associated with (1) inhibition of ARE/Nrf2/Keap1 antioxidant pathway; (2) decreased expression of antioxidant and phase I/II conjugation enzymes, most of which are Nrf2 transcriptional targets; (3) increased expression of molecular chaperones, many of which are also considered Nrf2 transcriptional targets; (4) increased expression of beta cell-specific genes and transcription factors that specify/maintain beta cell fate; and (5) reconstitution of glucose-stimulated insulin secretion. Conclusions/Significance: The molecular profile presented here will enable identification of individual genes or gene clusters that shape vulnerability to mitochondrial dysfunction and thus represent potential therapeutic targets for diabetes and neurodegenerative diseases. In addition, the newly identified CRI-G1-RS cell line represents a new experimental model for investigating how endogenous antioxidants affect glucose sensing and insulin release by pancreatic beta cells.	[Chandiramani, Natasha; Wang, Xianhong; Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chandiramani, N (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	Marta.Margeta@ucsf.edu		Margeta, Marta/0000-0001-6889-2488; Emmanuel, Natasha/0000-0003-0130-1094	National Institutes of Health [NS054113]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grant NS054113 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2004, THESIS U CALIFORNIA; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; CARRINGTON CA, 1986, J ENDOCRINOL, V109, P193, DOI 10.1677/joe.0.1090193; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Fonck C, 2003, BRAIN RES, V975, P214, DOI 10.1016/S0006-8993(03)02675-1; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gier B, 2009, J CLIN INVEST, V119, P3246, DOI 10.1172/JCI38817; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; INBERG A, 2010, J BIOL CHEM; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Leloup C, 2006, DIABETES, V55, pA323; Li XY, 2006, DIABETES, V55, P1592, DOI 10.2337/db05-1357; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Moriscot C, 2007, DIABETES METAB, V33, P44, DOI 10.1016/j.diabet.2006.09.004; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Ohsawa I, 2003, J NEUROCHEM, V84, P1110, DOI 10.1046/j.1471-4159.2003.01619.x; Ohsawa I, 2008, J NEUROSCI, V28, P6239, DOI 10.1523/JNEUROSCI.4956-07.2008; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; R Development Core Team, 2005, R LANG ENV STAT COMP; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Ronnemaa E, 2009, DIABETOLOGIA, V52, P1504, DOI 10.1007/s00125-009-1393-9; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; SIES H, 1984, METHOD ENZYMOL, V105, P445; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang BB, 2008, J NEUROL SCI, V268, P172, DOI 10.1016/j.jns.2007.12.006; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x	63	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14485	10.1371/journal.pone.0014485	http://dx.doi.org/10.1371/journal.pone.0014485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21249230	Green Published, gold			2022-12-27	WOS:000286510500004
J	Tobler, M; Healey, M; Olsson, M				Tobler, Michael; Healey, Mo; Olsson, Mats			Digit Ratio, Color Polymorphism and Egg Testosterone in the Australian Painted Dragon	PLOS ONE			English	Article							SECONDARY SEXUAL CHARACTERS; LENGTH RATIO; DEVELOPMENTAL PLASTICITY; PHASIANUS-COLCHICUS; YOLK TESTOSTERONE; MATERNAL HORMONES; MATING-BEHAVIOR; ZEBRA FINCH; LIZARD; DIFFERENTIATION	Variation in exposure to sex hormones during early development contributes to phenotypic plasticity in vertebrate offspring. As a proposed marker for prenatal sex hormone exposure and because of their association with various physiological and behavioral characteristics, digit ratio and/or digit length have received notable interest within the field of evolutionary ecology. However, the validity of digit measures as a proxy of prenatal sex hormone exposure is controversial and only few studies have provided direct evidence for the link between digit development and prenatal sex hormones. Here, we report morph- and sex-specific variation in digit ratio in wild painted dragon lizards (Ctenophorus pictus). Lizards expressing a yellow bib have significantly larger third-to-fourth toe ratios (3D:4D) than lizards without a bib. Males have significantly smaller 3D:4D than females. Furthermore, we show that experimental elevation of yolk testosterone significantly increases 3D:4D in hatchling painted dragon lizards, but has no influence on hatchling size. Our results provide direct and indirect evidence for the involvement of prenatal sex steroids in digit development and it is suggested that digit ratio may be used as a biomarker for prenatal steroid exposure in this reptilian species. As such, digit ratio may provide a useful tool to study temporal or spatial differences in the proximate hormonal mechanisms modulating physiological and behavioural phenotypes.	[Tobler, Michael] Lund Univ, Dept Biol, Sect Anim Ecol, Lund, Sweden; [Tobler, Michael; Healey, Mo; Olsson, Mats] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Tobler, Michael; Healey, Mo; Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Lund University; University of Wollongong; University of Sydney	Tobler, M (corresponding author), Lund Univ, Dept Biol, Sect Anim Ecol, Lund, Sweden.	michael.tobler@zooekol.lu.se	Tobler, Michael/B-2754-2013; Olsson, Mats/AAK-5565-2021	Tobler, Michael/0000-0001-5895-6302; Olsson, Mats/0000-0002-4130-1323	Swiss National Science Foundation [PBSKA-119056]; Australian Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Australian Research Council(Australian Research Council)	The Swiss National Science Foundation (postdoctoral research fellowship PBSKA-119056 to M.T.) and the Australian Research Council (to M.O.) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS EK, 1979, NEUROENDOCRINOLOGY, V29, P178, DOI 10.1159/000122920; Adkins-Regan E, 2009, DEV NEUROSCI-BASEL, V31, P342, DOI 10.1159/000216545; BALTHAZART J, 2003, HORMONES BRAIN BEHAV; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Brana F, 2008, OECOLOGIA, V156, P275, DOI 10.1007/s00442-008-0996-z; BREEDLOVE SM, 1982, BRAIN RES, V237, P173, DOI 10.1016/0006-8993(82)90565-0; Carere C, 2007, TRENDS ENDOCRIN MET, V18, P73, DOI 10.1016/j.tem.2007.01.003; Chang JL, 2006, CAN J ZOOL, V84, P1489, DOI 10.1139/Z06-144; CLARK MM, 1995, TRENDS ECOL EVOL, V10, P151, DOI 10.1016/S0169-5347(00)89025-4; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Crews D, 1998, AM ZOOL, V38, P118; Cutler GB, 1997, J STEROID BIOCHEM, V61, P141; DOHLER KD, 1984, BRAIN RES, V302, P291, DOI 10.1016/0006-8993(84)90242-7; Dreiss AN, 2008, BEHAV ECOL, V19, P16, DOI 10.1093/beheco/arm095; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Forstmeier W, 2008, GEN COMP ENDOCR, V156, P379, DOI 10.1016/j.ygcen.2008.01.007; Forstmeier W, 2010, P ROY SOC B-BIOL SCI, V277, P3353, DOI 10.1098/rspb.2010.1007; Garamszegi LZ, 2007, ANIM BEHAV, V74, P641, DOI 10.1016/j.anbehav.2006.11.023; Genovart M, 2008, BIOL LETTERS, V4, P461, DOI 10.1098/rsbl.2008.0272; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Healey M, 2007, ANIM BEHAV, V74, P337, DOI 10.1016/j.anbehav.2006.09.017; Healey M, 2009, AUSTRAL ECOL, V34, P636, DOI 10.1111/j.1442-9993.2009.01968.x; Helle S, 2010, BEHAV ECOL, V21, P1061, DOI 10.1093/beheco/arq105; HEWS DK, 1994, HORM BEHAV, V28, P1; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Kratochvil L, 2009, BIOL LETTERS, V5, P643, DOI 10.1098/rsbl.2009.0346; Lancaster LT, 2007, ECOL LETT, V10, P798, DOI 10.1111/j.1461-0248.2007.01069.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Littell R.C., 2004, SAS SYSTEM MIXED MOD, Vsixth; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Moore MC, 1998, AM ZOOL, V38, P133; Navarro C, 2007, BEHAV ECOL SOCIOBIOL, V61, P1161, DOI 10.1007/s00265-006-0329-3; Olsson M, 2007, MOL ECOL, V16, P5307, DOI 10.1111/j.1365-294X.2007.03578.x; Olsson M, 2007, PHYSIOL BEHAV, V91, P531, DOI 10.1016/j.physbeh.2007.04.025; Olsson M, 2009, EVOLUTION, V63, P695, DOI 10.1111/j.1558-5646.2008.00569.x; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Radder RS, 2009, CURR BIOL, V19, P1102, DOI 10.1016/j.cub.2009.05.027; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; Roberts EK, 2008, BIOL REPROD, V79, P43, DOI 10.1095/biolreprod.107.067074; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Schlinger BA, 1998, ANNU REV PHYSIOL, V60, P407, DOI 10.1146/annurev.physiol.60.1.407; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Thornton J, 2009, HORM BEHAV, V55, P633, DOI 10.1016/j.yhbeh.2009.03.015; Uller T, 2007, FUNCT ECOL, V21, P544, DOI 10.1111/j.1365-2435.2007.01264.x; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2006, BIOL LETTERS, V2, P569, DOI 10.1098/rsbl.2006.0526; Voracek M, 2007, AM J HUM BIOL, V19, P142, DOI 10.1002/ajhb.20581; Voracek M, 2009, PSYCHOL REP, V104, P922, DOI 10.2466/PR0.104.3.922-956	54	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16225	10.1371/journal.pone.0016225	http://dx.doi.org/10.1371/journal.pone.0016225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283539	Green Submitted, gold, Green Published			2022-12-27	WOS:000286661400036
J	Zhang, JS; Zhao, QM; Guo, XF; Zuo, SQ; Cheng, JX; Jia, N; Wu, C; Dai, PF; Zhao, JY				Zhang, Jiu-Song; Zhao, Qiu-Min; Guo, Xiao-Fang; Zuo, Shu-Qing; Cheng, Jing-Xia; Jia, Na; Wu, Chao; Dai, Pei-Fang; Zhao, Jun-Ying			Isolation and Genetic Characteristics of Human Genotype 1 Japanese Encephalitis Virus, China, 2009	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; NS1 PROTEIN; IMMUNIZATION; SEQUENCE; EPITOPE; DOMAIN	Background: Several studies have shown that the predominant genotype of Chinese Japanese encephalitis virus (JEV) is evolving from genotype 3 to genotype 1. However, in recent years, almost all genotype 1 isolates were from mosquitoes, and genotype 1 has been less associated with human disease than genotype 3. This study reports the isolation of human genotype 1 JEV and its genetic characteristics to provide additional insights into human JE pathogens that are currently circulating in China. Methods and Results: In 2009, 31 cerebrospinal fluid samples were collected from patients living in Yunnan and Shanxi provinces and were used to inoculate Aedes albopictus C6/36 cells for virus isolation. The JEV strains were identified using immunofluorescent assays and the reverse transcription-polymerase chain reaction. Phylogenetic analyses based on the partial capsid/pre-membrane and full envelope (E) sequences were performed using Clustalx 1.8 software. Three JEV isolates were obtained from a 4-year-old girl and a 2-year-old boy living in Yunnan and an 82-year-old woman in Shanxi. The boy had been immunized with one dose of JE live attenuated vaccine. New isolates were grouped into genotype 1. Amino acid sequence for the viral E protein indicated 95% to 100% identity with each other and with other JEV strains. When compared with a consensus sequence of E protein, two amino acid substitutions were found: Ser(E-123)-Asn in the two Yunnan isolates and Lys(E-166)-Arg in the Shanxi isolate. Conclusions: Our findings indicate that the genotype 1 of JEV is causing human infections in China. Our observation of a previously vaccinated boy developing JE from genotype 1 virus infection also calls for more detailed studies, both in vitro and in vivo neutralization tests as well as active surveillance, to examine the possibility of a lack of complete protection conferred by the live attenuated JE vaccine against genotype 1 virus.	[Zhang, Jiu-Song; Zhao, Qiu-Min; Zuo, Shu-Qing; Jia, Na] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Guo, Xiao-Fang] Yunnan Inst Parasit Dis, Simao, Peoples R China; [Cheng, Jing-Xia; Dai, Pei-Fang; Zhao, Jun-Ying] Shanxi Ctr Dis Control & Prevent, Taiyuan, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Zhang, JS (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zhang_jiusong@yahoo.com.cn			National High-Tech R & D Program (863 Project), China [2007AA02Z481]; National Natural Science Fund of China [30872152]	National High-Tech R & D Program (863 Project), China(National High Technology Research and Development Program of China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by National High-Tech R & D Program (863 Project) (No. 2007AA02Z481) of China and the National Natural Science Fund of China (No. 30872152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN WR, 1992, AM J TROP MED HYG, V47, P61, DOI 10.4269/ajtmh.1992.47.61; CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Kuwayama M, 2005, EMERG INFECT DIS, V11, P471; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Liu W, 2006, VACCINE, V24, P5178, DOI 10.1016/j.vaccine.2006.04.006; MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037; NI HL, 1995, J GEN VIROL, V76, P409, DOI 10.1099/0022-1317-76-2-409; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035; Takada K, 2000, ARCH VIROL, V145, P523, DOI 10.1007/s007050050043; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; WANG HY, 2009, CHIN J VACCINES IMMU, V15, P337; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; Wang XJ, 2004, CHIN J VACCINES IMMU, V10, P215; WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4; Xu GY, 2004, VACCINE, V22, P1846, DOI 10.1016/j.vaccine.2003.09.015; Ye XF, 2010, J CLIN MICROBIOL, V48, P1343, DOI 10.1128/JCM.01009-09; Zhang JS, 2009, ARCH VIROL, V154, P1177, DOI 10.1007/s00705-009-0421-x; 梁国栋, 2005, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V19, P305	27	37	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16418	10.1371/journal.pone.0016418	http://dx.doi.org/10.1371/journal.pone.0016418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283590	gold, Green Published, Green Submitted			2022-12-27	WOS:000286661400049
J	Zimmer, I; Ropert-Coudert, Y; Kato, A; Ancel, A; Chiaradia, A				Zimmer, Ilka; Ropert-Coudert, Yan; Kato, Akiko; Ancel, Andre; Chiaradia, Andre			Does Foraging Performance Change with Age in Female Little Penguins (Eudyptula minor)?	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; DIVING BEHAVIOR; BREEDING PERFORMANCE; ATTACHMENT; PATTERNS; SUCCESS; BIRDS; PERTURBATIONS	Age-related changes in breeding performance are likely to be mediated through changes in parental foraging performance. We investigated the relationship of foraging performance with age in female little penguins at Phillip Island, Australia, during the guard phase of the 2005 breeding season. Foraging parameters were recorded with accelerometers for birds grouped into three age-classes: (1) young, (2) middle age and (3) old females. We found the diving behaviour of middle-aged birds differed from young and old birds. The dive duration of middle age females was shorter than that of young and old birds while their dive effort (measure for dive and post-dive duration relation) was lower than that of young ones, suggesting middle-aged birds were in better physical condition than other ones. There was no difference in prey pursuit frequency or duration between age classes, but in the hunting tactic. Females pursued more prey around and after reaching the maximum depth of dives the more experienced they were (old > middle age > young), an energy saving hunting tactic by probably taking advantage of up-thrust momentum. We suggest middle age penguins forage better than young or old ones because good physical condition and foraging experience could act simultaneously.	[Zimmer, Ilka; Ropert-Coudert, Yan; Kato, Akiko; Ancel, Andre] Univ Strasbourg, IPHC, Strasbourg, France; [Zimmer, Ilka; Ropert-Coudert, Yan; Kato, Akiko; Ancel, Andre] CNRS, UMR7178, Strasbourg, France; [Kato, Akiko] Natl Inst Polar Res, Tokyo, Japan; [Chiaradia, Andre] Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Zimmer, I (corresponding author), Univ Strasbourg, IPHC, Strasbourg, France.	yan.ropert-coudert@c-strasbourg.fr	Chiaradia, Andre/AAG-4928-2022; Kato, Akiko/W-2447-2019; Chiaradia, Andre/AFK-6634-2022	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Kato, Akiko/0000-0002-8947-3634	BHP-Billiton; Japan Science Society; Australian Academy of Science; University of Strasbourg; Penguin Foundation; Japan Society for the Promotion of Science	BHP-Billiton; Japan Science Society; Australian Academy of Science; University of Strasbourg; Penguin Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the BHP-Billiton, the Japan Science Society, the Australian Academy of Science, the University of Strasbourg, the Penguin Foundation and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Note that Phillip Island Nature Park is a not-for-profit organization dedicated to the protection and conservation of little penguins. The Park is controlled by a Board of Management appointed by the Minister for Environment of Victoria, Australia.	BANNASCH R, 1994, J EXP BIOL, V194, P83; Bethge P, 1997, J ZOOL, V242, P483; BUCKLEY FG, 1974, ECOLOGY, V55, P1053, DOI 10.2307/1940355; Bunce A, 2005, J ZOOL, V266, P163, DOI 10.1017/S0952836905006734; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Chiaradia A, 2007, MAR BIOL, V151, P1535, DOI 10.1007/s00227-006-0593-9; Chiaradia A, 2006, ARDEA, V94, P257; Chiaradia Andre F., 1999, Marine Ornithology, V27, P13; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cockburn A., 1991, INTRO EVOLUTIONARY E; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Daunt F, 1999, P ROY SOC B-BIOL SCI, V266, P1489, DOI 10.1098/rspb.1999.0805; Devevey G, 2010, J ORNITHOL, V151, P251, DOI 10.1007/s10336-009-0456-5; DUNN EK, 1972, IBIS, V114, P360, DOI 10.1111/j.1474-919X.1972.tb00833.x; Elliott KH, 2008, ANIM BEHAV, V75, P1301, DOI 10.1016/j.anbehav.2007.09.024; Finch CE, 1990, LONGEVITY SENESCENCE; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; GREIG SA, 1983, ANIM BEHAV, V31, P1237, DOI 10.1016/S0003-3472(83)80030-X; Gremillet D, 1999, MAR ECOL PROG SER, V183, P263, DOI 10.3354/meps183263; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HOLMES DJ, 1995, AM ZOOL, V35, P307; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MORRIS M, 1990, SLEEP, V13, P1; Newton I, 1989, LIFETIME REPROD BIRD; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Nisbet ICT, 2002, J FIELD ORNITHOL, V73, P117, DOI 10.1648/0273-8570-73.2.117; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 1995, P ROY SOC LOND B BIO, V360, P113, DOI DOI 10.1098/RSPB.1995.0067; PUGESEK BH, 1983, ECOLOGY, V84, P829; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P579, DOI 10.1098/rspb.2005.3353; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Stearns S.C., 1992, pi; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Wilson RP, 2010, AQUAT BIOL, V8, P193, DOI 10.3354/ab00230; Wilson RP, 1997, POLAR BIOL, V17, P323, DOI 10.1007/PL00013373; WILSON RP, 1989, WILDLIFE SOC B, V17, P77; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; Wilson RP, 2004, MAR ECOL PROG SER, V278, P303, DOI 10.3354/meps278303; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273; Zuur Alain F., 2009, P1	51	54	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16098	10.1371/journal.pone.0016098	http://dx.doi.org/10.1371/journal.pone.0016098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283573	Green Published, gold			2022-12-27	WOS:000286661400025
J	Ashby, JA; Stevenson, CEM; Jarvis, GE; Lawson, DM; Maule, AJ				Ashby, Jamie A.; Stevenson, Clare E. M.; Jarvis, Gavin E.; Lawson, David M.; Maule, Andrew J.			Structure-Based Mutational Analysis of eIF4E in Relation to sbm1 Resistance to Pea Seed-Borne Mosaic Virus in Pea	PLOS ONE			English	Article							INITIATION-FACTOR 4E; GENOME-LINKED PROTEIN; CAP-BINDING PROTEIN; TOBACCO-ETCH-VIRUS; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; RECESSIVE POTYVIRUS RESISTANCE; TRANSLATION INITIATION; PISUM-SATIVUM; EIF4E-MEDIATED RESISTANCE; MACROMOLECULAR STRUCTURES	Background: Pea encodes eukaryotic translation initiation factor eIF4E (eIF4E(S)), which supports the multiplication of Pea seed-borne mosaic virus (PSbMV). In common with hosts for other potyviruses, some pea lines contain a recessive allele (sbm1) encoding a mutant eIF4E (eIF4E(R)) that fails to interact functionally with the PSbMV avirulence protein, VPg, giving genetic resistance to infection. Methodology/Principal Findings: To study structure-function relationships between pea eIF4E and PSbMV VPg, we obtained an X-ray structure for eIF4E(S) bound to m(7)GTP. The crystallographic asymmetric unit contained eight independent copies of the protein, providing insights into the structurally conserved and flexible regions of eIF4E. To assess indirectly the importance of key residues in binding to VPg and/or m(7)GTP, an extensive range of point mutants in eIF4E was tested for their ability to complement PSbMV multiplication in resistant pea tissues and for complementation of protein translation, and hence growth, in an eIF4E-defective yeast strain conditionally dependent upon ectopic expression of eIF4E. The mutants also dissected individual contributions from polymorphisms present in eIF4E(R) and compared the impact of individual residues altered in orthologous resistance alleles from other crop species. The data showed that essential resistance determinants in eIF4E differed for different viruses although the critical region involved (possibly in VPg-binding) was conserved and partially overlapped with the m(7)GTP-binding region. This overlap resulted in coupled inhibition of virus multiplication and translation in the majority of cases, although the existence of a few mutants that uncoupled the two processes supported the view that the specific role of eIF4E in potyvirus infection may not be restricted to translation. Conclusions/Significance: The work describes the most extensive structural analysis of eIF4E in relation to potyvirus resistance. In addition to defining functional domains within the eIF4E structure, we identified eIF4E alleles with the potential to convey novel virus resistance phenotypes.	[Ashby, Jamie A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Stevenson, Clare E. M.; Lawson, David M.; Maule, Andrew J.] John Innes Ctr, Norwich, Norfolk, England; [Jarvis, Gavin E.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Queens University Belfast	Ashby, JA (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	andy.maule@bbsrc.ac.uk		Jarvis, Gavin/0000-0003-4362-1133	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D521949/1]; BBSRC; BBSRC [BB/D521949/1] Funding Source: UKRI; MRC [G0601378] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521949/1] Funding Source: researchfish; Medical Research Council [G0601378] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JAA was supported by UK Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/D521949/1. The BBSRC also provides a grant-in-aid to the John Innes Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Razzak A, 2009, MOL PLANT PATHOL, V10, P109, DOI 10.1111/j.1364-3703.2008.00513.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashby JA, 2009, ACTA CRYSTALLOGR F, V65, P836, DOI 10.1107/S1744309109027389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Brown CJ, 2009, CELL CYCLE, V8, P1905, DOI 10.4161/cc.8.12.8742; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gao ZH, 2004, PLANT J, V40, P376, DOI 10.1111/j.1365-313X.2004.02215.x; German-Retana S, 2008, J VIROL, V82, P7601, DOI 10.1128/JVI.00209-08; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hughes JMX, 1999, J BIOL CHEM, V274, P3261, DOI 10.1074/jbc.274.6.3261; Hwang J, 2009, MOL CELLS, V27, P329, DOI 10.1007/s10059-009-0042-y; Johansen IE, 2001, J VIROL, V75, P6609, DOI 10.1128/JVI.75.14.6609-6614.2001; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Khan MA, 2009, J BIOL CHEM, V284, P35461, DOI 10.1074/jbc.M109.038463; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; LEVIS C, 1993, VIRUS GENES, V7, P367, DOI 10.1007/BF01703392; Ling KS, 2009, THEOR APPL GENET, V120, P191, DOI 10.1007/s00122-009-1169-0; Liu WZ, 2009, J BIOL CHEM, V284, P31336, DOI 10.1074/jbc.M109.049858; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARCOTRIGIANO J, 1997, NUCL ACIDS S SER; Michon T, 2006, FEBS J, V273, P1312, DOI 10.1111/j.1742-4658.2006.05156.x; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naderpour M, 2010, MOL PLANT PATHOL, V11, P255, DOI 10.1111/j.1364-3703.2009.00602.x; Nakahara KS, 2010, MOL PLANT MICROBE IN, V23, P1460, DOI 10.1094/MPMI-11-09-0277; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Okade H, 2009, J BIOCHEM, V145, P299, DOI 10.1093/jb/mvn180; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rantalainen KI, 2008, VIROLOGY, V377, P280, DOI 10.1016/j.virol.2008.04.025; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997	68	35	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15873	10.1371/journal.pone.0015873	http://dx.doi.org/10.1371/journal.pone.0015873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283665	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400008
J	Haddock, RE; Grayson, TH; Morris, MJ; Howitt, L; Chadha, PS; Sandow, SL				Haddock, Rebecca E.; Grayson, T. Hilton; Morris, Margaret J.; Howitt, Lauren; Chadha, Preet S.; Sandow, Shaun L.			Diet-Induced Obesity Impairs Endothelium-Derived Hyperpolarization via Altered Potassium Channel Signaling Mechanisms	PLOS ONE			English	Article							MYOENDOTHELIAL GAP-JUNCTIONS; CA2+-ACTIVATED K+ CHANNEL; SPONTANEOUSLY HYPERTENSIVE-RATS; MESENTERIC SMALL ARTERIES; DIABETIC ZDF RATS; SMALL-CONDUCTANCE; GUINEA-PIG; DEPENDENT HYPERPOLARIZATION; VASODILATOR FUNCTION; RESISTANCE ARTERIES	Background: The vascular endothelium plays a critical role in the control of blood flow. Altered endothelium-mediated vasodilator and vasoconstrictor mechanisms underlie key aspects of cardiovascular disease, including those in obesity. Whilst the mechanism of nitric oxide (NO)-mediated vasodilation has been extensively studied in obesity, little is known about the impact of obesity on vasodilation to the endothelium-derived hyperpolarization (EDH) mechanism; which predominates in smaller resistance vessels and is characterized in this study. Methodology/Principal Findings: Membrane potential, vessel diameter and luminal pressure were recorded in 4(th) order mesenteric arteries with pressure-induced myogenic tone, in control and diet-induced obese rats. Obesity, reflecting that of human dietary etiology, was induced with a cafeteria-style diet (similar to 30 kJ, fat) over 16-20 weeks. Age and sexed matched controls received standard chow (similar to 12 kJ, fat). Channel protein distribution, expression and vessel morphology were determined using immunohistochemistry, Western blotting and ultrastructural techniques. In control and obese rat vessels, acetylcholine-mediated EDH was abolished by small and intermediate conductance calcium-activated potassium channel (SK(Ca)/IK(Ca)) inhibition; with such activity being impaired in obesity. SK(Ca)-IK(Ca) activation with cyclohexyl-[2-(3,5-dimethylpyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA) and 1-ethyl-2-benzimidazolinone (1-EBIO), respectively, hyperpolarized and relaxed vessels from control and obese rats. IK(Ca)-mediated EDH contribution was increased in obesity, and associated with altered IK(Ca) distribution and elevated expression. In contrast, the SK(Ca)-dependent-EDH component was reduced in obesity. Inward-rectifying potassium channel (K(ir)) and Na(+)/K(+)-ATPase inhibition by barium/ouabain, respectively, attenuated and abolished EDH in arteries from control and obese rats, respectively; reflecting differential Kir expression and distribution. Although changes in medial properties occurred, obesity had no effect on myoendothelial gap junction density. Conclusion/Significance: In obese rats, vasodilation to EDH is impaired due to changes in the underlying potassium channel signaling mechanisms. Whilst myoendothelial gap junction density is unchanged in arteries of obese compared to control, increased IK(Ca) and Na(+)/K(+)-ATPase, and decreased Kir underlie changes in the EDH mechanism.	[Haddock, Rebecca E.; Grayson, T. Hilton; Morris, Margaret J.; Howitt, Lauren; Chadha, Preet S.; Sandow, Shaun L.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Haddock, Rebecca E.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 2601, Australia	University of New South Wales Sydney; Australian National University; John Curtin School of Medical Research	Haddock, RE (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	Rebecca.Haddock@anu.edu.au; Shaun.Sandow@unsw.edu.au	Morris, Margaret J/J-4285-2013; Sandow, Shaun/N-4256-2016; Grayson, Thomas H/F-2708-2011	Sandow, Shaun/0000-0002-0753-2742; Haddock, Rebecca/0000-0001-7755-7841; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia [ID 466009, ID 401112, ID 455243]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia [ID 466009 to REH, ID 401112 SLS and ID 455243 to SLS and MJM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Boettger MK, 2002, BRAIN, V125, P252, DOI 10.1093/brain/awf026; Brondum E, 2010, BRIT J PHARMACOL, V159, P154, DOI 10.1111/j.1476-5381.2009.00525.x; Bund SJ, 2003, J VASC RES, V40, P547, DOI 10.1159/000075678; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Cao YX, 2005, ARCH PHARM RES, V28, P709, DOI 10.1007/BF02969362; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Chen MX, 2004, N-S ARCH PHARMACOL, V369, P602, DOI 10.1007/s00210-004-0934-5; Coleman HA, 2001, J PHYSIOL-LONDON, V531, P359, DOI 10.1111/j.1469-7793.2001.0359i.x; Dalsgaard T, 2010, BRIT J PHARMACOL, V160, P1496, DOI 10.1111/j.1476-5381.2010.00803.x; de Kreutzenberg SV, 2003, ATHEROSCLEROSIS, V169, P147, DOI 10.1016/S0021-9150(03)00153-9; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Ellis A, 2009, J PHARMACOL EXP THER, V330, P413, DOI 10.1124/jpet.109.152116; Erdei N, 2006, AM J PHYSIOL-HEART C, V291, pH2107, DOI 10.1152/ajpheart.00389.2006; Feletou M, 2004, PHARMACOL RES, V49, P565, DOI 10.1016/j.phrs.2003.10.017; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Frisbee JC, 2002, AM J PHYSIOL-HEART C, V283, pH2160, DOI 10.1152/ajpheart.00379.2002; Fukao M, 1997, BRIT J PHARMACOL, V120, P1328, DOI 10.1038/sj.bjp.0701027; GARLAND CJ, 1995, TRENDS PHARMACOL SCI, V16, P23, DOI 10.1016/S0165-6147(00)88969-5; Giachini FRC, 2009, TRANSL RES, V154, P183, DOI 10.1016/j.trsl.2009.07.003; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Grassi G, 2010, OBESITY, V18, P92, DOI 10.1038/oby.2009.195; Haddock RE, 2006, AM J PHYSIOL-HEART C, V291, pH2047, DOI 10.1152/ajpheart.00484.2006; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Haslam D, 2010, PRIM CARE DIABETES, V4, P105, DOI 10.1016/j.pcd.2010.04.002; Hayashi K, 2002, METABOLISM, V51, P1553, DOI 10.1053/meta.2002.36311; Hilgers RHP, 2010, J PHARMACOL EXP THER, V333, P210, DOI 10.1124/jpet.109.161448; Hougaard C, 2007, BRIT J PHARMACOL, V151, P655, DOI 10.1038/sj.bjp.0707281; Jebelovszki E, 2008, AM J PHYSIOL-HEART C, V294, pH2558, DOI 10.1152/ajpheart.01198.2007; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kusama N, 2005, BRIT J PHARMACOL, V146, P487, DOI 10.1038/sj.bjp.0706363; Leuranguer V, 2008, N-S ARCH PHARMACOL, V377, P101, DOI 10.1007/s00210-008-0267-x; Matchkov VV, 2004, BRIT J PHARMACOL, V142, P961, DOI 10.1038/sj.bjp.0705870; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; McGuire JJ, 2001, CAN J PHYSIOL PHARM, V79, P443, DOI 10.1139/cjpp-79-6-443; MCNAMEE CJ, 1994, CIRC RES, V74, P1126, DOI 10.1161/01.RES.74.6.1126; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Murphy TV, 2007, BRIT J PHARMACOL, V151, P602, DOI 10.1038/sj.bjp.0707262; NEILD TO, 1989, BLOOD VESSELS, V26, P48; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Rummery NM, 2005, J HYPERTENS, V23, P317, DOI 10.1097/00004872-200502000-00014; Sandow SL, 2007, TRENDS PHARMACOL SCI, V28, P61, DOI 10.1016/j.tips.2006.12.007; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2009, CLIN EXP PHARMACOL P, V36, P67, DOI 10.1111/j.1440-1681.2008.05076.x; Sandow SL, 2004, CLIN EXP PHARMACOL P, V31, P563, DOI 10.1111/j.1440-1681.2004.04048.x; Sandow SL, 2004, J PHYSIOL-LONDON, V556, P875, DOI 10.1113/jphysiol.2003.058669; Sandow SL, 2003, CARDIOVASC RES, V60, P643, DOI 10.1016/j.cardiores.2003.09.017; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Tare M, 2002, AM J PHYSIOL-HEART C, V282, pH335, DOI 10.1152/ajpheart.2002.282.1.H335; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Weston AH, 2010, BRIT J PHARMACOL, V160, P836, DOI 10.1111/j.1476-5381.2010.00657.x; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y	58	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16423	10.1371/journal.pone.0016423	http://dx.doi.org/10.1371/journal.pone.0016423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283658	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300045
J	Zhou, YH; Liu, FL; Yao, ZH; Duo, L; Li, H; Sun, Y; Zheng, YT				Zhou, Yan-Heng; Liu, Feng-Liang; Yao, Zhi-Hong; Duo, Lin; Li, Hong; Sun, Yi; Zheng, Yong-Tang			Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region	PLOS ONE			English	Article							HEPATITIS-C VIRUS; VIRAL-HEPATITIS; YUNNAN PROVINCE; HARM REDUCTION; INFECTION; EPIDEMIOLOGY; TYPE-1; CHALLENGES; HIV/AIDS; PEOPLE	Background: Co-infection with HIV and HCV and/or HBV is highly prevalent in intravenous drug users (IDUs). Because of the proximity to the "Golden Triangle'', HIV prevalence among the IDUs is very high in the China-Myanmar border region. However, there are few studies about co-infection with HIV and HCV and/or HBV, especially in the region that belongs to Myanmar. Methods: 721 IDUs, including 403 Chinese and 318 Burmese, were investigated for their HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) serological status. Statistical analysis was performed to evaluate the differences of the epidemic situation between the Chinese IDUs and the Burmese IDUs. Results: Among the Chinese IDUs and the Burmese IDUs, HCV infection was the most prevalent (69.0% vs 48.1%, P<0.001), followed by HBV (51.6% vs 43.1%, P<0.05) and HIV (33.7% vs 27.0%, P>0.05). Besides, there were more HIV-HBV co-infected IDUs (20.1% vs 11.3%, P<0.005), and HIV-HCV co-infected IDUs (31.8% vs 23.9%, P<0.05) in China than in Myanmar, as well as HIV-HBV-HCV triple infection (19.1% vs 10.4%, P<0.005). Conclusion: Co-infection with HIV and HCV and/or HBV is highly prevalent among the IDUs in the China-Myanmar border region. The HIV epidemic appears to be in a downward trend, compared with previous reports. However, all infections were more prevalent among the Chinese IDUs than among the Burmese.	[Zhou, Yan-Heng; Liu, Feng-Liang; Yao, Zhi-Hong; Sun, Yi; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming, Peoples R China; [Duo, Lin] Second Peoples Hosp Yunnan Prov, Kunming, Peoples R China; [Li, Hong] Yunnan Ctr Dis Control & Prevent, Kunming, Peoples R China; [Sun, Yi] First Peoples Hosp Yunnan Prov, Kunming, Peoples R China; [Zhou, Yan-Heng; Liu, Feng-Liang; Yao, Zhi-Hong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, YH (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming, Peoples R China.	zhengyt@mail.kiz.ac.cn	Liu, Feng-Liang/O-4000-2019	Liu, Feng-Liang/0000-0002-5038-5012	National Basic Research Program of China [2006CB504302, 2009CB522306]; National Natural Science Foundation of China [30671960, U0832601]; Eleventh Five-Year Key Scientific and Technological Program of China [2009ZX10004-902, 2009ZX09501-029, 2008ZX10001-002, 2008ZX10001-015]; HIV/AIDS Asia Regional Program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Eleventh Five-Year Key Scientific and Technological Program of China; HIV/AIDS Asia Regional Program	This work was supported in part by grants from the National Basic Research Program of China (2006CB504302, 2009CB522306), the National Natural Science Foundation of China (30671960, U0832601), the Eleventh Five-Year Key Scientific and Technological Program of China (2009ZX10004-902, 2009ZX09501-029, 2008ZX10001-002, 2008ZX10001-015), and the HIV/AIDS Asia Regional Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Estrada AL, 2002, PUBLIC HEALTH REP, V117, pS126; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kusagawa S, 1998, AIDS RES HUM RETROV, V14, P1379, DOI 10.1089/aid.1998.14.1379; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Liu PP, 2008, AIDS RES HUM RETROV, V24, P1, DOI 10.1089/aid.2007.0144; Maier I, 2002, WORLD J GASTROENTERO, V8, P577, DOI 10.3748/wjg.v8.i4.577; Motomura K, 2000, AIDS RES HUM RETROV, V16, P1831, DOI 10.1089/08892220050195793; Okada S, 2000, ACTA MED OKAYAMA, V54, P137; Reid G, 2009, INT J DRUG POLICY, V20, P365, DOI 10.1016/j.drugpo.2008.10.004; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Saravanan S, 2007, WORLD J GASTROENTERO, V13, P5015, DOI 10.3748/wjg.v13.i37.5015; Sharma M, 2009, AIDS, V23, P1405, DOI 10.1097/QAD.0b013e32832bd7c9; SOLOMON SS, 2008, J ACQ IMMUN DEF SYND, V29, P191; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; UNODC, 2010, MYANM COUNTR ADV BRI; Vickerman P, 2010, ADDICTION, V105, P311, DOI 10.1111/j.1360-0443.2009.02759.x; Vlahov D, 1998, Public Health Rep, V113 Suppl 1, P75; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Wang You-Chun, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P777; Williams Brian, 2008, Confl Health, V2, P3, DOI 10.1186/1752-1505-2-3; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Zamani S, 2010, INT J DRUG POLICY, V21, P493, DOI 10.1016/j.drugpo.2010.04.006; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	33	43	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16349	10.1371/journal.pone.0016349	http://dx.doi.org/10.1371/journal.pone.0016349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283696	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300038
J	Wang, C; Fan, XL; Wang, GC; Niu, JF; Zhou, BC				Wang, Chao; Fan, Xiaolei; Wang, Guangce; Niu, Jianfeng; Zhou, Baicheng			Differential Expression of Rubisco in Sporophytes and Gametophytes of Some Marine Macroalgae	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; CARBOXYLASE ACTIVITY; LEAF DEVELOPMENT; MESSENGER-RNAS; GENE DOSAGE; POLYPLOIDY; RIBULOSE; PLANTS; CHLOROPHYLL; DIVERSITY	Rubisco (ribulose-1, 5-bisphosphate carboxylase/oxygenase), a key enzyme of photosynthetic CO2 fixation, is one of the most abundant proteins in both higher plants and algae. In this study, the differential expression of Rubisco in sporophytes and gametophytes of four seaweed species - Porphyra yezoensis, P. haitanensis, Bangia fuscopurpurea (Rhodophyte) and Laminaria japonica (Phaeophyceae) - was studied in terms of the levels of transcription, translation and enzyme activity. Results indicated that both the Rubisco content and the initial carboxylase activity were notably higher in algal gametophytes than in the sporophytes, which suggested that the Rubisco content and the initial carboxylase activity were related to the ploidy of the generations of the four algal species.	[Wang, Chao; Wang, Guangce; Niu, Jianfeng; Zhou, Baicheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Fan, Xiaolei] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, C (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	gcwang@ms.qdio.ac.cn			National Natural Science Foundation of China [30830015]; Project for Supporting the National Development [2006BAD09A04]; 863 High Technology projects [2007AA09Z406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Supporting the National Development; 863 High Technology projects(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (No. 30830015), Project for Supporting the National Development (No. 2006BAD09A04) and 863 High Technology projects (No. 2007AA09Z406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; BEER S, 1991, OECOLOGIA, V87, P429, DOI 10.1007/BF00634602; BHASKARAN S, 1987, J EXP BOT, V38, P270, DOI 10.1093/jxb/38.2.270; BHASKARAN S, 1983, PLANT PHYSIOL, V73, P639, DOI 10.1104/pp.73.3.639; Bischof K, 2002, PLANTA, V215, P502, DOI 10.1007/s00425-002-0774-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cabello-Pasini A, 2001, REV CHIL HIST NAT, V74, P229; CARLSON PS, 1972, MOL GEN GENET, V114, P273, DOI 10.1007/BF00267495; CIFERRI O, 1969, GENETICS, V61, P567; DEAN C, 1982, PLANT PHYSIOL, V70, P1605, DOI 10.1104/pp.70.6.1605; DEMAGGIO AE, 1974, BIOCHEM GENET, V12, P429, DOI 10.1007/BF00486060; DUDGEON SR, 1989, MAR BIOL, V101, P107, DOI 10.1007/BF00393483; Fan XL, 2007, J PHYCOL, V43, P1287, DOI 10.1111/j.1529-8817.2007.00415.x; GA YC, 2001, ALGAE, V16, P145; Gerard VA, 1996, J PHYCOL, V32, P880, DOI 10.1111/j.0022-3646.1996.00880.x; GUERN M, 1980, PLANTA, V149, P27, DOI 10.1007/BF00386223; [何培民 He Peimin], 2004, [水产学报, Journal of Fisheries of China], V28, P255; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEECH RM, 1985, PLANTA, V166, P259, DOI 10.1007/BF00397357; Lin AP, 2009, PLANTA, V229, P803, DOI 10.1007/s00425-008-0874-2; Maayan I, 2008, PHYSIOL PLANTARUM, V134, P547, DOI 10.1111/j.1399-3054.2008.01150.x; MALCOLM MJ, 1988, J BIOL CHEM, V263, P6005; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; MEYERS SP, 1982, PLANT PHYSIOL, V70, P1704, DOI 10.1104/pp.70.6.1704; Miao YouGang, 1996, Acta Phytophysiologica Sinica, V22, P40; Patel M, 2008, J EXP BOT, V59, P1625, DOI 10.1093/jxb/erm368; REISKIND JB, 1991, P NATL ACAD SCI USA, V88, P2883, DOI 10.1073/pnas.88.7.2883; Rodermel S, 1999, PHOTOSYNTH RES, V59, P105, DOI 10.1023/A:1006122619851; SATOKO I, 2009, PLOS ONE, V4, P1; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; TWELL D, 1994, SOC EXP BIOL SEMIN S, V55, P83, DOI 10.1017/CBO9780511752339.007; VALENTIN K, 1990, MOL GEN GENET, V222, P425, DOI 10.1007/BF00633849; WANG WG, 1985, EXPT HDB PLANT PHYSL, P125; WANNER LA, 1991, PLANT CELL, V3, P1289, DOI 10.1105/tpc.3.12.1289; WARNER DA, 1989, PLANT PHYSIOL, V91, P1143, DOI 10.1104/pp.91.3.1143; WILLING RP, 1988, THEOR APPL GENET, V75, P751, DOI 10.1007/BF00265600; WILLING RP, 1984, PLANT PHYSIOL, V75, P865, DOI 10.1104/pp.75.3.865; XU ZM, 1991, MAR SCI, V2, P41; Zhang BY, 2010, J PHYCOL, V46, P290, DOI 10.1111/j.1529-8817.2009.00801.x; [张国 Zhang Guo], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P633	43	27	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16351	10.1371/journal.pone.0016351	http://dx.doi.org/10.1371/journal.pone.0016351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283730	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200054
J	Biedenweg, TA; Parsons, MH; Fleming, PA; Blumstein, DT				Biedenweg, Tine A.; Parsons, Michael H.; Fleming, Patricia A.; Blumstein, Daniel T.			Sounds Scary? Lack of Habituation following the Presentation of Novel Sounds	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; WALLABIES MACROPUS-EUGENII; PREDATION; DETERRENTS; VIGILANCE; BEHAVIOR; STARTLE; DEVICE	Background: Animals typically show less habituation to biologically meaningful sounds than to novel signals. We might therefore expect that acoustic deterrents should be based on natural sounds. Methodology: We investigated responses by western grey kangaroos (Macropus fulignosus) towards playback of natural sounds (alarm foot stomps and Australian raven (Corvus coronoides) calls) and artificial sounds (faux snake hiss and bull whip crack). We then increased rate of presentation to examine whether animals would habituate. Finally, we varied frequency of playback to investigate optimal rates of delivery. Principal Findings: Nine behaviors clustered into five Principal Components. PC factors 1 and 2 (animals alert or looking, or hopping and moving out of area) accounted for 36% of variance. PC factor 3 (eating cessation, taking flight, movement out of area) accounted for 13% of variance. Factors 4 and 5 (relaxing, grooming and walking; 12 and 11% of variation, respectively) discontinued upon playback. The whip crack was most evocative; eating was reduced from 75% of time spent prior to playback to 6% following playback (post alarm stomp: 32%, raven call: 49%, hiss: 75%). Additionally, 24% of individuals took flight and moved out of area (50 m radius) in response to the whip crack (foot stomp: 0%, raven call: 8% and 4%, hiss: 6%). Increasing rate of presentation (12x/min x2 min) caused 71% of animals to move out of the area. Conclusions/Significance: The bull whip crack, an artificial sound, was as effective as the alarm stomp at eliciting aversive behaviors. Kangaroos did not fully habituate despite hearing the signal up to 20x/min. Highest rates of playback did not elicit the greatest responses, suggesting that 'more is not always better'. Ultimately, by utilizing both artificial and biological sounds, predictability may be masked or offset, so that habituation is delayed and more effective deterrents may be produced.	[Biedenweg, Tine A.] Curtin Univ Technol, Dept Environm & Aquat Sci, Perth, WA, Australia; [Parsons, Michael H.; Fleming, Patricia A.] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia; [Parsons, Michael H.] SUNY Empire State Coll, Dept Biol, Hartsdale, NY USA; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Curtin University; Murdoch University; State University of New York (SUNY) System; SUNY Empire State College; University of California System; University of California Los Angeles	Biedenweg, TA (corresponding author), Curtin Univ Technol, Dept Environm & Aquat Sci, Perth, WA, Australia.	Michael.Parsons@esc.edu	Blumstein, Daniel T./B-6199-2012	Blumstein, Daniel T./0000-0001-5793-9244; Fleming, Patricia/0000-0002-0626-3851	Australian Research Council (ARC) [LPO7766512]; Minerals and Energy Resources Institute of Western Australia (MERIWA) [M394]; Barrick Gold; ChemCentre WA; Iluka Resources	Australian Research Council (ARC)(Australian Research Council); Minerals and Energy Resources Institute of Western Australia (MERIWA); Barrick Gold; ChemCentre WA; Iluka Resources	This research was partly supported by the Australian Research Council LPO7766512 (ARC; http://www.arc.gov.au) and also by the Minerals and Energy Resources Institute of Western Australia M394 (MERIWA; http://www.dmp.wa.gov.au/meriwa/index.asp) sponsored by Barrick Gold, ChemCentre WA, and Iluka Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bender H, 2005, WILDLIFE RES, V32, P649, DOI 10.1071/WR04091; BERGERUD AT, 1984, CAN J ZOOL, V62, P1566, DOI 10.1139/z84-229; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; Blumstein DT, 2002, BEHAV ECOL, V13, P657, DOI 10.1093/beheco/13.5.657; BOMFORD M, 1990, WILDLIFE SOC B, V18, P411; DAVIS M, 1970, J COMP PHYSIOL PSYCH, V72, P177, DOI 10.1037/h0029472; Dawson T.J., 1995, KANGAROOS BIOL LARGE; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; Fischer J, 1998, ANIM BEHAV, V55, P799, DOI 10.1006/anbe.1997.0663; Gelperin A, 2008, J CHEM ECOL, V34, P928, DOI 10.1007/s10886-008-9483-6; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Kastelein RA, 2000, MAR MAMMAL SCI, V16, P46, DOI 10.1111/j.1748-7692.2000.tb00903.x; KOEHLER AE, 1990, P 14 VERT PEST C; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Linhart Samuel B., 1992, Proceedings of the Vertebrate Pest Conference, V15, P386; MCDONALD I, 2007, 6 INT C FERT CONTR W; Mott D. F., 1988, P VERT PEST C, V13, P301; Muirhead S, 2006, WILDLIFE RES, V33, P131, DOI 10.1071/WR04032; NEWSOME AE, 1975, Q REV BIOL, V50, P389, DOI 10.1086/408742; Parsons MH, 2007, J WILDLIFE MANAGE, V71, P1225, DOI 10.2193/2006-096; Parsons MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010403; Parsons Michael H., 2007, BMC Ecology, V7, P13, DOI 10.1186/1472-6785-7-13; PFEIFER WK, 1982, P VERT PEST C, V10, P55; Pusenius J, 2002, ECOGRAPHY, V25, P481, DOI 10.1034/j.1600-0587.2002.250410.x; RAMP D, 2007, EVALUATION ACOUSTIC; Smith ME, 2000, ACTA AGR SCAND A-AN, V50, P304, DOI 10.1080/090647000750069502; SPANIER E, 1980, J APPL ECOL, V17, P287, DOI 10.2307/2402325; Staddon John E.R., 1993, Adaptive Behavior, V1, P421, DOI 10.1177/105971239300100402; STANKOWICH T, 2003, P R SOC B, V272, P2627; Talling JC, 1998, APPL ANIM BEHAV SCI, V58, P255, DOI 10.1016/S0168-1591(97)00142-1; Teilmann J, 2006, MAR MAMMAL SCI, V22, P240, DOI 10.1111/j.1748-7692.2006.00031.x; VerCauteren KC, 2005, WILDLIFE SOC B, V33, P1282, DOI 10.2193/0091-7648(2005)33[1282:EOAAFD]2.0.CO;2; Voipio HM, 1997, SCAND J LAB ANIM SCI, V24, P1; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8	39	26	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14549	10.1371/journal.pone.0014549	http://dx.doi.org/10.1371/journal.pone.0014549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267451	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500017
J	Lima, MA; Rudd, TR; de Farias, EHC; Ebner, LF; Gesteira, TF; de Souza, LM; Mendes, A; Cordula, CR; Martins, JRM; Hoppensteadt, D; Fareed, J; Sassaki, GL; Yates, EA; Tersariol, ILS; Nader, HB				Lima, Marcelo A.; Rudd, Timothy R.; de Farias, Eduardo H. C.; Ebner, Lyvia F.; Gesteira, Tarsis F.; de Souza, Lauro M.; Mendes, Aline; Cordula, Carolina R.; Martins, Joao R. M.; Hoppensteadt, Debra; Fareed, Jawed; Sassaki, Guilherme L.; Yates, Edwin A.; Tersariol, Ivarne L. S.; Nader, Helena B.			A New Approach for Heparin Standardization: Combination of Scanning UV Spectroscopy, Nuclear Magnetic Resonance and Principal Component Analysis	PLOS ONE			English	Article							OVERSULFATED CHONDROITIN SULFATE; ADVERSE CLINICAL EVENTS; BOVINE CRUDE HEPARIN; BENZYL ALCOHOL; CONTAMINANT; GLYCOSAMINOGLYCANS; NMR; SPECTRA	The year 2007 was marked by widespread adverse clinical responses to heparin use, leading to a global recall of potentially affected heparin batches in 2008. Several analytical methods have since been developed to detect impurities in heparin preparations; however, many are costly and dependent on instrumentation with only limited accessibility. A method based on a simple UV-scanning assay, combined with principal component analysis (PCA), was developed to detect impurities, such as glycosaminoglycans, other complex polysaccharides and aromatic compounds, in heparin preparations. Results were confirmed by NMR spectroscopy. This approach provides an additional, sensitive tool to determine heparin purity and safety, even when NMR spectroscopy failed, requiring only standard laboratory equipment and computing facilities.	[Lima, Marcelo A.; de Farias, Eduardo H. C.; Ebner, Lyvia F.; Gesteira, Tarsis F.; Mendes, Aline; Cordula, Carolina R.; Martins, Joao R. M.; Tersariol, Ivarne L. S.; Nader, Helena B.] Univ Fed Sao Paulo, Dept Bioquim, Disciplina Biol Mol, Sao Paulo, Brazil; [Rudd, Timothy R.; Yates, Edwin A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Hoppensteadt, Debra; Fareed, Jawed] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; [de Souza, Lauro M.; Sassaki, Guilherme L.] Univ Fed Parana, Dept Bioquim & Biol Mol, Lab Quim Carboidratos, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal de Sao Paulo (UNIFESP); University of Liverpool; Loyola University Chicago; Universidade Federal do Parana	Lima, MA (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Disciplina Biol Mol, Sao Paulo, Brazil.	hbnader.bioq@epm.br	Rudd, Tim/M-6129-2019; Yates, Edwin A/I-4808-2013; Lima, Marcelo/E-6841-2012; Nader, Helena Bonciani/D-9253-2012; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; Martins, João Roberto M/J-6042-2015; Souza, Lauro/AAE-3273-2019; Martins, João Roberto/AAC-6063-2021; Sassaki, Guilherme/AAM-1112-2020	Rudd, Tim/0000-0003-4434-0333; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; Martins, João Roberto M/0000-0002-0204-3552; Souza, Lauro/0000-0001-9166-2146; Martins, João Roberto/0000-0002-0204-3552; Sassaki, Guilherme/0000-0001-7420-168X; NADER, HELENA/0000-0002-7569-2166; Yates, Edwin/0000-0001-9365-5433	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) www.fapesp.br, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) www.capes.gov.br and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASU B, 1987, LANCET, V1, P1088; CEBULA TA, 1984, INFECT IMMUN, V44, P91, DOI 10.1128/IAI.44.1.91-96.1984; de Micalizzi YC, 1998, TALANTA, V47, P525, DOI 10.1016/S0039-9140(98)00080-0; DIETRICH CP, 1980, MECHANISM SACCHARIDE, P317; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; GERSHANIK J, 1982, NEW ENGL J MED, V307, P1384, DOI 10.1056/NEJM198211253072206; GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7; Guerrini M, 2001, SEMIN THROMB HEMOST, V27, P473, DOI 10.1055/s-2001-17958; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Guerrini M, 2009, THROMB HAEMOSTASIS, V102, P907, DOI 10.1160/TH09-02-0079; Guerrini M, 2009, P NATL ACAD SCI USA, V106, P16956, DOI 10.1073/pnas.0906861106; HERMANN K, 1994, ALLERGY, V49, P569, DOI 10.1111/j.1398-9995.1994.tb01131.x; HOLME KR, 1989, CARBOHYD RES, V186, P301, DOI 10.1016/0008-6215(89)84044-3; HOVINGH P, 1986, BIOCHEM J, V237, P573, DOI 10.1042/bj2370573; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Keire DA, 2010, J PHARMACEUT BIOMED, V51, P921, DOI 10.1016/j.jpba.2009.10.017; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Laux V, 2009, THROMB HAEMOSTASIS, V102, P892, DOI 10.1160/TH09-02-0134; Levieux A, 2001, J IMMUNOASS IMMUNOCH, V22, P323, DOI 10.1081/IAS-100107398; LINDAHL U, 1977, FED PROC, V36, P19; Liverani L, 2009, THROMB HAEMOSTASIS, V102, P846, DOI 10.1160/TH09-01-0064; MCEWEN I, 2008, PHARMEUROPA BIO, V1, P31; McEwen I, 2009, J PHARMACEUT BIOMED, V49, P816, DOI 10.1016/j.jpba.2008.12.012; MCGEOWN MG, 1955, J CLIN PATHOL, V8, P247, DOI 10.1136/jcp.8.3.247; McKee J, 2010, J CLIN PHARMACOL, V50, P1159, DOI 10.1177/0091270009355158; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Nader H. B., 1989, HEPARIN CHEM BIOL PR, P81; NADER HB, 1988, CARBOHYD RES, V184, P292, DOI 10.1016/0008-6215(88)80034-X; Pan J, 2010, J BIOL CHEM, V285, P22964, DOI 10.1074/jbc.M109.063735; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; PERLIN AS, 1971, CARBOHYD RES, V18, P185, DOI 10.1016/S0008-6215(00)80341-9; Rivera V, 2002, J PHARMACEUT BIOMED, V29, P443, DOI 10.1016/S0731-7085(02)00084-5; Rudd TR, 2008, CARBOHYD RES, V343, P2184, DOI 10.1016/j.carres.2007.12.019; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; Rudd TR, 2009, THROMB HAEMOSTASIS, V102, P874, DOI 10.1160/TH08-12-0797; Rudd TR, 2009, GLYCOBIOLOGY, V19, P52, DOI 10.1093/glycob/cwn103; Viskov C, 2009, CLIN APPL THROMB-HEM, V15, P395, DOI 10.1177/1076029609338710; Zhang ZQ, 2009, J PHARM SCI-US, V98, P4017, DOI 10.1002/jps.21729; 2009, PHARMACOPEIAL FORUM, V35	40	25	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15970	10.1371/journal.pone.0015970	http://dx.doi.org/10.1371/journal.pone.0015970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267460	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500033
J	Stieler, JT; Bullmann, T; Kohl, F; Toien, O; Bruckner, MK; Hartig, W; Barnes, BM; Arendt, T				Stieler, Jens T.; Bullmann, Torsten; Kohl, Franziska; Toien, Oivind; Brueckner, Martina K.; Haertig, Wolfgang; Barnes, Brian M.; Arendt, Thomas			The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; CYCLIN-DEPENDENT KINASE-5; ALZHEIMERS-DISEASE; PROTEIN-TAU; MICROTUBULE-BINDING; GROUND-SQUIRRELS; SELF-AGGREGATION; MOUSE-BRAIN; NEURODEGENERATIVE DISEASES; ABNORMAL PHOSPHORYLATION	Abnormal phosphorylation and aggregation of tau protein are hallmarks of a variety of neurological disorders, including Alzheimer's disease (AD). Increased tau phosphorylation is assumed to represent an early event in pathogenesis and a pivotal aspect for aggregation and formation of neurofibrillary tangles. However, the regulation of tau phosphorylation in vivo and the causes for its increased stage of phosphorylation in AD are still not well understood, a fact that is primarily based on the lack of adequate animal models. Recently we described the reversible formation of highly phosphorylated tau protein in hibernating European ground squirrels. Hence, mammalian hibernation represents a model system very well suited to study molecular mechanisms of both tau phosphorylation and dephosphorylation under in vivo physiological conditions. Here, we analysed the extent and kinetics of hibernation-state dependent tau phosphorylation in various brain regions of three species of hibernating mammals: arctic ground squirrels, Syrian hamsters and black bears. Overall, tau protein was highly phosphorylated in torpor states and phosphorylation levels decreased after arousal in all species. Differences between brain regions, hibernation-states and phosphosites were observed with respect to degree and kinetics of tau phosphorylation. Furthermore, we tested the phosphate net turnover of tau protein to analyse potential alterations in kinase and/or phosphatase activities during hibernation. Our results demonstrate that the hibernation-state dependent phosphorylation of tau protein is specifically regulated but involves, in addition, passive, temperature driven regulatory mechanisms. By determining the activity-state profile for key enzymes of tau phosphorylation we could identify kinases potentially involved in the differentially regulated, reversible tau phosphorylation that occurs during hibernation. We show that in black bears hibernation is associated with conformational changes of highly phosphorylated tau protein that are typically related to neuropathological alterations. The particular hibernation characteristics of black bears with a continuous torpor period and an only slightly decreased body temperature, therefore, potentially reflects the limitations of this adaptive reaction pattern and, thus, might indicate a transitional state of a physiological process.	[Stieler, Jens T.; Bullmann, Torsten; Brueckner, Martina K.; Arendt, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, Leipzig, Germany; [Stieler, Jens T.] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Univ Med Ctr, Mainz, Germany; [Kohl, Franziska; Toien, Oivind; Barnes, Brian M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Pathophysiol Neuroglia, Leipzig, Germany	Leipzig University; Johannes Gutenberg University of Mainz; University of Alaska System; University of Alaska Fairbanks; Leipzig University	Stieler, JT (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, Leipzig, Germany.	jens.stieler@gmx.de	Arendt, Thomas/C-8747-2012; Stieler, Jens T/A-5111-2017; Brückner, Martina . K./A-5201-2017	Stieler, Jens T/0000-0002-3770-3258; Toien, Oivind/0000-0001-5967-2483; Arendt, Thomas/0000-0003-4553-1625	Medical Faculty of the University of Leipzig [formel.1-51]; Interdisciplinary Center for Clinical Research at the University of Leipzig [IZKF-C1]; National Science Foundation; U.S. Army Medical Research [W81XWH-06-1-0121]; Material Command	Medical Faculty of the University of Leipzig; Interdisciplinary Center for Clinical Research at the University of Leipzig; National Science Foundation(National Science Foundation (NSF)); U.S. Army Medical Research(United States Department of DefenseUS Army Research Laboratory (ARL)); Material Command	This study was supported by a grant from the Medical Faculty of the University of Leipzig (formel.1-51) to J.T. Stieler, a grant from the Interdisciplinary Center for Clinical Research at the University of Leipzig (IZKF-C1) to T. Arendt, and by grants from the National Science Foundation and Contract W81XWH-06-1-0121, from the U.S. Army Medical Research, and Material Command to B.M. Barnes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Bielska AA, 2006, BIOCHEMISTRY-US, V45, P5527, DOI 10.1021/bi052662c; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Chohan MO, 2005, J NEURAL TRANSM, V112, P1035, DOI 10.1007/s00702-004-0241-9; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P629, DOI 10.1097/00005072-198811000-00006; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Devous MD, 2002, EUR J NUCL MED MOL I, V29, P1685, DOI 10.1007/s00259-002-0967-2; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Du JT, 2007, FEBS J, V274, P5012, DOI 10.1111/j.1742-4658.2007.06018.x; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gartner U, 1998, NEUROBIOL AGING, V19, P535, DOI 10.1016/S0197-4580(98)00094-3; Gasparini L, 2003, TRENDS NEUROSCI, V26, P404, DOI 10.1016/S0166-2236(03)00163-2; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hartig W, 2007, EUR J NEUROSCI, V25, P69, DOI 10.1111/j.1460-9568.2006.05250.x; Haley AP, 2006, MAGN RESON IMAGING, V24, P715, DOI 10.1016/j.mri.2005.12.020; Heininger K, 2000, REV NEUROSCIENCE, V11, P213; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; Ikeda Y, 2007, FEBS LETT, V581, P891, DOI 10.1016/j.febslet.2007.01.064; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Iqbal K, 2005, ACTA NEUROPATHOL, V109, P25, DOI 10.1007/s00401-004-0951-y; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kim YK, 2003, J NUCL MED, V44, P1006; King ME, 2005, BBA-MOL BASIS DIS, V1739, P260, DOI 10.1016/j.bbadis.2004.06.019; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Long RA, 2007, J WILDLIFE MANAGE, V71, P1375, DOI 10.2193/2006-399; LYMAN CP, 1948, J EXP ZOOL, V109, P55, DOI 10.1002/jez.1401090105; MacDonald JA, 2005, INT J BIOCHEM CELL B, V37, P679, DOI 10.1016/j.biocel.2004.05.023; MERCKEN M, 1992, ACTA NEUROPATHOL, V84, P265, DOI 10.1007/BF00227819; Millesi E, 2001, J BIOL RHYTHM, V16, P264, DOI 10.1177/074873001129001971; NELSON RA, 1975, MAYO CLIN PROC, V50, P141; NELSON RA, 1973, MAYO CLIN PROC, V48, P733; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; Oklejewicz M, 2001, J COMP PHYSIOL B, V171, P431; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Stieler J.T., 2008, HYPOMETABOLISM ANIMA, P133; Stieler JT, 2009, J NEURAL TRANSM, V116, P345, DOI 10.1007/s00702-008-0181-x; Strijkstra AM, 2003, NEUROSCI LETT, V344, P29, DOI 10.1016/S0304-3940(03)00399-9; Su B, 2008, J NEUROCHEM, V105, P2098, DOI 10.1111/j.1471-4159.2008.05294.x; Swaab DF, 2003, ALZ DIS ASSOC DIS, V17, pS114, DOI 10.1097/00002093-200307004-00006; Toien O, 1999, FASEB J, V13, pA740; UEDA S, 1995, PHYSIOL BEHAV, V58, P653, DOI 10.1016/0031-9384(95)00095-Z; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x; Zhu XW, 2005, J NEUROSCI RES, V80, P862, DOI 10.1002/jnr.20526	85	76	76	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14530	10.1371/journal.pone.0014530	http://dx.doi.org/10.1371/journal.pone.0014530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267079	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500008
J	Tang, QQ; Jiang, DS; Shao, Z; Gomez, JMM; Schwarz, H				Tang, Qianqiao; Jiang, Dongsheng; Shao, Zhe; Gomez, Julia M. Martinez; Schwarz, Herbert			Species Difference of CD137 Ligand Signaling in Human and Murine Monocytes	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; RECEPTOR FAMILY; PROGENITOR CELLS; HUMAN 4-1BB; PROLIFERATION; DIFFERENTIATION; SURVIVAL; MEMBER; BLOOD; IDENTIFICATION	Background: Stimulation of CD137 ligand on human monocytes has been shown to induce DC differentiation, and these CD137L-DCs are more potent than classical DCs, in stimulating T cell responses in vitro. To allow an in vivo evaluation of the potency of CD137L-DCs in murine models we aimed at generating murine CD137L-DCs. Methodology/Principal Findings: When stimulated through CD137 ligand murine monocytes responded just as human monocytes with an increased adherence, morphological changes, proliferation and an increase in viable cell numbers. But CD137 ligand signaling did not induce expression of inflammatory cytokines and costimulatory molecules in murine monocytes and these cells had no T cell stimulatory activity. Murine monocytes did not differentiate to inflammatory DCs upon CD137 ligand signaling. Furthermore, while CD137 ligand signaling induces maturation of human immature classical DCs it failed to do so with murine immature classical DCs. Conclusions/Significance: These data demonstrate that both human and murine monocytes become activated by CD137 ligand signaling but only human and not murine monocytes differentiate to inflammatory DCs.	[Tang, Qianqiao; Jiang, Dongsheng; Shao, Zhe; Gomez, Julia M. Martinez; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Tang, Qianqiao; Schwarz, Herbert] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117595, Singapore; [Tang, Qianqiao; Jiang, Dongsheng; Shao, Zhe; Gomez, Julia M. Martinez; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Tang, QQ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	phssh@nus.edu.sg	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671	Singapore Immunology Network [SIgN 09-022]	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant (SIgN 09-022) from the Singapore Immunology Network (http://www.sign.a-star.edu.sg/) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; Baessler T, 2010, BLOOD, V115, P3058, DOI 10.1182/blood-2009-06-227934; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Ju SW, 2009, INT IMMUNOL, V21, P1135, DOI 10.1093/intimm/dxp077; Ju SW, 2003, HYBRIDOMA HYBRIDOM, V22, P333, DOI 10.1089/153685903322538872; Kang YJ, 2007, NAT IMMUNOL, V8, P601, DOI 10.1038/ni1471; Kim DK, 2009, EUR J IMMUNOL, V39, P2617, DOI 10.1002/eji.200939292; Kim YJ, 2002, J HEMATOTH STEM CELL, V11, P895, DOI 10.1089/152581602321080556; KWAJAH MMS, 2010, EUR J IMMUNOL; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Quek BZ, 2010, MOL IMMUNOL, V47, P1839, DOI 10.1016/j.molimm.2009.11.010; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; SETAREH M, 1995, GENE, V164, P311, DOI 10.1016/0378-1119(95)00349-B; Shao Z, 2008, MOL IMMUNOL, V45, P3990, DOI 10.1016/j.molimm.2008.05.028; Thomas-Kaskel AK, 2007, INT J CANCER, V121, P467, DOI 10.1002/ijc.22859; THUM E, 2009, BIOSCIENCE S, V1, P336; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Zhang AL, 2007, BLOOD, V110, P2484, DOI 10.1182/blood-2007-02-076364	32	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16129	10.1371/journal.pone.0016129	http://dx.doi.org/10.1371/journal.pone.0016129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264248	Green Submitted, Green Published, gold			2022-12-27	WOS:000286516500031
J	Bergstrom, HC; McDonald, CG; Johnson, LR				Bergstrom, Hadley C.; McDonald, Craig G.; Johnson, Luke R.			Pavlovian Fear Conditioning Activates a Common Pattern of Neurons in the Lateral Amygdala of Individual Brains	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-A; MEMORY; CIRCUITS; RAT	Understanding the physical encoding of a memory (the engram) is a fundamental question in neuroscience. Although it has been established that the lateral amygdala is a key site for encoding associative fear memory, it is currently unclear whether the spatial distribution of neurons encoding a given memory is random or stable. Here we used spatial principal components analysis to quantify the topography of activated neurons, in a select region of the lateral amygdala, from rat brains encoding a Pavlovian conditioned fear memory. Our results demonstrate a stable, spatially patterned organization of amygdala neurons are activated during the formation of a Pavlovian conditioned fear memory. We suggest that this stable neuronal assembly constitutes a spatial dimension of the engram.	[Bergstrom, Hadley C.; Johnson, Luke R.] Uniformed Serv Univ USU, Sch Med, Bethesda, MD USA; [Bergstrom, Hadley C.; Johnson, Luke R.] Ctr Neurosci & Regenerat Med CNRM, Rockville, MD USA; [McDonald, Craig G.] George Mason Univ, Fairfax, VA 22030 USA; [Bergstrom, Hadley C.; Johnson, Luke R.] Ctr Study Traumat Stress CSTS, Bethesda, MD USA	George Mason University	Bergstrom, HC (corresponding author), Uniformed Serv Univ USU, Sch Med, Bethesda, MD USA.	LukeJohnsonPhD@gmail.com	Bergstrom, Hadley/S-1178-2019; McDonald, Craig/H-7390-2013	Bergstrom, Hadley/0000-0003-3677-1619; Johnson PhD, Luke R/0000-0002-5088-1788	Center for the Study of Traumatic Stress (CSTS); Uniformed Services University (USU) [G188KY]	Center for the Study of Traumatic Stress (CSTS); Uniformed Services University (USU)	The authors are grateful to the Center for the Study of Traumatic Stress (CSTS) and the Uniformed Services University (USU) G188KY for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom HC, 2008, SYNAPSE, V62, P31, DOI 10.1002/syn.20467; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DESMITH MJ, 2009, GEOSPATIAL ANAL MATA; Doron NN, 1999, J COMP NEUROL, V412, P383; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Johnson LR, 2004, ANATOMY FEAR MICROCI; Johnson LR, 2009, FRONT NEUROSCI-SWITZ, V3, P198, DOI 10.3389/neuro.01.027.2009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCDONALD CG, 2010, PSYCHOPHYSIOLOGY; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nakamura NH, 2010, NEUROSCIENCE, V166, P994, DOI 10.1016/j.neuroscience.2009.12.069; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Radley JJ, 2007, BRAIN RES, V1134, P87, DOI 10.1016/j.brainres.2006.11.045; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2008, LEARN MEMORY, V15, P55, DOI 10.1101/lm.746808; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Veening JG, 2009, NEUROSCIENCE, V163, P1046, DOI 10.1016/j.neuroscience.2009.06.064	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e15698	10.1371/journal.pone.0015698	http://dx.doi.org/10.1371/journal.pone.0015698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LX	21264324	Green Published, Green Submitted, gold			2022-12-27	WOS:000286514300003
J	Iacob, RE; Zhang, JM; Gray, NS; Engen, JR				Iacob, Roxana E.; Zhang, Jianming; Gray, Nathanael S.; Engen, John R.			Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; TYROSINE KINASE; HYDROGEN-EXCHANGE; IN-VITRO; C-ABL; SELECTIVE INHIBITOR; CRYSTAL-STRUCTURE; T315I MUTANT	Abl kinase inhibitors targeting the ATP binding pocket are currently employed as potent anti-leukemogenic agents but drug resistance has become a significant clinical limitation. Recently, a compound that binds to the myristate pocket of Abl (GNF-5) was shown to act cooperatively with nilotinib, an ATP-competitive inhibitor to target the recalcitrant "T315I" gatekeeper mutant of Bcr-Abl. To uncover an explanation for how drug binding at a distance from the kinase active site could lead to inhibition and how inhibitors could combine their effects, hydrogen exchange mass spectrometry (HX MS) was employed to monitor conformational effects in the presence of both dasatinib, a clinically approved ATP-site inhibitor, and GNF-5. While dasatinib binding to wild type Abl clearly influenced Abl conformation, no binding was detected between dasatinib and T315I. GNF-5, however, elicited the same conformational changes in both wild type and T315I, including changes to dynamics within the ATP site located approximately 25 A from the site of GNF-5 interaction. Simultaneous binding of dasatinib and GNF-5 to T315I caused conformational and/or dynamics changes in Abl such that effects of dasatinib on T315I were the same as when it bound to wild type Abl. These results provide strong biophysical evidence that allosteric interactions play a role in Abl kinase downregulation and that targeting sites outside the ATP binding site can provide an important pharmacological tool to overcome mutations that cause resistance to ATP-competitive inhibitors.	[Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Zhang, Jianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Boston, MA USA; [Zhang, Jianming; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Iacob, RE (corresponding author), Pfizer Inc, Boston, MA USA.	j.engen@neu.edu		Engen, John R./0000-0002-6918-9476	NIH [R01-GM070590]; Novartis Institute of Biomedical Research; Waters Corporation; NATIONAL CANCER INSTITUTE [R01CA130876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institute of Biomedical Research; Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported with funding from the NIH: R01-GM070590 (JRE), the Novartis Institute of Biomedical Research (NSG), and a research collaboration with the Waters Corporation (JRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Dharmasiri K, 1996, ANAL CHEM, V68, P2340, DOI 10.1021/ac9601526; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Giles FJ, 2005, CURR MOL MED, V5, P615, DOI 10.2174/156652405774641115; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Huang WS, 2009, J MED CHEM, V52, P4743, DOI 10.1021/jm900166t; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Jabbour E, 2006, CURR OPIN ONCOL, V18, P578, DOI 10.1097/01.cco.0000245314.97638.d3; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; KORNBERG A, 1951, J BIOL CHEM, V189, P123; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Morgan CR, 2009, CURR PROTOC PROTEIN, P11; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Noronha G, 2008, CURR TOP MED CHEM, V8, P905, DOI 10.2174/156802608784911635; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2010, BLOOD, V115, P4206, DOI 10.1182/blood-2009-11-251751; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x	46	55	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15929	10.1371/journal.pone.0015929	http://dx.doi.org/10.1371/journal.pone.0015929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264348	gold, Green Published, Green Submitted			2022-12-27	WOS:000286513100018
J	Ravi, D; Chen, YD; Karia, B; Brown, A; Gu, TT; Li, J; Carey, MS; Hennessy, BT; Bishop, AJR				Ravi, Dashnamoorthy; Chen, Yidong; Karia, Bijal; Brown, Adam; Gu, Ting Ting; Li, Jie; Carey, Mark S.; Hennessy, Bryan T.; Bishop, Alexander J. R.			14-3-3 sigma Expression Effects G2/M Response to Oxygen and Correlates with Ovarian Cancer Metastasis	PLOS ONE			English	Article							CELL-CYCLE; BREAST-CANCER; DNA-DAMAGE; TUMOR OXYGENATION; MULTIPLE SITES; HUMAN CDC2; SOFT-AGAR; PROTEIN; CARCINOMA; GROWTH	Background: In vitro cell culture experiments with primary cells have reported that cell proliferation is retarded in the presence of ambient compared to physiological O-2 levels. Cancer is primarily a disease of aberrant cell proliferation, therefore, studying cancer cells grown under ambient O-2 may be undesirable. To understand better the impact of O-2 on the propagation of cancer cells in vitro, we compared the growth potential of a panel of ovarian cancer cell lines under ambient (21%) or physiological (3%) O-2. Principal Findings: Our observations demonstrate that similar to primary cells, many cancer cells maintain an inherent sensitivity to O-2, but some display insensitivity to changes in O-2 concentration. Further analysis revealed an association between defective G2/M cell cycle transition regulation and O-2 insensitivity resultant from overexpression of 14-3-3 sigma. Targeting 14-3-3 sigma overexpression with RNAi restored O-2 sensitivity in these cell lines. Additionally, we found that metastatic ovarian tumors frequently overexpress 14-3-3 sigma, which in conjunction with phosphorylated RB, results in poor prognosis. Conclusions: Cancer cells show differential proliferative sensitivity to changes in O-2 concentration. Although a direct link between O-2 insensitivity and metastasis was not determined, this investigation showed that an O-2 insensitive phenotype in cancer cells to correlate with metastatic tumor progression.	[Ravi, Dashnamoorthy; Chen, Yidong; Karia, Bijal; Brown, Adam; Gu, Ting Ting; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Ravi, Dashnamoorthy; Karia, Bijal; Brown, Adam; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Li, Jie; Carey, Mark S.; Hennessy, Bryan T.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA; [Carey, Mark S.] Univ British Columbia, Div Gynecol Oncol, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Hennessy, Bryan T.] Beaumont Hosp, Dept Med Oncol, Dublin 9, Ireland	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of British Columbia	Ravi, D (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	bishopa@uthscsa.edu	Dashnamoorthy, Ravi/B-8540-2013	Dashnamoorthy, Ravi/0000-0002-6108-2076; Hennessy, Bryan/0000-0002-7871-6477; Bishop, Alexander/0000-0002-5742-4387	NIEHS [K22-ES12264]; Max and Minnie Tomerlin Voelcker Fund; Robert and Janice McNair Foundation; American Society of Clinical Oncology (ASCO); Cancer FoundationScience Foundation Ireland (SFI)/Health Research Board (HRB (Ireland)); DOD CDRMP [BC093931]; NIA [T32AG021890]; NIH/NCI cancer center [P30 CA054174-17]; NIH/NCRR CTSA [1UL1RR025767]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Max and Minnie Tomerlin Voelcker Fund; Robert and Janice McNair Foundation; American Society of Clinical Oncology (ASCO); Cancer FoundationScience Foundation Ireland (SFI)/Health Research Board (HRB (Ireland))(Science Foundation Ireland); DOD CDRMP; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCRR CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIEHS (K22-ES12264) and a Voelcker Fund Young Investigator Award from the Max and Minnie Tomerlin Voelcker Fund to A.J.R. Bishop. Kleberg Center for Molecular Markers at the M.D. Anderson Cancer Center, The M.D. Anderson Cancer Center Physician Scientist Program, the McNair Scholars Program supported by the Robert and Janice McNair Foundation and an American Society of Clinical Oncology (ASCO) cancer foundation Career Development Award (CDA), Cancer Foundation and by a Science Foundation Ireland (SFI)/Health Research Board (HRB (Ireland)) Translational Research Award (TRA), all to B.T. Hennessy. B. Karia is supported by DOD CDRMP Breast Cancer Research Program Predoctoral Traineeship Award (BC093931). A. Brown is supported by NIA T32 training grant (T32AG021890). Y. Chen is supported by NIH/NCI cancer center grant (P30 CA054174-17) and NIH/NCRR CTSA grant (1UL1RR025767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaiz-Pena GN, 2009, CLIN CANCER RES, V15, P2971, DOI 10.1158/1078-0432.CCR-08-2525; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; BALIN AK, 1978, J CELL BIOL, V78, P390, DOI 10.1083/jcb.78.2.390; Berry L D, 1996, Prog Cell Cycle Res, V2, P99; BRIZEL DM, 1995, INT J RADIAT ONCOL, V32, P1121, DOI 10.1016/0360-3016(95)00106-9; Brown JM, 1998, CANCER RES, V58, P1408; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Carrera S, 2010, J BIOL CHEM, V285, P13658, DOI 10.1074/jbc.M109.062562; Chavez-Munoz C, 2008, J CELL BIOCHEM, V104, P2165, DOI 10.1002/jcb.21774; Cheng L, 2004, CLIN CANCER RES, V10, P3064, DOI 10.1158/1078-0432.CCR-03-0652; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Eguchi T, 2007, ONCOGENE, V26, P509, DOI 10.1038/sj.onc.1209810; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Ghahary A, 2005, J INVEST DERMATOL, V124, P170, DOI 10.1111/j.0022-202X.2004.23521.x; Ghahary A, 2004, J INVEST DERMATOL, V122, P1188, DOI 10.1111/j.0022-202X.2004.22519.x; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; GUPTA V, 1982, CANCER RES, V42, P1005; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HORNSBY PJ, 2003, SCI AGING KNOWLEDGE, pPE21; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ito Y, 2003, CANCER LETT, V200, P161, DOI 10.1016/S0304-3835(03)00282-9; Kaldis P, 2005, CELL CYCLE, V4, P1491, DOI 10.4161/cc.4.11.2124; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KISHIMOTO T, 1994, INT J DEV BIOL, V38, P185; Lam E, 2005, J INVEST DERMATOL, V125, P230, DOI 10.1111/j.0022-202X.2005.23765.x; Laser H, 1937, BIOCHEM J, V31, P1671, DOI 10.1042/bj0311671; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Li ZM, 2009, AM J TRANSL RES, V1, P326; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Magagnin MG, 2006, DRUG RESIST UPDATE, V9, P185, DOI 10.1016/j.drup.2006.07.002; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; Nakayama H, 2005, PATHOL INT, V55, P707, DOI 10.1111/j.1440-1827.2005.01900.x; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Okada T, 2006, ANTICANCER RES, V26, P3105; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Payton M, 2006, CANCER RES, V66, P4299, DOI 10.1158/0008-5472.CAN-05-2507; Perathoner A, 2005, CLIN CANCER RES, V11, P3274, DOI 10.1158/1078-0432.CCR-04-2207; Poot M, 1996, EXP CELL RES, V222, P262, DOI 10.1006/excr.1996.0033; POOT M, 1988, CYTOMETRY, V9, P332, DOI 10.1002/cyto.990090410; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Quayle SN, 2007, CANCER LETT, V254, P137, DOI 10.1016/j.canlet.2007.03.003; Ramirez PT, 2008, GYNECOL ONCOL, V108, P68, DOI 10.1016/j.ygyno.2007.08.071; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Ravi D, 1999, HISTOPATHOLOGY, V34, P241, DOI 10.1046/j.1365-2559.1999.00575.x; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shibuya EK, 2003, CELL CYCLE, V2, P39, DOI 10.4161/cc.2.1.291; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; SRIDHAR KS, 1983, CANCER RES, V43, P4629; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sullivan M, 2006, MOL HUM REPROD, V12, P653, DOI 10.1093/molehr/gal081; Tanaka K, 2004, INT J ONCOL, V25, P1591; TARNOWSKI BI, 1993, PEDIATR PATHOL, V13, P249, DOI 10.3109/15513819309048211; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Treacher DF, 1998, BRIT MED J, V317, P1302, DOI 10.1136/bmj.317.7168.1302; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; van Hemert MJ, 2004, J CELL SCI, V117, P1411, DOI 10.1242/jcs.00990; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yi B, 2009, J CELL BIOCHEM, V106, P858, DOI 10.1002/jcb.22051; Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663	71	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15864	10.1371/journal.pone.0015864	http://dx.doi.org/10.1371/journal.pone.0015864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249227	Green Published, Green Submitted, gold			2022-12-27	WOS:000286513100015
J	Li, Y; Cang, M; Lee, AS; Zhang, KH; Liu, DJ				Li, Yang; Cang, Ming; Lee, Andrew Stephen; Zhang, Kehua; Liu, Dongjun			Reprogramming of Sheep Fibroblasts into Pluripotency under a Drug-Inducible Expression of Mouse-Derived Defined Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CULTURE-MEDIUM; GENERATION; ESTABLISHMENT; LINES; SYSTEM	Animal embryonic stem cells (ESCs) provide powerful tool for studies of early embryonic development, gene targeting, cloning, and regenerative medicine. However, the majority of attempts to establish ESC lines from large animals, especially ungulate mammals have failed. Recently, another type of pluripotent stem cells, known as induced pluripotent stem cells (iPSCs), have been successfully generated from mouse, human, monkey, rat and pig. In this study we show sheep fibroblasts can be reprogrammed to pluripotency by defined factors using a drug-inducible system. Sheep iPSCs derived in this fashion have a normal karyotype, exhibit morphological features similar to those of human ESCs and express AP, Oct4, Sox2, Nanog and the cell surface marker SSEA-4. Pluripotency of these cells was further confirmed by embryoid body (EB) and teratoma formation assays which generated derivatives of all three germ layers. Our results also show that the substitution of knockout serum replacement (KSR) with fetal bovine serum in culture improves the reprogramming efficiency of sheep iPSCs. Generation of sheep iPSCs places sheep on the front lines of large animal preclinical trials and experiments involving modification of animal genomes.	[Li, Yang] Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Beijing 100871, Peoples R China; [Cang, Ming; Liu, Dongjun] Inner Mongolia Univ, Coll Life Sci, Lab Anim Res Ctr, Hohhot, Peoples R China; [Lee, Andrew Stephen] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Zhang, Kehua] China Japan Friendship Hosp, Inst Clin Med, Dept Immun, Beijing, Peoples R China; [Li, Yang] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100871, Peoples R China	Peking University; Inner Mongolia University; Stanford University; China-Japan Friendship Hospital; Peking University	Li, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Beijing 100871, Peoples R China.	liyang@bjmu.edu.cn; nmliudongjun@sina.com	Lee, Andrew/GVU-2817-2022		Chinese National 863 Project [2008AA101005]	Chinese National 863 Project	The Chinese National 863 Project (2008AA101005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CAMPBELL KH, 1996, NATURE, P380; Dattena M, 2006, MOL REPROD DEV, V73, P31, DOI 10.1002/mrd.20378; Denning C, 2001, Cloning Stem Cells, V3, P221, DOI 10.1089/15362300152725945; DOETSCHMAN T, 1988, DEV BIOL, V127, P224, DOI 10.1016/0012-1606(88)90204-7; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee ST, 2006, FERTIL STERIL, V86, P1137, DOI 10.1016/j.fertnstert.2006.01.056; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li Y, 2010, CELL REPROGRAM, V12, P237, DOI 10.1089/cell.2009.0103; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Moore K, 1997, IN VITRO CELL DEV-AN, V33, P62; NOTARIANNI E, 1991, J REPROD FERTIL, P255; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TALBOT NC, 1995, MOL REPROD DEV, V42, P35, DOI 10.1002/mrd.1080420106; TALBOT NC, 1993, IN VITRO CELL DEV-AN, V29A, P543; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	37	70	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15947	10.1371/journal.pone.0015947	http://dx.doi.org/10.1371/journal.pone.0015947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253598	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900029
J	Sharma, J; Baguley, J; Bluhm, BA; Rowe, G				Sharma, Jyotsna; Baguley, Jeffrey; Bluhm, Bodil A.; Rowe, Gilbert			Do Meio- and Macrobenthic Nematodes Differ in Community Composition and Body Weight Trends with Depth?	PLOS ONE			English	Article							DEEP-SEA MEIOBENTHOS; SIZE DISTRIBUTIONS; ASSEMBLAGES; ATLANTIC	Nematodes occur regularly in macrobenthic samples but are rarely identified from them and are thus considered exclusively a part of the meiobenthos. Our study compares the generic composition of nematode communities and their individual body weight trends with water depth in macrobenthic (>250/300 mu m) samples from the deep Arctic (Canada Basin), Gulf of Mexico (GOM) and the Bermuda slope with meiobenthic samples (<45 mu m) from GOM. The dry weight per individual (mu g) of all macrobenthic nematodes combined showed an increasing trend with increasing water depth, while the dry weight per individual of the meiobenthic GOM nematodes showed a trend to decrease with increasing depth. Multivariate analyses showed that the macrobenthic nematode community in the GOM was more similar to the macrobenthic nematodes of the Canada Basin than to the GOM meiobenthic nematodes. In particular, the genera Enoploides, Crenopharynx, Micoletzkyia, Phanodermella were dominant in the macrobenthos and accounted for most of the difference. Relative abundance of nonselective deposit feeders (1B) significantly decreased with depth in macrobenthos but remained dominant in the meiobenthic community. The occurrence of a distinct assemblage of bigger nematodes of high dry weight per individual in the macrobenthos suggests the need to include nematodes in macrobenthic studies.	[Sharma, Jyotsna] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Baguley, Jeffrey] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Bluhm, Bodil A.] Univ Alaska Fairbanks, Inst Marine Sci, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Rowe, Gilbert] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Texas System; University of Texas at San Antonio (UTSA); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Alaska System; University of Alaska Fairbanks; Texas A&M University System	Sharma, J (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	Jyotsna.Sharma@UTSA.edu	Bluhm, Bodil/E-7165-2015	Bluhm, Bodil/0000-0002-4584-7796	Minerals Management Service of the United States Department [30991]; National Oceanic and Atmospheric Administration (NOAA); Museum of Comparative Zoology, Harvard University, Cambridge, MA	Minerals Management Service of the United States Department; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Museum of Comparative Zoology, Harvard University, Cambridge, MA	The collection of the samples in this work was supported by the Minerals Management Service of the United States Department of the Interior contract 30991 to Texas A&M University. This study was made possible by funding from National Oceanic and Atmospheric Administration (NOAA) Ocean Exploration and Arctic Ocean Diversity Census of Marine Life. Examination of the nematodes from the Bermuda Slope was made possible by an Ernst Mayr Travel grant from the Museum of Comparative Zoology, Harvard University, Cambridge, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley JG, 2004, LIMNOL OCEANOGR-METH, V2, P181, DOI 10.4319/lom.2004.2.181; Bazzanti M, 2000, ARCH HYDROBIOL, V148, P59; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; BOLAND GS, 1991, LIMNOL OCEANOGR, V36, P1015, DOI 10.4319/lo.1991.36.5.1015; CLARKE AH, 1969, SCIENCE, V166, P1033, DOI 10.1126/science.166.3908.1033; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Dinet A., 1985, PEUPLEMENTS PROFONDS, P121; ELEFTHERIOUS E, 2005, METHODS STUDY MARINE, P160; Escobar-Briones EG, 2008, DEEP-SEA RES PT II, V55, P2627, DOI 10.1016/j.dsr2.2008.07.012; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2002, MAR ECOL PROG SER, V225, P97, DOI 10.3354/meps225097; Hope W. D., 2005, Journal of Nematology, V37, P1; JENSEN P, 1988, DEEP-SEA RES, V35, P1173, DOI 10.1016/0198-0149(88)90008-8; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; Mare M. F., 1942, Journal of the Marine Biological Association Plymouth, V25, P517; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Moens T, 2004, NEMATOL MONOGR PERSP, V2, P529; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rowe GT, 1983, SEA, P97; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; Seinhorst J. W., 1959, Nematologica, V4, P67; Sharma Jyotsna, 2011, Marine Biodiversity, V41, P455, DOI 10.1007/s12526-010-0060-1; SHIRAYAMA Y, 1983, INT REV GES HYDROBIO, V68, P799, DOI 10.1002/iroh.3510680605; SOETAERT K, 1995, MAR ECOL PROG SER, V125, P171, DOI 10.3354/meps125171; Soetaert K, 2009, MAR ECOL PROG SER, V392, P123, DOI 10.3354/meps08202; Soltwedel T, 1996, J MAR BIOL ASSOC UK, V76, P327, DOI 10.1017/S0025315400030587; THIEL H, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P575; THIEL H, 1979, INT REV GES HYDROBIO, V60, P576; TIETJEN JH, 1989, DEEP-SEA RES, V36, P1579, DOI 10.1016/0198-0149(89)90059-9; WARWICK RM, 1984, OECOLOGIA, V61, P32, DOI 10.1007/BF00379085; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; WIESER W, 1960, LIMNOL OCEANOGR, V5, P121, DOI 10.4319/lo.1960.5.2.0121; Wieser W., 1953, ARK ZOOL, V2, P439	34	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14491	10.1371/journal.pone.0014491	http://dx.doi.org/10.1371/journal.pone.0014491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253595	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900001
J	Tessema, GT; Moretro, T; Snipen, L; Axelsson, L; Naterstad, K				Tessema, Girum Tadesse; Moretro, Trond; Snipen, Lars; Axelsson, Lars; Naterstad, Kristine			Global Transcriptional Analysis of Spontaneous Sakacin P-Resistant Mutant Strains of Listeria monocytogenes during Growth on Different Sugars	PLOS ONE			English	Article							CLASS-IIA BACTERIOCINS; PHOSPHOTRANSFERASE SYSTEM; ENTEROCOCCUS-FAECALIS; FITNESS COSTS; PEDIOCIN PA-1; PTS PERMEASE; GENE; PEPTIDE; SENSITIVITY; EXPRESSION	Subclass IIa bacteriocins have strong antilisterial activity and can control the growth of Listeria monocytogenes in food. However, L. monocytogenes may develop resistance towards such bacteriocins. In this follow-up study, the transcriptomes of a high level (L502-1) and a low level (L502-6) spontaneous sakacin P-resistant mutant strain of L. monocytogenes were compared to the wild-type (L502). The growth of the resistant strains was reduced on mannose but not affected on cellobiose and the transcriptomics was performed during growth on these sugars. The mannose phosphotransferase system (PTS) encoded by the mptACD operon (mpt) is known for transporting mannose and also act as a receptor to class IIa bacteriocins. The mpt was repressed in L502-1 and this is in accordance with abolition of the bacteriocin receptor with resistance to class IIa bacteriocins. In contrast, the mpt was induced in L502-6. Despite the induction of the mpt, L502-6 showed 1,000 times more resistance phenotype and reduced growth on mannose suggesting the mannose-PTS may not be functional in L502-6. The microarray data suggests the presence of other transcriptional responses that may be linked to the sakacin P resistance phenotype particularly in L502-6. Most of commonly regulated genes encode proteins involved in transport and energy metabolism. The resistant strains displayed shift in general carbon catabolite control possibly mediated by the mpt. Our data suggest that the resistant strains may have a reduced virulence potential. Growth sugar- and mutant-specific responses were also revealed. The two resistant strains also displayed difference in stability of the sakacin P resistance phenotype, growth in the presence of both the lytic bacteriophage P100 and activated charcoal. Taken together, the present study showed that a single time exposure to the class IIa bacteriocin sakacin P may elicit contrasting phenotypic and transcriptome responses in L. monocytogenes possibly through regulation of the mpt.	[Tessema, Girum Tadesse; Moretro, Trond; Axelsson, Lars; Naterstad, Kristine] Nofima Mat AS, As, Norway; [Tessema, Girum Tadesse; Snipen, Lars] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Nofima; Norwegian University of Life Sciences	Tessema, GT (corresponding author), Nofima Mat AS, As, Norway.	girum.tadesse@nofima.no	Moretro, Trond/AAZ-5689-2021	Moretro, Trond/0000-0001-5176-1158	Foundation for Research Levy on Agricultural Products	Foundation for Research Levy on Agricultural Products	This work was funded by the Foundation for Research Levy on Agricultural Products. TM, LA, and KN are employees at Nofima Mat AS. GTT was a Nofima Mat AS full-time employee at the time when this study was performed. Since GTT, TM, LA, and KN were employees of Nofima Mat AS when the experiments reported in this publication were carried out, Nofima Mat AS is considered by PLoS ONE to have funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Arous S, 2004, FEMS MICROBIOL LETT, V238, P37, DOI 10.1016/j.femsle.2004.07.014; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Carlton RM, 2005, REGUL TOXICOL PHARM, V43, P301, DOI 10.1016/j.yrtph.2005.08.005; Coffey A, 1996, APPL ENVIRON MICROB, V62, P1252, DOI 10.1128/AEM.62.4.1252-1256.1996; D'Angelis CEM, 2009, J FOOD SAFETY, V29, P636, DOI 10.1111/j.1745-4565.2009.00183.x; Dalet K, 2001, MICROBIOL-SGM, V147, P3263, DOI 10.1099/00221287-147-12-3263; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Dieterich G, 2006, NUCLEIC ACIDS RES, V34, pD402, DOI 10.1093/nar/gkj071; Drider D, 2006, MICROBIOL MOL BIOL R, V70, P564, DOI 10.1128/MMBR.00016-05; Dykes GA, 1998, LETT APPL MICROBIOL, V26, P5, DOI 10.1046/j.1472-765X.1998.00255.x; ELLIOTT J, 1978, MOL GEN GENET, V161, P1, DOI 10.1007/BF00266608; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Gravesen A, 2004, APPL ENVIRON MICROB, V70, P1669, DOI 10.1128/AEM.70.3.1669-1679.2004; Gravesen A, 2002, MICROBIOL-SGM, V148, P2361, DOI 10.1099/00221287-148-8-2361; Gravesen A, 2002, APPL ENVIRON MICROB, V68, P756, DOI 10.1128/AEM.68.2.756-764.2002; Guinane CM, 2005, J APPL MICROBIOL, V98, P1316, DOI 10.1111/j.1365-2672.2005.02552.x; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hinds J, 2002, METHOD MICROBIOL, V33, P83; Katla T, 2003, APPL ENVIRON MICROB, V69, P4431, DOI 10.1128/AEM.69.8.4431-4437.2003; Kim HJ, 2006, J BACTERIOL, V188, P179, DOI 10.1128/JB.188.1.179-190.2006; KJOS M, 2010, J BACTERIOL IN PRESS; Kjos M, 2009, MICROBIOL-SGM, V155, P2949, DOI 10.1099/mic.0.030015-0; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Larsen MH, 2006, MOL MICROBIOL, V61, P1622, DOI 10.1111/j.1365-2958.2006.05328.x; Liu D., 2008, HDB LISTERIA MONOCYT; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Martinez RCR, 2005, BRAZ J MICROBIOL, V36, P83, DOI 10.1590/S1517-83822005000100016; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Moretro T, 2005, RES MICROBIOL, V156, P949, DOI 10.1016/j.resmic.2005.05.005; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Naghmouchi K, 2007, FOOD MICROBIOL, V24, P718, DOI 10.1016/j.fm.2007.03.012; Nes IF, 2007, FOOD SCI BIOTECHNOL, V16, P675; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Opsata M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-224; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Ramnath M, 2000, APPL ENVIRON MICROB, V66, P3098, DOI 10.1128/AEM.66.7.3098-3101.2000; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; Rodriguez JM, 2002, CRIT REV FOOD SCI, V42, P91, DOI 10.1080/10408690290825475; RYSER TE, 2007, LISTERIA LISTERIOSIS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soni KA, 2010, FOODBORNE PATHOG DIS, V7, P427, DOI 10.1089/fpd.2009.0432; Stevens MJA, 2010, APPL ENVIRON MICROB, V76, P3748, DOI 10.1128/AEM.00073-10; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; Tessema GT, 2009, APPL ENVIRON MICROB, V75, P6973, DOI 10.1128/AEM.00608-09; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vadyvaloo V, 2004, MICROBIOL-SGM, V150, P3025, DOI 10.1099/mic.0.27059-0; Vadyvaloo V, 2002, APPL ENVIRON MICROB, V68, P5223, DOI 10.1128/AEM.68.11.5223-5230.2002; Vignolo G, 2000, CURR MICROBIOL, V41, P410, DOI 10.1007/s002840010159; Vu-Khac H, 2009, APPL ENVIRON MICROB, V75, P6671, DOI 10.1128/AEM.01104-09	60	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16192	10.1371/journal.pone.0016192	http://dx.doi.org/10.1371/journal.pone.0016192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253597	gold, Green Submitted, Green Published			2022-12-27	WOS:000286511900041
J	Trombetta, B; Cruciani, F; Sellitto, D; Scozzari, R				Trombetta, Beniamino; Cruciani, Fulvio; Sellitto, Daniele; Scozzari, Rosaria			A New Topology of the Human Y Chromosome Haplogroup E1b1 (E-P2) Revealed through the Use of Newly Characterized Binary Polymorphisms	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; MIGRATORY EVENTS; AFRICA; DIVERSITY; EVOLUTION; ORIGIN; TREE	Haplogroup E1b1, defined by the marker P2, is the most represented human Y chromosome haplogroup in Africa. A phylogenetic tree showing the internal structure of this haplogroup was published in 2008. A high degree of internal diversity characterizes this haplogroup, as well as the presence of a set of chromosomes undefined on the basis of a derived character. Here we make an effort to update the phylogeny of this highly diverse haplogroup by including seven mutations which have been newly discovered by direct resequencing. We also try to incorporate five previously-described markers which were not, however, reported in the 2008 tree. Additionally, during the process of mapping, we found that two previously reported SNPs required a new position on the tree. There are three key changes compared to the 2008 phylogeny. Firstly, haplogroup E-M2 (former E1b1a) and haplogroup E-M329 (former E1b1c) are now united by the mutations V38 and V100, reducing the number of E1b1 basal branches to two. The new topology of the tree has important implications concerning the origin of haplogroup E1b1. Secondly, within E1b1b1 (E-M35), two haplogroups (E-V68 and E-V257) show similar phylogenetic and geographic structure, pointing to a genetic bridge between southern European and northern African Y chromosomes. Thirdly, most of the E1b1b1* (E-M35*) paragroup chromosomes are now marked by defining mutations, thus increasing the discriminative power of the haplogroup for use in human evolution and forensics.	[Trombetta, Beniamino; Cruciani, Fulvio; Sellitto, Daniele; Scozzari, Rosaria] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Sellitto, Daniele] CNR, Ist Biol & Patol Mol, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Trombetta, B (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy.	rosaria.scozzari@uniroma1.it	Cruciani, Fulvio/G-6105-2012	Trombetta, Beniamino/0000-0001-8245-9437; Cruciani, Fulvio/0000-0002-6900-024X	Sapienza Universita di Roma; Grandi Progetti di Ateneo	Sapienza Universita di Roma; Grandi Progetti di Ateneo	This work was supported by the Sapienza Universita di Roma, Grandi Progetti di Ateneo (to R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Butler JM, 2005, FORENSIC DNA TYPING; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2008, AM J HUM BIOL, V20, P614, DOI 10.1002/ajhb.20790; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Ellis N, 2002, GENOME RES, V12, P339; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M., 2007, BIOTECHNIQUES, V43, pS16; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	21	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16073	10.1371/journal.pone.0016073	http://dx.doi.org/10.1371/journal.pone.0016073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253605	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511900039
J	Antunes, MS; Morey, KJ; Smith, JJ; Albrecht, KD; Bowen, TA; Zdunek, JK; Troupe, JF; Cuneo, MJ; Webb, CT; Hellinga, HW; Medford, JI				Antunes, Mauricio S.; Morey, Kevin J.; Smith, J. Jeff; Albrecht, Kirk D.; Bowen, Tessa A.; Zdunek, Jeffrey K.; Troupe, Jared F.; Cuneo, Matthew J.; Webb, Colleen T.; Hellinga, Homme W.; Medford, June I.			Programmable Ligand Detection System in Plants through a Synthetic Signal Transduction Pathway	PLOS ONE			English	Article							PERIPLASMIC BINDING-PROTEINS; COMPUTATIONAL DESIGN; ESCHERICHIA-COLI; ARABIDOPSIS; NOISE; PHOB; IDENTIFICATION; PERCEPTION; PHOSPHATE; EVOLUTION	Background: There is an unmet need to monitor human and natural environments for substances that are intentionally or unintentionally introduced. A long-sought goal is to adapt plants to sense and respond to specific substances for use as environmental monitors. Computationally re-designed periplasmic binding proteins (PBPs) provide a means to design highly sensitive and specific ligand sensing capabilities in receptors. Input from these proteins can be linked to gene expression through histidine kinase (HK) mediated signaling. Components of HK signaling systems are evolutionarily conserved between bacteria and plants. We previously reported that in response to cytokinin-mediated HK activation in plants, the bacterial response regulator PhoB translocates to the nucleus and activates transcription. Also, we previously described a plant visual response system, the de-greening circuit, a threshold sensitive reporter system that produces a visual response which is remotely detectable and quantifiable. Methodology/Principal Findings: We describe assembly and function of a complete synthetic signal transduction pathway in plants that links input from computationally re-designed PBPs to a visual response. To sense extracellular ligands, we targeted the computational re-designed PBPs to the apoplast. PBPs bind the ligand and develop affinity for the extracellular domain of a chemotactic protein, Trg. We experimentally developed Trg fusions proteins, which bind the ligand-PBP complex, and activate intracellular PhoR, the HK cognate of PhoB. We then adapted Trg-PhoR fusions for function in plants showing that in the presence of an external ligand PhoB translocates to the nucleus and activates transcription. We linked this input to the de-greening circuit creating a detector plant. Conclusions/Significance: Our system is modular and PBPs can theoretically be designed to bind most small molecules. Hence our system, with improvements, may allow plants to serve as a simple and inexpensive means to monitor human surroundings for substances such as pollutants, explosives, or chemical agents.	[Antunes, Mauricio S.; Morey, Kevin J.; Albrecht, Kirk D.; Bowen, Tessa A.; Zdunek, Jeffrey K.; Troupe, Jared F.; Webb, Colleen T.; Medford, June I.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Smith, J. Jeff; Cuneo, Matthew J.; Hellinga, Homme W.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Colorado State University; Duke University	Antunes, MS (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	June.Medford@colostate.edu	Antunes, Mauricio/AAC-8139-2020	Cuneo, Matthew/0000-0002-1475-6656	United States Defense Advanced Research Project Agency (DARPA, Defense Science Office); Office of Naval Research (United States, ONR)	United States Defense Advanced Research Project Agency (DARPA, Defense Science Office)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (United States, ONR)(Office of Naval Research)	This work was supported by grants to June Medford and Homme Hellinga from the United States Defense Advanced Research Project Agency (DARPA, Defense Science Office) and the Office of Naval Research (United States, ONR). Dr. J. Jeff Smith was at Duke University when this work was accomplished. His current employer, Precision Biosciences did not provide funds nor did it play any role in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allert M, 2004, P NATL ACAD SCI USA, V101, P7907, DOI 10.1073/pnas.0401309101; Antunes MS, 2006, PLANT BIOTECHNOL J, V4, P605, DOI 10.1111/j.1467-7652.2006.00205.x; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; De Lorimier RM, 2006, PROTEIN SCI, V15, P1936, DOI 10.1110/ps.062261606; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Gallagher SR, 1992, GUS PROTOCOLS USING; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Harper RJ, 2005, TALANTA, V67, P313, DOI 10.1016/j.talanta.2005.05.019; HUPPERT H, 2004, MAKING UK SAFER DETE, P1; Johnston J.M., 1999, CANINE DETECTION CAP, P1; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kant P, 2008, PLANT CELL ENVIRON, V31, P697, DOI 10.1111/j.1365-3040.2008.01779.x; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; KURY J, 1995, UCRLID120385 LAWR LI, P1; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Oxley JC, 2009, ASPECTS OF EXPLOSIVES DETECTION, P27, DOI 10.1016/B978-0-12-374533-0.00003-9; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Shaw AK, 2007, PROC SPIE, V6554, DOI 10.1117/12.723247; Sola M, 2006, ACTA CRYSTALLOGR D, V62, P1046, DOI 10.1107/S0907444906024541; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	39	74	76	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16292	10.1371/journal.pone.0016292	http://dx.doi.org/10.1371/journal.pone.0016292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283542	Green Published, gold			2022-12-27	WOS:000286661400040
J	Scarf, D; Miles, K; Sloan, A; Goulter, N; Hegan, M; Seid-Fatemi, A; Harper, D; Colombo, M				Scarf, Damian; Miles, Kirby; Sloan, Amanda; Goulter, Natalie; Hegan, Matt; Seid-Fatemi, Azade; Harper, David; Colombo, Michael			Brain Cells in the Avian 'Prefrontal Cortex' Code for Features of Slot-Machine-Like Gambling	PLOS ONE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; PATHOLOGICAL GAMBLERS; REWARD EXPECTANCY; NEURONAL-ACTIVITY; DECISION-MAKING; PREMOTOR CORTEX; PERIOD ACTIVITY; WORKING-MEMORY; FRONTAL-CORTEX; PIGEON	Slot machines are the most common and addictive form of gambling. In the current study, we recorded from single neurons in the 'prefrontal cortex' of pigeons while they played a slot-machine-like task. We identified four categories of neurons that coded for different aspects of our slot-machine-like task. Reward-Proximity neurons showed a linear increase in activity as the opportunity for a reward drew near. I-Won neurons fired only when the fourth stimulus of a winning (four-of-a-kind) combination was displayed. I-Lost neurons changed their firing rate at the presentation of the first nonidentical stimulus, that is, when it was apparent that no reward was forthcoming. Finally, Near-Miss neurons also changed their activity the moment it was recognized that a reward was no longer available, but more importantly, the activity level was related to whether the trial contained one, two, or three identical stimuli prior to the display of the nonidentical stimulus. These findings not only add to recent neurophysiological research employing simulated gambling paradigms, but also add to research addressing the functional correspondence between the avian NCL and primate PFC.	[Scarf, Damian; Miles, Kirby; Sloan, Amanda; Goulter, Natalie; Hegan, Matt; Colombo, Michael] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Seid-Fatemi, Azade] Ruhr Univ Bochum, AE Biopsychol, Fak Psychol, Bochum, Germany; [Harper, David] Victoria Univ Wellington, Dept Psychol, Wellington, New Zealand	University of Otago; Ruhr University Bochum; Victoria University Wellington	Scarf, D (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	colombo@psy.otago.ac.nz		Goulter, Natalie/0000-0003-0682-7781; Scarf, Damian/0000-0002-9486-8059; Colombo, Michael/0000-0002-2574-4888	University of Otago [0109-0310]	University of Otago	The work was funded by a University of Otago Research Grant 0109-0310 to M. Colombo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Becona E, 1995, J Gambl Stud, V11, P265, DOI 10.1007/BF02104793; Bilkey DK, 2003, METHODS, V30, P152, DOI 10.1016/S1046-2023(03)00076-8; Breen Robert B, 2002, J Gambl Stud, V18, P31, DOI 10.1023/A:1014580112648; Campos M, 2005, J NEUROPHYSIOL, V94, P1325, DOI 10.1152/jn.00022.2005; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Chantal Y, 1996, J Gambl Stud, V12, P407, DOI 10.1007/BF01539185; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Cote D., 2003, J GAMBL STUD, V19, P380; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; DIVAC I, 1985, BRAIN RES, V332, P365, DOI 10.1016/0006-8993(85)90606-7; Dixon MR, 2002, PSYCHOL REC, V52, P417, DOI 10.1007/BF03395195; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Echeburua E, 2005, J GAMBL STUD, V21, P21, DOI 10.1007/s10899-004-1918-6; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; GRIFFITHS M, 1991, J COMMUNITY APPL SOC, V1, P309, DOI 10.1002/casp.2450010406; Gunturkun O, 1997, NEUROREPORT, V8, pR3; Gunturkun O, 2005, BRAIN RES BULL, V66, P311, DOI 10.1016/j.brainresbull.2005.02.004; Gunturkun O, 1997, J BRAIN RES, V38, P133; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Ichihara-Takeda S, 2006, J COGNITIVE NEUROSCI, V18, P212, DOI 10.1162/089892906775783679; Ichihara-Takeda S, 2008, J COGNITIVE NEUROSCI, V20, P563, DOI 10.1162/jocn.2008.20047; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Kassinove JI, 2001, PSYCHOL ADDICT BEHAV, V15, P155, DOI 10.1037/0893-164X.15.2.155; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; Lakey CE, 2007, J GAMBL STUD, V23, P285, DOI 10.1007/s10899-006-9034-4; Leaver AM, 2009, J NEUROSCI, V29, P2477, DOI 10.1523/JNEUROSCI.4921-08.2009; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Linnet J, 2006, SCAND J PSYCHOL, V47, P43, DOI 10.1111/j.1467-9450.2006.00491.x; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MOGENSEN J, 1982, BRAIN BEHAV EVOLUT, V21, P60, DOI 10.1159/000121617; MOGENSEN J, 1993, BEHAV BRAIN RES, V55, P101, DOI 10.1016/0166-4328(93)90012-F; Nakamura K, 2006, J NEUROPHYSIOL, V96, P478, DOI 10.1152/jn.01326.2005; Petry NM, 2001, DRUG ALCOHOL DEPEN, V63, P29, DOI 10.1016/S0376-8716(00)00188-5; Petry NM, 2003, ADDICTION, V98, P645, DOI 10.1046/j.1360-0443.2003.00336.x; PLUME J, 2001, CASINO EXECUTIVE REP, P22; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Roca M, 2008, COGN BEHAV NEUROL, V21, P1, DOI 10.1097/WNN.0b013e3181684358; Roesch MR, 2007, ANN NY ACAD SCI, V1121, P431, DOI 10.1196/annals.1401.004; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rose J, 2005, PLOS BIOL, V3, P1139, DOI 10.1371/journal.pbio.0030190; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Schull ND, 2005, ANN AM ACAD POLIT SS, V597, P65, DOI 10.1177/0002716204270435; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Skinner B. F., 1953, SCI HUMAN BEHAV; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; TURNER N, 2004, J GAMBLING       NOV; WASHINGTON G, 1783, WORDS WASHINGTON, P693; Watanabe M, 2005, EXP BRAIN RES, V166, P263, DOI 10.1007/s00221-005-2358-y; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; 2004, NY TIMES        0713; 2003, NY TIMES        0103	65	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14589	10.1371/journal.pone.0014589	http://dx.doi.org/10.1371/journal.pone.0014589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283622	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400006
J	Jerome, JP; Bell, JA; Plovanich-Jones, AE; Barrick, JE; Brown, CT; Mansfield, LS				Jerome, John P.; Bell, Julia A.; Plovanich-Jones, Anne E.; Barrick, Jeffrey E.; Brown, C. Titus; Mansfield, Linda S.			Standing Genetic Variation in Contingency Loci Drives the Rapid Adaptation of Campylobacter jejuni to a Novel Host	PLOS ONE			English	Article							GENOME-WIDE EXPRESSION; PHASE VARIATION; GASTROINTESTINAL-TRACT; ESCHERICHIA-COLI; MULTIPLE GENES; IN-VITRO; COLONIZATION; EVOLUTION; VIRULENCE; DNA	The genome of the food-borne pathogen Campylobacter jejuni contains multiple highly mutable sites, or contingency loci. It has been suggested that standing variation at these loci is a mechanism for rapid adaptation to a novel environment, but this phenomenon has not been shown experimentally. In previous work we showed that the virulence of C. jejuni NCTC11168 increased after serial passage through a C57BL/6 IL-10(-/-) mouse model of campylobacteriosis. Here we sought to determine the genetic basis of this adaptation during passage. Re-sequencing of the 1.64Mb genome to 200-500X coverage allowed us to define variation in 23 contingency loci to an unprecedented depth both before and after in vivo adaptation. Mutations in the mouse-adapted C. jejuni were largely restricted to the homopolymeric tracts of thirteen contingency loci. These changes cause significant alterations in open reading frames of genes in surface structure biosynthesis loci and in genes with only putative functions. Several loci with open reading frame changes also had altered transcript abundance. The increase in specific phases of contingency loci during in vivo passage of C. jejuni, coupled with the observed virulence increase and the lack of other types of genetic changes, is the first experimental evidence that these variable regions play a significant role in C. jejuni adaptation and virulence in a novel host.	[Jerome, John P.; Bell, Julia A.; Plovanich-Jones, Anne E.; Mansfield, Linda S.] Michigan State Univ, Comparat Enter Dis Lab, E Lansing, MI 48824 USA; [Jerome, John P.; Brown, C. Titus; Mansfield, Linda S.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Chem & Biochem, Inst Cell & Mol Biol, Austin, TX 78712 USA	Michigan State University; Michigan State University; Michigan State University; University of Texas System; University of Texas Austin	Jerome, JP (corresponding author), Michigan State Univ, Comparat Enter Dis Lab, E Lansing, MI 48824 USA.	mansfie4@cvm.msu.edu	Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Mansfield, Linda S./0000-0002-7523-7577; Brown, C. Titus/0000-0001-6001-2677	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [K99GM087550]; Department of Health and Human Services [NO1-AI-30058]; United States Department of Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087550, R00GM087550] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in whole by funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, under Contract No. NO1-AI-30058. JPJ was also supported as a United States Department of Agriculture National Needs Graduate Fellow, and JEB had support from NIH grant K99GM087550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acke E, 2010, VET REC, V166, P102, DOI 10.1136/vr.c357; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BARRICK JE, 2009, GENOME WIDE MUTATION; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Fenton JI, 2006, CARCINOGENESIS, V27, P893, DOI 10.1093/carcin/bgi355; Forster M, 2009, J MED ENTOMOL, V46, P1164, DOI 10.1603/033.046.0526; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hitchen P, 2010, MICROBIOL-SGM, V156, P1953, DOI 10.1099/mic.0.038091-0; Holmes EC, 2010, J MOL BIOL, V400, P271, DOI 10.1016/j.jmb.2010.05.032; Houliston RS, 2009, GLYCOBIOLOGY, V19, P153, DOI 10.1093/glycob/cwn117; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Josenhans C, 2000, INFECT IMMUN, V68, P4598, DOI 10.1128/IAI.68.8.4598-4603.2000; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lavitola A, 1999, MOL MICROBIOL, V33, P119, DOI 10.1046/j.1365-2958.1999.01454.x; Law BF, 2009, FOODBORNE PATHOG DIS, V6, P377, DOI 10.1089/fpd.2008.0183; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Lippert E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007413; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Moore JE, 2002, J VET MED B, V49, P388, DOI 10.1046/j.1439-0450.2002.00595.x; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; PACHA RE, 1988, CAN J MICROBIOL, V34, P80, DOI 10.1139/m88-015; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Ribot EM, 2001, J CLIN MICROBIOL, V39, P1889, DOI 10.1128/JCM.39.5.1889-1894.2001; Ridley AM, 2008, J APPL MICROBIOL, V105, P95, DOI 10.1111/j.1365-2672.2008.03759.x; Ringoir DD, 2003, VET MICROBIOL, V92, P225, DOI 10.1016/S0378-1135(02)00378-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Slev PR, 2002, CURR OPIN IMMUNOL, V14, P609, DOI 10.1016/S0952-7915(02)00381-3; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033; Wassenaar TM, 2002, FEMS MICROBIOL LETT, V212, P77, DOI 10.1111/j.1574-6968.2002.tb11248.x; Wassenaar TM, 1998, APPL ENVIRON MICROB, V64, P1816; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143; 2001, J AM VET MED ASS, V218, P669	64	76	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16399	10.1371/journal.pone.0016399	http://dx.doi.org/10.1371/journal.pone.0016399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283682	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400033
J	Liu, Z; Fan, FY; Xiao, XJ; Sun, YM				Liu, Zheng; Fan, Feiyue; Xiao, Xiangjun; Sun, Yuanming			Constitutive Activation of the Thyroid-Stimulating Hormone Receptor (TSHR) by Mutating Ile(691) in the Cytoplasmic Tail Segment	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; GERMLINE MUTATION; GENE; LOOP; PHOSPHOINOSITIDE; FAMILY	Background: Autosomal dominant non-autoimmune hyperthyroidism (ADNAH) is a rare genetic disorder of the endocrine system. Molecular genetic studies in ADNAH have revealed heterozygous germline mutations in the TSHR. To data, mutations leading to an increase in the constitutive activation of the TSHR have been described in the transmembrane segments, exoloops and cytoplasmic loop of TSHR. These mutations result in constitutive activation of the G(alpha s)/cAMP or G(alpha q/11)/inositol phosphate (IP) pathways, which stimulate thyroid hormone production and thyroid proliferation. Methodology/Principal Findings: In a previous study, we reported a new TSHR mutation located in the C-terminal domain of TSHR, which results in a substitution of the conserved Ile(691) for Phe. In this study, to address the question of whether the I691F mutated receptor could be responsible for G(alpha s)/cAMP or G(alpha q/11)/IP constitutive activity, wild-type and TSHR mutants were expressed in COS-7 cells to determine cAMP constitutive activity and IP formation. Compared to the cell surface with expression of the A623V mutated receptor as positive control, the I691F mutated receptor showed a slight increase of cAMP accumulation. Furthermore, I691F resulted in constitutive activation of the G(alpha q/11)/IP signaling pathway. Conclusions/Significance: Our results indicate that Ile(691) not only contributes to keeping TSHR inactive in the G(alpha s)/cAMP pathways but also in the G(alpha q/11)/IP cascade.	[Liu, Zheng; Fan, Feiyue; Sun, Yuanming] Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, Tianjin, Peoples R China; [Liu, Zheng; Fan, Feiyue; Sun, Yuanming] Peking Union Med Coll, Tianjin, Peoples R China; [Liu, Zheng] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Xiao, Xiangjun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University System of Georgia; Georgia Institute of Technology; University of Texas System; UTMD Anderson Cancer Center	Liu, Z (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, Tianjin, Peoples R China.	liu.zheng1111@gmail.com	xiao, xiang/GWU-6035-2022; Liu, Zheng/GVU-3695-2022	Liu, Zheng/0000-0003-4158-6768	National Nature Science Foundation of China [30970867, 30400240]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (No. 30970867, 30400240). (http://www.nsfc.gov.cn.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agretti P, 2003, EUR J BIOCHEM, V270, P3839, DOI 10.1046/j.1432-1033.2003.03778.x; Alberti L, 2001, EUR J ENDOCRINOL, V145, P249, DOI 10.1530/eje.0.1450249; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Biebermann H, 2001, J CLIN ENDOCR METAB, V86, P4429, DOI 10.1210/jc.86.9.4429; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; Claus M, 2006, J MOL MED, V84, P943, DOI 10.1007/s00109-006-0087-8; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; DUPREZ L, 1994, NAT GENET, V7, P396, DOI 10.1038/ng0794-396; Farid NR, 2004, ENDOCRINOLOGY, V145, P4048, DOI 10.1210/en.2004-0437; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Holzapfel HP, 2002, EUR J ENDOCRINOL, V147, P109, DOI 10.1530/eje.0.1470109; Khoo DHC, 1999, J CLIN ENDOCR METAB, V84, P1459, DOI 10.1210/jc.84.4.1459; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; KOSUGI S, 1994, BIOCHEM BIOPH RES CO, V200, P401, DOI 10.1006/bbrc.1994.1463; KOSUGI S, 1992, J BIOL CHEM, V267, P24153; KOSUGI S, 1993, MOL ENDOCRINOL, V7, P1009, DOI 10.1210/me.7.8.1009; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Lee YS, 2002, J PEDIATR ENDOCR MET, V15, P211; Liu Z, 2008, J HUM GENET, V53, P475, DOI 10.1007/s10038-008-0257-3; Ohmura T, 2001, PROTEIN ENG, V14, P421, DOI 10.1093/protein/14.6.421; PARMA J, 1995, MOL ENDOCRINOL, V9, P725, DOI 10.1210/me.9.6.725; Rodien P, 1998, NEW ENGL J MED, V339, P1823, DOI 10.1056/NEJM199812173392505; Schwab KO, 1997, J PEDIATR-US, V131, P899, DOI 10.1016/S0022-3476(97)70040-4; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tonacchera M, 1996, J CLIN ENDOCR METAB, V81, P547, DOI 10.1210/jc.81.2.547; Wonerow P, 2000, CLIN ENDOCRINOL, V53, P461, DOI 10.1046/j.1365-2265.2000.01119.x	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16335	10.1371/journal.pone.0016335	http://dx.doi.org/10.1371/journal.pone.0016335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283701	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522300035
J	Raja, SB; Murali, MR; Kumar, NK; Devaraj, SN				Raja, Subramaniya Bharathi; Murali, Malliga Raman; Kumar, Nirmal Kasinathan; Devaraj, Sivasitambaram Niranjali			Isolation and Partial Characterisation of a Novel Lectin from Aegle marmelos Fruit and Its Effect on Adherence and Invasion of Shigellae to HT29 Cells	PLOS ONE			English	Article							PURIFICATION; FLEXNERI; EXPRESSION; APOPTOSIS; SEEDS; ACID	Lectins are a class of ubiquitous proteins/glycoproteins that are abundantly found in nature. Lectins have unique carbohydrate binding property and hence have been exploited as drugs against various infectious diseases. We have isolated one such novel lectin from the fruit pulp of Aegle marmelos. The isolated lectin was partially characterised and its effect against Shigella dysenteriae infection was evaluated. The isolated lectin was found to be a dimeric protein with N-acetylgalactosamine, mannose and sialic acid binding specificity. The effect of Aegle marmelos fruit lectin on the adherence of Shigella dysenteriae to human colonic epithelial cells (HT29 cells) was evaluated by Enzyme Linked Immune Sorbent Assay and invasion was analysed. The protective nature of the Aegle marmelos fruit lectin was assessed by analyzing apoptosis through dual staining method. Aegle marmelos fruit lectin significantly inhibited hemagglutination activity of Shigella and its minimum inhibitory concentration is 0.625 mu g/well. Further, at this concentration lectin inhibited Shigella dysenteriae adherence and invasion of HT29 cells and protects the HT29 cells from Shigella dysenteriae induced apoptosis. To conclude, isolated lectin dimeric protein with N-acetylgalactosamine, Mannose and sialic acid binding specificity and inhibits adherence and invasion of Shigellae to HT29 cells thus, protects the host.	[Raja, Subramaniya Bharathi; Murali, Malliga Raman; Kumar, Nirmal Kasinathan; Devaraj, Sivasitambaram Niranjali] Univ Madras, Sch Life Sci, Dept Biochem, Madras, Tamil Nadu, India	University of Madras	Raja, SB (corresponding author), Univ Madras, Sch Life Sci, Dept Biochem, Madras, Tamil Nadu, India.	niranjali@yahoo.com	Raman, Murali Malliga/A-6987-2012; Subramaniya, Bharathi raja/A-7024-2012; Kasinathan, Nirmal Kumar/AAU-9161-2021	Raman, Murali Malliga/0000-0002-5696-4541; Kasinathan, Nirmal Kumar/0000-0002-8980-7198; S, BHARATHIRAJA/0000-0002-5680-7036	Indian Council of Medical Research (ICMR), Government of India	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This study was supported by Junior Research Fellowship from the Indian Council of Medical Research (ICMR), Government of India to S. Bharathi Raja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINOUZ IL, 1992, BOT MAR, V35, P475; ALI M, 1987, J INDIAN CHEM SOC, V64, P230; Alwan A, 1998, J MICROBIOL METH, V33, P163, DOI 10.1016/S0167-7012(98)00052-9; Assreuy AMS, 1999, J UROLOGY, V161, P1988, DOI 10.1016/S0022-5347(05)68870-2; AYOUBA A, 1991, FEBS LETT, V289, P102, DOI 10.1016/0014-5793(91)80918-S; Benevides NMB, 1998, BOT MAR, V41, P521, DOI 10.1515/botm.1998.41.1-6.521; CALDEON AM, 1997, ELECT LECTIN J LECTI, V12; CAMMUE BP, 1985, BIOCHEM J, V227, P949, DOI 10.1042/bj2270949; CHATTERJEE A, 1994, TREATISE INDIAN MED, V3, P86; DeBolle MFC, 1996, PLANT MOL BIOL, V31, P993, DOI 10.1007/BF00040718; DIGGER HR, 1998, ACTA ANAT, V16, P30; DIKSHIT BBL, 1932, J INDIAN CHEM SOC, V9, P271; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; HIRMO S, 1997, ELECT LECTIN J LECTI, V12; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIENER IE, 1976, ANNU REV PLANT PHYS, V27, P291, DOI 10.1146/annurev.pp.27.060176.001451; MACH L, 1991, BIOCHEM J, V278, P667, DOI 10.1042/bj2780667; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; Neumann D, 2004, ADV DRUG DELIVER REV, V56, P437, DOI 10.1016/j.addr.2003.10.019; PARIKH V. M., 1958, JOUR INDIAN CHEM SOC, V35, P125; PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029; PEREIRA MEA, 1979, ARCH BIOCHEM BIOPHYS, V194, P511, DOI 10.1016/0003-9861(79)90646-5; PEUMANS WJ, 1984, PLANTA, V160, P222, DOI 10.1007/BF00402858; Raja SB, 2009, AM J INFECT DIS, V5, P154, DOI 10.3844/ajidsp.2009.154.162; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sansonetti PJ, 1998, FOLIA MICROBIOL, V43, P239, DOI 10.1007/BF02818608; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sansonetti PJ, 1996, INFECT IMMUN, V64, P2752, DOI 10.1128/IAI.64.7.2752-2764.1996; Santi-Gadelha T, 2006, BIOCHEM BIOPH RES CO, V350, P1050, DOI 10.1016/j.bbrc.2006.09.149; Utsunomiya A, 2000, MICROBIOL IMMUNOL, V44, P529, DOI 10.1111/j.1348-0421.2000.tb02529.x; ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	33	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16231	10.1371/journal.pone.0016231	http://dx.doi.org/10.1371/journal.pone.0016231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283697	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522300022
J	Bora, H; Garg, S; Sen, P; Kumar, D; Kaur, P; Khan, RH; Sharma, YD				Bora, Hema; Garg, Sheena; Sen, Priyankar; Kumar, Deepak; Kaur, Punit; Khan, Rizwan Hasan; Sharma, Yagya D.			Plasmodium vivax Tryptophan-Rich Antigen PvTRAg33.5 Contains Alpha Helical Structure and Multidomain Architecture	PLOS ONE			English	Article							YOELII-INFECTED ERYTHROCYTES; CIRCULAR-DICHROISM; IMMUNOLOGICAL RESPONSES; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; CYTOCHROME-C; IN-VITRO; PROTEINS; MALARIA; FALCIPARUM	Tryptophan-rich proteins from several malarial parasites have been identified where they play an important role in host-parasite interaction. Structural characterization of these proteins is needed to develop them as therapeutic targets. Here, we describe a novel Plasmodium vivax tryptophan-rich protein named PvTRAg33.5. It is expressed by blood stage(s) of the parasite and its gene contains two exons. The exon 1 encodes for a 23 amino acids long putative signal peptide which is likely to be cleaved off whereas the exon 2 encodes for the mature protein of 252 amino acids. The mature protein contains B-cell epitopes which were recognized by the human immune system during P. vivax infection. The PvTRAg33.5 contains 24 (9.5%) tryptophan residues and six motifs whose patterns were similar among tryptophan-rich proteins. The modeled structure of the PvTRAg33.5 consists of a multidomain architecture which is stabilized by the presence of large number of tryptophan residues. The recombinant PvTRAg33.5 showed predominantly a helical structure and alpha helix to beta sheet transition at pH below 4.5. Protein acquires an irreversible non-native state at temperature more than 50 degrees C at neutral pH. Its secondary and tertiary structures remain stable in the presence of 35% alcohol but these structures are destabilized at higher alcohol concentrations due to the disturbance of hydrophobic interactions between tryptophanyl residues. These structural changes in the protein might occur during its translocation to interact with other proteins at its final destination for biological function such as erythrocyte invasion.	[Bora, Hema; Garg, Sheena; Kumar, Deepak; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Sen, Priyankar; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Kumar, Deepak; Kaur, Punit] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Aligarh Muslim University; All India Institute of Medical Sciences (AIIMS) New Delhi	Bora, H (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	rizwanhkhan@hotmail.com; ydsharma_aiims@yahoo.com	Khan, Rizwan Hasan/F-8276-2014; Khan, Rizwan/GXZ-5789-2022	Khan, Rizwan Hasan/0000-0002-9965-8982; Sen, Priyankar/0000-0003-4729-7297	Department of Biotechnology; Indian Council of Medical Research; Department of Science and Technology; Council for Scientific and Industrial Research	Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from Department of Biotechnology (to YDS and RHK), Indian Council of Medical Research (to YDS and PK), Department of Science and Technology (to RHK) and Council for Scientific and Industrial Research (to RHK). Junior Research Fellowship (to HB) and Senior Research Fellowships (to PS and SG) from Department of Biotechnology are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2004, PROTEIN PEPTIDE LETT, V11, P307, DOI 10.2174/0929866043406887; Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Alam MT, 2008, VACCINE, V26, P3787, DOI 10.1016/j.vaccine.2008.05.059; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bhakuni V, 1998, ARCH BIOCHEM BIOPHYS, V357, P274, DOI 10.1006/abbi.1998.0794; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; DIVITA G, 1995, J BIOL CHEM, V270, P28642, DOI 10.1074/jbc.270.48.28642; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gomi M., 2004, CHEM BIO INFORMATICS, V4, P142, DOI DOI 10.1273/CBIJ.4.142; Grundy WN, 1999, BIOINFORMATICS, V15, P463, DOI 10.1093/bioinformatics/15.6.463; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Karplus K, 2001, PROTEINS, P86, DOI 10.1002/prot.10021; Khan F, 2000, BBA-PROTEIN STRUCT M, V1481, P229, DOI 10.1016/S0167-4838(00)00129-1; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Konno T, 2000, PROTEIN SCI, V9, P564; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li B, 2004, BIOCHEMISTRY-US, V43, P2550, DOI 10.1021/bi0357863; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mcnae IW, 2009, J MOL BIOL, V385, P1519, DOI 10.1016/j.jmb.2008.11.047; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nishio M, 2002, VIROLOGY, V300, P92, DOI 10.1006/viro.2002.1509; Ntumngia FB, 2005, PARASITOL RES, V96, P347, DOI 10.1007/s00436-005-1398-3; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; RAY P, 1994, AM J TROP MED HYG, V51, P436, DOI 10.4269/ajtmh.1994.51.436; Reed ZH, 2006, CURR MOL MED, V6, P231, DOI 10.2174/156652406776055195; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Siddiqui AA, 2008, INFECT IMMUN, V76, P2576, DOI 10.1128/IAI.00677-07; Siddiqui AA, 2007, VACCINE, V26, P96, DOI 10.1016/j.vaccine.2007.10.042; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; XUE H, 1995, GENE, V165, P335, DOI 10.1016/0378-1119(95)00550-P; Yeliseev AA, 2000, J BIOL CHEM, V275, P5657, DOI 10.1074/jbc.275.8.5657; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zsila F, 2004, ORG BIOMOL CHEM, V2, P2902, DOI 10.1039/b409724f; [No title captured]	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16294	10.1371/journal.pone.0016294	http://dx.doi.org/10.1371/journal.pone.0016294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283717	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200048
J	Coumes-Florens, S; Brochier-Armanet, C; Guiseppi, A; Denizot, F; Foglino, M				Coumes-Florens, Stephanie; Brochier-Armanet, Celine; Guiseppi, Annick; Denizot, Francois; Foglino, Maryline			A New Highly Conserved Antibiotic Sensing/Resistance Pathway in Firmicutes Involves an ABC Transporter Interplaying with a Signal Transduction System	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BACITRACIN RESISTANCE; BACTERIAL LIPOPROTEINS; REGULATORY NETWORK; EXPRESSION; PYROPHOSPHATE; DETACHMENT; MECHANISM; PROTEINS; DATABASE	Signal transduction systems and ABC transporters often contribute jointly to adaptive bacterial responses to environmental changes. In Bacillus subtilis, three such pairs are involved in responses to antibiotics: BceRSAB, YvcPQRS and YxdJKLM. They are characterized by a histidine kinase belonging to the intramembrane sensing kinase family and by a translocator possessing an unusually large extracytoplasmic loop. It was established here using a phylogenomic approach that systems of this kind are specific but widespread in Firmicutes, where they originated. The present phylogenetic analyses brought to light a highly dynamic evolutionary history involving numerous horizontal gene transfers, duplications and lost events, leading to a great variety of Bce-like repertories in members of this bacterial phylum. Based on these phylogenetic analyses, it was proposed to subdivide the Bce-like modules into six well-defined subfamilies. Functional studies were performed on members of subfamily IV comprising BceRSAB from B. subtilis, the expression of which was found to require the signal transduction system as well as the ABC transporter itself. The present results suggest, for the members of this subfamily, the occurrence of interactions between one component of each partner, the kinase and the corresponding translocator. At functional and/or structural levels, bacitracin dependent expression of bceAB and bacitracin resistance processes require the presence of the BceB translocator loop. Some other members of subfamily IV were also found to participate in bacitracin resistance processes. Taken together our study suggests that this regulatory mechanism might constitute an important common antibiotic resistance mechanism in Firmicutes. [Supplemental material is available online at http://www.genome.org.]	[Coumes-Florens, Stephanie; Brochier-Armanet, Celine; Guiseppi, Annick; Denizot, Francois; Foglino, Maryline] CNRS, Inst Microbiol Mediterranee IFR88, Lab Chim Bacterienne UPR9043, Marseille, France; [Coumes-Florens, Stephanie; Guiseppi, Annick; Denizot, Francois; Foglino, Maryline] Univ Aix Marseille 2, Marseille, France; [Brochier-Armanet, Celine] Univ Aix Marseille 1, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Coumes-Florens, S (corresponding author), CNRS, Inst Microbiol Mediterranee IFR88, Lab Chim Bacterienne UPR9043, Marseille, France.	denizot@ifr88.cnrs-mrs.fr	Brochier-Armanet, Celine/B-7898-2011	Brochier-Armanet, Celine/0000-0003-4669-3589	Ministere de la Recherche et de la Technologie (France); Centre National de la Recherche Scientifique (CNRS); Universite de la Mediterranee; CNRS	Ministere de la Recherche et de la Technologie (France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; CNRS(Centre National de la Recherche Scientifique (CNRS))	S. Coumes-Florens was supported by a fellowship from the Ministere de la Recherche et de la Technologie (France). C. Brochier-Armanet is supported by an "Action Thematique et Incitative sur Programme (ATIP)" from the Centre National de la Recherche Scientifique (CNRS). This work was supported by the Universite de la Mediterranee and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Becker P, 2009, ANTIMICROB AGENTS CH, V53, P2034, DOI 10.1128/AAC.01485-08; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Bernard R, 2003, FEMS MICROBIOL LETT, V228, P93, DOI 10.1016/S0378-1097(03)00738-9; Bernard R, 2007, J BACTERIOL, V189, P8636, DOI 10.1128/JB.01132-07; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4416, DOI 10.1128/AAC.00503-10; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Majchrzykiewicz JA, 2010, ANTIMICROB AGENTS CH, V54, P440, DOI 10.1128/AAC.00769-09; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Ouyang J, 2010, ANTIMICROB AGENTS CH, V54, P3895, DOI 10.1128/AAC.01802-09; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J, 2001, MOL CLONING LAB MANU; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stock J. B., 1995, 2 COMPONENT SIGNAL T; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Tetsch L, 2009, MOL MICROBIOL, V73, P982, DOI 10.1111/j.1365-2958.2009.06847.x; Tetsch L, 2009, AMINO ACIDS, V37, P467, DOI 10.1007/s00726-009-0235-x; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; Tsuda H, 2002, ANTIMICROB AGENTS CH, V46, P3756, DOI 10.1128/AAC.46.12.3756-3764.2002; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; Wecke T, 2006, J BACTERIOL, V188, P7500, DOI 10.1128/JB.01110-06; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	40	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15951	10.1371/journal.pone.0015951	http://dx.doi.org/10.1371/journal.pone.0015951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283517	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600016
J	Arzy, S; Mohr, C; Molnar-Szakacs, I; Blanke, O				Arzy, Shahar; Mohr, Christine; Molnar-Szakacs, Istvan; Blanke, Olaf			Schizotypal Perceptual Aberrations of Time: Correlation between Score, Behavior and Brain Activity	PLOS ONE			English	Article							TEMPORAL PROCESSING DYSFUNCTION; SCHNEIDERIAN 1ST-RANK SYMPTOMS; COGNITIVE NEUROSCIENCE; EPISODIC MEMORY; FUNCTIONAL MECHANISMS; CONSCIOUS AWARENESS; PERSPECTIVE-TAKING; PREFRONTAL CORTEX; PARIETAL CORTEX; DEFAULT MODE	A fundamental trait of the human self is its continuum experience of space and time. Perceptual aberrations of this spatial and temporal continuity is a major characteristic of schizophrenia spectrum disturbances - including schizophrenia, schizotypal personality disorder and schizotypy. We have previously found the classical Perceptual Aberration Scale (PAS) scores, related to body and space, to be positively correlated with both behavior and temporo-parietal activation in healthy participants performing a task involving self-projection in space. However, not much is known about the relationship between temporal perceptual aberration, behavior and brain activity. To this aim, we composed a temporal Perceptual Aberration Scale (tPAS) similar to the traditional PAS. Testing on 170 participants suggested similar performance for PAS and tPAS. We then correlated tPAS and PAS scores to participants' performance and neural activity in a task of self-projection in time. tPAS scores correlated positively with reaction times across task conditions, as did PAS scores. Evoked potential mapping and electrical neuroimaging showed self-projection in time to recruit a network of brain regions at the left anterior temporal cortex, right temporo-parietal junction, and occipito-temporal cortex, and duration of activation in this network positively correlated with tPAS and PAS scores. These data demonstrate that schizotypal perceptual aberrations of both time and space, as reflected by tPAS and PAS scores, are positively correlated with performance and brain activation during self-projection in time in healthy individuals along the schizophrenia spectrum.	[Arzy, Shahar; Molnar-Szakacs, Istvan; Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Arzy, Shahar] Hadassah Hebrew Univ Hosp, Dept Neurol, Jerusalem, Israel; [Mohr, Christine] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Mohr, Christine] Univ Lausanne, Dept Psychol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Bristol; University of Lausanne	Arzy, S (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland.	shahar.arzy@hcuge.ch		Mohr, Christine/0000-0002-3720-7115; Arzy, Shahar/0000-0001-6500-8095	Hadassah's management fund	Hadassah's management fund	SA was partially supported by the Hadassah's management fund for residents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Angyal A, 1936, ARCH NEURO PSYCHIATR, V35, P1029, DOI 10.1001/archneurpsyc.1936.02260050103007; ARZY S, NEUROREPORT, V21, P569; ARZY S, 2009, MENTAL TIME LINE ANA; Arzy S, 2008, J NEUROSCI, V28, P6502, DOI 10.1523/JNEUROSCI.5712-07.2008; Arzy S, 2007, NEUROIMAGE, V35, P326, DOI 10.1016/j.neuroimage.2006.11.027; Arzy S, 2009, EUR J NEUROSCI, V30, P2009, DOI 10.1111/j.1460-9568.2009.06974.x; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Baars B. J., 1997, THEATER CONSCIOUSNES; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bourdet Catherine, 2003, Cogn Neuropsychiatry, V8, P89, DOI 10.1080/13546800244000238; Boyer P, 2007, BRAIN RES REV, V54, P92, DOI 10.1016/j.brainresrev.2006.12.008; BRANDEIS D, 1986, NEUROPSYCHOLOGIA, V24, P151, DOI 10.1016/0028-3932(86)90049-7; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; CARLSON EB, 1993, AM J PSYCHIAT, V150, P1030; Carroll CA, 2008, BRAIN COGNITION, V67, P150, DOI 10.1016/j.bandc.2007.12.005; Cellard C, 2007, BRAIN COGNITION, V64, P201, DOI 10.1016/j.bandc.2007.03.001; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Danion JM, 2007, CAN J PSYCHIAT, V52, P693, DOI 10.1177/070674370705201103; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; Davalos DB, 2005, J NEUROPSYCH CLIN N, V17, P517, DOI 10.1176/appi.neuropsych.17.4.517; Davalos DB, 2003, BRAIN COGNITION, V52, P295, DOI 10.1016/S0278-2626(03)00157-X; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Feinstein A, 1998, SCHIZOPHR RES, V30, P155, DOI 10.1016/S0920-9964(97)00129-1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franck N, 2002, J NEUROPSYCH CLIN N, V14, P277, DOI 10.1176/appi.neuropsych.14.3.277; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1996, BRIT MED BULL, V52, P644; Frith C, 1996, BRIT MED BULL, V52, P618; Frith C, 1996, COGNITIVE BRAIN RES, V5, P175, DOI 10.1016/S0926-6410(96)00054-7; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; GALLUP GG, 2003, SELF SCHIZOPHRENIA N; Ganesan V, 2005, AM J PSYCHIAT, V162, P1545, DOI 10.1176/appi.ajp.162.8.1545; Golland Y, 2008, NEUROPSYCHOLOGIA, V46, P540, DOI 10.1016/j.neuropsychologia.2007.10.003; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Langdon R, 1999, COGNITION, V71, P43, DOI 10.1016/S0010-0277(99)00018-9; LEHMANN D, 1984, PROG NEUROBIOL, V23, P227, DOI 10.1016/0301-0082(84)90003-0; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lenzenweger MF, 2000, SCHIZOPHR RES, V42, P111, DOI 10.1016/S0920-9964(99)00120-6; LENZENWEGER MF, 1994, SCHIZOPHRENIA BULL, V20, P121, DOI 10.1093/schbul/20.1.121; LHAMON WT, 1973, ARCH GEN PSYCHIAT, V28, P44; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mohr C, 2006, BEHAV NEUROSCI, V120, P528, DOI 10.1037/0735-7044.120.3.528; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Platek SA, 2002, SCHIZOPHR RES, V57, P81, DOI 10.1016/S0920-9964(01)00310-3; Ragland JD, 2004, AM J PSYCHIAT, V161, P1004, DOI 10.1176/appi.ajp.161.6.1004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2008, BIOL PSYCHIAT, V64, P18, DOI 10.1016/j.biopsych.2008.04.011; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saito N, 1998, BIOL PSYCHIAT, V43, P794, DOI 10.1016/S0006-3223(97)00547-7; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Tallent KA, 1999, PSYCHIAT RES, V89, P161, DOI 10.1016/S0165-1781(99)00101-8; Tendolkar I, 2002, PSYCHOL MED, V32, P1261, DOI 10.1017/S0033291702006335; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Varela F., 1999, NATURALIZING PHENOME, P265; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vogeley K, 2007, SCHIZOPHRENIA BULL, V33, P157, DOI 10.1093/schbul/sbl056; Walsh V, 2003, CURR BIOL, V13, pR447, DOI 10.1016/S0960-9822(03)00368-3; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	83	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16154	10.1371/journal.pone.0016154	http://dx.doi.org/10.1371/journal.pone.0016154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267456	Green Published, gold, Green Submitted			2022-12-27	WOS:000286519500043
J	Xu, JS; Monterosso, J; Kober, H; Balodis, IM; Potenza, MN				Xu, Jiansong; Monterosso, John; Kober, Hedy; Balodis, Iris M.; Potenza, Marc N.			Perceptual Load-Dependent Neural Correlates of Distractor Interference Inhibition	PLOS ONE			English	Article							PREFRONTAL CORTEX AREA-10; PRIMARY AUDITORY-CORTEX; SELECTIVE ATTENTION; WORKING-MEMORY; VISUAL-CORTEX; RESPONSES; TASK; MODULATION; NOISE; FMRI	Background: The load theory of selective attention hypothesizes that distractor interference is suppressed after perceptual processing (i.e., in the later stage of central processing) at low perceptual load of the central task, but in the early stage of perceptual processing at high perceptual load. Consistently, studies on the neural correlates of attention have found a smaller distractor-related activation in the sensory cortex at high relative to low perceptual load. However, it is not clear whether the distractor-related activation in brain regions linked to later stages of central processing (e. g., in the frontostriatal circuits) is also smaller at high rather than low perceptual load, as might be predicted based on the load theory. Methodology/Principal Findings: We studied 24 healthy participants using functional magnetic resonance imaging (fMRI) during a visual target identification task with two perceptual loads (low vs. high). Participants showed distractor-related increases in activation in the midbrain, striatum, occipital and medial and lateral prefrontal cortices at low load, but distractor-related decreases in activation in the midbrain ventral tegmental area and substantia nigra (VTA/SN), striatum, thalamus, and extensive sensory cortices at high load. Conclusions: Multiple levels of central processing involving midbrain and frontostriatal circuits participate in suppressing distractor interference at either low or high perceptual load. For suppressing distractor interference, the processing of sensory inputs in both early and late stages of central processing are enhanced at low load but inhibited at high load.	[Xu, Jiansong; Kober, Hedy; Balodis, Iris M.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Monterosso, John] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA	Yale University; University of Southern California; Yale University	Xu, JS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Jiansong.xu@yale.edu	kober, hedy/GPK-6402-2022	kober, hedy/0000-0001-9893-1046; Monterosso, John/0000-0002-5613-3182	National Institute On Drug Abuse (NIDA) [R03 DA022364, K01 DA027750, K12 DA00167]; U.S. Department of Veterans Affairs (VA) the New England Mental Illness Research, Education and Clinical Center [VISN 1 MIRECC]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027750, R03DA022364, K12DA000167] Funding Source: NIH RePORTER	National Institute On Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); U.S. Department of Veterans Affairs (VA) the New England Mental Illness Research, Education and Clinical Center(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the following grants: National Institute On Drug Abuse (NIDA) grants R03 DA022364, K01 DA027750, K12 DA00167, and the U.S. Department of Veterans Affairs (VA) the New England Mental Illness Research, Education and Clinical Centers (VISN 1 MIRECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kareem IA, 2008, J MAGN RESON IMAGING, V28, P287, DOI 10.1002/jmri.21445; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Ballard JC, 1996, J CLIN EXP NEUROPSYC, V18, P843, DOI 10.1080/01688639608408307; Berman RA, 2002, COGNITIVE BRAIN RES, V14, P64, DOI 10.1016/S0926-6410(02)00061-7; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Boulougouris V, 2008, PROG BRAIN RES, V172, P517, DOI 10.1016/S0079-6123(08)00925-4; BRETT M, 2002, NEUROIMAGE, V16, pA497; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Ciaramitaro VM, 2007, J NEUROPHYSIOL, V98, P2399, DOI 10.1152/jn.00580.2007; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Dalton P, 2009, Q J EXP PSYCHOL, V62, P2126, DOI 10.1080/17470210903023646; DAVIES DR, 1969, BRIT J PSYCHOL, V60, P453, DOI 10.1111/j.2044-8295.1969.tb01218.x; DAVIES DR, 1975, BRIT J PSYCHOL, V66, P61, DOI 10.1111/j.2044-8295.1975.tb01440.x; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DEUTSCH JA, 1963, PSYCHOL REV, V70, P80, DOI 10.1037/h0039515; DEUTSCH JA, 1967, Q J EXP PSYCHOL, V19, P362, DOI 10.1080/14640746708400117; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2006, CEREB CORTEX, V16, P1783, DOI 10.1093/cercor/bhj113; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; GULIAN E, 1970, ACTA PSYCHOL, V33, P381, DOI 10.1016/0001-6918(70)90148-4; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; HOLDING DH, 1987, J GEN PSYCHOL, V114, P395, DOI 10.1080/00221309.1987.9711078; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KELLEY TA, 2010, CEREB CORTEX; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Klemen J, 2009, EUR J NEUROSCI, V29, P2426, DOI 10.1111/j.1460-9568.2009.06774.x; Klemen J, 2010, J COGNITIVE NEUROSCI, V22, P437, DOI 10.1162/jocn.2009.21204; Kostopoulos P, 2007, P NATL ACAD SCI USA, V104, P10223, DOI 10.1073/pnas.0700253104; Kropotov JD, 1999, INT J PSYCHOPHYSIOL, V31, P197, DOI 10.1016/S0167-8760(98)00051-8; KROPOTOV JD, 1992, ELECTROEN CLIN NEURO, V84, P386, DOI 10.1016/0168-5597(92)90091-O; Lapish CC, 2007, PSYCHOPHARMACOLOGY, V191, P609, DOI 10.1007/s00213-006-0527-8; Lavie N, 2005, PSYCHON B REV, V12, P669, DOI 10.3758/BF03196756; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; LOEB M, 1981, Journal of Auditory Research, V21, P93; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Nyberg L, 2009, NEUROIMAGE, V46, P1194, DOI 10.1016/j.neuroimage.2009.03.035; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Pinsk MA, 2004, J NEUROPHYSIOL, V92, P622, DOI 10.1152/jn.00974.2003; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; Rose M, 2005, CEREB CORTEX, V15, P1290, DOI 10.1093/cercor/bhi012; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shelley BP, 2004, WORLD J BIOL PSYCHIA, V5, P176, DOI 10.1080/15622970410029933; Sheremata S, 2006, PERCEPT MOTOR SKILL, V102, P509, DOI 10.2466/PMS.102.2.509-516; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Shulman GL, 2007, CEREB CORTEX, V17, P2625, DOI 10.1093/cercor/bhl170; Sil'kis I G, 2007, Neurosci Behav Physiol, V37, P779, DOI 10.1007/s11055-007-0082-8; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; TREISMAN A, 1967, Q J EXP PSYCHOL, V19, P1, DOI 10.1080/14640746708400062; Wall JT, 2002, BRAIN RES REV, V39, P181, DOI 10.1016/S0165-0173(02)00192-3; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; WOODS DL, 1993, HEARING RES, V66, P46, DOI 10.1016/0378-5955(93)90258-3; Yi DJ, 2004, NAT NEUROSCI, V7, P992, DOI 10.1038/nn1294; Yucel G, 2005, J COGNITIVE NEUROSCI, V17, P1819, DOI 10.1162/089892905775008698	80	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14552	10.1371/journal.pone.0014552	http://dx.doi.org/10.1371/journal.pone.0014552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267080	Green Submitted, Green Published, gold			2022-12-27	WOS:000286519500020
J	Ondrusch, N; Kreft, J				Ondrusch, Nicolai; Kreft, Juergen			Blue and Red Light Modulates SigB-Dependent Gene Transcription, Swimming Motility and Invasiveness in Listeria monocytogenes	PLOS ONE			English	Article							ENVIRONMENTAL SIGNALING PATHWAY; SIGMA(B)-DEPENDENT STRESS-RESPONSE; PRFA-MEDIATED VIRULENCE; NTP-BINDING-PROPERTIES; BACILLUS-SUBTILIS; RECEPTOR YTVA; FACTOR SIGMA(B); REGULATOR PRFA; LOV DOMAIN; PROTEIN	Background: In a number of gram-positive bacteria, including Listeria, the general stress response is regulated by the alternative sigma factor B (SigB). Common stressors which lead to the activation of SigB and the SigB-dependent regulon are high osmolarity, acid and several more. Recently is has been shown that also blue and red light activates SigB in Bacillus subtilis. Methodology/Principal Findings: By qRT-PCR we analyzed the transcriptional response of the pathogen L. monocytogenes to blue and red light in wild type bacteria and in isogenic deletion mutants for the putative blue-light receptor Lmo0799 and the stress sigma factor SigB. It was found that both blue (455 nm) and red (625 nm) light induced the transcription of sigB and SigB-dependent genes, this induction was completely abolished in the SigB mutant. The blue-light effect was largely dependent on Lmo0799, proving that this protein is a genuine blue-light receptor. The deletion of lmo0799 enhanced the red-light effect, the underlying mechanism as well as that of SigB activation by red light remains unknown. Blue light led to an increased transcription of the internalin A/B genes and of bacterial invasiveness for Caco-2 enterocytes. Exposure to blue light also strongly inhibited swimming motility of the bacteria in a Lmo0799- and SigB-dependent manner, red light had no effect there. Conclusions/Significance: Our data established that visible, in particular blue light is an important environmental signal with an impact on gene expression and physiology of the non-phototrophic bacterium L. monocytogenes. In natural environments these effects will result in sometimes random but potentially also cyclic fluctuations of gene activity, depending on the light conditions prevailing in the respective habitat.	[Ondrusch, Nicolai; Kreft, Juergen] Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany	University of Wurzburg	Ondrusch, N (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany.	kreft@biozentrum.uni-wuerzburg.de			German Federal Ministry of Education and Research via Project Management Julich, ERA-NET PathoGenoMics [0313939C]; EU Network of Excellence EuroPathoGenomics	German Federal Ministry of Education and Research via Project Management Julich, ERA-NET PathoGenoMics; EU Network of Excellence EuroPathoGenomics	This work was supported by grants from the German Federal Ministry of Education and Research via Project Management Julich, ERA-NET PathoGenoMics (www.fz-juelich.de/ptj/pathogenomics) (grant no. 0313939C) and by the EU Network of Excellence EuroPathoGenomics (www.noe-epg.uniwuerzburg.de/). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Akbar S, 1997, MOL MICROBIOL, V24, P567, DOI 10.1046/j.1365-2958.1997.3631732.x; Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Becker LA, 1998, J BACTERIOL, V180, P4547, DOI 10.1128/JB.180.17.4547-4554.1998; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Braatsch S, 2004, PHOTOSYNTH RES, V79, P45, DOI 10.1023/B:PRES.0000011924.89742.f9; Buchrieser C, 2007, MICROBES INFECT, V9, P1147, DOI 10.1016/j.micinf.2007.05.002; Buttani V, 2007, EUR BIOPHYS J BIOPHY, V36, P831, DOI 10.1007/s00249-007-0155-1; Buttani V, 2007, PHOTOCH PHOTOBIO SCI, V6, P41, DOI 10.1039/b610375h; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Chaturongakul S, 2004, APPL ENVIRON MICROB, V70, P5349, DOI 10.1128/AEM.70.9.5349-5356.2004; Chaturongakul S, 2008, TRENDS MICROBIOL, V16, P388, DOI 10.1016/j.tim.2008.05.006; Chaturongakul S, 2006, APPL ENVIRON MICROB, V72, P5197, DOI 10.1128/AEM.03058-05; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Ferreira A, 2004, CURR MICROBIOL, V48, P39, DOI 10.1007/s00284-003-4020-x; Ferreira A, 2001, APPL ENVIRON MICROB, V67, P4454, DOI 10.1128/AEM.67.10.4454-4457.2001; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gardan R, 2003, APPL ENVIRON MICROB, V69, P154, DOI 10.1128/AEM.69.1.154-161.2003; GHETTI F, 1992, J PHOTOCH PHOTOBIO B, V15, P185, DOI 10.1016/1011-1344(92)85123-C; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; HALDENWANG WG, 1980, P NATL ACAD SCI-BIOL, V77, P7000, DOI 10.1073/pnas.77.12.7000; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hardwick SW, 2007, J BIOL CHEM, V282, P11562, DOI 10.1074/jbc.M609733200; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hellingwerf KJ, 1996, MOL MICROBIOL, V21, P683, DOI 10.1046/j.1365-2958.1996.411402.x; Hellingwerf KJ, 2002, ANTON LEEUW INT J G, V81, P51, DOI 10.1023/A:1020521424582; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Kamp HD, 2009, MOL MICROBIOL, V74, P421, DOI 10.1111/j.1365-2958.2009.06874.x; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kazmierczak MJ, 2006, MICROBIOL-SGM, V152, P1827, DOI 10.1099/mic.0.28758-0; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kim H, 2005, MICROBIOL-SGM, V151, P3215, DOI 10.1099/mic.0.28070-0; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Kreft J, 2002, CURR TOP MICROBIOL, V264, P109; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; McGann P, 2007, APPL ENVIRON MICROB, V73, P2919, DOI 10.1128/AEM.02664-06; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Oberpichler I, 2008, ENVIRON MICROBIOL, V10, P2020, DOI 10.1111/j.1462-2920.2008.01618.x; Ogata H, 2009, ACTA CRYSTALLOGR F, V65, P853, DOI 10.1107/S1744309109026670; Olesen I, 2009, FOODBORNE PATHOG DIS, V6, P669, DOI 10.1089/fpd.2008.0243; Oliver HF, 2010, APPL ENVIRON MICROB, V76, P4216, DOI 10.1128/AEM.00031-10; Ollinger J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Personnic N, 2010, INFECT IMMUN, V78, P1979, DOI 10.1128/IAI.01096-09; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Raengpradub S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07; Redmond RW, 1999, PHOTOCHEM PHOTOBIOL, V70, P391, DOI 10.1562/0031-8655(1999)070<0391:ACOSOY>2.3.CO;2; Reeves A, 2010, MICROBIOL-SGM, V156, P990, DOI 10.1099/mic.0.036095-0; Sambrook J, 2001, MOL CLONING LAB MANU; SAUNDERS B, 2007, LISTERIA LISTERIOSIS, P21; Schmid MW, 2005, SYST APPL MICROBIOL, V28, P1, DOI 10.1016/j.syapm.2004.09.005; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Sharrock RA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-230; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Stritzker J, 2005, J BACTERIOL, V187, P2836, DOI 10.1128/JB.187.8.2836-2845.2005; Sue D, 2004, MICROBIOL-SGM, V150, P3843, DOI 10.1099/mic.0.27257-0; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takano H, 2006, J IND MICROBIOL BIOT, V33, P88, DOI 10.1007/s10295-005-0005-z; Tang YF, 2010, PHOTOCH PHOTOBIO SCI, V9, P47, DOI 10.1039/b9pp00075e; THORINGTON L, 1985, ANN NY ACAD SCI, V453, P28, DOI 10.1111/j.1749-6632.1985.tb11796.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Williams T, 2005, FEMS MICROBIOL LETT, V252, P287, DOI 10.1016/j.femsle.2005.09.011; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465	108	66	69	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16151	10.1371/journal.pone.0016151	http://dx.doi.org/10.1371/journal.pone.0016151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264304	Green Submitted, Green Published, gold			2022-12-27	WOS:000286514000024
J	Pharris, A; Nguyen, TKC; Tishelman, C; Brugha, R; Nguyen, PH; Thorson, A				Pharris, Anastasia; Nguyen Thi Kim Chuc; Tishelman, Carol; Brugha, Ruairi; Nguyen Phuong Hoa; Thorson, Anna			Expanding HIV Testing Efforts in Concentrated Epidemic Settings: A Population-Based Survey from Rural Vietnam	PLOS ONE			English	Article							LOGISTIC-REGRESSION; PREGNANT-WOMEN; CONSEQUENCES; PREVALENCE; COUNTRIES; DETERMINANTS; INFECTION; AIDS; CARE	Background: To improve HIV prevention and care programs, it is important to understand the uptake of HIV testing and to identify population segments in need of increased HIV testing. This is particularly crucial in countries with concentrated HIV epidemics, where HIV prevalence continues to rise in the general population. This study analyzes determinants of HIV testing in a rural Vietnamese population in order to identify potential access barriers and areas for promoting HIV testing services. Methods: A population-based cross-sectional survey of 1874 randomly sampled adults was linked to pregnancy, migration and economic cohort data from a demographic surveillance site (DSS). Multivariate logistic regression analysis was used to determine which factors were associated with having tested for HIV. Results: The age-adjusted prevalence of ever-testing for HIV was 7.6%; however 79% of those who reported feeling at-risk of contracting HIV had never tested. In multivariate analysis, younger age (aOR 1.85, 95% CI 1.14-3.01), higher economic status (aOR 3.4, 95% CI 2.21-5.22), and semi-urban residence (aOR 2.37, 95% CI 1.53-3.66) were associated with having been tested for HIV. HIV testing rates did not differ between women of reproductive age who had recently been pregnant and those who had not. Conclusions: We found low testing uptake (6%) among pregnant women despite an existing prevention of mother-to-child HIV testing policy, and lower-than-expected testing among persons who felt that they were at-risk of HIV. Poverty and residence in a more geographically remote location were associated with less HIV testing. In addition to current HIV testing strategies focusing on high-risk groups, we recommend targeting HIV testing in concentrated HIV epidemic settings to focus on a scaled-up provision of antenatal testing. Additional recommendations include removing financial and geographic access barriers to client-initiated testing, and encouraging provider-initiated testing of those who believe that they are at-risk of HIV.	[Pharris, Anastasia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Nguyen Thi Kim Chuc; Nguyen Phuong Hoa] Hanoi Med Univ, Hlth Syst Res Project, Hanoi, Vietnam; [Tishelman, Carol] Karolinska Inst, Med Management Ctr, Dept Learning Informat Med Management & Eth LIME, Stockholm, Sweden; [Brugha, Ruairi] Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth, Populat Hlth Sci Div, Dublin 2, Ireland	Karolinska Institutet; Hanoi Medical University; Karolinska Institutet; Royal College of Surgeons - Ireland	Pharris, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	anastasia.pharris@ki.se	Tishelman, Carol/AAB-8936-2020; Brugha, Ruairi/C-8420-2012	Tishelman, Carol/0000-0003-4161-0342; Brugha, Ruairi/0000-0003-0729-0197; Thorson, Anna/0000-0002-8703-6561	Sida/SAREC	Sida/SAREC	Sida/SAREC are gratefully acknowledged for financial support to this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, IMP VOL COUNS TEST G; Carrizosa CM, 2010, AIDS PATIENT CARE ST, V24, P333, DOI 10.1089/apc.2009.0138; Castelli Francesco, 2010, Open AIDS J, V4, P28, DOI 10.2174/1874613601004020028; Chamratrithirong A, 2007, NATL SEXUAL BEHAV SU; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dinh TH, 2005, AIDS, V19, P1234, DOI 10.1097/01.aids.0000176228.09474.59; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; Hong K. T., 2004, UNDERSTANDING HIV AI; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Lanoy E, 2007, ANTIVIR THER, V12, P89; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; *MIN HLTH VIETN, 2005, VIETN HIV AIDS EST P; *MIN HLTH VIETN, 2009, VIETN HIV AIDS EST P; Monjok Emmanuel, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P23, DOI 10.1177/1545109709356355; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; *NAT I HYG EP VIET, 2006, VIETN POP AIDS IND S; Nguyen AT, 2008, AIDS RES HUM RETROV, V24, P1017, DOI 10.1089/aid.2007.0267; NGUYEN TA, 2007, B WORLD HEALTH ORGAN, V85, P35; Nguyen Thu Anh, 2008, AIDS Res Ther, V5, P7, DOI 10.1186/1742-6405-5-7; Nguyen TKC, 2003, SCAND J PUBLIC HEALT, V31, P3, DOI 10.1080/14034950310015031; *NIHE, 2006, RES HIV STI INT BIOL; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Oosterhoff P, 2008, AIDS CARE, V20, P654, DOI 10.1080/09540120701687026; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Rutstein S.O., 2004, DHS COMP REPORTS; Schur CL, 2002, J RURAL HEALTH, V18, P337, DOI 10.1111/j.1748-0361.2002.tb00895.x; *SOC REP VIETN, 2004, DEC PRIM MIN APPR NA; TAM VV, 2010, AIDS CARE IN PRESS; *THAIL NAT STAT OF, 2006, THAIL MULT IND CLUST; Thorson A, 2004, J CLIN EPIDEMIOL, V57, P398, DOI 10.1016/j.jclinepi.2002.11.001; Thorson A, 2003, EQUITY EQUALITY CASE; Thu AN, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-39; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; UNAIDS, 2008, REP GLOB AIDS EP; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, WORLD HLTH STAT; World Bank, 2008, WORLD DEV REP	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16017	10.1371/journal.pone.0016017	http://dx.doi.org/10.1371/journal.pone.0016017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LU	21264303	Green Published, gold			2022-12-27	WOS:000286514000017
J	Rymo, SF; Gerhardt, H; Sand, FW; Lang, R; Uv, A; Betsholtz, C				Rymo, Simin F.; Gerhardt, Holger; Sand, Fredrik Wolfhagen; Lang, Richard; Uv, Anne; Betsholtz, Christer			A Two-Way Communication between Microglial Cells and Angiogenic Sprouts Regulates Angiogenesis in Aortic Ring Cultures	PLOS ONE			English	Article							EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH-FACTOR; NERVOUS-SYSTEM; VEGF; MACROPHAGES; VASCULATURE; INHIBITION; EXPRESSION; ADULT; MODEL	Background: Myeloid cells have been associated with physiological and pathological angiogenesis, but their exact functions in these processes remain poorly defined. Monocyte-derived tissue macrophages of the CNS, or microglial cells, invade the mammalian retina before it becomes vascularized. Recent studies correlate the presence of microglia in the developing CNS with vascular network formation, but it is not clear whether the effect is directly caused by microglia and their contact with the endothelium. Methodology/Principal Findings: We combined in vivo studies of the developing mouse retina with in vitro studies using the aortic ring model to address the role of microglia in developmental angiogenesis. Our in vivo analyses are consistent with previous findings that microglia are present at sites of endothelial tip-cell anastomosis, and genetic ablation of microglia caused a sparser vascular network associated with reduced number of filopodia-bearing sprouts. Addition of microglia in the aortic ring model was sufficient to stimulate vessel sprouting. The effect was independent of physical contact between microglia and endothelial cells, and could be partly mimicked using microglial cell-conditioned medium. Addition of VEGF-A promoted angiogenic sprouts of different morphology in comparison with the microglial cells, and inhibition of VEGF-A did not affect the microglia-induced angiogenic response, arguing that the proangiogenic factor(s) released by microglia is distinct from VEGF-A. Finally, microglia exhibited oriented migration towards the vessels in the aortic ring cultures. Conclusions/Significance: Microglia stimulate vessel sprouting in the aortic ring cultures via a soluble microglial-derived product(s), rather than direct contact with endothelial cells. The observed migration of microglia towards the growing sprouts suggests that their position near endothelial tip-cells could result from attractive cues secreted by the vessels. Our data reveals a two-way communication between microglia and vessels that depends on soluble factors and should extend the understanding of how microglia promote vascular network formation.	[Rymo, Simin F.; Uv, Anne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London, England; [Sand, Fredrik Wolfhagen] Lund Univ, Stem Cell Ctr, Biomed Ctr BMC, Lund, Sweden; [Lang, Richard] Univ Cincinnati, Med Ctr, Visual Syst Grp,Dept Ophthalmol, Div Pediat Ophtalmol,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA; [Lang, Richard] Univ Cincinnati, Med Ctr, Visual Syst Grp, Div Dev Biol,Cincinnati Childrens Hosp,Dept Ophth, Cincinnati, OH 45267 USA; [Betsholtz, Christer] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Stockholm, Sweden	University of Gothenburg; Cancer Research UK; Lund University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Karolinska Institutet	Rymo, SF (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.	christer.betsholtz@ki.se	Lang, Richard/E-5578-2011; Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Lang, Richard/0000-0002-5212-254X; Gerhardt, Holger/0000-0001-9228-7472	Gothenburg University; Karolinska Institutet; Swedish Cancer Foundation; Swedish Research Council; Leducq Foundation; EU; Swedish Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Ludwig Institute for Cancer Research; Cancer Research UK; Lister Institute of Preventive Medicine; EMBO; National Eye Institute and National Cancer Institute of the NIH	Gothenburg University; Karolinska Institutet(Karolinska Institutet); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Leducq Foundation(Leducq Foundation); EU(European Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Ludwig Institute for Cancer Research; Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; EMBO(European Molecular Biology Organization (EMBO)); National Eye Institute and National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Eye Institute (NEI))	This study was supported by grants from the following sources: to SFR and AU: Gothenburg University; to CB: Karolinska Institutet, the Swedish Cancer Foundation, the Swedish Research Council, the Leducq Foundation, the EU Fp6 Program Lymphangiogenomics, the Swedish Strategic Research Foundation, Knut and Alice Wallenberg Foundation, Inga-Britt and Arne Lundberg Foundation, Torsten and Ragnar Soderberg Foundation and the Ludwig Institute for Cancer Research; to HG, Cancer Research UK, the Lister Institute of Preventive Medicine, the EMBO Young Investigator Programme, the Leducq Foundation; to RL: the National Eye Institute and National Cancer Institute of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; FANTIN A, 2010, BLOOD; Gelati M, 2008, J IMMUNOL, V181, P5711, DOI 10.4049/jimmunol.181.8.5711; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; JORDAN FL, 1988, BRAIN RES REV, V13, P165, DOI 10.1016/0165-0173(88)90019-7; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mitchell P, 2010, BRIT J OPHTHALMOL, V94, P2, DOI 10.1136/bjo.2009.159160; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; NICOSIA RF, 1990, LAB INVEST, V63, P115; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; ZORZI P, 2010, J LEUKOCYTE BIOL	36	153	160	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15846	10.1371/journal.pone.0015846	http://dx.doi.org/10.1371/journal.pone.0015846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264342	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000286513100013
J	Oeste, CL; Diez-Dacal, B; Bray, F; de Lacoba, MG; de la Torre, BG; Andreu, D; Ruiz-Sanchez, AJ; Perez-Inestrosa, E; Garcia-Dominguez, CA; Rojas, JM; Perez-Sala, D				Oeste, Clara L.; Diez-Dacal, Beatriz; Bray, Francesca; Garcia de Lacoba, Mario; de la Torre, Beatriz G.; Andreu, David; Ruiz-Sanchez, Antonio J.; Perez-Inestrosa, Ezequiel; Garcia-Dominguez, Carlota A.; Rojas, Jose M.; Perez-Sala, Dolores			The C-Terminus of H-Ras as a Target for the Covalent Binding of Reactive Compounds Modulating Ras-Dependent Pathways	PLOS ONE			English	Article							RECYCLING ENDOSOMES; PLASMA-MEMBRANE; PROTEIN; ACTIVATION; PROSTANOIDS; RESOLUTION; INDUCTION; BIOLOGY; FOCUS; J(2)	Ras proteins are crucial players in differentiation and oncogenesis and constitute important drug targets. The localization and activity of Ras proteins are highly dependent on posttranslational modifications at their C-termini. In addition to an isoprenylated cysteine, H-Ras, but not other Ras proteins, possesses two cysteine residues (C181 and C184) in the C-terminal hypervariable domain that act as palmitoylation sites in cells. Cyclopentenone prostaglandins (cyPG) are reactive lipidic mediators that covalently bind to H-Ras and activate H-Ras dependent pathways. Dienone cyPG, such as 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) and Delta(12)-PGJ(2) selectively bind to the H-Ras hypervariable domain. Here we show that these cyPG bind simultaneously C181 and C184 of H-Ras, thus potentially altering the conformational tendencies of the hypervariable domain. Based on these results, we have explored the capacity of several bifunctional cysteine reactive small molecules to bind to the hypervariable domain of H-Ras proteins. Interestingly, phenylarsine oxide (PAO), a widely used tyrosine phosphatase inhibitor, and dibromobimane, a cross-linking agent used for cysteine mapping, effectively bind H-Ras hypervariable domain. The interaction of PAO with H-Ras takes place in vitro and in cells and blocks modification of H-Ras by 15d-PGJ(2). Moreover, PAO treatment selectively alters H-Ras membrane partition and the pattern of H-Ras activation in cells, from the plasma membrane to endomembranes. These results identify H-Ras as a novel target for PAO. More importantly, these observations reveal that small molecules or reactive intermediates interacting with spatially vicinal cysteines induce intramolecular cross-linking of H-Ras C-terminus potentially contributing to the modulation of Ras-dependent pathways.	[Oeste, Clara L.; Diez-Dacal, Beatriz; Bray, Francesca; Garcia de Lacoba, Mario; Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain; [de la Torre, Beatriz G.; Andreu, David] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Ruiz-Sanchez, Antonio J.; Perez-Inestrosa, Ezequiel] Univ Malaga, Fac Sci, Dept Organ Chem, E-29071 Malaga, Spain; [Garcia-Dominguez, Carlota A.; Rojas, Jose M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Unidad Biol Celular, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Pompeu Fabra University; Universidad de Malaga; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Oeste, CL (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	dperezsala@cib.csic.es	Ruiz-Sánchez, Antonio Jesús/A-9145-2016; de la Torre, Beatriz G./N-6995-2019; Rojas, José M./AAA-3354-2021; Oeste, Clara/O-2873-2014; Rojas, José M/D-3718-2018; Andreu, David/I-4359-2014; de la Torre, Beatriz G/AAF-1419-2020; Ruiz-Sanchez, Antonio J/AAC-3192-2021; Perez-Inestrosa, Ezequiel/H-9801-2015; Perez-Sala, Dolores/L-5969-2014	Ruiz-Sánchez, Antonio Jesús/0000-0001-5272-4287; de la Torre, Beatriz G./0000-0001-8521-9172; Rojas, José M./0000-0002-7547-2825; Oeste, Clara/0000-0002-7035-132X; Rojas, José M/0000-0002-5383-3482; Andreu, David/0000-0002-6317-6666; Perez-Inestrosa, Ezequiel/0000-0001-7546-5273; Perez-Sala, Dolores/0000-0003-0600-665X	European Union [CM1001]; Ministerio de Ciencia e Innovacion and Red Tematica de Investigacion Cooperativa [SAF2009-11642]; Instituto de Salud Carlos III (Spain) [RD07/0064/0007, RD07/0064/0000]; Ministerio de Ciencia e Innovacion (Spain) [BIO2005-07592-CO2-02, BIO2008-04487-CO3-02, BES-2010-033718]; regional government of Catalunya [SGR2005-00494]; Fondo de Investigaciones Sanitarias-Intrasalud [PS09/00562]; Instituto de Salud Carlos III [RD06/0020/0003]; Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias-Beca de Formacion en Investigacion	European Union(European Commission); Ministerio de Ciencia e Innovacion and Red Tematica de Investigacion Cooperativa; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional government of Catalunya; Fondo de Investigaciones Sanitarias-Intrasalud; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias-Beca de Formacion en Investigacion	This work was supported by European Union Cooperation in the field of Scientific and Technical research (COST) Action CM1001, grant SAF2009-11642 from Ministerio de Ciencia e Innovacion and Red Tematica de Investigacion Cooperativa from Instituto de Salud Carlos III (Spain) RD07/0064/0007 to DP-S and RD07/0064/0000 to EP-I. Work at Universitat Pompeu Fabra was supported by grants BIO2005-07592-CO2-02 and BIO2008-04487-CO3-02 from Ministerio de Ciencia e Innovacion (Spain) to DA, and by the regional government of Catalunya (SGR2005-00494). JMR's work is supported by Fondo de Investigaciones Sanitarias-Intrasalud (PS09/00562) and Red Tematica de Investigacion Cooperativa RD06/0020/0003 from Instituto de Salud Carlos III, and the Spanish Association Against Cancer (AECC). CLO is the recipient of a predoctoral fellowship from the Formacion de Personal Investigador (FPI) program (Ministerio de Ciencia e Innovacion, Spain, BES-2010-033718). CAG-D is the recipient of a fellowship from Fondo de Investigaciones Sanitarias-Beca de Formacion en Investigacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker TL, 2000, J BIOL CHEM, V275, P22037, DOI 10.1074/jbc.M001813200; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Covian-Nares JF, 2008, DEV BIOL, V316, P135, DOI 10.1016/j.ydbio.2008.01.017; Diez-Dacal B, 2010, THESCIENTIFICWORLDJO, V10, P655, DOI 10.1100/tsw.2010.69; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gerhard R, 2003, MOL PHARMACOL, V63, P1349, DOI 10.1124/mol.63.6.1349; Gharbi S, 2007, J MASS SPECTROM, V42, P1474, DOI 10.1002/jms.1291; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Gomez GA, 2005, J BIOL CHEM, V280, P34997, DOI 10.1074/jbc.M506256200; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; He XQ, 2009, J BIOL CHEM, V284, P12609, DOI 10.1074/jbc.M901204200; Heo J, 2005, J MOL BIOL, V346, P1423, DOI 10.1016/j.jmb.2004.12.050; Ishii T, 2004, CHEM RES TOXICOL, V17, P1313, DOI 10.1021/tx049860+; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MEDEMA RH, 1991, J BIOL CHEM, V266, P21186; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Perez-Sala D, 1999, CELL DEATH DIFFER, V6, P722, DOI 10.1038/sj.cdd.4400557; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sanchez-Gomez FJ, 2010, MOL PHARMACOL, V78, P723, DOI 10.1124/mol.110.065391; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Sinz A, 2001, BIOCHEMISTRY-US, V40, P7903, DOI 10.1021/bi010259+; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Valero RA, 2010, TRAFFIC, V11, P1221, DOI 10.1111/j.1600-0854.2010.01091.x; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200	45	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15866	10.1371/journal.pone.0015866	http://dx.doi.org/10.1371/journal.pone.0015866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253588	Green Published, gold			2022-12-27	WOS:000286511900017
J	Luise, C; Capra, M; Donzelli, M; Mazzarol, G; Jodice, MG; Nuciforo, P; Viale, G; Di Fiore, PP; Confalonieri, S				Luise, Chiara; Capra, Maria; Donzelli, Maddalena; Mazzarol, Giovanni; Jodice, Maria Giovanna; Nuciforo, Paolo; Viale, Giuseppe; Di Fiore, Pier Paolo; Confalonieri, Stefano			An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; FANCONI-ANEMIA PATHWAY; BETA-CATENIN; BREAST-CANCER; DEUBIQUITYLATING ENZYMES; PROTEIN TRAFFICKING; CYSTEINE PROTEASES; THERAPY FAILURE; TGF-BETA; TUMOR	Background: Deubiquitinating enzymes (DUBs) are proteases that process ubiquitin (Ub) or ubiquitin-like gene products, remodel polyubiquitin(-like) chains on target proteins, and counteract protein ubiquitination exerted by E3 ubiquitin-ligases. A wealth of studies has established the relevance of DUBs to the control of physiological processes whose subversion is known to cause cellular transformation, including cell cycle progression, DNA repair, endocytosis and signal transduction. Altered expression of DUBs might, therefore, subvert both the proteolytic and signaling functions of the Ub system. Methodology/Principal Findings: In this study, we report the first comprehensive screening of DUB dysregulation in human cancers by in situ hybridization on tissue microarrays (ISH-TMA). ISH-TMA has proven to be a reliable methodology to conduct this kind of study, particularly because it allows the precise identification of the cellular origin of the signals. Thus, signals associated with the tumor component can be distinguished from those associated with the tumor microenvironment. Specimens derived from various normal and malignant tumor tissues were analyzed, and the "normal'' samples were derived, whenever possible, from the same patients from whom tumors were obtained. Of the similar to 90 DUBs encoded by the human genome, 33 were found to be expressed in at least one of the analyzed tissues, of which 22 were altered in cancers. Selected DUBs were subjected to further validation, by analyzing their expression in large cohorts of tumor samples. This analysis unveiled significant correlations between DUB expression and relevant clinical and pathological parameters, which were in some cases indicative of aggressive disease. Conclusions/Significance: The results presented here demonstrate that DUB dysregulation is a frequent event in cancer, and have implications for therapeutic approaches based on DUB inhibition.	[Luise, Chiara; Capra, Maria; Jodice, Maria Giovanna; Nuciforo, Paolo; Di Fiore, Pier Paolo; Confalonieri, Stefano] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Donzelli, Maddalena; Mazzarol, Giovanni; Viale, Giuseppe; Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy; [Viale, Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Luise, C (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; stefano.confalonieri@ifom-ieo-campus.it	Viale, Giuseppe/AAE-8921-2019; Confalonieri, Stefano/AAQ-6786-2020; Donzelli, Maddalena/ABD-3774-2020; Nuciforo, Paolo/Q-2885-2019; Capra, Maria/AAM-8054-2020; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; Nuciforo, Paolo/0000-0003-1380-0990; DONZELLI, MADDALENA/0000-0002-4045-0802; Iodice, Maria Giovanna/0000-0002-6173-1080	Associazione Italiana per la Ricerca sul Cancro; European Community; European Research Council; Italian Ministry of Education-University-Research (MIUR); Ferrari Foundation; Monzino Foundation; CARIPLO Foundation; Italian Ministry of Health	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Education-University-Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ferrari Foundation; Monzino Foundation; CARIPLO Foundation(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy)	The work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro, the European Community (FP6 and FP7), the European Research Council, the Italian Ministries of Education-University-Research (MIUR) and of Health, the Ferrari Foundation, the Monzino Foundation, and the CARIPLO Foundation to PPDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Akishima-Fukasawa Y, 2010, AM J CLIN PATHOL, V134, P71, DOI 10.1309/AJCPRJP39MIDSGBH; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Carolan BJ, 2006, CANCER RES, V66, P10729, DOI 10.1158/0008-5472.CAN-06-2224; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Dong YY, 2005, CLIN CANCER RES, V11, P259; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Glittenberg M, 2007, FLY, V1, P330, DOI 10.4161/fly.5399; Goldenberg SJ, 2008, BIOCHEM SOC T, V36, P828, DOI 10.1042/BST0360828; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Ivan D, 2004, MODERN PATHOL, V17, P811, DOI 10.1038/modpathol.3800123; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Liu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005544; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; LV L, 2010, MOL CELL BIOCH; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nabhan JF, 2006, J BIOL CHEM, V281, P16099, DOI 10.1074/jbc.M512086200; Nicassio F, 2005, J CLIN INVEST, V115, P3015, DOI 10.1172/JCI24862; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Osoegawa A, 2006, CANCER, V107, P154, DOI 10.1002/cncr.21961; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sasaki H, 2001, JPN J CLIN ONCOL, V31, P532, DOI 10.1093/jjco/hye113; Schwarz T, 2010, J CELL BIOCHEM, V109, P967, DOI 10.1002/jcb.22475; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Seki S, 2007, GENES CELLS, V12, P299, DOI 10.1111/j.1365-2443.2007.01054.x; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Watt FM, 2008, COLD SH Q B, V73, P503, DOI 10.1101/sqb.2008.73.011; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	75	75	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15891	10.1371/journal.pone.0015891	http://dx.doi.org/10.1371/journal.pone.0015891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283576	Green Published, gold			2022-12-27	WOS:000286661400017
J	Wang, L; Lai, LH; Qi, OY; Tang, C				Wang, Lu; Lai, Luhua; Qi Ouyang; Tang, Chao			Flux Balance Analysis of Ammonia Assimilation Network in E. coli Predicts Preferred Regulation Point	PLOS ONE			English	Article							INTERCONVERTIBLE ENZYME CASCADES; SIGNAL-TRANSDUCTION PROTEINS; ESCHERICHIA-COLI; GLUTAMINE-SYNTHETASE; SALMONELLA-TYPHIMURIUM; NITROGEN-METABOLISM; STOICHIOMETRIC MODEL; ALPHA-KETOGLUTARATE; BIOMASS COMPOSITION; KINETIC MECHANISM	Nitrogen assimilation is a critical biological process for the synthesis of biomolecules in Escherichia coli. The central ammonium assimilation network in E. coli converts carbon skeleton a-ketoglutarate and ammonium into glutamate and glutamine, which further serve as nitrogen donors for nitrogen metabolism in the cell. This reaction network involves three enzymes: glutamate dehydrogenase (GDH), glutamine synthetase (GS) and glutamate synthase (GOGAT). In minimal media, E. coli tries to maintain an optimal growth rate by regulating the activity of the enzymes to match the availability of the external ammonia. The molecular mechanism and the strategy of the regulation in this network have been the research topics for many investigators. In this paper, we develop a flux balance model for the nitrogen metabolism, taking into account of the cellular composition and biosynthetic requirements for nitrogen. The model agrees well with known experimental results. Specifically, it reproduces all the N-15 isotope labeling experiments in the wild type and the two mutant (Delta GDH and Delta GOGAT) strains of E. coli. Furthermore, the predicted catalytic activities of GDH, GS and GOGAT in different ammonium concentrations and growth rates for the wild type, Delta GDH and Delta GOGAT strains agree well with the enzyme concentrations obtained from western blots. Based on this flux balance model, we show that GS is the preferred regulation point among the three enzymes in the nitrogen assimilation network. Our analysis reveals the pattern of regulation in this central and highly regulated network, thus providing insights into the regulation strategy adopted by the bacteria. Our model and methods may also be useful in future investigations in this and other networks.	[Wang, Lu; Qi Ouyang] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Wang, Lu; Lai, Luhua; Qi Ouyang; Tang, Chao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Qi Ouyang] Hong Kong Baptist Univ, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Tang, Chao] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	Peking University; Peking University; Peking University; Hong Kong Baptist University; University of California System; University of California San Francisco	Wang, L (corresponding author), Peking Univ, Sch Phys, Beijing 100871, Peoples R China.	qi@pku.edu.cn; chao.tang@ucsf.edu		Tang, Chao/0000-0003-1474-3705	Natural Science Foundation of China [10721403]; Ministry of Science and Technology of China [2009CB918500]; U.S. National Science Foundation [0804183, 0941355]; Direct For Mathematical & Physical Scien [0804183] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by Natural Science Foundation of China (10721403), Ministry of Science and Technology of China (2009CB918500) and U.S. National Science Foundation (0804183; 0941355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL LM, 1991, BIOCHEMISTRY-US, V30, P1413, DOI 10.1021/bi00219a035; ALIBHAI M, 1994, BIOCHEMISTRY-US, V33, P682, DOI 10.1021/bi00169a008; Atkinson MR, 2002, J BACTERIOL, V184, P5358, DOI 10.1128/JB.184.19.5358-5363.2002; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bremer H, 1996, ESCHERICHIA COLI SAL; Bruggeman FJ, 2005, FEBS J, V272, P1965, DOI 10.1111/j.1742-4658.2005.04626.x; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; GINSBURG A, 1970, BIOCHEMISTRY-US, V9, P633, DOI 10.1021/bi00805a025; GOTTSCHALK G, 1986, BACTERIAL METABOLISM, pR13; Helling RB, 2002, J BACTERIOL, V184, P1041, DOI 10.1128/jb.184.4.1041-1045.2002; Helling RB, 1998, J BACTERIOL, V180, P4571, DOI 10.1128/JB.180.17.4571-4575.1998; HELLING RB, 1994, J BACTERIOL, V176, P4664, DOI 10.1128/JB.176.15.4664-4668.1994; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12795, DOI 10.1021/bi9802420; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12782, DOI 10.1021/bi980667m; Jiang P, 2007, BIOCHEMISTRY-US, V46, P4133, DOI 10.1021/bi0620510; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Khademi S, 2006, PHYSIOLOGY, V21, P419, DOI 10.1152/physiol.00051.2005; KLEINER D, 1985, FEBS LETT, V187, P237, DOI 10.1016/0014-5793(85)81249-7; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Lodeiro A, 2008, J BIOL PHYS, V34, P91, DOI 10.1007/s10867-008-9109-9; Maaloe O., 1979, BIOL REGUL DEV, V1, P487; Mathai JC, 2001, J BIOL CHEM, V276, P27266, DOI 10.1074/jbc.M103265200; MEEK TD, 1980, BIOCHEMISTRY-US, V19, P5513, DOI 10.1021/bi00565a008; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; Mutalik VK, 2007, BIOSYSTEMS, V90, P1, DOI 10.1016/j.biosystems.2006.06.003; Mutalik VK, 2003, J BIOL CHEM, V278, P26327, DOI 10.1074/jbc.M300129200; NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL, pR7; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Ortega F, 2002, MOL BIOL REP, V29, P211, DOI 10.1023/A:1020334014497; Phillips R, 2009, PHYS BIOL CELL, pxxiv; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Pramanik J, 1998, BIOTECHNOL BIOENG, V60, P230, DOI 10.1002/(SICI)1097-0290(19981020)60:2<230::AID-BIT10>3.0.CO;2-Q; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; REITZER L, 1996, ESCHERICHIA COLI SAL; RENDINA AR, 1978, BIOCHEMISTRY-US, V17, P5388, DOI 10.1021/bi00618a011; RHEE SG, 1978, P NATL ACAD SCI USA, V75, P3138, DOI 10.1073/pnas.75.7.3138; RITCHIE AWS, 1987, SEMIN NEPHROL, V7, P131; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHUTT H, 1972, EUR J BIOCHEM, V26, P68, DOI 10.1111/j.1432-1033.1972.tb01740.x; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; van Heeswijk WC, 2009, FEBS J, V276, P3324, DOI 10.1111/j.1742-4658.2009.07058.x; van Riel NAW, 1998, J THEOR BIOL, V191, P397, DOI 10.1006/jtbi.1997.0600; WHITE D, 2007, PHYSL BIOCH PROKARYO, pR19; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Yan DL, 1996, P NATL ACAD SCI USA, V93, P6527, DOI 10.1073/pnas.93.13.6527; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	61	8	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16362	10.1371/journal.pone.0016362	http://dx.doi.org/10.1371/journal.pone.0016362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283535	Green Published, gold			2022-12-27	WOS:000286661400045
J	de Vries, M; Deijs, M; Canuti, M; van Schaik, BDC; Faria, NR; van de Garde, MDB; Jachimowski, LCM; Jebbink, MF; Jakobs, M; Luyf, ACM; Coenjaerts, FEJ; Claas, ECJ; Molenkamp, R; Koekkoek, SM; Lammens, C; Leus, F; Goossens, H; Ieven, M; Baas, F; van der Hoek, L				de Vries, Michel; Deijs, Martin; Canuti, Marta; van Schaik, Barbera D. C.; Faria, Nuno R.; van de Garde, Martijn D. B.; Jachimowski, Loes C. M.; Jebbink, Maarten F.; Jakobs, Marja; Luyf, Angela C. M.; Coenjaerts, Frank E. J.; Claas, Eric C. J.; Molenkamp, Richard; Koekkoek, Sylvie M.; Lammens, Christine; Leus, Frank; Goossens, Herman; Ieven, Margareta; Baas, Frank; van der Hoek, Lia			A Sensitive Assay for Virus Discovery in Respiratory Clinical Samples	PLOS ONE			English	Article							INFECTIONS; COMMUNITY; CHILDREN; DISEASE; IDENTIFICATION; CORONAVIRUS; PNEUMONIA; DIAGNOSIS; ETIOLOGY; PCR	In 5-40% of respiratory infections in children, the diagnostics remain negative, suggesting that the patients might be infected with a yet unknown pathogen. Virus discovery cDNA-AFLP (VIDISCA) is a virus discovery method based on recognition of restriction enzyme cleavage sites, ligation of adaptors and subsequent amplification by PCR. However, direct discovery of unknown pathogens in nasopharyngeal swabs is difficult due to the high concentration of ribosomal RNA (rRNA) that acts as competitor. In the current study we optimized VIDISCA by adjusting the reverse transcription enzymes and decreasing rRNA amplification in the reverse transcription, using hexamer oligonucleotides that do not anneal to rRNA. Residual cDNA synthesis on rRNA templates was further reduced with oligonucleotides that anneal to rRNA but can not be extended due to 3'-dideoxy-C6-modification. With these modifications >90% reduction of rRNA amplification was established. Further improvement of the VIDISCA sensitivity was obtained by high throughput sequencing (VIDISCA-454). Eighteen nasopharyngeal swabs were analysed, all containing known respiratory viruses. We could identify the proper virus in the majority of samples tested (11/18). The median load in the VIDISCA-454 positive samples was 7.2 E5 viral genome copies/ml (ranging from 1.4 E3-7.7 E6). Our results show that optimization of VIDISCA and subsequent high-throughput-sequencing enhances sensitivity drastically and provides the opportunity to perform virus discovery directly in patient material.	[de Vries, Michel; Deijs, Martin; Canuti, Marta; Faria, Nuno R.; van de Garde, Martijn D. B.; Jachimowski, Loes C. M.; Jebbink, Maarten F.; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van Schaik, Barbera D. C.; Luyf, Angela C. M.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Jakobs, Marja; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Coenjaerts, Frank E. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Claas, Eric C. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Molenkamp, Richard; Koekkoek, Sylvie M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Clin Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Lammens, Christine; Goossens, Herman; Ieven, Margareta] Univ Antwerp, Univ Antwerp Hosp, Vaccine & Infect Dis Inst, Dept Med Microbiol, Antwerp, Belgium; [Leus, Frank] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Data Management, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Antwerp; Utrecht University; Utrecht University Medical Center	de Vries, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.m.vanderhoek@amc.uva.nl	Canuti, Marta/I-3145-2019; Faria, Nuno R/I-2975-2012; van der Hoek, Lia/Y-6412-2019; Baas, Frank/F-9574-2010	Canuti, Marta/0000-0002-9959-128X; Faria, Nuno R/0000-0001-8839-2798; Baas, Frank/0000-0003-3912-5428; van Schaik, Barbera/0000-0002-5568-8127; van de Garde, Martijn/0000-0003-0509-7713; Rodrigues Faria, Nuno/0000-0002-9747-8822	European Community (EC) [FP7/2007-2013, 223498, LSHM-CT-2005-518226]; Netherlands Organization for Scientific Research (NWO) [016.066.318]	European Community (EC)(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE, EC grant agreement number 223498, European Community's Sixth Framework Programme under the project GRACE, EC grant agreement number LSHM-CT-2005-518226 and VIDI grant 016.066.318 from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brilot F, 2004, J VIROL, V78, P9854, DOI 10.1128/JVI.78.18.9854-9861.2004; de Pol ACV, 2010, J CLIN MICROBIOL, V48, P3569, DOI 10.1128/JCM.00097-10; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Jubelt B, 2001, NEUROLOGY, V57, P945, DOI 10.1212/WNL.57.6.945; Leitch ECM, 2009, J CLIN VIROL, V44, P119, DOI 10.1016/j.jcv.2008.11.015; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Pyrc K, 2006, ANTIMICROB AGENTS CH, V50, P2000, DOI 10.1128/AAC.01598-05; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Scheltinga SA, 2005, J CLIN VIROL, V33, P306, DOI 10.1016/j.jcv.2004.08.021; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shingadia D, 2002, LANCET INFECT DIS, V2, P310, DOI 10.1016/S1473-3099(02)00265-7; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van de Pol AC, 2006, CRIT CARE, V10, DOI 10.1186/cc4895; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	25	66	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16118	10.1371/journal.pone.0016118	http://dx.doi.org/10.1371/journal.pone.0016118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283679	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400019
J	Tarazona-Santos, E; Castilho, L; Amaral, DRT; Costa, DC; Furlani, NG; Zuccherato, LW; Machado, M; Reid, ME; Zalis, MG; Rossit, AR; Santos, SEB; Machado, RL; Lustigman, S				Tarazona-Santos, Eduardo; Castilho, Lilian; Amaral, Daphne R. T.; Costa, Daiane C.; Furlani, Natalia G.; Zuccherato, Luciana W.; Machado, Moara; Reid, Marion E.; Zalis, Mariano G.; Rossit, Andrea R.; Santos, Sidney E. B.; Machado, Ricardo L.; Lustigman, Sara			Population Genetics of GYPB and Association Study between GYPB*S/s Polymorphism and Susceptibility to P. falciparum Infection in the Brazilian Amazon	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; ERYTHROCYTE INVASION PHENOTYPES; PLASMODIUM-FALCIPARUM; BLOOD-GROUP; MALARIA PARASITES; RED-CELLS; LINKAGE DISEQUILIBRIUM; ANTIGEN DANTU; HUMAN GENOME; GLYCOPHORIN	Background: Merozoites of Plasmodium falciparum invade through several pathways using different RBC receptors. Field isolates appear to use a greater variability of these receptors than laboratory isolates. Brazilian field isolates were shown to mostly utilize glycophorin A-independent invasion pathways via glycophorin B (GPB) and/or other receptors. The Brazilian population exhibits extensive polymorphism in blood group antigens, however, no studies have been done to relate the prevalence of the antigens that function as receptors for P. falciparum and the ability of the parasite to invade. Our study aimed to establish whether variation in the GYPB*S/s alleles influences susceptibility to infection with P. falciparum in the admixed population of Brazil. Methods: Two groups of Brazilian Amazonians from Porto Velho were studied: P. falciparum infected individuals (cases); and uninfected individuals who were born and/or have lived in the same endemic region for over ten years, were exposed to infection but have not had malaria over the study period (controls). The GPB Ss phenotype and GYPB*S/s alleles were determined by standard methods. Sixty two Ancestry Informative Markers were genotyped on each individual to estimate admixture and control its potential effect on the association between frequency of GYPB*S and malaria infection. Results: GYPB*S is associated with host susceptibility to infection with P. falciparum; GYPB*S/GYPB*S and GYPB*S/GYPB*s were significantly more prevalent in the in the P. falciparum infected individuals than in the controls (69.87% vs. 49.75%; P<0.02). Moreover, population genetics tests applied on the GYPB exon sequencing data suggest that natural selection shaped the observed pattern of nucleotide diversity. Conclusion: Epidemiological and evolutionary approaches suggest an important role for the GPB receptor in RBC invasion by P. falciparum in Brazilian Amazons. Moreover, an increased susceptibility to infection by this parasite is associated with the GPB S+ variant in this population.	[Tarazona-Santos, Eduardo; Zuccherato, Luciana W.; Machado, Moara] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Castilho, Lilian; Amaral, Daphne R. T.; Costa, Daiane C.] Hemoterapia Hemoctr Campinas, Lab Pesquisa, Sao Paulo, Brazil; [Furlani, Natalia G.; Rossit, Andrea R.; Machado, Ricardo L.] Fac Med Sao Jose do Rio Preto, Centro Invest Microrganismos, Sao Jose Do Rio Preto, Brazil; [Reid, Marion E.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Immunochem, New York, NY 10021 USA; [Zalis, Mariano G.] Univ Fed Rio de Janeiro, Lab Infectol & Parasitol Mol, Rio De Janeiro, Brazil; [Santos, Sidney E. B.] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol Lab, New York, NY 10021 USA	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); New York Blood Center; Universidade Federal do Rio de Janeiro; Universidade Federal do Para; New York Blood Center	Tarazona-Santos, E (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil.	slustigman@nybloodcenter.org	Tarazona-Santos, Eduardo/AAF-1110-2019; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014; Castilho, Lilian/F-6123-2012; Baptista, Andrea/N-2879-2017; Machado, Ricardo/GXM-8198-2022; baptista, Andrea/L-5970-2016; de Souza Baptista, Andrea Regina/AAA-2998-2019	Machado, Ricardo Luiz Dantas Dantas/0000-0002-8955-3204; Castilho, Lilian/0000-0002-3104-647X; Baptista, Andrea/0000-0002-0461-7521; baptista, Andrea/0000-0002-0461-7521; de Souza Baptista, Andrea Regina/0000-0002-0461-7521; Tarazona, Eduardo/0000-0003-3508-3160; Zalis, Mariano/0000-0002-6858-8483	National Institute of Allergy and Infectious Diseases, National Institutes of Health [5R03TW007349-3, 1R56AI069547-01A2]; New York Blood Center; Brazilian National Research Council (CNPq); Sao Paulo State Research Agency (FAPESP); Minas Gerais State Research Agency (FAPEMIG); Brazilian Ministry of Education (CAPES); Hematology and Hemotherapy Center - Hemocentro UNICAMP; National Institute of Science and Technology of Blood, Brazil (INCT do Sangue -CNPq / MCT / FAPESP); FOGARTY INTERNATIONAL CENTER [R03TW007349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069547] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York Blood Center; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Minas Gerais State Research Agency (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hematology and Hemotherapy Center - Hemocentro UNICAMP; National Institute of Science and Technology of Blood, Brazil (INCT do Sangue -CNPq / MCT / FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health number 5R03TW007349-3 and 1R56AI069547-01A2 to SL. This research was also supported in part by the intramural funding of the New York Blood Center to SL and by funding from Brazilian National Research Council (CNPq) to LC, ETS and MM; Sao Paulo State Research Agency (FAPESP) to LC, DRTA, DCC, NGF, ARBR, RLDM; Minas Gerais State Research Agency (FAPEMIG) to ETS, Brazilian Ministry of Education (CAPES) to LWZ. The Hematology and Hemotherapy Center - Hemocentro UNICAMP, forms part of the National Institute of Science and Technology of Blood, Brazil (INCT do Sangue -CNPq / MCT / FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Baleotti W, 2006, VOX SANG, V91, P81, DOI 10.1111/j.1423-0410.2006.00787.x; Baleotti W, 2003, VOX SANG, V84, P326, DOI 10.1046/j.1423-0410.2003.00297.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baum J, 2003, GENETICS, V163, P1327; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007; Beiguelman B, 2003, MEM I OSWALDO CRUZ, V98, P455, DOI 10.1590/S0074-02762003000400004; Blumenfeld OO, 1997, TRANSFUS CLIN BIOL, V4, P357, DOI 10.1016/S1246-7820(97)80041-9; BOOTH P B, 1972, Human Biology in Oceania, V1, P259; BOOTH PB, 1970, NATURE, V228, P462, DOI 10.1038/228462a0; BOOTH PB, 1982, HUM HERED, V32, P385, DOI 10.1159/000153328; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Castilho L, 2004, VOX SANG, V87, P190, DOI 10.1111/j.1423-0410.2004.00554.x; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Cavasini CE, 2006, HUM BIOL, V78, P215, DOI 10.1353/hub.2006.0034; CONRAD DF, NATURE, V464, P704; CONTRERAS M, 1984, VOX SANG, V46, P377, DOI 10.1111/j.1423-0410.1984.tb00102.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DAHR W, 1987, BIOL CHEM H-S, V368, P659, DOI 10.1515/bchm3.1987.368.1.659; DAHR W, 1986, RECENT ADV BLOOD GRO, P23; DASILVA MC, 2010, GENET MOL RES, V9, P2069; Deans AM, 2007, INFECT IMMUN, V75, P3014, DOI 10.1128/IAI.00249-07; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; FACER CA, 1983, B SOC PATHOL EXOT, V76, P463; FACER CA, 1983, T ROY SOC TROP MED H, V77, P524, DOI 10.1016/0035-9203(83)90130-X; FIELD SP, 1994, HUM GENET, V93, P148; FRASER GR, 1966, AM J HUM GENET, V18, P546; FU YX, 1993, GENETICS, V133, P693; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; HADLEY TJ, 1986, ANNU REV MICROBIOL, V40, P451, DOI 10.1146/annurev.mi.40.100186.002315; Haldane J. B. S, 1949, RICERCA SCIENTIFIC S, V19, P3; Hashmi G, 2005, TRANSFUSION, V45, P680, DOI 10.1111/j.1537-2995.2005.04362.x; Hashmi G, 2007, TRANSFUSION, V47, P736, DOI 10.1111/j.1537-2995.2007.01178.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HUANG CH, 1988, P NATL ACAD SCI USA, V85, P9640, DOI 10.1073/pnas.85.24.9640; Huang CH, 1997, BLOOD, V90, P391; Issitt, 1998, APPL BLOOD GROUP SER; Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Li N, 2003, GENETICS, V165, P2213; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; LOWE RF, 1972, HUM HERED, V22, P344, DOI 10.1159/000152509; MACGREGOR A, 1973, VOX SANG, V25, P474, DOI 10.1111/j.1423-0410.1973.tb03540.x; MACHADO M, 2010, INVESTIGATI IN PRESS; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; MCGHEE RB, 1953, J EXP MED, V97, P773, DOI 10.1084/jem.97.6.773; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1994, P NATL ACAD SCI USA, V91, P2415, DOI 10.1073/pnas.91.7.2415; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1977, J EXP MED, V146, P277, DOI 10.1084/jem.146.1.277; Montgomery KT, 2008, CURR PROTOC HUM GENE; Montoya Fabiola, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P33, DOI 10.1590/S0036-46651994000100006; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Omoto R, 2008, Immunohematology, V24, P148; PASVOL G, 1984, PHILOS T ROY SOC B, V307, P189, DOI 10.1098/rstb.1984.0119; PASVOL G, 1982, NATURE, V297, P64, DOI 10.1038/297064a0; PASVOL G, 1982, LANCET, V2, P947; Patel SS, 2004, AM J HEMATOL, V75, P1, DOI 10.1002/ajh.10448; PATEL SS, 2004, MULTIPLE ERYTHROCYTE, V913, P2004; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reid ME, 1996, TRANSFUSION, V36, P719, DOI 10.1046/j.1537-2995.1996.36896374376.x; Reid ME., 2012, BLOOD GROUP ANTIGEN; Sabeti P, 2008, NATURE ED, V1; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SERJEANTSON SW, 1994, IMMUNOL CELL BIOL, V72, P23, DOI 10.1038/icb.1994.4; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Storry JR, 2003, TRANSFUSION, V43, p1A; Storry JR, 2001, TRANSFUSION, V41, P269, DOI 10.1046/j.1537-2995.2001.41020269.x; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; UNGER P, 1987, BLUT, V55, P33, DOI 10.1007/BF00319639; VOS G H, 1971, South African Journal of Medical Sciences, V36, P1; Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weatherall DJ, 1996, PARASITOLOGY, V112, pS23, DOI 10.1017/S0031182000076630; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	90	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16123	10.1371/journal.pone.0016123	http://dx.doi.org/10.1371/journal.pone.0016123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283638	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400021
J	Velthuis, AJWT; Sakalis, PA; Fowler, DA; Bagowski, CP				Velthuis, Aartjan J. W. te; Sakalis, Philippe A.; Fowler, Donald A.; Bagowski, Christoph P.			Genome-Wide Analysis of PDZ Domain Binding Reveals Inherent Functional Overlap within the PDZ Interaction Network	PLOS ONE			English	Article							PEPTIDE INTERACTIONS; ESCHERICHIA-COLI; PROTEIN; PROMISCUITY; RECOGNITION; SPECIFICITY; SELECTIVITY; PHOSPHORYLATION; CLASSIFICATION; ORGANIZATION	Binding selectivity and cross-reactivity within one of the largest and most abundant interaction domain families, the PDZ family, has long been enigmatic. The complete human PDZ domain complement (the PDZome) consists of 267 domains and we applied here a Bayesian selectivity model to predict hundreds of human PDZ domain interactions, using target sequences of 22,997 non-redundant proteins. Subsequent analysis of these binding scores shows that PDZs can be divided into two genome-wide clusters that coincide well with the division between canonical class 1 and 2 PDZs. Within the class 1 PDZs we observed binding overlap at unprecedented levels, mediated by two residues at positions 1 and 5 of the second alpha-helix of the binding pocket. Eight PDZ domains were subsequently selected for experimental binding studies and to verify the basics of our predictions. Overall, the PDZ domain class 1 cross-reactivity identified here implies that auxiliary mechanisms must be in place to overcome this inherent functional overlap and to minimize cross-selectivity within the living cell. Indeed, when we superimpose PDZ domain binding affinities with gene ontologies, network topology data and the domain position within a PDZ superfamily protein, functional overlap is minimized and PDZ domains position optimally in the binding space. We therefore propose that PDZ domain selectivity is achieved through cellular context rather than inherent binding specificity.	[Velthuis, Aartjan J. W. te] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Velthuis, Aartjan J. W. te] Delft Univ Technol, Dept Bionanosci, Delft, Netherlands; [Sakalis, Philippe A.; Fowler, Donald A.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Bagowski, Christoph P.] German Univ Cairo, Inst Pharm & Biotechnol, New Cairo City, Egypt	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University - Excl LUMC; Egyptian Knowledge Bank (EKB); German University in Cairo	Velthuis, AJWT (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.	christoph.bagowski@guc.edu.eg	Velthuis, AJ te/H-7981-2019	Velthuis, AJ te/0000-0002-5129-3953	Nederlands Organization for Scientific Research (NWO) [021.001.037]	Nederlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	AV is supported by a Toptalent grant from the Nederlands Organization for Scientific Research (NWO) via grant 021.001.037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Harris BZ, 2001, J CELL SCI, V114, P3219; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hu ZJ, 2007, NAT BIOTECHNOL, V25, P547, DOI 10.1038/nbt1304; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Inaba K, 2008, J BIOL CHEM, V283, P35042, DOI 10.1074/jbc.M806603200; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Pallen MJ, 1997, MOL MICROBIOL, V26, P411, DOI 10.1046/j.1365-2958.1997.5591911.x; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; Schillinger C, 2009, BIOINFORMATICS, V25, P1632, DOI 10.1093/bioinformatics/btp264; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; Velthuis AJWT, 2008, CURR GENOMICS, V9, P88, DOI 10.2174/138920208784139537; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	46	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16047	10.1371/journal.pone.0016047	http://dx.doi.org/10.1371/journal.pone.0016047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283644	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400013
J	Baliga, SS; Merrill, GF; Shinohara, ML; Denhardt, DT				Baliga, Sunanda S.; Merrill, Gary F.; Shinohara, Mari L.; Denhardt, David T.			Osteopontin Expression during Early Cerebral Ischemia-Reperfusion in Rats: Enhanced Expression in the Right Cortex Is Suppressed by Acetaminophen	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; MESSENGER-RNA; POSTISCHEMIC REPERFUSION; STRESS RESPONSES; GENE-EXPRESSION; UP-REGULATION; BRAIN; INFLAMMATION; INFARCTION	Osteopontin (OPN) is a pleiotropic protein implicated in various inflammatory responses including ischemia-reperfusion (I-R) injury. Two distinct forms of the protein have been identified: an extensively studied secreted form (sOPN) and a less-well-known intracellular form (iOPN). Studies have shown that increased OPN expression parallels the time course of macrophage infiltration into injured tissue, a late event in the development of cerebral infarcts. sOPN has been suggested to promote remodeling of the extracellular matrix in the brain; the function of iOPN may be to facilitate certain signal transduction processes. Here, we studied OPN expression in adult male Sprague-Dawley rats subjected to global forebrain I-R injury. We found iOPN in the cytoplasm of both cortices and the hippocampus, but unexpectedly only the right cortex exhibited a marked increase in the iOPN level after 45 min of reperfusion. Acetaminophen, a drug recently shown to decrease apoptotic incidence, caspase-9 activation, and mitochondrial dysfunction during global I-R, significantly inhibited the increase in iOPN protein in the right cortex, suggesting a role for iOPN in the response to I-R injury in the right cortex.	[Baliga, Sunanda S.; Merrill, Gary F.; Denhardt, David T.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Div Immunol, Durham, NC 27710 USA	Rutgers State University New Brunswick; Duke University	Baliga, SS (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	denhardt@biology.rutgers.edu		Shinohara, Mari/0000-0002-6808-9844	Johnson & Johnson Corporate Office of Science and Technology/McNeil; J&J Corporate Office of Science and Technology; McNeil; JJ-owned company; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088100] Funding Source: NIH RePORTER	Johnson & Johnson Corporate Office of Science and Technology/McNeil(Johnson & JohnsonJohnson & Johnson USA); J&J Corporate Office of Science and Technology; McNeil; JJ-owned company; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by a donation from Mrs. J. G. Harrar and from Johnson & Johnson Corporate Office of Science and Technology/McNeil Consumer Specialty Products (http://www.jnj.com) to Gary F. Merrill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; G.F. Merrill was funded by J&J Corporate Office of Science and Technology in 1992-1995 (Focused Funding, adenosine research) and again in 2001-2003 (Seed Grant, acetaminophen in the heart). This was not contract research and Merrill was not a consultant for J&J nor was he ever employed by them. The experiments described herein were funded, in part, by McNeil, and J&J-owned company. Merrill has never been employed by McNeil, is not currently a consultant for them, nor has any conflict of interest related to them and this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; Baliga SS, 2010, BRAIN RES, V1319, P142, DOI 10.1016/j.brainres.2010.01.013; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; GLICK SD, 1979, LIFE SCI, V25, P395, DOI 10.1016/0024-3205(79)90272-8; GRAY H, 1973, GRAYS ANATOMY, V14; Holtz ML, 2001, BRAIN RES, V898, P49, DOI 10.1016/S0006-8993(01)02140-0; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; HWANG S, 1994, J BIOL CHEM, V269, P711; INOUE M, 2010, IMMUNOL RES IN PRESS; Iwanaga Y, 2008, NEUROPATH APPL NEURO, V34, P145, DOI 10.1111/j.1365-2990.2007.00877.x; Kang WS, 2008, BRAIN RES, V1228, P208, DOI 10.1016/j.brainres.2008.06.106; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P925, DOI 10.1002/jcb.21487; Kleinschnitz C, 2003, J CEREBR BLOOD F MET, V23, P1356, DOI 10.1097/01.WCB.0000090505.76664.DB; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; KOLB B, 2010, DEV PSYCHOBIOL  1124; Kristofikova Z, 2010, NEUROCHEM RES, V35, P1138, DOI 10.1007/s11064-010-0165-8; Lajtha A., 2007, HDB NEUROCHEMISTRY M; Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; PARIKH RM, 1988, STROKE, V19, P472, DOI 10.1161/01.STR.19.4.472; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; ROBINSON RG, 1980, BRAIN RES, V188, P63, DOI 10.1016/0006-8993(80)90557-0; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; SAMARA A, 2009, HIPPOCAMPUS     1217; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; SINGH K, 1995, J BIOL CHEM, V270, P28471; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SORIANO MA, 1995, BRAIN RES, V670, P317, DOI 10.1016/0006-8993(94)01352-I; Spalletta G, 2002, J NEUROL, V249, P1541, DOI 10.1007/s00415-002-0885-z; Sullivan RM, 1999, J NEUROSCI, V19, P2834; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang XK, 1998, J NEUROSCI, V18, P2075; Westedt U, 2004, EUR J PHARM BIOPHARM, V58, P161, DOI 10.1016/j.ejpb.2004.03.009; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WU B, 2010, NEUROCRIT CARE  0504; Wung JK, 2007, CURR ALZHEIMER RES, V4, P67, DOI 10.2174/156720507779939869; Yokasaki Y, 2000, TRENDS CARDIOVAS MED, V10, P155, DOI 10.1016/S1050-1738(00)00055-4; ZHANG ZG, 1993, STROKE, V24, P2016, DOI 10.1161/01.STR.24.12.2016	48	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14568	10.1371/journal.pone.0014568	http://dx.doi.org/10.1371/journal.pone.0014568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283687	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300006
J	Hu, S; Dong, TS; Dalal, SR; Wu, F; Bissonnette, M; Kwon, JH; Chang, EB				Hu, Shien; Dong, Tien Sy; Dalal, Sushila R.; Wu, Feng; Bissonnette, Marc; Kwon, John H.; Chang, Eugene B.			The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC-CANCER; MICRORNAS; CELLS; INHIBITION; PHENOTYPE; PROMOTER; CLONING; ARREST	Colonic microbiota ferment non-absorbed dietary fiber to produce prodigious amounts of short chain fatty acids (SCFAs) that benefit the host through a myriad of metabolic, trophic, and chemopreventative effects. The chemopreventative effects of the SCFA butyrate are, in part, mediated through induction of p21 gene expression. In this study, we assessed the role of microRNA(miRNA) in butyrate's induction of p21 expression. The expression profiles of miRNAs in HCT-116 cells and in human sporadic colon cancers were assessed by microarray and quantitative PCR. Regulation of p21 gene expression by miR-106b was assessed by 3' UTR luciferase reporter assays and transfection of specific miRNA mimics. Butyrate changed the expression of 44 miRNAs in HCT-116 cells, many of which were aberrantly expressed in colon cancer tissues. Members of the miR-106b family were decreased in the former and increased in the latter. Butyrate-induced p21 protein expression was dampened by treatment with a miR-106b mimic. Mutated p21 3'UTR-reporter constructs expressed in HCT-116 cells confirmed direct miR-106b targeting. Butyrate decreased HCT-116 proliferation, an effect reversed with the addition of the miR-106b mimic. We conclude that microbe-derived SCFAs regulate host gene expression involved in intestinal homeostasis as well as carcinogenesis through modulation of miRNAs.	[Hu, Shien; Dong, Tien Sy; Dalal, Sushila R.; Wu, Feng; Bissonnette, Marc; Kwon, John H.; Chang, Eugene B.] Univ Chicago, Dept Med, Martin Boyer Labs, Chicago, IL 60637 USA	University of Chicago	Hu, S (corresponding author), Univ Chicago, Dept Med, Martin Boyer Labs, 5841 S Maryland Ave, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu		Dong, Tien/0000-0003-0105-8063	Human Microbiome Project [DK083993, HG004858, R37 DK47722, K08 DK078046]; Digestive Disease Research Core Center of the University of Chicago [DK-42086]; Gastro-intestinal Research Foundation Associates' Board; Crohn's and Colitis Foundation of America [T35 DK62719, T32 DK07074]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH3DK083993, T32DK007074, P30DK042086, UH2DK083993, T35DK062719, R37DK047722, K08DK078046] Funding Source: NIH RePORTER	Human Microbiome Project; Digestive Disease Research Core Center of the University of Chicago(University of Chicago); Gastro-intestinal Research Foundation Associates' Board; Crohn's and Colitis Foundation of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Human Microbiome Project (DK083993, HG004858), R37 DK47722 (EBC), K08 DK078046 (JHK), the Digestive Disease Research Core Center DK-42086 of the University of Chicago, and the Gastro-intestinal Research Foundation Associates' Board (SRD). Trainees were supported by a Research Fellowship Award from the Crohn's and Colitis Foundation of America (SH), T35 DK62719 (TSD), and (SRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dahm CC, 2010, JNCI-J NATL CANCER I, V102, P614, DOI 10.1093/jnci/djq092; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lee EM, 2009, INT J MOL MED, V24, P45, DOI 10.3892/ijmm_00000204; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Ogino S, 2009, CANCER EPIDEM BIOMAR, V18, P2513, DOI 10.1158/1055-9965.EPI-09-0451; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saito Y, 2009, J GASTROENTEROL, V44, P18, DOI 10.1007/s00535-008-2285-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Weaver GA, 1997, J NUTR, V127, P717, DOI 10.1093/jn/127.5.717; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	33	151	166	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16221	10.1371/journal.pone.0016221	http://dx.doi.org/10.1371/journal.pone.0016221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283757	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200038
J	Lin, XZ; Liang, DG; He, ZH; Deng, QA; Robertson, ES; Lan, K				Lin, Xianzhi; Liang, Deguang; He, Zhiheng; Deng, Qiang; Robertson, Erle S.; Lan, Ke			miR-K12-7-5p Encoded by Kaposi's Sarcoma-Associated Herpesvirus Stabilizes the Latent State by Targeting Viral ORF50/RTA	PLOS ONE			English	Article							RBP-J-KAPPA; TRANSCRIPTIONAL REGULATION; LYTIC REACTIVATION; MICRORNAS; GENE; RTA; IDENTIFICATION; EXPRESSION; RNA; REPLICATION	Seventeen miRNAs encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) have been identified and their functions have begun to be characterized. Among these miRNAs, we report here that miR-K12-7 directly targets the replication and transcription activator (RTA) encoded by open reading frame 50. We found that miR-K12-7 targeted the RTA 39 untranslated region (RTA3'UTR) in a seed sequence-dependent manner. miR-K12-7-5p derived from miR-K12-7 mediates the inhibition of RTA expression, and the mutation of the seed match site totally abrogated the inhibitory effect of miR-K12-7 on RTA3'UTR. The inhibition of RTA expression by miR-K12-7 was further confirmed in the latently KSHV-infected 293/Bac36 cell line through transient transfection of miR-K12-7 expression plasmid or specific inhibitor of miR-K12-7-5p, respectively. The transient transfection of miR-K12-7 into 293/Bac36 cells reduced RTA expression and the expression of the downstream early genes regulated by RTA, and also the production of progeny virus was significantly reduced after treatment with chemical inducers. Our study revealed that another miRNA, miR-K12-7-5p, targets the viral immediate early gene RTA and that this miRNA contributes to the maintenance of viral latency.	[Lin, Xianzhi; Liang, Deguang; He, Zhiheng; Deng, Qiang; Lan, Ke] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Robertson, Erle S.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Robertson, Erle S.] Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lin, XZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	lanke@sibs.ac.cn	Lin, Xianzhi/O-2130-2017; HE, ZHIHENG/E-4354-2016	Lin, Xianzhi/0000-0001-9802-9896; Lan, Ke/0000-0002-0384-8598; HE, ZHIHENG/0000-0002-0088-178X	Natural Science Foundation of China [30770098, 30970154]; 973 program of China [2011CB504800]; Pu Jiang Talent Program (A) [08PJ14103]; Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of China(National Basic Research Program of China); Pu Jiang Talent Program (A); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors are grateful to SA-SIBS Scholarship program. This was supported by grants from the 100 Talent Program of the Chinese Academy of Sciences, Natural Science Foundation of China (30770098 and 30970154), 973 program of China (No. 2011CB504800), and the Pu Jiang Talent Program (A) (08PJ14103) to KL. KL is a special fellow and ESR is a scholar of the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; Chen JG, 2000, J VIROL, V74, P8623, DOI 10.1128/JVI.74.18.8623-8634.2000; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; Liu YH, 2008, VIROLOGY, V380, P264, DOI 10.1016/j.virol.2008.08.011; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; McAllister SC, 2005, J VIROL, V79, P2626, DOI 10.1128/JVI.79.4.2626-2630.2005; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Zhang L, 1998, DNA CELL BIOL, V17, P735; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	29	98	105	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16224	10.1371/journal.pone.0016224	http://dx.doi.org/10.1371/journal.pone.0016224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283761	gold, Green Published			2022-12-27	WOS:000286522200040
J	Tarabbo, M; Lapa, D; Castilletti, C; Tommaselli, P; Guarducci, R; Luca, G; Emanuele, A; Zaccaria, O; La Gioia, VFP; Girardi, E; Capobianchi, MR; Ippolito, G				Tarabbo, Mario; Lapa, Daniele; Castilletti, Concetta; Tommaselli, Pietro; Guarducci, Riccardo; Luca, Giuditta; Emanuele, Alessandro; Zaccaria, Onofrio; La Gioia, Vincenzo F. P.; Girardi, Enrico; Capobianchi, Maria R.; Ippolito, Giuseppe			Retrospective Investigation of an Influenza A/H1N1pdm Outbreak in an Italian Military Ship Cruising in the Mediterranean Sea, May-September 2009	PLOS ONE			English	Article								Background: Clinical surveillance may have underestimated the real extent of the spread of the new strain of influenza A/H1N1, which surfaced in April 2009 originating the first influenza pandemic of the 21(st) century. Here we report a serological investigation on an influenza A/H1N1pdm outbreak in an Italian military ship while cruising in the Mediterranean Sea (May 24-September 6, 2009). Methods: The contemporary presence of HAI and CF antibodies was used to retrospectively estimate the extent of influenza A/H1N1pdm spread across the crew members (median age: 29 years). Findings: During the cruise, 2 crew members fulfilled the surveillance case definition for influenza, but only one was laboratory confirmed by influenza A/H1N1pdm-specific RT-PCR; 52 reported acute respiratory illness (ARI) episodes, and 183 reported no ARI episodes. Overall, among the 211 crew member for whom a valid serological result was available, 39.3% tested seropositive for influenza A/H1N1pdm. The proportion of seropositives was significantly associated with more crowded living quarters and tended to be higher in those aged <40 and in those reporting ARI or suspected/confirmed influenza A/H1N1pdm compared to the asymptomatic individuals. No association was found with previous seasonal influenza vaccination. Conclusions: These findings underline the risk for rapid spread of novel strains of influenza A in confined environment, such as military ships, where crowding, rigorous working environment, physiologic stress occur. The high proportion of asymptomatic infections in this ship-borne outbreak supports the concept that serological surveillance in such semi-closed communities is essential to appreciate the real extent of influenza A/H1N1pdm spread and can constitute, since the early stage of a pandemic, an useful model to predict the public health impact of pandemic influenza and to establish proportionate and effective countermeasures.	[Tarabbo, Mario] ITA Navy, Inspectorate Hlth, Rome, Italy; [Lapa, Daniele; Castilletti, Concetta; Capobianchi, Maria R.] Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy; [Guarducci, Riccardo; Emanuele, Alessandro] ITA Navy, Mil Hosp, Taranto, Italy; [Zaccaria, Onofrio; La Gioia, Vincenzo F. P.] ITA Def Gen Staff, Med Situat Awareness Off, Rome, Italy; [Girardi, Enrico; Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani, Dept Epidemiol, Rome, Italy; [Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani, Sci Direct, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Tarabbo, M (corresponding author), ITA Navy, Inspectorate Hlth, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/AAA-8408-2019; Ippolito, Giuseppe/J-7207-2017; Castilletti, Concetta/B-6545-2016	Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Ippolito, Giuseppe/0000-0002-1076-2979; Girardi, Enrico/0000-0001-8182-5896	Italian Ministry of Health; Ricerca Corrente; Ricerca Finalizzata	Italian Ministry of Health(Ministry of Health, Italy); Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work has been partly supported by the Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond N. B., 2009, Medical Surveillance Montly Report, V16, P8; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2010, MMWR-MORBID MORTAL W, V51, P1440; *CDCP, 2010, MMWR-MORBID MORTAL W, V6, P162; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Dill CE, 2009, DISASTER MED PUBLIC, V3, pS117, DOI 10.1097/DMP.0b013e3181bf249b; FIELD AM, 1967, J HYG-CAMB, V65, P409, DOI 10.1017/S0022172400045927; Ikonen N, 2010, EURO SURVEILL, V15; Lennette EH, 1979, DIAGNOSTIC PROCEDURE; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; LOUIE JK, 2009, JAMA-J AM MED ASSOC, V17, P1896; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MORGAN OW, 2010, EID, V4, P631; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Pebody RG, 2010, EUROSURVEILLANCE, V15; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; ROSS T, 2010, PLOS CURR INFLUENZA, V24; *WHO, WHOCDSCRS20025; World Health Organization, CDC PROT REALT RT PC; 2010, NEJM, V18, P1708	24	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15933	10.1371/journal.pone.0015933	http://dx.doi.org/10.1371/journal.pone.0015933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283749	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200018
J	Chao, DY; Cheng, KF; Li, TC; Wu, TN; Chen, CY; Tsai, CA; Chen, JH; Chiu, HT; Lu, JJ; Su, MC; Liao, YH; Chan, WC; Hsieh, YH				Chao, Day-Yu; Cheng, Kuang-Fu; Li, Tsai-Chung; Wu, Trong-Neng; Chen, Chiu-Ying; Tsai, Chen-An; Chen, Jin-Hwa; Chiu, Hsien-Tsai; Lu, Jang-Jih; Su, Mei-Chi; Liao, Yu-Hsin; Chan, Wei-Cheng; Hsieh, Ying-Hen			Serological Evidence of Subclinical Transmission of the 2009 Pandemic H1N1 Influenza Virus Outside of Mexico	PLOS ONE			English	Article							A H1N1; EPIDEMIOLOGY; INFECTION; ANTIBODY	Background: Relying on surveillance of clinical cases limits the ability to understand the full impact and severity of an epidemic, especially when subclinical cases are more likely to be present in the early stages. Little is known of the infection and transmissibility of the 2009 H1N1 pandemic influenza (pH1N1) virus outside of Mexico prior to clinical cases being reported, and of the knowledge pertaining to immunity and incidence of infection during April-June, which is essential for understanding the nature of viral transmissibility as well as for planning surveillance and intervention of future pandemics. Methodology/Principal Findings: Starting in the fall of 2008, 306 persons from households with schoolchildren in central Taiwan were followed sequentially and serum samples were taken in three sampling periods for haemagglutination inhibition (HI) assay. Age-specific incidence rates were calculated based on seroconversion of antibodies to the pH1N1 virus with an HI titre of 1: 40 or more during two periods: April-June and September-October in 2009. The earliest time period with HI titer greater than 40, as well as a four-fold increase of the neutralization titer, was during April 26-May 3. The incidence rates during the pre-epidemic phase (April-June) and the first wave (July-October) of the pandemic were 14.1% and 29.7%, respectively. The transmissibility of the pH1N1 virus during the early phase of the epidemic, as measured by the effective reproductive number R-0, was 1.16 (95% confidence interval (CI): 0.98-1.34). Conclusions: Approximately one in every ten persons was infected with the 2009 pH1N1 virus during the pre-epidemic phase in April-June. The lack of age-pattern in seropositivity is unexpected, perhaps highlighting the importance of children as asymptomatic transmitters of influenza in households. Although without virological confirmation, our data raise the question of whether there was substantial pH1N1 transmission in Taiwan before June, when clinical cases were first detected by the surveillance network.	[Chao, Day-Yu; Liao, Yu-Hsin; Chan, Wei-Cheng] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Cheng, Kuang-Fu; Li, Tsai-Chung; Tsai, Chen-An; Chen, Jin-Hwa; Chiu, Hsien-Tsai] China Med Univ, CMU Biostat Ctr, Taichung, Taiwan; [Li, Tsai-Chung; Wu, Trong-Neng; Tsai, Chen-An; Chen, Jin-Hwa; Hsieh, Ying-Hen] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Wu, Trong-Neng; Chen, Chiu-Ying; Chiu, Hsien-Tsai; Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lu, Jang-Jih] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lu, Jang-Jih; Su, Mei-Chi] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chao, DY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010; Chao, Day-Yu/AFH-8360-2022; Li, Tsai-Chung/P-2052-2015	Chao, Day-Yu/0000-0001-7139-026X; Li, Tsai-Chung/0000-0002-3346-7462; Tsai, Chen-An/0000-0002-7490-4331	National Science Council of Taiwan [NSC 97-2118-M-039-004]; China Medical University, Taiwan [CMU 97 323]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This study was supported by National Science Council of Taiwan (NSC 97-2118-M-039-004) and China Medical University, Taiwan (CMU 97 323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter R, 2010, EMERG INFECT DIS, V16, P504, DOI 10.3201/eid1603.091285; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Boelle PY, 2009, EURO SURVEILL, V14; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Principi N, 2004, LANCET INFECT DIS, V4, P75, DOI 10.1016/S1473-3099(04)00926-0; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yang JR, 2010, VIRUS RES, V151, P33, DOI 10.1016/j.virusres.2010.03.011; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14555	10.1371/journal.pone.0014555	http://dx.doi.org/10.1371/journal.pone.0014555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267441	gold, Green Submitted, Green Published			2022-12-27	WOS:000286519500022
J	Inostroza-Ponta, M; Berretta, R; Moscato, P				Inostroza-Ponta, Mario; Berretta, Regina; Moscato, Pablo			QAPgrid: A Two Level QAP-Based Approach for Large-Scale Data Analysis and Visualization	PLOS ONE			English	Article							MEMETIC ALGORITHM; GENETIC ALGORITHM; ASSIGNMENT; SEARCH; LAYOUT	Background: The visualization of large volumes of data is a computationally challenging task that often promises rewarding new insights. There is great potential in the application of new algorithms and models from combinatorial optimisation. Datasets often contain "hidden regularities" and a combined identification and visualization method should reveal these structures and present them in a way that helps analysis. While several methodologies exist, including those that use non-linear optimization algorithms, severe limitations exist even when working with only a few hundred objects. Methodology/Principal Findings: We present a new data visualization approach (QAPgrid) that reveals patterns of similarities and differences in large datasets of objects for which a similarity measure can be computed. Objects are assigned to positions on an underlying square grid in a two-dimensional space. We use the Quadratic Assignment Problem (QAP) as a mathematical model to provide an objective function for assignment of objects to positions on the grid. We employ a Memetic Algorithm (a powerful metaheuristic) to tackle the large instances of this NP-hard combinatorial optimization problem, and we show its performance on the visualization of real data sets. Conclusions/Significance: Overall, the results show that QAPgrid algorithm is able to produce a layout that represents the relationships between objects in the data set. Furthermore, it also represents the relationships between clusters that are feed into the algorithm. We apply the QAPgrid on the 84 Indo-European languages instance, producing a near-optimal layout. Next, we produce a layout of 470 world universities with an observed high degree of correlation with the score used by the Academic Ranking of World Universities compiled in the The Shanghai Jiao Tong University Academic Ranking of World Universities without the need of an ad hoc weighting of attributes. Finally, our Gene Ontology-based study on Saccharomyces cerevisiae fully demonstrates the scalability and precision of our method as a novel alternative tool for functional genomics.	[Inostroza-Ponta, Mario] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Inostroza-Ponta, Mario; Moscato, Pablo] Australian Res Ctr Excellence Bioinformat, Callaghan, NSW, Australia; [Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarkers Discovery & Informat B, Callaghan, NSW 2308, Australia; [Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Informat Based Med Program, Hunter Med Res Inst, New Lambton Hts, Australia	Universidad de Santiago de Chile; University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Inostroza-Ponta, M (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Inostroza-Ponta, Mario/G-7548-2012	Moscato, Pablo/0000-0003-2570-5966; Inostroza-Ponta, Mario/0000-0003-1295-8972; Berretta, Regina/0000-0002-4420-3446	Australian Research Council Centre of Excellence in Bioinformatics; Australian Research Council [DP0559755]; Universidad de Santiago de Chile; Departamento de Investigaciones Cientificas y Tecnologicas [060919IP]; University of Newcastle's Strategic Initiative	Australian Research Council Centre of Excellence in Bioinformatics(Australian Research Council); Australian Research Council(Australian Research Council); Universidad de Santiago de Chile; Departamento de Investigaciones Cientificas y Tecnologicas; University of Newcastle's Strategic Initiative	This project was supported by the the Australian Research Council Centre of Excellence in Bioinformatics (PM) and Australian Research Council Discovery project DP0559755 titled "Evolutionary algorithms for problems in functional genomics data analysis" (PM and RB). The authors also thank for support Universidad de Santiago de Chile (MIP), the Departamento de Investigaciones Cientificas y Tecnologicas project 060919IP and The University of Newcastle's Strategic Initiative Fund (project: Newcastle Bioinformatics Initiative), 2003-2007 (PM, RB, MIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the support of the ARC Centre of Excellence in Bioinformatics and the DICYT-USACH (060919IP).	Abbiw-Jackson R, 2006, COMPUT OPER RES, V33, P3070, DOI 10.1016/j.cor.2005.01.020; Ahuja RK, 2000, COMPUT OPER RES, V27, P917, DOI 10.1016/S0305-0548(99)00067-2; Battiti R., 1994, ORSA Journal on Computing, V6, P126, DOI 10.1287/ijoc.6.2.126; Berretta R, 2004, INT J PROD ECON, V87, P67, DOI 10.1016/S0925-5273(03)00093-8; Berretta R, 1999, NEW IDEAS OPTIMIZATI, P261; Bryant D., 2005, EVOLUTION CULTURAL D, P67; Buriol L, 2004, J HEURISTICS, V10, P483, DOI 10.1023/B:HEUR.0000045321.59202.52; Capp A, 2009, RADIOTHER ONCOL, V90, P400, DOI 10.1016/j.radonc.2008.09.019; CARRIZO J, 1992, P 21 M INF OR BUEN A; Demirel NC, 2006, APPL MATH COMPUT, V183, P427, DOI 10.1016/j.amc.2006.05.073; DICKEY JW, 1972, TRANSPORT RES, V6, P59, DOI 10.1016/0041-1647(72)90111-6; Drezner Z, 2003, INFORMS J COMPUT, V15, P320, DOI 10.1287/ijoc.15.3.320.16076; Drezner Z, 2008, COMPUT OPER RES, V35, P717, DOI 10.1016/j.cor.2006.05.004; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELSHAFEI AN, 1977, OPER RES QUART, V28, P167, DOI 10.2307/3008789; FLEURENT C, 1994, DIMACS SERIES MATH T, V16, P190; Franca PM, 2005, COMPUT IND ENG, V48, P491, DOI 10.1016/j.cie.2003.11.004; Gambardella LM, 1999, J OPER RES SOC, V50, P167, DOI 10.2307/3010565; Glover F., 1997, TABU SEARCH; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156; Inostroza-Ponta M, 2006, INT FED INFO PROC, V217, P179; James T, 2009, EUR J OPER RES, V195, P810, DOI 10.1016/j.ejor.2007.06.061; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; KOOPMANS TC, 1957, ECONOMETRICA, V25, P53, DOI 10.2307/1907742; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; Loiola EM, 2007, EUR J OPER RES, V176, P657, DOI 10.1016/j.ejor.2005.09.032; MARGISON S, 2007, 16 ANN NZ INT ED C; Mendes A, 2005, INT CONF PARA PROC, P604, DOI 10.1109/ICPPW.2005.34; Merz P., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P2063, DOI 10.1109/CEC.1999.785529; Merz P, 2000, IEEE T EVOLUT COMPUT, V4, P337, DOI 10.1109/4235.887234; Miranda G, 2005, COMPUT OPER RES, V32, P2937, DOI 10.1016/j.cor.2004.04.014; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Moscato P., 1993, Annals of Operations Research, V41, P85, DOI 10.1007/BF02022564; MOSCATO P, 2003, HDB METAHEURISTICS, P105; Moscato P., 2002, HDB APPL OPTIMIZATIO; MOSCATO P, WILEY ENCY IN PRESS; Rabak CS, 2003, ADV ENG INFORM, V17, P95, DOI 10.1016/j.aei.2003.08.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; *STANF U SGD, 2007, GEN ONT TERM FIND; TAILLARD E, 1991, PARALLEL COMPUT, V17, P443, DOI 10.1016/S0167-8191(05)80147-4; *YWORKS GMBH, 2004, YED JAV GRAPH ED	44	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14468	10.1371/journal.pone.0014468	http://dx.doi.org/10.1371/journal.pone.0014468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267077	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500001
J	Kitamura, N; Nakamura, Y; Miyamoto, Y; Miyamoto, T; Kabu, K; Yoshida, M; Futamura, M; Ichinose, S; Arakawa, H				Kitamura, Noriaki; Nakamura, Yasuyuki; Miyamoto, Yuji; Miyamoto, Takafumi; Kabu, Koki; Yoshida, Masaki; Futamura, Manabu; Ichinose, Shizuko; Arakawa, Hirofumi			Mieap, a p53-Inducible Protein, Controls Mitochondrial Quality by Repairing or Eliminating Unhealthy Mitochondria	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; AUTOPHAGIC DEGRADATION; TUMOR-SUPPRESSOR; MITOPHAGY; NIX; P53; HOMEOSTASIS; MATURATION; APOPTOSIS; PARKIN	Maintenance of healthy mitochondria prevents aging, cancer, and a variety of degenerative diseases that are due to the result of defective mitochondrial quality control (MQC). Recently, we discovered a novel mechanism for MQC, in which Mieap induces intramitochondrial lysosome-like organella that plays a critical role in the elimination of oxidized mitochondrial proteins (designated MALM for Mieap-induced accumulation of lysosome-like organelles within mitochondria). However, a large part of the mechanisms for MQC remains unknown. Here, we report additional mechanisms for Mieap-regulated MQC. Reactive oxygen species (ROS) scavengers completely inhibited MALM. A mitochondrial outer membrane protein NIX interacted with Mieap in a ROS-dependent manner via the BH3 domain of NIX and the coiled-coil domain of Mieap. Deficiency of NIX also completely impaired MALM. When MALM was inhibited, Mieap induced vacuole-like structures (designated as MIV for Mieap-induced vacuole), which engulfed and degraded the unhealthy mitochondria by accumulating lysosomes. The inactivation of p53 severely impaired both MALM and MIV generation, leading to accumulation of unhealthy mitochondria. These results suggest that (1) mitochondrial ROS and NIX are essential factors for MALM, (2) MIV is a novel mechanism for lysosomal degradation of mitochondria, and (3) the p53-Mieap pathway plays a pivotal role in MQC by repairing or eliminating unhealthy mitochondria via MALM or MIV generation, respectively.	[Kitamura, Noriaki; Nakamura, Yasuyuki; Miyamoto, Yuji; Miyamoto, Takafumi; Kabu, Koki; Yoshida, Masaki; Futamura, Manabu; Arakawa, Hirofumi] Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo, Japan	National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan.	harakawa@ncc.go.jp	Miyamoto, Takafumi/T-6950-2019; Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638; Miyamoto, Takafumi/0000-0001-9363-2864; Miyamoto, Yuji/0000-0003-3948-5044; Kabu, Koki/0000-0003-2753-4259	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [23591966] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant support was provided by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Ministry of Health, Labor and Welfare for the 3rd-Term Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Devenish RJ, 2007, AUTOPHAGY, V3, P293, DOI 10.4161/auto.4273; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Futamura M, 2007, CANCER RES, V67, P1451, DOI 10.1158/0008-5472.CAN-06-2485; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Kissova I, 2006, FREE RADICAL BIO MED, V41, P1655, DOI 10.1016/j.freeradbiomed.2006.08.012; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Masuda Yoshiko, 2006, J Hum Genet, V51, P652, DOI 10.1007/s10038-006-0004-6; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Mijaljica D, 2007, AUTOPHAGY, V3, P417, DOI 10.4161/auto.4441; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohi N, 1999, CELL DEATH DIFFER, V6, P314, DOI 10.1038/sj.cdd.4400493; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tomiyama A, 2006, JNCI-J NATL CANCER I, V98, P1462, DOI 10.1093/jnci/djj395; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	41	71	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16060	10.1371/journal.pone.0016060	http://dx.doi.org/10.1371/journal.pone.0016060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264228	gold, Green Published, Green Submitted			2022-12-27	WOS:000286517600020
J	Reinhard, H; Vu, TKL; Ohlin, M; Hengel, H; Trilling, M				Reinhard, Henrike; Vu Thuy Khanh Le; Ohlin, Mats; Hengel, Hartmut; Trilling, Mirko			Exploitation of Herpesviral Transactivation Allows Quantitative Reporter Gene-Based Assessment of Virus Entry and Neutralization	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS-INFECTION; THYMIDINE KINASE GENE; TRANSFORMED L-CELLS; SIMPLEX-VIRUS; IMMUNOGLOBULIN-G; MICRONEUTRALIZATION ASSAY; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN-D; FC-RECEPTOR; EXPRESSION	Herpesviral entry is a highly elaborated process requiring many proteins to act in precise conjunction. Neutralizing antibodies interfere with this process to abrogate viral infection. Based on promoter transactivation of a reporter gene we established a novel method to quantify herpesvirus entry and neutralization by antibodies. Following infection with mouse and human cytomegalovirus and Herpes simplex virus 1 we observed promoter transactivation resulting in substantial luciferase expression (>1000-fold). No induction was elicited by UV-inactivated viruses. The response was MOI-dependent and immunoblots confirmed a correlation between luciferase induction and pp72-IE1 expression. Monoclonal antibodies, immune sera and purified immunoglobulin preparations decreased virus-dependent luciferase induction dose-dependently, qualifying this approach as surrogate virus neutralization test. Besides the reduced hands-on time, this assay allows analysis of herpesvirus entry in semi-permissive and non-adherent cells, which were previously non-assessable but play significant roles in herpesvirus pathology.	[Reinhard, Henrike; Vu Thuy Khanh Le; Hengel, Hartmut; Trilling, Mirko] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Ohlin, Mats] Lund Univ, Dept Immunotechnol, Lund, Sweden	Heinrich Heine University Dusseldorf; Lund University	Reinhard, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Univ Canc Ctr Hamburg, Dept Internal Med 2, Hamburg, Germany.	hartmut.hengel@uni-duesseldorf.de; mirko.trilling@uni-duesseldorf.de	Ohlin, Mats/A-7307-2010; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020; Trilling, Mirko/AAL-3533-2021	Ohlin, Mats/0000-0002-5105-1938; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; Trilling, Mirko/0000-0003-3659-3541	Deutsche Forschungsgemeinschaft [GK1045, He2526/6-2]; European Commission [FP6-037517]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants of the Deutsche Forschungsgemeinschaft through GK1045 and He2526/6-2 and by the European Commission FP6-037517 'Targetherpes'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abai AM, 2007, J IMMUNOL METHODS, V322, P82, DOI 10.1016/j.jim.2007.02.001; ANDREONI M, 1989, J VIROL METHODS, V23, P157, DOI 10.1016/0166-0934(89)90129-8; Antonsson A, 2001, J GEN VIROL, V82, P1137, DOI 10.1099/0022-1317-82-5-1137; Atalay R, 2002, J VIROL, V76, P8596, DOI 10.1128/JVI.76.17.8596-8608.2002; BAUCKE RB, 1979, J VIROL, V32, P779, DOI 10.1128/JVI.32.3.779-789.1979; BOPPANA SB, 1992, J CLIN MICROBIOL, V30, P721, DOI 10.1128/JCM.30.3.721-723.1992; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Burkhardt C, 2009, J GEN VIROL, V90, P1951, DOI 10.1099/vir.0.010967-0; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Eggers M, 1998, J MED VIROL, V56, P351, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;351::AID-JMV11&gt;3.0.CO;2-K; Eggers M, 2001, J MED VIROL, V63, P135, DOI 10.1002/1096-9071(20000201)63:2&lt;135::AID-JMV1008&gt;3.0.CO;2-P; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Le VTK, 2008, J GEN VIROL, V89, P1131, DOI 10.1099/vir.0.83538-0; LEIDEN JM, 1976, J VIROL, V20, P413, DOI 10.1128/JVI.20.2.413-424.1976; Lilley BN, 2001, J VIROL, V75, P11218, DOI 10.1128/JVI.75.22.11218-11221.2001; LIN SS, 1974, J VIROL, V14, P1199, DOI 10.1128/JVI.14.5.1199-1208.1974; Lopez M, 2000, J VIROL, V74, P1267, DOI 10.1128/JVI.74.3.1267-1274.2000; Marshall EE, 2009, J INTERF CYTOK RES, V29, P609, DOI 10.1089/jir.2009.0064; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Nicola AV, 1998, J VIROL, V72, P3595, DOI 10.1128/JVI.72.5.3595-3601.1998; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; OHE Y, 1995, HUM GENE THER, V6, P325, DOI 10.1089/hum.1995.6.3-325; OHLIN M, 1993, J VIROL, V67, P703, DOI 10.1128/JVI.67.2.703-710.1993; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; PEREIRA L, 1980, INFECT IMMUN, V29, P724; Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47; RODRIGUEZ JE, 1987, ARCH VIROL, V94, P177, DOI 10.1007/BF01310712; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Sprague ER, 2008, J VIROL, V82, P3490, DOI 10.1128/JVI.01476-07; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2007, P NATL ACAD SCI USA, V104, P20037, DOI 10.1073/pnas.0709704104; Wang XQ, 2003, J VIROL, V77, P7182, DOI 10.1128/JVI.77.13.7182-7192.2003	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14532	10.1371/journal.pone.0014532	http://dx.doi.org/10.1371/journal.pone.0014532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264213	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600008
J	Jin, Z; Jin, Y; Kumar-Mendu, S; Degerman, E; Groop, L; Birnir, B				Jin, Zhe; Jin, Yang; Kumar-Mendu, Suresh; Degerman, Eva; Groop, Leif; Birnir, Bryndis			Insulin Reduces Neuronal Excitability by Turning on GABA(A) Channels that Generate Tonic Current	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; A RECEPTORS; INHIBITION; CELLS; ACTIVATION; MEMORY; BRAIN; MICE	Insulin signaling to the brain is important not only for metabolic homeostasis but also for higher brain functions such as cognition. GABA (c-aminobutyric acid) decreases neuronal excitability by activating GABA(A) channels that generate phasic and tonic currents. The level of tonic inhibition in neurons varies. In the hippocampus, interneurons and dentate gyrus granule cells normally have significant tonic currents under basal conditions in contrast to the CA1 pyramidal neurons where it is minimal. Here we show in acute rat hippocamal slices that insulin (1 nM) "turns on" new extrasynaptic GABA(A) channels in CA1 pyramidal neurons resulting in decreased frequency of action potential firing. The channels are activated by more than million times lower GABA concentrations than synaptic channels, generate tonic currents and show outward rectification. The single-channel current amplitude is related to the GABA concentration resulting in a single-channel GABA affinity (EC50) in intact CA1 neurons of 17 pM with the maximal current amplitude reached with 1 nM GABA. They are inhibited by GABA(A) antagonists but have novel pharmacology as the benzodiazepine flumazenil and zolpidem are inverse agonists. The results show that tonic rather than synaptic conductances regulate basal neuronal excitability when significant tonic conductance is expressed and demonstrate an unexpected hormonal control of the inhibitory channel subtypes and excitability of hippocampal neurons. The insulin-induced new channels provide a specific target for rescuing cognition in health and disease.	[Jin, Zhe; Jin, Yang; Kumar-Mendu, Suresh; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Degerman, Eva; Groop, Leif] Lund Univ, Lund Univ Diabet Ctr, Lund, Sweden	Uppsala University; Lund University	Jin, Z (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Jin, Zhe/C-5150-2008	Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266; Mendu, Suresh Kumar/0000-0002-6785-0806	Uppsala University; Swedish Research Council; LUDC; Segerfalks Foundation; Pahlsons Foundation; Fredrik and Ingrid Thurings Foundation; EXODIAB; Svenska Sallskapet	Uppsala University; Swedish Research Council(Swedish Research CouncilEuropean Commission); LUDC; Segerfalks Foundation; Pahlsons Foundation; Fredrik and Ingrid Thurings Foundation; EXODIAB; Svenska Sallskapet	This work is supported by Uppsala University, Swedish Research Council, LUDC, the Segerfalks Foundation, the Pahlsons Foundation and Fredrik and Ingrid Thurings Foundation. ZJ held a Swedish Research Council, EXODIAB and Svenska Sallskapet for Medicinsk Forskning postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; BIRNIR B, 1994, J MEMBRANE BIOL, V142, P93; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chisalita SI, 2006, GROWTH HORM IGF RES, V16, P258, DOI 10.1016/j.ghir.2006.06.003; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; de Groote L, 2007, NEUROSCIENCE, V148, P794, DOI 10.1016/j.neuroscience.2007.06.030; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Ju YH, 2009, J NEUROSCI RES, V87, P1737, DOI 10.1002/jnr.21991; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Martin LJ, 2009, BIOCHEM SOC T, V37, P1334, DOI 10.1042/BST0371334; PALOVCIK RA, 1984, BRAIN RES, V309, P187, DOI 10.1016/0006-8993(84)91028-X; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; PRUT L, 2010, GENES BRAIN BEHAV; Ronnemaa E, 2008, NEUROLOGY, V71, P1065, DOI 10.1212/01.wnl.0000310646.32212.3a; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Seaquist ER, 2010, DIABETES, V59, P4, DOI 10.2337/db09-1600; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Tschritter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001196; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792	31	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16188	10.1371/journal.pone.0016188	http://dx.doi.org/10.1371/journal.pone.0016188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264261	Green Published, Green Submitted, gold			2022-12-27	WOS:000286516500036
J	Sueur, C				Sueur, Cedric			A Non-Levy Random Walk in Chacma Baboons: What Does It Mean?	PLOS ONE			English	Article							MOVEMENT PATTERNS; SPATIAL MEMORY; RESOURCES; CONTEXT; RANGE	The Levy walk is found from amoebas to humans and has been described as the optimal strategy for food research. Recent results, however, have generated controversy about this conclusion since animals also display alternatives to the Levy walk such as the Brownian walk or mental maps and because movement patterns found in some species only seem to depend on food patches distribution. Here I show that movement patterns of chacma baboons do not follow a Levy walk but a Brownian process. Moreover this Brownian walk is not the main process responsible for movement patterns of baboons. Findings about their speed and trajectories show that baboons use metal maps and memory to find resources. Thus the Brownian process found in this species appears to be more dependent on the environment or might be an alternative when known food patches are depleted and when animals have to find new resources.	[Sueur, Cedric] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sueur, Cedric] Free Univ Brussels, Unit Social Ecol, Brussels, Belgium	Princeton University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Sueur, C (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	csueur@ulb.ac.be	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	Alsace region; Franco-American Commission; Fyssen Foundation	Alsace region(Region Grand-Est); Franco-American Commission; Fyssen Foundation	This study was funded by the Alsace region (http://www.region-alsace.eu/), the Franco-American Commission and the Fyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RPD, 2002, OIKOS, V98, P134, DOI 10.1034/j.1600-0706.2002.980114.x; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boinski S., 2000, MOVE WHY ANIMALS TRA; Boyer D, 2004, PHYSICA A, V342, P329, DOI 10.1016/j.physa.2004.04.091; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Dai XH, 2007, J MAMMAL, V88, P151, DOI 10.1644/06-MAMM-A-035R1.1; Einstein A, 1956, INVESTIGATIONS THEOR; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Garber PA, 1997, FOLIA PRIMATOL, V68, P236, DOI 10.1159/000157250; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Janson CH, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P309; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Kummer H., 1968, SOCIAL ORG HAMADRYAS; KUMMER H, 1971, ALDINE T; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; MACDONALD SE, 1990, J COMP PSYCHOL, V104, P382, DOI 10.1037/0735-7036.104.4.382; MENZEL CR, 1991, ANIM BEHAV, V41, P397, DOI 10.1016/S0003-3472(05)80840-1; MENZEL CR, 1996, AM J OF PRIMATOLOGY, P117; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Pombo AR, 2004, LAND USE NATURE CONS, P313; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Riley EP, 2008, AM J PRIMATOL, V70, P670, DOI 10.1002/ajp.20543; Schreier AL, 2010, ANIM BEHAV, V80, P75, DOI 10.1016/j.anbehav.2010.04.002; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; SIGG H, 1981, FOLIA PRIMATOL, V36, P40, DOI 10.1159/000156008; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; THOMAN DR, 1969, TECHNOMETRICS, V11, P445, DOI 10.2307/1267019; Tomasello M, 1997, PRIMATE COGNITION; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zuberbuhler K., 2010, FORAGING COGNITION N	34	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16131	10.1371/journal.pone.0016131	http://dx.doi.org/10.1371/journal.pone.0016131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249200	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000021
J	Walia, G; Gajendar, K; Surolia, A				Walia, Guneet; Gajendar, Komatireddy; Surolia, Avadhesha			Identification of Critical Residues of the Mycobacterial Dephosphocoenzyme A Kinase by Site-Directed Mutagenesis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ATP-BINDING; A KINASE; ESCHERICHIA-COLI; ADENYLATE KINASE; P-LOOP; ENZYME; SEQUENCES; PROTEINS; SYNTHASE	Dephosphocoenzyme A kinase performs the transfer of the c-phosphate of ATP to dephosphocoenzyme A, catalyzing the last step of coenzyme A biosynthesis. This enzyme belongs to the P-loop-containing NTP hydrolase superfamily, all members of which posses a three domain topology consisting of a CoA domain that binds the acceptor substrate, the nucleotide binding domain and the lid domain. Differences in the enzymatic organization and regulation between the human and mycobacterial counterparts, have pointed out the tubercular CoaE as a high confidence drug target (HAMAP database). Unfortunately the absence of a three-dimensional crystal structure of the enzyme, either alone or complexed with either of its substrates/regulators, leaves both the reaction mechanism unidentified and the chief players involved in substrate binding, stabilization and catalysis unknown. Based on homology modeling and sequence analysis, we chose residues in the three functional domains of the enzyme to assess their contributions to ligand binding and catalysis using site-directed mutagenesis. Systematically mutating the residues from the P-loop and the nucleotide-binding site identified Lys14 and Arg140 in ATP binding and the stabilization of the phosphoryl intermediate during the phosphotransfer reaction. Mutagenesis of Asp32 and Arg140 showed catalytic efficiencies less than 5-10% of the wild type, indicating the pivotal roles played by these residues in catalysis. Non-conservative substitution of the Leu114 residue identifies this leucine as the critical residue from the hydrophobic cleft involved in leading substrate, DCoA binding. We show that the mycobacterial enzyme requires the Mg(2+) for its catalytic activity. The binding energetics of the interactions of the mutant enzymes with the substrates were characterized in terms of their enthalpic and entropic contributions by ITC, providing a complete picture of the effects of the mutations on activity. The properties of mutants defective in substrate recognition were consistent with the ordered sequential mechanism of substrate addition for CoaE.	[Walia, Guneet; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Gajendar, Komatireddy; Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Walia, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in		KOMATI REDDY, GAJENDAR/0000-0002-1471-4966	Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	This work was supported by a Centre of Excellence grant from the Department of Biotechnology (DBT), Government of India to AS and by another Department of Science and Technology (DST), Government of India grant to AS. AS is also a J. C. Bose Fellow of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Berry MB, 1998, PROTEINS, V32, P276, DOI 10.1002/(SICI)1097-0134(19980815)32:3<276::AID-PROT3>3.0.CO;2-G; Cantwell JS, 2001, BIOCHEMISTRY-US, V40, P3056, DOI 10.1021/bi0020980; DELEPELAIRE P, 1994, J BIOL CHEM, V269, P27952; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Driscoll WJ, 1995, P NATL ACAD SCI USA, V92, P12328, DOI 10.1073/pnas.92.26.12328; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; JEYAKANTHAN J, 2007, CRYSTAL STR IN PRESS; Kraft L, 2002, J MOL BIOL, V318, P1057, DOI 10.1016/S0022-2836(02)00215-2; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; O'Toole N, 2003, PROTEIN SCI, V12, P327, DOI 10.1110/ps.0227803; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; Seto A, 2005, PROTEINS, V58, P235, DOI 10.1002/prot.20276; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Walia G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007645; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15228	10.1371/journal.pone.0015228	http://dx.doi.org/10.1371/journal.pone.0015228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264299	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000286514000003
J	Edwards, CJ; Ginja, C; Kantanen, J; Perez-Pardal, L; Tresset, A; Stock, F; Gama, LT; Penedo, MCT; Bradley, DG; Lenstra, JA; Nijman, IJ				Edwards, Ceiridwen J.; Ginja, Catarina; Kantanen, Juha; Perez-Pardal, Lucia; Tresset, Anne; Stock, Frauke; Gama, Luis T.; Penedo, M. Cecilia T.; Bradley, Daniel G.; Lenstra, Johannes A.; Nijman, Isaac J.		European Cattle Genetic Diversity	Dual Origins of Dairy Cattle Farming - Evidence from a Comprehensive Survey of European Y-Chromosomal Variation	PLOS ONE			English	Article							GENETIC DIVERSITY; BOS-TAURUS; DOMESTIC CATTLE; LINKAGE MAP; MITOCHONDRIAL; DNA; AFRICAN; MARKERS; BREEDS; EVOLUTION	Background: Diversity patterns of livestock species are informative to the history of agriculture and indicate uniqueness of breeds as relevant for conservation. So far, most studies on cattle have focused on mitochondrial and autosomal DNA variation. Previous studies of Y-chromosomal variation, with limited breed panels, identified two Bos taurus (taurine) haplogroups (Y1 and Y2; both composed of several haplotypes) and one Bos indicus (indicine/zebu) haplogroup (Y3), as well as a strong phylogeographic structuring of paternal lineages. Methodology and Principal Findings: Haplogroup data were collected for 2087 animals from 138 breeds. For 111 breeds, these were resolved further by genotyping microsatellites INRA189 (10 alleles) and BM861 (2 alleles). European cattle carry exclusively taurine haplotypes, with the zebu Y-chromosomes having appreciable frequencies in Southwest Asian populations. Y1 is predominant in northern and north-western Europe, but is also observed in several Iberian breeds, as well as in Southwest Asia. A single Y1 haplotype is predominant in north-central Europe and a single Y2 haplotype in central Europe. In contrast, we found both Y1 and Y2 haplotypes in Britain, the Nordic region and Russia, with the highest Y-chromosomal diversity seen in the Iberian Peninsula. Conclusions: We propose that the homogeneous Y1 and Y2 regions reflect founder effects associated with the development and expansion of two groups of dairy cattle, the pied or red breeds from the North Sea and Baltic coasts and the spotted, yellow or brown breeds from Switzerland, respectively. The present Y1-Y2 contrast in central Europe coincides with historic, linguistic, religious and cultural boundaries.	[Edwards, Ceiridwen J.; Stock, Frauke; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Edwards, Ceiridwen J.] Univ Oxford, Res Lab Archaeol, Oxford, England; [Ginja, Catarina; Penedo, M. Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Ginja, Catarina; Gama, Luis T.] Inst Nacl Recursos Biol, Dept Genet Melhoramento Anim & Reprod, Fonte Boa, Vale Santarem, Portugal; [Kantanen, Juha] MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland; [Perez-Pardal, Lucia] SERIDA, Area Genet & Reprod Anim, Gijon, Spain; [Tresset, Anne] Museum Natl Hist Nat, CNRS, Paris, France; [Lenstra, Johannes A.; Nijman, Isaac J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Trinity College Dublin; University of Oxford; University of California System; University of California Davis; Natural Resources Institute Finland (Luke); Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Utrecht University	Edwards, CJ (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	J.A.Lenstra@uu.nl	Bradley, Daniel G/A-3240-2012; gautier, mathieu/F-7429-2010; Cuppen, Edwin/F-5696-2011; Edwards, Ceiridwen/F-8855-2010; Gama, Luis T/N-4172-2018; gautier, mathieu/AAU-8789-2020; Longeri, Maria/L-1557-2017; Goyache, Felix/B-7764-2009; Cuppen, Edwin/H-2389-2016; Simianer, Henner/A-6574-2015; Holm, Lars-Erik/A-4678-2013; Lenstra, Johannes A./H-2988-2019; Kantanen, Juha/AAA-4333-2022	gautier, mathieu/0000-0001-7257-5880; Cuppen, Edwin/0000-0002-0400-9542; Edwards, Ceiridwen/0000-0001-9126-1377; Gama, Luis T/0000-0003-3894-3488; gautier, mathieu/0000-0001-7257-5880; Longeri, Maria/0000-0001-7863-1855; Goyache, Felix/0000-0002-6872-1045; Cuppen, Edwin/0000-0002-0400-9542; Simianer, Henner/0000-0002-7551-3797; Holm, Lars-Erik/0000-0002-5312-3579; Lenstra, Johannes A./0000-0003-1745-7739; Bradley, Daniel G/0000-0001-7335-7092; Perez Pardal, Lucia/0000-0002-9751-6550; Laloe, Denis/0000-0001-8359-0760; Nijman, Isaac/0000-0002-1840-1158; Williams, John/0000-0001-5188-7957; Ginja, Catarina/0000-0003-2278-7089; Medugorac, Ivica/0000-0002-6891-3039	Enterprise Ireland Basic Research Grants Programme [SC/1999/409, SC/2002/510]; Fundacao Portuguesa para a Ciencia e a Tecnologia [SFRH/BD/13502/2003]; Academy of Finland; Finnish Ministry of Agriculture and Forestry; European Union [98-118 (1999-2002)]; Wellcome Trust [047485/Z/96/Z]; CNRS, France;  [BES-2006-13545]	Enterprise Ireland Basic Research Grants Programme; Fundacao Portuguesa para a Ciencia e a Tecnologia; Academy of Finland(Academy of Finland); Finnish Ministry of Agriculture and Forestry; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); CNRS, France(Centre National de la Recherche Scientifique (CNRS)); 	CJE was supported by the Enterprise Ireland Basic Research Grants Programme (project numbers SC/1999/409 and SC/2002/510). CG was supported by a grant from Fundacao Portuguesa para a Ciencia e a Tecnologia (Ref. SFRH/BD/13502/2003). JK was supported by the Academy of Finland and the Finnish Ministry of Agriculture and Forestry (SUNARE-program and 'Russia in Flux' program). LP-P was supported by grant BES-2006-13545. Collection of several samples was supported by the Resgen project 98-118 (1999-2002) funded by the European Union. This work was also part-funded by The Wellcome Trust (grant no. 047485/Z/96/Z), and a Eurocores OMLL Programme Grant via CNRS, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; BAKER CMA, 1980, GENETICS, V11, P127; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; Beja-Pereira A, 2003, J HERED, V94, P243, DOI 10.1093/jhered/esg055; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; BISHOP MD, 1994, GENETICS, V136, P619; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; BRADLEY DG, 1994, ANIM GENET, V25, P7, DOI 10.1111/j.1365-2052.1994.tb00048.x; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Caroli A, 2010, J DAIRY SCI, V93, P1260, DOI 10.3168/jds.2009-2521; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Edwards CJ, 2007, ANIM GENET, V38, P520, DOI 10.1111/j.1365-2052.2007.01638.x; Edwards CJ, 2000, ANIM GENET, V31, P127, DOI 10.1046/j.1365-2052.2000.00602.x; FABER JA, 1962, MEDEDELINGEN LANDBOU, V12, P1; Felius M., 1995, CATTLE BREEDS ENCY; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Ginja C, 2009, J HERED, V100, P148, DOI 10.1093/jhered/esn080; Ginja C, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-18; Ginja C, 2010, J HERED, V101, P201, DOI 10.1093/jhered/esp104; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Healy J. F, 1991, PLINY ELDER NATURAL; Ibeagha-Awemu EM, 2006, TROP ANIM HEALTH PRO, V38, P431, DOI 10.1007/s11250-006-4347-y; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JONES HL, 1924, LOEB CLASSICAL LIB G; Kantanen J, 2009, HEREDITY, V103, P404, DOI 10.1038/hdy.2009.68; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; Laloe D., 2010, Diversity, V2, P932, DOI 10.3390/d2060932; Li MH, 2010, ANIM GENET, V41, P150, DOI 10.1111/j.1365-2052.2009.01980.x; Li MH, 2007, MOL ECOL, V16, P3839, DOI 10.1111/j.1365-294X.2007.03437.x; LOFTUS RT, 1994, ANIM GENET, V25, P265, DOI 10.1111/j.1365-2052.1994.tb00203.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacHugh DE, 1997, GENETICS, V146, P1071; MARCHAND G, 2005, MARGES GRANDS FOYERS, P255; Martin-Burriel I, 2007, J HERED, V98, P687, DOI 10.1093/jhered/esm096; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; Mohamad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005490; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Negrini R, 2007, ANIM GENET, V38, P60, DOI 10.1111/j.1365-2052.2007.01554.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nijman IJ, 2008, CLADISTICS, V24, P723, DOI 10.1111/j.1096-0031.2008.00201.x; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Perez-Pardal L, 2010, ANIM GENET, V41, P232, DOI 10.1111/j.1365-2052.2009.01988.x; Perez-Pardal L, 2009, ANIM GENET, V40, P560, DOI 10.1111/j.1365-2052.2009.01870.x; Pieragostini E, 2000, COMP BIOCHEM PHYS B, V127, P1, DOI 10.1016/S0305-0491(00)00218-2; Schibler J, 2007, SCHWEIZ ARCH TIERH, V149, P23, DOI 10.1024/0036-7281.149.1.23; Schneider S., 2000, ARLEQUIN VER 2 000 S; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Svensson E, 2008, BIOL LETTERS, V4, P752, DOI 10.1098/rsbl.2008.0342; TEALE AJ, 1995, ANIM GENET, V26, P243, DOI 10.1111/j.1365-2052.1995.tb03251.x; Tresset A., 2007, GOING MESOLITHIC NEO, P189, DOI DOI 10.5871/BACAD/9780197264140.003.0010; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; VAIMAN D, 1994, MAMM GENOME, V5, P288, DOI 10.1007/BF00389543; Verkaar ELC, 2004, MOL BIOL EVOL, V21, P1165, DOI 10.1093/molbev/msh064; WATERBOL.HT, 1968, SCIENCE, V162, P1093, DOI 10.1126/science.162.3858.1093; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898; 2006, ANIM GENET, V37, P475	73	62	66	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15922	10.1371/journal.pone.0015922	http://dx.doi.org/10.1371/journal.pone.0015922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253012	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000286511900024
J	Puccio, S; Chu, J; Pratico, D				Puccio, Simone; Chu, Jin; Pratico, Domenico			Involvement of 5-Lipoxygenase in the Corticosteroid-Dependent Amyloid Beta Formation: In Vitro and In Vivo Evidence	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PSYCHOLOGICAL DISTRESS; TRANSGENIC MICE; UP-REGULATION; MOUSE MODEL; EXPRESSION; CORTISOL; PROTEIN; STRESS; BRAIN	Background: Numerous studies show that high circulating level of glucocorticosteroids is a biochemical characteristic of Alzheimer's disease (AD). These stress hormones can increase the amount of AD-like pathology in animal models of the disease. Since they also up-regulate the 5-Lipoxygenase (5-LO), an enzyme which modulates amyloid beta (A beta) formation, in the present paper we tested the hypothesis that this enzymatic pathway is involved in the glucocorticoid-induced pro-amyloidotic effect. Methodology/Principal Findings: Incubation of neuronal cells with dexamethasone resulted in a significant increase in 5-LO activity and A beta formation. By contrast, pharmacological inhibition of 5-LO prevented the dexamethasone-dependent increase in A beta levels. Mouse embryonic fibroblasts responded with a significant increase in A beta formation after dexamethasone challenge. However, this effect was abolished when dexamethasone was incubated with fibroblasts genetically deficient for 5-LO. No difference in the glucocorticoid receptor levels was observed between the two groups. Finally, treatment of wild type mice with dexamethasone resulted in a significant increase in endogenous brain A beta levels, which was prevented in mice genetically lacking 5-LO. Conclusions: These findings suggest that 5-LO plays a functional role in the glucocorticoid-induced brain AD-like amyloid pathology.	[Puccio, Simone; Chu, Jin; Pratico, Domenico] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Puccio, S (corresponding author), Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA.	praticod@temple.edu	Pratico, Domenico/ABA-9590-2020; Chu, Jin/A-4737-2012; Puccio, Simone/P-9571-2018	Puccio, Simone/0000-0003-4007-4365	National Institutes of Health [AG33568]; Alzheimer's Association [59289]; NATIONAL INSTITUTE ON AGING [R01AG033568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was in funded by grants from the National Institutes of Health (AG33568) and the Alzheimer's Association (59289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinnici CM, 2007, NEUROBIOL AGING, V28, P1457, DOI 10.1016/j.neurobiolaging.2006.06.007; Csernansky JG, 2006, AM J PSYCHIAT, V163, P2164, DOI 10.1176/appi.ajp.163.12.2164; Dong HX, 2009, J ALZHEIMERS DIS, V18, P459, DOI 10.3233/JAD-2009-1152; Firuzi O, 2008, FASEB J, V22, P1169, DOI 10.1096/fj.07-9131.com; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; JEONG YH, FASEB J, V20, P729; MAEDA K, 1991, NEUROBIOL AGING, V12, P161, DOI 10.1016/0197-4580(91)90055-O; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Peskind ER, 2001, NEUROLOGY, V56, P1094, DOI 10.1212/WNL.56.8.1094; Pomara Nunzio, 2003, Psychopharmacol Bull, V37, P120; Qu TY, 2001, J NEUROPSYCH CLIN N, V13, P304, DOI 10.1176/appi.neuropsych.13.2.304; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Riccioni G, 2004, ANN CLIN LAB SCI, V34, P379; Succol F, 2007, J NEUROCHEM, V103, P380, DOI 10.1111/j.1471-4159.2007.04742.x; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Swanwick GRJ, 1998, AM J PSYCHIAT, V155, P286; Uz T, 1998, FASEB J, V12, P439, DOI 10.1096/fasebj.12.6.439; Uz T, 2001, FASEB J, V15, P1792, DOI 10.1096/fj.00-0836fje; Uz T, 1999, J NEUROCHEM, V73, pS209; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761; Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15163	10.1371/journal.pone.0015163	http://dx.doi.org/10.1371/journal.pone.0015163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253592	gold, Green Submitted, Green Published			2022-12-27	WOS:000286511900006
J	Wang, Y; Sun, DQ; Liu, DG				Wang, Ying; Sun, Da-Quan; Liu, Ding-Gan			Tumor Suppression by RNA from C/EBP beta 3 ' UTR through the Inhibition of Protein Kinase C epsilon Activity	PLOS ONE			English	Article							3 UNTRANSLATED REGIONS; PKC-EPSILON; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; GROWTH; ACTIVATION; CELLS; OVEREXPRESSION; SEQUENCES; REVERSION	Background: Since the end of last century, RNAs from the 3' untranslated region (3'UTR) of several eukaryotic mRNAs have been found to exert tumor suppression activity when introduced into malignant cells independent of their whole mRNAs. In this study, we sought to determine the molecular mechanism of the tumor suppression activity of a short RNA from 3'UTR of C/EBP beta mRNA (C/EBP beta 3'UTR RNA) in human hepatocarcinoma cells SMMC-7721. Methodology/Principal Findings: By using Western blotting, immunocytochemistry, molecular beacon, confocal microscopy, protein kinase inhibitors and in vitro kinase assays, we found that, in the C/EBP beta 3'UTR-transfectant cells of SMMC-7721, the overexpressed C/EBP beta 3'UTR RNA induced reorganization of keratin 18 by binding to this keratin; that the C/EBP beta 3'UTR RNA also reduced phosphorylation and expression of keratin 18; and that the enzyme responsible for phosphorylating keratin 18 is protein kinase Ce. We then found that the C/EBP beta 3'UTR RNA directly inhibited the phosphorylating activity of protein kinase C epsilon; and that C/EBP beta 3'UTR RNA specifically bound with the protein kinase C epsilon-keratin 18 conjugate. Conclusion/Significance: Together, these facts suggest that the tumor suppression in SMMC-7721 by C/EBP beta 3'UTR RNA is due to the inhibition of protein kinase Ce activity through direct physical interaction between C/EBP beta 3'UTR RNA and protein kinase Ce. These facts indicate that the 3'UTR of some eukaryotic mRNAs may function as regulators for genes other than their own.	[Wang, Ying; Sun, Da-Quan; Liu, Ding-Gan] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, Y (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	kinverskur@gmail.com			State Natural Science Foundation of China [30670449, 30540079, 30970585]; State Key Laboratory of Molecular Biology open research team [0109S 11282]	State Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Molecular Biology open research team	State Natural Science Foundation of China (www.nsfc.gov.cn), grants number: 30670449, 30540079, 30970585 (for free applications). State Key Laboratory of Molecular Biology (www.sibcb.ac.cn) open research team grant, number: 0109S 11282 (for open research teams). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Bronfman M, 1998, ANAL BIOCHEM, V255, P252, DOI 10.1006/abio.1997.2453; Cacace AM, 1996, ONCOGENE, V13, P2517; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; Dong R, 1980, J 2 MILITARY MED U S, V1, P5; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan HZ, 1996, CANCER RES, V56, P4366; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Ishiwatari H, 1997, CANCER LETT, V117, P57, DOI 10.1016/S0304-3835(97)00200-0; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Liu DG, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni133; LIU DG, 1992, SCI CHINA SER B, V35, P822; Liu DG, 1996, SCI CHINA SER C, V39, P300; Liu DG, 2003, CELL RES, V13, P509, DOI 10.1038/sj.cr.7290195; Manjeshwar S, 2003, CANCER RES, V63, P5251; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; OMARY MB, 1992, J CELL BIOL, V117, P583, DOI 10.1083/jcb.117.3.583; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Steitz JA, 2009, BIOCHEM SOC T, V37, P931, DOI 10.1042/BST0370931; Ueffing M, 1997, ONCOGENE, V15, P2921, DOI 10.1038/sj.onc.1201477; Veyrune J L, 1997, Prog Mol Subcell Biol, V18, P35; Vondriska TM, 2001, CIRC RES, V88, P1306, DOI 10.1161/hh1201.092994; Wang HZ, 2009, ACTA BIOCH BIOPH SIN, V41, P456, DOI 10.1093/abbs/gmp032; Wu DQ, 2002, CANCER RES, V62, P2423; Yoon KH, 2008, RNA BIOL, V5, P255, DOI 10.4161/rna.7116; ZHANG WY, 1980, J 2 MILITARY MED U, V1, P10; 刘定干, 1991, 生物化学与生物物理学报, V23, P246	39	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16543	10.1371/journal.pone.0016543	http://dx.doi.org/10.1371/journal.pone.0016543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283634	Green Submitted, Green Published, gold			2022-12-27	WOS:000286523400041
J	Al-Alem, L; Southard, RC; Kilgore, MW; Curry, TE				Al-Alem, Linah; Southard, R. Chase; Kilgore, Michael W.; Curry, Thomas E.			Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPAR gamma Independent Manner	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HUMAN BREAST-CANCER; IN-VITRO; LIGAND TROGLITAZONE; INDUCE APOPTOSIS; CARCINOMA CELLS; GROWTH; EXPRESSION; ROSIGLITAZONE; MICE	Background: Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) agonists, such as the thiazolinediones (TZDs), have been studied for their potential use as cancer therapeutic agents. We investigated the effect of four TZDs-Rosiglitazone (Rosi), Ciglitazone (CGZ), Troglitazone (TGZ), and Pioglitazone (Pio)-on ovarian cancer cell proliferation, PPAR gamma expression and PPAR luciferase reporter activity. We explored whether TZDs act in a PPAR gamma dependent or independent manner by utilizing molecular approaches to inhibit or overexpress PPAR gamma activity. Principal Findings: Treatment with CGZ or TGZ for 24 hours decreased proliferation in three ovarian cancer cell lines, Ovcar3, CaOv3, and Skov3, whereas Rosi and Pio had no effect. This decrease in Ovcar3 cell proliferation was due to a higher fraction of cells in the G(0)/G(1) stage of the cell cycle. CGZ and TGZ treatment increased apoptosis after 4 hours of treatment but not after 8 or 12 hours. Treatment with TGZ or CGZ increased PPAR gamma mRNA expression in Ovcar3 cells; however, protein levels were unchanged. Surprisingly, luciferase promoter assays revealed that none of the TZDs increased PPAR gamma activity. Overexpression of wild type PPAR gamma increased reporter activity. This was further augmented by TGZ, Rosi, and Pio indicating that these cells have the endogenous capacity to mediate PPAR gamma transactivation. To determine whether PPAR gamma mediates the TZD-induced decrease in proliferation, cells were treated with CGZ or TGZ in the absence or presence of a dominant negative (DN) or wild type overexpression PPAR gamma construct. Neither vector changed the TZD-mediated cell proliferation suggesting this effect of TZDs on ovarian cancer cells may be PPAR gamma independent. Conclusions: CGZ and TGZ cause a decrease in ovarian cancer cell proliferation that is PPAR gamma independent. This concept is supported by the finding that a DN or overexpression of the wild type PPAR gamma did not affect the changes in cell proliferation and cell cycle.	[Al-Alem, Linah; Southard, R. Chase; Kilgore, Michael W.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA; [Al-Alem, Linah; Curry, Thomas E.] Univ Kentucky, Coll Med, Dept Obstet & Gynecol, Lexington, KY USA	University of Kentucky; University of Kentucky	Al-Alem, L (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA.	tecurry@uky.edu			National Institutes of Health [CA95609, HD057446, RR15592]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057446] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095609] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (grant numbers CA95609, HD057446 and RR15592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred CD, 2005, MOL CELL ENDOCRINOL, V235, P21, DOI 10.1016/j.mce.2005.02.003; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Clay CE, 2001, J INVEST MED, V49, P413, DOI 10.2310/6650.2001.33786; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Faich GA, 2001, PHARMACOEPIDEM DR S, V10, P537, DOI 10.1002/pds.652; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Flessner MF, 2004, J APPL PHYSIOL, V97, P1518, DOI 10.1152/japplphysiol.00305.2004; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Houseknecht KL, 2002, DOMEST ANIM ENDOCRIN, V22, P1, DOI 10.1016/S0739-7240(01)00117-5; Jarrar MH, 2007, J CELL MOL MED, V11, P71, DOI 10.1111/j.1582-4934.2007.00003.x; Jiang GQ, 2002, DIABETES, V51, P2412, DOI 10.2337/diabetes.51.8.2412; KOSZEWSKI NJ, 2010, J STEROID BIOCH MOL; Kubota T, 1998, CANCER RES, V58, P3344; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Mustafa A, 2008, CLIN CANCER RES, V14, P4935, DOI 10.1158/1078-0432.CCR-08-0958; Nakashiro K, 2001, AM J PATHOL, V159, P591, DOI 10.1016/S0002-9440(10)61730-0; Ohta K, 2001, J CLIN ENDOCR METAB, V86, P2170, DOI 10.1210/jc.86.5.2170; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; R Development Core Team, 2005, R LANG ENV STAT COMP; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Saiki M, 2006, INT J ONCOL, V29, P437; Seargent JM, 2004, BRIT J PHARMACOL, V143, P933, DOI 10.1038/sj.bjp.0705973; Shigeto T, 2007, ONCOL REP, V18, P833; Smith U, 2001, INT J CLIN PRACT, P13; Soller M, 2007, MOL PHARMACOL, V71, P1535, DOI 10.1124/mol.107.034371; Talbert DR, 2008, BREAST CANCER RES TR, V108, P23, DOI 10.1007/s10549-007-9575-y; Valentiner U, 2005, TOXICOLOGY, V213, P157, DOI 10.1016/j.tox.2005.05.024; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; VEATCH AL, 1995, CLIN EXP METASTAS, V13, P165, DOI 10.1007/BF00132204; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Wang X, 2004, CANCER RES, V64, P5592, DOI 10.1158/0008-5472.CAN-04-0043; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Yang FG, 2005, ACTA PHARMACOL SIN, V26, P753, DOI 10.1111/j.1745-7254.2005.00753.x; Yang YC, 2007, INT J GYNECOL CANCER, V17, P418, DOI 10.1111/j.1525-1438.2006.00866.x; Yang ZB, 2003, CLIN CANCER RES, V9, P3198; Zaytseva YY, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-90; Zhang GY, 2005, BRIT J CANCER, V92, P113, DOI 10.1038/sj.bjc.6602244; ZHANG Z, 2010, J CELL PHYSL	56	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16179	10.1371/journal.pone.0016179	http://dx.doi.org/10.1371/journal.pone.0016179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283708	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522300018
J	Bippes, CC; Feldmann, A; Stamova, S; Cartellieri, M; Schwarzer, A; Wehner, R; Schmitz, M; Rieber, EP; Zhao, SM; Schakel, K; Temme, A; Scofield, RH; Kurien, BT; Bartsch, H; Bachmann, M				Bippes, Claudia C.; Feldmann, Anja; Stamova, Slava; Cartellieri, Marc; Schwarzer, Adrian; Wehner, Rebekka; Schmitz, Marc; Rieber, E. Peter; Zhao, Senming; Schaekel, Knut; Temme, Achim; Scofield, R. Hal; Kurien, Biji T.; Bartsch, Holger; Bachmann, Michael			A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; CD8(+) T-CELLS; IN-VIVO; SOMATIC HYPERMUTATION; DEC-205 RECEPTOR; PROTEIN; ACTIVATION; UNRESPONSIVENESS; AUTOIMMUNITY; AUTOANTIBODY	Background: Previously, we identified a major myeloid-derived proinflammatory subpopulation of human blood dendritic cells which we termed slanDCs (e.g. Schakel et al. (2006) Immunity 24, 767-777). The slan epitope is an O-linked sugar modification (6-sulfo LacNAc, slan) of P-selectin glycoprotein ligand-1 (PSGL-1). As slanDCs can induce neoantigen-specific CD4+ T cells and tumor-reactive CD8+ cytotoxic T cells, they appear as promising targets for an in vivo delivery of antigens for vaccination. However, tools for delivery of antigens to slanDCs were not available until now. Moreover, it is unknown whether or not antigens delivered via the slan epitope can be taken up, properly processed and presented by slanDCs to T cells. Methodology/Principal Findings: Single chain fragment variables were prepared from presently available decavalent monoclonal anti-slan IgM antibodies but failed to bind to slanDCs. Therefore, a novel multivalent anti-slanDC scaffold was developed which consists of two components: (i) a single chain bispecific recombinant diabody (scBsDb) that is directed on the one hand to the slan epitope and on the other hand to a novel peptide epitope tag, and (ii) modular (antigen-containing) linker peptides that are flanked at both their termini with at least one peptide epitope tag. Delivery of a Tetanus Toxin-derived antigen to slanDCs via such a scBsDb/antigen scaffold allowed us to recall autologous Tetanus-specific memory T cells. Conclusions/Significance: In summary our data show that (i) the slan epitope can be used for delivery of antigens to this class of human-specific DCs, and (ii) antigens bound to the slan epitope can be taken up by slanDCs, processed and presented to T cells. Consequently, our novel modular scaffold system may be useful for the development of human vaccines.	[Bippes, Claudia C.; Feldmann, Anja; Stamova, Slava; Cartellieri, Marc; Schwarzer, Adrian; Wehner, Rebekka; Schmitz, Marc; Rieber, E. Peter; Zhao, Senming; Schaekel, Knut; Temme, Achim; Bartsch, Holger; Bachmann, Michael] Tech Univ Dresden, Inst Immunol, Med Fac Carl Gustav Carus, Dresden, Germany; [Schmitz, Marc; Bachmann, Michael] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Zhao, Senming] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Scofield, R. Hal; Kurien, Biji T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Hebei Medical University; Oklahoma Medical Research Foundation	Bippes, CC (corresponding author), Tech Univ Dresden, Inst Immunol, Med Fac Carl Gustav Carus, Dresden, Germany.	michael.bachmann@tu-dresden.de	Cartellieri, Marc/M-3281-2013; Scofield, Robert Hal/AEJ-8314-2022; Cartellieri, Marc/AAL-8197-2020; Bachmann, Michael P/E-8850-2010; Schwarzer, Adrian/AAA-2571-2022; Feldmann, Anja/AAI-1809-2020; Kurien, Biji T/C-2392-2008; Feldmann, Anja/D-7843-2014; Bachmann, Michael/AAA-5153-2020	Cartellieri, Marc/0000-0002-4672-3963; Bachmann, Michael P/0000-0002-8029-5755; Feldmann, Anja/0000-0001-5099-2448; Kurien, Biji T/0000-0002-7877-6859; Feldmann, Anja/0000-0001-5099-2448; Bachmann, Michael/0000-0002-8029-5755; Schwarzer, Adrian/0000-0001-5684-2280; Stamova, Slava/0000-0002-2543-1523	Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Germany; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER	Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Germany; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by a seed grant given to MB by the Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; BIRKHOLZ K, 2010, BLOOD; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bruder D, 2005, DIABETES, V54, P3395, DOI 10.2337/diabetes.54.12.3395; CARMOFONSECA M, 1989, EXP CELL RES, V185, P73, DOI 10.1016/0014-4827(89)90038-4; Charalambous A, 2006, J IMMUNOL, V177, P8410, DOI 10.4049/jimmunol.177.12.8410; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; GAITHER KK, 1987, J CLIN INVEST, V79, P841, DOI 10.1172/JCI112892; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Malik S, 2007, LUPUS, V16, P863, DOI 10.1177/0961203307083365; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mannering SI, 2003, J IMMUNOL METHODS, V283, P173, DOI 10.1016/j.jim.2003.09.004; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; Moll H, 2003, CELL MICROBIOL, V5, P493, DOI 10.1046/j.1462-5822.2003.00291.x; Morgenroth A, 2007, PROSTATE, V67, P1121, DOI 10.1002/pros.20608; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Proudfoot O, 2007, MOL PHARMACEUT, V4, P58, DOI 10.1021/mp0601087; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Schakel K, 1999, PATHOBIOLOGY, V67, P287, DOI 10.1159/000028081; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmitz M, 2005, J IMMUNOL, V174, P4127, DOI 10.4049/jimmunol.174.7.4127; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3	39	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16315	10.1371/journal.pone.0016315	http://dx.doi.org/10.1371/journal.pone.0016315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283706	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522300033
J	Rhome, R; Singh, A; Kechichian, T; Drago, M; Morace, G; Luberto, C; Del Poeta, M				Rhome, Ryan; Singh, Arpita; Kechichian, Talar; Drago, Monica; Morace, Giulia; Luberto, Chiara; Del Poeta, Maurizio			Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; DIACYLGLYCEROL; SPHINGOLIPIDS; SYNTHASE; PATHWAY; BURDEN	Cryptococcus neoformans (Cn) is a significant human pathogen that, despite current treatments, continues to have a high morbidity rate especially in sub-Saharan Africa. The need for more tolerable and specific therapies has been clearly shown. In the search for novel drug targets, the gene for glucosylceramide synthase (GCS1) was deleted in Cn, resulting in a strain (Delta gcs1) that does not produce glucosylceramide (GlcCer) and is avirulent in mouse models of infection. To understand the biology behind the connection between virulence and GlcCer, the production and localization of GlcCer must be characterized in conditions that are prohibitive to the growth of Delta gcs1 (neutral pH and high CO2). These prohibitive conditions are physiologically similar to those found in the extracellular spaces of the lung during infection. Here, using immunofluorescence, we have shown that GlcCer localization to the cell surface is significantly increased during growth in these conditions and during infection. We further seek to exploit this localization by treatment with Cerezyme (Cz), a recombinant enzyme that metabolizes GlcCer, as a potential treatment for Cn. Cz treatment was found to reduce the amount of GlcCer in vitro, in cultures, and in Cn cells inhabiting the mouse lung. Treatment with Cz induced a membrane integrity defect in wild type Cn cells similar to Delta gcs1. Cz treatment also reduced the in vitro growth of Cn in a dose and condition dependent manner. Finally, Cz treatment was shown to have a protective effect on survival in mice infected with Cn. Taken together, these studies have established the legitimacy of targeting the GlcCer and other related sphingolipid systems in the development of novel therapeutics.	[Rhome, Ryan; Singh, Arpita; Kechichian, Talar; Luberto, Chiara; Del Poeta, Maurizio] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Rhome, Ryan; Singh, Arpita; Kechichian, Talar; Luberto, Chiara; Del Poeta, Maurizio] Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Microbiol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Immunol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Div Infect Dis, Charleston, SC 29425 USA; [Drago, Monica; Morace, Giulia] Univ Milan, Dipartimento Sanita Pubbl, Milan, Italy	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Milan	Rhome, R (corresponding author), Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA.	delpoeta@musc.edu	Morace, Giulia/I-8809-2012	Morace, Giulia/0000-0003-1696-1183	National Institutes of Health; National Center for Research Resources [C06 RR015455]; United States Department of Education; American Heart Association;  [AI56168];  [AI72142];  [AI78493]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072142, R56AI072142, R01AI056168, R21AI078493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Education(US Department of Education); American Heart Association(American Heart Association); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants AI56168, AI72142, and AI78493 (to M.D.P) and was conducted in a facility constructed with support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. During his PhD Program, RR was supported in part by the Graduate Assistance in Areas of National Need (GAANN) training grant in "Lipidology and New Technologies'' (to M.D.P.) from the United States Department of Education and in part by an American Heart Association Pre-doctoral Fellowship Program. Dr. Maurizio Del Poeta is a Burroughs Wellcome New Investigator in Pathogenesis of Infectious Diseases.	CASADEVALL A, 1998, CRYPTOCOCCUS NEOFORM, P381; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen LC, 1996, CLIN DIAGN LAB IMMUN, V3, P570, DOI 10.1128/CDLI.3.5.570-574.1996; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Garcia J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.17; Hanada K, 2005, JPN J INFECT DIS, V58, P131; HARLOW E, 1988, ANTIBODIES LABORATOR, P274; Harrison TS, 2009, AIDS, V23, P531, DOI 10.1097/QAD.0b013e328322ffc3; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hillig I, 2003, FEBS LETT, V553, P365, DOI 10.1016/S0014-5793(03)01058-5; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Levery SB, 2002, FEBS LETT, V525, P59, DOI 10.1016/S0014-5793(02)03067-3; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349; MCQUISTON T, INFECT IMMUN, P2342; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Rhome R, 2010, ADV EXP MED BIOL, V688, P232; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, CLIN VACCINE IMMUNOL, V14, P1372, DOI 10.1128/CVI.00202-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; SHEA J, 2005, IDENTIFICATION CHARA; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Toledo MS, 2001, GLYCOBIOLOGY, V11, P105, DOI 10.1093/glycob/11.2.105; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4	33	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e15572	10.1371/journal.pone.0015572	http://dx.doi.org/10.1371/journal.pone.0015572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283686	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300013
J	Tollner, T; Zehetleitner, M; Gramann, K; Muller, HJ				Toellner, Thomas; Zehetleitner, Michael; Gramann, Klaus; Mueller, Hermann J.			Stimulus Saliency Modulates Pre-Attentive Processing Speed in Human Visual Cortex	PLOS ONE			English	Article							LATERAL INTRAPARIETAL AREA; SINGLETON FEATURE TARGETS; NEURAL-CONTROL; SEARCH; PARIETAL; INTERFERENCE; DIMENSIONS; SELECTION; SHIFTS; DISCRIMINATION	The notion of a saliency-based processing architecture [1] underlying human vision is central to a number of current theories of visual selective attention [e.g., 2]. On this view, focal-attention is guided by an overall-saliency map of the scene, which integrates (sums) signals from pre-attentive sensory feature-contrast computations (e. g., for color, motion, etc.). By linking the Posterior Contralateral Negativity (PCN) component to reaction time (RT) performance, we tested one specific prediction of such salience summation models: expedited shifts of focal-attention to targets with low, as compared to high, target-distracter similarity. For two feature-dimensions (color and orientation), we observed decreasing RTs with increasing target saliency. Importantly, this pattern was systematically mirrored by the timing, as well as amplitude, of the PCN. This pattern demonstrates that visual saliency is a key determinant of the time it takes for focal-attention to be engaged onto the target item, even when it is just a feature singleton.	[Toellner, Thomas; Zehetleitner, Michael; Mueller, Hermann J.] Univ Munich, Dept Psychol, Munich, Germany; [Gramann, Klaus] Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, La Jolla, CA 92093 USA; [Mueller, Hermann J.] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; University of California System; University of California San Diego; University of London; Birkbeck University London	Tollner, T (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	thomas.toellner@psy.lmu.de	Töllner, Thomas/E-4912-2012; Gramann, Klaus/AAD-7313-2019; Zehetleitner, Michael/AHE-2494-2022		German Research Foundation (DFG) [EC142]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG) grant EC142 (Excellence Cluster 'CoTeSys'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brisson B, 2007, NEUROREPORT, V18, P1627, DOI 10.1097/WNR.0b013e3282f0b559; Chan LKH, 2009, J EXP PSYCHOL HUMAN, V35, P119, DOI 10.1037/0096-1523.35.1.119; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Edelman JA, 2003, J NEUROPHYSIOL, V90, P1728, DOI 10.1152/jn.00016.2003; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Geyer T, 2010, J VISION, V10, DOI 10.1167/10.2.3; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hopf JM, 2006, J NEUROSCI, V26, P3532, DOI 10.1523/JNEUROSCI.4510-05.2006; Hopf JM, 2002, COGNITIVE BRAIN RES, V15, P17, DOI 10.1016/S0926-6410(02)00213-6; Ipata AE, 2006, NAT NEUROSCI, V9, P1071, DOI 10.1038/nn1734; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krummenacher J, 2001, PERCEPT PSYCHOPHYS, V63, P901, DOI 10.3758/BF03194446; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LABERGE D, 1990, J NEUROSCI, V10, P613; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 2006, SCHIZOPHR RES, V85, P174, DOI 10.1016/j.schres.2006.03.040; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; MEVORACH C, J COGNITIVE IN PRESS; MORDKOFF JT, 1991, J EXP PSYCHOL HUMAN, V17, P520, DOI 10.1037/0096-1523.17.2.520; MULLER HJ, 1995, PERCEPT PSYCHOPHYS, V57, P1, DOI 10.3758/BF03211845; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; NOTHDURFT HC, 1990, EXP BRAIN RES, V82, P48; Nothdurft HC, 2000, VISION RES, V40, P3181, DOI 10.1016/S0042-6989(00)00168-1; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Roitman JD, 2002, J NEUROSCI, V22, P9475; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Sato TR, 2003, EXP BRAIN RES, V151, P356, DOI 10.1007/s00221-003-1461-1; Shedden JM, 2001, COGNITIVE BRAIN RES, V11, P59, DOI 10.1016/S0926-6410(00)00064-1; Tollner T, 2008, J EXP PSYCHOL HUMAN, V34, P531, DOI 10.1037/0096-1523.34.3.531; Tollner T, 2011, J COGNITIVE NEUROSCI, V23, P137, DOI 10.1162/jocn.2010.21422; Tollner T, 2010, VISION RES, V50, P1372, DOI 10.1016/j.visres.2009.11.009; Tollner T, 2009, J COGNITIVE NEUROSCI, V21, P1653, DOI 10.1162/jocn.2009.21108; TOLLNER T, 2010, DETECTING LOCA UNPUB; TOLLNER T, 2010, TOP DOWN DIMEN UNPUB; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; Wolber M, 2005, J PSYCHOPHYSIOL, V19, P182, DOI 10.1027/0269-8803.19.3.182; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; ZEHETLEITNER M, ATTENTION P IN PRESS; Zehetleitner M, 2010, J VISION, V10, DOI 10.1167/10.14.35; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1739, DOI 10.3758/APP.71.8.1739; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1760, DOI 10.3758/APP.71.8.1760; Zenon A, 2010, J COGNITIVE NEUROSCI, V22, P918, DOI 10.1162/jocn.2009.21233	63	81	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16276	10.1371/journal.pone.0016276	http://dx.doi.org/10.1371/journal.pone.0016276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OY	21283699	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000286522300028
J	Ewens, KG; Jones, MR; Ankener, W; Stewart, DR; Urbanek, M; Dunaif, A; Legro, RS; Chua, A; Azziz, R; Spielman, RS; Goodarzi, MO; Strauss, JF				Ewens, Kathryn G.; Jones, Michelle R.; Ankener, Wendy; Stewart, Douglas R.; Urbanek, Margrit; Dunaif, Andrea; Legro, Richard S.; Chua, Angela; Azziz, Ricardo; Spielman, Richard S.; Goodarzi, Mark O.; Strauss, Jerome F., III			FTO and MC4R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome	PLOS ONE			English	Article							DIABETES-MELLITUS; FAT MASS; PREVALENCE; LINKAGE; REGION; ADULT; RISK	Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility in women. It is also associated with metabolic disturbances that place women at increased risk for obesity and type 2 diabetes. There is strong evidence for familial clustering of PCOS and a genetic predisposition. However, the gene(s) responsible for the PCOS phenotypes have not been elucidated. This two-phase family-based and case-control genetic study was designed to address the question of whether SNPs identified as susceptibility loci for obesity in genome-wide association studies (GWAS) are also associated with PCOS and elevated BMI. Members of 439 families having at least one offspring with PCOS were genotyped for 15 SNPs previously shown to be associated with obesity. Linkage and association with PCOS was assessed using the transmission/disequilibrium test (TDT). These SNPs were also analyzed in an independent case-control study involving 395 women with PCOS and 176 healthy women with regular menstrual cycles. Only one of these 15 SNPs (rs2815752 in NEGR1) was found to have a nominally significant association with PCOS (chi(2) = 6.11, P = 0.013), but this association failed to replicate in the case-control study. While not associated with PCOS itself, five SNPs in FTO and two in MC4R were associated with BMI as assessed with a quantitative-TDT analysis, several of which replicated association with BMI in the case-control cohort. These findings demonstrate that certain SNPs associated with obesity contribute to elevated BMI in PCOS, but do not appear to play a major role in PCOS per se. These findings support the notion that PCOS phenotypes are a consequence of an oligogenic/polygenic mechanism.	[Ewens, Kathryn G.; Ankener, Wendy; Spielman, Richard S.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Stewart, Douglas R.] NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, Rockville, MD USA; [Urbanek, Margrit; Dunaif, Andrea] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Legro, Richard S.] Penn State Hershey Coll Med, Dept Obstet & Gynecol, Hershey, PA USA; [Jones, Michelle R.; Chua, Angela; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Azziz, Ricardo] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Virginia Commonwealth University	Ewens, KG (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	mark.goodarzi@cshs.org; jfstrauss@vcu.edu	Azziz, Ricardo/N-7229-2014; Goodarzi, Mark/AAH-7106-2021	Azziz, Ricardo/0000-0002-3917-0483; Goodarzi, Mark/0000-0001-6364-5103; Legro, Richard/0000-0001-9927-7584; Urbanek, Margrit/0000-0001-6994-7110	National Institutes of Health (NIH) [U54HD034449]; Division of Intramural Research of the National Human Genome Research Institute; NCRR [M01-RR00425]; Winnick Clinical Scholars Award; Pennsylvania Department of Health [RSL- SAP 41-000-26343];  [P50 HD44405];  [U54 HD34449];  [RR10732];  [C06 RR016499];  [M01 RR00048];  [M01 RR10732];  [M01 RR02635];  [R01-HD29364];  [K24-HD01346];  [R01-DK79888]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449, R01HD056510, P50HD044405] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029364, K24HD001346] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010144] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, M01RR010732, M01RR000048, M01RR002635, C06RR016499, UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Winnick Clinical Scholars Award; Pennsylvania Department of Health; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (NIH) Grants U54HD034449 (to J.F.S. and R.S.S.); Division of Intramural Research of the National Human Genome Research Institute (D.R.S.); P50 HD44405 (A.D.); U54 HD34449 (to M.U. and A.D.); RR10732 and C06 RR016499 (to Pennsylvania State University General Clinical Research Center (GCRC)); M01 RR00048 (to Northwestern University GCRC); M01 RR10732 and M01 RR02635 (to Brigham and Women's Hospital GCRC); R01-HD29364 and K24-HD01346 (to RA); R01-DK79888 (to M.O.G.); and M01-RR00425 (General Clinical Research Center Grant from the NCRR); the Winnick Clinical Scholars Award (to M.O.G.); and an endowment from the Helping Hand of Los Angeles, Inc. This project is funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds (RSL- SAP 41-000-26343). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barber TM, 2008, DIABETOLOGIA, V51, P1153, DOI 10.1007/s00125-008-1028-6; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Biyasheva A, 2009, J CLIN ENDOCR METAB, V94, P2617, DOI 10.1210/jc.2008-1664; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; EWENS KG, 2010, J CLIN ENDOCR METAB, P2306; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Gunderson KL, 2006, PHARMACOGENOMICS, V7, P641, DOI 10.2217/14622416.7.4.641; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; Pasquali R., 1997, Human Reproduction (Oxford), V12, P82; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stewart DR, 2006, J CLIN ENDOCR METAB, V91, P4112, DOI 10.1210/jc.2006-0951; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Urbanek M, 2005, J CLIN ENDOCR METAB, V90, P6623, DOI 10.1210/jc.2005-0622; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; Urbanek M, 2007, NAT CLIN PRACT ENDOC, V3, P103, DOI 10.1038/ncpendmet0400; Wehr E, 2010, METABOLISM, V59, P575, DOI 10.1016/j.metabol.2009.08.023; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	31	77	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16390	10.1371/journal.pone.0016390	http://dx.doi.org/10.1371/journal.pone.0016390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283731	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200057
J	Viswanath, K; Ackerson, LK				Viswanath, Kasisomayajula; Ackerson, Leland K.			Race, Ethnicity, Language, Social Class, and Health Communication Inequalities: A Nationally-Representative Cross-Sectional Study	PLOS ONE			English	Article							INFORMATION-SEEKING; DECISION-MAKING; CANCER; INTERNET; TRENDS; DISPARITIES; RESOURCES; PATIENT; SUPPORT; MEDIA	Background: While mass media communications can be an important source of health information, there are substantial social disparities in health knowledge that may be related to media use. The purpose of this study is to investigate how the use of cancer-related health communications is patterned by race, ethnicity, language, and social class. Methodology/Principal Findings: In a nationally-representative cross-sectional telephone survey, 5,187 U.S. adults provided information about demographic characteristics, cancer information seeking, and attention to and trust in health information from television, radio, newspaper, magazines, and the Internet. Cancer information seeking was lowest among Spanish-speaking Hispanics (odds ratio: 0.42; 95% confidence interval: 0.28-0.63) compared to non-Hispanic whites. Spanish-speaking Hispanics were more likely than non-Hispanic whites to pay attention to (odds ratio: 3.10; 95% confidence interval: 2.07-4.66) and trust (odds ratio: 2.61; 95% confidence interval: 1.53-4.47) health messages from the radio. Non-Hispanic blacks were more likely than non-Hispanic whites to pay attention to (odds ratio: 2.39; 95% confidence interval: 1.88-3.04) and trust (odds ratio: 2.16; 95% confidence interval: 1.61-2.90) health messages on television. Those who were college graduates tended to pay more attention to health information from newspapers (odds ratio: 1.98; 95% confidence interval: 1.42-2.75), magazines (odds ratio: 1.86; 95% confidence interval: 1.32-2.60), and the Internet (odds ratio: 4.74; 95% confidence interval: 2.70-8.31) and had less trust in cancer-related health information from television (odds ratio: 0.44; 95% confidence interval: 0.32-0.62) and radio (odds ratio: 0.54; 95% confidence interval: 0.34-0.86) compared to those who were not high school graduates. Conclusions/Significance: Health media use is patterned by race, ethnicity, language and social class. Providing greater access to and enhancing the quality of health media by taking into account factors associated with social determinants may contribute to addressing social disparities in health.	[Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Ackerson, Leland K.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts Lowell, Dept Community Hlth & Sustainabil, Lowell, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell	Viswanath, K (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	leland_ackerson@uml.edu			Dana-Farber/Harvard Cancer Center	Dana-Farber/Harvard Cancer Center	This work was supported by the Dana-Farber/Harvard Cancer Center (http://www.dana-farber.org/res/dana-farber/default.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 2007, ETHNIC DIS, V17, P153; Ackerson LK, 2009, J HEALTH COMMUN, V14, P5, DOI 10.1080/10810730902806836; Arora NK, 2008, J GEN INTERN MED, V23, P223, DOI 10.1007/s11606-007-0406-y; Baty BJ, 2003, AM J MED GENET A, V118A, P146, DOI 10.1002/ajmg.a.10150; Beaudoin CE, 2007, COMMUN RES, V34, P637, DOI 10.1177/0093650207307902; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Brodie M, 2000, HEALTH AFFAIR, V19, P255, DOI 10.1377/hlthaff.19.6.255; Cheong PH, 2007, HEALTH COMMUN, V21, P153, DOI 10.1080/10410230701307188; Cotten SR, 2004, SOC SCI MED, V59, P1795, DOI 10.1016/j.socscimed.2004.02.020; Duerksen SC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-85; Duggan C, 2008, QUAL SAF HEALTH CARE, V17, P85, DOI 10.1136/qshc.2005.017590; Eakin EG, 2001, PSYCHO-ONCOL, V10, P103, DOI 10.1002/pon.500; FINNEGAN JR, 2002, HLTH BEHAV HLTH ED T, P361; Rutten LJF, 2006, J HEALTH COMMUN, V11, P147, DOI 10.1080/10810730600637574; Freimuth VS, 2004, AM J PUBLIC HEALTH, V94, P2053, DOI 10.2105/AJPH.94.12.2053; Friedman DB, 2003, J CANCER EDUC, V18, P43, DOI 10.1207/S15430154JCE1801_14; Gordon NP, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-305; Gronke P, 2007, POLIT COMMUN, V24, P259, DOI 10.1080/10584600701471591; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Hornik R. C., 2002, PUBLIC HLTH COMMUNIC, P1; *I MED, 2003, UN TREATM CONFR RAC; Institute of Medicine (US) Committee on Communication for Behavior Change in the 21st Century: improving the health of diverse populations, 2002, SPEAK HLTH ASS HLTH; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Martin SP, 2007, SOC PROBL, V54, P1, DOI 10.1525/sp.2007.54.1.1; Mayer DK, 2007, PATIENT EDUC COUNS, V65, P342, DOI 10.1016/j.pec.2006.08.015; McNeill LH, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.4.e35; Nelson A. R., 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Niederdeppe J, 2007, HEALTH COMMUN, V22, P153, DOI 10.1080/10410230701454189; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Rimer BK, 2004, CANCER-AM CANCER SOC, V101, P1214, DOI 10.1002/cncr.20512; *USDA, 2008, MEAS RUR RUR URB CON; Viswanath K, 2006, J HEALTH COMMUN, V11, P1, DOI 10.1080/10810730600637426; Viswanath K, 2005, NAT REV CANCER, V5, P828, DOI 10.1038/nrc1718; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011	38	122	123	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14550	10.1371/journal.pone.0014550	http://dx.doi.org/10.1371/journal.pone.0014550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267450	Green Published, Green Submitted, gold			2022-12-27	WOS:000286519500018
J	Bandoh, H; Kida, I; Ueda, H				Bandoh, Hiroshi; Kida, Ikuhiro; Ueda, Hiroshi			Olfactory Responses to Natal Stream Water in Sockeye Salmon by BOLD fMRI	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SEXUAL-BEHAVIOR; PREOPTIC AREAS; FUNCTIONAL MRI; AMINO-ACIDS; TELENCEPHALON; MEMORY; BULB; DISCRIMINATION; STIMULATION	Many studies have shown that juvenile salmon imprint olfactory memory of natal stream odors during downstream migration, and adults recall this stream-specific odor information to discriminate their natal stream during upstream migration for spawning. The odor information processing of the natal stream in the salmon brain, however, has not been clarified. We applied blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging to investigate the odor information processing of the natal stream in the olfactory bulb and telencephalon of lacustrine sockeye salmon (Oncorhynchus nerka). The strong responses to the natal stream water were mainly observed in the lateral area of dorsal telencephalon (Dl), which are homologous to the medial pallium (hippocampus) in terrestrial vertebrates. Although the concentration of L-serine (1 mM) in the control water was 20,000-times higher than that of total amino acid in the natal stream water (47.5 nM), the BOLD signals resulting from the natal stream water were stronger than those by L-serine in the Dl. We concluded that sockeye salmon could process the odor information of the natal stream by integrating information in the Dl area of the telencephalon.	[Bandoh, Hiroshi; Ueda, Hiroshi] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan; [Kida, Ikuhiro] Tokyo Inst Psychiat, Integrated Neurosci Res Team, Tokyo, Japan; [Ueda, Hiroshi] Hokkaido Univ, Field Sci Ctr No Biosphere, Lab Aquat Ecosyst Conservat, Sapporo, Hokkaido, Japan	Hokkaido University; Tokyo Institute of Psychiatry; Hokkaido University	Bandoh, H (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan.	hueda@fsc.hokudai.ac.jp	Kida, Ikuhiro/A-4704-2011; Ueda, Hiroshi/G-4446-2010	Kida, Ikuhiro/0000-0001-6592-3349; Ueda, Hiroshi/0000-0002-4706-8665	Hokkaido University Clark Memorial Foundation; Japanese Society for the Promotion of Science [18208017]; Mitsubishi Foundation [35-4]; Mitsui Co. Ltd [08-A10]	Hokkaido University Clark Memorial Foundation; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; Mitsui Co. Ltd(Mitsui & Co., LTD.)	This study was supported by a research grant to HB from the Hokkaido University Clark Memorial Foundation, as well as partly by Grant-in-Aid for Scientific Research (A) (18208017) from the Japanese Society for the Promotion of Science, a natural science grant (35-4) from the Mitsubishi Foundation, and an environmental research grant (08-A10) from Mitsui & Co. Ltd to HU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni A, 2004, MECH DEVELOP, V121, P977, DOI 10.1016/j.mod.2004.03.023; ANZAI S, 1996, NEUROSCI RES       S, V20, pS223; COOPER JC, 1976, J FISH RES BOARD CAN, V33, P703, DOI 10.1139/f76-087; Dittman AH, 1996, CAN J FISH AQUAT SCI, V53, P434, DOI 10.1139/cjfas-53-2-434; Dittman AH, 1996, J EXP BIOL, V199, P83; EVANS RE, 1985, BRAIN RES, V330, P65, DOI 10.1016/0006-8993(85)90008-3; Folgueira M, 2004, J COMP NEUROL, V480, P180, DOI 10.1002/cne.20340; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; HARA TJ, 1970, J FISH RES BOARD CAN, V27, P565, DOI 10.1139/f70-059; HARA TJ, 1982, CHEMORECEPTION FISHE, P135; Hasler A.D., 1983, OLFACTORY IMPRINTING; Hino H, 2009, J FISH BIOL, V75, P945, DOI 10.1111/j.1095-8649.2009.02341.x; Hyder F, 2001, NMR BIOMED, V14, P413, DOI 10.1002/nbm.733; Kage T, 2004, J COMP NEUROL, V476, P219, DOI 10.1002/cne.20219; KENNETH JL, 2008, P NATL ACAD SCI USA, V105, P19096; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; KOYAMA Y, 1985, ZOOL SCI, V2, P565; LIEM KF, 2001, FUNCTIONAL VERTEBRAT; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nam RH, 2004, NEUROSCI LETT, V370, P248, DOI 10.1016/j.neulet.2004.08.037; Nevitt G., 1998, INTEGR BIOL, V1, P215, DOI [10.1002/(SICI)1520-6602(1998)1:6%3C215:AID-INBI3%3E3.0.CO;2-V, DOI 10.1002/(SICI)1520-6602(1998)1:6<215::AID-INBI3>3.0.C0;2-V]; NEVITT GA, 1994, P NATL ACAD SCI USA, V91, P4288, DOI 10.1073/pnas.91.10.4288; Nikonov AA, 2005, P NATL ACAD SCI USA, V102, P18688, DOI 10.1073/pnas.0505241102; Northcutt RG, 2006, J COMP NEUROL, V494, P903, DOI 10.1002/cne.20853; NORTHCUTT RG, 2006, BRAIN RES B, V75, P191; Quinn TP, 2005, BEHAV ECOLOGY PACIFI, P85; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; Saito K, 2004, NEUROREPORT, V15, P2695; Satou M, 2006, J COMP PHYSIOL A, V192, P135, DOI 10.1007/s00359-005-0056-7; SATOU M, 1984, PHYSIOL BEHAV, V33, P441, DOI 10.1016/0031-9384(84)90167-7; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Shoji T, 2000, CHEM SENSES, V25, P533, DOI 10.1093/chemse/25.5.533; Tabor R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001416; UEDA H, 2010, GEN COMP EN IN PRESS, DOI DOI 10.1016/J.YGEN.2010.02.003; Ueda H, 2007, AM FISH S S, V54, P5; UEDA K, 1971, Journal of the Faculty of Science University of Tokyo Section IV Zoology, V12, P167; UEDA K, 1967, COMP BIOCHEM PHYSIOL, V21, P133, DOI 10.1016/0010-406X(67)90123-5; VADENBURG EH, 2006, J EXP BIOL, V209, P2015; VADENBURG EH, 2005, J NEUROPHYSIOL, V93, P2849; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633; Yamamoto Y, 2009, ZOOL SCI, V26, P778, DOI 10.2108/zsj.26.778	47	26	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16051	10.1371/journal.pone.0016051	http://dx.doi.org/10.1371/journal.pone.0016051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264223	Green Published, gold, Green Submitted			2022-12-27	WOS:000286517600018
J	Kalluri, SR; Rothhammer, V; Staszewski, O; Srivastava, R; Petermann, F; Prinz, M; Hemmer, B; Korn, T				Kalluri, Sudhakar Reddy; Rothhammer, Veit; Staszewski, Ori; Srivastava, Rajneesh; Petermann, Franziska; Prinz, Marco; Hemmer, Bernhard; Korn, Thomas			Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; WATER CHANNEL; BRAIN EDEMA; B-CELLS; LESIONS; MICE; DISEASE; AUTOIMMUNITY; PATHOGENESIS; DISTINCTION	Background: Antibodies to the water channel protein aquaporin-4 (AQP4), which is expressed in astrocytic endfeet at the blood brain barrier, have been identified in the serum of Neuromyelitis optica (NMO) patients and are believed to induce damage to astrocytes. However, AQP4 specific T helper cell responses that are required for the generation of anti-AQP4 antibodies and most likely also for the formation of intraparenchymal CNS lesions have not been characterized. Methodology/Principal Findings: Using overlapping 15-meric peptides of AQP4, we identified the immunogenic T cell epitopes of AQP4 that are restricted to murine major histocompatibility complex (MHC) I-A(b). The N-terminal region of AQP4 was highly immunogenic. More precisely, the intracellular epitope AQP4(22-36) was detected as major immunogenic determinant. AQP4(82-108) (located in the second transmembrane domain), AQP4(139-153) (located in the second extracellular loop), AQP4(211-225) (located in the fifth transmembrane domain), AQP4(235-249) (located in the sixth transmembrane domain), as well as AQP4(289-306) in the intracellular C-terminal region were also immunogenic epitopes. AQP4(22-36) and AQP4(289-303) specific T cells were present in the natural T cell repertoire of wild type C57BL/6 mice and T cell lines were raised. However, active immunization with these AQP4 peptides did not induce signs of spinal cord disease. Rather, sensitization with AQP4 peptides resulted in production of IFN-gamma, but also IL-5 and IL-10 by antigen-specific T cells. Consistent with this cytokine profile, the AQP4 specific antibody response upon immunization with full length AQP4 included IgG1 and IgG2, which are associated with a mixed Th2/Th1 T cell response. Conclusions and Significance: AQP4 is able to induce an autoreactive T cell response. The identification of I-Ab restricted AQP4 specific T cell epitopes will allow us to investigate how AQP4 specific autoimmune reactions are regulated and to establish faithful mouse models of NMO that include both cellular and humoral responses against AQP4.	[Kalluri, Sudhakar Reddy; Rothhammer, Veit; Srivastava, Rajneesh; Petermann, Franziska; Hemmer, Bernhard; Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany; [Staszewski, Ori; Prinz, Marco] Univ Freiburg Klinikum, Dept Neuropathol, Inst Pathol, Freiburg, Germany	Technical University of Munich; University of Freiburg	Kalluri, SR (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany.	korn@lrz.tum.de	Kalluri, Sudhakar Reddy/C-6928-2013; Korn, Thomas/AAE-6960-2019; Srivastava, Rajneesh/A-7943-2012; Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021	Korn, Thomas/0000-0002-3633-0955; Hemmer, Bernhard/0000-0001-5985-6784; Staszewski, Ori/0000-0002-0579-6701	DFG [HE 2386/4-1, KO 2964/2-1, 3-1]; BMBF funded competence network of Multiple Sclerosis (KKNMS); DFG funded research unit [1336]; Gemeinnutzige Hertie-Stiftung; Technical University Munich	DFG(German Research Foundation (DFG)); BMBF funded competence network of Multiple Sclerosis (KKNMS)(Federal Ministry of Education & Research (BMBF)); DFG funded research unit; Gemeinnutzige Hertie-Stiftung; Technical University Munich	SRK and BH were supported by a grant from the DFG (HE 2386/4-1). MP was supported by the BMBF funded competence network of Multiple Sclerosis (KKNMS) and by the DFG funded research unit (FOR) 1336 "From monocytes to brain macrophages - conditions influencing the fate of myeloid cells in the brain". TK was funded by the DFG (KO 2964/2-1 and 3-1) and the Gemeinnutzige Hertie-Stiftung as well as intramural grants from the Technical University Munich (KKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Devic E., 1894, B MED PARIS, V8, P1033; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Jarius S, 2010, CLIN CHEM LAB MED, V48, P659, DOI 10.1515/CCLM.2010.127; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Saini H, 2010, J NEUROIMMUNOL, V221, P68, DOI 10.1016/j.jneuroim.2010.02.007; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wingerchuk D, 2006, NEUROLOGY, V66, pA380	34	44	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16083	10.1371/journal.pone.0016083	http://dx.doi.org/10.1371/journal.pone.0016083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264240	gold, Green Published, Green Submitted			2022-12-27	WOS:000286516500026
J	Wang, IJ; Tsai, RJF; Yeh, LK; Tsai, RYN; Hu, FR; Kao, WWY				Wang, I-Jong; Tsai, Ray Jui-Fang; Yeh, Lung-Kun; Tsai, Ryan Yao-Nien; Hu, Fung-Rong; Kao, Winston W. Y.			Changes in Corneal Basal Epithelial Phenotypes in an Altered Basement Membrane	PLOS ONE			English	Article							STEM-CELL NICHE; KERATINOCYTE GROWTH-FACTOR; HUMAN OCULAR SURFACE; AMNIOTIC MEMBRANE; AUTOGRAFT TRANSPLANTATION; LIMBAL TRANSPLANTATION; RADIAL KERATOTOMY; CLONAL ANALYSIS; EX-VIVO; EXPRESSION	Background: To examine the corneal epithelial phenotype in an altered basement membrane. Methodology/Principal Findings: Corneas from 9 patients with symptoms of continuous unstable corneal curvature (CUCC) were harvested by penetrating keratoplasty and subjected to histology examination and immunohistochemical staining with transactivating and N-terminally truncated pP63 transcript (Delta Np63), cytokeratin 3 (Krt3), ATP-binding cassette sub-family G member 2 (ABCG2), connexin 43 (CX43), p38 mitogen-activated protein kinases (p38MAPK), activating protein 2 (TFAP2), and extracellular signal-regulated kinase (Erk1/2) monoclonal antibodies. Positive immunostaining with ABCG2, p38MAPK, and TFAP2 monoclonal antibodies was observed in the basal epithelial cells of CUCC patients, and CX43 and Delta Np63 were detected in the full-thickness epithelial cells of CUCC patients. Conclusions/Significance: Our results indicate that alteration of the corneal basement membrane induces a de-differentiation-like phenotype in corneal basal epithelial cells.	[Wang, I-Jong; Hu, Fung-Rong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Tsai, Ray Jui-Fang; Tsai, Ryan Yao-Nien] Taipei Eye Ctr, Taipei, Taiwan; [Tsai, Ray Jui-Fang] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Tsai, Ray Jui-Fang] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Dept Ophthalmol, Coll Med, Chang Gung Mem Hosp Linko, Tao Yuan, Taiwan; [Kao, Winston W. Y.] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	raytsai@ms4.hinet.net		Wang, I-Jong/0000-0002-3045-0614; HU, FUNG-RONG/0000-0002-2102-5317	National Institutes of Health/National Eye Institute (NIH/NEI) [EY 010556]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation;  [NSC-98-3112-B-002-040];  [NSC-98-2627-B-002-004]; NATIONAL EYE INSTITUTE [R01EY010556] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	IJW was supported in part by NSC-98-3112-B-002-040, NSC-98-2627-B-002-004; WWK was supported in part by National Institutes of Health/National Eye Institute (NIH/NEI) grant EY 010556, from the Research to Prevent Blindness and Ohio Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM JL, 1970, AM J OPHTHALMOL, V69, P669, DOI 10.1016/0002-9394(70)91637-5; Bergmanson J, 2001, CORNEA, V20, P866, DOI 10.1097/00003226-200111000-00018; Cheng CC, 2009, J CELL SCI, V122, P4473, DOI 10.1242/jcs.054791; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; GIPSON IK, 1989, EYE, V3, P132, DOI 10.1038/eye.1989.21; Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155; Grueterich M, 2002, ARCH OPHTHALMOL-CHIC, V120, P783; Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003; Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; Hollingsworth JG, 2005, OPHTHAL PHYSL OPT, V25, P254, DOI 10.1111/j.1475-1313.2005.00278.x; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Kamalati T, 1993, EXS, V65, P201; Kedinger M, 1998, PHILOS T R SOC B, V353, P847, DOI 10.1098/rstb.1998.0249; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Lehrer MS, 1998, J CELL SCI, V111, P2867; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; LJUBIMOV AV, 1995, LAB INVEST, V72, P461; Ljubimov AV, 1998, EXP EYE RES, V67, P265, DOI 10.1006/exer.1998.0511; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Peifer M, 1999, NATURE, V400, P213, DOI 10.1038/22214; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Shanmuganathan VA, 2007, BRIT J OPHTHALMOL, V91, P514, DOI 10.1136/bjo.2006.102640; Sherwin T, 2004, CLIN EXP OPHTHALMOL, V32, P211, DOI 10.1111/j.1442-9071.2004.00805.x; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; SOUZA P, 1995, DEVELOPMENT, V121, P2559; STEPP MA, 1995, J HISTOCHEM CYTOCHEM, V43, P353, DOI 10.1177/43.4.7534781; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSAI RJF, 1995, CORNEA, V14, P439; TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003; Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010; Ucakhan Omur O, 2006, Eye Contact Lens, V32, P183; VANTRAPPEN L, 1985, INVEST OPHTH VIS SCI, V26, P220; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14537	10.1371/journal.pone.0014537	http://dx.doi.org/10.1371/journal.pone.0014537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264285	gold, Green Submitted, Green Published			2022-12-27	WOS:000286516500009
J	de Sousa, AA; Reis, R; Bento-Torres, J; Trevia, N; Lins, NAD; Passos, A; Santos, Z; Diniz, JAP; Vasconcelos, PFD; Cunningham, C; Perry, VH; Diniz, CWP				de Sousa, Aline Andrade; Reis, Renata; Bento-Torres, Joao; Trevia, Nonata; de Almeida Lins, Nara Alves; Passos, Aline; Santos, Zaire; Picanco Diniz, Jose Antonio; da Costa Vasconcelos, Pedro Fernando; Cunningham, Colm; Perry, Victor Hugh; Picano Diniz, Cristovam Wanderley			Influence of Enriched Environment on Viral Encephalitis Outcomes: Behavioral and Neuropathological Changes in Albino Swiss Mice	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; GLYCOSAMINOGLYCAN-BINDING VARIANTS; SPECIES-TYPICAL BEHAVIORS; EXTRACELLULAR-MATRIX; VIRULENCE ATTENUATION; JAPANESE ENCEPHALITIS; HIPPOCAMPAL-LESIONS; CELL LAYER; TENASCIN-R	An enriched environment has previously been described as enhancing natural killer cell activity of recognizing and killing virally infected cells. However, the effects of environmental enrichment on behavioral changes in relation to virus clearance and the neuropathology of encephalitis have not been studied in detail. We tested the hypothesis that environmental enrichment leads to less CNS neuroinvasion and/or more rapid viral clearance in association with T cells without neuronal damage. Stereology-based estimates of activated microglia perineuronal nets and neurons in CA3 were correlated with behavioral changes in the Piry rhabdovirus model of encephalitis in the albino Swiss mouse. Two-month-old female mice maintained in impoverished (IE) or enriched environments (EE) for 3 months were behaviorally tested. After the tests, an equal volume of Piry virus (IEPy, EEPy)-infected or normal brain homogenates were nasally instilled. Eight days post-instillation (dpi), when behavioral changes became apparent, brains were fixed and processed to detect viral antigens, activated microglia, perineuronal nets, and T lymphocytes by immuno-or histochemical reactions. At 20 or 40 dpi, the remaining animals were behaviorally tested and processed for the same markers. In IEPy mice, burrowing activity decreased and recovered earlier (8-10 dpi) than open field (20-40 dpi) but remained unaltered in the EEPy group. EEPy mice presented higher T-cell infiltration, less CNS cell infection by the virus and/or faster virus clearance, less microgliosis, and less damage to the extracellular matrix than IEPy. In both EEPy and IEPy animals, CA3 neuronal number remained unaltered. The results suggest that an enriched environment promotes a more effective immune response to clear CNS virus and not at the cost of CNS damage.	[de Sousa, Aline Andrade; Reis, Renata; Bento-Torres, Joao; Trevia, Nonata; de Almeida Lins, Nara Alves; Passos, Aline; Santos, Zaire; Picano Diniz, Cristovam Wanderley] Fed Univ Para, Inst Ciencias Biol, Hosp Univ Joao de Barros Barreto, Lab Invest Neurodegeneracao & Infeccao, BR-66059 Belem, Para, Brazil; [Picanco Diniz, Jose Antonio; da Costa Vasconcelos, Pedro Fernando] IEC, Dept Arbovirol & Febres Hemorrag, Ananindeua, Brazil; [da Costa Vasconcelos, Pedro Fernando] Univ Estado Para, Dept Patol, Belem, Para, Brazil; [Cunningham, Colm] Trinity Coll Dublin, Inst Neurosci, Sch Biochem & Immunol, Dublin, Ireland; [Perry, Victor Hugh] Univ Southampton, Sch Biol Sci, Southampton, Hants, England	Universidade Federal do Para; Universidade do Estado do Para (UEPA); Trinity College Dublin; University of Southampton	de Sousa, AA (corresponding author), Fed Univ Para, Inst Ciencias Biol, Hosp Univ Joao de Barros Barreto, Lab Invest Neurodegeneracao & Infeccao, BR-66059 Belem, Para, Brazil.	cwpdiniz@gmail.com	Vasconcelos, Pedro/AAH-3142-2019; NETO, JOAO BENTO TORRES/N-5458-2019; FHV, Inct/K-2346-2013; Sousa, Aline/ABE-9376-2020; Bento Torres, João/F-5129-2016; Perry, V. Hugh/Y-2935-2019; Diniz, Cristovam W.P./G-1474-2010; Cunningham, Colm/A-1743-2010	NETO, JOAO BENTO TORRES/0000-0002-9155-9445; Bento Torres, João/0000-0002-9155-9445; Diniz, Cristovam W.P./0000-0001-6611-6880; Cunningham, Colm/0000-0003-1423-5209	CNPq [300460/2005-8, 301955/2007-7, 471444/2006-5]; INCT-FHV/CNPq/CAPES/FAPESPA [573739/2008-0]; FINEP/FADESP [01.04.0043.00]; Instituto Brasileiro de Neurociencias - IBNnet	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-FHV/CNPq/CAPES/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP/FADESP(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Brasileiro de Neurociencias - IBNnet	This study had financial support from CNPq (grant no. 300460/2005-8, 301955/2007-7, and 471444/2006-5), INCT-FHV/CNPq/CAPES/FAPESPA (grant no. 573739/2008-0), and FINEP/FADESP (grant no. 01.04.0043.00). CWPD is supported by Instituto Brasileiro de Neurociencias - IBNnet. REIS, R. R. and SOUSA, A. A. equally contributed to the data generation and analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Altavilla G, 2002, J NEUROVIROL, V8, P180, DOI 10.1080/13550280290049633; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P1033, DOI 10.1037/0735-7044.118.5.1033; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; BERGE T., 1975, INT CATALOGUE ARBOVI; BI ZB, 1995, J VIROL, V69, P6466, DOI 10.1128/JVI.69.10.6466-6472.1995; Bonthius DJ, 2004, BRAIN RES PROTOC, V14, P45, DOI 10.1016/j.brainresprot.2004.09.003; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; CHIANG J, IMMUNOL INVEST; Christian AY, 1996, VIRAL IMMUNOL, V9, P195, DOI 10.1089/vim.1996.9.195; Ciavarra RP, 2006, J IMMUNOL, V177, P492, DOI 10.4049/jimmunol.177.1.492; Cunningham C, 2005, NEURODEGENERATION AND PRION DISEASE, P111, DOI 10.1007/0-387-23923-5_5; da Cruz E R, 1981, Rev Inst Med Trop Sao Paulo, V23, P194; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Diniz JAP, 2006, ARCH VIROL, V151, P2519, DOI 10.1007/s00705-006-0812-1; EDWARDS AJ, 1984, CLIN EXP IMMUNOL, V58, P420; Everall IP, 1999, BRAIN PATHOL, V9, P209; FORGER JM, 1991, J VIROL, V65, P4950, DOI 10.1128/JVI.65.9.4950-4958.1991; Franklin SL, 2008, J NEUROPATH EXP NEUR, V67, P189, DOI 10.1097/NEN.0b013e3181654386; Gabriel AF, 2009, BRAIN RES, V1276, P83, DOI 10.1016/j.brainres.2009.04.039; Gaskin S, 2009, BEHAV BRAIN RES, V202, P64, DOI 10.1016/j.bbr.2009.03.016; Gomes-Leal W, 2006, ACTA TROP, V97, P126, DOI 10.1016/j.actatropica.2005.09.006; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; Hascoet M, 2000, PHARMACOL BIOCHEM BE, V67, P45, DOI 10.1016/S0091-3057(00)00293-8; Hilbig H, 2002, J CHEM NEUROANAT, V23, P199, DOI 10.1016/S0891-0618(01)00159-4; Ho Christopher S. K., 2001, Blood, V98, P140; JOHNSTON SC, 2008, ANN NEUROL, V64, pA11; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KETZLER S, 1990, ACTA NEUROPATHOL, V80, P92, DOI 10.1007/BF00294228; KILPATRICK DC, 1986, SCAND J IMMUNOL, V24, P11, DOI 10.1111/j.1365-3083.1986.tb02064.x; Kizaki T, 2008, BIOCHEM BIOPH RES CO, V372, P152, DOI 10.1016/j.bbrc.2008.05.005; Komatsu T, 1997, J IMMUNOL, V159, P3444; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0; Liao HF, 2006, J SPORT MED PHYS FIT, V46, P307; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Magalon K, 2007, EUR J NEUROSCI, V25, P761, DOI 10.1111/j.1460-9568.2007.05335.x; Marcario JK, 2004, J NEUROVIROL, V10, P387, DOI 10.1080/13550280490521131; Marquette C, 1996, J NEUROIMMUNOL, V68, P45, DOI 10.1016/0165-5728(96)00056-2; Marriott AC, 2005, ARCH VIROL, V150, P671, DOI 10.1007/s00705-004-0452-2; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; Nansen A, 2000, EUR J IMMUNOL, V30, P1797, DOI 10.1002/1521-4141(200007)30:7<1797::AID-IMMU1797>3.0.CO;2-B; Olival KJ, 2005, J NEUROVIROL, V11, P441, DOI 10.1080/13550280591002450; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Park CH, 2006, J VET MED SCI, V68, P589, DOI 10.1292/jvms.68.589; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Rasalingam P, 2005, CAN J VET RES, V69, P100; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, pS267; SATO S, 1994, J BIOL CHEM, V269, P4424; Scott CA, 2008, J VIROL, V82, P513, DOI 10.1128/JVI.01677-07; Simonetti T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006780; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; STEEL CD, J NEUROIMMUNOL; Steel CD, 2009, VIROLOGY, V387, P117, DOI 10.1016/j.virol.2009.01.032; Tauber SC, 2009, J NEUROSCI RES, V87, P1877, DOI 10.1002/jnr.22010; Travassos da Rosa Amelia P.A., 2001, American Journal of Tropical Medicine and Hygiene, V64, P93; van den Pol AN, 2009, J COMP NEUROL, V516, P456, DOI 10.1002/cne.22131; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILKS CR, 1984, J HYG-CAMBRIDGE, V93, P147, DOI 10.1017/S0022172400061039; Zhou JH, 2005, J VIROL, V79, P4764, DOI 10.1128/JVI.79.8.4764-4773.2005; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	78	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15597	10.1371/journal.pone.0015597	http://dx.doi.org/10.1371/journal.pone.0015597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264301	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000286514000006
J	Lederle, L; Weber, S; Wright, T; Feyder, M; Brigman, JL; Crombag, HS; Saksida, LM; Bussey, TJ; Holmes, A				Lederle, Lauren; Weber, Susanna; Wright, Tara; Feyder, Michael; Brigman, Jonathan L.; Crombag, Hans S.; Saksida, Lisa M.; Bussey, Timothy J.; Holmes, Andrew			Reward-Related Behavioral Paradigms for Addiction Research in the Mouse: Performance of Common Inbred Strains	PLOS ONE			English	Article							REPEATED MATERNAL SEPARATION; CONDITIONED-STIMULUS; AMPA RECEPTOR; MICE; STRESS; EXTINCTION; REINFORCER; PHENOTYPES; DELETION; AMYGDALA	The mouse has emerged as a uniquely valuable species for studying the molecular and genetic basis of complex behaviors and modeling neuropsychiatric disease states. While valid and reliable preclinical assays for reward-related behaviors are critical to understanding addiction-related processes, and various behavioral procedures have been developed and characterized in rats and primates, there have been relatively few studies using operant-based addiction-relevant behavioral paradigms in the mouse. Here we describe the performance of the C57BL/6J inbred mouse strain on three major reward-related paradigms, and replicate the same procedures in two other commonly used inbred strains (DBA/2J, BALB/cJ). We examined Pavlovian-instrumental transfer (PIT) by measuring the ability of an auditory cue associated with food reward to promote an instrumental (lever press) response. In a separate experiment, we assessed the acquisition and extinction of a simple stimulus-reward instrumental behavior on a touchscreen-based task. Reinstatement of this behavior was then examined following either continuous exposure to cues (conditioned reinforcers, CRs) associated with reward, brief reward and CR exposure, or brief reward exposure followed by continuous CR exposure. The third paradigm examined sensitivity of an instrumental (lever press) response to devaluation of food reward (a probe for outcome insensitive, habitual behavior) by repeated pairing with malaise. Results showed that C57BL/6J mice displayed robust PIT, as well as clear extinction and reinstatement, but were insensitive to reinforcer devaluation. DBA/2J mice showed good PIT and (rewarded) reinstatement, but were slow to extinguish and did not show reinforcer devaluation or significant CR-reinstatement. BALB/cJ mice also displayed good PIT, extinction and reinstatement, and retained instrumental responding following devaluation, but, unlike the other strains, demonstrated reduced Pavlovian approach behavior (food magazine head entries). Overall, these assays provide robust paradigms for future studies using the mouse to elucidate the neural, molecular and genetic factors underpinning reward-related behaviors relevant to addiction research.	[Lederle, Lauren; Weber, Susanna; Wright, Tara; Feyder, Michael; Brigman, Jonathan L.; Holmes, Andrew] NIAAA, Sect Behav Sci & Genet, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA; [Crombag, Hans S.] Univ Sussex, Sch Psychol, Behav & Clin Neurosci Res Grp, Brighton, E Sussex, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Med Res Council, Cambridge, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Sussex; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Lederle, L (corresponding author), NIAAA, Sect Behav Sci & Genet, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA.	holmesan@mail.nih.gov	Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016; Brigman, Jonathan/O-4978-2016	Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171; 	National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000411] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research supported by National Institute on Alcohol Abuse and Alcoholism Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037/0097-7403.21.3.203; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BAXTER DJ, 1982, ANIM LEARN BEHAV, V10, P201, DOI 10.3758/BF03212271; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boyce-Rustay JM, 2008, BEHAV BRAIN RES, V186, P133, DOI 10.1016/j.bbr.2007.07.031; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chen YC, 2009, NEUROPSYCHOPHARMACOL, V34, P1454, DOI 10.1038/npp.2008.182; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Crabbe J C, 1994, Alcohol Alcohol Suppl, V2, P67; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRAWLEY JN, 2009, WHATS WRONG MY MOUSE; Crombag HS, 2008, EUR J NEUROSCI, V27, P3284, DOI 10.1111/j.1460-9568.2008.06299.x; Crombag HS, 2008, LEARN MEMORY, V15, P299, DOI 10.1101/lm.762508; Crombag HS, 2010, LEARN MEMORY, V17, P807, DOI 10.1101/lm.1610510; CROMBAG HS, 2008, BEHAV BRAIN RES; CRUSIO WE, 2008, STANDARDS PUBLICATIO; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; ESTES WK, 1948, J EXP PSYCHOL, V38, P173, DOI 10.1037/h0057525; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0; Holland PC, 2003, EUR J NEUROSCI, V17, P1680, DOI 10.1046/j.1460-9568.2003.02585.x; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029; Jackson KJ, 2009, NEUROPHARMACOLOGY, V57, P347, DOI 10.1016/j.neuropharm.2009.07.020; Janowsky A, 2001, J PHARMACOL EXP THER, V298, P634; Johnson AW, 2007, J NEUROSCI, V27, P13430, DOI 10.1523/JNEUROSCI.4320-07.2007; Johnson AW, 2007, BEHAV NEUROSCI, V121, P1192, DOI 10.1037/0735-7044.121.6.1192; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; KHEIRBEK MA, LEARN MEM, V17, P148; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; LOVIBOND PF, 1988, BIOL PSYCHOL, V27, P199, DOI 10.1016/0301-0511(88)90052-X; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Mead AN, 2003, J NEUROSCI, V23, P1041; Mead AN, 2003, J NEUROSCI, V23, P9500; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Norcross M, 2008, PSYCHOPHARMACOLOGY, V200, P413, DOI 10.1007/s00213-008-1215-7; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Sanders AC, 2007, NEUROPSYCHOPHARMACOL, V32, P2321, DOI 10.1038/sj.npp.1301368; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Wiltgen BJ, 2007, EUR J NEUROSCI, V25, P2491, DOI 10.1111/j.1460-9568.2007.05487.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Yu CX, 2009, J NEUROSCI, V29, P15100, DOI 10.1523/JNEUROSCI.4215-09.2009	60	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15536	10.1371/journal.pone.0015536	http://dx.doi.org/10.1371/journal.pone.0015536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249214	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000286513100006
J	Brust, JCM; Lygizos, M; Chaiyachati, K; Scott, M; van der Merwe, TL; Moll, AP; Li, XA; Loveday, M; Bamber, SA; Lalloo, UG; Friedland, GH; Shah, NS; Gandhi, NR				Brust, James C. M.; Lygizos, Melissa; Chaiyachati, Krisda; Scott, Michelle; van der Merwe, Theo L.; Moll, Anthony P.; Li, Xuan; Loveday, Marian; Bamber, Sheila A.; Lalloo, Umesh G.; Friedland, Gerald H.; Shah, N. Sarita; Gandhi, Neel R.			Culture Conversion Among HIV Co-Infected Multidrug-Resistant Tuberculosis Patients in Tugela Ferry, South Africa	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; PREDICTORS; OUTCOMES	Background: Little is known about the time to sputum culture conversion in MDR-TB patients co-infected with HIV, although such patients have, historically, had poor outcomes. We describe culture conversion rates among MDR-TB patients with and without HIV-co-infection in a TB-endemic, high-HIV prevalent, resource-limited setting. Methods: Patients with culture-proven MDR-TB were treated with a standardized second-line regimen. Sputum cultures were taken monthly and conversion was defined as two negative cultures taken at least one month apart. Time-to-conversion was measured from the day of initiation of MDR-TB therapy. Subjects with HIV received antiretroviral therapy (ART) regardless of CD4 count. Results: Among 45 MDR-TB patients, 36 (80%) were HIV-co-infected. Overall, 40 (89%) of the 45 patients culture-converted within the first six months and there was no difference in the proportion who converted based on HIV status. Median time-to-conversion was 62 days (IQR 48-111). Among the five patients who did not culture convert, three died, one was transferred to another facility, and one refused further treatment before completing 6 months of therapy. Thus, no patients remained persistently culture-positive at 6 months of therapy. Conclusions: With concurrent second-line TB and ART medications, MDR-TB/HIV co-infected patients can achieve culture conversion rates and times similar to those reported from HIV-negative patients worldwide. Future studies are needed to examine whether similar cure rates are achieved at the end of MDR-TB treatment and to determine the optimal use and timing of ART in the setting of MDR-TB treatment.	[Brust, James C. M.; Li, Xuan; Shah, N. Sarita; Gandhi, Neel R.] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Brust, James C. M.; Li, Xuan; Shah, N. Sarita; Gandhi, Neel R.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Brust, James C. M.; Lygizos, Melissa; Chaiyachati, Krisda; Scott, Michelle; van der Merwe, Theo L.; Moll, Anthony P.; Bamber, Sheila A.; Friedland, Gerald H.; Shah, N. Sarita; Gandhi, Neel R.] Tugela Ferry Care & Res Collaborat TF CARES, Tugela Ferry, South Africa; [Lygizos, Melissa; Chaiyachati, Krisda] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Scott, Michelle] Harvard Univ, Sch Med, Boston, MA USA; [van der Merwe, Theo L.; Moll, Anthony P.; Bamber, Sheila A.] Philanjalo, Tugela Ferry, South Africa; [Loveday, Marian] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Loveday, Marian; Lalloo, Umesh G.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Friedland, Gerald H.] Yale Univ, Sch Med, New Haven, CT USA; [Shah, N. Sarita; Gandhi, Neel R.] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; University of Kwazulu Natal; Yale University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Brust, JCM (corresponding author), Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA.	jcmbrust@gmail.com	Loveday, Marian/M-8016-2013	Loveday, Marian/0000-0001-9205-9314; Chaiyachati, Krisda/0000-0003-3326-6641	National Institute of Allergy and Infectious Diseases [K23AI083088]; Doris Duke Charitable Foundation; U.S. President's Emergency Plan for AIDS Relief (PEPFAR); GlaxoSmithKline; Boehringer Ingelheim; Merck Sharp and Dohme; AstraZeneca; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087465, K23AI083088, R01AI089349, P30AI051519] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp and Dohme(Merck & Company); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases (K23AI083088 to J.C.M.B.); Doris Duke Charitable Foundation (Clinical Scientist Development Awards to N.S.S. and N.R.G; ORACTA grant to G. H. F.); and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Statistical support was provided by the Center for AIDS Research (CFAR) of Albert Einstein College of Medicine/Montefiore Medical Center (P30 AI051519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project described is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy and Infectious Diseases or the National Institutes of Health.; U.G. L. has no competing interests with respect to this study. He has consulted for GlaxoSmithKline, Boehringer Ingelheim, Merck Sharp and Dohme, and AstraZeneca) and has received financial support from these companies to attend research conferences. The current study, however, was not funded by these or any other pharmaceutical or device companies. None of the companies listed were involved in any part of the study's design, execution, or analysis and Dr. Lalloo's relationship with the listed companies does not affect the authors' adherence to any of PLoS One's policies on sharing data and materials. None of the other authors has any competing or potentially competing interests.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Chirenda J, 2009, 40 UN WORLD C LUNG H; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Lienhardt C, 2010, INT J TUBERC LUNG D, V14, P528; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; MOODLEY P, 2007, 47 INT C ANT AG CHEM; Munsiff SS, 2006, INT J TUBERC LUNG D, V10, P639; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; SALOMON N, 1995, CLIN INFECT DIS, V21, P1245, DOI 10.1093/clinids/21.5.1245; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; *USDA, 2009, DEV DRUGS TREAT MULT; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization (WHO), 2008, 4 WHOIUATLD; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; 2008, 2 M GLOB XDR TB TASK	24	32	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15841	10.1371/journal.pone.0015841	http://dx.doi.org/10.1371/journal.pone.0015841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253585	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900012
J	Wardle, DJ; Burgon, J; Sabroe, I; Bingle, CD; Whyte, MKB; Renshaw, SA				Wardle, David J.; Burgon, Joseph; Sabroe, Ian; Bingle, Colin D.; Whyte, Moira K. B.; Renshaw, Stephen A.			Effective Caspase Inhibition Blocks Neutrophil Apoptosis and Reveals Mcl-1 as Both a Regulator and a Target of Neutrophil Caspase Activation	PLOS ONE			English	Article							CELL-SURVIVAL; EXPRESSION; RESOLUTION; CLEAVAGE; INFLAMMATION; RECEPTOR; HYPOXIA; DEATH; LIPOPOLYSACCHARIDE; GRANULOCYTES	Human tissue inflammation is terminated, at least in part, by the death of inflammatory neutrophils by apoptosis. The regulation of this process is therefore key to understanding and manipulating inflammation resolution. Previous data have suggested that the short-lived pro-survival Bcl-2 family protein, Mcl-1, is instrumental in determining neutrophil lifespan. However, Mcl-1 can be cleaved following caspase activity, and the possibility therefore remains that the observed fall in Mcl-1 levels is due to caspase activity downstream of caspase activation, rather than being a key event initiating apoptosis in human neutrophils. We demonstrate that apoptosis in highly purified neutrophils can be almost completely abrogated by caspase inhibition with the highly effective di-peptide caspase inhibitor, Q-VD. OPh, confirming the caspase dependence of neutrophil apoptosis. Effective caspase inhibition does not prevent the observed fall in Mcl-1 levels early in ultrapure neutrophil culture, suggesting that this fall in Mcl-1 levels is not a consequence of neutrophil apoptosis. However, at later timepoints, declines in Mcl-1 can be reversed with effective caspase inhibition, suggesting that Mcl-1 is both an upstream regulator and a downstream target of caspase activity in human neutrophils.	[Wardle, David J.; Burgon, Joseph; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Sabroe, Ian; Bingle, Colin D.; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Wardle, DJ (corresponding author), Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	s.a.renshaw@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013; Renshaw, Steve/E-6192-2010	Sabroe, Ian/0000-0001-9750-8975; Renshaw, Steve/0000-0003-1790-1641; Bingle, Colin/0000-0002-5405-6988	Medical Research Council [G0701932]; MRC Centre [G0700091]; MRC [G0701932, G108/595] Funding Source: UKRI; Medical Research Council [G108/595] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council Senior Clinical Fellowship to SAR (reference number: G0701932), and by an MRC Centre grant (G0700091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Harter L, 2001, J TRAUMA, V50, P982; HASLETT C, 1985, AM J PATHOL, V119, P101; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Kato T, 2006, FEBS LETT, V580, P4582, DOI 10.1016/j.febslet.2006.07.034; Knepper-Nicolai B, 1998, J BIOL CHEM, V273, P30530, DOI 10.1074/jbc.273.46.30530; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Leuenroth SJ, 2000, SURGERY, V128, P171, DOI 10.1067/msy.2000.107609; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; LUO HR, 2007, AM J HEMATOL; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Mecklenburgh KI, 2002, BLOOD, V100, P3008, DOI 10.1182/blood-2002-02-0454; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Rasband W., 2006, IMAGEJ; Renshaw SA, 2000, J LEUKOCYTE BIOL, V67, P662, DOI 10.1002/jlb.67.5.662; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Sambrook J, 1989, MOL CLONING LABORATO; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sunil VR, 2002, RESP RES, V3, DOI 10.1186/rr171; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Walmsley SR, 2004, BIOCHEM SOC T, V32, P456, DOI 10.1042/BST0320456; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Zhu D, 2006, P NATL ACAD SCI USA, V103, P14836, DOI 10.1073/pnas.0605722103; ANAL LOCATION DENSIT	39	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15768	10.1371/journal.pone.0015768	http://dx.doi.org/10.1371/journal.pone.0015768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253591	Green Accepted, Green Published, gold			2022-12-27	WOS:000286511900009
J	Gauthier, L; Ravallec, M; Tournaire, M; Cousserans, F; Bergoin, M; Dainat, B; de Miranda, JR				Gauthier, Laurent; Ravallec, Marc; Tournaire, Magali; Cousserans, Francois; Bergoin, Max; Dainat, Benjamin; de Miranda, Joachim R.			Viruses Associated with Ovarian Degeneration in Apis mellifera L. Queens	PLOS ONE			English	Article							DEFORMED WING VIRUS; BEE PARALYSIS VIRUS; HONEY-BEE; VERTICAL-TRANSMISSION; NOSEMA-APIS; VIRAL LOAD; INFECTION; DIFFERENTIATION; VITELLOGENIN; POPULATIONS	Queen fecundity is a critical issue for the health of honeybee (Apis mellifera L.) colonies, as she is the only reproductive female in the colony and responsible for the constant renewal of the worker bee population. Any factor affecting the queen's fecundity will stagnate colony development, increasing its susceptibility to opportunistic pathogens. We discovered a pathology affecting the ovaries, characterized by a yellow discoloration concentrated in the apex of the ovaries resulting from degenerative lesions in the follicles. In extreme cases, marked by intense discoloration, the majority of the ovarioles were affected and these cases were universally associated with egg-laying deficiencies in the queens. Microscopic examination of the degenerated follicles showed extensive paracrystal lattices of 30 nm icosahedral viral particles. A cDNA library from degenerated ovaries contained a high frequency of deformed wing virus (DWV) and Varroa destructor virus 1 (VDV-1) sequences, two common and closely related honeybee Iflaviruses. These could also be identified by in situ hybridization in various parts of the ovary. A large-scale survey for 10 distinct honeybee viruses showed that DWV and VDV-1 were by far the most prevalent honeybee viruses in queen populations, with distinctly higher prevalence in mated queens (100% and 67%, respectively for DWV and VDV-1) than in virgin queens (37% and 0%, respectively). Since very high viral titres could be recorded in the ovaries and abdomens of both functional and deficient queens, no significant correlation could be made between viral titre and ovarian degeneration or egg-laying deficiency among the wider population of queens. Although our data suggest that DWV and VDV-1 have a role in extreme cases of ovarian degeneration, infection of the ovaries by these viruses does not necessarily result in ovarian degeneration, even at high titres, and additional factors are likely to be involved in this pathology.	[Gauthier, Laurent; Dainat, Benjamin] Agroscope Liebefeld Posieux Res Stn ALP, Swiss Bee Res Ctr, Bern, Switzerland; [Gauthier, Laurent; Ravallec, Marc; Cousserans, Francois; Bergoin, Max] Univ Montpellier 2, UMR 1231, Lab Biol Integrat & Virol Insectes, Montpellier, France; [Gauthier, Laurent; Tournaire, Magali] Montpellier SupAgro, Montpellier, France; [de Miranda, Joachim R.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swiss Federal Research Station Agroscope; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Queens University Belfast; Swedish University of Agricultural Sciences	Gauthier, L (corresponding author), Agroscope Liebefeld Posieux Res Stn ALP, Swiss Bee Res Ctr, Bern, Switzerland.	laurent.gauthier@alp.admin.ch	Dainat, Benjamin/AFN-8922-2022	Dainat, Benjamin/0000-0002-1740-7136; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	French Ministere de l'agriculture et de l'Alimentation; "Fonds Europeens d'Orientation et de Garantie Agricole" (FEOGA)	French Ministere de l'agriculture et de l'Alimentation; "Fonds Europeens d'Orientation et de Garantie Agricole" (FEOGA)	This work was supported by the French Ministere de l'agriculture et de l'Alimentation and with funds from the "Fonds Europeens d'Orientation et de Garantie Agricole" (FEOGA), in accordance with the French programme for the improvement of the production and commercialization of beekeeping products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; Anderson D., 1993, Australasian Beekeeper, V94, P292; AUSUBEL FM, 2007, CURRENTS PROTOCOLS M; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; BRUN G, 1977, ANN INST PASTEUR MIC, VA128, P119; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Camazine S, 1998, AM BEE J, V138, P677; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Chen YP, 2005, J INVERTEBR PATHOL, V90, P118, DOI 10.1016/j.jip.2005.08.005; CHEN YP, 2007, HONEY BEE VIRUSES AD, P33; Czekonska K, 2000, APIDOLOGIE, V31, P701, DOI 10.1051/apido:2000154; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; DEBURON I, 1998, VIRUSES INSECT CELLS, P1143; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; ENGELS W, 1974, AM ZOOL, V14, P1229; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Fujiyuki T, 2005, ADV VIRUS RES, V65, P1, DOI 10.1016/S0065-3527(05)65001-4; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; FYG W, 1964, ANNU REV ENTOMOL, V9, P207, DOI 10.1146/annurev.en.09.010164.001231; FYG W., 1945, SCHWEIZ BIENEN ZEITUNG, V68, P67; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; GENERSCH E, 2010, APIDOLOGIE, P1; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; GUTZEIT HO, 1993, ROUX ARCH DEV BIOL, V202, P181, DOI 10.1007/BF00365309; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Haydak MH, 1943, J ECON ENTOMOL, V36, P778, DOI 10.1093/jee/36.5.778; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; LIU TP, 1992, TISSUE CELL, V24, P131, DOI 10.1016/0040-8166(92)90087-N; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; ONGUS JR, 2006, THESIS WAGENINGEN U; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Patricio K, 2008, IHERINGIA SER ZOOL, V98, P421, DOI 10.1590/S0073-47212008000400001; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Ramamurty P.S., 1977, Proceedings Congr Int Un Study Soc Ins, V8, P30; Rhodes JW, 2004, APIDOLOGIE, V35, P383, DOI 10.1051/apido:2004028; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Tettamanti G, 2008, CURR PHARM DESIGN, V14, P116, DOI 10.2174/138161208783378716; Valles SM, 2007, J INVERTEBR PATHOL, V96, P18, DOI 10.1016/j.jip.2007.02.006; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Webster TC, 2008, J APICULT RES, V47, P53, DOI 10.1080/00218839.2008.11101423; Winston, 1987, BIOL HONEYBEE; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001	68	49	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16217	10.1371/journal.pone.0016217	http://dx.doi.org/10.1371/journal.pone.0016217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283547	Green Published, Green Submitted, gold			2022-12-27	WOS:000286661400034
J	Liu, Z; Kim, W; Chen, ZK; Shin, YK; Carlson, OD; Fiori, JL; Xin, L; Napora, JK; Short, R; Odetunde, JO; Lao, QZ; Egan, JM				Liu, Zhuo; Kim, Wook; Chen, Zhike; Shin, Yu-Kyong; Carlson, Olga D.; Fiori, Jennifer L.; Xin, Li; Napora, Joshua K.; Short, Ryan; Odetunde, Juliana O.; Lao, Qizong; Egan, Josephine M.			Insulin and Glucagon Regulate Pancreatic alpha-Cell Proliferation	PLOS ONE			English	Article							DIABETES-MELLITUS; GLUCOSE-HOMEOSTASIS; GENE-EXPRESSION; CANCER-CELLS; BETA-CELLS; IN-VIVO; RECEPTOR; GROWTH; MICE; HYPERGLUCAGONEMIA	Type 2 diabetes mellitus (T2DM) results from insulin resistance and beta-cell dysfunction, in the setting of hyperglucagonemia. Glucagon is a 29 amino acid peptide hormone, which is secreted from pancreatic alpha cells: excessively high circulating levels of glucagon lead to excessive hepatic glucose output. We investigated if alpha-cell numbers increase in T2DM and what factor (s) regulate alpha-cell turnover. Lepr(db)/Lepr(db) (db/db) mice were used as a T2DM model and alpha TC1 cells were used to study potential alpha-cell trophic factors. Here, we demonstrate that in db/db mice alpha-cell number and plasma glucagon levels increased as diabetes progressed. Insulin treatment (EC50 = 2 nM) of alpha cells significantly increased alpha-cell proliferation in a concentration-dependent manner compared to non-insulin-treated alpha cells. Insulin up-regulated alpha-cell proliferation through the IR/IRS2/AKT/mTOR signaling pathway, and increased insulin-mediated proliferation was prevented by pretreatment with rapamycin, a specific mTOR inhibitor. GcgR antagonism resulted in reduced rates of cell proliferation in alpha TC1 cells. In addition, blockade of GcgRs in db/db mice improved glucose homeostasis, lessened alpha-cell proliferation, and increased intraislet insulin content in beta cells in db/db mice. These studies illustrate that pancreatic alpha-cell proliferation increases as diabetes develops, resulting in elevated plasma glucagon levels, and both insulin and glucagon are trophic factors to alpha-cells. Our current findings suggest that new therapeutic strategies for the treatment of T2DM may include targeting alpha cells and glucagon.	[Liu, Zhuo; Kim, Wook; Chen, Zhike; Shin, Yu-Kyong; Carlson, Olga D.; Fiori, Jennifer L.; Xin, Li; Napora, Joshua K.; Short, Ryan; Odetunde, Juliana O.; Lao, Qizong; Egan, Josephine M.] NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Liu, Z (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	eganj@grc.nia.nih.gov		Short, Ryan/0000-0003-3483-2895	NIH, National Institute on Aging	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bae-Jump VL, 2009, CANCER-AM CANCER SOC, V115, P3887, DOI 10.1002/cncr.24431; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cassidy RS, 2008, BIOL CHEM, V389, P189, DOI 10.1515/BC.2008.019; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; COX LS, 2009, AGING CELL; DOBBS R, 1975, SCIENCE, V187, P544, DOI 10.1126/science.1089999; Gelling RW, 2009, AM J PHYSIOL-ENDOC M, V297, pE695, DOI 10.1152/ajpendo.00082.2009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz George G, 2005, Sci STKE, V2005, ppe2; Hudes GR, 2009, CANCER, V115, P2313, DOI 10.1002/cncr.24239; Iki K, 2007, J HISTOCHEM CYTOCHEM, V55, P111, DOI 10.1369/jhc.6A7024.2006; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Li XC, 2008, CLIN SCI, V114, P591, DOI 10.1042/CS20070257; Li XC, 2007, CLIN SCI, V113, P183, DOI 10.1042/CS20070040; Ma XS, 2005, MOL ENDOCRINOL, V19, P198, DOI 10.1210/me.2004-0059; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; McBride SM, 2010, J NEURO-ONCOL, V97, P33, DOI 10.1007/s11060-009-0004-4; McKinnon CM, 2006, J BIOL CHEM, V281, P39358, DOI 10.1074/jbc.M605022200; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; RASKIN P, 1978, NEW ENGL J MED, V299, P433, DOI 10.1056/NEJM197808312990901; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; SAKURAI H, 1975, METABOLISM, V24, P1287, DOI 10.1016/0026-0495(75)90067-0; Schlosshauer PW, 2009, GYNECOL ONCOL, V114, P516, DOI 10.1016/j.ygyno.2009.06.002; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; UNGER RH, 1975, LANCET, V1, P14; Wagner M, 2009, J GASTROINTEST SURG, V13, P1781, DOI 10.1007/s11605-009-0948-x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu GG, 1998, DIABETES, V47, P1243, DOI 10.2337/diabetes.47.8.1243; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	44	51	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16096	10.1371/journal.pone.0016096	http://dx.doi.org/10.1371/journal.pone.0016096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283589	Green Submitted, Green Published, gold			2022-12-27	WOS:000286661400024
J	Wurbel, MA; McIntire, MG; Dwyer, P; Fiebiger, E				Wurbel, Marc-Andre; McIntire, Maria G.; Dwyer, Peter; Fiebiger, Edda			CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; SULFATE-MEDIATED COLITIS; CD4(+) T-CELLS; CHEMOKINE RECEPTOR; BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; MICE; CCR9; EXPRESSION	Background & Aims: CCL25/CCR9 is a non-promiscuous chemokine/receptor pair and a key regulator of leukocyte migration to the small intestine. We investigated here whether CCL25/CCR9 interactions also play a role in the regulation of inflammatory responses in the large intestine. Methods: Acute inflammation and recovery in wild-type (WT) and CCR9(-/-) mice was studied in a model of dextran sulfate sodium (DSS)-induced colitis. Distribution studies and phenotypic characterization of dendritic cell subsets and macrophage were performed by flow cytometry. Inflammatory bowel disease (IBD) scores were assessed and expression of inflammatory cytokines was studied at the mRNA and the protein level. Results: CCL25 and CCR9 are both expressed in the large intestine and are upregulated during DSS colitis. CCR9(-/-) mice are more susceptible to DSS colitis than WT littermate controls as shown by higher mortality, increased IBD score and delayed recovery. During recovery, the CCR9(-/-) colonic mucosa is characterized by the accumulation of activated macrophages and elevated levels of Th1/Th17 inflammatory cytokines. Activated plasmacytoid dendritic cells (DCs) accumulate in mesenteric lymph nodes (MLNs) of CCR9(-/-) animals, altering the local ratio of DC subsets. Upon re-stimulation, T cells isolated from these MLNs secrete significantly higher levels of TNF alpha, IFN gamma, IL2, IL-6 and IL-17A while down modulating IL-10 production. Conclusions: Our results demonstrate that CCL25/CCR9 interactions regulate inflammatory immune responses in the large intestinal mucosa by balancing different subsets of dendritic cells. These findings have important implications for the use of CCR9-inhibitors in therapy of human IBD as they indicate a potential risk for patients with large intestinal inflammation.	[Wurbel, Marc-Andre; Dwyer, Peter; Fiebiger, Edda] Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA; [Wurbel, Marc-Andre; Dwyer, Peter; Fiebiger, Edda] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; [McIntire, Maria G.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wurbel, MA (corresponding author), Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA.	marc-andre.wurbel@childrens.harvard.edu; edda.fiebiger@childrens.harvard.edu			Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center [P30 DK034854]; American Gastroenterological Association; National Institutes of Health [R01AI075037]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center; American Gastroenterological Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Crohn's & Colitis Foundation of America Career Development Award (to MAW), by a Pilot Project Grant from the Harvard Digestive Diseases Center P30 DK034854 (to MAW), by a Research Scholar Award from the American Gastroenterological Association (to EF) and by grant R01AI075037 from the National Institutes of Health (to EF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Apostolaki M, 2008, GASTROENTEROLOGY, V134, P2025, DOI 10.1053/j.gastro.2008.02.085; Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Garside P, 1999, CLIN EXP IMMUNOL, V118, P337; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kaser A, 2008, CURR OPIN GASTROEN, V24, P455, DOI 10.1097/MOG.0b013e328304d60d; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Keshav S, 2009, GASTROENTEROLOGY, V136, pA65; KOSTADINOVA FI, 2010, J LEUKOC BIOL; Matsuzaki K, 2005, CLIN EXP IMMUNOL, V140, P22, DOI 10.1111/j.1365-2249.2005.02742.x; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Qualls JE, 2009, INFLAMM BOWEL DIS, V15, P236, DOI 10.1002/ibd.20733; Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Sainathan SK, 2008, INFLAMM BOWEL DIS, V14, P88, DOI 10.1002/ibd.20279; Shintani N, 1998, GEN PHARMACOL-VASC S, V31, P477, DOI 10.1016/S0306-3623(98)00004-4; Shintani N, 1997, SCAND J IMMUNOL, V46, P581, DOI 10.1046/j.1365-3083.1997.d01-169.x; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Stenstad H, 2007, P NATL ACAD SCI USA, V104, P10122, DOI 10.1073/pnas.0700269104; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Varona R, 2003, EUR J IMMUNOL, V33, P2937, DOI 10.1002/eji.200324347; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Weber B, 2009, SEMIN IMMUNOPATHOL, V31, P171, DOI 10.1007/s00281-009-0156-5; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598	49	102	107	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16442	10.1371/journal.pone.0016442	http://dx.doi.org/10.1371/journal.pone.0016442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283540	gold, Green Submitted, Green Published			2022-12-27	WOS:000286661400053
J	Liu, L; Fang, Y; Huang, QS; Wu, JH				Liu, Li; Fang, Ying; Huang, Qingsheng; Wu, Jianhua			A Rigidity-Enhanced Antimicrobial Activity: A Case for Linear Cationic alpha-Helical Peptide HP(2-20) and Its Four Analogues	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPE; MOLECULAR-DYNAMICS; HELICOBACTER-PYLORI; MECHANICS; SIMULATIONS; POLYPEPTIDE; ELASTICITY; RESISTANCE; STABILITY; MEMBRANE	Linear cationic a-helical antimicrobial peptides are referred to as one of the most likely substitutes for common antibiotics, due to their relatively simple structures (<= 40 residues) and various antimicrobial activities against a wide range of pathogens. Of those, HP(2-20) was isolated from Helicobacter pylori ribosomal protein. To reveal a mechanical determinant that may mediate the antimicrobial activities, we examined the mechanical properties and structural stabilities of HP(2-20) and its four analogues of same chain length by steered molecular dynamics simulation. The results indicated the following: the resistance of H-bonds to the tensile extension mediated the early extensive stage; with the loss of H-bonds, the tensile force was dispensed to prompt the conformational phase transition; and Young's moduli (N/m(2)) of the peptides were about 4 similar to 8 x 10(9). These mechanical features were sensitive to the variation of the residue compositions. Furthermore, we found that the antimicrobial activity is rigidity-enhanced, that is, a harder peptide has stronger antimicrobial activity. It suggests that the molecular spring constant may be used to seek a new structure-activity relationship for different a-helical peptide groups. This exciting result was reasonably explained by a possible mechanical mechanism that regulates both the membrane pore formation and the peptide insertion.	[Liu, Li; Fang, Ying; Huang, Qingsheng; Wu, Jianhua] S China Univ Technol, Inst Biomech, Guangzhou, Guangdong, Peoples R China; [Liu, Li; Fang, Ying; Huang, Qingsheng; Wu, Jianhua] S China Univ Technol, Dept Biomed Engn, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Huang, Qingsheng] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China University of Technology; South China University of Technology; Sun Yat Sen University	Liu, L (corresponding author), S China Univ Technol, Inst Biomech, Guangzhou, Guangdong, Peoples R China.	wujianhua@scut.edu.cn	Huang, Alexander/AAL-5365-2021	Huang, Alexander/0000-0001-7352-0435	NSFC [10772069, 10972081]; Guangdong Science and Technology Projects of Industrial Research grant [B011000017]	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Projects of Industrial Research grant	This work was supported by NSFC grants 10772069 (JW) and 10972081 (YF) and by Guangdong Science and Technology Projects of Industrial Research grant B011000017 (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2009, BIOPHYS J, V96, P1105, DOI 10.1016/j.bpj.2008.10.046; Ajesh K, 2009, PEPTIDES, V30, P999, DOI 10.1016/j.peptides.2009.01.026; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Chakrabarti B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031903; Chen HM, 2001, J BIOMOL STRUCT DYN, V19, P193, DOI 10.1080/07391102.2001.10506731; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; GREENLEAF WJ, 2007, HIGH RESOLUTION SING; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Gunnerson KN, 2009, J PHYS CHEM B, V113, P2090, DOI 10.1021/jp803955u; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hertadi R, 2002, PROTEIN SCI, V11, P1532, DOI 10.1110/ps.3600102; Houston ME, 1998, J PEPT RES, V52, P81; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Idiris A, 2000, PROTEIN ENG, V13, P763, DOI 10.1093/protein/13.11.763; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Kageshima M, 2001, CHEM PHYS LETT, V343, P77, DOI 10.1016/S0009-2614(01)00678-9; KATAOKA N, 2002, PNAS, V99, P24; Lee KH, 2006, BIOCHEM J, V394, P105, DOI 10.1042/BJ20051574; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Lim SS, 2005, BIOCHEM BIOPH RES CO, V334, P1329, DOI 10.1016/j.bbrc.2005.07.029; LIPHARDT J, 1997, BIOL, V32, P101; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Marshall BT, 2006, BIOPHYS J, V90, P681, DOI 10.1529/biophysj.105.061010; MEHTA AD, SINGLE MOL BIOMECHAN; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Park SC, 2008, BBA-BIOMEMBRANES, V1778, P229, DOI 10.1016/j.bbamem.2007.09.020; PAULITSCHKE M, 1995, BLOOD, V86, P342, DOI 10.1182/blood.V86.1.342.bloodjournal861342; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rohs R, 1999, BIOPHYS J, V76, P2760, DOI 10.1016/S0006-3495(99)77429-1; Root DD, 2006, BIOPHYS J, V90, P2852, DOI 10.1529/biophysj.105.071597; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Vanselow DG, 2002, BIOPHYS J, V82, P2293, DOI 10.1016/S0006-3495(02)75575-6; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	45	12	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16441	10.1371/journal.pone.0016441	http://dx.doi.org/10.1371/journal.pone.0016441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283643	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400036
J	Strnad, P; Schwarz, P; Rasenack, MCD; Kucukoglu, O; Habib, RI; Heuberger, D; Ehehalt, R; Muller, MW; Stiehl, A; Adler, G; Kulaksiz, H				Strnad, Pavel; Schwarz, Peggy; Rasenack, Maria C. D.; Kucukoglu, Ozlem; Habib, Rayan I.; Heuberger, Dominik; Ehehalt, Robert; Mueller, Michael W.; Stiehl, Adolf; Adler, Guido; Kulaksiz, Hasan			Hepcidin Is an Antibacterial, Stress-Inducible Peptide of the Biliary System	PLOS ONE			English	Article							REGULATORY PEPTIDE; CELL-LINES; IRON; EXPRESSION; INFLAMMATION; HEMOCHROMATOSIS; LOCALIZATION; ANEMIA; CHOLESTASIS; NEPHRITIS	Background/Aims: Hepcidin (gene name HAMP), an IL-6-inducible acute phase peptide with antimicrobial properties, is the key negative regulator of iron metabolism. Liver is the primary source of HAMP synthesis, but it is also produced by other tissues such as kidney or heart and is found in body fluids such as urine or cerebrospinal fluid. While the role of hepcidin in biliary system is unknown, a recent study demonstrated that conditional gp130-knockout mice display diminished hepcidin levels and increased rate of biliary infections. Methods: Expression and localization of HAMP in biliary system was analyzed by real time RT-PCR, in-situ hybridization, immunostaining and -blotting, while prohepcidin levels in human bile were determined by ELISA. Results: Hepcidin was detected in mouse/human gallbladder and bile duct epithelia. Biliary HAMP is stress-inducible, in that it is increased in biliary cell lines upon IL-6 stimulation and in gallbladder mucosa of patients with acute cholecystitis. Hepcidin is also present in the bile and elevated prohepcidin levels were observed in bile of primary sclerosing cholangitis ( PSC) patients with concurrent bacterial cholangitis compared to PSC subjects without bacterial infection ( median values 22.3 vs. 8.9; p = 0.03). In PSC-cholangitis subjects, bile prohepcidin levels positively correlated with C-reactive protein and bilirubin levels ( r = 0.48 and r = 0.71, respectively). In vitro, hepcidin enhanced the antimicrobial capacity of human bile (p < 0.05). Conclusion: Hepcidin is a stress-inducible peptide of the biliary epithelia and a potential marker of biliary stress. In the bile, hepcidin may serve local functions such as protection from bacterial infections.	[Strnad, Pavel; Schwarz, Peggy; Rasenack, Maria C. D.; Kucukoglu, Ozlem; Habib, Rayan I.; Adler, Guido; Kulaksiz, Hasan] Univ Hosp Ulm, Dept Internal Med 1, Ulm, Germany; [Heuberger, Dominik; Ehehalt, Robert; Stiehl, Adolf; Kulaksiz, Hasan] Univ Heidelberg Hosp, Dept Internal Med, Div Gastroenterol, Heidelberg, Germany; [Mueller, Michael W.] Med Ctr Stuttgart, Dept Gen & Visceral Surg, Stuttgart, Germany	Ulm University; Ruprecht Karls University Heidelberg	Strnad, P (corresponding author), Univ Hosp Ulm, Dept Internal Med 1, Ulm, Germany.	hasan.kulaksiz@uniklinik-ulm.de	Kucukoglu, Ozlem/J-4713-2019	Kucukoglu, Ozlem/0000-0002-4217-9075; Ehehalt, Robert/0000-0003-4252-5801	Deutsche Forschungsgemeinschaft [KU 1253/5-3]; Emmy-Noether-Programme funding [STR 1095/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy-Noether-Programme funding	Funded by grant of the Deutsche Forschungsgemeinschaft (KU 1253/5-3) to H. K. and by the Emmy-Noether-Programme funding to P. S. (STR 1095/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2010, WORLD J GASTROENTERO, V16, P2129, DOI 10.3748/wjg.v16.i17.2129; Ashrafian H, 2003, INFECT IMMUN, V71, P6693, DOI 10.1128/IAI.71.12.6693-6700.2003; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Brissot P, 1997, HEPATOLOGY, V25, P1457, DOI 10.1002/hep.510250625; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Falzacappa MVV, 2005, GENE, V364, P37, DOI 10.1016/j.gene.2005.07.020; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Huang YH, 2009, LAB INVEST, V89, P1128, DOI 10.1038/labinvest.2009.82; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Knutson MD, 2010, ANNU REV NUTR, V30, P149, DOI 10.1146/annurev.nutr.012809.104801; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Kulaksiz H, 2004, GUT, V53, P735, DOI 10.1136/gut.2003.022863; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Kulaksiz H, 2008, J ENDOCRINOL, V197, P241, DOI 10.1677/JOE-07-0528; Marques F, 2009, ENDOCRINOLOGY, V150, P2822, DOI 10.1210/en.2008-1610; Merle U, 2007, ENDOCRINOLOGY, V148, P2663, DOI 10.1210/en.2006-1331; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Punnonen EL, 1999, J HISTOCHEM CYTOCHEM, V47, P99, DOI 10.1177/002215549904700111; STORTO PD, 1990, GENE CHROMOSOME CANC, V2, P300, DOI 10.1002/gcc.2870020408; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Wenderfer SE, 2009, AM J NEPHROL, V30, P450, DOI 10.1159/000242430; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wuestefeld T, 2005, HEPATOLOGY, V42, P1082, DOI 10.1002/hep.20912; Zhang XL, 2008, KIDNEY INT, V74, P799, DOI 10.1038/ki.2008.316; Zhong BH, 2007, MOL BIOL CELL, V18, P4969, DOI 10.1091/mbc.E07-02-0180	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16454	10.1371/journal.pone.0016454	http://dx.doi.org/10.1371/journal.pone.0016454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283681	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400038
J	Vavricka, C; Han, QA; Huang, YP; Erickson, SM; Harich, K; Christensen, BM; Li, JY				Vavricka, Christopher; Han, Qian; Huang, Yongping; Erickson, Sara M.; Harich, Kim; Christensen, Bruce M.; Li, Jianyong			From L-Dopa to Dihydroxyphenylacetaldehyde: A Toxic Biochemical Pathway Plays a Vital Physiological Function in Insects	PLOS ONE			English	Article							ALPHA-METHYL-DOPA; DROSOPHILA-MELANOGASTER; MONOAMINE-OXIDASE; HYPERSENSITIVE GENE; PARKINSONS-DISEASE; DECARBOXYLASE; EXPRESSION; INHIBITOR; MUTANTS; 3,4-DIHYDROXYPHENYLACETALDEHYDE	One protein in Aedes aegypti, classified into the aromatic amino acid decarboxylase (AAAD) family based on extremely high sequence homology (similar to 70%) with dopa decarboxylase (Ddc), was biochemically investigated. Our data revealed that this predicted AAAD protein use L-dopa as a substrate, as does Ddc, but it catalyzes the production of 3,4-dihydroxylphenylacetaldehyde (DHPAA) directly from L-dopa and apparently has nothing to do with the production of any aromatic amine. The protein is therefore named DHPAA synthase. This subsequently led to the identification of the same enzyme in Drosophila melanogaster, Anopheles gambiae and Culex quinquefasciatus by an initial prediction of putative DHPAA synthase based on sequence homology and subsequent verification of DHPAA synthase identity through protein expression and activity assays. DHPAA is highly toxic because its aldehyde group readily reacts with the primary amino groups of proteins, leading to protein crosslinking and inactivation. It has previously been demonstrated by several research groups that Drosophila DHPAA synthase was expressed in tissues that produce cuticle materials and apparent defects in regions of colorless, flexible cuticular structures have been observed in its gene mutants. The presence of free amino groups in proteins, the high reactivity of DHPAA with the free amino groups, and the genetically ascertained function of the Drosophila DHPAA synthase in the formation of colorless, flexible cuticle, when taken together, suggest that mosquito and Drosophila DHPAA synthases are involved in the formation of flexible cuticle through their reactive DHPAA-mediated protein crosslinking reactions. Our data illustrate how a seemingly highly toxic pathway can serve for an important physiological function in insects.	[Vavricka, Christopher; Han, Qian; Harich, Kim; Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Huang, Yongping] Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Erickson, Sara M.; Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol, Madison, WI USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison	Vavricka, C (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014; Vavricka, Christopher/AAU-8080-2021	Han, Qian/0000-0001-6245-5252; 	National Institutes of Health [AI 19769]; College of Agriculture and Life Sciences, Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019769, R37AI019769, R22AI019769, T32AI007414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Agriculture and Life Sciences, Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grant AI 19769 and the College of Agriculture and Life Sciences, Virginia Tech (http://www.cals.vt.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2001, INSECT BIOCHEM MOLEC, V31, P445, DOI 10.1016/S0965-1748(00)00139-9; ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Cutillas B, 2002, NEUROSCI LETT, V329, P165, DOI 10.1016/S0304-3940(02)00614-6; Dunkel P, 2008, CURR MED CHEM, V15, P1827, DOI 10.2174/092986708785133022; Han Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008826; Loutelier-Bourhis C, 2004, RAPID COMMUN MASS SP, V18, P571, DOI 10.1002/rcm.1369; Luz C, 2005, MYCOPATHOLOGIA, V160, P51, DOI 10.1007/s11046-005-0210-3; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MARSH JL, 1986, GENETICS, V112, P249; MARSH JL, 1986, GENETICS, V114, P453; MATTAMMAL MB, 1993, J CHROMATOGR-BIOMED, V614, P205, DOI 10.1016/0378-4347(93)80310-Z; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Petzer JP, 2009, NEUROTHERAPEUTICS, V6, P141, DOI 10.1016/j.nurt.2008.10.035; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; Saunder EFH, 2009, J CLIN PSYCHOPHARM, V29, P461, DOI 10.1097/JCP.0b013e3181b2b9f3; Sheng JZ, 2006, CURR MICROBIOL, V53, P124, DOI 10.1007/s00284-005-5336-5; SHERALD AF, 1974, MOL GEN GENET, V133, P25, DOI 10.1007/BF00268674; SLATES HL, 1964, J ORG CHEM, V29, P1424, DOI 10.1021/jo01029a039; SPARROW JC, 1974, MOL GEN GENET, V130, P127, DOI 10.1007/BF00269084; WANG DG, 1995, DEV BIOL, V168, P598, DOI 10.1006/dbio.1995.1105; Wang DG, 1996, P NATL ACAD SCI USA, V93, P7103, DOI 10.1073/pnas.93.14.7103; WRIGHT TRF, 1976, GENETICS, V84, P287; WRIGHT TRF, 1976, GENETICS, V84, P267; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Youdim Moussa B. H., 2006, Current Alzheimer Research, V3, P541, DOI 10.2174/156720506779025288	31	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16124	10.1371/journal.pone.0016124	http://dx.doi.org/10.1371/journal.pone.0016124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283636	Green Published, gold			2022-12-27	WOS:000286523400022
J	Hirrlinger, PG; Pannicke, T; Winkler, U; Claudepierre, T; Varshney, S; Schulze, C; Reichenbach, A; Brunken, WJ; Hirrlinger, J				Hirrlinger, Petra G.; Pannicke, Thomas; Winkler, Ulrike; Claudepierre, Thomas; Varshney, Shweta; Schulze, Christine; Reichenbach, Andreas; Brunken, William J.; Hirrlinger, Johannes			Genetic Deletion of Laminin Isoforms beta 2 and gamma 3 Induces a Reduction in Kir4.1 and Aquaporin-4 Expression and Function in the Retina	PLOS ONE			English	Article							RECTIFYING POTASSIUM CHANNEL; MULLER GLIAL-CELLS; SENSORINEURAL DEAFNESS; GLYCOPROTEIN COMPLEX; GLUTAMATE UPTAKE; MOUSE RETINA; RAT RETINA; MEMBRANE; MICE; MUTATIONS	Background: Glial cells such as retinal Muller glial cells are involved in potassium ion and water homeostasis of the neural tissue. In these cells, inwardly rectifying potassium (Kir) channels and aquaporin-4 water channels play an important role in the process of spatial potassium buffering and water drainage. Moreover, Kir4.1 channels are involved in the maintenance of the negative Muller cell membrane potential. The subcellular distribution of Kir4.1 and aquaporin-4 channels appears to be maintained by interactions with extracellular and intracellular molecules. Laminins in the extracellular matrix, dystroglycan in the membrane, and dystrophins in the cytomatrix form a complex mediating the polarized expression of Kir4.1 and aquaporin-4 in Muller cells. Methodology/Principal Findings: The aim of the present study was to test the function of the beta 2 and gamma 3 containing laminins in murine Muller cells. We used knockout mice with genetic deletion of both beta 2 and gamma 3 laminin genes to assay the effects on Kir4.1 and aquaporin-4. We studied protein and mRNA expression by immunohistochemistry, Western Blot, and quantitative RT-PCR, respectively, and membrane currents of isolated cells by patch-clamp experiments. We found a down-regulation of mRNA and protein of Kir4.1 as well as of aquaporin-4 protein in laminin knockout mice. Moreover, Muller cells from laminin beta 2 and gamma 3 knockout mice had reduced Kir-mediated inward currents and their membrane potentials were more positive than those in age-matched wild-type mice. Conclusion: These findings demonstrate a strong impact of laminin beta 2 and gamma 3 subunits on the expression and function of both aquaporin-4 and Kir4.1, two important membrane proteins in Muller cells.	[Hirrlinger, Petra G.; Pannicke, Thomas; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Winkler, Ulrike; Schulze, Christine; Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Winkler, Ulrike; Schulze, Christine; Hirrlinger, Johannes] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Claudepierre, Thomas] Univ Leipzig, Dept Ophthalmol, Leipzig, Germany; [Claudepierre, Thomas] Univ Leipzig, Hosp Eye, Leipzig, Germany; [Varshney, Shweta; Brunken, William J.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Varshney, Shweta; Brunken, William J.] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hirrlinger, PG (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany.	petra.hirrlinger@medizin.uni-leipzig.de	Pannicke, Thomas/A-5078-2017; Hirrlinger, Johannes/F-5984-2010; Reichenbach, Andreas/B-2510-2017	Pannicke, Thomas/0000-0001-7435-9540; Brunken, William J/0000-0001-7330-1814; Claudepierre, Thomas/0000-0001-6968-8518	Deutsche Forschungsgemeinschaft [RE 849/10 (SSP1172), RE 849/12 (FOR748), GRK 1097/1, HI1414/1 (SPP1172)]; Bundesministerium fur Bildung und Forschung [DLR/01GZ0703]; Interdisciplinary Centre for Clinical Research (IZKF) at the Faculty of Medicine, University of Leipzig [N05]; National Institutes of Health [EY12676, NS39502]; NATIONAL EYE INSTITUTE [R01EY012676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039502] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Centre for Clinical Research (IZKF) at the Faculty of Medicine, University of Leipzig; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the Deutsche Forschungsgemeinschaft (RE 849/10 (SSP1172), RE 849/12 (FOR748), GRK 1097/1, to A.R.; HI1414/1 (SPP1172) to J.H.), the Bundesministerium fur Bildung und Forschung (DLR/01GZ0703, to A. R.), the Interdisciplinary Centre for Clinical Research (IZKF) at the Faculty of Medicine, University of Leipzig (N05 to J.H.) and the National Institutes of Health (EY12676; NS39502 to W.J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Blank M, 2002, NEUROSCIENCE, V111, P259, DOI 10.1016/S0306-4522(02)00032-5; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bolz S, 2008, GRAEF ARCH CLIN EXP, V246, P1249, DOI 10.1007/s00417-008-0872-x; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Claudepierre T, 2000, J CELL SCI, V113, P3409; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Egles C, 2007, MOL CELL NEUROSCI, V34, P288, DOI 10.1016/j.mcn.2006.11.004; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Francke M, 1997, GLIA, V20, P210, DOI 10.1002/(SICI)1098-1136(199707)20:3<210::AID-GLIA5>3.0.CO;2-B; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Halfter W, 1998, J COMP NEUROL, V397, P89, DOI 10.1002/(SICI)1096-9861(19980720)397:1<89::AID-CNE7>3.0.CO;2-E; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hirrlinger PG, 2010, NEUROSCI LETT, V472, P73, DOI 10.1016/j.neulet.2010.01.062; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Ishii M, 1997, J NEUROSCI, V17, P7725; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Landiev I, 2006, EXP EYE RES, V82, P449, DOI 10.1016/j.exer.2005.07.018; Libby RT, 1999, J NEUROSCI, V19, P9399; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2002, GLIA, V38, P268, DOI 10.1002/glia.10068; Pinzon-Duarte G, 2010, INVEST OPHTH VIS SCI, V51, P1773, DOI 10.1167/iovs.09-4645; Puwarawuttipanit W, 2006, NEUROSCIENCE, V137, P165, DOI 10.1016/j.neuroscience.2005.08.051; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	51	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16106	10.1371/journal.pone.0016106	http://dx.doi.org/10.1371/journal.pone.0016106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283711	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300017
J	Kundu, P; De, R; Pal, I; Mukhopadhyay, AK; Saha, DR; Swarnakar, S				Kundu, Parag; De, Ronita; Pal, Ipsita; Mukhopadhyay, Asish K.; Saha, Dhira Rani; Swarnakar, Snehasikta			Curcumin Alleviates Matrix Metalloproteinase-3 and-9 Activities during Eradication of Helicobacter pylori Infection in Cultured Cells and Mice	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED RECEPTOR-GAMMA; GASTRIC EPITHELIAL-CELLS; NITRIC-OXIDE; DOWN-REGULATION; MOLECULAR-MECHANISMS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; SECRETION; SUPPRESSION	Current therapy-regimens against Helicobacter pylori (Hp) infections have considerable failure rates and adverse side effects that urge the quest for an effective alternative therapy. We have shown that curcumin is capable of eradicating Hp-infection in mice. Here we examine the mechanism by which curcumin protects Hp infection in cultured cells and mice. Since, MMP-3 and -9 are inflammatory molecules associated to the pathogenesis of Hp-infection, we investigated the role of curcumin on inflammatory MMPs as well as proinflammatory molecules. Curcumin dose dependently suppressed MMP-3 and -9 expression in Hp infected human gastric epithelial (AGS) cells. Consistently, Hp-eradication by curcumin-therapy involved significant downregulation of MMP-3 and -9 activities and expression in both cytotoxic associated gene (cag)(+ve) and cag(-ve) Hp-infected mouse gastric tissues. Moreover, we demonstrate that the conventional triple therapy (TT) alleviated MMP-3 and -9 activities less efficiently than curcumin and curcumin's action on MMPs was linked to decreased pro-inflammatory molecules and activator protein-1 activation in Hp-infected gastric tissues. Although both curcumin and TT were associated with MMP-3 and -9 downregulation during Hp-eradication, but unlike TT, curcumin enhanced peroxisome proliferator-activated receptor-gamma and inhibitor of kappa B-alpha. These data indicate that curcumin-mediated healing of Hp-infection involves regulation of MMP-3 and -9 activities.	[Kundu, Parag; Pal, Ipsita; Swarnakar, Snehasikta] Indian Inst Chem Biol, Kolkata, India; [De, Ronita; Mukhopadhyay, Asish K.; Saha, Dhira Rani] Natl Inst Cholera & Enter Dis, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Kundu, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	snehasiktas@hotmail.com	DE, RONITA/HDM-7066-2022; Mukhopadhyay, Asish/ABE-7697-2020; Pal, Ipsita/AAX-4410-2020	Kundu, Parag/0000-0002-8684-7530; Swarnakar, Snehasikta/0000-0002-7139-9683; De, Ronita/0000-0002-1469-6139	Council of Scientific and Industrial Research, India [IAP001]; National Tea Research Foundation, India; Founding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); National Tea Research Foundation, India(National Tea Research Foundation (NTRF), Government of India); Founding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by IAP001 grant of Council of Scientific and Industrial Research, India, National Tea Research Foundation, India. Part of the work was supported by the "Program of Founding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bergin PJ, 2004, HELICOBACTER, V9, P201, DOI 10.1111/j.1083-4389.2004.00232.x; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Bytzer P, 2005, HELICOBACTER, V10, P40, DOI 10.1111/j.1523-5378.2005.00333.x; Cameron EAB, 2004, J MED MICROBIOL, V53, P535, DOI 10.1099/jmm.0.05499-0; Chattopadhyay S, 2002, J CLIN MICROBIOL, V40, P2622, DOI 10.1128/JCM.40.7.2622-2625.2002; Clutterbuck AL, 2009, CURR DRUG TARGETS, V10, P1245, DOI 10.2174/138945009789753264; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; Foryst-Ludwig A, 2004, BIOCHEM BIOPH RES CO, V316, P1065, DOI 10.1016/j.bbrc.2004.02.158; Franchi A, 2002, CANCER-AM CANCER SOC, V95, P1902, DOI 10.1002/cncr.10916; Francois M, 2004, J BIOL CHEM, V279, P28411, DOI 10.1074/jbc.M312708200; Ganguly K, 2006, FREE RADICAL BIO MED, V41, P911, DOI 10.1016/j.freeradbiomed.2006.04.022; Ganguly K, 2010, J PINEAL RES, V49, P130, DOI 10.1111/j.1600-079X.2010.00776.x; GHOSH MN, 2005, FUNDAMENTALS PHARM; Gooz M, 2003, GUT, V52, P1250, DOI 10.1136/gut.52.9.1250; Han C, 2006, FEBS J, V273, P4682, DOI 10.1111/j.1742-4658.2006.05469.x; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim SY, 2005, BIOCHEM BIOPH RES CO, V337, P510, DOI 10.1016/j.bbrc.2005.09.079; KONTUREK PC, 2003, MED SCI MONITOR, V9, pSR65; Kositchaiwat Chomsri, 1993, Journal of the Medical Association of Thailand, V76, P601; Kundu P, 2006, J BIOL CHEM, V281, P34651, DOI 10.1074/jbc.M604574200; Lee KJ, 2004, EXP MOL MED, V36, P534, DOI 10.1038/emm.2004.68; Mahady GB, 2002, ANTICANCER RES, V22, P4179; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mian BM, 2003, CLIN CANCER RES, V9, P3167; MOLLER H, 1995, INT J CANCER, V60, P587, DOI 10.1002/ijc.2910600502; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Munzenmaier A, 1997, J IMMUNOL, V159, P6140; Nam KT, 2004, GUT, V53, P1250, DOI 10.1136/gut.2003.030684; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Parks WC, 1998, BIOL EXTRAC, P263; Pillinger MH, 2005, J BIOL CHEM, V280, P9973, DOI 10.1074/jbc.M413522200; QURESHI S, 1992, PLANTA MED, V58, P124, DOI 10.1055/s-2006-961412; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Saia K, 2007, INT IMMUNOPHARMACOL, V7, P1659, DOI 10.1016/j.intimp.2007.08.018; Sambrook J, 2001, MOL CLONING LAB MANU; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shimada T, 1998, J GASTROENTEROL, V33, P613, DOI 10.1007/s005350050146; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Wu CY, 2005, WORLD J GASTROENTERO, V11, P3197, DOI 10.3748/wjg.v11.i21.3197; Zhang M, 2006, INT IMMUNOPHARMACOL, V6, P1233, DOI 10.1016/j.intimp.2006.02.013	54	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16306	10.1371/journal.pone.0016306	http://dx.doi.org/10.1371/journal.pone.0016306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283694	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522300032
J	Miller-Delaney, SFC; Lieberam, I; Murphy, P; Mitchell, KJ				Miller-Delaney, Suzanne F. C. d; Lieberam, Ivo; Murphy, Paula; Mitchell, Kevin J.			Plxdc2 Is a Mitogen for Neural Progenitors	PLOS ONE			English	Article							DEVELOPING NERVOUS-SYSTEM; GENE-EXPRESSION; ENDOTHELIAL MARKERS; CEREBRAL-CORTEX; IN-VIVO; CELLS; PROLIFERATION; MICE; DIFFERENTIATION; CANCER	The development of different brain regions involves the coordinated control of proliferation and cell fate specification along and across the neuraxis. Here, we identify Plxdc2 as a novel regulator of these processes, using in ovo electroporation and in vitro cultures of mammalian cells. Plxdc2 is a type I transmembrane protein with some homology to nidogen and to plexins. It is expressed in a highly discrete and dynamic pattern in the developing nervous system, with prominent expression in various patterning centres. In the chick neural tube, where Plxdc2 expression parallels that seen in the mouse, misexpression of Plxdc2 increases proliferation and alters patterns of neurogenesis, resulting in neural tube thickening at early stages. Expression of the Plxdc2 extracellular domain alone, which can be cleaved and shed in vivo, is sufficient for this activity, demonstrating a cell non-autonomous function. Induction of proliferation is also observed in cultured embryonic neuroepithelial cells( ENCs) derived from E9.5 mouse neural tube, which express a Plxdc2-binding activity. These experiments uncover a direct molecular activity of Plxdc2 in the control of proliferation, of relevance in understanding the role of this protein in various cancers, where its expression has been shown to be altered. They also implicate Plxdc2 as a novel component of the network of signalling molecules known to coordinate proliferation and differentiation in the developing nervous system.	[Miller-Delaney, Suzanne F. C. d; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Miller-Delaney, Suzanne F. C. d; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Lieberam, Ivo] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Murphy, Paula] Trinity Coll Dublin, Dept Zool, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Columbia University; Howard Hughes Medical Institute; Trinity College Dublin	Miller-Delaney, SFC (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	Kevin.Mitchell@tcd.ie		Murphy, Paula/0000-0002-8048-6850; Lieberam, Ivo/0000-0003-3539-3054; Mitchell, Kevin/0000-0002-3433-4530	Science Foundation Ireland [01/F1/B006, 02/IN1/B267]; MRC [G0900585] Funding Source: UKRI; Medical Research Council [G0900585] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Science Foundation Ireland (www.sfi.ie) Investigator grants to KJM (01/F1/B006) and PM (02/IN1/B267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaty RM, 2007, J NEURO-ONCOL, V81, P241, DOI 10.1007/s11060-006-9227-9; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cheung AFP, 2007, J ANAT, V211, P164, DOI 10.1111/j.1469-7580.2007.00769.x; Davies G, 2004, CLIN EXP METASTAS, V21, P31, DOI 10.1023/B:CLIN.0000017168.83616.d0; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Echevarria D, 2003, BRAIN RES REV, V43, P179, DOI 10.1016/j.brainresrev.2003.08.002; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Ishibashi Makoto, 2005, Anatomical Science International, V80, P30; JASONI CL, 1994, DEVELOPMENT, V120, P769; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee HK, 2006, FEBS LETT, V580, P2253, DOI 10.1016/j.febslet.2006.03.033; Lee HK, 2007, J NEUROCHEM, V102, P686, DOI 10.1111/j.1471-4159.2007.04580.x; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lee SMK, 1997, DEVELOPMENT, V124, P959; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Megason SG, 2002, DEVELOPMENT, V129, P2087; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Miller SFC, 2007, GENE EXPR PATTERNS, V7, P635, DOI 10.1016/j.modgep.2006.12.002; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nanda A, 2004, CANCER RES, V64, P8507, DOI 10.1158/0008-5472.CAN-04-2716; Nardelli J, 2003, J NEUROSCI RES, V73, P737, DOI 10.1002/jnr.10716; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; St Croix B, 2000, SCIENCE, V289, P1197; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang XQ, 2005, MICROVASC RES, V70, P189, DOI 10.1016/j.mvr.2005.08.004; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3	50	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14565	10.1371/journal.pone.0014565	http://dx.doi.org/10.1371/journal.pone.0014565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283688	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522300005
J	Campbell, MG; Karbstein, K				Campbell, Melody G.; Karbstein, Katrin			Protein-Protein Interactions within Late Pre-40S Ribosomes	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC MATURATION; EUKARYOTIC RIBOSOME; SUBUNIT PRECURSORS; PRE-RIBOSOMES; CROSS-LINKING; PIN DOMAIN; RNA; BIOGENESIS; YEAST	Ribosome assembly in eukaryotic organisms requires more than 200 assembly factors to facilitate and coordinate rRNA transcription, processing, and folding with the binding of the ribosomal proteins. Many of these assembly factors bind and dissociate at defined times giving rise to discrete assembly intermediates, some of which have been partially characterized with regards to their protein and RNA composition. Here, we have analyzed the protein-protein interactions between the seven assembly factors bound to late cytoplasmic pre-40S ribosomes using recombinant proteins in binding assays. Our data show that these factors form two modules: one comprising Enp1 and the export adaptor Ltv1 near the beak structure, and the second comprising the kinase Rio2, the nuclease Nob1, and a regulatory RNA binding protein Dim2/Pno1 on the front of the head. The GTPase-like Tsr1 and the universally conserved methylase Dim1 are also peripherally connected to this second module. Additionally, in an effort to further define the locations for these essential proteins, we have analyzed the interactions between these assembly factors and six ribosomal proteins: Rps0, Rps3, Rps5, Rps14, Rps15 and Rps29. Together, these results and previous RNA-protein crosslinking data allow us to propose a model for the binding sites of these seven assembly factors. Furthermore, our data show that the essential kinase Rio2 is located at the center of the pre-ribosomal particle and interacts, directly or indirectly, with every other assembly factor, as well as three ribosomal proteins required for cytoplasmic 40S maturation. These data suggest that Rio2 could play a central role in regulating cytoplasmic maturation steps.	[Campbell, Melody G.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Scripps Research Institute	Campbell, MG (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Karbstein, Katrin/0000-0002-4034-1331; Campbell, Melody/0000-0003-1909-5751	NIH [R01-GM086451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grant R01-GM086451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Jia MZ, 2010, J MOL BIOL, V398, P774, DOI 10.1016/j.jmb.2010.03.055; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; TONE Y, 2002, GENE DEV, V16; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Wehner KA, 2002, MOL CELL BIOL, V22, P7258, DOI 10.1128/MCB.22.20.7258-7267.2002; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	44	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16194	10.1371/journal.pone.0016194	http://dx.doi.org/10.1371/journal.pone.0016194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283762	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200034
J	Goyal, P; Behring, A; Kumar, A; Siess, W				Goyal, Pankaj; Behring, Antje; Kumar, Abhishek; Siess, Wolfgang			STK35L1 Associates with Nuclear Actin and Regulates Cell Cycle and Migration of Endothelial Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; SMOOTH-MUSCLE-CELLS; BETA-CATENIN; PROTEIN; P27(KIP1); PHOSPHORYLATION; DISEASE; ATHEROSCLEROSIS; DIFFERENTIATION; IDENTIFICATION	Background: Migration and proliferation of vascular endothelial cells are essential for repair of injured endothelium and angiogenesis. Cyclins, cyclin-dependent kinases (CDKs), and cyclin-dependent kinase inhibitors play an important role in vascular tissue injury and wound healing. Previous studies suggest a link between the cell cycle and cell migration: cells present in the G(1) phase have the highest potential to migrate. The molecular mechanism linking these two processes is not understood. Methodology/Principal Findings: In this study, we explored the function of STK35L1, a novel Ser/Thr kinase, localized in the nucleus and nucleolus of endothelial cells. Molecular biological analysis identified a bipartite nuclear localization signal, and nucleolar localization sequences in the N-terminal part of STK35L1. Nuclear actin was identified as a novel binding partner of STK35L1. A class III PDZ binding domains motif was identified in STK35L1 that mediated its interaction with actin. Depletion of STK35L1 by siRNA lead to an accelerated G(1) to S phase transition after serum-stimulation of endothelial cells indicating an inhibitory role of the kinase in G(1) to S phase progression. Cell cycle specific genes array analysis revealed that one gene was prominently downregulated (8.8 fold) in STK35L1 silenced cells: CDKN2A alpha transcript, which codes for p16(INK4a) leading to G(1) arrest by inhibition of CDK4/6. Moreover in endothelial cells seeded on Matrigel, STK35L1 expression was rapidly upregulated, and silencing of STK35L1 drastically inhibited endothelial sprouting that is required for angiogenesis. Furthermore, STK35L1 depletion profoundly impaired endothelial cell migration in two wound healing assays. Conclusion/Significance: The results indicate that by regulating CDKN2A and inhibiting G(1)-to S-phase transition STK35L1 may act as a central kinase linking the cell cycle and migration of endothelial cells. The interaction of STK35L1 with nuclear actin might be critical in the regulation of these fundamental endothelial functions.	[Goyal, Pankaj; Behring, Antje; Siess, Wolfgang] Univ Munich, Klinikum Innenstadt, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, D-8000 Munich, Germany; [Kumar, Abhishek] Univ Padua, Dept Biol, Padua, Italy	University of Munich; University of Padua	Goyal, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Greifswald, Germany.	pankaj.goyal@med.uni-muenchen.de	Goyal, Pankaj/C-3567-2012; Siess, Wolfgang/A-6430-2009; Kumar, Abhishek/A-8727-2012	Siess, Wolfgang/0000-0003-0698-6416; Kumar, Abhishek/0000-0003-4172-4059	August-Lenz-Stiftung [Si 274/11-1]; Deutsche Forschungsgemeinschaft [GRK 438]; Forderprogramm fur Forschung und Lehre (FoFoLe) [541]; Medical Faculty, University of Munich	August-Lenz-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forderprogramm fur Forschung und Lehre (FoFoLe); Medical Faculty, University of Munich	The work was supported by grants from the Si 274/11-1, August-Lenz-Stiftung and the Deutsche Forschungsgemeinschaft (Graduate Program "Vascular Biology in Medicine'' Grants GRK 438 to PG and AB), and Forderprogramm fur Forschung und Lehre (FoFoLe) Reg. Nr. 541 (to AB), Medical Faculty, University of Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bauer K, 2000, BLOOD, V96, P4236; Bonneton C, 1999, CELL MOTIL CYTOSKEL, V43, P288, DOI 10.1002/(SICI)1097-0169(1999)43:4<288::AID-CM2>3.3.CO;2-P; Bornfeldt KE, 2003, CIRC RES, V92, P345, DOI 10.1161/01.RES.0000061765.06145.10; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Freedman DA, 2005, EXP CELL RES, V307, P118, DOI 10.1016/j.yexcr.2005.03.025; Fukui R, 2000, AM J PHYSIOL-CELL PH, V279, pC999, DOI 10.1152/ajpcell.2000.279.4.C999; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Goyal P, 2005, J BIOL CHEM, V280, P27569, DOI 10.1074/jbc.M504448200; Goyal P, 2006, J BIOL CHEM, V281, P25223, DOI 10.1074/jbc.M603399200; Goyal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006981; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nabel EG, 2002, NAT REV DRUG DISCOV, V1, P587, DOI 10.1038/nrd869; Nourry Claire, 2003, Sci STKE, V2003, pRE7; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; Saegusa M, 2006, INT J CANCER, V119, P2294, DOI 10.1002/ijc.22112; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Wassermann S, 2009, GASTROENTEROLOGY, V136, P196, DOI 10.1053/j.gastro.2008.09.019; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	49	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16249	10.1371/journal.pone.0016249	http://dx.doi.org/10.1371/journal.pone.0016249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283756	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200043
J	Wu, N; Zhao, XZ; Liu, M; Liu, HZ; Yao, WC; Zhang, YY; Cao, SS; Lin, XK				Wu, Ning; Zhao, Xiangzhong; Liu, Ming; Liu, Haizhou; Yao, Weicheng; Zhang, Yuyan; Cao, Shousong; Lin, Xiukun			Role of MicroRNA-26b in Glioma Development and Its Mediated Regulation on EphA2	PLOS ONE			English	Article							CELL VASCULOGENIC MIMICRY; PROTEIN-TYROSINE KINASES; OVEREXPRESSION; EXPRESSION; RECEPTOR; APOPTOSIS; PROLIFERATION; TUMORIGENESIS; SIGNATURES; TARGET	Background: MicroRNAs (miRNAs) are short, non-coding RNAs that regulate the expression of multiple target genes. Deregulation of miRNAs is common in human tumorigenesis. Low level expression of miR-26b has been found in glioma cells. However, its underlying mechanism of action has not been determined. Methodology/Principal Findings: Real-time PCR was employed to measure the expression level of miR-26b in glioma patients and cells. The level of miR-26b was inversely correlated with the grade of glioma. Ectopic expression of miR-26b inhibited the proliferation, migration and invasion of human glioma cells. A binding site for miR-26b was identified in the 3'UTR of EphA2. Over-expression of miR-26b in glioma cells repressed the endogenous level of EphA2 protein. Vasculogenic mimicry (VM) experiments were performed to further confirm the effects of miR-26b on the regulation of EphA2, and the results showed that miR-26b inhibited the VM processes which regulated by EphA2. Significance: This study demonstrated that miR-26b may act as a tumor suppressor in glioma and it directly regulates EphA2 expression. EphA2 is a direct target of miR-26b, and the down-regulation of EphA2 mediated by miR-26b is dependent on the binding of miR-26b to a specific response element of microRNA in the 3'UTR region of EphA2 mRNA.	[Wu, Ning; Zhao, Xiangzhong; Liu, Ming; Liu, Haizhou; Zhang, Yuyan; Lin, Xiukun] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Yao, Weicheng] Qingdao Med Univ, Inst Brain, Affiliated Hosp, Qingdao, Peoples R China; [Cao, Shousong] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Wu, Ning] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Roswell Park Cancer Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, N (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	shousong.cao@RoswellPark.org; linxiukun@yahoo.com		Lin, Xiukun/0000-0002-0306-4953	National High Technology 863 Program of China [2007AA091403, 200709Z408]; National Innovative Drug Development Programs of China [2009ZX09102-240, 2009ZX09103-661]; National Natural Science Foundation of China [81072065]	National High Technology 863 Program of China(National High Technology Research and Development Program of China); National Innovative Drug Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology 863 Program of China (Nos. 2007AA091403 and 200709Z408), National Innovative Drug Development Programs of China (Nos. 2009ZX09102-240 and 2009ZX09103-661) and National Natural Science Foundation of China (Nos. 81072065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten CIM, 2009, DIS COLON RECTUM, V52, P2028, DOI 10.1007/DCR.0b013e3181beb4ff; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Easty DJ, 2000, MELANOMA RES, V10, P401, DOI 10.1097/00008390-200010000-00001; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hess AR, 2007, DEV DYNAM, V236, P3283, DOI 10.1002/dvdy.21190; Hess AR, 2001, CANCER RES, V61, P3250; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamat AA, 2009, CANCER-AM CANCER SOC, V115, P2684, DOI 10.1002/cncr.24335; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Li X, 2007, TUMOR BIOL, V28, P165, DOI 10.1159/000103010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2008, CANCER BIOL THER, V7, P1098, DOI 10.4161/cbt.7.7.6168; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2002, CANCER RES, V62, P560; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wang JY, 2008, CANCER BIOL THER, V7, P758, DOI 10.4161/cbt.7.5.5765; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xu F, 2005, ANTICANCER RES, V25, P2943; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang SW, 2007, CANCER LETT, V254, P157, DOI 10.1016/j.canlet.2006.12.036; Zhou ZM, 2008, SURG NEUROL, V70, P562, DOI 10.1016/j.surneu.2008.04.031	42	101	111	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16264	10.1371/journal.pone.0016264	http://dx.doi.org/10.1371/journal.pone.0016264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264258	Green Submitted, gold, Green Published			2022-12-27	WOS:000286516500042
J	Ridgway, CL; Brage, S; Sharp, SJ; Corder, K; Westgate, KL; van Sluijs, EM; Goodyer, IM; Hallal, PC; Anderssen, SA; Sardinha, LB; Andersen, LB; Ekelund, U				Ridgway, Charlotte L.; Brage, Soren; Sharp, Stephen J.; Corder, Kirsten; Westgate, Kate L.; van Sluijs, Esther M.; Goodyer, Ian M.; Hallal, Pedro C.; Anderssen, Sigmund A.; Sardinha, Luis B.; Andersen, Lars Bo; Ekelund, Ulf			Does Birth Weight Influence Physical Activity in Youth? A Combined Analysis of Four Studies Using Objectively Measured Physical Activity	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; SEDENTARY BEHAVIOR; METABOLIC SYNDROME; RISK-FACTORS; CHILDREN; SIZE; LIFE; ASSOCIATIONS; DETERMINANTS; CHILDHOOD	Animal models suggest growth restriction in utero leads to lower levels of motor activity. Furthermore, individuals with very low birth weight report lower levels of physical activity as adults. The aim of this study was to examine whether birth weight acts as a biological determinant of physical activity and sedentary time. This study uses combined analysis of three European cohorts and one from South America (n = 4,170). Birth weight was measured or parentally reported. Height and weight were measured and used to calculate Body Mass Index (BMI). PA was objectively measured using accelerometry for >= 3 days, >= 10 hours day. Data was standardized to allow comparisons between different monitors. Total physical activity was assessed as counts per minute (cpm), with time spent above moderate activity (MVPA) > 2,000 counts and time spent sedentary (<100 counts). There was no evidence for an association between birth weight and total physical activity (p = 0.9) or MVPA (p = 0.7). Overall there was no evidence for an association between birth weight and sedentary time (p = 0.8). However in the Pelotas study we did find an association between higher birth weight (kg) and lower overall physical activity (cpm) (beta = -31, 95%CI: -58, -46, p = 0.03) and higher birth weight and greater sedentary time (mins/day) (beta = 16.4, 95%CI: 5.3, 27.5, p = 0.004), although this was attenuated and no longer significant with further adjustment for gestational age. Overall this combined analysis suggests that birth weight may not be an important biological determinant of habitual physical activity or sedentary behaviour in children and adolescents.	[Ridgway, Charlotte L.; Brage, Soren; Sharp, Stephen J.; Corder, Kirsten; Westgate, Kate L.; van Sluijs, Esther M.; Ekelund, Ulf] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Goodyer, Ian M.] Univ Cambridge, Cambridge, England; [Hallal, Pedro C.] Univ Fed Pelotas, Pelotas, Brazil; [Anderssen, Sigmund A.; Andersen, Lars Bo] Norwegian Sch Sports Sci, Dept Sports Med, Oslo, Norway; [Sardinha, Luis B.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, P-1499002 Lisbon, Portugal; [Andersen, Lars Bo] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	University of Cambridge; University of Cambridge; Universidade Federal de Pelotas; Norwegian School of Sport Sciences; Universidade de Lisboa; University of Southern Denmark	Ridgway, CL (corresponding author), Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	ulf.ekelund@mrc-epid.cam.ac.uk	Curtis, Charlotte/AAV-1156-2020; Ekelund, Ulf/AAE-8471-2019; Brage, Soren/C-6415-2013; Ridgway, Charlotte/H-4378-2013; Sardinha, Luís Bettencourt/F-2641-2013; Hallal, Pedro C/A-3249-2011; Sardinha, Luís B./ABG-5389-2020	Curtis, Charlotte/0000-0002-1022-3887; Ekelund, Ulf/0000-0003-2115-9267; Brage, Soren/0000-0002-1265-7355; Ridgway, Charlotte/0000-0002-1022-3887; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Hallal, Pedro C/0000-0003-1470-6461; Sardinha, Luís B./0000-0002-6230-6027; Westgate, Kate/0000-0002-0283-3562; van Sluijs, Esther/0000-0001-9141-9082	Danish Heart Foundation; Danish Medical Research Council Health Foundation; Danish Council for Sports Research; Foundation in Memory of Asta Florida Bolding Renee Andersen; Faculty of Health Sciences; University of Southern Denmark; Estonian Science Foundation [3277, 5209]; Norwegian Council of Cardiovascular Diseases; Eckbo Legacy; European Social Fund; Wellcome Trust; NIHR; National Prevention Research Initiative, UK; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_U106179474, MC_U106179473] Funding Source: researchfish; National Institute for Health Research [06/05/01, 97/29/01] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474, MC_U106179473] Funding Source: UKRI	Danish Heart Foundation; Danish Medical Research Council Health Foundation(Danish Medical Research Council); Danish Council for Sports Research; Foundation in Memory of Asta Florida Bolding Renee Andersen; Faculty of Health Sciences(European Commission); University of Southern Denmark; Estonian Science Foundation; Norwegian Council of Cardiovascular Diseases; Eckbo Legacy; European Social Fund(European Social Fund (ESF)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); National Prevention Research Initiative, UK; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The EYHS was Supported by grants from the Danish Heart Foundation, the Danish Medical Research Council Health Foundation, the Danish Council for Sports Research, the Foundation in Memory of Asta Florida Bolding Renee Andersen, the Faculty of Health Sciences, the University of Southern Denmark, the Estonian Science Foundation (grant nos. 3277 and 5209), the Norwegian Council of Cardiovascular Diseases, the Eckbo Legacy, and the European Social Fund. The Pelotas study was funded by grants from the Wellcome Trust. The ROOTS study was funded by the The Wellcome Trust and NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC, for Cambridgeshire & Peterborough). The SPEEDY study was funded by grants from the National Prevention Research Initiative, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Barker DJP, 1998, MOTHERS BABIES HLTH; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Boreham CA, 2001, PUBLIC HEALTH, V115, P373; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Corder K, 2005, MED SCI SPORT EXER, V37, P1761, DOI 10.1249/01.mss.0000176466.78408.cc; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Corder K, 2007, J SPORT SCI, V25, P1607, DOI 10.1080/02640410701283841; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Frontini Maria G, 2004, BMC Pediatr, V4, P22, DOI 10.1186/1471-2431-4-22; GOODYER IM, 2009, INT J EPIDEMIOL, V8, P8; Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; KAJANTIE E, 2010, J PEDIAT, P19; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P411, DOI 10.1007/s10654-008-9259-x; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; Murdey ID, 2004, ANN HUM BIOL, V31, P75, DOI 10.1080/03014460310001636589; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; YLIHARSILA H, 2007, INT J OBES LOND	36	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16125	10.1371/journal.pone.0016125	http://dx.doi.org/10.1371/journal.pone.0016125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264270	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000286514300007
J	Centelles, L; Assaiante, C; Nazarian, B; Anton, JL; Schmitz, C				Centelles, Laurie; Assaiante, Christine; Nazarian, Bruno; Anton, Jean-Luc; Schmitz, Christina			Recruitment of Both the Mirror and the Mentalizing Networks When Observing Social Interactions Depicted by Point-Lights: A Neuroimaging Study	PLOS ONE			English	Article							FRONTAL EYE-FIELD; BIOLOGICAL MOTION; MOTOR COGNITION; JOINT-ACTION; BRAIN-AREAS; PERCEPTION; SIMULATION; MIND; SYSTEMS; RECOGNITION	Background: Understanding social interactions requires the ability to accurately interpret conspecifics' actions, sometimes only on the basis of subtle body language analysis. Here we address an important issue that has not yet received much attention in social neuroscience, that of an interaction between two agents. We attempted to isolate brain responses to two individuals interacting compared to two individuals acting independently. Methodology/Principal Findings: We used minimalistic point-light displays to depict the characters, as they provide the most straightforward way to isolate mechanisms used to extract information from motion per se without any interference with other visual information. Functional magnetic resonance imaging (fMRI) method was used to determine which brain regions were recruited during the observation of two interacting agents, mimicking everyday social scenes. While the mirror and mentalizing networks are rarely concurrently active, we found that both of them might be needed to catch the social intentions carried by whole-body motion. Conclusions/Significance: These findings shed light on how motor cognition contributes to social cognition when social information is embedded in whole-body motion only. Finally, the approach described here provides a valuable and original tool for investigating the brain networks responsible for social understanding, in particular in psychiatric disorders.	[Centelles, Laurie; Assaiante, Christine; Schmitz, Christina] Univ Aix Marseille 1, Lab Neurosci Integrat & Adaptat, Marseille, France; [Centelles, Laurie; Assaiante, Christine; Schmitz, Christina] CNRS, Marseille, France; [Centelles, Laurie] CNRS, Lab Motricite Adaptat & Cognit, Bordeaux, France; [Nazarian, Bruno; Anton, Jean-Luc] CHU Timone, Ctr IRM Fonct Cerebrale, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Centelles, L (corresponding author), Univ Aix Marseille 1, Lab Neurosci Integrat & Adaptat, Marseille, France.	christina.schmitz@univ-provence.fr	Schmitz, Christina/G-9195-2011	Schmitz, Christina/0000-0002-8377-9608	Fondation Orange; Centre National de la Recherche Scientique	Fondation Orange; Centre National de la Recherche Scientique	The sources of funding for this work were the Fondation Orange (http://www.orange.com/fr_FR/mecenat/) and the Centre National de la Recherche Scientique (http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; Bedny M, 2009, P NATL ACAD SCI USA, V106, P11312, DOI 10.1073/pnas.0900010106; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; Bonda E, 1996, J NEUROSCI, V16, P3737; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Chouchourelou A, 2006, SOC NEUROSCI-UK, V1, P63, DOI 10.1080/17470910600630599; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Hu SY, 2009, EUR J NEUROSCI, V29, P2083, DOI 10.1111/j.1460-9568.2009.06757.x; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kilner JM, 2008, CURR BIOL, V18, pR32, DOI 10.1016/j.cub.2007.11.008; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Macrae CN, 2008, COGNITION, V109, P152, DOI 10.1016/j.cognition.2008.07.007; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Newman-Norlund RD, 2007, SOC NEUROSCI-UK, V2, P48, DOI 10.1080/17470910701224623; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Piefke M, 2009, HUM BRAIN MAPP, V30, P432, DOI 10.1002/hbm.20514; Pierno AC, 2008, SOC NEUROSCI-UK, V3, P51, DOI 10.1080/17470910701563269; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schmitz C, 2003, NEUROSCI LETT, V348, P17, DOI 10.1016/S0304-3940(03)00644-X; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; Schultz J, 2005, NEURON, V45, P625, DOI 10.1016/j.neuron.2004.12.052; Sebanz N, 2004, NAT NEUROSCI, V7, P5, DOI 10.1038/nn0104-5; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Troje NF, 2005, PERCEPT PSYCHOPHYS, V67, P667, DOI 10.3758/BF03193523; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Virji-Babul N, 2007, NEUROREPORT, V18, P1125, DOI 10.1097/WNR.0b013e32821c5470; Walker R, 2009, BRAIN RES, V1270, P54, DOI 10.1016/j.brainres.2009.02.081; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	72	93	94	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15749	10.1371/journal.pone.0015749	http://dx.doi.org/10.1371/journal.pone.0015749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LL	21249224	Green Published, gold, Green Submitted			2022-12-27	WOS:000286513100009
J	Takeuchi, H; Yokota, A; Ohoka, Y; Iwata, M				Takeuchi, Hajime; Yokota, Aya; Ohoka, Yoshiharu; Iwata, Makoto			Cyp26b1 Regulates Retinoic Acid-Dependent Signals in T Cells and Its Expression Is Inhibited by Transforming Growth Factor-beta	PLOS ONE			English	Article							TGF-BETA; DENDRITIC CELLS; METABOLIZING ENZYME; HUMAN CYTOCHROME-P450; RESPONSE ELEMENTS; DIFFERENTIATION; IDENTIFICATION; 4-HYDROXYLASE; ACTIVATION; GENERATION	Background: The vitamin A metabolite, retinoic acid (RA), plays important roles in the regulation of lymphocyte properties. Dendritic cells in gut-related lymphoid organs can produce RA, thereby imprinting gut-homing specificity on T cells and enhancing transforming growth factor (TGF)-beta-dependent induction of Foxp3(+) regulatory T cells upon antigen presentation. In general, RA concentrations in cells and tissues are regulated by its degradation as well. However, it remained unclear if T cells could actively catabolize RA. Methodology/Principal Findings: We assessed the expression of known RA-catabolizing enzymes in T cells from mouse lymphoid tissues. Antigen-experienced CD44(+) T cells in gut-related lymphoid organs selectively expressed Cyp26b1, a member of the cytochrome P450 family 26. However, T cells in the spleen or skin-draining lymph nodes did not significantly express Cyp26b1. Accordingly, physiological levels of RA (1-10 nM) could induce Cyp26b1 expression in naive T cells upon activation in vitro, but could not do so in the presence of TGF-beta. Overexpression of Cyp26b1 significantly suppressed the RA effect to induce expression of the gut-homing receptor CCR9 on T cells. On the other hand, knocking down Cyp26b1 gene expression with small interfering RNA or inhibiting CYP26 enzymatic activity led to enhancement of the RA-induced CCR9 expression. Conclusions/Significance: Our data demonstrate a role for CYP26B1 in regulating RA-dependent signals in activated T cells but not during TGF-beta-dependent differentiation to Foxp3(+) regulatory T cells. Aberrant expression of CYP26B1 may disturb T cell trafficking and differentiation in the gut and its related lymphoid organs.	[Takeuchi, Hajime; Yokota, Aya; Ohoka, Yoshiharu; Iwata, Makoto] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biodef Res, Sanuki, Japan; [Takeuchi, Hajime; Yokota, Aya; Ohoka, Yoshiharu; Iwata, Makoto] CREST, Japan Sci & Technol Agcy, Tokyo, Japan	Tokushima Bunri University; Japan Science & Technology Agency (JST)	Takeuchi, H (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biodef Res, Kagawa Campus, Sanuki, Japan.	takeuchih@kph.bunri-u.ac.jp; iwatam@kph.bunri-u.ac.jp	Miyakawa, Tsuyoshi/A-7741-2008; Takao, Keizo/B-9527-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Takao, Keizo/0000-0002-4734-3583	Japan Society for the Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Long-Range Research Initiative of Japan Chemical Industry Association; Skylark Food Science Institute, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Long-Range Research Initiative of Japan Chemical Industry Association; Skylark Food Science Institute, Japan	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and from the Japanese Ministry of Education, Culture, Sports, Science and Technology, The Long-Range Research Initiative of Japan Chemical Industry Association, and The Skylark Food Science Institute, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; BRUYNSEELS J, 1990, PROSTATE, V16, P345, DOI 10.1002/pros.2990160409; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MAHMOOD R, 1992, DEVELOPMENT, V115, P67; MAHMOOD R, 1995, ANAT EMBRYOL, V192, P21; Marchetti MN, 1997, DRUG METAB DISPOS, V25, P637; Marikar Y, 1998, J INVEST DERMATOL, V111, P434, DOI 10.1046/j.1523-1747.1998.00297.x; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; NUGENT P, 1995, EXP CELL RES, V220, P495, DOI 10.1006/excr.1995.1341; NUGENT P, 1994, DIFFERENTIATION, V58, P149; OHOKA Y, 2011, J IMMUNOL IN PRESS; Ozpolat B, 2002, AM J HEMATOL, V70, P39, DOI 10.1002/ajh.10099; Papadakis KA, 2001, GASTROENTEROLOGY, V121, P246, DOI 10.1053/gast.2001.27154; Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tahayato A, 2003, GENE EXPR PATTERNS, V3, P449, DOI 10.1016/S1567-133X(03)00066-8; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Takeuchi H, 2010, J IMMUNOL, V185, P5289, DOI 10.4049/jimmunol.1000101; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	46	42	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16089	10.1371/journal.pone.0016089	http://dx.doi.org/10.1371/journal.pone.0016089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249211	Green Published, Green Submitted, gold			2022-12-27	WOS:000286512900022
J	Bhattacharjee, PS; Huq, TS; Mandal, TK; Graves, RA; Muniruzzaman, S; Clement, C; McFerrin, HE; Hill, JM				Bhattacharjee, Partha S.; Huq, Tashfin S.; Mandal, Tarun K.; Graves, Richard A.; Muniruzzaman, Syed; Clement, Christian; McFerrin, Harris E.; Hill, James M.			A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis	PLOS ONE			English	Article							HEPARIN-BINDING-SITES; E MIMETIC PEPTIDE; NITRIC-OXIDE; CELL-MIGRATION; IN-VITRO; RECEPTOR; KINASE; SRC; LIPOPROTEIN; ACTIVATION	Angiogenesis is a hallmark of tumor development and metastasis and now a validated target for cancer treatment. We previously reported that a novel dimer peptide (apoEdp) derived from the receptor binding region of human apolipoprotein E (apoE) inhibits virus-induced angiogenesis. However, its role in tumor anti-angiogenesis is unknown. This study demonstrates that apoEdp has anti-angiogenic property in vivo through reduction of tumor growth in a mouse model and ocular angiogenesis in a rabbit eye model. Our in vitro studies show that apoEdp inhibits human umbilical vein endothelial cell proliferation, migration, invasion and capillary tube formation. We document that apoEdp inhibits vascular endothelial growth factor-induced Flk-1 activation as well as downstream signaling pathways that involve c-Src, Akt, eNOS, FAK, and ERK1/2. These in vitro data suggest potential sites of the apoE dipeptide inhibition that could occur in vivo. This is the first evidence that a synthetic dimer peptide mimicking human apoE has anti-angiogenesis functions and could be an anti-tumor drug candidate.	[Bhattacharjee, Partha S.; Huq, Tashfin S.; Muniruzzaman, Syed; McFerrin, Harris E.] Xavier Univ, Dept Biol, New Orleans, LA 70125 USA; [Bhattacharjee, Partha S.; Clement, Christian; Hill, James M.] Louisiana State Univ, Dept Ophthalmol, Hlth Sci Ctr, New Orleans, LA USA; [Mandal, Tarun K.; Graves, Richard A.] Xavier Univ, Coll Pharm, New Orleans, LA 70125 USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Dept Microbiol Immunol & Parasitol, Ctr Neurosci, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Dept Pharmacol, Hlth Sci Ctr, New Orleans, LA USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bhattacharjee, PS (corresponding author), Xavier Univ, Dept Biol, New Orleans, LA 70125 USA.	jhill@lsuhsc.edu		Mandal, Tarun/0000-0002-4966-2094	National Institutes of Health (NIH) [EY019144, EY006311, EY02377]; Louisiana Cancer Research Consortium; Xavier University of Louisiana Center for Undergraduate Research; Model Institutions for Excellence (MIE)-Science, Technology, Engineering and Mathematics (STEM); Louisiana Board of Regents, RC/EEP [07-10]; LSU Health Sciences Center; Research to Prevent Blindness; Senior Scientific Investigator Award; Research to Prevent Blindness, New York, New York; Louisiana Lions Eye Foundation, New Orleans, Louisian; Louisiana Board of Regents; Lions International, United States of America; NATIONAL EYE INSTITUTE [R21EY019144, P30EY002377, R01EY006311] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Consortium; Xavier University of Louisiana Center for Undergraduate Research; Model Institutions for Excellence (MIE)-Science, Technology, Engineering and Mathematics (STEM); Louisiana Board of Regents, RC/EEP; LSU Health Sciences Center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Senior Scientific Investigator Award; Research to Prevent Blindness, New York, New York(Research to Prevent Blindness (RPB)); Louisiana Lions Eye Foundation, New Orleans, Louisian; Louisiana Board of Regents; Lions International, United States of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants EY019144 (PSB, partial salary; TSH, some supplies, mice purchase and boarding), Louisiana Cancer Research Consortium (PSB, HEM, partial salary; PSB, HEM, TSH, some supplies and mice), Xavier University of Louisiana Center for Undergraduate Research (PSB, partial salary), Model Institutions for Excellence (MIE)-Science, Technology, Engineering and Mathematics (STEM) faculty mini-grants (PSB, supplies), Louisiana Board of Regents, RC/EEP (07-10) (TKM, production of VEGF pellet), NIH grants EY006311 (JMH, partial salaries JMH and CC, some supplies, and rabbit purchase and boarding), and EY02377 (Louisiana State University (LSU) Eye Center Core Grant for Vision Research, partial salary for editorial consultant and statistical analysis), an unrestricted research grant from LSU Health Sciences Center (JMH, some supplies), a Research to Prevent Blindness (RPB) Senior Scientific Investigator Award (JMH, supplies and the apoE dipeptide), an unrestricted grant from Research to Prevent Blindness, New York, New York, to the LSU Eye Center (partial salary for editorial consultant, graphics, and statistical analysis), Louisiana Lions Eye Foundation, New Orleans, Louisiana (part of supplies and rabbit board), Vaccine Center and the South Louisiana Institute for Infectious Disease Research sponsored by the Louisiana Board of Regents (partial salary JMH), and Lions International, United States of America (partial cost of supplies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhattacharjee PS, 2008, INVEST OPHTH VIS SCI, V49, P4263, DOI 10.1167/iovs.08-2077; Bhattacharjee PS, 2009, CURR EYE RES, V34, P99, DOI 10.1080/02713680802647662; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Fairweather JK, 2008, BIOORGAN MED CHEM, V16, P699, DOI 10.1016/j.bmc.2007.10.044; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Herbst Roy S, 2006, Expert Opin Emerg Drugs, V11, P635, DOI 10.1517/14728214.11.4.635; Hill JM, 2007, EXP EYE RES, V84, P801, DOI 10.1016/j.exer.2006.08.001; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; Huang YD, 2010, CURR OPIN LIPIDOL, V21, P337, DOI 10.1097/MOL.0b013e32833af368; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kelly BA, 2007, FEBS J, V274, P4511, DOI 10.1111/j.1742-4658.2007.05981.x; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Lee TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009945; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MARZ W, 1993, FEBS LETT, V325, P271, DOI 10.1016/0014-5793(93)81087-G; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Presta M, 2003, CURR PHARM DESIGN, V9, P553, DOI 10.2174/1381612033391379; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Su L, 2010, BIOCHEM BIOPH RES CO, V396, P1012, DOI 10.1016/j.bbrc.2010.05.048; Thomas JP, 2003, J CLIN ONCOL, V21, P223, DOI 10.1200/JCO.2003.12.120; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Wegrowski Y, 2004, CRIT REV ONCOL HEMAT, V49, P259, DOI 10.1016/j.critrevonc.2003.10.005; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yi T, 2008, CANCER RES, V68, P1843, DOI 10.1158/0008-5472.CAN-07-5944; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120	53	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15905	10.1371/journal.pone.0015905	http://dx.doi.org/10.1371/journal.pone.0015905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253017	Green Submitted, gold, Green Published			2022-12-27	WOS:000286511900020
J	Budkowska, A; Kakkanas, A; Nerrienet, E; Kalinina, O; Maillard, P; Horm, SV; Dalagiorgou, G; Vassilaki, N; Georgopoulou, U; Martinot, M; Sall, AA; Mavromara, P				Budkowska, Agata; Kakkanas, Athanassios; Nerrienet, Eric; Kalinina, Olga; Maillard, Patrick; Horm, Srey Viseth; Dalagiorgou, Geena; Vassilaki, Niki; Georgopoulou, Urania; Martinot, Michelle; Sall, Amadou Alpha; Mavromara, Penelope			Synonymous Mutations in the Core Gene Are Linked to Unusual Serological Profile in Hepatitis C Virus Infection	PLOS ONE			English	Article							OPEN READING FRAME; F-PROTEIN; MOLECULAR-BIOLOGY; IMMUNOBLOT ASSAY; MAMMALIAN-CELLS; EXPRESSION; TRANSLATION; GENOME; REGION; SEQUENCES	The biological role of the protein encoded by the alternative open reading frame (core+1/ARF) of the Hepatitis C virus (HCV) genome remains elusive, as does the significance of the production of corresponding antibodies in HCV infection. We investigated the prevalence of anti-core and anti-core+1/ARFP antibodies in HCV-positive blood donors from Cambodia, using peptide and recombinant protein-based ELISAs. We detected unusual serological profiles in 3 out of 58 HCV positive plasma of genotype 1a. These patients were negative for anti-core antibodies by commercial and peptide-based assays using C-terminal fragments of core but reacted by Western Blot with full-length core protein. All three patients had high levels of anti-core+1/ARFP antibodies. Cloning of the cDNA that corresponds to the core-coding region from these sera resulted in the expression of both core and core+1/ARFP in mammalian cells. The core protein exhibited high amino-acid homology with a consensus HCV1a sequence. However, 10 identical synonymous mutations were found, and 7 were located in the aa(99-124) region of core. All mutations concerned the third base of a codon, and 5/10 represented a T>C mutation. Prediction analyses of the RNA secondary structure revealed conformational changes within the stem-loop region that contains the core+1/ARFP internal AUG initiator at position 85/87. Using the luciferase tagging approach, we showed that core+1/ARFP expression is more efficient from such a sequence than from the prototype HCV1a RNA. We provide additional evidence of the existence of core+1/ARFP in vivo and new data concerning expression of HCV core protein. We show that HCV patients who do not produce normal anti-core antibodies have unusually high levels of antit-core+1/ARFP and harbour several identical synonymous mutations in the core and core+1/ARFP coding region that result in major changes in predicted RNA structure. Such HCV variants may favour core+1/ARFP production during HCV infection.	[Budkowska, Agata; Maillard, Patrick] Inst Pasteur, CNRS, URA 3015, Paris, France; [Kakkanas, Athanassios; Dalagiorgou, Geena; Vassilaki, Niki; Georgopoulou, Urania; Mavromara, Penelope] Hellenic Pasteur Inst, Mol Virol Lab, Athens, Greece; [Nerrienet, Eric; Horm, Srey Viseth] Pasteur Inst Cambodia, Virol Lab, Phnom Penh, Cambodia; [Kalinina, Olga] Pasteur Inst St Petersburg, Mol Microbiol Virol Lab, St Petersburg, Russia; [Martinot, Michelle] Univ Paris 07, INSERM, Hop Beaujon, U773,Ctr Rech Biomed Bichat Beaujon CRB3, Clichy, France; [Sall, Amadou Alpha] Pasteur Inst Dakar, Dakar, Senegal	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Saint-Petersburg Pasteur Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Budkowska, A (corresponding author), Inst Pasteur, CNRS, URA 3015, Paris, France.	agata.budkowska@pasteur.fr	Georgopoulou, Urania/AAQ-3831-2020; Kalinina, Olga/L-1822-2017; Kakkanas, Athanassios/AAQ-5185-2020; Kalinina, Olga V/M-8482-2016	Kalinina, Olga/0000-0003-1916-5705; Kalinina, Olga V/0000-0002-9445-477X	Institut Pasteur, Paris, France [126]; "Agence Nationale de Recherche sur le SIDA et les Hepatites Virales" (ANRS)	Institut Pasteur, Paris, France; "Agence Nationale de Recherche sur le SIDA et les Hepatites Virales" (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by the Transversal Project (PTR#126) from Institut Pasteur, Paris, France. Olga Kalinina was granted a fellowship from the "Agence Nationale de Recherche sur le SIDA et les Hepatites Virales" (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Baril M, 2005, NUCLEIC ACIDS RES, V33, P1474, DOI 10.1093/nar/gki292; Basu A, 2004, J GEN VIROL, V85, P2299, DOI 10.1099/vir.0.80028-0; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; BOUMLIC A, FEBS J, V277, P774; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chuang WCM, 2008, J GEN VIROL, V89, P1890, DOI 10.1099/vir.0.83677-0; Cohen M, 2007, DIGEST DIS SCI, V52, P2427, DOI 10.1007/s10620-006-9630-2; Eng FJ, 2009, J VIROL, V83, P3104, DOI 10.1128/JVI.01679-08; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fiorucci M, 2007, J GEN VIROL, V88, P1149, DOI 10.1099/vir.0.82575-0; Goymer P, 2007, NAT REV GENET, V8, P92, DOI 10.1038/nrg2056; IMBERTI L, 1991, J VIROL METHODS, V34, P233, DOI 10.1016/0166-0934(91)90103-7; Irshad M, 2006, MED PRIN PRACT, V15, P405, DOI 10.1159/000095485; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Lohmann Volker, 2009, V510, P145, DOI 10.1007/978-1-59745-394-3_11; Martin P, 1998, J CLIN MICROBIOL, V36, P387, DOI 10.1128/JCM.36.2.387-390.1998; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Morice Y, 2009, HEPATOLOGY, V49, P1449, DOI 10.1002/hep.22821; Nagasaka A, 1996, J MED VIROL, V49, P91, DOI 10.1002/(SICI)1096-9071(199606)49:2<91::AID-JMV4>3.0.CO;2-E; OKAMOTO H, 1990, JPN J EXP MED, V60, P167; PAWLOTSKY JM, 1995, J CLIN MICROBIOL, V33, P1357, DOI 10.1128/JCM.33.5.1357-1359.1995; Ratinier M, 2008, J GEN VIROL, V89, P1569, DOI 10.1099/vir.0.83614-0; Roussel J, 2003, J GEN VIROL, V84, P1751, DOI 10.1099/vir.0.19065-0; Shao SW, 2009, HEPATOL RES, V39, P282, DOI 10.1111/j.1872-034X.2008.00452.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Troesch M, 2005, AIDS, V19, P775, DOI 10.1097/01.aids.0000168971.57681.6e; Tsao ML, 2006, BIOCHEM BIOPH RES CO, V348, P271, DOI 10.1016/j.bbrc.2006.07.062; Tsitoura P, 2007, FEBS LETT, V581, P4049, DOI 10.1016/j.febslet.2007.07.032; Varaklioti A, 2002, J BIOL CHEM, V277, P17713, DOI 10.1074/jbc.M201722200; Vassilaki N, 2003, J BIOL CHEM, V278, P40503, DOI 10.1074/jbc.M305504200; Vassilaki N, 2008, VIRUS RES, V133, P123, DOI 10.1016/j.virusres.2007.10.019; Vassilaki N, 2007, FEBS J, V274, P4057, DOI 10.1111/j.1742-4658.2007.05929.x; Vassilaki N, 2009, IUBMB LIFE, V61, P739, DOI 10.1002/iub.201; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Wu WB, 2007, INTERVIROLOGY, V50, P341, DOI 10.1159/000107271; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yeh CT, 1997, J GEN VIROL, V78, P2761, DOI 10.1099/0022-1317-78-11-2761; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08	43	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15871	10.1371/journal.pone.0015871	http://dx.doi.org/10.1371/journal.pone.0015871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21283512	Green Published, gold			2022-12-27	WOS:000286511900019
J	Wegmann, F; Krashias, G; Luhn, K; Laamanen, K; Vieira, S; Jeffs, SA; Shattock, RJ; Sattentau, QJ				Wegmann, Frank; Krashias, George; Luehn, Kerstin; Laamanen, Karoliina; Vieira, Sueli; Jeffs, Simon A.; Shattock, Robin J.; Sattentau, Quentin J.			A Novel Strategy for Inducing Enhanced Mucosal HIV-1 Antibody Responses in an Anti-Inflammatory Environment	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GENITAL-TRACT; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; PRO-2000 GEL; IN-VIVO; TYPE-1; TRANSMISSION; CELLS; IMMUNIZATION	Prophylactic vaccination against HIV-1 sexual transmission will probably require antibody elicitation at genital mucosal surfaces. However, HIV-1 envelope glycoprotein (Env)-based antigens are weakly immunogenic, particularly when applied mucosally. The polyanion PRO 2000 is safe for human vaginal application, and thus may represent a potential formulating agent for vaginal delivery of experimental vaccine immunogens. Based upon its biochemical properties, we hypothesized that PRO 2000 might enhance mucosal immunogenicity of HIV-1 envelope glycoprotein (Env)-based antigens, promoting local and systemic immune responses. Vaginal immunization with Env-PRO 2000 resulted in significantly increased titres of Env-specific mucosal IgA and IgG in mice and rabbits, respectively, compared to Env alone, revealing modest but significant mucosal adjuvant activity for PRO 2000. In vitro, PRO 2000 associated with Env, protecting the glycoprotein from proteolytic degradation in human vaginal lavage. Unexpectedly, PRO 2000 antagonized TLR4 activation, suppressing local production of inflammatory cytokines. Since inflammation-mediated recruitment of viral target cells is a major risk factor in HIV-1 transmission, the immune modulatory and anti-inflammatory activities of PRO 2000 combined with its intravaginal safety profile suggests promise as an HIV-1 mucosal vaccine formulating agent.	[Wegmann, Frank; Krashias, George; Laamanen, Karoliina; Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Luehn, Kerstin] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Vieira, Sueli; Jeffs, Simon A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Jefferiss Trust Res Labs, London, England; [Shattock, Robin J.] Univ London, Ctr Infect, London, England	University of Oxford; University of Oxford; Imperial College London; University of London	Wegmann, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	frank.wegmann@path.ox.ac.uk		Wegmann, Frank/0000-0002-9821-1492	Bill and Melinda Gates Foundation [37872]; Wellcome Trust through the Grand Challenges in Global Health initiative [077384]; European Union Network of Excellence; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium; Fondation Dormeur and the Microbicide Development Programme (MDP); Bodossaki Foundation; Medical Research Council [G0000635] Funding Source: researchfish; MRC [G0000635] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust through the Grand Challenges in Global Health initiative(Wellcome Trust); European Union Network of Excellence(European Commission); International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium; Fondation Dormeur and the Microbicide Development Programme (MDP); Bodossaki Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was primarily funded by a grant to St George's, University of London, from the Bill and Melinda Gates Foundation (ref. 37872) and the Wellcome Trust (ref. 077384), through the Grand Challenges in Global Health initiative. The authors also acknowledge support from The European Union Network of Excellence 'EUROPRISE', The International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium, Fondation Dormeur and the Microbicide Development Programme (MDP). QJS is a Jenner Institute Investigator and GK was supported by the Bodossaki Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AW, 2007, IMMUNOL LETT, V110, P1, DOI 10.1016/j.imlet.2007.02.012; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brandtzaeg P, 1997, J REPROD IMMUNOL, V36, P23, DOI 10.1016/S0165-0378(97)00061-2; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Imaoka K, 1998, J IMMUNOL, V161, P5952; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Johansson EL, 1998, INFECT IMMUN, V66, P514, DOI 10.1128/IAI.66.2.514-520.1998; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lacey CJN, 2006, AIDS, V20, P1027, DOI 10.1097/01.aids.0000222075.83490.ca; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mayer KH, 2003, AIDS, V17, P321, DOI 10.1097/00002030-200302140-00005; MCCORMACK S, 2010, LANCET, P17; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; ROEHR B, 2009, BMJ, V18; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Spirig R, 2008, J IMMUNOL, V181, P878, DOI 10.4049/jimmunol.181.2.878; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Takahashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2358, DOI 10.1271/bbb.70142; Teleshova N, 2008, ANTIMICROB AGENTS CH, V52, P1751, DOI 10.1128/AAC.00707-07; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yip HC, 1999, J IMMUNOL, V162, P3942; Zariffard MR, 2005, J INFECT DIS, V191, P1913, DOI 10.1086/429922; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu Y, 2003, BBA-BIOMEMBRANES, V1611, P234, DOI 10.1016/S0005-2736(03)00060-9	56	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15861	10.1371/journal.pone.0015861	http://dx.doi.org/10.1371/journal.pone.0015861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253014	Green Published, gold			2022-12-27	WOS:000286511900016
J	Peters, KM; Brooks, BE; Schumacher, MA; Skurray, RA; Brennan, RG; Brown, MH				Peters, Kate M.; Brooks, Benjamin E.; Schumacher, Maria A.; Skurray, Ronald A.; Brennan, Richard G.; Brown, Melissa H.			A Single Acidic Residue Can Guide Binding Site Selection but Does Not Govern QacR Cationic-Drug Affinity	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; TRANSCRIPTIONAL REGULATOR; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURES; CONFORMATIONAL-CHANGE; COMPLEXES REVEAL; STRUCTURAL BASIS; LIGAND-BINDING; TETR FAMILY; DNA-BINDING	Structures of the multidrug-binding repressor protein QacR with monovalent and bivalent cationic drugs revealed that the carboxylate side-chains of E90 and E120 were proximal to the positively charged nitrogens of the ligands ethidium, malachite green and rhodamine 6G, and therefore may contribute to drug neutralization and binding affinity. Here, we report structural, biochemical and in vivo effects of substituting these glutamate residues. Unexpectedly, substitutions had little impact on ligand affinity or in vivo induction capabilities. Structures of QacR(E90Q) and QacR(E120Q) with ethidium or malachite green took similar global conformations that differed significantly from all previously described QacR-drug complexes but still prohibited binding to cognate DNA. Strikingly, the QacR(E90Q)-rhodamine 6G complex revealed two mutually exclusive rhodamine 6G binding sites. Despite multiple structural changes, all drug binding was essentially isoenergetic. Thus, these data strongly suggest that rather than contributing significantly to ligand binding affinity, the role of acidic residues lining the QacR multidrug-binding pocket is primarily to attract and guide cationic drugs to the "best available'' positions within the pocket that elicit QacR induction.	[Peters, Kate M.; Skurray, Ronald A.; Brown, Melissa H.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Brooks, Benjamin E.; Schumacher, Maria A.; Brennan, Richard G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Brown, Melissa H.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	University of Sydney; University of Texas System; UTMD Anderson Cancer Center; Flinders University South Australia	Peters, KM (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	rgbrenna@mdanderson.org; melissa.brown@flinders.edu.au	Giampietro, Vincent P/D-1279-2011; Williams, Steve/D-6979-2011; Brown, Melissa/V-2296-2017; Uher, Rudolf/A-5477-2008	Giampietro, Vincent P/0000-0002-9381-8201; Williams, Steve/0000-0003-4299-1941; Treasure, Janet/0000-0003-0871-4596; Brown, Melissa/0000-0001-6461-7550; Uher, Rudolf/0000-0002-2998-0546; opoku, anita/0000-0001-7243-8157; Brennan, Richard/0000-0001-7647-485X; Brooks, Samantha/0000-0002-9146-6257	National Health and Medical Research Council (Australia) [301941]; National Institutes of Health [AI048593]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Project Grant 301941 from the National Health and Medical Research Council (Australia) (to R.A.S. and M.H.B.) and by grant AI048593 from the National Institutes of Health Grant (to R.G.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Aramaki H, 1995, PROTEIN ENG, V8, P1259, DOI 10.1093/protein/8.12.1259; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brooks BE, 2007, J AM CHEM SOC, V129, P8389, DOI 10.1021/ja072576v; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., 2006, PYMOL MOL GRAPHICS S; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grkovic S, 2003, BIOCHEMISTRY-US, V42, P15226, DOI 10.1021/bi035447+; Grkovic S, 2003, MICROBIOL-SGM, V149, P785, DOI 10.1099/mic.0.25951-0; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; Gu RY, 2008, ACTA CRYSTALLOGR F, V64, P584, DOI 10.1107/S1744309108016035; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAATZ GW, 1995, ANTIMICROB AGENTS CH, V39, P2650, DOI 10.1128/AAC.39.12.2650; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, NEWSL PROT CRYSTALL, V26; LYON BR, 1983, ANTIMICROB AGENTS CH, V23, P817, DOI 10.1128/AAC.23.6.817; Madoori PK, 2009, EMBO J, V28, P156, DOI 10.1038/emboj.2008.263; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128, DOI 10.1128/AAC.37.1.128; Paulsen IT, 1996, P NATL ACAD SCI USA, V93, P3630, DOI 10.1073/pnas.93.8.3630; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Peters KM, 2009, BIOCHEMISTRY-US, V48, P9794, DOI 10.1021/bi901102h; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Price CTD, 2002, INT J ANTIMICROB AG, V20, P206, DOI 10.1016/S0924-8579(02)00162-0; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Routh MD, 2009, BBA-PROTEINS PROTEOM, V1794, P844, DOI 10.1016/j.bbapap.2008.12.001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sigal N, 2009, J BIOL CHEM, V284, P6966, DOI 10.1074/jbc.M808877200; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; YOON KP, 1991, J BACTERIOL, V173, P7643, DOI 10.1128/jb.173.23.7643-7649.1991	55	67	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15974	10.1371/journal.pone.0015974	http://dx.doi.org/10.1371/journal.pone.0015974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21799807	Green Published, Green Submitted, gold			2022-12-27	WOS:000286517600015
J	Wang, J; Li, CH; Wang, EK; Wang, XD				Wang, Jin; Li, Chunhe; Wang, Erkang; Wang, Xidi			An FPT Approach for Predicting Protein Localization from Yeast Genomic Data	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BAYESIAN NETWORKS; DATA INTEGRATION; GENE-EXPRESSION; CLASSIFICATION; IDENTIFICATION; GENERATION; SEQUENCES; PATTERNS; SYSTEM	Accurately predicting the localization of proteins is of paramount importance in the quest to determine their respective functions within the cellular compartment. Because of the continuous and rapid progress in the fields of genomics and proteomics, more data are available now than ever before. Coincidentally, data mining methods been developed and refined in order to handle this experimental windfall, thus allowing the scientific community to quantitatively address long-standing questions such as that of protein localization. Here, we develop a frequent pattern tree (FPT) approach to generate a minimum set of rules (mFPT) for predicting protein localization. We acquire a series of rules according to the features of yeast genomic data. The mFPT prediction accuracy is benchmarked against other commonly used methods such as Bayesian networks and logistic regression under various statistical measures. Our results show that mFPT gave better performance than other approaches in predicting protein localization. Meanwhile, setting 0.65 as the minimum hit-rate, we obtained 138 proteins that mFPT predicted differently than the simple naive bayesian method (SNB). In our analysis of these 138 proteins, we present novel predictions for the location for 17 proteins, which currently do not have any defined localization. These predictions can serve as putative annotations and should provide preliminary clues for experimentalists. We also compared our predictions against the eukaryotic subcellular localization database and related predictions by others on protein localization. Our method is quite generalized and can thus be applied to discover the underlying rules for protein-protein interactions, genomic interactions, and structure-function relationships, as well as those of other fields of research.	[Wang, Jin; Li, Chunhe; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Astron, Stony Brook, NY 11794 USA; [Li, Chunhe] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Xidi] Citibank NA, Sao Paulo, Brazil	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China.	jin.wang.1@stonybrook.edu; ekwang@ciac.jl.cn	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022; , 汪尔康/P-1748-2019; Li, Chunhe/C-8132-2011	Li, Chunhe/0000-0002-9127-3930	National Science Foundation; National Natural Science Foundation of China [90713022, 20735003]; 973 project [2009CB930100, 2010CB833600]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	JW acknowledges support from the National Science Foundation. CHL and EKW are supported by the National Natural Science Foundation of China (grants 90713022 and 20735003) and the 973 project (grants 2009CB930100 and 2010CB833600). The funder of XW from a commercial company had a role in preparation of the manuscript. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RC, 2001, J PARALLEL DISTR COM, V61, P350, DOI 10.1006/jpdc.2000.1693; Agrawal R., 1994, P 20 INT C VERY LARG, V1215, P487; ALEXANDROV V, 2001, INT J QUANTUM CHEM, V4, P188; Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Boyd D, 1998, PROTEIN SCI, V7, P201, DOI 10.1002/pro.5560070121; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Frishman D, 1998, BIOINFORMATICS, V14, P551, DOI 10.1093/bioinformatics/14.7.551; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; GERSTEIN M, 2000, PAC S BIOCOMP, V5, P30; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; HAN J, 2000, SIGKDD EXPLORATIONS, V2, P14; Han JW, 2004, DATA MIN KNOWL DISC, V8, P53, DOI 10.1023/B:DAMI.0000005258.31418.83; HAN JW, 2006, DATA MINING CONCEPTS, P475; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Mewes HW, 1998, NUCLEIC ACIDS RES, V26, P33, DOI 10.1093/nar/26.1.33; NACHMAN I, 2004, THESIS HEBREW U; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKAI K, 1996, INTELL SYS MOL BIOL, V4, P109; NAKAI K, 1997, INTELL SYS MOL BIOL, V5, P147; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pierleoni A, 2007, NUCLEIC ACIDS RES, V35, pD208, DOI 10.1093/nar/gkl775; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Riffle M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-263; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stephenson T. A., 2000, INTRO BAYESIAN NETWO; Stryer L, 1996, BIOCHEMISTRY; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; VERHASSELT P, 1995, YEAST, V11, P961, DOI 10.1002/yea.320111007; Wang J, 2009, P NATL ACAD SCI USA, V106, P3752, DOI 10.1073/pnas.0806427106; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38	53	114	143	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14449	10.1371/journal.pone.0014449	http://dx.doi.org/10.1371/journal.pone.0014449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21915343	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600001
J	Bai, XD; Mamidala, P; Rajarapu, SP; Jones, SC; Mittapalli, O				Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna P.; Jones, Susan C.; Mittapalli, Omprakash			Transcriptomics of the Bed Bug (Cimex lectularius)	PLOS ONE			English	Article							ARTHROPOD CUTICULAR PROTEINS; EXPRESSED SEQUENCE TAGS; PUBLIC-HEALTH PROBLEM; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; HEMIPTERA-CIMICIDAE; WOLBACHIA; GENES; EVOLUTION; DATABASE	Background: Bed bugs (Cimex lectularius) are blood-feeding insects poised to become one of the major pests in households throughout the United States. Resistance of C. lectularius to insecticides/pesticides is one factor thought to be involved in its sudden resurgence. Despite its high-impact status, scant knowledge exists at the genomic level for C. lectularius. Hence, we subjected the C. lectularius transcriptome to 454 pyrosequencing in order to identify potential genes involved in pesticide resistance. Methodology and Principal Findings: Using 454 pyrosequencing, we obtained a total of 216,419 reads with 79,596,412 bp, which were assembled into 35,646 expressed sequence tags (3902 contigs and 31744 singletons). Nearly 85.9% of the C. lectularius sequences showed similarity to insect sequences, but 44.8% of the deduced proteins of C. lectularius did not show similarity with sequences in the GenBank non-redundant database. KEGG analysis revealed putative members of several detoxification pathways involved in pesticide resistance. Lamprin domains, Protein Kinase domains, Protein Tyrosine Kinase domains and cytochrome P450 domains were among the top Pfam domains predicted for the C. lectularius sequences. An initial assessment of putative defense genes, including a cytochrome P450 and a glutathione-S-transferase (GST), revealed high transcript levels for the cytochrome P450 (CYP9) in pesticide-exposed versus pesticide-susceptible C. lectularius populations. A significant number of single nucleotide polymorphisms (296) and microsatellite loci (370) were predicted in the C. lectularius sequences. Furthermore, 59 putative sequences of Wolbachia were retrieved from the database. Conclusions: To our knowledge this is the first study to elucidate the genetic makeup of C. lectularius. This pyrosequencing effort provides clues to the identification of potential detoxification genes involved in pesticide resistance of C. lectularius and lays the foundation for future functional genomics studies.	[Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna P.; Mittapalli, Omprakash] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Jones, Susan C.] Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bai, XD (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	mittapalli.1@osu.edu	Rajarapu, Swapna Priya/H-3514-2019	Mamidala, Praveen/0000-0001-8587-0635	State and Federal funds	State and Federal funds	This research was supported by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naser M, 2006, PARASITOL RES, V98, P550, DOI 10.1007/s00436-005-0076-9; Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson AL, 2008, J ENVIRON HEALTH, V70, P24; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Barbehenn RV, 2002, J CHEM ECOL, V28, P1329, DOI 10.1023/A:1016288201110; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Boase C., 2001, Pesticide Outlook, V12, P159, DOI 10.1039/b106301b; Bochicchio B, 2001, MATRIX BIOL, V20, P243, DOI 10.1016/S0945-053X(01)00139-1; COGILL P, 2008, CURR PROTOC BIOINFOR, V2; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Gangloff-Kaufmann J., 2006, American Entomologist, V52, P105; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goddard J., 2010, INFECT DIS ARTHROPOD, P177; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HAMODRAKAS SJ, 1988, PROTEIN ENG, V2, P201, DOI 10.1093/protein/2.3.201; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lee IY, 2008, KOREAN J PARASITOL, V46, P269, DOI 10.3347/kjp.2008.46.4.269; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Maier D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-74; McNeil GP, 2001, GENETICS, V159, P229; Mittapalli O, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2001; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; Olafson PU, 2010, ARCH INSECT BIOCHEM, V74, P179, DOI 10.1002/arch.20372; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Potter M. F., 2005, Pest Control Technology, V33, P82; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Rendahl KG, 1996, J NEUROSCI, V16, P1511; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robson P, 2000, MOL BIOL EVOL, V17, P1739, DOI 10.1093/oxfordjournals.molbev.a026272; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Rose RL, 1997, INSECT BIOCHEM MOLEC, V27, P605, DOI 10.1016/S0965-1748(97)00036-2; Rossi L, 2010, J ENVIRON HEALTH, V72, P34; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Scarupa MD, 2006, J ALLERGY CLIN IMMUN, V117, P1508, DOI 10.1016/j.jaci.2006.03.034; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Stanewsky R, 1996, GENETICS, V143, P259; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Stibich AS, 2001, DERMATOLOGY, V202, P193, DOI 10.1159/000051635; Stucki A, 2008, NEW ENGL J MED, V359, P1047, DOI 10.1056/NEJMicm060268; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Ter Poorten MC, 2005, PEDIATR DERMATOL, V22, P183, DOI 10.1111/j.1525-1470.2005.22301.x; THURSTON MI, 2005, MSATFINDER DETECTION; TOMITA T, 1995, INSECT BIOCHEM MOLEC, V25, P275, DOI 10.1016/0965-1748(94)00066-Q; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WERREN JH, 1995, P ROY SOC LOND B BIO, V265, P1447; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	94	123	139	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16336	10.1371/journal.pone.0016336	http://dx.doi.org/10.1371/journal.pone.0016336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283830	gold, Green Published, Green Submitted			2022-12-27	WOS:000286520600041
J	Perrin, RJ; Craig-Schapiro, R; Malone, JP; Shah, AR; Gilmore, P; Davis, AE; Roe, CM; Peskind, ER; Li, G; Galasko, DR; Clark, CM; Quinn, JF; Kaye, JA; Morris, JC; Holtzman, DM; Townsend, RR; Fagan, AM				Perrin, Richard J.; Craig-Schapiro, Rebecca; Malone, James P.; Shah, Aarti R.; Gilmore, Petra; Davis, Alan E.; Roe, Catherine M.; Peskind, Elaine R.; Li, Ge; Galasko, Douglas R.; Clark, Christopher M.; Quinn, Joseph F.; Kaye, Jeffrey A.; Morris, John C.; Holtzman, David M.; Townsend, R. Reid; Fagan, Anne M.			Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EPITHELIUM-DERIVED FACTOR; CELL-ADHESION MOLECULE; AMYLOID-BETA-PROTEIN; IMMUNODEFICIENCY-VIRUS ENCEPHALITIS; FRONTOTEMPORAL LOBAR DEGENERATION; SECRETORY GRANULE MEMBRANE; CEREBRAL-ARTERY OCCLUSION; GENOME-WIDE ASSOCIATION; CARBONIC-ANHYDRASE-IV	Background: Ideally, disease modifying therapies for Alzheimer disease (AD) will be applied during the 'preclinical' stage (pathology present with cognition intact) before severe neuronal damage occurs, or upon recognizing very mild cognitive impairment. Developing and judiciously administering such therapies will require biomarker panels to identify early AD pathology, classify disease stage, monitor pathological progression, and predict cognitive decline. To discover such biomarkers, we measured AD-associated changes in the cerebrospinal fluid (CSF) proteome. Methods and Findings: CSF samples from individuals with mild AD (Clinical Dementia Rating [CDR] 1) (n = 24) and cognitively normal controls (CDR 0) (n = 24) were subjected to two-dimensional difference-in-gel electrophoresis. Within 119 differentially-abundant gel features, mass spectrometry (LC-MS/MS) identified 47 proteins. For validation, eleven proteins were re-evaluated by enzyme-linked immunosorbent assays (ELISA). Six of these assays (NrCAM, YKL-40, chromogranin A, carnosinase I, transthyretin, cystatin C) distinguished CDR 1 and CDR 0 groups and were subsequently applied (with tau, p-tau181 and A beta 42 ELISAs) to a larger independent cohort (n = 292) that included individuals with very mild dementia (CDR 0.5). Receiver-operating characteristic curve analyses using stepwise logistic regression yielded optimal biomarker combinations to distinguish CDR 0 from CDR. 0 (tau, YKL-40, NrCAM) and CDR 1 from CDR, 1 (tau, chromogranin A, carnosinase I) with areas under the curve of 0.90 (0.85-0.94 95% confidence interval [CI]) and 0.88 (0.81-0.94 CI), respectively. Conclusions: Four novel CSF biomarkers for AD (NrCAM, YKL-40, chromogranin A, carnosinase I) can improve the diagnostic accuracy of A beta 42 and tau. Together, these six markers describe six clinicopathological stages from cognitive normalcy to mild dementia, including stages defined by increased risk of cognitive decline. Such a panel might improve clinical trial efficiency by guiding subject enrollment and monitoring disease progression. Further studies will be required to validate this panel and evaluate its potential for distinguishing AD from other dementing conditions.	[Perrin, Richard J.] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA; [Perrin, Richard J.; Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Perrin, Richard J.; Roe, Catherine M.; Morris, John C.; Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA; [Craig-Schapiro, Rebecca; Shah, Aarti R.; Roe, Catherine M.; Morris, John C.; Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Div Metab, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Prote Ctr, St Louis, MO USA; [Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Peskind, Elaine R.] Univ Washington, Sch Med, Dept Vet Affairs, NW Network,Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Peskind, Elaine R.; Li, Ge] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Galasko, Douglas R.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Clark, Christopher M.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Clark, Christopher M.] Univ Penn, Rush Alzheimers Dis Ctr, Philadelphia, PA 19104 USA; [Clark, Christopher M.] Avid Radiopharmaceut, Philadelphia, PA USA; [Quinn, Joseph F.; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Layton Aging & Alzheimers Dis Ctr, Portland, OR USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Pennsylvania; University of Pennsylvania; Oregon Health & Science University	Perrin, RJ (corresponding author), Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA.	rperrin@path.wustl.edu	Morris, John C/A-1686-2012	Roe, Catherine/0000-0002-1405-0485; Kaye, Jeffrey/0000-0002-9971-3478; Misko, Thomas/0000-0001-7917-422X; Quinn, Joseph/0000-0001-7305-2256; Kuhn, Max/0000-0003-2402-136X	National Alzheimer's Coordinating Center (NACC) [U01 AG16976, P50 AG05681, P01 AG026276, P50 AG05136, P01 AG03991, P30 NS057105, UL1 RR024992]; W.M. Keck Foundation [P41 RR00954]; Dept. of Veterans Affairs [AG020020, AG23185, AG08017, AG10124, T32 NS007205]; Charles and Joanne Knight Alzheimer Research Initiative; Avid Radiopharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007205, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P50AG005681, P30AG008017, P50AG005136, P01AG026276, R01AG023185, K23AG020020, P01AG003991, U01AG016976] Funding Source: NIH RePORTER	National Alzheimer's Coordinating Center (NACC); W.M. Keck Foundation(W.M. Keck Foundation); Dept. of Veterans Affairs(US Department of Veterans Affairs); Charles and Joanne Knight Alzheimer Research Initiative; Avid Radiopharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Alzheimer's Coordinating Center (NACC) Grant U01 AG16976 (A.M.F.); P50 AG05681 (C.M.R., E.A.G.); P01 AG026276 (C.M.R., E.A.G.); P50 AG05136; P01 AG03991(J.C.M.); P30 NS057105 (D.M.H.); UL1 RR024992 (R.R.T.; C.M.R.); W.M. Keck Foundation (R.R.T.); P41 RR00954 (R.R.T); Dept. of Veterans Affairs (E.R.P.); AG020020 (G.L.); AG23185 (D.R.G.); AG08017 (J.F.Q.); AG08017 (J.A.K.); AG10124 (C.M.C); T32 NS007205 (R.J.P.); and the Charles and Joanne Knight Alzheimer Research Initiative (A.M.F.); Avid Radiopharmaceuticals (C.M.C., employment unrelated to this study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Abraham CR, 2000, ANN NY ACAD SCI, V920, P245; Aisa B, 2010, J ALZHEIMERS DIS, V20, P659, DOI 10.3233/JAD-2010-1398; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alder J, 2003, J NEUROSCI, V23, P10800; Antequera D, 2009, NEUROBIOL DIS, V36, P42, DOI 10.1016/j.nbd.2009.06.018; Arun P, 2009, NEUROCHEM INT, V55, P219, DOI 10.1016/j.neuint.2009.03.003; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Bergamaschini L, 2001, MECH AGEING DEV, V122, P1971, DOI 10.1016/S0047-6374(01)00311-6; BERGGARD I, 1968, J BIOL CHEM, V243, P4095; Bian H, 2008, NEUROLOGY, V70, P1827, DOI 10.1212/01.wnl.0000311445.21321.fc; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Biroccio A, 2006, PROTEOMICS, V6, P2305, DOI 10.1002/pmic.200500285; BLENNOW K, 1995, DEMENTIA, V6, P306, DOI 10.1159/000106963; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Castellani RJ, 1999, FREE RADICAL BIO MED, V26, P1508, DOI 10.1016/S0891-5849(99)00016-7; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Choi-Miura N.-H., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P239, DOI 10.2174/1568016043356327; Choi-Miura NH, 2000, INFLAMM RES, V49, P305, DOI 10.1007/PL00000211; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Costa R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002899; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; D'Aniello A, 2005, NEUROSCI LETT, V388, P49, DOI 10.1016/j.neulet.2005.06.030; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Eder U, 1998, J NEURAL TRANSM, V105, P39, DOI 10.1007/s007020050036; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Finehout EJ, 2005, DIS MARKERS, V21, P93, DOI 10.1155/2005/806573; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Gao J, 2008, BBA-BIOMEMBRANES, V1778, P1429, DOI 10.1016/j.bbamem.2008.03.013; Gasser MC, 2003, J NEUROCHEM, V85, P662, DOI 10.1046/j.1471-4159.2003.01677.x; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Gunzburg MJ, 2007, J BIOL CHEM, V282, P35831, DOI 10.1074/jbc.M706425200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; HARIGAYA Y, 1995, INTERNAL MED, V34, P481, DOI 10.2169/internalmedicine.34.481; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harr SD, 1996, J NEUROCHEM, V66, P2429; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2010, ENDOCR J, V57, P275, DOI 10.1507/endocrj.K10E-038; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; HOULDEN H, 1995, NEUROSCI LETT, V188, P202, DOI 10.1016/0304-3940(95)11422-S; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Ji LN, 2009, J ALZHEIMERS DIS, V18, P105, DOI 10.3233/JAD-2009-1127; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kaneko K, 2002, J NEUROPATH EXP NEUR, V61, P1069, DOI 10.1093/jnen/61.12.1069; Kapaki E, 2008, ALZ DIS ASSOC DIS, V22, P47, DOI 10.1097/WAD.0b013e3181610fea; KATZAV A, 2009, NEUROBIOL AGING; Kaufmann WA, 1998, EUR J NEUROSCI, V10, P1084, DOI 10.1046/j.1460-9568.1998.00121.x; Kaynar MY, 2005, J CLIN NEUROSCI, V12, P754, DOI 10.1016/j.jocn.2005.06.001; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kessler H, 2006, J NEURAL TRANSM, V113, P1763, DOI 10.1007/s00702-006-0485-7; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Koch S, 2001, J LIPID RES, V42, P1143; Kolson DL, 2008, AM J PATHOL, V173, P25, DOI 10.2353/ajpath.2008.080389; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; Kubota K, 2009, J NEUROCHEM, V110, P496, DOI 10.1111/j.1471-4159.2009.06099.x; Kuncl RW, 2002, J NEUROCHEM, V81, P178, DOI 10.1046/j.1471-4159.2002.00813.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LASSMANN H, 1992, NEUROSCIENCE, V46, P1, DOI 10.1016/0306-4522(92)90003-K; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Levin Edward D., 2005, Current Alzheimer Research, V2, P191; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Li L, 2008, CELL DEATH DIFFER, V15, P879, DOI 10.1038/cdd.2008.8; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; LOB HE, HYPERTENSION, V55, P283; Lob HE, 2010, HYPERTENSION, V55, P277, DOI 10.1161/HYPERTENSIONAHA.109.142646; Loeffler DA, 2004, NEUROBIOL AGING, V25, P1001, DOI 10.1016/j.neurobiolaging.2003.11.003; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Lovell MA, 2008, NEUROLOGY, V70, P2212, DOI 10.1212/01.wnl.0000312383.39973.88; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; MASAKI T, 1992, J BIOCHEM-TOKYO, V111, P573, DOI 10.1093/oxfordjournals.jbchem.a123799; Massaro AR, 2009, EUR REV MED PHARMACO, V13, P397; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Misasi Roberta, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P119; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Montine TJ, 1997, AM J PATHOL, V151, P1571; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Narita M, 1997, J NEUROCHEM, V69, P1904; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Okii N, 2007, ACTA HISTOCHEM CYTOC, V40, P113, DOI 10.1267/ahc.07011; Ostergaard C, 2002, CLIN DIAGN LAB IMMUN, V9, P598, DOI 10.1128/CDLI.9.3.598-604.2002; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Paco S, 2010, CEREB CORTEX, V20, P1386, DOI 10.1093/cercor/bhp202; PALMER RH, 1995, BIOCHEM J, V309, P315, DOI 10.1042/bj3090315; Pan S, 2008, J PROTEOME RES, V7, P720, DOI 10.1021/pr700630x; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; PERARNAU B, 1990, NATURE, V346, P751, DOI 10.1038/346751a0; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Puche AC, 1997, NEUROREPORT, V8, P3183, DOI 10.1097/00001756-199710200-00001; Ray I, 2000, BRAIN RES, V853, P344, DOI 10.1016/S0006-8993(99)02315-X; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Riemenschneider M, 1998, LANCET, V351, P63, DOI 10.1016/S0140-6736(05)78060-0; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Sanagi T, 2005, NEUROSCI LETT, V380, P105, DOI 10.1016/j.neulet.2005.01.035; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; SCHMIDBAUER JM, 1990, HISTOCHEMISTRY, V94, P427; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; SCHWEDEN J, 1989, BIOCHEM J, V264, P347, DOI 10.1042/bj2640347; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Simonsen AH, 2008, NEUROBIOL AGING, V29, P961, DOI 10.1016/j.neurobiolaging.2007.01.011; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Squitti R, 2009, NEUROLOGY, V72, P50, DOI 10.1212/01.wnl.0000338568.28960.3f; Squitti R, 2008, PRION, V2, P23, DOI 10.4161/pri.2.1.6297; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Steur EJ, 1998, LANCET, V351, P1105, DOI 10.1016/S0140-6736(05)79387-9; Stoltzner SE, 2000, AM J PATHOL, V156, P489, DOI 10.1016/S0002-9440(10)64753-0; Storan MJ, 2004, J COMP NEUROL, V475, P289, DOI 10.1002/cne.20167; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; Svichar N, 2009, J NEUROSCI, V29, P3252, DOI 10.1523/JNEUROSCI.0036-09.2009; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Takanohashi A, 2005, GLIA, V51, P266, DOI 10.1002/glia.20203; Tapiola T, 1998, LANCET, V352, P287, DOI 10.1016/S0140-6736(05)60260-7; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Todaro L, 2004, NEUROBIOL DIS, V15, P387, DOI 10.1016/j.nbd.2003.11.014; Tolboom N, 2009, J NUCL MED, V50, P1464, DOI 10.2967/jnumed.109.064360; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Ueyama T, 2001, J NEUROCHEM, V79, P903, DOI 10.1046/j.1471-4159.2001.00624.x; UMEZAWA Y, 1991, JPN J CLIN ONCOL, V21, P251; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593; Vukovic J, 2009, MATRIX BIOL, V28, P406, DOI 10.1016/j.matbio.2009.06.001; Wati H, 2009, BRAIN PATHOL, V19, P48, DOI 10.1111/j.1750-3639.2008.00166.x; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Woronowicz A, 2010, J NEUROSCI RES, V88, P64, DOI 10.1002/jnr.22174; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; WURDIG S, 1991, NEUROSCI LETT, V130, P165, DOI 10.1016/0304-3940(91)90388-A; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; Yamagishi S, 2004, MED HYPOTHESES, V63, P115, DOI 10.1016/j.mehy.2004.02.022; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236; Zhu XM, 2005, J NEUROCHEM, V95, P1351, DOI 10.1111/j.1471-4159.2005.03460.x; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	230	155	162	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16032	10.1371/journal.pone.0016032	http://dx.doi.org/10.1371/journal.pone.0016032			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264269	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514300004
J	Hu, AYC; Tseng, YF; Weng, TC; Liao, CC; Wu, J; Chou, AH; Chao, HJ; Gu, AN; Chen, J; Lin, SC; Hsiao, CH; Wu, SC; Chong, P				Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele			Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium	PLOS ONE			English	Article							SCALE MICROCARRIER CULTURE; VIRUS PRODUCTION; ANIMAL-CELLS; VERO CELLS; RABIES VACCINE; WHOLE VIRUS; CULTIVATION; BIOREACTOR; SYSTEM; GROWTH	Background: Highly pathogenic influenza viruses pose a constant threat which could lead to a global pandemic. Vaccination remains the principal measure to reduce morbidity and mortality from such pandemics. The availability and surging demand for pandemic vaccines needs to be addressed in the preparedness plans. This study presents an improved high-yield manufacturing process for the inactivated influenza H5N1 vaccines using Madin-Darby canine kidney (MDCK) cells grown in a serum-free (SF) medium microcarrier cell culture system. Principal Finding: The current study has evaluated the performance of cell adaptation switched from serum-containing (SC) medium to several commercial SF media. The selected SF medium was further evaluated in various bioreactor culture systems for process scale-up evaluation. No significant difference was found in the cell growth in different sizes of bioreactors studied. In the 7.5 L bioreactor runs, the cell concentration reached to 2.3x10(6) cells/mL after 5 days. The maximum virus titers of 1024 Hemagglutinin (HA) units/50 mu L and 7.1 +/- 0.3x10(8) pfu/mL were obtained after 3 days infection. The concentration of HA antigen as determined by SRID was found to be 14.1 mu g/mL which was higher than those obtained from the SC medium. A mouse immunogenicity study showed that the formalin-inactivated purified SF vaccine candidate formulated with alum adjuvant could induce protective level of virus neutralization titers similar to those obtained from the SC medium. In addition, the H5N1 viruses produced from either SC or SF media showed the same antigenic reactivity with the NIBRG14 standard antisera. Conclusions: The advantages of this SF cell-based manufacturing process could reduce the animal serum contamination, the cost and lot-to-lot variation of SC medium production. This study provides useful information to manufacturers that are planning to use SF medium for cell-based influenza vaccine production.	[Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Hu, AYC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan.	pelechong@nhri.org.tw	Chong, Pele/E-3855-2010; Hu, Alan Yung-Chih/G-3708-2011; Wu, Suh-Chin/AAV-6233-2021		Taiwan Pandemic Influenza Vaccine Research and Development Program [DOH95-DC-1408]	Taiwan Pandemic Influenza Vaccine Research and Development Program	This study was funded by the Taiwan Pandemic Influenza Vaccine Research and Development Program (Grant no. DOH95-DC-1408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Croughan MS, 2000, BIOTECHNOL BIOENG, V67, P841, DOI 10.1002/(SICI)1097-0290(20000320)67:6<841::AID-BIT19>3.0.CO;2-K; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Frazatti-Gallina NM, 2004, VACCINE, V23, P511, DOI 10.1016/j.vaccine.2004.06.014; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Kistner O, 1999, WIEN KLIN WOCHENSCHR, V111, P207; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Merten O W, 2002, Dev Biol (Basel), V111, P233; Merten OW, 2000, CYTOTECHNOLOGY, V34, P181, DOI 10.1023/A:1008160817560; Merten OW, 1999, CYTOTECHNOLOGY, V30, pIX; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Nerome K, 1999, Dev Biol Stand, V98, P53; Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086; Toriniwa H, 2007, BIOLOGICALS, V35, P221, DOI 10.1016/j.biologicals.2007.02.002; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WOOD JM, 1989, VIROLOGY, V171, P214, DOI 10.1016/0042-6822(89)90528-X; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; ZHANG S, 1992, J BIOTECHNOL, V25, P289, DOI 10.1016/0168-1656(92)90162-3	29	88	102	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14578	10.1371/journal.pone.0014578	http://dx.doi.org/10.1371/journal.pone.0014578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	22216221	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400002
J	Michalik, P; Rittschof, CC				Michalik, Peter; Rittschof, Clare C.			A Comparative Analysis of the Morphology and Evolution of Permanent Sperm Depletion in Spiders	PLOS ONE			English	Article							ORB-WEAVING SPIDER; NEPHILA PLUMIPES ARANEOIDEA; ARGIOPE-BRUENNICHI ARANEAE; MALE COPULATION FREQUENCY; SEXUAL CANNIBALISM; WEB SPIDER; MATING-BEHAVIOR; CLAVIPES ARANEAE; SIZE DIMORPHISM; NATURAL-HISTORY	Once thought to be energetically cheap and easy to produce, empirical work has shown that sperm is a costly and limited resource for males. In some spider species, there is behavioral evidence that sperm are permanently depleted after a single mating. This extreme degree of mating investment appears to co-occur with other reproductive strategies common to spiders, e. g. genital mutilation and sexual cannibalism. Here we corroborate that sperm depletion in the golden orb-web spider Nephila clavipes is permanent by uncovering its mechanistic basis using light and electron microscopy. In addition, we use a phylogeny-based statistical analysis to test the evolutionary relationships between permanent sperm depletion (PSD) and other reproductive strategies in spiders. Male testes do not produce sperm during adulthood, which is unusual in spiders. Instead, spermatogenesis is nearly synchronous and ends before the maturation molt. Testis size decreases as males approach their maturation molt and reaches its lowest point after sperm is transferred into the male copulatory organs (pedipalps). As a consequence, the amount of sperm available to males for mating is limited to the sperm contained in the pedipalps, and once it is used, males lose their ability to fertilize eggs. Our data suggest that PSD has evolved independently at least three times within web-building spiders and is significantly correlated with the evolution of other mating strategies that limit males to monogamy, including genital mutilation and sexual cannibalism. We conclude that PSD may be an energy-saving adaptation in species where males are limited to monogamy. This could be particularly important in web-building spiders where extreme sexual size dimorphism results in large, sedentary females and small, searching males who rarely feed as adults and are vulnerable to starvation. Future work will explore possible energetic benefits and the evolutionary lability of PSD relative to other mate-limiting reproductive behaviors.	[Michalik, Peter] Ernst Moritz Arndt Univ Greifswald, Zoolog Inst & Museum, Greifswald, Germany; [Michalik, Peter] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Rittschof, Clare C.] Univ Florida, Dept Biol, Gainesville, FL USA	Ernst Moritz Arndt Universitat Greifswald; American Museum of Natural History (AMNH); State University System of Florida; University of Florida	Michalik, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zoolog Inst & Museum, Greifswald, Germany.	michalik@uni-greifswald.de	Michalik, Peter/E-6757-2010	Michalik, Peter/0000-0003-2459-9153	NSF-DDIG [IOS-0909367]; University of Greifswald	NSF-DDIG(National Science Foundation (NSF)); University of Greifswald	NSF-DDIG Grant No. IOS-0909367. Travel grant by the University of Greifswald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI G, 1990, ACTA ZOOL FENN, V190, P17; Andrade MCB, 2005, INTEGR COMP BIOL, V45, P838, DOI 10.1093/icb/45.5.838; Andrade MCB, 2002, ANIM BEHAV, V63, P857, DOI 10.1006/anbe.2002.2003; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Bateman PW, 2001, ETHOLOGY, V107, P1087, DOI 10.1046/j.1439-0310.2001.00756.x; Boivin G, 2005, OECOLOGIA, V143, P198, DOI 10.1007/s00442-004-1800-3; Bukowski TC, 2001, ANIM BEHAV, V62, P887, DOI 10.1006/anbe.2001.1834; Bukowski TC, 1997, J ARACHNOL, V25, P307; CHRISTENSON T, 1989, J ARACHNOL, V17, P115; CHRISTENSON TE, 1979, BEHAV ECOL SOCIOBIOL, V5, P87, DOI 10.1007/BF00302697; CHRISTENSON TE, 1985, J COMP PSYCHOL, V99, P160, DOI 10.1037/0735-7036.99.2.160; CHRISTENSON TE, 1988, J COMP PSYCHOL, V102, P312, DOI 10.1037/0735-7036.102.4.312; Coddington JA, 1997, NATURE, V385, P687, DOI 10.1038/385687a0; Corcobado G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-236; Costa FG, 1998, J ARACHNOL, V26, P106; Danielson-Francois AM, 2006, J ARACHNOL, V34, P387, DOI 10.1636/S04-46.1; Danielson-Francois AM, 2005, J INSECT BEHAV, V18, P131, DOI 10.1007/s10905-005-9352-x; DEWSBURY DA, 1983, J COMP PSYCHOL, V97, P34, DOI 10.1037/0735-7036.97.1.34; Eberhard WG, 2004, J ARACHNOL, V32, P545, DOI 10.1636/0161-8202(2004)032[0545:WSSSST]2.0.CO;2; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Engqvist L, 2006, J EVOLUTION BIOL, V19, P1448, DOI 10.1111/j.1420-9101.2006.01134.x; Foelix R., 2011, BIOL SPIDERS, V3; Foellmer MW, 2004, EVOL ECOL RES, V6, P163; FOELLMER MW, 2003, P ROYAL SOC LONDON B; FORSTER LM, 1992, AUST J ZOOL, V40, P1, DOI 10.1071/ZO9920001; Fromhage L, 2003, BEHAV ECOL SOCIOBIOL, V55, P60, DOI 10.1007/s00265-003-0656-6; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2005, EVOLUTION, V59, P1400; GAGE MJG, 1994, FUNCT ECOL, V8, P594, DOI 10.2307/2389920; Herberstein ME, 2005, ETHOLOGY, V111, P1050, DOI 10.1111/j.1439-0310.2005.01114.x; Herberstein ME, 2002, BEHAV ECOL SOCIOBIOL, V51, P440, DOI 10.1007/s00265-002-0460-8; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; HUBER BA, 1995, J ZOOL, V235, P689, DOI 10.1111/j.1469-7998.1995.tb01778.x; Huber Bernhard A., 1998, Bulletin of the British Arachnological Society, V11, P81; Knoflach B, 2000, J NAT HIST, V34, P1639, DOI 10.1080/00222930050117530; Knoflach B, 2001, J ZOOL, V254, P449, DOI 10.1017/S0952836901000954; Knoflach B., 2004, Denisia, P161; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, 2009, J ARACHNOL, V37, P266, DOI 10.1636/St08-67.1; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lemaitre JF, 2009, ANIM BEHAV, V77, P49, DOI 10.1016/j.anbehav.2008.08.028; Linn CD, 2007, ANIM BEHAV, V74, P481, DOI 10.1016/j.anbehav.2007.02.004; MADDISON WP, 1990, EVOLUTION, V44, P539, DOI 10.2307/2409434; MADDISON WP, 2000, MACCLADE VERSION 4; MADDISON WP, 2010, MESQUITE; Michalik P, 2006, ZOOLOGY, V109, P14, DOI 10.1016/j.zool.2005.09.010; Michalik P, 2006, J MORPHOL, V267, P129, DOI 10.1002/jmor.10226; MICHALIK P, 2006, THESIS ERNST MORITZ; Michalik Peter, 2005, Front Zool, V2, P12, DOI 10.1186/1742-9994-2-12; Michalik P, 2010, AM MUS NOVIT, P1, DOI 10.1206/680.1; Michalik Peter, 2009, Contributions to Natural History (Bern), V12, P959; Michalik P, 2010, TISSUE CELL, V42, P32, DOI 10.1016/j.tice.2009.06.004; Miller JA, 2007, EVOLUTION, V61, P1301, DOI 10.1111/j.1558-5646.2007.00115.x; Molina Y, 2008, ANIM BEHAV, V76, P1327, DOI 10.1016/j.anbehav.2008.04.021; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MYERS L, 1988, J ARACHNOL, V16, P254; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Nessler SH, 2007, P R SOC B, V274, P2337, DOI 10.1098/rspb.2007.0585; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler S, 2009, BEHAV ECOL SOCIOBIOL, V63, P355, DOI 10.1007/s00265-008-0669-2; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Radhakrishnan P, 2009, ANIM BEHAV, V78, P839, DOI 10.1016/j.anbehav.2009.07.002; Ramos M, 2004, P NATL ACAD SCI USA, V101, P4883, DOI 10.1073/pnas.0400324101; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Schneider JM, 2005, J ARACHNOL, V33, P663, DOI 10.1636/S03-32.1; Schneider JM, 2006, ANIM BEHAV, V71, P781, DOI 10.1016/j.anbehav.2005.05.012; Schneider JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P410, DOI 10.1007/s002650000307; Schneider JM, 2001, BEHAV ECOL, V12, P547, DOI 10.1093/beheco/12.5.547; Schneider JM, 2008, AUST J ZOOL, V56, P233, DOI 10.1071/ZO08041; SIMMONS LW, 1993, P ROY SOC B-BIOL SCI, V251, P183, DOI 10.1098/rspb.1993.0027; Smith C, 2009, ANIM BEHAV, V77, P1227, DOI 10.1016/j.anbehav.2009.01.027; Snow LSE, 2006, ETHOLOGY, V112, P379, DOI 10.1111/j.1439-0310.2006.01163.x; Snow LSE, 2004, BEHAV ECOL, V15, P785, DOI 10.1093/beheco/arh080; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stoltz JA, 2010, P ROY SOC B-BIOL SCI, V277, P585, DOI 10.1098/rspb.2009.1554; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	81	69	72	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16014	10.1371/journal.pone.0016014	http://dx.doi.org/10.1371/journal.pone.0016014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21525987	Green Submitted, Green Published, gold			2022-12-27	WOS:000286514000016
J	Wang, JB; Zhao, HP; Zhao, YL; Jin, C; Liu, DJ; Kong, WJ; Fang, F; Zhang, L; Wang, HJ; Xiao, XH				Wang, Jia-bo; Zhao, Hai-ping; Zhao, Yan-ling; Jin, Cheng; Liu, Dao-jian; Kong, Wei-jun; Fang, Fang; Zhang, Lin; Wang, Hong-juan; Xiao, Xiao-he			Hepatotoxicity or Hepatoprotection? Pattern Recognition for the Paradoxical Effect of the Chinese Herb Rheum palmatum L. in Treating Rat Liver Injury	PLOS ONE			English	Article							GROWTH-FACTOR; MEDICINE; HEPATITIS; FIBROSIS; RHUBARB; EXPRESSION; EMODIN; ACID	The hepatotoxicity of some Chinese herbs has been a cause for concern in recent years. However, some herbs, such as rhubarb, have been documented as having both therapeutic and toxic effects on the liver, leading to the complex problem of distinguishing the benefits from the risks of using this herb. To comparatively analyze the dose-response relationship between rhubarb and hepatic health, we administrated total rhubarb extract(RE) to normal and carbon tetrachloride(CCl4)-treated rats for 12 weeks at 4 dosage levels(2.00, 5.40, 14.69 and 40.00 g.kg(-1), measured as the quantity of crude material), followed by biochemical and histopathological tests of the rats' livers. A composite pattern was extracted by factor analysis, using all the biochemical indices as variables, into a visual representation of two mathematically obtained factors, which could be interpreted as the fibrosis factor and the cellular injury factor, according to the values of the variable loadings. The curative effect of administering the two lowest dosages of RE to CCl4-treated rats was mainly expressed as a decrease in the extent of cellular injury. The hepatoprotective mechanism of RE might be related to its antioxidant effect, the antagonism of the free radical damage to hepatocytes caused by CCl4. By contrast, the RE-induced liver damage was mainly expressed as a significant increase in the amount of fibrosis in both normal rats at all dosage levels and CCl4-treated rats at the two highest dosage levels. Therefore, the hepatotoxic potential of RE could be attributable to the liver cell fibrosis induced by high doses of the herb. This study illustrates the bidirectional potential of rhubarb and demonstrates the feasibility of using factor analysis to study the dose-response relationships between herbal medicines and hepatotoxicity or the healing effects of these herbs by extracting the underlying interrelationships among a number of functional bio-indices in a holistic manner.	[Wang, Jia-bo; Zhao, Hai-ping; Zhao, Yan-ling; Jin, Cheng; Liu, Dao-jian; Kong, Wei-jun; Fang, Fang; Zhang, Lin; Wang, Hong-juan; Xiao, Xiao-he] 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China; [Zhao, Hai-ping] Jiangxi Univ Tradit Chinese Med, Minist Educ, Key Lab Modern Preparat Tradit Chinese Med, Nanchang, Peoples R China; [Kong, Wei-jun; Fang, Fang; Zhang, Lin] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Jiangxi University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Wang, JB (corresponding author), 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China.	pharmacy302@126.com	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022; , 汪尔康/P-1748-2019; Li, Chunhe/C-8132-2011	Li, Chunhe/0000-0002-9127-3930	National Key Technologies R&D Program of China [2009ZX09502-022]; National Natural Science Foundation of China [30625042, 30973947]	National Key Technologies R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies R&D Program of China (No. 2009ZX09502-022) and by the National Natural Science Foundation of China (No. 30625042 and 30973947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, JAP PHARM; Arosio B, 2000, PHARMACOL TOXICOL, V87, P229, DOI 10.1034/j.1600-0773.2000.d01-79.x; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P199, DOI 10.1080/15321810701454649; Battinelli L, 2004, ANN INTERN MED, V140, pE589, DOI 10.7326/0003-4819-140-7-200404060-00042-w3; Cao Z, 2001, J 4 MILITARY MED U, V22, P530; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chitturi S, 2000, J GASTROEN HEPATOL, V15, P1093, DOI 10.1046/j.1440-1746.2000.02349.x; Ding Y, 2008, EUR J PHARMACOL, V590, P377, DOI 10.1016/j.ejphar.2008.06.044; *EUR DIR QUAL MED, 2001, EUR PHARM; Huang Z H, 1997, Zhongguo Zhong Xi Yi Jie He Za Zhi, V17, P459; Iizuka A, 2004, J ETHNOPHARMACOL, V91, P89, DOI 10.1016/j.jep.2003.11.021; ITOH S, 1995, DIGEST DIS SCI, V40, P1845, DOI 10.1007/BF02212712; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; Jin HY, 2005, LIFE SCI, V76, P2805, DOI 10.1016/j.lfs.2004.09.041; Leung TF, 2005, THORAX, V60, P822, DOI 10.1136/thx.2004.039321; Luo Z. Y., 2007, CHIN ARCH TRADIT CHI, V25, P612; Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029; Medicines and Healthcare products Regulatory Agency, POL MULT LIV REACT; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Napoli J, 1997, HEPATOLOGY, V26, P624, DOI 10.1053/jhep.1997.v26.pm0009303492; *NAT TOX PROGR, 2001, SERIES NAT TOX PROGR, V493; Ni M., 1995, YELLOW EMPERORS CLAS; Qin Y, 2011, J ETHNOPHARMACOL, V133, P1096, DOI 10.1016/j.jep.2010.11.041; Sharma S., 1996, APPL MULTIVARIATE TE, P90; Tafeit E, 2000, COMPUT BIOMED RES, V33, P365, DOI 10.1006/cbmr.2000.1550; Thoefner MB, 2001, PREV VET MED, V48, P201, DOI 10.1016/S0167-5877(00)00193-8; TIAN Y, 2008, CHIN J HISTOCHEM CYT, V17, P303; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Vanderperren B, 2005, ANN PHARMACOTHER, V39, P1353, DOI 10.1345/aph.1E670; WAEL ED, 1997, NMR BIOMED, V10, P99; Wan Shao-hui, 2006, Zhongguo Yaolixue Tongbao, V22, P1405; WANG GS, 1985, CHIN J INTEGR TRAD W, V5, P322; WANG GS, 1985, CHIN J INTEGR TRAD W, V5, P329; Wang JB, 2009, J ETHNOPHARMACOL, V124, P18, DOI 10.1016/j.jep.2009.04.018; World Health Organization, 1999, WHO MONOGRAPHS SELEC, P231; Wu C X, 1984, Zhong Xi Yi Jie He Za Zhi, V4, P88; XU Y, 2005, MOD J INTEGR TRADIT, V14, P600; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x; [张陆勇 Zhang Liuyong], 2004, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V25, P206; Zhao YL, 2009, BASIC CLIN PHARMACOL, V104, P463, DOI 10.1111/j.1742-7843.2009.00389.x; 2005, PHARMACOPOEIA PEOPLE, P17	42	114	143	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24498	10.1371/journal.pone.0024498	http://dx.doi.org/10.1371/journal.pone.0024498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915343	Green Published, gold, Green Submitted			2022-12-27	WOS:000294689200050
J	Xia, HB; Wang, W; Xia, H; Zhao, W; Lu, BR				Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong			Conspecific Crop-Weed Introgression Influences Evolution of Weedy Rice (Oryza sativa f. spontanea) across a Geographical Range	PLOS ONE			English	Article							GENETIC DIVERSITY; RED RICE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; POPULATION-GENETICS; CULTIVATED RICE; HYBRIDIZATION; FLOW; TRAITS; EXTENSIONS	Background: Introgression plays an important role in evolution of plant species via its influences on genetic diversity and differentiation. Outcrossing determines the level of introgression but little is known about the relationships of outcrossing rates, genetic diversity, and differentiation particularly in a weedy taxon that coexists with its conspecific crop. Methodology/Principal Findings: Eleven weedy rice (Oryza sativa f. spontanea) populations from China were analyzed using microsatellite (SSR) fingerprints to study outcrossing rate and its relationship with genetic variability and differentiation. To estimate outcrossing, six highly polymorphic SSR loci were used to analyze >5500 progeny from 216 weedy rice families, applying a mixed mating model; to estimate genetic diversity and differentiation, 22 SSR loci were analyzed based on 301 weedy individuals. Additionally, four weed-crop shared SSR loci were used to estimate the influence of introgression from rice cultivars on weedy rice differentiation. Outcrossing rates varied significantly (0.4 similar to 11.7%) among weedy rice populations showing relatively high overall Nei's genetic diversity (0.635). The observed heterozygosity was significantly correlated with outcrossing rates among populations (r(2) = 0.783; P<0.001) although no obvious correlation between outcrossing rates and genetic diversity parameters was observed. Allelic introgression from rice cultivars to their coexisting weedy rice was detected. Weedy rice populations demonstrated considerable genetic differentiation that was correlated with their spatial distribution (r(2) = 0.734; P<0.001), and possibly also influenced by the introgression from rice cultivars. Conclusions/Significance: Outcrossing rates can significantly affect heterozygosity of populations, which may shape the evolutionary potential of weedy rice. Introgression from the conspecific crop rice can influence the genetic differentiation and possibly evolution of its coexisting weedy rice populations.	[Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong] Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Fudan University	Lu, BR (corresponding author), Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009; Xia, Hui/L-7129-2019	Lu, Bao-Rong/0000-0002-0214-2390; Xia, Hui/0000-0003-2446-5171	Nature Science Foundation of China [30730066, 30871503]; Chinese Ministry of Science and Technology [2006CB100205, 2007CB109202]; National Program of Development of Transgenic New Species of China [2008ZX08011-006]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Program of Development of Transgenic New Species of China	This work was supported by the Nature Science Foundation of China (grant numbers 30730066, 30871503), Chinese Ministry of Science and Technology (grant numbers 2006CB100205, 2007CB109202), and the National Program of Development of Transgenic New Species of China (2008ZX08011-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2005, CROP SCI, V45, P98, DOI 10.2135/cropsci2005.0098; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Burgos NR, 2008, WEED TECHNOL, V22, P200, DOI 10.1614/WT-07-075.1; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hansen LB, 2001, GENET RESOUR CROP EV, V48, P621, DOI 10.1023/A:1013825816443; HARLAN JR, 1965, EUPHYTICA, V14, P173, DOI 10.1007/BF00038984; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hiscock SJ, 2003, PHILOS T R SOC B, V358, P1037, DOI 10.1098/rstb.2003.1297; HOLTSFORD TP, 1989, THEOR APPL GENET, V78, P480, DOI 10.1007/BF00290831; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Ishikawa R, 2005, GENET RESOUR CROP EV, V52, P395, DOI 10.1007/s10722-005-2257-x; Jarne P, 2008, HEREDITY, V100, P431, DOI 10.1038/hdy.2008.2; LANGEVIN SA, 1990, EVOLUTION, V44, P1000, DOI 10.1111/j.1558-5646.1990.tb03820.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; NEI M, 1974, GENETICS, V76, P379; Oka H. I., 1988, Origin of cultivated rice.; OKA H. I. W. T. CHANG, 1959, PHYTON REV INTERNAC BOT EXPTL ARGENTINA, V13, P105; Quilichini A, 2001, HEREDITY, V87, P190, DOI 10.1046/j.1365-2540.2001.00897.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rohlf FJ, 1998, NTSYSPC NUMERICAL TA; Rong J, 2010, PLANT BIOTECHNOL J, V8, P452, DOI 10.1111/j.1467-7652.2009.00488.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Olguin ERS, 2009, TRANSGENIC RES, V18, P633, DOI 10.1007/s11248-009-9255-2; SHAW DV, 1981, P NATL ACAD SCI-BIOL, V78, P1298, DOI 10.1073/pnas.78.2.1298; Shivrain VK, 2008, WEED SCI, V56, P807, DOI 10.1614/WS-08-026.1; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Suh H., 2008, WEEDY RICE; Suh H. S., 1996, International Rice Research Notes, V21, P7; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Vaughan DA, 2002, W CROP SCI, P27; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Wright S, 1921, GENETICS, V6, P111; Wright S, 1978, VARIABILITY NATURAL; Yu GQ, 2005, BIOCHEM GENET, V43, P261, DOI 10.1007/s10528-005-5218-3; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhao R, 2009, AM J BOT, V96, P1138, DOI 10.3732/ajb.0800173	62	95	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16189	10.1371/journal.pone.0016189	http://dx.doi.org/10.1371/journal.pone.0016189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	22174836	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000030
J	Wei, J; Wu, A; Kong, LY; Wang, YT; Fuller, G; Fokt, I; Melillo, G; Priebe, W; Heimberger, AB				Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Fuller, Gregory; Fokt, Isabella; Melillo, Giovanni; Priebe, Waldemar; Heimberger, Amy B.			Hypoxia Potentiates Glioma-Mediated Immunosuppression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; IMMUNE DYSFUNCTION; SIGNAL TRANSDUCERS; INDUCIBLE FACTORS; TUMOR; MACROPHAGE; CANCER; EXPRESSION; HIF-1-ALPHA	Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GBM associated cancer stem cells (gCSCs) as a treatment resistant population that has been shown to inhibit both innate and adaptive immune responses, we compared immunosuppressive properties under both normoxic and hypoxic conditions. Functional immunosuppression was characterized based on production of immunosuppressive cytokines and chemokines, the inhibition of T cell proliferation and effector responses, induction of FoxP3+ regulatory T cells, effect on macrophage phagocytosis, and skewing to the immunosuppressive M2 phenotype. We found that hypoxia potentiated the gCSC-mediated inhibition of T cell proliferation and activation and especially the induction of FoxP3+T cells, and further inhibited macrophage phagocytosis compared to normoxia condition. These immunosuppressive hypoxic effects were mediated by signal transducer and activator of transcription 3 (STAT3) and its transcriptionally regulated products such as hypoxia inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF). Inhibitors of STAT3 and HIF-1 alpha down modulated the gCSCs' hypoxia-induced immunosuppressive effects. Thus, hypoxia further enhances GBM-mediated immunosuppression, which can be reversed with therapeutic inhibition of STAT3 and HIF-1 alpha and also helps to reconcile the disparate findings that immune therapeutic approaches can be used successfully in model systems but have yet to achieve generalized successful responses in the vast majority of GBM patients by demonstrating the importance of the tumor hypoxic environment.	[Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Heimberger, Amy B.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Fuller, Gregory] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fokt, Isabella; Priebe, Waldemar] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Melillo, Giovanni] NCI, Frederick, MD 21701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wei, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	aheimber@mdanderson.org		Fuller, Gregory/0000-0001-9447-2647	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health [CA120813-03, A177225-01, P50 CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459, R01CA120813] Funding Source: NIH RePORTER	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Anthony Bullock III Foundation (ABH), the Mitchell Foundation (ABH), the Dr. Marnie Rose Foundation (ABH), and the U.S. National Institutes of Health grants CA120813-03, A177225-01, P50 CA093459 (ABH), and P50 CA093459 (WP). The funding organizations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Biollaz G, 2009, EUR J IMMUNOL, V39, P1323, DOI 10.1002/eji.200838921; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Brault MS, 2005, J BIOMED BIOTECHNOL, P37, DOI 10.1155/JBB.2005.37; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; CRANE CA, NEURO ONCOL, V12, P7; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Faderl S, 2001, ANTICANCER RES, V21, P3777; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Johnson B, 2009, CURR MOL MED, V9, P702, DOI 10.2174/156652409788970634; Johnson BF, 2007, EXPERT OPIN BIOL TH, V7, P449, DOI 10.1517/14712598.7.4.449; Jordan JT, 2008, CANCER IMMUNOL IMMUN, V57, P123, DOI 10.1007/s00262-007-0336-x; Jung JI, 2005, FASEB J, V19, pA81; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Kuklinski S, 2000, J NEUROSCI RES, V60, P45, DOI 10.1002/(SICI)1097-4547(20000401)60:1<45::AID-JNR5>3.0.CO;2-Y; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lucas T, 2008, FRONT BIOSCI, V13, P5580; MAEDA H, 1995, J IMMUNOL, V155, P4926; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Negus RPM, 1997, AM J PATHOL, V150, P1723; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Owegi Henry O, 2010, Biomed Sci Instrum, V46, P57; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sarwat AM, 2009, J NEURO-ONCOL, V92, P111, DOI 10.1007/s11060-008-9729-8; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Tabatabai G, 2006, BRAIN, V129, P2426, DOI 10.1093/brain/awl173; WEI J, CLIN CANC RES, V16, P461; WEI J, MOL CANC THER, V9, P67; WU A, NEURO ONCOL; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102	58	149	156	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16195	10.1371/journal.pone.0016195	http://dx.doi.org/10.1371/journal.pone.0016195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283755	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200035
J	Wang, QY; Chen, GR; Perc, M				Wang, Qingyun; Chen, Guanrong; Perc, Matjaz			Synchronous Bursts on Scale-Free Neuronal Networks with Attractive and Repulsive Coupling	PLOS ONE			English	Article							SYNCHRONIZATION; OSCILLATIONS; REGULARIZATION; CHAOS	This paper investigates the dependence of synchronization transitions of bursting oscillations on the information transmission delay over scale-free neuronal networks with attractive and repulsive coupling. It is shown that for both types of coupling, the delay always plays a subtle role in either promoting or impairing synchronization. In particular, depending on the inherent oscillation period of individual neurons, regions of irregular and regular propagating excitatory fronts appear intermittently as the delay increases. These delay-induced synchronization transitions are manifested as well-expressed minima in the measure for spatiotemporal synchrony. For attractive coupling, the minima appear at every integer multiple of the average oscillation period, while for the repulsive coupling, they appear at every odd multiple of the half of the average oscillation period. The obtained results are robust to the variations of the dynamics of individual neurons, the system size, and the neuronal firing type. Hence, they can be used to characterize attractively or repulsively coupled scale-free neuronal networks with delays.	[Wang, Qingyun] Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China; [Chen, Guanrong] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia	Beihang University; City University of Hong Kong; University of Maribor	Wang, QY (corresponding author), Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China.	drwangqy@gmail.com; matjaz.perc@uni-mb.si	wang, qinyu/GYA-0366-2022; Wang, Qingyun/G-2309-2010; Chen, Guanrong/F-6000-2011; Perc, Matjaz/A-5148-2009	Wang, Qingyun/0000-0003-2931-4663; Chen, Guanrong/0000-0003-1381-7418; Perc, Matjaz/0000-0002-3087-541X; Zhang, Min/0000-0001-5812-9518	National Science Foundation of China [10972001, 10702023, 10832006]; Slovenian Research Agency [Z1-2032]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	QW and GC acknowledge support from the National Science Foundation of China (Funds number 10972001, 10702023 and 10832006). MP acknowledges support from the Slovenian Research Agency (Grant Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H. D. I., 1996, Physics-Uspekhi, V39, P337, DOI 10.1070/PU1996v039n04ABEH000141; Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Arenas A, 2006, PHYSICA D, V224, P27, DOI 10.1016/j.physd.2006.09.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista CAS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016218; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; DAVID G, 2001, PHYS REV LETT, V86, P4179; Drover J, 2004, SIAM J APPL MATH, V65, P69, DOI 10.1137/S0036139903431233; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Gao Z., 2001, PHYS REV E, V65, DOI DOI 10.1103/PHYSREVE.65.016209; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016103; Huang L, 2008, CHAOS, V18, DOI 10.1063/1.2826289; Hunt D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.068701; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Kunichika T., 2003, INT J BIFURCAT CHAOS, V13, P653; Lai YC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108102; Leyva I, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056112; Li XM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083045; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Neiman A, 1999, PHYS REV LETT, V83, P4896, DOI 10.1103/PhysRevLett.83.4896; Nowotny T, 2008, CHAOS, V18, DOI 10.1063/1.2949925; Oh M, 2009, J COMPUT NEUROSCI, V26, P303, DOI 10.1007/s10827-008-0112-8; Osan R, 2002, PHYSICA D, V163, P217, DOI 10.1016/S0167-2789(02)00347-0; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rossoni E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061904; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Sainz-Trapaga M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031904; Shein M, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036008; Shilnikov AL, 2003, INT J BIFURCAT CHAOS, V13, P3325, DOI 10.1142/S0218127403008521; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Suykens JAK, 2008, CHAOS, V18, DOI 10.1063/1.2985139; Martins TV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041103; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Wang QY, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/383; Wang QY, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/10004; Wang QY, 2006, PHYS LETT A, V356, P17, DOI 10.1016/j.physleta.2006.03.017; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang QY, 2005, CHINESE PHYS LETT, V22, P543, DOI 10.1088/0256-307X/22/3/007; Yanagita T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056218	56	311	316	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15851	10.1371/journal.pone.0015851	http://dx.doi.org/10.1371/journal.pone.0015851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21701596	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900014
J	Tanaka, Y; Taneichi, M; Kasai, M; Kakiuchi, T; Uchida, T				Tanaka, Yuriko; Taneichi, Maiko; Kasai, Michiyuki; Kakiuchi, Terutaka; Uchida, Tetsuya			Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8(+) T Cells	PLOS ONE			English	Article							IN-VIVO; VACCINE; RECOGNITION; DIPHTHERIA; TRANSPORT; IMMUNITY; TETANUS; BOOSTER; CYTOSOL; WORLD	We have previously demonstrated that antigens chemically coupled to the surface of liposomes consisting of unsaturated fatty acids were cross-presented by antigen-presenting cells (APCs) to CD8(+) T cells, and that this process resulted in the induction of antigen-specific cytotoxic T lymphocytes. In the present study, the mechanism by which the liposome-coupled antigens were cross-presented to CD8(+) T cells by APCs was investigated. Confocal laser scanning microscopic analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-based liposomes received processing at both MHC class I and class II compartments, while most of the antigens coupled to the surface of saturated-fatty-acid-based liposomes received processing at the class II compartment. In addition, flow cytometric analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-liposomes were taken up by APCs even in a 4 degrees C environment; this was not true of saturated-fatty-acid-liposomes. When two kinds of inhibitors, dimethylamiloride (DMA) and cytochalasin B, which inhibit pinocytosis and phagocytosis by APCs, respectively, were added to the culture of APCs prior to the antigen pulse, DMA but not cytochalasin B significantly reduced uptake of liposome-coupled antigens. Further analysis of intracellular trafficking of liposomal antigens using confocal laser scanning microscopy revealed that a portion of liposome-coupled antigens taken up by APCs were delivered to the lysosome compartment. In agreement with the reduction of antigen uptake by APCs, antigen presentation by APCs was significantly inhibited by DMA, and resulted in the reduction of IFN-gamma production by antigen-specific CD8(+) T cells. These results suggest that antigens coupled to the surface of liposomes consisting of unsaturated fatty acids might be pinocytosed by APCs, loaded onto the class I MHC processing pathway, and presented to CD8(+) T cells. Thus, these liposome-coupled antigens are expected to be applicable for the development of vaccines that induce cellular immunity.	[Tanaka, Yuriko; Kakiuchi, Terutaka] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan; [Taneichi, Maiko; Kasai, Michiyuki; Uchida, Tetsuya] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan	Toho University; National Institute of Infectious Diseases (NIID)	Tanaka, Y (corresponding author), Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan.	taneichi@nih.go.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science [21790963]; Toho University Graduate School of Medicine [08-02]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toho University Graduate School of Medicine(Toho University)	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (to TU), grants-in-aid for young scientists from the Japan Society for the Promotion of Science (21790963 to YT) and the research promotion grant from Toho University Graduate School of Medicine (No. 08-02 to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1996, VACCINE, V14, P1265, DOI 10.1016/S0264-410X(96)00092-8; BANKOWSKI MK, 1995, SCIENCE, V267, P243; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Chen M, 1999, GASTROENTEROLOGY, V116, P135, DOI 10.1016/S0016-5085(99)70237-4; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gurnani K, 2004, J IMMUNOL, V173, P566, DOI 10.4049/jimmunol.173.1.566; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Kasturi SP, 2008, NAT IMMUNOL, V9, P461, DOI 10.1038/ni0508-461; MARK A, 1995, VACCINE, V13, P669, DOI 10.1016/0264-410X(94)00017-H; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Naito S, 1996, INT ARCH ALLERGY IMM, V109, P223, DOI 10.1159/000237241; Nakano Y, 1999, INT ARCH ALLERGY IMM, V120, P199, DOI 10.1159/000024268; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Nothdurft HD, 1996, J INFECTION, V32, P119, DOI 10.1016/S0163-4453(96)91281-5; Ohno S, 2009, VACCINE, V27, P3912, DOI 10.1016/j.vaccine.2009.04.001; Rock KL, 2006, IMMUNITY, V25, P523, DOI 10.1016/j.immuni.2006.09.003; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Taneichi M, 2006, J IMMUNOL, V177, P2324, DOI 10.4049/jimmunol.177.4.2324; UCHIDA T, 1985, J IMMUNOL, V134, P772; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07	31	51	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15225	10.1371/journal.pone.0015225	http://dx.doi.org/10.1371/journal.pone.0015225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179411	Green Submitted, Green Published, gold			2022-12-27	WOS:000285572900015
J	Lin, HY; Kao, CH; Lin, KMC; Kaartinen, V; Yang, LT				Lin, Hsien-Yi; Kao, Cheng-Heng; Lin, Kurt Ming-Chao; Kaartinen, Vesa; Yang, Liang-Tung			Notch Signaling Regulates Late-Stage Epidermal Differentiation and Maintains Postnatal Hair Cycle Homeostasis	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; EPITHELIAL STEM-CELLS; RBP-J; MULTIPLE ROLES; FOLLICLE BULGE; MOUSE MODEL; O-FUCOSE; SKIN; EXPRESSION; ACTIVATION	Background: Notch signaling involves ligand-receptor interactions through direct cell-cell contact. Multiple Notch receptors and ligands are expressed in the epidermis and hair follicles during embryonic development and the adult stage. Although Notch signaling plays an important role in regulating differentiation of the epidermis and hair follicles, it remains unclear how Notch signaling participates in late-stage epidermal differentiation and postnatal hair cycle homeostasis. Methodology and Principal Findings: We applied Cre/loxP system to generate conditional gene targeted mice that allow inactivation of critical components of Notch signaling pathway in the skin. Rbpj, the core component of all four Notch receptors, and Pofut1, an essential factor for ligand-receptor interactions, were inactivated in hair follicle lineages and suprabasal layer of the epidermis using the Tgfb3-Cre mouse line. Rbpj conditional inactivation resulted in granular parakeratosis and reactive epidermal hyperplasia. Pofut1 conditional inactivation led to ultrastructural abnormalities in the granular layer and altered filaggrin processing in the epidermis, suggesting a perturbation of the granular layer differentiation. Disruption of Pofut1 in hair follicle lineages resulted in aberrant telogen morphology, a decrease of bulge stem cell markers, and a concomitant increase of K14-positive keratinocytes in the isthmus of mutant hair follicles. Pofut1-deficent hair follicles displayed a delay in anagen re-entry and dysregulation of proliferation and apoptosis during the hair cycle transition. Moreover, increased DNA double stand breaks were detected in Pofut1-deficent hair follicles, and real time PCR analyses on bulge keratinocytes isolated by FACS revealed an induction of DNA damage response and a paucity of DNA repair machinery in mutant bulge keratinocytes. Significance: our data reveal a role for Notch signaling in regulating late-stage epidermal differentiation. Notch signaling is required for postnatal hair cycle homeostasis by maintaining proper proliferation and differentiation of hair follicle stem cells.	[Lin, Hsien-Yi; Yang, Liang-Tung] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli Cty, Taiwan; [Kao, Cheng-Heng] Chang Gung Univ, Ctr Gen Educ, Tao Yuan, Taiwan; [Lin, Kurt Ming-Chao] Natl Hlth Res Inst, Div Med Engn, Miaoli Cty, Taiwan; [Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	National Health Research Institutes - Taiwan; Chang Gung University; National Health Research Institutes - Taiwan; University of Michigan System; University of Michigan	Lin, HY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli Cty, Taiwan.	ltyang@nhri.org.tw	Kaartinen, Vesa/AAU-5396-2021; Yang, Liang-Tung/B-2661-2010; Lin, Kurt Ming-Chao/E-3975-2010	doddapaneni, harshavardhan/0000-0002-2433-633X; Kaartinen, Vesa/0000-0002-9432-510X; Lin, Kurt/0000-0003-1371-5569	CIRM [T2-00005]; NHRI [97A1-SCPP07-014, 98A1-CSPP13-014, 99A1-CSPP10-014]; NSC [97-2321-B-400-003-MY3]; NIH [DE013085]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013085] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NHRI(National Health Research Institutes - Taiwan); NSC(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the CIRM (T2-00005), NHRI (97A1-SCPP07-014, 98A1-CSPP13-014, 99A1-CSPP10-014), NSC (97-2321-B-400-003-MY3), and NIH (DE013085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Demehri S, 2009, DEVELOPMENT, V136, P891, DOI 10.1242/dev.030700; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guilmeau S, 2008, GASTROENTEROLOGY, V135, P849, DOI 10.1053/j.gastro.2008.05.050; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; HOGAN B, 1994, MANIPULATING MOUSE E, pR17; HU B, GENES DEV, V24, P1519; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KAO CH, 1995, ATHEROSCLEROSIS, V116, P27, DOI 10.1016/0021-9150(95)05519-3; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; OKA C, 1995, DEVELOPMENT, V121, P3291; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SCHMID P, 1993, J PATHOL, V171, P191, DOI 10.1002/path.1711710307; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Turksen K, 2002, DEVELOPMENT, V129, P1775; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weibel E. R., 1973, STEREOLOGICAL TECHNI; Yang LT, 2008, GENESIS, V46, P112, DOI 10.1002/dvg.20372; Zheng JL, 2000, DEVELOPMENT, V127, P4551	63	97	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15842	10.1371/journal.pone.0015842	http://dx.doi.org/10.1371/journal.pone.0015842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21552483	Green Submitted, gold, Green Published			2022-12-27	WOS:000286519500028
J	Yu, ZY; Wang, R; Xu, LY; Xie, SW; Dong, JH; Jing, YK				Yu, Zhiying; Wang, Rui; Xu, Liying; Xie, Siwei; Dong, Jinhua; Jing, Yongkui			beta-Elemene Piperazine Derivatives Induce Apoptosis in Human Leukemia Cells through Downregulation of c-FLIP and Generation of ROS	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; LUNG-CANCER CELLS; PEROXIDE-DEPENDENT PATHWAY; ARSENIC TRIOXIDE; PROSTATE-CANCER; UP-REGULATION; PROTEIN; DEATH; EXPRESSION; TARGET	beta-Elemene is an active component of the herb medicine Curcuma Wenyujin with reported antitumor activity. To improve its antitumor ability, five novel piperazine derivatives of beta-elemene, 13-(3-methyl-1-piperazinyl)-beta-elemene (DX1), 13-(cis-3,5-dimethyl-1-piperazinyl)-beta-elemene (DX2), 13-(4-ethyl-1-piperazinyl)-beta-elemene (DX3), 13-(4-isopropyl-1-piperazinyl)-beta-elemene (DX4) and 13-piperazinyl-beta-elemene (DX5), were synthesized. The antiproliferative and apoptotic effects of these derivatives were determined in human leukemia HL-60, NB4, K562 and HP100-1 cells. DX1, DX2 and DX5, which contain a secondary amino moiety, were more active in inhibiting cell growth and in inducing apoptosis than DX3 and DX4. The apoptosis induction ability of DX1 was associated with the generation of hydrogen peroxide (H(2)O(2)), a decrease of mitochondrial membrane potential (MMP), and the activation of caspase-8. Pretreatment with the antioxidants N-acetylcysteine and catalase completely blocked DX1-induced H(2)O(2) production, but only partially its activation of caspase-8 and induction of apoptosis. HL-60 cells were more sensitive than its H(2)O(2)-resistant subclone HP100-1 cells to DX1-induced apoptosis. The activation of caspase-8 by these compounds was correlated with the decrease in the levels of cellular FLICE-inhibitory protein (c-FLIP). The proteasome inhibitor MG-132 augmented the decrease in c-FLIP levels and apoptosis induced by these derivatives. FADD-and caspase-8-deficient Jurkat subclones have a decreased response to DX1-induced apoptosis. Our data indicate that these novel beta-elemene piperazine derivatives induce apoptosis through the decrease in c-FLIP levels and the production of H(2)O(2) which leads to activation of both death receptor-and mitochondrial-mediated apoptotic pathways.	[Yu, Zhiying] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Xu, Liying; Xie, Siwei; Dong, Jinhua] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China; [Wang, Rui; Jing, Yongkui] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, New York, NY USA	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Icahn School of Medicine at Mount Sinai	Yu, ZY (corresponding author), Guangdong Food & Drug Vocat Coll, Guangzhou, Guangdong, Peoples R China.	yongkui.jing@mssm.edu		Bonini, Nancy/0000-0003-0226-5291; Gitler, Aaron/0000-0001-8603-1526	National Natural Science Foundation of China [30328030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the past funding from National Natural Science Foundation of China (No. 30328030) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Day TW, 2006, BIOCHEM PHARMACOL, V71, P1551, DOI 10.1016/j.bcp.2006.02.015; Decaudin D, 1998, INT J ONCOL, V12, P141; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; KASUGAI I, 1992, LEUKEMIA RES, V16, P173, DOI 10.1016/0145-2126(92)90129-U; KAUH J, PLOS ONE, V5; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kouhara J, 2007, INT J ONCOL, V30, P679; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Li X, 2005, CELL MOL LIFE SCI, V62, P894, DOI 10.1007/s00018-005-5027-1; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lombard C, 2005, LEUKEMIA RES, V29, P915, DOI 10.1016/j.leukres.2005.01.014; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Peter Marcus E, 2004, Biochem J, V382, pe1; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Wang YZ, 2005, DRUG DEV IND PHARM, V31, P769, DOI 10.1080/03639040500216329; Xia LJ, 2005, MOL CANCER THER, V4, P381; Xu LY, 2006, BIOORGAN MED CHEM, V14, P5351, DOI 10.1016/j.bmc.2006.03.041; YAMADA M, 1991, DNA CELL BIOL, V10, P735, DOI 10.1089/dna.1991.10.735; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu ZY, 2008, CANCER LETT, V269, P165, DOI 10.1016/j.canlet.2008.04.034; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249	36	171	176	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15843	10.1371/journal.pone.0015843	http://dx.doi.org/10.1371/journal.pone.0015843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283566	Green Published, gold, Green Submitted			2022-12-27	WOS:000286661400015
J	Wang, Y; Yan, LL; Jin, ZD; Xin, X				Wang, Yan; Yan, Lingling; Jin, Zhendong; Xin, Xin			Effects of Sleeve Gastrectomy in Neonatally Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							PLASMA GHRELIN CONCENTRATIONS; WEIGHT-LOSS; BETA-CELLS; MODEL; MELLITUS; REGENERATION; MANAGEMENT; EFFICACY; SURGERY	Background: Sleeve gastrectomy (SG) has emerged recently as a stand-alone bariatric procedure to treat morbid obesity and enhance glucose homeostasis. The aim of the study was to evaluate its effects in neonatally streptozotocin (STZ)induced diabetic rats (n-STZ diabetic rats). Methodology and Principal Findings: To induce diabetes, STZ (90 mg/kg) was administered intraperitoneally to 2-day-old male pups. When 12 weeks old, diabetic rats were randomized into sleeve operation group (SLG, n = 6) and sham operation group (SOG, n = 6). Body weights were monitored weekly, and daily consumption of water and food were followed for eight consecutive weeks postoperatively. Serum glucose levels were measured periodically at the 4th and 8th week after surgery. Insulin, ghrelin, glucose-dependent insulinotropic polypeptide (GIP) and Glucagon-like peptide-1 (GLP-1) levels were assayed at the end of the study. Our data showed that SLG rats exhibited significantly lower body weight gain in addition to reduced food and water intakes postoperatively compared to their sham-operation counterparts. However, resolution of diabetes was not observed in our study. Correspondingly, there were no significant differences between SOG rats and SLG rats in glucose metabolism-associated hormones, including insulin, GIP and GLP-1. In contrast, ghrelin level significantly decreased (P<0.01) in SLG group (58.01 +/- 3.75 pg/ml) after SG surgery compared to SOG group (76.36 +/- 3.51 pg/ml). Conclusions: These observations strongly suggest that SG is effective in controlling body weight. However, SG did not achieve resolution or improvement of diabetes in n-STZ diabetic rats.	[Wang, Yan; Jin, Zhendong; Xin, Xin] Tongji Med Coll, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China; [Yan, Lingling] Tongji Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, Y (corresponding author), Tongji Med Coll, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China.	wangyantj2008@yahoo.com.cn						Abbatini F, 2010, SURG ENDOSC, V24, P1005, DOI 10.1007/s00464-009-0715-9; Akkary E, 2008, OBES SURG, V18, P1323, DOI 10.1007/s11695-008-9551-6; Bohdjalian A, 2010, OBES SURG, V20, P535, DOI 10.1007/s11695-009-0066-6; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; CASTELAN JD, 2007, OBES SURG, V17, P957; Chakrabarti S, 2005, J ETHNOPHARMACOL, V97, P117, DOI 10.1016/j.jep.2004.10.025; Chen D, 2005, DIABETES OBES METAB, V7, P307, DOI 10.1111/j.1463-1326.2004.00392.x; Deitel M, 2008, OBES SURG, V18, P487, DOI 10.1007/s11695-008-9471-5; Frezza EE, 2009, OBES SURG, V19, P684, DOI 10.1007/s11695-008-9677-6; Fuks D, 2009, SURGERY, V145, P106, DOI 10.1016/j.surg.2008.07.013; Gelling RW, 2004, ENDOCRINOLOGY, V145, P4575, DOI 10.1210/en.2004-0605; Goitein D, 2009, SURG ENDOSC, V23, P1559, DOI 10.1007/s00464-009-0337-2; Goldfine AB, 2009, NAT MED, V15, P616, DOI 10.1038/nm0609-616; Hemmings SJ, 2000, INT J BIOCHEM CELL B, V32, P905, DOI 10.1016/S1357-2725(00)00019-4; Herron DM, 2009, MT SINAI J MED, V76, P281, DOI 10.1002/msj.20114; Ishii S, 2002, ENDOCRINOLOGY, V143, P4934, DOI 10.1210/en.2002-220612; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Langer FB, 2005, OBES SURG, V15, P1024, DOI 10.1381/0960892054621125; Lee WJ, 2010, SURGERY, V147, P664, DOI 10.1016/j.surg.2009.10.059; Li F, 2009, J GASTROINTEST SURG, V13, P2302, DOI 10.1007/s11605-009-0997-1; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lopez PP, 2009, J SURG RES, V157, P243, DOI 10.1016/j.jss.2008.10.025; Melissas J, 2008, OBES SURG, V18, P1251, DOI 10.1007/s11695-008-9634-4; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Patrikakos P, 2009, OBES SURG, V19, P1586, DOI 10.1007/s11695-009-9965-9; Pereferrer FS, 2008, OBES SURG, V18, P97, DOI 10.1007/s11695-007-9351-4; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rizzello M, 2010, OBES SURG, V20, P50, DOI 10.1007/s11695-009-0017-2; Rosenthal R, 2009, SURG OBES RELAT DIS, V5, P429, DOI 10.1016/j.soard.2008.11.006; Sabbagh C, 2010, OBES SURG, V20, P679, DOI 10.1007/s11695-009-0007-4; Saber AA, 2008, OBES SURG, V18, P121, DOI 10.1007/s11695-007-9308-7; Sammour T, 2010, OBES SURG, V20, P271, DOI 10.1007/s11695-009-0038-x; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021; Tan JT, 2010, OBES SURG, V20, P403, DOI 10.1007/s11695-009-0020-7; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Tsubone T, 2005, AM J PHYSIOL-REG I, V289, pR1703, DOI 10.1152/ajpregu.00773.2004; Vidal J, 2007, OBES SURG, V17, P1069, DOI 10.1007/s11695-007-9180-5; Wang Y, 2009, OBES SURG, V19, P921, DOI 10.1007/s11695-008-9663-z	39	53	64	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16383	10.1371/journal.pone.0016383	http://dx.doi.org/10.1371/journal.pone.0016383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21655253	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522300043
J	Michelena, P; Deneubourg, JL				Michelena, Pablo; Deneubourg, Jean-Louis			How Group Size Affects Vigilance Dynamics and Time Allocation Patterns: The Key Role of Imitation and Tempo	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; SOCIAL FACILITATION; PUBLIC INFORMATION; SPATIAL POSITION; FLOCK SIZE; BEHAVIOR; MAMMALS; ATTACK; FLIGHT	In the context of social foraging, predator detection has been the subject of numerous studies, which acknowledge the adaptive response of the individual to the trade-off between feeding and vigilance. Typically, animals gain energy by increasing their feeding time and decreasing their vigilance effort with increasing group size, without increasing their risk of predation ('group size effect'). Research on the biological utility of vigilance has prevailed over considerations of the mechanistic rules that link individual decisions to group behavior. With sheep as a model species, we identified how the behaviors of conspecifics affect the individual decisions to switch activity. We highlight a simple mechanism whereby the group size effect on collective vigilance dynamics is shaped by two key features: the magnitude of social amplification and intrinsic differences between foraging and scanning bout durations. Our results highlight a positive correlation between the duration of scanning and foraging bouts at the level of the group. This finding reveals the existence of groups with high and low rates of transition between activies, suggesting individual variations in the transition rate, or 'tempo'. We present a mathematical model based on behavioral rules derived from experiments. Our theoretical predictions show that the system is robust in respect to variations in the propensity to imitate scanning and foraging, yet flexible in respect to differences in the duration of activity bouts. The model shows how individual decisions contribute to collective behavior patterns and how the group, in turn, facilitates individual-level adaptive responses.	[Michelena, Pablo; Deneubourg, Jean-Louis] ULB, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Michelena, P (corresponding author), ULB, Unit Social Ecol, Brussels, Belgium.	Pablo.Michelena@ulb.ac.be	Michalik, Peter/E-6757-2010	Michalik, Peter/0000-0003-2459-9153	Universite libre de Bruxelles (ULB); European Community [IST-2001-35506]	Universite libre de Bruxelles (ULB); European Community(European Commission)	This study was supported by a post doctoral fellow of the Universite libre de Bruxelles (ULB) and the experiments were sponsored by the the LEURRE project of the Future and Emerging Technologies program of the European Community (IST-2001-35506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DB, 1999, ANIM BEHAV, V58, P831, DOI 10.1006/anbe.1999.1227; Beauchamp G, 2003, BEHAV PROCESS, V63, P111, DOI 10.1016/S0376-6357(03)00002-0; Beauchamp G, 2002, CAN J ZOOL, V80, P1634, DOI 10.1139/Z02-156; Beauchamp G, 2007, ANIM BEHAV, V73, P445, DOI 10.1016/j.anbehav.2006.09.004; BEKOFF M, 1995, ETHOLOGY, V99, P150, DOI 10.1111/j.1439-0310.1995.tb01096.x; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Blanchard P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1863, DOI 10.1007/s00265-008-0615-3; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fernandez-Juricic E, 2008, ETHOLOGY, V114, P105, DOI 10.1111/j.1439-0310.2007.01433.x; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Geist V., 1971, MOUNTAIN SHEEP STUDY; Hilton GM, 1999, BEHAV ECOL, V10, P391, DOI 10.1093/beheco/10.4.391; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Jewell P.A., 1974, ISLAND SURVIVORS ECO; KAUTZ MA, 1982, J WILDLIFE MANAGE, V46, P704, DOI 10.2307/3808562; Krause J, 2002, LIVING GROUPS; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; LAWRENCE AB, 1984, APPL ANIM BEHAV SCI, V13, P176, DOI 10.1016/0168-1591(84)90075-3; LAZARUS J, 1979, BEHAVIOUR, V71, P127, DOI 10.1163/156853979X00133; LIMA SL, 1995, ANIM BEHAV, V50, P1097, DOI 10.1016/0003-3472(95)80109-X; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Michelena P, 2006, OECOLOGIA, V148, P170, DOI 10.1007/s00442-005-0347-2; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; NICOLIS G, 1971, P NATL ACAD SCI USA, V68, P2102, DOI 10.1073/pnas.68.9.2102; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; Periquet S, 2010, ANIM BEHAV, V79, P665, DOI 10.1016/j.anbehav.2009.12.016; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; QUENETTE PY, 1990, ACTA OECOL, V11, P801; QUENETTE PY, 1992, CAN J ZOOL, V70, P1632, DOI 10.1139/z92-226; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rieucau G, 2009, ANIM BEHAV, V78, P961, DOI 10.1016/j.anbehav.2009.06.023; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sumpter D. J. T., 2009, COLLECTIVE ANIMAL BE; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; [No title captured]; [No title captured]	56	69	72	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18631	10.1371/journal.pone.0018631	http://dx.doi.org/10.1371/journal.pone.0018631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525987	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600021
J	Yu, XY; Chen, HM; Liang, JL; Lin, QX; Tan, HH; Fu, YH; Liu, XY; Shan, ZX; Li, XH; Yang, HZ; Yang, M; Li, YX; Lin, SG				Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Hua-Zhang; Yang, Min; Li, Yangxin; Lin, Shu-Guang			Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; COUPLED RECEPTOR KINASES; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DEFICIENT MICE; ATHEROSCLEROSIS; MIF; INFLAMMATION; MECHANISMS; EXPRESSION	Background: Diabetes has been regarded as an inflammatory condition which is associated with left ventricular diastolic dysfunction (LVDD). The purpose of this study was to examine the expression levels of macrophage migration inhibitory factor (MIF) and G protein-coupled receptor kinase 2 (GRK2) in patients with early diabetic cardiomyopathy, and to investigate the mechanisms involved in MIF expression and GRK2 activation. Methods: 83 patients in the age range of 30-64 years with type 2 diabetes and 30 matched healthy men were recruited. Left ventricular diastolic function was evaluated by cardiac Doppler echocardiography. Plasma MIF levels were determined by ELISA. To confirm the clinical observation, we also studied MIF expression in prediabetic rats with impaired glucose tolerance (IGT) and relationship between MIF and GRK2 expression in H9C2 cardiomyoblasts exposed to high glucose. Results: Compared with healthy subjects, patients with diabetes have significantly increased levels of plasma MIF which was further increased in diabetic patients with Left ventricular diastolic dysfunction (LVDD). The increased plasma MIF levels in diabetic patients correlated with plasma glucose, glycosylated hemoglobin and urine albumin levels. We observed a significant number of TUNEL-positive cells in the myocardium of IGT-rats but not in the control rats. Moreover, we found higher MIF expression in the heart of IGT with cardiac dysfunction compared to that of the controls. In H9C2 cardiomyoblast cells, MIF and GRK2 expression was significantly increased in a glucose concentration-dependant manner. Furthermore, GRK2 expression was abolished by siRNA knockdown of MIF and by the inhibition of CXCR4 in H9C2 cells. Conclusions: Our findings indicate that hyperglycemia is a causal factor for increased levels of pro-inflammatory cytokine MIF which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes. The elevated levels of MIF are associated with cardiac dysfunction in diabetic patients, and the MIF effects are mediated by GRK2.	[Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Min; Lin, Shu-Guang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Hong-Mei; Yang, Hua-Zhang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Div Endocrinol, Guangzhou, Guangdong, Peoples R China; [Li, Yangxin] Texas Heart Inst, Houston, TX 77025 USA; [Li, Yangxin] Univ Texas Hlth Sci Ctr, Houston, TX USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Yu, XY (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; yangxin_li@yahoo.com; yuxycn@163.com	LIANG, JIALIANG/L-5865-2015	LIANG, JIALIANG/0000-0001-8033-741X; Liang, Jialiang/0000-0002-1556-7195	National Natural Science Foundation of China [30772142, 81070103, 81070102, 30900610]; National Key Basic Research Program (NKBRP) of China [2006CB503806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program (NKBRP) of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772142, 81070103, 81070102, 30900610) and the National Key Basic Research Program (NKBRP) of China (No. 2006CB503806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Bacha F, 2009, DIABETES CARE, V32, P100, DOI 10.2337/dc08-1030; Bartels ED, 2009, EUR J CLIN INVEST, V39, P190, DOI 10.1111/j.1365-2362.2009.02086.x; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Dhanantwari P, 2008, BIOCHEM BIOPH RES CO, V371, P298, DOI 10.1016/j.bbrc.2008.04.070; Garner LB, 2003, AM J PHYSIOL-HEART C, V285, pH2500, DOI 10.1152/ajpheart.00432.2003; Grandi AM, 2006, AM J CARDIOL, V97, P71, DOI 10.1016/j.amjcard.2005.07.110; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Liang JL, 2010, CLIN EXP PHARMACOL P, V37, P969, DOI 10.1111/j.1440-1681.2010.05420.x; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Suys BE, 2004, DIABETES CARE, V27, P1947, DOI 10.2337/diacare.27.8.1947; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Tevaearai HT, 2004, TRENDS CARDIOVAS MED, V14, P252, DOI 10.1016/j.tcm.2004.07.002; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Willis MS, 2005, AM J PHYSIOL-HEART C, V288, pH795, DOI 10.1152/ajpheart.00189.2004; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Yu XY, 2007, J INTERF CYTOK RES, V27, P103, DOI 10.1089/jir.2006.0054	32	81	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16239	10.1371/journal.pone.0016239	http://dx.doi.org/10.1371/journal.pone.0016239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	22163012	Green Submitted, gold, Green Published			2022-12-27	WOS:000286661400038
